PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sommers, JA; Banerjee, T; Hinds, T; Wan, BB; Wold, MS; Lei, M; Brosh, RM				Sommers, Joshua A.; Banerjee, Taraswi; Hinds, Twila; Wan, Bingbing; Wold, Marc S.; Lei, Ming; Brosh, Robert M., Jr.			Novel Function of the Fanconi Anemia Group J or RECQ1 Helicase to Disrupt Protein-DNA Complexes in a Replication Protein A-stimulated Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX DNA; WERNER-SYNDROME HELICASE; BLOOMS-SYNDROME HELICASE; ESCHERICHIA-COLI; BINDING PROTEIN; HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; GENOMIC STABILITY; NUCLEOPROTEIN FILAMENTS; SUBSTRATE-SPECIFICITY	Understanding how cellular machinery deals with chromosomal genome complexity is an important question because protein bound to DNA may affect various cellular processes of nucleic acid metabolism. DNA helicases are at the forefront of such processes, yet there is only limited knowledge how they remodel protein-DNA complexes and how these mechanisms are regulated. We have determined that representative human RecQ and Fe-S cluster DNA helicases are potently blocked by a protein-DNA interaction. The Fanconi anemia group J (FANCJ) helicase partners with the single-stranded DNA-binding protein replication protein A (RPA) to displace BamHI-E111A bound to duplex DNA in a specific manner. Protein displacement was dependent on the ATPase-driven function of the helicase and unique properties of RPA. Further biochemical studies demonstrated that the shelterin proteins TRF1 and TRF2, which preferentially bind the telomeric repeat found at chromosome ends, effectively block FANCJ from unwinding the forked duplex telomeric substrate. RPA, but not the Escherichia coli single-stranded DNA-binding protein or shelterin factor Pot1, stimulated FANCJ ejection of TRF1 from the telomeric DNA substrate. FANCJ was also able to displace TRF2 from the telomeric substrate in an RPA-dependent manner. The stimulation of helicase-catalyzed protein displacement is also observed with the DNA helicase RECQ1, suggesting a conserved functional interaction of RPA-interacting helicases. These findings suggest that partnerships between RPA and interacting human DNA helicases may greatly enhance their ability to dislodge proteins bound to duplex DNA, an activity that is likely to be highly relevant to their biological roles in DNA metabolism.	[Sommers, Joshua A.; Banerjee, Taraswi; Hinds, Twila; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Wan, Bingbing; Lei, Ming] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan; University of Iowa	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Brosh, Robert/AAR-6124-2020; Banerjee, Taraswi/AAC-6093-2020	Wold, Marc/0000-0002-4580-1624; Wan, Bingbing/0000-0001-8629-0616	National Institutes of Health Intramural Research Program of the NIA; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIA. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.).	Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P949, DOI 10.1093/nar/gkq889; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; Bharti SK, 2013, J BIOL CHEM, V288, P28217, DOI 10.1074/jbc.M113.496463; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bosco N, 2012, CHROMOSOMA, V121, P465, DOI 10.1007/s00412-012-0377-6; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chavez A, 2009, BBA-MOL BASIS DIS, V1792, P329, DOI 10.1016/j.bbadis.2009.02.008; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; De Septenville AL, 2012, PLOS GENET, V8, P116, DOI 10.1371/journal.pgen.1002622; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Engler LE, 2001, J MOL BIOL, V307, P619, DOI 10.1006/jmbi.2000.4428; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Fujimoto S, 2009, BIOCHEM CELL BIOL, V87, P875, DOI [10.1139/O09-051, 10.1139/o09-051]; Gupta MK, 2013, P NATL ACAD SCI USA, V110, P7252, DOI 10.1073/pnas.1303890110; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Hass CS, 2012, J BIOL CHEM, V287, P3908, DOI 10.1074/jbc.M111.287441; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Le Breton C, 2008, NUCLEIC ACIDS RES, V36, P4964, DOI 10.1093/nar/gkn441; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; McGlynn P, 2011, BIOCHEM SOC T, V39, P606, DOI 10.1042/BST0390606; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Popuri V, 2014, NUCLEIC ACIDS RES, V42, P5671, DOI 10.1093/nar/gku200; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Simandlova J, 2013, J BIOL CHEM, V288, P34168, DOI 10.1074/jbc.M113.484493; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Uringa EJ, 2011, NUCLEIC ACIDS RES, V39, P1647, DOI 10.1093/nar/gkq1045; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang F, 2011, METHODS MOL BIOL, V735, P173, DOI 10.1007/978-1-61779-092-8_17; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; YANCEYWRONA JE, 1992, NUCLEIC ACIDS RES, V20, P6713, DOI 10.1093/nar/20.24.6713; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	80	25	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19928	19941		10.1074/jbc.M113.542456	http://dx.doi.org/10.1074/jbc.M113.542456			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895130	Green Published, hybrid			2022-12-25	WOS:000339395200011
J	Santovito, E; Mascia, T; Siddiqui, SA; Minutillo, SA; Valkonen, JPT; Gallitelli, D				Santovito, Elisa; Mascia, Tiziana; Siddiqui, Shahid A.; Minutillo, Serena Anna; Valkonen, Jari P. T.; Gallitelli, Donato			Infection Cycle of Artichoke Italian Latent Virus in Tobacco Plants: Meristem Invasion and Recovery from Disease Symptoms	PLOS ONE			English	Article							SMALL INTERFERING RNAS; MOSAIC-VIRUS; NICOTIANA-BENTHAMIANA; RINGSPOT-VIRUS; SILENCING SUPPRESSORS; SEED TRANSMISSION; TOMATO PLANTS; PROTEIN; THERMOTHERAPY; POTYVIRUS	Nepoviral infections induce recovery in fully expanded leaves but persist in shoot apical meristem (SAM) by a largely unknown mechanism. The dynamics of infection of a grapevine isolate of Artichoke Italian latent virus (AILV-V, genus Nepovirus) in tobacco plants, including colonization of SAM, symptom induction and subsequent recovery of mature leaves from symptoms, were characterized. AILV-V moved from the inoculated leaves systemically and invaded SAM in 7 days post-inoculation (dpi), remaining detectable in SAM at least up to 40 dpi. The new top leaves recovered from viral symptoms earliest at 21 dpi. Accumulation of viral RNA to a threshold level was required to trigger the overexpression of RDR6 and DCL4. Consequently, accumulation of viral RNA decreased in the systemically infected leaves, reaching the lowest concentration in the 3rd and 4th leaves at 23 dpi, which was concomitant with recovery of the younger, upper leaves from disease symptoms. No evidence of virus replication was found in the recovered leaves, but they contained infectious virus particles and were protected against re-inoculation with AILV-V. In this study we also showed that AILV-V did not suppress initiation or maintenance of RNA silencing in transgenic plants, but was able to interfere with the cell-to-cell movement of the RNA silencing signal. Our results suggest that AILV-V entrance in SAM and activation of RNA silencing may be distinct processes since the latter is triggered in fully expanded leaves by the accumulation of viral RNA above a threshold level rather than by virus entrance in SAM.	[Santovito, Elisa; Mascia, Tiziana; Minutillo, Serena Anna; Gallitelli, Donato] Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Mascia, Tiziana; Gallitelli, Donato] CNR, Ist Virol Vegetale, Unita Operat Supporto Bari, I-70126 Bari, Italy; [Siddiqui, Shahid A.; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); University of Helsinki	Mascia, T (corresponding author), Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.	tiziana.mascia@uniba.it	Santovito, Elisa/P-6553-2018	Santovito, Elisa/0000-0001-8793-6351; Gallitelli, Donato/0000-0003-3699-2681; Valkonen, Jari/0000-0002-3704-9911	University of Bari, Italy [ORBA10Q104]; Academy of Finland [1253126]	University of Bari, Italy; Academy of Finland(Academy of Finland)	This work was supported, by a grant of University of Bari (http://www.uniba.it), Italy in the framework of Research funds 2010 "Study of plant-pathogen interactions in Artichoke'' grant ORBA10Q104. Financial support from the Academy of Finland (http://www.aka.fi/en-GB/A/), grant 1253126 to JPTV, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2010, PLANT CELL TISS ORG, V100, P329, DOI 10.1007/s11240-009-9654-3; Adams M, 2011, VIRUS TAXONOMY; Bedoya LC, 2012, PLANT PHYSIOL, V158, P1130, DOI 10.1104/pp.111.192922; Bottalico G, 2002, J PLANT PATHOL, V84, P167; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cheng NH, 2000, PLANT J, V23, P349, DOI 10.1046/j.1365-313x.2000.00788.x; Cillo F, 2004, MOL PLANT MICROBE IN, V17, P98, DOI 10.1094/MPMI.2004.17.1.98; Dong F, 2010, EUR J PLANT PATHOL, V126, P117, DOI 10.1007/s10658-009-9518-z; Faccioli G, 1998, PLANT VIRUS DISEASE CONTROL, P346; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Gallitelli D, 2012, ADV VIRUS RES, V84, P289, DOI 10.1016/B978-0-12-394314-9.00008-7; Gammelgard E, 2007, J GEN VIROL, V88, P2337, DOI 10.1099/vir.0.82928-0; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hirai K, 2008, J VIROL, V82, P3250, DOI 10.1128/JVI.02139-07; Holmes FO, 1930, AM J BOT, V17, P789, DOI 10.2307/2435688; Hull R., 2002, MATTHEWS PLANT VIROL; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martelli GP, 1977, CMI AAB DESCR PLANT; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Matthews REF., 2002, PLANT VIROLOGY; Mink GI, 1998, PLANT VIRUS DISEASE CONTROL, P332; Minutillo SA, 2012, EUR J PLANT PATHOL, V134, P459, DOI 10.1007/s10658-012-0032-3; Mochizuki Tomofumi, 2004, Journal of General Plant Pathology, V70, P363, DOI 10.1007/s10327-004-0140-9; Parent JS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00179; Puurand U, 1996, VIRUS RES, V40, P135, DOI 10.1016/0168-1702(95)01263-X; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; ROBERTS DA, 1970, VIROLOGY, V42, P217, DOI 10.1016/0042-6822(70)90255-2; Sanfacon H, 2011, VIRUS TAXONOMY, P881; Savenkov EI, 2002, J GEN VIROL, V83, P2325, DOI 10.1099/0022-1317-83-9-2325; SAVINO V, 1977, PHYTOPATHOL MEDITERR, V16, P41; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sharma S, 2008, PLANT CELL TISS ORG, V92, P85, DOI 10.1007/s11240-007-9307-3; Siddiqui SA, 2008, J GEN VIROL, V89, P1502, DOI 10.1099/vir.0.83621-0; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; Sunpapao A, 2009, J GEN VIROL, V90, P3015, DOI 10.1099/vir.0.013219-0; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang DW, 1997, VIROLOGY, V234, P112, DOI 10.1006/viro.1997.8637; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]	46	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99446	10.1371/journal.pone.0099446	http://dx.doi.org/10.1371/journal.pone.0099446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911029	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600090
J	Tang, HY; Huang, CH; Zhuang, YH; Christianson, JC; Chen, X				Tang, Hsiang-Yun; Huang, Chih-Hsiang; Zhuang, Ya-Han; Christianson, John C.; Chen, Xin			EDEM2 and OS-9 Are Required for ER-Associated Degradation of Non-Glycosylated Sonic Hedgehog	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; UBIQUITIN LIGASE COMPLEX; ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; RETRO-TRANSLOCATION; ALPHA-MANNOSIDASES; IDENTIFIES YOS9P; N-GLYCOSYLATION	Misfolded proteins of the endoplasmic reticulum (ER) are eliminated by the ER-associated degradation (ERAD) in eukaryotes. In S. cerevisiae, ER-resident lectins mediate substrate recognition through bipartite signals consisting of an unfolded local structure and the adjacent glycan. Trimming of the glycan is essential for the directional delivery of the substrates. Whether a similar recognition and delivery mechanism exists in mammalian cells is unknown. In this study, we systematically study the function and substrate specificity of known mammalian ER lectins, including EDEM1/2/3, OS-9 and XTP-3B using the recently identified ERAD substrate sonic hedgehog (SHH), a soluble protein carrying a single N-glycan, as well as its nonglycosylated mutant N278A. Efficient ERAD of N278A requires the core processing complex of HRD1, SEL1L and p97, similar to the glycosylated SHH. While EDEM2 was required for ERAD of both glycosylated and non-glycosylated SHHs, EDEM3 was only necessary for glycosylated SHH and EDEM1 was dispensable for both. Degradation of SHH and N278A also required OS-9, but not the related lectin XTP3-B. Robust interaction of both EDEM2 and OS-9 with a non-glycosylated SHH variant indicates that the misfolded polypeptide backbone, rather than a glycan signature, functions as the predominant signal for recognition for ERAD. Notably, SHH-N278A is the first nonglycosylated substrate to require EDEM2 for recognition and targeting for ERAD. EDEM2 also interacts with calnexin and SEL1L, suggesting a potential avenue by which misfolded glycoproteins may be shunted towards SEL1L and ERAD rather than being released into the secretory pathway. Thus, ER lectins participate in the recognition and delivery of misfolded ER substrates differently in mammals, with an underlying mechanism distinct from that of S. cerevisiae.	[Tang, Hsiang-Yun; Huang, Chih-Hsiang; Zhuang, Ya-Han; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Chunan Town, Miaoli, Taiwan; [Christianson, John C.] Univ Oxford, Ludwig Inst Canc Res, ORCRB, Oxford, England; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Ludwig Institute for Cancer Research; University of Oxford; China Medical University Taiwan	Chen, X (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Chunan Town, Miaoli, Taiwan.	xchen@nhri.org.tw	Christianson, John C/Y-4567-2019	Christianson, John/0000-0002-0474-1207	NRPGM, National Science Council, Taiwan; National Health Research Institutes, Taiwan, ROC; Medical Research Council [MR/L001209/1] Funding Source: researchfish	NRPGM, National Science Council, Taiwan; National Health Research Institutes, Taiwan, ROC(National Health Research Institutes - Taiwan); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by NRPGM, National Science Council, Taiwan and National Health Research Institutes, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock F, 2009, J MOL BIOL, V385, P1032, DOI 10.1016/j.jmb.2008.11.045; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Huang CH, 2013, J BIOL CHEM, V288, P25330, DOI 10.1074/jbc.M113.455212; Jakob CA, 2001, EMBO REP, V2, P423; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Plemper RK, 1999, J CELL SCI, V112, P4123; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sato T, 2012, MOL CELL, V47, P99, DOI 10.1016/j.molcel.2012.04.015; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e92164	10.1371/journal.pone.0092164	http://dx.doi.org/10.1371/journal.pone.0092164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910992	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600120
J	Doritchamou, J; Sossou-tchatcha, S; Cottrell, G; Moussiliou, A; Houngbeme, CH; Massougbodji, A; Deloron, P; Ndam, NT				Doritchamou, Justin; Sossou-tchatcha, Sylvain; Cottrell, Gilles; Moussiliou, Azizath; Houngbeme, Christophe Hounton; Massougbodji, Achille; Deloron, Philippe; Ndam, Nicaise Tuikue			Dynamics in the Cytoadherence Phenotypes of Plasmodium falciparum Infected Erythrocytes Isolated during Pregnancy	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; INTERCELLULAR-ADHESION MOLECULE-1; PLACENTAL MALARIA; VAR GENE; ANTIGENIC PROPERTIES; PARASITE ADHESION; ANALYSIS REVEALS; IMMUNOGLOBULIN-G; VAR2CSA PROTEIN; ANTIBODIES	Pregnant women become susceptible to malaria infection despite their acquired immunity to this disease from childhood. The placental sequestration of Plasmodium falciparum infected erythrocytes (IE) is the major feature of malaria during pregnancy, due to ability of these parasites to bind chondroitin sulfate A (CSA) in the placenta through the VAR2CSA protein that parasites express on the surface of IE. We collected parasites at different times of pregnancy and investigated the adhesion pattern of freshly collected isolates on the three well described host receptors (CSPG, CD36 and ICAM-1). Var genes transcription profile and VAR2CSA surface-expression were assessed in these isolates. Although adhesion of IE to CD36 and ICAM-1 was observed in some isolates, CSA-adhesion was the predominant binding feature in all isolates analyzed. Co-existence in the peripheral blood of several adhesion phenotypes in early pregnancy isolates was observed, a diversity that gradually tightens with gestational age in favour of the CSA-adhesion phenotype. Infections occurring in primigravidae were often by parasites that adhered more to CSA than those from multigravidae. Data from this study further emphasize the specificity of CSA adhesion and VAR2CSA expression by parasites responsible for pregnancy malaria, while drawing attention to the phenotypic complexity of infections occurring early in pregnancy as well as in multigravidae.	[Doritchamou, Justin; Cottrell, Gilles; Deloron, Philippe; Ndam, Nicaise Tuikue] Univ Paris 05, PRES Sorbonne Paris Cite, Fac Pharm, Paris, France; [Doritchamou, Justin; Cottrell, Gilles; Moussiliou, Azizath; Deloron, Philippe; Ndam, Nicaise Tuikue] Inst Rech Dev, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Doritchamou, Justin; Sossou-tchatcha, Sylvain; Massougbodji, Achille; Ndam, Nicaise Tuikue] Univ Abomey Calavi, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Moussiliou, Azizath] Univ Paris 06, ED Physiol Physiopathol & Therapeut Sorbone Univ, Paris, France; [Houngbeme, Christophe Hounton] Hop Zone Suru Lere, Cotonou, Benin	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; UDICE-French Research Universities; Sorbonne Universite	Ndam, NT (corresponding author), Univ Paris 05, PRES Sorbonne Paris Cite, Fac Pharm, Paris, France.	nicaise.ndam@ird.fr	Doritchamou, Justin/T-5671-2017; Deloron, Philippe/G-6305-2010	Doritchamou, Justin/0000-0002-4589-7216; Deloron, Philippe/0000-0003-4705-2484; Cottrell, Gilles/0000-0002-7964-8963; Tuikue Ndam, Nicaise/0000-0003-2646-2513	DVS-Maturation-IRD grant [DVS-2011]; Agence Inter-etablissements de Recherche pour le Developement; Universite Paris Descartes [BDMU 2013]	DVS-Maturation-IRD grant; Agence Inter-etablissements de Recherche pour le Developement; Universite Paris Descartes	This work received funding from DVS-Maturation-IRD grant DVS-2011 and J. D was supported by PhD studentships from Agence Inter-etablissements de Recherche pour le Developement and mobility grant (BDMU 2013) from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Andrews KT, 2002, PARASITOL RES, V88, P715, DOI 10.1007/s00436-002-0624-5; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Brabin BJ, 2004, ANN TROP PAEDIATR, V24, P311, DOI 10.1179/027249304225019136; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Doritchamou J, 2013, VACCINE, V31, P4516, DOI 10.1016/j.vaccine.2013.07.072; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Maubert B, 1997, INFECT IMMUN, V65, P1251, DOI 10.1128/IAI.65.4.1251-1257.1997; Maubert B, 2000, PARASITE IMMUNOL, V22, P191, DOI 10.1046/j.1365-3024.2000.00292.x; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Ndam NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001855; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sartelet H, 2000, HISTOPATHOLOGY, V36, P62, DOI 10.1046/j.1365-2559.2000.00742.x; Staalsoe T, 2004, INFECT IMMUN, V72, P5027, DOI 10.1128/IAI.72.9.5027-5030.2004; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98577	10.1371/journal.pone.0098577	http://dx.doi.org/10.1371/journal.pone.0098577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905223	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000041
J	Bai, LC; Chen, JF; McEachern, D; Liu, L; Zhou, HB; Aguilar, A; Wang, SM				Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng			BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITORS; BH3 MIMETIC ABT-737; BCL-X-L; FAMILY; MCL-1; APOPTOSIS; POTENT; PROTEINS; ABT-263	Bcl-2 and Bcl-xL are critical regulators of apoptosis that are overexpressed in a variety of human cancers and pharmacological inhibition of Bcl-2 and Bcl-xL represents a promising strategy for cancer treatment. Using a structure-based design approach, we have designed BM-1197 as a potent and efficacious dual inhibitor of Bcl-2 and Bcl-xL. BM-1197 binds to Bcl-2 and Bcl-xL proteins with K-i values less than 1 nM and shows >1,000-fold selectivity over Mcl-1. Mechanistic studies performed in the Mcl-1 knockout mouse embryonic fibroblast (MEF) cells revealed that BM-1197 potently disassociates the heterodimeric interactions between anti-apoptotic and pro-apoptotic Bcl-2 family proteins, concomitant with conformational changes in Bax protein, loss of mitochondrial membrane potential and subsequent cytochrome c release to the cytosol, leading to activation of the caspase cascade and apoptosis. BM-1197 exerts potent growth-inhibitory activity in 7 of 12 small cell lung cancer cell lines tested and induces mechanism-based apoptotic cell death. When intravenously administered at daily or weekly in H146 and H1963 small-cell lung cancer xenograft models, it achieves complete and long-term tumor regression. Consistent with its targeting of Bcl-xL, BM-1197 causes transit platelet reduction in mice. Collectively, our data indicate that BM-1197 is a promising dual Bcl-2/Bcl-xL inhibitor which warrants further investigation as a new anticancer drug.	[Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Bai, Longchuan; Chen, Jianfang; McEachern, Donna; Liu, Liu; Zhou, Haibin; Aguilar, Angelo; Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, SM (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	shaomeng@umich.edu	liu, liu/GXF-0906-2022; liu, li/HGC-0900-2022; zhou, haibin/N-4597-2014	zhou, haibin/0000-0003-0879-790X; Wang, Shaomeng/0000-0002-8782-6950	National Cancer Institute, National Institutes of Health [U19CA113317]; University of Michigan Comprehensive Cancer Center Core grant [P30 CA046592]; Ascentage; NATIONAL CANCER INSTITUTE [P30CA046592, U19CA113317] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Michigan Comprehensive Cancer Center Core grant; Ascentage; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by funding from the National Cancer Institute, National Institutes of Health (U19CA113317), the University of Michigan Comprehensive Cancer Center Core grant (P30 CA046592), and Ascentage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aguilar A, 2013, J MED CHEM, V56, P3048, DOI 10.1021/jm4001105; Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; Bai LC, 2012, CANCER RES, V72, P1229, DOI 10.1158/0008-5472.CAN-11-2428; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen JF, 2012, J MED CHEM, V55, P8502, DOI 10.1021/jm3010306; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Park D, 2013, CANCER RES, V73, P5485, DOI 10.1158/0008-5472.CAN-12-2272; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Shore GC, 2008, CELL, V135, P1004, DOI 10.1016/j.cell.2008.11.029; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Vogler M, 2010, CLIN CANCER RES, V16, P4217, DOI 10.1158/1078-0432.CCR-10-0777; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng CH, 2012, BIOORG MED CHEM LETT, V22, P39, DOI 10.1016/j.bmcl.2011.11.101; Zhou HB, 2012, J MED CHEM, V55, P4664, DOI 10.1021/jm300178u	47	57	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99404	10.1371/journal.pone.0099404	http://dx.doi.org/10.1371/journal.pone.0099404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901320	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400126
J	Takahashi, R; Ishimaru, Y; Shimo, H; Bashir, K; Senoura, T; Sugimoto, K; Ono, K; Suzui, N; Kawachi, N; Ishii, S; Yin, YG; Fujimaki, S; Yano, M; Nishizawa, NK; Nakanishi, H				Takahashi, Ryuichi; Ishimaru, Yasuhiro; Shimo, Hugo; Bashir, Khurram; Senoura, Takeshi; Sugimoto, Kazuhiko; Ono, Kazuko; Suzui, Nobuo; Kawachi, Naoki; Ishii, Satomi; Yin, Yong-Gen; Fujimaki, Shu; Yano, Masahiro; Nishizawa, Naoko K.; Nakanishi, Hiromi			From Laboratory to Field: OsNRAMP5-Knockdown Rice Is a Promising Candidate for Cd Phytoremediation in Paddy Fields	PLOS ONE			English	Article							CADMIUM UPTAKE; TRANSPORTER GENES; IRON TRANSPORTER; MANGANESE UPTAKE; TRANSLOCATION; ACCUMULATION; PLANT; NRAMP; ARABIDOPSIS; ATNRAMP3	Previously, we reported that OsNRAMP5 functions as a manganese, iron, and cadmium (Cd) transporter. The shoot Cd content in OsNRAMP5 RNAi plants was higher than that in wild-type (WT) plants, whereas the total Cd content (roots plus shoots) was lower. For efficient Cd phytoremediation, we produced OsNRAMP5 RNAi plants using the natural high Cd-accumulating cultivar Anjana Dhan (A5i). Using a positron-emitting tracer imaging system, we assessed the time-course of Cd absorption and accumulation in A5i plants. Enhanced Cd-107 translocation from the roots to the shoots was observed in A5i plants. To evaluate the phytoremediation capability of A5i plants, we performed a field experiment in a Cd-contaminated paddy field. The biomass of the A5i plants was unchanged by the suppression of OsNRAMP5 expression; the A5i plants accumulated twice as much Cd in their shoots as WT plants. Thus, A5i plants could be used for rapid Cd extraction and the efficient phytoremediation of Cd from paddy fields, leading to safer food production.	[Takahashi, Ryuichi; Ishimaru, Yasuhiro; Shimo, Hugo; Bashir, Khurram; Senoura, Takeshi; Nishizawa, Naoko K.; Nakanishi, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Ishimaru, Yasuhiro] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Sugimoto, Kazuhiko; Ono, Kazuko; Yano, Masahiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Tsukuba, Ibaraki, Japan; [Suzui, Nobuo; Kawachi, Naoki; Ishii, Satomi; Yin, Yong-Gen; Fujimaki, Shu] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Takasaki, Gunma, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan	University of Tokyo; Tohoku University; National Institute of Agrobiological Sciences - Japan; Japan Atomic Energy Agency; Ishikawa Prefecture University	Nakanishi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	ahnaka@mail.ecc.u-tokyo.ac.jp	ISHIMARU, Yasuhiro/AAS-5947-2020; Suzui, Nobuo/C-5855-2013; Bashir, Khurram/Z-5650-2019; Bashir, Khurram/C-6870-2011; Yano, Masahiro/AAC-5441-2019; Nakanishi, Hiromi/C-6461-2015	ISHIMARU, Yasuhiro/0000-0003-4723-8844; Suzui, Nobuo/0000-0003-1081-7578; Bashir, Khurram/0000-0001-7123-8380; Bashir, Khurram/0000-0001-7123-8380; Yin, Yong-Gen/0000-0002-2930-0141; Kawachi, Naoki/0000-0002-3991-5035; Nakanishi, Hiromi/0000-0001-5556-5058	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Program for Promotion of Basic Research Activities for Innovative Biosciences; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences and by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics for Agricultural Innovation, GMB0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczky Z, 2003, J BIOL CHEM, V278, P24697, DOI 10.1074/jbc.M301365200; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Cailliatte R, 2009, BIOCHEM J, V422, P217, DOI 10.1042/BJ20090655; Cheng FM, 2006, SCI TOTAL ENVIRON, V359, P156, DOI 10.1016/j.scitotenv.2005.05.005; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Fujimaki S, 2010, PLANT PHYSIOL, V152, P1796, DOI 10.1104/pp.109.151035; Ibaraki T, 2009, SOIL SCI PLANT NUTR, V55, P421, DOI 10.1111/j.1747-0765.2009.00367.x; Ishikawa S, 2006, SOIL SCI PLANT NUTR, V52, P32, DOI 10.1111/j.1747-0765.2006.00008.x; Ishikawa S, 2005, SOIL SCI PLANT NUTR, V51, P101, DOI 10.1111/j.1747-0765.2005.tb00012.x; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Ishikawa S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-172; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Ishimaru Y, 2012, PLANT SIGNAL BEHAV, V7, P763, DOI 10.4161/psb.20510; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Kaiser BN, 2003, PLANT J, V35, P295, DOI 10.1046/j.1365-313X.2003.01802.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Mizuno T, 2005, PLANT PHYSIOL BIOCH, V43, P793, DOI 10.1016/j.plaphy.2005.07.006; Moon CS, 2003, INT ARCH OCC ENV HEA, V76, P282, DOI 10.1007/s00420-002-0415-4; Nakamura S, 2013, J EXP BOT, V64, P1073, DOI 10.1093/jxb/ers388; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Okumura M, 2012, PLANT SIGNAL BEHAV, V7, P979, DOI 10.4161/psb.20936; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Takahashi R, 2012, PLANT CELL ENVIRON, V35, P1948, DOI 10.1111/j.1365-3040.2012.02527.x; Takahashi R, 2011, PLANT SIGNAL BEHAV, V6, P1813, DOI 10.4161/psb.6.11.17587; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tsukamoto T, 2009, PLANT CELL PHYSIOL, V50, P48, DOI 10.1093/pcp/pcn192; Tsukamoto T, 2006, SOIL SCI PLANT NUTR, V52, P717, DOI 10.1111/j.1747-0765.2006.00096.x; Uraguchi S, 2009, J EXP BOT, V60, P2677, DOI 10.1093/jxb/erp119; Watanabe T, 2004, SCI TOTAL ENVIRON, V329, P17, DOI 10.1016/j.scitotenv.2004.03.010; World Health Organization (WHO) International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xiao HH, 2008, ANN BOT-LONDON, V102, P881, DOI 10.1093/aob/mcn178	44	44	48	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98816	10.1371/journal.pone.0098816	http://dx.doi.org/10.1371/journal.pone.0098816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901230	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400055
J	Barber, AG; Castillo-Martin, M; Bonal, DM; Rybicki, BA; Christiano, AM; Cordon-Cardo, C				Barber, Alison G.; Castillo-Martin, Mireia; Bonal, Dennis M.; Rybicki, Benjamin A.; Christiano, Angela M.; Cordon-Cardo, Carlos			Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; AUTOSOMAL RECESSIVE HYPOTRICHOSIS; STRIATE PALMOPLANTAR KERATODERMA; SQUAMOUS-CELL CARCINOMA; DESMOSOMAL CADHERIN; HAIR FOLLICLE; MUTATIONS; GENE; MONILETHRIX; ADHESION	Purpose: The expression of desmogleins (DSGs), which are known to be crucial for establishing and maintaining the cell-cell adhesion required for tissue integrity, has been well characterized in the epidermis and hair follicle; however, their expression in other epithelial tissues such as prostate is poorly understood. Although downregulation of classical cadherins, such as E-cadherin, has been described in prostate cancer tissue samples, the expression of desmogleins has only been previously reported in prostate cancer cell lines. In this study we characterized desmoglein expression in normal prostate tissues, and further investigated whether Desmoglein 2 (DSG2) expression specifically can serve as a potential clinical prognostic factor for patients diagnosed with primary prostate cancer. Experimental Design: We utilized immunofluorescence to examine DSG2 expression in normal prostate (n = 50) and in a clinically well-characterized cohort of prostate cancer patients (n = 414). Correlation of DSG2 expression with clinicopathological characteristics and biochemical recurrence was analyzed to assess its clinical significance. Results: These studies revealed that DSG2 and DSG4 were specifically expressed in prostatic luminal cells, whereas basal cells lack their expression. In contrast, DSG1 and DSG3 were not expressed in normal prostate epithelium. Further analyses of DSG2 expression in prostate cancer revealed that reduced levels of this biomarker were a significant independent marker of poor clinical outcome. Conclusion: Here we report for the first time that a low DSG2 expression phenotype is a useful prognostic biomarker of tumor aggressiveness and may serve as an aid in identifying patients with clinically significant prostate cancer.	[Barber, Alison G.; Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY USA; [Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10027 USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Cordon-Cardo, Carlos] Columbia Univ, Dept Urol, New York, NY USA; [Cordon-Cardo, Carlos] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Rybicki, Benjamin A.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Castillo-Martin, Mireia; Bonal, Dennis M.; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Henry Ford Health System; Henry Ford Hospital; Icahn School of Medicine at Mount Sinai	Castillo-Martin, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.	mireia.castillo-martin@mssm.edu; carlos.cordon-cardo@mssm.edu	Castillo-Martin, Mireia/H-6152-2013; Rybicki, Benjamin/L-4614-2019	Rybicki, Benjamin/0000-0003-3190-3467	National Institutes of Health [P01-CA087497, R01-ES11126]; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been partially supported by National Institutes of Health grants P01-CA087497 (CCC and MCM) and R01-ES11126 (BAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Amagai M, 1999, J DERMATOL SCI, V20, P92, DOI 10.1016/S0923-1811(99)00016-X; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Barber AG, 2007, J DERMATOL SCI, V45, P161, DOI 10.1016/j.jdermsci.2006.11.013; Baron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050024; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bonkhoff H, 1996, PROSTATE, V28, P98; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Davies G, 2000, J UROLOGY, V163, P985, DOI 10.1016/S0022-5347(05)67869-X; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karkera JD, 2000, CLIN CANCER RES, V6, P3565; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Ramani VC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-373; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Rybicki BA, 2006, CANCER DETECT PREV, V30, P412, DOI 10.1016/j.cdp.2006.09.004; Schafer S, 1996, DIFFERENTIATION, V60, P99, DOI 10.1046/j.1432-0436.1996.6020099.x; Schaffer JV, 2006, J INVEST DERMATOL, V126, P1286, DOI 10.1038/sj.jid.5700237; Schweizer J, 2006, J INVEST DERMATOL, V126, P1216, DOI 10.1038/sj.jid.5700266; Shimomura Y, 2006, J INVEST DERMATOL, V126, P1281, DOI 10.1038/sj.jid.5700113; Simpson MA, 2009, CARDIOLOGY, V113, P28, DOI 10.1159/000165696; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Takebayashi S, 2000, CANCER RES, V60, P3397; Trojan L, 2005, ANTICANCER RES, V25, P183; Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064; Wahl JK, 2002, HYBRIDOMA HYBRIDOM, V21, P37, DOI 10.1089/15368590252917629; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zlotogorski A, 2006, J INVEST DERMATOL, V126, P1292, DOI 10.1038/sj.jid.5700251	43	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98786	10.1371/journal.pone.0098786	http://dx.doi.org/10.1371/journal.pone.0098786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896103	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700077
J	Oboshi, Y; Kikuchi, M; Shimizu, Y; Yoshimura, Y; Hiraishi, H; Okada, H; Magata, Y; Ouchi, Y				Oboshi, Yumi; Kikuchi, Mitsuru; Shimizu, Yoshiyuki; Yoshimura, Yuko; Hiraishi, Hirotoshi; Okada, Hiroyuki; Magata, Yasuhiro; Ouchi, Yasuomi			Pre-Task Prefrontal Activation during Cognitive Processes in Aging: A Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							CORTEX AREA-10; FUNCTIONAL SPECIALIZATION; PROSPECTIVE MEMORY; BRAIN; AGE; METAANALYSIS; INVOLVEMENT; ATTENTION; WORKING; FUTURE	Purpose: Cognitive processing generally deteriorates as people age. Recent neuroimaging studies have shown that the prefrontal cortex (PFC) is involved in human-specific behavior, such as preparing for future actions and prospective memory; hence, the PFC may be voluntarily activated even during the "resting'' condition that precedes task execution. The purpose of the present study was to investigate changes in voluntary pre-task activation as a result of aging using a paradigm that includes a longer intertrial interval (e.g., 30 sec) than has been used in previous studies. Methods: A total of 120 cognitively normal adults (young: 60, old: 60) participated in this near-infrared spectroscopy (NIRS) study. All subjects performed 6 repetitions of the working memory task, which included a 30 sec resting period and a 28.8 sec task period. The resting period was divided into baseline and pre-task (preT) periods, and the task period was divided into early easy task (eT) and late difficult task (dT) periods. We then normalized the data, analyzed the magnitude of task-related NIRS responses in each period and compared the results between groups using an analysis of variance test. Results: Statistical analyses revealed a significant interaction between group x optode location x period, in which hemodynamic responses in the PFC during the preT period were smaller in the elderly in than young adults. By contrast, during the task period, the hemodynamic responses were higher in the lateral PFC in the elderly than in young adults. Spearman's rank correlation analysis showed a positive correlation between hemodynamic changes during the preT period in the PFC and correct answer ratios in both groups. Conclusions: These findings suggest that more pre-task activation in the anterior PFC is related to better cognitive performance in humans. Thus, a reduction in this activation might partly explain cognitive decline in the elderly.	[Oboshi, Yumi; Shimizu, Yoshiyuki; Okada, Hiroyuki; Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan; [Oboshi, Yumi] Tokoha Univ, Fac Hlth & Med Sci, Dept Occupat Therapy, Hamamatsu, Shizuoka, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Shimizu, Yoshiyuki; Okada, Hiroyuki] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Magata, Yasuhiro] Hamamatsu Univ Sch Med, Dept Mol Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Kanazawa University; Hamamatsu Photonics; Hamamatsu University School of Medicine	Ouchi, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Med Photon Res Ctr, Hamamatsu, Shizuoka 4313192, Japan.	ouchi@hama-med.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); Japanese Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Japan Health Foundation; Ishikawa High-Tech Sensing Cluster	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Health Foundation(Japan Health Foundation); Ishikawa High-Tech Sensing Cluster	This work was supported by the grants from Ishikawa High-Tech Sensing Cluster, from New Energy and Industrial Technology Development Organization (NEDO), from the Japanese Ministry of Education, Culture, Sports, Science and Technology, from the Takeda Science Foundation and from the Japan Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Berchicci M, 2013, J GERONTOL A-BIOL, V68, P1337, DOI 10.1093/gerona/glt094; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Browning M, 2012, NEUROIMAGE, V59, P1942, DOI 10.1016/j.neuroimage.2011.09.007; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Dreher JC, 2002, NEUROIMAGE, V17, P95, DOI 10.1006/nimg.2002.1169; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2006, CEREB CORTEX, V16, P1783, DOI 10.1093/cercor/bhj113; Gilbert SJ, 2010, NEUROIMAGE, V53, P1359, DOI 10.1016/j.neuroimage.2010.07.032; Gilbert SJ, 2010, J NEUROSCI, V30, P1233, DOI 10.1523/JNEUROSCI.3220-09.2010; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; HENNIGHAUSEN E, 1993, ELECTROEN CLIN NEURO, V86, P199, DOI 10.1016/0013-4694(93)90008-J; Henseler I, 2011, NEUROIMAGE, V56, P1666, DOI 10.1016/j.neuroimage.2011.02.056; Jimura K, 2010, CEREB CORTEX, V20, P1420, DOI 10.1093/cercor/bhp206; Kikuchi M, 2011, J NEUROSCI, V31, P11193, DOI 10.1523/JNEUROSCI.2535-11.2011; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Koshino H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022909; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Makizako H, 2013, ARCH GERONTOL GERIAT, V56, P118, DOI 10.1016/j.archger.2012.08.017; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, CEREB CORTEX, V31, P219; Schoofs D, 2012, BEHAV BRAIN RES; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Straube T, 2010, HUM BRAIN MAPP, V31, P36, DOI 10.1002/hbm.20843; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045	37	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98779	10.1371/journal.pone.0098779	http://dx.doi.org/10.1371/journal.pone.0098779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897305	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700075
J	Brojatsch, J; Lima, H; Kar, AK; Jacobson, LS; Muehlbauer, SM; Chandran, K; Diaz-Griffero, F				Brojatsch, Juergen; Lima, Heriberto, Jr.; Kar, Alak K.; Jacobson, Lee S.; Muehlbauer, Stefan M.; Chandran, Kartik; Diaz-Griffero, Felipe			A Proteolytic Cascade Controls Lysosome Rupture and Necrotic Cell Death Mediated by Lysosome-Destabilizing Adjuvants	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-I; LEUCINE METHYL-ESTER; CYTOTOXIC LYMPHOCYTES; PROTEASOME INHIBITORS; CATHEPSIN-B; URIC-ACID; NECROSIS; INFLAMMASOME; ACTIVATE; DISRUPTION	Recent studies have linked necrotic cell death and proteolysis of inflammatory proteins to the adaptive immune response mediated by the lysosome-destabilizing adjuvants, alum and Leu-Leu-OMe (LLOMe). However, the mechanism by which lysosome-destabilizing agents trigger necrosis and proteolysis of inflammatory proteins is poorly understood. The proteasome is a cellular complex that has been shown to regulate both necrotic cell death and proteolysis of inflammatory proteins. We found that the peptide aldehyde proteasome inhibitors, MG115 and MG132, block lysosome rupture, degradation of inflammatory proteins and necrotic cell death mediated by the lysosome-destabilizing peptide LLOMe. However, non-aldehyde proteasome inhibitors failed to prevent LLOMe-induced cell death suggesting that aldehyde proteasome inhibitors triggered a pleotropic effect. We have previously shown that cathepsin C controls lysosome rupture, necrotic cell death and the adaptive immune response mediated by LLOMe. Using recombinant cathepsin C, we found that aldehyde proteasome inhibitors directly block cathepsin C, which presumably prevents LLOMe toxicity. The cathepsin B inhibitor CA-074-Me also blocks lysosome rupture and necrotic cell death mediated by a wide range of necrosis inducers, including LLOMe. Using cathepsin-deficient cells and recombinant cathepsins, we demonstrate that the cathepsins B and C are not required for the CA-074-Me block of necrotic cell death. Taken together, our findings demonstrate that lysosome-destabilizing adjuvants trigger an early proteolytic cascade, involving cathepsin C and a CA-074-Me-dependent protease. Identification of these early events leading to lysosome rupture will be crucial in our understanding of processes controlling necrotic cell death and immune responses mediated by lysosome-destabilizing adjuvants.	[Brojatsch, Juergen; Lima, Heriberto, Jr.; Kar, Alak K.; Jacobson, Lee S.; Muehlbauer, Stefan M.; Chandran, Kartik; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	jurgen.brojatsch@einstein.yu.edu		brojatsch, jurgen/0000-0002-7424-365X	National Institutes of Health [1R56AI092497-01A1, 5R01AI088027-02, R01 AI087390]; Martin Turkish Foundation; M-O'Connor-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092497, R01AI087390, R01AI088027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Turkish Foundation; M-O'Connor-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HL, LSJ, SMM, and JB were funded by the National Institutes of Health grants 1R56AI092497-01A1 (to HL, LSJ, SMM, and JB), 5R01AI088027-02 (to KC), and R01 AI087390 (to AK and FD-G), and by the Martin Turkish Foundation and the M-O'Connor-Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Basu S, 2000, CELL STRESS CHAPERON, V5, P373; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Brojatsch Jurgen, 2014, Front Biosci (Elite Ed), V6, P139; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Diaz-Griffero F, 2002, J VIROL, V76, P12866, DOI 10.1128/JVI.76.24.12866-12876.2002; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Guicciardi ME, 2013, CELL CYCLE, V12, P1995, DOI 10.4161/cc.25317; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lima H, 2013, CELL CYCLE, V12, P1868, DOI 10.4161/cc.24903; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Muehlbauer SM, 2010, AM J PATHOL, V177, P735, DOI 10.2353/ajpath.2010.090828; Newman Z, 2009, INFECT IMMUN, P1; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nour AM, 2009, INFECT IMMUN, V77, P1262, DOI 10.1128/IAI.01032-08; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Reinheckel T, 2013, CELL CYCLE, V12, P1994, DOI 10.4161/cc.25316; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; THIELE DL, 1990, P NATL ACAD SCI USA, V87, P83, DOI 10.1073/pnas.87.1.83; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Wang F, 2011, MOL BIOCHEM PARASIT, V175, P10, DOI 10.1016/j.molbiopara.2010.08.004	44	23	25	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e95032	10.1371/journal.pone.0095032	http://dx.doi.org/10.1371/journal.pone.0095032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893007	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400003
J	Kumar, S; Torres, MP; Kaur, S; Rachagani, S; Joshi, S; Johansson, SL; Momi, N; Baine, MJ; Gilling, CE; Smith, LM; Wyatt, TA; Jain, M; Joshi, SS; Batra, SK				Kumar, S.; Torres, M. P.; Kaur, S.; Rachagani, S.; Joshi, S.; Johansson, S. L.; Momi, N.; Baine, M. J.; Gilling, C. E.; Smith, L. M.; Wyatt, T. A.; Jain, M.; Joshi, S. S.; Batra, S. K.			Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages	ONCOGENE			English	Article							TRANS-RETINOIC ACID; STELLATE CELL ACTIVATION; SUPPRESSOR-CELLS; CIGARETTE-SMOKE; MONOCYTE DIFFERENTIATION; IMMUNE-RESPONSE; MYELOID CELLS; GROWTH-FACTOR; MICE; ADENOCARCINOMA	Smoking is an established risk factor for pancreatic cancer (PC), but late diagnosis limits the evaluation of its mechanistic role in the progression of PC. We used a well-established genetically engineered mouse model (LSL-K-ras(G12D)) of PC to elucidate the role of smoking during initiation and development of pancreatic intraepithelial neoplasia (PanIN). The 10-week-old floxed mice (K-ras(G12D); Pdx-1cre) and their control unfloxed (LSL-K-ras(G12D)) littermates were exposed to cigarette smoke (total suspended particles: 150 mg/m(3)) for 20 weeks. Smoke exposure significantly accelerated the development of PanIN lesions in the floxed mice, which correlated with tenfold increase in the expression of cytokeratin19. The systemic accumulation of myeloid-derived suppressor cells (MDSCs) decreased significantly in floxed mice compared with unfloxed controls (P<0.01) after the smoke exposure with the concurrent increase in the macrophage (P<0.05) and dendritic cell (DCs) (P<0.01) population. Further, smoking-induced inflammation (IFN-gamma, CXCL2; P<0.05) was accompanied by enhanced activation of pancreatic stellate cells and elevated levels of serum retinoic acid-binding protein 4, indicating increased bioavailability of retinoic acid which contributes to differentiation of MDSCs to tumor-associated macrophages (TAMs) and DCs. TAMs predominantly contribute to the increased expression of heparin-binding epidermal growth factor-like growth factor (EGFR ligand) in pre-neoplastic lesions in smoke-exposed floxed mice that facilitate acinar-to-ductal metaplasia (ADM). Further, smoke exposure also resulted in partial suppression of the immune system early during PC progression. Overall, the present study provides a novel mechanism of smoking-induced increase in ADM in the presence of constitutively active K-ras mutation.	[Kumar, S.; Torres, M. P.; Kaur, S.; Rachagani, S.; Joshi, S.; Momi, N.; Baine, M. J.; Jain, M.; Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Torres, M. P.; Batra, S. K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Johansson, S. L.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Gilling, C. E.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Smith, L. M.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68198 USA; [Wyatt, T. A.] Univ Nebraska Med Ctr, Div Pulm Crit Care Sleep & Allergy, Omaha, NE 68198 USA; [Jain, M.; Batra, S. K.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Joshi, S. S.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu	Joshi, Sudhanshu/L-2284-2019; Torres, Maria/GVU-3391-2022	Joshi, Sudhanshu/0000-0003-4748-5001; 	National Institute of Health [R01CA78590, EDRN U01 CA111294, R01 CA133774, R01 CA131944, SPORE P50 CA127297, T32 CA009476, P20 GM103480, R21 CA156037, U54 TMEN CA163120]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA078590, R21CA156037, R01CA131944, U54CA163120, P50CA127297, R01CA133774, T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103480] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr Patrick C Swanson, Creighton University, Omaha, for suggestions. We appreciate the UNMC Cell Analysis Facility for analysis and graduate students and technician Erik Moore from Dr Batra's lab for help in sample preparation. This work was supported in part by the grant from National Institute of Health (R01CA78590, EDRN U01 CA111294, R01 CA133774, R01 CA131944, SPORE P50 CA127297, T32 CA009476, P20 GM103480, R21 CA156037 and U54 TMEN CA163120).	Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Blackford A, 2009, CANCER RES, V69, P3681, DOI 10.1158/0008-5472.CAN-09-0015; Braat H, 2012, CANCER LETT, V318, P1, DOI 10.1016/j.canlet.2011.11.034; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; BREITMAN TR, 1981, BLOOD, V57, P1000; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330; Ding QR, 2007, J LEUKOCYTE BIOL, V81, P1568, DOI 10.1189/jlb.1106672; Duell EJ, 2002, JNCI-J NATL CANCER I, V94, P297, DOI 10.1093/jnci/94.4.297; Duell EJ, 2012, MOL CARCINOGEN, V51, P40, DOI 10.1002/mc.20786; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Elliott MK, 2006, EXP LUNG RES, V32, P99, DOI 10.1080/01902140600710546; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Habisch Hansjorg, 2010, Cancers (Basel), V2, P1661, DOI 10.3390/cancers2031661; Hengesbach LM, 2004, J NUTR, V134, P2653, DOI 10.1093/jn/134.10.2653; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Hutchison SK, 2008, DIABETES CARE, V31, P1427, DOI 10.2337/dc07-2265; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Kusmartsev S, 2003, CANCER RES, V63, P4441; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; McCarroll JA, 2006, GUT, V55, P79, DOI 10.1136/gut.2005.064543; McCarroll JA, 2003, PANCREAS, V27, P150, DOI 10.1097/00006676-200308000-00008; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Mohty M, 2003, BRIT J HAEMATOL, V122, P829, DOI 10.1046/j.1365-2141.2003.04489.x; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Nouri-Shirazi M, 2003, IMMUNOLOGY, V109, P365, DOI 10.1046/j.1365-2567.2003.01655.x; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Ray KC, 2014, ONCOGENE, V33, P823, DOI 10.1038/onc.2013.3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Toh B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001162; van Geenen EJM, 2011, AM J GASTROENTEROL, V106, P1161, DOI 10.1038/ajg.2011.43; VANBOCKSTAELE DR, 1993, ANN HEMATOL, V66, P61, DOI 10.1007/BF01695885; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x; Zhang QL, 2012, LECT NOTES CONTR INF, V421, P7; Zhang SB, 1996, INT J IMMUNOPHARMACO, V18, P467, DOI 10.1016/S0192-0561(96)00054-9; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x	53	39	40	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2052	2060		10.1038/onc.2014.154	http://dx.doi.org/10.1038/onc.2014.154			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909166	Green Accepted			2022-12-25	WOS:000353173400005
J	Meng, XW; Koh, BD; Zhang, JS; Flatten, KS; Schneider, PA; Billadeau, DD; Hess, AD; Smith, BD; Karp, JE; Kaufmann, SH				Meng, X. Wei; Koh, Brian D.; Zhang, Jin-San; Flatten, Karen S.; Schneider, Paula A.; Billadeau, Daniel D.; Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.; Kaufmann, Scott H.			Poly(ADP-ribose) Polymerase Inhibitors Sensitize Cancer Cells to Death Receptor-mediated Apoptosis by Enhancing Death Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; NUCLEAR-MATRIX; PANCREATIC-CANCER; GENOTOXIC STRESS; TOPOISOMERASE-I; CHICKEN OVIDUCT; LEUKEMIA-CELLS; PARP; TRAIL; GENE	Recombinant human tumor necrosis factor-alpha-related apoptosis inducing ligand (TRAIL), agonistic monoclonal antibodies to TRAIL receptors, and small molecule TRAIL receptor agonists are in various stages of preclinical and early phase clinical testing as potential anticancer drugs. Accordingly, there is substantial interest in understanding factors that affect sensitivity to these agents. In the present study we observed that the poly(ADP-ribose) polymerase (PARP) inhibitors olaparib and veliparib sensitize the myeloid leukemia cell lines ML-1 and K562, the ovarian cancer line PEO1, non-small cell lung cancer line A549, and a majority of clinical AML isolates, but not normal marrow, to TRAIL. Further analysis demonstrated that PARP inhibitor treatment results in activation of the FAS and TNFRSF10B (death receptor 5 (DR5)) promoters, increased Fas and DR5 mRNA, and elevated cell surface expression of these receptors in sensitized cells. Chromatin immunoprecipitation demonstrated enhanced binding of the transcription factor Sp1 to the TNFRSF10B promoter in the presence of PARP inhibitor. Knockdown of PARP1 or PARP2 (but not PARP3 and PARP4) not only increased expression of Fas and DR5 at the mRNA and protein level, but also recapitulated the sensitizing effects of the PARP inhibition. Conversely, Sp1 knockdown diminished the PARP inhibitor effects. In view of the fact that TRAIL is part of the armamentarium of natural killer cells, these observations identify a new facet of PARP inhibitor action while simultaneously providing the mechanistic underpinnings of a novel therapeutic combination that warrants further investigation.	[Meng, X. Wei; Koh, Brian D.; Zhang, Jin-San; Flatten, Karen S.; Schneider, Paula A.; Billadeau, Daniel D.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Meng, X. Wei; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA	Mayo Clinic; Mayo Clinic; Johns Hopkins University	Meng, XW (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	Meng.Xue@Mayo.edu; Kaufmann.scott@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [P50 CA136393, P30 CA15083]; Ovarian Cancer Research Fund; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [P50CA136393, P30CA006973, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 CA136393 and P30 CA15083. This work was also supported by the Ovarian Cancer Research Fund and the Mayo Foundation for Education and Research.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bajaj M, 2011, EXPERT OPIN BIOL TH, V11, P1519, DOI 10.1517/14712598.2011.610788; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; BI SC, 1992, LEUKEMIA, V6, P839; Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Eaves C, 1995, ATLAS HUMAN HEMATOPO; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Falschlehner C, 2009, ADV EXP MED BIOL, V647, P195, DOI 10.1007/978-0-387-89520-8_14; FEINSTEIN E, 1992, ONCOGENE, V7, P1853; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gagne JP, 2012, NUCLEIC ACIDS RES, V40, P7788, DOI 10.1093/nar/gks486; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Hilton JF, 2013, FRONT BIOSCI-LANDMRK, V18, P1393, DOI 10.2741/4188; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMANN SH, 1986, J BIOL CHEM, V261, P1962; Kaufmann SH, 2001, ANAL BIOCHEM, V296, P283, DOI 10.1006/abio.2001.5313; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Matthews DE, 1988, USING UNDERSTANDING, P178; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Meng XW, 2010, J BIOL CHEM, V285, P888, DOI 10.1074/jbc.M109.057638; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Naka T, 2002, CANCER RES, V62, P5800; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Patel AG, 2012, J BIOL CHEM, V287, P4198, DOI 10.1074/jbc.M111.296475; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Plummer Ruth, 2012, Clin Adv Hematol Oncol, V10, P322; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; ROBINSON SI, 1983, NUCLEIC ACIDS RES, V11, P5113, DOI 10.1093/nar/11.15.5113; ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8; Rosato RR, 2007, CANCER RES, V67, P9490, DOI 10.1158/0008-5472.CAN-07-0598; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smith MA, 2013, CLIN CANCER RES, V19, P2828, DOI 10.1158/1078-0432.CCR-13-0043; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUN JM, 1993, FEBS LETT, V331, P141, DOI 10.1016/0014-5793(93)80313-J; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang GL, 2013, NAT CHEM BIOL, V9, P84, DOI [10.1038/NCHEMBIO.1153, 10.1038/nchembio.1153]; Wang S, 2010, CURR MED CHEM, V17, P3309, DOI 10.2174/092986710793176285; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wilson NS, 2012, CANCER CELL, V22, P80, DOI 10.1016/j.ccr.2012.05.014; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yelamos J, 2008, TRENDS MOL MED, V14, P169, DOI 10.1016/j.molmed.2008.02.003; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Yuan KY, 2013, CLIN CANCER RES, V19, P4750, DOI 10.1158/1078-0432.CCR-13-0516; Zhang JS, 2011, ONCOGENE, V30, P3705, DOI 10.1038/onc.2011.90	79	41	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20543	20558		10.1074/jbc.M114.549220	http://dx.doi.org/10.1074/jbc.M114.549220			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895135	Green Published, hybrid			2022-12-25	WOS:000339396600015
J	Saraf, A; Luo, J; Morris, DR; Storm, DR				Saraf, Amit; Luo, Jie; Morris, David R.; Storm, Daniel R.			Phosphorylation of Eukaryotic Translation Initiation Factor 4E and Eukaryotic Translation Initiation Factor 4E-binding Protein (4EBP) and Their Upstream Signaling Components Undergo Diurnal Oscillation in the Mouse Hippocampus IMPLICATIONS FOR MEMORY PERSISTENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE ACTIVATION; LONG-TERM-MEMORY; MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; SYNAPTIC PLASTICITY; CIRCADIAN-RHYTHMS; MNK1; FEAR; CONSOLIDATION; CLOCK	Translation of mRNA plays a critical role in consolidation of long-term memory. Here, we report that markers of initiation of mRNA translation are activated during training for contextual memory and that they undergo diurnal oscillation in the mouse hippocampus with maximal activity observed during the daytime (zeitgeber time 4-8 h). Phosphorylation and activation of eukaryotic translation initiation factor 4E (eIF4E), eIF4E-binding protein 1 (4EBP1), ribosomal protein S6, and eIF4F cap-complex formation, all of which are markers for translation initiation, were higher in the hippocampus during the daytime compared with night. The circadian oscillation in markers of mRNA translation was lost in memory-deficient transgenic mice lacking calmodulin-stimulated adenylyl cyclases. Moreover, disruption of the circadian rhythm blocked diurnal oscillations in eIF4E, 4EBP1, rpS6, Akt, and ERK1/2 phosphorylation and impaired memory consolidation. Furthermore, repeated inhibition of translation in the hippocampus 48 h after contextual training with the protein synthesis inhibitor anisomycin impaired memory persistence. We conclude that repeated activation of markers of translation initiation in hippocampus during the circadian cycle might be critical for memory persistence.	[Saraf, Amit; Luo, Jie; Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Morris, David R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357750,Hlth Sci Bldg, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Saraf, amit/GZL-0533-2022	Saraf, amit/0000-0002-0823-2266; Luo, Jie/0000-0003-1899-3111	National Institutes of Health [NS 20498, MH 073601]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 20498 and MH 073601 (to D. R. S.).	Akashi M, 2000, GENE DEV, V14, P645; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Blum S, 1999, J NEUROSCI, V19, P3535; Cao R, 2011, NEUROSCIENCE, V181, P79, DOI 10.1016/j.neuroscience.2011.03.005; Cao R, 2013, NEURON, V79, P712, DOI 10.1016/j.neuron.2013.06.026; Coogan AN, 2003, J NEUROSCI, V23, P3085; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; de Paula RM, 2008, CELL CYCLE, V7, P2630, DOI 10.4161/cc.7.17.6516; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Duncan RF, 2003, BIOCHEM J, V369, P213, DOI 10.1042/BJ20020435; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gal-Ben-Ari S, 2012, LEARN MEMORY, V19, P410, DOI 10.1101/lm.026849.112; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Ho AK, 2003, MOL CELL ENDOCRINOL, V208, P23, DOI 10.1016/S0303-7207(03)00260-0; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Luo J, 2013, J NEUROSCI, V33, P6460, DOI 10.1523/JNEUROSCI.5018-12.2013; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Senthil D, 2002, AM J PHYSIOL-RENAL, V283, pF1226, DOI 10.1152/ajprenal.00109.2002; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sudo M, 2003, NEUROSCIENCE, V121, P493, DOI 10.1016/S0306-4522(03)00457-3; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wanisch K, 2008, NEUROBIOL LEARN MEM, V90, P485, DOI 10.1016/j.nlm.2008.02.007; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	54	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20129	20138		10.1074/jbc.M114.552638	http://dx.doi.org/10.1074/jbc.M114.552638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895127	Green Published, hybrid			2022-12-25	WOS:000339395200026
J	Yang, RY; Dong, J; Zhao, HJ; Li, HX; Guo, HB; Wang, S; Zhang, CB; Wang, SM; Wang, M; Yu, SL; Chen, WX				Yang, Ruiyue; Dong, Jun; Zhao, Haijian; Li, Hongxia; Guo, Hanbang; Wang, Shu; Zhang, Chuanbao; Wang, Siming; Wang, Mo; Yu, Songlin; Chen, Wenxiang			Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; METABOLIC PROFILE; OBESE; ATHEROSCLEROSIS; PATHWAYS	Background: Recent studies have determined that branched-chain (BCAAs) and aromatic (AAAs) amino acids are strongly correlated with obesity and atherogenic dyslipidemia and are strong predictors of diabetes. However, it is not clear if these amino acids are capable of identifying subjects with coronary artery disease (CAD), particularly with subclinical atherosclerosis who are at risk of developing CAD. Methods: Four hundred and seventy two Chinese subjects (272 males and 200 females, 42-97 y of age) undergoing physical exams were recruited at random for participation in the cross-sectional study. Serum BCAAs and AAAs were measured using our previously reported isotope dilution liquid chromatography tandem mass spectrometry method. Bilateral B-mode carotid artery images for carotid intima-media thickness (cIMT) were acquired at end diastole and cIMT values more than 0.9 mm were categorized as increased. Correlations of BCAAs with cIMT and other CAD risk factors were analyzed. Results: BCAAs and AAAs were significantly and positively associated with risk factors of CAD, e. g., cIMT, BMI, waist circumference, blood pressure, fasting blood glucose, TG, apoB, apoB/apoAI ratio, apoCII, apoCIII and hsCRP, and were significantly and negatively associated with HDL-C and apoAI. Stepwise multiple linear regression analysis revealed that age (beta= 0.175, P<0.001), log BCAA (beta= 0.147, P<0.001) and systolic blood pressure (beta= 0.141, P = 0.012) were positively and independently associated with cIMT. In the logistic regression model, the most and only powerful laboratory factor correlated with increased cIMT was BCAA (the odds ratio of the fourth quartile compared to the first quartile was 2.679; P = 0.009). Conclusion: BCAAs are independently correlated with increased cIMT. This correlation would open a new field of research in the mechanistic understanding and risk assessment of CAD.	[Yang, Ruiyue; Dong, Jun; Li, Hongxia; Guo, Hanbang; Wang, Shu; Wang, Siming; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Yang, Ruiyue; Dong, Jun; Li, Hongxia; Guo, Hanbang; Wang, Shu; Wang, Siming; Chen, Wenxiang] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhao, Haijian; Zhang, Chuanbao; Wang, Mo; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Beijing, Peoples R China; [Zhao, Haijian; Zhang, Chuanbao; Wang, Mo; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Natl Ctr Clin Labs, Beijing, Peoples R China	Beijing Hospital; Beijing Hospital	Chen, WX (corresponding author), Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	wchen@bjhmoh.cn	Yang, Ruiyue/HDN-2405-2022	Yang, Ruiyue/0000-0002-2304-6728	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China [2012BAI37B01]; National Natural Science Foundation of China [81171647, 81301487]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201002011, 201302008]	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation by Ministry of Health P. R. China	This study was supported by research grants from the National Science & Technology Pillar Program under the Twelfth Five-year Plan of China (2012BAI37B01), the National Natural Science Foundation of China (81171647 and 81301487) and the National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201002011 and 201302008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fernandes VRS, 2006, J AM COLL CARDIOL, V47, P2420, DOI 10.1016/j.jacc.2005.12.075; Gilstrap LG, 2012, CLIN CHEM, V58, P72, DOI 10.1373/clinchem.2011.165712; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Yang RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081144	23	58	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99598	10.1371/journal.pone.0099598	http://dx.doi.org/10.1371/journal.pone.0099598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910999	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600109
J	Ejarque-Gonzalez, E; Butturini, A				Ejarque-Gonzalez, Elisabet; Butturini, Andrea			Self-Organising Maps and Correlation Analysis as a Tool to Explore Patterns in Excitation-Emission Matrix Data Sets and to Discriminate Dissolved Organic Matter Fluorescence Components	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; PARALLEL FACTOR-ANALYSIS; REGIONAL-INTEGRATION; QUANTIFY SPECTRA; CALIBRATION; DOM; CLASSIFICATION; SPECTROSCOPY; ABSORBENCY; WATERS	Dissolved organic matter (DOM) is a complex mixture of organic compounds, ubiquitous in marine and freshwater systems. Fluorescence spectroscopy, by means of Excitation-Emission Matrices (EEM), has become an indispensable tool to study DOM sources, transport and fate in aquatic ecosystems. However the statistical treatment of large and heterogeneous EEM data sets still represents an important challenge for biogeochemists. Recently, Self-Organising Maps (SOM) has been proposed as a tool to explore patterns in large EEM data sets. SOM is a pattern recognition method which clusterizes and reduces the dimensionality of input EEMs without relying on any assumption about the data structure. In this paper, we show how SOM, coupled with a correlation analysis of the component planes, can be used both to explore patterns among samples, as well as to identify individual fluorescence components. We analysed a large and heterogeneous EEM data set, including samples from a river catchment collected under a range of hydrological conditions, along a 60-km downstream gradient, and under the influence of different degrees of anthropogenic impact. According to our results, chemical industry effluents appeared to have unique and distinctive spectral characteristics. On the other hand, river samples collected under flash flood conditions showed homogeneous EEM shapes. The correlation analysis of the component planes suggested the presence of four fluorescence components, consistent with DOM components previously described in the literature. A remarkable strength of this methodology was that outlier samples appeared naturally integrated in the analysis. We conclude that SOM coupled with a correlation analysis procedure is a promising tool for studying large and heterogeneous EEM data sets.	[Ejarque-Gonzalez, Elisabet; Butturini, Andrea] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Catalunya, Spain	University of Barcelona	Ejarque-Gonzalez, E (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Catalunya, Spain.	elisabet.ejarque@ub.edu	Butturini, Andrea/K-4991-2014; Ejarque, Elisabet/Q-9444-2016	Butturini, Andrea/0000-0002-7712-6328; Ejarque, Elisabet/0000-0002-9399-968X	Spanish Ministry of Economy and Competitiveness [CGL2011-30151-C02-02]; FPU doctoral scholarship from the MEC [AP2008-03431]	Spanish Ministry of Economy and Competitiveness(Spanish Government); FPU doctoral scholarship from the MEC(German Research Foundation (DFG))	This research was funded by the Spanish Ministry of Economy and Competitiveness (CGL2011-30151-C02-02). Elisabet Ejarque-Gonzalez's research was in part supported by an FPU doctoral scholarship from the MEC (AP2008-03431). Both authors are members of the GRACCIE consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACA, 2013, CONS DAD XARX CONTR; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baker A, 2004, SCI TOTAL ENVIRON, V333, P217, DOI 10.1016/j.scitotenv.2004.04.013; Baker A, 2001, ENVIRON SCI TECHNOL, V35, P948, DOI 10.1021/es000177t; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; Bieroza M, 2012, ADV ENG SOFTW, V44, P126, DOI 10.1016/j.advengsoft.2011.05.031; Bieroza M, 2012, EDUC CHEM ENG, V7, pE22, DOI 10.1016/j.ece.2011.10.002; Bieroza M, 2011, ENVIRONMETRICS, V22, P256, DOI 10.1002/env.1045; Bieroza M, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000940; Boehme JR, 2000, ENVIRON SCI TECHNOL, V34, P3283, DOI 10.1021/es9911263; Borisover M, 2011, WATER AIR SOIL POLL, V222, P255, DOI 10.1007/s11270-011-0821-x; Brereton RG, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-S2-S1; Bro R, 2011, CHEMOMETR INTELL LAB, V106, P86, DOI 10.1016/j.chemolab.2010.06.005; Brooks ML, 2007, LIMNOL OCEANOGR, V52, P766, DOI 10.4319/lo.2007.52.2.0766; Cammack WKL, 2004, LIMNOL OCEANOGR, V49, P2034, DOI 10.4319/lo.2004.49.6.2034; Cattell R.B., 1952, FACTOR ANAL INTRO MA; Cereghino R, 2009, ENVIRON MODELL SOFTW, V24, P945; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Cinar O, 2009, ECOL RES, V24, P163, DOI 10.1007/s11284-008-0495-z; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cory RM, 2012, LIMNOL OCEANOGR, V57, P1347, DOI 10.4319/lo.2012.57.5.1347; Cory RM, 2010, LIMNOL OCEANOGR-METH, V8, P67; Cottrell M, 2001, ADVANCES IN SELF-ORGANISING MAPS, P7; de Bodt E, 2002, NEURAL NETWORKS, V15, P967, DOI 10.1016/S0893-6080(02)00071-0; Elkins KM, 2002, COORDIN CHEM REV, V228, P205, DOI 10.1016/S0010-8545(02)00040-1; Engelen S, 2011, ANAL CHIM ACTA, V705, P155, DOI 10.1016/j.aca.2011.04.043; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Foden J, 2008, ESTUAR COAST SHELF S, V79, P707, DOI 10.1016/j.ecss.2008.06.015; Gardecki JA, 1998, APPL SPECTROSC, V52, P1179, DOI 10.1366/0003702981945192; Goletz C, 2011, TALANTA, V85, P650, DOI 10.1016/j.talanta.2011.04.045; Henderson RK, 2009, WATER RES, V43, P863, DOI 10.1016/j.watres.2008.11.027; Hudson N, 2007, RIVER RES APPL, V23, P631, DOI 10.1002/rra.1005; Huguet A, 2009, ORG GEOCHEM, V40, P706, DOI 10.1016/j.orggeochem.2009.03.002; Hur J, 2009, CHEMOSPHERE, V75, P483, DOI 10.1016/j.chemosphere.2008.12.056; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Kohonen T., 1998, Neurocomputing, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Kohonen T, 2001, SELF ORGANIZING MAPS; Lakowicz J, 2006, PRINCIPLES FLUORESCE, DOI [DOI 10.1007/978-0-387-46312-4, 10.1007/978-0-387-46312-4]; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Larsson T, 2007, ANAL CHIM ACTA, V583, P357, DOI 10.1016/j.aca.2006.09.067; Lawaetz AJ, 2009, APPL SPECTROSC, V63, P936, DOI 10.1366/000370209788964548; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lloyd GR, 2008, ANALYST, V133, P1046, DOI 10.1039/b715390b; Marhuenda-Egea FC, 2007, CHEMOSPHERE, V68, P301, DOI 10.1016/j.chemosphere.2006.12.075; Mat-Desa WNS, 2011, ANAL CHEM, V83, P7745, DOI 10.1021/ac202315y; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Mostofa KMG, 2007, GEOCHEM J, V41, P323, DOI 10.2343/geochemj.41.323; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Oja M, 2006, COMPUTATIONAL STAT A, P61; Oksanen J., 2017, R PACKAGE VERSION 26; Osburn CL, 2009, MAR CHEM, V115, P10, DOI 10.1016/j.marchem.2009.05.003; Park YS, 2006, ECOL INFORM, V1, P247, DOI 10.1016/j.ecoinf.2006.03.005; Parlanti E, 2000, ORG GEOCHEM, V31, P1765, DOI 10.1016/S0146-6380(00)00124-8; Quinn MJ, 2010, UNDUE INFLUENCE DEFI; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; S MAB, 2007, LECT NOTES COMPUT SC, V4669, P379; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; SOM toolbox team, 2000, NEURAL NETWORK TOOL; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; ULTSCH A, 1990, INTERNATIONAL NEURAL NETWORK CONFERENCE, VOLS 1 AND 2, P305; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 1999, Intelligent Data Analysis, V3, P111, DOI 10.1016/S1088-467X(99)00013-X; Vesanto J, 2002, LECT NOTES COMPUT SC, V2415, P951; Wang ZW, 2009, WATER RES, V43, P1533, DOI 10.1016/j.watres.2008.12.033; Wehrens R, 2007, J STAT SOFTW, V21, P1; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Yamashita Y, 2003, MAR CHEM, V82, P255, DOI 10.1016/S0304-4203(03)00073-2; Zhou J, 2013, J ENVIRON QUAL, V42, P925, DOI 10.2134/jeq2012.0460; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0	74	19	20	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99618	10.1371/journal.pone.0099618	http://dx.doi.org/10.1371/journal.pone.0099618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906009	Green Published, gold			2022-12-25	WOS:000341869000125
J	Francescato, MP; Stel, G; Geat, M; Cauci, S				Francescato, Maria Pia; Stel, Giuliana; Geat, Mario; Cauci, Sabina			Oxidative Stress in Patients with Type 1 Diabetes Mellitus: Is It Affected by a Single Bout of Prolonged Exercise?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; URIC-ACID; ANTIOXIDANT; RADICALS; DISEASE; YOUNG; COMPLICATIONS; HYPERGLYCEMIA; HYPOGLYCEMIA; ASSOCIATION	Presently, no clear-cut guidelines are available to suggest the more appropriate physical activity for patients with type 1 diabetes mellitus due to paucity of experimental data obtained under patients' usual life conditions. Accordingly, we explored the oxidative stress levels associated with a prolonged moderate intensity, but fatiguing, exercise performed under usual therapy in patients with type 1 diabetes mellitus and matched healthy controls. Eight patients (4 men, 4 women; 49 +/- 11 years; Body Mass Index 25.0 +/- 3.2 kg.m(-2); HbA(1c) 57 +/- 10 mmol.mol(-1)) and 14 controls (8 men, 6 women; 47 +/- 11 years; Body Mass Index 24.3 +/- 3.3 kg.m(-2)) performed a 3-h walk at 30% of their heart rate reserve. Venous blood samples were obtained before and at the end of the exercise for clinical chemistry analysis and antioxidant capacity. Capillary blood samples were taken at the start and thereafter every 30 min to determine lipid peroxidation. Patients showed higher oxidative stress values as compared to controls (95.9 +/- 9.7 vs. 74.1 +/- 12.2 mg.L-1 H2O2; p<0.001). In both groups, oxidative stress remained constant throughout the exercise (p = NS), while oxidative defence increased significantly at the end of exercise (p<0.02) from 1.16 +/- 0.13 to 1.19 +/- 0.10 mmol.L-1 Trolox in patients and from 1.09 +/- 0.21 to 1.22 +/- 0.14 mmol.L-1 Trolox in controls, without any significant difference between the two groups. Oxidative stress was positively correlated to HbA(1c) (p<0.005) and negatively related with uric acid (p<0.005). In conclusion, we were the first to evaluate the oxidative stress in patients with type 1 diabetes exercising under their usual life conditions (i.e. usual therapy and diet). Specifically, we found that the oxidative stress was not exacerbated due to a single bout of prolonged moderate intensity aerobic exercise, a condition simulating several outdoor leisure time physical activities. Oxidative defence increased in both patients and controls, suggesting beneficial effects of prolonged aerobic fatiguing exercise.	[Francescato, Maria Pia; Stel, Giuliana; Geat, Mario; Cauci, Sabina] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Francescato, MP (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	maria.francescato@uniud.it	Francescato, Maria Pia/O-7010-2014	Francescato, Maria Pia/0000-0002-7892-863X; Cauci, Sabina/0000-0001-7443-1899				Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Berg TJ, 1998, DIABETES CARE, V21, P1295, DOI 10.2337/diacare.21.8.1295; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Chokkalingam K, 2007, DIABETOLOGIA, V50, P414, DOI 10.1007/s00125-006-0520-0; Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0; De Cosmo S, 2006, DIABETES CARE, V29, P2467, DOI 10.2337/dc06-0940; Di Santolo M, 2009, EUR J APPL PHYSIOL, V105, P111, DOI 10.1007/s00421-008-0880-x; Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Francescato MP, 2011, CURR DIABETES REV, V7, P253, DOI 10.2174/157339911796397875; Francescato MP, 2011, MED SCI SPORT EXER, V43, P2, DOI 10.1249/MSS.0b013e3181e6d6a1; Garelnabi MO, 2008, CLIN BIOCHEM, V41, P1250, DOI 10.1016/j.clinbiochem.2008.07.009; Geat M, 2013, METABOLISM, V62, P836, DOI 10.1016/j.metabol.2013.01.004; Gilbert J, 2004, DIABETES CARE, V27, P990, DOI 10.2337/diacare.27.4.990; Golbidi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/941868; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Goodarzi MT, 2010, J CLIN LAB ANAL, V24, P72, DOI 10.1002/jcla.20328; Grimm JJ, 2004, DIABETES METAB, V30, P465, DOI 10.1016/S1262-3636(07)70144-1; Jenni S, 2008, DIABETOLOGIA, V51, P1457, DOI 10.1007/s00125-008-1045-5; Kamhieh-Milz J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/720347; Laaksonen DE, 1996, DIABETES CARE, V19, P569, DOI 10.2337/diacare.19.6.569; Lippi G, 2008, CLIN CHIM ACTA, V392, P1, DOI 10.1016/j.cca.2008.02.024; Mantovani G, 2004, CANCER EPIDEM BIOMAR, V13, P1651; Marra G, 2002, DIABETES CARE, V25, P370, DOI 10.2337/diacare.25.2.370; Menon V, 2004, DIABETIC MED, V21, P1346, DOI 10.1111/j.1464-5491.2004.01417.x; Owen WE, 2004, CLIN CHEM, V50, P257, DOI 10.1373/clinchem.2003.026625; Pavlatou MG, 2009, METABOLISM, V58, P1657, DOI 10.1016/j.metabol.2009.05.022; Peluso Ilaria, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P351; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Reis JS, 2012, DIABETES VASC DIS RE, V9, P309, DOI 10.1177/1479164111436316; Sharma A, 2000, METABOLISM, V49, P160, DOI 10.1016/S0026-0495(00)91117-X; Stettler C, 2006, DIABETES-METAB RES, V22, P300, DOI 10.1002/dmrr.608; Takahashi M, 2013, EUR J APPL PHYSIOL, V113, P1117, DOI 10.1007/s00421-012-2531-5; Tamborlane WV, 2007, J CLIN ENDOCR METAB, V92, P815, DOI 10.1210/jc.2007-0016; VanderJagt DJ, 2001, CLIN BIOCHEM, V34, P265, DOI 10.1016/S0009-9120(01)00204-1; Vessby J, 2002, J INTERN MED, V251, P69, DOI 10.1046/j.1365-2796.2002.00927.x; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99062	10.1371/journal.pone.0099062	http://dx.doi.org/10.1371/journal.pone.0099062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905823	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000101
J	Hortal, M; Estevan, M; Meny, M; Iraola, I; Laurani, H				Hortal, Maria; Estevan, Miguel; Meny, Miguel; Iraola, Ines; Laurani, Hilda			Impact of Pneumococcal Conjugate Vaccines on the Incidence of Pneumonia in Hospitalized Children after Five Years of Its Introduction in Uruguay	PLOS ONE			English	Article							VACCINATION; INFECTIONS; PROGRAM; DISEASE; BURDEN	Background: Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay. Methods and Findings: Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31 st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age. Conclusions: An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.	[Hortal, Maria] Natl Univ, Montevideo, Uruguay; [Estevan, Miguel] Childrens Hosp, Dept Radiol, Minist Hlth, Montevideo, Uruguay; [Meny, Miguel] Montevideo Municipal, Dept Stat, Montevideo, Uruguay; [Iraola, Ines] Social Secur, Dept Pediat, Montevideo, Uruguay; [Laurani, Hilda] CHLAP, Immunizat Dept, Montevideo, Uruguay		Hortal, M (corresponding author), Natl Univ, Montevideo, Uruguay.	marujahortal@gmail.com			Pfizer inc.	Pfizer inc.(Pfizer)	Study supported by an irrestrictive grant of Pfizer inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; CDC, 2000, RECOMMENDATIONS COMM; Dagan R, 2001, PEDIATR INFECT DIS J, V20, P951, DOI 10.1097/00006454-200110000-00008; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Fitzwater SP, 2012, PEDIATR INFECT DIS J, V31, P501, DOI 10.1097/INF.0b013e31824de9f6; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Hortal M, 2007, PEDIATR INFECT DIS J, V26, P1; Hortal M, 2007, INT J INFECT DIS, V11, P273, DOI 10.1016/j.ijid.2006.05.006; Hortal M, 2012, VACCINE, V30, P4934, DOI 10.1016/j.vaccine.2012.05.054; IRAOLA INéS, 2005, Arch. Pediatr. Urug., V76, P196; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Magnus MC, 2012, PEDIATR INFECT DIS J, V31, P951, DOI 10.1097/INF.0b013e31825d2f76; Pan American Health Organization, 2012, SIREVIA 2 REP 2012; Ruocco G, 1999, Rev Panam Salud Publica, V5, P197, DOI 10.1590/S1020-49891999000300021; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; Verani JR, 2014, PNEUMONIA, V3, P278; World Health Organization, 2001, STAND INT CHEST RAD; 2009, MMWR, V58, P1	18	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98567	10.1371/journal.pone.0098567	http://dx.doi.org/10.1371/journal.pone.0098567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905093	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000040
J	Page, P; Favre, A; Schiestl, FP; Karrenberg, S				Page, Paul; Favre, Adrien; Schiestl, Florian P.; Karrenberg, Sophie			Do Flower Color and Floral Scent of Silene Species affect Host Preference of Hadena bicruris, a Seed-Eating Pollinator, under Field Conditions?	PLOS ONE			English	Article							NEIGHBORING UNINFECTED PLANTS; MILL GARCKE CARYOPHYLLACEAE; NURSERY POLLINATION; DIOICA CARYOPHYLLACEAE; REPRODUCTIVE ISOLATION; VOLATILE INDUCTION; CO-POLLINATORS; MODEL SYSTEM; S-DIOICA; LATIFOLIA	Specialization in plant-insect interactions is an important driver of evolutionary divergence; yet, plant traits mediating such interactions are poorly understood. In this study, we investigated how flower color and floral scent are related to seed predation by a seed-eating pollinator. We used field-transplanted recombinant F-2 hybrids between Silene latifolia and S. dioica that are the preferred and alternative hosts of the moth Hadena bicruris and crosses within these species for comparison. We scored seed predation and flower color and analyzed floral scent. Pinker S. dioica-like flowers and emission of a-pinene decreased the odds of seed predation while emission of benzyl acetate and 6-methyl-5-hepten-2-one increased the odds of seed predation. Emission of these compounds did not differ significantly between the two Silene species. Our results suggest that flower color plays an important role in the specific interaction of H. bicruris with its preferred host S. latifolia. The compounds alpha-pinene, benzyl acetate and 6-methyl-5-hepten-2-one could represent non-specific deterrents and attractants to ovipositing moths. Alternatively, emission of these compounds could be related to herbivory or pathogen attack and act as a signal for host quality. This would weaken the predictability of the plant's costs and benefits of the interaction and act to maintain an imperfect degree of specialization.	[Page, Paul; Favre, Adrien; Schiestl, Florian P.; Karrenberg, Sophie] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland; [Favre, Adrien] Univ Leipzig, Inst Biol, Dept Mol Evolut & Systemat Plants, D-04109 Leipzig, Germany; [Schiestl, Florian P.] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Karrenberg, Sophie] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; University of Zurich; Uppsala University	Karrenberg, S (corresponding author), ETH, Inst Integrat Biol IBZ, Zurich, Switzerland.	sophie.karrenberg@ebc.uu.se	Favre, Adrien/J-8989-2019	Favre, Adrien/0000-0001-6132-2992; Schiestl, Florian/0000-0001-7637-6918	Swiss National Science Foundation [31003A-112342, 31003A-118221]; Swedish Research Council (VR)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Research Council (VR)(Swedish Research Council)	This research was funded by the Swiss National Science Foundation (http://www.snf.ch/), grants no. 31003A-112342 to FPS and no. 31003A-118221 to SK and a project grant of the Swedish Research Council (VR, http://www.vr.se) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Bernasconi G, 2009, HEREDITY, V103, P5, DOI 10.1038/hdy.2009.34; Biere A, 1996, OIKOS, V77, P467, DOI 10.2307/3545936; Biere A, 2006, NEW PHYTOL, V169, P719, DOI 10.1111/j.1469-8137.2005.01511.x; Biere A, 1998, INT J PLANT SCI, V159, P228, DOI 10.1086/297543; Bopp S, 2004, OIKOS, V105, P221, DOI 10.1111/j.0030-1299.2004.12625.x; BRANTJES NBM, 1976, OECOLOGIA, V24, P1, DOI 10.1007/BF00545483; BRANTJES NBM, 1976, P K NED AKAD C BIOL, V79, P127; BRANTJES NBM, 1976, P K NED AKAD C BIOL, V79, P1; Brothers AN, 2014, INT J PLANT SCI, V175, P287, DOI 10.1086/673883; Burkhardt A, 2009, OECOLOGIA, V161, P87, DOI 10.1007/s00442-009-1359-0; Crawley MJ., 2007, R BOOK; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; Dotterl S, 2009, J CHEM ECOL, V35, P307, DOI 10.1007/s10886-009-9601-0; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dotterl S, 2006, NEW PHYTOL, V169, P707, DOI 10.1111/j.1469-8137.2005.01509.x; Dotterl S, 2005, PLANT SYST EVOL, V255, P99, DOI 10.1007/s00606-005-0344-2; Dufay M, 2003, OIKOS, V100, P3, DOI 10.1034/j.1600-0706.2003.12053.x; Elzinga JA, 2005, OECOLOGIA, V144, P416, DOI 10.1007/s00442-005-0096-2; Elzinga JA, 2009, J ECOL, V97, P1010, DOI 10.1111/j.1365-2745.2009.01534.x; Faegri K, 1971, PRINCIPLES POLLINATI; Favre A, 2010, THESIS ETH ZURICH ZU; Favre A, 2011, J ECOL, V99, P1415, DOI 10.1111/j.1365-2745.2011.01865.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Goulson D, 1997, OIKOS, V79, P115, DOI 10.2307/3546096; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Hirota SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039010; Holland JN, 2002, OECOLOGIA, V133, P534, DOI 10.1007/s00442-002-1061-y; Hothorn T., 2006, EXACTRANKTESTS EXACT; Jurgens A, 2002, BIOCHEM SYST ECOL, V30, P383, DOI 10.1016/S0305-1978(01)00106-5; Karrenberg S, 2008, EVOLUTION, V62, P763, DOI 10.1111/j.1558-5646.2008.00330.x; Kephart S, 2006, NEW PHYTOL, V169, P667, DOI 10.1111/j.1469-8137.2005.01619.x; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, ECOLOGY, V92, P1769, DOI 10.1890/10-1945.1; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2007, PLANT J, V49, P840, DOI 10.1111/j.1365-313X.2006.02995.x; Kessler D, 2012, ENTOMOL EXP APPL, V144, P112, DOI 10.1111/j.1570-7458.2012.01270.x; Kigathi RN, 2009, J CHEM ECOL, V35, P1335, DOI 10.1007/s10886-009-9716-3; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Knudsen GK, 2008, PHYSIOL ENTOMOL, V33, P1, DOI 10.1111/j.1365-3032.2007.00592.x; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Labouche AM, 2013, FUNCT ECOL, V27, P509, DOI [10.1111/1365-2435.12062, 10.1111/j.1468-3083.2011.04323.x]; Labouche AM, 2010, FUNCT ECOL, V24, P534, DOI 10.1111/j.1365-2435.2009.01658.x; Lexer C, 2003, ECOLOGY, V84, P1688, DOI 10.1890/0012-9658(2003)084[1688:EHAATF]2.0.CO;2; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Lynch M., 1998, GENETICS ANAL QUANTI; Minder AM, 2007, MOL ECOL, V16, P2504, DOI 10.1111/j.1365-294X.2007.03292.x; Muhlemann JK, 2006, J CHEM ECOL, V32, P1855, DOI 10.1007/s10886-006-9113-0; Pareja M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031971; Piesik D, 2013, J APPL ENTOMOL, V137, P296, DOI 10.1111/j.1439-0418.2012.01742.x; Piesik D, 2011, J PLANT PHYSIOL, V168, P1534, DOI 10.1016/j.jplph.2011.01.032; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Reisenman CE, 2010, P ROY SOC B-BIOL SCI, V277, P2371, DOI 10.1098/rspb.2010.0163; Reynolds RJ, 2012, OECOLOGIA, V168, P439, DOI 10.1007/s00442-011-2095-9; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schiestl FP, 2011, EVOL ECOL, V25, P237, DOI 10.1007/s10682-010-9409-y; Schiestl FP, 2003, J CHEM ECOL, V29, P253, DOI 10.1023/A:1021932131526; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; Tang RB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045597, 10.1371/journal.pone.0049256]; THOMPSON JN, 1992, ECOLOGY, V73, P1780, DOI 10.2307/1940029; van Putten WF, 2007, INT J PLANT SCI, V168, P421, DOI 10.1086/511050; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Waelti MO, 2008, J EVOLUTION BIOL, V21, P111, DOI 10.1111/j.1420-9101.2007.01461.x; Waelti MO, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-190; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Wolfe LM, 2004, ECOL LETT, V7, P813, DOI 10.1111/j.1461-0248.2004.00649.x; Young HJ, 2002, AM J BOT, V89, P1237, DOI 10.3732/ajb.89.8.1237; Young HJ, 2002, AM J BOT, V89, P433, DOI 10.3732/ajb.89.3.433	73	12	12	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98755	10.1371/journal.pone.0098755	http://dx.doi.org/10.1371/journal.pone.0098755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905986	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341869000059
J	Salomon, C; Torres, MJ; Kobayashi, M; Scholz-Romero, K; Sobrevia, L; Dobierzewska, A; Illanes, SE; Mitchell, MD; Rice, GE				Salomon, Carlos; Jose Torres, Maria; Kobayashi, Miharu; Scholz-Romero, Katherin; Sobrevia, Luis; Dobierzewska, Aneta; Illanes, Sebastian E.; Mitchell, Murray D.; Rice, Gregory E.			A Gestational Profile of Placental Exosomes in Maternal Plasma and Their Effects on Endothelial Cell Migration	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; 1ST-ENA OBSERVATIONS; PREGNANT-WOMEN; MARS; EXPRESSION; MICRORNAS; RECEPTOR; BLOOD	Studies completed to date provide persuasive evidence that placental cell-derived exosomes play a significant role in intercellular communication pathways that potentially contribute to placentation and development of materno-fetal vascular circulation. The aim of this study was to establish the gestational-age release profile and bioactivity of placental cell-derived exosome in maternal plasma. Plasma samples (n = 20 per pregnant group) were obtained from non-pregnant and pregnant women in the first (FT, 6-12 weeks), second (ST, 22-24 weeks) and third (TT, 32-38 weeks) trimester. The number of exosomes and placental exosome contribution were determined by quantifying immunoreactive exosomal CD63 and placenta-specific marker (PLAP), respectively. The effect of exosomes isolated from FT, ST and TT on endothelial cell migration were established using a real-time, live-cell imaging system (Incucyte). Exosome plasma concentration was more than 50-fold greater in pregnant women than in non-pregnant women (p<0.001). During normal healthy pregnancy, the number of exosomes present in maternal plasma increased significantly with gestational age by more that two-fold (p<0.001). Exosomes isolated from FT, ST and TT increased endothelial cell migration by 1.9 +/- 0.1, 1.6 +/- 0.2 and 1.3 +/- 0.1-fold, respectively compared to the control. Pregnancy is associated with a dramatic increase in the number of exosomes present in plasma and maternal plasma exosomes are bioactive. While the role of placental cell-derived exosome in regulating maternal and/or fetal vascular responses remains to be elucidated, changes in exosome profile may be of clinical utility in the diagnosis of placental dysfunction.	[Salomon, Carlos; Kobayashi, Miharu; Scholz-Romero, Katherin; Sobrevia, Luis; Illanes, Sebastian E.; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld 4072, Australia; [Jose Torres, Maria; Dobierzewska, Aneta; Illanes, Sebastian E.] Univ Los Andes, Fac Med, Dept Obstetr & Gynaecol, Santiago, Chile; [Sobrevia, Luis] Pontificia Univ Catolica Chile, Fac Med, Sch Med, CMPL,Div Obstet & Gynaecol, Santiago, Chile	Royal Brisbane & Women's Hospital; University of Queensland; Universidad de los Andes - Chile; Pontificia Universidad Catolica de Chile	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Ctr Clin Diagnost, Royal Brisbane & Womens Hosp, Brisbane, Qld 4072, Australia.	c.salomongallo@uq.edu.au	Torres, Maria/GVU-3391-2022; Salomon, Carlos F/L-2167-2013; RICE, GREGORY E/F-2412-2010; Sobrevia, Luis/H-9608-2016; Mitchell, Murray/A-8639-2010	Salomon, Carlos F/0000-0003-4474-0046; RICE, GREGORY E/0000-0001-7177-0246; Mitchell, Murray/0000-0002-6167-7176; Sobrevia, Luis/0000-0001-5802-2243; Illanes, Sebastian/0000-0001-5433-9315	CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile); FONDECYT [1110977]; CONICYT; Faculty of Medicine/PUC; University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC; CIEF grant (University of Queensland); Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government); Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government)	CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Faculty of Medicine/PUC; University of Queensland Centre for Clinical Research, Brisbane, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIEF grant (University of Queensland); Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government); Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government)(Australian Government)	This investigation was supported by CONICYT (ACT-73 PIA, PasantA-a Doctoral en el Extranjero BECAS Chile), FONDECYT (1110977). CS hold CONICYT-PhD fellowships and Faculty of Medicine/PUC-PhD fellowships. CS holds a Postdoctoral Fellowship at The University of Queensland Centre for Clinical Research, Brisbane, Australia. GER was in receipt of an NHMRC Principal Research Fellowship. The work described herein was partially funded by a CIEF grant (University of Queensland), a Smart Futures Fund grant (Department of Employment, Economic Development and Innovation, Queensland Government) and a Translating Health Discovery into Clinical Applications SuperScience Award (Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Biswas S, 2008, J OBSTET GYNAECOL RE, V34, P487, DOI 10.1111/j.1447-0756.2008.00719.x; Brinkfeldt K, 2006, ICARUS, V182, P439, DOI 10.1016/j.icarus.2005.12.023; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Chen YW, 2012, INT J MOL MED, V29, P601, DOI 10.3892/ijmm.2012.894; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Denzer K, 2000, J CELL SCI, V113, P3365; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Futaana Y, 2006, ICARUS, V182, P413, DOI 10.1016/j.icarus.2005.08.024; Illsley NP, 2011, PLACENTA DEV DIS, P50, DOI [10.1002/9781444393927, DOI 10.1002/9781444393927]; Kshirsagar SK, 2012, PLACENTA; Liersch R, 2010, ONKOLOGIE, V33, P230; Lok CAR, 2012, AM J REPROD IMMUNOL, V67, P206, DOI 10.1111/j.1600-0897.2011.01079.x; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Lundin R, 2006, ICARUS, V182, P308, DOI 10.1016/j.icarus.2005.10.035; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; van der Post JAM, 2011, SEMIN THROMB HEMOST, V37, P146, DOI 10.1055/s-0030-1270342; Verweij Frederik J, 2012, Commun Integr Biol, V5, P88; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155	39	223	231	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98667	10.1371/journal.pone.0098667	http://dx.doi.org/10.1371/journal.pone.0098667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905832	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000046
J	Svishcheva, GR; Belonogova, NM; Axenovich, TI				Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.			FFBSKAT: Fast Family-Based Sequence Kernel Association Test	PLOS ONE			English	Article							GENETIC PATHWAY; RARE VARIANTS; REGRESSION; MODEL	The kernel machine-based regression is an efficient approach to region-based association analysis aimed at Identification of rare genetic variants. However, this method is computationally complex. The running time of kernel-based association analysis becomes especially long for samples with genetic (sub) structure h increasing the need to develop new and effective methods, algorithms, and software packages. We have developed a new R-package called fast family-based sequence kernel association test (FFBSKAT) for analysis of quantitative traits in samples of related individuals. This software implements a score-based variance component test to assess he association of a given set of single nucleotide polymorphisrns with a continuous phenotype. We compared the performance of our software with that of two existing software for family-based sequence kernel association testing, namely, ASKAT and farnSKAT, using the Genetic Analysis Workshop 17 family sample. Results demonstrate that FFBSKAT is several times faster than other available programs In addition, the calculations of the three-compared software were similarly accurate. With respect to the available analysis modes, we combined the advantages of both ASKAT and farnSKAT and added new options to empower FFBSKAT users. The FFBSIKAT package is fast, user-friendly, and provides an easy-to-use method to perform whole-exome kernel machine-based regression association analysis of quantitative traits in samples of related individuals. The FFBSKAT package, along with its manual, is available for free download at http://mga.bionet.nsc.rui/soft/FFBSKAT/.	[Svishcheva, Gulnara R.; Belonogova, Nadezhda M.; Axenovich, Tatiana I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Axenovich, Tatiana I.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Axenovich, TI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	aks@bionet.nsc.ru	Svishcheva, Gulnara/AAD-2881-2022; Axenovich, Tatiana I/AAD-2595-2022; Svishcheva, Gulnara/L-4010-2015	Svishcheva, Gulnara/0000-0001-9478-267X; Axenovich, Tatiana I/0000-0002-4318-4458; 	Russian Foundation for Basic Research [13-04-00272, 14-04-00126]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grants from the Russian Foundation for Basic Research (13-04-00272, 14-04-00126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy Laura, 2011, BMC Proc, V5 Suppl 9, pS2, DOI 10.1186/1753-6561-5-S9-S2; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Rhudy Matthew, 2011, International Journal of Navigation and Observation, DOI 10.1155/2011/416828; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Zhang Qunyuan, 2011, BMC Proc, V5 Suppl 9, pS35, DOI 10.1186/1753-6561-5-S9-S35; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	30	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99407	10.1371/journal.pone.0099407	http://dx.doi.org/10.1371/journal.pone.0099407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905468	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000120
J	Castano-Rodriguez, N; Kaakoush, NO; Goh, KL; Fock, KM; Mitchell, HM				Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Goh, Khean-Lee; Fock, Kwong Ming; Mitchell, Hazel M.			The NOD-Like Receptor Signalling Pathway in Helicobacter pylori Infection and Related Gastric Cancer: A Case-Control Study and Gene Expression Analyses	PLOS ONE			English	Article							NF-KAPPA-B; COLON INFLAMMATION; PROTEIN; ACTIVATION; SUSCEPTIBILITY; IMMUNITY; CARD8; IL-1-BETA; INDUCTION; CASPASE-1	Background: Currently, it is well established that cancer arises in chronically inflamed tissue. A number of NOD-like receptors (NLRs) form inflammasomes, intracellular multiprotein complexes critical for generating mature pro-inflammatory cytokines (IL-1 beta and IL-18). As chronic inflammation of the gastric mucosa is a consequence of Helicobacter pylori infection, we investigated the role of genetic polymorphisms and expression of genes involved in the NLR signalling pathway in H. pylori infection and related gastric cancer (GC). Materials and Methods: Fifty-one genetic polymorphisms were genotyped in 310 ethnic Chinese (87 non-cardia GC cases and 223 controls with functional dyspepsia). In addition, gene expression of 84 molecules involved in the NLR signalling pathway was assessed in THP-1 cells challenged with two H. pylori strains, GC026 (GC) and 26695 (gastritis). Results: CARD8-rs11672725, NLRP3-rs10754558, NLRP3-rs4612666, NLRP12-rs199475867 and NLRX1-rs10790286 showed significant associations with GC. On multivariate analysis, CARD8-rs11672725 remained a risk factor (OR: 4.80, 95% CI: 1.39-16.58). Further, NLRP12-rs2866112 increased the risk of H. pylori infection (OR: 2.13, 95% CI: 1.22-3.71). Statistical analyses assessing the joint effect of H. pylori infection and the selected polymorphisms revealed strong associations with GC (CARD8, NLRP3, CASP1 and NLRP12 polymorphisms). In gene expression analyses, five genes encoding NLRs were significantly regulated in H. pylori-challenged cells (NLRC4, NLRC5, NLRP9, NLRP12 and NLRX1). Interestingly, persistent up-regulation of NFKB1 with simultaneous down-regulation of NLRP12 and NLRX1 was observed in H. pylori GC026-challenged cells. Further, NF-kappa B target genes encoding pro-inflammatory cytokines, chemokines and molecules involved in carcinogenesis were markedly up-regulated in H. pylori GC026-challenged cells. Conclusions: Novel associations between polymorphisms in the NLR signalling pathway (CARD8, NLRP3, NLRP12, NLRX1, and CASP1) and GC were identified in Chinese individuals. Our genetic polymorphisms and gene expression results highlight the relevance of the NLR signalling pathway in gastric carcinogenesis and its close interaction with NF-kappa B.	[Castano-Rodriguez, Natalia; Kaakoush, Nadeem O.; Mitchell, Hazel M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Fock, Kwong Ming] Changi Gen Hosp, Div Gastroenterol, Dept Med, Singapore, Singapore	University of New South Wales Sydney; Universiti Malaya; Changi General Hospital	Mitchell, HM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	h.mitchell@unsw.edu.au	Kaakoush, Nadeem/ABG-9499-2020; Goh, Khean-Lee/B-6404-2009	Goh, Khean-Lee/0000-0002-9965-1561; Castano-Rodriguez, Natalia/0000-0001-8819-8872; Kaakoush, Nadeem Omar/0000-0003-4017-1077	Cancer Council of New South Wales, Australia [66/04]; National Health and Medical Research Council, Australia	Cancer Council of New South Wales, Australia(Cancer Council New South Wales); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by The Cancer Council of New South Wales, Australia (Grant no.66/04). N.O. Kaakoush is supported by an Early Career fellowship from the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; AKOPYANTS NS, 1995, INFECT IMMUN, V63, P116, DOI 10.1128/IAI.63.1.116-121.1995; Allen IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060842; Allen IC, 2012, IMMUNITY, V36, P742, DOI 10.1016/j.immuni.2012.03.012; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bouchier-Hayes L, 2001, J BIOL CHEM, V276, P44069, DOI 10.1074/jbc.M107373200; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure E, 2014, AM J RESP CRIT CARE; Fehlings M, 2012, INFECT IMMUN, V80, P2724, DOI 10.1128/IAI.00381-12; Ferlay J SI, 2013, IARC CANCERBASE; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gunaletchumy SP, 2012, J BACTERIOL, V194, P5695, DOI 10.1128/JB.01278-12; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hitzler I, 2012, J IMMUNOL, V188, P3594, DOI 10.4049/jimmunol.1103212; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim DJ, 2013, EUR J IMMUNOL, V43, P2650, DOI 10.1002/eji.201243281; Lavender NA, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-11; Li ZS, 2011, CANCER LETT, V313, P192, DOI 10.1016/j.canlet.2011.09.007; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Maeda S, 2002, GUT, V50, P771, DOI 10.1136/gut.50.6.771; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mitchell H, 2008, ALIMENT PHARM THER, V28, P903, DOI 10.1111/j.1365-2036.2008.03792.x; Mockelmann N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-79; Oeth PB M, 2005, IPLEX ASSAY INCREASE, P12; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pathan N, 2001, J BIOL CHEM, V276, P32220, DOI 10.1074/jbc.M100433200; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Schmausser B, 2004, INFECT IMMUN, V72, P6773, DOI 10.1128/IAI.72.12.6773-6779.2004; Schmidt HMA, 2010, EUR J CLIN MICROBIOL, V29, P439, DOI 10.1007/s10096-010-0881-7; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada M, 2008, EUR J GASTROEN HEPAT, V20, P1144, DOI 10.1097/MEG.0b013e32830edb15; Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Tadaki H, 2011, J HUM GENET, V56, P343, DOI 10.1038/jhg.2011.16; Talley NJ, 1999, GUT, V45, P37; Tamm I, 2000, CLIN CANCER RES, V6, P1796; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Williams KL, 2005, J BIOL CHEM, V280, P39914, DOI 10.1074/jbc.M502820200; Wu WKK, 2010, CANCER LETT, V295, P7, DOI 10.1016/j.canlet.2010.03.015; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yang JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/248585; Yang SK, 2011, J HUM GENET, V56, P217, DOI 10.1038/jhg.2010.170; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	61	61	63	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98899	10.1371/journal.pone.0098899	http://dx.doi.org/10.1371/journal.pone.0098899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901306	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400070
J	Dave, LA; Montoya, CA; Rutherfurd, SM; Moughan, PJ				Dave, Lakshmi A.; Montoya, Carlos A.; Rutherfurd, Shane M.; Moughan, Paul J.			Gastrointestinal Endogenous Proteins as a Source of Bioactive Peptides - An In Silico Study	PLOS ONE			English	Article							ACTIVE PEPTIDES; FOOD PROTEINS; SERUM-ALBUMIN; PIGS; DIGESTIBILITY; PRECURSORS; DATABASE; DIGESTA; MOTIFS; TRACT	Dietary proteins are known to contain bioactive peptides that are released during digestion. Endogenous proteins secreted into the gastrointestinal tract represent a quantitatively greater supply of protein to the gut lumen than those of dietary origin. Many of these endogenous proteins are digested in the gastrointestinal tract but the possibility that these are also a source of bioactive peptides has not been considered. An in silico prediction method was used to test if bioactive peptides could be derived from the gastrointestinal digestion of gut endogenous proteins. Twenty six gut endogenous proteins and seven dietary proteins were evaluated. The peptides present after gastric and intestinal digestion were predicted based on the amino acid sequence of the proteins and the known specificities of the major gastrointestinal proteases. The predicted resultant peptides possessing amino acid sequences identical to those of known bioactive peptides were identified. After gastrointestinal digestion (based on the in silico simulation), the total number of bioactive peptides predicted to be released ranged from 1 (gliadin) to 55 (myosin) for the selected dietary proteins and from 1 (secretin) to 39 (mucin-5AC) for the selected gut endogenous proteins. Within the intact proteins and after simulated gastrointestinal digestion, angiotensin converting enzyme (ACE)-inhibitory peptide sequences were the most frequently observed in both the dietary and endogenous proteins. Among the dietary proteins, after in silico simulated gastrointestinal digestion, myosin was found to have the highest number of ACE-inhibitory peptide sequences (49 peptides), while for the gut endogenous proteins, mucin-5AC had the greatest number of ACE-inhibitory peptide sequences (38 peptides). Gut endogenous proteins may be an important source of bioactive peptides in the gut particularly since gut endogenous proteins represent a quantitatively large and consistent source of protein.	[Dave, Lakshmi A.; Montoya, Carlos A.; Rutherfurd, Shane M.; Moughan, Paul J.] Massey Univ, Riddet Inst, Palmerston North, New Zealand	Massey University	Rutherfurd, SM (corresponding author), Massey Univ, Riddet Inst, Palmerston North, New Zealand.	S.M.Rutherfurd@massey.ac.nz	Rutherfurd, Shane M/D-8254-2011	Montoya, Carlos A./0000-0001-6953-8624; Dave, Lakshmi/0000-0003-0271-4296	Centre of Research Excellence fund from the Tertiary Education Commission; Ministry of Education, New Zealand	Centre of Research Excellence fund from the Tertiary Education Commission; Ministry of Education, New Zealand	The authors acknowledge the financial support provided by the Centre of Research Excellence fund from the Tertiary Education Commission and the Ministry of Education, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 14719827 FAO, V14719827, P421; Boutrou R, 2013, AM J CLIN NUTR, V97, P1314, DOI 10.3945/ajcn.112.055202; BRASSINNE A, 1974, GUT, V15, P194, DOI 10.1136/gut.15.3.194; Chair of Food Biochemistry University of Warmia and Mazury in Olsztyn Poland, 2012, BIOPEP; Cheung IWY, 2009, J AGR FOOD CHEM, V57, P9234, DOI 10.1021/jf9018245; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1, 10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A]; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ERICKSON RH, 1990, ANNU REV MED, V41, P133; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; HERCZEG B, 1975, ACTA CHIR HUNG, V16, P13; Iwaniak A, 2011, FOOD TECHNOL BIOTECH, V49, P118; Iwaniak A, 2009, FOOD TECHNOL BIOTECH, V47, P441; Iwaniak A, 2009, ACTA SCI POLON-TECHN, V8, P59; Keil B., 1992, SPECIFICITY PROTEOLY, V331, P201, DOI DOI 10.1007/978-3-642-48380-6; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; Meisel H, 1997, LIVEST PROD SCI, V50, P125, DOI 10.1016/S0301-6226(97)00083-3; Meisel H., 1990, Trends in Food Science & Technology, V1, P41, DOI 10.1016/0924-2244(90)90029-X; Miner-Williams W, 2012, AM J CLIN NUTR, V96, P508, DOI 10.3945/ajcn.111.033472; Miner-Williams W, 2009, J AGR FOOD CHEM, V57, P2072, DOI 10.1021/jf8023886; Minkiewicz P, 2011, FOOD SCI TECHNOL INT, V17, P39, DOI 10.1177/1082013210368461; Minkiewicz P, 2008, J AOAC INT, V91, P965; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Moughan PJ, 2012, AMINO ACIDS IN HUMAN NUTRITION AND HEALTH, P245, DOI 10.1079/9781845937980.0245; Moughan P. J., 2013, NUTR RES REV, P1; Moughan PJ, 2007, INT J SPORT NUTR EXE, V17, pS5, DOI 10.1123/ijsnem.17.s1.s5; Moughan PJ, 2012, BRIT J NUTR, V108, pS258, DOI 10.1017/S0007114512002474; Urista CM, 2011, FOOD SCI TECHNOL INT, V17, P293, DOI 10.1177/1082013211398801; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Nutrient Data Laboratory, REL 25 NAT NUTR DAT; Nyachoti CM, 1997, CAN J ANIM SCI, V77, P149, DOI 10.4141/A96-044; Ohsawa K, 2008, J AGR FOOD CHEM, V56, P854, DOI 10.1021/jf072671n; Rutherfurd-Markwick KJ, 2005, J AOAC INT, V88, P955; Ryan JT, 2011, NUTRIENTS, V3, P765, DOI 10.3390/nu3090765; Segura-Campos M, 2011, FOOD REV INT, V27, P213, DOI 10.1080/87559129.2011.563395; Shahidi F, 2008, J AOAC INT, V91, P914; SOUFFRANT WB, 1993, REPROD NUTR DEV, V33, P373, DOI 10.1051/rnd:19930406; Terashima M, 2010, J AGR FOOD CHEM, V58, P7432, DOI 10.1021/jf100977z; The UniProt Consortium, 2012, PEPTIDECUTTER; The UniProt Consortium, 2012, UNIPROTKB; Vercruysse L, 2009, PEPTIDES, V30, P575, DOI 10.1016/j.peptides.2008.06.027; WHO, 2007, WHO TECH REP SER, V935, P1; Wilkins MR, 1999, METH MOL B, V112, P531	42	20	20	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98922	10.1371/journal.pone.0098922	http://dx.doi.org/10.1371/journal.pone.0098922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901416	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400071
J	Hao, CL; Huang, S; Deng, ZX; Zhao, CM; Yu, Y				Hao, Chunlin; Huang, Sheng; Deng, Zixin; Zhao, Changming; Yu, Yi			Mining of the Pyrrolamide Antibiotics Analogs in Streptomyces netropsis Reveals the Amidohydrolase-Dependent ``Iterative Strategy'' Underlying the Pyrrole Polymerization	PLOS ONE			English	Article							NATURAL-PRODUCT EXTRACTS; MINOR-GROOVE BINDERS; BIOSYNTHETIC PATHWAYS; ALKYLATING-AGENTS; DISTAMYCIN-A; DEREPLICATION; CONGOCIDINE	In biosynthesis of natural products, potential intermediates or analogs of a particular compound in the crude extracts are commonly overlooked in routine assays due to their low concentration, limited structural information, or because of their insignificant bio-activities. This may lead into an incomplete and even an incorrect biosynthetic pathway for the target molecule. Here we applied multiple compound mining approaches, including genome scanning and precursor ion scan-directed mass spectrometry, to identify potential pyrrolamide compounds in the fermentation culture of Streptomyces netropsis. Several novel congocidine and distamycin analogs were thus detected and characterized. A more reasonable route for the biosynthesis of pyrrolamides was proposed based on the structures of these newly discovered compounds, as well as the functional characterization of several key biosynthetic genes of pyrrolamides. Collectively, our results implied an unusual ``iterative strategy'' underlying the pyrrole polymerization in the biosynthesis of pyrrolamide antibiotics.	[Hao, Chunlin; Huang, Sheng; Deng, Zixin; Zhao, Changming; Yu, Yi] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430072, Peoples R China; [Yu, Yi] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Deng, Zixin] Wuhan Inst Biotechnol, Hubei Engn Lab Synthet Microbiol, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Zhao, CM (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatory Biosynth & Drug Discovery, Wuhan 430072, Peoples R China.	cmzhao03@whu.edu.cn; yu_yi@whu.edu.cn		Hao, Chunlin/0000-0002-5818-1954	Ministry of Science and Technology of the People's Republic of China ("973" Program) [2013CB734003, 2012CB721006]; Ministry of Science and Technology of the People's Republic of China ("863" Program) [2012AA02A701]; National Natural Science Foundation of China [81102357, 81273411, 31200037]; Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry	Ministry of Science and Technology of the People's Republic of China ("973" Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China ("863" Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry	This work was financially supported in part by grants from Ministry of Science and Technology of the People's Republic of China ("973" Program 2013CB734003 and 2012CB721006, "863" Program 2012AA02A701), National Natural Science Foundation of China (81102357, 81273411 and 31200037), and the Open Fund of the State Key Laboratory of Bio-Organic and Natural Products Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2000, J ANTIBIOT, V53, P66, DOI 10.7164/antibiotics.53.66; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P231, DOI 10.2174/1568026043451474; Barrett MP, 2013, PHARMACOL THERAPEUT, V139, P12, DOI 10.1016/j.pharmthera.2013.03.002; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bumpus SB, 2009, NAT BIOTECHNOL, V27, P951, DOI 10.1038/nbt.1565; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Cordell GA, 1999, PURE APPL CHEM, V71, P1089, DOI 10.1351/pac199971061089; Corre C, 2009, NAT PROD REP, V26, P977, DOI 10.1039/b713024b; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Nguyen DD, 2013, P NATL ACAD SCI USA, V110, pE2611, DOI 10.1073/pnas.1303471110; Fuchs JE, 2011, J CHEM INF MODEL, V51, P2223, DOI 10.1021/ci200237c; Hertweck C, 2009, NAT CHEM BIOL, V5, P450, DOI 10.1038/nchembio0709-450; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Iyer P, 2013, CHEM RES TOXICOL, V26, P156, DOI 10.1021/tx300437x; Juguet M, 2009, CHEM BIOL, V16, P421, DOI 10.1016/j.chembiol.2009.03.010; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; Lang G, 2008, J NAT PROD, V71, P1595, DOI 10.1021/np8002222; Lautru S, 2012, ANGEW CHEM INT EDIT, V51, P7454, DOI 10.1002/anie.201201445; Matteoli B, 2008, INTERVIROLOGY, V51, P166, DOI 10.1159/000148199; Menzella HG, 2007, CURR OPIN MICROBIOL, V10, P238, DOI 10.1016/j.mib.2007.05.005; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Qu XD, 2011, ANGEW CHEM INT EDIT, V50, P9651, DOI 10.1002/anie.201103085; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Shanna Sudha, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P183; Uria-Nickelsen M, 2013, INT J ANTIMICROB AG, V41, P28, DOI 10.1016/j.ijantimicag.2012.08.017; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Yamanaka K, 2008, NAT CHEM BIOL, V4, P766, DOI 10.1038/nchembio.125; Yamanaka K, 2010, APPL ENVIRON MICROB, V76, P5669, DOI 10.1128/AEM.00853-10; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	33	11	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99077	10.1371/journal.pone.0099077	http://dx.doi.org/10.1371/journal.pone.0099077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901640	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400093
J	Nayak, S; Doerfler, PA; Porvasnik, SL; Cloutier, DD; Khanna, R; Valenzano, KJ; Herzog, RW; Byrne, BJ				Nayak, Sushrusha; Doerfler, Phillip A.; Porvasnik, Stacy L.; Cloutier, Denise D.; Khanna, Richie; Valenzano, Ken J.; Herzog, Roland W.; Byrne, Barry J.			Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent	PLOS ONE			English	Article							ACID ALPHA-GLUCOSIDASE; ENZYME REPLACEMENT THERAPY; FACTOR-IX; TOLERANCE INDUCTION; GENE-THERAPY; GLYCOGEN; ANAPHYLAXIS; CHAPERONES; CLEARANCE; EFFICACY	Enzyme replacement therapy (ERT) with recombinant human acid-a-glucosidase (rhGAA) is the only FDA approved therapy for Pompe disease. Without ERT, severely affected individuals (early onset) succumb to the disease within 2 years of life. A spectrum of disease severity and progression exists depending upon the type of mutation in the GAA gene (GAA), which in turn determines the amount of defective protein produced and its enzymatic activity. A large percent of the early onset patients are also cross reactive immunological material negative (CRIM-) and develop high titer immune responses to ERT with rhGAA. New insights from our studies in pre-clinical murine models reveal that the type of Gaa mutation has a profound effect on the immune responses mounted against ERT and the associated toxicities, including activation of clotting factors and disseminated intravascular coagulation (DIC). Additionally, the mouse strain affects outcomes, suggesting the influence of additional genetic components or modifiers. High doses of rhGAA (20 mg/kg) are currently required to achieve therapeutic benefit. Our studies indicate that lower enzyme doses reduce the antibody responses to rhGAA, reduce the incidence of immune toxicity and avoid ERT-associated anaphylaxis. Therefore, development of rhGAA with increased efficacy is warranted to limit immunotoxicities.	[Nayak, Sushrusha; Doerfler, Phillip A.; Porvasnik, Stacy L.; Cloutier, Denise D.; Byrne, Barry J.] Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32611 USA; [Nayak, Sushrusha] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Khanna, Richie; Valenzano, Ken J.] Amicus Therapeut Inc, Cranbury, NJ USA; [Herzog, Roland W.] Univ Florida, Dept Pediat Cellular & Mol Therapy, Gainesville, FL USA	State University System of Florida; University of Florida; Karolinska Institutet; State University System of Florida; University of Florida	Nayak, S (corresponding author), Univ Florida, Dept Pediat, Powell Gene Therapy Ctr, Gainesville, FL 32611 USA.	sushrusha.nayak@ki.se; bbyrne@ufl.edu		Byrne, Barry J./0000-0002-7302-1756; Doerfler, Phillip/0000-0001-7566-9073; nayak, sushrusha/0000-0003-1243-5792	NIH [P01 HL59412, P01 DK58327, R01 HL107904]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043730] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059412, R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIH grants P01 HL59412 and P01 DK58327 to BJ Byrne and R01 HL107904 to RW Herzog. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banugaria SG, 2012, GENETICS MED OFFICIA; Banugaria S, 2011, MOL GENET METAB, V102, pS6, DOI 10.1016/j.ymgme.2010.11.020; Byrne BJ, 2011, HUM MOL GENET, V20, pR61, DOI 10.1093/hmg/ddr174; Byrne BJ, 2011, MOL GENET METAB, V103, P1, DOI 10.1016/j.ymgme.2011.02.004; Cao O, 2009, MOL THER, V17, P1733, DOI 10.1038/mt.2009.159; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Cousens LP, 2012, HUM VACC IMMUNOTHER, V8, P1459, DOI 10.4161/hv.21405; de Vries JM, 2010, MOL GENET METAB, V101, P338, DOI 10.1016/j.ymgme.2010.08.009; Elder ME, 2013, J PEDIATR-US, V163, P847, DOI 10.1016/j.jpeds.2013.03.002; ElMallah MK, 2014, MOL THER, V22, P702, DOI 10.1038/mt.2013.282; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; FELIX SB, 1990, RES EXP MED, V190, P239, DOI 10.1007/BF00000029; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Hughes DA, 2013, MOL GENET METAB, V109, P269, DOI 10.1016/j.ymgme.2013.04.015; Khanna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040776; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Korpela MP, 2009, MUSCLE NERVE, V40, P143, DOI 10.1002/mus.21291; Lacana E, 2012, AM J MED GENET C, V160C, P30, DOI [10.1002/ajmc.31316, 10.1002/ajmg.c.31316]; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663; Markusic DM, 2013, EMBO MOL MED, V5, P1698, DOI 10.1002/emmm.201302859; Messinger YH, 2012, GENET MED, V14, P135, DOI 10.1038/gim.2011.4; Nayak S, 2012, MOL GENET METAB, V106, P189, DOI 10.1016/j.ymgme.2012.03.009; Nemeth N, 2009, BIORHEOLOGY, V46, P155, DOI 10.3233/BIR-2009-0533; Ohashi T, 2011, MOL GENET METAB, V103, P98, DOI 10.1016/j.ymgme.2011.01.009; Okumiya T, 2007, MOL GENET METAB, V90, P49, DOI 10.1016/j.ymgme.2006.09.010; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; Regnery C, 2012, J INHERITED METABOLI; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Sun BD, 2010, MOL THER, V18, P353, DOI 10.1038/mt.2009.195; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; van Gelder CM, 2014, J INHERITED METABOLI; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Weinreb NJ, 2013, J INHERIT METAB DIS, V36, P543, DOI 10.1007/s10545-012-9528-4; Zhu YX, 2004, J BIOL CHEM, V279, P50336, DOI 10.1074/jbc.M409676200	38	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98336	10.1371/journal.pone.0098336	http://dx.doi.org/10.1371/journal.pone.0098336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897114	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700033
J	Wu, DW; Hsu, NY; Wang, YC; Lee, MC; Cheng, YW; Chen, CY; Lee, H				Wu, D-W; Hsu, N-Y; Wang, Y-C; Lee, M-C; Cheng, Y-W; Chen, C-Y; Lee, H.			c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT	ONCOGENE			English	Article							NF-KAPPA-B; DNA METHYLTRANSFERASES; ABERRANT METHYLATION; PROTEIN EXPRESSION; ALLELIC DELETION; CHRONIC SMOKERS; DOWN-REGULATION; GENE; CARCINOMA; APOPTOSIS	The dual role of the microRNA-29 (miR-29) family in tumor progression and metastasis in solid tumors has been reported. Evidence for the role of miR-29 in tumor malignancy and its prognostic value in overall survival (OS) and relapse-free survival (RFS) in non-small cell lung cancer (NSCLC) remains conflicting. Mechanistic studies presented herein demonstrated that c-Myc suppressed the expression of miR-29b, promoting soft agar growth and invasion capability in lung cancer cells. Interestingly, the decrease in the expression of miR-29b by c-Myc is responsible for soft agar growth and invasiveness mediated by FHIT loss due to promoter methylation. Among patients, low expression of miR-29b and FHIT was more common in tumors with high c-Myc expression than in tumors with low c-Myc expression. Kaplan-Meier and Cox regression analysis showed that tumors with high c-Myc, low miR-29b and low FHIT expression had shorter OS and RFS periods than their counterparts. In conclusion, the decrease in the expression of miR-29b by c-Myc may be responsible for FHIT loss-mediated tumor aggressiveness and for poor outcome in NSCLC. Therefore, we suggest that restoration of the miR-29b expression using the c-Myc inhibitor might be helpful in suppressing tumor aggressiveness mediated by FHIT loss and consequently improving outcomes in NSCLC patients with tumors with low expression of FHIT.	[Wu, D-W; Hsu, N-Y; Cheng, Y-W; Lee, H.] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei 115, Taiwan; [Wang, Y-C] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wang, Y-C] Chung Shan Med Univ Hosp, Dept Chest Med, Taichung 40201, Taiwan; [Lee, M-C] Taichung Vet Gen Hosp, Dept Thorac Surg, Taichung, Taiwan; [Chen, C-Y] China Med Univ Hosp, Dept Surg, Taichung, Taiwan	Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, H (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Room 5,12th Floor,3,Pk St, Taipei 115, Taiwan.	hl@tmu.edu.tw			National Health Research Institute [NHRI96-TD-G-111-006, NHRI97-TD-G-111-006]; National Science Council of Taiwan, ROC [100-2314-B-038-043-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Health Research Institute (NHRI96-TD-G-111-006; NHRI97-TD-G-111-006) and the National Science Council(100-2314-B-038-043-MY3) of Taiwan, ROC.	Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Burke L, 1998, CANCER RES, V58, P2533; Butler D, 2000, J PATHOL, V192, P502, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH718&gt;3.0.CO;2-H; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheng YW, 2007, CANCER RES, V67, P10686, DOI 10.1158/0008-5472.CAN-07-1461; Connolly DC, 2000, CLIN CANCER RES, V6, P3505; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gong JN, 2014, CELL DEATH DIFFER, V21, P100, DOI 10.1038/cdd.2013.133; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; James MA, 2006, J VIROL, V80, P5301, DOI 10.1128/JVI.01942-05; Jin BL, 2013, ADV EXP MED BIOL, V754, P3, DOI 10.1007/978-1-4419-9967-2_1; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Lee YC, 2004, BRIT J CANCER, V90, P2378, DOI 10.1038/sj.bjc.6601778; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; McMurray HR, 2003, J VIROL, V77, P9852, DOI 10.1128/JVI.77.18.9852-9861.2003; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Napoli C, 2002, NEOPLASIA, V4, P185, DOI 10.1038/sj.neo.7900232; Okuyama H, 2010, CANCER RES, V70, P10213, DOI 10.1158/0008-5472.CAN-10-2720; Pavelic K, 2001, MOL MED, V7, P442, DOI 10.1007/BF03401849; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Pylkkanen L, 2002, INT J ONCOL, V20, P285; Robson S, 2006, RECENT PAT ANTI-CANC, V1, P305, DOI 10.2174/157489206778776934; Rothschild SI, 2012, ONCOGENE, V31, P4221, DOI 10.1038/onc.2011.578; Tomizawa Y, 1998, CANCER RES, V58, P5478; Treppendahl MB, 2012, BLOOD, V119, P206, DOI 10.1182/blood-2011-06-362541; Tseng JE, 1999, CANCER RES, V59, P4798; Wang J, 2006, CANCER LETT, V235, P18, DOI 10.1016/j.canlet.2005.03.058; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Wu MF, 2005, INT J CANCER, V113, P440, DOI 10.1002/ijc.20597; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu M, 2010, J VIROL, V84, P11461, DOI 10.1128/JVI.00538-10; Yoon SO, 2007, HUM PATHOL, V38, P326, DOI 10.1016/j.humpath.2006.08.012; Yu PN, 2014, INT J CANCER, V134, P542, DOI 10.1002/ijc.28399; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003	41	62	68	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2072	2082		10.1038/onc.2014.152	http://dx.doi.org/10.1038/onc.2014.152			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909176				2022-12-25	WOS:000353173400007
J	Martin, KR; Cooper, R; Harris, TB; Brage, S; Hardy, R; Kuh, D				Martin, Kathryn R.; Cooper, Rachel; Harris, Tamara B.; Brage, Soren; Hardy, Rebecca; Kuh, Diana		NSHD Sci Data Collection Team	Patterns of Leisure-Time Physical Activity Participation in a British Birth Cohort at Early Old Age	PLOS ONE			English	Article							UNITED-STATES; HEALTH SURVEY; ADULTS; TRENDS; DETERMINANTS; DISABILITY; COMPENDIUM; FITNESS; BARRIER; OBESITY	Using data from a nationally representative British birth cohort we characterized the type and diversity of leisure-time physical activity that 2,188 participants (age 60-64 years) engaged in throughout the year by gender and obesity. Participants most commonly reported walking (71%), swimming (33%), floor exercises ( 24%) and cycling (15%). Sixty-two percent of participants reported >= 2 activities in the past year and 40% reported diversity on a regular basis. Regular engagement in different types of activity (cardio-respiratory, balance/flexibility and strength) was reported by 67%, 19% and 11% of participants, respectively. We found gender differences, as well as differences by obesity status, in the activities reported, the levels of activity diversity and activity type. Non-obese participants had greater activity diversity, and more often reported activities beneficial for cardio-respiratory health and balance/flexibility than obese participants. These findings may be used to inform the development of trials of physical activity interventions targeting older adults, and those older adults with high body mass index.	[Martin, Kathryn R.] Univ Aberdeen, Sch Med & Dent, Epidemiol Grp, Aberdeen, Scotland; [Martin, Kathryn R.; Cooper, Rachel; Hardy, Rebecca; Kuh, Diana] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Martin, Kathryn R.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, NIH, Bethesda, MD 20892 USA; [Brage, Soren] Univ Cambridge, Inst Metab Sci, Sch Clin Med, MRC,Epidemiol Unit, Cambridge, England	University of Aberdeen; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge	Martin, KR (corresponding author), Univ Aberdeen, Sch Med & Dent, Epidemiol Grp, Aberdeen, Scotland.	kathryn.martin@abdn.ac.uk	Osika, Walter/AAH-7966-2020; Brage, Soren/C-6415-2013; Wong, Andrew/M-8899-2016; Kuh, Diana/L-6019-2014; Cooper, Rachel/ABE-3768-2021; Hardy, Rebecca/AFR-1989-2022	Osika, Walter/0000-0002-1583-7319; Brage, Soren/0000-0002-1265-7355; Wong, Andrew/0000-0003-2079-4779; Kuh, Diana/0000-0001-7386-2857; Cooper, Rachel/0000-0003-3370-5720; Masi, Stefano/0000-0002-7591-3686; Westgate, Kate/0000-0002-0283-3562; Chowienczyk, Phil/0000-0003-4507-038X; Hardy, Rebecca/0000-0001-9949-0799	Intramural Research Program of the National Institute on Aging, NIH; UK Medical Research Council [MC_UU_12019/1, MC_UU_12015/3]; MRC [MC_UU_12019/1, MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; Medical Research Council [MC_UU_12015/3, MC_UU_12019/1, MC_U106179473] Funding Source: researchfish	Intramural Research Program of the National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported in part by the Intramural Research Program of the National Institute on Aging, NIH, and was carried out while KRM was an IRTA postdoctoral research fellow in the Laboratory of Epidemiology and Population Sciences at the National Institute of Aging, National Institutes of Health. This work was supported by the UK Medical Research Council (programme codes MC_UU_12019/1 and MC_UU_12015/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Ball K, 2000, AUST NZ J PUBL HEAL, V24, P331, DOI 10.1111/j.1467-842X.2000.tb01579.x; Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Chen Y, 2006, PREV MED, V42, P261, DOI 10.1016/j.ypmed.2006.01.006; Chipperfield JG, 2008, J GERONTOL B-PSYCHOL, V63, pS211, DOI 10.1093/geronb/63.4.S211; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Craig R, 2009, HEALTH SURVEY FOR EN, V1, P8; Dafna M, 2012, J SCI MED SPORT, V15, P213, DOI 10.1016/j.jsams.2011.10.009; de Almeida MDV, 1999, PUBLIC HEALTH NUTR, V2, P105, DOI 10.1017/S1368980099000154; Deaner RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049168; Department of Health PAHIaP, 2011, START ACTIVE STAY AC; Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085; Finch C, 2001, MED SCI SPORT EXER, V33, P778; Golubic R, 2013, INT J OBESITY, V37, P404, DOI 10.1038/ijo.2012.58; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Hughes JP, 2008, J PHYS ACT HEALTH, V5, P347, DOI 10.1123/jpah.5.3.347; Juneau CE, 2010, PREV MED, V51, P384, DOI 10.1016/j.ypmed.2010.09.002; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; KUH DJL, 1992, J EPIDEMIOL COMMUN H, V46, P114, DOI 10.1136/jech.46.2.114; Lee IM, 2014, BRIT J SPORT MED, V48, P197, DOI 10.1136/bjsports-2013-093154; Livingstone MBE, 2001, PUBLIC HEALTH NUTR, V4, P1107, DOI 10.1079/PHN2001192; Loney T, 2011, J PHYS ACT HEALTH, V8, P62, DOI 10.1123/jpah.8.1.62; Moore LV, 2012, RES Q EXERCISE SPORT, V83, P587; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Moschny A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-121; NICE, 2013, PUBLIC HEALTH GUIDAN, V44; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sport England, 2014, ACTIVE PEOPLE SURVEY; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Waumsley J, 2011, OBESITY IN THE UK A, P5; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; Xue QL, 2012, AM J EPIDEMIOL, V176, P534, DOI 10.1093/aje/kws125; YOUNG A, 1994, BRIT MED J, V309, P331, DOI 10.1136/bmj.309.6950.331	47	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98901	10.1371/journal.pone.0098901	http://dx.doi.org/10.1371/journal.pone.0098901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI8LF	24911018	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600020
J	Ji, LL; Ma, YB; Wang, ZY; Cai, ZX; Pang, C; Wang, ZT				Ji, Lili; Ma, Yibo; Wang, Zaiyong; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao			Quercetin Prevents Pyrrolizidine Alkaloid Clivorine-Induced Liver Injury in Mice by Elevating Body Defense Capacity	PLOS ONE			English	Article							METABOLIC-ACTIVATION; MEDICINAL-PLANTS; GLUTATHIONE; HEPATOTOXICITY; INVOLVEMENT; MECHANISMS; METHIONINE; APOPTOSIS; PATHWAY; STRESS	Quercetin is a plant-derived flavonoid that is widely distributed in nature. The present study is designed to analyze the underlying mechanism in the protection of quercetin against pyrrolizidine alkaloid clivorine-induced acute liver injury in vivo. Serum transaminases, total bilirubin analysis, and liver histological evaluation demonstrated the protection of quercetin against clivorine-induced liver injury. Terminal dUTP nick end-labeling assay demonstrated that quercetin reduced the increased amount of liver apoptotic cells induced by clivorine. Western-blot analysis of caspase-3 showed that quercetin inhibited the cleaved activation of caspase-3 induced by clivorine. Results also showed that quercetin reduced the increase in liver glutathione and lipid peroxidative product malondialdehyde induced by clivorine. Quercetin reduced the enhanced liver immunohistochemical staining for 4-hydroxynonenal induced by clivorine. Results of the Mouse Stress and Toxicity PathwayFinder RT2 Profiler PCR Array demonstrated that the expression of genes related with oxidative or metabolic stress and heat shock was obviously altered after quercetin treatment. Some of the alterations were confirmed by real-time PCR. Our results demonstrated that quercetin prevents clivorine-induced acute liver injury in vivo by inhibiting apoptotic cell death and ameliorating oxidative stress injury. This protection may be caused by the elevation of the body defense capacity induced by quercetin.	[Ji, Lili; Ma, Yibo; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, SATCM Key Lab New Resources & Qual Evaluat Chines, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Ji, Lili; Ma, Yibo; Cai, Zhunxiu; Pang, Chun; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Complex Prescript, Shanghai, Peoples R China; [Ji, Lili; Wang, Zaiyong; Wang, Zhengtao] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Ji, LL (corresponding author), Shanghai Univ Tradit Chinese Med, SATCM Key Lab New Resources & Qual Evaluat Chines, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.	lichenyue1307@126.com	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	National Natural Science Foundation of China [81322053]; Program for New Century Excellent Talents in University [NCET-11-1054]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was financially supported by National Natural Science Foundation of China (81322053), the Program for New Century Excellent Talents in University (NCET-11-1054), and partially supported by Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2012, EXPERT OPIN DRUG MET, V8, P335, DOI 10.1517/17425255.2012.658041; Chen Y, 2013, FOOD CHEM TOXICOL, V60, P38, DOI 10.1016/j.fct.2013.07.008; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; de Groot H, 1998, FUND CLIN PHARMACOL, V12, P249; Domitrovic R, 2012, ACTA PHARMACOL SIN, V33, P1260, DOI 10.1038/aps.2012.62; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426; HOGBERG J, 1974, BIOCHEM BIOPH RES CO, V56, P836, DOI 10.1016/0006-291X(74)90681-0; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Ji LL, 2008, EXP TOXICOL PATHOL, V60, P87, DOI 10.1016/j.etp.2007.11.010; Ji LL, 2008, ENVIRON TOXICOL PHAR, V26, P331, DOI 10.1016/j.etap.2008.06.007; Ji LL, 2008, TOXICOL APPL PHARM, V231, P393, DOI 10.1016/j.taap.2008.05.015; Ji LL, 2010, HUM EXP TOXICOL, V29, P303, DOI 10.1177/0960327110361757; Ji LL, 2009, J CELL BIOCHEM, V108, P424, DOI 10.1002/jcb.22269; Ji LL, 2002, TOXICON, V40, P1685, DOI 10.1016/S0041-0101(02)00184-8; Jiang J., 2008, PHARM CLIN RES, V16, P178; Jie QF, 2013, ALCOHOL, V47, P141, DOI 10.1016/j.alcohol.2012.10.006; Krause RJ, 2006, CHEM RES TOXICOL, V19, P1643, DOI 10.1021/tx0601915; KUHARA K, 1980, CANCER LETT, V10, P117, DOI 10.1016/0304-3835(80)90034-8; Laverty HG, 2010, EUR J CLIN PHARMACOL, V66, P961, DOI 10.1007/s00228-010-0862-x; Li N, 2011, CURR DRUG METAB, V12, P823, DOI 10.2174/138920011797470119; Liang QN, 2011, ARCH TOXICOL, V85, P1267, DOI 10.1007/s00204-011-0664-7; Lin G, 2007, DRUG METAB DISPOS, V35, P607, DOI 10.1124/dmd.106.014100; Lin G, 2011, J HEPATOL, V54, P666, DOI 10.1016/j.jhep.2010.07.031; Ma Hong-Yan, 2009, Chinese Journal of Natural Medicines, V7, P28, DOI 10.3724/SP.J.1009.2009.00028; Ma Hongyan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P166; Mancuso C, 2009, CURR DRUG METAB, V10, P579, DOI 10.2174/138920009789375405; MIRANDA CL, 1991, CARCINOGENESIS, V12, P515, DOI 10.1093/carcin/12.3.515; Miriyala S, 2012, BBA-MOL BASIS DIS, V1822, P794, DOI 10.1016/j.bbadis.2011.12.002; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Roeder E, 2000, PHARMAZIE, V55, P711; ROEDER E, 1995, PHARMAZIE, V50, P83; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang YP, 2005, CANCER LETT, V226, P27, DOI 10.1016/j.canlet.2004.11.039; Yamamoto Y, 1998, RECENT RES CANCER, V147, P157; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003	38	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98970	10.1371/journal.pone.0098970	http://dx.doi.org/10.1371/journal.pone.0098970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905073	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000084
J	Liang, XD; Dai, YC; Li, ZY; Gan, MF; Zhang, SR; Yin-Pan; Lu, HS; Cao, XQ; Zheng, BJ; Bao, LF; Wang, DD; Zhang, LM; Ma, SL				Liang, Xiao-Dong; Dai, Yue-Chu; Li, Zhao-Yun; Gan, Mei-Fu; Zhang, Shi-Rong; Yin-Pan; Lu, Hong-Sheng; Cao, Xue-Quan; Zheng, Bei-jia; Bao, Ling-Fen; Wang, Dan-Dan; Zhang, Li-Ming; Ma, Sheng-Lin			Expression and Function Analysis of Mitotic Checkpoint Genes Identifies TTK as a Potential Therapeutic Target for Human Hepatocellular Carcinoma	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN PHOSPHATASE; CANCER-CELLS; SORAFENIB; GLIOBLASTOMA; MITOSIS; GROWTH; INHIBITION; ANEUPLOIDY; MUTATIONS	The mitotic spindle checkpoint (SAC) genes have been considered targets of anticancer therapies. Here, we sought to identify the attractive mitotic spindle checkpoint genes appropriate for human hepatocellular carcinoma (HCC) therapies. Through expression profile analysis of 137 selected mitotic spindle checkpoint genes in the publicly available microarray datasets, we showed that 13 genes were dramatically up-regulated in HCC tissues compared to normal livers and adjacent non-tumor tissues. A role of the 13 genes in proliferation was evaluated by knocking them down via small interfering RNA (siRNA) in HCC cells. As a result, several mitotic spindle checkpoint genes were required for maintaining the proliferation of HCC cells, demonstrated by cell viability assay and soft agar colony formation assay. Then we established sorafenib-resistant sublines of HCC cell lines Huh7 and HepG2. Intriguingly, increased TTK expression was significantly associated with acquired sorafenib-resistance in Huh7, HepG2 cells. More importantly, TTK was observably up-regulated in 46 (86.8%) of 53 HCC specimens. A series of in vitro and in vivo functional experiment assays showed that TTK overexpression promoted cell proliferation, anchor-dependent colony formation and resistance to sorafenib of HCC cells; TTK knockdown restrained cell growth, soft agar colony formation and resistance to sorafenib of HCC cells. Collectively, TTK plays an important role in proliferation and sorafenib resistance and could act as a potential therapeutic target for human hepatocellular carcinoma.	[Liang, Xiao-Dong; Zhang, Shi-Rong; Ma, Sheng-Lin] Nanjing Med Univ, Affiliated Hangzhou Hosp, Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Dai, Yue-Chu; Li, Zhao-Yun; Yin-Pan; Lu, Hong-Sheng; Cao, Xue-Quan; Zheng, Bei-jia; Bao, Ling-Fen; Wang, Dan-Dan; Zhang, Li-Ming] Cent Hosp Taizhou City, Taizhou, Zhejiang, Peoples R China; [Gan, Mei-Fu] Wenzhou Med Univ Linhai, Taizhou Hosp, Linhai, Zhejiang, Peoples R China	Nanjing Medical University	Ma, SL (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Hosp, Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China.	mashenglinhz@163.com	Zhang, Li/GWM-7501-2022; Liang, Xiaodong/S-7749-2019	Liang, xiaodong/0000-0001-9479-0936	Zhejiang Natural Science Foundation [Z13H160012]; Medical Science and Technology Fund of Zhejiang Provincial Health Department [2010KYA186]; Science Project of Taizhou City [141KY15-6]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Medical Science and Technology Fund of Zhejiang Provincial Health Department; Science Project of Taizhou City	This work was supported by grants from Zhejiang Natural Science Foundation (Z13H160012), Medical Science and Technology Fund of Zhejiang Provincial Health Department (2010KYA186), and Science Project of Taizhou City (141KY15-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carr BI, 2013, J CELL PHYSIOL, V228, P1344, DOI 10.1002/jcp.24291; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiou JF, 2010, ANN SURG ONCOL, V17, P603, DOI 10.1245/s10434-009-0718-8; Cormier JN, 2006, J GASTROINTEST SURG, V10, P761, DOI 10.1016/j.gassur.2005.10.006; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Fisk HA, 2004, CELL CYCLE, V3, P439; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ito Y, 2000, ONCOLOGY-BASEL, V59, P68, DOI 10.1159/000012140; Janssen Aniek, 2011, Hormones & Cancer, V2, P113, DOI 10.1007/s12672-010-0059-x; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Liu LL, 2013, ONCOGENE; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Masuzaki Ryota, 2008, Indian J Gastroenterol, V27, P113; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Musacchio A, 2012, NAT STRUCT MOL BIOL, V19, P1059, DOI 10.1038/nsmb.2429; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Nakagawa H., 2012, CANC LETT; Niittymaki I, 2011, CARCINOGENESIS, V32, P305, DOI 10.1093/carcin/bgq272; Nishida N, 2013, ONCOLOGY-BASEL, V84, P93, DOI 10.1159/000345897; Palmer DH, 2013, BRIT J CANCER, V109, P888, DOI 10.1038/bjc.2013.410; Qin X, 2013, SCAND J GASTROENTERO; Saeki A, 2002, CANCER-AM CANCER SOC, V94, P2047, DOI 10.1002/cncr.10448; Tannous BA, 2013, JNCI-J NATL CANCER I, V105, P1322, DOI 10.1093/jnci/djt168; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yeh CT, 2000, CANCER RES, V60, P4697; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang L, 2013, CANCER LETT, V337, P125, DOI 10.1016/j.canlet.2013.05.029	43	33	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97739	10.1371/journal.pone.0097739	http://dx.doi.org/10.1371/journal.pone.0097739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905462	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000010
J	Shlyakhtenko, LS; Lushnikov, AJ; Li, M; Harris, RS; Lyubchenko, YL				Shlyakhtenko, Luda S.; Lushnikov, Alexander J.; Li, Ming; Harris, Reuben S.; Lyubchenko, Yuri L.			Interaction of APOBEC3A with DNA Assessed by Atomic Force Microscopy	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; CYTIDINE DEAMINASE; HIV-1 RESTRICTION; VIRUS TYPE-1; FOREIGN DNA; PROTEINS; VIF; BINDING	The APOBEC3 family of DNA cytosine deaminases functions block the spread of endogenous retroelements and retroviruses including HIV-1. Potency varies among family members depending on the type of parasitic substrate. APOBEC3A (A3A) is unique among the human enzymes in that it is expressed predominantly in myeloid lineage cell types, it strongly induced by innate immune agonists such as type 1 interferon, and it has the capacity to accommodate both normal and 5-methyl cytosine nucleobases Here we apply atomic force microscopy (AFM) to characterize the interaction between A3A and single- and double-stranded DNA using a hybrid DNA approach in which a single-stranded region is flanked by defined length duplexes. AFM image analyses reveal A3A binding to single-stranded DNA, and that this interaction becomes most evident (similar to 80% complex yield) at high protein-to-DNA ratios (at least 100:1). A3A is predominantly monomeric when bound to single-stranded DNA, and it is also monomeric in solution at concentrations as high as 50 nM. These properties agree well with recent, biochemical, biophysical, and structural studies. However, these characteristics contrast with those of the related enzyme APOBEC3G, which in similar assays can exist as a monomer but tends to form oligomers in a concentration-dependent manner. These AFM data indicate that A3A has intrinsic biophysical differences that distinguish it from APOBEC3G. The potential relationships between these properties and biological functions in innate immunity are discussed.	[Shlyakhtenko, Luda S.; Lushnikov, Alexander J.; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Li, Ming; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Ctr Genome Engn,Masonic Canc Ctr, Minneapolis, MN USA	University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu			National Institutes of Health [1P01 GM091743-02, 5R01 GM096039-02]; National Science Foundation [EPS - 1004094]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM091743, R01GM096039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by grants from National Institutes of Health (1P01 GM091743-02, 5R01 GM096039-02), and National Science Foundation (EPS - 1004094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Desimmie BA, 2013, J MOL BIOL; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2006, NAT STRUCT MOL BIOL, V13, P380, DOI 10.1038/nsmb0506-380; Henry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030036; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Imahashi M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00250; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kitamura S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00258; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; McDougall WM, 2011, BIOCHEM BIOPH RES CO, V412, P612, DOI 10.1016/j.bbrc.2011.08.009; McDougall WM, 2011, J BIOL CHEM; Miyagi E, 2010, J VIROL, V84, P11067, DOI 10.1128/JVI.01249-10; Narvaiza I, 2012, CELL CYCLE, V11, P33, DOI 10.4161/cc.11.1.18706; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2007, BIOCHEMISTRY-US, V46, P11128, DOI 10.1021/bi701123u; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Shlyakhtenko Luda S, 2013, Methods Mol Biol, V931, P295, DOI 10.1007/978-1-62703-056-4_14; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P1500, DOI 10.1021/bi201863z; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2007, PLOS PATHOG, V3, P1320, DOI 10.1371/journal.ppat.0030135; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685	46	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99354	10.1371/journal.pone.0099354	http://dx.doi.org/10.1371/journal.pone.0099354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905100	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000117
J	An, GP; Du, ZQ; Meng, X; Guo, T; Shang, R; Li, JF; An, FS; Li, WJ; Zhang, C				An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Li, Wenjing; Zhang, Cheng			Association between Low Serum Magnesium Level and Major Adverse Cardiac Events in Patients Treated with Drug-Eluting Stents for Acute Myocardial Infarction	PLOS ONE			English	Article							PLATELET-DEPENDENT THROMBOSIS; SMOOTH-MUSCLE; HEART-DISEASE; HYPOMAGNESEMIA; METAANALYSIS; MECHANISMS; MODEL; RISK	Objectives: We investigated the association of serum magnesium (Mg) levels and major adverse cardiac events (MACEs) after drug-eluting stent (DES) implantation. Background: Mg depletion plays a key role in the pathphysiologic features of diabetes mellitus, hypertension, thrombosis, arrhythmias and coronary artery disease. Whether the depletion is related to the long-term prognosis of DES implantation is not known. Methods: From 2008 to 2011, we enrolled 414 consecutive patients,50 years old who underwent DES implantation for acute coronary syndrome. Serum Mg level was analyzed and patients were followed up for a median of 24 months (interquartile range 14-32 months) for the occurrence of MACEs defined as death, myocardial infarction, stroke, and any revascularization. Results: For patients with unstable angina, no significant association between serum Mg level and MACEs was found in the multivariate model. For patients with myocardial infarction, after adjusting for age, positive family history, smoking status, hypertension, hypercholesterolemia, and diabetes at baseline, the risk was 8.11-fold higher for patients with quartile 1 than 4 Mg level (95% confidence interval 1.7-38.75; P< 0.01). In addition, when tested as a continuous variable, serum magnesium was a significant predictor for MACEs of acute myocardial infarction (HR [per 0.1 mM increase], 0.35 [95% CI, 0.19-0.63], p< 0.01), after adjustment for other confounders. Conclusions: Low serum level of Mg may be an important predictor of MACEs with DES implantation for acute myocardial infarction. Further research into the effectiveness of Mg supplementation for these patients is warranted.	[An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan, Shandong, Peoples R China; [An, Guipeng; Du, Zhongqi; Meng, Xiao; Guo, Tao; Shang, Rui; Li, Jifu; An, Fengshuang; Zhang, Cheng] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Li, Wenjing] Shandong Univ, Fine Arts Sch, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, WJ (corresponding author), Shandong Univ, Fine Arts Sch, Jinan, Shandong, Peoples R China.	tianya_79@163.com; zhangc@sdu.edu.cn			National Natural Science Foundation of China [81000125]; Specialized Research Fund for the Doctoral Program of Higher Education [20100131120057]; Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province [BS2012YY017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province	This study was supported by the National Natural Science Foundation of China (No. 81000125), Specialized Research Fund for the Doctoral Program of Higher Education (20100131120057) and Promotive Research Fund for Young and Middle-aged Scientisits of Shandong Province (BS2012YY017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946; Cojocaru Inimioara Mihaela, 2007, Rom J Intern Med, V45, P269; Dasgupta Arundhati, 2012, Indian J Endocrinol Metab, V16, P1000, DOI 10.4103/2230-8210.103020; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Fiset C, 1996, J AM COLL CARDIOL, V27, P1771, DOI 10.1016/0735-1097(96)00089-7; Ford ES, 1999, INT J EPIDEMIOL, V28, P645, DOI 10.1093/ije/28.4.645; GARTSIDE PS, 1995, J AM COLL NUTR, V14, P71; Ishikawa K, 2012, J INVASIVE CARDIOL, V24, P178; Khan AM, 2013, CIRCULATION, V127, P33, DOI 10.1161/CIRCULATIONAHA.111.082511; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Lima MD, 2009, DIABETES RES CLIN PR, V83, P257, DOI 10.1016/j.diabres.2008.11.019; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Morrill GA, 1997, FEBS LETT, V408, P191, DOI 10.1016/S0014-5793(97)00420-1; Peacock JM, 2010, AM HEART J, V160, P464, DOI 10.1016/j.ahj.2010.06.012; Pollak A, 2004, EUR HEART J, V25, P240, DOI 10.1016/j.ehj.2003.10.028; Qin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072710; RASMUSSEN HS, 1986, ARCH INTERN MED, V146, P872, DOI 10.1001/archinte.146.5.872; Ravn HB, 1996, BLOOD COAGUL FIBRIN, V7, P241, DOI 10.1097/00001721-199603000-00033; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; ROTH A, 1994, NEW STATESMAN SOC, V7, P9; Roukoz H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2008.12.019; Shechter M, 2000, AM HEART J, V140, P212, DOI 10.1067/mhj.2000.107553; Shechter M, 1999, AM J CARDIOL, V84, P152, DOI 10.1016/S0002-9149(99)00225-8; Shechter M, 2000, CIRCULATION, V102, P2353, DOI 10.1161/01.CIR.102.19.2353; Sherer Y, 2001, MAGNESIUM RES, V14, P173; Shivakumar K, 2001, MED HYPOTHESES, V56, P110, DOI 10.1054/mehy.2000.1123; Sternberg K, 2012, J BIOMED MATER RES B, V100B, P41, DOI 10.1002/jbm.b.31918; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058	29	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98971	10.1371/journal.pone.0098971	http://dx.doi.org/10.1371/journal.pone.0098971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901943	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400081
J	Coumailleau, F; Schweisguth, F				Coumailleau, Franck; Schweisguth, Francois			Insensible Is a Novel Nuclear Inhibitor of Notch Activity in Drosophila	PLOS ONE			English	Article							ORGAN PRECURSOR CELL; SPLIT COMPLEX GENES; HAIRLESS; SUPPRESSOR; BINDING; PROTEIN; COREPRESSOR; ACTIVATION; REPRESSION; FATE	Notch signalling regulates a wide range of developmental processes. In the Drosophila peripheral nervous system, Notch regulates a series of binary fate decisions that lead to the formation of regularly spaced sensory organs. Each sensory organ is generated by single sensory organ precursor cell (SOP) via a series of asymmetric cell divisions. Starting from a SOP-specific Cis-Regulatory Module (CRM), we identified insensible (insb), a.k.a CG6520, as a SOP/neuron-specific gene encoding a nuclear factor that inhibits Notch signalling activity. First, over-expression of Insb led to the transcriptional repression of a Notch reporter and to phenotypes associated with the inhibition of Notch. Second, while the complete loss of insb activity had no significant phenotype, it enhanced the bristle phenotype associated with reduced levels of Hairless, a nuclear protein acting as a co-repressor for Suppressor of Hairless. In conclusion, our work identified Insb as a novel SOP/neuron-specific nuclear inhibitor of Notch activity in Drosophila.	[Coumailleau, Franck; Schweisguth, Francois] Inst Pasteur, Dev & Stem Cell Biol Dept, Paris, France; [Coumailleau, Franck; Schweisguth, Francois] CNRS, URA2578, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Schweisguth, F (corresponding author), Inst Pasteur, Dev & Stem Cell Biol Dept, Paris, France.	fschweis@pasteur.fr		COUMAILLEAU, Franck/0000-0002-1392-5665	CNRS; Institut Pasteur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission)	This work was funded by the CNRS and Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BANG AG, 1991, DEVELOPMENT, V111, P89; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Dai Q, 2013, DEVELOPMENT, V140, P1892, DOI 10.1242/dev.087502; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Duan H, 2011, EMBO J, V30, P3120, DOI 10.1038/emboj.2011.218; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; Gho M, 1999, DEVELOPMENT, V126, P3573; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Morel V, 2000, GENE DEV, V14, P377; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rouault H, 2010, P NATL ACAD SCI USA, V107, P14615, DOI 10.1073/pnas.1002876107; Schweisguth F, 1998, DEV GENES EVOL, V208, P19, DOI 10.1007/s004270050149; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zheng L, 2008, MECH DEVELOP, V125, P18, DOI 10.1016/j.mod.2007.10.007	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98213	10.1371/journal.pone.0098213	http://dx.doi.org/10.1371/journal.pone.0098213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902027	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400019
J	Frei, ER; Ghazoul, J; Pluess, AR				Frei, Esther R.; Ghazoul, Jaboury; Pluess, Andrea R.			Plastic Responses to Elevated Temperature in Low and High Elevation Populations of Three Grassland Species	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; CLIMATE-CHANGE; LOCAL ADAPTATION; MATURATION TEMPERATURE; PHENOLOGICAL RESPONSE; HABITAT FRAGMENTATION; ALTITUDINAL GRADIENT; ADAPTIVE PLASTICITY; PLANT-RESPONSES; RAPID EVOLUTION	Local persistence of plant species in the face of climate change is largely mediated by genetic adaptation and phenotypic plasticity. In species with a wide altitudinal range, population responses to global warming are likely to differ at contrasting elevations. In controlled climate chambers, we investigated the responses of low and high elevation populations (1200 and 1800 m a.s.l.) of three nutrient-poor grassland species, Trifolium montanum, Ranunculus bulbosus, and Briza media, to ambient and elevated temperature. We measured growth-related, reproductive and phenological traits, evaluated differences in trait plasticity and examined whether trait values or plasticities were positively related to approximate fitness and thus under selection. Elevated temperature induced plastic responses in several growth-related traits of all three species. Although flowering phenology was advanced in T. montanum and R. bulbosus, number of flowers and reproductive allocation were not increased under elevated temperature. Plasticity differed between low and high elevation populations only in leaf traits of T. montanum and B. media. Some growth-related and phenological traits were under selection. Moreover, plasticities were not correlated with approximate fitness indicating selectively neutral plastic responses to elevated temperature. The observed plasticity in growth-related and phenological traits, albeit variable among species, suggests that plasticity is an important mechanism in mediating plant responses to elevated temperature. However, the capacity of species to respond to climate change through phenotypic plasticity is limited suggesting that the species additionally need evolutionary adaptation to adjust to climate change. The observed selection on several growth-related and phenological traits indicates that the study species have the potential for future evolution in the context of a warming climate.	[Frei, Esther R.; Ghazoul, Jaboury; Pluess, Andrea R.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Frei, ER (corresponding author), WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland.	esther.frei@slf.ch	Ghazoul, Jaboury/B-2121-2018	Frei, Esther R./0000-0003-1910-7900	Swiss National Science Foundation [3100A0-116277]; Competence Center Environment and Sustainability (CCES) BioChange; Basler Stiftung fur biologische Forschung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Competence Center Environment and Sustainability (CCES) BioChange; Basler Stiftung fur biologische Forschung	This study was funded by the Swiss National Science Foundation No. 3100A0-116277 (www.snf.ch) to J.G. and A. R. P., the Competence Center Environment and Sustainability (CCES) BioChange (http://www.cces.ethz.ch/projects/clench/BioChange) to J.G., and the Basler Stiftung fur biologische Forschung to E. R. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D, 2004, FLORA ALPINA; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Atkin OK, 2006, J EXP BOT, V57, P267, DOI 10.1093/jxb/erj029; BARLING DM, 1955, J ECOL, V43, P207, DOI 10.2307/2257130; Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Begert M, 2003, HOMOGENISIERUNG KLIM; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; COLEMAN JS, 1994, TRENDS ECOL EVOL, V9, P187, DOI 10.1016/0169-5347(94)90087-6; COLES S M, 1973, Watsonia, V9, P207; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; De Frenne P, 2011, GLOBAL CHANGE BIOL, V17, P3240, DOI 10.1111/j.1365-2486.2011.02449.x; De Valpine P, 2001, ECOLOGY, V82, P637, DOI 10.1890/0012-9658(2001)082[0637:PRTEWI]2.0.CO;2; Didiano TJ, 2014, J ECOL, V102, P584, DOI 10.1111/1365-2745.12227; Diggle PK, 1997, AM J BOT, V84, P154, DOI 10.2307/2446077; Dixon JM, 2002, J ECOL, V90, P737, DOI 10.1046/j.1365-2745.2002.00684.x; Donnelly A, 2012, CLIM RES, V53, P245, DOI 10.3354/cr01102; Draghi JA, 2012, EVOLUTION, V66, P2891, DOI 10.1111/j.1558-5646.2012.01649.x; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Faraway J.J., 2005, LINEAR MODELS R; Fischer SF, 1996, J APPL ECOL, V33, P1206, DOI 10.2307/2404699; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Frei E, 2010, BOT HELV, V120, P117, DOI 10.1007/s00035-010-0076-y; Frei ER, 2014, GLOBAL CHANGE BIOL, V20, P441, DOI 10.1111/gcb.12403; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GOLDSTEIN G, 1985, OECOLOGIA, V68, P147, DOI 10.1007/BF00379487; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; Grime J P, 1986, Symp Soc Exp Biol, V40, P5; Hahn MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050284; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heschel MS, 2004, INT J PLANT SCI, V165, P817, DOI 10.1086/421477; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; HOPKINS W. G., 2008, INTRO PLANT PHYSL, VFourth; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kochanek J, 2010, AUSTRAL ECOL, V35, P837, DOI 10.1111/j.1442-9993.2010.02118.x; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lesica P, 2004, J VEG SCI, V15, P679, DOI 10.1111/j.1654-1103.2004.tb02310.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Menzel A, 2003, CLIMATIC CHANGE, V57, P243, DOI 10.1023/A:1022880418362; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Molau U, 1997, GLOB CHANGE BIOL, V3, P97, DOI 10.1111/j.1365-2486.1997.gcb138.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; PARSONS AN, 1995, OIKOS, V72, P61, DOI 10.2307/3546038; POLLOCK CJ, 1990, J AGR SCI, V115, P1, DOI 10.1017/S0021859600073834; Pratt JD, 2013, GLOBAL CHANGE BIOL, V19, P2454, DOI 10.1111/gcb.12199; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Pulido F, 2004, ADV ECOL RES, V35, P151, DOI 10.1016/S0065-2504(04)35008-7; Qaderi MM, 2006, CAN J BOT, V84, P28, DOI [10.1139/B05-139, 10.1139/b05-139]; R Core Team, 2021, R LANG ENV STAT COMP; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROUGHLEY RJ, 1970, J EXP BOT, V21, P776, DOI 10.1093/jxb/21.3.776; SARUKHAN J, 1973, J ECOL, V61, P675, DOI 10.2307/2258643; Schleuning M, 2009, BASIC APPL ECOL, V10, P61, DOI 10.1016/j.baae.2007.12.002; Shukla P.R., 2022, CLIMATE CHANGE 2013; Springate DA, 2014, GLOBAL CHANGE BIOL, V20, P456, DOI 10.1111/gcb.12430; Steadman KJ, 2004, AUST J AGR RES, V55, P1047, DOI 10.1071/AR04083; STEINBACH K, 1994, PHYTON-ANN REI BOT A, V34, P203; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson JD, 2010, PHILOS T R SOC B, V365, P3187, DOI 10.1098/rstb.2010.0115; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Kleunen M, 2007, J EVOLUTION BIOL, V20, P2126, DOI 10.1111/j.1420-9101.2007.01431.x; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Vliet AJH, 2003, INT J BIOMETEOROL, V47, P202, DOI 10.1007/s00484-003-0174-2; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vitasse Y, 2014, FUNCT ECOL, V28, P243, DOI 10.1111/1365-2435.12161; Vitasse Y, 2013, OECOLOGIA, V171, P663, DOI 10.1007/s00442-012-2580-9; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warwick KR, 1998, GLOB CHANGE BIOL, V4, P375, DOI 10.1046/j.1365-2486.1998.00159.x; Weiner J., 1988, Plant reproductive ecology: patterns and strategies, P228; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Welker JM, 1997, GLOB CHANGE BIOL, V3, P61, DOI 10.1111/j.1365-2486.1997.gcb143.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wolfe DW, 2005, INT J BIOMETEOROL, V49, P303, DOI 10.1007/s00484-004-0248-9	113	22	23	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98677	10.1371/journal.pone.0098677	http://dx.doi.org/10.1371/journal.pone.0098677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901500	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400044
J	Ghouila, A; Florent, I; Guerfali, FZ; Terrapon, N; Laouini, D; Ben Yahia, S; Gascuel, O; Brehelin, L				Ghouila, Amel; Florent, Isabelle; Guerfali, Fatma Zahra; Terrapon, Nicolas; Laouini, Dhafer; Ben Yahia, Sadok; Gascuel, Olivier; Brehelin, Laurent			Identification of Divergent Protein Domains by Combining HMM-HMM Comparisons and Co-Occurrence Detection	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; PARASITE PLASMODIUM-FALCIPARUM; RNA-POLYMERASE-II; COMPARATIVE GENOMICS; TRANSCRIPTION FACTORS; SHIKIMATE PATHWAY; CRYSTAL-STRUCTURE; HOST-CELL; SEQUENCE; BINDING	Identification of protein domains is a key step for understanding protein function. Hidden Markov Models (HMMs) have proved to be a powerful tool for this task. The Pfam database notably provides a large collection of HMMs which are widely used for the annotation of proteins in sequenced organisms. This is done via sequence/HMM comparisons. However, this approach may lack sensitivity when searching for domains in divergent species. Recently, methods for HMM/HMM comparisons have been proposed and proved to be more sensitive than sequence/HMM approaches in certain cases. However, these approaches are usually not used for protein domain discovery at a genome scale, and the benefit that could be expected from their utilization for this problem has not been investigated. Using proteins of P. falciparum and L. major as examples, we investigate the extent to which HMM/HMM comparisons can identify new domain occurrences not already identified by sequence/HMM approaches. We show that although HMM/HMM comparisons are much more sensitive than sequence/HMM comparisons, they are not sufficiently accurate to be used as a standalone complement of sequence/HMM approaches at the genome scale. Hence, we propose to use domain co-occurrence - the general domain tendency to preferentially appear along with some favorite domains in the proteins - to improve the accuracy of the approach. We show that the combination of HMM/HMM comparisons and co-occurrence domain detection boosts protein annotations. At an estimated False Discovery Rate of 5%, it revealed 901 and 1098 new domains in Plasmodium and Leishmania proteins, respectively. Manual inspection of part of these predictions shows that it contains several domain families that were missing in the two organisms. All new domain occurrences have been integrated in the EuPathDomains database, along with the GO annotations that can be deduced.	[Ghouila, Amel; Gascuel, Olivier; Brehelin, Laurent] Univ Montpellier 2, CNRS, LIRMM, Inst Biol Computat, Montpellier, France; [Ghouila, Amel; Ben Yahia, Sadok] Fac Sci Tunis, Dept Comp Sci, Tunis 1060, Tunisia; [Florent, Isabelle] Museum Natl Hist Nat, CNRS, Mol Commun & Adaptat Microorganismes UMR7245, Paris, France; [Guerfali, Fatma Zahra; Laouini, Dhafer] Inst Pasteur Tunis, LR11IPT02, LTCII, Tunis, Tunisia; [Guerfali, Fatma Zahra; Laouini, Dhafer] Univ Tunis El Manar, Tunis, Tunisia; [Terrapon, Nicolas] Aix Marseille Univ, CNRS, UMR 7257, AFMB, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Brehelin, L (corresponding author), Univ Montpellier 2, CNRS, LIRMM, Inst Biol Computat, Montpellier, France.	brehelin@lirmm.fr	Terrapon, Nicolas/AAA-9033-2019; Florent, Isabelle/M-6838-2019; Guerfali, Fatma/S-8626-2019; BEN YAHIA, Sadok/C-8239-2019; Terrapon, Nicolas/O-3630-2014; Laouini, Dhafer/Q-6535-2019	Terrapon, Nicolas/0000-0002-3693-6017; Florent, Isabelle/0000-0002-7140-6417; BEN YAHIA, Sadok/0000-0001-8939-8948; Terrapon, Nicolas/0000-0002-3693-6017; Laouini, Dhafer/0000-0003-1222-4880; Guerfali, Fatma/0000-0002-6973-2870	French National Research Agency: PlasmoExpress project (ANR JCJC)	French National Research Agency: PlasmoExpress project (ANR JCJC)(French National Research Agency (ANR))	This research work was supported by the French National Research Agency: PlasmoExpress project (ANR JCJC2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Bonin I, 2004, BIOCHEM J, V383, P419, DOI 10.1042/BJ20040889; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Brehelin L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-35; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cohen G, 2007, BMC GENOMICS, V8; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Dlakic M, 2009, BIOINFORMATICS, V25, P3071, DOI 10.1093/bioinformatics/btp555; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Forslund K, 2008, BIOINFORMATICS, V24, P1681, DOI 10.1093/bioinformatics/btn312; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Ghouila A, 2011, INFECT GENET EVOL, V11, P698, DOI 10.1016/j.meegid.2010.09.008; Gopal B, 2000, NAT STRUCT BIOL, V7, P475; Hager KM, 2008, TRENDS PARASITOL, V24, P51, DOI 10.1016/j.pt.2007.10.008; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; JORIS B, 1992, FEMS MICROBIOL LETT, V91, P257; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Ochoa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-90; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; Pasek Sophie, 2007, V396, P17; Passos-Silva DG, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/840768; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Santos JM, 2012, MOL BIOCHEM PARASIT, V182, P27, DOI 10.1016/j.molbiopara.2011.11.010; Sato Y, 2001, GENES GENET SYST, V76, P373, DOI 10.1266/ggs.76.373; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Terrapon N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-67; Terrapon N, 2009, BIOINFORMATICS, V25, P3077, DOI 10.1093/bioinformatics/btp560; Thompson J, 2007, CELL MICROBIOL, V9, P1466, DOI 10.1111/j.1462-5822.2006.00885.x; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	57	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95275	10.1371/journal.pone.0095275	http://dx.doi.org/10.1371/journal.pone.0095275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901648	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400003
J	Liu, ZX; Wu, YC; Guo, ZR; Liu, Y; Shen, YJ; Zhou, P; Lu, X				Liu, Zhengxia; Wu, Yucheng; Guo, Zhirui; Liu, Ying; Shen, Yujie; Zhou, Ping; Lu, Xiang			Effects of Internalized Gold Nanoparticles with Respect to Cytotoxicity and Invasion Activity in Lung Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; INHIBITION; RISK; SIZE; CHEMOTHERAPY; PROGRESSION; MOLECULES; THERAPY	The effect of gold nanoparticles on lung cancer cells is not yet clear. In this study, we investigated the cytotoxicity and cell invasion activity of lung cancer cells after treatment with gold nanoparticles and showed that small gold nanoparticles can be endocytosed by lung cancer cells and that they facilitate cell invasion. The growth of A549 cells was inhibited after treatment with 5-nm gold nanoparticles, but cell invasion increased. Endocytosed gold nanoparticles (size, 10 nm) notably promoted the invasion activity of 95D cells. All these effects of gold nanoparticles were not seen after treatment with larger particles (20 and 40 nm). The enhanced invasion activity may be associated with the increased expression of matrix metalloproteinase 9 and intercellular adhesion molecule-1. In this study, we obtained evidence for the effect of gold nanoparticles on lung cancer cell invasion activity in vitro. Moreover, matrix metalloproteinase 9 and intercellular adhesion molecule-1, key modulators of cell invasion, were found to be regulated by gold nanoparticles. These data also demonstrate that the responses of the A549 and 95D cells to gold nanoparticles have a remarkable relationship with their unique size-dependent physiochemical properties. Therefore, this study provides a new perspective for cell biology research in nanomedicine.	[Liu, Zhengxia; Wu, Yucheng; Guo, Zhirui; Liu, Ying; Shen, Yujie; Zhou, Ping; Lu, Xiang] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lu, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China.	luxiang66@njmu.edu.cn			National Science Foundation of China [81270428, 81300999]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Science Foundation of China(No.81270428 and 81300999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Arvizo R, 2010, EXPERT OPIN DRUG DEL, V7, P753, DOI 10.1517/17425241003777010; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Coulter JA, 2012, INT J NANOMED, V7, P2673, DOI 10.2147/IJN.S31751; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Dreaden EC, 2011, CHEM SOC REV, V40, P3391, DOI 10.1039/c0cs00180e; Eccles SA, 2005, BIOTECHNOL ANN REV, V11, P391, DOI 10.1016/S1387-2656(05)11013-8; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e; Fajersztajn L, 2013, NAT REV CANCER, V13, P674, DOI 10.1038/nrc3572; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Guo CB, 2007, MOL DIAGN THER, V11, P183, DOI 10.1007/BF03256240; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Han SW, 2006, J BIOL CHEM, V281, P29614, DOI 10.1074/jbc.M604013200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Ju DW, 2012, MED ONCOL, V29, P91, DOI 10.1007/s12032-010-9780-0; Li Y, 2012, EXP THER MED, V3, P673, DOI 10.3892/etm.2012.453; Lin SS, 2009, CANCER LETT, V285, P127, DOI 10.1016/j.canlet.2009.04.037; Lin YC, 2006, CLIN CANCER RES, V12, P7165, DOI 10.1158/1078-0432.CCR-06-1393; Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703; Manegold C, 2001, LUNG CANCER, V34, pS165, DOI 10.1016/S0169-5002(01)00363-4; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Pan Y, 2009, SMALL, V5, P2067, DOI 10.1002/smll.200900466; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pritchard SC, 2001, ONCOL REP, V8, P421; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Tsai SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076545; Veiseh O, 2009, SMALL, V5, P256, DOI 10.1002/smll.200800646; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949	38	64	65	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99175	10.1371/journal.pone.0099175	http://dx.doi.org/10.1371/journal.pone.0099175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901215	Green Submitted, gold, Green Published			2022-12-25	WOS:000336841400104
J	Eykelbosh, AJ; Johnson, MS; de Queiroz, ES; Dalmagro, HJ; Couto, EG				Eykelbosh, Angela Joy; Johnson, Mark S.; de Queiroz, Edmar Santos; Dalmagro, Higo Jose; Couto, Eduardo Guimaraes			Biochar from Sugarcane Filtercake Reduces Soil CO2 Emissions Relative to Raw Residue and Improves Water Retention and Nutrient Availability in a Highly-Weathered Tropical Soil	PLOS ONE			English	Article							BLACK CARBON; ORGANIC-CARBON; PARTICLE-SIZE; PYROLYSIS; NITROGEN; IMPACT; AGRICULTURE; MANAGEMENT; INCREASES; SORPTION	In Brazil, the degradation of nutrient-poor Ferralsols limits productivity and drives agricultural expansion into pristine areas. However, returning agricultural residues to the soil in a stabilized form may offer opportunities for maintaining or improving soil quality, even under conditions that typically promote carbon loss. We examined the use of biochar made from filtercake (a byproduct of sugarcane processing) on the physicochemical properties of a cultivated tropical soil. Filtercake was pyrolyzed at 575 degrees C for 3 h yielding a biochar with increased surface area and porosity compared to the raw filtercake. Filtercake biochar was primarily composed of aromatic carbon, with some residual cellulose and hemicellulose. In a three-week laboratory incubation, CO2 effluxes from a highly weathered Ferralsol soil amended with 5% biochar (dry weight, d.w.) were roughly four-fold higher than the soil-only control, but 23-fold lower than CO2 effluxes from soil amended with 5% (d.w.) raw filtercake. We also applied vinasse, a carbon-rich liquid waste from bioethanol production typically utilized as a fertilizer on sugarcane soils, to filtercake- and biochar-amended soils. Total CO2 efflux from the biochar-amended soil in response to vinasse application was only 5% of the efflux when vinasse was applied to soil amended with raw filtercake. Furthermore, mixtures of 5 or 10% biochar (d.w.) in this highly weathered tropical soil significantly increased water retention within the plant-available range and also improved nutrient availability. Accordingly, application of sugarcane filtercake as biochar, with or without vinasse application, may better satisfy soil management objectives than filtercake applied to soils in its raw form, and may help to build soil carbon stocks in sugarcane-cultivating regions.	[Eykelbosh, Angela Joy; Johnson, Mark S.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Johnson, Mark S.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [de Queiroz, Edmar Santos; Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Fac Agron Med Vet & Zootecnia FAMEV, Cuiabaa, Mato Grosso, Brazil; [Dalmagro, Higo Jose] Univ Fed Mato Grosso, Inst Fis, Cuiaba, Mato Grosso, Brazil	University of British Columbia; University of British Columbia; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Eykelbosh, AJ (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	a.eykelbosh@alumni.ubc.ca	Couto, Eduardo Guimarães/E-4240-2010; Couto, Eduardo Guimarães/AAF-5790-2019; Johnson, Mark S./B-4445-2008	Couto, Eduardo Guimarães/0000-0002-5271-9709; Couto, Eduardo Guimarães/0000-0002-5271-9709; Johnson, Mark S./0000-0001-5070-7539; Eykelbosh, Angela/0000-0003-3880-9019	UBC Bridge Program; National Sciences and Engineering Research Council (NSERC) of Canada; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil	UBC Bridge Program; National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was obtained from the UBC Bridge Program and the National Sciences and Engineering Research Council (NSERC) of Canada (awarded to AJE), and from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil (awarded to AJE, MSJ, and EGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; Abiven S, 2014, NAT GEOSCI, V7, P326, DOI 10.1038/ngeo2154; Anderson-Teixeira KJ, 2009, GCB BIOENERGY, V1, P75, DOI 10.1111/j.1757-1707.2008.01001.x; ArsÃ¨ne Marie-Ange, 2013, Mat. Res., V16, P903; Asadullah M, 2010, BIORESOURCE TECHNOL, V101, P7935, DOI 10.1016/j.biortech.2010.05.048; Basso Andres S., 2013, GCB Bioenergy, V5, P132, DOI 10.1111/gcbb.12026; de Vasconcelos RFB, 2010, REV BRAS CIENC SOLO, V34, P309, DOI 10.1590/S0100-06832010000200004; Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cagnon Benoit, 2009, Bioresour Technol, V100, P292, DOI 10.1016/j.biortech.2008.06.009; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; de Oliveira BG, 2013, GEODERMA, V200, P77, DOI 10.1016/j.geoderma.2013.02.005; de Resende AS, 2006, PLANT SOIL, V281, P339, DOI 10.1007/s11104-005-4640-y; Demirbas A, 2004, J ANAL APPL PYROL, V72, P243, DOI 10.1016/j.jaap.2004.07.003; do Carmo JB, 2013, GCB BIOENERGY, V5, P267, DOI 10.1111/j.1757-1707.2012.01199.x; Elsayed MT, 2008, BIORESOURCE TECHNOL, V99, P4164, DOI 10.1016/j.biortech.2007.08.079; EMBRAPA, 2009, MAN AN QUI MIC SOL P; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Fuertes AB, 2010, AUST J SOIL RES, V48, P618, DOI 10.1071/SR10010; Gaunt JL, 2008, ENVIRON SCI TECHNOL, V42, P4152, DOI 10.1021/es071361i; George PAO, 2010, WASTE BIOMASS VALORI, V1, P407, DOI 10.1007/s12649-010-9046-2; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; GOEDERT WJ, 1983, J SOIL SCI, V34, P405, DOI 10.1111/j.1365-2389.1983.tb01045.x; HAMBLIN AP, 1985, ADV AGRON, V38, P95, DOI 10.1016/S0065-2113(08)60674-4; Hoffmann WA, 2000, J CLIMATE, V13, P1593, DOI 10.1175/1520-0442(2000)013<1593:VCFITC>2.0.CO;2; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Inyang M, 2010, BIORESOURCE TECHNOL, V101, P8868, DOI 10.1016/j.biortech.2010.06.088; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P1723, DOI 10.1016/j.soilbio.2011.04.018; Joseph S, 2009, BIOCHR ENG MANAGE SC, V1, P107; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Kasozi GN, 2010, ENVIRON SCI TECHNOL, V44, P6189, DOI 10.1021/es1014423; Khalil MI, 2005, SOIL BIOL BIOCHEM, V37, P1507, DOI 10.1016/j.soilbio.2005.01.014; Kim P, 2011, ENERG FUEL, V25, P4693, DOI 10.1021/ef200915s; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lee Y, 2013, BIORESOURCE TECHNOL, V148, P196, DOI 10.1016/j.biortech.2013.08.135; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Liska AJ, 2014, NAT CLIM CHANGE, V4, P398, DOI [10.1038/NCLIMATE2187, 10.1038/nclimate2187]; Machado PLOD, 2001, NUTR CYCL AGROECOSYS, V61, P119, DOI 10.1023/A:1013331805519; Major J, 2012, J ENVIRON QUAL, V41, P1076, DOI 10.2134/jeq2011.0128; Martinelli LA, 2010, CURR OPIN ENV SUST, V2, P431, DOI 10.1016/j.cosust.2010.09.008; Mathews JA, 2008, ENERG POLICY, V36, P940, DOI 10.1016/j.enpol.2007.11.029; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; Oliveira VS, 2010, REV BRAS ENG AGR AMB, V14, P907, DOI 10.1590/S1415-43662010000900001; Prado R.M., 2013, APPL ENVIRON SOIL SC, V2013, P1, DOI [DOI 10.1155/2013/581984, 10.1155/2013/581984]; R Core Team, 2021, R LANG ENV STAT COMP; Roscoe R, 2001, GEODERMA, V104, P185, DOI 10.1016/S0016-7061(01)00080-5; Sparovek G, 2007, SCI AGR, V64, P77, DOI 10.1590/S0103-90162007000100012; Spokas K. A., 2009, Annals of Environmental Science, V3, P179; Steinbeiss S, 2009, SOIL BIOL BIOCHEM, V41, P1301, DOI 10.1016/j.soilbio.2009.03.016; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Ulyett J, 2014, EUR J SOIL SCI, V65, P96, DOI 10.1111/ejss.12081; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	59	25	26	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98523	10.1371/journal.pone.0098523	http://dx.doi.org/10.1371/journal.pone.0098523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897522	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700048
J	Hu, WD; Liu, Y; Zhou, WH; Si, LL; Ren, L				Hu, Weidong; Liu, Yue; Zhou, Wenhui; Si, Lianlian; Ren, Liang			CXCL16 and CXCR6 Are Coexpressed in Human Lung Cancer In Vivo and Mediate the Invasion of Lung Cancer Cell Lines In Vitro	PLOS ONE			English	Article							DECIDUAL STROMAL CELLS; CHEMOKINE CXCL16; SCAVENGER RECEPTOR; EXPRESSION; INFLAMMATION; MIGRATION; LYMPHOCYTES; PROGRESSION; LIGAND-16; PROMOTES	Despite advances in early diagnosis and multimodality therapy for cancers, most of lung cancer patients have been locally advanced or metastatic at the time of diagnosis, suggesting the highly progressive characteristic of lung cancer cells. The mechanisms underling invasiveness and metastasis of lung cancer are yet to be elucidated. In the present study, immunohistochemistry was performed to detect the expression of CXCL16-CXCR6 in human lung cancer tissues. It was demonstrated that similar to CXCL12 and CXCR4, CXCL16 and CXCR6 were also coexpressed in human primary lung cancer tissues. After confirming the functional existence of CXCL16 and CXCR6 protein in A549, 95D and H292 cells by ELSA and flow cytometry analysis, we further explored the significance of CXCL16-CXCR6 axis in the biological functions of lung cancer cell lines in vitro. It was found that CXCL16 had no effects on the PCNA (proliferating cell nuclear antigen) expression of A549, 95D and H292 cells. However, both exogenous CXCL16 and CM (conditioned medium from A549, 95D or H292) significantly improved the in vitro viability and invasion of three lung cancer cell lines. The neutralizing antibody to CXCL16 or down-regulation of CXCR6 was able to inhibit the increased viability and invasiveness of A549, 95D and H292 cells stimulated by CXCL16 or CM. Our results imply that CXCL16-CXCR6 axis is involved in the regulation of viability and invasion rather than PCNA expression of lung caner cells, which opens the door for better understanding the mechanisms of lung tumor progression and metastasis.	[Hu, Weidong; Liu, Yue; Si, Lianlian] Wuhan Univ, Zhongnan Hosp, Dept Thorac Oncol, Wuhan 430072, Peoples R China; [Hu, Weidong] Hubei Canc Clin Study Ctr, Wuhan, Peoples R China; [Hu, Weidong] Hubei Key Lab Tumor Biol Behav, Wuhan, Peoples R China; [Zhou, Wenhui] Capital Med Univ, Beijing Chao Yang Hosp, Reprod Med Ctr, Beijing, Peoples R China; [Ren, Liang] Wuhan Univ, Zhongnan Hosp, Reprod Med Ctr, Wuhan 430072, Peoples R China	Wuhan University; Capital Medical University; Wuhan University	Hu, WD (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Thorac Oncol, Wuhan 430072, Peoples R China.	weidhu@aliyun.com; 77305875@qq.com			National Natural Science Foundation of China [81270753]; Wuhan Science and Technology [2013060602010249]; Natural Science Foundation of Science and Technology Ministry of Hubei Province [2010CDB05502]; Personnel Training Plan of The Health Care System of Beijing [2013-3-021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology; Natural Science Foundation of Science and Technology Ministry of Hubei Province; Personnel Training Plan of The Health Care System of Beijing	This work is supported by National Natural Science Foundation of China 81270753 (to W.-H.Z.), Wuhan Science and Technology Project 2013060602010249 (to W.-D.H.), Natural Science Foundation of Science and Technology Ministry of Hubei Province 2010CDB05502 (to W.-D.H.) and Personnel Training Plan of The Health Care System of Beijing 2013-3-021 (to W.-H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darash-Yahana M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006695; Day C, 2009, EXP LUNG RES, V35, P272, DOI 10.1080/01902140802635517; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Fahham D, 2012, J THORAC CARDIOV SUR, V144, P1167, DOI 10.1016/j.jtcvs.2012.07.031; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Hara T, 2006, INT IMMUNOL, V18, P301, DOI 10.1093/intimm/dxh369; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Hu WD, 2008, CANCER SCI, V99, P1362, DOI 10.1111/j.1349-7006.2008.00833.x; Huang Y, 2006, HUM REPROD, V21, P1083, DOI 10.1093/humrep/dei436; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Keeley EC, 2010, ADV CANCER RES, V106, P91, DOI 10.1016/S0065-230X(10)06003-3; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Oldham KA, 2012, EUR UROL, V61, P385, DOI 10.1016/j.eururo.2011.10.035; Otsuka S, 2008, J THORAC ONCOL, V3, P1379, DOI 10.1097/JTO.0b013e31818dda9d; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Raynaud CM, 2010, CLIN LUNG CANCER, V11, P187, DOI 10.3816/CLC.2010.n.024; Ren L, 2012, HUM REPROD, V27, P366, DOI 10.1093/humrep/der395; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wald O, 2013, THERANOSTICS, V3, P26, DOI 10.7150/thno.4922; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308; Zhou WH, 1998, ZHONGHUA WEI SHENG W, V31, P1076	32	33	34	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99056	10.1371/journal.pone.0099056	http://dx.doi.org/10.1371/journal.pone.0099056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897301	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700110
J	Huang, Q; Sparatore, A; Del Soldato, P; Wu, LY; Desai, K				Huang, Qian; Sparatore, Anna; Del Soldato, Piero; Wu, Lingyun; Desai, Kaushik			Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose-Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells	PLOS ONE			English	Article							GLYOXALASE SYSTEM; PEROXYNITRITE PRODUCTION; ENDOTHELIAL DYSFUNCTION; DIABETIC COMPLICATIONS; NITRIC-OXIDE; IN-VITRO; TISSUES; RATS; HYPERTENSION; INFLAMMATION	Hydrogen sulfide is a gasotransmitter with vasodilatory and anti-inflammatory properties. Aspirin is an irreversible cyclooxygenase inhibitor anti-inflammatory drug. ACS14 is a novel synthetic hydrogen sulfide releasing aspirin which inhibits cyclooxygenase and has antioxidant effects. Methylglyoxal is a chemically active metabolite of glucose and fructose, and a major precursor of advanced glycation end products formation. Methylglyoxal is harmful when produced in excess. Plasma methylglyoxal levels are significantly elevated in diabetic patients. Our aim was to investigate the effects of ACS14 on methylglyoxal levels in cultured rat aortic vascular smooth muscle cells. We used cultured rat aortic vascular smooth muscle cells for the study. Methylglyoxal was measured by HPLC after derivatization, and nitrite+nitrate with an assay kit. Western blotting was used to determine NADPH oxidase 4 (NOX4) and inducible nitric oxide synthase (iNOS) protein expression. Dicholorofluorescein assay was used to measure oxidative stress. ACS14 significantly attenuated elevation of intracellular methylglyoxal levels caused by incubating cultured vascular smooth muscle cells with methylglyoxal (30 mu M) and high glucose (25 mM). ACS14, but not aspirin, caused a significant attenuation of increase in nitrite+nitrate levels caused by methylglyoxal or high glucose. ACS14, aspirin, and sodium hydrogen sulfide (NaHS, a hydrogen sulfide donor), all attenuated the increase in oxidative stress caused by methylglyoxal and high glucose in cultured cells. ACS14 prevented the increase in NOX4 expression caused by incubating the cultured VSMCs with MG (30 mu M). ACS14, aspirin and NaHS attenuated the increase in iNOS expression caused by high glucose (25 mM). In conclusion, ACS14 has the novel ability to attenuate an increase in methylglyoxal levels which in turn can reduce oxidative stress, decrease the formation of advanced glycation end products and prevent many of the known deleterious effects of elevated methylglyoxal. Thus, ACS14 has the potential to be especially beneficial for diabetic patients pending further in vivo studies.	[Huang, Qian; Desai, Kaushik] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 0W0, Canada; [Huang, Qian] Shanghai Jiao Tong Univ, Kings Lab, Sch Pharm, Shanghai 200030, Peoples R China; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut, Milan, Italy; [Del Soldato, Piero] CTG Pharma, Milan, Italy; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; Shanghai Jiao Tong University; University of Milan; Lakehead University; Northern Ontario School of Medicine	Wu, LY (corresponding author), Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada.	lwu@lakeheadu.ca; k.desai@usask.ca	Sparatore, Anna/J-8634-2015	Sparatore, Anna/0000-0003-2135-2649; Desai, Kaushik/0000-0001-9355-4528	CTG Pharma; Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research grant [MOP-68938]	CTG Pharma; Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	Professor Anna Sparatore received a grant from CTG Pharma. This work was supported by a Grant-In-Aid from the Heart and Stroke Foundation of Saskatchewan to Dr. Kaushik Desai and Dr. Lingyun Wu, and the Canadian Institutes of Health Research grant # MOP-68938 to Dr. Lingyun Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2003, BBA-MOL BASIS DIS, V1639, P121, DOI 10.1016/j.bbadis.2003.08.002; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2010, ANTIOXID REDOX SIGN, V12, P1093, DOI 10.1089/ars.2009.2918; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Dhar A, 2008, METABOLISM, V57, P1211, DOI 10.1016/j.metabol.2008.04.014; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dhar A, 2010, BRIT J PHARMACOL, V161, P1843, DOI 10.1111/j.1476-5381.2010.01017.x; Dhar A, 2009, J CHROMATOGR B, V877, P1093, DOI 10.1016/j.jchromb.2009.02.055; Dhar I, 2012, J PHARMACOL EXP THER, V342, P196, DOI 10.1124/jpet.112.192112; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lee M, 2010, GLIA, V58, P103, DOI 10.1002/glia.20905; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; Pircher J, 2012, ARTERIOSCL THROM VAS, V32, P2884, DOI 10.1161/ATVBAHA.112.300627; RAO GN, 1985, BIOCHEM BIOPH RES CO, V128, P1125, DOI 10.1016/0006-291X(85)91057-5; Sparatore A, 2009, FREE RADICAL BIO MED, V46, P586, DOI 10.1016/j.freeradbiomed.2008.11.013; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Vander Jagt DL, 2003, CHEM-BIOL INTERACT, V143, P341, DOI 10.1016/S0009-2797(02)00212-0; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang H, 2006, LIFE SCI, V79, P2448, DOI 10.1016/j.lfs.2006.08.009; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	37	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97315	10.1371/journal.pone.0097315	http://dx.doi.org/10.1371/journal.pone.0097315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896242	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700009
J	Liu, J; Li, M; Li, Z; Zuo, XL; Li, CQ; Dong, YY; Zhou, CJ; Li, YQ				Liu, Jing; Li, Ming; Li, Zhen; Zuo, Xiu-Li; Li, Chang-Qing; Dong, Yan-Yan; Zhou, Cheng-Jun; Li, Yan-Qing			Learning Curve and Interobserver Agreement of Confocal Laser Endomicroscopy for Detecting Precancerous or Early-Stage Esophageal Squamous Cancer	PLOS ONE			English	Article							DIAGNOSTIC-ACCURACY; DYSPLASIA	Background: Confocal laser endomicroscopy (CLE) can provide in vivo subcellular resolution images of esophageal lesions. However, the learning curve in interpreting CLE images of precancerous or early-stage esophageal squamous cancer is unknown. The goal of this study is to evaluate the diagnostic accuracy and inter-observer agreement for differentiating esophageal lesions in CLE images among experienced and inexperienced observers and to assess the learning curve. Method: After a short training, 8 experienced and 14 inexperienced endoscopists evaluated in sequence 4 sets of high-quality CLE images. Their diagnoses were corrected and discussed after each set. For each image, the diagnostic results, confidence in diagnosis, quality and time to evaluate were recorded. Results: Overall, diagnostic accuracy was greater for the second, third, fourth set of images as compared with the initial set (odds ratio [OR] 2.01, 95% CI 1.22-3.31; 7.95, 3.74-16.87; and 6.45, 3.14-13.27), respectively, with no difference between the third and fourth sets in accuracy (p = 0.67). Previous experience affected the diagnostic accuracy only in the first set of images (OR 3.70, 1.87-7.29, p < 0.001). Inter-observer agreement was higher for experienced than inexperienced endoscopists (0.732 vs. 0.666, p < 0.01) Conclusion: CLE is a promising technology that can be quickly learned after a short training period; previous experience is associated with diagnostic accuracy only at the initial stage of learning.	[Liu, Jing; Li, Ming; Li, Zhen; Zuo, Xiu-Li; Li, Chang-Qing; Dong, Yan-Yan; Li, Yan-Qing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Liu, Jing] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan 250100, Peoples R China; [Zhou, Cheng-Jun] Shandong Univ, Affiliated Hosp 2, Dept Pathol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China.	Liyanqing@sdu.edu.cn	Li, Zhen/AFK-5293-2022; Li, Zhen/AAH-2515-2022; Li, Zhen/HHM-3328-2022	Li, Zhen/0000-0002-9783-169X; Li, Chang-Qing/0000-0003-4380-2284; Liu, Jing/0000-0001-9149-7339				Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Buchner AM, 2011, GASTROINTEST ENDOSC, V73, P556, DOI 10.1016/j.gie.2011.01.002; DAWSEY SM, 1993, GASTROENTEROLOGY, V105, P1333, DOI 10.1016/0016-5085(93)90137-2; Gaddam S, 2011, AM J GASTROENTEROL, V106, P1961, DOI 10.1038/ajg.2011.294; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeon SR, 2011, GASTROINTEST ENDOSC, V74, P772, DOI 10.1016/j.gie.2011.05.005; Koh CE, 2011, SURG ENDOSC, V25, P947, DOI 10.1007/s00464-010-1259-8; Kuiper T, 2012, GASTROINTEST ENDOSC, V75, P1211, DOI 10.1016/j.gie.2012.01.040; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li M, 2012, GUT; Li WB, 2011, GUT, V60, P299, DOI 10.1136/gut.2010.223586; Lim LG, 2011, GASTROINTEST ENDOSC, V73, P1141, DOI 10.1016/j.gie.2011.01.068; Liu H, 2009, ENDOSCOPY, V41, P99, DOI 10.1055/s-0028-1119492; Pech O, 2008, CLIN GASTROENTEROL H, V6, P89, DOI 10.1016/j.cgh.2007.10.013; Polglase AL, 2006, EXPERT REV MED DEVIC, V3, P549, DOI 10.1586/17434440.3.5.549; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Rispo A, 2012, WORLD J GASTRO ENDOS, V4, P414, DOI 10.4253/wjge.v4.i9.414; Shahid MW, 2012, ENDOSCOPY, V44, P343, DOI 10.1055/s-0031-1291589; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Su P, 2013, COLORECTAL DIS, V15, pE1, DOI 10.1111/codi.12033; Ussui VM, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/545679	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99089	10.1371/journal.pone.0099089	http://dx.doi.org/10.1371/journal.pone.0099089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897112	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700116
J	Cheung, KSC; Sposito, N; Stumpf, PS; Wilson, DI; Sanchez-Elsner, T; Oreffo, ROC				Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Wilson, David I.; Sanchez-Elsner, Tilman; Oreffo, Richard O. C.			MicroRNA-146a Regulates Human Foetal Femur Derived Skeletal Stem Cell Differentiation by Down-Regulating SMAD2 and SMAD3	PLOS ONE			English	Article							CHONDROGENESIS; OSTEOBLAST; TISSUE; SKELETOGENESIS; EXPRESSION; CARTILAGE; LEVEL; RNA	MicroRNAs (miRs) play a pivotal role in a variety of biological processes including stem cell differentiation and function. Human foetal femur derived skeletal stem cells (SSCs) display enhanced proliferation and multipotential capacity indicating excellent potential as candidates for tissue engineering applications. This study has examined the expression and role of miRs in human foetal femur derived SSC differentiation along chondrogenic and osteogenic lineages. Cells isolated from the epiphyseal region of the foetal femur expressed higher levels of genes associated with chondrogenesis while cells from the foetal femur diaphyseal region expressed higher levels of genes associated with osteogenic differentiation. In addition to the difference in osteogenic and chondrogenic gene expression, epiphyseal and diaphyseal cells displayed distinct miRs expression profiles. miR-146a was found to be expressed by human foetal femur diaphyseal cells at a significantly enhanced level compared to epiphyseal populations and was predicted to target various components of the TGF-beta pathway. Examination of miR-146a function in foetal femur cells confirmed regulation of protein translation of SMAD2 and SMAD3, important TGF-b and activin ligands signal transducers following transient overexpression in epiphyseal cells. The down-regulation of SMAD2 and SMAD3 following overexpression of miR-146a resulted in an up-regulation of the osteogenesis related gene RUNX2 and down-regulation of the chondrogenesis related gene SOX9. The current findings indicate miR-146a plays an important role in skeletogenesis through attenuation of SMAD2 and SMAD3 function and provide further insight into the role of miRs in human skeletal stem cell differentiation modulation with implications therein for bone reparation.	[Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Oreffo, Richard O. C.] Southampton Gen Hosp, Inst Dev Sci, Bone & Joint Res Grp, Southampton SO9 4XY, Hants, England; [Cheung, Kelvin S. C.; Sposito, Nunzia; Stumpf, Patrick S.; Wilson, David I.; Oreffo, Richard O. C.] Univ Southampton, Ctr Human Dev Stem Cells & Regenerat, Southampton, Hants, England; [Sanchez-Elsner, Tilman] Univ Southampton, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Oreffo, ROC (corresponding author), Southampton Gen Hosp, Inst Dev Sci, Bone & Joint Res Grp, Southampton SO9 4XY, Hants, England.	richard.oreffo@soton.ac.uk	Oreffo, Richard OC/A-4615-2011; Cheung, Kelvin Sin Chi/AID-4386-2022; Wilson, David/A-6264-2010; Stumpf, Patrick/AAK-1895-2020	Oreffo, Richard OC/0000-0001-5995-6726; Cheung, Kelvin Sin Chi/0000-0002-1562-8883; Wilson, David/0000-0001-8779-2060; Stumpf, Patrick/0000-0003-0862-0290; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Biotechnology and Biological Sciences Research Council UK [BB/G010579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work carried out in this manuscript was supported by a strategic longer and larger grant (sLOLA) from the Biotechnology and Biological Sciences Research Council UK (BB/G010579/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baek Wook-Young, 2011, Front Biosci (Schol Ed), V3, P126, DOI 10.2741/s138; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Developmental plasticity of human foetal femur-derived cells in pellet culture: self assembly of an osteoid shell around a cartilaginous core, 2011, EUR CELL MAT, V21, P558; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.TEA.2010.0043, 10.1089/ten.tea.2010.0043]; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Karsenty G, 1998, DEV GENET, V22, P301, DOI 10.1002/(SICI)1520-6408(1998)22:4&lt;301::AID-DVG1&gt;3.0.CO;2-A; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Lewis BP, TARGETSCANHUMAN; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu XD, 2009, BIOCHEM BIOPH RES CO, V380, P177, DOI 10.1016/j.bbrc.2009.01.066; Liu Z, 2012, ARCH DERMATOL RES, V304, P195, DOI 10.1007/s00403-011-1178-0; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Michigami Toshimi, 2014, Clin Pediatr Endocrinol, V23, P1, DOI 10.1292/cpe.23.1; Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Moustakas A, 2001, J CELL SCI, V114, P4359; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pratap J, 2003, CANCER RES, V63, P5357; Song B, 2009, CYTOKINE GROWTH F R, V20, P379, DOI 10.1016/j.cytogfr.2009.10.010; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; TUCH B, 1988, HASTINGS CENT REP, V18, P44, DOI 10.2307/3563238; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang L, 2012, J BONE MINER RES, V27, P1598, DOI 10.1002/jbmr.1621; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	45	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98063	10.1371/journal.pone.0098063	http://dx.doi.org/10.1371/journal.pone.0098063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892945	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400032
J	Packham, S; Warsito, D; Lin, Y; Sadi, S; Karlsson, R; Sehat, B; Larsson, O				Packham, S.; Warsito, D.; Lin, Y.; Sadi, S.; Karlsson, R.; Sehat, B.; Larsson, O.			Nuclear translocation of IGF-1R via p150(Glued) and an importin-beta/RanBP2-dependent pathway in cancer cells	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; IMPORTIN-BETA; DYNACTIN COMPLEX; EARLY ENDOSOME; TUMOR-CELLS; INSULIN; PROTEIN; TRANSPORT; SUMOYLATION	Mounting evidence has shown that the insulin-like growth factor-1 receptor (IGF-1R) has critical roles in cancer cell growth. This has prompted pharmacological companies to develop agents targeting the receptor. Surprisingly, clinical trials using specific IGF-1R antibodies have, however, revealed disappointing results. Further understanding of the role of IGF-1R in cancer cells is therefore necessary for development of efficient therapeutic strategies. Recently, we showed that IGF-1R is sumoylated and translocated into the cell nucleus where it activates gene transcription. Several other studies have confirmed our findings and it has been reported that nuclear IGF-1R (nIGF-1R) has prognostic and predictive impact in cancer. To increase the understanding of IGF-1R in cancer cells, we here present the first study that proposes a pathway by which IGF-1R translocates into the cell nucleus. We could demonstrate that IGF-1R first associates with the dynactin subunit p150(Glued), which transports the receptor to the nuclear pore complex, where it co-localizes with importin-beta followed by association with RanBP2. Sumoylation of IGF-1R seems to be required for interaction with RanBP2, which in turn may serve as the SUMO E3 ligase. In the context of sumoylation, we provided evidence that it may favor nIGF-1R accumulation by increasing the stability of the receptor. Taken together, topographic and functional interactions between dynactin, importin-beta and RanBP2 are involved in nuclear translocation of IGF-1R. Our results provide new understanding of IGF-1R in cancer, which in turn may contribute to development of new therapeutic strategies.	[Packham, S.; Warsito, D.; Lin, Y.; Sehat, B.; Larsson, O.] Karolinska Inst, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden; [Sadi, S.; Karlsson, R.] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Packham, S (corresponding author), Karolinska Inst, Dept Pathol & Oncol, CCK R8 04, SE-17176 Stockholm, Sweden.	Sylvia.packham@ki.se			Swedish Cancer Foundation; Swedish Research Council; Cancer Society in Stockholm; Swedish Children Cancer Society; Stockholm County Council; Karolinska Institutet	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Swedish Children Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, the Swedish Research Council, the Cancer Society in Stockholm, the Swedish Children Cancer Society, the Stockholm County Council and the Karolinska Institutet.	Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; Asmane I, 2012, EUR J CANCER, V48, P3027, DOI 10.1016/j.ejca.2012.05.009; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 2013, J CELL PHYSIOL, V228, P675, DOI 10.1002/jcp.24217; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bodzin AS, 2012, J CELL PHYSIOL, V227, P2947, DOI 10.1002/jcp.23041; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deng H, 2011, BIOCHEM BIOPH RES CO, V404, P667, DOI 10.1016/j.bbrc.2010.12.038; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Flores-Rodriguez N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024479; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hilgarth Roland S., 2005, V301, P329; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Ozaki Y, 2011, J BIOL CHEM, V286, P5589, DOI 10.1074/jbc.M110.167742; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Resnicoff M, 1996, J Exp Ther Oncol, V1, P385; Roscioli E, 2012, J CELL BIOL, V196, P435, DOI 10.1083/jcb.201109104; Sarfstein R, 2012, J BIOL CHEM, V287, P2766, DOI 10.1074/jbc.M111.281782; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; SKOUFIAS DA, 1992, BIOCHEMISTRY-US, V31, P738, DOI 10.1021/bi00118a015; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Strom AC, 2001, GENOME BIOL, V2; van Gaal JC, 2013, EUR J CANCER, V49, P3462, DOI 10.1016/j.ejca.2013.06.022; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042483; Yeh TY, 2012, MOL BIOL CELL, V23, P3827, DOI 10.1091/mbc.E12-07-0496; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	51	44	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2227	2238		10.1038/onc.2014.165	http://dx.doi.org/10.1038/onc.2014.165			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24909165				2022-12-25	WOS:000353473000008
J	McMillan, SJ; Sharma, RS; Richards, HE; Hegde, V; Crocker, PR				McMillan, Sarah J.; Sharma, Ritu S.; Richards, Hannah E.; Hegde, Vikas; Crocker, Paul R.			Siglec-E Promotes beta 2-Integrin-dependent NADPH Oxidase Activation to Suppress Neutrophil Recruitment to the Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; MICE; INFLAMMATION; P47(PHOX); RESPONSES; INJURY	Siglec-E is a sialic acid-binding Ig-like lectin expressed on murine myeloid cells. It has recently been shown to function as a negative regulator of beta 2-integrin-dependent neutrophil recruitment to the lung following exposure to lipopolysaccharide (LPS). Here, we demonstrate that siglec-E promoted neutrophil production of reactive oxygen species (ROS) following CD11b beta 2-integrin ligation with fibrinogen in a sialic acid-dependent manner, but it had no effect on ROS triggered by a variety of other stimulants. Siglec-E promotion of ROS was likely mediated via Akt activation, because siglec-E-deficient neutrophils plated on fibrinogen exhibited reduced phosphorylation of Akt, and the Akt inhibitor, MK2206, blocked fibrinogen-induced ROS. In vivo imaging showed that siglec-E also promoted ROS in acutely inflamed lungs following exposure of mice to LPS. Importantly, siglec-E-promoted ROS were required for its inhibitory function, as the NADPH oxidase inhibitor, apocynin, reversed the siglec-E-mediated suppression of neutrophil recruitment and blocked neutrophil ROS production in vitro. Taken together, these results demonstrate that siglec-E functions as an inhibitory receptor of neutrophils via positive regulation of NADPH oxidase activation and ROS production. Our findings have implications for the inhibitory role of siglec-9 on human neutrophils in sepsis and acute lung injury.	[McMillan, Sarah J.; Sharma, Ritu S.; Richards, Hannah E.; Crocker, Paul R.] Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Hegde, Vikas] Univ Dundee, Ctr Dermatol & Genet Med, Div Mol Med, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Crocker, PR (corresponding author), Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.r.crocker@dundee.ac.uk			Medical Research Council [G0700314, G0801742]; MRC [G0700314, G0801742] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. Angelika Grundling, Imperial College London, for the generous gift of S. aureus and Alena Shmakova for initial observations with MK2206. We also thank Prof. W. H. Irwin McLean, supported by the Medical Research Council (Grants G0700314 and G0801742) for use of the IVIS imaging system.	Anderson KE, 2008, BLOOD, V112, P5202, DOI 10.1182/blood-2008-04-149450; Boyle KB, 2012, ANN NY ACAD SCI, V1273, P68, DOI 10.1111/j.1749-6632.2012.06821.x; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Kielland A, 2009, FREE RADICAL BIO MED, V47, P760, DOI 10.1016/j.freeradbiomed.2009.06.013; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; McMillan SJ, 2013, BLOOD, V121, P2084, DOI 10.1182/blood-2012-08-449983; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang WJ, 2009, FREE RADICAL BIO MED, V46, P791, DOI 10.1016/j.freeradbiomed.2008.12.003	23	38	41	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20370	20376		10.1074/jbc.M114.574624	http://dx.doi.org/10.1074/jbc.M114.574624			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895121	Green Published, hybrid			2022-12-25	WOS:000339395200047
J	Hsieh, JY; Liu, JH; Yang, PC; Lin, CL; Liu, GY; Hung, HC				Hsieh, Ju-Yi; Liu, Jyung-Hurng; Yang, Pai-Chun; Lin, Chi-Li; Liu, Guang-Yaw; Hung, Hui-Chih			Fumarate Analogs Act as Allosteric Inhibitors of the Human Mitochondrial NAD(P)(+) -Dependent Malic Enzyme	PLOS ONE			English	Article							FUNCTIONAL ROLES; OXIDATIVE DECARBOXYLASES; CATALYTIC MECHANISM; CDNA CLONING; PURIFICATION; METABOLISM; EXPRESSION; SUBSTRATE; SITE; ATP	Human mitochondrial NAD(P)(+)-dependent malic enzyme (m-NAD(P)-ME) is allosterically activated by the four-carbon trans dicarboxylic acid, fumarate. Previous studies have suggested that the dicarboxylic acid in a trans conformation around the carbon-carbon double bond is required for the allosteric activation of the enzyme. In this paper, the allosteric effects of fumarate analogs on m-NAD(P)-ME are investigated. Two fumarate-insensitive mutants, m-NAD(P)-ME_R67A/R91A and mNAD( P)-ME_K57S/E59N/K73E/D102S, as well as c-NADP-ME, were used as the negative controls. Among these analogs, mesaconate, trans-aconitate, monomethyl fumarate and monoethyl fumarate were allosteric activators of the enzyme, while oxaloacetate, diethyl oxalacetate, and dimethyl fumarate were found to be allosteric inhibitors of human m-NAD(P)-ME. The IC50 value for diethyl oxalacetate was approximately 2.5 mM. This paper suggests that the allosteric inhibitors may impede the conformational change from open form to closed form and therefore inhibit m-NAD(P)-ME enzyme activity.	[Hsieh, Ju-Yi; Liu, Jyung-Hurng; Yang, Pai-Chun; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Jyung-Hurng; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Lin, Chi-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Liu, GY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	hchung@dragon.nchu.edu.tw; liugy@csmu.edu.tw	Hung, Hui-Chih/L-8061-2019; Liu, Jyung-Hurng/C-1340-2010; Lin, Chih-Li/H-9515-2019; Lin, Chih-Li/GQZ-6480-2022; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Liu, Jyung-Hurng/0000-0002-7173-0372; Lin, Chih-Li/0000-0003-4553-3727; Hung, Hui-Chih/0000-0003-0180-1822; YANG, PAN-CHYR/0000-0001-6330-6048	Ministry of Science and Technology, ROC [NSC 101-2311-B-005-005-MY3]; Ministry of Education, Taiwan, R.O.C. under the ATU plan	Ministry of Science and Technology, ROC; Ministry of Education, Taiwan, R.O.C. under the ATU plan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology, ROC (NSC 101-2311-B-005-005-MY3 to H.-C.H.) and in part by the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Bhargava G, 1999, J STRUCT BIOL, V127, P72, DOI 10.1006/jsbi.1999.4126; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1992, ARCH BIOCHEM BIOPHYS, V296, P468, DOI 10.1016/0003-9861(92)90599-R; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; FAHIEN LA, 1992, J BIOL CHEM, V267, P10411; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsieh JY, 2006, J BIOL CHEM, V281, P23237, DOI 10.1074/jbc.M603451200; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; Hsieh JY, 2009, BIOCHEM J, V420, P201, DOI 10.1042/BJ20090076; Hsieh JY, 2009, FEBS J, V276, P983, DOI 10.1111/j.1742-4658.2008.06834.x; Hsieh JY, 2009, J BIOL CHEM, V284, P4536, DOI 10.1074/jbc.M807008200; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; Hsu WC, 2004, BIOCHEMISTRY-US, V43, P7382, DOI 10.1021/bi049600r; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Hung HC, 2005, BIOCHEMISTRY-US, V44, P12737, DOI 10.1021/bi050510b; Jiang DD, 2013, CELL RES, V23, P739, DOI 10.1038/cr.2013.34; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1991, J BIOL CHEM, V266, P3016; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Murugan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050143; Rao GSJ, 2000, PROTEIN PEPTIDE LETT, V7, P297; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Su KL, 2009, BIOORGAN MED CHEM, V17, P5414, DOI 10.1016/j.bmc.2009.06.052; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8	33	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98385	10.1371/journal.pone.0098385	http://dx.doi.org/10.1371/journal.pone.0098385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911153	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600003
J	Mueller, C; Blum, CA; Trummler, M; Stolz, D; Bingisser, R; Mueller, C; Tamm, M; Mueller, B; Schuetz, P; Christ-Crain, M				Mueller, Cornelia; Blum, Claudine A.; Trummler, Michael; Stolz, Daiana; Bingisser, Roland; Mueller, Christian; Tamm, Michael; Mueller, Beat; Schuetz, Philipp; Christ-Crain, Mirjam			Association of Adrenal Function and Disease Severity in Community- Acquired Pneumonia	PLOS ONE			English	Article							DEHYDROEPIANDROSTERONE-SULFATE; CORTISOL; SEPSIS; DHEA	Introduction: Rapid and accurate risk stratification in patients with community-acquiredpneumonia (CAP) is an unmet clinical need. Cortisol to dehydroepiandrosterone (DHEA) ratio was put forward as a prognostic marker in sepsis. We herein validatedthe prognostic value of the adrenal hormones DHEA, DHEA-Sulfate (DHEAS), cortisol/DHEA-, cortisol/DHEAS- and DHEA/DHEAS - ratios in patients with CAP. Methods: We assessed severity of illness using the pneumonia severityindex (PSI) and measured adrenal hormone concentrations in 179 serumsamples of prospectively recruited patients hospitalized with CAP. We calculatedspearman rank correlation, logistic regression analysis and Kaplan Meier curvesto study associations of adrenal hormones and outcomes. Results: There was a significant correlation between PSI score and totalcortisol (r = 0.24, p = 0.001), DHEAS (r = -0.23, p = 0.002), cortisol/DHEA (r = 0.23, p = 0.003), cortisol/ DHEAS (r = 0.32, p =, 0.0001) and DHEA/DHEAS (r = 0.20, p = 0.009). In age and gender adjusted logistic regression analysis, cortisol (OR: 2.8, 95% CI: 1.48- 5.28) and DHEA (OR: 2.62,95% CI: 1.285.34), but not DHEAS and the differentratios were associated with all- cause mortality. The discriminatoryaccuracy of cortisol and DHEA in ROC analysis (area under the curve) was 0.74 and 0.61. In Kaplan Meier analysis, patients in the highest decilesof cortisol and DHEA (p = 0.005 and p = 0.015), and toa lesser extent of cortisol/ DHEAS ratio (p = 0.081) hada higher risk of death. Conclusion: Cortisol, DHEAS and their ratios correlate with CAP severity, and cortisol and DHEA predict mortality. Adrenal function in severe pneumoniamay be an important factor for CAP outcomes.	[Mueller, Cornelia; Blum, Claudine A.; Christ-Crain, Mirjam] UniversityHosp, Dept Endocrinol Diabetol & Metab, Basel, Switzerland; [Trummler, Michael] Bioanalytica AG, Luzern, Switzerland; [Stolz, Daiana; Tamm, Michael] Univ Basel Hosp, Dept Pneumol, CH-4031 Basel, Switzerland; [Bingisser, Roland] Univ Basel Hosp, Dept Emergency Med, CH-4031 Basel, Switzerland; [Mueller, Christian] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Mueller, Beat; Schuetz, Philipp] Med Univ Clin, CantonalHosp, Dept Endocrinol, Aarau, Switzerland	University of Basel; University of Basel; University of Basel	Mueller, C (corresponding author), UniversityHosp, Dept Endocrinol Diabetol & Metab, Basel, Switzerland.	muellerc.mail@gmail.com	schuetz, philipp/C-8475-2013; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016; Müller, Christian/AAB-4783-2022	schuetz, philipp/0000-0001-6400-4949; Blum, Claudine Angela A/0000-0003-0487-5587; Müller, Christian/0000-0002-1120-6405; Christ-Crain, Mirjam/0000-0002-6336-0965; Stolz, Daiana/0000-0003-0099-882X	Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel; University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation [PP00P3-12346]	Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel; University of Basel, Switzerland; Bangerter-Rhyner-Foundation, Basel, Switzerland; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by in-house grantsfrom the Department of Endocrinology, Diabetology, Clinical Nutrition of theUniversity Hospital of Basel, as well as by a grant for young research scientistsof the University of Basel, Switzerland, a grant from the Bangerter-Rhyner-Foundation, Basel, Switzerland, to CAB and by research grants of the Swiss National Foundation, PP00P3-12346, to MCC. MT of Bioanalytica AG, Lucerne, Switzerland, granted a discount for analyzing DHEA and DHEAS. The funders had no role instudy design, data collection and analysis, decision to publish, or preparationof the manuscript.	Arlt W, 2006, J CLIN ENDOCR METAB, V91, P2548, DOI 10.1210/jc.2005-2258; Beishuizen A, 2002, CRIT CARE, V6, P434, DOI 10.1186/cc1530; Blum CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063224; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Christ-Crain M, 2007, AM J RESP CRIT CARE, V176, P913, DOI 10.1164/rccm.200702-307OC; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Girard TD, 2007, CLIN GERIATR MED, V23, P633, DOI 10.1016/j.cger.2007.05.003; Kolditz M, 2010, EUR RESPIR J, V36, P615, DOI 10.1183/09031936.00191709; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; Oberbeck R, 2001, CRIT CARE MED, V29, P380, DOI 10.1097/00003246-200102000-00029; Oberbeck R, 2010, CURR MED CHEM, V17, P1039; Radford DJ, 2010, MOL ENDOCRINOL, V24, P813, DOI 10.1210/me.2009-0390; ROSENFELD RS, 1971, J CLIN ENDOCR METAB, V33, P87, DOI 10.1210/jcem-33-1-87; Schmitz D, 2010, J SURG RES, V163, pE73, DOI 10.1016/j.jss.2010.05.017; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Vermes I, 2001, BEST PRACT RES CL EN, V15, P495, DOI 10.1053/beem.2001.0166; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99518	10.1371/journal.pone.0099518	http://dx.doi.org/10.1371/journal.pone.0099518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910975	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600099
J	Niu, XL; Zhao, LY; Li, X; Xue, YS; Wang, B; Lv, ZQ; Chen, JH; Sun, DD; Zheng, QS				Niu, Xiaolin; Zhao, Lianyou; Li, Xue; Xue, Yusheng; Wang, Bin; Lv, Zongqiang; Chen, Jianghong; Sun, Dongdong; Zheng, Qiangsun			beta 3-Adrenoreceptor Stimulation Protects against Myocardial Infarction Injury via eNOS and nNOS Activation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; HUMAN FAILING MYOCARDIUM; HUMAN HEART; BETA(3)-ADRENOCEPTOR STIMULATION; CARDIOVASCULAR-SYSTEM; PHOSPHORYLATION; RECEPTOR; FAILURE; DEFICIENCY	beta 3-adrenergic receptor (AR) and the downstream signaling, nitric oxide synthase (NOS) isoforms, have been emerged as novel modulators of heart function and even potential therapeutic targets for cardiovascular diseases. However, it is not known whether beta 3-AR plays cardioprotective effects against myocardial infarction (MI) injury. Therefore, the present study was designed to determine the effects of beta 3-AR on MI injury and to elucidate the underlying mechanism. MI model was constructed by left anterior descending (LAD) artery ligation. Animals were administrated with beta 3-AR agonist BRL37344 (BRL) or beta 3-AR inhibitor SR59230A (SR) respectively at 0.1 mg/kg/hour one day after MI operation. The scar area, cardiac function and the apoptosis of myocardial were assessed by Masson's trichrome stain, echocardiography and TUNEL assay respectively. Western blot analysis was performed to elucidate the expressions of target proteins. beta 3-AR activation with BRL administration significantly attenuated fibrosis and decreased scar area after MI. Moreover, BRL also preserved heart function, and reduced the apoptosis of cardiomyocyte induced by MI. Furthermore, BRL treatment altered the phosphorylation status of endothelial NOS (eNOS) and increased the expression of neuronal NOS (nNOS). These results suggested that beta 3-AR stimulation has a substantial effect on recovery of heart function. In addition, the activations of both eNOS and nNOS may be associated with the cardiac protective effects of beta 3-AR.	[Niu, Xiaolin; Zhao, Lianyou; Li, Xue; Xue, Yusheng; Wang, Bin; Chen, Jianghong; Zheng, Qiangsun] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Sun, Dongdong] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Lv, Zongqiang] Fourth Mil Med Univ, Cadet Brigade, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Sun, DD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China.	dongdongSun@163.com; zhengqiangsun123@163.com		niu, xiaolin/0000-0002-8320-5516	National Nature Science Foundation of China [81200099]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (No. 81200099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Balligand JL, 2009, J AM COLL CARDIOL, V53, P1539, DOI 10.1016/j.jacc.2009.01.048; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Braunwald E, 2000, CIRCULATION, V102, P14; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Brixius K, 2006, CAN J PHYSIOL PHARM, V84, P1051, DOI 10.1139/Y06-033; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Mishra OP, 2009, NEUROSCI LETT, V462, P64, DOI 10.1016/j.neulet.2009.06.075; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; Napp A, 2009, J CARD FAIL, V15, P57, DOI 10.1016/j.cardfail.2008.08.006; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Rozec B, 2003, ARCH MAL COEUR VAISS, V96, P905; Rozec B, 2006, PHARMACOL THERAPEUT, V111, P652, DOI 10.1016/j.pharmthera.2005.12.002; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Sharp BR, 2002, AM J PHYSIOL-HEART C, V282, pH2422, DOI 10.1152/ajpheart.00855.2001; Simard P M, 1994, Obes Res, V2, P424; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; Zhang Z, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0333-5; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	39	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98713	10.1371/journal.pone.0098713	http://dx.doi.org/10.1371/journal.pone.0098713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911015	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600010
J	Kuzilek, J; Kremen, V; Soucek, F; Lhotska, L				Kuzilek, Jakub; Kremen, Vaclav; Soucek, Filip; Lhotska, Lenka			Independent Component Analysis and Decision Trees for ECG Holter Recording De-Noising	PLOS ONE			English	Article							REMOVING ARTIFACTS; REDUCTION; DATABASE; ELECTROCARDIOGRAMS; DYNAMICS; PCA	We have developed a method focusing on ECG signal de-noising using Independent component analysis (ICA). This approach combines JADE source separation and binary decision tree for identification and subsequent ECG noise removal. In order to to test the efficiency of this method comparison to standard filtering a wavelet-based de-noising method was used. Freely data available at Physionet medical data storage were evaluated. Evaluation criteria was root mean square error (RMSE) between original ECG and filtered data contaminated with artificial noise. Proposed algorithm achieved comparable result in terms of standard noises (power line interference, base line wander, EMG), but noticeably significantly better results were achieved when uncommon noise (electrode cable movement artefact) were compared.	[Kuzilek, Jakub; Kremen, Vaclav; Lhotska, Lenka] Czech Tech Univ, FEE, Dept Cybernet, Prague, Czech Republic; [Kremen, Vaclav] Czech Tech Univ, Czech Inst Informat Robot & Cybernet, Prague, Czech Republic; [Soucek, Filip] St Annes Hosp Brno, ICRC, Dept Cardiovasc Dis, Brno, Czech Republic	Czech Technical University Prague; Czech Technical University Prague; St Anne's University Hospital Brno (FNUSA-ICRC)	Kuzilek, J (corresponding author), Czech Tech Univ, FEE, Dept Cybernet, Prague, Czech Republic.	jakub.kuzilek@fel.cvut.cz	Kremen, Vaclav/G-7612-2017; Kuzilek, Jakub/M-4316-2019; Lhotska, Lenka/X-1866-2019; Kuzilek, Jakub/G-6733-2012	Kremen, Vaclav/0000-0001-9844-7617; Kuzilek, Jakub/0000-0002-8656-0599; Lhotska, Lenka/0000-0003-0742-5645; Kuzilek, Jakub/0000-0002-8656-0599	Czech Science Foundation GACR [P103/11/P106]; CTU [SGS13/203/OHK3/3T/13]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); CTU	This work was supported by post doctoral research project by Czech Science Foundation GACR #P103/11/P106 and by the CTU Grant SGS13/203/OHK3/3T/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya A, 2010, IEEE ENG MED BIO, P1142, DOI 10.1109/IEMBS.2010.5627133; Agrawal G, 2008, J SCI IND RES INDIA, V67, P43; Albrecht P., 1983, ST SEGMENT CHARACTER; Barros AK, 1998, NEUROCOMPUTING, V22, P173, DOI 10.1016/S0925-2312(98)00056-3; Breiman L., 2017, CLASSIFICATION REGRE; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Castells F, 2007, BIOMED TECH, V52, P18, DOI 10.1515/BMT.2007.005; Chawla MPS, 2008, INT J CARDIOL, V129, P278, DOI 10.1016/j.ijcard.2007.06.037; Chawla MPS, 2011, APPL SOFT COMPUT, V11, P2216, DOI 10.1016/j.asoc.2010.08.001; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; DiPietroPaolo D, 2006, MED BIOL ENG COMPUT, V44, P489, DOI 10.1007/s11517-006-0055-z; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; FRIESEN GM, 1990, IEEE T BIO-MED ENG, V37, P85, DOI 10.1109/10.43620; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; He TG, 2006, NEURAL COMPUT APPL, V15, P105, DOI 10.1007/s00521-005-0013-y; HIRANO K, 1974, IEEE T COMMUN, VCO22, P964, DOI 10.1109/TCOM.1974.1092311; Hong X., 2009, 2009 9 INT C INFORM, P1, DOI [10.1109/ITAB.2009.5394306, DOI 10.1109/ITAB.2009.5394306]; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jager F, 2003, MED BIOL ENG COMPUT, V41, P172, DOI 10.1007/BF02344885; Jimenez-Gonzalez A, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P949, DOI 10.1109/CIC.2008.4749200; Keralapura Mallika, 2011, IAENG International Journal of Computer Science, V38, P38; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Kuzilek J, 2013, THESIS CZECH TU; Liu YD, 2008, IEEE J-STSP, V2, P870, DOI 10.1109/JSTSP.2008.2008495; Mallat S, 1999, WAVELT TOUR SIGNAL P; Milanesi M, 2008, MED BIOL ENG COMPUT, V46, P251, DOI 10.1007/s11517-007-0293-8; Milanesi M, 2006, 2006 28 ANN INT C IE; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Oster J, 2009, PHYSIOL MEAS, V30, P1381, DOI 10.1088/0967-3334/30/12/007; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patil P.B., 2012, INT C PATTERN RECOGN, P278, DOI [DOI 10.1109/ICPRIME.2012.6208358, 10.1109/ICPREIME.2012.6208358, DOI 10.1109/ICPREIME.2012.6208358]; Romero I, 2011, COMPUT CARDIOL CONF, V38, P613; TADDEI A, 1992, EUR HEART J, V13, P1164, DOI 10.1093/oxfordjournals.eurheartj.a060332; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Tu YW, 2012, ANN BIOMED ENG, V40, P1917, DOI 10.1007/s10439-012-0551-2; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wisbeck J.O., 1998, APPL ICA SEPARATION	38	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98450	10.1371/journal.pone.0098450	http://dx.doi.org/10.1371/journal.pone.0098450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905359	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000031
J	Li, M; Zhang, YJ; Zhang, L; Yang, XY; Jiang, XL				Li, Mei; Zhang, Yujie; Zhang, Lin; Yang, Xiaoyan; Jiang, Xiliang			Exploring the Electron Transfer Pathway in the Oxidation of Avermectin by CYP107Z13 in Streptomyces ahygroscopicus ZB01	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; CYTOCHROME-P450 COMPLEMENT; BIOCATALYTIC CONVERSION; HYDROXYLATION; COELICOLOR; FERREDOXIN; REDUCTASE; CLONING; 4''-OXO-AVERMECTIN; MONOOXYGENASE	Streptomyces ahygroscopicus ZB01 can effectively oxidize 4 ''-OH of avermectin to form 4 ''-oxo-avermectin. CYP107Z13 is responsible for this site-specific oxidation in ZB01. In the present study, we explored the electron transfer pathway in oxidation of avermectin by CYP107Z13 in ZB01. A putative [3Fe-4S] ferredoxin gene fd68 and two possible NADH-dependent ferredoxin reductase genes fdr18 and fdr28 were cloned from the genomic DNA of ZB01. fd68 gene disruption mutants showed no catalytic activity in oxidation of avermectin to form 4 ''-oxo-avermectin. To clarify whether FdR18 and FdR28 participate in the electron transfer during avermectin oxidation by CYP107Z13, two whole-cell biocatalytic systems were designed in E. coli BL21 (DE3), with one co-expressing CYP107Z13, Fd68 and FdR18 and the other co-expressing CYP107Z13, Fd68 and FdR28. Both of the two biocatalytic systems were found to be able to mediate the oxidation of avermectin to form 4 ''-oxo-avermectin. Thus, we propose an electron transfer pathway NADH -> FdR18/FdR28 -> Fd68 -> CYP107Z13 for oxidation of avermectin to form 4 ''-oxo-avermectin in ZB01.	[Li, Mei; Zhang, Yujie; Zhang, Lin; Yang, Xiaoyan; Jiang, Xiliang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Jiang, XL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	jiangxiliang@caas.cn			National Natural Science Foundation of China [31101484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant No. 31101484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SG, 2010, APPL MICROBIOL BIOT, V86, P163, DOI 10.1007/s00253-009-2234-y; Bell SG, 2010, MOL BIOSYST, V6, P206, DOI 10.1039/b913487e; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Choi KY, 2013, CHEMBIOCHEM, V14, P1231, DOI 10.1002/cbic.201300212; Chun YJ, 2006, BIOCHEM SOC T, V34, P1183, DOI 10.1042/BST0341183; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Cornelissen S, 2013, BIOTECHNOL BIOENG, V110, P1282, DOI 10.1002/bit.24801; Duetz WA, 2001, CURR OPIN BIOTECH, V12, P419, DOI 10.1016/S0958-1669(00)00237-8; Green AJ, 2003, J INORG BIOCHEM, V93, P92, DOI 10.1016/S0162-0134(02)00456-7; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hopwood D. A., 1985, GENETIC MANIPULATION; [黄敏红 HUANG Min-hong], 2010, [微生物学杂志, Journal of Mirobiology], V30, P75; Jiang XL, 2012, APPL MICROBIOL BIOT, V93, P1957, DOI 10.1007/s00253-011-3490-1; Joo YC, 2012, BIOCHIMIE, V94, P907, DOI 10.1016/j.biochi.2011.12.011; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kleser M, 2012, J BIOTECHNOL, V157, P405, DOI 10.1016/j.jbiotec.2011.12.006; Lamb DC, 2003, BIOCHEM BIOPH RES CO, V307, P610, DOI 10.1016/S0006-291X(03)01231-2; [李梅 LI Mei], 2008, [微生物学通报, Microbiology], V35, P1107; Lim YR, 2012, ARCH BIOCHEM BIOPHYS, V528, P111, DOI 10.1016/j.abb.2012.09.001; Liu Weide, 2011, Weishengwu Xuebao, V51, P410; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; Molnar I, 2006, BIOCHEM SOC T, V34, P1236, DOI 10.1042/BST0341236; Molnar I, 2005, APPL ENVIRON MICROB, V71, P6977, DOI 10.1128/AEM.71.11.6977-6985.2005; Nie Y, 2014, APPL MICROBIOL BIOT, V98, P163, DOI 10.1007/s00253-013-4821-1; Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011; PETERSON JA, 1990, J BIOL CHEM, V265, P6066; Pramod S, 2008, BIOTECHNOL LETT, V30, P1100; [乔峰 Qiao Feng], 2012, [中国医药生物技术, Chinese Medicinal Biotechnolog], V7, P178; RAMACHANDRA M, 1991, J BACTERIOL, V173, P7106, DOI 10.1128/jb.173.22.7106-7112.1991; Roh C, 2009, J MOL CATAL B-ENZYM, V59, P248, DOI 10.1016/j.molcatb.2008.07.005; Sambrook J, 2001, MOL CLONING LAB MANU; Sevrioukova IF, 2011, ARCH BIOCHEM BIOPHYS, V507, P66, DOI 10.1016/j.abb.2010.08.022; Shrestha P, 2008, APPL MICROBIOL BIOT, V79, P555, DOI 10.1007/s00253-008-1455-9; Sielaff B, 2005, MICROBIOL-SGM, V151, P2593, DOI 10.1099/mic.0.28039-0; van Beilen JB, 2006, APPL ENVIRON MICROB, V72, P59, DOI 10.1128/AEM.72.1.59-65.2006	38	2	2	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98916	10.1371/journal.pone.0098916	http://dx.doi.org/10.1371/journal.pone.0098916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905717	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000078
J	Villanueva, A; Vlachos, P; Priya, S				Villanueva, Alex; Vlachos, Pavlos; Priya, Shashank			Flexible Margin Kinematics and Vortex Formation of Aurelia aurita and Robojelly	PLOS ONE			English	Article							SWIMMING PERFORMANCE; FLOW PATTERNS; JELLYFISH; MORPHOLOGY; RINGS	The development of a rowing jellyfish biomimetic robot termed as "Robojelly'', has led to the discovery of a passive flexible flap located between the flexion point and bell margin on the Aurelia aurita. A comparative analysis of biomimetic robots showed that the presence of a passive flexible flap results in a significant increase in the swimming performance. In this work we further investigate this concept by developing varying flap geometries and comparing their kinematics with A. aurita. It was shown that the animal flap kinematics can be replicated with high fidelity using a passive structure and a flap with curved and tapered geometry gave the most biomimetic performance. A method for identifying the flap location was established by utilizing the bell curvature and the variation of curvature as a function of time. Flaps of constant cross-section and varying lengths were incorporated on the Robojelly to conduct a systematic study of the starting vortex circulation. Circulation was quantified using velocity field measurements obtained from planar Time Resolved Digital Particle Image Velocimetry (TRDPIV). The starting vortex circulation was scaled using a varying orifice model and a pitching panel model. The varying orifice model which has been traditionally considered as the better representation of jellyfish propulsion did not appear to capture the scaling of the starting vortex. In contrast, the pitching panel representation appeared to better scale the governing flow physics and revealed a strong dependence on the flap kinematics and geometry. The results suggest that an alternative description should be considered for rowing jellyfish propulsion, using a pitching panel method instead of the traditional varying orifice model. Finally, the results show the importance of incorporating the entire bell geometry as a function of time in modeling rowing jellyfish propulsion.	[Villanueva, Alex; Priya, Shashank] Virginia Polytech Inst & State Univ, Dept Mech Engn, BMDL, CEHMS, Blacksburg, VA 24061 USA; [Vlachos, Pavlos] Purdue Univ, Dept Mech Engn, W Lafayette, IN 47907 USA	Virginia Polytechnic Institute & State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Villanueva, A (corresponding author), Virginia Polytech Inst & State Univ, Dept Mech Engn, BMDL, CEHMS, Blacksburg, VA 24061 USA.	alexv@vt.edu	Priya, S/GQH-7176-2022; Vlachos, Pavlos P/G-3779-2010	Priya, Shashank/0000-0003-1367-3434; Vlachos, Pavlos P/0000-0002-8040-9257	Office of Naval Research [N00014-08-1-0654]	Office of Naval Research(Office of Naval Research)	The authors gratefully acknowledge the financial support from the Office of Naval Research through grant #N00014-08-1-0654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1921949; Batchelor G., 1967, INTRO FLUID DYNAMICS; Buchholz JHJ, 2008, J FLUID MECH, V603, P331, DOI 10.1017/S0022112008000906; Buchholz JHJ, 2011, J FLUID MECH, V688, P591, DOI 10.1017/jfm.2011.408; Chakraborty P, 2005, J FLUID MECH, V535, P189, DOI 10.1017/S0022112005004726; Chapman DM, 1999, CAN J ZOOL, V77, P34, DOI 10.1139/cjz-77-1-34; Charonko JJ, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/6/065301; Colin SP, 2002, J EXP BIOL, V205, P427; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; Dabiri JO, 2005, J FLUID MECH, V538, P111, DOI 10.1017/S002211200500515X; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; DIDDEN N, 1979, Z ANGEW MATH PHYS, V30, P101, DOI 10.1007/BF01597484; DOLIGALSKI TL, 1994, ANNU REV FLUID MECH, V26, P573, DOI 10.1146/annurev.fl.26.010194.003041; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/5/055401; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/075402; Eckstein AC, 2008, EXP FLUIDS, V45, P485, DOI 10.1007/s00348-008-0492-6; Gemmell BJ, 2013, PNAS, V110, P44; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WB, 1972, MAR BIOL, V14, P150, DOI 10.1007/BF00373214; Green MA, 2008, J FLUID MECH, V615, P211, DOI 10.1017/S0022112008003583; Holden D, 2011, THESIS VIRGINIA POLY; Jiang M, 2002, P IEEE TCVG, V217; Joshi K, 2013, INTEGR FERROELECTR, V148, P53, DOI 10.1080/10584587.2013.851591; KRAMP PL, 1961, J MAR BIOL ASSOC UK, V40, P7, DOI 10.1017/S0025315400007347; LARSON RJ, 1987, CAN J ZOOL, V65, P2690, DOI 10.1139/z87-408; Mayor AG, 1910, MEDUSAE WORLD; McHenry MJ, 2003, J EXP BIOL, V206, P4125, DOI 10.1242/jeb.00649; Megill WM, 2005, J EXP BIOL, V208, P3819, DOI 10.1242/jeb.01765; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Scarano F, 2002, MEAS SCI TECHNOL, V13, pR1, DOI 10.1088/0957-0233/13/1/201; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Smith C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/1/012001; Timmins BH, 2012, EXP FLUIDS, V53, P1133, DOI 10.1007/s00348-012-1341-1; Villanueva AA, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/2/025013; Wilson MM, 2011, INT J NONLIN MECH, V46, P557, DOI 10.1016/j.ijnonlinmec.2010.12.005; Zhou J, 1999, J FLUID MECH, V387, P353, DOI 10.1017/S002211209900467X	40	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98310	10.1371/journal.pone.0098310	http://dx.doi.org/10.1371/journal.pone.0098310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905025	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000028
J	Wang, Y; Sun, ZH; Zhou, L; Li, Z; Gui, JF				Wang, Yang; Sun, Zhi-Hui; Zhou, Li; Li, Zhi; Gui, Jian-Fang			Grouper tsh beta Promoter-Driven Transgenic Zebrafish Marks Proximal Kidney Tubule Development	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; THYROTROPIN RECEPTOR; SEX REVERSAL; PRONEPHROS; GENE; SPECIFICATION; REVEALS; PROTEIN; MODEL	Kidney tubule plays a critical role in recovering or secreting solutes, but the detailed morphogenesis remains unclear. Our previous studies have found that grouper tsh beta (gtsh beta) is also expressed in kidney, however, the distribution significance is still unknown. To understand the gtshb role and kidney tubule morphogenesis, here, we have generated a transgenic zebrafish line Tg(gtsh beta: GFP) with green fluorescent protein driven by the gtshb promoter. Similar to the endogenous tshb in zebrafish or in grouper, the gtsh beta promoter-driven GFP is expressed in pituitary and kidney, and the developing details of proximal kidney tubule are marked in the transgenic zebrafish line. The gfp initially transcribes at 16 hours post fertilization (hpf) above the dorsal mesentery, and partially co-localizes with pronephric tubular markers slc20a1a and cdh17. Significantly, the GFP specifically localizes in proximal pronephric segments during embryogenesis and resides at kidney duct epithelium in adult fish. To test whether the gtsh beta promoter-driven GFP may serve as a readout signal of the tubular development, we have treated the embryos with retinoic acid signaing (RA) reagents, in which exogenous RA addition results in a distal extension of the proximal segments, while RA inhibition induces a weakness and shortness of the proximal segments. Therefore, this transgenic line provides a useful tool for genetic or chemical analysis of kidney tubule.	[Wang, Yang; Sun, Zhi-Hui; Zhou, Li; Li, Zhi; Gui, Jian-Fang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of Chinese Academy of Sciences, CAS	Gui, JF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			National Major Basic Research Program [2010CB126301]; National 863 High Technology Research Program [2012AA092201-3]; Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest [200903045]; National Natural Science Foundation of China [30971414]	National Major Basic Research Program(National Basic Research Program of China); National 863 High Technology Research Program(National High Technology Research and Development Program of China); Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Major Basic Research Program (2010CB126301), the National 863 High Technology Research Program (Grants No 2012AA092201-3), the Ministry of Agriculture of China within the special Fund for Agro-scientific Research in the Public Interest (200903045), the National Natural Science Foundation of China (Grant No. 30971414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER LM, 1989, MOL ENDOCRINOL, V3, P1037, DOI 10.1210/mend-3-7-1037; BauerHofmann R, 1995, NUCLEIC ACIDS RES, V23, P5034, DOI 10.1093/nar/23.24.5034; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Braat AK, 2000, MECH DEVELOP, V95, P271, DOI 10.1016/S0925-4773(00)00344-0; Bricaud O, 2006, J NEUROSCI, V26, P10438, DOI 10.1523/JNEUROSCI.1025-06.2006; Bryson-Richardson R, 2005, DEV DYNAM, V233, P1018, DOI 10.1002/dvdy.20380; Burrow CR, 2000, EXP NEPHROL, V8, P219; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drummond I, 2003, TRENDS CELL BIOL, V13, P357, DOI 10.1016/S0962-8924(03)00124-7; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; EMERMAN JT, 1977, IN VITRO CELL DEV B, V13, P316, DOI 10.1007/BF02616178; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Gerlach GF, 2013, WIRES DEV BIOL, V2, P559, DOI 10.1002/wdev.92; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grossmann M, 1997, ENDOCR REV, V18, P476, DOI 10.1210/er.18.4.476; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Heliot C, 2013, DEVELOPMENT, V140, P873, DOI 10.1242/dev.086538; Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Hurtado R, 2006, DEV DYNAM, V235, P2811, DOI 10.1002/dvdy.20909; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Inoue M, 1998, THYROID, V8, P1059, DOI 10.1089/thy.1998.8.1059; Ji C, 2012, TOXICOL APPL PHARM, V262, P149, DOI 10.1016/j.taap.2012.04.029; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Koprunner M, 2001, GENE DEV, V15, P2877; Kumar RS, 2001, COMP BIOCHEM PHYS B, V129, P347, DOI 10.1016/S1096-4959(01)00317-7; Lancman JJ, 2013, DEVELOPMENT, V140, P2669, DOI 10.1242/dev.090993; Levenson RM, 2006, CYTOM PART A, V69A, P748, DOI 10.1002/cyto.a.20319; Li Chen-Yu, 2010, Acta Hydrobiologica Sinica, V34, P822, DOI 10.3724/SP.J.1035.2010.00822; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007261; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; MacKenzie DS, 2009, GEN COMP ENDOCR, V161, P83, DOI 10.1016/j.ygcen.2008.12.010; Majumdar A, 2000, DEVELOPMENT, V127, P2089; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mudumana SP, 2008, DEVELOPMENT, V135, P3355, DOI 10.1242/dev.022830; Naylor RW, 2013, J AM SOC NEPHROL, V24, P77, DOI 10.1681/ASN.2012070756; Naylor RW, 2013, PEDIAT NEPHROL; Nichane M, 2006, GENE EXPR PATTERNS, V6, P667, DOI 10.1016/j.modgep.2006.01.005; O'Brien LL, 2011, DEV BIOL, V358, P318, DOI 10.1016/j.ydbio.2011.08.005; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Roelfsema F, 2013, ENDOCRINE REV; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Sellitti DF, 1997, THYROID, V7, P641, DOI 10.1089/thy.1997.7.641; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; VIZE P, 2002, KIDNEY NORMAL DEV CO; Walsh SB, 2012, CLIN MED, V12, P476, DOI 10.7861/clinmedicine.12-5-476; Wang HC, 2003, BLOOD, V101, P119, DOI 10.1182/blood-2002-02-0544; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022555; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Wang Y, 2013, SCI CHINA LIFE SCI, V56, P975, DOI 10.1007/s11427-013-4563-4; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wingert RA, 2008, KIDNEY INT, V73, P1120, DOI 10.1038/ki.2008.37; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Wingert RA, 2011, DEV DYNAM, V240, P2011, DOI 10.1002/dvdy.22691; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xu HY, 2005, DEV DYNAM, V233, P872, DOI 10.1002/dvdy.20410; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yue HM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108043; Zhong J, 2014, CELL DEATH DIFFERENT; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	79	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97806	10.1371/journal.pone.0097806	http://dx.doi.org/10.1371/journal.pone.0097806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905828	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000013
J	FitzGerald, J; Murillo, LS; O'Brien, G; O'Connell, E; O'Connor, A; Wu, K; Wang, GN; Rainey, MD; Natoni, A; Healy, S; O'Dwyer, M; Santocanale, C				FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connell, Enda; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; O'Dwyer, Michael; Santocanale, Corrado			A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response	PLOS ONE			English	Article							CDC7 KINASE INHIBITORS; CELL-CYCLE REGULATION; DOUBLE-STRAND BREAKS; S-PHASE; TOPOISOMERASE-II; CANCER-THERAPY; IONIZING-RADIATION; REPLICATION STRESS; ANTITUMOR-ACTIVITY; PROTEIN	DNA replication is an essential process for cell division and as such it is a process that is directly targeted by several anticancer drugs. CDC7 plays an essential role in the activation of replication origins and has recently been proposed as a novel target for drug discovery. The MCM DNA helicase complex (MCM2-7) is a key target of the CDC7 kinase, and MCM phosphorylation status at specific sites is a reliable biomarker of CDC7 cellular activity. In this work we describe a cell-based assay that utilizes the "In Cell Western Technique'' (ICW) to identify compounds that affect cellular CDC7 activity. By screening a library of approved drugs and kinase inhibitors we found several compounds that can affect CDC7-dependent phosphorylation of MCM2 in HeLa cells. Among these, Mitoxantrone, a topoisomerase inhibitor, and Ryuvidine, previously described as a CDK4 inhibitor, cause a reduction in phosphorylated MCM2 levels and a sudden blockade of DNA synthesis that is accompanied by an ATM-dependent checkpoint response. This study sheds light on the previously observed cytotoxity of Ryuvidine, strongly suggesting that it is related to its effect of causing DNA damage.	[FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; Santocanale, Corrado] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [FitzGerald, Jennifer; Murillo, Laura S.; O'Brien, Gemma; O'Connor, Aisling; Wu, Kevin; Wang, Guan-Nan; Rainey, Michael D.; Natoni, Alessandro; Healy, Sandra; Santocanale, Corrado] Natl Univ Ireland Galway, Sch Nat Sci, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Murillo, Laura S.; Natoni, Alessandro; O'Dwyer, Michael] Natl Univ Ireland Galway, Sch Med, Galway, Ireland; [O'Connell, Enda] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Screening Core, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Santocanale, C (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland.	corrado.santocanale@nuigalway.ie		Wu, Kevin/0000-0003-3597-8714; Natoni, Alessandro/0000-0003-4321-9005; O'Connell, Enda/0000-0001-7441-0262; Murillo, Laura/0000-0002-2493-8584; o'dwyer, michael/0000-0002-6173-7140; Santocanale, Corrado/0000-0003-1337-5656; Rainey, Michael/0000-0001-9777-873X	Science Foundation Ireland [08/IN.1/B2064]; Irish Health Research Board [HRA/2009/89]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board	This work was partially supported by Science Foundation Ireland (http://www.sfi.ie http://www.sfi.ie) grant 08/IN.1/B2064 and the Irish Health Research Board (http://www.hrb.ie http://www.hrb.ie) grant HRA/2009/89. Screening Core and Flow Cytomerty facilities are supported by HEA (www.hea.ie http://www.hea.ie) PRTLI5 Advancing Medicine through Discovery programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2012, EXPERT OPIN INV DRUG, V21, P619, DOI 10.1517/13543784.2012.676043; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Barkley LR, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.20; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BEGLEITER A, 1984, CANCER RES, V44, P78; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bryan MC, 2013, BIOORG MED CHEM LETT, V23, P2056, DOI 10.1016/j.bmcl.2013.02.007; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Cicenas J, 2011, J CANCER RES CLIN, V137, P1409, DOI 10.1007/s00432-011-1039-4; Collins FS, 2011, NAT REV DRUG DISCOV, V10, P397, DOI 10.1038/nrd3461; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Diaz-Moralli S, 2013, PHARMACOL THERAPEUT, V138, P255, DOI 10.1016/j.pharmthera.2013.01.011; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Hande KR, 1998, BBA-GENE STRUCT EXPR, V1400, P173, DOI 10.1016/S0167-4781(98)00134-1; Harrington PE, 2013, BIOORG MED CHEM LETT, V23, P6396, DOI 10.1016/j.bmcl.2013.09.055; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hoffman GR, 2010, ASSAY DRUG DEV TECHN, V8, P186, DOI 10.1089/adt.2009.0213; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Ito S, 2008, DRUG NEWS PERSPECT, V21, P481, DOI 10.1358/dnp.2008.21.9.1290818; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kurose A, 2005, CYTOM PART A, V68A, P1, DOI 10.1002/cyto.a.20186; Menichincheri M, 2010, J MED CHEM, V53, P7296, DOI 10.1021/jm100504d; Menichincheri M, 2009, J MED CHEM, V52, P293, DOI 10.1021/jm800977q; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Natoni A, 2011, MOL CANCER THER, V10, P1624, DOI 10.1158/1535-7163.MCT-10-1119; Paul SM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004452; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rainey MD, 2013, CELL CYCLE, V12, P1560, DOI 10.4161/cc.24675; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Ryu CK, 2000, BIOORG MED CHEM LETT, V10, P461, DOI 10.1016/S0960-894X(00)00014-7; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Singh M, 2013, ANTICANCER AGENTS ME; Smart DJ, 2008, MUTAT RES-FUND MOL M, V641, P43, DOI 10.1016/j.mrfmmm.2008.03.005; Suzuki T, 2012, J BIOL CHEM, V287, P40256, DOI 10.1074/jbc.M112.353805; Swords R, 2010, EUR J CANCER, V46, P33, DOI 10.1016/j.ejca.2009.09.020; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Vanotti E, 2008, J MED CHEM, V51, P487, DOI 10.1021/jm700956r; Wan XB, 2013, J MED CHEM, V56, P2619, DOI 10.1021/jm400045y; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; Wu X, 2002, ONCOGENE, V21, P7786, DOI 10.1038/sj.onc.1205914; Yamada M, 2013, GENE DEV, V27, P2459, DOI 10.1101/gad.224568.113; Yin RC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01269; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao CL, 2009, BIOORG MED CHEM LETT, V19, P319, DOI 10.1016/j.bmcl.2008.11.093; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	64	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98891	10.1371/journal.pone.0098891	http://dx.doi.org/10.1371/journal.pone.0098891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24902048	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400068
J	Luzwick, JW; Nam, EA; Zhao, RX; Cortez, D				Luzwick, Jessica W.; Nam, Edward A.; Zhao, Runxiang; Cortez, David			Mutation of Serine 1333 in the ATR HEAT Repeats Creates a Hyperactive Kinase	PLOS ONE			English	Article							EARLY EMBRYONIC LETHALITY; PIK-RELATED KINASES; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; GENOME MAINTENANCE; PROTEIN; DOMAIN; PHOSPHORYLATION; REPLICATION; AUTOPHOSPHORYLATION	Subcellular localization, protein interactions, and post-translational modifications regulate the DNA damage response kinases ATR, ATM, and DNA-PK. During an analysis of putative ATR phosphorylation sites, we found that a single mutation at S1333 creates a hyperactive kinase. In vitro and in cells, mutation of S1333 to alanine (S1333A-ATR) causes elevated levels of kinase activity with and without the addition of the protein activator TOPBP1. S1333 mutations to glycine, arginine, or lysine also create a hyperactive kinase, while mutation to aspartic acid decreases ATR activity. S1333A-ATR maintains the G(2) checkpoint and promotes completion of DNA replication after transient exposure to replication stress but the less active kinase, S1333D-ATR, has modest defects in both of these functions. While we find no evidence that S1333 is phosphorylated in cultured cells, our data indicate that small changes in the HEAT repeats can have large effects on kinase activity. These mutants may serve as useful tools for future studies of the ATR pathway.	[Luzwick, Jessica W.; Nam, Edward A.; Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu			NIH [CA102792, S10RR027714]; Vanderbilt Ingram Cancer Center [P30CA06485]; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA102729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027714] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was funded by NIH grant CA102792 to D.C. Additional funds for mass spectrometry were obtained from NIH grant S10RR027714 and the Vanderbilt Ingram Cancer Center support grant P30CA06485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chen XP, 2007, EXP CELL RES, V313, P1667, DOI 10.1016/j.yexcr.2007.02.015; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Nam EA, 2011, J BIOL CHEM, V286, P37320, DOI 10.1074/jbc.M111.276113; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sirbu B. M., 2013, COLD SPRING HARBOR P, V5; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	35	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99397	10.1371/journal.pone.0099397	http://dx.doi.org/10.1371/journal.pone.0099397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901225	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400125
J	Daignan, JM; Chen, R; Mahmoud, KA; Ma, Y; Hill, IG; Kreplak, L				Daignan, Jean-Michel; Chen, Ran; Mahmoud, Khaled A.; Ma, Yuan; Hill, Ian G.; Kreplak, Laurent			Patterning of Nanocrystalline Cellulose Gel Phase by Electrodissolution of a Metallic Electrode	PLOS ONE			English	Article							SUSPENSIONS; SEPARATION; COPPER	At high concentration or in the presence of electrolytes and organic solvents, solutions of cellulose nanocrystals (CNCs) can form gels exhibiting optical properties similar to the ones of liquid crystal phases. In an attempt to pattern such a gel phase, we have studied the electrodissolution of a metallic electrode in a water suspension of carboxylated CNCs (cCNCs). Depending on the metal used, the electrodissolution process was observed at a different positive potential. In the case of copper the minimum potential at which we could observe optically the growth of the gel phase was 200 mV. The growth rate was current limited indicating that the process was controlled by the electrodissolution of the copper electrode. This hypothesis was confirmed by using circular and square copper patterns as positive electrodes. In both cases, the consumption of the electrode material was observed optically and correlated with the growth of the gel phase.	[Daignan, Jean-Michel; Hill, Ian G.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Chen, Ran; Ma, Yuan] Dalhousie Univ, Dept Elect & Comp Engn, Halifax, NS, Canada; [Mahmoud, Khaled A.] Qatar Fdn, QEERI, Doha, Qatar	Dalhousie University; Dalhousie University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Environment & Energy Research Institute	Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.	kreplak@dal.ca	Hill, Ian G/L-9743-2018	Hill, Ian G/0000-0001-6180-9311; kreplak, laurent/0000-0001-9370-9809; Mahmoud, Khaled/0000-0003-1246-4067	Biovision Technology (Nova Scotia, Canada)	Biovision Technology (Nova Scotia, Canada)	The authors would like to thank Biovision Technology (Nova Scotia, Canada) for support during the course of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck-Candanedo S, 2007, MACROMOLECULES, V40, P3429, DOI 10.1021/ma0704818; Beck-Candanedo S, 2006, LANGMUIR, V22, P8690, DOI 10.1021/la061310j; Beck-Candanedo S, 2006, CELLULOSE, V13, P629, DOI 10.1007/s10570-006-9084-x; Bordel D, 2006, LANGMUIR, V22, P4899, DOI 10.1021/la0600402; BRAUN M, 1979, J ELECTROCHEM SOC, V126, P1666, DOI 10.1149/1.2128773; CROUSIER J, 1988, CORROSION, V44, P768, DOI 10.5006/1.3584945; DEVRIES H, 1951, ACTA CRYSTALLOGR, V4, P219, DOI 10.1107/S0365110X51000751; Dong SP, 2007, J AM CHEM SOC, V129, P13810, DOI 10.1021/ja076196l; Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Heux L, 2000, LANGMUIR, V16, P8210, DOI 10.1021/la9913957; Jasmani L, 2013, NANOSCALE, V5, P10207, DOI 10.1039/c3nr03456a; Leung ACW, 2011, SMALL, V7, P302, DOI 10.1002/smll.201001715; Mahmoud KA, 2009, ACS APPL MATER INTER, V1, P1383, DOI 10.1021/am900331d; MARCHESSAULT RH, 1959, NATURE, V184, P632, DOI 10.1038/184632a0; ONDRISCRAWFORD R, 1991, J APPL PHYS, V69, P6380, DOI 10.1063/1.348840; RANBY BG, 1950, EXPERIENTIA, V6, P12, DOI 10.1007/BF02154044; RANBY BG, 1949, ACTA CHEM SCAND, V3, P649, DOI 10.3891/acta.chem.scand.03-0649; REVOL JF, 1994, LIQ CRYST, V16, P127, DOI 10.1080/02678299408036525; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Roman M, 2009, ACS SYM SER, V1017, P81	22	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99202	10.1371/journal.pone.0099202	http://dx.doi.org/10.1371/journal.pone.0099202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897116	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700123
J	Rohatgi, N; Nielsen, TK; Bjorn, SP; Axelsson, I; Paglia, G; Voldborg, BG; Palsson, BO; Rolfsson, O				Rohatgi, Neha; Nielsen, Tine Kragh; Bjorn, Sara Petersen; Axelsson, Ivar; Paglia, Giuseppe; Voldborg, Bjorn Gunnar; Palsson, Bernhard O.; Rolfsson, Ottar			Biochemical Characterization of Human Gluconokinase and the Proposed Metabolic Impact of Gluconic Acid as Determined by Constraint Based Metabolic Network Analysis	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; CELL; RECONSTRUCTION; GENES; GNTK	The metabolism of gluconate is well characterized in prokaryotes where it is known to be degraded following phosphorylation by gluconokinase. Less is known of gluconate metabolism in humans. Human gluconokinase activity was recently identified proposing questions about the metabolic role of gluconate in humans. Here we report the recombinant expression, purification and biochemical characterization of isoform I of human gluconokinase alongside substrate specificity and kinetic assays of the enzyme catalyzed reaction. The enzyme, shown to be a dimer, had ATP dependent phosphorylation activity and strict specificity towards gluconate out of 122 substrates tested. In order to evaluate the metabolic impact of gluconate in humans we modeled gluconate metabolism using steady state metabolic network analysis. The results indicate that significant metabolic flux changes in anabolic pathways linked to the hexose monophosphate shunt (HMS) are induced through a small increase in gluconate concentration. We argue that the enzyme takes part in a context specific carbon flux route into the HMS that, in humans, remains incompletely explored. Apart from the biochemical description of human gluconokinase, the results highlight that little is known of the mechanism of gluconate metabolism in humans despite its widespread use in medicine and consumer products.	[Rohatgi, Neha; Axelsson, Ivar; Paglia, Giuseppe; Palsson, Bernhard O.; Rolfsson, Ottar] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Rohatgi, Neha; Rolfsson, Ottar] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Nielsen, Tine Kragh; Bjorn, Sara Petersen; Voldborg, Bjorn Gunnar] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Copenhagen, Denmark	University of Iceland; University of Iceland; University of Copenhagen	Rolfsson, O (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ottarr@hi.is	Paglia, Giuseppe/H-2012-2018	Paglia, Giuseppe/0000-0003-4724-6801; Rohatgi, Neha/0000-0003-1103-0259; Palsson, Bernhard/0000-0003-2357-6785; Voldborg, Bjorn Gunnar/0000-0002-7005-1642; Rolfsson, Ottar/0000-0003-4258-6057	European Research Council [232816]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council grant proposal no. 232816. The funders had no role in study design, data collection and analysis.	Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; [Anonymous], 2004, UNEPREPORT; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; BIRNESSER H, 1973, DIABETOLOGIA, V9, P30, DOI 10.1007/BF01225997; BLOOM B, 1955, J BIOL CHEM, V212, P555; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; BUBLITZ C, 1988, J BIOL CHEM, V263, P12849; DAHL JL, 1974, ANNU REV BIOCHEM, V43, P327; Frank JE, 2005, AM FAM PHYSICIAN, V72, P1277; Gebauer J, 2012, FEBS J, V279, P3192, DOI 10.1111/j.1742-4658.2012.08700.x; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Hu ZP, 2012, J PROTEOME RES, V11, P5903, DOI 10.1021/pr300666p; Izu H, 1996, FEBS LETT, V394, P14, DOI 10.1016/0014-5793(96)00923-4; JOSHI A, 1990, J THEOR BIOL, V142, P41, DOI 10.1016/S0022-5193(05)80012-8; Karlstadt A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-114; Kolodziejczyk J, 2011, J PHYSIOL BIOCHEM, V67, P175, DOI 10.1007/s13105-010-0061-3; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kraft L, 2002, J MOL BIOL, V318, P1057, DOI 10.1016/S0022-2836(02)00215-2; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LEDER IG, 1957, J BIOL CHEM, V225, P125; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Ramachandran S, 2006, FOOD TECHNOL BIOTECH, V44, P185; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Rolfsson O, 2013, BIOCHEM J, V449, P427, DOI 10.1042/BJ20120980; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146; STETTEN MR, 1953, J BIOL CHEM, V203, P653; Sweetser DA, 2005, GENE CHROMOSOME CANC, V44, P279, DOI 10.1002/gcc.20236; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Tong SX, 1996, J BACTERIOL, V178, P3260, DOI 10.1128/jb.178.11.3260-3269.1996; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	44	23	24	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98760	10.1371/journal.pone.0098760	http://dx.doi.org/10.1371/journal.pone.0098760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896608	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700072
J	Wallace, IJ; Demes, B; Mongle, C; Pearson, OM; Polk, JD; Lieberman, DE				Wallace, Ian J.; Demes, Brigitte; Mongle, Carrie; Pearson, Osbjorn M.; Polk, John D.; Lieberman, Daniel E.			Exercise-Induced Bone Formation Is Poorly Linked to Local Strain Magnitude in the Sheep Tibia	PLOS ONE			English	Article							GRADIENTS CORRELATE; LAW; PATTERNS; SKELETON; GROWTH; SITES; WOLFF	Functional interpretations of limb bone structure frequently assume that diaphyses adjust their shape by adding bone primarily across the plane in which they are habitually loaded in order to minimize loading-induced strains. Here, to test this hypothesis, we characterize the in vivo strain environment of the sheep tibial midshaft during treadmill exercise and examine whether this activity promotes bone formation disproportionately in the direction of loading in diaphyseal regions that experience the highest strains. It is shown that during treadmill exercise, sheep tibiae were bent in an anteroposterior direction, generating maximal tensile and compressive strains on the anterior and posterior shaft surfaces, respectively. Exercise led to significantly increased periosteal bone formation; however, rather than being biased toward areas of maximal strains across the anteroposterior axis, exercise-related osteogenesis occurred primarily around the medial half of the shaft circumference, in both high and low strain regions. Overall, the results of this study demonstrate that loading-induced bone growth is not closely linked to local strain magnitude in every instance. Therefore, caution is necessary when bone shaft shape is used to infer functional loading history in the absence of in vivo data on how bones are loaded and how they actually respond to loading.	[Wallace, Ian J.; Mongle, Carrie] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Demes, Brigitte] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Pearson, Osbjorn M.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Polk, John D.] Univ Illinois, Dept Anthropol, Urbana, IL USA; [Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University	Wallace, IJ (corresponding author), SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA.	ian.wallace@stonybrook.edu		Pearson, Osbjorn/0000-0002-1814-7663; Mongle, Carrie/0000-0002-5474-0501	NSF [IBN 96-03833]	NSF(National Science Foundation (NSF))	This research was supported by NSF (www.nsf.gov) grant no. IBN 96-03833 to DEL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM JEA, 1991, BIOL REV, V66, P245, DOI 10.1111/j.1469-185X.1991.tb01142.x; BIEWENER A A, 1992, P123; Carter DR, 2001, SKELETAL FUNCTION FO; Demes B, 2001, AM J PHYS ANTHROPOL, V116, P257, DOI 10.1002/ajpa.1122.abs; Demes B, 1998, AM J PHYS ANTHROPOL, V106, P87, DOI 10.1002/(SICI)1096-8644(199805)106:1<87::AID-AJPA6>3.0.CO;2-A; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Gross TS, 1997, J BONE MINER RES, V12, P982, DOI 10.1359/jbmr.1997.12.6.982; Judex S, 1997, J BONE MINER RES, V12, P1737, DOI 10.1359/jbmr.1997.12.10.1737; Lanyon L.E., 1985, P1; Larsen C.S., 1997, BIOARCHAEOLOGY INTER; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; Moore MK, 2013, RESEARCH METHODS IN HUMAN SKELETAL BIOLOGY, P397; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; OCONNOR JA, 1982, J BIOMECH, V15, P767, DOI 10.1016/0021-9290(82)90092-6; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF CB, 2008, BIOL ANTHR HUMAN SKE, P183, DOI DOI 10.1002/9780470245842.CH6; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Wallace IJ, 2013, J MUSCULOSKEL NEURON, V13, P283; Warden S J, 2004, Eura Medicophys, V40, P223	23	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99108	10.1371/journal.pone.0099108	http://dx.doi.org/10.1371/journal.pone.0099108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897411	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700118
J	Ohlberger, J; Rogers, LA; Stenseth, NC				Ohlberger, Jan; Rogers, Lauren A.; Stenseth, Nils Chr			Stochasticity and Determinism: How Density-Independent and Density-Dependent Processes Affect Population Variability	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; AT-AGE DATA; GADUS-MORHUA; CLASS STRENGTH; FISH RECRUITMENT; BARENTS SEA; TIME-SERIES; STOCK; MORTALITY; ABUNDANCE	A persistent debate in population ecology concerns the relative importance of environmental stochasticity and density dependence in determining variability in adult year-class strength, which contributes to future reproduction as well as potential yield in exploited populations. Apart from the strength of the processes, the timing of density regulation may affect how stochastic variation, for instance through climate, translates into changes in adult abundance. In this study, we develop a life-cycle model for the population dynamics of a large marine fish population, Northeast Arctic cod, to disentangle the effects of density-independent and density-dependent processes on early life-stages, and to quantify the strength of compensatory density dependence in the population. The model incorporates information from scientific surveys and commercial harvest, and dynamically links multiple effects of intrinsic and extrinsic factors on all life-stages, from eggs to spawners. Using a state-space approach we account for observation error and stochasticity in the population dynamics. Our findings highlight the importance of density-dependent survival in juveniles, indicating that this period of the life cycle largely determines the compensatory capacity of the population. Density regulation at the juvenile life-stage dampens the impact of stochastic processes operating earlier in life such as environmental impacts on the production of eggs and climate-dependent survival of larvae. The timing of stochastic versus regulatory processes thus plays a crucial role in determining variability in adult abundance. Quantifying the contribution of environmental stochasticity and compensatory mechanisms in determining population abundance is essential for assessing population responses to climate change and exploitation by humans.	[Ohlberger, Jan; Rogers, Lauren A.; Stenseth, Nils Chr] Univ Oslo, Dept Biosci, CEES, Oslo, Norway	University of Oslo	Ohlberger, J (corresponding author), Univ Oslo, Dept Biosci, CEES, Oslo, Norway.	jan.ohlberger@ibv.uio.no	Ohlberger, Jan/H-3262-2019; Stenseth, Nils Chr./G-5212-2016	Ohlberger, Jan/0000-0001-6795-240X; Stenseth, Nils Chr./0000-0002-1591-5399; Rogers, Lauren/0000-0003-3305-6441	VISTA; Statoil; Norwegian Academy of Science and Letters; Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	VISTA; Statoil; Norwegian Academy of Science and Letters; Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER)	JO was supported by VISTA (http://www.vista.no), a basic research program funded by Statoil and conducted in close collaboration with The Norwegian Academy of Science and Letters (http://english.dnva.no). LAR acknowledges support by the Norden Top-Level Research Initiative through the Nordic Centre for Research on Marine Ecosystems and Resources under Climate Change (NorMER, http://www.normer.uio.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes S, 2007, CAN J FISH AQUAT SCI, V64, P1130, DOI 10.1139/F07-074; Andrewartha HG, 1954, THE DISTRIBUTION AND; BOGSTAD B, 1994, ICES MAR SC, V198, P576; Brinch CN, 2011, CAN J FISH AQUAT SCI, V68, P1717, DOI 10.1139/F2011-085; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Ciannelli L, 2007, ECOLOGY, V88, P635, DOI 10.1890/05-2035; Dingsor GE, 2007, ECOLOGY, V88, P625, DOI 10.1890/05-1782; Eikeset AM, 2010, THE ECOLOGICAL AND E; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GUDMUNDSSON G, 1994, J R STAT SOC C-APPL, V43, P117; HANSKI I, 1990, PHILOS T R SOC B, V330, P141; Hixon MA, 2002, ECOLOGY, V83, P1490, DOI 10.1890/0012-9658(2002)083[1490:PRHCAC]2.0.CO;2; Hjermann DO, 2004, CAN J FISH AQUAT SCI, V61, P1747, DOI 10.1139/F04-115; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hylen A., 2002, ICES MARINE SCI S, V215, P543, DOI [10.1046/j.1467-2979.2003.00112.x, DOI 10.1046/J.1467-2979.2003.00112.X]; ICES, 2013, REPORT OF THE ARCTIC; ICES, 2007, REPORT OF THE ARCTIC; Jakobsen T, 1997, ICES CM 1997 Y 17; Keith DM, 2012, CAN J FISH AQUAT SCI, V69, P1150, DOI 10.1139/F2012-055; Korsbrekke K, 2001, ICES J MAR SCI, V58, P763, DOI 10.1006/jmsc.2001.1064; Langangen O, 2014, ICES J MAR SCI, V71, P1129, DOI 10.1093/icesjms/fst007; Marshall CT, 2006, CAN J FISH AQUAT SCI, V63, P980, DOI 10.1139/F05-270; Maunder MN, 2011, CAN J FISH AQUAT SCI, V68, P1285, DOI 10.1139/F2011-071; Michalsen K, 1998, ICES J MAR SCI, V55, P863, DOI 10.1006/jmsc.1998.0364; Millar RB, 2000, CAN J FISH AQUAT SCI, V57, P43, DOI 10.1139/f99-169; Mukhina NV, 2003, J SEA RES, V50, P57, DOI 10.1016/S1385-1101(03)00046-7; Mukhina NV, 1992, EKOLOGICHESKIE PROBL; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1265, DOI 10.1139/f95-123; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; Myers RA, 1996, FISH B-NOAA, V94, P707; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Ottersen G, 1995, FISH OCEANOGR, V4, P278, DOI 10.1111/j.1365-2419.1995.tb00073.x; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; Quinn T. J., 1999, BIOL RES MANAG SER; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rubin D. B., 2003, BAYESIAN DATA ANALYS; SHEPHERD JG, 1990, PHILOS T ROY SOC B, V330, P151, DOI 10.1098/rstb.1990.0189; Stige LC, 2013, MAR ECOL PROG SER, V480, P245, DOI 10.3354/meps10246; Stige LC, 2010, P ROY SOC B-BIOL SCI, V277, P3411, DOI 10.1098/rspb.2010.0602; Su Y-S, 2013, PACKAGE R2JAGS; SUNDBY S, 1989, RAP PROCES, V191, P351; Tereshchenko VV, 1996, ICES CM 1996 C 11; Walters C.J., 2004, FISHERIES ECOLOGY MA; Yaragina NA, 2009, MAR BIOL RES, V5, P75, DOI 10.1080/17451000802512739	52	27	27	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98940	10.1371/journal.pone.0098940	http://dx.doi.org/10.1371/journal.pone.0098940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893001	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400112
J	Xu, J; Li, WL; Zhang, CH; Liu, W; Du, GZ				Xu, Jing; Li, Wenlong; Zhang, Chunhui; Liu, Wei; Du, Guozhen			Variation in Seed Germination of 134 Common Species on the Eastern Tibetan Plateau: Phylogenetic, Life History and Environmental Correlates	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SIZE; DISPERSAL; ECOLOGY; SEEDLINGS; DORMANCY; CLIMATE; MASS	Seed germination is a crucial stage in the life history of a species because it represents the pathway from adult to offspring, and it can affect the distribution and abundance of species in communities. In this study, we examined the effects of phylogenetic, life history and environmental factors on seed germination of 134 common species from an alpine/subalpine meadow on the eastern Tibetan Plateau. In one-way ANOVAs, phylogenetic groups (at or above order) explained 13.0% and 25.9% of the variance in germination percentage and mean germination time, respectively; life history attributes, such as seed size, dispersal mode, explained 3.7%, 2.1% of the variance in germination percentage and 6.3%, 8.7% of the variance in mean germination time, respectively; the environmental factors temperature and habitat explained 4.7%, 1.0% of the variance in germination percentage and 13.5%, 1.7% of the variance in mean germination time, respectively. Our results demonstrated that elevated temperature would lead to a significant increase in germination percentage and an accelerated germination. Multi-factorial ANOVAs showed that the three major factors contributing to differences in germination percentage and mean germination time in this alpine/subalpine meadow were phylogenetic attributes, temperature and seed size (explained 10.5%, 4.7% and 1.4% of the variance in germination percentage independently, respectively; and explained 14.9%, 13.5% and 2.7% of the variance in mean germination time independently, respectively). In addition, there were strong associations between phylogenetic group and life history attributes, and between life history attributes and environmental factors. Therefore, germination variation are constrained mainly by phylogenetic inertia in a community, and seed germination variation correlated with phylogeny is also associated with life history attributes, suggesting a role of niche adaptation in the conservation of germination variation within lineages. Meanwhile, selection can maintain the association between germination behavior and the environmental conditions within a lineage.	[Xu, Jing; Zhang, Chunhui; Liu, Wei; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China; [Li, Wenlong] Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Du, GZ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	guozhendu2013@gmail.com	Zhang, Chunhui/G-4663-2016	Zhang, Chunhui/0000-0002-1500-4114	National Natural Science Foundation of China [40930533, 41171214, 31170430]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Key Program of National Natural Science Foundation of China (Grant No. 40930533) and the National Natural Science Foundation of China (Grant No. 41171214 and No. 31170430). Funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIA, 2004, IMP WARM ARCT ARCT C; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; BAKER HG, 1972, ECOLOGY, V53, P997, DOI 10.2307/1935413; Baskin C. C., 1998, Seeds: ecology, biogeography, and evolution of dormancy and germination.; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Chen ZH, 2002, ACTA BOT SIN, V44, P1469; Ellis RH, 1978, SEED PRODUCTION, P605; Flora China Editing Group, 2004, FLORA REIPUBLICAE PO; GRIME JP, 1981, J ECOL, V69, P1017, DOI 10.2307/2259651; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; JOHNSON SD, 1993, J ECOL, V81, P567, DOI 10.2307/2261535; Jurado E, 2005, J VEG SCI, V16, P559, DOI 10.1111/j.1654-1103.2005.tb02396.x; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; KONIAK S, 1985, GREAT BASIN NAT, V45, P556; Lacey EP, 2003, ECOLOGY, V84, P2462, DOI 10.1890/02-0101; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Lopez-Castaneda C., 1996, Crop Science, V36, P1257, DOI 10.2135/cropsci1996.0011183X003600050031x; Luzuriaga AL, 2006, WEED RES, V46, P163, DOI 10.1111/j.1365-3180.2006.00496.x; MAZER SJ, 1989, ECOL MONOGR, V59, P153, DOI 10.2307/2937284; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; MILES DB, 1993, ANNU REV ECOL SYST, V24, P587, DOI 10.1146/annurev.es.24.110193.003103; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Moles AT, 2004, OIKOS, V106, P193, DOI 10.1111/j.0030-1299.2004.13101.x; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; REES M, 1994, AM NAT, V144, P43, DOI 10.1086/285660; Ruf M, 2003, TREE PHYSIOL, V23, P257, DOI 10.1093/treephys/23.4.257; Sadeghi H., 2011, Journal of Agricultural and Biological Science, V6, P5; Schippers P, 2001, OIKOS, V95, P198, DOI 10.1034/j.1600-0706.2001.950202.x; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Smith-Ramirez C, 1998, PLANT ECOL, V136, P119, DOI 10.1023/A:1009730810655; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Wang JH, 2009, EVOL ECOL, V23, P827, DOI 10.1007/s10682-008-9273-1; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhang ST, 2004, FOLIA GEOBOT, V39, P129, DOI 10.1007/BF02805242; Ziello C, 2009, CLIM RES, V39, P227, DOI 10.3354/cr00822	52	17	18	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98601	10.1371/journal.pone.0098601	http://dx.doi.org/10.1371/journal.pone.0098601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893308	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400074
J	Kobayashi, T; Masoumi, KC; Massoumi, R				Kobayashi, T.; Masoumi, K. C.; Massoumi, R.			Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells	ONCOGENE			English	Article							NF-KAPPA-B; HIGH-RISK NEUROBLASTOMA; ACID-INDUCED DIFFERENTIATION; HUMAN NEURO-BLASTOMA; TRANS-RETINOIC ACID; 13-CIS-RETINOIC ACID; GENE-EXPRESSION; ENZYME; POLYUBIQUITIN; APOPTOSIS	CYLD is a deubiquitinating (DUB) enzyme that has a pivotal role in modulating nuclear factor kappa B (NF-kappa B) signaling pathways by removing the lysine 63- and linear-linked ubiquitin chain from substrates such as tumor necrosis factor receptor-associated factor 2 (TRAF2) and TRAF6. Loss of CYLD activity is associated with tumorigenicity, and levels of CYLD are lost or downregulated in different types of human tumors. In the present study, we found that high CYLD expression was associated with better overall survival and relapse-free neuroblastoma patient outcome, as well as inversely correlated with the stage of neuroblastoma. Retinoic acid-mediated differentiation of neuroblastoma restored CYLD expression and promoted SUMOylation of CYLD. This posttranslational modification inhibited deubiquitinase activity of CYLD against TRAF2 and TRAF6 and facilitated NF-kappa B signaling. Overexpression of non-SUMOylatable mutant CYLD in neuroblastoma cells reduced retinoic acid-induced NF-kappa B activation and differentiation of cells, but instead promoted cell death.	[Kobayashi, T.; Masoumi, K. C.; Massoumi, R.] Lund Univ, Translat Canc Res, Div Mol Tumor Pathol, Dept Lab Med, S-22363 Lund, Sweden	Lund University	Massoumi, R (corresponding author), Lund Univ, Translat Canc Res, Div Mol Tumor Pathol, Dept Lab Med, Bldg 404,A3,Scheelevagen 8, S-22363 Lund, Sweden.	Ramin.Massoumi@med.lu.se	Massoumi, Ramin/AAG-4786-2019	Masoumi, Katarzyna/0000-0002-9277-6505	Swedish Cancer Foundation; Swedish Medical Research Council; Royal Physiographic Society in Lund; Gunnar Nilsson Foundations; Gyllenstiernska Krapperupps Foundations; BioCARE; European Research Council (ERC), under the European Union [260460]	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Physiographic Society in Lund; Gunnar Nilsson Foundations; Gyllenstiernska Krapperupps Foundations; BioCARE; European Research Council (ERC), under the European Union(European Research Council (ERC))	The plasmid for mammalian expression of His-SUMO1, His-SUMO2 and MYC-SUMO1 plasmids were a kind gift from Dr Frauke Melchior (ZMBH, Heidelberg, Germany). Flag-TRAF2 and Flag-TRAF6 plasmids were a kind gift from Dr Rene Bernards (The Netherlands Cancer Institute, Amsterdam, The Netherlands). We thank Dr Ingrid Ora for her critical reading of this manuscript. This work was supported by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Royal Physiographic Society in Lund, the Gunnar Nilsson Foundations, the Gyllenstiernska Krapperupps Foundations, the BioCARE and by funding from the European Research Council (ERC), under the European Union's Seventh Framework Programme for Research and Technology Development (grant agreement no. 260460, awarded to RM).	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1991, J NEUROSCI, V11, P3507; Bauters TGM, 2011, INT J CLIN PHARM-NET, V33, P597, DOI 10.1007/s11096-011-9519-9; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Celay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062771; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Feng ZW, 1999, J BIOL CHEM, V274, P30341, DOI 10.1074/jbc.274.43.30341; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kiningham KK, 2008, FREE RADICAL BIO MED, V44, P1610, DOI 10.1016/j.freeradbiomed.2008.01.015; KOGNER P, 1993, CANCER RES, V53, P2044; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee Moon H, 2011, MOL CELL, V43, P180; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Lovat PE, 1997, JNCI-J NATL CANCER I, V89, P446, DOI 10.1093/jnci/89.6.446; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2011, FUTURE ONCOL, V7, P285, DOI 10.2217/FON.10.187; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; ORTOFT E, 1993, MOL CELL NEUROSCI, V4, P549, DOI 10.1006/mcne.1993.1068; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Westermark UK, 2011, SEMIN CANCER BIOL, V21, P256, DOI 10.1016/j.semcancer.2011.08.001; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007	43	25	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2251	2260		10.1038/onc.2014.159	http://dx.doi.org/10.1038/onc.2014.159			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24909169	Green Submitted			2022-12-25	WOS:000353473000010
J	Fan, D; Zhou, X; Li, Z; Li, ZQ; Duan, C; Liu, T; Zhang, F; Huang, Y; Zhang, Y; Gao, F; Guo, Y; Gupta, R; Chen, G; Enver, T; Tang, J; Hong, D				Fan, D.; Zhou, X.; Li, Z.; Li, Z-Q; Duan, C.; Liu, T.; Zhang, F.; Huang, Y.; Zhang, Y.; Gao, F.; Guo, Y.; Gupta, R.; Chen, G.; Enver, T.; Tang, J.; Hong, D.			Stem cell programs are retained in human leukemic lymphoblasts	ONCOGENE			English	Article							HUMAN HEMATOPOIETIC STEM; ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; BONE-MARROW; GENE; TRANSPLANTATION; EXPANSION; CAPACITY; LINEAGE; BMI-1	Leukemic lymphoblasts within different immunophenotypic populations possess stem cell properties. However, whether or not the self-renewal program is retained from stem cells or conferred on progenitors by leukemogenic molecules remains unknown. We have addressed the issue in the context of TEL-AML1-associated acute lymphoblastic leukemia (ALL) by profiling a refined program edited from genes essential for self-renewal of hematopoietic stem cells and B-cell development. Bioinformatic analysis shows that ALL populations are loosely clustered and close to the normal population that contains stem and primitive progenitor cells. This finding indicates that immunophenotypes do not reflect maturation stages in ALL and that the self-renewal program may be retained from stem cells. Results of assessing 'first hit' function of TEL-AML1 in different populations of normal cells demonstrate the molecular model. Therefore, the current study shows a leukemogenic scenario of human ALL in which programs of stem cells are sustained in distinct fractions by leukemogenic mutations.	[Fan, D.; Zhang, F.; Tang, J.; Hong, D.] Shanghai Jiao Tong Univ, Dept Pediat Hematol & Oncol, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol,Minist Hlth,Sch Me, Shanghai 200030, Peoples R China; [Zhou, X.; Li, Z-Q; Huang, Y.; Chen, G.; Hong, D.] SJTU SM, Dept Pathophysiol, Minist Educ, Key Lab Cell Differentiat & Apoptosis Natl, Shanghai, Peoples R China; [Li, Z.; Duan, C.; Liu, T.] SJTU SM, Ruijin Hosp, Shanghai, Peoples R China; [Zhang, Y.; Gao, F.] Shanghai Cord Blood Bank, Shanghai, Peoples R China; [Guo, Y.; Gupta, R.; Enver, T.] UCL, UCL Canc Inst, Stem Cell Lab, London, England	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of London; University College London	Tang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat Hematol & Oncol, Shanghai 200030, Peoples R China.	yantfk@gmail.com; dlhong@sjtu.edu.cn	Zhang, Fang/HHN-2153-2022	Gupta, Rajeev/0000-0001-9573-0505; chen, guo qiang/0000-0003-4936-2363; Hong, Dengli/0000-0001-5251-0297; Liu, Tianhui/0000-0002-9301-641X; Guo, Yanping/0000-0001-6217-7133	National Natural Science Foundation of China (NSFC) [90919055, 81120108006]; National Basic Research Program of China [2012CB967000]; Shanghai Pujiang Program [10PJ1406500]; Cancer Research UK [12796] Funding Source: researchfish; Medical Research Council [G1000801g, MC_U137973817, MC_qA137913] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1062] Funding Source: researchfish; MRC [MC_qA137913, MC_U137973817] Funding Source: UKRI	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T Tanaka for providing hybridoma TM-beta 1; and Chenzhi Guo for technical help in flow sorting. This work was supported by grants from the National Natural Science Foundation of China (NSFC, 90919055 and 81120108006), the National Basic Research Program of China (2012CB967000) and the Shanghai Pujiang Program (10PJ1406500).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dorrell C, 2000, BLOOD, V95, P102; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghia P, 1998, IMMUNOL TODAY, V19, P480, DOI 10.1016/S0167-5699(98)01330-9; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; GREAVES MF, 1993, BRIT J CANCER, V67, P413, DOI 10.1038/bjc.1993.81; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Kong Y, 2008, LEUKEMIA, V22, P1207, DOI 10.1038/leu.2008.83; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Pina C, 2007, ONCOGENE, V26, P6750, DOI 10.1038/sj.onc.1210759; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Tsuzuki S, 2013, STEM CELLS, V31, P236, DOI 10.1002/stem.1277; Zelent A, 2004, ONCOGENE, V23, P4275, DOI 10.1038/sj.onc.1207672; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	34	5	7	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2083	2093		10.1038/onc.2014.148	http://dx.doi.org/10.1038/onc.2014.148			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909160				2022-12-25	WOS:000353173400008
J	Jeong, SM; Lee, J; Finley, LWS; Schmidt, PJ; Fleming, MD; Haigis, MC				Jeong, S. M.; Lee, J.; Finley, L. W. S.; Schmidt, P. J.; Fleming, M. D.; Haigis, M. C.			SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1	ONCOGENE			English	Article							TRANSFERRIN RECEPTOR; OXIDATIVE STRESS; ACTIVATION; HOMEOSTASIS; RESTRICTION; DEACETYLASE; HYPOXIA; ATAXIA	Iron metabolism is essential for many cellular processes, including oxygen transport, respiration and DNA synthesis, and many cancer cells exhibit dysregulation in iron metabolism. Maintenance of cellular iron homeostasis is regulated by iron regulatory proteins (IRPs), which control the expression of iron-related genes by binding iron-responsive elements (IREs) of target mRNAs. Here, we report that mitochondrial SIRT3 regulates cellular iron metabolism by modulating IRP1 activity. SIRT3 loss increases reactive oxygen species production, leading to elevated IRP1 binding to IREs. As a consequence, IRP1 target genes, such as the transferrin receptor (TfR1), a membrane-associated glycoprotein critical for iron uptake and cell proliferation, are controlled by SIRT3. Importantly, SIRT3 deficiency results in a defect in cellular iron homeostasis. SIRT3 null cells contain high levels of iron and lose iron-dependent TfR1 regulation. Moreover, SIRT3 null mice exhibit higher levels of iron and TfR1 expression in the pancreas. We found that the regulation of iron uptake and TfR1 expression contribute to the tumor-suppressive activity of SIRT3. Indeed, SIRT3 expression is negatively correlated with TfR1 expression in human pancreatic cancers. SIRT3 overexpression decreases TfR1 expression by inhibiting IRP1 and represses proliferation in pancreatic cancer cells. Our data uncover a novel role of SIRT3 in cellular iron metabolism through IRP1 regulation and suggest that SIRT3 functions as a tumor suppressor, in part, by modulating cellular iron metabolism.	[Jeong, S. M.; Lee, J.; Finley, L. W. S.; Haigis, M. C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Schmidt, P. J.; Fleming, M. D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Schmidt, P. J.; Fleming, M. D.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, SGM 329C,240 Longwood Ave, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu		Fleming, Mark/0000-0003-0948-4024; Lee, Jaewon/0000-0002-5677-2398	Takeda Pharmaceuticals; NIH [R01/AG032375]; American Cancer Society New Scholar Award; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society New Scholar Award; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ditte Lee and Annie Lee for technical assistance. We are also grateful to Alec C Kimmelman for providing cell lines and helpful discussions. This work was funded by a grant from Takeda Pharmaceuticals (to MCH). MCH is supported by NIH grant R01/AG032375, the American Cancer Society New Scholar Award and the Glenn Foundation for Medical Research.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; KOPPENOL WH, 1993, FREE RADICAL BIO MED, V15, P645, DOI 10.1016/0891-5849(93)90168-T; Lobmayr L, 2005, GENE, V354, P157, DOI 10.1016/j.gene.2005.04.040; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Mueller S, 2005, BIOFACTORS, V24, P171, DOI 10.1002/biof.5520240121; Nunez-Millacura C, 2002, J NEUROCHEM, V82, P240, DOI 10.1046/j.1471-4159.2002.00971.x; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Sanchez M, 2011, BLOOD, V118, pE168, DOI 10.1182/blood-2011-04-343541; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	32	47	49	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2115	2124		10.1038/onc.2014.124	http://dx.doi.org/10.1038/onc.2014.124			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909164	Green Accepted, Green Submitted			2022-12-25	WOS:000353173400011
J	Adijanto, J; Du, JH; Moffat, C; Seifert, EL; Hurley, JB; Philp, NJ				Adijanto, Jeffrey; Du, Jianhai; Moffat, Cynthia; Seifert, Erin L.; Hurley, James B.; Philp, Nancy J.			The Retinal Pigment Epithelium Utilizes Fatty Acids for Ketogenesis IMPLICATIONS FOR METABOLIC COUPLING WITH THE OUTER RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR PHAGOCYTOSIS; ARACHIDONIC ACIDS; BETA-OXIDATION; KETONE-BODIES; GLIAL-CELLS; EXPRESSION; TRANSCRIPTOME; TRANSPORTERS; ASTROCYTES; INHIBITOR	Every day, shortly after light onset, photoreceptor cells shed approximately a tenth of their outer segment. The adjacent retinal pigment epithelial (RPE) cells phagocytize and digest shed photoreceptor outer segment, which provides a rich source of fatty acids that could be utilized as an energy substrate. From a microarray analysis, we found that RPE cells express particularly high levels of the mitochondrial HMG-CoA synthase 2 (Hmgcs2) compared with all other tissues (except the liver and colon), leading to the hypothesis that RPE cells, like hepatocytes, can produce beta-hydroxybutyrate (beta-HB) from fatty acids. Using primary human fetal RPE (hfRPE) cells cultured on Transwell filters with separate apical and basal chambers, we demonstrate that hfRPE cells can metabolize palmitate, a saturated fatty acid that constitutes approximate to 15% of all lipids in the photoreceptor outer segment, to produce beta-HB. Importantly, we found that hfRPE cells preferentially release beta-HB into the apical chamber and that this process is mediated primarily by monocarboxylate transporter isoform 1 (MCT1). Using a GC-MS analysis of C-13-labeled metabolites, we showed that retinal cells can take up and metabolize 13C-labeled beta-HB into various TCA cycle intermediates and amino acids. Collectively, our data support a novel mechanism of RPE-retina metabolic coupling in which RPE cells metabolize fatty acids to produce beta-HB, which is transported to the retina for use as a metabolic substrate.	[Adijanto, Jeffrey; Moffat, Cynthia; Seifert, Erin L.; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Jefferson University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Adijanto, J (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jadijan1@gmail.com; nancy.philp@jefferson.edu	Du, Jianhai/J-6197-2014	Du, Jianhai/0000-0002-5612-4091; Philp, Nancy/0000-0001-7028-0448	National Institutes of Health [EY012042, EY017863, EY006641]; NATIONAL EYE INSTITUTE [R56EY012042, R01EY017863, R01EY006641, F32EY006641, R01EY012042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012042 (to N. J. P.) and EY017863 and EY006641 (to J. B. H.).	Blazquez C, 1998, J NEUROCHEM, V71, P1597; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; CHEN HM, 1993, EXP EYE RES, V57, P369, DOI 10.1006/exer.1993.1136; CHEN HM, 1993, J LIPID RES, V34, P1943; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher-Colombo S, 2010, INVEST OPHTH VIS SCI, V51, P5343, DOI 10.1167/iovs.09-5028; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Hugo SE, 2012, GENE DEV, V26, P282, DOI 10.1101/gad.180968.111; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Li R, 2009, AM J PHYSIOL-CELL PH, V297, pC1452, DOI 10.1152/ajpcell.00255.2009; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mustafi D, 2013, FASEB J, V27, P4585, DOI 10.1096/fj.13-237537; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Oyster C. W., 1999, HUMAN EYE STRUCTURE, P714; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Price NT, 1998, BIOCHEM J, V329, P321; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 2002, PEDIATR RES, V52, P595, DOI 10.1203/01.PDR.0000030874.20888.2D; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	40	78	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20570	20582		10.1074/jbc.M114.565457	http://dx.doi.org/10.1074/jbc.M114.565457			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898254	Green Published, hybrid			2022-12-25	WOS:000339396600017
J	Zhao, X; Kuja-Panula, J; Sundvik, M; Chen, YC; Aho, V; Peltola, MA; Porkka-Heiskanen, T; Panula, P; Rauvala, H				Zhao, Xiang; Kuja-Panula, Juha; Sundvik, Maria; Chen, Yu-Chia; Aho, Vilma; Peltola, Marjaana A.; Porkka-Heiskanen, Tarja; Panula, Pertti; Rauvala, Heikki			Amigo Adhesion Protein Regulates Development of Neural Circuits in Zebrafish Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARVAL ZEBRAFISH; EMBRYONIC-DEVELOPMENT; POTASSIUM CHANNEL; ROBO RECEPTORS; MESSENGER-RNA; AXON TRACT; NEURONS; CELL; SLIT; CARBOHYDRATE	The Amigo protein family consists of three transmembrane proteins characterized by six leucine-rich repeat domains and one immunoglobulin-like domain in their extracellular moieties. Previous in vitro studies have suggested a role as homophilic adhesion molecules in brain neurons, but the in vivo functions remain unknown. Here we have cloned all three zebrafish amigos and show that amigo1 is the predominant family member expressed during nervous system development in zebrafish. Knockdown of amigo1 expression using morpholino oligonucleotides impairs the formation of fasciculated tracts in early fiber scaffolds of brain. A similar defect in fiber tract development is caused by mRNA-mediated expression of the Amigo1 ectodomain that inhibits adhesion mediated by the full-length protein. Analysis of differentiated neural circuits reveals defects in the catecholaminergic system. At the behavioral level, the disturbed formation of neural circuitry is reflected in enhanced locomotor activity and in the inability of the larvae to perform normal escape responses. We suggest that Amigo1 is essential for the development of neural circuits of zebrafish, where its mechanism involves homophilic interactions within the developing fiber tracts and regulation of the Kv2.1 potassium channel to form functional neural circuitry that controls locomotion.	[Zhao, Xiang; Kuja-Panula, Juha; Sundvik, Maria; Chen, Yu-Chia; Peltola, Marjaana A.; Panula, Pertti; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Sundvik, Maria; Chen, Yu-Chia; Panula, Pertti] Univ Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland; [Aho, Vilma; Porkka-Heiskanen, Tarja] Univ Helsinki, Inst Biomed Physiol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Rauvala, H (corresponding author), Univ Helsinki, Ctr Neurosci, POB 56 Viikinkaari 4, FIN-00014 Helsinki, Finland.	heikki.rauvala@helsinki.fi	Zhao, Xiang/AAK-9641-2020	Zhao, Xiang/0000-0002-3339-4806; Lammi, Vilma/0000-0002-3256-5239; Rauvala, Heikki/0000-0001-7809-9811; Stenberg, Tarja/0000-0003-1843-7625; Panula, Pertti/0000-0002-1189-5132	Academy of Finland; Sigrid Juselius Foundation; Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences	This work was supported by the Academy of Finland and the Sigrid Juselius Foundation.; Supported by the Doctoral Program in Brain and Mind of the Doctoral School in Health Sciences.	Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chen YA, 2012, J CELL PHYSIOL, V227, P2217, DOI 10.1002/jcp.22958; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KIMMEL CB, 1980, J COMP PHYSIOL, V140, P343, DOI 10.1007/BF00606274; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Laeremans A, 2013, BRAIN STRUCT FUNCT, V218, P123, DOI 10.1007/s00429-012-0387-4; Liu YC, 2012, J COMP PHYSIOL A, V198, P11, DOI 10.1007/s00359-011-0682-1; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Mueller T., 2005, ATLAS EARLY ZEBRAFIS, P29; Mueller T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00064; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; Ono T, 2003, J NEUROSCI, V23, P5887; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Peltola MA, 2011, EMBO REP, V12, P1293, DOI 10.1038/embor.2011.204; PETERS A, 1967, J CELL BIOL, V32, P113, DOI 10.1083/jcb.32.1.113; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rivera J, 2007, EUR J NEUROSCI, V25, P136, DOI 10.1111/j.1460-9568.2006.05277.x; ROSS LS, 1992, J NEUROSCI, V12, P467; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Thisse C., 2005, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WILSON SW, 1990, DEVELOPMENT, V108, P121; Wullimann Mario F, 2002, Brain Res Gene Expr Patterns, V1, P187; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Zhao X, 2011, J BIOL CHEM, V286, P23200, DOI 10.1074/jbc.M111.223834	50	10	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19958	19975		10.1074/jbc.M113.545582	http://dx.doi.org/10.1074/jbc.M113.545582			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24904058	Green Published, hybrid			2022-12-25	WOS:000339395200013
J	Zhou, JJ; Wang, F; Xu, ZW; Lo, WS; Lau, CF; Chiang, KP; Nangle, LA; Ashlock, MA; Mendlein, JD; Yang, XL; Zhang, MJ; Schimmel, P				Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun; Chiang, Kyle P.; Nangle, Leslie A.; Ashlock, Melissa A.; Mendlein, John D.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul			Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CYTOKINE; COMPLEX; NOISE; AUTOANTIGENS; FRAGMENT; MODEL; AIMP2	Inflammatory and debilitating myositis and interstitial lung disease are commonly associated with autoantibodies (anti-Jo-1 antibodies) to cytoplasmic histidyl-tRNA synthetase (HisRS). Anti-Jo-1 antibodies from different disease-afflicted patients react mostly with spatially separated epitopes in the three-dimensional structure of human HisRS. We noted that two HisRS splice variants (SVs) include these spatially separated regions, but each SV lacks the HisRS catalytic domain. Despite the large deletions, the two SVs cross-react with a substantial population of anti-Jo-1 antibodies from myositis patients. Moreover, expression of at least one of the SVs is up-regulated in dermatomyositis patients, and cell-based experiments show that both SVs and HisRS can be secreted. We suggest that, in patients with inflammatory myositis, anti-Jo-1 antibodies may have extracellular activity.	[Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul] Hong Kong Univ Sci & Technol, IAS HKUST Scripps R&D Lab, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhou, Jie J.; Wang, Feng; Xu, Zhiwen; Lo, Wing-Sze; Lau, Ching-Fun] Pangu BioPharma, Hong Kong, Hong Kong, Peoples R China; [Chiang, Kyle P.; Nangle, Leslie A.; Ashlock, Melissa A.; Mendlein, John D.] aTyr Pharma, San Diego, CA 92121 USA; [Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, La Jolla, CA 92037 USA; [Schimmel, Paul] Scripps Florida, Jupiter, FL 33458 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Scripps Research Institute; State University System of Florida; University of Florida	Schimmel, P (corresponding author), Hong Kong Univ Sci & Technol, IAS HKUST Scripps R&D Lab, Inst Adv Study, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Lo, Cario Wing Sze/DGZ-8810-2022; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X; Zhang, Mingjie/0000-0001-9404-0190	National Institutes of Health from NCI [CA92577]; Innovation and Technology Fund of Hong Kong [UIM181, UIM192, UIM199]; aTyr Pharma; NFCR Fellowship from the National Foundation for Cancer Research;  [GM88278]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Innovation and Technology Fund of Hong Kong; aTyr Pharma; NFCR Fellowship from the National Foundation for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA92577 from NCI and Grant GM88278. This work was also supported by Innovation and Technology Fund of Hong Kong Grants UIM181, UIM192, and UIM199; aTyr Pharma; and an NFCR Fellowship (to the Scripps Laboratory for tRNA synthetase research) from the National Foundation for Cancer Research. Professors Mingjie Zhang, Xiang-Lei Yang, and Paul Schimmel are financially benefited by aTyr Pharma in the form of compensation, stock ownership, or both.	Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Choi JW, 2012, J MOL CELL BIOL, V4, P164, DOI 10.1093/jmcb/mjs018; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg Y, 2008, FASEB J, V22, P1597, DOI 10.1096/fj.07-9973com; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Harlow E., 1999, USING ANTIBODIES LAB, P449; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jura M, 2007, CRIT REV IMMUNOL, V27, P559, DOI 10.1615/CritRevImmunol.v27.i6.60; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; Kim HO, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-113; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Kron MA, 2013, CLIN VACCINE IMMUNOL, V20, P276, DOI 10.1128/CVI.00594-12; Kron MA, 2012, MOL BIOCHEM PARASIT, V185, P66, DOI 10.1016/j.molbiopara.2012.06.003; Kuznetsov VA, 2002, GENETICS, V161, P1321; Kwon HS, 2012, J CELL SCI, V125, P4620, DOI 10.1242/jcs.108209; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mammen AL, 2011, NAT REV NEUROL, V7, P343, DOI 10.1038/nrneurol.2011.63; MARTIN A, 1995, FASEB J, V9, P1226, DOI 10.1096/fasebj.9.12.7672516; MATHEWS MB, 1983, NATURE, V304, P177, DOI 10.1038/304177a0; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; NISHIKAI M, 1980, ARTHRITIS RHEUM, V23, P881, DOI 10.1002/art.1780230802; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; RABEN N, 1994, J BIOL CHEM, V269, P24277; Rouabhia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071660; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Soejima M, 2011, ARTHRITIS RHEUM-US, V63, P479, DOI 10.1002/art.30113; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Targoff IN, 2000, CURR OPIN RHEUMATOL, V12, P475, DOI 10.1097/00002281-200011000-00001; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; Vo MN, 2011, J BIOL CHEM, V286, P11563, DOI 10.1074/jbc.C110.213876; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang F, 2013, J BIOL CHEM, V288, P29223, DOI 10.1074/jbc.C113.490599; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Wu PC, 1999, CANCER RES, V59, P205; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	49	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19269	19275		10.1074/jbc.C114.571026	http://dx.doi.org/10.1074/jbc.C114.571026			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24898250	Green Published, hybrid			2022-12-25	WOS:000339326800002
J	Lin, P; Pratt, WE				Lin, Peagan; Pratt, Wayne E.			Inactivation of the Nucleus Accumbens Core or Medial Shell Attenuates Reinstatement of Sugar-Seeking Behavior following Sugar Priming or Exposure to Food-Associated Cues	PLOS ONE			English	Article							COCAINE-SEEKING; SUCROSE-SEEKING; HEROIN-SEEKING; YOHIMBINE; RELAPSE; DOPAMINE; RECEPTORS; MOTIVATION; DISSOCIATION; SPECIFICITY	Re-exposure to either palatable food or to conditioned stimuli associated with food is known to reinstate food-seeking after periods of abstinence. The nucleus accumbens core and shell are important for reinstatement in both food-and drug-seeking paradigms, although their potential differential roles have been difficult to delineate due to methodological differences in paradigms across laboratories. The present studies assessed the effects of temporary inactivation of the core or shell on priming-and cue-induced reinstatement of food-seeking in identically-trained rats. Inactivation of either the nucleus accumbens core (Experiment 1A; N = 10) or medial shell (Experiment 1B; N = 12) blocked priming-induced reinstatement in an equivalent manner. Similarly, inactivation of the core or medial shell (Experiments 2A & 2B; N = 11 each) also blocked cue-induced reinstatement, although there was also a significant treatment day X brain region X drug order interaction. Specifically, rats with core inactivation reinstated lever-pressing on the vehicle injection day regardless of whether that was their first or second test, whereas rats that had medial shell inactivation on the first day did not significantly reinstate lever-pressing on the second day of testing (when they received vehicle). Yohimbine, while a reportedly robust pharmacological stressor, was ineffective at inducing reinstatement in the current stress-induced reinstatement procedure. These data suggest that both the nucleus accumbens core and shell serve important roles in reinstatement of food-seeking in response to priming and cues.	[Lin, Peagan; Pratt, Wayne E.] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA	Wake Forest University	Pratt, WE (corresponding author), Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA.	prattwe@wfu.edu		Pratt, Wayne/0000-0001-6627-6825	National Institute of Drug Abuse [R15 DA030618]; Wake Forest University Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA030618] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wake Forest University Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	These experiments were supported by the National Institute of Drug Abuse (R15 DA030618 to WEP) and the Wake Forest University Department of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi F, 2011, J NEUROSCI, V31, P6820, DOI 10.1523/JNEUROSCI.6491-10.2011; Anderson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P1452, DOI 10.1038/sj.npp.1300922; [Anonymous], 2007, LEARNING BEHAV CONT; Baldo BA, 2013, NEUROSCI BIOBEHAV R, V37, P1985, DOI 10.1016/j.neubiorev.2013.02.017; Banna KM, 2010, BEHAV BRAIN RES, V208, P144, DOI 10.1016/j.bbr.2009.11.030; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Brown ZJ, 2012, PSYCHOPHARMACOLOGY, V224, P431, DOI 10.1007/s00213-012-2772-3; Byrne S, 2003, INT J OBESITY, V27, P955, DOI 10.1038/sj.ijo.0802305; Calu DJ, 2014, NEUROPHARMACOLOGY, V76, P395, DOI 10.1016/j.neuropharm.2013.04.030; Chaudhri N, 2008, EUR J NEUROSCI, V28, P2288, DOI 10.1111/j.1460-9568.2008.06517.x; CHOPIN P, 1986, NEUROPHARMACOLOGY, V25, P53, DOI 10.1016/0028-3908(86)90058-4; Corbit LH, 2011, J NEUROSCI, V31, P11786, DOI 10.1523/JNEUROSCI.2711-11.2011; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Floresco SB, 2008, NEUROSCIENCE, V154, P877, DOI 10.1016/j.neuroscience.2008.04.004; Fuchs RA, 2004, PSYCHOPHARMACOLOGY, V176, P459, DOI 10.1007/s00213-004-1895-6; Ghitza UE, 2007, J NEUROSCI, V27, P11522, DOI 10.1523/JNEUROSCI.5405-06.2007; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Ghods-Sharifi S, 2010, BEHAV NEUROSCI, V124, P179, DOI 10.1037/a0018932; Gorin AA, 2004, INT J OBESITY, V28, P278, DOI 10.1038/sj.ijo.0802550; GRILO CM, 1989, J CONSULT CLIN PSYCH, V57, P488, DOI 10.1037/0022-006X.57.4.488; Guy EG, 2011, BEHAV BRAIN RES, V219, P265, DOI 10.1016/j.bbr.2011.01.024; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; HUBBARD JW, 1988, N-S ARCH PHARMACOL, V337, P583; Hughes CE, 1996, PHARMACOL BIOCHEM BE, V53, P979, DOI 10.1016/0091-3057(95)02151-5; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Jeanblanc J, 2002, NEUROSCIENCE, V111, P315, DOI 10.1016/S0306-4522(02)00019-2; KAYMAN S, 1990, AM J CLIN NUTR, V52, P800, DOI 10.1093/ajcn/52.5.800; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; KRAMER FM, 1989, INT J OBESITY, V13, P123; Le AD, 2011, PSYCHOPHARMACOLOGY, V218, P89, DOI 10.1007/s00213-011-2178-7; McFarland K, 2001, J NEUROSCI, V21, P8655; Meredith GE, 2008, BRAIN STRUCT FUNCT, V213, P17, DOI 10.1007/s00429-008-0175-3; Munzar P, 1999, PSYCHOPHARMACOLOGY, V143, P293, DOI 10.1007/s002130050950; Nair SG, 2008, BRIT J PHARMACOL, V154, P406, DOI 10.1038/bjp.2008.3; Nair SG, 2006, PHYSIOL BEHAV, V88, P559, DOI 10.1016/j.physbeh.2006.05.014; Nair SG, 2011, NEUROPSYCHOPHARMACOL, V36, P497, DOI 10.1038/npp.2010.181; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Ogden Cynthia L, 2012, NCHS Data Brief, P1; PAPESCHI R, 1971, EUR J PHARMACOL, V15, P318, DOI 10.1016/0014-2999(71)90098-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pratt WE, 2013, NEUROSCI LETT, V556, P232, DOI 10.1016/j.neulet.2013.10.030; Richard JM, 2013, NEUROSCI BIOBEHAV R, V37, P1919, DOI 10.1016/j.neubiorev.2012.12.008; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; SETHY VH, 1972, PSYCHOPHARMACOLOGIA, V23, P160, DOI 10.1007/BF00401190; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shelton KL, 2005, INT J COMP PSYCHOL, V18, P154; Shepard JD, 2004, BIOL PSYCHIAT, V55, P1082, DOI 10.1016/j.biopsych.2004.02.032; Simms JA, 2011, PSYCHOPHARMACOLOGY, V218, P101, DOI 10.1007/s00213-011-2451-9; Stopper CM, 2011, COGN AFFECT BEHAV NE, V11, P97, DOI 10.3758/s13415-010-0015-9; Torregrossa MM, 2013, J NEUROSCI, V33, P8370, DOI 10.1523/JNEUROSCI.0489-13.2013; Torregrossa MM, 2010, J NEUROSCI, V30, P10526, DOI 10.1523/JNEUROSCI.2523-10.2010; Yee J, 2011, EUR J PHARMACOL, V650, P596, DOI 10.1016/j.ejphar.2010.10.045; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99301	10.1371/journal.pone.0099301	http://dx.doi.org/10.1371/journal.pone.0099301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910996	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600069
J	Newman, CL; Moe, SM; Chen, NX; Hammond, MA; Wallace, JM; Nyman, JS; Allen, MR				Newman, Christopher L.; Moe, Sharon M.; Chen, Neal X.; Hammond, Max A.; Wallace, Joseph M.; Nyman, Jeffry S.; Allen, Matthew R.			Cortical Bone Mechanical Properties Are Altered in an Animal Model of Progressive Chronic Kidney Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; IN-VIVO MEASUREMENT; HEMODIALYSIS-PATIENTS; RENAL OSTEODYSTROPHY; MINERAL DENSITY; RAT MODEL; HIP FRACTURE; CROSS-LINKS; ZOLEDRONIC ACID; OLDER-ADULTS	Chronic kidney disease (CKD), which leads tocortical bone loss and increasedporosity, increases therisk of fracture. Animal models have confirmed that these changes compromise whole bone mechanical properties. Estimates from whole bone testing suggest that material properties are negatively affected, though tissue-level assessmentshavenot been conducted. Therefore, the goal of the present study was to examine changes in cortical bone at different length scales using a rat model with theprogressive development of CKD. At 30 weeks of age (similar to 75% reduction in kidney function), skeletally mature male Cy/+ rats were compared to their normal littermates. Cortical bone material propertieswere assessed with reference point indentation (RPI), atomic force microscopy (AFM), Raman spectroscopy, and high performance liquid chromatography (HPLC). Bones from animals with CKD had higher (+18%) indentation distance increase and first cycle energy dissipation (+ 8%) as measured by RPI. AFM indentation revealed a broader distribution of elastic modulus values in CKD animals witha greater proportion of both higher and lower modulus values compared to normal controls. Yet, tissue composition, collagen morphology, and collagen cross-linking fail to account for these differences. Though the specific skeletal tissue alterations responsible for these mechanical differences remain unclear, these results indicate that cortical bone material properties are altered in these animals and may contribute to the increased fracture risk associated with CKD.	[Newman, Christopher L.; Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Moe, Sharon M.; Chen, Neal X.] Indiana Univ Sch Med, Div Nephrol, Dept Med, Indianapolis, IN 46202 USA; [Moe, Sharon M.] Roudebush VA Med Ctr, Indianapolis, IN USA; [Hammond, Max A.; Wallace, Joseph M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Nashville, TN USA; [Nyman, Jeffry S.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, Nashville, TN USA; [Nyman, Jeffry S.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	matallen@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058; Hammond, Max/0000-0003-2103-7884; Nyman, Jeffry/0000-0001-7403-7605	National Institutes of Health [AR58005, DL100093]; Indiana Clinical Translational Science Institute [TR000162]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical Translational Science Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants AR58005 (SM) and DL100093 (CN); Indiana Clinical Translational Science Institute grant TR000162 (CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2013, OSTEOPOROSIS INT, V24, P1471, DOI 10.1007/s00198-012-2103-x; Aoki C, 2013, LAB INVEST, V93, P1170, DOI 10.1038/labinvest.2013.105; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Arsov S, 2014, CLIN CHEM LAB MED, V52, P11, DOI 10.1515/cclm-2012-0832; BUCKLEY A, 1988, METHOD ENZYMOL, V163, P674; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Cole JH, 2011, CLIN ORTHOP RELAT R, V469, P2139, DOI 10.1007/s11999-011-1784-3; Currey J., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P317; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Galli F, 2007, NEPHROL DIAL TRANSPL, V22, P20, DOI 10.1093/ndt/gfm294; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Glenn JV, 2007, FASEB J, V21, P3542, DOI 10.1096/fj.06-7896com; Guerri-Fernandez RC, 2013, J BONE MINER RES, V28, P162, DOI 10.1002/jbmr.1731; Hammond MA, 2014, BONE, V60, P26, DOI 10.1016/j.bone.2013.11.015; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Iwamoto J, 2012, CALCIFIED TISSUE INT, V90, P50, DOI 10.1007/s00223-011-9548-3; Iwasaki Y, 2013, BONE, V57, P477, DOI 10.1016/j.bone.2013.07.037; Iwasaki Y, 2011, BONE, V48, P1260, DOI 10.1016/j.bone.2011.03.672; Jamal SA, 2012, OSTEOPOROSIS INT, V23, P2805, DOI 10.1007/s00198-012-1908-y; Jamal SA, 2007, AM J KIDNEY DIS, V49, P674, DOI 10.1053/j.ajkd.2007.02.264; Jassal SK, 2007, J BONE MINER RES, V22, P203, DOI 10.1359/JBMR.061014; Jokihaara J, 2006, J BONE MINER RES, V21, P745, DOI 10.1359/JBMR.060114; Kadokawa S, 2011, J HARD TISSUE BIOL, V20, P79; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Klawansky S, 2003, OSTEOPOROSIS INT, V14, P570, DOI 10.1007/s00198-003-1435-y; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Malluche HH, 2012, J AM SOC NEPHROL, V23, P525, DOI 10.1681/ASN.2010121253; Mitome J, 2011, CALCIFIED TISSUE INT, V88, P521, DOI 10.1007/s00223-011-9488-y; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Moe SM, 2014, J BONE MINER RES, V29, P902, DOI 10.1002/jbmr.2089; Moe SM, 2011, J BONE MINER RES, V26, P2672, DOI 10.1002/jbmr.485; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477; Nagao S, 2010, AM J PHYSIOL-RENAL, V299, pF1078, DOI 10.1152/ajprenal.00504.2009; Nickolas TL, 2006, J AM SOC NEPHROL, V17, P3223, DOI 10.1681/ASN.2005111194; Nickolas TL, 2011, J AM SOC NEPHROL, V22, P1560, DOI 10.1681/ASN.2010121275; Nickolas TL, 2010, J AM SOC NEPHROL, V21, P1371, DOI 10.1681/ASN.2009121208; Nitsch D, 2009, NEPHROL DIAL TRANSPL, V24, P1539, DOI 10.1093/ndt/gfn678; Nyman JS, 2006, BONE, V39, P1210, DOI 10.1016/j.bone.2006.06.026; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Phelps JB, 2000, J BIOMED MATER RES, V51, P735, DOI 10.1002/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G; PIRAINO B, 1988, CLIN NEPHROL, V30, P57; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Sakata N, 2003, NEPHROL DIAL TRANSPL, V18, P1601, DOI 10.1093/ndt/gfg200; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Wallace JM, 2012, BONE, V50, P420, DOI 10.1016/j.bone.2011.11.008; Yamaguchi T, 1996, BONE, V19, P549, DOI 10.1016/S8756-3282(96)00246-3; Zoccali C, 2001, J NEPHROL, V14, P293	59	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99262	10.1371/journal.pone.0099262	http://dx.doi.org/10.1371/journal.pone.0099262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911162	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600062
J	Oka, S; Furukawa, H; Kawasaki, A; Shimada, K; Sugii, S; Hashimoto, A; Komiya, A; Fukui, N; Ito, S; Nakamura, T; Saisho, K; Katayama, M; Tsunoda, S; Sano, H; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Oka, Shomi; Furukawa, Hiroshi; Kawasaki, Aya; Shimada, Kota; Sugii, Shoji; Hashimoto, Atsushi; Komiya, Akiko; Fukui, Naoshi; Ito, Satoshi; Nakamura, Tadashi; Saisho, Koichiro; Katayama, Masao; Tsunoda, Shinichiro; Sano, Hajime; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Protective Effect of the HLA-DRB1*13: 02 Allele in Japanese Rheumatoid Arthritis Patients	PLOS ONE			English	Article							SHARED EPITOPE HYPOTHESIS; HLA-DRB1 ALLELES; ASSOCIATION; DISEASE; RISK; CLASSIFICATION; SUSCEPTIBILITY; PREDISPOSITION; MOLECULE; MARKER	Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease. Certain HLA-DRB1 "shared-epitope'' alleles are reported to be positively associated with increased RA susceptibility, whereas some of the other alleles may be negatively associated. However, studies on the latter are rare. Here, we focus on the protective effects of DRB1 alleles in Japanese RA patients in an association study. Relative predispositional effects (RPE) were analyzed by sequential elimination of carriers of each allele with the strongest association. The protective effects of DRB1 alleles were investigated in patients stratified according to whether they possessed anti-citrullinated peptide antibodies (ACPA). The DRB1*13:02 allele was found to be negatively associated with RA (P = 4.59x10(-10), corrected P (Pc) = 1.42x10(-8), odds ratio [OR] 0.42, 95% CI 0.32-0.55, P [RPE] = 1.27x10(-6)); the genotypes DRB1*04:05/*13:02 and * 09:01/*13:02 were also negatively associated with RA. The protective effect of * 13:02 was also present in ACPA-positive patients (P = 3.95x10(-8), Pc = 1.22x10(-6), OR 0.42, 95% CI 0.310.58) whereas * 15:02 was negatively associated only with ACPA-negative RA (P = 8.87x10(-5), Pc = 0.0026, OR 0.26, 95% CI 0.12-0.56). Thus, this study identified a negative association of DRB1*13:02 with Japanese RA; our findings support the protective role of DRB1*1 3:02 in the pathogenesis of ACPA-positive RA.	[Oka, Shomi; Furukawa, Hiroshi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Shimada, Kota; Hashimoto, Atsushi] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Dept Rheumatol, Fuchu, Tokyo, Japan; [Ito, Satoshi] Niigata Rheumat Ctr, Dept Rheumatol, Shibata, Japan; [Nakamura, Tadashi] Kumamoto Shinto Gen Hosp, Dept Rheumatol, Kumamoto, Japan; [Saisho, Koichiro] Natl Hosp Org, Miyakonojo Hosp, Dept Orthoped Rheumatol, Miyakonojo, Japan; [Katayama, Masao] Natl Hosp Org, Nagoya Med Ctr, Dept Internal Med, Nagoya, Aichi, Japan; [Tsunoda, Shinichiro; Sano, Hajime] Hyogo Coll Med, Dept Internal Med, Div Rheumatol, Nishinomiya, Hyogo 6638501, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Yokohama, Kanagawa, Japan; [Suda, Akiko] Yokohama City Univ, Med Ctr, Ctr Rheumat Dis, Yokohama, Kanagawa 232, Japan	University of Tsukuba; Nagoya Medical Center; Hyogo College of Medicine; Yokohama City University	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Ito, Satoshi/AAL-9615-2020; Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580	Japan Society for the Promotion of Science [24791018]; Health and Labour Science Research Grants from the Ministry of Health; Labour and Welfare of Japan; National Hospital Organization, Research Grants from Daiwa Securities Health Foundation; Research Grants from Japan Research Foundation for Clinical Pharmacology; Research Grants from The Nakatomi Foundation; Research Grants from Takeda Science Foundation; Research Grants from Mitsui Sumitomo Insurance Welfare Foundation; Research Grants from SENSHIN Medical Research Foundation; Abbott Japan Co., Ltd.; Astellas Pharma Inc.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Mitsubishi Tanabe Pharma Corporation; Merck Sharp and Dohme Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Company Limited; Teijin Pharma Limited;  [22390199];  [22591090];  [25670458]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Science Research Grants from the Ministry of Health; Labour and Welfare of Japan; National Hospital Organization, Research Grants from Daiwa Securities Health Foundation; Research Grants from Japan Research Foundation for Clinical Pharmacology; Research Grants from The Nakatomi Foundation; Research Grants from Takeda Science Foundation; Research Grants from Mitsui Sumitomo Insurance Welfare Foundation; Research Grants from SENSHIN Medical Research Foundation; Abbott Japan Co., Ltd.(Abbott Laboratories); Astellas Pharma Inc.(Astellas Pharmaceuticals); Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.(Eisai Co Ltd); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Merck Sharp and Dohme Inc.(Merck & Company); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Teijin Pharma Limited(Teijin Pharma Limited); ; ; 	This work was supported by Grants-in-Aid for Scientific Research (B, C) (22390199, 22591090), for Exploratory Research (25670458) and for Young Scientists (B) (24791018) from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Daiwa Securities Health Foundation, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from The Nakatomi Foundation, Research Grants from Takeda Science Foundation, Research Grants from Mitsui Sumitomo Insurance Welfare Foundation, Research Grants from SENSHIN Medical Research Foundation and research grants from pharmaceutical companies: Abbott Japan Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp and Dohme Inc., Pfizer Japan Inc., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited. The funders had no role in study design, data collection and analysis, decision to publish or preparing the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; de Vries N, 2002, ARTHRITIS RHEUM-US, V46, P921, DOI 10.1002/art.10210; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Furukawa H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053910; Furukawa H, 2013, ANN RHEUM DIS, V72, P153, DOI 10.1136/annrheumdis-2012-201944; Furukawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033133; Gourraud PA, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2131; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046806; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027175; Liu SC, 2007, J RHEUMATOL, V34, P674; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Mattey DL, 2001, J RHEUMATOL, V28, P232; Mewar D, 2008, ANN RHEUM DIS, V67, P980, DOI 10.1136/ard.2007.075382; Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078699; Mitsunaga S, 2012, TISSUE ANTIGENS, V80, P16, DOI 10.1111/j.1399-0039.2012.01872.x; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Terao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040067; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; van der Woude D, 2010, ARTHRITIS RHEUM-US, V62, P1236, DOI 10.1002/art.27366; Wakitani S, 1997, BRIT J RHEUMATOL, V36, P630	33	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99453	10.1371/journal.pone.0099453	http://dx.doi.org/10.1371/journal.pone.0099453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911054	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600091
J	Chen, MM; Cao, HX; Peng, HS; Hu, HB; Wang, W; Zhang, XH				Chen, Mingmin; Cao, Hongxia; Peng, Huasong; Hu, Hongbo; Wang, Wei; Zhang, Xuehong			Reaction Kinetics for the Biocatalytic Conversion of Phenazine-1-Carboxylic Acid to 2-Hydroxyphenazine	PLOS ONE			English	Article							FLUORESCENT PSEUDOMONADS; PHENAZINE; BIOSYNTHESIS; GENES; METABOLITES; LACTONE; LOCUS	The phenazine derivative 2-hydroxyphenazine (2-OH-PHZ) plays an important role in the biocontrol of plant diseases, and exhibits stronger bacteriostatic and fungistatic activity than phenazine-1-carboxylic acid (PCA) toward some pathogens. PhzO has been shown to be responsible for the conversion of PCA to 2-OH-PHZ, however the kinetics of the reaction have not been systematically studied. Further, the yield of 2-OH-PHZ in fermentation culture is quite low and enhancement in our understanding of the reaction kinetics may contribute to improvements in large-scale, high-yield production of 2-OH-PHZ for biological control and other applications. In this study we confirmed previous reports that free PCA is converted to 2-hydroxy-phenazine-1-carboxylic acid (2-OH-PCA) by the action of a single enzyme PhzO, and particularly demonstrate that this reaction is dependent on NADP(H) and Fe3+. Fe3+ enhanced the conversion from PCA to 2-OH-PHZ and 28 degrees C was a optimum temperature for the conversion. However, PCA added in excess to the culture inhibited the production of 2-OH-PHZ. 2-OH-PCA was extracted and purified from the broth, and it was confirmed that the decarboxylation of 2-OH-PCA could occur without the involvement of any enzyme. A kinetic analysis of the conversion of 2-OH-PCA to 2-OH-PHZ in the absence of enzyme and under different temperatures and pHs in vitro, revealed that the conversion followed first-order reaction kinetics. In the fermentation, the concentration of 2-OH-PCA increased to about 90 mg/L within a red precipitate fraction, as compared to 37 mg/L within the supernatant. The results of this study elucidate the reaction kinetics involved in the biosynthesis of 2-OH-PHZ and provide insights into in vitro methods to enhance yields of 2-OH-PHZ.	[Chen, Mingmin; Cao, Hongxia; Peng, Huasong; Hu, Hongbo; Wang, Wei; Zhang, Xuehong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xuehzhang@sjtu.edu.cn			National Key Basic Research Program of China [2012CB721005]; National Natural Science Foundation of China [31270084]; National High Technology Research and Development Program of China [2012AA022107]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Key Basic Research Program of China (No. 2012CB721005), the National Natural Science Foundation of China (No. 31270084), and the National High Technology Research and Development Program of China (No. 2012AA022107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumer C, 2000, MICROBIOL-SGM, V146, P2417, DOI 10.1099/00221287-146-10-2417; BUDZIKIEWICZ H, 1993, FEMS MICROBIOL LETT, V104, P209, DOI 10.1111/j.1574-6968.1993.tb05868.x; Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P1006, DOI 10.1094/MPMI.2001.14.8.1006; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Du X, 2013, APPL MICROBIOL BIOTE; Dwivedi D, 2003, CURR SCI INDIA, V85, P1693; Huang L, 2011, APPL MICROBIOL BIOT, V89, P169, DOI 10.1007/s00253-010-2863-1; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Khan SR, 2007, APPL ENVIRON MICROB, V73, P7443, DOI 10.1128/AEM.01354-07; LEVITCH ME, 1966, BIOCHEMISTRY-US, V5, P689, DOI 10.1021/bi00866a040; Liu HM, 2007, CURR MICROBIOL, V54, P302, DOI 10.1007/s00284-006-0444-4; Maddula VSRK, 2008, J BACTERIOL, V190, P2759, DOI 10.1128/JB.01587-07; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616, DOI 10.1128/AEM.58.8.2616-2624.1992; Mehnaz S, 2009, J MICROBIOL BIOTECHN, V19, P1688, DOI 10.4014/jmb.0904.04022; Menezes SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037969; Park GK, 2012, J MICROBIOL BIOTECHN, V22, P326, DOI 10.4014/jmb.1106.06042; Park JY, 2011, LETT APPL MICROBIOL, V52, P532, DOI 10.1111/j.1472-765X.2011.03036.x; PIERSON LS, 1992, MOL PLANT MICROBE IN, V5, P330, DOI 10.1094/MPMI-5-330; PIERSON LS, 1995, FEMS MICROBIOL LETT, V134, P299, DOI 10.1111/j.1574-6968.1995.tb07954.x; Selin C, 2012, MICROBIOLOGY; Shen XM, 2012, J BACTERIOL, V194, P1269, DOI 10.1128/JB.06713-11; Tietze M, 2005, ORG LETT, V7, P1549, DOI 10.1021/ol050198y; TOOHEY JI, 1965, CAN J BOTANY, V43, P1151, DOI 10.1139/b65-128; TURNER JM, 1986, ADV MICROB PHYSIOL, V27, P211, DOI 10.1016/S0065-2911(08)60306-9; Zhang JF, 2010, PEST MANAG SCI, V66, P248, DOI 10.1002/ps.1856; Zhou Q, 2010, APPL MICROBIOL BIOT, V86, P1761, DOI 10.1007/s00253-010-2464-z	31	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98537	10.1371/journal.pone.0098537	http://dx.doi.org/10.1371/journal.pone.0098537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905009	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000039
J	Dong, J; Guan, HZ; Jiang, ZY; Chen, X				Dong, Jing; Guan, Hong-Zai; Jiang, Zheng-Yao; Chen, Xi			Nesfatin-1 Influences the Excitability of Glucosensing Neurons in the Dorsal Vagal Complex and Inhibits Food Intake	PLOS ONE			English	Article							C-FOS; PARAVENTRICULAR NUCLEUS; SOLITARY TRACT; BRAIN; IMMUNOREACTIVITY; HYPOTHALAMUS; EXPRESSION	Nesfatin-1 is a recently discovered metabolic peptide hormone that decreases food intake after lateral, third, or fourth brain ventricle; cisterna magna; or paraventricular nucleus (PVN) injection in ad libitum fed rats. Additional micro-injection studies will improve the understanding of how nesfatin-1 acts on the brain and define specific nuclei responsive to nesfatin-1, which will provide insight on its effects on food intake. We evaluated how nesfatin-1 injection into the dorsal vagal complex (DVC) modulates food intake response in rats during the dark phase. Consistent with previous observations, nesfatin-1-injected rats significantly reduced cumulative food intake over a 5-h period in rats. Chronic administration of nesfatin-1 into the DVC reduced body weight gain over a 10-day period. Because glucosensing neurons in the DVC are involved in glucoprivic feeding and homeostatic control of blood glucose, we examined the effect of nesfatin-1 on the excitability of DVC glucosensing neurons. Nesfatin-1 inhibited most of the glucose-inhibitory (GI) neurons and excited most of the glucose-excitatory (GE) neurons in the DVC. Current-clamp electrophysiology recordings from DVC glucosensing neurons in slice preparation showed that bath applied nesfatin-1(10 nM) increased the firing frequency of GE neurons and inhibited the firing rate of GI-neurons. Nesfatin-1 inhibited 88.9% (16/18) of gastric distension inhibitory (GD-INH) neurons and excited 76.2% (32/42) of gastric distension excitatory (GD-EXC) neurons. Thus, nesfatin-1 may control food intake by modulating the excitability of glucosensing neurons in the DVC.	[Dong, Jing] Qingdao Univ, Coll Med, Dept Special Med, Qingdao 266071, Peoples R China; [Dong, Jing; Guan, Hong-Zai; Jiang, Zheng-Yao; Chen, Xi] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Jiang, ZY (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China.	qd-zyj@163.com; casey1201@163.com			National Natural Science Foundation of China [31071013, 31371168, 31200868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31071013 to Z-Y Jiang, 31371168 to J. Dong and 31200868 to X. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet MS, 2013, J NEUROENDOCRINOL, V25, P1, DOI 10.1111/j.1365-2826.2012.02375.x; Bonnet MS, 2013, REGUL PEPTIDES, V187, P17, DOI 10.1016/j.regpep.2013.10.001; Briski KP, 2000, EXP BRAIN RES, V133, P547, DOI 10.1007/s002210000448; Chen X, 2012, REGUL PEPTIDES, V177, P21, DOI 10.1016/j.regpep.2012.04.003; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Dallaporta M, 1999, NEUROREPORT, V10, P2657, DOI 10.1097/00001756-199908200-00040; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Goebel-Stengel M, 2011, BRAIN RES, V1396, P20, DOI 10.1016/j.brainres.2011.04.031; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Noetzel S, 2009, REGUL PEPTIDES, V157, P84, DOI 10.1016/j.regpep.2009.06.009; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ritter S, 1998, BRAIN RES, V805, P41, DOI 10.1016/S0006-8993(98)00655-6; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Vrang N, 2003, AM J PHYSIOL-REG I, V285, pR470, DOI 10.1152/ajpregu.00732.2002; Watts AG, 2010, FRONT NEUROENDOCRIN, V31, P32, DOI 10.1016/j.yfrne.2009.10.006; Willing AE, 1997, AM J PHYSIOL-REG I, V272, pR59, DOI 10.1152/ajpregu.1997.272.1.R59; Yosten GLC, 2009, AM J PHYSIOL-REG I, V297, pR330, DOI 10.1152/ajpregu.90867.2008	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98967	10.1371/journal.pone.0098967	http://dx.doi.org/10.1371/journal.pone.0098967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906120	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000082
J	Gomez-Gomez, E; Rios-Martinez, ME; Castro-Rodriguez, EM; Del-Toro-Equihua, M; Ramirez-Flores, M; Delgado-Enciso, I; Perez-Huitimea, AL; Baltazar-Rodriguez, LM; Velasco-Pineda, G; Muniz-Murguia, J				Gomez-Gomez, Eduardo; Efren Rios-Martinez, Martin; Margarita Castro-Rodriguez, Elena; Del-Toro-Equihua, Mario; Ramirez-Flores, Mario; Delgado-Enciso, Ivan; Lilia Perez-Huitimea, Ana; Margarita Baltazar-Rodriguez, Luz; Velasco-Pineda, Gilberto; Muniz-Murguia, Jesus			Carnitine Palmitoyltransferase 1B 531K Allele Carriers Sustain a Higher Respiratory Quotient after Aerobic Exercise, but beta 3-Adrenoceptor 64R Allele Does Not Affect Lipolysis: A Human Model	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISM; FATTY-ACID OXIDATION; TRP64ARG POLYMORPHISM; MUSCLE; ASSOCIATION; AVAILABILITY; METABOLISM; INCREASES; JAPANESE; BMI	Carnitine palmitoyltransferase IB (CPT1B) and adrenoceptor beta-3 (ADRB3) are critical regulators of fat metabolism. CPT1B transports free acyl groups into mitochondria for oxidation, and ADRB3 triggers lipolysis in adipocytes, and their respective polymorphisms E531K and W64R have been identified as indicators of obesity in population studies. It is therefore important to understand the effects of these mutations on ADRB3 and CPT1B function in adipose and skeletal muscle tissue, respectively. This study aimed to analyze the rate of lipolysis of plasma indicators (glycerol, free fatty acids, and beta hydroxybutyrate) and fat oxidation (through the non-protein respiratory quotient). These parameters were measured in 37 participants during 30 min of aerobic exercise at approximately 62% of maximal oxygen uptake, followed by 30 min of recovery. During recovery, mean respiratory quotient values were higher in K allele carriers than in non-carriers, indicating low post-exercise fatty acid oxidation rates. No significant differences in lipolysis or lipid oxidation were observed between R and W allele carriers of ADRB3 at any time during the aerobic load. The substitution of glutamic acid at position 531 by lysine in the CPT1B protein decreases the mitochondrial beta-oxidation pathway, which increases the non-protein respiratory quotient value during recovery from exercise. This may contribute to weight gain or reduced weight-loss following exercise.	[Gomez-Gomez, Eduardo; Efren Rios-Martinez, Martin; Margarita Castro-Rodriguez, Elena; Ramirez-Flores, Mario; Muniz-Murguia, Jesus] Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico; [Del-Toro-Equihua, Mario; Delgado-Enciso, Ivan; Margarita Baltazar-Rodriguez, Luz; Velasco-Pineda, Gilberto] Univ Colima, Fac Med, Colima, Mexico; [Lilia Perez-Huitimea, Ana] Univ Colima, Fac Ciencias & Educ, Colima, Mexico	Universidad de Colima; Universidad de Colima; Universidad de Colima	Muniz-Murguia, J (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima, Mexico.	mmurguia@ucol.mx	Delgado-Enciso, Ivan/B-1743-2018	Delgado-Enciso, Ivan/0000-0001-9848-862X; Baltazar Rodriguez, Luz Margarita/0000-0002-6531-9624; Ramirez-Flores, Mario/0000-0003-3375-715X	Mexican government through National Council of Science and Technology (CONACYT) [81471]	Mexican government through National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded by the Mexican government through National Council of Science and Technology (CONACYT), www.conacyt.gob.mx: project 81471 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sport Medicine, 1991, AM COLL SPORTS MED G, P55; Auinger A, 2013, BRIT J NUTR, V109, P810, DOI 10.1017/S0007114512002656; Baturin A. K., 2012, Voprosy Pitaniya, V81, P23; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ellsworth DL, 2005, OBES RES, V13, P519, DOI 10.1038/oby.2005.55; Garenc C, 2001, OBES RES, V9, P337, DOI 10.1038/oby.2001.43; Gene cards, HUM GEN COMP; Hargreaves M, 2006, EXERCISE METABOLISM, P291; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; *INT SOC ADV KIN, 2001, INT STANDARDS ANTHRO; Jekal Yoonsuk, 2010, Korean Diabetes J, V34, P182, DOI 10.4093/kdj.2010.34.3.182; Kurokawa N, 2001, OBES RES, V9, P741, DOI 10.1038/oby.2001.102; Leggate M, 2010, CELL STRESS CHAPERON, V15, P827, DOI 10.1007/s12192-010-0192-z; Liu HY, 2007, ARCH BIOCHEM BIOPHYS, V465, P437, DOI 10.1016/j.abb.2007.06.026; Love LK, 2011, J APPL PHYSIOL, V111, P427, DOI 10.1152/japplphysiol.00672.2010; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P379, DOI 10.1113/jphysiol.2002.021022; McArdle WD, 2010, EXERCISE PHYSL NUTR, P1038; McArdle WD, 2000, ESSENTIALS EXERCISE; Miljkovic I, 2009, OBESITY, V17, P1396, DOI 10.1038/oby.2008.677; Mirrakhimov AE, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-89; Napal L, 2003, J BIOL CHEM, V278, P34084, DOI 10.1074/jbc.M305826200; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Norton K, 1996, ANTHROPOMETRICA TXB; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Rankinen T, 2012, PROG MOL BIOL TRANSL, V108, P447, DOI 10.1016/B978-0-12-398397-8.00017-4; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Robitaille J, 2007, J MOL MED, V85, P129, DOI 10.1007/s00109-006-0116-7; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Levy TS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-152; Tahara Aya, 2010, Environmental Health and Preventive Medicine, V15, P392, DOI 10.1007/s12199-010-0157-y; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; WALSTON J, 1995, NEW ENGL J MED, V333, P343, DOI 10.1056/NEJM199508103330603; World Health Organization (WHO), GUID DRAW BLOOD BEST; Zhan SY, 2005, OBES RES, V13, P1709, DOI 10.1038/oby.2005.209	37	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96791	10.1371/journal.pone.0096791	http://dx.doi.org/10.1371/journal.pone.0096791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905907	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000002
J	Krishnan, SG; Waters, DLE; Henry, RJ				Krishnan, Gopala S.; Waters, Daniel L. E.; Henry, Robert J.			Australian Wild Rice Reveals Pre-Domestication Origin of Polymorphism Deserts in Rice Genome	PLOS ONE			English	Article							GREEN-REVOLUTION; GIBBERELLIN-SYNTHESIS; GRAIN WIDTH; GENE; ENCODES; SNP; TRANSITION; DIVERSITY; SELECTION; PERICARP	Background: Rice is a major source of human food with a predominantly Asian production base. Domestication involved selection of traits that are desirable for agriculture and to human consumers. Wild relatives of crop plants are a source of useful variation which is of immense value for crop improvement. Australian wild rices have been isolated from the impacts of domestication in Asia and represents a source of novel diversity for global rice improvement. Oryza rufipogon is a perennial wild progenitor of cultivated rice. Oryza meridionalis is a related annual species in Australia. Results: We have examined the sequence of the genomes of AA genome wild rices from Australia that are close relatives of cultivated rice through whole genome re-sequencing. Assembly of the resequencing data to the O. sativa ssp. japonica cv. Nipponbare shows that Australian wild rices possess 2.5 times more single nucleotide polymorphisms than in the Asian wild rice and cultivated O. sativa ssp. indica. Analysis of the genome of domesticated rice reveals regions of low diversity that show very little variation (polymorphism deserts). Both the perennial and annual wild rice from Australia show a high degree of conservation of sequence with that found in cultivated rice in the same 4.58Mbp region on chromosome 5, which suggests that some of the 'polymorphism deserts' in this and other parts of the rice genome may have originated prior to domestication due to natural selection. Conclusions: Analysis of genes in the 'polymorphism deserts' indicates that this selection may have been due to biotic or abiotic stress in the environment of early rice relatives. Despite having closely related sequences in these genome regions, the Australian wild populations represent an invaluable source of diversity supporting rice food security.	[Krishnan, Gopala S.; Waters, Daniel L. E.] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Krishnan, Gopala S.] Indian Agr Res Inst, Div Genet, New Delhi 110012, India; [Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia	Southern Cross University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Queensland	Henry, RJ (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.	robert.henry@uq.edu.au	Henry, Robert J/B-5824-2008	Henry, Robert J/0000-0002-4060-0292; Subbaiyan, Gopala Krishnan/0000-0003-3443-8767; Waters, Daniel/0000-0002-8622-3162	Australian Research Council; Department of Science and Technology, Government of India; Indian Council for Agricultural Research, New Delhi	Australian Research Council(Australian Research Council); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Council for Agricultural Research, New Delhi	The research was funded by the Australian Research Council, the Department of Science and Technology, Government of India under the BOYSCAST Fellowship and the Indian Council for Agricultural Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Flowers JM, 2012, MOL BIOL EVOL, V29, P675, DOI 10.1093/molbev/msr225; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Henry RJ, 2010, RICE, V3, P235, DOI 10.1007/s12284-009-9034-y; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ishii T, 2011, RICE, V4, P170, DOI 10.1007/s12284-011-9067-x; Kharabian-Masouleh A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00557; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2008, CURR OPIN PLANT BIOL, V11, P193, DOI 10.1016/j.pbi.2007.12.006; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Waters DLE, 2012, ECOL EVOL, V2, P211, DOI 10.1002/ece3.66; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	36	29	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98843	10.1371/journal.pone.0098843	http://dx.doi.org/10.1371/journal.pone.0098843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905808	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000068
J	Porter, KM; Kang, BY; Adesina, SE; Murphy, TC; Hart, CM; Sutliff, RL				Porter, Kristi M.; Kang, Bum-Yong; Adesina, Sherry E.; Murphy, Tamara C.; Hart, C. Michael; Sutliff, Roy L.			Chronic Hypoxia Promotes Pulmonary Artery Endothelial Cell Proliferation through H2O2-Induced 5-Lipoxygenase	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; P38 MAPK; BARRIER DYSFUNCTION; GENE-EXPRESSION; IN-VITRO; HYPERTENSION; GROWTH; OXYGEN; PROTEIN	Pulmonary Hypertension (PH) is a progressive disorder characterized by endothelial dysfunction and proliferation. Hypoxia induces PH by increasing vascular remodeling. A potential mediator in hypoxia-induced PH development is arachidonate 5-Lipoxygenase (ALOX5). While ALOX5 metabolites have been shown to promote pulmonary vasoconstriction and endothelial cell proliferation, the contribution of ALOX5 to hypoxia-induced proliferation remains unknown. We hypothesize that hypoxia exposure stimulates HPAEC proliferation by increasing ALOX5 expression and activity. To test this, human pulmonary artery endothelial cells (HPAEC) were cultured under normoxic (21% O-2) or hypoxic (1% O-2) conditions for 24-, 48-, or 72 hours. In a subset of cells, the ALOX5 inhibitor, zileuton, or the 5-lipoxygenase activating protein inhibitor, MK-886, was administered during hypoxia exposure. ALOX5 expression was measured by qRT-PCR and western blot and HPAEC proliferation was assessed. Our results demonstrate that 24 and 48 hours of hypoxia exposure have no effect on HPAEC proliferation or ALOX5 expression. Seventy two hours of hypoxia significantly increases HPAEC ALOX5 expression, hydrogen peroxide (H2O2) release, and HPAEC proliferation. We also demonstrate that targeted ALOX5 gene silencing or inhibition of the ALOX5 pathway by pharmacological blockade attenuates hypoxia-induced HPAEC proliferation. Furthermore, our findings indicate that hypoxia-induced increases in cell proliferation and ALOX5 expression are dependent on H2O2 production, as administration of the antioxidant PEG-catalase blocks these effects and addition of H2O2 to HPAEC promotes proliferation. Overall, these studies indicate that hypoxia exposure induces HPAEC proliferation by activating the ALOX5 pathway via the generation of H2O2.	[Porter, Kristi M.; Kang, Bum-Yong; Adesina, Sherry E.; Murphy, Tamara C.; Hart, C. Michael; Sutliff, Roy L.] Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Dept Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Sutliff, RL (corresponding author), Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Dept Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA.	rsutlif@emory.edu			National Science Foundation [0450303, I-66-606-63]; Pharmacological Sciences Training Grant [TM GM 008602]; National Institute of Allergy and Infectious Diseases [1-F31-AI084460, HL 102167];  [HL070892]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102167, R01HL070892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI084460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001910] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Pharmacological Sciences Training Grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by HL070892 to RLS, National Science Foundation Award #0450303 Subaward # I-66-606-63 to Emory University, Pharmacological Sciences Training Grant TM GM 008602, National Institute of Allergy and Infectious Diseases 1-F31-AI084460 to KMP, and HL 102167 to RLS and CMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Agbani EO, 2011, PULM PHARMACOL THER, V24, P100, DOI 10.1016/j.pupt.2010.09.003; Banks MF, 2005, J APPL PHYSIOL, V98, P732, DOI 10.1152/japplphysiol.00821.2004; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; BHAT GB, 1992, J CELL PHYSIOL, V151, P228, DOI 10.1002/jcp.1041510203; Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; BOTNEY MD, 1994, AM J PATHOL, V144, P286; Breton-Romero R, 2013, METHOD ENZYMOL, V528, P49, DOI 10.1016/B978-0-12-405881-1.00003-3; Breton-Romero R, 2012, FREE RADICAL BIO MED, V52, P1093, DOI 10.1016/j.freeradbiomed.2011.12.026; Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Dishart D, 2005, BBA-MOL CELL BIOL L, V1738, P37, DOI 10.1016/j.bbalip.2005.11.008; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Fresquet F, 2006, BRIT J PHARMACOL, V148, P714, DOI 10.1038/sj.bjp.0706779; FRIEDMAN Z, 1984, PROSTA LEUKOTR MED, V14, P279, DOI 10.1016/0262-1746(84)90211-7; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Green DE, 2012, AM J RESP CELL MOL B; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Hartney T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027531; HATZELMANN A, 1989, EUR J BIOCHEM, V180, P527, DOI 10.1111/j.1432-1033.1989.tb14678.x; HATZELMANN A, 1987, EUR J BIOCHEM, V169, P175, DOI 10.1111/j.1432-1033.1987.tb13595.x; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; ISHII Y, 1992, J CLIN INVEST, V89, P794, DOI 10.1172/JCI115658; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Jin BY, 2012, P NATL ACAD SCI USA, V109, P14864, DOI 10.1073/pnas.1204974109; Jones JE, 2004, AM J PHYSIOL-HEART C, V286, pH1775, DOI 10.1152/ajpheart.00281.2003; Kang BY, 2011, AM J PHYSIOL-LUNG C, V301, pL881, DOI 10.1152/ajplung.00195.2011; Katryniok C, 2010, BBA-MOL CELL BIOL L, V1801, P49, DOI 10.1016/j.bbalip.2009.09.003; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; Lee YJ, 2004, J APPL PHYSIOL, V96, P793, DOI 10.1152/japplphysiol.00797.2003; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; MEYRICK B, 1979, AM J PATHOL, V96, P51; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; MORGANROTH ML, 1985, AM REV RESPIR DIS, V131, P488, DOI 10.1164/arrd.1985.131.4.488; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Orr R, 2012, CURR OPIN PULM MED, V18, P138, DOI 10.1097/MCP.0b013e32834f2093; Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200; RABINOVITCH M, 1986, LAB INVEST, V55, P632; Radmark O, 2005, BIOCHEM BIOPH RES CO, V338, P102, DOI 10.1016/j.bbrc.2005.08.013; Richter A, 2004, AM J RESP CRIT CARE, V170, P1340, DOI 10.1164/rccm.200311-1602OC; RIENDEAU D, 1989, BIOCHEM J, V263, P565, DOI 10.1042/bj2630565; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; SAMUELSSON B, 1991, ADV PROSTAG THROMB L, V21, P1; Schaefer CA, 2006, ATHEROSCLEROSIS, V185, P290, DOI 10.1016/j.atherosclerosis.2005.06.035; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Silverman ES, 2002, AM J RESP CELL MOL, V26, P475, DOI 10.1165/ajrcmb.26.4.4747; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Stanke-Labesque F, 2003, BRIT J PHARMACOL, V140, P186, DOI 10.1038/sj.bjp.0705405; Stanke-Labesque F, 2001, CARDIOVASC RES, V49, P152, DOI 10.1016/S0008-6363(00)00238-8; STENMARK KR, 1985, AM J PHYSIOL, V248, pH859, DOI 10.1152/ajpheart.1985.248.6.H859; Stiebellehner L, 1998, AM J PHYSIOL-LUNG C, V275, pL593, DOI 10.1152/ajplung.1998.275.3.L593; Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009; TUDER RM, 1994, AM J PATHOL, V144, P275; TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; Voelkel NF, 1997, PULM PHARMACOL THER, V10, P231, DOI 10.1006/pupt.1998.0100; Walker JL, 2002, AM J PHYSIOL-HEART C, V282, pH585, DOI 10.1152/ajpheart.00003.2001; Wang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL570, DOI 10.1152/ajplung.00262.2005; Weerackody RP, 2009, AM J PHYSIOL-HEART C, V296, pH1312, DOI 10.1152/ajpheart.00977.2008; Werz O, 2000, EUR J BIOCHEM, V267, P1263, DOI 10.1046/j.1432-1327.2000.01000.x; WRIGHT JL, 1983, AM REV RESPIR DIS, V128, P702; Yu LY, 2011, J VASC RES, V48, P465, DOI 10.1159/000327005; Zanetti M, 2002, AM J PHYSIOL-HEART C, V283, pH2620, DOI 10.1152/ajpheart.00358.2001; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	77	33	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98532	10.1371/journal.pone.0098532	http://dx.doi.org/10.1371/journal.pone.0098532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906007	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000037
J	Banjare, P; Pradhan, J				Banjare, Pallavi; Pradhan, Jalandhar			Socio-Economic Inequalities in the Prevalence of Multi-Morbidity among the Rural Elderly in Bargarh District of Odisha (India)	PLOS ONE			English	Article							QUALITY-OF-LIFE; SMOKELESS TOBACCO; CHRONIC DISEASES; MULTIMORBIDITY; MORTALITY; PATTERNS; PEOPLE; POPULATION; DISABILITY; CARE	Background: Multi-morbidity among elderly is increasingly recognized as a major public health challenge in most of the developing countries. However, information on the size of population suffering from multi-morbidity and socio-economic differentials of multi-morbidity is scarce. The objectives of this paper are twofold; first, to assess the prevalence of various chronic conditions and morbidity among rural elderly and second, to examine the socio-economic and demographic factors that have a significant effect on the morbidity. Methods: A cross-sectional survey has been done using multi-stage random sampling procedure that was conducted among elderly (60+ years) in Bargarh District of Odisha during October 2011-February 2012. The survey was conducted among 310 respondents including 153 males and 157 females. Descriptive analyses were performed to assess the pattern of multi-morbidity. Logistic regression analyses were used to see the adjusted effect of various socio-economic and demographic covariates of multi-morbidity. Results: The overall prevalence of multi-morbidity is 57% among rural elderly in Bargarh District of Odisha. The most common diseases in rural areas are: Arthritis, Chronic Obstructive Pulmonary Disease (COPD), High Blood Pressure and Cataract. Results from the logistic regression analyses show that age, state of economic independence and life style indicators are the most important measured predictors of multi-morbidity. Unlike earlier studies, wealth index and education have a marginal impact on multi-morbidity rate. Moreover, the occurrence of multi-morbidity is higher for elderly males compared to their female counterparts, though the difference is not significant. Conclusion: The high prevalence of morbidity observed in the present study suggests that there is an urgent need to develop geriatric health care services in a developing country like India. Any effort to reorganize primary care for elderly people should also consider the high prevalence of multi-morbidity among rural elderly in India.	[Banjare, Pallavi; Pradhan, Jalandhar] Natl Inst Technol, Dept Humanities & Social Sci, Rourkela, Odisha, India	National Institute of Technology (NIT System); National Institute of Technology Rourkela	Pradhan, J (corresponding author), Natl Inst Technol, Dept Humanities & Social Sci, Rourkela, Odisha, India.	jpp_pradhan@yahoo.co.uk	Pradhan, Jalandhar/N-1820-2017; Pradhan, Jalandhar/HIK-1917-2022	Pradhan, Jalandhar/0000-0001-5998-0363; 				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; Angra SK, 1997, INDIAN J MED RES, V106, P312; [Anonymous], 2008, AG FRIENDL PRIM HLTH; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bhattacharya P., 2005, LIV 100 S SPONS SOC; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; By Yuvaraj, 2010, Indian J Community Med, V35, P138, DOI 10.4103/0970-0218.62578; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chinnakali P, 2012, N AM J MED SCI, V4, P558, DOI 10.4103/1947-2714.103314; DAVELUY C, 2000, ENQUETE SOCIALE SANT; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Fortin M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-52; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Fuchs Z, 1998, J GERONTOL A-BIOL, V53, pM447, DOI 10.1093/gerona/53A.6.M447; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hudon C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-304; Jindal S K, 2006, Indian J Chest Dis Allied Sci, V48, P23; Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Khokhar A, 2001, Indian J Med Sci, V55, P609; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Lyon F, 2007, INT AGENCY RES CANC, V89, P55; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Maranetra Khun Nanta, 2002, Journal of the Medical Association of Thailand, V85, P1147; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Ministry of Social Justice & Empowerment, 2008, INT PROGR OLD PERS C; Mohan M, 1992, NATL PROGRAMS ME CON, P80; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Palloni A., 2001, LIVING ARRANGE OLDER, V42, P54; Purty AJ, 2006, TURKISH J MED SCI, V36, P45; Rajan SI., 1995, HONG KONG J GERONTOL, V9, P20; Rajshree Bhatt, 2011, National Journal of Community Medicine, V2, P233; Rana AM, 2009, AGEING SOC, V29, P727, DOI 10.1017/S0144686X09008411; Rapoport John, 2004, Chronic Dis Can, V25, P13; Roland M, 2002, 3 INT C SMOK TOB STO; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Shankar R, 2007, Indian J Public Health, V51, P56; Shraddha K., 2012, International Journal of Medicine and Biomedical Research, V1, P215; Solomons NW, 2001, J HLTH AGEING, V3, P3; Swami HM, 2002, BAHRAIN MED B, V24, P13; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van den Akker M, 2000, SOC SCI MED, V50, P1679, DOI 10.1016/S0277-9536(99)00408-6; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [10.3109/13814789609162146, DOI 10.3109/13814789609162146]; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Wong SY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-119; World Health Organization, 2004, AG FRIENDL PRIM HLTH	58	49	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97832	10.1371/journal.pone.0097832	http://dx.doi.org/10.1371/journal.pone.0097832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24902041	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400012
J	Chen, H; Gurmesa, GA; Liu, L; Zhang, T; Fu, SL; Liu, ZF; Dong, SF; Ma, C; Mo, JM				Chen, Hao; Gurmesa, Geshere A.; Liu, Lei; Zhang, Tao; Fu, Shenglei; Liu, Zhanfeng; Dong, Shaofeng; Ma, Chuan; Mo, Jiangming			Effects of Litter Manipulation on Litter Decomposition in a Successional Gradients of Tropical Forests in Southern China	PLOS ONE			English	Article							SUBSTRATE UTILIZATION PATTERNS; NORTHERN HARDWOOD FORESTS; LEAF-LITTER; NITROGEN ADDITIONS; SUBTROPICAL CHINA; MICROBIAL BIOMASS; MATURE FORESTS; MOIST FOREST; SOIL; CARBON	Global changes such as increasing CO2, rising temperature, and land-use change are likely to drive shifts in litter inputs to forest floors, but the effects of such changes on litter decomposition remain largely unknown. We initiated a litter manipulation experiment to test the response of litter decomposition to litter removal/addition in three successional forests in southern China, namely masson pine forest (MPF), mixed coniferous and broadleaved forest (MF) and monsoon evergreen broadleaved forest (MEBF). Results showed that litter removal decreased litter decomposition rates by 27%, 10% and 8% and litter addition increased litter decomposition rates by 55%, 36% and 14% in MEBF, MF and MPF, respectively. The magnitudes of changes in litter decomposition were more significant in MEBF forest and less significant in MF, but not significant in MPF. Our results suggest that change in litter quantity can affect litter decomposition, and this impact may become stronger with forest succession in tropical forest ecosystem.	[Chen, Hao; Liu, Lei; Zhang, Tao; Fu, Shenglei; Liu, Zhanfeng; Dong, Shaofeng; Ma, Chuan; Mo, Jiangming] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Gurmesa, Geshere A.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Liu, Lei] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Tao] Zhanjiang Normal Univ, Inst Trop Pratacultural Sci, Zhanjiang, Peoples R China; [Chen, Hao; Gurmesa, Geshere A.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gurmesa, Geshere A.] Sino Danish Ctr Educ & Res, Aarhus, Denmark	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Copenhagen; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); LingNan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mo, JM (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	mojm@scib.ac.cn	Gurmesa, Geshere Abdisa/GPX-2764-2022; Gurmesa, Geshere Abdisa/C-2126-2015; Liu, Zhanfeng/ABD-3933-2021; Chen, Hao/U-4752-2017; Fu, Shenglei/B-2729-2012; Lei, Liu/J-7929-2017	Gurmesa, Geshere Abdisa/0000-0002-2340-6076; Liu, Zhanfeng/0000-0002-6602-6196; Chen, Hao/0000-0003-3577-2345; Lei, Liu/0000-0002-8063-610X	National Key Basic Research 973 Programme [2011CB403204]	National Key Basic Research 973 Programme	This study was founded by National Key Basic Research 973 Programme (2011CB403204) and National Natural Science Foundation of China (No: 41273143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamd L, 2004, FOREST ECOL MANAG, V202, P1, DOI 10.1016/j.foreco.2004.02.062; Anderson JM., 1989, TROPICAL SOIL BIOL F; [Anonymous], 1982, TROP SUBTROP ECOSYS; [Anonymous], [No title captured]; Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; BINGEMAN CW, 1953, SOIL SCI SOC AM PRO, V17, P34, DOI 10.2136/sssaj1953.03615995001700010008x; Boberg J, 2008, SOIL BIOL BIOCHEM, V40, P995, DOI 10.1016/j.soilbio.2007.11.005; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen H, 2013, PLOS ONE IN PRESS; Chigineva NI, 2009, APPL SOIL ECOL, V42, P264, DOI 10.1016/j.apsoil.2009.05.001; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Crow SE, 2009, FOREST ECOL MANAG, V258, P2224, DOI 10.1016/j.foreco.2009.01.014; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Dzwonko Z, 2002, BIOL CONSERV, V106, P389, DOI 10.1016/S0006-3207(01)00266-X; Fahey TJ, 1998, ECOL MONOGR, V68, P183, DOI 10.1890/0012-9615(1998)068[0183:ROESNH]2.0.CO;2; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Fang YT, 2006, J ENVIRON SCI, V18, P752; Fisk MC, 2001, BIOGEOCHEMISTRY, V53, P201, DOI 10.1023/A:1010693614196; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Holmes KW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002507; Huang WJ, 2012, ACTA OECOL, V44, P20, DOI 10.1016/j.actao.2011.06.005; Kranabetter JM, 1999, CAN J SOIL SCI, V79, P543, DOI 10.4141/S98-081; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; Loranger G, 2002, BIOL FERT SOILS, V35, P247, DOI 10.1007/s00374-002-0467-3; Matsushima M, 2007, PLANT SOIL, V292, P243, DOI 10.1007/s11104-007-9220-x; McGroddy ME, 2004, ECOSYSTEMS, V7, P172, DOI 10.1007/s10021-003-0208-y; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; MO JM, 1995, BIOTROPICA, V27, P290, DOI 10.2307/2388915; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Ostertag R, 2003, ECOSYSTEMS, V6, P261, DOI 10.1007/PL00021512; Peng SL, 1993, J TROPICAL SUBTROPIC, V2, P34; PONGE JF, 1993, EUR J SOIL BIOL, V29, P141; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Ruan HH, 2005, PEDOBIOLOGIA, V49, P529, DOI 10.1016/j.pedobi.2005.08.001; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Villalobos-Vega R, 2011, PLANT SOIL, V346, P385, DOI 10.1007/s11104-011-0860-5; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Zhang D.Q., 2000, ACTA ECOL SIN, V20, P938; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9	54	20	20	9	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99018	10.1371/journal.pone.0099018	http://dx.doi.org/10.1371/journal.pone.0099018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901698	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400087
J	Cinkova, I; Policht, R				Cinkova, Ivana; Policht, Richard			Contact Calls of the Northern and Southern White Rhinoceros Allow for Individual and Species Identification	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-COTTONI; CAPTIVE SOUTHERN; VOCAL REPERTOIRE; RECOGNITION; COMMUNICATION; VOCALIZATIONS; IDENTITY; SEX; CONSPECIFICS; INFORMATION	Inter-individual relationships particularly in socially living mammals often require a well-developed communication system. Vocal and olfactory signals are the most important for the communication of rhinos, however, their vocal communication has been investigated to a very limited extent so far. White rhinos have the most developed social system out of all the rhinoceros species and vocal signals might therefore play an important role in their social interactions. We recorded repetitive contact pant calls from six captive northern white rhinos (Ceratotherium cottoni) and 14 captive and free-ranging southern white rhinos (Ceratotherium simum) and examined if they transmit information about individual identity, species, social context and age class. Discriminant analyses revealed that a high percentage of the pant calls of both species could be classified to a correct individual. We calculated signature information capacity of pant calls recorded from adult animals in isolation at 3.19 bits for the northern white rhinos and at 3.15 bits for the southern white rhinos, which can potentially allow for a vocal discrimination of nine individuals of both species. We found that pant calls varied by species. Northern white rhinos had longer calls and also differed from the southern white rhinos in several frequency parameters of their calls. We also analysed the pant calls of southern white rhinos for the differences between the age classes and between social contexts in which they were recorded. Our results show that pant calls carry information about individual, species, age class and context. The ability to recognize this information would allow rhinos, in addition to olfactory cues, to communicate with highly increased accuracy. A better understanding of communication of white rhinos has potential practical use in their management and conservation particularly because of the low breeding success of white rhinos in captivity.	[Cinkova, Ivana] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Cinkova, Ivana] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic; [Policht, Richard] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Policht, Richard] Czech Univ Life Sci Prague, Dept Game Management & Wildlife Biol, Fac Forestry & Wood Sci, Prague, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Cinkova, I (corresponding author), Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic.	ivanacinkova@centrum.cz	Policht, Richard/H-3039-2015; Cinkova, Ivana/L-5582-2019	Policht, Richard/0000-0002-8026-3964; Cinkova, Ivana/0000-0002-6653-0907	Internal Grant Agency of the Palacky University in Olomouc [PRF 2014-018]; Palacky University; Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague [20134363]; Internal Grant Agency of the Czech University of Life Sciences Prague CIGA [20115005 (51120/1313/3104)]	Internal Grant Agency of the Palacky University in Olomouc; Palacky University; Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague; Internal Grant Agency of the Czech University of Life Sciences Prague CIGA	The project was financially supported by the Internal Grant Agency of the Palacky University in Olomouc PRF 2014-018, by the mobility grants from the Palacky University to IC and by the Internal Grant Agency of the Faculty of Forestry and Wood Sciences, Czech University of Life Sciences Prague (no. 20134363). The participation of RP was supported by the Internal Grant Agency of the Czech University of Life Sciences Prague CIGA 20115005 (51120/1313/3104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; Aubin T, 2002, J EXP BIOL, V205, P3793; BASKIN Y, 1991, SCIENCE, V252, P1256, DOI 10.1126/science.252.5010.1256; BEECHER MD, 1982, AM ZOOL, V22, P477; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Blumstein DT, 2012, CURR ZOOL, V58, P765, DOI 10.1093/czoolo/58.5.765; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; Blumstein DT, 2004, ANIM BEHAV, V68, P1257, DOI 10.1016/j.anbehav.2003.12.024; Bouchet H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00390; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Budde C, 2003, MAMM BIOL, V68, P42, DOI 10.1078/1616-5047-00060; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Cinkova I, 2009, 7 INT C BEH PHYS GEN; Cinkova I, 2013, MAMM BIOL, V78, P50, DOI 10.1016/j.mambio.2012.09.007; COSENS SE, 1984, BEHAV ECOL SOCIOBIOL, V15, P161, DOI 10.1007/BF00292970; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; EMSLIE R, 2011, IUCN RED LIST THREAT; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fischer J, 2004, ANIM BEHAV, V67, P655, DOI 10.1016/j.anbehav.2003.08.006; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Goddard J., 1967, East African Wildlife Journal, V5, P133; Groves CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009703; Hammerschmidt K, 1998, PRIMATES, V39, P231, DOI 10.1007/BF02557735; Heller E., 1913, SMITHSONIAN MISCELLA, V61, P1; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2005, THERIOGENOLOGY, V63, P219, DOI 10.1016/j.theriogenology.2004.04.007; Hillman-Smith K, 1987, PACHYDERM, V9, P19; Hillman-Smith K, 1982, WWF YB, V1982, P273; Illmann G, 2002, BEHAVIOUR, V139, P487, DOI 10.1163/15685390260135970; Insley SJ, 2012, J ACOUST SOC AM, V131, pEL35, DOI 10.1121/1.3665259; Knight M, 2011, PACHYDERM, P7; Kunes M, 2002, ACTA U PALACKI OLOMU, V39-40, P81; LAURIE A, 1982, J ZOOL, V196, P307; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Metrione LC, 2007, ZOO BIOL, V26, P487, DOI 10.1002/zoo.20143; Mikulica V., 1991, Zoologische Garten, V61, P365; Milliken T., 2012, S AFRICA VIET NAM RH; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith RN, 1973, THESIS WISCONSIN U M; Penny M, 1987, RHINOS ENDANGERED SP; Pienaar D. J., 1993, Koedoe, V36, P79; Pienaar D. J., 1992, Koedoe, V35, P1; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Policht R, 2011, AFR ZOOL, V46, P18, DOI 10.3377/004.046.0110; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Rookmaaker K, 2014, NILE RHINOCEROS SPEC; Rookmaaker K, 2011, PACHYDERM, P72; RUBENSTEIN DI, 1992, EVOL ECOL, V6, P254, DOI 10.1007/BF02214165; Ryan MJ, 2003, SPR HDB AUD, V16, P225; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Sebe F, 2010, ANIM BEHAV, V79, P1055, DOI 10.1016/j.anbehav.2010.01.021; Shrader AM, 2002, BEHAV ECOL SOCIOBIOL, V52, P255, DOI 10.1007/s00265-002-0506-y; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048907; Swaisgood Ronald R., 2004, P106; Swaisgood RR, 2006, BIOL CONSERV, V129, P468, DOI 10.1016/j.biocon.2005.11.015; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; VANGYSEGHEM R, 1984, Z SAUGETIERKD, V49, P348; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; von Muggenthaler E, 2003, ACOUST RES LETT ONL, V4, P83, DOI 10.1121/1.1588271; von Muggenthaler EK, 1993, INT RHIN C SAN DIEG; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	71	21	21	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98475	10.1371/journal.pone.0098475	http://dx.doi.org/10.1371/journal.pone.0098475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901244	Green Submitted, gold, Green Published			2022-12-25	WOS:000336841400034
J	Freires, ID; Murata, RM; Furletti, VF; Sartoratto, A; de Alencar, SM; Figueira, GM; Rodrigues, JAD; Duarte, MCT; Rosalen, PL				Freires, Irlan de Almeida; Murata, Ramiro Mendonca; Furletti, Vivian Fernandes; Sartoratto, Adilson; de Alencar, Severino Matias; Figueira, Glyn Mara; de Oliveira Rodrigues, Janaina Aparecida; Teixeira Duarte, Marta Cristina; Rosalen, Pedro Luiz			Coriandrum sativum L. (Coriander) Essential Oil: Antifungal Activity and Mode of Action on Candida spp., and Molecular Targets Affected in Human Whole-Genome Expression	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; ALBICANS; ASSAY; IDENTIFICATION; PHOSPHOLIPASE; EPIDEMIOLOGY; SURVEILLANCE; INHIBITORS; VIRULENCE	candidiasis is an opportunistic fungal infection of the oral cavity with increasingly worldwide prevalence and incidence Novel specifically-targeted strategies to manage this ailment have been proposed using essential oils CEO) known to have antifungal properties. In this study, we aim to investigate the antifungal activity and mode of action of the EO from Coriandrum sativurn L (coriander) leaves on Candida spp. In addition detected the molecular targets affected in who genorne expression in human cells. The EO phytochernical profile indicates monoterpenes and sesquiterpenes as components, which are likely to negatively impact the viability of yeast cells. There seems to be a synergistic activity of EO chemical compounds as their isolation into fractions led to a decreased antimicrobial effect. C. sativum EO may bind membrane ergosterol, increasing ionic permeability and causing membrane damage leading to cell death, but it does not on cell wall biosynthesis-related pathways. This mode of action is illustrated by photomicrographs showing disruption in caused by the EO at varied concentrations. The EO also inhibited Candida biofilm adherence to polystyrene substrate at low concentrations, and decreased the proteolytic activity of Candida albicans at mini inhibitory concentration. Finally, the EO and its selected active fraction had low cytotoxicity on human cells, mechanisms affecting gene expression in pathways involving chernokines and MAP-kinase (proliferation/apoptosis), as adhesion proteins. These findings highlight the potential antifungal activity of the EO from C. sativum leaves and suggest avenues for future translational toxicological research.	[Freires, Irlan de Almeida; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA; [Murata, Ramiro Mendonca] Univ So Calif, Ostrow Sch Dent, Div Biomed Sci, Los Angeles, CA USA; [Furletti, Vivian Fernandes; Sartoratto, Adilson; Figueira, Glyn Mara; Teixeira Duarte, Marta Cristina] Univ Estadual Campinas, Res Ctr Chem Biol & Agr, Campinas, SP, Brazil; [de Alencar, Severino Matias] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Agri Food Ind Food & Nutr, Piracicaba, SP, Brazil; [de Oliveira Rodrigues, Janaina Aparecida] Univ Sao Paulo, Sch Engn Sao Carlos, Postgrad Program Interunits Bioengn, Sao Carlos, SP, Brazil	Universidade Estadual de Campinas; University of Southern California; University of Southern California; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Murata, RM (corresponding author), Univ So Calif, Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA.	ramiro.murata@usc.edu; rosalen@fop.unicamp.br	Rosalen, Pedro Luiz/I-3718-2012; Alencar, Severino Matias/B-7743-2012; Sartoratto, Adilson/C-4349-2012; Duarte, Marta CT/L-1401-2014; Freires, Irlan/M-9214-2014; Figueira, Glyn/C-9605-2017; Murata, Ramiro M/P-9052-2014	Rosalen, Pedro Luiz/0000-0003-0812-4027; Alencar, Severino Matias/0000-0002-6637-7973; Sartoratto, Adilson/0000-0002-1763-3715; Freires, Irlan/0000-0002-1079-6941; Figueira, Glyn/0000-0002-0159-9735; Murata, Ramiro M/0000-0002-8478-6981; Duarte, Marta Cristina Teixeira/0000-0001-7604-629X	Sao Paulo Research Foundation (FAPESP, Brazil) [2011/14757-0, 2011/15984-0, 2014/09742-2]; National Council for Scientific and Technological Development (CNPq, Brazil) [308644/2011-5]; National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA) [5R00AT00650704]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R00AT006507] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this publication was supported by Sao Paulo Research Foundation (FAPESP, Brazil, grants #2011/14757-0, #2011/15984-0 and #2014/09742-2), National Council for Scientific and Technological Development (CNPq, Brazil, grant #308644/2011-5), and the National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (NIH, USA, award #5R00AT00650704). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; [Anonymous], 2002, M27A2 NAT COMM CLIN, VSecond; Asgarpanah J, 2012, AFR J PHARM PHARMACO, V6, P2340, DOI 10.5897/AJPP12.901; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Begnami AF, 2010, FOOD CHEM, V118, P74, DOI 10.1016/j.foodchem.2009.04.089; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bhuiyan MNI, 2009, J PHARM, V4, P150; Burdock GA, 2009, FOOD CHEM TOXICOL, V47, P22, DOI 10.1016/j.fct.2008.11.006; Cal K, 2006, PLANTA MED, V72, P311, DOI 10.1055/s-2005-916230; Choudhary V., 2012, J ACAD IND RES, V1, P215; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Galvao LCD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/751435; Delaquis PJ, 2002, INT J FOOD MICROBIOL, V74, P101, DOI 10.1016/S0168-1605(01)00734-6; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Drago L, 2000, INT J ANTIMICROB AG, V16, P545, DOI 10.1016/S0924-8579(00)00296-X; Escalante A, 2008, J NAT PROD, V71, P1720, DOI 10.1021/np070660i; Eyres G, 2005, J SEP SCI, V28, P1061, DOI 10.1002/jssc.200500012; FROST DJ, 1995, J ANTIBIOT, V48, P306, DOI 10.7164/antibiotics.48.306; Furletti VF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/985832; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Ghoreyshi E, 2008, PHARM SCI, V3, P1; Guba R, 2001, INT J AROMATHER, V11, P76, DOI DOI 10.1016/s0962-4562(01)80021-7; Harsha SN, 2014, J FOOD SCI TECH MYS, V51, P1533, DOI 10.1007/s13197-012-0648-5; Hasan F, 2009, MICROBES INFECT, V11, P753, DOI 10.1016/j.micinf.2009.04.018; Hofling JF, 2011, MYCOPATHOLOGIA, V172, P117, DOI 10.1007/s11046-011-9404-z; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kantarcioglu AS, 2002, MYCOSES, V45, P160, DOI 10.1046/j.1439-0507.2002.00727.x; Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186; Lima IO, 2013, J ESSENT OIL RES, V25, P138, DOI 10.1080/10412905.2012.754728; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Matasyoh JC, 2009, FOOD CHEM, V113, P526, DOI 10.1016/j.foodchem.2008.07.097; Messer SA, 2009, J CLIN MICROBIOL, V47, P1942, DOI 10.1128/JCM.02434-08; Muller C, 2013, STEROIDS, V78, P483, DOI 10.1016/j.steroids.2013.02.006; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ozbek H, 2006, EGE J MED, V45, P163; Pauli A, 2006, MED RES REV, V26, P223, DOI 10.1002/med.20050; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pierce CG, 2013, CURR OPIN PHARMACOL, V13, P726, DOI 10.1016/j.coph.2013.08.008; Potter TL, 1996, J AGR FOOD CHEM, V44, P1824, DOI 10.1021/jf950814c; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rane HS, 2014, J ANTIMICROB CHEMOTH, V69, P428, DOI 10.1093/jac/dkt398; Rodrigues JADO, 2007, HYBRIDOMA, V26, P201, DOI 10.1089/hyb.2007.007; Sahib NG, 2013, PHYTOTHER RES, V27, P1439, DOI 10.1002/ptr.4897; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; Siddiqui ZN, 2013, J SAUDI CHEM SOC, V17, P237, DOI 10.1016/j.jscs.2011.03.016; Silva F, 2011, PHYTOMEDICINE, V19, P42, DOI 10.1016/j.phymed.2011.06.033; Silva F, 2011, J MED MICROBIOL, V60, P1479, DOI 10.1099/jmm.0.034157-0; Skloot R, 2011, IMMORTAL LIFE HENRIE; Snigdha Chawla, 2013, Medicinal Plants - International Journal of Phytomedicines and Related Industries, V5, P59; Soares BV, 2012, MOLECULES, V17, P8439, DOI 10.3390/molecules17078439; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; Vermelho AB, 1996, MEM I OSWALDO CRUZ, V91, P755, DOI 10.1590/S0074-02761996000600020; Wachtler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036952	60	89	92	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99086	10.1371/journal.pone.0099086	http://dx.doi.org/10.1371/journal.pone.0099086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901768	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400094
J	Gudex, B; Johnson, D; Singh, K				Gudex, Boyd; Johnson, David; Singh, Kuljeet			Prenatal Maternal and Possible Transgenerational Epigenetic Effects on Milk Production	PLOS ONE			English	Article							INHERITANCE; CONCEPTION; DISEASE	This study investigated whether the prenatal maternal environment in dairy cattle influences the postnatal milking performance of the resulting daughters and grand-daughters. Linear mixed models were used to analyse whole season milk production from similar to 46000 Jersey and similar to 123000 Holstein Friesian cows in their 1st and 2nd lactations. Variation in the prenatal environment was associated with a small but significant (P<0.05) proportion of the total phenotypic variation (0.010 to 0.015) in all traits in Holstein Friesian cows and in the first lactation milk volume (0.011) and milk protein (0.011), and the second lactation milk fat (0.015) in the Jersey breed. This indicates that the prenatal environment does influence the adult performance of the subsequent daughter. Associations between daughter performance and dam and grand-dam traits indicative of their prenatal environment were also estimated. A one litre increase in the dam's herd test milk volume was associated with a 7.5 litre increase in the daughters' whole season milk yield and a 1% increase in either the dams' herd test milk fat or protein percentage was associated with a reduction in daughter whole season milk volume (-49.6 and -45.0 litres for dam fat and protein, respectively). Similar results between the grand-dam herd test traits ansd the daughters' whole season milk production were observed with a 1% increase in either grand-dam milk fat or protein percentage associated with a reduction in daughter whole season milk yield (-34.7 and -9.7 litres for fat and protein, respectively). This study revealed that the prenatal environment of the dam and the grand-dam can influence milk production in the subsequent daughters, though the effects are small. The similarity of the results between the dam daughter and the grand-dam daughter analyses suggests that the majority of the prenatal maternal effects are mediated by epigenetic mechanisms.	[Gudex, Boyd; Johnson, David] Livestock Improvement Corp, Hamilton, New Zealand; [Gudex, Boyd] Univ New England, Armidale, NSW, Australia; [Singh, Kuljeet] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand	Livestock Improvement Corporation; University of New England; AgResearch - New Zealand	Gudex, B (corresponding author), Livestock Improvement Corp, Hamilton, New Zealand.	bgudex@lic.co.nz			Ministry of Business, Innovation and Employment [C10X0702]	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was funded by the Ministry of Business, Innovation and Employment (www.mbie.govt.nz) grant number C10X0702. Livestock Improvement Corporation (www.lic.co.nz) supplied the data that was analysed and together with AgResearch Limited (www.agresearch.co.nz) approved the publication of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos G, 2007, J DAIRY SCI, V90, P3490, DOI 10.3168/jds.2006-809; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berry DP, 2008, J DAIRY SCI, V91, P329, DOI 10.3168/jds.2007-0438; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Erdman RA, 2009, J DAIRY SCI S1, V92, pi; Gilmour A. R., 2009, ASREML REFERENCE MAN; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Gonzalez-Recio O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051816; Gonzalez-Recio Oscar, 2012, Frontiers in Genetics, V2, P106, DOI 10.3389/fgene.2011.00106; Gudex B. W., 2012, Proceedings of the New Zealand Society of Animal Production, V72, P19; Johnson D. L., 1996, Proceedings of the New Zealand Society of Animal Production, V56, P16; Park CS, 2005, FASEB J, V19, P1586, DOI 10.1096/fj.05-3816hyp; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryce JE, 2006, J DAIRY SCI, V89, P4424, DOI 10.3168/jds.S0022-0302(06)72490-0; Roche JR, 2006, J DAIRY SCI, V89, P2119, DOI 10.3168/jds.S0022-0302(06)72282-2; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Singh K, 2010, J MAMMARY GLAND BIOL, V15, P101, DOI 10.1007/s10911-010-9164-2; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136	18	10	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98928	10.1371/journal.pone.0098928	http://dx.doi.org/10.1371/journal.pone.0098928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901792	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400074
J	Kalinski, T; Sel, S; Hutten, H; Ropke, M; Roessner, A; Nass, N				Kalinski, Thomas; Sel, Saadettin; Huetten, Heiko; Roepke, Martin; Roessner, Albert; Nass, Norbert			Curcumin Blocks Interleukin-1 Signaling in Chondrosarcoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ARTICULAR CHONDROCYTES; TUMOR INVASIVENESS; EXPRESSION; CANCER; CARTILAGE; IL-1; ANGIOGENESIS; INFLAMMATION; METASTASIS	Interleukin (IL)-1 signaling plays an important role in inflammatory processes, but also in malignant processes. The essential downstream event in IL-1 signaling is the activation of nuclear factor (NF)-kappa B, which leads to the expression of several genes that are involved in cell proliferation, invasion, angiogenesis and metastasis, among them VEGF-A. As microenvironment-derived IL-1 beta is required for invasion and angiogenesis in malignant tumors, also in chondrosarcomas, we investigated IL-1 beta-induced signal transduction and VEGF-A expression in C3842 and SW1353 chondrosarcoma cells. We additionally performed in vitro angiogenesis assays and NF-kappa B-related gene expression analyses. Curcumin is a substance which inhibits IL-1 signaling very early by preventing the recruitment of IL-1 receptor associated kinase (IRAK) to the IL-1 receptor. We demonstrate that IL-1 signaling and VEGF-A expression are blocked by Curcumin in chondrosarcoma cells. We further show that Curcumin blocks IL-1 beta-induced angiogenesis and NF-kappa B-related gene expression. We suppose that IL-1 blockade is an additional treatment option in chondrosarcoma, either by Curcumin, its derivatives or other IL-1 blocking agents.	[Kalinski, Thomas; Roessner, Albert; Nass, Norbert] Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany; [Sel, Saadettin] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Huetten, Heiko] Klinikum Braunschweig, Dept Hematol & Oncol, Braunschweig, Germany; [Roepke, Martin] Univ Magdeburg, Dept Orthoped, D-39106 Magdeburg, Germany	Otto von Guericke University; Ruprecht Karls University Heidelberg; Otto von Guericke University	Kalinski, T (corresponding author), Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany.	kalinski@med.ovgu.de	Nass, Norbert/A-5592-2011	Nass, Norbert/0000-0003-2563-0386; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305				Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Apte RN, 2006, EUR J CANCER, V42, P751, DOI 10.1016/j.ejca.2006.01.010; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bresnihan B, 2003, RHEUMATOLOGY, V42, P22, DOI 10.1093/rheumatology/keg329; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Fan Z, 2007, AM J PATHOL, V171, P938, DOI 10.2353/ajpath.2007.061083; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gebauer M, 2005, OSTEOARTHR CARTILAGE, V13, P697, DOI 10.1016/j.joca.2005.04.004; GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507; Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002; Jurrmann N, 2005, J NUTR, V135, P1859, DOI 10.1093/jn/135.8.1859; Kalinski T, 2006, CANCER, V106, P2028, DOI 10.1002/cncr.21848; Kalinski T, 2005, VIRCHOWS ARCH, V446, P287, DOI 10.1007/s00428-004-1194-y; Kalinski T, 2007, HUM PATHOL, V38, P86, DOI 10.1016/j.humpath.2006.06.012; Kalinski T, 2009, PATHOL RES PRACT, V205, P339, DOI 10.1016/j.prp.2008.12.008; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Lavi G, 2007, J CONTROL RELEASE, V123, P123, DOI 10.1016/j.jconrel.2007.07.015; Lay E, 2012, J NUTR BIOCHEM, V23, P106, DOI 10.1016/j.jnutbio.2010.11.004; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Li TM, 2012, J CELL BIOCHEM, V113, P3353, DOI 10.1002/jcb.24211; Liu G, 2007, J IMMUNOL, V179, P4125, DOI 10.4049/jimmunol.179.6.4125; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Mosley CA, 2007, ADV EXP MED BIOL, V595, P77; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x; Roomi MW, 2014, INT J ONCOL, V44, P27, DOI 10.3892/ijo.2013.2159; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100	39	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99296	10.1371/journal.pone.0099296	http://dx.doi.org/10.1371/journal.pone.0099296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901233	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400118
J	Liu, Q; Liu, N; Zang, SL; Liu, H; Wang, P; Ji, CY; Sun, XL				Liu, Qiang; Liu, Na; Zang, Shaolei; Liu, Heng; Wang, Pin; Ji, Chunyan; Sun, Xiulian			Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; PROTEIN-KINASES; TRANSGENIC MICE; FAMILY KINASES; DNA-DAMAGE; CYCLE; PHOSPHORYLATION; EXPRESSION; SURVIVAL	Acute myeloid leukemia (AML), caused by abnormal proliferation and accumulation of hematopoietic progenitor cells, is one of the most common malignancies in adults. We reported here DYRK1A expression level was reduced in the bone marrow of adult AML patients, comparing to normal controls. Overexpression of DYRK1A inhibited the proliferation of AML cell lines by increasing the proportion of cells undergoing G0/G1 phase. We reasoned that the proliferative inhibition was due to downregulation of c-Myc by DYRK1A, through mediating its degradation. Moreover, overexpression of c-Myc markedly reversed AML cell growth inhibition induced by DYRK1A. DYRK1A also had significantly lower expression in relapsed/refractory AML patients, comparing to newly-diagnosed AML patients, which indicated the role of DYRK1A in chemoresistance of AML. Our study provided functional evidences for DYRK1A as a potential tumor suppressor in AML.	[Liu, Qiang; Liu, Heng; Wang, Pin; Sun, Xiulian] Shandong Univ, Qilu Hosp, Key Lab Otolaryngol, Jinan 250100, Peoples R China; [Liu, Na; Zang, Shaolei; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	jichunyan@sdu.edu.cn; xiulians@gmail.com			National Natural Science Foundation of China [81171030, 81370662, 81000223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81171030 (X. Sun), 81370662 (C. Ji), and 81000223 (S. Zang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Birger Y, 2012, J CLIN INVEST, V122, P807, DOI 10.1172/JCI62372; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; DAKSIS JI, 1994, ONCOGENE, V9, P3635; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee Y, 2009, J BIOL CHEM, V284, P33343, DOI 10.1074/jbc.M109.042234; Licht Jonathan D, 2005, Hematology Am Soc Hematol Educ Program, P137; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lu M, 2011, J BIOL CHEM, V286, P10755, DOI 10.1074/jbc.M110.174540; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oran B, 2012, HAEMATOL-HEMATOL J, V97, P1916, DOI 10.3324/haematol.2012.066100; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pulte D, 2013, HAEMATOLOGICA, V98, P693, DOI 10.3324/haematol.2012.063602; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reddy BY, 2009, P NATL ACAD SCI USA, V106, P4408, DOI 10.1073/pnas.0809130106; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Satge D, 1998, CANCER RES, V58, P448; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Strom DK, 1998, CELL GROWTH DIFFER, V9, P59; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Xie RL, 2003, J BIOL CHEM, V278, P26589, DOI 10.1074/jbc.M301491200; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; Zhang JR, 2012, ONCOL REP, V28, P1503, DOI 10.3892/or.2012.1943	46	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98853	10.1371/journal.pone.0098853	http://dx.doi.org/10.1371/journal.pone.0098853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901999	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400061
J	Lobo, L; Travieso, D; Barrientos, A; Jacobs, DM				Lobo, Lorena; Travieso, David; Barrientos, Antonio; Jacobs, David M.			Stepping on Obstacles with a Sensory Substitution Device on the Lower Leg: Practice without Vision Is More Beneficial than Practice with Vision	PLOS ONE			English	Article							AUDITORY SUBSTITUTION; SYSTEM; LOCALIZATION; PERCEPTION; ATTENTION; PERCEIVE; GUIDANCE	Practice is essential for an adapted use of sensory substitution devices. Understanding the learning process is therefore a fundamental issue in this field of research. This study presents a novel sensory substitution device worn on the lower leg and uses the device to study learning. The device includes 32 vibrotactile actuators that each vibrate as a function of the distance to the nearest surface in a particular direction. Participants wearing the device were asked to approach an object and to step on the object. Two 144-trial practice conditions were compared in a pretest-practice-posttest design. Participants in the first condition practiced with vibrotactile stimulation while blindfolded. Participants in the second condition practiced with vibrotactile stimulation along with normal vision. Performance was relatively successful, both types of practice led to improvements in performance, and practice without vision led to a larger reduction in the number of errors than practice with vision. These results indicate that distance-based sensory substitution is promising in addition to the more traditional light-intensity-based sensory substitution and that providing appropriate sensorimotor couplings is more important than applying the stimulation to highly sensitive body parts. The observed advantage of practice without vision over practice with vision is interpreted in terms of the guidance hypothesis of feedback and learning.	[Lobo, Lorena; Travieso, David; Jacobs, David M.] Univ Autonoma Madrid, Fac Psicol, Madrid, Spain; [Barrientos, Antonio] Univ Politecn Madrid, CSIC, Ctr Automat & Robot, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Politecnica de Madrid; CSIC-UPM - Centro de Automatica y Robotica	Jacobs, DM (corresponding author), Univ Autonoma Madrid, Fac Psicol, Madrid, Spain.	david.jacobs@uam.es	Lobo, Lorena/U-8397-2019; Barrientos, Antonio/B-4053-2013; Travieso, David/B-5321-2012; Jacobs, David M/C-5216-2011	Lobo, Lorena/0000-0002-2697-3244; Barrientos, Antonio/0000-0003-1691-3907; Travieso, David/0000-0002-5804-4212; Jacobs, David M/0000-0003-2954-5293	Spanish Ministry of Science and Innovation [FFI2009-13416-C02-02]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This material is based upon work supported by Grant FFI2009-13416-C02-02 of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzamarski R, 2010, ATTEN PERCEPT PSYCHO, V72, P721, DOI 10.3758/APP.72.3.721; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Auvray M, 2009, COGNITIVE SCI, V33, P1036, DOI 10.1111/j.1551-6709.2009.01040.x; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Cancar L, 2013, INT J ADV ROBOT SYST, V10, DOI 10.5772/56235; Cardin S, 2007, VISUAL COMPUT, V23, P109, DOI 10.1007/s00371-006-0032-4; Dakopoulos D, 2010, IEEE T SYST MAN CY C, V40, P25, DOI 10.1109/TSMCC.2009.2021255; Diaz A, 2011, STUDIES PERCEPTION A, P8; Diaz A, 2012, HUM MOVEMENT SCI, V31, P1571, DOI 10.1016/j.humov.2012.05.006; Durette B, 2008, WORKSH COMP VIS APPL, P1; EPSTEIN W, 1989, J EXP PSYCHOL HUMAN, V15, P28, DOI 10.1037/0096-1523.15.1.28; FLEURY M, 1995, BRAIN, V118, P1149, DOI 10.1093/brain/118.5.1149; Gibson JJ, 1979, ECOLOGICAL APPROACH; GUARNIER.G, 1974, PERCEPTION, V3, P101, DOI 10.1068/p030101; GUARNIERO G, 1977, J VISUAL IMPAIR BLIN, V71, P125; Huet M, 2011, J EXP PSYCHOL HUMAN, V37, P1841, DOI 10.1037/a0024386; Huet M, 2009, HUM MOVEMENT SCI, V28, P450, DOI 10.1016/j.humov.2008.12.004; Jacobs DM, 2009, ECOL PSYCHOL, V21, P245, DOI 10.1080/10407410903058302; Jacobs DM, 2001, J EXP PSYCHOL HUMAN, V27, P1019, DOI 10.1037/0096-1523.27.5.1019; JANSSON G, 1983, INT J NEUROSCI, V19, P37, DOI 10.3109/00207458309148644; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Kim JK, 2008, BRAIN RES, V1242, P263, DOI 10.1016/j.brainres.2008.06.038; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Michaels CF, 2008, J EXP PSYCHOL HUMAN, V34, P944, DOI 10.1037/0096-1523.34.4.944; Michaels CF, 2011, ATTEN PERCEPT PSYCHO, V73, P160, DOI 10.3758/s13414-010-0024-3; Nagel SK, 2005, J NEURAL ENG, V2, pR13, DOI 10.1088/1741-2560/2/4/R02; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Proulx MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001840; Rovira Katia, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P1, DOI 10.1109/DEVLRN.2010.5578875; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Segond H, 2005, PERCEPTION, V34, P1231, DOI 10.1068/p3409; Smeeton NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079811; Turvey MT, 1996, AM PSYCHOL, V51, P1134, DOI 10.1037/0003-066X.51.11.1134; van Erp JBF, 2007, THESIS UTRECHT U; WARREN DH, 1984, PERCEPTION, V13, P331, DOI 10.1068/p130331	37	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98801	10.1371/journal.pone.0098801	http://dx.doi.org/10.1371/journal.pone.0098801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4NF	24901843	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400053
J	Maffei, R; Bulgarelli, J; Fiorcari, S; Martinelli, S; Castelli, I; Valenti, V; Rossi, D; Bonacorsi, G; Zucchini, P; Potenza, L; Vallisa, D; Gattei, V; Del Poeta, G; Forconi, F; Gaidano, G; Narni, F; Luppi, M; Marasca, R				Maffei, Rossana; Bulgarelli, Jenny; Fiorcari, Stefania; Martinelli, Silvia; Castelli, Ilaria; Valenti, Vanessa; Rossi, Davide; Bonacorsi, Goretta; Zucchini, Patrizia; Potenza, Leonardo; Vallisa, Daniele; Gattei, Valter; Del Poeta, Giovanni; Forconi, Francesco; Gaidano, Gianluca; Narni, Franco; Luppi, Mario; Marasca, Roberto			Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ETA Receptor	PLOS ONE			English	Article							COLORECTAL-CANCER; INDUCED APOPTOSIS; PROGNOSTIC-FACTOR; SUBTYPE-B; PROLIFERATION; MICROENVIRONMENT; ACTIVATION; IDENTIFICATION; MACITENTAN; PACLITAXEL	The endothelin axis, comprising endothelins (ET-1, ET-2 and ET-3) and their receptors (ETAR and ETBR), has emerged as relevant player in tumor growth and metastasis. Here, we investigated the involvement of ET-1/ETAR axis in chronic lymphocytic leukemia (CLL). CLL cells expressed higher levels of ET-1 and ETA receptor as compared to normal B cells. ET-1 peptide stimulated phosphoinositide-3-kinase and mitogen-activated protein kinase signaling pathways, improved survival and promoted proliferation of leukemic cells throughout ETAR triggering. Moreover, the blockade of ETAR by the selective antagonist BQ-123 inhibited the survival advantage acquired by CLL cells in contact with endothelial layers. We also found that blocking ETAR via BQ-123 interferes with ERK phosphorylation and CLL pro-survival effect mediated by B-cell receptor (BCR) activation. The pro-apoptotic effect of phosphoinositide-3-kinase delta inhibitor idelalisib and mitogen-activated protein kinase inhibitor PD98059 was decreased by the addition of ET-1 peptide. Then, ET-1 also reduced the cytotoxic effect of fludarabine on CLL cells cultured alone or co-cultured on endothelial layers. ETAR blockade by BQ-123 inhibited the ET-1-mediated protection against drug-induced apoptosis. Lastly, higher plasma levels of big ET-1 were detected in patients (n = 151) with unfavourable prognostic factors and shorter time to first treatment. In conclusion, our data describe for the first time a role of ET-1/ETAR signaling in CLL pathobiology. ET-1 mediates survival, drug-resistance, and growth signals in CLL cells that can be blocked by ETAR inhibition.	[Maffei, Rossana; Bulgarelli, Jenny; Fiorcari, Stefania; Martinelli, Silvia; Castelli, Ilaria; Bonacorsi, Goretta; Zucchini, Patrizia; Potenza, Leonardo; Narni, Franco; Luppi, Mario; Marasca, Roberto] Univ Modena & Reggio Emilia, Div Hematol, Dept Med & Surg Sci, Modena, Italy; [Valenti, Vanessa; Vallisa, Daniele] Piacenza Hosp, Div Hematol, Piacenza, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, Novara, Italy; [Gattei, Valter] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy; [Del Poeta, Giovanni] S Eugenio Hosp, Div Hematol, Rome, Italy; [Del Poeta, Giovanni] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Forconi, Francesco] Univ Southampton, CRUK Clin Ctr, Canc Sci Unit, Southampton, Hants, England; [Forconi, Francesco] Univ Siena, Div Hematol, Dept Clin Med & Immunol Sci, I-53100 Siena, Italy	Universita di Modena e Reggio Emilia; Ospedale di Piacenza; University of Eastern Piedmont Amedeo Avogadro; IRCCS Aviano (CRO); Sant'Eugenio Hospital; University of Rome Tor Vergata; University of Southampton; University of Siena	Marasca, R (corresponding author), Univ Modena & Reggio Emilia, Div Hematol, Dept Med & Surg Sci, Modena, Italy.	roberto.marasca@unimore.it	Luppi, Mario/J-3668-2016; Maffei, Rossana/O-4836-2016; Bulgarelli, Jenny/AAB-6083-2021; Gaidano, Gianluca/AAW-2773-2021; Martinelli, Silvia/J-9080-2016; Forconi, Francesco/AAO-2694-2021; Fiorcari, Stefania/I-7240-2018; Gattei, Valter/AAB-5048-2020; Potenza, Leonardo/P-9579-2016; Marasca, Roberto/I-8072-2013	Luppi, Mario/0000-0002-0373-1154; Maffei, Rossana/0000-0002-3518-2006; Bulgarelli, Jenny/0000-0002-6551-0189; Gaidano, Gianluca/0000-0002-4681-0151; Martinelli, Silvia/0000-0002-2856-6327; Forconi, Francesco/0000-0002-2211-1831; Fiorcari, Stefania/0000-0002-8582-4951; Gattei, Valter/0000-0001-5933-9680; Potenza, Leonardo/0000-0002-2738-6105; Marasca, Roberto/0000-0002-6431-6878; DEL POETA, GIOVANNI/0000-0003-2443-1422; NARNI, Franco/0000-0003-3994-9101; Vallisa, Daniele/0000-0002-3130-1979	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy [AIRC IG14376-R.Mar.]; Programma di Ricerca di Interesse Nazionale (PRIN), Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro); Programma di Ricerca di Interesse Nazionale (PRIN), Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from: Associazione Italiana per la Ricerca sul Cancro (AIRC IG14376-R.Mar.), Milan, Italy; Programma di Ricerca di Interesse Nazionale (PRIN) 2008, Ministero dell'Universita e della Ricerca (MIUR), Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apollonio B, 2013, BLOOD, V121, P3879, DOI 10.1182/blood-2012-12-474718; Arun C, 2004, INT J BIOL MARKER, V19, P262, DOI 10.1177/172460080401900402; Arun C, 2004, INT J BIOL MARKER, V19, P32, DOI 10.1177/172460080401900104; Asham E, 2001, BRIT J CANCER, V85, P1759, DOI 10.1054/bjoc.2001.2193; Badoux X, 2011, HUM PATHOL, V42, P1989, DOI 10.1016/j.humpath.2011.02.027; Bagnato A, 1997, CANCER RES, V57, P1306; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bagnato A, 2001, AM J PATHOL, V158, P841, DOI 10.1016/S0002-9440(10)64032-1; Bagnato A, 2008, INT J BIOCHEM CELL B, V40, P1443, DOI 10.1016/j.biocel.2008.01.022; Barone F, 2002, FASEB J, V16, DOI 10.1096/fj.01-0749com; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Brown JR, 2014, BLOOD, V124; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2012, CURR OPIN ONCOL, V24, P643, DOI 10.1097/CCO.0b013e3283589950; Burger JA, 2011, HEMATOL-AM SOC HEMAT, P96, DOI 10.1182/asheducation-2011.1.96; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Cols M, 2012, J IMMUNOL, V188, P6071, DOI 10.4049/jimmunol.1102066; Damle RN, 2010, BEST PRACT RES CL HA, V23, P33, DOI 10.1016/j.beha.2010.02.001; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; EHRENREICH H, 1990, J EXP MED, V172, P1741, DOI 10.1084/jem.172.6.1741; Evans NJ, 2008, CAN J PHYSIOL PHARM, V86, P526, DOI 10.1139/Y08-050; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gambara G, 2008, J CELL PHYSIOL, V216, P396, DOI 10.1002/jcp.21407; Grant K, 2007, BRIT J SURG, V94, P106, DOI 10.1002/bjs.5536; Guruli G, 2004, BLOOD, V104, P2107, DOI 10.1182/blood-2003-10-3559; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamilton E, 2012, BRIT J HAEMATOL, V158, P589, DOI 10.1111/j.1365-2141.2012.09191.x; HEMSEN A, 1995, REGUL PEPTIDES, V55, P287, DOI 10.1016/0167-0115(94)00119-I; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Jiao WJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-334; Kalles V, 2012, TUMOR BIOL, V33, P1231, DOI 10.1007/s13277-012-0371-x; Kim SJ, 2012, TRANSL ONCOL, V5, P39, DOI 10.1593/tlo.11286; Kim SJ, 2011, NEOPLASIA, V13, P167, DOI 10.1593/neo.10806; KONDO M, 1992, BIOCHIM BIOPHYS ACTA, V1134, P242, DOI 10.1016/0167-4889(92)90182-B; KUSUHARA M, 1990, CANCER RES, V50, P3257; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Maffei R, 2013, HAEMATOLOGICA; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; Maffei R, 2010, BLOOD, V116, P584, DOI 10.1182/blood-2009-11-252494; Mai HQ, 2006, CANCER-AM CANCER SOC, V106, P1548, DOI 10.1002/cncr.21790; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Stevenson FK, 2004, BLOOD, V103, P4389, DOI 10.1182/blood-2003-12-4312; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF169, DOI 10.1152/ajprenal.00079.2009; Wang R, 2011, PHARMACOL RES, V63, P519, DOI 10.1016/j.phrs.2011.01.002; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Yamaguchi E, 2007, J GASTROEN HEPATOL, V22, P1134, DOI 10.1111/j.1440-1746.2006.04822.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang WM, 2008, LIFE SCI, V82, P764, DOI 10.1016/j.lfs.2008.01.008; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zwick C, 2013, BLOOD, V121, P4708, DOI 10.1182/blood-2012-08-447904	53	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98818	10.1371/journal.pone.0098818	http://dx.doi.org/10.1371/journal.pone.0098818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901342	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400056
J	Thierry, S; Tourterel, C; Le Fleche, P; Derzelle, S; Dekhil, N; Mendy, C; Colaneri, C; Vergnaud, G; Madani, N				Thierry, Simon; Tourterel, Christophe; Le Fleche, Philippe; Derzelle, Sylviane; Dekhil, Neira; Mendy, Christiane; Colaneri, Cecile; Vergnaud, Gilles; Madani, Nora			Genotyping of French Bacillus anthracis Strains Based on 31-Loci Multi Locus VNTR Analysis: Epidemiology, Marker Evaluation, and Update of the Internet Genotype Database	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; HIGH-RESOLUTION; IDENTIFICATION; EVOLUTION; OUTBREAK; FRANCE; MLVA	Background: Bacillus anthracis is known to have low genetic variability. In spite of this lack of diversity, multiple-locus variable-number tandem repeat (VNTR) analysis (MLVA) and single nucleotide polymorphisms (SNPs) including the canonical SNPs assay (canSNP) have proved to be highly effective to differentiate strains. Five different MLVA schemes based on a collection of 31 VNTR loci (MLVA8, MLVA15, MLVA20, MLVA25 and MLVA31) with increased resolving power have been described. Results: MLVA31 was applied to characterize the French National Reference Laboratory collection. The total collection of 130 strains is resolved in 35 genotypes. The 119 veterinary and environmental strains collection in France were resolved into 26 genotypes belonging to three canSNP lineages and four MLVA clonal complexes (CCs) with particular geographical clustering. A subset of seven loci (MLVA7) is proposed to constitute a first line assay. The loci are compatible with moderate resolution equipment such as agarose gel electrophoresis and show a good congruence value with MLVA31. The associated MLVA and SNP data was imported together with published genotyping data by taking advantage of major enhancements to the MLVAbank software and web site. Conclusions: The present report provides a wide coverage of the genetic diversity of naturally occurring B. anthracis strains in France as can be revealed by MLVA. The data obtained suggests that once such coverage is achieved, it becomes possible to devise optimized first-line MLVA assays comprising a sufficiently low number of loci to be typed either in one multiplex PCR or on agarose gels. Such a selection of seven loci is proposed here, and future similar investigations in additional countries will indicate to which extend the same selection can be used worldwide as a common minimum set. It is hoped that this approach will contribute to an efficient and low-cost routine surveillance of important pathogens for biosecurity such as B. anthracis.	[Thierry, Simon; Derzelle, Sylviane; Dekhil, Neira; Mendy, Christiane; Colaneri, Cecile; Madani, Nora] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonosis Unit, Maisons Alfort, France; [Tourterel, Christophe; Le Fleche, Philippe; Vergnaud, Gilles] Univ Paris Sud, Inst Genet & Microbiol, UMR 8621, Orsay, France; [Tourterel, Christophe; Le Fleche, Philippe; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Le Fleche, Philippe] DGA CBRN Def, Div Analyt Microbiol, Vert Le Petit, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Madani, N (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonosis Unit, Maisons Alfort, France.	nora.madani@anses.fr	Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Derzelle, Sylviane/0000-0002-2302-2291	DGA [REI2010 34 0003];  [ANR11ASTR007]	DGA; 	This work was made possible by ANR11ASTR007 grant Franthracis (SD, ST). CT is supported by DGA grant Brucella REI2010 34 0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaraki S, 2008, EURO SURVEILL, V13; Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Cheung DTL, 2005, J CLIN MICROBIOL, V43, P1992, DOI 10.1128/JCM.43.4.1992-1994.2005; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Drevet Christine, 2012, Methods Mol Biol, V905, P15, DOI 10.1007/978-1-61779-949-5_2; Durmaz R, 2012, EUR J CLIN MICROBIOL, V31, P2783, DOI 10.1007/s10096-012-1628-4; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fouet AS, 2002, J CLIN MICROBIOL, V40, P4732, DOI 10.1128/JCM.40.12.4732-4734.2002; Gierczynski R, 2004, FEMS MICROBIOL LETT, V239, P235, DOI 10.1016/j.femsle.2004.08.038; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Karlsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085417; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Larkeryd A, 2014, BIOINFORMATICS; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Leski TA, 2009, APPL ENVIRON MICROB, V75, P7163, DOI 10.1128/AEM.01069-09; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Madani N, 2010, B EPIDEMIOLOGIQUE HE; Maho A, 2006, J CLIN MICROBIOL, V44, P3422, DOI 10.1128/JCM.01269-06; Mayo L., 2010, Morbidity and Mortality Weekly Report, V59, P872; Merabishvili M, 2006, APPL ENVIRON MICROB, V72, P5631, DOI 10.1128/AEM.00440-06; O'Sullivan MVN, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-148; Okutani A, 2010, J VET MED SCI, V72, P93, DOI 10.1292/jvms.09-0213; Patra G, 1998, J CLIN MICROBIOL, V36, P3412, DOI 10.1128/JCM.36.11.3412-3414.1998; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pilo P, 2008, APPL ENVIRON MICROB, V74, P2928, DOI 10.1128/AEM.02574-07; Ryu C, 2005, APPL ENVIRON MICROB, V71, P4664, DOI 10.1128/AEM.71.8.4664-4671.2005; Smith KL, 2000, J CLIN MICROBIOL, V38, P3780, DOI 10.1128/JCM.38.10.3780-3784.2000; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Stratilo CW, 2012, APPL ENVIRON MICROB, V78, P6433, DOI 10.1128/AEM.01036-12; Stratilo CW, 2006, J CLIN MICROBIOL, V44, P777, DOI 10.1128/JCM.44.3.777-782.2006; Sue D, 2007, J CLIN MICROBIOL, V45, P1777, DOI 10.1128/JCM.02488-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Visca P, 2011, MICROBIOLOGY	46	29	33	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95131	10.1371/journal.pone.0095131	http://dx.doi.org/10.1371/journal.pone.0095131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901417	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400001
J	Weinsaft, JW; Kochav, JD; Kim, J; Gurevich, S; Volo, SC; Afroz, A; Petashnick, M; Kim, A; Devereux, RB; Okin, PM				Weinsaft, Jonathan W.; Kochav, Jonathan D.; Kim, Jiwon; Gurevich, Sergey; Volo, Samuel C.; Afroz, Anika; Petashnick, Maya; Kim, Agnes; Devereux, Richard B.; Okin, Peter M.			P Wave Area for Quantitative Electrocardiographic Assessment of Left Atrial Remodeling	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; CONGESTIVE-HEART-FAILURE; ECHOCARDIOGRAPHIC PREDICTORS; FIBRILLATION RECURRENCE; ENLARGEMENT; CRITERIA; STROKE; RISK; SIZE	Background: Left atrial (LA) dilation provides a substrate for mitral regurgitation (MR) and atrial arrhythmias. ECG can screen for LA dilation but standard approaches do not assess LA geometry as a continuum, as does non-invasive imaging. This study tested ECG-quantified P wave area as an index of LA geometry. Methods and Results: 342 patients with CAD underwent ECG and CMR within 7 (0.1 +/- 1.4) days. LA area on CMR correlated best with P wave area in ECG lead V1 (r = 0.42, p < 0.001), with lesser correlations for P wave amplitude and duration. P wave area increased stepwise in relation to CMR-evidenced MR severity (p < 0.001), with similar results for MR on echocardiography (performed in 86% of patients). Pulmonary arterial (PA) pressure on echo was increased by 50% among patients in the highest (45 +/- 14 mmHg) vs. the lowest (31 +/- 9 mmHg) P wave area quartile of the population. In multivariate regression, CMR and echo-specific models demonstrated P wave area to be independently associated with LA size after controlling for MR, as well as echo-evidenced PA pressure. Clinical follow-up (mean 2.4 +/- 1.9 years) demonstrated ECG and CMR to yield similar results for stratification of arrhythmic risk, with a 2.6-fold increase in risk for atrial fibrillation/flutter among patients in the top P wave area quartile of the population (CI 1.1-5.9, p = 0.02), and a 3.2-fold increase among patients in the top LA area quartile (CI 1.4-7.0, p = 0.005). Conclusions: ECG-quantified P wave area provides an index of LA remodeling that parallels CMR-evidenced LA chamber geometry, and provides similar predictive value for stratification of atrial arrhythmic risk.	[Weinsaft, Jonathan W.; Kochav, Jonathan D.; Kim, Jiwon; Gurevich, Sergey; Volo, Samuel C.; Afroz, Anika; Petashnick, Maya; Kim, Agnes; Devereux, Richard B.; Okin, Peter M.] Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY 10021 USA; [Weinsaft, Jonathan W.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Weinsaft, Jonathan W.; Kim, Jiwon] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Kochav, Jonathan D.] Duke Univ, Sch Med, Durham, NC USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Duke University	Weinsaft, JW (corresponding author), Weill Cornell Med Coll, Dept Med, Greenberg Cardiol Div, New York, NY 10021 USA.	jww2001@med.cornell.edu	Kim, Agnes/ABD-2784-2020		United States National Institutes of Health [K23 HL102249-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102249] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was conducted with salary support as provided by the United States National Institutes of Health (grant number K23 HL102249-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; CHIRIFE R, 1975, BRIT HEART J, V37, P1281; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Heitner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040491; John B, 2008, EUR HEART J, V29, P2234, DOI 10.1093/eurheartj/ehn329; John B, 2010, J AM COLL CARDIOL, V55, P1217, DOI 10.1016/j.jacc.2009.10.046; Jones EC, 2001, AM J CARDIOL, V87, P298, DOI 10.1016/S0002-9149(00)01362-X; Kochav JD, 2013, AM J CARDIOL, V112, P174, DOI 10.1016/j.amjcard.2013.03.013; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauren A, 2013, J CARDIOVASCULAR MAG, V2013; Lewis T, 1911, Proc R Soc Med, V4, P81; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Magnani JW, 2011, AM J CARDIOL, V107, P917, DOI 10.1016/j.amjcard.2010.10.075; Maunganidze F, 2013, J HYPERTENS, V31, P377, DOI 10.1097/HJH.0b013e32835b8daa; MILLER DH, 1983, J ELECTROCARDIOL, V16, P15, DOI 10.1016/S0022-0736(83)80154-X; MORRIS JJ, 1964, CIRCULATION, V29, P242, DOI 10.1161/01.CIR.29.2.242; MUNUSWAMY K, 1984, AM J CARDIOL, V53, P829, DOI 10.1016/0002-9149(84)90413-2; Nasir JM, 2012, J ELECTROCARDIOL, V45, P646, DOI 10.1016/j.jelectrocard.2012.07.022; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Okin PM, 1998, HYPERTENSION, V31, P937, DOI 10.1161/01.HYP.31.4.937; Olshansky B, 2005, J AM COLL CARDIOL, V45, P2026, DOI 10.1016/j.jacc.2005.03.020; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P1000, DOI 10.1016/j.hrthm.2009.03.050; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; TERMINI BA, 1975, SOUTHERN MED J, V68, P161, DOI 10.1097/00007611-197502000-00010; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Tsao CW, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-7; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; WAGGONER AD, 1976, CIRCULATION, V54, P553, DOI 10.1161/01.CIR.54.4.553; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	34	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99178	10.1371/journal.pone.0099178	http://dx.doi.org/10.1371/journal.pone.0099178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901435	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400106
J	Xiao, QH; Cui, YY				Xiao, Qinghuan; Cui, Yuanyuan			Acidic Amino Acids in the First Intracellular Loop Contribute to Voltage- and Calcium- Dependent Gating of Anoctamin1/TMEM16A	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNELS; SMOOTH-MUSCLE-CELLS; FAMILY-MEMBERS; ION-BINDING; TMEM16A; PROTEIN; EXPRESSION; CURRENTS; ANOCTAMINS	Anoctamin1 (Ano1, or TMEM16A) is a Ca2+-activated chloride channel that is gated by both voltage and Ca2+. We have previously identified that the first intracellular loop that contains a high density of acidic residues mediates voltage-and calcium-dependent gating of Ano1. Mutation of the four consecutive glutamates (444EEEE447) inhibits the voltage-dependent activation of Ano1, whereas deletion of these residues decreases apparent Ca2+ sensitivity. In the present study, we further found that deletion of (444)EEEEEAVKD(452) produced a more than 40-fold decrease in the apparent Ca2+ sensitivity with altered activation kinetics. We then systematically mutated each acidic residue into alanine, and analyzed the voltage-and calcium dependent activation of each mutation. Activation kinetics of wild type Ano1 consisted of a fast component (tau(fast)) that represented voltage-dependent mode, and a slow component (tau(slow)) that reflected the Ca2+-dependent modal gating. E444A, E445A, E446A, E447A, E448A, and E457A mutations showed a decrease in the tau(fast), significantly inhibited voltage-dependent activation of Ano1 in the absence of Ca2+, and greatly shifted the G-V curve to the right, suggesting that these glutamates are involved in voltage-gating of Ano1. Furthermore, D452A, E464A, E470A, and E475A mutations that did not alter voltage-dependent activation of the channel, significantly decreased Ca2+ dependence of G-V curve, exhibited an increase in the tau(slow), and produced a 2-3 fold decrease in the apparent Ca2+ sensitivity, suggesting that these acidic residues are involved in Ca2+-dependent gating of the channel. Our data show that acidic residues in the first intracellular loop are the important structural determinant that couples the voltage and calcium dependent gating of Ano1.	[Xiao, Qinghuan] China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang, Peoples R China; [Cui, Yuanyuan] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	China Medical University; Emory University	Xiao, QH (corresponding author), China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang, Peoples R China.	qinghuanxiao@gmail.com	Xiao, Qinghuan/L-1114-2019		American Heart Association; National Natural Science Foundation of China [31371145]; NATIONAL EYE INSTITUTE [R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by an American Heart Association postdoctoral fellowship, and a grant from the National Natural Science Foundation of China (No. 31371145) to QX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Ferrera L, 2011, BBA-BIOMEMBRANES, V1808, P2214, DOI 10.1016/j.bbamem.2011.05.017; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jaiswal JK, 2001, J BIOSCIENCES, V26, P357, DOI 10.1007/BF02703745; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Thomas-Gatewood C, 2011, AM J PHYSIOL-HEART C, V301, pH1819, DOI 10.1152/ajpheart.00404.2011; Tian YM, 2011, FASEB J, V25, P1058, DOI 10.1096/fj.10-166884; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440	42	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99376	10.1371/journal.pone.0099376	http://dx.doi.org/10.1371/journal.pone.0099376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901998	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400124
J	Zhong, MG; Zheng, K; Chen, MY; Xiang, YF; Jin, FJ; Ma, KQ; Qiu, XX; Wang, QL; Peng, T; Kitazato, K; Wang, YF				Zhong, Meigong; Zheng, Kai; Chen, Maoyun; Xiang, Yangfei; Jin, Fujun; Ma, Kaiqi; Qiu, Xianxiu; Wang, Qiaoli; Peng, Tao; Kitazato, Kaio; Wang, Yifei			Heat-Shock Protein 90 Promotes Nuclear Transport of Herpes Simplex Virus 1 Capsid Protein by Interacting with Acetylated Tubulin	PLOS ONE			English	Article							CELLULAR CHAPERONE; VIRAL TRANSPORT; HSP90; LOCALIZATION; REORGANIZATION; IDENTIFICATION; STABILIZATION; REPLICATION; ACTIVATION; BINDING	Although it is known that inhibitors of heat shock protein 90 (Hsp90) can inhibit herpes simplex virus type 1 (HSV-1) infection, the role of Hsp90 in HSV-1 entry and the antiviral mechanisms of Hsp90 inhibitors remain unclear. In this study, we found that Hsp90 inhibitors have potent antiviral activity against standard or drug-resistant HSV-1 strains and viral gene and protein synthesis are inhibited in an early phase. More detailed studies demonstrated that Hsp90 is upregulated by virus entry and it interacts with virus. Hsp90 knockdown by siRNA or treatment with Hsp90 inhibitors significantly inhibited the nuclear transport of viral capsid protein (ICP5) at the early stage of HSV-1 infection. In contrast, overexpression of Hsp90 restored the nuclear transport that was prevented by the Hsp90 inhibitors, suggesting that Hsp90 is required for nuclear transport of viral capsid protein. Furthermore, HSV-1 infection enhanced acetylation of alpha-tubulin and Hsp90 interacted with the acetylated alpha-tubulin, which is suppressed by Hsp90 inhibition. These results demonstrate that Hsp90, by interacting with acetylated alpha-tubulin, plays a crucial role in viral capsid protein nuclear transport and may provide novel insight into the role of Hsp90 in HSV-1 infection and offer a promising strategy to overcome drug-resistance.	[Zhong, Meigong; Zheng, Kai; Chen, Maoyun; Xiang, Yangfei; Jin, Fujun; Ma, Kaiqi; Qiu, Xianxiu; Wang, Qiaoli; Wang, Yifei] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Zhong, Meigong; Chen, Maoyun; Jin, Fujun; Qiu, Xianxiu] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Peng, Tao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Kitazato, Kaio] Nagasaki Univ, Dept Mol Microbiol & Immunol, Div Mol Pharmacol Infect Agents, Grad Sch Biomed Sci, Nagasaki 852, Japan	Jinan University; Jinan University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Nagasaki University	Peng, T (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	peng_tao@gibh.ac.cn; kkholi@nagasaki-u.ac.jp; twang-yf@163.com	Qiu, Xianxiu/AAN-1006-2020; Zheng, Kai/AAT-8994-2021	Zheng, Kai/0000-0001-9275-1239; Jin, Fujun/0000-0002-7314-0085; Peng, Tao/0000-0001-5260-7128	Twelfth Five-Year National Science and Technology Support Program [2012BAI29B06]; National Natural Science Foundation of China [81274170]; Foundation for High-level Talents in Higher Education of Guangdong, China [79]	Twelfth Five-Year National Science and Technology Support Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for High-level Talents in Higher Education of Guangdong, China	This work was supported by the Twelfth Five-Year National Science and Technology Support Program (2012BAI29B06), the National Natural Science Foundation of China (81274170, http://www.nsfc.gov.cn/), and the Foundation for High-level Talents in Higher Education of Guangdong, China ([2010]NO.79). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; Cheng HY, 2002, ANTIVIR RES, V55, P447, DOI 10.1016/S0166-3542(02)00077-3; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Crevel G, 2001, J CELL SCI, V114, P2015; De Regge N, 2006, J CELL BIOL, V174, P267, DOI 10.1083/jcb.200510156; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Geller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056762; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; Hino M, 2000, BIOCHEM BIOPH RES CO, V271, P164, DOI 10.1006/bbrc.2000.2553; Huang KH, 2009, J MED CHEM, V52, P4288, DOI 10.1021/jm900230j; Husain M, 2011, FEBS LETT, V585, P128, DOI 10.1016/j.febslet.2010.11.023; Jaeger V, 2010, J GEN VIROL, V91, P2152, DOI 10.1099/vir.0.021055-0; Ju HQ, 2011, BIOORG MED CHEM LETT, V21, P1675, DOI 10.1016/j.bmcl.2011.01.098; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krtkova J, 2012, J PLANT PHYSIOL, V169, P1329, DOI 10.1016/j.jplph.2012.06.010; Lamberti C, 1998, J VIROL, V72, P2463, DOI 10.1128/JVI.72.3.2463-2473.1998; Li YH, 2004, ANTIMICROB AGENTS CH, V48, P867, DOI 10.1128/AAC.48.3.867-872.2004; Makhnevych T, 2012, BBA-MOL CELL RES, V1823, P674, DOI 10.1016/j.bbamcr.2011.09.001; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Pei Y, 2011, ANTIVIR RES, V89, P98, DOI 10.1016/j.antiviral.2010.11.012; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reynolds AE, 2002, J VIROL, V76, P8939, DOI 10.1128/JVI.76.17.8939-8952.2002; SANCHEZ C, 1994, ARCH BIOCHEM BIOPHYS, V310, P428, DOI 10.1006/abbi.1994.1188; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Wang Y, 2011, J CLIN VIROL, V52, P107, DOI 10.1016/j.jcv.2011.06.009; Weller SK, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P1; Xiang YF, 2012, BIOORG MED CHEM LETT, V22, P4703, DOI 10.1016/j.bmcl.2012.05.079; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Zheng K, 2014, MBIO, V5, DOI [10.1128/mBio.00942-13, 10.1128/mBio.00958-13]	46	31	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99425	10.1371/journal.pone.0099425	http://dx.doi.org/10.1371/journal.pone.0099425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901434	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400127
J	Carle, T; Yamawaki, Y; Watanabe, H; Yokohari, F				Carle, Thomas; Yamawaki, Yoshifumi; Watanabe, Hidehiro; Yokohari, Fumio			Antennal Development in the Praying Mantis (Tenodera aridifolia) Highlights Multitudinous Processes in Hemimetabolous Insect Species	PLOS ONE			English	Article							SEX ATTRACTANT SPECIFICITY; SENSE-ORGANS; POSTEMBRYONIC DEVELOPMENT; PERIPLANETA-AMERICANA; GENUS PERIPLANETA; JUVENILE-HORMONE; MATE LOCATION; DIMORPHISM; MORPHOLOGY; DROSOPHILA	Insects possess antennae equipped with a large number of segments (flagellomeres) on which sensory organs (sensilla) are located. Hemimetabolous insects grow by molting until they reach adulthood. In these species, the sensory structures develop and mature during each stage of development; new flagellomeres are generated at each molt elongating the antennae, and new sensilla appear. The praying mantis (Tenodera aridifolia) is a hemimetabolous insect with 7 different instars before it reaches adulthood. Because their antennae are provided with an atypical sensillar distribution, we previously suggested that their antennae develop with a different mechanism to other hemimetaboulous insect species. In the present study, we measured the number, length and width of flagellomeres along the antennae in nymph and adult mantis Tenodera aridifolia. For this study, we developed a new and innovative methodology to reconstruct the antennal development based on the length of flagellomeres. We observed and confirmed that the antennae of mantises develop with the addition of new segments at two distinct sites. In addition, we constructed a complete database of the features of the flagellum for each stage of development. From our data, we found that sexual dimorphism appears from the 6 instar (larger number and wider flagellomeres in males) in accordance with the appearance of their genital apparatus. The antennal sexual dimorphism completes at adulthood with longer flagellomeres and the emergence of a huge number of grooved peg sensilla in males during the last molting, which suggests once again their function as sex-pheromone receptive sensilla.	[Carle, Thomas; Watanabe, Hidehiro; Yokohari, Fumio] Fukuoka Univ, Fac Sci, Div Biol, Dept Earth Syst Sci, Fukuoka 81401, Japan; [Yamawaki, Yoshifumi] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Fukuoka University; Kyushu University	Carle, T (corresponding author), Fukuoka Univ, Fac Sci, Div Biol, Dept Earth Syst Sci, Fukuoka 81401, Japan.	th.carle@gmail.com			Fyssen Foundation; Japan Society for the Promotion of Science [PE12038]; Mishima Kaiun Memorial Foundation	Fyssen Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This work was supported by a postdoctoral fellowship from the Fyssen Foundation and the Japan Society for the Promotion of Science (PE12038) (TC), as well as a grant from the Mishima Kaiun Memorial Foundation. Fyssen foundation: http://www. fondationfyssen. fr/Japan Society for the Promotion of Science: http://www. jsps. go. jp/Kaiun Memorial Foundation: http://www. mishima-kaiun. or. jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LE, 2012, AUST J ENTOMOL, V51, P133, DOI 10.1111/j.1440-6055.2011.00843.x; Brown V.K., 1975, International J Insect Morph Embryol, V4, P49, DOI 10.1016/0020-7322(75)90005-7; Campbell FL, 1969, ANN ENTOMOLOGICAL SO, V63, P81; Carle T, 2014, ARTHROPOD STRUCT DEV, V43, P103, DOI 10.1016/j.asd.2013.10.005; Chapman RF, 2002, J MORPHOL, V254, P186, DOI 10.1002/jmor.10026; Darwin C., 1860, ORIGIN SPECIES MEANS; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; De Loof A, 2013, GEN COMP ENDOCR, V188, P35, DOI 10.1016/j.ygcen.2013.02.004; FINLAYSON LH, 1956, Q J MICROSC SCI, V97, P215; Hansson B.S., 1999, INSECT OLFACTION; Hockman D, 2009, ARTHROPOD STRUCT DEV, V38, P125, DOI 10.1016/j.asd.2008.08.001; Holwell GI, 2007, BIOL J LINN SOC, V91, P307, DOI 10.1111/j.1095-8312.2007.00788.x; HUSTERT R, 1986, CELL TISSUE RES, V245, P615; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kristensen N.P., 2003, LEPIDOPTERA MOTHS BU; Lelito JP, 2008, BEHAV ECOL SOCIOBIOL, V63, P313, DOI 10.1007/s00265-008-0663-8; Loudon C, 2009, ENCY INSECTS; MORRIS MR, 1992, COPEIA, P980, DOI 10.2307/1446627; PARTRIDGE L, 1983, ANIM BEHAV, V31, P871, DOI 10.1016/S0003-3472(83)80242-5; Prete F.R., 2004, COMPLEX WORLDS SIMPL; PRETE FR, 1992, BRAIN BEHAV EVOLUT, V39, P124, DOI 10.1159/000114110; RILLING SUSAN, 1959, BEHAVIOUR, V14, P164, DOI 10.1163/156853959X00063; Saito K, 1972, JPN J MED ENTMOL ZOO, V23, P181; Monteys VSI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029282; SCHAFER R, 1976, J MORPHOL, V149, P139, DOI 10.1002/jmor.1051490202; SCHAFER R, 1973, J COMP NEUROL, V149, P335, DOI 10.1002/cne.901490304; SCHAFER R, 1977, J EXP ZOOL, V199, P189, DOI 10.1002/jez.1401990204; SCHAFER R, 1973, J EXP ZOOL, V183, P353, DOI 10.1002/jez.1401830309; SCHALLER D, 1978, CELL TISSUE RES, V191, P121, DOI 10.1007/BF00223221; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLIFER EH, 1968, J MORPHOL, V124, P105, DOI 10.1002/jmor.1051240107; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Yamawaki Y, 1998, J ETHOL, V16, P23, DOI 10.1007/BF02896350; Yamawaki Y, 2003, ZOOL SCI, V20, P819, DOI 10.2108/zsj.20.819; Yamawaki Yoshifumi, 2006, P147	37	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98324	10.1371/journal.pone.0098324	http://dx.doi.org/10.1371/journal.pone.0098324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896610	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700031
J	Casique-Arroyo, G; Martinez-Gallardo, N; de la Vara, LG; Delano-Frier, JP				Casique-Arroyo, Gabriela; Martinez-Gallardo, Norma; Gonzalez de la Vara, Luis; Delano-Frier, John P.			Betacyanin Biosynthetic Genes and Enzymes Are Differentially Induced by (a)biotic Stress in Amaranthus hypochondriacus	PLOS ONE			English	Article							GRAIN AMARANTH; CYCLO-DOPA; BACTERIAL INFILTRATION; BETALAIN BIOSYNTHESIS; SUSPENSION-CULTURES; POLYPHENOL OXIDASE; 4 OCLOCKS; RED; ACCUMULATION; EXPRESSION	An analysis of key genes and enzymes of the betacyanin biosynthetic pathway in Amaranthus hypochondriacus (Ah) was performed. Complete cDNA sequence of Ah genes coding for cyclo-DOPA 5-O glucosyltransferase (AhcDOPA5-GT), two 4, 5-DOPA-extradiol-dioxygenase isoforms (AhDODA-1 and AhDODA-2, respectively), and a betanidin 5-O-glucosyltransferase (AhB5-GT), plus the partial sequence of an orthologue of the cytochrome P-450 R gene (CYP76AD1) were obtained. With the exception AhDODA-2, which had a closer phylogenetic relationship to DODA-like genes in anthocyanin-synthesizing plants, all genes analyzed closely resembled those reported in related Caryophyllales species. The measurement of basal gene expression levels, in addition to the DOPA oxidase tyrosinase (DOT) activity, in different tissues of three Ah genotypes having contrasting pigmentation levels (green to red-purple) was determined. Additional analyses were performed in Ah plants subjected to salt and drought stress and to two different insect herbivory regimes. Basal pigmentation accumulation in leaves, stems and roots of betacyanic plants correlated with higher expression levels of AhDODA-1 and AhB5-GT, whereas DOT activity levels coincided with pigment accumulation in stems and roots and with the acyanic nature of green plants, respectively, but not with pigmentation in leaves. Although the abiotic stress treatments tested produced changes in pigment levels in different tissues, pigment accumulation was the highest in leaves and stems of drought stressed betacyanic plants, respectively. However, tissue pigment accumulation in stressed Ah plants did not always correlate with betacyanin biosynthetic gene expression levels and/or DOT activity. This effect was tissue- and genotype-dependent, and further suggested that other unexamined factors were influencing pigment content in stressed Ah. The results obtained from the insect herbivory assays, particularly in acyanic plants, also support the proposal that these genes could have functions other than betacyanin biosynthesis.	[Casique-Arroyo, Gabriela; Martinez-Gallardo, Norma; Gonzalez de la Vara, Luis; Delano-Frier, John P.] Ctr Invest & Estudios Avanzados Unidad Irapuato, Guanajuato, Mexico		Delano-Frier, JP (corresponding author), Ctr Invest & Estudios Avanzados Unidad Irapuato, Guanajuato, Mexico.	jdelano@ira.cinvestav.mx	Délano-Frier, John/B-5768-2015; Martínez Gallardo, Norma/B-6181-2015; de la Vara, Luis Gonzalez/J-9119-2012	Martínez Gallardo, Norma/0000-0001-5726-091X; de la Vara, Luis Gonzalez/0000-0003-0275-7202	European Commission; Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico) [203537]; AMARANTH: FUTURE-FOOD [032263]	European Commission(European CommissionEuropean Commission Joint Research Centre); Mexico Tierra de Amaranto A. C.; Deborah Presser-Velder Foundation; National Council for Science and Technology (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); AMARANTH: FUTURE-FOOD	This work was largely supported financially by the European Commission 6th Framework Programme, AMARANTH: FUTURE-FOOD, Contract No. 032263. Financial support by Mexico Tierra de Amaranto A. C. and The Deborah Presser-Velder Foundation is also acknowledged. GCA was supported by a postgraduate scholarship (code 203537) granted by The National Council for Science and Technology (CONACyT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huerta-Ocampo JA, 2011, CURR NUTR FOOD SCI, V7, P1, DOI 10.2174/157340111794941076; Huerta-Ocampo JA, 2009, INT J PLANT SCI, V170, P990, DOI 10.1086/605119; Bahramnejad B, 2010, PLANT SCI, V178, P147, DOI 10.1016/j.plantsci.2009.10.007; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner D. M., 2000, Plant Breeding Reviews, V19, P227, DOI 10.1002/9780470650172.ch7; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Cai YZ, 2001, J AGR FOOD CHEM, V49, P1971; Cai YZ, 1998, J AGR FOOD CHEM, V46, P2063, DOI 10.1021/jf9709966; Cao SF, 2012, FOOD CHEM, V134, P1715, DOI 10.1016/j.foodchem.2012.03.129; Chang-Quan W, 2007, PLANT SCI, V173, P487, DOI 10.1016/j.plantsei.2007.07.010; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Das SS, 2013, PLANT SCI, V211, P61, DOI 10.1016/j.plantsci.2013.07.003; Delano-Frier JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-363; Edreva A, 2005, AGR ECOSYST ENVIRON, V106, P135, DOI 10.1016/j.agee.2004.10.002; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; Gandia-Herrero F, 2004, J AGR FOOD CHEM, V52, P609, DOI 10.1021/jf034381m; Gandia-Herrero F, 2007, J AGR FOOD CHEM, V55, P1546, DOI 10.1021/jf062858z; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Georgiev VG, 2010, PLANT FOOD HUM NUTR, V65, P105, DOI 10.1007/s11130-010-0156-6; Gins MS, 2002, APPL BIOCHEM MICRO+, V38, P474, DOI 10.1023/A:1019980821313; Han XH, 2009, AFR J BIOTECHNOL, V8, P6735; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Hauptli H, 1977, P AM SEM; Hempel J, 1997, PHYTOCHEMISTRY, V44, P847, DOI 10.1016/S0031-9422(96)00633-4; HIRANO H, 1994, PHYSIOL PLANTARUM, V90, P239, DOI 10.1111/j.1399-3054.1994.tb00383.x; Huerta-Ocampo JA, 2011, PLANT BIOLOGY, V13, P472, DOI 10.1111/j.1438-8677.2010.00391.x; Ibdah M, 2002, PLANT CELL ENVIRON, V25, P1145, DOI 10.1046/j.1365-3040.2002.00895.x; Iwamoto K, 2001, PLANT J, V27, P275, DOI 10.1046/j.1365-313x.2001.01082.x; Johnson BL, 2002, AGRON J, V94, P1437, DOI 10.2134/agronj2002.1437; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Kujala T, 2001, Z NATURFORSCH C, V56, P343; KUMON K, 1990, PLANT CELL PHYSIOL, V31, P233; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Parra J, 2001, J AGR FOOD CHEM, V49, P4064, DOI 10.1021/jf0013555; Massey B, 2012, THESIS U QUEENSLAND; Moreno Diego A., 2008, Phytochemistry Reviews, V7, P261, DOI 10.1007/s11101-007-9084-y; Mosco A, 2012, REV MEX BIODIVERS, V83, P413; Mueller LA, 1997, PLANTA, V203, P260, DOI 10.1007/s004250050190; Myers R. L., 1996, Progress in new crops: Proceedings of the Third National Symposium Indianapolis, Indiana, 22-25 October, 1996., P207; Omami EN, 2006, NEW ZEAL J CROP HORT, V34, P11, DOI 10.1080/01140671.2006.9514382; Pavokovic D, 2011, FOOD TECHNOL BIOTECH, V49, P145; PIATTELL.M, 1969, PHYTOCHEMISTRY, V8, P731, DOI 10.1016/S0031-9422(00)85844-6; Piattelli M., 1966, ANN CHIM-ROME, V56, P1060; PIHA MI, 1995, TROP AGRIC, V72, P7; Putnam D. H, 1990, P NATL AM S 4 MINN M, P151; SAKUTA M, 1986, J PLANT PHYSIOL, V125, P337, DOI 10.1016/S0176-1617(86)80155-9; Sasaki N, 2005, J PLANT RES, V118, P439, DOI 10.1007/s10265-005-0237-z; Sasaki N, 2005, PLANT CELL PHYSIOL, V46, P666, DOI 10.1093/pcp/pci064; Sasaki N, 2004, FEBS LETT, V568, P159, DOI 10.1016/j.febslet.2004.04.097; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; SCIUTO S, 1974, PHYTOCHEMISTRY, V13, P947, DOI 10.1016/S0031-9422(00)91427-4; Sepulveda-Jimenez G, 2005, J EXP BOT, V56, P605, DOI 10.1093/jxb/eri036; Sepulveda-Jimenez G, 2004, PHYSIOL MOL PLANT P, V64, P125, DOI 10.1016/j.pmpp.2004.08.003; Shao L, 2013, PAK J BOT, V45, P1905; Shao Ling, 2008, Plant Physiology Communications, V44, P923; Stagnari F, 2014, SCI HORTIC-AMSTERDAM, V165, P13, DOI 10.1016/j.scienta.2013.10.026; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Strack D, 2003, PHYTOCHEMISTRY, V62, P247, DOI 10.1016/S0031-9422(02)00564-2; Takahashi K, 2009, Z NATURFORSCH C, V64, P564; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venskutonis PR, 2013, COMPR REV FOOD SCI F, V12, P381, DOI 10.1111/1541-4337.12021; Wang CQ, 2007, J INTEGR PLANT BIOL, V49, P1378, DOI 10.1111/j.1744-7909.2007.00489.x; Wang CQ, 2007, PLANT SCI, V172, P1, DOI 10.1016/j.plantsci.2006.06.015; Wang Chang-Quan, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P195; Weber LE, 1990, AMARANTH GRAIN PRODU; WYLER H, 1984, HELV CHIM ACTA, V67, P1348, DOI 10.1002/hlca.19840670520; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125; Yuan JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S6; Zhao SZ, 2010, PLANT CELL TISS ORG, V102, P99, DOI 10.1007/s11240-010-9710-z	77	38	38	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99012	10.1371/journal.pone.0099012	http://dx.doi.org/10.1371/journal.pone.0099012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896616	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700107
J	Toh, TC; Ng, CSL; Peh, JWK; Ben Toh, K; Chou, LM				Toh, Tai Chong; Ng, Chin Soon Lionel; Peh, Jia Wei Kassler; Ben Toh, Kok; Chou, Loke Ming			Augmenting the Post-Transplantation Growth and Survivorship of Juvenile Scleractinian Corals via Nutritional Enhancement	PLOS ONE			English	Article							POCILLOPORA-DAMICORNIS; PORITES-COMPRESSA; REEF; RESTORATION; RECRUITS; SIZE; TRANSPLANTATION; HETEROTROPHY; ZOOPLANKTON; STRATEGIES	Size-dependant mortality influences the recolonization success of juvenile corals transplanted for reef restoration and assisting juvenile corals attain a refuge size would thus improve post-transplantation survivorship. To explore colony size augmentation strategies, recruits of the scleractinian coral Pocillopora damicornis were fed with live Artemia salina nauplii twice a week for 24 weeks in an ex situ coral nursery. Fed recruits grew significantly faster than unfed ones, with corals in the 3600, 1800, 600 and 0 (control) nauplii/L groups exhibiting volumetric growth rates of 10.65 +/- 1.46, 4.69 +/- 0.9, 3.64 +/- 0.55 and 1.18 +/- 0.37 mm(3)/week, respectively. Corals supplied with the highest density of nauplii increased their ecological volume by more than 74 times their initial size, achieving a mean final volume of 248.38 +/- 33.44 mm(3). The benefits of feeding were apparent even after transplantation to the reef. The corals in the 3600, 1800, 600 and 0 nauplii/L groups grew to final sizes of 4875 +/- 260 mm(3), 203 +/- 6627 mm(3), 1066 +/- 70 mm 3 and 512 +/- 116 mm(3), respectively. The fed corals had significantly higher survival rates than the unfed ones after transplantation (63%, 59%, 56% and 38% for the 3600, 1800, 600 and 0 nauplii/L treatments respectively). Additionally, cost-effectiveness analysis revealed that the costs per unit volumetric growth were drastically reduced with increasing feed densities. Corals fed with the highest density of nauplii were the most cost-effective (US$ 0.02/mm(3)), and were more than 12 times cheaper than the controls. This study demonstrated that nutrition enhancement can augment coral growth and post-transplantation survival, and is a biologically and economically viable option that can be used to supplement existing coral mariculture procedures and enhance reef restoration outcomes.	[Toh, Tai Chong; Ng, Chin Soon Lionel; Peh, Jia Wei Kassler; Ben Toh, Kok; Chou, Loke Ming] Natl Univ Singapore, Dept Biol Sci, Reef Ecol Lab, Singapore 117548, Singapore	National University of Singapore	Toh, TC (corresponding author), Natl Univ Singapore, Dept Biol Sci, Reef Ecol Lab, Singapore 117548, Singapore.	taichong.toh@gmail.com	Toh, Kok Ben/D-7294-2014; Chou, Loke/AAE-5266-2020; Ng, Lionel/AAF-5117-2020	Chou, Loke/0000-0001-6668-399X; Ng, Lionel/0000-0003-2700-3474; Toh, Kok Ben/0000-0003-1371-817X; Toh, Tai Chong/0000-0003-2961-4199	Wildlife Reserves Singapore Conservation Fund; National University of Singapore Research Scholarship; SingHaiyi Scholarship	Wildlife Reserves Singapore Conservation Fund; National University of Singapore Research Scholarship(National University of Singapore); SingHaiyi Scholarship	Funding for the research was provided by Wildlife Reserves Singapore Conservation Fund awarded to TCT. TCT was supported by the National University of Singapore Research Scholarship and the SingHaiyi Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Benijts F., 1976, P 10 EUR S MAR BIOL, V1, P1; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Chou L., 2012, CONTRIBUTIONS MARI S, V5, P81; Chou LM, 1993, P 7 INT COR REEF S, P500; Cumbo VR, 2012, CORAL REEFS, V31, P1155, DOI 10.1007/s00338-012-0940-x; Dikou A, 2006, MAR POLLUT BULL, V52, P1340, DOI 10.1016/j.marpolbul.2006.02.011; Edwards AJ, 1998, MAR POLLUT BULL, V37, P474; Edwards AJ, 2010, REEF REHABILITATION; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; Forsman ZH, 2006, AQUACULTURE, V261, P89, DOI 10.1016/j.aquaculture.2006.06.040; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Guest J., 2010, REEF REHABILITATION, P73; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Hii YS, 2009, AQUACULT INT, V17, P363, DOI 10.1007/s10499-008-9208-4; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; Levy G, 2010, ECOL ENG, V36, P560, DOI 10.1016/j.ecoleng.2009.12.003; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; Nakamura R, 2011, MAR ECOL PROG SER, V436, P161, DOI 10.3354/meps09257; Ng C.S.L., 2012, CONTRIBUTIONS MARINE, P95; Omori M, 2008, CORAL REEFS, V27, P165, DOI 10.1007/s00338-007-0312-0; PANCER Z, 1995, BIOL BULL, V189, P106, DOI 10.2307/1542460; Petersen D, 2008, AQUACULTURE, V277, P174, DOI 10.1016/j.aquaculture.2008.02.034; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Rinkevich B, 1995, RESTOR ECOL, V3, P241, DOI 10.1111/j.1526-100X.1995.tb00091.x; RINKEVICH B, 1992, OIKOS, V63, P119, DOI 10.2307/3545520; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Shafir S, 2006, MAR BIOL, V149, P679, DOI 10.1007/s00227-005-0236-6; Shaish L, 2010, ECOL ENG, V36, P1424, DOI 10.1016/j.ecoleng.2010.06.022; Shearer TL, 2009, CORAL REEFS, V28, P727, DOI 10.1007/s00338-009-0520-x; SOROKIN YI, 1973, LIMNOL OCEANOGR, V18, P380, DOI 10.4319/lo.1973.18.3.0380; Toh TC, 2013, AQUACULTURE, V414, P288, DOI 10.1016/j.aquaculture.2013.08.025; Toh TC, 2013, MAR FRESHW BEHAV PHY, V46, P313, DOI 10.1080/10236244.2013.832890; Toh TC, 2013, MAR BIODIVERS, V43, P177, DOI 10.1007/s12526-013-0156-5; VANMOORSEL GWNM, 1985, MAR ECOL PROG SER, V24, P99, DOI 10.3354/meps024099; Veron J.E.N., 2000, CORALS WORLD, V1-3; Villanueva RD, 2012, MAR BIOL RES, V8, P877, DOI 10.1080/17451000.2012.682582; Wallace CC, 1985, MAR BIOL, V88, P21; WOOD R, 1993, PALAIOS, V8, P526, DOI 10.2307/3515030; Yap HT, 1998, J EXP MAR BIOL ECOL, V229, P69, DOI 10.1016/S0022-0981(98)00041-0	45	30	30	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98529	10.1371/journal.pone.0098529	http://dx.doi.org/10.1371/journal.pone.0098529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896085	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700049
J	Vallur, R; Kalbacher, H; Feil, R				Vallur, Raghavan; Kalbacher, Hubert; Feil, Robert			Catalytic Activity of cGMP-Dependent Protein Kinase Type I in Intact Cells Is Independent of N-Terminal Autophosphorylation	PLOS ONE			English	Article							BINDING-SITES; SMOOTH-MUSCLE; BOVINE LUNG; CYCLIC-GMP; ACTIVATION; PHOSPHORYLATION; ACID; MICE; IDENTIFICATION; SEQUENCE	Although cGMP-dependent protein kinase type I (cGKI) is an important mediator of cGMP signaling and upcoming drug target, its in vivo-biochemistry is not well understood. Many studies showed that purified cGKI autophosphorylates multiple sites at its N-terminus. Autophosphorylation might be involved in kinase activation, but it is unclear whether this happens also in intact cells. To study cGKI autophosphorylation in vitro and in vivo, we have generated phospho-specific antisera against major in vitro-autophosphorylation sites of the cGKI isoforms, cGKI alpha and cGKI beta. These antisera detected specifically and with high sensitivity phospho-cGKI alpha (Thr58), phospho-cGKI alpha (Thr84), or phospho-cGKI beta (Thr56/Ser63/Ser79). Using these antisera, we show that ATP-induced autophosphorylation of cGKI in purified preparations and cell extracts did neither require nor induce an enzyme conformation capable of substrate heterophosphorylation; it was even inhibited by pre-incubation with cGMP. Interestingly, phospho-cGKI species were not detectable in intact murine cells and tissues, both under basal conditions and after induction of cGKI catalytic activity. We conclude that N-terminal phosphorylation, although readily induced in vitro, is not required for the catalytic activity of cGKI alpha and cGKI beta in vivo. These results will also inform screening strategies to identify novel cGKI modulators.	[Vallur, Raghavan; Kalbacher, Hubert; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany; [Vallur, Raghavan] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Vallur, Raghavan] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Feil, R (corresponding author), Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany.	robert.feil@uni-tuebingen.de	Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841	Deutsche Forschungsgemeinschaft; Tubingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; DEJONGE HR, 1977, J BIOL CHEM, V252, P2780; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; HOFMANN F, 1983, FEBS LETT, V164, P350, DOI 10.1016/0014-5793(83)80315-9; Hou YL, 2003, J BIOL CHEM, V278, P16706, DOI 10.1074/jbc.M300045200; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; LINCOLN TM, 1978, J BIOL CHEM, V253, P6002; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; MONKEN CE, 1980, J BIOL CHEM, V255, P7067; Muller PM, 2012, FREE RADICAL BIO MED, V53, P1574, DOI 10.1016/j.freeradbiomed.2012.08.011; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Rasband W., 2006, IMAGEJ; Ruth P, 1997, J BIOL CHEM, V272, P10522; Samara P, 2013, J IMMUNOL METHODS, V395, P54, DOI 10.1016/j.jim.2013.06.011; Sellak H, 2013, CARDIOVASC RES, V97, P200, DOI 10.1093/cvr/cvs327; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Smith JK, 2000, J BIOL CHEM, V275, P154, DOI 10.1074/jbc.275.1.154; TAKIO K, 1983, J BIOL CHEM, V258, P5531; Thunemann M, 2013, CIRC RES, V113, P365, DOI 10.1161/CIRCRESAHA.113.301063; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Waraich RS, 2008, BIOCHEM BIOPH RES CO, V376, P26, DOI 10.1016/j.bbrc.2008.08.053; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98946	10.1371/journal.pone.0098946	http://dx.doi.org/10.1371/journal.pone.0098946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897423	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700097
J	Vogel, I; van de Looij-Jansen, PM; Mieloo, CL; Burdorf, A; de Waart, F				Vogel, Ineke; van de Looij-Jansen, Petra M.; Mieloo, Cathelijne L.; Burdorf, Alex; de Waart, Frouwkje			Risky Music Listening, Permanent Tinnitus and Depression, Anxiety, Thoughts about Suicide and Adverse General Health	PLOS ONE			English	Article							INDUCED HEARING-LOSS; NOISE EXPOSURE; MENTAL-HEALTH; MP3 PLAYERS; ADOLESCENTS; CHILDREN; CONSERVATION; DISCOTHEQUES; PREVENTION; PEOPLE	Objective: To estimate the extent to which exposure to music through earphones or headphones with MP3 players or at discotheques and pop/rock concerts exceeded current occupational safety standards for noise exposure, to examine the extent to which temporary and permanent hearing-related symptoms were reported, and to examine whether the experience of permanent symptoms was associated with adverse perceived general and mental health, symptoms of depression, and thoughts about suicide. Methods: A total of 943 students in Dutch inner-city senior-secondary vocational schools completed questionnaires about their sociodemographics, music listening behaviors and health. Multiple logistic regression analyses were used to examine associations. Results: About 60% exceeded safety standards for occupational noise exposure; about one third as a result of listening to MP3 players. About 10% of the participants experienced permanent hearing-related symptoms. Temporary hearing symptoms that occurred after using an MP3 player or going to a discotheque or pop/rock concert were associated with exposure to high-volume music. However, compared to participants not experiencing permanent hearing-related symptoms, those experiencing permanent symptoms were less often exposed to high volume music. Furthermore, they reported at least two times more often symptoms of depression, thoughts about suicide and adverse self-assessed general and mental health. Conclusions: Risky music-listening behaviors continue up to at least the age of 25 years. Permanent hearing-related symptoms are associated with people's health and wellbeing. Participants experiencing such symptoms appeared to have changed their behavior to be less risky. In order to induce behavior change before permanent and irreversible hearing-related symptoms occur, preventive measurements concerning hearing health are needed.	[Vogel, Ineke; Burdorf, Alex] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Vogel, Ineke; van de Looij-Jansen, Petra M.; Mieloo, Cathelijne L.; de Waart, Frouwkje] Municipal Publ Hlth Serv Rotterdam Area, Dept Youth Policy, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Vogel, I (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogel@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862				American Academy of Audiology, 2003, POS STAT PREV NOIS I; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Blasing L, 2010, INT J AUDIOL, V49, P518, DOI 10.3109/14992021003724996; Boorsma M, 2012, AM J GERIAT PSYCHIAT, V20, P932, DOI 10.1097/JGP.0b013e31825d08ac; BROOKHOUSER PE, 1994, PREV MED, V23, P665, DOI 10.1006/pmed.1994.1111; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Dreschler WA, 2007, 20071 NHS; European Parliament and Council, 2003, OFFICIAL J EUROP UNI; Fausti SA, 2005, J REHABIL RES DEV, V42, P45, DOI 10.1682/JRRD.2005.02.0039; Gopinath B, 2009, J AM GERIATR SOC, V57, P1306, DOI 10.1111/j.1532-5415.2009.02317.x; Hogan A, 2009, J AGING HEALTH, V21, P1098, DOI 10.1177/0898264309347821; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005; ISO, 1990, 19991990 ISO; Kelly MJ, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-10; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Portnuff CDF, 2006, SOUND OUTPUT LEVELS; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rasic D, 2013, DRUG ALCOHOL DEPEN, V129, P49, DOI 10.1016/j.drugalcdep.2012.09.009; Rawool V, 2011, NOISE HEALTH, V13, P356, DOI 10.4103/1463-1741.85508; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8; Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 2008, POT HLTH RISKS EXP N; Seniors Research Group, 1999, CONSEQUENCES UNTREAT; Serra MR, 2005, INT J AUDIOL, V44, P65, DOI 10.1080/14992020400030010; Shetye A, 2010, ARCH DIS CHILD, V95, P645, DOI 10.1136/adc.2009.168252; *STAT NETH, 2007, STATLINE; Strasser H, 1999, NOISE CONTROL ENG, V47, P187, DOI 10.3397/1.599303; Theunissen SCPM, 2014, JAMA PEDIATR, V168, P170, DOI 10.1001/jamapediatrics.2013.3974; VERNON JA, 1987, AM J OTOL, V8, P201; Vogel I, 2008, J PEDIATR-US, V152, P400, DOI 10.1016/j.jpeds.2007.07.009; Vogel I, 2012, PEDIATRICS, V129, P1097, DOI 10.1542/peds.2011-1948; Vogel I, 2011, HEALTH EDUC RES, V26, P254, DOI 10.1093/her/cyq091; Vogel I, 2010, HEALTH EDUC RES, V25, P737, DOI 10.1093/her/cyq018; Vogel I, 2010, AM J PUBLIC HEALTH, V100, P1095, DOI 10.2105/AJPH.2009.168690; Vogel I, 2009, INT J AUDIOL, V48, P531, DOI 10.1080/14992020902845907; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Ward WD, 1986, NOISE HEARING CONSER, P197; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization WHO, 1997, PREV NOIS IND HEAR L; World Medical Association, 2008, DECL HELS ETH PRINC	43	25	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98912	10.1371/journal.pone.0098912	http://dx.doi.org/10.1371/journal.pone.0098912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897078	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700095
J	Walther-Antonio, MRS; Jeraldo, P; Miller, MEB; Yeoman, CJ; Nelson, KE; Wilson, BA; White, BA; Chia, N; Creedon, DJ				Walther-Antonio, Marina R. S.; Jeraldo, Patricio; Miller, Margret E. Berg; Yeoman, Carl J.; Nelson, Karen E.; Wilson, Brenda A.; White, Bryan A.; Chia, Nicholas; Creedon, Douglas J.			Pregnancy's Stronghold on the Vaginal Microbiome	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; PRETERM DELIVERY; WOMEN; BIRTH; IDENTIFICATION; COMMUNITIES; INFECTION; RISK	Objective: To assess the vaginal microbiome throughout full-term uncomplicated pregnancy. Methods: Vaginal swabs were obtained from twelve pregnant women at 8-week intervals throughout their uncomplicated pregnancies. Patients with symptoms of vaginal infection or with recent antibiotic use were excluded. Swabs were obtained from the posterior fornix and cervix at 8-12, 17-21, 27-31, and 36-38 weeks of gestation. The microbial community was profiled using hypervariable tag sequencing of the V3-V5 region of the 16S rRNA gene, producing approximately 8 million reads on the Illumina MiSeq. Results: Samples were dominated by a single genus, Lactobacillus, and exhibited low species diversity. For a majority of the patients (n = 8), the vaginal microbiome was dominated by Lactobacillus crispatus throughout pregnancy. Two patients showed Lactobacillus iners dominance during the course of pregnancy, and two showed a shift between the first and second trimester from L. crispatus to L. iners dominance. In all of the samples only these two species were identified, and were found at an abundance of higher than 1% in this study. Comparative analyses also showed that the vaginal microbiome during pregnancy is characterized by a marked dominance of Lactobacillus species in both Caucasian and African-American subjects. In addition, our Caucasian subject population clustered by trimester and progressed towards a common attractor while African-American women clustered by subject instead and did not progress towards a common attractor. Conclusion: Our analyses indicate normal pregnancy is characterized by a microbiome that has low diversity and high stability. While Lactobacillus species strongly dominate the vaginal environment during pregnancy across the two studied ethnicities, observed differences between the longitudinal dynamics of the analyzed populations may contribute to divergent risk for pregnancy complications. This helps establish a baseline for investigating the role of the microbiome in complications of pregnancy such as preterm labor and preterm delivery.	[Walther-Antonio, Marina R. S.; Jeraldo, Patricio; Chia, Nicholas] Mayo Clin, Dept Surg Res, Rochester, MN USA; [Jeraldo, Patricio; Miller, Margret E. Berg; Wilson, Brenda A.; White, Bryan A.; Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Yeoman, Carl J.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Nelson, Karen E.] J Craig Venter Inst, Genom Med Grp, Rockville, MD USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Urbana, IL USA; [Chia, Nicholas] Mayo Coll, Dept Physiol & Biomed Engn, Rochester, MN USA; [Creedon, Douglas J.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic	Creedon, DJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	creedon.douglas@mayo.edu	Yeoman, Carl/ABA-1906-2021; Jeraldo, Patricio/H-8178-2019	Yeoman, Carl/0000-0002-8775-7879; Jeraldo, Patricio/0000-0003-0282-4217; Chia, Nicholas/0000-0001-9652-691X; Walther-Antonio, Marina/0000-0002-5531-3712; Berg, Margret/0000-0002-0411-1619	National Institutes of Health (NIH) [R56 AI085096-01]; Center for Individualized Medicine; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085096] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Individualized Medicine; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grant R56 AI085096-01, the Center for Individualized Medicine, and the Mayo-Illinois Strategic Alliance for Technology-Based Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Huppertz B, 2003, PLACENTA, V24, P181, DOI 10.1053/plac.2002.0903; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson T, 2007, J CLIN MICROBIOL, V45, P3145, DOI 10.1128/JCM.00558-07; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MCDONALD HM, 1991, BRIT J OBSTET GYNAEC, V98, P427, DOI 10.1111/j.1471-0528.1991.tb10335.x; McGregor JA, 2000, OBSTET GYNECOL SURV, V55, pS1; Oakeshott P, 2002, BRIT MED J, V325, P1334, DOI 10.1136/bmj.325.7376.1334; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; PLATZCHRISTENSEN JJ, 1993, ACTA OBSTET GYN SCAN, V72, P99, DOI 10.3109/00016349309023420; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Saito S, 2007, MOL ASPECTS MED, V28, P192, DOI 10.1016/j.mam.2007.02.006; Sipos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015220; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Wilks M, 2004, J CLIN MICROBIOL, V42, P713, DOI 10.1128/JCM.42.2.713-717.2004; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	35	111	121	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98514	10.1371/journal.pone.0098514	http://dx.doi.org/10.1371/journal.pone.0098514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896831	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700045
J	Aoki, Y; Yoshida, K; Nishizawa, D; Kasai, S; Ichinohe, T; Ikeda, K; Fukuda, K				Aoki, Yoshinori; Yoshida, Kaori; Nishizawa, Daisuke; Kasai, Shinya; Ichinohe, Tatsuya; Ikeda, Kazutaka; Fukuda, Ken-ichi			Factors that Affect Intravenous Patient-Controlled Analgesia for Postoperative Pain Following Orthognathic Surgery for Mandibular Prognathism	PLOS ONE			English	Article							ASSOCIATION; GENE	The predictors of postoperative pain and analgesic consumption were previously found to include preoperative pain, anxiety, age, type of surgery, and genotype, but remaining unclear was whether intraoperative factors could predict postoperative pain. In the present study, we investigated the time-course of fentanyl consumption using intravenous patient-controlled analgesia records from patients who underwent orthognathic surgery for mandibular prognathism and analyzed the influence of anesthesia methods and surgical methods together with sex on the time course. A significant difference in the time course of fentanyl administration was found (P<0.001). No significant difference in the time course of fentanyl administration was found between males and females (P = 0.653), with no interaction between time course and sex (P = 0.567). No significant difference in the time course of fentanyl administration was found among anesthesia methods, such as fentanyl induction followed by fentanyl maintenance, fentanyl induction followed by remifentanil maintenance, and remifentanil induction followed by remifentanil maintenance (P = 0.512), but an interaction between time course and anesthesia method was observed (P = 0.004). A significant difference in the time course of fentanyl administration was found between surgical methods, such as bilateral mandibular sagittal split ramus osteotomy (BSSRO) and BSSRO combined with Le Fort I osteotomy (bimaxillary; P = 0.008), with no interaction between time course and surgical method (P = 0.535). Total postoperative 24 h consumption associated with the bimaxillary procedure was significantly higher than with BSSRO (P = 0.008). The present results indicate that administration patterns and total 24 h consumption were different among the three groups of anesthesia methods and between the two groups of surgical methods, respectively. Although more research on patient-controlled analgesia patterns and consumption is necessary, the present study will contribute to adequately relieving individual patients from postoperative pain.	[Aoki, Yoshinori; Yoshida, Kaori; Nishizawa, Daisuke; Kasai, Shinya; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan; [Aoki, Yoshinori; Yoshida, Kaori; Ichinohe, Tatsuya; Fukuda, Ken-ichi] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Dental College	Ikeda, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Addict Subst Project, Tokyo 113, Japan.	ikeda-kz@igakuken.or.jp		Ichinohe, Tatsuya/0000-0001-5793-3379	Ministry of Health, Labour and Welfare (MHLW) of Japan [H21-3jigan-ippan-011, H22-Iyaku-015, H25-Iyaku-020]; JSPS KAKENHI [20602020, 20390162, 23390377, 24790544, 24659549, 26293347]; MEXT KAKENHI [25116532]; Smoking Research Foundation; Naito Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [25116532] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (MHLW) of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smoking Research Foundation; Naito Foundation(Naito Memorial Foundation); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare (MHLW) of Japan (H21-3jigan-ippan-011, H22-Iyaku-015, and H25-Iyaku-020), JSPS KAKENHI grant no. 20602020, 20390162, 23390377, 24790544, 24659549, and 26293347, MEXT KAKENHI grant no. 25116532, the Smoking Research Foundation, the Naito Foundation, and the Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2013, NEUROSCI LETT, V542, P1, DOI 10.1016/j.neulet.2013.02.039; BELL WH, 1975, J ORAL SURG, V33, P412; Burkle H, 1996, ANESTH ANALG, V83, P646, DOI 10.1097/00000539-199609000-00038; Chegini Soudeh, 2012, Anesth Prog, V59, P69, DOI 10.2344/11-10.1; de Santana-Santos T, 2013, MED ORAL PATOL ORAL, V18, pE65, DOI 10.4317/medoral.18039; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fukuda K, 2009, PAIN, V147, P194, DOI 10.1016/j.pain.2009.09.004; Haerle F, 1997, ATLAS CRANIOMAXILLOF, p[90, 100]; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Nagatsuka C, 2000, Anesth Prog, V47, P119; Nishizawa D, 2014, MOL PSYCHIATR, V19, P55, DOI 10.1038/mp.2012.164; Nishizawa D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007060; OBWEGESER H, 1965, SSO Schweiz Monatsschr Zahnheilkd, V75, P365; TRAUNER R, 1957, Oral Surg Oral Med Oral Pathol, V10, P677, DOI 10.1016/S0030-4220(57)80063-2; United Nations, 2011, REP INT NARC CONTR B, P59; Warltier DC, 2000, ANESTHESIOLOGY, V92, P253, DOI 10.1097/00000542-200001000-00038; Wassmund M, 1935, LEHRBUCH PRAKTISCHEN, VI, P282; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	19	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98548	10.1371/journal.pone.0098548	http://dx.doi.org/10.1371/journal.pone.0098548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893040	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400063
J	Ray, P; Stacer, AC; Fenner, J; Cavnar, SP; Meguiar, K; Brown, M; Luker, KE; Luker, GD				Ray, P.; Stacer, A. C.; Fenner, J.; Cavnar, S. P.; Meguiar, K.; Brown, M.; Luker, K. E.; Luker, G. D.			CXCL12-gamma in primary tumors drives breast cancer metastasis	ONCOGENE			English	Article							LUNG METASTASIS; CXCR4; EXPRESSION; CHEMOKINE; CELLS; ANGIOGENESIS; ISOFORMS; GROWTH; RECRUITMENT; DISRUPTION	Compelling evidence shows that chemokine C-X-C motif chemokine ligand 12 (CXCL12) drives metastasis in multiple malignancies. Similar to other key cytokines in cancer, CXCL12 exists as several isoforms with distinct biophysical properties that may alter signaling and functional outputs. However, effects of CXCL12 isoforms in cancer remain unknown. CXCL12-alpha, -beta and -gamma showed cell-type-specific differences in activating signaling through G protein-dependent pathways in cell-based assays, while CXCL12-gamma had greatest effects on recruitment of the adapter protein beta-arrestin 2. CXCL12-beta and -gamma also stimulated endothelial tube formation to a greater extent than CXCL12-alpha. To investigate the effects of CXCL12 isoforms on tumor growth and metastasis, we used a mouse xenograft model of metastatic human breast cancer combining CXCR4+ breast cancer cells and mammary fibroblasts secreting an isoform of CXCL12. Altough all CXCL12 isoforms produced comparable growth of mammary tumors, CXCL12-gamma significantly increased metastasis to bone marrow and other sites. Breast cancer cells originating from tumors with CXCL12-gamma fibroblasts upregulated RANKL (receptor activator of nuclear factor-kappa B ligand), contributing to bone marrow tropism of metastatic cancer cells. CXCL12-gamma was expressed in metastatic tissues in mice, and we also detected CXCL12-gamma in malignant pleural effusions from patients with breast cancer. In our mouse model, mammary fibroblasts disseminated to sites of breast cancer metastases, providing another mechanism to increase levels of CXCL12 in metastatic environments. These studies identify CXCL12-gamma as a potent pro-metastatic molecule with important implications for cancer biology and effective therapeutic targeting of CXCL12 pathways.	[Ray, P.; Stacer, A. C.; Fenner, J.; Meguiar, K.; Luker, K. E.; Luker, G. D.] Univ Michigan, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA; [Cavnar, S. P.; Luker, G. D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Brown, M.; Luker, G. D.] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Breast Oncol Program, Ann Arbor, MI 48109 USA; [Luker, G. D.] Univ Michigan Ctr, Dept Microbiol & Immunol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Sch Med, Dept Radiol, 109 Zina Pitcher Pl,A526 BSRB, Ann Arbor, MI 48109 USA.	gluker@umich.edu		luker, gary/0000-0001-6832-2581	United States National Institutes of Health [R01CA136553, R01CA136829, R01CA142750, P50CA093990]; NSF; Fashion Footwear Association of New York (FFANY)/QVC; NATIONAL CANCER INSTITUTE [R01CA136829, R01CA136553, R01CA142750, P50CA093990] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Fashion Footwear Association of New York (FFANY)/QVC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States National Institutes of Health grants R01CA136553, R01CA136829, R01CA142750 and P50CA093990. SPC was supported by an NSF predoctoral fellowship. Research was also supported by Fashion Footwear Association of New York (FFANY)/QVC presents Shoes on Sale.	Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Brown Julie M, 2004, Cancer Treat Res, V118, P149; Cavnar SP, 2014, INTEGR BIOL-UK, V6, P564, DOI 10.1039/c4ib00015c; Chu QYD, 2010, J SURG RES, V159, P689, DOI 10.1016/j.jss.2008.09.020; Chueh BH, 2007, ANAL CHEM, V79, P3504, DOI 10.1021/ac062118p; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Diamond P, 2009, J BONE MINER RES, V24, P1150, DOI [10.1359/jbmr.090210, 10.1359/JBMR.090210]; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Gahan JC, 2012, J UROLOGY, V187, P827, DOI 10.1016/j.juro.2011.10.150; Guo P, 2001, CANCER RES, V61, P8569; Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044; Holland J, 2013, CELL REP; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Kim HR, 2014, ARTHRITIS RHEUMATOL, V66, P538, DOI 10.1002/art.38286; Kloen P, 1997, CANCER, V80, P2230; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luker K, 2012, ONCOGENE, V31, P4570, DOI DOI 10.1038/0NC.2011.633; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nixon AB, 2013, CLIN CANCER RES, V19, P6957, DOI 10.1158/1078-0432.CCR-13-0926; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park HR, 2003, J KOREAN MED SCI, V18, P541, DOI 10.3346/jkms.2003.18.4.541; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ray P, INT J BIOCH CELL BIO, V44, P669; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Stumm R, 2007, J COMP NEUROL, V502, P382, DOI 10.1002/cne.21336; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zannettino ACW, 2005, CANCER RES, V65, P1700, DOI 10.1158/0008-5472.CAN-04-1687; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	55	47	47	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2043	2051		10.1038/onc.2014.157	http://dx.doi.org/10.1038/onc.2014.157			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909174	Green Accepted			2022-12-25	WOS:000353173400004
J	Kumar, P; Tripathi, A; Ranjan, R; Halbert, J; Gilberger, T; Doerig, C; Sharma, P				Kumar, Praveen; Tripathi, Anuj; Ranjan, Ravikant; Halbert, Jean; Gilberger, Tim; Doerig, Christian; Sharma, Pushkar			Regulation of Plasmodium falciparum Development by Calcium-dependent Protein Kinase 7 (PfCDPK7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; MALARIA PARASITES; FOOD VACUOLE; HOST-CELL; LOCALIZATION; PATHWAY; EVENTS	Second messengers such as phosphoinositides and calcium are known to control diverse processes involved in the development of malaria parasites. However, the underlying molecular mechanisms and pathways need to be unraveled, which may be achieved by understanding the regulation of effectors of these second messengers. Calcium-dependent protein kinase (CDPK) family members regulate diverse parasitic processes. Because CDPKs are absent from the host, these kinases are considered as potential drug targets. We have dissected the function of an atypical CDPK from Plasmodium falciparum, PfCDPK7. The domain architecture of PfCDPK7 is very different from that of other CDPKs; it has a pleckstrin homology domain adjacent to the kinase domain and two calcium-binding EF-hands at its N terminus. We demonstrate that PfCDPK7 interacts with PI(4,5)P-2 via its pleckstrin homology domain, which may guide its subcellular localization. Disruption of PfCDPK7 caused a marked reduction in the growth of the blood stage parasites, as maturation of rings to trophozoites was markedly stalled. In addition, parasite proliferation was significantly attenuated. These findings shed light on an important role for PfCDPK7 in the erythrocytic asexual cycle of malaria parasites.	[Kumar, Praveen; Tripathi, Anuj; Ranjan, Ravikant; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Halbert, Jean; Doerig, Christian] Ecole Polytech Fed Lausanne, Global Hlth Inst, Inserm EPFL Joint Lab, CH-1015 Lausanne, Switzerland; [Gilberger, Tim] McMaster Univ, Dept Pathol & Mol Med, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L8, Canada; [Gilberger, Tim] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Doerig, Christian] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; McMaster University; Bernhard Nocht Institut fur Tropenmedizin; Monash University	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.ac.in	Kumar, Praveen/S-8449-2019; Ranjan, Ravikant/AAT-1000-2021; Doerig, Christian/Q-9900-2019	Ranjan, Ravikant/0000-0002-3997-4879; Gilberger, Tim-Wolf/0000-0002-7965-8272; Kumar, Praveen/0000-0002-9438-0731; Doerig, Christian/0000-0002-3188-094X	Department of Science and Technology (DST), India; MALSIG project - European Union; Department of Biotechnology (DBT), India; IR-BMBF (Federal Ministry of Education and Research), Germany [IND 09/024]; Council for Scientific and Industrial Research, India	Department of Science and Technology (DST), India(Department of Science & Technology (India)); MALSIG project - European Union; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); IR-BMBF (Federal Ministry of Education and Research), Germany; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a Swarnajayanti Fellowship Grant from Department of Science and Technology (DST), India (to P. S.), the MALSIG project funded by the European Union under FP7, and a Indo-German collaborative grant by Department of Biotechnology (DBT), India, and IR-BMBF (Federal Ministry of Education and Research) Grant IND 09/024, Germany (to P. S. and T. G.).; Supported by the Junior Research Fellowship by the Council for Scientific and Industrial Research, India.; Supported by the Senior Research Fellowship by the Council for Scientific and Industrial Research, India.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Dorin- Semblat D., 2013, KINOME, V1, P4, DOI DOI 10.2478/KIN0ME-2013-0001; Dorin-Semblat D, 2008, EUKARYOT CELL, V7, P279, DOI 10.1128/EC.00245-07; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leber W, 2009, INT J PARASITOL, V39, P645, DOI 10.1016/j.ijpara.2008.11.015; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; McIntosh MT, 2007, J BIOL CHEM, V282, P11499, DOI 10.1074/jbc.M610974200; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sharma P, 2013, CURR OPIN MICROBIOL, V16, P432, DOI 10.1016/j.mib.2013.07.004; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657	27	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20386	20395		10.1074/jbc.M114.561670	http://dx.doi.org/10.1074/jbc.M114.561670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895132	hybrid, Green Published			2022-12-25	WOS:000339395200049
J	Ge, Y; Schimel, JP; Holden, PA				Ge, Yuan; Schimel, Joshua P.; Holden, Patricia A.			Analysis of Run-to-Run Variation of Bar-Coded Pyrosequencing for Evaluating Bacterial Community Shifts and Individual Taxa Dynamics	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; MULTIPLEX; SCALE	Bar-coded pyrosequencing has been increasingly used due to its fine taxonomic resolution and high throughput. Yet, concerns arise regarding the reproducibility of bar-coded pyrosequencing. We evaluated the run-to-run variation of barcoded pyrosequencing in detecting bacterial community shifts and taxa dynamics. Our results demonstrate that pyrosequencing is reproducible in evaluating community shifts within a run, but not between runs. Also, the reproducibility of pyrosequencing in detecting individual taxa increased as a function of taxa abundance. Based on our findings: (1) for studies with modest sequencing depth, it is doubtful that data from different pyrosequencing runs can be considered comparable; (2) if multiple pyrosequencing runs are needed to increase the sequencing depth, additional sequencing efforts should be applied to all samples, rather than to selected samples; (3) if pyrosequencing is used for estimating bacterial population dynamics, only the abundant taxa should be considered; (4) for less-abundant taxa, the sequencing depth should be increased to ensure an accurate evaluation of taxon variation trends across samples.	[Ge, Yuan; Holden, Patricia A.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Ge, Yuan; Holden, Patricia A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Ge, Yuan; Schimel, Joshua P.; Holden, Patricia A.] Univ Calif Santa Barbara, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA; [Schimel, Joshua P.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Holden, PA (corresponding author), Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA.	holden@bren.ucsb.edu	Schimel, Joshua/AAE-7380-2019; Ge, Yuan/D-2997-2009	Schimel, Joshua/0000-0002-1022-6623; Ge, Yuan/0000-0003-0234-5638	National Science Foundation; Environmental Protection Agency [DBI-0830117]	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the Environmental Protection Agency under Cooperative Agreement DBI-0830117. Any opinions, findings, and conclusions are those of the authors and do not necessarily reflect the views of the National Science Foundation or the Environmental Protection Agency. This work has not been subjected to EPA review and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Delmont TO, 2012, ISME J, V6, P1625, DOI 10.1038/ismej.2012.55; Deng Y, 2012, APPL ENVIRON MICROB, V78, P2991, DOI 10.1128/AEM.06924-11; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Ge Y, 2012, APPL ENVIRON MICROB, V78, P6749, DOI 10.1128/AEM.00941-12; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Zhou J., 2013, MBIO, V4; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	25	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99414	10.1371/journal.pone.0099414	http://dx.doi.org/10.1371/journal.pone.0099414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911191	Green Published, gold			2022-12-25	WOS:000337165600083
J	Ying, W; Kanameni, S; Chang, CA; Nair, V; Safe, S; Bazer, FW; Zhou, BY				Ying, Wei; Kanameni, Srikanth; Chang, Cheng-An; Nair, Vijayalekshmi; Safe, Stephen; Bazer, Fuller W.; Zhou, Beiyan			Interferon Tau Alleviates Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Macrophage Polarization	PLOS ONE			English	Article							PREGNANCY RECOGNITION HORMONE; NF-KAPPA-B; PPAR-GAMMA; T-CELLS; ACTIVATION; ENCEPHALOMYELITIS; INFILTRATION; MODULATION; STEATOSIS	Chronic adipose tissue inflammation is a hallmark of obesity-induced insulin resistance and anti-inflammatory agents can benefit patients with obesity-associated syndromes. Currently available type I interferons for therapeutic immunomodulation are accompanied by high cytotoxicity and therefore in this study we have examined anti-inflammatory effects of interferon tau (IFNT), a member of the type I interferon family with low cellular toxicity even at high doses. Using a diet-induced obesity mouse model, we observed enhanced insulin sensitivity in obese mice administered IFNT compared to control mice, which was accompanied by a significant decrease in secretion of proinflammatory cytokines and elevated anti-inflammatory macrophages (M2) in adipose tissue. Further investigations revealed that IFNT is a potent regulator of macrophage activation that favors anti-inflammatory responses as evidenced by activation of associated surface antigens, production of anti-inflammatory cytokines, and activation of selective cell signaling pathways. Thus, our study demonstrates, for the first time, that IFNT can significantly mitigate obesity-associated systemic insulin resistance and tissue inflammation by controlling macrophage polarization, and thus IFNT can be a novel bio-therapeutic agent for treating obesity-associated syndromes and type 2 diabetes.	[Ying, Wei; Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Kanameni, Srikanth; Chang, Cheng-An; Nair, Vijayalekshmi; Safe, Stephen; Zhou, Beiyan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Bazer, FW (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	FBAZER@cvm.tamu.edu; bzhou@cvm.tamu.edu	Ying, Wei/N-5157-2016; Bazer, Fuller/AAF-4317-2021	Bazer, Fuller/0000-0002-5823-5086; Zhou, Beiyan/0000-0003-0638-2428	American Heart Association [13PRE17050104]; American Diabetes Association [1-13-JF-59]; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases [NIH/NIDDK 1R01DK098662]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098662] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association (13PRE17050104 to W. Ying), American Diabetes Association (1-13-JF-59 to B. Zhou) and National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK 1R01DK098662 to B. Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barbuio R, 2007, J ENDOCRINOL, V194, P539, DOI 10.1677/JOE-07-0234; Bazer FW, 2012, ANN NY ACAD SCI, V1271, P88, DOI 10.1111/j.1749-6632.2012.06741.x; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Bosca L, 2000, GENE THER, V7, P817, DOI 10.1038/sj.gt.3301179; Charo IF, 2007, CELL METAB, V6, P96, DOI 10.1016/j.cmet.2007.07.006; Chon TW, 2010, J INTERF CYTOK RES, V30, P477, DOI 10.1089/jir.2009.0089; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jongen PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026568; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; PONTZER CH, 1991, CANCER RES, V51, P5304; Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Sleijfer S, 2005, PHARM WORLD SCI, V27, P423, DOI 10.1007/s11096-005-1319-7; Sobel DO, 2008, AUTOIMMUNITY, V41, P543, DOI 10.1080/08916930802194195; Soos JM, 2002, J IMMUNOL, V169, P2231, DOI 10.4049/jimmunol.169.5.2231; SOOS JM, 1995, J IMMUNOL, V155, P2747; Spencer M, 2013, DIABETES, V62, P1709, DOI 10.2337/db12-1042; Tekwe CD, 2013, BIOFACTORS, V39, P552, DOI 10.1002/biof.1113; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Wang MH, 2003, J CELL BIOCHEM, V89, P38, DOI 10.1002/jcb.10492; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ying W., 2013, JOVE-J VIS EXP, V76; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	39	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98835	10.1371/journal.pone.0098835	http://dx.doi.org/10.1371/journal.pone.0098835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905566	Green Submitted, gold, Green Published			2022-12-25	WOS:000341869000066
J	Henneberg, A; Bender, K; Blaha, L; Giebner, S; Kuch, B; Kohler, HR; Maier, D; Oehlmann, J; Richter, D; Scheurer, M; Schulte-Oehlmann, U; Sieratowicz, A; Ziebart, S; Triebskorn, R				Henneberg, Anja; Bender, Katrin; Blaha, Ludek; Giebner, Sabrina; Kuch, Bertram; Koehler, Heinz-R.; Maier, Diana; Oehlmann, Joerg; Richter, Doreen; Scheurer, Marco; Schulte-Oehlmann, Ulrike; Sieratowicz, Agnes; Ziebart, Simone; Triebskorn, Rita			Are In Vitro Methods for the Detection of Endocrine Potentials in the Aquatic Environment Predictive for In Vivo Effects? Outcomes of the Projects SchussenAktiv and SchussenAktiv plus in the Lake Constance Area, Germany	PLOS ONE			English	Article							TREATMENT-PLANT EFFLUENTS; MUNICIPAL SEWAGE PLANT; UNITED-KINGDOM RIVERS; TROUT SALMO-TRUTTA; E-SCREEN ASSAY; POTAMOPYRGUS-ANTIPODARUM; ESTROGENIC ACTIVITY; WASTE-WATER; DISRUPTING CHEMICALS; BISPHENOL-A	Many studies about endocrine pollution in the aquatic environment reveal changes in the reproduction system of biota. We analysed endocrine activities in two rivers in Southern Germany using three approaches: (1) chemical analyses, (2) in vitro bioassays, and (3) in vivo investigations in fish and snails. Chemical analyses were based on gas chromatography coupled with mass spectrometry. For in vitro analyses of endocrine potentials in water, sediment, and waste water samples, we used the E-screen assay (human breast cancer cells MCF-7) and reporter gene assays (human cell line HeLa-9903 and MDA-kb2). In addition, we performed reproduction tests with the freshwater mudsnail Potamopyrgus antipodarum to analyse water and sediment samples. We exposed juvenile brown trout (Salmo trutta f. fario) to water downstream of a wastewater outfall (Schussen River) or to water from a reference site (Argen River) to investigate the vitellogenin production. Furthermore, two feral fish species, chub (Leuciscus cephalus) and spirlin (Alburnoides bipunctatus), were caught in both rivers to determine their gonadal maturity and the gonadosomatic index. Chemical analyses provided only little information about endocrine active substances, whereas the in vitro assays revealed endocrine potentials in most of the samples. In addition to endocrine potentials, we also observed toxic potentials (E-screen/reproduction test) in waste water samples, which could interfere with and camouflage endocrine effects. The results of our in vivo tests were mostly in line with the results of the in vitro assays and revealed a consistent reproduction-disrupting (reproduction tests) and an occasional endocrine action (vitellogenin levels) in both investigated rivers, with more pronounced effects for the Schussen river (e. g. a lower gonadosomatic index). We were able to show that biological in vitro assays for endocrine potentials in natural stream water reasonably reflect reproduction and endocrine disruption observed in snails and field-exposed fish, respectively.	[Henneberg, Anja; Koehler, Heinz-R.; Maier, Diana; Triebskorn, Rita] Univ Tubingen, Tubingen, Germany; [Blaha, Ludek] Masaryk Univ, Fac Sci, RECETOX, CS-61137 Brno, Czech Republic; [Bender, Katrin; Giebner, Sabrina; Oehlmann, Joerg; Schulte-Oehlmann, Ulrike; Sieratowicz, Agnes; Ziebart, Simone] Goethe Univ Frankfurt, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany; [Kuch, Bertram] Univ Stuttgart, Inst Sanit Engn Water Qual & Solid Waste Manageme, D-70174 Stuttgart, Germany; [Richter, Doreen; Scheurer, Marco] Water Technol Ctr Karlsruhe, Karlsruhe, Germany	Eberhard Karls University of Tubingen; Masaryk University Brno; Goethe University Frankfurt; University of Stuttgart	Henneberg, A (corresponding author), Univ Tubingen, Tubingen, Germany.	anja.henneberg@uni-tuebingen.de	Oehlmann, Jörg/B-4565-2010; Blaha, Ludek/N-6343-2013; Köhler, Heinz-R./AAL-1350-2021; Schulte-Oehlmann, Ulrike/D-1339-2010	Oehlmann, Jörg/0000-0002-6075-2701; Blaha, Ludek/0000-0002-7314-7455; 	Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM); foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University; Federal Ministry for Education and Research (BMBF); Jedele Partner GmbH; Okonsult GbR; city of Ravensburg; AZV Mariatal; AV Unteres Schussental; BMBF frame programme "Research for sustainable development FONA" [02WRS1281A]	Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM); foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University; Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Jedele Partner GmbH; Okonsult GbR; city of Ravensburg; AZV Mariatal; AV Unteres Schussental; BMBF frame programme "Research for sustainable development FONA"	The project SchussenAktiv was funded by the Ministerium fur Umwelt, Naturschutz und Verkehr Baden-Wurttemberg (UVM), and the foundation "Natur und Umwelt" of the Landesbank Baden-Wurttemberg (LBBW). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University. The project SchussenAktivplus is funded by the Federal Ministry for Education and Research (BMBF) and cofounded by the Ministry of Environment Baden-Wurttemberg. In addition, the city of Ravensburg, the AZV Mariatal and the AV Unteres Schussental financially contribute to the project. The commercial companies (Jedele & Partner GmbH and Okonsult GbR) provided funding to this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials. SchussenAktivplus is connected to the BMBF action plan "Sustainable water management (NaWaM)" and is integrated in the BMBF frame programme "Research for sustainable development FONA". Contract period: 1/2012 to 12/2014, Funding number: 02WRS1281A. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann GE, 2002, AQUAT TOXICOL, V60, P203, DOI 10.1016/S0166-445X(02)00003-6; Adams SM, 1999, ENVIRON TOXICOL CHEM, V18, P628, DOI 10.1002/etc.5620180407; ANDERSSON T, 1988, CAN J FISH AQUAT SCI, V45, P1525, DOI 10.1139/f88-181; Bernet D, 2003, BATTERY TECHNOLOGY H, P1; Bicchi C, 2009, SCI TOTAL ENVIRON, V407, P1842, DOI 10.1016/j.scitotenv.2008.11.039; Bjerregaard LB, 2006, ECOTOXICOLOGY, V15, P315, DOI 10.1007/s10646-006-0061-9; Bjerregaard P, 2008, ENVIRON TOXICOL CHEM, V27, P2387, DOI 10.1897/08-148.1; Bless R, 1996, ADV LIF SCI, P249; Bolong N, 2009, DESALINATION, V239, P229, DOI 10.1016/j.desal.2008.03.020; Brander SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074251; Brauch H-J, 2011, GWF WASSER ABWASSER, V12, P1206; Burki R, 2006, ENVIRON TOXICOL CHEM, V25, P2077, DOI 10.1897/05-545R.1; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; DICKSON RB, 1981, ENDOCRINOLOGY, V108, P1511, DOI 10.1210/endo-108-4-1511; Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4; Duft M, 2007, ECOTOXICOLOGY, V16, P169, DOI 10.1007/s10646-006-0106-0; ECONOMOU AN, 1991, J FISH BIOL, V39, P393, DOI 10.1111/j.1095-8649.1991.tb04371.x; Folmar LC, 2002, AQUAT TOXICOL, V60, P101, DOI 10.1016/S0166-445X(01)00276-4; Fretter V, 1994, J MAR BIOL ASSOC UK, V74, P985; Galluba S, 2012, J SOIL SEDIMENT, V12, P252, DOI 10.1007/s11368-011-0454-0; Giesy JP, 2000, ENVIRON TOXICOL CHEM, V19, P1368, DOI 10.1002/etc.5620190520; Grund S, 2011, ENVIRON SCI POLLUT R, V18, P446, DOI 10.1007/s11356-010-0390-3; Gutendorf B, 2001, TOXICOLOGY, V166, P79, DOI 10.1016/S0300-483X(01)00437-1; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Heinz B, 2009, ENVIRON GEOL, V57, P797, DOI 10.1007/s00254-008-1359-0; Hilscherova K, 2002, ARCH ENVIRON CON TOX, V43, P175, DOI 10.1007/s00244-002-1128-0; Hilscherova K, 2010, ENVIRON TOXICOL CHEM, V29, P522, DOI 10.1002/etc.83; Houtman CJ, 2006, CHEMOSPHERE, V65, P2244, DOI 10.1016/j.chemosphere.2006.05.043; Jacobsen R, 1997, FUNCT ECOL, V11, P260, DOI 10.1046/j.1365-2435.1997.00082.x; Janosek J, 2006, TOXICOL IN VITRO, V20, P18, DOI 10.1016/j.tiv.2005.06.001; Jarosova B, 2012, ENVIRON INT, V45, P22, DOI 10.1016/j.envint.2012.04.001; Jarosova B, 2014, ENVIRON INT, V64, P98, DOI 10.1016/j.envint.2013.12.009; Jeffries MKS, 2011, AQUAT TOXICOL, V105, P189, DOI 10.1016/j.aquatox.2011.04.008; Jobling S, 2004, AQUAT TOXICOL, V66, P205, DOI 10.1016/j.aquatox.2004.01.001; Jobling S, 2002, BIOL REPROD, V66, P272, DOI 10.1095/biolreprod66.2.272; Jobling S, 2006, ENVIRON HEALTH PERSP, V114, P7, DOI 10.1289/ehp.8046; Jobling S, 2009, ENVIRON HEALTH PERSP, V117, P797, DOI 10.1289/ehp.0800197; Kang IJ, 2008, AQUAT TOXICOL, V87, P37, DOI 10.1016/j.aquatox.2008.01.010; Kavlock RJ, 1996, RISK ANAL, V16, P731, DOI 10.1111/j.1539-6924.1996.tb00824.x; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kime DE, 1999, AQUACULTURE, V177, P345, DOI 10.1016/S0044-8486(99)00097-6; Kinani S, 2010, ENVIRON POLLUT, V158, P74, DOI 10.1016/j.envpol.2009.07.041; Kobler B, 2004, OKOLOGISCHE FISCHBIO; Koc HT, 2007, J APPL ICHTHYOL, V23, P19, DOI 10.1111/j.1439-0426.2006.00787.x; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Korner W, 1999, SCI TOTAL ENVIRON, V225, P33; Korner W, 2000, CHEMOSPHERE, V40, P1131, DOI 10.1016/S0045-6535(99)00362-8; Korner W., 2001, Journal of Aquatic Ecosystem Stress and Recovery, V8, P215, DOI 10.1023/A:1012976800922; Korner W, 1999, 95004 PUGU U TUB U W; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024; Louiz I, 2008, SCI TOTAL ENVIRON, V402, P318, DOI 10.1016/j.scitotenv.2008.05.005; Mazurova E, 2008, BIOLOGIA, V63, P139, DOI 10.2478/s11756-008-0027-x; Mazurova E, 2010, J SOIL SEDIMENT, V10, P423, DOI 10.1007/s11368-009-0166-x; Mert R, 2011, AFYON KOCATEPE U J S, V6, P1; MUNKITTRICK KR, 1992, CAN J FISH AQUAT SCI, V49, P1560, DOI 10.1139/f92-173; Nagel R, 2004, RINGTEST VALIDIERUNG, V200, P411; Nilsen BM, 1998, MAR ENVIRON RES, V46, P153, DOI 10.1016/S0141-1136(98)00019-1; OECD, 2010, OECD SER TEST ASS, P182; Oehlmann J, 2000, ECOTOXICOLOGY, V9, P383, DOI 10.1023/A:1008972518019; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Peck M, 2004, ENVIRON TOXICOL CHEM, V23, P945, DOI 10.1897/03-41; PONDER WF, 1988, J MOLLUS STUD, V54, P271, DOI 10.1093/mollus/54.3.271; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Runnalls TJ, 2010, HUM ECOL RISK ASSESS, V16, P1318, DOI 10.1080/10807039.2010.526503; Schmitt C, 2008, SOP TESTING CHEM R 3; Schmitt C, 2008, ENVIRON POLLUT, V152, P322, DOI 10.1016/j.envpol.2007.06.031; Schmitt C, 2010, CHEMOSPHERE, V80, P13, DOI 10.1016/j.chemosphere.2010.03.050; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Sharpe RM, 2004, BMJ-BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447; Sieratowicz A, 2011, ENVIRON POLLUT, V159, P2766, DOI 10.1016/j.envpol.2011.05.012; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Stalter D, 2010, WATER RES, V44, P439, DOI 10.1016/j.watres.2009.07.025; Stenseth N., 2004, MARINE ECOSYSTEMS CL; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Triebskorn Rita, 2013, Environmental Sciences Europe, V25, P2, DOI 10.1186/2190-4715-25-2; Triebskorn Rita, 2012, Environmental Sciences Europe, V24, P8, DOI 10.1186/2190-4715-24-8; Turkmen Mustafa, 1999, Turkish Journal of Zoology, V23, P355; Tyler CR, 1999, ENVIRON TOXICOL CHEM, V18, P337, DOI 10.1002/etc.5620180234; U. S. EPA, 2011, ESTR REC TRANSCR ACT; Urbatzka R, 2007, CHEMOSPHERE, V67, P1080, DOI 10.1016/j.chemosphere.2006.11.041; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Van den Belt K, 2004, AQUAT TOXICOL, V66, P183, DOI 10.1016/j.aquatox.2003.09.004; Velasco-Santamaria YM, 2010, MAR ENVIRON RES, V69, pS67, DOI 10.1016/j.marenvres.2009.09.009; Vigano L, 2008, CHEMOSPHERE, V73, P1078, DOI 10.1016/j.chemosphere.2008.07.057; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Vondracek J, 2001, ENVIRON TOXICOL CHEM, V20, P1499, DOI 10.1002/etc.5620200712; Wallace C, 1979, J MOLLUS STUD, V45, P383; Weltje L, 2005, HUM EXP TOXICOL, V24, P431, DOI 10.1191/0960327105ht551oa; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhao JL, 2011, ENVIRON TOXICOL CHEM, V30, P2208, DOI 10.1002/etc.625	93	28	28	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98307	10.1371/journal.pone.0098307	http://dx.doi.org/10.1371/journal.pone.0098307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901835	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400025
J	Gao, R; Chen, J; Hu, YX; Li, ZY; Wang, SX; Shetty, S; Fu, J				Gao, Rong; Chen, Jiao; Hu, Yuxin; Li, Zhenyu; Wang, Shuxia; Shetty, Sreerama; Fu, Jian			Sirt1 Deletion Leads to Enhanced Inflammation and Aggravates Endotoxin-Induced Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ADHESION MOLECULES; CELL APOPTOSIS; SEVERE SEPSIS; SEPTIC SHOCK; MOUSE MODELS; ACTIVATION; SURVIVAL; MICE; LIPOPOLYSACCHARIDE	Bacterial endotoxin has been known to induce excessive inflammatory responses and acute kidney injury. In the present study, we used a mouse model of endotoxemia to investigate the role of Sirt1 in inflammatory kidney injury. We examined molecular and cellular responses in inducible Sirt1 knockout (Sirt1(-/-)) mice and wild type littermates (Sirt1(+/+)) in lipopolysaccharide (LPS)-induced kidney injury. Our studies demonstrated that Sirt1 deletion caused aggravated kidney injury, which was associated with increased inflammatory responses including elevated pro-inflammatory cytokine production, and increased ICAM-1 and VCAM-1 expression. Inflammatory signaling such as STAT3/ERK phosphorylation and NF-kappa B activation was markedly elevated in kidney tissues of Sirt1 knockout mice after LPS challenge. The results indicate that Sirt1 is protective against LPS-induced acute kidney injury by suppressing kidney inflammation and down-regulating inflammatory signaling.	[Gao, Rong; Hu, Yuxin] Jilin Univ, Hosp 2, Changchun 130023, Jilin, Peoples R China; [Gao, Rong; Chen, Jiao; Hu, Yuxin; Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40506 USA; [Fu, Jian] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY 40536 USA; [Li, Zhenyu] Univ Kentucky, Coll Med, Div Cardiovasc Med, Lexington, KY USA; [Wang, Shuxia] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY USA; [Shetty, Sreerama] Univ Texas Hlth Sci Ctr Tyler, Ctr Biomed Res, Tyler, TX USA	Jilin University; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Fu, J (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40506 USA.	jian.fu@uky.edu			National Institutes of Health [1R01GM099744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the National Institutes of Health (http://www.nih.gov) grant (1R01GM099744) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Masataka, 2005, Nihon Rinsho, V63, P45; Araujo M, 2013, INFLAMM RES; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busch F, 2012, J BIOL CHEM, V287, P25770, DOI 10.1074/jbc.M112.355420; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen SH, 2012, J LEUKOCYTE BIOL, V92, P851, DOI 10.1189/jlb.0212060; Chen T, 2013, EXP DERMATOL, V22, P453, DOI 10.1111/exd.12174; Coldewey S.M., 2013, KIDNEY INT; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Danoff TM, 1998, KIDNEY INT, V53, P1807, DOI 10.1046/j.1523-1755.1998.00920.x; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Doi K, 2008, KIDNEY INT, V73, P1266, DOI 10.1038/ki.2008.97; Fan H, 2013, KIDNEY INT, V83, P404, DOI 10.1038/ki.2012.394; Gautier EL, 2008, J IMMUNOL, V180, P6941, DOI 10.4049/jimmunol.180.10.6941; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Horky K, 1967, Cas Lek Cesk, V106, P105; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hwang JW, 2010, ARCH BIOCHEM BIOPHYS, V500, P203, DOI 10.1016/j.abb.2010.05.013; Jeong SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12742; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Kasprzak A, 2013, J PERIODONTAL RES, V48, P1, DOI 10.1111/j.1600-0765.2012.01492.x; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Lampinen M, 2008, INT J COLORECTAL DIS, V23, P939, DOI 10.1007/s00384-008-0509-x; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lim JH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/171383; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Maddens B, 2012, CRIT CARE MED, V40, P2638, DOI 10.1097/CCM.0b013e3182591ebe; McCurdy TR, 2013, MICROCIRCULATION; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Miyaji T, 2003, KIDNEY INT, V64, P1620, DOI 10.1046/j.1523-1755.2003.00268.x; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; Peng XJ, 2013, EXP BIOL MED, V238, P960, DOI 10.1177/1535370213497176; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V304, pF1054, DOI 10.1152/ajprenal.00650.2012; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Sabbisetti VS, 2013, TOXICOL SCI, V131, P13, DOI 10.1093/toxsci/kfs268; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Singer M, 2013, CURR OPIN PULM MED, V19, P305, DOI 10.1097/MCP.0b013e32835f1b49; Suh SH, 2013, YONSEI MED J, V54, P965, DOI 10.3349/ymj.2013.54.4.965; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Uribarri J, 2013, AMINO ACIDS; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Van de Wiele C, 2012, EUR J NUCL MED MOL I, V39, P1646, DOI 10.1007/s00259-012-2189-6; Venkataraman R, 2013, ADV CHRONIC KIDNEY D, V20, P6, DOI 10.1053/j.ackd.2012.10.013; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Wang SX, 2013, BBA-MOL BASIS DIS, V1832, P1582, DOI 10.1016/j.bbadis.2013.05.023; Wei Q, 2013, KIDNEY INT, V84, P138, DOI 10.1038/ki.2013.68; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Wu Z, 2012, BLOOD, V119, P2422, DOI 10.1182/blood-2011-04-350413; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Zager RA, 2006, KIDNEY INT, V69, P1181, DOI 10.1038/sj.ki.5000022; Zhang DS, 2013, J PHARMACOL EXP THER, V345, P69, DOI 10.1124/jpet.112.202481	59	59	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98909	10.1371/journal.pone.0098909	http://dx.doi.org/10.1371/journal.pone.0098909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896770	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700094
J	Li, L; Lian, BF; Li, C; Li, W; Li, J; Zhang, YN; He, XH; Li, YX; Xie, L				Li, Ling; Lian, Baofeng; Li, Chao; Li, Wei; Li, Jing; Zhang, Yuannv; He, Xianghuo; Li, Yixue; Xie, Lu			Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROTEIN-INTERACTION NETWORKS; HEPATITIS-C-VIRUS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; BREAST-CANCER; CELL-MIGRATION; IN-VIVO; B-VIRUS; METASTASIS	Background: Transcriptional regulatory network (TRN) is used to study conditional regulatory relationships between transcriptional factors and genes. However few studies have tried to integrate genomic variation information such as copy number variation (CNV) with TRN to find causal disturbances in a network. Intrahepatic cholangiocarcinoma (ICC) is the second most common hepatic carcinoma with high malignancy and poor prognosis. Research about ICC is relatively limited comparing to hepatocellular carcinoma, and there are no approved gene therapeutic targets yet. Method: We first constructed TRN of ICC (ICC-TRN) using forward-and-reverse combined engineering method, and then integrated copy number variation information with ICC-TRN to select CNV-related modules and constructed CNV-ICC-TRN. We also integrated CNV-ICC-TRN with KEGG signaling pathways to investigate how CNV genes disturb signaling pathways. At last, unsupervised clustering method was applied to classify samples into distinct classes. Result: We obtained CNV-ICC-TRN containing 33 modules which were enriched in ICC-related signaling pathways. Integrated analysis of the regulatory network and signaling pathways illustrated that CNV might interrupt signaling through locating on either genomic sites of nodes or regulators of nodes in a signaling pathway. In the end, expression profiles of nodes in CNV-ICC-TRN were used to cluster the ICC patients into two robust groups with distinct biological function features. Conclusion: Our work represents a primary effort to construct TRN in ICC, also a primary effort to try to identify key transcriptional modules based on their involvement of genetic variations shown by gene copy number variations (CNV). This kind of approach may bring the traditional studies of TRN based only on expression data one step further to genetic disturbance. Such kind of approach can easily be extended to other disease samples with appropriate data.	[Li, Ling; Li, Yixue] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Li, Ling; Lian, Baofeng; Li, Wei; Li, Jing; Xie, Lu] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Lian, Baofeng; Li, Yixue] Shanghai Jiao Tong Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Li, Chao; Zhang, Yuannv; He, Xianghuo; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, YX (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	yxli@sibs.ac.cn; xielu@scbit.org	He, Xianghuo/I-1497-2014	He, Xianghuo/0000-0001-8872-668X	Key Infectious Disease Project [2012ZX10002012-014]; National Natural Science Foundation of China [31070752]; National Hi-Tech program [2012AA020201]; National Key Basic Research Program [2010CB912702, 2011CB910204]	Key Infectious Disease Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech program; National Key Basic Research Program(National Basic Research Program of China)	This work was funded by Key Infectious Disease Project (2012ZX10002012-014), National Natural Science Foundation of China (31070752), National Hi-Tech program 2012AA020201, and National Key Basic Research Program 2010CB912702, 2011CB910204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, CROSS TALK MITOGENIC; Baum B, 2004, ONCOGENE, V23, P8336, DOI 10.1038/sj.onc.1208009; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Demichelis F, 2012, P NATL ACAD SCI USA, V109, P6686, DOI 10.1073/pnas.1117405109; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Essaghir A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039666; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Geynisman DM, 2012, DISCOV MED, V14, P41; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hodgson PD, 2005, COMP FUNCT GENOM, V6, P244, DOI 10.1002/cfg.474; Homayounfar K, 2009, HUM PATHOL, V40, P834, DOI 10.1016/j.humpath.2008.11.005; Huang Q, 2012, ASIAN PAC J CANCER P, V13, P5161, DOI 10.7314/APJCP.2012.13.10.5161; Huang Tao, 2011, International Journal of Computational Biology and Drug Design, V4, P5, DOI 10.1504/IJCBDD.2011.038654; Kiesslich T, 2010, INT J ONCOL, V36, P49, DOI 10.3892/ijo_00000474; Ling Q, 2013, GENE, V522, P214, DOI 10.1016/j.gene.2013.03.089; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S5; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Munker S, 2012, Z GASTROENTEROL, V50, p5_40; Nagayama S, 2009, CANCER SCI, V100, P405, DOI 10.1111/j.1349-7006.2008.01052.x; Narong S, 2011, ONCOL LETT, V2, P821, DOI 10.3892/ol.2011.333; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pylkas K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002734; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez-Molinero A, 2007, MED HYPOTHESES, V68, P1333, DOI 10.1016/j.mehy.2006.10.033; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Sirica AE, 2008, WORLD J GASTROENTERO, V14, P7033, DOI 10.3748/wjg.14.7033; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Sun Q, 2007, CANCER BIOL THER, V6, P668, DOI 10.4161/cbt.6.5.3955; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Uhm KO, 2005, CANCER GENET CYTOGEN, V157, P37, DOI 10.1016/j.cancergencyto.2004.05.007; Villard J, 2004, SWISS MED WKLY, V134, P571; WORKMAN C, 2002, GENOME BIOL, V0003; Xu HY, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S7; Xu Y, 2012, MOL BIOL REP, V39, P1627, DOI 10.1007/s11033-011-0902-3; Yu H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-61; Yuan WL, 2014, BBA-PROTEINS PROTEOM, V1844, P271, DOI 10.1016/j.bbapap.2013.06.002; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028; Zeng LY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S14; Zhai Y, 2006, GASTROENTEROLOGY, V130, P2001, DOI 10.1053/j.gastro.2006.02.030; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang KS, 2013, ONCOL REP, V30, P1430, DOI 10.3892/or.2013.2560	57	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98653	10.1371/journal.pone.0098653	http://dx.doi.org/10.1371/journal.pone.0098653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897108	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700060
J	Maras, B; Angiolella, L; Mignogna, G; Vavala, E; Macone, A; Colone, M; Pitari, G; Stringaro, A; Dupre, S; Palamara, AT				Maras, Bruno; Angiolella, Letizia; Mignogna, Giuseppina; Vavala, Elisabetta; Macone, Alberto; Colone, Marisa; Pitari, Giuseppina; Stringaro, Annarita; Dupre, Silvestro; Palamara, Anna Teresa			Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; CELL-WALL; MECHANISMS	Currently available therapies for candidiasis are based on antifungal drugs belonging to azole and echinocandin families that interfere with different aspects of fungal metabolism. These drugs, beyond their specific effects, elicit also a cellular stress including an unbalance of redox state that is counteracted not only utilizing antioxidant species but also increasing the outcome export by transporters to detoxify the internal environment. These cellular actions are both based on the cytosolic concentration of reduced glutathione (GSH). In this paper we investigated the effects of two antifungal drugs fluconazole and micafungin on the redox state of the cell in C. albicans to understand if the resistance to these drugs is accompanied by variation of glutathione metabolism. Analyses of resistant strains showed a marked difference in glutathione contents in strains resistant to fluconazole (CO23RFLC) or micafungin (CO23RFK). In CO23RFLC, the total amount of glutathione was more than doubled with respect to CO23RFK thanks to the increased activity of gamma-glutamilcysteine synthetase, the key enzyme involved in GSH synthesis. We demonstrated that the GSH increase in CO23RFLC conferred to this strain a clear advantage in counteracting oxidative toxic agents while assignment of other roles, such as a more efficient elimination of the drug from the cell, should be considered more speculative. As far as MCFG resistance is concerned, from our data a role of glutathione metabolism in supporting this condition is not evident. Overall our data indicate that glutathione metabolism is differently affected in the two resistant strains and that glutathione system may play an important role in the global organization of C. albicans cells for resistance to fluconazole. Such scenario may pave the way to hypothesize the use of oxidant drugs or inhibitors able to deplete reduced glutathione level as a novel approach, for counteracting the resistance to this specific antifungal drug.	[Maras, Bruno; Mignogna, Giuseppina; Macone, Alberto; Dupre, Silvestro] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Angiolella, Letizia; Vavala, Elisabetta; Palamara, Anna Teresa] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Sanita Pubbl & Malattie Infett, I-00185 Rome, Italy; [Colone, Marisa; Stringaro, Annarita] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy; [Pitari, Giuseppina] Univ Aquila, Dipartimento Biol Base & Applicata, I-67100 Laquila, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of L'Aquila	Maras, B (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	bruno.maras@uniroma1.it	COLONE, MARISA/E-9089-2015; STRINGARO, ANNARITA/E-9092-2015; Macone, Alberto/AAB-2570-2019; angiolella, letizia/P-3878-2015	COLONE, MARISA/0000-0002-7522-7483; STRINGARO, ANNARITA/0000-0002-0143-2978; Macone, Alberto/0000-0003-0455-1400; angiolella, letizia/0000-0002-0473-5587; Mignogna, Giuseppina/0000-0001-9238-132X; pitari, giuseppina/0000-0002-1244-6451; PALAMARA, ANNA TERESA/0000-0001-8330-4381	Sapienza University of Rome;  [PON 01_01802]	Sapienza University of Rome; 	This work was supported by funds from Sapienza University of Rome and partially by the Project PON 01_01802 (to ATP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Angiolella L, 2005, J CHEMOTHERAPY, V17, P409, DOI 10.1179/joc.2005.17.4.409; Angiolella L, 2009, INT J ANTIMICROB AG, V33, P143, DOI 10.1016/j.ijantimicag.2008.08.021; Angiolella L, 2008, ANTIMICROB AGENTS CH, V52, P927, DOI 10.1128/AAC.01223-07; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Calcabrini A, 2002, INT J CANCER, V99, P43, DOI 10.1002/ijc.10310; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Fortun J, 2012, J INFECTION, V65, P64, DOI 10.1016/j.jinf.2012.02.011; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gutierrez-Escobedo G, 2013, CURR GENET, V59, P91, DOI 10.1007/s00294-013-0390-1; Herrero E., 2007, BIOCHIM BIOPHYS ACTA, V1780, P1217; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Niimi K, 2006, ANTIMICROB AGENTS CH, V50, P1148, DOI 10.1128/AAC.50.4.1148-1155.2006; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Pocsi I, 2004, ADV MICROB PHYSIOL, V49, P1, DOI 10.1016/S0065-2911(04)49001-8; Sobhakumari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048175; Vavala E, 2013, J CHEMOTHERAPY, V25, P332, DOI 10.1179/1973947813Y.0000000091; Yadav AK, 2011, MICROBIOL-SGM, V157, P484, DOI 10.1099/mic.0.045054-0; Zhu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028830	26	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98387	10.1371/journal.pone.0098387	http://dx.doi.org/10.1371/journal.pone.0098387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896636	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700038
J	Sahoo, DK; Dey, N; Maiti, IB				Sahoo, Dipak Kumar; Dey, Nrisingha; Maiti, Indu Bhushan			pSiM24 Is a Novel Versatile Gene Expression Vector for Transient Assays As Well As Stable Expression of Foreign Genes in Plants	PLOS ONE			English	Article							LENGTH TRANSCRIPT PROMOTER; FIGWORT-MOSAIC-VIRUS; AGROBACTERIUM-MEDIATED TRANSFORMATION; VEGETATIVE INSECTICIDAL PROTEIN; BINARY TI VECTOR; TRANSGENIC TOBACCO; DELETION ANALYSIS; CHIMERIC GENES; DNA; SYSTEM	We have constructed a small and highly efficient binary Ti vector pSiM24 for plant transformation with maximum efficacy. In the pSiM24 vector, the size of the backbone of the early binary vector pKYLXM24 (GenBank Accession No. HM036220; a derivative of pKYLX71) was reduced from 12.8 kb to 7.1 kb. The binary vector pSiM24 is composed of the following genetic elements: left and right T-DNA borders, a modified full-length transcript promoter (M24) of Mirabilis mosaic virus with duplicated enhancer domains, three multiple cloning sites, a 3'rbcsE9 terminator, replication functions for Escherichia coli (ColE1) and Agrobacterium tumefaciens (pRK2-OriV) and the replicase trfA gene, selectable marker genes for kanamycin resistance (nptII) and ampicillin resistance (bla). The pSiM24 plasmid offers a wide selection of cloning sites, high copy numbers in E. coli and a high cloning capacity for easily manipulating different genetic elements. It has been fully tested in transferring transgenes such as green fluorescent protein (GFP) and beta-glucuronidase (GUS) both transiently (agro-infiltration, protoplast electroporation and biolistic) and stably in plant systems (Arabidopsis and tobacco) using both agrobacterium-mediated transformation and biolistic procedures. Not only reporter genes, several other introduced genes were also effectively expressed using pSiM24 expression vector. Hence, the pSiM24 vector would be useful for various plant biotechnological applications. In addition, the pSiM24 plasmid can act as a platform for other applications, such as gene expression studies and different promoter expressional analyses.	[Sahoo, Dipak Kumar; Maiti, Indu Bhushan] Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY 40506 USA; [Dey, Nrisingha] Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Odisha, India	University of Kentucky; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Sahoo, DK (corresponding author), Univ Kentucky, Coll Agr Food & Environm, KTRDC, Lexington, KY 40506 USA.	dipak_sahoo11@rediffmail.com; imaiti@uky.edu	Sahoo, Dipak Kumar/M-8818-2013	Sahoo, Dipak Kumar/0000-0003-3748-3395	KY state KTRDC [1235411320]	KY state KTRDC	This work was fully supported by the KY state KTRDC grant (no. 1235411320) to IBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2013, PLANTA; Ali MA, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-37; AN G, 1986, PLANT PHYSIOL, V81, P301, DOI 10.1104/pp.81.1.301; Banerjee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079622; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREYNE P, 1992, MOL GEN GENET, V235, P389, DOI 10.1007/BF00279385; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chan V., 2002, J EXP MICROBIOL IMMU, V2, P207; Chatterjee A, 2010, IN VITRO CELL DEV-PL, V46, P198, DOI 10.1007/s11627-010-9283-x; Dey N, 1999, PLANT MOL BIOL, V40, P771, DOI 10.1023/A:1006285426523; Dey N, 1999, TRANSGENICS, V3, P61; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Filippi CM, 2008, J PATHOL, V214, P224, DOI 10.1002/path.2272; FLUHR R, 1986, EMBO J, V5, P2063, DOI 10.1002/j.1460-2075.1986.tb04467.x; FLUHR R, 1986, SCIENCE, V232, P1106, DOI 10.1126/science.232.4754.1106; FLUHR R, 1986, P NATL ACAD SCI USA, V83, P2358, DOI 10.1073/pnas.83.8.2358; Gelderblom H, 2007, AM J PATHOL, V170, P251, DOI 10.2353/ajpath.2007.060407; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hiei Y, 2006, PLANT CELL TISS ORG, V85, P271, DOI 10.1007/s11240-005-9069-8; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; JEFFERSON RA, 1987, J MOL BIOL, V193, P41, DOI 10.1016/0022-2836(87)90624-3; JEFFERSON RA, 1987, EMBO J, V6, P3901; KLEE HJ, 1985, BIO-TECHNOL, V3, P637, DOI 10.1038/nbt0785-637; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Komari T, 2006, METH MOL B, V343, P15; Komori T, 2007, PLANT PHYSIOL, V145, P1155, DOI 10.1104/pp.107.105734; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kroumova AB, 2007, PLANT PHYSIOL, V144, P1843, DOI 10.1104/pp.107.097584; Kroumova ABM, 2013, PLANT CELL REP, V32, P1771, DOI 10.1007/s00299-013-1490-6; Kumar D, 2012, GENE, V503, P36, DOI 10.1016/j.gene.2012.04.053; Kumar D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024627; Kusaba M, 1996, PLANT PHYSIOL, V111, P1161, DOI 10.1104/pp.111.4.1161; Lee S, 2012, PLANT SCI, V187, P49, DOI 10.1016/j.plantsci.2012.01.012; LEMOS ML, 1992, PLASMID, V27, P161, DOI 10.1016/0147-619X(92)90016-4; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Lu YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057171; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; MAITI IB, 1993, P NATL ACAD SCI USA, V90, P6110, DOI 10.1073/pnas.90.13.6110; Minter RM, 2001, P NATL ACAD SCI USA, V98, P277, DOI 10.1073/pnas.250489297; Murai N., 2013, American Journal of Plant Sciences, V4, P932, DOI 10.4236/ajps.2013.44115; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Patro S, 2013, J BIOTECHNOL, V163, P311, DOI 10.1016/j.jbiotec.2012.11.009; Pattanaik S, 2004, PLANT SCI, V167, P427, DOI 10.1016/j.plantsci.2004.04.011; Ranjan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031931; Ranjan R, 2011, J BIOTECHNOL, V152, P58, DOI 10.1016/j.jbiotec.2011.01.015; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahoo DK, 2014, SCI WORLD J, DOI 10.1155/2014/601314; Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; Sahoo DK, 2014, ACTA BIOL HUNG, V65, P189, DOI 10.1556/ABiol.65.2014.2.7; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; Selvapandiyan A, 2001, APPL ENVIRON MICROB, V67, P5855, DOI 10.1128/AEM.67.12.5855-5858.2001; Shah KH, 2013, PLANT MOL BIOL REP, V31, P1529, DOI 10.1007/s11105-013-0614-z; Shepherd RW, 2005, PLANT CELL, V17, P1851, DOI 10.1105/tpc.105.031559; Song F, 2014, IRISH J MED SCI, V183, P85, DOI 10.1007/s11845-013-0980-4; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; SVAB Z, 1990, P NATL ACAD SCI USA, V87, P8526, DOI 10.1073/pnas.87.21.8526; Takken FLW, 2004, CURR GENET, V45, P242, DOI 10.1007/s00294-003-0481-5; Thole V, 2007, PLANT PHYSIOL, V145, P1211, DOI 10.1104/pp.107.108563; TOLSON DL, 1994, INFECT IMMUN, V62, P4893, DOI 10.1128/IAI.62.11.4893-4899.1994; Untergasser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047885; Vasil IK, 1996, NAT BIOTECHNOL, V14, P702, DOI 10.1038/nbt0696-702; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang C, 2013, PLOS ONE, V8; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; YADAV NS, 1982, P NATL ACAD SCI-BIOL, V79, P6322, DOI 10.1073/pnas.79.20.6322; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; ZUPAN JR, 1995, PLANT PHYSIOL, V107, P1041, DOI 10.1104/pp.107.4.1041	86	11	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98988	10.1371/journal.pone.0098988	http://dx.doi.org/10.1371/journal.pone.0098988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897541	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700104
J	Spada, J; Sander, C; Burkhardt, R; Hantzsch, M; Mergl, R; Scholz, M; Hegerl, U; Hensch, T				Spada, Janek; Sander, Christian; Burkhardt, Ralph; Haentzsch, Madlen; Mergl, Roland; Scholz, Markus; Hegerl, Ulrich; Hensch, Tilman			Genetic Association of Objective Sleep Phenotypes with a Functional Polymorphism in the Neuropeptide S Receptor Gene	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEURONS; WAKEFULNESS; AROUSAL; DURATION; RHYTHMS; BRAIN; MODEL	Background: The neuropeptide S receptor (NPSR1) and its ligand neuropeptide S (NPS) have received increased attention in the last few years, as both establish a previously unknown system of neuromodulation. Animal research studies have suggested that NPS may be involved in arousal/wakefulness and may also have a crucial role in sleep regulation. The single nucleotide polymorphism (SNP) rs324981 in NPSR1 has begun to shed light on a function of the NPS-system in human sleep regulation. Due to an amino acid exchange, the T-allele leads to an increased sensitivity of the NPSR1. In the only genome-wide association study to date on circadian sleep parameters in humans, an association was found between rs324981 and regular bedtime. However, the sleep parameters in this study were only measured by self-rating. Therefore, our study aimed to replicate these findings using an objective measure of sleep. Methods: The study included n = 393 white subjects (62-79 years) who participated in an actigraphic assessment for determining sleep duration, rest duration, sleep onset, rest onset and sleep onset latency. Genotyping of the SNP rs324981 was performed using the TaqMan OpenArray System. Results: The genotype at rs324981 was not significantly associated with rest onset (bedtime) or sleep onset (p = .146 and p = .199, respectively). However, the SNP showed a significant effect on sleep- and rest duration (p = .007 and p = .003, respectively). Subjects that were homozygous for the minor T-allele had a significantly decreased sleep-and rest duration compared to A-allele carriers. Conclusion: The results of this study indicate that the sleep pattern in humans is influenced by the NPS-system. However, the previously reported association between bedtime and rs324981 could not be confirmed. The current finding of decreased sleep duration in T/T allele carriers is in accordance with studies in rodents reporting similar results after NPS application.	[Spada, Janek; Sander, Christian; Burkhardt, Ralph; Haentzsch, Madlen; Mergl, Roland; Scholz, Markus; Hegerl, Ulrich; Hensch, Tilman] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Spada, Janek; Sander, Christian; Mergl, Roland; Hegerl, Ulrich; Hensch, Tilman] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany; [Burkhardt, Ralph; Haentzsch, Madlen] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Spada, J (corresponding author), Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany.	janek.spada@medizin.uni-leipzig.de	Sander, Christian/AAB-8674-2022	Sander, Christian/0000-0002-5402-6631; Burkhardt, Ralph/0000-0003-1924-1202; Hegerl, Ulrich/0000-0002-3039-7470; Hensch, Tilman/0000-0003-2696-6017	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; German Research Foundation (DFG); UniversitAt Leipzig within the program of Open Access Publishing	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); UniversitAt Leipzig within the program of Open Access Publishing	This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. Moreover, the authors acknowledge support from the German Research Foundation (DFG) and UniversitAt Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; CAIRNS BE, 1995, J NEUROPHYSIOL, V73, P2486, DOI 10.1152/jn.1995.73.6.2486; Clark SD, 2011, J COMP NEUROL, V519, P1867, DOI 10.1002/cne.22606; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; Domschke K, 2011, MOL PSYCHIATR, V16, P938, DOI 10.1038/mp.2010.81; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Glotzbach-Schoon E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00031; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Hegerl U, 2012, NEUROSCI BI IN PRESS; Hegerl U, 2012, WORLD J BIOL PSYCHIA, V13, P436, DOI 10.3109/15622975.2011.579164; Hegerl U, 2010, CURR OPIN PSYCHIATR, V23, P1, DOI 10.1097/YCO.0b013e328331f694; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Klauke B, 2014, WORLD J BIOL PSYCHIA, V15, P17, DOI 10.3109/15622975.2011.646302; Kohlmeier KA, 2006, EUR J NEUROSCI, V23, P3245, DOI 10.1111/j.1460-9568.2006.04875.x; Krishnan V, 2006, CURR OPIN PULM MED, V12, P383, DOI 10.1097/01.mcp.0000245705.69440.6a; Laas K, 2014, INT J NEUROPSYCHOPH, V17, P541, DOI 10.1017/S1461145713001478; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Moraes W, 2013, SLEEP MED, V14, P312, DOI 10.1016/j.sleep.2012.11.010; Pitti T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034046; Raymann RJEM, 2007, PHYSIOL BEHAV, V90, P257, DOI 10.1016/j.physbeh.2006.09.008; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Sander C, 2010, CLIN NEUROPHYSIOL, V121, P1511, DOI 10.1016/j.clinph.2010.03.021; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Sharif MM, 2013, ANN THORAC MED, V8, P53, DOI 10.4103/1817-1737.105720; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; von Arb M, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-11; Wang MY, 2011, J NURS RES, V19, P173, DOI 10.1097/JNR.0b013e318229c42f; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zhao P, 2012, NEUROSCIENCE, V207, P218, DOI 10.1016/j.neuroscience.2012.01.022	39	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98789	10.1371/journal.pone.0098789	http://dx.doi.org/10.1371/journal.pone.0098789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896296	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700078
J	Yuan, DQ; Xu, YD; Hang, H; Liu, XY; Chen, X; Xie, P; Yuan, ST; Zhang, WW; Lin, XJ; Liu, QH				Yuan, Dongqing; Xu, Yidan; Hang, Hui; Liu, Xiaoyi; Chen, Xi; Xie, Ping; Yuan, Songtao; Zhang, Weiwei; Lin, Xiaojun; Liu, Qinghuai			Edaravone Protect against Retinal Damage in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							FREE-RADICAL SCAVENGER; GANGLION-CELLS; OXIDATIVE STRESS; OPTIC-NERVE; APOPTOSIS; DEGENERATION; MODEL	Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, is used for the clinical treatment of retinal injury. In this study, we investigated the protective effects of edaravone against diabetic retinal damage in the mouse. Diabetic retinopathy in the mouse was induced by injection of streptozotocin. Edaravone was given once-daily and was intraperitoneally (i.p.) treated at a dose of 3 mg/kg from streptozotocin injection to 4 weeks after onset of diabetes. Retinal ganglion cells (RGCs) damage was evaluated by recording the pattern electroretinogram (ERG). RGCs damage was also detected by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and the levels of reactive oxygen species (ROS) were determined fluorometrically. The expressions of phosporylated-ERK1/2, BDNF, and caspase-3 were determined by Western blot analysis. Retinal levels of ROS, phosphorylated ERK1/2, and cleaved caspase-3 were significantly increased, whereas the expression of BDNF was significantly decreased in the retinas of diabetic mice, compared to nondiabetic mice. Administration of edaravone significantly attenuated diabetes induced RGCs death, upregulation of ROS, ERK1/2 phosphorylation, and cleaved caspase-3 and downregulation of BDNF. These findings suggest that oxidative stress plays a pivotal role in diabetic retinal damage and that systemic administration of edaravone may slow the progression of retinal neuropathy induced by diabetes.	[Yuan, Dongqing; Xu, Yidan; Hang, Hui; Liu, Xiaoyi; Chen, Xi; Xie, Ping; Yuan, Songtao; Zhang, Weiwei; Lin, Xiaojun; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn		Liu, Qinghuai/0000-0003-1605-1964; Xie, Ping/0000-0003-4257-8970	National Basic Research Program of China (973 Program) [2012CB066300, 2011CB510200]; National Natural Science Fund [81170855, 81070743]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ12_0586]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province	This research project was supported by National Basic Research Program of China (973 Program, No. 2012CB066300 and No. 2011CB510200, http://www.973.gov.cn/AreaAppl.aspx), General Project of the National Natural Science Fund (No. 81170855 and No. 81070743, http://www.nsfc.gov.cn/Portal0/default152.htm) and Research and Innovation Project for College Graduates of Jiangsu Province (No. CXZZ12_0586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizu Y, 2002, NEUROPATHOLOGY, V22, P161, DOI 10.1046/j.1440-1789.2002.00439.x; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Carmody RJ, 2000, CELL DEATH DIFFER, V7, P282, DOI 10.1038/sj.cdd.4400646; [程海霞 Cheng Haixia], 2012, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V30, P50; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Imai S, 2010, EUR J PHARMACOL, V642, P77, DOI 10.1016/j.ejphar.2010.05.057; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Ji Y, 2011, INT J MOL SCI, V12, P4722, DOI 10.3390/ijms12074722; Kawasaki T, 2007, GLIA, V55, P1325, DOI 10.1002/glia.20541; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kusari J, 2007, INVEST OPHTH VIS SCI, V48, P5152, DOI 10.1167/iovs.07-0427; Lee BJ, 2010, BRAIN RES, V1307, P22, DOI 10.1016/j.brainres.2009.10.026; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li GY, 2009, EXP EYE RES, V89, P581, DOI 10.1016/j.exer.2009.06.004; Li WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076025; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Ola MS, 2012, J DIABETES COMPLICAT, V26, P56, DOI 10.1016/j.jdiacomp.2011.11.004; Qin YW, 2006, CURR EYE RES, V31, P967, DOI 10.1080/02713680600987674; Roh MI, 2011, INVEST OPHTH VIS SCI, V52, P3825, DOI 10.1167/iovs.10-6797; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; SCOTT TM, 1986, J ANAT, V144, P145; Seigel GM, 2006, J DIABETES COMPLICAT, V20, P196, DOI 10.1016/j.jdiacomp.2005.06.007; Seki M, 2003, INVEST OPHTH VIS SCI, V44, P3211, DOI 10.1167/iovs.02-1089; Shimazaki H, 2011, INVEST OPHTH VIS SCI, V52, P7289, DOI 10.1167/iovs.11-7983; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; SIMA AAF, 1992, DIABETOLOGIA, V35, P602, DOI 10.1007/BF00400249; Toyoda K, 2004, J NEUROL SCI, V221, P11, DOI 10.1016/j.jns.2004.03.002; Yang Y, 2012, MOL VIS, V18, P1411; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789	35	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99219	10.1371/journal.pone.0099219	http://dx.doi.org/10.1371/journal.pone.0099219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897298	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700124
J	Mahadevan, D; Morales, C; Cooke, LS; Manziello, A; Mount, DW; Persky, DO; Fisher, RI; Miller, TP; Qi, WQ				Mahadevan, Daruka; Morales, Carla; Cooke, Laurence S.; Manziello, Ann; Mount, David W.; Persky, Daniel O.; Fisher, Richard I.; Miller, Thomas P.; Qi, Wenqing			Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2	PLOS ONE			English	Article							B-CELL LYMPHOMA; PLUS CYCLOPHOSPHAMIDE; AURORA; PROLIFERATION; DOXORUBICIN; EXPRESSION; INHIBITOR; SURVIVAL; THERAPY; MLN8237	Pearson correlation coefficient for expression analysis of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP) demonstrated Aurora A and B are highly correlated with MYC in DLBCL and mantle cell lymphoma (MCL), while both Auroras correlate with BCL2 only in DLBCL. Auroras are up-regulated by MYC dysregulation with associated aneuploidy and resistance to microtubule targeted agents such as vincristine. Myc and Bcl2 are differentially expressed in U-2932, TMD-8, OCI-Ly10 and Granta-519, but only U-2932 cells over-express mutated p53. Alisertib [MLN8237 or M], a highly selective small molecule inhibitor of Aurora A kinase, was synergistic with vincristine [VCR] and rituximab [R] for inhibition of cell proliferation, abrogation of cell cycle checkpoints and enhanced apoptosis versus single agent or doublet therapy. A DLBCL (U-2932) mouse model showed tumor growth inhibition (TGI) of similar to 10-20% (p = 0.001) for M, VCR and M-VCR respectively, while R alone showed similar to 50% TGI (p = 0.001). M-R and VCR-R led to tumor regression [TR], but relapsed 10 days after discontinuing therapy. In contrast, M-VCR-R demonstrated TR with no relapse >40 days after stopping therapy with a Kaplan-Meier survival of 100%. Genes that are modulated by M-VCR-R (CENP-C, Auroras) play a role in centromere-kinetochore function in an attempt to maintain mitosis in the presence of synthetic lethality. Together, our data suggest that the interaction between alisertib plus VCR plus rituximab is synergistic and synthetic lethal in Myc and Bcl-2 co-expressing DLBCL. Alisertib plus vincristine plus rituximab [M-VCR-R] may represent a new strategy for DLBCL therapy.	[Mahadevan, Daruka; Morales, Carla; Cooke, Laurence S.; Qi, Wenqing] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Manziello, Ann; Mount, David W.; Persky, Daniel O.; Miller, Thomas P.] Univ Arizona, Dept Med, Ctr Canc, Tucson, AZ USA; [Fisher, Richard I.] Fox Chase Canc Ctr Temple Hlth, Dept Med, Philadelphia, PA USA	University of Tennessee System; University of Tennessee Health Science Center; University of Arizona	Mahadevan, D (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dmahadevan@westclinic.com; wqi@uthsc.edu			Lymphoma SPORE [1 P5O CA B080501A1]	Lymphoma SPORE	This work was supported by Lymphoma SPORE (1 P5O CA B080501A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Dunleavy K, 2011, ANN ONCOL, V22, P106; Friedberg JW, 2014, J CLIN ONCOL, V32, P44, DOI 10.1200/JCO.2012.46.8793; Friedberg JW, 2012, J CLIN ONCOL, V30, P3439, DOI 10.1200/JCO.2012.43.5800; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Mahadevan D, 2012, CLIN CANCER RES, V18, P2210, DOI 10.1158/1078-0432.CCR-11-2413; Mead GM, 2008, BLOOD, V112, P2248, DOI 10.1182/blood-2008-03-145128; Pfreundschuh M, 2012, J CLIN ONCOL, V30, P3433, DOI 10.1200/JCO.2012.44.4729; Qi WQ, 2013, LEUKEMIA RES, V37, P434, DOI 10.1016/j.leukres.2012.10.017; Qi WQ, 2011, BIOCHEM PHARMACOL, V81, P881, DOI 10.1016/j.bcp.2011.01.017; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sasaki N, 2011, EXP HEMATOL, V39, P817, DOI 10.1016/j.exphem.2011.05.002; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095	18	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e95184	10.1371/journal.pone.0095184	http://dx.doi.org/10.1371/journal.pone.0095184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893165	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400004
J	Zeng, T; Zhang, CL; Song, FY; Zhao, XL; Xie, KQ				Zeng, Tao; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin			CMZ Reversed Chronic Ethanol-Induced Disturbance of PPAR-alpha Possibly by Suppressing Oxidative Stress and PGC-1 alpha Acetylation, and Activating the MAPK and GSK3 beta Pathway	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; FATTY-ACID SYNTHESIS; MOLECULAR-MECHANISMS; RECEPTOR-ALPHA; GARLIC OIL; RAT-LIVER; HEPATIC STEATOSIS; OXIDANT STRESS; CYP2E1; CONTRIBUTES	Background: Cytochrome P4502E1 (CYP2E1) has been suggested to play critical roles in the pathogenesis of alcoholic fatty liver (AFL), but the underlying mechanisms remains unclear. The current study was designed to evaluate whether CYP2E1 suppression by chlormethiazole (CMZ) could suppress AFL in mice, and to explore the underlying mechanisms. Methods: Mice were treated with or without CMZ (50 mg/kg bw, i.p.) and subjected to liquid diet with or without ethanol (5%, w/v) for 4 weeks. Biochemical parameters were measured using commercial kits. The protein and mRNA levels were detected by western blot and qPCR, respectively. Histopathology and immunohistochemical assay were performed with routine methods. Results: CYP2E1 inhibition by CMZ completely blocked AFL in mice, shown as the decline of the hepatic and serum triglyceride levels, and the fewer fat droplets in the liver sections. Chronic ethanol exposure led to significant decrease of the mRNA and protein levels of peroxisome proliferator-activated receptor alpha (PPAR-alpha), which was blocked by CMZ co-treatment. CMZ co-treatment suppressed ethanol-induced oxidative stress, overproduction of tumor necrosis alpha (TNF-alpha), and decrease of protein levels of the PPAR-alpha co-activators including p300 and deacetylated PGC1-alpha. Furthermore, CMZ co-treatment led to the activation of AMP-activated protein kinase (AMPK), mitogen-activated protein kinase (MAPK), and PI3K/Akt/GSK3 beta pathway. However, chronic ethanol-induced decline of acyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) protein levels was partially restored by CMZ, while the activation of autophagy appeared to be suppressed by CMZ. Conclusion: These results suggested that CMZ suppressed chronic ethanol-induced oxidative stress, TNF-alpha overproduction, decline of p300 protein level and deacetylation of PGC1-alpha, and activated AMPK, MAPK, and PI3K/Akt/GSK3 beta pathway, which might contribute to the activation of PPAR-alpha and account for the protection of CMZ against AFL.	[Zeng, Tao; Zhang, Cui-Li; Song, Fu-Yong; Zhao, Xiu-Lan; Xie, Ke-Qin] Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China	Shandong University	Xie, KQ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Toxicol, Jinan 250100, Shandong, Peoples R China.	keqinx@sdu.edu.cn	Zeng, T/CAJ-0684-2022	Zeng, T/0000-0002-1145-2059	National Science Foundation of China [81102153]; China Postdoctoral Science Foundation [201104626]; Postdoctoral Science Foundation funded Project of Shandong Province [201002020]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation funded Project of Shandong Province	This work was supported by the National Science Foundation of China (Grant No. 81102153), the Special Financial Grant from the China Postdoctoral Science Foundation (Grant No. 201104626), and Postdoctoral Science Foundation funded Project of Shandong Province (Grant No. 201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Beier K, 1997, FEBS LETT, V412, P385, DOI 10.1016/S0014-5793(97)00805-3; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cederbaum AI, 2010, DIGEST DIS, V28, P802, DOI 10.1159/000324289; Cho K, 2009, J MED FOOD, V12, P1293, DOI 10.1089/jmf.2009.0085; Crabb David W., 1999, Keio Journal of Medicine, V48, P184; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; Day CP, 1998, HEPATOLOGY, V27, P1463, DOI 10.1002/hep.510270601; Ding WX, 2011, EXP BIOL MED, V236, P546, DOI 10.1258/ebm.2011.010360; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Donohue TM, 2007, WORLD J GASTROENTERO, V13, P4974; Eid N, 2013, J MOL HISTOL, V44, P311, DOI 10.1007/s10735-013-9483-x; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; He L, 2007, MOL ENDOCRINOL, V21, P2541, DOI 10.1210/me.2007-0036; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Ki SH, 2007, CHEM-BIOL INTERACT, V169, P80, DOI 10.1016/j.cbi.2007.05.008; Kong LB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-246; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; LEEVY CM, 1962, MEDICINE, V41, P249, DOI 10.1097/00005792-196209000-00003; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; LIEBER CS, 1965, J CLIN INVEST, V44, P1009, DOI 10.1172/JCI105200; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Medina J, 2005, DRUGS, V65, P2445, DOI 10.2165/00003495-200565170-00003; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Ogita S, 2011, TARGET ONCOL, V6, P103, DOI 10.1007/s11523-011-0176-7; Pahan K, 1997, FREE RADICAL BIO MED, V23, P963, DOI 10.1016/S0891-5849(97)00017-8; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Ramaiah SK, 2004, INT J TOXICOL, V23, P217, DOI 10.1080/10915810490502069; REINKE LA, 1987, P NATL ACAD SCI USA, V84, P9223, DOI 10.1073/pnas.84.24.9223; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Shearn CT, 2013, J NUTR BIOCHEM, V24, P1436, DOI 10.1016/j.jnutbio.2012.12.002; Shen Z., 2009, AM J PHYSL GASTROINT; SIMPSON KJ, 1994, CLIN SCI, V87, P441, DOI 10.1042/cs0870441; SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Wan YJY, 2001, HEPATOL RES, V19, P117, DOI 10.1016/S1386-6346(00)00089-9; Yin HQ, 2007, TOXICOL APPL PHARM, V223, P225, DOI 10.1016/j.taap.2007.06.018; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zeng T, 2013, BBA-GEN SUBJECTS, V1830, P4848, DOI 10.1016/j.bbagen.2013.06.028; Zeng T, 2012, TOXICOLOGY, V296, P56, DOI 10.1016/j.tox.2012.03.005; Zeng T, 2012, FOOD CHEM TOXICOL, V50, P485, DOI 10.1016/j.fct.2011.11.030; Zeng T, 2009, HUM EXP TOXICOL, V28, P777, DOI 10.1177/0960327109353057; Zeng T, 2009, ARCH TOXICOL, V83, P1075, DOI 10.1007/s00204-009-0457-4; Zhao ZW, 2011, ALCOHOL CLIN EXP RES, V35, P229, DOI 10.1111/j.1530-0277.2010.01338.x; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	55	35	41	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98658	10.1371/journal.pone.0098658	http://dx.doi.org/10.1371/journal.pone.0098658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892905	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400081
J	Hutcheson, R; Chaplin, J; Hutcheson, B; Borthwick, F; Proctor, S; Gebb, S; Jadhav, R; Smith, E; Russell, JC; Rocic, P				Hutcheson, Rebecca; Chaplin, Jennifer; Hutcheson, Brenda; Borthwick, Faye; Proctor, Spencer; Gebb, Sarah; Jadhav, Rashmi; Smith, Erika; Russell, James C.; Rocic, Petra			miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndrome	FASEB JOURNAL			English	Article						transient repetitive ischemia; insulin resistance; arteriogenesis; molecular mechanisms; cell cycle	ACTIVATION; ENDOSTATIN; ISCHEMIA; VESSELS; INSULIN; DISEASE; IMPACT; CELLS; VEGF; RAT	Inadequate cell proliferation is considered a major causative factor for impaired coronary collateral growth (CCG). Proangiogenic growth factors (GFs) stimulate cell proliferation, but their administration does not promote CCG in patients. These GFs are increased in patients with metabolic syndrome and in animal models, where CCG is impaired. Here, we investigated whether excessive cell proliferation underlies impaired CCG in metabolic syndrome. Normal [Sprague-Dawley (SD)] and metabolic syndrome [James C. Russell (JCR)] rats underwent repetitive ischemia (RI; transient, repetitive coronary artery occlusion and myocardial ischemia). We have shown that CCG was maximal at d 9 of RI in SD rats but did not occur in JCR rats. The increase in cell proliferation (PCNA, Ki-67, cyclin A, phospho-cdc2, p21Waf, p27Kip) was transient (similar to 4-fold, d 3 RI) in SD rats but greater and sustained in JCR rats (similar to 8- to 6-fold, d 3-9 RI). In JCR rats, this was associated with increased and sustained miR-21 expression and accumulation of proliferating synthetic vascular smooth muscle cells in the lumen of small arterioles, which failed to undergo outward expansion. Administration of anti-miR-21 blocked RI-induced cell proliferation and significantly improved CCG in JCR rats (similar to 60%). miR-21-dependent excessive cell proliferation in the later stages of collateral remodeling correlates with impaired CCG in metabolic syndrome.	[Hutcheson, Rebecca; Hutcheson, Brenda; Rocic, Petra] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Chaplin, Jennifer; Jadhav, Rashmi; Smith, Erika] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Gebb, Sarah] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Borthwick, Faye; Proctor, Spencer; Russell, James C.] Univ Alberta, Alberta Inst Human Nutr, Metab & Cardiovasc Dis Lab, Edmonton, AB, Canada	New York Medical College; University of South Alabama; University of South Alabama; University of Alberta	Rocic, P (corresponding author), New York Med Coll, Dept Pharmacol, 15 Dana Rd,BSB 502, Valhalla, NY 10595 USA.	petra_rocic@nymc.edu	JADHAV, RASHMI/GQI-2890-2022	Rocic, Petra/0000-0002-5781-3075; Proctor, Spencer/0000-0002-7597-5262	U.S. National Institutes of Health [R01HL093052]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093052] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by U.S. National Institutes of Health grant R01HL093052.	Cai WJ, 2009, MOL CELL BIOCHEM, V322, P161, DOI 10.1007/s11010-008-9953-8; Choy JS, 2009, AM J PHYSIOL-HEART C, V297, pH750, DOI 10.1152/ajpheart.01136.2008; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dodd T, 2013, ARTERIOSCL THROM VAS, V33, P1339, DOI 10.1161/ATVBAHA.113.301533; Dodd T, 2011, J MOL CELL CARDIOL, V51, P1015, DOI 10.1016/j.yjmcc.2011.08.012; Hattan N, 2007, BASIC RES CARDIOL, V102, P217, DOI 10.1007/s00395-007-0646-3; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hutcheson R, 2013, ARTERIOSCL THROM VAS, V33, P727, DOI 10.1161/ATVBAHA.112.301116; Hutcheson R, 2012, EXP DIABETES RES, DOI 10.1155/2012/271028; Jadhav R, 2011, AM J PHYSIOL-HEART C, V300, pH1938, DOI 10.1152/ajpheart.00282.2010; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jones WS, 2007, CURR OPIN CARDIOL, V22, P458, DOI 10.1097/HCO.0b013e328236741b; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Matsunaga T, 2003, AM J PHYSIOL-HEART C, V285, pH352, DOI 10.1152/ajpheart.00621.2002; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Rayner KJ, 2014, CIRC RES, V114, P183, DOI 10.1161/CIRCRESAHA.114.300645; Reed R, 2008, ARTERIOSCL THROM VAS, V28, P61, DOI 10.1161/ATVBAHA.107.154294; Reed R, 2009, AM J PHYSIOL-HEART C, V296, pH1811, DOI 10.1152/ajpheart.00920.2008; Ruiter MS, 2010, CLIN SCI, V119, P225, DOI 10.1042/CS20100082; Russell JC, 1998, MOL CELL BIOCHEM, V188, P113, DOI 10.1023/A:1006828724405; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Sasmaz H, 2009, ANGIOLOGY, V60, P164, DOI 10.1177/0003319708316007; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schneider DJ, 1998, DIABETOLOGIA, V41, P141, DOI 10.1007/s001250050882; Silvestri Pasquale, 2009, Recent Pat Cardiovasc Drug Discov, V4, P109; Sodha NR, 2009, AM J PHYSIOL-HEART C, V296, pH428, DOI 10.1152/ajpheart.00283.2008; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang Y, 2009, J NUTR, V139, P2049, DOI 10.3945/jn.109.109488; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	33	18	20	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4088	4099		10.1096/fj.14-251223	http://dx.doi.org/10.1096/fj.14-251223			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24903275	Green Published			2022-12-25	WOS:000340845900026
J	Skilandat, M; Sigel, RKO				Skilandat, Miriam; Sigel, Roland K. O.			The Role of Mg(II) in DNA Cleavage Site Recognition in Group II Intron Ribozymes SOLUTION STRUCTURE AND METAL ION BINDING SITES OF THE RNA.DNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HYBRID DUPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NUCLEIC-ACIDS; NMR STRUCTURE; EXON-BINDING; XPLOR-NIH; MG2+ IONS; IN-VIVO; MAGNESIUM	Group II intron ribozymes catalyze the cleavage of (and their reinsertion into) DNA and RNA targets using a Mg2+-dependent reaction. The target is cleaved 3' to the last nucleotide of intron binding site 1 (IBS1), one of three regions that form base pairs with the intron's exon binding sites (EBS1 to -3). We solved the NMR solution structure of the d3' hairpin of the Sc.ai5 gamma intron containing EBS1 in its 11-nucleotide loop in complex with the dIBS1 DNA 7-mer and compare it with the analogous RNA.RNA contact. The EBS1.dIBS1 helix is slightly flexible and non-symmetric. NMR data reveal two major groove binding sites for divalent metal ions at the EBS1.dIBS1 helix, and surface plasmon resonance experiments show that low concentrations of Mg2+ considerably enhance the affinity of dIBS1 for EBS1. Our results indicate that identification of both RNA and DNA IBS1 targets, presentation of the scissile bond, and stabilization of the structure by metal ions are governed by the overall structure of EBS1.dIBS1 and the surrounding loop nucleotides but are irrespective of different EBS1.(d)IBS1 geometries and interstrand affinities.	[Skilandat, Miriam; Sigel, Roland K. O.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland	University of Zurich	Sigel, RKO (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	roland.sigel@chem.uzh.ch	Sigel, Roland/O-9883-2016	Sigel, Roland/0000-0002-1307-7993	Swiss National Science Foundation [200021-124834]; University of Zurich; European Research Commission Starting Grant MIRNA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; European Research Commission Starting Grant MIRNA	This work was supported by Swiss National Science Foundation Grant 200021-124834 (to R. K. O. S.), the University of Zurich, and European Research Commission Starting Grant MIRNA (to R. K. O. S.).	ALLAIN FHT, 1995, NUCLEIC ACIDS RES, V23, P341, DOI 10.1093/nar/23.3.341; AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Barrientos-Duran A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-24; Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Bradshaw Patrick C, 2006, BMC Biochem, V7, P4, DOI 10.1186/1471-2091-7-4; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Chan RT, 2012, NAT STRUCT MOL BIOL, V19, P555, DOI 10.1038/nsmb.2270; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Cross CW, 1997, BIOCHEMISTRY-US, V36, P4096, DOI 10.1021/bi962382k; Curcio MJ, 1996, CELL, V84, P9, DOI 10.1016/S0092-8674(00)80987-3; de Lencastre A, 2005, NAT STRUCT MOL BIOL, V12, P626, DOI 10.1038/nsmb957; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donghi D, 2013, NUCLEIC ACIDS RES, V41, P2489, DOI 10.1093/nar/gks1179; Donghi D, 2011, METAL IONS LIFE SCI, V9, P197, DOI 10.1039/978184973251200197; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Erat MC, 2008, J BIOL INORG CHEM, V13, P1025, DOI 10.1007/s00775-008-0390-7; Erat MC, 2007, INORG CHEM, V46, P11224, DOI 10.1021/ic701627t; Erat MC, 2007, CHEMBIOCHEM, V8, P306, DOI 10.1002/cbic.200600459; Erat MC, 2011, METAL IONS LIFE SCI, V9, P37, DOI 10.1039/978184973251200037; Fedor MJ, 2002, CURR OPIN STRUC BIOL, V12, P289, DOI 10.1016/S0959-440X(02)00324-X; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Freisinger E, 2007, COORDIN CHEM REV, V251, P1834, DOI 10.1016/j.ccr.2007.03.008; Gallo S, 2005, CHIMIA, V59, P812, DOI 10.2533/000942905777675589; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Gordon PM, 2007, CHEM BIOL, V14, P607, DOI 10.1016/j.chembiol.2007.05.008; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; HUNG SH, 1994, NUCLEIC ACIDS RES, V22, P4326, DOI 10.1093/nar/22.20.4326; HURD RE, 1979, BIOCHEMISTRY-US, V18, P4012, DOI 10.1021/bi00585a026; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; Kieft JS, 1997, STRUCTURE, V5, P713, DOI 10.1016/S0969-2126(97)00225-6; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruschel D, 2014, RNA, V20, P295, DOI 10.1261/rna.041137.113; Kruschel D, 2008, J INORG BIOCHEM, V102, P2147, DOI 10.1016/j.jinorgbio.2008.08.006; Kurz JC, 2002, BIOCHEMISTRY-US, V41, P9545, DOI 10.1021/bi025553w; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; Mills DA, 1996, J BACTERIOL, V178, P3531, DOI 10.1128/jb.178.12.3531-3538.1996; Mohr G, 2000, GENE DEV, V14, P559; MORL M, 1992, CELL, V70, P803, DOI 10.1016/0092-8674(92)90313-2; Pechlaner M, 2012, METAL IONS LIFE SCI, V10, P1, DOI 10.1007/978-94-007-2172-2_1; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Qin PZ, 1999, J MOL BIOL, V291, P15, DOI 10.1006/jmbi.1999.2922; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Robinson H, 1996, NUCLEIC ACIDS RES, V24, P676, DOI 10.1093/nar/24.4.676; Rowinska-Zyrek M, 2013, Z ANORG ALLG CHEM, V639, P1313, DOI 10.1002/zaac.201300123; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; Schnabl J, 2012, NUCLEIC ACIDS RES, V40, pD434, DOI 10.1093/nar/gkr920; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SERAPHIN B, 1992, GENE, V113, P1, DOI 10.1016/0378-1119(92)90663-A; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SIGEL H, 1990, COORDIN CHEM REV, V100, P453, DOI 10.1016/0010-8545(90)85018-N; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Sigel RKO, 2005, EUR J INORG CHEM, P2281, DOI 10.1002/ejic.200401007; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Su LHJ, 2001, J MOL BIOL, V306, P655, DOI 10.1006/jmbi.2000.4323; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Swisher JF, 2002, J MOL BIOL, V315, P297, DOI 10.1006/jmbi.2001.5233; Tjandra N, 1997, J MAGN RESON, V124, P512, DOI 10.1006/jmre.1996.1088; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Varani G, 1996, PROG NUCL MAG RES SP, V29, P51, DOI 10.1016/0079-6565(96)01028-X; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang JM, 2010, ACTA CRYSTALLOGR D, V66, P988, DOI 10.1107/S0907444910029938; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; Xiang Q, 1998, BIOCHEMISTRY-US, V37, P3839, DOI 10.1021/bi972661n; Xiong Y, 2000, NUCLEIC ACIDS RES, V28, P2171, DOI 10.1093/nar/28.10.2171; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	107	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20650	20663		10.1074/jbc.M113.542381	http://dx.doi.org/10.1074/jbc.M113.542381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895129	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000339396600024
J	Lee, SC; Lin, CC; Wang, CH; Wu, PL; Huang, HW; Chang, CI; Wu, WG				Lee, Shao-Chen; Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Chang, Chung-I; Wu, Wen-guey			Endocytotic Routes of Cobra Cardiotoxins Depend on Spatial Distribution of Positively Charged and Hydrophobic Domains to Target Distinct Types of Sulfated Glycoconjugates on Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; PENETRATING PEPTIDES; LIPID RAFTS; CATHEPSIN-D; X-RAY; MEMBRANE; BINDING; VENOM; PATHWAY; DYNAMIN	Cobra cardiotoxins (CTX) are a family of three-fingered basic polypeptides known to interact with diverse targets such as heparan sulfates, sulfatides, and integrins on cell surfaces. After CTX bind to the membrane surface, they are internalized to intracellular space and exert their cytotoxicity via an unknown mechanism. By the combined in vitro kinetic binding, three-dimensional x-ray structure determination, and cell biology studies on the naturally abundant CTX homologues from the Taiwanese cobra, we showed that slight variations on the spatial distribution of positively charged or hydrophobic domains among CTX A2, A3, and A4 could lead to significant changes in their endocytotic pathways and action mechanisms via distinct sulfated glycoconjugate-mediated processes. The intracellular locations of these structurally similar CTX after internalization are shown to vary between the mitochondria and lysosomes via either dynamin2-dependent or -independent processes with distinct membrane cholesterol sensitivity. Evidence is presented to suggest that the shifting between the sulfated glycoconjugates as distinct targets of CTX A2, A3, and A4 might play roles in the co-evolutionary arms race between venomous snake toxins to cope with different membrane repair mechanisms at the cellular levels. The sensitivity of endocytotic routes to the spatial distribution of positively charged or hydrophobic domains may provide an explanation for the diverse endocytosis pathways of other cell-penetrating basic polypeptides.	[Lee, Shao-Chen] FuJen Catholic Univ, Sch Med, New Taipei City 24205, Taiwan; [Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Wu, Wen-guey] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Lin, Chien-Chu; Wang, Chia-Hui; Wu, Po-Long; Huang, Hsuan-Wei; Wu, Wen-guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Lin, Chien-Chu; Chang, Chung-I] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan	Fu Jen Catholic University; National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Wu, WG (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan.	lswwg@life.nthu.edu.tw		Huang, Hsuan-wei/0000-0003-2924-1118	National Science Council, Taiwan [NSC94-2311-B007-023, NSC98-2311-B007-009-MY3, NSC97-2311-B030-001, NSC101-2311-B-030-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NSC94-2311-B007-023 and NSC98-2311-B007-009-MY3 (to W.-G. W.) and NSC97-2311-B030-001 and NSC101-2311-B-030-002 (to S-C. L.) from the National Science Council, Taiwan.	BJORNSSON TD, 1988, J PHARMACOL EXP THER, V245, P804; Chen TS, 2005, BIOCHEMISTRY-US, V44, P7414, DOI 10.1021/bi050172e; CHIEN KY, 1994, J BIOL CHEM, V269, P14473; Cleal K, 2013, CURR PHARM DESIGN, V19, P2878; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gupta A, 2011, EUR BIOPHYS J BIOPHY, V40, P727, DOI 10.1007/s00249-011-0685-4; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h; Kuo JH, 2013, J BIOL CHEM, V288, P13522, DOI 10.1074/jbc.M113.455329; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SC, 2005, J BIOL CHEM, V280, P9567, DOI 10.1074/jbc.M412398200; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P159; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nugent MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P726, DOI 10.1134/S0006297913070055; Ohara K, 2013, PEPTIDES, V50, P28, DOI 10.1016/j.peptides.2013.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Patel HV, 1997, J BIOL CHEM, V272, P1484, DOI 10.1074/jbc.272.32.20185; Patel LN, 2007, PHARM RES, V24, P1977, DOI 10.1007/s11095-007-9303-7; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Su SH, 2003, TOXICOL APPL PHARM, V193, P97, DOI 10.1016/S0041-008X(03)00327-2; Tang Q, 2012, LANGMUIR, V28, P16126, DOI 10.1021/la303299s; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang CH, 2005, TOXICON, V46, P430, DOI 10.1016/j.toxicon.2005.06.012; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; Wu MY, 2013, AM J CHINESE MED, V41, P643, DOI 10.1142/S0192415X13500456; Yamano S, 2011, J CONTROL RELEASE, V152, P278, DOI 10.1016/j.jconrel.2011.02.004; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	56	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20170	20181		10.1074/jbc.M114.557157	http://dx.doi.org/10.1074/jbc.M114.557157			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898246	hybrid, Green Published			2022-12-25	WOS:000339395200030
J	Munoz, P; Lopez, C; Moralejo, M; Perez-Hedo, M; Eizaguirre, M				Munoz, Pilar; Lopez, Carmen; Moralejo, Marian; Perez-Hedo, Meritxell; Eizaguirre, Matilde			Response of Last Instar Helicoverpa armigera Larvae to Bt Toxin Ingestion: Changes in the Development and in the CYP6AE14, CYP6B2 and CYP9A12 Gene Expression	PLOS ONE			English	Article							SESAMIA-NONAGRIOIDES LEPIDOPTERA; CYTOCHROMES P450; CORN-BORER; INSECTICIDE RESISTANCE; TOBACCO HORNWORM; MAIZE; PERFORMANCE; NOCTUIDAE; INDUCTION; CYP6CM1	Bt crops are able to produce Cry proteins, which were originally present in Bacillus thuringiensis bacteria. Although Bt maize is very efficient against corn borers, Spanish crops are also attacked by the earworm H. armigera, which is less susceptible to Bt maize. Many mechanisms could be involved in this low susceptibility to the toxin, including the insect's metabolic resistance to toxins due to cytochrome P450 monooxygenases. This paper examines the response of last instar H. armigera larvae to feeding on a diet with Bt and non-Bt maize leaves in larval development and in the gene expression of three P450 cytochromes: CYP6AE14, CYP6B2 and CYP9A12. Larvae fed on sublethal amounts of the Bt toxin showed reduced food ingestion and reduced growth and weight, preventing most of them from achieving the critical weight and pupating; additionally, after feeding for one day on the Bt diet the larvae showed a slight increase in juvenile hormone II in the hemolymp. Larvae fed on the non-Bt diet showed the highest CYP6AE14, CYP6B2 and CYP9A12 expression one day after feeding on the non-Bt diet, and just two days later the expression decreased abruptly, a finding probably related to the developmental programme of the last instar. Moreover, although the response of P450 genes to plant allelochemicals and xenobiotics has been related in general to overexpression in the resistant insect, or induction of the genes when feeding takes place, the expression of the three genes studied was suppressed in the larvae feeding on the Bt toxin. The unexpected inhibitory effect of the Cry1Ab toxin in the P450 genes of H. armigera larvae should be thoroughly studied to determine whether this response is somehow related to the low susceptibility of the species to the Bt toxin.	[Munoz, Pilar; Lopez, Carmen; Eizaguirre, Matilde] Univ Lleida, Agrotecnio Ctr, Lleida, Spain; [Perez-Hedo, Meritxell] Univ Lleida, Crop Forest Sci Dept, Lleida, Spain; [Moralejo, Marian] Univ Lleida, Dept Chem, Lleida, Spain	Universitat de Lleida; Universitat de Lleida; Universitat de Lleida	Eizaguirre, M (corresponding author), Univ Lleida, Agrotecnio Ctr, Lleida, Spain.	eizaguirre@pvcf.udl.cat	Lopez, Carmen/K-9280-2014; Eizaguirre, Matilde/B-4109-2011; Muñoz, Pilar/K-9261-2014; Perez-Hedo, Meritxell/O-6441-2019; Moralejo, Marian/L-5351-2014	Lopez, Carmen/0000-0001-5447-009X; Eizaguirre, Matilde/0000-0001-9371-3314; Muñoz, Pilar/0000-0001-9700-374X; Perez-Hedo, Meritxell/0000-0003-3411-0761; Moralejo, Marian/0000-0003-4667-6770	Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia) [AGL2011-23996]	Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia)	This work was supported by a grant from the Spanish R&D Agency (Comision Interministerial de Ciencia y Tecnologia) through project AGL2011-23996. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, COMPREHENSIVE INSECT; Baek JH, 2010, PESTIC BIOCHEM PHYS, V96, P43, DOI 10.1016/j.pestbp.2009.08.014; Barry BD, 2000, J ECON ENTOMOL, V93, P993, DOI 10.1603/0022-0493-93.3.993; Bautista MAM, 2007, PESTIC BIOCHEM PHYS, V87, P85, DOI 10.1016/j.pestbp.2006.06.004; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; BERNARD L, 1993, PESTIC BIOCHEM PHYS, V46, P171, DOI 10.1006/pest.1993.1048; Brun-Barale A, 2010, PEST MANAG SCI, V66, P900, DOI 10.1002/ps.1960; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DAUTERMAN WC, 1985, COMPREHENSIVE INSECT, V12, P713; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Fan YL, 1999, INSECT BIOCHEM MOLEC, V29, P635, DOI 10.1016/S0965-1748(99)00041-7; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gonzalez-Cabrera J, 2013, INSECT BIOCHEM MOLEC, V43, P635, DOI 10.1016/j.ibmb.2013.04.001; Hodgson E, 1985, COMPREHENSIVE INSECT, P225; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; *MAN, 1997, STATGR PLUS VERS 3 0; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Martinez SS, 1999, B ENTOMOL RES, V89, P65, DOI 10.1017/S0007485399000085; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Perez-Hedo M, 2012, B ENTOMOL RES, V102, P737, DOI 10.1017/S0007485312000351; Perez-Hedo M, 2011, IOBC WPRS B, V73, P75; Perez-Hedo M, 2013, ENTOMOL EXP APPL, V148, P56, DOI 10.1111/eea.12074; Perez-Hedo M, 2011, J ECON ENTOMOL, V104, P853, DOI 10.1603/EC10449; Rupasinghe SG, 2007, PROTEIN ENG DES SEL, V20, P615, DOI 10.1093/protein/gzm063; SAS Institute Inc, 2008, JMP 8 0; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Slansky F. Jr, 1985, P87; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Vilaro F, 2012, J AGR FOOD CHEM, V60, P3020, DOI 10.1021/jf204621h; Yu YS, 2007, J ECON ENTOMOL, V100, P1188, DOI 10.1603/0022-0493(2007)100[1188:CILOJH]2.0.CO;2; Zhang H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.002287420:615-624., DOI 10.1371/J0URNAL.P0NE.002287420615-624]; Zhang XT, 2013, EUR J ENTOMOL, V110, P39, DOI 10.14411/eje.2013.005; Zhao GD, 2011, PESTIC BIOCHEM PHYS, V100, P251, DOI 10.1016/j.pestbp.2011.04.009; Zhou XJ, 2010, PESTIC BIOCHEM PHYS, V97, P209, DOI 10.1016/j.pestbp.2010.02.003	41	15	15	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99229	10.1371/journal.pone.0099229	http://dx.doi.org/10.1371/journal.pone.0099229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910993	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600059
J	Lopez-Guimera, G; Dashti, HS; Smith, CE; Sanchez-Carracedo, D; Ordovas, JM; Garaulet, M				Lopez-Guimera, Gemma; Dashti, Hassan S.; Smith, Caren E.; Sanchez-Carracedo, David; Ordovas, Jose M.; Garaulet, Marta			CLOCK 3111 T/C SNP Interacts with Emotional Eating Behavior for Weight-Loss in a Mediterranean Population	PLOS ONE			English	Article							FOOD-INTAKE; METABOLIC SYNDROME; LOSS MAINTENANCE; LIFE-STYLE; OBESITY; OVERWEIGHT; GENE; STRESS; PREDICTORS; WOMEN	Objective: The goals of this research was (1) to analyze the role of emotional eating behavior on weight-loss progression during a 30-week weight-loss program in 1,272 individuals from a large Mediterranean population and (2) to test for interaction between CLOCK 3111 T/C SNP and emotional eating behavior on the effectiveness of the weight-loss program. Design and Methods: A total of 1,272 overweight and obese participants (BMI: 31 +/- 5 kg/m(2)), aged 20 to 65 years, attending outpatient weight-loss clinics were recruited for this analysis. Emotional eating behavior was assessed by the Emotional Eating Questionnaire (EEQ), a questionnaire validated for overweight and obese Spanish subjects. Anthropometric measures, dietary intake and weight-loss progression were assessed and analyzed throughout the 30-week program. Multivariate analysis and linear regression models were performed to test for gene-environment interaction. Results: Weight-loss progression during the 30-week program differed significantly according to the degree of emotional eating behavior. Participants classified as 'very emotional eaters' experienced more irregular (P = 0.007) weight-loss, with a lower rate of weight decline (-0.002 vs. -0.003, P<0.05) in comparison with less emotional eaters. The percentage of weight-loss was also significantly higher in 'non-emotional eaters' (P = 0.009). Additionally, we identified a significant gene-environment interaction associated with weight-loss at the CLOCK 3111 T/C locus (P = 0.017). By dichotomizing the emotional eating behavior score, linear regression analysis indicated that minor C allele carriers with a high emotional score (> = 11), lost significantly less weight than those C carriers with a low emotional score (<11) (P = 0.005). Conclusions: Emotional eating behavior associates with weight-loss pattern, progression and total weight-loss. Additionally, CLOCK 3111 T/C SNP interacts with emotional eating behavior to modulate total weight loss. These results suggest that the assessment of this locus and emotional eating behavior could improve the development of effective, long-tern weight-management interventions.	[Lopez-Guimera, Gemma; Sanchez-Carracedo, David] Univ Autonoma Barcelona, Dept Clin & Hlth Psychol, E-08193 Barcelona, Spain; [Dashti, Hassan S.; Smith, Caren E.; Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Garaulet, Marta] Univ Murcia, Dept Physiol, Murcia, Spain; [Ordovas, Jose M.] CNIC, Dept Epidemiol, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain	Autonomous University of Barcelona; Tufts University; United States Department of Agriculture (USDA); University of Murcia; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Murcia, Spain.	garaulet@um.es	Greiver, Michelle/N-8764-2015; Sánchez-Carracedo, David/A-4505-2009; Garaulet, Marta/K-6625-2014; Ordovas, Jose/B-8727-2013	Greiver, Michelle/0000-0001-8957-0285; Sánchez-Carracedo, David/0000-0002-3945-6940; Garaulet, Marta/0000-0002-4066-3509; Dashti, Hassan/0000-0002-1650-679X; Ordovas, Jose/0000-0002-7581-5680	NHLBI NIH HHS [HL-54776, K08 HL112845, R01 HL054776] Funding Source: Medline; NIDDK NIH HHS [DK075030, R01 DK075030] Funding Source: Medline; NIMHD NIH HHS [L60 MD003562] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776, K08HL112845] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Bandin C, 2013, INT J OBESITY, V37, P1044, DOI 10.1038/ijo.2012.180; Bandin C, 2014, INT J OBESITY, V38, P1083, DOI 10.1038/ijo.2013.211; Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x; Benedetti F, 2003, AM J MED GENET B, V123B, P23, DOI 10.1002/ajmg.b.20038; BLAIR AJ, 1990, APPETITE, V15, P151, DOI 10.1016/0195-6663(90)90047-C; Bond DS, 2009, INT J OBESITY, V33, P173, DOI 10.1038/ijo.2008.256; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bryant EJ, 2008, OBES REV, V9, P409, DOI 10.1111/j.1467-789X.2007.00426.x; Carter FA, 2012, APPETITE, V58, P1063, DOI 10.1016/j.appet.2012.01.016; Corbalan-Tutau M.D., 2009, REV ESP OBES, V7, P144; Corbalan MD, 2009, NUTRITION, V25, P861, DOI 10.1016/j.nut.2009.02.013; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Evers C, 2010, PERS SOC PSYCHOL B, V36, P792, DOI 10.1177/0146167210371383; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2012, INT J OBESITY, V36, P1436, DOI 10.1038/ijo.2011.270; Garaulet M, 2012, NUTR HOSP, V27, P645, DOI [10.3305/nh.2012.27.2.5659, 10.1590/S0212-16112012000200043]; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 1999, J HUM NUTR DIET, V12, P219, DOI 10.1046/j.1365-277x.1999.00163.x; Garaulet M, 2010, J AM DIET ASSOC, V110, P917, DOI 10.1016/j.jada.2010.03.017; Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435; Garaulet M, 2010, ADV DRUG DELIVER REV, V62, P967, DOI 10.1016/j.addr.2010.05.005; Garaulet M, 2010, EUR J HUM GENET, V18, P364, DOI 10.1038/ejhg.2009.176; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Hainer V, 2008, DIABETES CARE, V31, pS269, DOI 10.2337/dc08-s265; Hays NP, 2008, OBESITY, V16, P52, DOI 10.1038/oby.2007.12; Jansen A, 2008, APPETITE, V51, P556, DOI 10.1016/j.appet.2008.04.009; KARLSSON J, 1994, APPETITE, V23, P15, DOI 10.1006/appe.1994.1031; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Konttinen H, 2010, APPETITE, V54, P473, DOI 10.1016/j.appet.2010.01.014; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; LAVERY MA, 1993, J AM DIET ASSOC, V93, P1017, DOI 10.1016/0002-8223(93)92041-U; Leblanc V, 2012, CLIN NUTR, V31, P481, DOI 10.1016/j.clnu.2011.12.013; Macht M, 2003, PHYSIOL BEHAV, V80, P367, DOI 10.1016/j.physbeh.2003.08.012; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Mann T, 2007, AM PSYCHOL, V62, P220, DOI 10.1037/0003-066X.62.3.220; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Nguyen-Michel ST, 2007, APPETITE, V49, P494, DOI 10.1016/j.appet.2007.03.005; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Royal JD, 2010, PERS INDIV DIFFER, V49, P565, DOI 10.1016/j.paid.2010.04.022; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Serra-Majem L, 2001, PUBLIC HEALTH NUTR, V4, P1409, DOI 10.1079/PHN2001229; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Sherwood NE, 1999, INT J OBESITY, V23, P485, DOI 10.1038/sj.ijo.0800846; Teixeira Pedro J, 2004, Int J Behav Nutr Phys Act, V1, P12; Teixeira PJ, 2010, OBESITY, V18, P725, DOI 10.1038/oby.2009.281; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Teixeira PJ, 2002, J BEHAV MED, V25, P499, DOI 10.1023/A:1020687832448; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; Wallis DJ, 2009, APPETITE, V52, P355, DOI 10.1016/j.appet.2008.11.007; Wallis DJ, 2004, APPETITE, V43, P39, DOI 10.1016/j.appet.2004.02.001; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	58	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99152	10.1371/journal.pone.0099152	http://dx.doi.org/10.1371/journal.pone.0099152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905098	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000106
J	Phua, DCY; Xu, JL; Ali, SM; Boey, A; Gounko, NV; Hunziker, W				Phua, Dominic C. Y.; Xu, Jianliang; Ali, Safiah Mohamed; Boey, Adrian; Gounko, Natalia V.; Hunziker, Walter			ZO-1 and ZO-2 Are Required for Extra-Embryonic Endoderm Integrity, Primitive Ectoderm Survival and Normal Cavitation in Embryoid Bodies Derived from Mouse Embryonic Stem Cells	PLOS ONE			English	Article							TIGHT-JUNCTION; MOLECULE PODOCALYXIN; BASEMENT-MEMBRANES; LACKING EXPRESSION; ZONULA OCCLUDENS; MAGUK PROTEIN; IDENTIFICATION; POLARIZATION; EZRIN; GENE	The Zonula Occludens proteins ZO-1 and ZO-2 are cell cell junction-associated adaptor proteins that are essential for the structural and regulatory functions of tight junctions in epithelial cells and their absence leads to early embryonic lethality in mouse models. Here, we use the embryoid body, an in vitro pen-implantation mouse embryogenesis model, to elucidate and dissect the roles ZO-1 and ZO-2 play in epithelial morphogenesis and de novo tight junction assembly. Through the generation of individual or combined ZO-1 and ZO-2 null embryoid bodies, we show that their dual deletion prevents tight junction formation, resulting in the disorganization and compromised barrier function of embryoid body epithelial layers. The disorganization is associated with poor microvilli development, fragmented basement membrane deposition and impaired cavity formation, all of which are key epithelial tissue morphogenetic processes. Expression of Podocalyxin, which positively regulates the formation of microvilli and the apical membrane, repressed in embryoid bodies lacking both ZO-1 and ZO-2 and this correlates with an aberrant subrnembranous localization of Ezrin. The null embryoid bodies thus give an insight into how the two ZO proteins influence early mouse embryogenesis and possible mechanisms underlying the embryonic lethal phenotype.	[Phua, Dominic C. Y.; Xu, Jianliang; Ali, Safiah Mohamed; Boey, Adrian; Gounko, Natalia V.; Hunziker, Walter] ASTAR, Inst Mol & Cell Biol IMCB, Epithelial Cell Biol Lab, Singapore, Singapore; [Boey, Adrian; Gounko, Natalia V.] ASTAR, IMB IMCB Joint Electron Microscopy Suite, Singapore, Singapore; [Hunziker, Walter] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hunziker, Walter] Singapore Eye Res Inst SERI, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Hunziker, W (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, Epithelial Cell Biol Lab, Singapore, Singapore.	hunziker@imcb.a-star.edu.sg	Gounko, Natalia/N-4102-2019; Hunziker, Walter/B-3140-2010; Gounko, Natalia V/J-9085-2015; Hunziker, Walter/GSM-8190-2022	Gounko, Natalia/0000-0003-0791-9477; Hunziker, Walter/0000-0002-5265-4933; Boey, Adrian/0000-0003-2835-6159; Xu, Jianliang/0000-0002-2277-2197; Mohamed Ali, Safiah/0000-0003-1821-2581	Agency for Science and Technology and Research (A*STAR), Singapore	Agency for Science and Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science and Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, MOL CELL BIOL, V26, P9003, DOI 10.1128/MCB.01811-05; AHMADZADEH C, 1971, IMMUNOLOGY, V21, P1065; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bielinska M, 1996, BLOOD, V88, P3720, DOI 10.1182/blood.V88.10.3720.bloodjournal88103720; Bielinska M, 1999, INT J DEV BIOL, V43, P183; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hernandez S, 2007, EXP CELL RES, V313, P1533, DOI 10.1016/j.yexcr.2007.01.026; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2013, J CELL SCI, V126, P3585, DOI 10.1242/jcs.122325; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Li Shaohua, 2006, V329, P113; Liu J, 2009, J CELL SCI, V122, P233, DOI 10.1242/jcs.037663; Lopez-Bayghen Esther, 2006, P76; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sheth B, 2008, EXP CELL RES, V314, P3356, DOI 10.1016/j.yexcr.2008.08.021; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Takeda Tetsuro, 2003, Clin Exp Nephrol, V7, P260, DOI 10.1007/s10157-003-0257-8; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Wang DS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00037; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Xu JL, 2008, MOL CELL BIOL, V28, P1669, DOI 10.1128/MCB.00891-07; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yasuda T, 2012, MOL BIOL CELL, V23, P3229, DOI 10.1091/mbc.E12-02-0104; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	68	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99532	10.1371/journal.pone.0099532	http://dx.doi.org/10.1371/journal.pone.0099532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905925	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000124
J	Picard, N; Liang, JJ				Picard, Nicolas; Liang, Jingjing			Matrix Models for Size-Structured Populations: Unrealistic Fast Growth or Simply Diffusion?	PLOS ONE			English	Article							INTEGRAL PROJECTION MODELS; FINDING CONFIDENCE-LIMITS; ELASTICITY ANALYSIS; DYNAMICS; FOREST; RATES; RECONCILIATION; CONSTRUCTION; HYPOTHESIS; MANAGEMENT	Matrix population models are widely used to study population dynamics but have been criticized because their outputs are sensitive to the dimension of the matrix (or, equivalently, to the class width). This sensitivity is concerning for the population growth rate (lambda) because this is an intrinsic characteristic of the population that should not depend on the model specification. It has been suggested that the sensitivity of lambda to matrix dimension was linked to the existence of fast pathways (i.e. the fraction of individuals that systematically move up a class), whose proportion increases when class width increases. We showed that for matrix population models with growth transition only from class i to class i + 1, lambda was independent of the class width when the mortality and the recruitment rates were constant, irrespective of the growth rate. We also showed that if there were indeed fast pathways, there were also in about the same proportion slow pathways (i.e. the fraction of individuals that systematically remained in the same class), and that they jointly act as a diffusion process (where diffusion here is the movement in size of an individual whose size increments are random according to a normal distribution with mean zero). For 53 tree species from a tropical rain forest in the Central African Republic, the diffusion resulting from common matrix dimensions was much stronger than would be realistic. Yet, the sensitivity of lambda to matrix dimension for a class width in the range 1-10 cm was small, much smaller than the sampling uncertainty on the value of lambda Moreover, lambda could either increase or decrease when class width increased depending on the species. Overall, even if the class width should be kept small enough to limit diffusion, it had little impact on the estimate of lambda for tree species.	[Picard, Nicolas] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France; [Liang, Jingjing] W Virginia Univ, Div Forestry & Nat Resources, Morgantown, WV 26506 USA	CIRAD; West Virginia University	Picard, N (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR Biens & Serv Ecosyst Forestiers Trop BSEF, Montpellier, France.	nicolas.picard@cirad.fr	Picard, Nicolas/T-2447-2018; Liang, Jingjing/AAM-1913-2021	Picard, Nicolas/0000-0001-5548-9171; Liang, Jingjing/0000-0001-9439-9320				ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; ANDERSON TW, 1957, ANN MATH STAT, V28, P89, DOI 10.1214/aoms/1177707039; Batabyal AA, 1996, ECOL MODEL, V89, P67, DOI 10.1016/0304-3800(95)00122-0; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; CASWELL H, 1978, ECOLOGY, V59, P53, DOI 10.2307/1936631; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Coulson T, 2012, OIKOS, V121, P1337, DOI 10.1111/j.1600-0706.2012.00035.x; Cushing J. M., 1998, CBMS NSF REGIONAL C, V71; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; ENRIGHT NJ, 1995, OECOLOGIA, V104, P79, DOI 10.1007/BF00365565; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; GOODMAN LA, 1967, J R STAT SOC SER A-G, V130, P541, DOI 10.2307/2982523; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; HARA T, 1994, ANN BOT-LONDON, V73, P285, DOI 10.1006/anbo.1994.1034; HARRISON TP, 1985, FOREST SCI, V31, P850; Henson SM, 1998, J MATH BIOL, V37, P309, DOI 10.1007/s002850050131; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Hooley D.E, 2000, COLL MATH J, V31, P297; HOULLIER F, 1989, MATH BIOSCI, V95, P161, DOI 10.1016/0025-5564(89)90030-8; HOULLIER F, 1986, MATH BIOSCI, V79, P185, DOI 10.1016/0025-5564(86)90147-1; Hurst JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026670; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; ITO K, 1991, SIAM J NUMER ANAL, V28, P923, DOI 10.1137/0728050; KEYFITZ N, 1967, J R STAT SOC SER A-G, V130, P61, DOI 10.2307/2344038; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Liang JJ, 2013, FOREST SCI, V59, P359, DOI 10.5849/forsci.11-123; LIU LF, 1987, J MATH BIOL, V25, P73, DOI 10.1007/BF00275889; Logofet DO, 2008, ECOL MODEL, V216, P217, DOI 10.1016/j.ecolmodel.2008.03.004; Marescot L, 2012, ECOL MODEL, V232, P91, DOI 10.1016/j.ecolmodel.2012.02.017; MOLONEY KA, 1986, OECOLOGIA, V69, P176, DOI 10.1007/BF00377618; Nelson ESD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013628; Pfister CA, 2005, ECOLOGY, V86, P2673, DOI 10.1890/04-1952; Picard N, 2003, FOREST ECOL MANAG, V180, P389, DOI 10.1016/S0378-1127(02)00653-9; Picard N, 2007, ECOL MODEL, V204, P59, DOI 10.1016/j.ecolmodel.2006.12.016; Picard N, 2010, ECOL MODEL, V221, P2270, DOI 10.1016/j.ecolmodel.2010.06.010; Picard N, 2009, CAN J FOREST RES, V39, P2138, DOI 10.1139/X09-103; Picard N, 2009, MATH BIOSCI, V219, P23, DOI 10.1016/j.mbs.2009.02.002; Press W. H., 2007, NUMERICAL RECIPES AR, V3rd, P1235; Ramula S, 2005, OIKOS, V111, P563, DOI 10.1111/j.0030-1299.2005.13808.x; Ramula S, 2009, J APPL ECOL, V46, P1048, DOI 10.1111/j.1365-2664.2009.01706.x; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; Salguero-Gomez R, 2010, AM NAT, V176, P710, DOI 10.1086/657044; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Stott I, 2010, J ECOL, V98, P302, DOI 10.1111/j.1365-2745.2009.01632.x; Suzuki T., 1974, GROWTH MODELS TREE S, P358; Tibshirani R., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Torres L, 2008, ECOL MODEL, V218, P307, DOI 10.1016/j.ecolmodel.2008.07.007; URIBE G., 1993, THESIS U ARIZONA TUC; USHER MB, 1966, J APPL ECOL, V3, P355, DOI 10.2307/2401258; USHER MB, 1969, BIOMETRICS, V25, P309, DOI 10.2307/2528791; VANDERMEER J, 1978, OECOLOGIA, V32, P79, DOI 10.1007/BF00344691; VANDERMEER JH, 1975, BIOMETRICS, V31, P239, DOI 10.2307/2529726; Yearsley JM, 2002, MATH BIOSCI, V179, P131, DOI 10.1016/S0025-5564(02)00119-0; Zavala MA, 2007, J THEOR BIOL, V244, P440, DOI 10.1016/j.jtbi.2006.08.024; Zhou M, 2004, ECOL MODEL, V180, P291, DOI 10.1016/j.ecolmodel.2004.04.023; ZUIDEMA P. A., 2006, DEMOGRAPHY THREATENE, P107; Zuidema PA, 2010, J ECOL, V98, P345, DOI 10.1111/j.1365-2745.2009.01626.x	59	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98254	10.1371/journal.pone.0098254	http://dx.doi.org/10.1371/journal.pone.0098254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905941	Green Published, gold			2022-12-25	WOS:000341869000026
J	Wu, CY; Lin, F; Qiu, SW; Jiang, ZL				Wu, Chuyan; Lin, Feng; Qiu, Shuwei; Jiang, Zhongli			The Characterization of Obese Polycystic Ovary Syndrome Rat Model Suitable for Exercise Intervention	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; NERVE GROWTH-FACTOR; INSULIN-RESISTANCE; METABOLIC SYNDROME; FEMALE RATS; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; DIET; WOMEN; RISK	Objective: To develop a new polycystic ovary syndrome (PCOS) rat model suitable for exercise intervention. Method: Thirty six rats were randomly divided into three experimental groups: PCOS rats with high-fat diet (PF, n = 24), PCOS rats with ordinary diet (PO, n = 6), and control rats with ordinary diet (CO, n = 6). Two kinds of PCOS rat model were made by adjustment diet structure and testosterone injection for 28 days. After a successful animal model, PF model rats were randomly assigned to three groups: exercise with a continuation of high-fat diet (PF-EF, n = 6), sedentary with a continuation of high-fat diet (PF-SF, n = 6), exercise with an ordinary diet (PF-EO, n = 6). Fasting blood glucose (FBG) and insulin (FINS), estrogen (E2), progesterone (P), and testosterone (T) in serum were determined by RIA, and ovarian morphology was evaluated by Image-Pro plus 6.0. Results: Body weight, Lee index, FINS increased significantly in PF rat model. Serum levels of E2 and T were significantly higher in PF and PO than in CO. Ovary organ index and ovarian areas were significant lower in PF than in CO. After intervention for 2 weeks, the levels of 1 h postprandial blood glucose (PBG(1)), 2 h postprandial blood glucose (PBG(2)), FINS and the serum levels of T decreased significantly in PF-EF rats and PF-EO rats. The ratio of FBG/FINS was significant higher in PF-EO rats than in PF-SF rats. Ovarian morphology showed that the numbers of preantral follicles and atretic follicles decreased significantly, and the numbers of antral follicles and corpora lutea increased significantly in the rats of PF-EF and PF-EO. Conclusion: By combination of high-fat diet and testosterone injection, the obese PCOS rat model is conformable with the lifestyle habits of fatty foods and insufficient exercise, and has metabolic and reproductive characteristics of human PCOS. This model can be applied to study exercise intervention.	[Wu, Chuyan; Lin, Feng; Qiu, Shuwei; Jiang, Zhongli] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Jiang, ZL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China.	jiangzh3721@163.com	wu, chuyan/ABH-1698-2021					Al-Nozha Omar, 2013, Pathophysiology, V20, P131, DOI 10.1016/j.pathophys.2013.03.002; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Beloosesky R, 2004, INT J MOL MED, V14, P207; Benrick A, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/964070; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Cataldo NA, 2006, HUM REPROD, V21, P109, DOI 10.1093/humrep/dei289; Cavagni J, 2013, ARCH ORAL BIOL, V58, P1034, DOI 10.1016/j.archoralbio.2013.03.006; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Diamanti-Kandarakis E, 2007, J MOL MED-JMM, V85, P1413, DOI 10.1007/s00109-007-0246-6; Diamanti-Kandarakis E, 2012, CURR PHARM DESIGN, V18, P270, DOI 10.2174/138161212799040457; Douglas CC, 2006, FERTIL STERIL, V85, P679, DOI 10.1016/j.fertnstert.2005.08.045; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Flanagan AM, 2008, J NUTR BIOCHEM, V19, P505, DOI 10.1016/j.jnutbio.2007.06.005; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Guzick DS, 2007, CLIN OBSTET GYNECOL, V50, P255, DOI 10.1097/GRF.0b013e31802f361e; HAMILTONFAIRLEY D, 1993, CLIN ENDOCRINOL, V39, P363, DOI 10.1111/j.1365-2265.1993.tb02378.x; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hoeger KM, 2007, CLIN OBSTET GYNECOL, V50, P277, DOI 10.1097/GRF.0b013e31802f54c8; Khorram O, 2006, FERTIL STERIL, V85, P1448, DOI 10.1016/j.fertnstert.2005.10.042; LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690; Liu GT, 2005, REPROD NUTR DEV, V45, P185, DOI 10.1051/rnd:2005010; Lord JM, 2006, BRIT MED J, V332, P609, DOI 10.1136/bmj.332.7541.609-a; Lunger F, 2013, GYNECOL ENDOCRINOL, V29, P541, DOI 10.3109/09513590.2013.774362; Maliqueo M, 2013, ENDOCRINOLOGY, V154, P434, DOI 10.1210/en.2012-1693; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Manni L, 2005, J NEUROENDOCRINOL, V17, P846, DOI 10.1111/j.1365-2826.2005.01378.x; Moran LJ, 2013, HUM REPROD, V28, P2276, DOI 10.1093/humrep/det256; Morifuji M, 2006, BRIT J NUTR, V96, P469, DOI 10.1079/BJN20061855; National Institute of Clinical Excellence, 2004, FERT ASS TREATM PEOP; Norman RJ, 2004, MED J AUSTRALIA, V180, P132, DOI 10.5694/j.1326-5377.2004.tb05838.x; Norman RJ, 2002, TRENDS ENDOCRIN MET, V13, P251, DOI 10.1016/S1043-2760(02)00612-4; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Palomba S, 2008, HUM REPROD, V23, P642, DOI 10.1093/humrep/dem391; Qiu S, 2009, HORM METAB RES, V41, P880, DOI 10.1055/s-0029-1234119; Rajaie S, 2014, NUTRITION, V30, P61, DOI 10.1016/j.nut.2013.06.011; Schuering Andreas N., 2008, Gynaekologisch-Geburtshilfliche Rundschau, V48, P9, DOI 10.1159/000111465; Shi D, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.006; Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497; Stener-Victorin E, 2004, BIOL REPROD, V70, P329, DOI 10.1095/biolreprod.103.022368; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Tierney AC, 2011, INT J OBESITY, V35, P800, DOI 10.1038/ijo.2010.209; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; Vignesh JP, 2007, J POSTGRAD MED, V53, P128; Yildiz BO, 2008, J CLIN ENDOCR METAB, V93, P162, DOI 10.1210/jc.2007-1834; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045; Zhao S, 2008, J ANIM PHYSIOL AN N, V92, P105, DOI 10.1111/j.1439-0396.2007.00723.x	49	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99155	10.1371/journal.pone.0099155	http://dx.doi.org/10.1371/journal.pone.0099155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905232	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000107
J	Huang, FY; Wong, DKH; Seto, WK; Zhang, AY; Lee, CK; Lin, CK; Fung, J; Lai, CL; Yuen, MF				Huang, Fung-Yu; Wong, Danny Ka-Ho; Seto, Wai-Kay; Zhang, An-Ye; Lee, Cheuk-Kwong; Lin, Che-Kit; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung			Sequence Variations of Full-Length Hepatitis B Virus Genomes in Chinese Patients with HBsAg-Negative Hepatitis B Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; FUNCTIONAL-ANALYSIS; MOLECULAR CHARACTERIZATION; DELAYED CLEARANCE; SERUM HBSAG; GENOTYPE-C; CARRIERS; GENE; PROTEIN; SEROCLEARANCE	Background: The underlying mechanism of HBsAg-negative hepatitis B virus (HBV) infection is notoriously difficult to elucidate because of the extremely low DNA levels which define the condition. We used a highly efficient amplification method to overcome this obstacle and achieved our aim which was to identify specific mutations or sequence variations associated with this entity. Methods: A total of 185 sera and 60 liver biopsies from HBsAg-negative, HBV DNA-positive subjects or known chronic hepatitis B (CHB) subjects with HBsAg seroclearance were amplified by rolling circle amplification followed by full-length HBV genome sequencing. Eleven HBsAg-positive CHB subjects were included as controls. The effects of pivotal mutations identified on regulatory regions on promoter activities were analyzed. Results: 22 and 11 full-length HBV genomes were amplified from HBsAg-negative and control subjects respectively. HBV genotype C was the dominant strain. A higher mutation frequency was observed in HBsAg-negative subjects than controls, irrespective of genotype. The nucleotide diversity over the entire HBV genome was significantly higher in HBsAg-negative subjects compared with controls (p = 0.008) and compared with 49 reference sequences from CHB patients (p = 0.025). In addition, HBsAg-negative subjects had significantly higher amino acid substitutions in the four viral genes than controls (all p<0.001). Many mutations were uniquely found in HBsAg-negative subjects, including deletions in promoter regions (13.6%), abolishment of pre-S2/S start codon (18.2%), disruption of pre-S2/S mRNA splicing site (4.5%), nucleotide duplications (9.1%), and missense mutations in ``alpha'' determinant region, contributing to defects in HBsAg production. Conclusions: These data suggest an accumulation of multiple mutations constraining viral transcriptional activities contribute to HBsAg-negativity in HBV infection.	[Huang, Fung-Yu; Wong, Danny Ka-Ho; Seto, Wai-Kay; Zhang, An-Ye; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Fung, James; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Kwong; Lin, Che-Kit] Hosp Author, Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hku.hk	Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012	SETO, Wai-Kay/0000-0002-9012-313X; Lai, Ching-Lung/0000-0002-5927-2436; /0000-0001-9078-5005; Fung, James/0000-0002-1286-8902	Research Grants Council General Research Fund [HKU 782809M]	Research Grants Council General Research Fund	The study was supported by Research Grants Council General Research Fund (HKU 782809M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2009, HEPATOLOGY, V49, P1868, DOI 10.1002/hep.22879; Allain JP, 2004, VOX SANG, V86, P83, DOI 10.1111/j.0042-9007.2004.00406.x; ALWARD WLM, 1985, J INFECT DIS, V151, P604, DOI 10.1093/infdis/151.4.604; Bock CT, 1999, HEPATOLOGY, V30, P517, DOI 10.1002/hep.510300206; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Chaudhuri V, 2004, GASTROENTEROLOGY, V127, P1356, DOI 10.1053/j.gastro.2004.08.003; Coleman PF, 1999, J MED VIROL, V59, P19, DOI 10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B; DaSilva LC, 1996, J GASTROENTEROL, V31, P696, DOI 10.1007/BF02347619; De Mitri MS, 2010, EUR J CANCER, V46, P2178, DOI 10.1016/j.ejca.2010.03.034; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Fattovich G, 1998, AM J GASTROENTEROL, V93, P896, DOI 10.1111/j.1572-0241.1998.00272.x; Gunther S, 1998, J CLIN MICROBIOL, V36, P531; Hass M, 2005, HEPATOLOGY, V42, P93, DOI 10.1002/hep.20748; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709; Huo TI, 1998, HEPATOLOGY, V28, P231, DOI 10.1002/hep.510280130; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIAW YF, 1991, HEPATOLOGY, V13, P627, DOI 10.1002/hep.1840130403; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Margeridon S, 2008, ANTIMICROB AGENTS CH, V52, P3068, DOI 10.1128/AAC.01318-07; Martin CM, 2012, J VIRAL HEPATITIS, V19, P716, DOI 10.1111/j.1365-2893.2012.01595.x; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Sommer G, 2008, FRONT BIOSCI-LANDMRK, V13, P5533; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Xu ZC, 1996, J VIROL, V70, P133, DOI 10.1128/JVI.70.1.133-140.1996; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; YAMAMOTO K, 1994, J VIROL, V68, P2671, DOI 10.1128/JVI.68.4.2671-2676.1994; Yuen MF, 2008, GASTROENTEROLOGY, V135, P1192, DOI 10.1053/j.gastro.2008.07.008; Yuen MF, 2004, J CLIN MICROBIOL, V42, P4882, DOI 10.1128/JCM.42.10.4882-4884.2004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99028	10.1371/journal.pone.0099028	http://dx.doi.org/10.1371/journal.pone.0099028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901840	Green Published, gold			2022-12-25	WOS:000336841400088
J	Ramos, CG; Grilo, AM; Sousa, SA; Feliciano, JR; da Costa, PJP; Leitao, JH				Ramos, Christian G.; Grilo, Andre M.; Sousa, Silvia A.; Feliciano, Joana R.; da Costa, Paulo J. P.; Leitao, Jorge H.			Regulation of Hfq mRNA and Protein Levels in Escherichia coli and Pseudomonas aeruginosa by the Burkholderia cenocepacia MtvR sRNA	PLOS ONE			English	Article							NONCODING RNAS; GENE-EXPRESSION; CHAPERONE HFQ; CEPACIA; PREDICTION; BACTERIA; PATHOGENICITY; CONSTRUCTION; RESISTANCE; VIRULENCE	Small non-coding RNAs (sRNAs) are important players of gene expression regulation in bacterial pathogens. MtvR is a 136-nucleotide long sRNA previously identified in the human pathogen Burkholderia cenocepacia J2315 and with homologues restricted to bacteria of the Burkholderia cepacia complex. In this work we have investigated the effects of expressing MtvR in Escherichia coli and Pseudomonas aeruginosa. Results are presented showing that MtvR negatively regulates the hfq mRNA levels in both bacterial species. In the case of E. coli, this negative regulation is shown to involve binding of MtvR to the 5'-UTR region of the hfq(Ec) mRNA. Results presented also show that expression of MtvR in E. coli and P. aeruginosa originates multiple phenotypes, including reduced resistance to selected stresses, biofilm formation ability, and increased susceptibility to various antibiotics.	[Leitao, Jorge H.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; Univ Lisbon, Inst Super Tecn, Inst Biotechnol & Bioengn, P-1699 Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Leitao, JH (corresponding author), Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal.	jorgeleitao@tecnico.ulisboa.pt	Sousa, Sílvia A./G-8502-2011; Ramos, Christian G/A-8588-2010; Ramos, Christian Gomes/H-5855-2019; Leitão, Jorge H./A-5122-2012; Feliciano, Joana R/K-1473-2016	Sousa, Sílvia A./0000-0001-9291-9169; Ramos, Christian G/0000-0003-0970-7750; Ramos, Christian Gomes/0000-0003-0970-7750; Leitão, Jorge H./0000-0001-8850-274X; Feliciano, Joana R/0000-0002-4906-676X	Fundacao Ciencia e Tecnologia, Portugal [PTDC/BIA-MIC/119091/2010, PTDC/BBB-BIO/1958/2012]	Fundacao Ciencia e Tecnologia, Portugal	This work was partially supported by Fundacao Ciencia e Tecnologia, Portugal (contracts PTDC/BIA-MIC/119091/2010 and PTDC/BBB-BIO/1958/2012), a post-Doc grant to CGR, and doctoral grants to AMG and JRF, respectively. SAS and PJPDC acknowledge research grants from projects PTDC/BBB-BIO/1958/2012 and PTDC/BIA-MIC/119091/2010, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Bobrovskyy M, 2013, ANNU REV GENET, V47, P209, DOI 10.1146/annurev-genet-111212-133445; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; CLSI, 2013, PERFORMANCE STANDARD; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Han YP, 2013, FUTURE MICROBIOL, V8, P579, DOI [10.2217/FMB.13.20, 10.2217/fmb.13.20]; Harris JF, 2013, VIRULENCE, V4, P785, DOI 10.4161/viru.26119; HASSAN HM, 1979, J BIOL CHEM, V254, P846; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Pichon C, 2008, BIOINFORMATICS, V24, P2807, DOI 10.1093/bioinformatics/btn560; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ramos CG, 2013, J BACTERIOL, V195, P3514, DOI 10.1128/JB.00242-13; Ramos CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047896; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roscetto E, 2012, J BACTERIOL, V194, P5864, DOI 10.1128/JB.00746-12; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wesolowski D, 2013, P NATL ACAD SCI USA, V110, P8686, DOI 10.1073/pnas.1306911110; Wright JS, 2001, J BACTERIOL, V183, P3149, DOI 10.1128/JB.183.10.3149-3159.2001; Yamada J, 2010, J ANTIMICROB CHEMOTH, V65, P853, DOI 10.1093/jac/dkq067; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	40	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98813	10.1371/journal.pone.0098813	http://dx.doi.org/10.1371/journal.pone.0098813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901988	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400054
J	Ahmed, W; Philip, PS; Tariq, S; Khan, G				Ahmed, Waqar; Philip, Pretty S.; Tariq, Saeed; Khan, Gulfaraz			Epstein-Barr Virus-Encoded Small RNAs (EBERs) Are Present in Fractions Related to Exosomes Released by EBV-Transformed Cells	PLOS ONE			English	Article							CONFERS RESISTANCE; INDUCED APOPTOSIS; CARCINOMA CELLS; NONCODING RNA; VIRAL MIRNAS; IN-VITRO; PROTEIN; LYMPHOMA; GROWTH; GENES	Epstein-Barr virus (EBV) is an oncogenic herpesvirus associated with a number of human malignancies of epithelial and lymphoid origin. However, the mechanism of oncogenesis is unclear. A number of viral products, including EBV latent proteins and non-protein coding RNAs have been implicated. Recently it was reported that EBV-encoded small RNAs (EBERs) are released from EBV infected cells and they can induce biological changes in cells via signaling from toll-like receptor 3. Here, we investigated if these abundantly expressed non-protein coding EBV RNAs (EBER-1 and EBER-2) are excreted from infected cells in exosomal fractions. Using differential ultracentrifugation we isolated exosomes from three EBV positive cell lines (B95-8, EBV-LCL, BL30-B95-8), one EBER-1 transfected cell line (293T-pHEBo-E1) and two EBV-negative cell lines (BL30, 293T-pHEBo). The identity of purified exosomes was determined by electron microscopy and western blotting for CD63. The presence of EBERs in cells, culture supernatants and purified exosomal fractions was determined using RT-PCR and confirmed by sequencing. Purified exosomal fractions were also tested for the presence of the EBER-1-binding protein La, using western blotting. Both EBER-1 and EBER-2 were found to be present not only in the culture supernatants, but also in the purified exosome fractions of all EBV-infected cell lines. EBER-1 could also be detected in exosomal fractions from EBER-1 transfected 293T cells whilst the fractions from vector only transfectants were clearly negative. Furthermore, purified exosomal fractions also contained the EBER-binding protein (La), supporting the notion that EBERs are most probably released from EBV infected cells in the form of EBER-La complex in exosomes.	[Ahmed, Waqar; Philip, Pretty S.; Khan, Gulfaraz] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Al Alin, U Arab Emirates; [Tariq, Saeed] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Anat, Al Alin, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Khan, G (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Al Alin, U Arab Emirates.	g_khan@uaeu.ac.ae	Khan, Gulfaraz/AAC-2859-2022	Khan, Gulfaraz/0000-0001-6836-1783	College of Medicine & Health Sciences [NP-14-05]; UAE University [31R016]	College of Medicine & Health Sciences; UAE University	This work was funded by a Faculty Grant from the College of Medicine & Health Sciences (NP-14-05), UAE University and a Center-Based Interdisciplinary Grant (31R016) from UAE University awarded to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, REV MED VIROL, V24, P3, DOI 10.1002/rmv.1763; Amoroso R, 2011, J VIROL, V85, P996, DOI 10.1128/JVI.01528-10; ARRAND JR, 1982, J VIROL, V41, P376, DOI 10.1128/JVI.41.2.376-389.1982; Canitano A, 2013, CANCER LETT, V337, P193, DOI 10.1016/j.canlet.2013.05.012; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; CLARKE PA, 1992, J GEN VIROL, V73, P3169, DOI 10.1099/0022-1317-73-12-3169; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dellis O, 2011, J BIOL CHEM, V286, P18583, DOI 10.1074/jbc.M111.222257; Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0; Forte E, 2012, J VIROL, V86, P6889, DOI 10.1128/JVI.07056-11; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Gregorovic G, 2011, J VIROL, V85, P3535, DOI 10.1128/JVI.02086-10; HENDERSON E, 1977, VIROLOGY, V76, P152, DOI 10.1016/0042-6822(77)90292-6; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HOWE JG, 1988, J VIROL, V62, P2790, DOI 10.1128/JVI.62.8.2790-2798.1988; Hui-Yuen J, 2011, JOVE-J VIS EXP, DOI 10.3791/3321; Iwakiri D, 2003, CANCER RES, V63, P7062; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kelly GL, 2006, P NATL ACAD SCI USA, V103, P14935, DOI 10.1073/pnas.0509988103; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Khan G, 2012, BRIT J CANCER, V106, P1166, DOI 10.1038/bjc.2012.51; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Kieff E, 2007, FIELDS VIROLOGY, P2603; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Laing KG, 2002, VIROLOGY, V297, P253, DOI 10.1006/viro.2002.1354; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meckes DG, 2010, P NATL ACAD SCI; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Owen TJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-241; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; Repellin CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009092; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; RIO DC, 1985, SCIENCE, V227, P23, DOI 10.1126/science.2981116; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; SWAMINATHAN S, 1991, P NATL ACAD SCI USA, V88, P1546, DOI 10.1073/pnas.88.4.1546; Takada K, 2012, SEMIN CANCER BIOL, V22, P162, DOI 10.1016/j.semcancer.2011.12.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; TOCZYSKI DP, 1993, MOL CELL BIOL, V13, P703, DOI 10.1128/MCB.13.1.703; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Verweij Frederik J, 2013, Methods Mol Biol, V1024, P53, DOI 10.1007/978-1-62703-453-1_5; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; WEISS LM, 1991, AM J PATHOL, V139, P1259; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wong HL, 2005, MOL CARCINOGEN, V44, P92, DOI 10.1002/mc.20133; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733	63	63	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99163	10.1371/journal.pone.0099163	http://dx.doi.org/10.1371/journal.pone.0099163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896633	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700121
J	Cole, HA; Ohba, T; Ichikawa, J; Nyman, JS; Cates, JMM; Haro, H; Schwartz, HS; Schoenecker, JG				Cole, Heather A.; Ohba, Tetsuro; Ichikawa, Jiro; Nyman, Jeffry S.; Cates, Justin M. M.; Haro, Hirotaka; Schwartz, Herbert S.; Schoenecker, Jonathan G.			Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model	PLOS ONE			English	Article							TRABECULAR BONE; PERIOSTEAL OSTEOSARCOMA; IN-VIVO; CT; MICROSTRUCTURE; OSTEOPOROSIS; GROWTH; CANCER	Radiographic imaging plays a crucial role in the diagnosis of osteosarcoma. Currently, computed-tomography (CT) is used to measure tumor-induced osteolysis as a marker for tumor growth by monitoring the bone fractional volume. As most tumors primarily induce osteolysis, lower bone fractional volume has been found to correlate with tumor aggressiveness. However, osteosarcoma is an exception as it induces osteolysis and produces mineralized osteoid simultaneously. Given that competent bone is highly anisotropic (systematic variance in its architectural order renders its physical properties dependent on direction of load) and that tumor induced osteolysis and osteogenesis are structurally disorganized relative to competent bone, we hypothesized that mu CT-derived measures of anisotropy could be used to qualitatively and quantitatively detect osteosarcoma provoked deviations in bone, both osteolysis and osteogenesis, in vivo. We tested this hypothesis in a murine model of osteosarcoma cells orthotopically injected into the tibia. We demonstrate that, in addition to bone fractional volume, mu CT-derived measure of anisotropy is a complete and accurate method to monitor osteosarcoma-induced osteolysis. Additionally, we found that unlike bone fractional volume, anisotropy could also detect tumor-induced osteogenesis. These findings suggest that monitoring tumor-induced changes in the structural property isotropy of the invaded bone may represent a novel means of diagnosing primary and metastatic bone tumors.	[Cole, Heather A.; Ohba, Tetsuro; Ichikawa, Jiro; Nyman, Jeffry S.; Schwartz, Herbert S.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA; [Cates, Justin M. M.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Haro, Hirotaka] Univ Yamanashi, Dept Orthopaed Surg, Fac Med, Yamanashi, Japan	Vanderbilt University; Vanderbilt University; University of Yamanashi	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Nashville, TN 37232 USA.	jon.schoenecker@vanderbilt.edu	Cates, Justin M/D-5927-2014	Cates, Justin M/0000-0002-7336-5196; Schoenecker, Jonathan/0000-0002-3097-5496; Nyman, Jeffry/0000-0001-7403-7605	Caitlin Lovejoy Foundation	Caitlin Lovejoy Foundation	The authors thank the Caitlin Lovejoy Foundation for funding this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERLIN O, 1993, CANCER RES, V53, P4890; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chiba K, 2013, BONE, V56, P139, DOI 10.1016/j.bone.2013.05.019; Cole HA, 2011, J ORTHOP RES, V29, P1957, DOI 10.1002/jor.21474; DESANTOS LA, 1978, RADIOLOGY, V127, P123, DOI 10.1148/127.1.123; Effendy NM, 2013, CURR DRUG TARGETS, V14, P1542, DOI 10.2174/13894501113149990196; Gautam Ajay, 2003, Methods Mol Med, V75, P607; Gordon N, 2007, CLIN CANCER RES, V13, P4503, DOI 10.1158/1078-0432.CCR-07-0313; HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446; Ichikawa J, 2012, CANCER-AM CANCER SOC, V118, P2494, DOI 10.1002/cncr.26518; Johnson LC, 2010, BONE; Klein MJ, 2006, AM J CLIN PATHOL, V125, P555, DOI 10.1309/UC6KQHLD9LV2KENN; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; Liao SH, 2008, COMPUT MED IMAG GRAP, V32, P53, DOI 10.1016/j.compmedimag.2007.09.001; Lindner NJ, 1998, J CANCER RES CLIN, V124, P575, DOI 10.1007/s004320050217; Matsuura M, 2008, BIOMECH MODEL MECHAN, V7, P27, DOI 10.1007/s10237-006-0073-7; Moio A, 1994, Minerva Med, V85, P615; MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009; Murphey MD, 2004, RADIOLOGY, V233, P129, DOI 10.1148/radiol.2331030326; Ohba T, 2014, BONE; Ohba T, 2014, J BONE MINER RES; Ravoori M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009854; Szabo ME, 2013, J BIOMECH, V46, P2, DOI 10.1016/j.jbiomech.2012.08.002; Tabor Z, 2012, MED ENG PHYS; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Yarmish G, 2010, RADIOGRAPHICS, V30, P1653, DOI 10.1148/rg.306105524	26	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97381	10.1371/journal.pone.0097381	http://dx.doi.org/10.1371/journal.pone.0097381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892952	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400012
J	Ramos-Silva, P; Kaandorp, J; Herbst, F; Plasseraud, L; Alcaraz, G; Stern, C; Corneillat, M; Guichard, N; Durlet, C; Luquet, G; Marin, F				Ramos-Silva, Paula; Kaandorp, Jaap; Herbst, Frederic; Plasseraud, Laurent; Alcaraz, Gerard; Stern, Christine; Corneillat, Marion; Guichard, Nathalie; Durlet, Christophe; Luquet, Gilles; Marin, Frederic			The Skeleton of the Staghorn Coral Acropora millepora: Molecular and Structural Characterization	PLOS ONE			English	Article							SOLUBLE ORGANIC MATRICES; SHELL MATRIX; CRYSTAL-GROWTH; MINERAL PHASE; PROTEINS; BIOMINERALIZATION; CALCIFICATION; POLYSACCHARIDES; ACIDIFICATION; PURIFICATION	The scleractinian coral Acropora millepora is one of the most studied species from the Great Barrier Reef. This species has been used to understand evolutionary, immune and developmental processes in cnidarians. It has also been subject of several ecological studies in order to elucidate reef responses to environmental changes such as temperature rise and ocean acidification (OA). In these contexts, several nucleic acid resources were made available. When combined to a recent proteomic analysis of the coral skeletal organic matrix (SOM), they enabled the identification of several skeletal matrix proteins, making A. millepora into an emerging model for biomineralization studies. Here we describe the skeletal microstructure of A. millepora skeleton, together with a functional and biochemical characterization of its occluded SOM that focuses on the protein and saccharidic moieties. The skeletal matrix proteins show a large range of isoelectric points, compositional patterns and signatures. Besides secreted proteins, there are a significant number of proteins with membrane attachment sites such as transmembrane domains and GPI anchors as well as proteins with integrin binding sites. These features show that the skeletal proteins must have strong adhesion properties in order to function in the calcifying space. Moreover this data suggest a molecular connection between the calcifying epithelium and the skeletal tissue during biocalcification. In terms of sugar moieties, the enrichment of the SOM in arabinose is striking, and the monosaccharide composition exhibits the same signature as that of mucus of acroporid corals. Finally, we observe that the interaction of the acetic acid soluble SOM on the morphology of in vitro grown CaCO3 crystals is very pronounced when compared with the calcifying matrices of some mollusks. In light of these results, we wish to commend Acropora millepora as a model for biocalcification studies in scleractinians, from molecular and structural viewpoints.	[Ramos-Silva, Paula; Guichard, Nathalie; Durlet, Christophe; Luquet, Gilles; Marin, Frederic] Univ Bourgogne, UMR Biogeosci 6282, Dijon, France; [Ramos-Silva, Paula; Kaandorp, Jaap] Univ Amsterdam, Fac Sci, Sect Computat Sci, Amsterdam, Netherlands; [Herbst, Frederic] Univ Bourgogne, UMR 5209, Dijon, France; [Plasseraud, Laurent; Stern, Christine] Univ Bourgogne, Inst Chim Mol, UMR 6302, Dijon, France; [Alcaraz, Gerard; Corneillat, Marion] Univ Bourgogne, UMR 1347, Agroecol INRA, AgroSup Dijon,ERL 6300, Dijon, France; [Luquet, Gilles] Museum Natl Hist Nat, UMR 7245, F-75231 Paris, France	Universite de Bourgogne; University of Amsterdam; Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Kaandorp, J (corresponding author), Univ Amsterdam, Fac Sci, Sect Computat Sci, Amsterdam, Netherlands.	J.A.Kaandorp@uva.nl; frederic.marin@u-bourgogne.fr	Ramos-Silva, Paula/N-1196-2016; Herbst, Frederic/AAM-9143-2021; Plasseraud, Laurent/ABD-5845-2020; Ramos-Silva, Paula/AAC-6126-2020; Christine, Stern/G-1280-2014	Ramos-Silva, Paula/0000-0002-0798-1724; Plasseraud, Laurent/0000-0002-7870-1881; Ramos-Silva, Paula/0000-0002-0798-1724; Christine, Stern/0000-0002-2929-6429	Marie Curie ITN (Initial Training Network); ANR project (ACCRO-EARTH) [BLAN06-2_159971]; COST project [TD0903]; CNRS-INSU institute	Marie Curie ITN (Initial Training Network); ANR project (ACCRO-EARTH)(French National Research Agency (ANR)); COST project; CNRS-INSU institute	The work of P.R.-S. was supported by the Marie Curie ITN (Initial Training Network), BIOMINTEC piloted by the Johannes Gutenberg University, Mainz, Germany (Pr. H. C. Schroder, see www.biomintec.de) and the BioPreDyn project, coordinated by the Centre for Genomic Regulation (CRG) in Barcelona (see www.biopredyn.eu). Additional support included an ANR project (ACCRO-EARTH, ref. BLAN06-2_159971, Gilles Ramstein, LSCE) during the 2007-2011 period, and the COST project TD0903 ('Biomineralix', www.biomineralix.eu) during the 2012-2013 period. The work of F. Marin was also supported by an INTERRVIE project from the CNRS-INSU institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Allemand D, 1998, J EXP BIOL, V201, P2001; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; BARNES DJ, 1970, SCIENCE, V170, P1305, DOI 10.1126/science.170.3964.1305; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bryan W. H., 1941, PROC ROY SOC QUEENSLAND, V52, P78; Clode PL, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-010-0673-7; Clode PL, 2003, BIOL BULL-US, V204, P146, DOI 10.2307/1543550; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; CONSTANTZ B, 1988, J EXP ZOOL, V248, P253, DOI 10.1002/jez.1402480302; CONSTANTZ B R, 1986, Palaios, V1, P152, DOI 10.2307/3514508; Cuif J.P., 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P359; Cuif J-P, 1998, PALFIONTOLOGISCHE Z, V72; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, INT J EARTH SCI, V88, P582, DOI 10.1007/s005310050286; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Dauphin Y, 2008, COMP BIOCHEM PHYS B, V150, P10, DOI 10.1016/j.cbpb.2008.01.002; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Debreuil J, 2012, J BIOL CHEM, V287, P19367, DOI 10.1074/jbc.M112.352005; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Falini G., 2013, J STRUCT BIOL; Farre B, 2010, ZOOLOGY, V113, P250, DOI 10.1016/j.zool.2009.11.004; Fricain JC, 2002, BIOMATERIALS, V23, P673, DOI 10.1016/S0142-9612(01)00155-7; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; GAFFEY SJ, 1993, J SEDIMENT PETROL, V63, P752, DOI 10.1306/D4267BE0-2B26-11D7-8648000102C1865D; Gaspard D, 2008, EARTH ENV SCI T R SO, V98, P415, DOI 10.1017/S1755691007078401; Gattuso JP, 1999, AM ZOOL, V39, P160; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; GOREAU T, 1956, NATURE, V177, P1029, DOI 10.1038/1771029a0; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Ingalls AE, 2003, GEOCHIM COSMOCHIM AC, V67, P2827, DOI 10.1016/S0016-7037(03)00079-6; ISA Y, 1987, COMP BIOCHEM PHYS B, V87, P507, DOI 10.1016/0305-0491(87)90045-9; Iwai H, 2001, PLANTA, V213, P907, DOI 10.1007/s004250100559; Johnston I.S., 1980, International Review of Cytology, V67, P171; Jones GC., 1993, INFRARED TRANSMISSIO; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marie B, 2008, CHEMBIOCHEM, V9, P2515, DOI 10.1002/cbic.200800159; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 1996, P NATL ACAD SCI USA, V93, P1554, DOI 10.1073/pnas.93.4.1554; Marin F, 2001, PROTEIN EXPRES PURIF, V23, P175, DOI 10.1006/prep.2001.1487; MARIN F, 1994, B SOC GEOL FR, V165, P77; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Marxen JC, 1998, BIOL BULL-US, V194, P231, DOI 10.2307/1543052; Meibom A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025968; MITTERER RM, 1978, B MAR SCI, V28, P173; Moore JP, 2008, PLANT SIGNAL BEHAV, V3, P102, DOI 10.4161/psb.3.2.4959; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Mosele MM, 2011, PHYTOCHEMISTRY, V72, P1466, DOI 10.1016/j.phytochem.2011.03.027; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Ogilvie MM, 1896, P R SOC LOND, V59, P9; Pavat C, 2012, COMP BIOCHEM PHYS B, V161, P303, DOI 10.1016/j.cbpb.2011.12.003; Pramod SN, 2006, GLYCOCONJUGATE J, V23, P481, DOI 10.1007/s10719-006-6217-2; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Rahman MA, 2006, CALCIFIED TISSUE INT, V78, P178, DOI 10.1007/s00223-005-0253-y; Ramos-Silva P, 2013, P NATL ACAD SCI USA, P3; Ramos-Silva P, 2013, MOL BIOL EVOL; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Tambutte S, 2008, HDB BIOMINERALIZATIO, P243; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; VANDERMEULEN JH, 1975, MAR BIOL, V31, P69, DOI 10.1007/BF00390649; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; von Koch G., 1882, MITTHEILUNGEN ZOOLOG, V3, P282; WAINWRIGHT SA, 1963, Q J MICROSC SCI, V104, P169; WAINWRIGHT SA, 1964, EXP CELL RES, V34, P213, DOI 10.1016/0014-4827(64)90358-1; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Wendt J., 1990, P45; WHEELER AP, 1984, AM ZOOL, V24, P933; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; XYLA AG, 1989, J CHEM SOC FARAD T 1, V85, P3165, DOI 10.1039/f19898503165; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	88	28	29	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97454	10.1371/journal.pone.0097454	http://dx.doi.org/10.1371/journal.pone.0097454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893046	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400013
J	Qin, XJ; Hao, ZT; Tian, QN; Zhang, ZM; Zhou, C; Xie, W				Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Zhou, Chun; Xie, Wei			Cocrystal Structures of Glycyl-tRNA Synthetase in Complex with tRNA Suggest Multiple Conformational States in Glycylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MUTATIONS; PURIFICATION; SEQUENCES; GARS; 2D	Aminoacyl-tRNA synthetases are an ancient enzyme family that specifically charges tRNA molecules with cognate amino acids for protein synthesis. Glycyl-tRNA synthetase (GlyRS) is one of the most intriguing aminoacyl-tRNA synthetases due to its divergent quaternary structure and abnormal charging properties. In the past decade, mutations of human GlyRS (hGlyRS) were also found to be associated with Charcot-Marie-Tooth disease. However, the mechanisms of traditional and alternative functions of hGlyRS are poorly understood due to a lack of studies at the molecular basis. In this study we report crystal structures of wild type and mutant hGlyRS in complex with tRNA and with small substrates and describe the molecular details of enzymatic recognition of the key tRNA identity elements in the acceptor stem and the anticodon loop. The cocrystal structures suggest that insertions 1 and 3 work together with the active site in a cooperative manner to facilitate efficient substrate binding. Both the enzyme and tRNA molecules undergo significant conformational changes during glycylation. A working model of multiple conformations for hGlyRS catalysis is proposed based on the crystallographic and biochemical studies. This study provides insights into the catalytic pathway of hGlyRS and may also contribute to our understanding of Charcot-Marie-Tooth disease.	[Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Xie, Wei] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Xiangjing; Hao, Zhitai; Tian, Qingnan; Zhang, Zhemin; Xie, Wei] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou 510006, Guangdong, Peoples R China; [Zhou, Chun] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Sun Yat Sen University; Sun Yat Sen University; Memorial Sloan Kettering Cancer Center	Xie, W (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, 132 E Circle Rd, Guangzhou 510275, Guangdong, Peoples R China.	xiewei6@mail.sysu.edu.cn		Xie, Wei/0000-0003-2410-2135; zhou, chun/0000-0002-9257-468X; Hao, Zhitai/0000-0001-9369-976X	National Sciences Foundation of China [4103041]; Fundamental Research Funds for the Central Universities SYSU [11lgjc09]; Guangdong Innovative Research Team Program Grant [201001Y0104687244]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities SYSU; Guangdong Innovative Research Team Program Grant	This work was supported by National Sciences Foundation of China Grant 4103041, Fundamental Research Funds for the Central Universities SYSU 11lgjc09, and Guangdong Innovative Research Team Program Grant 201001Y0104687244.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Chen SJ, 2011, ACS CHEM BIOL, V6, P1182, DOI 10.1021/cb200240a; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Freist W, 1996, BIOL CHEM H-S, V377, P343; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Jani-Acsadi A, 2008, SEMIN NEUROL, V28, P185, DOI 10.1055/s-2008-1062264; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; Nameki N, 1997, Nucleic Acids Symp Ser, P123; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; SCHIMMEL P, 1995, J MOL EVOL, V40, P531; SHIBA K, 1994, J BIOL CHEM, V269, P30049; SKRE H, 1974, CLIN GENET, V6, P98; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SURGUCHOV AP, 1975, EUR J BIOCHEM, V54, P175, DOI 10.1111/j.1432-1033.1975.tb04127.x; Tan Kemin, 2012, Journal of Structural and Functional Genomics, V13, P233, DOI 10.1007/s10969-012-9142-6; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xie W, 2006, ACTA CRYSTALLOGR F, V62, P1243, DOI 10.1107/S1744309106046434; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626	44	35	37	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20359	20369		10.1074/jbc.M114.557249	http://dx.doi.org/10.1074/jbc.M114.557249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898252	Green Published, hybrid			2022-12-25	WOS:000339395200046
J	Apenteng, OO; Ismail, NA				Apenteng, Ofosuhene O.; Ismail, Noor Azina			The Impact of the Wavelet Propagation Distribution on SEIRS Modeling with Delay	PLOS ONE			English	Article							EPIDEMIC MODEL	Previous models of disease spread involving delay have used basic SIR (susceptible - infectious - recovery) formulae and approaches. This paper demonstrates how time-varying SEIRS (S - exposed -I -R -S) models can be extended with delay to produce wave propagations that simulate periodic wave fronts of disease spread in the context of population movements. The model also takes into account the natural mortality associated with the disease spread. Understanding the delay of an infectious disease is critical when attempting to predict where and how fast the disease will propagate. We use cellular automata to model the delay and its effect on the spread of infectious diseases where population movement occurs. We illustrate an approach using wavelet transform analysis to understand the impact of the delay on the spread of infectious diseases. The results indicate that including delay provides novel ways to understand the effects of migration and population movement on disease spread.	[Apenteng, Ofosuhene O.; Ismail, Noor Azina] Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia	Universiti Malaya	Apenteng, OO (corresponding author), Univ Malaya, Dept Appl Stat, Fac Econ & Adm, Kuala Lumpur, Malaysia.	oapenten@siswa.um.edu.my; nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162; Apenteng, Ofosuhene O./0000-0001-9991-1709	University of Malaya Research Grant [RP004J-13ICT]	University of Malaya Research Grant	This research is funded by the University of Malaya Research Grant (RP004J-13ICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2010, MODELING PROPAGATION, P1; Apenteng OO, 2012, USE CELLULAR AUTOMAT; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Athanassopoulos S, 2012, CELLULAR AUTOMATA SI, P63; Bhunu CP., 2011, J MATH MODEL ALGOR, V10, P31, DOI DOI 10.1007/S10852-010-9134-0; Bjornstad O., 2005, SEIR MODELS; Chan T., 2005, IMAGE PROCESSING ANA; Cui X, 2012, WHAT DOES WAVELET TR; Das P., 2011, J MATH MODELLING ALG, V10, P181, DOI [10.1007/s10852-010-9148-7, DOI 10.1007/S10852-010-9148-7]; De la Sen M, 2010, ADV DIFFER EQU-NY, DOI 10.1155/2010/281612; Kaddar A, 2011, COMPARISON DELAYED S, V16; Keeling MJ, 2008, MODELING INFECT DIS, P1; Kim H-J, 2001, CONTINUOUS MODEL TRA; Landguth EL, 2007, CELLULAR AUTOMATA SI, P1; Meng XZ, 2007, APPL MATH MECH-ENGL, V28, P1259, DOI 10.1007/s10483-007-0914-x; Naresh R, 2006, APPL MATH COMPUT, V178, P262, DOI 10.1016/j.amc.2005.11.041; Ozalp N, 2011, MATH COMPUT MODEL, V54, P1, DOI 10.1016/j.mcm.2010.12.051; Shuai Z., 2011, CAN APPL MATH Q, V19, P235; Thornley S, 2008, J THEOR BIOL, V254, P599, DOI 10.1016/j.jtbi.2008.06.022; Van den Driessche P., MATH BIOSCIENCES, V180, P29; Yan P, 2006, ANZIAM J, V48, P119, DOI 10.1017/S144618110000345X	21	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98288	10.1371/journal.pone.0098288	http://dx.doi.org/10.1371/journal.pone.0098288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911023	Green Published, gold			2022-12-25	WOS:000337165600131
J	Li, XL; Gao, XY; Ren, ZP; Cao, YX; Wang, JF; Liang, GD				Li, Xiaolong; Gao, Xiaoyan; Ren, Zhoupeng; Cao, Yuxi; Wang, Jinfeng; Liang, Guodong			A Spatial and Temporal Analysis of Japanese Encephalitis in Mainland China, 1963-1975: A Period without Japanese Encephalitis Vaccination	PLOS ONE			English	Article							TORRES STRAIT; VIRUS; ASIA; INFECTIONS; AUSTRALIA; ABUNDANCE; OUTBREAK; DISTRICT; MALAYSIA; CLIMATE	More than a million Japanese encephalitis (JE) cases occurred in mainland China from the 1960s to 1970s without vaccine interventions. The aim of this study is to analyze the spatial and temporal pattern of JE cases reported in mainland China from 1965 to 1973 in the absence of JE vaccination, and to discuss the impacts of climatic and geographical factors on JE during that period. Thus, the data of reported JE cases at provincial level and monthly precipitation and monthly mean temperature from 1963 to 1975 in mainland China were collected. Local Indicators of Spatial Association analysis was performed to identify spatial clusters at the province level. During that period, The epidemic peaked in 1966 and 1971 and the JE incidence reached up to 20.58/100000 and 20.92/100000, respectively. The endemic regions can be divided into three classes including high, medium, and low prevalence regions. Through spatial cluster analysis, JE epidemic hot spots were identified; most were located in the Yangtze River Plain which lies in the southeast of China. In addition, JE incidence was shown to vary among eight geomorphic units in China. Also, the JE incidence in the Loess Plateau and the North China Plain was showed to increase with the rise of temperature. Likewise, JE incidence in the Loess Plateau and the Yangtze River Plain was observed a same trend with the increase of rainfall. In conclusion, the JE cases clustered geographically during the epidemic period. Besides, the JE incidence was markedly higher on the plains than plateaus. These results may provide an insight into the epidemiological characteristics of JE in the absence of vaccine interventions and assist health authorities, both in China and potentially in Europe and Americas, in JE prevention and control strategies.	[Li, Xiaolong; Gao, Xiaoyan; Cao, Yuxi; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Li, Xiaolong; Gao, Xiaoyan; Cao, Yuxi; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Ren, Zhoupeng; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	Ren, Zhoupeng/AAV-2806-2020	Ren, Zhoupeng/0000-0003-1766-2820; Wang, Jinfeng/0000-0002-6687-9420; Li, Xiaolong/0000-0002-8396-2912	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	This work is supported by grants from National Natural Science Foundation of China (81290342), The Ministry of Science and Technology, China (2011CB504702) and Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; ArcGIS help 10.1, 2012, CLUST OUTL AN; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Elias C, 2009, LANCET INFECT DIS, V9, P7, DOI 10.1016/S1473-3099(08)70290-1; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; GINGRICH JB, 1992, J MED ENTOMOL, V29, P436, DOI 10.1093/jmedent/29.3.436; Gregory D., 2009, DICT HUMAN GEOGRAPHY; Halstead SBJJ, 2008, VACCINES-BASEL, V5th; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; Hsu SM, 2008, EPIDEMIOL INFECT, V136, P980, DOI 10.1017/S0950268807009454; Impoinvil DE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002334; Impoinvil DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022192; Johansen CA, 2001, J MED ENTOMOL, V38, P581, DOI 10.1603/0022-2585-38.4.581; Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Lindenbach BD, 2007, FIELDS VIROLOGY, P1102; Lvov DK, 1993, SOV MED REV E, P1; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; MOGI M, 1983, AM J TROP MED HYG, V32, P170, DOI 10.4269/ajtmh.1983.32.170; Murty US, 2010, J VECTOR DIS, V47, P26; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Saxena SK, 2009, J INFECT DEV COUNTR, V3, P517, DOI 10.3855/jidc.470; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; TAKAHASHI M, 1976, J MED ENTOMOL, V13, P275, DOI 10.1093/jmedent/13.3.275; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Vythilingam I, 1997, J MED ENTOMOL, V34, P257, DOI 10.1093/jmedent/34.3.257; Wang G, 2004, CHINESE J APPL METER, V15, P10; Wang LY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002285; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	35	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99183	10.1371/journal.pone.0099183	http://dx.doi.org/10.1371/journal.pone.0099183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911168	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600052
J	Saliasi, E; Geerligs, L; Lorist, MM; Maurits, NM				Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.			Neural Correlates Associated with Successful Working Memory Performance in Older Adults as Revealed by Spatial ICA	PLOS ONE			English	Article							AGE-RELATED-CHANGES; VENTROLATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; FUNCTIONAL CONNECTIVITY; CORTICAL RECRUITMENT; BRAIN ACTIVATION; CONTROL NETWORK; FMRI; MAINTENANCE; STATE	To investigate which neural correlates are associated with successful working memory performance, fMRI was recorded in healthy younger and older adults during performance on an n-back task with varying task demands. To identify functional networks supporting working memory processes, we used independent component analysis (ICA) decomposition of the fMRI data. Compared to younger adults, older adults showed a larger neural ( BOLD) response in the more complex (2-back) than in the baseline (O-back) task condition, in the ventral lateral prefrontal cortex (VLPFC) and in the right fronto-parietal network (FPN). Our results indicated that a higher BOLD response in the VLPFC was associated with increased performance accuracy in older adults, in both the baseline and the more complex task condition. This `BOLD-performance' relationship suggests that the neural correlates linked with successful performance in the older adults are not uniquely related to specific working memory processes present in the complex but not in the baseline task condition. Furthermore, the selective presence of this relationship in older but not in younger adults suggests that increased neural activity in the VLPFC serves a compensatory role in the aging brain which benefits task performance in the elderly.	[Saliasi, Emi; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Saliasi, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.saliasi@umcg.nl	Geerligs, Linda/D-5212-2013	Geerligs, Linda/0000-0002-1624-8380; Saliasi, Emi/0000-0003-1009-6010; Lorist, Monicque M./0000-0002-7361-093X; Maurits, Natasha/0000-0001-6231-7044				Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Backman L, 2011, NEUROBIOL AGING, V32, P1849, DOI 10.1016/j.neurobiolaging.2009.10.018; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett IJ, 2013, NEUROIMAGE, V72, P20, DOI 10.1016/j.neuroimage.2013.01.030; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braver T. S., 2007, EXPLAINING MANY VARI, P76; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calhoun VD, 2004, NEUROIMAGE, V22, P252, DOI 10.1016/j.neuroimage.2003.12.029; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Chen YN, 2008, CLIN NEUROPHYSIOL, V119, P1546, DOI 10.1016/j.clinph.2008.03.003; Cohen J., 1983, APPL MULTIPLE REGRES; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; de Fockert Jan W, 2005, Sci Aging Knowledge Environ, V2005, ppe34, DOI 10.1126/sageke.2005.44.pe34; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Geerligs L, 2012, HUM BRAIN MAPP; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Habeck C, 2012, BRAIN RES, V1467, P27, DOI 10.1016/j.brainres.2012.05.045; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Klarborg B, 2012, HUM BRAIN MAPP; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Meier TB, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00281; Morcom AM, 2007, CEREB CORTEX, V17, P2491, DOI 10.1093/cercor/bhl155; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2013, PERSPECT PSYCHOL SCI, V8, P62, DOI 10.1177/1745691612469034; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2007, CORTEX, V43, P65, DOI 10.1016/S0010-9452(08)70446-5; Sala-Llonch R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00152; Saliasi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063701; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schmand B., 1992, NEDERLANDSE LEESTEST; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; Stevens WD, 2008, J NEUROSCI, V28, P12820, DOI 10.1523/JNEUROSCI.2622-08.2008; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Uterwijk J., 2001, WAIS 3 NEDERLANDSTAL; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wolf RC, 2006, NEUROPSYCHOLOGIA, V44, P2558, DOI 10.1016/j.neuropsychologia.2006.05.015; Xu J., 2013, NEUROIMAGE; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99250	10.1371/journal.pone.0099250	http://dx.doi.org/10.1371/journal.pone.0099250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911016	Green Published, gold			2022-12-25	WOS:000337165600060
J	Commandeur, S; Coppola, M; Dijkman, K; Friggen, AH; van Meijgaarden, KE; Van den Eeden, SJF; Wilson, L; Van der Ploeg-van Schip, JJ; Franken, KLMC; Geluk, A; Ottenhoff, THM				Commandeur, Susanna; Coppola, Mariateresa; Dijkman, Karin; Friggen, Annemieke H.; van Meijgaarden, Krista E.; Van den Eeden, Susan J. F.; Wilson, Louis; Van der Ploeg-van Schip, Jolien J.; Franken, Kees L. M. C.; Geluk, Annemieke; Ottenhoff, Tom H. M.			Clonal Analysis of the T-Cell Response to In Vivo Expressed Mycobacterium tuberculosis Protein Rv2034, Using a CD154 Expression Based T-Cell Cloning Method	PLOS ONE			English	Article							CD40 LIGAND; TRANSCRIPTION FACTOR; CD4(+); ANTIGENS; IDENTIFICATION; RESTRICTION; PEPTIDES; EPITOPES; VACCINE; TCR	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of death worldwide. A better understanding of the role of CD4(+) and CD8(+) T cells, which are both important to TB protection, is essential to unravel the mechanisms of protection and to identify the key antigens seen by these T cells. We have recently identified a set of in vivo expressed Mtb genes (IVE-TB) which is expressed during in vivo pulmonary infection in mice, and shown that their encoded antigens are potently recognized by polyclonal T cells from tuberculin skin test-positive, in vitro ESAT-6/CFP10-responsive individuals. Here we have cloned T cells specific for one of these newly identified in vivo expressed Mtb (IVE-TB) antigens, Rv2034. T cells were enriched based on the expression of CD154 (CD40L), which represents a new method for selecting antigen-specific (low frequency) T cells independent of their specific function. An Rv2034-specific CD4(+) T-cell done expressed the Th1 markers T-bet, IFN-gamma, TNF-alpha, IL-2 and the cytotoxicity related markers granzyme B and CD107a as measured by flow cytometry. The clone specifically recognized Rv2034 protein, Rv2034 peptide p81-100 and Mtb lysate. Remarkably, while the recognition of the dominant p81-100 epitope was HLA-DR restricted, the T-cell clone also recognized a neighboring epitope (p88-107) in an HLA-DR- as well as HLA-DQ1-restricted fashion. Importantly, the T-cell clone was able to inhibit Mtb outgrowth from infected monocytes significantly. The characterization of the polyfunctional and Mtb inhibitory T-cell response to WE-TB Rv2034 at the clonal level provides detailed further insights into the potential of WE-TB antigens as new vaccine candidate antigens in TB. Our new approach allowed the identification of T-cell subsets that likely play a significant role in controlling Mtb infection, and can be applied to the analysis of T-cell responses in patient populations.	[Commandeur, Susanna; Coppola, Mariateresa; Dijkman, Karin; Friggen, Annemieke H.; van Meijgaarden, Krista E.; Van den Eeden, Susan J. F.; Wilson, Louis; Van der Ploeg-van Schip, Jolien J.; Franken, Kees L. M. C.; Geluk, Annemieke; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	t.h.m.ottenhoff@lumc.nl	Franken, Kees/ABA-7095-2021; Dijkman, Karin/AAR-1994-2020	Franken, Kees/0000-0002-4747-6060; Dijkman, Karin/0000-0002-5395-505X	European Commission FP7 NEWTBVAC project [LSHP-CT-2003-503367]; FP7 VACTRAIN project; FP7 IDEA [FP7-HEALTH-2009-241642]; FP7 ADITEC [FP7-HEALTH-2010-280873]; FP7 EURIPRED, Top Institute Pharma [FP7-INFRA-2012-312661, D-101-1]; EDCTP (AE-TBC project) [IP_09_32040]	European Commission FP7 NEWTBVAC project; FP7 VACTRAIN project; FP7 IDEA; FP7 ADITEC; FP7 EURIPRED, Top Institute Pharma; EDCTP (AE-TBC project)	This study was supported by the European Commission FP7 NEWTBVAC project (LSHP-CT-2003-503367); FP7 VACTRAIN project; FP7 IDEA (FP7-HEALTH-2009-241642); FP7 ADITEC (FP7-HEALTH-2010-280873); FP7 EURIPRED (FP7-INFRA-2012-312661) Top Institute Pharma (project D-101-1); and EDCTP (AE-TBC project grant agreement No. IP_09_32040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Arden Bernhard, 1995, Immunogenetics, V42, P455; Axelsson-Robertson R, 2010, IMMUNOLOGY, V129, P496, DOI 10.1111/j.1365-2567.2009.03201.x; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Bastian M, 2008, J IMMUNOL, V180, P3436, DOI 10.4049/jimmunol.180.5.3436; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10; Boer MC, 2013, EUR J IMMUNOL; Caccamo N, 2003, CLIN EXP IMMUNOL, V133, P260, DOI 10.1046/j.1365-2249.2003.02201.x; Commandeur S, 2013, J IMMUNOL; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Commandeur S, 2011, CLIN VACCINE IMMUNOL, V18, P676, DOI 10.1128/CVI.00492-10; Corti D, 2011, CURR OPIN IMMUNOL, V23, P430, DOI 10.1016/j.coi.2011.04.006; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Derrick SC, 2007, IMMUNOLOGY, V120, P192, DOI 10.1111/j.1365-2567.2006.02491.x; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Geluk A, 1997, IMMUNOLOGY, V90, P370, DOI 10.1111/j.1365-2567.1997.00370.x; GELUK A, 1992, J IMMUNOL, V149, P2864; Geluk A, 2012, VACCINE, V30, P7513, DOI 10.1016/j.vaccine.2012.10.045; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Hatton RD, 2003, SCIENCE, V302, P993, DOI 10.1126/science.1092040; HERMANN P, 1995, EUR J IMMUNOL, V25, P2972, DOI 10.1002/eji.1830251039; HO PC, 1990, EUR J IMMUNOL, V20, P477, DOI 10.1002/eji.1830200304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lindgren H, 2001, J IMMUNOL, V166, P4578, DOI 10.4049/jimmunol.166.7.4578; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McKinney DM, 2013, IMMUNOGENETICS; Moncrieffe H, 2010, J IMMUNOL, V185, P134, DOI 10.4049/jimmunol.0803474; Mustafa AS, 1999, INFECT IMMUN, V67, P5683, DOI 10.1128/IAI.67.11.5683-5689.1999; MUTIS T, 1993, EUR J IMMUNOL, V23, P2189, DOI 10.1002/eji.1830230921; Ottenhoff THM, 2012, INT J TUBERC LUNG D, V16, P1424, DOI 10.5588/ijtld.12.0479; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; OTTENHOFF THM, 1995, EUR J CLIN INVEST, V25, P371, DOI 10.1111/j.1365-2362.1995.tb01716.x; OTTENHOFF THM, 1986, J EXP MED, V164, P1923, DOI 10.1084/jem.164.6.1923; OTTENHOFF THM, 1986, NATURE, V319, P66, DOI 10.1038/319066a0; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2010, CURR PROTOC CYTOM; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sospedra M, 2010, J IMMUNOL METHODS, V353, P93, DOI 10.1016/j.jim.2009.12.006; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Triplett TA, 2012, EUR J IMMUNOL, V42, P1893, DOI 10.1002/eji.201242444; Unger WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049213; Wehler TC, 2008, J IMMUNOL METHODS, V339, P23, DOI 10.1016/j.jim.2008.07.017; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yousef S, 2012, J IMMUNOL, V189, P3618, DOI 10.4049/jimmunol.1201612; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	69	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99203	10.1371/journal.pone.0099203	http://dx.doi.org/10.1371/journal.pone.0099203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905579	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000110
J	Moran, P; Bromaghin, JF; Masuda, M				Moran, Paul; Bromaghin, Jeffrey F.; Masuda, Michele			Use of Genetic Data to Infer Population-Specific Ecological and Phenotypic Traits from Mixed Aggregations	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; COLUMBIA RIVER; STOCK; HABITATS; ESTUARY	Many applications in ecological genetics involve sampling individuals from a mixture of multiple biological populations and subsequently associating those individuals with the populations from which they arose. Analytical methods that assign individuals to their putative population of origin have utility in both basic and applied research, providing information about population-specific life history and habitat use, ecotoxins, pathogen and parasite loads, and many other non-genetic ecological, or phenotypic traits. Although the question is initially directed at the origin of individuals, in most cases the ultimate desire is to investigate the distribution of some trait among populations. Current practice is to assign individuals to a population of origin and study properties of the trait among individuals within population strata as if they constituted independent samples. It seemed that approach might bias population-specific trait inference. In this study we made trait inferences directly through modeling, bypassing individual assignment. We extended a Bayesian model for population mixture analysis to incorporate parameters for the phenotypic trait and compared its performance to that of individual assignment with a minimum probability threshold for assignment. The Bayesian mixture model outperformed individual assignment under some trait inference conditions. However, by discarding individuals whose origins are most uncertain, the individual assignment method provided a less complex analytical technique whose performance may be adequate for some common trait inference problems. Our results provide specific guidance for method selection under various genetic relationships among populations with different trait distributions.	[Moran, Paul] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Bromaghin, Jeffrey F.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Masuda, Michele] Alaska Fisheries Sci Ctr, Ted Stevens Marine Res Inst, Auke Bay Labs, Juneau, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Moran, P (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	paul.moran@noaa.gov	Bromaghin, Jeffrey/B-5058-2009	Bromaghin, Jeffrey/0000-0002-7209-9500	HPC from the Arctic Region Supercomputing Center; University of Alaska, Fairbanks; National Marine Fisheries Service; United States Geological Survey	HPC from the Arctic Region Supercomputing Center; University of Alaska, Fairbanks; National Marine Fisheries Service; United States Geological Survey(United States Geological Survey)	This work was supported in part by a grant of HPC resources from the Arctic Region Supercomputing Center and the University of Alaska, Fairbanks. Support also came from National Marine Fisheries Service and United States Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, CAN J FISH AQUAT SCI, V65, P1475, DOI 10.1139/F08-049; Bottom D. L., 2008, SALMON LIFE HIST HAB; Bromaghin JF, 2011, T AM FISH SOC, V140, P235, DOI 10.1080/00028487.2011.558776; Claxton A, 2013, HYDROBIOLOGIA, V717, P27, DOI 10.1007/s10750-013-1564-z; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; FOURNIER DA, 1984, CAN J FISH AQUAT SCI, V41, P400, DOI 10.1139/f84-047; Gelman A., 2004, BAYESIAN DATA ANAL; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; *INS CORP, 2001, S PLUS 6 WIND GUID S, V1; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Johnson L, 2013, T AM FISH SOC, V142, P21, DOI 10.1080/00028487.2012.720627; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Koljonen ML, 2005, CAN J FISH AQUAT SCI, V62, P2143, DOI 10.1139/F05-128; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mank JE, 2004, GENET RES, V84, P135, DOI 10.1017/S0016672304007190; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Pella J, 2001, FISH B-NOAA, V99, P151; PELLA JJ, 1987, POPULATION GENETICS, P247; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhodes LD, 2011, MAR ECOL PROG SER, V432, P161, DOI 10.3354/meps09160; Roegner GC, 2012, MAR COAST FISH, V4, P450, DOI 10.1080/19425120.2012.675982; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98470	10.1371/journal.pone.0098470	http://dx.doi.org/10.1371/journal.pone.0098470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905464	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000032
J	Ueda, S; Kuji, I; Shigekawa, T; Takeuchi, H; Sano, H; Hirokawa, E; Shimada, H; Suzuki, H; Oda, M; Osaki, A; Saeki, T				Ueda, Shigeto; Kuji, Ichiei; Shigekawa, Takashi; Takeuchi, Hideki; Sano, Hiroshi; Hirokawa, Eiko; Shimada, Hiroko; Suzuki, Hiroaki; Oda, Motoki; Osaki, Akihiko; Saeki, Toshiaki			Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; NORMALIZATION; VASCULATURE; TOMOGRAPHY; CRITERIA; VERSION	Purpose: Optical imaging techniques for measuring tissue hemoglobin concentration have been recently accepted as a way to assess tumor vascularity and oxygenation. We investigated the correlation between early optical response to single-agent bevacizumab and treatment outcome. Methods: Seven patients with advanced or metastatic breast cancer were treated with single-agent bevacizumab followed by addition of weekly paclitaxel. Optical imaging of patient's breasts was performed to measure tumor total hemoglobin concentration (tHb) and oxygen saturation (stO(2)) at baseline and on days 1, 3, 6, 8, and 13 after the first infusion of bevacizumab. To assess early metabolic response, 2-deoxy-2-(F-18)-fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT), F-18-fluoromisonidazole (FMISO)-PET/CT, and magnetic resonance imaging were performed at baseline and after two cycles of the regimen. Results: Seven patients were grouped as responders (n = 4) and nonresponders (n = 3) on the basis of metabolic response measured by FDG-PET/CT. The responders showed remarkable tumor shrinkage and low accumulations of FMISO tracer relative to those of the nonresponders at the completion of two cycles of chemotherapy. Tumors of both groups showed remarkable attenuation of mean tHb as early as day 1 after therapy initiation. The nonresponders had lower baseline stO(2) levels compared with adjacent breast tissue stO(2) levels along with a pattern of steadily low stO(2) levels during the observation window. On the other hand, the responders appeared to sustain high stO(2) levels with temporal fluctuation. Conclusions: Low tumor stO(2) level after single-agent bevacizumab treatment was characteristic of the nonresponders. Tumor stO(2) level could be a predictor of an additional benefit of bevacizumab over that provided by paclitaxel.	[Ueda, Shigeto; Shigekawa, Takashi; Takeuchi, Hideki; Sano, Hiroshi; Hirokawa, Eiko; Shimada, Hiroko; Osaki, Akihiko; Saeki, Toshiaki] Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka, Saitama, Japan; [Kuji, Ichiei] Saitama Med Univ, Int Med Ctr, Dept Nucl Med, Hidaka, Saitama, Japan; [Suzuki, Hiroaki; Oda, Motoki] Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Shizuoka, Japan	Saitama Medical University; Saitama Medical University; Hamamatsu Photonics	Ueda, S (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Breast Oncol, Hidaka, Saitama, Japan.	syueda@saitama-med.ac.jp		Kuji, Ichiei/0000-0002-5797-3482	JSPS KAKENHI [25830105]; Hidaka Research Grant	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hidaka Research Grant	This work was supported by JSPS KAKENHI Grant Number 25830105 and Hidaka Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aogi K, 2011, BREAST CANCER RES TR, V129, P829, DOI 10.1007/s10549-011-1685-x; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Cerussi A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337546; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Imabayashi E, 2011, BRAIN BEHAV, V1, P63, DOI 10.1002/brb3.13; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Mghanga FP, 2013, CLIN BREAST CANCER, V13, P271, DOI 10.1016/j.clbc.2013.02.003; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Mizukoshi W, 2013, EUR RADIOL, V23, P75, DOI 10.1007/s00330-012-2555-6; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Roblyer D, 2011, P NATL ACAD SCI USA, V108, P14626, DOI 10.1073/pnas.1013103108; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; Ueda S, 2012, INT J CLIN ONCOL, V17, P276, DOI 10.1007/s10147-011-0287-2; Ueda Y, 2011, TECHNOL CANCER RES T, V10, P393, DOI 10.7785/tcrt.2012.500217; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Wang YT, 2012, BREAST CANCER RES TR, V131, P357, DOI 10.1007/s10549-011-1780-z; Zhu Q, 2013, RADIOLOGY, V266, P433, DOI 10.1148/radiol.12112415	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98715	10.1371/journal.pone.0098715	http://dx.doi.org/10.1371/journal.pone.0098715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905225	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000052
J	Zhang, ML; Meng, HH; Zhang, HX; Vyacheslav, BV; Sanderson, SC				Zhang, Ming-Li; Meng, Hong-Hu; Zhang, Hong-Xiang; Vyacheslav, Byalt V.; Sanderson, Stewart C.			Himalayan Origin and Evolution of Myricaria (Tamaricaeae) in the Neogene	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; QINGHAI-TIBETAN PLATEAU; MOLECULAR PHYLOGENY; GEOGRAPHIC RANGE; CENOZOIC UPLIFT; NUCLEAR RDNA; DIVERSIFICATION; HISTORY; MIOCENE; BIOGEOGRAPHY	Background: Myricaria consists of about twelve-thirteen species and occurs in Eurasian North Temperate zone, most species in the Qinghai-Tibet Plateau (QTP) and adjacent areas. Methodology/Principal Findings: Twelve species of Myricaria plus two other genera Tamarix and Reaumuria in Tamaricaceae, were sampled, and four markers, ITS, rps16, psbB-psbH, and trnL-trnF were sequenced. The relaxed Bayesian molecular clock BEAST method was used to perform phylogenetic analysis and molecular dating, and Diva, S-Diva, and maximum likelihood Lagrange were used to estimate the ancestral area. The results indicated that Myricaria could be divided into four phylogenetic clades, which correspond to four sections within the genus, of them two are newly described in this paper. The crown age of Myricaria was dated to early Miocene ca. 20 Ma, at the probable early uplifting time of the Himalayas. The Himalayas were also shown as the center of origin for Myricaria from the optimization of ancestral distribution. Migration and dispersal of Myricaria were indicated to have taken place along the Asian Mountains, including the Himalayas, Kunlun, Altun, Hendukosh, Tianshan, Altai, and Caucasus etc., westward to Europe, eastward to Central China, and northward to the Mongolian Plateau. Conclusions/Significance: Myricaria spatiotemporal evolution presented here, especially the Himalayan origin at early Miocene ca. 20 Ma, and then migrated westward and eastward along the Asian mountains, offers a significant evolutionary case for QTP and Central Asian biogeography.	[Zhang, Ming-Li; Meng, Hong-Hu; Zhang, Hong-Xiang] Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Vyacheslav, Byalt V.] Russian Acad Sci, VL Komarov Bot Inst, St Petersburg 196140, Russia	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences	Zhang, ML (corresponding author), Chinese Acad Sci, Key Lab Biogeog & Bioresource Arid Land, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn	Meng, Hong-Hu/Y-9861-2019; Meng, Hong-Hu/B-6775-2016	Meng, Hong-Hu/0000-0002-4504-0001; Meng, Hong-Hu/0000-0002-4504-0001	China National Key Basic Research Program [2012FY111500, 2014CB954201]; CAS Important Direction for Knowledge Innovation Project [KZCX2-EW-305]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Key Basic Research Program(National Basic Research Program of China); CAS Important Direction for Knowledge Innovation Project; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by China National Key Basic Research Program (No. 2012FY111500, 2014CB954201), CAS Important Direction for Knowledge Innovation Project (No. KZCX2-EW-305), and the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1984, BULL BOT RES; Baum B., 1966, MONOGRAPHIC REVISION; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carlquist S, 2010, BOT J LINN SOC, V164, P342, DOI 10.1111/j.1095-8339.2010.01095.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eggens F, 2006, SYSTEMATICS SILENEAE; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Gaskin JF, 2004, ANN MO BOT GARD, V91, P401; Gorschkova S G, 1949, FLORA USSR, V15, P290; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Harris AJ, 2009, TAXON, V58, P108, DOI 10.1002/tax.581012; Hua Li, 2004, Acta Botanica Yunnanica, V26, P283; Institute of Botany NIoGaP Academia Sinica (IB-NIGP), 1978, CHIN PLANT FOSS; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kadereit JW, 2008, PLANT ECOL DIVERS, V1, P171, DOI 10.1080/17550870802328751; Kitamura S, 1955, FAUNA FLORA NEPAL HI, P73; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Liu DL, 2010, TECTONOPHYSICS, V486, P108, DOI 10.1016/j.tecto.2010.01.014; Liu J, 2007, NEWSLETT HIMALAYAN B, V40, P20; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu JQ, 2002, MOL PHYLOGENET EVOL, V23, P307, DOI 10.1016/S1055-7903(02)00039-8; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Liu YF, 2009, MOL ECOL, V18, P2700, DOI 10.1111/j.1365-294X.2009.04214.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mao KS, 2010, NEW PHYTOL, V188, P254, DOI 10.1111/j.1469-8137.2010.03351.x; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Molnar P, 2005, PALAEONTOL ELECTRON, V8; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Najman YMR, 1997, GEOLOGY, V25, P535, DOI 10.1130/0091-7613(1997)025<0535:LAADOS>2.3.CO;2; Niedenzu F, 1925, NATURL PFLANZ, P276; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Ovezinrlikov PN, 1977, DOKL AKAD NAUK SSSR, V20, P54; Owen LA, 2005, QUATERN INT, V138, P55, DOI 10.1016/j.quaint.2005.02.006; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; QAISER M, 1978, Blumea, V24, P151; Qiang XK, 2011, SCI CHINA EARTH SCI, V54, P136, DOI 10.1007/s11430-010-4126-5; Rajbhandary S., 2011, Gardens' Bulletin (Singapore), V63, P277; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reveal James L., 2011, Kew Bulletin, V66, P5, DOI 10.1007/s12225-011-9259-y; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; RONQUIST F, 1996, DIVA VERSION 1 1 COM; Royle JF, 1839, ILLUSTRATION BOT OTH; Schuster TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061261; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Sun JM, 2006, SCIENCE, V312, P1621, DOI 10.1126/science.1124616; TABATA H, 1988, Acta Phytotaxonomica et Geobotanica, V39, P13; Tabata H, 2004, HIMALAYAN J SCI, V2, P256; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; Tu TY, 2010, MOL PHYLOGENET EVOL, V57, P1226, DOI 10.1016/j.ympev.2010.09.007; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang YD, 2012, GEOSCI FRONT, V3, P175, DOI 10.1016/j.gsf.2011.11.005; Wang Y, 2009, BOT STUD, V50, P343; Wang YJ, 2007, ANN BOT-LONDON, V99, P311, DOI 10.1093/aob/mcl259; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis K. J., 2002, EVOLUTION PLANTS; Wu ZY, 1987, FLORA XIZANGICA, P874; Wu ZY, 1988, J JPN BOT, V63, P1; WULFF E. V., 1943, An introduction to historical plant geography.; Xu DH, 2000, THEOR APPL GENET, V101, P724, DOI 10.1007/s001220051537; Xu L., 2010, FLORA CHINA, V10, P322; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang Q., 2007, FLORA CHINA, V13, P58; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zhang Dao-Yuan, 2005, Acta Botanica Yunnanica, V27, P471; Zhang DY, 2000, ACTA BOT BOREALI-OCC, V20, P421; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang Ming-Li, 2003, Acta Botanica Yunnanica, V25, P25; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhang ML, 1997, ACTA BOT YUNNAN, V19, P331; Zhang PY, 1990, FLORA REIPUBLICAE PO, P142; Zhou LL, 2012, J BIOGEOGR, V39, P322, DOI 10.1111/j.1365-2699.2011.02598.x	84	18	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97582	10.1371/journal.pone.0097582	http://dx.doi.org/10.1371/journal.pone.0097582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905234	Green Published, gold			2022-12-25	WOS:000341869000008
J	Huang, HL; Hsieh, MJ; Chien, MH; Chen, HY; Yang, SF; Hsiao, PC				Huang, Hsin-Lien; Hsieh, Ming-Ju; Chien, Ming-Hsien; Chen, Hui-Yu; Yang, Shun-Fa; Hsiao, Pei-Ching			Glabridin Mediate Caspases Activation and Induces Apoptosis through JNK1/2 and p38 MAPK Pathway in Human Promyelocytic Leukemia Cells	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; INHIBITS MIGRATION; CANCER; LICORICE; INVASION; ANGIOGENESIS; DYSFUNCTION; METASTASIS; GENERATION; DIOSCIN	Background: Glabridin, a prenylated isoflavonoid of G. glabra L. roots, has been associated with a wide range of biological properties such as regulation of energy metabolism, estrogenic, neuroprotective, anti-osteoporotic, and skin-whitening in previous studies. However, the effect of glabridin on tumor cells metastasis has not been clearly clarified. Here, the molecular mechanism by which glabridin anticancer effects in human promyelocytic leukemia cells was investigated. Methodology and Principal Findings: The results showed that glabridin significantly inhibited cell proliferation of four AML cell lines (HL-60, MV4-11, U937, and THP-1). Furthermore, glabridin induced apoptosis of HL-60 cells through caspases-3, -8, and -9 activations and PARP cleavage in dose-and time-dependent manner. Moreover, western blot analysis also showed that glabridin increase phosphorylation of ERK1/2, p38 MAPK and JNK1/2 in dose-and time-dependent manner. Inhibition of p38 MAPK and JNK1/2 by specific inhibitors significantly abolished the glabridin-induced activation of the caspase-3, -8 and -9. Conclusion: Taken together, our results suggest that glabridin induced HL-60 cell apoptosis through p38 MAPK and JNK1/2 pathways and could serve as a potential additional chemotherapeutic agent for treating AML.	[Huang, Hsin-Lien; Hsieh, Ming-Ju; Chen, Hui-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Hsieh, Ming-Ju] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Hsieh, Ming-Ju] Chung Shan Med Univ, Sch Optometry, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsiao, Pei-Ching] Chung Shan Med Univ, Dept Internal Med, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Hsiao, PC (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy046@csh.org.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2014-C-020]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a grant (CSH-2014-C-020) from Chung Shan Medical University Hospital, Taiwan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, FOOD CHEM TOXICOL, V51, P439, DOI 10.1016/j.fct.2012.08.048; Aoki F, 2007, J AM COLL NUTR, V26, P209, DOI 10.1080/07315724.2007.10719603; Belinky PA, 1998, FREE RADICAL BIO MED, V24, P1419, DOI 10.1016/S0891-5849(98)00006-9; Bishop JF, 1997, SEMIN ONCOL, V24, P57; Cai J, 2002, BIOL PHARM BULL, V25, P193, DOI 10.1248/bpb.25.193; Carmeli E, 2009, TOXICOL IND HEALTH, V25, P321, DOI 10.1177/0748233709103034; Carter BZ, 2012, LEUKEMIA, V26, P443, DOI 10.1038/leu.2011.246; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; Chen TF, 2008, J AGR FOOD CHEM, V56, P10574, DOI 10.1021/jf802125t; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Huang ST, 2010, PHYTOMEDICINE, V17, P47, DOI 10.1016/j.phymed.2009.06.005; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Jia W, 2003, PHYTOTHER RES, V17, P1127, DOI 10.1002/ptr.1398; Kang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028706; Kim HS, 2013, INT J MOL MED, V31, P243, DOI 10.3892/ijmm.2012.1172; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li QH, 2013, INT J HEMATOL, V97, P617, DOI 10.1007/s12185-013-1317-9; Li XM, 2005, ADV CHRONIC KIDNEY D, V12, P276, DOI 10.1016/j.ackd.2005.03.007; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Ravindranath MH, 2009, EVID-BASED COMPL ALT, V6, P523, DOI 10.1093/ecam/nem140; Repicky A, 2009, CANCER LETT, V277, P55, DOI 10.1016/j.canlet.2008.11.026; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Tsai YM, 2011, INTEGR CANCER THER, V10, P341, DOI 10.1177/1534735410384860; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/732562; Wang Y, 2007, J PROTEOME RES, V6, P4703, DOI 10.1021/pr070399r; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Wu FH, 2013, MOL MED REP, V7, P1278, DOI 10.3892/mmr.2013.1330; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853; Zhou Fen, 2013, Chinese Medical Sciences Journal, V28, P72	42	36	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98943	10.1371/journal.pone.0098943	http://dx.doi.org/10.1371/journal.pone.0098943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901249	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400076
J	Lei, HT; Chou, TH; Su, CC; Bolla, JR; Kumar, N; Radhakrishnan, A; Long, F; Delmar, JA; Do, SV; Rajashankar, KR; Shafer, WM; Yu, EW				Lei, Hsiang-Ting; Chou, Tsung-Han; Su, Chih-Chia; Bolla, Jani Reddy; Kumar, Nitin; Radhakrishnan, Abhijith; Long, Feng; Delmar, Jared A.; Do, Sylvia V.; Rajashankar, Kanagalaghatta R.; Shafer, William M.; Yu, Edward W.			Crystal Structure of the Open State of the Neisseria gonorrhoeae MtrE Outer Membrane Channel	PLOS ONE			English	Article							MULTIDRUG EFFLUX; FUSION PROTEIN; PUMP; RESISTANCE; SYSTEM; TRANSPORTER; MUTATIONS; SOFTWARE; AGENTS; MEMBER	Active efflux of antimicrobial agents is one of the most important strategies used by bacteria to defend against antimicrobial factors present in their environment. Mediating many cases of antibiotic resistance are transmembrane efflux pumps, composed of one or more proteins. The Neisseria gonorrhoeae MtrCDE tripartite multidrug efflux pump, belonging to the hydrophobic and amphiphilic efflux resistance-nodulation-cell division (HAE-RND) family, spans both the inner and outer membranes of N. gonorrhoeae and confers resistance to a variety of antibiotics and toxic compounds. We here describe the crystal structure of N. gonorrhoeae MtrE, the outer membrane component of the MtrCDE tripartite multidrug efflux system. This trimeric MtrE channel forms a vertical tunnel extending down contiguously from the outer membrane surface to the periplasmic end, indicating that our structure of MtrE depicts an open conformational state of this channel.	[Lei, Hsiang-Ting; Bolla, Jani Reddy; Kumar, Nitin; Radhakrishnan, Abhijith; Long, Feng; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Chou, Tsung-Han; Su, Chih-Chia; Delmar, Jared A.; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA USA; [Do, Sylvia V.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA USA; [Rajashankar, Kanagalaghatta R.] NE CAT, Argonne, IL USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL USA; [Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] VA Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	, Nitin/J-8078-2019; Bolla, Jani Reddy/AAT-1370-2020; Long, Feng/F-5475-2011; Radhakrishnan, Abhijith/V-6182-2019	Bolla, Jani Reddy/0000-0003-4346-182X; Long, Feng/0000-0001-6313-8558; Radhakrishnan, Abhijith/0000-0001-8107-3487	NIH [R37AI021150, R01GM086431]; VA Merit Award from the Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM086431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award from the Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants R37AI021150 (W. M. S.) and R01GM086431 (E.W.Y.) and a VA Merit Award (W. M. S.) from the Medical Research Service of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Andersen C, 2002, MOL MICROBIOL, V44, P1131, DOI 10.1046/j.1365-2958.2002.02898.x; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delahay RM, 1997, MICROBIOL-SGM, V143, P2127, DOI 10.1099/00221287-143-7-2127; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Hagman KE, 1997, MICROBIOL-SGM, V143, P2117, DOI 10.1099/00221287-143-7-2117; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lei HT, 2014, J MOL BIOL, V426, P403, DOI 10.1016/j.jmb.2013.09.042; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei XY, 2011, P NATL ACAD SCI USA, V108, P2112, DOI 10.1073/pnas.1012588108; Rouquette-Loughlin C, 2003, J BACTERIOL, V185, P1101, DOI 10.1128/JB.185.3.1101-1106.2003; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shafer WM, 2001, J MOL MICROB BIOTECH, V3, P219; Su CC, 2012, J MOL BIOL, V422, P429, DOI 10.1016/j.jmb.2012.05.038; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tapsall John, 2006, Expert Rev Anti Infect Ther, V4, P619, DOI 10.1586/14787210.4.4.619; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Veal WL, 1998, MICROBIOL-SGM, V144, P621, DOI 10.1099/00221287-144-3-621; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x	44	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97475	10.1371/journal.pone.0097475	http://dx.doi.org/10.1371/journal.pone.0097475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901251	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400006
J	Sarria, FA; Morris, GK; Windmill, JFC; Jackson, J; Montealegre, F				Sarria-S, Fabio A.; Morris, Glenn K.; Windmill, James F. C.; Jackson, Joseph; Montealegre-Z, Fernando			Shrinking Wings for Ultrasonic Pitch Production: Hyperintense Ultra-Short-Wavelength Calls in a New Genus of Neotropical Katydids (Orthoptera: Tettigoniidae)	PLOS ONE			English	Article							SOUND PRODUCTION; GLEANING BAT; GENERATION; DESIGN; COMMUNICATION; CONSTRAINTS; PHYLOGENY	This article reports the discovery of a new genus and three species of predaceous katydid (Insecta: Orthoptera) from Colombia and Ecuador in which males produce the highest frequency ultrasonic calling songs so far recorded from an arthropod. Male katydids sing by rubbing their wings together to attract distant females. Their song frequencies usually range from audio (5 kHz) to low ultrasonic (30 kHz). However, males of Supersonus spp. call females at 115 kHz, 125 kHz, and 150 kHz. Exceeding the human hearing range (50 Hz-20 kHz) by an order of magnitude, these insects also emit their ultrasound at unusually elevated sound pressure levels (SPL). In all three species these calls exceed 110 dB SPL rms re 20 mu Pa (at 15 cm). Males of Supersonus spp. have unusually reduced forewings (<0.5 mm(2)). Only the right wing radiates appreciable sound, the left bears the file and does not show a particular resonance. In contrast to most katydids, males of Supersonus spp. position and move their wings during sound production so that the concave aspect of the right wing, underlain by the insect dorsum, forms a contained cavity with sharp resonance. The observed high SPL at extreme carrier frequencies can be explained by wing anatomy, a resonant cavity with a membrane, and cuticle deformation.	[Sarria-S, Fabio A.; Montealegre-Z, Fernando] Lincoln Univ, Sch Life Sci, Lincoln, England; [Morris, Glenn K.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Windmill, James F. C.; Jackson, Joseph] Univ Strathclyde, Dept Elect & Elect Engn, Glasgow G1 1XW, Lanark, Scotland	University of Lincoln; University of Toronto; University Toronto Mississauga; University of Strathclyde	Montealegre, F (corresponding author), Lincoln Univ, Sch Life Sci, Riseholme Campus, Lincoln, England.	fmontealegrez@lincoln.ac.uk	Windmill, James F C/I-1117-2019; Jackson, Joseph/AAE-1204-2021	Windmill, James F C/0000-0003-4878-349X; Jackson, Joseph/0000-0001-9302-8157	National Geographic [GEFNE17-11]; Royal Society [RG120495]; Engineering and Physical Sciences Research Council (EPSRC) [EP/H02848X/1]; Biotechnology & Biological Sciences Research Council (BBSRC) [BB/H0046371]; BBSRC [BB/H004637/1] Funding Source: UKRI; EPSRC [EP/H02848X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004637/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H02848X/1] Funding Source: researchfish	National Geographic(National Geographic Society); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology & Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was sponsored by National Geographic (http://www.nationalgeographic.co.uk/explorers/grants-programs/),grant #GEFNE17-11 to FM-Z). Royal Society (http://royalsociety.org/grants/) provided funds for equipment used in this research (grant no. RG120495) to FM-Z. JCJ was supported by the Engineering and Physical Sciences Research Council (EPSRC) (http://www.epsrc.ac.uk/Pages/default.aspx) grant no. EP/H02848X/1. JFCW was supported by the Biotechnology & Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/home/home.aspx) grant no. BB/H0046371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet-Clark HC, 1999, J EXP BIOL, V202, P1803; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bowen-Jones E., 1994, J ORTHOPTERA RES, V2, P46, DOI DOI 10.2307/3503609; Braun H, 2002, THESIS FRIEDRICH ALE; Chivers B, 2014, BIOACOUSTICS, V23, P67, DOI 10.1080/09524622.2013.816639; Cortes A, 2010, ANFIBIOS REPTILES AR, P37; Farris HE, 1998, PHYSIOL ENTOMOL, V23, P322, DOI 10.1046/j.1365-3032.1998.00093.x; FAURE PA, 1990, J COMP PHYSIOL A, V166, P843; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; FORREST TG, 1982, FLA ENTOMOL, V65, P33, DOI 10.2307/3494144; Gorochov A. V., 2012, ZOOSYSTEMATICA ROSSICA, V22, P59; Gorochov A. V., 2012, Trudy Zoologicheskogo Instituta, V316, P285; HEBARD MORGAN, 1927, TRANS AMER ENT SOC, V53, P79; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; Heller KG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092366; Karny H., 1911, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V61; Montealegre Z. Fernando, 1999, Journal of Orthoptera Research, V8, P163; Montealegre-Z F, 2004, SYST ENTOMOL, V29, P21, DOI 10.1111/j.1365-3113.2004.00223.x; Montealegre-Z F, 2009, J EVOLUTION BIOL, V22, P355, DOI 10.1111/j.1420-9101.2008.01652.x; Montealegre-Z F, 2005, THESIS U TORONTO TOR; Montealegre-Z F, 2006, J EXP BIOL, V209, P4923, DOI 10.1242/jeb.02608; Montealegre F, 2014, REV BIOL TROP, V62, P289, DOI 10.15517/rbt.v62i0.16342; Montealegre F, 2013, ZOOTAXA, V3666, P591, DOI 10.11646/zootaxa.3666.4.11; Montealegre-Z F, 2011, SYST BIODIVERS, V9, P77, DOI 10.1080/14772000.2011.560209; MORRIS G K, 1982, Transactions of the American Entomological Society (Philadelphia), V108, P287; MORRIS GK, 1980, ANIM BEHAV, V28, P42, DOI 10.1016/S0003-3472(80)80006-6; MORRIS GK, 1988, T AM ENTOMOL SOC, V114, P215; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; MORRIS GK, 1995, NATURWISSENSCHAFTEN, V82, P96, DOI 10.1007/s001140050150; Morris Glenn K., 2001, Revista Colombiana de Entomologia, V27, P93; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; Nickle David A., 2002, Journal of Orthoptera Research, V11, P125, DOI 10.1665/1082-6467(2002)011[0125:NSOKOT]2.0.CO;2; Pierce G. W., 1948, SONGS INSECTS RELATE; Prestwich KN, 2000, J EXP BIOL, V203, P585; RAFIQ M, 1991, MEAS SCI TECHNOL, V2, P168, DOI 10.1088/0957-0233/2/2/014; RANDELL RL, 1964, CAN ENTOMOL, V96, P1608, DOI 10.4039/Ent961608-12; Rausch M, 1999, ACUSTICA, V85, P412; Redtenbacher J., 1891, Verhandlungen der Zoologisch botanischen Wien, Vxli, P315; Russell DA, 1999, AM J PHYS, V67, P660, DOI 10.1119/1.19349; Sales GD, 1974, ULTRASONIC COMMUNICA; Sueur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021089; SUGA N, 1966, J INSECT PHYSIOL, V12, P1039, DOI 10.1016/0022-1910(66)90119-3; ter Hofstede HM, 2008, J EXP BIOL, V211, P2431, DOI 10.1242/jeb.017285; ter Hofstede HM, 2010, J COMP PHYSIOL A, V196, P349, DOI 10.1007/s00359-010-0518-4; THEISS J, 1982, BEHAV ECOL SOCIOBIOL, V10, P225, DOI 10.1007/BF00299689; VanStaaden MJ, 1997, J EXP BIOL, V200, P2597; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Windmill JFC, 2006, CURR BIOL, V16, P2418, DOI 10.1016/j.cub.2006.09.066	49	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98708	10.1371/journal.pone.0098708	http://dx.doi.org/10.1371/journal.pone.0098708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901234	Green Published, Green Accepted, gold			2022-12-25	WOS:000336841400048
J	Chakraborty, D; Conley, SM; Al-Ubaidi, MR; Naash, MI				Chakraborty, Dibyendu; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna I.			Initiation of Rod Outer Segment Disc Formation Requires RDS	PLOS ONE			English	Article							MUTANT MICE; RETINAL DEGENERATION; PERIPHERIN/RDS; MORPHOGENESIS; CONE; KNOCKOUT; PHOTORECEPTORS; OLIGOMERIZATION; MEMBRANES; MOUSE	Rod outer segment (OS) morphogenesis involves assembly of flattened discs circumscribed by a hairpin-like rim, however, the role of the rim and rim proteins such as retinal degeneration slow (RDS) and its homologue rod OS membrane protein-1 (ROM-1) in this process remains unclear. Here we show that without RDS, no disc/OS formation occurs, while without rhodopsin, small OS structures form containing aligned nascent discs. In the absence of both rhodopsin and RDS, RDS-associated degeneration is slowed, and ROM-1 is stabilized and trafficked to the OS. These animals (rho(-/-)/rds(-/-)) exhibit OSs slightly better than those lacking only RDS, but still without signs of disc formation. These results clearly demonstrate that OS morphogenesis is initiated by RDS-mediated rim formation, a process ROM-1 cannot recapitulate, with subsequent disc growth mediated by rhodopsin. The critical role of RDS in this process helps explain why photoreceptors are so sensitive to varied RDS levels, and why mutations in RDS cause debilitating retinal disease.	[Chakraborty, Dibyendu; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73106 USA.	muna-naash@ouhsc.edu			National Institutes of Health [EY10609, 5P30EY021725]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY010609, P30EY021725, R56EY010609, R55EY010609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (http://www.nei.nih.gov/) (EY10609, MIN, and core grant 5P30EY021725), and the Foundation Fighting Blindness (https://www.blindness.org/) (MIN, MRA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Conley SM, 2014, FASEB J; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jaissle GB, 2001, INVEST OPHTH VIS SCI, V42, P506; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Kisselev OG, 2005, EXP EYE RES, V81, P366, DOI 10.1016/j.exer.2005.06.018; Lee ES, 2006, INVEST OPHTH VIS SCI, V47, P2150, DOI 10.1167/iovs.05-0919; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037832; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Salinas RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054292; SANYAL S, 1984, EXP EYE RES, V39, P231, DOI 10.1016/0014-4835(84)90011-3; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; SCHALKEN JJ, 1990, BIOCHIM BIOPHYS ACTA, V1033, P103, DOI 10.1016/0304-4165(90)90201-7; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	42	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98939	10.1371/journal.pone.0098939	http://dx.doi.org/10.1371/journal.pone.0098939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897172	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700096
J	Dey, S; Chellappa, MM; Gaikwad, S; Kataria, JM; Vakharia, VN				Dey, Sohini; Chellappa, Madhan Mohan; Gaikwad, Satish; Kataria, Jag Mohan; Vakharia, Vikram N.			Genotype Characterization of Commonly Used Newcastle Disease Virus Vaccine Strains of India	PLOS ONE			English	Article							PROTEIN CLEAVAGE SITE; FUSION PROTEIN; HEMAGGLUTININ-NEURAMINIDASE; GENOME SEQUENCE; HN PROTEIN; VIRULENCE; GENE; PATHOGENICITY; IDENTIFICATION; GLYCOPROTEIN	Newcastle disease is an avian pathogen causing severe economic losses to the Indian poultry industry due to recurring outbreaks in vaccinated and unvaccinated flocks. India being an endemic country, advocates vaccination against the virus using lentogenic and mesogenic strains. Two virus strains which are commonly used for vaccination are strain F (a lentogenic virus) and strain R2B (a mesogenic virus). Strain F is given to 0-7 days old chicks and R2B is given to older birds which are around 6-8 weeks old. To understand the genetic makeup of these two strains, a complete genome study and phylogenetic analysis of the F, HN genes of these vaccine strains were carried out. Both the viral strains had a genome length of 15,186 nucleotides and consisted of six genes with conserved complimentary 3' leader and 5' trailer regions. The fusion protein cleavage site of strain F is GGRQGRL and strain R2B is RRQKRF. Although both the viral strains had different virulence attributes, the length of the HN protein was similar with 577 amino acids. Phylogenetic analysis of F, HN and complete genome sequences grouped these two strains in genotype II category which are considered as early genotypes and corroborated with their years of isolation.	[Dey, Sohini; Chellappa, Madhan Mohan] Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India; [Gaikwad, Satish] Anim & Plant Quarantine Agcy, Avian Dis Sect, OIE Reference Lab Newcastle Dis, Anyang, South Korea; [Kataria, Jag Mohan] Cent Avian Res Inst, Bareilly, Uttar Pradesh, India; [Vakharia, Vikram N.] Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD 21228 USA	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Animal & Plant Quarantine Agency; Indian Council of Agricultural Research (ICAR); ICAR - Central Avian Research Institute; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Dey, S (corresponding author), Indian Vet Res Inst, Div Vet Biotechnol, Bareilly, Uttar Pradesh, India.	sohinimadhan@yahoo.com	Gaikwad, Satish/AGZ-6274-2022; Dey, Sohini/GZM-9514-2022	Gaikwad, Satish/0000-0002-1031-5677; Vakharia, Vikram/0000-0002-0955-3010; Chellappa, Madhan Mohan/0000-0003-0477-6829	National Fund for Basic, Strategic and Frontier Application Research in Agriculture; Indian Council of Agricultural Research [NFBSFARA/BS-3010]; Department of Biotechnology, Ministry of Science and Technology [BT/PR15373/AAQ/57/116/2011]	National Fund for Basic, Strategic and Frontier Application Research in Agriculture; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); Department of Biotechnology, Ministry of Science and Technology	This work was supported by a research grant from the National Fund for Basic, Strategic and Frontier Application Research in Agriculture, Indian Council of Agricultural Research to S.D. (NFBSFARA/BS-3010), and a grant from Department of Biotechnology, Ministry of Science and Technology to M.M.C. (BT/PR15373/AAQ/57/116/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D.J., 1989, LAB MANUAL ISOLATION; Alexander DJ, 2008, POULTRY DIS, P75; [Anonymous], 1954, ANN REP IND VET RES; ASPLIN F. D., 1952, VET REC, V64, P245; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Chellappa MM, 2012, J VIROL, V86, P13814, DOI 10.1128/JVI.02552-12; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chen L, 2001, VIROLOGY, V290, P290, DOI 10.1006/viro.2001.1172; COLEMAN NA, 1993, VIROLOGY, V195, P596, DOI 10.1006/viro.1993.1411; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw O, 1999, J GEN VIROL, V80, P131, DOI 10.1099/0022-1317-80-1-131; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IYER GS, 1945, INDIAN J VET SCI, V15, P155; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Khattar SK, 2009, J VIROL, V83, P7779, DOI 10.1128/JVI.00536-09; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; LANCASTER JE, 1962, CAN J COMP MED VET S, V26, P244; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; McGinnes LW, 2001, VIROLOGY, V289, P343, DOI 10.1006/viro.2001.1123; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Mohamed MHA, 2009, VIRUS GENES, V39, P234, DOI 10.1007/s11262-009-0385-7; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; Nanthakumar T, 2000, AVIAN PATHOL, V29, P603, DOI 10.1080/713651205; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Ragavan VS, 1998, INDIAN VET J, V75, P1079; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; SAKAGUCHI T, 1989, VIROLOGY, V169, P260, DOI 10.1016/0042-6822(89)90151-7; SCHUY W, 1984, VIRUS RES, V1, P415, DOI 10.1016/0168-1702(84)90027-3; SEETHARAMAN C., 1951, Indian Veterinary Journal, V28, P13; StoneHulslander J, 1997, J VIROL, V71, P6287, DOI 10.1128/JVI.71.9.6287-6295.1997; Tirumurugaan KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028414; Zanetti F, 2008, MICROB PATHOGENESIS, V44, P135, DOI 10.1016/j.micpath.2007.08.012	42	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98869	10.1371/journal.pone.0098869	http://dx.doi.org/10.1371/journal.pone.0098869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897503	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700090
J	Guo, YL; Han, Y; Ma, J; Wang, HP; Sang, XC; Li, MY				Guo, Yulong; Han, Yao; Ma, Jing; Wang, Huiping; Sang, Xianchun; Li, Mingyang			Undesired Small RNAs Originate from an Artificial microRNA Precursor in Transgenic Petunia (Petunia hybrida)	PLOS ONE			English	Article							REAL-TIME PCR; ARABIDOPSIS-THALIANA; PLANT MICRORNAS; FLOWER DEVELOPMENT; BIOGENESIS; EXPRESSION; MIRNA; DISTINCT; TARGETS; GENES	Although artificial microRNA (amiRNA) technology has been used frequently in gene silencing in plants, little research has been devoted to investigating the accuracy of amiRNA precursor processing. In this work, amiRNAchs1 (amiRchs1), based on the Arabidopsis miR319a precursor, was expressed in order to suppress the expression of CHS genes in petunia. The transgenic plants showed the CHS gene-silencing phenotype. A modified 5' RACE technique was used to map small-RNA-directed cleavage sites and to detect processing intermediates of the amiRchs1 precursor. The results showed that the target CHS mRNAs were cut at the expected sites and that the amiRchs1 precursor was processed from loop to base. The accumulation of small RNAs in amiRchs1 transgenic petunia petals was analyzed using the deep-sequencing technique. The results showed that, alongside the accumulation of the desired artificial microRNAs, additional small RNAs that originated from other regions of the amiRNA precursor were also accumulated at high frequency. Some of these had previously been found to be accumulated at low frequency in the products of ath-miR319a precursor processing and some of them were accompanied by 3'-tailing variant. Potential targets of the undesired small RNAs were discovered in petunia and other Solanaceae plants. The findings draw attention to the potential occurrence of undesired target silencing induced by such additional small RNAs when amiRNA technology is used. No appreciable production of secondary small RNAs occurred, despite the fact that amiRchs1 was designed to have perfect complementarity to its CHS-J target. This confirmed that perfect pairing between an amiRNA and its targets is not the trigger for secondary small RNA production. In conjunction with the observation that amiRNAs with perfect complementarity to their target genes show high efficiency and specificity in gene silencing, this finding has an important bearing on future applications of amiRNAs in gene silencing in plants.	[Guo, Yulong; Han, Yao; Ma, Jing; Wang, Huiping; Li, Mingyang] Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mountainous Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China; [Sang, Xianchun] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Li, MY (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mountainous Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China.	limy@swu.edu.cn	wang, hui/GRS-4730-2022	Guo, Yulong/0000-0003-0926-200X	National Natural Science Foundation of China [31272199]; Fundamental Research Funds for the Central Universities [2362014xk10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (31272199, http://www.nsfc.gov.cn/) and Fundamental Research Funds for the Central Universities (2362014xk10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Ehya F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066372; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Haney CH, 2010, P NATL ACAD SCI USA, V107, P478, DOI 10.1073/pnas.0910081107; Hauser F, 2013, PLANT CELL, V25, P2848, DOI 10.1105/tpc.113.112805; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; KOES RE, 1990, PLANT CELL, V2, P379, DOI 10.1105/tpc.2.5.379; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu CG, 2012, PLANT PHYSIOL, V159, P748, DOI 10.1104/pp.112.193508; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Mateos JL, 2010, CURR BIOL, V20, P49, DOI 10.1016/j.cub.2009.10.072; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Park W, 2009, PLANT CELL REP, V28, P469, DOI 10.1007/s00299-008-0651-5; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sobkowiak L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00046; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Sun GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032017; Sun PL, 2013, PLANT CELL, V25, P470, DOI 10.1105/tpc.112.106294; Szarzynska B, 2009, NUCLEIC ACIDS RES, V37, P3083, DOI 10.1093/nar/gkp189; Tedder P, 2009, RNA, V15, P1012, DOI 10.1261/rna.1517209; Toppino L, 2011, PLANT BIOTECHNOL J, V9, P684, DOI 10.1111/j.1467-7652.2010.00567.x; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Verdonk JC, 2013, BOTANY, V91, P117, DOI 10.1139/cjb-2012-0166; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Werner S, 2010, CURR BIOL, V20, P42, DOI 10.1016/j.cub.2009.10.073; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhai JX, 2013, PLANT CELL, V25, P2417, DOI 10.1105/tpc.113.114603; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhao T, 2009, PLANT J, V58, P157, DOI 10.1111/j.1365-313X.2008.03758.x; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	10	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98783	10.1371/journal.pone.0098783	http://dx.doi.org/10.1371/journal.pone.0098783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897430	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700076
J	Marth, K; Wollmann, E; Gallerano, D; Ndlovu, P; Makupe, I; Valenta, R; Sibanda, E				Marth, Katharina; Wollmann, Eva; Gallerano, Daniela; Ndlovu, Portia; Makupe, Ian; Valenta, Rudolf; Sibanda, Elopy			Persistence of IgE-Associated Allergy and Allergen-Specific IgE despite CD4+T Cell Loss in AIDS	PLOS ONE			English	Article							SERUM IGE; HIV; SENSITIZATION; INFECTION; INDIVIDUALS; REACTIVITY; ADULTS; T(H)2	The infection of CD4+ cells by HIV leads to the progressive destruction of CD4+ T lymphocytes and, after a severe reduction of CD4+ cells, to AIDS. The aim of the study was to investigate whether HIV-infected patients with CD4 cell counts <200 cells/mu l can suffer from symptoms of IgE-mediated allergy, produce allergen-specific IgE antibody responses and show boosts of allergen-specific IgE production. HIV-infected patients with CD4 counts <= 200 cells/mu l suffering from AIDS and from IgE-mediated allergy were studied. Allergy was diagnosed according to case history, physical examination, skin prick testing (SPT), and serological analyses including allergen microarrays. HIV infection was confirmed serologically and the disease was staged clinically. The predominant allergic symptoms in the studied patients were acute allergic rhinitis (73%) followed by asthma (27%) due to IgE-mediated mast cell activation whereas no late phase allergic symptoms such as atopic dermatitis, a mainly T cell-mediated skin manifestation, were found in patients suffering from AIDS. According to IgE serology allergies to house dust mites and grass pollen were most common besides IgE sensitizations to various food allergens. Interestingly, pollen allergen-specific IgE antibody levels in the patients with AIDS and in additional ten IgE-sensitized patients with HIV infections and low CD4 counts appeared to be boosted by seasonal allergen exposure and were not associated with CD4 counts. Our results indicate that secondary allergen-specific IgE production and IgE-mediated allergic inflammation do not require a fully functional CD4+ T lymphocyte repertoire.	[Marth, Katharina; Wollmann, Eva; Gallerano, Daniela; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Marth, Katharina; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Allergy Res,Div Immunopatho, Vienna, Austria; [Ndlovu, Portia; Makupe, Ian; Sibanda, Elopy] Asthma Allergy & Immune Dysfunct Clin, Harare, Zimbabwe	Medical University of Vienna; Medical University of Vienna	Sibanda, E (corresponding author), Asthma Allergy & Immune Dysfunct Clin, Harare, Zimbabwe.	esibanda@africaonline.co.zw		Valenta, Rudolf/0000-0001-5944-3365; Rigler, Eva/0000-0002-3596-3937	Austrian Science Fund (FWF) [SFB F4605]; doctoral program IAI; Biomay AG, Vienna, Austria; Christian Doppler Research Association, Vienna, Austria	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); doctoral program IAI; Biomay AG, Vienna, Austria; Christian Doppler Research Association, Vienna, Austria	This study was supported by research grants from the Austrian Science Fund (FWF), SFB project F4605 and the doctoral program IAI, by research grants from Biomay AG, Vienna, Austria and the Christian Doppler Research Association, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro KG, 1993, MMWR RECOMM REP, V4, P1; Durham SR, 2000, AM J RHINOL, V14, P305, DOI 10.2500/105065800781329492; Egger C, 2010, J ALLERGY CLIN IMMUN, V126, P1312, DOI 10.1016/j.jaci.2010.06.008; Goetz DW, 1997, ANN ALLERG ASTHMA IM, V78, P301, DOI 10.1016/S1081-1206(10)63186-9; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Katelaris CH, 2012, CLIN EXP ALLERGY, V42, P186, DOI 10.1111/j.1365-2222.2011.03891.x; Kling S, 2013, SAMJ S AFR MED J, V103, P200, DOI [10.7196/SAMJ.6658, 10.7196/samj.6658]; LEVY JA, 1988, NATURE, V333, P519, DOI 10.1038/333519a0; Linhart B, 2007, J IMMUNOL, V178, P3924, DOI 10.4049/jimmunol.178.6.3924; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Lupinek C, 2012, J ALLERGY CLIN IMMUN, V130, P1418, DOI 10.1016/j.jaci.2012.06.028; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MAZZA DS, 1995, ANN ALLERG ASTHMA IM, V74, P411; Mpairwe H, 2008, T ROY SOC TROP MED H, V102, P367, DOI 10.1016/j.trstmh.2008.01.017; Niederberger V, 2007, INT ARCH ALLERGY IMM, V142, P133, DOI 10.1159/000096439; Obeng BB, 2011, INT ARCH ALLERGY IMM, V155, P63, DOI 10.1159/000318704; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Rujeni N, 2012, INT ARCH ALLERGY IMM, V158, P288, DOI 10.1159/000332949; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Sibanda E, 2012, EUR J IMMUNOL, V42, P1070, DOI 10.1002/eji.2012700025; Sibanda EN, 2003, INT ARCH ALLERGY IMM, V130, P2, DOI 10.1159/000068377; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Westritschnig K, 2003, CLIN EXP ALLERGY, V33, P22, DOI 10.1046/j.1365-2222.2003.01540.x; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97893	10.1371/journal.pone.0097893	http://dx.doi.org/10.1371/journal.pone.0097893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896832	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700018
J	Zhai, C; Zhang, Y; Yao, N; Lin, F; Liu, Z; Dong, ZQ; Wang, L; Pan, QH				Zhai, Chun; Zhang, Yu; Yao, Nan; Lin, Fei; Liu, Zhe; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua			Function and Interaction of the Coupled Genes Responsible for Pik-h Encoded Rice Blast Resistance	PLOS ONE			English	Article							DISEASE-RESISTANCE; MAGNAPORTHE-ORYZAE; NUCLEAR ACCUMULATION; IMMUNE RECEPTORS; COILED-COIL; FLAX RUST; PROTEIN INTERACTIONS; DEFENSE RESPONSES; AVIRULENCE GENES; LRR PROTEIN	Pik-h, an allele of Pik, confers resistance against the rice blast pathogen Magnaporthe oryzae. Its positional cloning has shown that it comprises a pair of NBS-LRR genes, Pikh-1 and Pikh-2. While Pikh-1 appears to be constitutively transcribed, the transcript abundance of Pikh-2 responds to pathogen challenge. The Pikh-1 CC (coiled coil) domain interacts directly with both AvrPik-h and Pikh-2. Transient expression assays demonstrated that Pikh-2 mediates the initiation of the host defence response. Nucleocytoplasmic partitioning of both Pikh-1 and Pikh-2 is required for their functionalities. In a proposed mechanistic model of Pik-h resistance, it is suggested that Pikh-1 acts as an adaptor between AvrPik-h and Pikh-2, while Pikh-2 transduces the signal to trigger Pik-h-specific resistance.	[Zhai, Chun; Zhang, Yu; Lin, Fei; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua] South China Agr Univ, Natl Key Lab Conservat & Utilizat Subtrop Agrobio, Guangzhou, Guangdong, Peoples R China; [Zhai, Chun; Zhang, Yu; Lin, Fei; Dong, Zhongqiu; Wang, Ling; Pan, Qinghua] South China Agr Univ, Guangdong Prov Key Lab Microbe Signals & Crop Dis, Guangzhou, Guangdong, Peoples R China; [Yao, Nan; Liu, Zhe] Sun Yat Sen Univ, Natl Key Lab Biocontrol, Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Sun Yat Sen University	Pan, QH (corresponding author), South China Agr Univ, Natl Key Lab Conservat & Utilizat Subtrop Agrobio, Guangzhou, Guangdong, Peoples R China.	panqh@scau.edu.cn	yao, nan/F-2095-2011	yao, nan/0000-0002-2045-5462	National Natural Science Foundation [U1131003, 30870102, 31170247]; National 973 Project [2011CB1007001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China)	This research was carried out with financial support from the National Natural Science Foundation (U1131003; 30870102; 31170247) and the National 973 Project (2011CB1007001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Catanzariti AM, 2010, MOL PLANT MICROBE IN, V23, P49, DOI 10.1094/MPMI-23-1-0049; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Chen Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002595; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frost D, 2004, MOL PLANT MICROBE IN, V17, P224, DOI 10.1094/MPMI.2004.17.2.224; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Haasen D, 1999, PLANT J, V20, P695, DOI 10.1046/j.1365-313X.1999.00644.x; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Mang HG, 2012, PLANT CELL, V24, P1271, DOI 10.1105/tpc.112.096198; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Shen CJ, 2010, J EXP BOT, V61, P3971, DOI 10.1093/jxb/erq208; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yoshida K, 2009, PLANT CELL, V21, P1573, DOI 10.1105/tpc.109.066324; Yuan B, 2011, THEOR APPL GENET, V122, P1017, DOI 10.1007/s00122-010-1506-3; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x	55	107	118	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98067	10.1371/journal.pone.0098067	http://dx.doi.org/10.1371/journal.pone.0098067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896089	Green Published, gold			2022-12-25	WOS:000338430700022
J	Zheng, H; Wang, QF; Zhu, XJ; Li, YN; Yu, GR				Zheng, Han; Wang, Qiufeng; Zhu, Xianjin; Li, Yingnian; Yu, Guirui			Hysteresis Responses of Evapotranspiration to Meteorological Factors at a Diel Timescale: Patterns and Causes	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; TIBETAN PLATEAU; CARBON-DIOXIDE; WATER-VAPOR; TRANSPIRATION; AUSTRALIA; FLUX; CHINA; ASSIMILATION; CONDUCTANCE	Evapotranspiration (ET) is an important component of the water cycle in terrestrial ecosystems. Understanding the ways in which ET changes with meteorological factors is central to a better understanding of ecological and hydrological processes. In this study, we used eddy covariance measurements of ET from a typical alpine shrubland meadow ecosystem in China to investigate the hysteresis response of ET to environmental variables including air temperature (T-a), vapor pressure deficit (VPD) and net radiation (R-n) at a diel timescale. Meanwhile, the simulated ET by Priestly-Taylor equation was used to interpret the measured ET under well-watered conditions. Pronounced hysteresis was observed in both T-a and VPD response curves of ET. At a similar T-a and VPD, ET was always significantly depressed in the afternoon compared with the morning. But the hysteresis response of ET to R-n was not evident. Similar hysteresis patterns were also observed in the T-a/ VPD response curves of simulated ET. The magnitudes of the measured and simulated hysteresis loops showed similar seasonal variation, with relatively smaller values occurring from May to September, which agreed well with the lifetime of plants and the period of rainy season at this site. About 62% and 23% of changes in the strength of measured ET-T-a and ET-VPD loops could be explained by the changes in the strength of simulated loops, respectively. Thus, the time lag between R-n and T-a/VPD is the most important factor generating and modulating the ET-T-a/VPD hysteresis, but plants and water status also contribute to the hysteresis response of ET. Our research confirmed the different hysteresis in the responses of ET to meteorological factors and proved the vital role of Rn in driving the diel course of ET.	[Zheng, Han; Wang, Qiufeng; Zhu, Xianjin; Yu, Guirui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr,Chinese Ecosyst Res Network, Beijing, Peoples R China; [Li, Yingnian] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining, Peoples R China; [Zheng, Han; Zhu, Xianjin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, QF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr,Chinese Ecosyst Res Network, Beijing, Peoples R China.	qfwang@igsnrr.ac.cn; yugr@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; wang, qiufeng/C-1654-2013; Zhu, XianJin/B-2779-2009	于, 贵瑞/0000-0002-1859-8966; Zhu, XianJin/0000-0002-5662-3472; Zheng, Han/0000-0002-0721-1594	Key program of National Natural Science Foundation of China [31290221]; National Basic Research Program [2010CB833504]; Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes program [STSN-02- 02]	Key program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes program	This research was jointly supported by Key program of National Natural Science Foundation of China (Grant NO. 31290221), National Basic Research Program (Grant NO. 2010CB833504), and Remote Sensing Investigation and Assessment on National Ecological Environment Decade Changes (2000-2010) program (STSN-02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen LX, 2011, J HYDROL, V402, P388, DOI 10.1016/j.jhydrol.2011.03.034; Eamus D, 1997, AUST J BOT, V45, P275, DOI 10.1071/BT96020; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Gu S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009173; Gwenzi W, 2012, HYDROL PROCESS, V26, P3281, DOI 10.1002/hyp.8330; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Jarvis PG, 1986, ADV ECOL RES, V15, P49; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; [李英年 Li Yingnian], 2003, [山地学报, Journal of Mountain Science], V21, P257; [李英年 Li Yingnian], 2004, [高原气象, Plateau Meteorology], V23, P558; Li ZQ, 2004, SCI CHINA SER D, V34, P46, DOI [10.1360/zd2004-34-S2-46, DOI 10.1360/ZD2004-34-S2-46]; Liu HZ, 2012, J APPL METEOROL CLIM, V51, P1875, DOI 10.1175/JAMC-D-11-0229.1; Lu N, 2011, J PLANT ECOL, V4, P49, DOI 10.1093/jpe/rtq035; Meinzer FC, 1997, PLANT CELL ENVIRON, V20, P1301, DOI 10.1046/j.1365-3040.1997.d01-18.x; O'Brien JJ, 2004, PLANT CELL ENVIRON, V27, P551, DOI 10.1111/j.1365-3040.2003.01160.x; O'Grady AP, 2008, AGR FOREST METEOROL, V148, P453, DOI 10.1016/j.agrformet.2007.10.006; O'Grady AP, 1999, TREE PHYSIOL, V19, P591; Pan RZ, 2008, PLANT PHYSL; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Unsworth MH, 2004, ECOSYSTEMS, V7, P468, DOI 10.1007/s10021-004-0138-3; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2; Wilson KB, 2000, AGR FOREST METEOROL, V100, P1, DOI 10.1016/S0168-1923(99)00088-X; Yu Gui-Rui, 1996, Journal of Agricultural Meteorology, V52, P311; Yu GR, 2006, SCI CHINA SER D, V49, P1, DOI 10.1007/s11430-006-8001-3; Zeppel MJB, 2004, FUNCT PLANT BIOL, V31, P461, DOI 10.1071/FP03220; Zhang Q, 2014, J GEOPHYS RES-BIOGEO, V119, P125, DOI 10.1002/2013JG002484; Zhao L, 2005, J INTEGR PLANT BIOL, V47, P271, DOI 10.1111/j.1744-7909.2005.00066.x; Zheng CL, 2014, ECOHYDROLOGY, V7, P56, DOI 10.1002/eco.1321	36	36	41	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98857	10.1371/journal.pone.0098857	http://dx.doi.org/10.1371/journal.pone.0098857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896829	Green Published, gold			2022-12-25	WOS:000338430700087
J	Belka, M; Hewelt-Belka, W; Slawinski, J; Baczek, T				Belka, Mariusz; Hewelt-Belka, Weronika; Slawinski, Jaroslaw; Baczek, Tomasz			Mass Spectrometry Based Identification of Geometric Isomers during Metabolic Stability Study of a New Cytotoxic Sulfonamide Derivatives Supported by Quantitative Structure-Retention Relationships	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SPRAGUE-DAWLEY RATS; ANTITUMOR-ACTIVITY; DRUG DISCOVERY; 4-CHLORO-2-MERCAPTO-5-METHYLBENZENESULFONAMIDE DERIVATIVES; BENZENSULFONAMIDE DERIVATIVES; PHYSIOCHEMICAL PROPERTIES; MOLECULAR DESCRIPTORS; CYTOCHROME P4502C9; TISSUE DISPOSITION	A set of 15 new sulphonamide derivatives, presenting antitumor activity have been subjected to a metabolic stability study. The results showed that besides products of biotransformation, some additional peaks occurred in chromatograms. Tandem mass spectrometry revealed the same mass and fragmentation pathway, suggesting that geometric isomerization occurred. Thus, to support this hypothesis, quantitative structure-retention relationships were applied. Human liver microsomes were used as an in vitro model of metabolism. The biotransformation reactions were tracked by liquid chromatography assay and additionally, fragmentation mass spectra were recorded. In silico molecular modeling at a semi-empirical level was conducted as a starting point for molecular descriptor calculations. A quantitative structure-retention relationship model was built applying multiple linear regression based on selected three-dimensional descriptors. The studied compounds revealed high metabolic stability, with a tendency to form hydroxylated biotransformation products. However, significant chemical instability in conditions simulating human body fluids was noticed. According to literature and MS data geometrical isomerization was suggested. The developed in sillico model was able to describe the relationship between the geometry of isomer pairs and their chromatographic retention properties, thus it supported the hypothesis that the observed pairs of peaks are most likely geometric isomers. However, extensive structural investigations are needed to fully identify isomers' geometry. An effort to describe MS fragmentation pathways of novel chemical structures is often not enough to propose structures of potent metabolites and products of other chemical reactions that can be observed in compound solutions at early drug discovery studies. The results indicate that the relatively non-expensive and not time-and labor-consuming in sillico approach could be a good supportive tool assisting the identification of cis-trans isomers based on retention data. This methodology can be helpful during the structural identification of biotransformation and degradation products of new chemical entities - potential new drugs.	[Belka, Mariusz; Baczek, Tomasz] Med Univ Gdansk, Fac Pharm, Dept Pharmaceut Chem, Gdansk, Poland; [Hewelt-Belka, Weronika] Gdansk Univ Technol, Fac Chem, Dept Analyt Chem, Gdansk, Poland; [Hewelt-Belka, Weronika] Pomeranian Sci & Technol Pk, Mass Spectrometry & Chromatog Lab, Gdynia, Poland; [Slawinski, Jaroslaw] Med Univ Gdansk, Fac Pharm, Dept Organ Chem, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk	Baczek, T (corresponding author), Med Univ Gdansk, Fac Pharm, Dept Pharmaceut Chem, Gdansk, Poland.	tbaczek@gumed.edu.pl	Baczek, Tomasz/K-6467-2018; Hewelt-Belka, Weronika/ABF-1232-2021; Belka, Mariusz/AAQ-8911-2020; Belka, Mariusz/M-6288-2018; Hewelt-Belka, Weronika/X-9907-2019	Baczek, Tomasz/0000-0001-6468-1974; Hewelt-Belka, Weronika/0000-0002-1990-2130; Belka, Mariusz/0000-0003-4413-1080; 	Polish National Science Centre [UMO-2011/01/N/NZ1/00214, UMO-2011/03/B/NZ1/03113]; National Science Centre [UMO-2013/08/T/NZ1/00764]; system project "InnoDoktorant - Scholarships for PhD students, Vth edition"; European Union; quality-promoting subsidy under the KNOW programme	Polish National Science Centre; National Science Centre(National Science Centre, Poland); system project "InnoDoktorant - Scholarships for PhD students, Vth edition"; European Union(European Commission); quality-promoting subsidy under the KNOW programme	The project was funded by the Polish National Science Centre granted under decision no. UMO-2011/01/N/NZ1/00214 and UMO-2011/03/B/NZ1/03113. M. B has obtained funding for the preparation of a doctoral dissertation from the National Science Centre under decision no. UMO-2013/08/T/NZ1/00764. This research work was supported by the system project "InnoDoktorant - Scholarships for PhD students, Vth edition". The project was co-financed by the European Union in the frame of the European Social Fund supported by funds obtained from the quality-promoting subsidy under the KNOW programme 2012 - 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baczek T, 2005, J PROTEOME RES, V4, P555, DOI 10.1021/pr049780r; Baranczewski P, 2006, PHARMACOL REP, V58, P453; Baranczewski P, 2006, PHARMACOL REP, V58, P341; Belka M, 2013, MED CHEM, V9, P517, DOI 10.2174/1573406411309040005; Belka M, 2012, LETT DRUG DES DISCOV, V9, P288, DOI 10.2174/157018012799129945; Beumer JH, 2005, INVEST NEW DRUG, V23, P317, DOI 10.1007/s10637-005-1440-4; Bodzioch K, 2010, TALANTA, V81, P1711, DOI 10.1016/j.talanta.2010.03.028; Boobis A, 2002, EUR J PHARM SCI, V17, P183, DOI 10.1016/S0928-0987(02)00185-9; Boyer S, 2007, J CHEM INF MODEL, V47, P583, DOI 10.1021/ci600376q; Brozewicz K, 2012, MONATSH CHEM, V143, P975, DOI 10.1007/s00706-012-0732-6; Carta F, 2012, EXPERT OPIN THER PAT, V22, P747, DOI 10.1517/13543776.2012.698264; Casini A, 2002, CURR CANCER DRUG TAR, V2, P55, DOI 10.2174/1568009023334060; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a; Creek DJ, 2011, ANAL CHEM, V83, P8703, DOI 10.1021/ac2021823; Dagliyan O, 2009, J CHEM INF MODEL, V49, P2403, DOI 10.1021/ci900247t; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Fox T, 2006, CURR TOP MED CHEM, V6, P1579, DOI 10.2174/156802606778108915; Greene N, 1999, SAR QSAR ENVIRON RES, V10, P299, DOI 10.1080/10629369908039182; Hakk H, 2006, XENOBIOTICA, V36, P79, DOI 10.1080/00498250500491675; Hakk H, 2004, CHEMOSPHERE, V54, P1367, DOI 10.1016/j.chemosphere.2003.10.032; Hennemann M, 2009, CHEMMEDCHEM, V4, P657, DOI 10.1002/cmdc.200800384; Kaliszan R, 2005, PROTEOMICS, V5, P409, DOI 10.1002/pmic.200400973; Keisner SV, 2011, DRUGS, V71, P443, DOI 10.2165/11588960-000000000-00000; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Kovarikova P, 2008, J PHARMACEUT BIOMED, V48, P295, DOI 10.1016/j.jpba.2007.12.017; Levsel K, 2007, J MASS SPECTROM, V42, P1024, DOI 10.1002/jms.1234; Liu RF, 2012, J CHEM INF MODEL, V52, P1698, DOI 10.1021/ci3001524; Mansuy D, 1998, COMP BIOCHEM PHYS C, V121, P5, DOI 10.1016/S0742-8413(98)10026-9; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; Nasal A, 2002, J SEP SCI, V25, P273, DOI 10.1002/1615-9314(20020401)25:5/6<273::AID-JSSC273>3.0.CO;2-5; Nassar AEF, 2004, DRUG DISCOV TODAY, V9, P317, DOI 10.1016/S1359-6446(03)03018-6; Prakash C, 2007, MASS SPECTROM REV, V26, P340, DOI 10.1002/mas.20128; Schuster Daniela, 2006, Curr Drug Discov Technol, V3, P1, DOI 10.2174/157016306776637609; Slawinski J, 2007, POL J CHEM, V81, P1433; Slawinski J, 2004, EUR J MED CHEM, V39, P179, DOI 10.1016/j.ejmech.2003.09.013; Slawinski J, 2013, J ENZYM INHIB MED CH, V28, P41, DOI 10.3109/14756366.2011.625024; Slawinski J, 2012, MONATSH CHEM, V143, P1705, DOI 10.1007/s00706-012-0849-7; Supuran CT, 2012, WORLD J CLIN ONCOL, V3, P98, DOI 10.5306/wjco.v3.i7.98; Sykes MJ, 2008, J MED CHEM, V51, P780, DOI 10.1021/jm7009793; Terhorst JP, 2010, J CHEM THEORY COMPUT, V6, P2762, DOI 10.1021/ct1004017; Todeschini R, 2009, MOL DESCRIPTORS CHEM; Tolonen A, 2009, DRUG DISCOV TODAY, V14, P120, DOI 10.1016/j.drudis.2008.11.002; Tyrkko E, 2012, ANAL CHIM ACTA, V720, P142, DOI 10.1016/j.aca.2012.01.024; Wang S, 2011, CHEMOSPHERE, V85, P379, DOI 10.1016/j.chemosphere.2011.07.002; Wiczling P, 2008, J CHROMATOGR A, V1214, P109, DOI 10.1016/j.chroma.2008.10.085; Zamora I, 2003, J MED CHEM, V46, P2313, DOI 10.1021/jm021104i; Zandvliet AS, 2007, CLIN CANCER RES, V13, P2970, DOI 10.1158/1078-0432.CCR-06-2978; Zhu MS, 2006, DRUG METAB DISPOS, V34, P1722, DOI 10.1124/dmd.106.009241	49	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98096	10.1371/journal.pone.0098096	http://dx.doi.org/10.1371/journal.pone.0098096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893169	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400034
J	Stebbing, J; Zhang, H; Xu, Y; Lit, LC; Green, AR; Grothey, A; Lombardo, Y; Periyasamy, M; Blighe, K; Zhang, W; Shaw, JA; Ellis, IO; Lenz, HJ; Giamas, G				Stebbing, J.; Zhang, H.; Xu, Y.; Lit, L. C.; Green, A. R.; Grothey, A.; Lombardo, Y.; Periyasamy, M.; Blighe, K.; Zhang, W.; Shaw, J. A.; Ellis, I. O.; Lenz, H. J.; Giamas, G.			KSR1 regulates BRCA1 degradation and inhibits breast cancer growth	ONCOGENE			English	Article							KINASE SUPPRESSOR; IN-VIVO; SIGNAL-TRANSDUCTION; UBIQUITIN LIGASE; RAS-1 PROTECTS; GENE ENCODES; DNA-DAMAGE; C-ELEGANS; ACTIVATION; EXPRESSION	Kinase suppressor of Ras-1 (KSR1) facilitates signal transduction in Ras-dependent cancers, including pancreatic and lung carcinomas but its role in breast cancer has not been well studied. Here, we demonstrate for the first time it functions as a tumor suppressor in breast cancer in contrast to data in other tumors. Breast cancer patients (n>1000) with high KSR1 showed better disease-free and overall survival, results also supported by Oncomine analyses, microarray data (n = 2878) and genomic data from paired tumor and cell-free DNA samples revealing loss of heterozygosity. KSR1 expression is associated with high breast cancer 1, early onset (BRCA1), high BRCA1-associated ring domain 1 (BARD1) and checkpoint kinase 1 (Chk1) levels. Phospho-profiling of major components of the canonical Ras-RAF-mitogen-activated protein kinases pathway showed no significant changes after KSR1 overexpression or silencing. Moreover, KSR1 stably transfected cells formed fewer and smaller size colonies compared to the parental ones, while in vivo mouse model also demonstrated that the growth of xenograft tumors overexpressing KSR1 was inhibited. The tumor suppressive action of KSR1 is BRCA1 dependent shown by 3D-matrigel and soft agar assays. KSR1 stabilizes BRCA1 protein levels by reducing BRCA1 ubiquitination through increasing BARD1 abundance. These data link these proteins in a continuum with clinical relevance and position KSR1 in the major oncoprotein pathways in breast tumorigenesis.	[Stebbing, J.; Zhang, H.; Xu, Y.; Lit, L. C.; Grothey, A.; Lombardo, Y.; Periyasamy, M.; Giamas, G.] Univ London Imperial Coll Sci Technol & Med, Ctr Translat & Expt Med, Dept Surg & Canc, Div Canc, London W12 0NN, England; [Lit, L. C.; Ellis, I. O.] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Green, A. R.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Cellular Pathol, Nottingham, England; [Blighe, K.; Shaw, J. A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Zhang, W.; Lenz, H. J.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90033 USA	Imperial College London; Universiti Malaya; Nottingham University Hospital NHS Trust; University of Nottingham; University of Leicester; University of Southern California	Giamas, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Translat & Expt Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus,Cane Rd, London W12 0NN, England.	g.giamas@imperial.ac.uk	Periyasamy, Manikandan/AAL-6211-2020; Zhang, Hua/AAV-2344-2020; LIT, LEI CHENG/B-8875-2010; Green, Andrew/AAF-1991-2020; periyasamy, manikandan/AAB-7924-2020; Giamas, Georgios/AAP-3487-2021; Lit, Lei Cheng/AAS-9778-2021	Zhang, Hua/0000-0001-7704-4712; LIT, LEI CHENG/0000-0002-3210-4491; Lit, Lei Cheng/0000-0002-3210-4491; Giamas, Georgios/0000-0002-4417-2707; Shaw, Jacqui/0000-0003-4227-503X; Green, Andrew/0000-0002-0488-5913; Stebbing, Justin/0000-0002-1117-6947; Periyasamy, Manikandan/0000-0001-7626-2531; Blighe, Kevin/0000-0002-6322-6571; Ellis, Ian/0000-0001-5292-8474	Imperial Biomedical Research Centre; Experimental Cancer Medicine Centre; National Institute for Health Research; Pink Ribbon Foundation; China Scholarship Council; Action Against Cancer; Breast Cancer Campaign; Cancer Research UK; Cancer Research UK [13462, 14549] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish	Imperial Biomedical Research Centre; Experimental Cancer Medicine Centre; National Institute for Health Research(National Institute for Health Research (NIHR)); Pink Ribbon Foundation; China Scholarship Council(China Scholarship Council); Action Against Cancer; Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We would like to thank Chun Fui Lai, Aleksandra Filipovic, Monica Faronato and Dongyun Yang for their technical assistance and Pritesh Trivedi for performing the immunohistochemistry staining. This work was supported by the Imperial Biomedical Research Centre, the Experimental Cancer Medicine Centre, the National Institute for Health Research, the Pink Ribbon Foundation, China Scholarship Council, Action Against Cancer, Breast Cancer Campaign and Cancer Research UK. We thank Richard and Evelina Girling and the 'kinase group' for their support.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Dalton LW, 2000, MODERN PATHOL, V13, P730, DOI 10.1038/modpathol.3880126; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fusello AM, 2006, J IMMUNOL, V177, P6152, DOI 10.4049/jimmunol.177.9.6152; Giamas G, 2011, NAT MED, V17, P715, DOI 10.1038/nm.2351; Goettel JA, 2011, EXP CELL RES, V317, P452, DOI 10.1016/j.yexcr.2010.11.018; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hayami R, 2005, CANCER RES, V65, P6; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim HS, 2006, CANCER RES, V66, P4561, DOI 10.1158/0008-5472.CAN-05-3629; Kim M, 2005, CANCER RES, V65, P3986, DOI 10.1158/0008-5472.CAN-03-2334; Kolesnick R, 2004, J CLIN INVEST, V114, P1233, DOI 10.1172/JCI200423441; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lombardo Y, 2012, P NATL ACAD SCI USA, V109, P16558, DOI 10.1073/pnas.1206268109; Lozano J, 2003, CANCER RES, V63, P4232; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Shaw JA, 2012, GENOME RES, V22, P220, DOI 10.1101/gr.123497.111; Stebbing J, 2010, CLIN EVID, V2010, P1; Stebbing J, 2012, BREAST CANCER RES TR, V132, P537, DOI 10.1007/s10549-011-1622-z; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Wallace MD, 2012, GENETICS, V192, P385, DOI 10.1534/genetics.112.142802; Witzel F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00475; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xing HR, 2003, NAT MED, V9, P1266, DOI 10.1038/nm927; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Zafrullah M, 2009, BIOCHEM BIOPH RES CO, V390, P434, DOI 10.1016/j.bbrc.2009.09.048; Zhang H, 2013, BRIT J CANCER, V109, P2675, DOI 10.1038/bjc.2013.628; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x; Zhang H, 2013, BIOCHEM SOC T, V41, P1078, DOI 10.1042/BST20130042; Zhang H, 2012, CELL SIGNAL, V24, P1173, DOI 10.1016/j.cellsig.2012.01.017; Zhang JJ, 2008, CANCER BIOL THER, V7, P1492, DOI 10.4161/cbt.7.9.6472; Zhang Y, 2011, NAT MED, V17, P341, DOI 10.1038/nm.2296	52	11	11	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2103	2114		10.1038/onc.2014.129	http://dx.doi.org/10.1038/onc.2014.129			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909178	Green Submitted			2022-12-25	WOS:000353173400010
J	Haldeman, BD; Brizendine, RK; Facemyer, KC; Baker, JE; Cremo, CR				Haldeman, Brian D.; Brizendine, Richard K.; Facemyer, Kevin C.; Baker, Josh E.; Cremo, Christine R.			The Kinetics Underlying the Velocity of Smooth Muscle Myosin Filament Sliding on Actin Filaments in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; PHOSPHORYLATION-DEPENDENT REGULATION; RABBIT SKELETAL-MUSCLE; HEAVY-MEROMYOSIN; NONMUSCLE MYOSIN; SIDE-POLAR; NONLINEAR ELASTICITY; NUCLEOTIDE-BINDING; MASS DETERMINATION; WORKING STROKE	Actin-myosin interactions are well studied using soluble myosin fragments, but little is known about effects of myosin filament structure on mechanochemistry. We stabilized unphosphorylated smooth muscle myosin (SMM) and phosphorylated smooth muscle myosin (pSMM) filaments against ATP-induced depolymerization using a cross-linker and attached fluorescent rhodamine (XL-Rh-SMM). Electron micrographs showed that these side polar filaments are very similar to unmodified filaments. They are similar to 0.63 mu m long and contain similar to 176 molecules. Rate constants for ATP-induced dissociation and ADP release from acto-myosin for filaments and S1 heads were similar. Actin-activated ATPases of SMM and XL-Rh-SMM were similarly regulated. XL-Rh-pSMM filaments moved processively on F-actin that was bound to a PEG brush surface. ATP dependence of filament velocities was similar to that for solution ATPases at high [actin], suggesting that both processes are limited by the same kinetic step (weak to strong transition) and therefore are attachment-limited. This differs from actin sliding over myosin monomers, which is primarily detachment-limited. Fitting filament data to an attachment-limited model showed that approximately half of the heads are available to move the filament, consistent with a side polar structure. We suggest the low stiffness subfragment 2 (S2) domain remains unhindered during filament motion in our assay. Actin-bound negatively displaced heads will impart minimal drag force because of S2 buckling. Given the ADP release rate, the velocity, and the length of S2, these heads will detach from actin before slack is taken up into a backwardly displaced high stiffness position. This mechanism explains the lack of detachment-limited kinetics at physiological [ATP]. These findings address how nonlinear elasticity in assemblies of motors leads to efficient collective force generation.	[Haldeman, Brian D.; Brizendine, Richard K.; Facemyer, Kevin C.; Baker, Josh E.; Cremo, Christine R.] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Cremo, CR (corresponding author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	cremo@unr.edu			National Institutes of Health [5R01HL110214]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01HL110214 (to C. R. C., K. C. F., and J. E. B.).	Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; APPLEGATE D, 1992, J CELL BIOL, V117, P1223, DOI 10.1083/jcb.117.6.1223; Baker JE, 2003, J BIOL CHEM, V278, P28533, DOI 10.1074/jbc.M303583200; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; CHACKO S, 1977, P NATL ACAD SCI USA, V74, P129, DOI 10.1073/pnas.74.1.129; COATES JH, 1985, BIOCHEM J, V232, P351, DOI 10.1042/bj2320351; COOKE PH, 1989, J MUSCLE RES CELL M, V10, P206, DOI 10.1007/BF01739811; CRAIG R, 1977, J CELL BIOL, V75, P990, DOI 10.1083/jcb.75.3.990; CRAIG R, 1987, J CELL BIOL, V105, P1319, DOI 10.1083/jcb.105.3.1319; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; Cremo CR, 2007, MYOS SUP MOL MOT, P171; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; CROSS RA, 1991, J MOL BIOL, V222, P455, DOI 10.1016/0022-2836(91)90487-Q; CROSS RA, 1984, FEBS LETT, V176, P197, DOI 10.1016/0014-5793(84)80940-0; CROSS RA, 1991, EMBO J, V10, P747, DOI 10.1002/j.1460-2075.1991.tb08006.x; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Eddinger TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC493, DOI 10.1152/ajpcell.00131.2007; Ellison PA, 2000, J BIOL CHEM, V275, P15142, DOI 10.1074/jbc.275.20.15142; Ellison PA, 2003, J BIOL CHEM, V278, P4410, DOI 10.1074/jbc.M211016200; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; HARRIS DE, 1993, CIRC RES, V72, P219, DOI 10.1161/01.RES.72.1.219; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ikebe M, 1999, BIOCHEMISTRY-US, V38, P10768, DOI 10.1021/bi990915u; IKEBE M, 1986, J BIOL CHEM, V261, P8249; IKEBE M, 1985, J BIOL CHEM, V260, P3146; IKEBE M, 1984, BIOCHEMISTRY-US, V23, P5062, DOI 10.1021/bi00316a036; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Kaya M, 2013, CELL MOL LIFE SCI, V70, P4275, DOI 10.1007/s00018-013-1353-x; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; KUMON A, 1986, EUR J BIOCHEM, V160, P499, DOI 10.1111/j.1432-1033.1986.tb10067.x; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; SELLERS JR, 1985, J BIOL CHEM, V260, P5815; Seow CY, 2005, AM J PHYSIOL-CELL PH, V289, pC1363, DOI 10.1152/ajpcell.00329.2005; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y; Tonino P, 2002, J MOL BIOL, V318, P999, DOI 10.1016/S0022-2836(02)00191-2; Trybus KM, 1991, CURR OPIN CELL BIOL, V3, P105, DOI 10.1016/0955-0674(91)90172-U; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; WALSH MP, 1983, METHOD ENZYMOL, V99, P279; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Xu JQ, 1996, J CELL BIOL, V134, P53, DOI 10.1083/jcb.134.1.53	61	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21055	21070		10.1074/jbc.M114.564740	http://dx.doi.org/10.1074/jbc.M114.564740			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907276	Green Published, hybrid			2022-12-25	WOS:000339396600057
J	Bernin, D; Koch, V; Nyden, M; Topgaard, D				Bernin, Diana; Koch, Vanessa; Nyden, Magnus; Topgaard, Daniel			Multi-Scale Characterization of Lyotropic Liquid Crystals Using H-2 and Diffusion MRI with Spatial Resolution in Three Dimensions	PLOS ONE			English	Article							TENSOR IMAGING MATHEMATICS; INDUCED MULTILAMELLAR VESICLES; HOMOGENEOUS LENGTH-SCALE; LAMELLAR PHASE; DOMAIN-STRUCTURE; SELF-DIFFUSION; FIELD GRADIENT; NMR; SYSTEM; WATER	The ability of lyotropic liquid crystals to form intricate structures on a range of length scales can be utilized for the synthesis of structurally complex inorganic materials, as well as in devices for controlled drug delivery. Here we employ magnetic resonance imaging (MRI) for non-invasive characterization of nano-, micro-, and millimeter scale structures in liquid crystals. The structure is mirrored in the translational and rotational motion of the water, which we assess by measuring spatially resolved self-diffusion tensors and H-2 spectra. Our approach differs from previous works in that the MRI parameters are mapped with spatial resolution in all three dimensions, thus allowing for detailed studies of liquid crystals with complex millimeter-scale morphologies that are stable on the measurement time-scale of 10 hours. The H-2 data conveys information on the nanometer-scale structure of the liquid crystalline phase, while the combination of diffusion and H-2 data permits an estimate of the orientational distribution of micrometer-scale anisotropic domains. We study lamellar phases consisting of the nonionic surfactant C10E3 in (H2O)-H-2, and follow their structural equilibration after a temperature jump and the cessation of shear. Our experimental approach may be useful for detailed characterization of liquid crystalline materials with structures on multiple length scales, as well as for studying the mechanisms of phase transitions.	[Bernin, Diana] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Bernin, Diana] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Nyden, Magnus] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5001, Australia; [Koch, Vanessa; Topgaard, Daniel] Lund Univ, Dept Chem, Div Phys Chem, Lund, Sweden	Chalmers University of Technology; University of Gothenburg; University of South Australia; Lund University	Topgaard, D (corresponding author), Lund Univ, Dept Chem, Div Phys Chem, Lund, Sweden.	daniel.topgaard@fkem1.lu.se	Bernin, Diana/P-3643-2019; Nyden, Magnus/D-3359-2012	Bernin, Diana/0000-0002-9611-2263; Nyden, Magnus/0000-0002-3036-1152; Topgaard, Daniel/0000-0001-9373-6348	VINNOVA through the VINN Excellence Centre SuMo Biomaterials; Swedish Research Council VR [2009-6794, 2011-4334]	VINNOVA through the VINN Excellence Centre SuMo Biomaterials(Vinnova); Swedish Research Council VR(Swedish Research Council)	This work is funded by VINNOVA through the VINN Excellence Centre SuMo Biomaterials (Supramolecular Biomaterials - Structure dynamics and properties) and the Swedish Research Council VR (grant numbers 2009-6794 and 2011-4334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SPIN DYNAMICS BASICS; Aslund I, 2008, J PHYS CHEM B, V112, P2782, DOI 10.1021/jp076174l; Aslund I, 2011, J MAGN RESON, V209, P291, DOI 10.1016/j.jmr.2011.01.024; ATTARD GS, 1995, NATURE, V378, P366, DOI 10.1038/378366a0; Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872; Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Briganti G, 1999, J PHYS CHEM B, V103, P825, DOI 10.1021/jp982967j; Brown JR, 2011, SOFT MATTER, V7, P10472, DOI 10.1039/c1sm06135f; Bulut S, 2010, SOFT MATTER, V6, P4520, DOI 10.1039/c0sm00085j; Callaghan P. T., 2011, TRANSLATIONAL DYNAMI; CALLAGHAN PT, 1983, J PHYS CHEM-US, V87, P1737, DOI 10.1021/j100233a019; CALLAGHAN PT, 1988, J PHYS E SCI INSTRUM, V21, P820, DOI 10.1088/0022-3735/21/8/017; Capitani D, 1999, J PHYS CHEM B, V103, P6088, DOI 10.1021/jp990143b; Capitani D, 2007, LANGMUIR, V23, P3036, DOI 10.1021/la062798r; Chen L, 2002, J MAGN RESON, V158, P164, DOI 10.1016/S1090-7807(02)00069-1; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Dvinskikh SV, 2001, LANGMUIR, V17, P6455, DOI 10.1021/la010693c; Evans D.F, 1999, COLLOIDAL DOMAIN PHY, V2nd; Fanfoni M, 1998, NUOVO CIMENTO D, V20, P1171, DOI 10.1007/BF03185527; Ferreira TM, 2013, ANNU REP NMR SPECTRO, V79, P73, DOI 10.1016/B978-0-12-408098-0.00003-3; Fischer E, 2000, EUROPHYS LETT, V50, P803, DOI 10.1209/epl/i2000-00552-9; Freund O, 2000, LIFE SCI, V67, P411, DOI 10.1016/S0024-3205(00)00640-8; Gauffre F, 1999, LANGMUIR, V15, P3738, DOI 10.1021/la981541t; Gotter M, 2005, FARADAY DISCUSS, V129, P327, DOI 10.1039/b405363j; Harris R. K., 1983, NUCL MAGNETIC RESONA; Hubbard PL, 2006, J PHYS CHEM B, V110, P20781, DOI 10.1021/jp0601872; Iwashita Y, 2006, NAT MATER, V5, P147, DOI 10.1038/nmat1580; Johnson WA, 1939, T AM I MIN MET ENG, V135, P416; Jonsson B., 2002, SURFACTANTS POLYM AQ; KHAN A, 1982, J PHYS CHEM-US, V86, P383, DOI 10.1021/j100392a020; KHAN A, 1982, J PHYS CHEM-US, V86, P4266, DOI 10.1021/j100218a034; Kindlmann G, 2004, P 6 JOINT EUR IEEE T, P1, DOI [DOI 10.2312/VISSYM/VISSYM04/147-154, 10.2312/VisSym/VisSym04/147-154]; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P101, DOI 10.1002/cmr.a.20048; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P123, DOI 10.1002/cmr.a.20049; Klinkenberg M, 1996, J MAGN RESON SER A, V119, P197, DOI 10.1006/jmra.1996.0073; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Le TD, 2001, LANGMUIR, V17, P999, DOI 10.1021/la001227a; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Medronho B, 2008, LANGMUIR, V24, P6480, DOI 10.1021/la800326a; Medronho B, 2007, LANGMUIR, V23, P5270, DOI 10.1021/la063599a; Medronho B, 2010, LANGMUIR, V26, P1477, DOI 10.1021/la903682p; Medronho B, 2012, Z PHYS CHEM, V226, P1293, DOI 10.1524/zpch.2012.0313; Medronho B, 2011, SOFT MATTER, V7, P4938, DOI 10.1039/c0sm01323d; Nettesheim F, 2003, LANGMUIR, V19, P3603, DOI 10.1021/la026654y; Oliviero C, 2003, COLLOID SURFACE A, V228, P85, DOI 10.1016/S0927-7757(03)00356-X; PAKE GE, 1948, J CHEM PHYS, V16, P327, DOI 10.1063/1.1746878; Pommella A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.138301; Price W.S., 2009, NMR STUDIES TRANSLAT; Redkar M, 2007, J PHARM SCI-US, V96, P2436, DOI 10.1002/jps.20863; ROSEDALE JH, 1990, MACROMOLECULES, V23, P2329, DOI 10.1021/ma00210a032; Squires AM, 2013, LANGMUIR, V29, P1726, DOI 10.1021/la304726m; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; STRUIS RPWJ, 1987, J PHYS CHEM-US, V91, P1639, DOI 10.1021/j100290a069; Susumu M., 2007, INTRO DIFFUSION TENS; Szutkowski K, 2010, J PHYS CHEM B, V114, P165, DOI 10.1021/jp9072087; Topgaard D, 2002, J PHYS CHEM B, V106, P11887, DOI 10.1021/jp020130p; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; Westin C.F., 1997, GEOMETRICAL DIFFUSIO, P1742; Yethiraj A, 2005, LANGMUIR, V21, P3311, DOI 10.1021/la046962r; Zipfel J, 2001, EUROPHYS LETT, V53, P335, DOI 10.1209/epl/i2001-00158-3	65	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98752	10.1371/journal.pone.0098752	http://dx.doi.org/10.1371/journal.pone.0098752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905818	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000057
J	Lamarca, A; Gella, A; Martianez, T; Segura, M; Figueiro-Silva, J; Grijota-Martinez, C; Trullas, R; Casals, N				Lamarca, Aloa; Gella, Alejandro; Martianez, Tania; Segura, Monica; Figueiro-Silva, Joana; Grijota-Martinez, Carmen; Trullas, Ramon; Casals, Nuria			Uridine 5 '-Triphosphate Promotes In Vitro Schwannoma Cell Migration through Matrix Metalloproteinase-2 Activation	PLOS ONE			English	Article							RAT SCIATIC-NERVE; PERIPHERAL-NERVE; P2Y RECEPTORS; PROTEIN-KINASES; GROWTH-FACTOR; UP-REGULATION; SIGNALING MOLECULE; BASEMENT-MEMBRANE; MAP KINASES; INJURY	In response to peripheral nerve injury, Schwann cells adopt a migratory phenotype and modify the extracellular matrix to make it permissive for cell migration and axonal re-growth. Uridine 5'-triphosphate (UTP) and other nucleotides are released during nerve injury and activate purinergic receptors expressed on the Schwann cell surface, but little is known about the involvement of purine signalling in wound healing. We studied the effect of UTP on Schwannoma cell migration and wound closure and the intracellular signaling pathways involved. We found that UTP treatment induced Schwannoma cell migration through activation of P2Y(2) receptors and through the increase of extracellular matrix metalloproteinase-2 (MMP-2) activation and expression. Knockdown P2Y(2) receptor or MMP-2 expression greatly reduced wound closure and MMP-2 activation induced by UTP. MMP-2 activation evoked by injury or UTP was also mediated by phosphorylation of all 3 major mitogen-activated protein kinases (MAPKs): JNK, ERK1/2, and p38. Inhibition of these MAPK pathways decreased both MMP-2 activation and cell migration. Interestingly, MAPK phosphorylation evoked by UTP exhibited a biphasic pattern, with an early transient phosphorylation 5 min after treatment, and a late and sustained phosphorylation that appeared at 6 h and lasted up to 24 h. Inhibition of MMP-2 activity selectively blocked the late, but not the transient, phase of MAPK activation. These results suggest that MMP-2 activation and late MAPK phosphorylation are part of a positive feedback mechanism to maintain the migratory phenotype for wound healing. In conclusion, our findings show that treatment with UTP stimulates in vitro Schwannoma cell migration and wound repair through a MMP-2-dependent mechanism via P2Y(2) receptors and MAPK pathway activation.	[Lamarca, Aloa; Gella, Alejandro; Martianez, Tania; Segura, Monica; Grijota-Martinez, Carmen; Casals, Nuria] Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain; [Figueiro-Silva, Joana; Trullas, Ramon] CSIC, Inst Invest Biomed Pi & Sunyer, Neurobiol Unit, Inst Invest Biomed Barcelona, Barcelona, Spain; [Casals, Nuria] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Universitat Internacional de Catalunya (UIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Gella, A (corresponding author), Univ Int Catalunya, Fac Med, Dept Basic Sci, Sant Cugat Del Valles, Spain.	alexgella@gmail.com	Trullas, Ramon/D-2197-2016; Gella, Alejandro/H-3845-2019; LAMARCA DAMS, ALOA/Q-4765-2017; Casals, Nuria/L-3378-2014; Grijota-Martinez, Carmen/P-5093-2017	Trullas, Ramon/0000-0001-7951-9881; Gella, Alejandro/0000-0002-3983-1392; LAMARCA DAMS, ALOA/0000-0001-8324-3195; Casals, Nuria/0000-0002-6719-4300; Grijota-Martinez, Carmen/0000-0003-2656-9062	Ferrer S.A. (Barcelona, Spain); Ministerio de Economia y Competitividad of Spain [SAF2011-23550]	Ferrer S.A. (Barcelona, Spain); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This research was supported by an unrestricted research grant from Ferrer S.A. (Barcelona, Spain) and by grant SAF2011-23550 from Ministerio de Economia y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Ando K, 2010, J PHARMACOL EXP THER, V334, P809, DOI 10.1124/jpet.110.167528; Arai K, 2003, GLIA, V43, P254, DOI 10.1002/glia.10255; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Boucher I, 2007, EXP EYE RES, V85, P130, DOI 10.1016/j.exer.2007.03.009; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chattopadhyay S, 2009, GLIA, V57, P1316, DOI 10.1002/glia.20851; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Demestre M, 2004, NEUROSCIENCE, V124, P767, DOI 10.1016/j.neuroscience.2003.12.037; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859; Ferreira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062345; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Gerevich Zoltan, 2004, Purinergic Signal, V1, P3, DOI 10.1007/s11302-004-4740-9; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Gurjar MV, 2001, AM J PHYSIOL-HEART C, V281, pH2568, DOI 10.1152/ajpheart.2001.281.6.H2568; He Y, 2010, NAT NEUROSCI, V13, P1472, DOI 10.1038/nn.2686; HEUMANN R, 1987, P NATL ACAD SCI USA, V84, P8735, DOI 10.1073/pnas.84.23.8735; Hossain S, 2012, GLIA, V60, P1130, DOI 10.1002/glia.22340; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; KENNEDY C, 1985, BLOOD VESSELS, V22, P145; Kherif S, 1998, NEUROPATH APPL NEURO, V24, P309; Kim MS, 2003, CANCER RES, V63, P5454; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; KREIDER BQ, 1981, BRAIN RES, V207, P433, DOI 10.1016/0006-8993(81)90375-9; Krekoski CA, 2002, J NEUROSCI, V22, P10408; LaFleur M, 1996, J EXP MED, V184, P2311; Lakka SS, 2000, CLIN EXP METASTAS, V18, P245, DOI 10.1023/A:1006724826083; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Leppert D, 1999, NEUROLOGY, V53, P62, DOI 10.1212/WNL.53.1.62; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Li WH, 2013, BRIT J CANCER, V109, P1666, DOI 10.1038/bjc.2013.484; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Martianez T, 2013, PURINERG SIGNAL, V9, P259, DOI 10.1007/s11302-012-9348-x; Martianez T, 2012, PROTEOMICS, V12, P145, DOI 10.1002/pmic.201100187; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Pintor J, 2004, OPHTHAL PHYSL OPT, V24, P186, DOI 10.1111/j.1475-1313.2004.00182.x; Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Santiago-Perez LI, 2001, J CELL PHYSIOL, V187, P196, DOI 10.1002/jcp.1063; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Van Kolen Kristof, 2006, Purinergic Signal, V2, P451, DOI 10.1007/s11302-006-9008-0; Vazquez-Cuevas FG, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-88; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Weisman GA, 2012, PURINERG SIGNAL, V8, P559, DOI 10.1007/s11302-012-9307-6; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zine A, 2004, CNS NEUROL DISORD-DR, V3, P325, DOI 10.2174/1568007043337166	76	16	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98998	10.1371/journal.pone.0098998	http://dx.doi.org/10.1371/journal.pone.0098998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905332	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000341869000086
J	Qin, C; Han, ZJ; Qian, J; Bao, ML; Li, P; Ju, XB; Zhang, SB; Zhang, L; Li, S; Cao, Q; Lu, Q; Li, J; Shao, PF; Meng, XX; Zhang, W; Yin, CJ				Qin, Chao; Han, Zhijian; Qian, Jian; Bao, Meiling; Li, Pu; Ju, Xiaobing; Zhang, Shaobo; Zhang, Lei; Li, Shuang; Cao, Qiang; Lu, Qiang; Li, Jie; Shao, Pengfei; Meng, Xiaoxin; Zhang, Wei; Yin, Changjun			Expression Pattern of Long Non-Coding RNAs in Renal Cell Carcinoma Revealed by Microarray	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCOMB GROUP; CANCER; TRANSCRIPTION; PROTEIN; BRAIN; MEG3; ACTIVATION; DOMAINS; COMPLEX	Background: Recent large-scale transcriptome analyses have found large numbers of transcripts, including that of long non-coding RNAs (IncRNAs), which are aberrant in various diseases, especially cancers. However, it is not clear whether IncRNAs are involved specifically in renal cell carcinoma (RCC). We investigated the expression patterns of IncRNAs in five RCC tumor samples M relative to those of matched adjacent non-tumor tissues (N) via microarray. Methods: A microarray with 33,045 IncRNA probes and 30,215 mRNA probes was used to identify deregulated IncRNAs in five RCC patients. Furthermore, we confirmed the relative expression levels of AK096725 and EN5T00000453068 in 70 paired samples by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Results:The IncRNA microarray revealed 27,279 IncRNAs in RCC samples, of which 480 were significantly upregulated (P<0.05; T/N>1.5) and 417 were significantly downregulated (P<0.05; N/T>1.5) compared with the matched non-tumor samples. In addition, 19,995 mRNAs were detected, of which 458 were significantly upregulated (P<0.05; T/N>1.5) and 413 were significantly downregulated (P<0.05; N/T>1.5). The expression level changes of AK096725 (P=0.043) and ENST00000453068 (P<0.001) in 70 paired samples were in accord with the microarray data. Conclusions: The study uncovered expression patterns of IncRNAs in 5 RCC patients, as well as a number of aberrant IncRNAs and mRNAs in tumor samples compared with the non-tumor tissues. The revelation of an association between AK096725 expression and RCC is especially noteworthy. These findings may help to find new biomarkers in RCC.	[Qin, Chao; Han, Zhijian; Qian, Jian; Bao, Meiling; Li, Pu; Ju, Xiaobing; Zhang, Shaobo; Zhang, Lei; Li, Shuang; Cao, Qiang; Lu, Qiang; Li, Jie; Shao, Pengfei; Meng, Xiaoxin; Zhang, Wei; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	drwzhang@163.com	Cao, Qiang/K-2349-2019		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81171963, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, by the National Natural Science Foundation of China [grant number 81171963 and 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Beckedorff FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003705; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Brito GC, 2008, MOL CARCINOGEN, V47, P757, DOI 10.1002/mc.20433; Chen F, 1999, MECH DEVELOP, V84, P181, DOI 10.1016/S0925-4773(99)00073-8; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fachel AA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-140; Garcia JA, 2009, CURR OPIN ONCOL, V21, P266, DOI 10.1097/CCO.0b013e32832a05c8; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gong YH, 2005, FEBS LETT, V579, P115, DOI 10.1016/j.febslet.2004.11.056; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Maruyama R, 2012, BMB REP, V45, P604, DOI 10.5483/BMBRep.2012.45.11.227; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Novikova Irina V, 2012, Bioarchitecture, V2, P189, DOI 10.4161/bioa.22592; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Takahashi M, 2006, J MED INVESTIG, V53, P9, DOI 10.2152/jmi.53.9; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; van Spronsen DJ, 2005, ANTI-CANCER DRUG, V16, P709, DOI 10.1097/01.cad.0000167901.58877.a3; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Worner M, 2012, DRUG METAB DISPOS, V40, P414, DOI 10.1124/dmd.111.040402; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	47	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99372	10.1371/journal.pone.0099372	http://dx.doi.org/10.1371/journal.pone.0099372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905231	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000118
J	Hernandez, C; Barrachina, MD; Cosin-Roger, J; Ortiz-Masia, D; Alvarez, A; Terradez, L; Nicolau, MJ; Alos, R; Esplugues, JV; Calatayud, S				Hernandez, Carlos; Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Terradez, Liria; Jesus Nicolau, Maria; Alos, Rafael; Vicente Esplugues, Juan; Calatayud, Sara			Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells	PLOS ONE			English	Article							GASTRIN; INHIBITION; EXPRESSION; PEPTIDES; INVASION; GROWTH; M2	Macrophage infiltration is a negative prognostic factor for most cancers but gastrointestinal tumors seem to be an exception. The effect of macrophages on cancer progression depends on their phenotype, which may vary between M1 (pro-inflammatory, defensive) to M2 (tolerogenic, pro-tumoral). Gastrointestinal cancers often become an ectopic source of gastrins and macrophages present receptors for these peptides. The aim of the present study is to analyze whether gastrins can affect the pattern of macrophage infiltration in colorectal tumors. We have evaluated the relationship between gastrin expression and the pattern of macrophage infiltration in samples from colorectal cancer and the influence of these peptides on the phenotype of macrophages differentiated from human peripheral monocytes in vitro. The total number of macrophages (CD68+ cells) was similar in tumoral and normal surrounding tissue, but the number of M2 macrophages (CD206+ cells) was significantly higher in the tumor. However, the number of these tumor-associated M2 macrophages correlated negatively with the immunoreactivity for gastrin peptides in tumor epithelial cells. Macrophages differentiated from human peripheral monocytes in the presence of progastrin showed lower levels of M2-markers (CD206, IL10) with normal amounts of M1-markers (CD86, IL12). Progastrin induced similar effects in mature macrophages treated with IL4 to obtain a M2-phenotype or with LPS plus IFN gamma to generate M1-macrophages. Macrophages differentiated in the presence of progastrin presented a reduced expression of Wnt ligands and decreased the number and increased cell death of co-cultured colorectal cancer epithelial cells. Our results suggest that progastrin inhibits the acquisition of a M2-phenotype in human macrophages. This effect exerted on tumor associated macrophages may modulate cancer progression and should be taken into account when analyzing the therapeutic value of gastrin immunoneutralization.	[Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] Univ Valencia, Dept Farmacol, Fac Med, Valencia, Spain; [Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] Univ Valencia, CIBER, Fac Med, Valencia, Spain; [Hernandez, Carlos; Vicente Esplugues, Juan] Hosp Dr Peset, FISABIO, Valencia, Spain; [Hernandez, Carlos; Dolores Barrachina, Maria; Cosin-Roger, Jesus; Ortiz-Masia, Dolores; Alvarez, Angeles; Vicente Esplugues, Juan; Calatayud, Sara] UVEG, Hosp Dr Peset, FISABIO, Unidad Mixta Invest Biomed & Farmacol, Valencia, Spain; [Alvarez, Angeles] Fdn Gen Univ Valencia, Valencia, Spain; [Terradez, Liria; Jesus Nicolau, Maria; Alos, Rafael] Hosp Manises, Valencia, Spain	University of Valencia; University of Valencia	Calatayud, S (corresponding author), Univ Valencia, Dept Farmacol, Fac Med, Valencia, Spain.	sara.calatayud@uv.es	Calatayud, Sara/ABB-9665-2021; Alvarez, Angeles/ABF-4589-2020; ORTIZ-MASIA, MARIA DOLORES/M-1413-2017; Esplugues, Juan/ABC-1488-2021; Barrachina, Maria/ABB-9683-2021; SAEZ, CARLOS HERNANDEZ/M-3029-2014	Calatayud, Sara/0000-0001-9675-2423; ORTIZ-MASIA, MARIA DOLORES/0000-0002-7924-9962; SAEZ, CARLOS HERNANDEZ/0000-0001-8536-429X; Barrachina, Maria Dolores/0000-0002-4332-2929; Alvarez, Angeles/0000-0002-2301-9746; Cosin roger, Jesus/0000-0002-2468-4908; Esplugues Mota, Juan Vicente/0000-0001-8205-021X	Ministerio de Educacion y Ciencia/FEDER [SAF2007-064201]; Ministerio de Ciencia e Innovacion [SAF2010-20231, SAF2010-16030, RYC-2011-09571]; Ministerio de Sanidad y Consumo [PI11/00327]; CIBERehd [CB06/04/0071]; Generalitat Valenciana [PROMETEO/2010/060]; 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain [RYC-2011-09571]; Ministerio de Educacion, Cultura y Deporte	Ministerio de Educacion y Ciencia/FEDER(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); CIBERehd; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain; Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This work was supported by Ministerio de Educacion y Ciencia/FEDER [grant number SAF2007-064201], Ministerio de Ciencia e Innovacion [grant numbers SAF2010-20231, SAF2010-16030 and RYC-2011-09571], Ministerio de Sanidad y Consumo [grant number PI11/00327], CIBERehd [grant number CB06/04/0071] and Generalitat Valenciana [grant number PROMETEO/2010/060]. Carlos Hernandez acknowledges support from the 'Ramon y Cajal' program from Ministerio de Ciencia e Innovacion of Spain (RYC-2011-09571). Jesus Cosin-Roger is supported by FPU fellowships from Ministerio de Educacion, Cultura y Deporte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Alvarez A, 2007, J PHARMACOL EXP THER, V323, P406, DOI 10.1124/jpet.107.122754; Alvarez A, 2006, FASEB J, V20, P2396, DOI 10.1096/fj.05-5696fje; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cosin-Roger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078128; Edin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074982; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Gilliam AD, 2007, EXPERT OPIN BIOL TH, V7, P397, DOI 10.1517/14712598.7.3.397; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grabowska AM, 2007, CANCER LETT, V257, P1, DOI 10.1016/j.canlet.2007.06.017; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Ibiza S, 2009, AM J PHYSIOL-CELL PH, V297, pC1588, DOI 10.1152/ajpcell.00082.2009; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Ortiz-Masia D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048535; Pickert G, 2013, INT J CANCER, V132, P591, DOI 10.1002/ijc.27706; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rengifo-Cam W, 2004, CURR PHARM DESIGN, V10, P2345, DOI 10.2174/1381612043383999; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Singh P, 2012, CURR COLORECT CANC R, V8, P277, DOI 10.1007/s11888-012-0144-3; Swisher JFA, 2010, BLOOD, V115, P549, DOI 10.1182/blood-2009-06-226944; Tai SK, 2012, J IMMUNOL, V188, P2464, DOI 10.4049/jimmunol.1101101; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Watson SA, 2006, NAT REV CANCER, V6, P936, DOI 10.1038/nrc2014; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001	31	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98458	10.1371/journal.pone.0098458	http://dx.doi.org/10.1371/journal.pone.0098458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901518	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400030
J	Liu, MF; He, ZH; Xi, LF; Li, JJ; Liu, FF; Liu, Y; Pan, YQ; Ning, T; Guo, CH; Xu, RP; Zhang, LX; Cai, H; Ke, Y				Liu, Mengfei; He, Zhonghu; Xi, Longfu; Li, Jingjing; Liu, Fangfang; Liu, Ying; Pan, Yaqi; Ning, Tao; Guo, Chuanhai; Xu, Ruiping; Zhang, Lixin; Cai, Hong; Ke, Yang			The Distribution and Common Amino Acid Polymorphisms of Human Papillomavirus (HPV)-31 Variants in 2700 Women from Northern China	PLOS ONE			English	Article							ABNORMAL CERVICAL CYTOLOGY; E7 ONCOPROTEINS; ADENOVIRUS E1A; TYPE-16 E6; HPV E6; CANCER; RISK; PROTEINS; P53; METAANALYSIS	To investigate the distribution of Human papillomavirus (HPV)-31 A, B and C variants as well as the common amino acid polymorphisms in Chinese women, all 14 HPV-31 positive cervical exfoliated cell specimens identified from a descriptive study including similar to 2700 women from Northern China were analyzed. HPV-31 positive specimens were identified by Mass Spectrometry and the fragments of partial Long Control Region, E6 and E7 were amplified and directly sequenced or cloned into vector and then sequenced to confirm the variant information. HPV-31 prevalence in Northern Chinese female population was 0.52%. Six different sequences represented all 14 isolates, and these isolates were subsequently classified into variant lineage A (9), B (0) and C (5) by phylogenetic analysis. Five common amino acid polymorphism sites (2 in E6 and 3 in E7) and a novel non-synonymous mutation were detected in the current study. Our investigation suggested that HPV-31 was much less detected in Chinese women population than that in western countries. A and C variants were commonly detected while B variants were rarely detected in this population.	[Liu, Mengfei; He, Zhonghu; Li, Jingjing; Liu, Fangfang; Liu, Ying; Pan, Yaqi; Ning, Tao; Guo, Chuanhai; Cai, Hong; Ke, Yang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Genet Lab, Minist Educ,Canc Hosp & Inst, Beijing 100871, Peoples R China; [Xi, Longfu] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Xu, Ruiping; Zhang, Lixin] Anyang Canc Hosp, Anyang, Henan, Peoples R China	Peking University; University of Washington; University of Washington Seattle	Cai, H (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Genet Lab, Minist Educ,Canc Hosp & Inst, Beijing 100871, Peoples R China.	drhcai@gmail.com; keyang@bjmu.edu.cn	Zhang, Li/GWM-7501-2022	He, Zhonghu/0000-0002-4444-7950	National Natural Science Foundation of China [81161120411, 30930102]; "973" Project of National Ministry of Science and Technology [2011CB504300, 2012CB910800]; "863" Key Projects of National Ministry of Science and Technology [2012AA02A209, 2012AA022502]; Charity Project of National Ministry of Health [201202014, 200902002]; Specialized Research Fund for the Doctoral Program of Higher Education [20110001110037]; Natural Science Foundation of Beijing [7100001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" Project of National Ministry of Science and Technology; "863" Key Projects of National Ministry of Science and Technology(National High Technology Research and Development Program of China); Charity Project of National Ministry of Health; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (grant number 81161120411, 30930102); "973" Project of National Ministry of Science and Technology Grant (grant number 2011CB504300, 2012CB910800); "863" Key Projects of National Ministry of Science and Technology Grant (grant number 2012AA02A209, 2012AA022502); Charity Project of National Ministry of Health (grant number 201202014, 200902002); the Specialized Research Fund for the Doctoral Program of Higher Education (20110001110037); and Natural Science Foundation of Beijing (grant number 7100001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Cento V, 2011, J MED VIROL, V83, P1752, DOI 10.1002/jmv.22201; Chagas BS, 2011, GYNECOL ONCOL, V123, P284, DOI 10.1016/j.ygyno.2011.07.008; Chagas BS, 2013, INFECT GENET EVOL, V16, P13, DOI 10.1016/j.meegid.2013.02.001; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; CROOK T, 1994, BIOCHEM SOC T, V22, P52, DOI 10.1042/bst0220052; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; ELLIS JRM, 1995, NAT MED, V1, P464, DOI 10.1038/nm0595-464; Farthing Alan J., 1994, Trends in Microbiology, V2, P170, DOI 10.1016/0966-842X(94)90667-X; Ferenczi A, 2013, J MED VIROL, V85, P852, DOI 10.1002/jmv.23542; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gagnon S, 2005, J MED VIROL, V75, P213, DOI 10.1002/jmv.20259; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; KAST WM, 1994, J IMMUNOL, V152, P3904; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; MUNGER K, 1992, CANCER SURV, V12, P197; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Raiol T, 2009, J MED VIROL, V81, P685, DOI 10.1002/jmv.21432; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stoppler MC, 1996, J VIROL, V70, P6987; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Werness B A, 1991, Important Adv Oncol, P3; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Xi LF, 2013, INT J CANCER, V132, P549, DOI 10.1002/ijc.27689; Xi LF, 2012, INT J CANCER, V131, P2300, DOI 10.1002/ijc.27520; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yi X, 2011, AM J CLIN PATHOL, V136, P913, DOI 10.1309/AJCPWTZDT0Q7DOVI; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	38	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99141	10.1371/journal.pone.0099141	http://dx.doi.org/10.1371/journal.pone.0099141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901850	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400102
J	Schmidt, MA; Mennecke, A; Michelson, G; Doerfler, A; Engelhorn, T				Schmidt, Manuel A.; Mennecke, Angelika; Michelson, Georg; Doerfler, Arnd; Engelhorn, Tobias			DTI Analysis in Patients with Primary Open-Angle Glaucoma: Impact of Registration on Voxel-Wise Statistics	PLOS ONE			English	Article							WHITE-MATTER; NEURAL DEGENERATION; SPATIAL STATISTICS; VISUAL PATHWAY; BRAIN; MORPHOMETRY; PARAMETERS; INTEGRITY; CORTEX; FSL	Background and Purpose: Tract-based spatial statistics (TBSS) has been used to assess the integrity of the visual pathway in glaucoma patients. TBSS uses the subjects' FA data to create a mean FA skeleton of white matter tracts before running voxel-wise cross-subject statistics. We compared four different approaches of registration of FA maps to create the skeleton and evaluated alignment and subsequently the impact of the chosen registration on voxel-wise statistics. Material and Methods: Our study comprised 69 subjects, i.e. 46 patients with primary open angle glaucoma (POAG) and a healthy, age-matched control group of 23 subjects. Mean FA skeletons were created using the following registration approaches: registration to a standard template (T), registration to the group mean (GM), registration to a group-wise atlas (GW) and registration to the most typical subject (N). Subsequently, maps of standard deviation of the 4D images were created to assess the alignment. Voxel-wise statistics for each registration approach were performed. Results: We found distinct differences in voxel-wise statistics depending on the chosen registration approach. Best alignment results were achieved by registration to a study specific template, i.e. to the group mean (GM) or to a group-wise atlas (GW). Overall alignment did not differ between these two approaches. However, voxel-wise statistics showed clusters of significantly decreased FA values in the T and GM approach, which were not significant after GW registration. These voxels of significantly decreased FA values after T and GM registration did not represent white matter tracts and correlated with higher standard deviation in FA maps across subjects, thus implying registration errors, especially in the optic radiation. Conclusion: Registration to a study-specific template, i.e. to the group mean or a group-wise atlas seems to be the method of choice in TBSS-analysis of glaucoma patients as it shows better alignment of the optic radiation and helps to rule out registration errors due to misalignment.	[Schmidt, Manuel A.; Mennecke, Angelika; Doerfler, Arnd; Engelhorn, Tobias] Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany; [Michelson, Georg] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schmidt, MA (corresponding author), Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany.	manuel.schmidt@uk-erlangen.de	Schmidt, Manuel Alexander/HFZ-9950-2022; Schmidt, Manuel A./AAN-1586-2020	Schmidt, Manuel Alexander/0000-0002-8560-2582; Schmidt, Manuel A./0000-0002-8560-2582				Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Dai H, 2013, NEURORADIOLOGY, V55, P233, DOI 10.1007/s00234-012-1122-9; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Engelhorn T, 2012, SCI WORLD J, P1, DOI 10.1100/2012/849632; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Lu PG, 2013, J NEURORADIOLOGY, V40, P89, DOI 10.1016/j.neurad.2012.04.001; Michelson G, 2013, GRAEF ARCH CLIN EXP, V251, P243, DOI 10.1007/s00417-011-1887-2; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99344	10.1371/journal.pone.0099344	http://dx.doi.org/10.1371/journal.pone.0099344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901535	Green Published, gold			2022-12-25	WOS:000336841400121
J	Steinbrunn, T; Chatterjee, M; Bargou, RC; Stuhmer, T				Steinbrunn, Torsten; Chatterjee, Manik; Bargou, Ralf C.; Stuehmer, Thorsten			Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation - An Appraisal	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; SIRNAS; APOPTOSIS; STRATEGY; PATHWAY	Cell lines represent the everyday workhorses for in vitro research on multiple myeloma (MM) and are regularly employed in all aspects of molecular and pharmacological investigations. Although loss-of-function studies using RNA interference in MM cell lines depend on successful knockdown, no well-established and widely applied protocol for efficient transient transfection has so far emerged. Here, we provide an appraisal of electroporation as a means to introduce either short-hairpin RNA expression vectors or synthesised siRNAs into MM cells. We found that electroporation using siRNAs was much more efficient than previously anticipated on the basis of transfection efficiencies deduced from EGFP-expression off protein expression vectors. Such knowledge can even confidently be exploited in "hard-to-transfect'' MM cell lines to generate large numbers of transient knockdown phenotype MM cells. In addition, special attention was given to developing a protocol that provides easy implementation, good reproducibility and manageable experimental costs.	[Steinbrunn, Torsten; Chatterjee, Manik; Stuehmer, Thorsten] Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany; [Bargou, Ralf C.] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stuhmer, T (corresponding author), Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany.	stuehmer_t@ukw.de			Deutsche Forschungsgemeinschaft [KFO 216]; Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg [B-188]; Wilhelm Sander-Stiftung [2011.114.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg; Wilhelm Sander-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (KFO 216), the Interdisziplinares Zentrum fur Klinische Forschung of the Universitatsklinikum Wurzburg (B-188), and the Wilhelm Sander-Stiftung (2011.114.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brito JLR, 2008, J IMMUNOL METHODS, V333, P147, DOI 10.1016/j.jim.2008.01.009; Brito JLR, 2010, METHODS MOL BIOL, V623, P299, DOI 10.1007/978-1-60761-588-0_19; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2; de Queiroz FM, 2012, MOL BIOL REP, V39, P2187, DOI 10.1007/s11033-011-0967-z; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fonseca R, 2013, SEMIN ONCOL, V40, P554, DOI 10.1053/j.seminoncol.2013.07.002; Gomez-Benito M, 2007, CELL SIGNAL, V19, P844, DOI 10.1016/j.cellsig.2006.10.009; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Kanduser M, 2009, BIOELECTROCHEMISTRY, V74, P265, DOI 10.1016/j.bioelechem.2008.09.002; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar SK, 2013, LEUKEMIA; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Steinbrunn T, 2012, LEUKEMIA RES, V36, P1165, DOI 10.1016/j.leukres.2012.05.005; Steinbrunn T, 2011, BLOOD, V117, P1998, DOI 10.1182/blood-2010-05-284422; Stroh T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009488; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Tiedemann RE, 2012, CANCER RES, V72, P757, DOI 10.1158/0008-5472.CAN-11-2781; Uphoff CC, 2004, METH MOLEC MED, V88, P319; Usmani SZ, 2013, LEUKEMIA, V27, P226, DOI 10.1038/leu.2012.160; Walters DK, 2002, ANTISENSE NUCLEIC A, V12, P411, DOI 10.1089/108729002321082483; Zhang HR, 2013, J INT MED RES, V41, P584, DOI 10.1177/0300060513480920; Zhang J, 2009, CANCER RES, V69, P5082, DOI 10.1158/0008-5472.CAN-08-4603; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	32	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97443	10.1371/journal.pone.0097443	http://dx.doi.org/10.1371/journal.pone.0097443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901949	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400005
J	Zis, P; McHugh, P; McQuillin, A; Pratico, D; Dickinson, M; Shende, S; Walker, Z; Strydom, A				Zis, Panagiotis; McHugh, Patrick; McQuillin, Andrew; Pratico, Domenico; Dickinson, Mark; Shende, Sima; Walker, Zuzana; Strydom, Andre			Memory Decline in Down Syndrome and Its Relationship to iPF2alpha, a Urinary Marker of Oxidative Stress	PLOS ONE			English	Article							OXIDATIVE/NITROSATIVE STRESS; AMINO-ACIDS; ADULTS; CHILDREN; BIOMARKERS; DEMENTIA; F-2-ISOPROSTANES; ASSOCIATION; DYSFUNCTION; IMPAIRMENT	Background: Lipid peroxidation may be a marker of free-radical-mediated injury associated with Alzheimer's disease (AD). We aimed to investigate whether changes in lipid peroxidation is associated with cognitive decline in individuals with Down syndrome over a 4-year period. Methods: Thirty-two adults with DS participated in a longitudinal study with urinary isoprostane 8,12-iso-iPF2alpha (iPF2alpha) assays at baseline and four years follow-up. Informants rated their functional ability and memory function and the adults with DS attempted assessments of language skills and memory. Twenty-six individuals completed assessments of memory (Modified Memory Object Task, MOMT), adaptive behavior (ABAS), and receptive vocabulary (British Picture vocabulary, BPVS) at both time-points. Results: Overall change in iPF2alpha level was negatively correlated with change in the MOMT score (Spearman's Rho = -0.576, p = 0.006), i.e., increased lipid peroxidation was correlated with worse memory functioning over time. An increase of >= 0.02 ng/mg creatinine iPF2 alpha had good sensitivity (85.7%), positive predictive value (75%,), specificity (85.7%) and negative predictive value (92.3%) for memory decline. Conclusion: Change in iPF2alpha over time may have potential as a biomarker for memory decline in Down syndrome and potentially also help to track progression of MCI to AD in the general population.	[Zis, Panagiotis; Shende, Sima; Walker, Zuzana; Strydom, Andre] UCL, Div Psychiat, London, England; [McHugh, Patrick] Univ Huddersfield, Sch Appl Sci, Div Pharm & Pharmaceut Sci, Huddersfield HD1 3DH, W Yorkshire, England; [McQuillin, Andrew] UCL, Mol Psychiat Lab, London, England; [Pratico, Domenico] Temple Univ, Dept Pharmacol, Philadelphia, PA 19122 USA; [Pratico, Domenico] Temple Univ, Ctr Translat Med, Philadelphia, PA 19122 USA; [Dickinson, Mark] Enfield Integrated Learning Disabil Team, Enfield, Middx, England	University of London; University College London; University of Huddersfield; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zis, P (corresponding author), UCL, Div Psychiat, London, England.	takiszis@gmail.com	Pratico, Domenico/ABA-9590-2020; McQuillin, Andrew/C-1623-2008; Zis, Panagiotis/L-1335-2019; Zis, Panagiotis/AAH-8027-2021; Walker, Zuzana/B-8339-2009	McQuillin, Andrew/0000-0003-1567-2240; Zis, Panagiotis/0000-0001-8567-3092; Walker, Zuzana/0000-0001-7346-8200; McHugh, Patrick/0000-0003-0661-919X; Strydom, Andre/0000-0002-2502-6704	north central London research consortium (NoCloR)	north central London research consortium (NoCloR)	Funding for the baseline work was provided by the north central London research consortium (NoCloR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomolafe A, 2006, CLIN GENET, V70, P49, DOI 10.1111/j.1399-0004.2006.00638.x; Brugge K, 1999, BIOL PSYCHIAT, V46, P1682, DOI 10.1016/S0006-3223(99)00026-8; Burt DB, 2000, J INTELL DISABIL RES, V44, P175, DOI 10.1046/j.1365-2788.2000.00264.x; Callewaert DM, 2010, METHODS MOL BIOL, V610, P435, DOI 10.1007/978-1-60327-029-8_26; Campos C, 2011, LIFE SCI, V89, P655, DOI 10.1016/j.lfs.2011.08.006; Campos C, 2011, BBA-MOL BASIS DIS, V1812, P760, DOI 10.1016/j.bbadis.2011.03.013; Campos C, 2010, CLIN BIOCHEM, V43, P228, DOI 10.1016/j.clinbiochem.2009.09.017; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cenini G, 2012, BBA-MOL BASIS DIS, V1822, P130, DOI 10.1016/j.bbadis.2011.10.001; Coppus AMW, 2010, AMINO ACIDS, V38, P923, DOI 10.1007/s00726-009-0300-5; Coppus AW, 2007, J NEURAL TRANSM, V114, P1041, DOI 10.1007/s00702-007-0656-1; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Evenhuis HM, 1996, J INTELL DISABIL RES, V40, P369, DOI 10.1046/j.1365-2788.1996.786786.x; Ferreiro E, 2012, Int J Cell Biol, V2012, P735206, DOI 10.1155/2012/735206; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Garlet TR, 2013, LIFE SCI, V93, P558, DOI 10.1016/j.lfs.2013.08.017; Guzman R, 2011, BIOMARKERS, V16, P679, DOI 10.3109/1354750X.2011.626527; Harrison P. L., 2000, ADAPTIVE BEHAV ASSES; Ji L, 2010, J ALZHEIMERS DIS, V22, P609, DOI 10.3233/JAD-2010-101029; Kester MI, 2012, FREE RADIC BIOL MED, V62, P157; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lott IT, 2012, BBA-MOL BASIS DIS, V1822, P657, DOI 10.1016/j.bbadis.2011.12.010; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Pastor MC, 1998, CLIN CHEM, V44, P924; Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498; Pratico D, 1999, ATHEROSCLEROSIS, V147, P1, DOI 10.1016/S0021-9150(99)00257-9; Pratico D, 2000, ANN NEUROL, V48, P795, DOI 10.1002/1531-8249(200011)48:5<795::AID-ANA15>3.0.CO;2-#; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2010, BBA-MOL CELL BIOL L, V1801, P930, DOI 10.1016/j.bbalip.2010.01.009; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Ripoll C, 2013, BIOMARKERS, V18, P373, DOI 10.3109/1354750X.2013.783117; Sanchez MM, 2012, BIOL PSYCHIAT, V71, P403, DOI 10.1016/j.biopsych.2011.08.016; SPSS Inc, 2001, SPSS WIND REL 11 0 0; Strydom A, 2009, PROG NEURO-PSYCHOPH, V33, P76, DOI 10.1016/j.pnpbp.2008.10.006; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Tolun AA, 2012, ANN EPIDEMIOL, V22, P892, DOI 10.1016/j.annepidem.2012.09.005; Uberos J, 2010, J PEDIATR ENDOCR MET, V23, P277; Yang B, 2012, NEUROSCI BULL, V28, P233, DOI 10.1007/s12264-012-1239-1; Yang HX, 2010, BIOL PSYCHIAT, V68, P922, DOI 10.1016/j.biopsych.2010.04.010; Zis P, 2012, J ALZHEIMERS DIS, V31, P277, DOI 10.3233/JAD-2012-120073	41	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97709	10.1371/journal.pone.0097709	http://dx.doi.org/10.1371/journal.pone.0097709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901945	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400011
J	Fuqua, BK; Lu, Y; Darshan, D; Frazer, DM; Wilkins, SJ; Wolkow, N; Bell, AG; Hsu, J; Yu, CC; Chen, HJ; Dunaief, JL; Anderson, GJ; Vulpe, CD				Fuqua, Brie K.; Lu, Yan; Darshan, Deepak; Frazer, David M.; Wilkins, Sarah J.; Wolkow, Natalie; Bell, Austin G.; Hsu, JoAnn; Yu, Catherine C.; Chen, Huijun; Dunaief, Joshua L.; Anderson, Gregory J.; Vulpe, Chris D.			The Multicopper Ferroxidase Hephaestin Enhances Intestinal Iron Absorption in Mice	PLOS ONE			English	Article							LINKED ANEMIA; CERULOPLASMIN; CELLS; EXPRESSION; TRANSPORT; ANAEMIA; EFFLUX; MOUSE; GENE; FERROPORTIN	Hephaestin is a vertebrate multicopper ferroxidase important for the transfer of dietary iron from intestinal cells to the blood. Hephaestin is mutated in the sex-linked anemia mouse, resulting in iron deficiency. However, sex-linked anemia mice still retain some hephaestin ferroxidase activity. They survive, breed, and their anemia improves with age. To gain a better understanding of the role of hephaestin in iron homeostasis, we used the Cre-lox system to generate knockout mouse models with whole body or intestine-specific (Villin promoter) ablation of hephaestin. Both types of mice were viable, indicating that hephaestin is not essential and that other mechanisms, multicopper ferroxidase-dependent or not, must compensate for hephaestin deficiency. The knockout strains, however, both developed a microcytic, hypochromic anemia, suggesting severe iron deficiency and confirming that hephaestin plays an important role in body iron acquisition. Consistent with this, the knockout mice accumulated iron in duodenal enterocytes and had reduced intestinal iron absorption. In addition, the similarities of the phenotypes of the whole body and intestine-specific hephaestin knockout mice clarify the important role of hephaestin specifically in intestinal enterocytes in maintaining whole body iron homeostasis. These mouse models will serve as valuable tools to study the role of hephaestin and associated proteins in iron transport in the small intestine and other tissues.	[Fuqua, Brie K.; Bell, Austin G.; Hsu, JoAnn; Yu, Catherine C.; Vulpe, Chris D.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Fuqua, Brie K.; Lu, Yan; Darshan, Deepak; Frazer, David M.; Wilkins, Sarah J.; Anderson, Gregory J.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia; [Wolkow, Natalie; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Chen, Huijun] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of California System; University of California Berkeley; QIMR Berghofer Medical Research Institute; University of Pennsylvania; Pennsylvania Medicine; Nanjing University; University of Queensland	Anderson, GJ (corresponding author), QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia.	Greg.Anderson@qimrberghofer.edu.au	Frazer, David M/L-3570-2014; Anderson, Gregory J/G-4148-2013; Vulpe, Chris/AAF-9170-2020; Darshan, Deepak/B-8259-2013	Frazer, David M/0000-0003-4098-1379; Anderson, Gregory J/0000-0002-8814-5866; Vulpe, Chris/0000-0001-5134-8929; Darshan, Deepak/0000-0001-9719-5980; Bell, Austin/0000-0002-4647-1882; Wolkow, Natalie/0000-0003-1524-115X	National Institutes of Health (NIH)/NIGMS [1R01GM083198-01A1]; California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project [CA-B-NTS-0020H]; Australian Research Council [DP120103746]; NIH (NEI) [EY015240]; National Science Foundation; National Health and Medical Research Council of Australia; NATIONAL EYE INSTITUTE [R01EY015240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project; Australian Research Council(Australian Research Council); NIH (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation(National Science Foundation (NSF)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research funding from the National Institutes of Health (NIH)/NIGMS, http://www.nih.gov, grant number 1R01GM083198-01A1, to CDV; the California Agricultural Experiment Station, University of California, Berkeley through NIFA Hatch Project CA-B-NTS-0020H, to CDV; the Australian Research Council, www.arc.gov.au, grant number DP120103746, to GJA and CDV; the NIH (NEI), grant number EY015240, to JLD; and the National Science Foundation graduate research fellowship to BKF. GJA is the recipient of a Senior Research Fellowship from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNERMAN RM, 1967, BRIT J HAEMATOL, V13, P1000, DOI 10.1111/j.1365-2141.1967.tb08869.x; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Chen HJ, 2009, BIOMETALS, V22, P827, DOI 10.1007/s10534-009-9229-0; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; Collins JF, 2012, PHYSL GASTROINTESTIN, P1921; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; Darshan D, 2010, HAEMATOL-HEMATOL J, V95, P1660, DOI 10.3324/haematol.2010.022426; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; GREWAL MS, 1962, GENET RES, V3, P238, DOI 10.1017/S0016672300035023; Hudson DM, 2009, AM J PHYSL GASTROINT; Jankowska Ewa A, 2010, Heart Fail Clin, V6, P295, DOI 10.1016/j.hfc.2010.03.003; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Kuo YM, 2004, GUT, V53, P201, DOI 10.1136/gut.2003.019026; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Perls M, 1867, VIRCHOW ARCH A, V39, P42, DOI DOI 10.1007/BF01878983; PINKERTO.PH, 1967, NATURE, V216, P482, DOI 10.1038/216482a0; PINKERTON PH, 1970, BRIT J HAEMATOL, V18, P211, DOI 10.1111/j.1365-2141.1970.tb01435.x; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Ranganathan PN, 2012, P NATL ACAD SCI USA, V109, P3564, DOI 10.1073/pnas.1120833109; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; SORBIE J, 1974, BRIT J HAEMATOL, V27, P559, DOI 10.1111/j.1365-2141.1974.tb06621.x; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Syed BA, 2002, PROTEIN ENG, V15, P205, DOI 10.1093/protein/15.3.205; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; WELCH S, 1992, TRANSFERRIN IRON CAR; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041	36	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98792	10.1371/journal.pone.0098792	http://dx.doi.org/10.1371/journal.pone.0098792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896847	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700080
J	Xu, KD; Chang, YX; Liu, K; Wang, FG; Liu, ZY; Zhang, T; Li, T; Zhang, Y; Zhang, FL; Zhang, J; Wang, Y; Niu, W; Jia, SZ; Xie, HC; Tan, GX; Li, CW				Xu, Kedong; Chang, Yunxia; Liu, Kun; Wang, Feige; Liu, Zhongyuan; Zhang, Ting; Li, Tong; Zhang, Yi; Zhang, Fuli; Zhang, Ju; Wang, Yan; Niu, Wei; Jia, Shuzhao; Xie, Hengchang; Tan, Guangxuan; Li, Chengwei			Regeneration of Solanum nigrum by Somatic Embryogenesis, Involving Frog Egg-Like Body, a Novel Structure	PLOS ONE			English	Article							L.; PROTOPLASTS; MECHANISM; APOPTOSIS; GROWTH; CELLS; FRUIT	A new protocol was established for the regeneration of Solanum nigrum by frog egg-like bodies (FELBs), which are novel somatic embryogenesis (SE) structures induced from the root, stem, and leaf explants. The root, stem, and leaf explants (93.33%, 85.10%, and 100.00%, respectively) were induced to form special embryonic calli on Murashige and Skoog (MS) medium containing 1.0 mg/L 2,4-dichlorophenoxyacetic acid, under dark condition. Further, special embryonic calli from the root, stem, and leaf explants (86.97%, 83.30%, and 99.47%, respectively) were developed into FELBs. Plantlets of FELBs from the three explants were induced in vitro on MS medium supplemented with 5.0 mg/L 6-benzylaminopurine and 0.1 mg/L gibberellic acid, and 100.00% plantlet induction rates were noted. However, plantlet induction in vivo on MS medium supplemented with 20 mg/L thidiazuron showed rates of 38.63%, 15.63%, and 61.30% for the root, stem, and leaf explants, respectively, which were lower than those of the in vitro culture. Morphological and histological analyses of FELBs at different development stages revealed that they are a novel type of SE structure that developed from the mesophyll (leaf) or cortex (stem and root) cells of S. nigrum.	[Xu, Kedong; Liu, Kun; Zhang, Yi; Zhang, Fuli; Zhang, Ju; Wang, Yan; Tan, Guangxuan; Li, Chengwei] Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China; [Chang, Yunxia; Wang, Feige; Liu, Zhongyuan; Zhang, Ting; Li, Tong; Niu, Wei; Jia, Shuzhao; Xie, Hengchang] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Peoples R China; [Wang, Yan] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Zhoukou Normal University; Zhoukou Normal University; Henan Agricultural University	Li, CW (corresponding author), Zhoukou Normal Univ, Key Lab Plant Genet & Mol Breeding, Zhoukou, Peoples R China.	lichengweiwau@hotmail.com			National Natural Science Foundation of China [31272168]; Plan For Scientific Innovation Talent of Henan Province [124100510021]; Science and Technology Research Major Projects of Department of Education of Henan Province [13B210270, 14A180003]; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University [zksybscx201108]; Scientific Research and Innovation Fund Projects of Zhoukou Normal University [zksykycx201306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan For Scientific Innovation Talent of Henan Province; Science and Technology Research Major Projects of Department of Education of Henan Province; Doctoral Scientific Research Starting Foundation of Zhoukou Normal University; Scientific Research and Innovation Fund Projects of Zhoukou Normal University	The research was funded by National Natural Science Foundation of China (No. 31272168) (http://www.nsfc.gov.cn/), Plan For Scientific Innovation Talent of Henan Province (No. 124100510021) (http://www.hnkjt.gov.cn), Science and Technology Research Major Projects of Department of Education of Henan Province (No. 13B210270 and No. 14A180003) (http://www.haedu.gov.cn/), Doctoral Scientific Research Starting Foundation of Zhoukou Normal University (No. zksybscx201108) (http://www.zknu.edu.cn/) and Scientific Research and Innovation Fund Projects of Zhoukou Normal University (No. zksykycx201306) (http://www.zknu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulmozhi V, 2012, J BIOTECHNOL TECHNOL, V3, P339; Bedford ID, 1998, EUR J PLANT PATHOL, V104, P221, DOI 10.1023/A:1008627419450; BINDING H, 1982, THEOR APPL GENET, V63, P273, DOI 10.1007/BF00304007; Chen XQ, 2005, J CENT SOUTH UNIV T, V12, P556, DOI 10.1007/s11771-005-0122-x; Correia S, 2012, PLANT CELL TISS ORG, V109, P143, DOI 10.1007/s11240-011-0082-9; Ding X, 2012, J ETHNOPHARMACOL, V139, P599, DOI 10.1016/j.jep.2011.11.058; Essien EE, 2012, PHARM BIOL, V50, P474, DOI 10.3109/13880209.2011.614623; GUPTA PK, 1987, BIO-TECHNOL, V5, P147, DOI 10.1038/nbt0287-147; Inta A, 2008, J ETHNOPHARMACOL, V116, P508, DOI 10.1016/j.jep.2007.12.015; Jainu M, 2006, J ETHNOPHARMACOL, V104, P156, DOI 10.1016/j.jep.2005.08.064; Jainu Mallika, 2004, Indian J Clin Biochem, V19, P57, DOI 10.1007/BF02872391; Javed T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-26; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Jimoh FO, 2010, FOOD CHEM TOXICOL, V48, P964, DOI 10.1016/j.fct.2010.01.007; Kumar GK, 2012, PLANT CELL TISS ORG, V110, P141, DOI 10.1007/s11240-012-0138-5; Kumar VP, 2001, FITOTERAPIA, V72, P481, DOI 10.1016/S0367-326X(01)00266-0; Lebecka R, 2008, EUR J PLANT PATHOL, V120, P233, DOI 10.1007/s10658-007-9211-z; Luo SL, 2011, APPL MICROBIOL BIOT, V89, P1637, DOI 10.1007/s00253-010-2927-2; MACEK T, 1994, BIOTECHNOL LETT, V16, P621, DOI 10.1007/BF00128611; Man SL, 2012, PHYTOTHER RES, V26, P1449, DOI 10.1002/ptr.4609; Muhammad Zubair, 2011, International Journal of Phytomedicine, V3, P63; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NEHLS R, 1978, PLANT SCI LETT, V12, P183, DOI 10.1016/0304-4211(78)90152-9; QUAKENBUSH LS, 1985, WEED SCI, V33, P386, DOI 10.1017/S0043174500082473; Raghavendra K, 2009, INDIAN J MED RES, V130, P74; RAO GR, 1978, ACTA BOT INDICA, V6, P41; RAO MK, 1971, GENETICA, V42, P157, DOI 10.1007/BF00154846; Rawani A, 2010, PARASITOL RES, V107, P1235, DOI 10.1007/s00436-010-1993-9; Rohani ER, 2012, PLANT CELL TISS ORG, V110, P251, DOI 10.1007/s11240-012-0147-4; Son YO, 2003, FOOD CHEM TOXICOL, V41, P1421, DOI 10.1016/S0278-6915(03)00161-3; Sun Y, 2012, DRUG DISCOV THER, V6, P242, DOI 10.5582/ddt.2012.v6.5.242; Venkatesan D, 2004, BIOORGAN MED CHEM, V15, P2528; WEI ZM, 1986, PLANT CELL REP, V5, P93, DOI 10.1007/BF00269242; Xu J, 2009, PLANT CELL REP, V28, P325, DOI 10.1007/s00299-008-0643-5; Xu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083556; Yang L, 2012, PLANT CELL TISS ORG, V109, P547, DOI 10.1007/s11240-012-0121-1; Yogananth N, 2012, GLOB J BIOTECHNOL BI, V7, P86; Zhao WN, 2011, PLANT CELL TISS ORG, V106, P475, DOI 10.1007/s11240-011-9946-2; Zhou HC, 2010, PLANT CELL TISS ORG, V101, P79, DOI 10.1007/s11240-010-9666-z; Zhou XL, 2006, J NAT PROD, V69, P1158, DOI 10.1021/np060091z; Zimnoch-Guzowska E, 2003, THEOR APPL GENET, V107, P43, DOI 10.1007/s00122-003-1221-4	41	15	18	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98672	10.1371/journal.pone.0098672	http://dx.doi.org/10.1371/journal.pone.0098672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896090	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700063
J	Inacio, V; Rocheta, M; Morais-Cecilio, L				Inacio, Vera; Rocheta, Margarida; Morais-Cecilio, Leonor			Molecular Organization of the 25S-18S rDNA IGS of Fagus sylvatica and Quercus suber: A Comparative Analysis	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; INTERGENIC SPACER REGION; STRUCTURAL-ANALYSIS; POLYMERASE-I; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE; EXTERNAL SPACER; WESTERN EURASIA; LENGTH VARIANTS; DNA REPEAT	The 35S ribosomal DNA (rDNA) units, repeated in tandem at one or more chromosomal loci, are separated by an intergenic spacer (IGS) containing functional elements involved in the regulation of transcription of downstream rRNA genes. In the present work, we have compared the IGS molecular organizations in two divergent species of Fagaceae, Fagus sylvatica and Quercus suber, aiming to comprehend the evolution of the IGS sequences within the family. Self- and cross-hybridization FISH was done on representative species of the Fagaceae. The IGS length variability and the methylation level of 18 and 25S rRNA genes were assessed in representatives of three genera of this family: Fagus, Quercus and Castanea. The intergenic spacers in Beech and Cork Oak showed similar overall organizations comprising putative functional elements needed for rRNA gene activity and containing a non-transcribed spacer (NTS), a promoter region, and a 5'-external transcribed spacer. In the NTS: the sub-repeats structure in Beech is more organized than in Cork Oak, sharing some short motifs which results in the lowest sequence similarity of the entire IGS; the AT-rich region differed in both spacers by a GC-rich block inserted in Cork Oak. The 5'-ETS is the region with the higher similarity, having nonetheless different lengths. FISH with the NTS-5'-ETS revealed fainter signals in cross-hybridization in agreement with the divergence between genera. The diversity of IGS lengths revealed variants from similar to 2 kb in Fagus, and Quercus up to 5.3 kb in Castanea, and a lack of correlation between the number of variants and the number of rDNA loci in several species. Methylation of 25S Bam HI site was confirmed in all species and detected for the first time in the 18S of Q. suber and Q. faginea. These results provide important clues for the evolutionary trends of the rDNA 25S-18S IGS in the Fagaceae family.	[Inacio, Vera; Rocheta, Margarida; Morais-Cecilio, Leonor] Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal	Universidade de Lisboa	Morais-Cecilio, L (corresponding author), Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal.	lmorais@isa.ulisboa.pt	Rocheta, Margarida/E-9156-2015; Inacio, Vera/AAY-2356-2020; Morais-Cecilio, Leonor/AAH-5920-2019	Rocheta, Margarida/0000-0003-3939-4564; Inacio, Vera/0000-0002-5652-2540; Morais-Cecilio, Leonor/0000-0001-9313-2253	Fundacao para a Ciencia e Tecnologia - FCT [PTDC/AGR-GFL/104197/2008, SFRH/BPD/64905/2009]	Fundacao para a Ciencia e Tecnologia - FCT(Portuguese Foundation for Science and Technology)	This research was funded by Fundacao para a Ciencia e Tecnologia - FCT (www.fct.pt/) through project PTDC/AGR-GFL/104197/2008 and the post-doc grant SFRH/BPD/64905/2009 that supported MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-13; APPELS R, 1986, CAN J GENET CYTOL, V28, P673, DOI 10.1139/g86-097; APPELS R, 1980, CHROMOSOMA, V78, P293, DOI 10.1007/BF00327389; ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BARKER RF, 1988, J MOL BIOL, V201, P1, DOI 10.1016/0022-2836(88)90434-2; Bauer N, 2009, MOL GENET GENOMICS, V281, P207, DOI 10.1007/s00438-008-0404-8; Bellarosa R, 2005, MOL PHYLOGENET EVOL, V34, P355, DOI 10.1016/j.ympev.2004.10.014; BELLAROSA R, 1990, PLANT SYST EVOL, V172, P127, DOI 10.1007/BF00937803; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhatia S, 1996, J MOL EVOL, V43, P460, DOI 10.1007/BF02337518; Bierhoff H, 2013, EPIGENETICS, V9; BORISJUK N, 1993, PLANT MOL BIOL, V21, P381, DOI 10.1007/BF00019953; Borisjuk NV, 1997, PLANT MOL BIOL, V35, P655, DOI 10.1023/A:1005856618898; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; Bryant JA, 2011, ANN BOT-LONDON, V107, P1119, DOI 10.1093/aob/mcr075; Cannon CH, 2001, SYST BIOL, V50, P860, DOI 10.1080/106351501753462849; Chang KD, 2010, GENOMICS, V96, P181, DOI 10.1016/j.ygeno.2010.05.005; Chokchaichamnankit P, 2008, SILVAE GENET, V57, P5, DOI 10.1515/sg-2008-0002; Coffman FD, 2006, CELL CYCLE, V5, P1223, DOI 10.4161/cc.5.11.2814; CORDESSE F, 1993, J MOL EVOL, V36, P369, DOI 10.1007/BF00182184; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DAROCHA PSCF, 1995, EUR J BIOCHEM, V229, P550, DOI 10.1111/j.1432-1033.1995.tb20497.x; DELCASSOTREMOUSAYGUE D, 1988, EUR J BIOCHEM, V172, P767, DOI 10.1111/j.1432-1033.1988.tb13956.x; Denk T, 2002, PLANT SYST EVOL, V232, P213, DOI 10.1007/s006060200044; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Denk T, 2009, INT J PLANT SCI, V170, P926, DOI 10.1086/600134; DOELLING JH, 1993, P NATL ACAD SCI USA, V90, P7528, DOI 10.1073/pnas.90.16.7528; DOVER GA, 1986, PHILOS T R SOC B, V312, P275, DOI 10.1098/rstb.1986.0007; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; ELLIS THN, 1984, CHROMOSOMA, V91, P74, DOI 10.1007/BF00286487; Gallois A, 1999, ANN FOREST SCI, V56, P615, DOI 10.1051/forest:19990709; Garcia S, 2013, HEREDITY, V111, P23, DOI 10.1038/hdy.2013.11; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GERSTNER J, 1988, GENOME, V30, P723, DOI 10.1139/g88-120; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GRUENDLER P, 1991, J MOL BIOL, V221, P1209, DOI 10.1016/0022-2836(91)90929-Z; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HUANG LH, 1982, NUCLEIC ACIDS RES, V10, P1579, DOI 10.1093/nar/10.5.1579; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; KARVONEN P, 1993, HEREDITY, V71, P614, DOI 10.1038/hdy.1993.186; KATO A, 1990, PLANT MOL BIOL, V14, P983, DOI 10.1007/BF00019395; KELLY RJ, 1989, GENE, V80, P239, DOI 10.1016/0378-1119(89)90288-6; KIM J, 1995, J BIOL CHEM, V270, P1282, DOI 10.1074/jbc.270.3.1282; KING K, 1993, J MOL EVOL, V36, P144, DOI 10.1007/BF00166250; Komarova NY, 2008, PLANT SYST EVOL, V276, P59, DOI 10.1007/s00606-008-0091-2; Komarova NY, 2004, PLANT MOL BIOL, V56, P439, DOI 10.1007/s11103-004-4678-x; Kremer Antoine, 2007, V7, P161; KUHN A, 1990, P NATL ACAD SCI USA, V87, P7527, DOI 10.1073/pnas.87.19.7527; LABHART P, 1984, CELL, V37, P285, DOI 10.1016/0092-8674(84)90324-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim KY, 2004, GENETICS, V166, P1935, DOI 10.1534/genetics.166.4.1935; MAGGINI F, 1981, PROTOPLASMA, V108, P163, DOI 10.1007/BF01276890; MAGGINI F, 1992, PLANT MOL BIOL, V18, P1073, DOI 10.1007/BF00047710; Maggini F, 2008, TREE GENET GENOMES, V4, P293, DOI 10.1007/s11295-007-0109-x; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Manos PS, 2001, INT J PLANT SCI, V162, P1361, DOI 10.1086/322949; Matyasek R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-722; MCMULLEN MD, 1986, NUCLEIC ACIDS RES, V14, P4953, DOI 10.1093/nar/14.12.4953; MITCHELSON K, 1987, NUCLEIC ACIDS RES, V15, P9577, DOI 10.1093/nar/15.22.9577; Miyano M, 2001, MOL BIOL REP, V28, P53, DOI 10.1023/A:1011999730828; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; NEVES N, 1995, THEOR APPL GENET, V91, P529, DOI 10.1007/BF00222984; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parvaresh M, 2013, PLANT SYST EVOL, P1, DOI DOI 10.1109/ICIEV.2013.6572592; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; PERRY KL, 1990, MOL GEN GENET, V221, P102, DOI 10.1007/BF00280374; PIKAARD CS, 1994, P NATL ACAD SCI USA, V91, P464, DOI 10.1073/pnas.91.2.464; Poczai P, 2010, MOL BIOL REP, V37, P1897, DOI 10.1007/s11033-009-9630-3; Polanco C, 1998, GENETICS, V149, P243; POLANS NO, 1986, THEOR APPL GENET, V72, P289, DOI 10.1007/BF00288563; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pontvianne F, 2012, GENE DEV, V26, P945, DOI 10.1101/gad.182865.111; Preuss SB, 2008, MOL CELL, V32, P673, DOI 10.1016/j.molcel.2008.11.009; Ribeiro T, 2011, TREE GENET GENOMES, V7, P1113, DOI 10.1007/s11295-011-0399-x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; ROGERS SO, 1987, GENETICS, V117, P285; Santoro R, 2010, EMBO REP, V11, P52, DOI 10.1038/embor.2009.254; SCHIEBEL K, 1989, MOL GEN GENET, V218, P302, DOI 10.1007/BF00331282; Schwarzacher T., 2000, PRACTICAL IN SITU HY; Singh GB., 2000, ACM SIGKDD EXPLOR NE, V1, P39, DOI [10.1145/846183.846184, DOI 10.1145/846183.846184]; Smarda P, 2012, PLANT GENOME DIVERSI, V1, P209, DOI [10.1007/978-3-7091-1130-7_14, DOI 10.1007/978-3-7091-1130-7_14]; Suzuki A, 1996, PLANT CELL PHYSIOL, V37, P233, DOI 10.1093/oxfordjournals.pcp.a028937; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; TORRES RA, 1990, J MOL EVOL, V30, P170, DOI 10.1007/BF02099943; TORRESRUIZ RA, 1994, PLANT MOL BIOL, V26, P1167, DOI 10.1007/BF00040697; TREMOUSAYGUE D, 1992, PLANT MOL BIOL, V18, P1013, DOI 10.1007/BF00019222; TUCCI GF, 1986, PROTOPLASMA, V132, P76, DOI 10.1007/BF01275793; UEKI M, 1992, PLANT MOL BIOL, V18, P175, DOI 10.1007/BF00018476; VIEIRA R, 1990, GENOME, V33, P707, DOI 10.1139/g90-106; Volkov RA, 1999, PLANT SYST EVOL, V218, P89, DOI 10.1007/BF01087037; Votkov RA, 2007, SYST BIODIVERS, V5, P261, DOI 10.1017/S1477200007002447; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Woo HR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-92; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZENTGRAF U, 1990, PLANT MOL BIOL, V15, P465, DOI 10.1007/BF00019163; Zhang DM, 1999, AM J BOT, V86, P735, DOI 10.2307/2656583; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158; Zoldos V, 1998, GENOME, V41, P162, DOI 10.1139/gen-41-2-162; Zoldos V, 1999, THEOR APPL GENET, V99, P969, DOI 10.1007/s001220051404	107	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98678	10.1371/journal.pone.0098678	http://dx.doi.org/10.1371/journal.pone.0098678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893289	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400084
J	Zhou, C; Mao, FL; Yin, YB; Huang, JL; Gogarten, JP; Xu, Y				Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Huang, Jinling; Gogarten, Johann Peter; Xu, Ying			AST: An Automated Sequence-Sampling Method for Improving the Taxonomic Diversity of Gene Phylogenetic Trees	PLOS ONE			English	Article							SPECIES TREES; EVOLUTION; ACCURACY; ALGORITHM; INFERENCE; ALIGNMENT; GENERATION; MODEL; DNA	A challenge in phylogenetic inference of gene trees is how to properly sample a large pool of homologous sequences to derive a good representative subset of sequences. Such a need arises in various applications, e. g. when (1) accuracy-oriented phylogenetic reconstruction methods may not be able to deal with a large pool of sequences due to their high demand in computing resources; (2) applications analyzing a collection of gene trees may prefer to use trees with fewer operational taxonomic units (OTUs), for instance for the detection of horizontal gene transfer events by identifying phylogenetic conflicts; and (3) the pool of available sequences is biased towards extensively studied species. In the past, the creation of subsamples often relied on manual selection. Here we present an Automated sequence-Sampling method for improving the Taxonomic diversity of gene phylogenetic trees, AST, to obtain representative sequences that maximize the taxonomic diversity of the sampled sequences. To demonstrate the effectiveness of AST, we have tested it to solve four problems, namely, inference of the evolutionary histories of the small ribosomal subunit protein S5 of E. coli, 16 S ribosomal RNAs and glycosyl-transferase gene family 8, and a study of ancient horizontal gene transfers from bacteria to plants. Our results show that the resolution of our computational results is almost as good as that of manual inference by domain experts, hence making the tool generally useful to phylogenetic studies by non-phylogeny specialists. The program is available at http://csbl.bmb.uga.edu/similar to zhouchan/AST.php.	[Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Zhou, Chan; Mao, Fenglou; Yin, Yanbin; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Huang, Jinling] E Carolina Univ, Dept Biol, Greenville, NC USA; [Gogarten, Johann Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of North Carolina; East Carolina University; University of Connecticut; Jilin University	Xu, Y (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Huang, Jinling/ABI-6699-2020; Yin, Yanbin/AAH-2665-2020; ZHOU, Chan/A-7110-2009; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; ZHOU, Chan/0000-0002-0351-6235; Yin, Yanbin/0000-0001-7667-881X; Huang, Jinling/0000-0003-4893-4171; Gogarten, Johann Peter/0000-0001-6459-6518	National Science Foundation Assembling the Tree of Life program [DEB 0830024]; DOE; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	National Science Foundation Assembling the Tree of Life program(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported from the National Science Foundation Assembling the Tree of Life program (DEB 0830024 to CZ, FLM, JLH and JPG) and was in part supported by the DOE grant for the BioEnergy Science Center (to YB and YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-484; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Chauve C, 2007, LECT N BIOINFORMAT, V4751, P45; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Frickey T, 2004, NUCLEIC ACIDS RES, V32, P5231, DOI 10.1093/nar/gkh867; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall BG, 2008, MOL BIOL EVOL, V25, P688, DOI 10.1093/molbev/msn008; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Jacobsen F, 2011, MOL PHYLOGENET EVOL, V61, P460, DOI 10.1016/j.ympev.2011.06.017; Jenuth J P, 2000, Methods Mol Biol, V132, P301; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Linder CR, 2010, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1195; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nelesen S, 2012, BIOINFORMATICS, V28, pI274, DOI 10.1093/bioinformatics/bts218; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuin PAS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-471; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Pecon-Slattery J, 2004, MOL BIOL EVOL, V21, P2299, DOI 10.1093/molbev/msh241; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Poptsova Maria, 2009, V532, P227, DOI 10.1007/978-1-60327-853-9_13; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg MS, 2001, P NATL ACAD SCI USA, V98, P10751, DOI 10.1073/pnas.191248498; Rosenberg MS, 2003, SYST BIOL, V52, P119, DOI 10.1080/10635150390132894; Syvanen M, 2006, SYSTEMS BIOL, VI, P248; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yin YB, 2011, ANNU PLANT REV, V41, P167, DOI 10.1002/9781444391015.ch6; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Zhou C, 2010, J PROTEOME RES, V9, P5025, DOI 10.1021/pr100249c; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	55	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98844	10.1371/journal.pone.0098844	http://dx.doi.org/10.1371/journal.pone.0098844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892935	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400101
J	Ruangprasert, A; Maehigashi, T; Miles, SJ; Giridharan, N; Liu, JX; Dunham, CM				Ruangprasert, Ajchareeya; Maehigashi, Tatsuya; Miles, Stacey J.; Giridharan, Nisha; Liu, Julie X.; Dunham, Christine M.			Mechanisms of Toxin Inhibition and Transcriptional Repression by Escherichia coli DinJ-YafQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ANTITOXIN SYSTEM; YOEB TOXIN; YEFM-YOEB; STRUCTURAL BASIS; 3-GUANYLIC ACID; STRESS-RESPONSE; LON PROTEASE; RELE; RIBONUCLEASE	Bacteria encounter environmental stresses that regulate a gene expression program required for adaptation and survival. Here, we report the 1.8-angstrom crystal structure of the Escherichia coli toxin-antitoxin complex YafQ-(DinJ)(2)-YafQ, a key component of the stress response. The antitoxin DinJ dimer adopts a ribbon-helix-helix motif required for transcriptional autorepression, and toxin YafQ contains a microbial RNase fold whose proposed active site is concealed by DinJ binding. Contrary to previous reports, our studies indicate that equivalent levels of transcriptional repression occur by direct interaction of either YafQ-(DinJ)(2)-YafQ or a DinJ dimer at a single inverted repeat of its recognition sequence that overlaps with the -10 promoter region. Surprisingly, multiple YafQ-(DinJ)(2)-YafQ complexes binding to the operator region do not appear to amplify the extent of repression. Our results suggest an alternative model for transcriptional autorepression that may be novel to DinJ-YafQ.	[Ruangprasert, Ajchareeya; Maehigashi, Tatsuya; Miles, Stacey J.; Giridharan, Nisha; Liu, Julie X.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE,Ste G223, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu			National Institutes of Health from NCRR [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank K. Rajashankar and S. Banerjee at the Northeastern Collaborative Access Team beamline for assistance during data collection and G. L. Conn and M. A. Schureck for helpful discussions throughout the project and critical reading of the manuscript. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, National Institutes of Health Grant RR-15301 from NCRR, and at the SER-CAT beamline. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Chan WT, 2011, J BACTERIOL, V193, P4612, DOI 10.1128/JB.05187-11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2013, PROKARYOTIC TOXIN AN, P69; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Griffin MA, 2013, BIOCHEMISTRY-US, V52, P8633, DOI 10.1021/bi401325c; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu Y, 2012, ENVIRON MICROBIOL, V14, P669, DOI 10.1111/j.1462-2920.2011.02618.x; Johnson EP, 1996, J BACTERIOL, V178, P1420, DOI 10.1128/jb.178.5.1420-1429.1996; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Lazazzera BA, 2005, CURR OPIN MICROBIOL, V8, P222, DOI 10.1016/j.mib.2005.02.015; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Magnuson R, 1998, J BACTERIOL, V180, P6342; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2013, STRUCTURE, V21, P627, DOI 10.1016/j.str.2013.02.008; Miller JH., 1972, EXPT MOL GENETICS; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1155, DOI 10.1016/j.bbapap.2013.02.027; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; Schreiter ER, 2007, NAT REV MICROBIOL, V5, P710, DOI 10.1038/nrmicro1717; Schureck MA, 2014, J BIOL CHEM, V289, P1060, DOI 10.1074/jbc.M113.512095; SEVCIK J, 1991, ACTA CRYSTALLOGR B, V47, P240, DOI 10.1107/S0108768190009569; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shinagawa H, 1996, EXS, V77, P221; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; ZEGERS I, 1994, J BIOL CHEM, V269, P127; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	67	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20559	20569		10.1074/jbc.M114.573006	http://dx.doi.org/10.1074/jbc.M114.573006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898247	hybrid, Green Published			2022-12-25	WOS:000339396600016
J	Tso, SC; Gui, WJ; Wu, CY; Chuang, JL; Qi, XB; Skvorak, KJ; Dorko, K; Wallace, AL; Morlock, LK; Lee, BH; Hutson, SM; Strom, SC; Williams, NS; Tambar, UK; Wynn, RM; Chuang, DT				Tso, Shih-Chia; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Qi, Xiangbing; Skvorak, Kristen J.; Dorko, Kenneth; Wallace, Amy L.; Morlock, Lorraine K.; Lee, Brendan H.; Hutson, Susan M.; Strom, Stephen C.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.			Benzothiophene Carboxylate Derivatives as Novel Allosteric Inhibitors of Branched-chain alpha-Ketoacid Dehydrogenase Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2CM; AMINO-ACID CATABOLISM; INSULIN-RESISTANCE; CLOFIBRIC ACID; OBESE; RAT; MECHANISMS; SURVIVAL; DISEASE; COMPLEX	The mitochondrial branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) is negatively regulated by reversible phosphorylation. BCKDCkinase (BDK) inhibitors that augment BCKDC flux have been shown to reduce branched-chain amino acid (BCAA) concentrations in vivo. In the present study, we employed high-throughput screens to identify compound 3,6-dichlorobenzo[b]thiophene-2-carboxylic acid (BT2) as a novel BDK inhibitor (IC50 = 3.19 mu M). BT2 binds to the same site in BDK as other known allosteric BDK inhibitors, including (S)-alpha-cholorophenylproprionate ((S)-CPP). BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the BCKDC accompanied by accelerated degradation of the released kinase in vivo. BT2 shows excellent pharmacokinetics (terminal T-1/2 = 730 min) and metabolic stability (no degradation in 240 min), which are significantly better than those of (S)-CPP. BT2, its analog 3-chloro-6-fluorobenzo-[b]thiophene-2-carboxylic acid (BT2F), and a prodrug of BT2 (i.e. N-(4-acetamido-1,2,5-oxadiazol-3-yl)-3,6-dichlorobenzo[b]thiophene-2-carboxamide (BT3)) significantly increase residual BCKDC activity in cultured cells and primary hepatocytes from patients and a mouse model of maple syrup urine disease. Administration of BT2 at 20 mg/kg/day to wild-type mice for 1 week leads to nearly complete dephosphorylation and maximal activation of BCKDC in heart, muscle, kidneys, and liver with reduction in plasma BCAA concentrations. The availability of benzothiophene carboxylate derivatives as stable BDK inhibitors may prove useful for the treatment of metabolic disease caused by elevated BCAA concentrations.	[Tso, Shih-Chia; Gui, Wen-Jun; Wu, Cheng-Yang; Chuang, Jacinta L.; Qi, Xiangbing; Wallace, Amy L.; Morlock, Lorraine K.; Williams, Noelle S.; Tambar, Uttam K.; Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Skvorak, Kristen J.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; [Dorko, Kenneth] KU Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan H.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Hutson, Susan M.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Strom, Stephen C.] Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Virginia Polytechnic Institute & State University; Karolinska Institutet	Wynn, RM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	Richard.wynn@utsouthwestern.edu; david.chuang@utsouthwestern.edu	qi, xiangbing/A-4043-2019	qi, xiangbing/0000-0002-7139-5164; Wu, Cheng-Yang/0000-0002-3582-083X; Wynn, Richard/0000-0002-1879-2136	Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092921, R01DK062306, R01DK026758, R56DK062306] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to Drs. Shuquang Wei and Bruce Posner for assistance in the high-throughput screens of BDK inhibitors, Dr. Changguang Wang for conducting measurements of protein binding for BT2 and (S)-CPP, and Dr. Laszlo Kurti for help in the HPLC separation of compounds BT1 and BT2. We are grateful to Dr. Yibin Wang for the generous supply of wild-type and BDP<SUP>-/-</SUP> MEF cells, Crystal structures presented in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, operated under Department of Energy Contract DE-AC02-06CH11357.	AEvarsson A, 1999, NAT STRUCT BIOL, V6, P785; Banerjee T, 2011, IUBMB LIFE, V63, P1101, DOI 10.1002/iub.553; Brunetti-Pierri N, 2011, HUM MOL GENET, V20, P631, DOI 10.1093/hmg/ddq507; Capek P, 2011, ACS CHEM NEUROSCI, V2, P288, DOI 10.1021/cn200021q; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chuang D. T., 2008, ONLINE METABOLIC MOL, P1; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Chuang JL, 2000, METHOD ENZYMOL, V324, P413; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FELIG P, 1975, ANNU REV BIOCHEM, V44, P933, DOI 10.1146/annurev.bi.44.070175.004441; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HARRIS RA, 1994, J NUTR, V124, pS1499, DOI 10.1093/jn/124.suppl_8.1499S; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; HARRIS RA, 1982, J BIOL CHEM, V257, P3915; Homanics GE, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-33; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Iwasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070309; Kobayashi R, 2002, ARCH BIOCHEM BIOPHYS, V407, P231, DOI 10.1016/S0003-9861(02)00472-1; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P58, DOI 10.1016/0003-9861(84)90362-X; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; Skvorak KJ, 2009, MOL THER, V17, P1266, DOI 10.1038/mt.2009.99; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Wang CG, 2013, J PHARMACEUT BIOMED, V75, P112, DOI 10.1016/j.jpba.2012.11.018; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Wynn RM, 2012, J BIOL CHEM, V287, P9178, DOI 10.1074/jbc.M111.314963; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHAO Y, 1994, J BIOL CHEM, V269, P18583; Zhou MY, 2012, J BIOL CHEM, V287, P23397, DOI 10.1074/jbc.M112.351031	44	42	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20583	20593		10.1074/jbc.M114.569251	http://dx.doi.org/10.1074/jbc.M114.569251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895126	Green Published, hybrid			2022-12-25	WOS:000339396600018
J	Hashimoto, M; Koen, T; Takahashi, H; Suda, C; Kitamoto, K; Fujii, I				Hashimoto, Makoto; Koen, Tsukasa; Takahashi, Hiroaki; Suda, Chihiro; Kitamoto, Katsuhiko; Fujii, Isao			Aspergillus oryzae CsyB Catalyzes the Condensation of Two beta-Ketoacyl-CoAs to Form 3-Acetyl-4-hydroxy-6-alkyl-alpha-pyrone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASE; ACID; BIOSYNTHESIS; SUPERFAMILY; DISCOVERY; STARTER; PATHWAY	The type III polyketide synthases from fungi produce a variety of secondary metabolites including pyrones, resorcinols, and resorcylic acids. We previously reported that CsyB from Aspergillus oryzae forms alpha-pyrone csypyrone B compounds when expressed in A. oryzae. Feeding experiments of labeled acetates indicated that a fatty acyl starter is involved in the reaction catalyzed by CsyB. Here we report the in vivo and in vitro reconstitution analysis of CsyB. When CsyB was expressed in Escherichia coli, we observed the production of 3-acetyl-4-hydroxy-alpha-pyrones with saturated or unsaturated straight aliphatic chains of C-9-C-17 in length at the 6 position. Subsequent in vitro analysis using recombinant CsyB revealed that CsyB could accept butyryl-CoA as a starter substrate and malonyl-CoA and acetoacetyl-CoA as extender substrates to form 3-acetyl-4-hydroxy-6-propyl-alpha-pyrone. CsyB also afforded dehydroacetic acid from two molecules of acetoacetyl-CoA. Furthermore, synthetic N-acetylcysteamine thioester of beta-ketohexanoic acid was converted to 3-butanoyl-4-hydroxy-6-propyl-alpha-pyrone by CsyB. These results therefore confirmed that CsyB catalyzed the synthesis of beta-ketoacyl-CoA from the reaction of the starter fatty acyl CoA thioesters with malonyl-CoA as the extender through decarboxylative condensation and further coupling with acetoacetyl-CoA to form 3-acetyl-4-hydroxy-6-alkyl-alpha-pyrone. CsyB is the first type III polyketide synthase that synthesizes3-acetyl-4-hydroxy-6-alkyl-alpha-pyrone by catalyzed the coupling of two beta-ketoacyl-CoAs.	[Hashimoto, Makoto; Koen, Tsukasa; Takahashi, Hiroaki; Suda, Chihiro; Fujii, Isao] Iwate Med Univ, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Iwate Medical University; University of Tokyo	Fujii, I (corresponding author), Iwate Med Univ, Sch Pharm, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	ifujii@iwate-med.ac.jp	橋元, 誠/GVU-4362-2022	橋元, 誠/0000-0002-8716-4985	Ministry of Education, Culture, Sports, Science and Technology, Japan; Keiryokai Research Foundation, Japan; Grants-in-Aid for Scientific Research [25108722] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keiryokai Research Foundation, Japan(Keiryokai Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and grant from Keiryokai Research Foundation, Japan.	Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Erol O, 2010, CHEMBIOCHEM, V11, P1253, DOI 10.1002/cbic.201000085; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Funa N, 2002, J BIOL CHEM, V277, P4628, DOI 10.1074/jbc.M110357200; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P5637, DOI 10.1016/j.bmcl.2013.08.036; Hashimoto M, 2013, BIOORG MED CHEM LETT, V23, P650, DOI 10.1016/j.bmcl.2012.11.119; Jeong JC, 2005, J AM CHEM SOC, V127, P64, DOI 10.1021/ja0441559; Jeya M, 2012, MOL BIOSYST, V8, P2864, DOI 10.1039/c2mb25282a; KANESHIRO T, 1961, J BIOL CHEM, V236, P2615; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Li J, 2011, BIOORG MED CHEM LETT, V21, P6085, DOI 10.1016/j.bmcl.2011.08.058; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Morita H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P171; OIKAWA Y, 1978, J ORG CHEM, V43, P2087, DOI 10.1021/jo00404a066; Piasecki SK, 2011, CHEM BIOL, V18, P1331, DOI 10.1016/j.chembiol.2011.07.021; Ramkumar K, 2008, BIOORGAN MED CHEM, V16, P8988, DOI 10.1016/j.bmc.2008.08.067; Seshime Y, 2005, BIOCHEM BIOPH RES CO, V331, P253, DOI 10.1016/j.bbrc.2005.03.160; Seshime Y, 2010, BIOORGAN MED CHEM, V18, P4542, DOI 10.1016/j.bmc.2010.04.058; Song LJ, 2006, J AM CHEM SOC, V128, P14754, DOI 10.1021/ja065247w; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Sucipto H, 2013, CHEMBIOCHEM, V14, P1581, DOI 10.1002/cbic.201300289; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Yu DY, 2010, ENZYME MICROB TECH, V46, P575, DOI 10.1016/j.enzmictec.2010.02.011	26	16	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19976	19984		10.1074/jbc.M114.569095	http://dx.doi.org/10.1074/jbc.M114.569095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895122	hybrid, Green Published			2022-12-25	WOS:000339395200014
J	Ota, K; Kohda, M				Ota, Kazutaka; Kohda, Masanori			Maternal Food Provisioning in a Substrate-Brooding African Cichlid	PLOS ONE			English	Article							PARENTAL CARE; EGG SIZE; EVOLUTIONARY TRANSITIONS; MOUTHBROODING FEMALES; LIFE-HISTORY; FITNESS; FISHES; FEED	Fish demonstrate the greatest variety of parental care strategies within the animal kingdom. Fish parents seldom provision food for offspring, with some exceptions predominantly found in substrate-brooding Central American cichlids and mouth brooding African cichlids. Here, we provide the first evidence of food provisioning in a substrate-brooding African cichlid Neolamprologus mondabu. This fish is a maternal substrate-brooding cichlid endemic to Lake Tanganyika, and feeds on benthic animals using unique techniques-individuals typically feed on the surface of sandy substrates, but also expose prey by digging up substrates with vigorous wriggling of their body and fins. Young also feed on benthos on the substrate surface, but only using the first technique. We observed that feeding induced by digging accounted for 30% of total feeding bouts in adult females, demonstrating that digging is an important foraging tactic. However, parental females fed less frequently after digging than non-parental females, although both females stayed in pits created by digging for approximately 30 s. Instead, young gathered in the pit and fed intensively, suggesting that parental females provision food for young by means of digging. We tested this hypothesis by comparing the feeding frequency of young before and after digging that was simulated by hand, and observed that young doubled their feeding frequency after the simulated digging. This suggests that parental females engage in digging to uncover food items that are otherwise unavailable to young, and provision food for them at the expense of their own foraging. This behavior was similar to what has been observed in Central American cichlids.	[Ota, Kazutaka; Kohda, Masanori] Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 558, Japan	Osaka Metropolitan University	Ota, K (corresponding author), Osaka City Univ, Dept Biol & Geosci, Sumiyoshi Ku, Osaka 558, Japan.	otkztk@gmail.com		Ota, Kazutaka/0000-0002-7097-7330	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (B) (to KO) and Grants-in-Aid for Overseas Scientific Research (to MK) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow G., 2002, CICHLID FISHES NATUR; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Friedman M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1733; GASHAGAZA M M, 1991, Physiology and Ecology Japan, V28, P29; Gashagaza M.M., 1986, AFR STUDY MONOGR, V6, P37; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; GROSS MR, 1985, AM ZOOL, V25, P807; HILDEMANN WH, 1959, AM NAT, V93, P27, DOI 10.1086/282054; Hori M., 1983, Physiology and Ecology Japan, V20, P129; Keenleyside M.H.A., 1991, PARENTAL CARE; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Klug H, 2010, EVOLUTION, V64, P823, DOI 10.1111/j.1558-5646.2009.00854.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mank JE, 2005, EVOLUTION, V59, P1570; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Monteith KM, 2012, J EVOLUTION BIOL, V25, P1815, DOI 10.1111/j.1420-9101.2012.02567.x; Nagoshi M., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P2663; Nagoshi M., 1983, AFR STUDY MONOGR, V3, P39; NOAKES DLG, 1973, BEHAVIOUR, V46, P221, DOI 10.1163/156853973X00021; Ota K, 2014, J ZOOL, V293, P63, DOI 10.1111/jzo.12125; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; REZNICK DN, 1990, J EVOLUTION BIOL, V3, P185, DOI 10.1046/j.1420-9101.1990.3030185.x; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; Segers FHID, 2011, FUNCT ECOL, V25, P166, DOI 10.1111/j.1365-2435.2010.01790.x; SMITH C, 1994, ENVIRON BIOL FISH, V40, P99, DOI 10.1007/BF00002184; Sogard SM, 1997, B MAR SCI, V60, P1129; Taborsky B, 2004, ANIM BEHAV, V68, P1275, DOI 10.1016/j.anbehav.2004.03.005; Taborsky B, 2003, P ROY SOC B-BIOL SCI, V270, P713, DOI 10.1098/rspb.2002.2255; Takemon Y, 1998, ENVIRON BIOL FISH, V52, P261, DOI 10.1023/A:1007380431013; TRIVERS RL, 1974, AM ZOOL, V14, P249; WISENDEN BD, 1995, ANIM BEHAV, V49, P623; YANAGISAWA Y, 1990, ENVIRON BIOL FISH, V27, P43, DOI 10.1007/BF00004903; YANAGISAWA Y, 1991, ENVIRON BIOL FISH, V30, P353, DOI 10.1007/BF02028851; Zworykin DD, 1998, ETHOLOGY, V104, P771	38	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99094	10.1371/journal.pone.0099094	http://dx.doi.org/10.1371/journal.pone.0099094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911060	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600041
J	Damasceno, MV; Duarte, M; Pasqua, LA; Lima-Silva, AE; MacIntosh, BR; Bertuzzi, R				Damasceno, Mayara V.; Duarte, Marcos; Pasqua, Leonardo A.; Lima-Silva, Adriano E.; MacIntosh, Brian R.; Bertuzzi, Romulo			Static Stretching Alters Neuromuscular Function and Pacing Strategy, but Not Performance during a 3-Km Running Time-Trial	PLOS ONE			English	Article							VERTICAL JUMP PERFORMANCE; OXYGEN-UPTAKE; PERCEIVED EXERTION; SPRINT PERFORMANCE; HAMSTRING MUSCLES; FORCE PRODUCTION; BODY-COMPOSITION; ECONOMY; RUNNERS; STIFFNESS	Purpose: Previous studies report that static stretching (SS) impairs running economy. Assuming that pacing strategy relies on rate of energy use, this study aimed to determine whether SS would modify pacing strategy and performance in a 3-km running time-trial. Methods: Eleven recreational distance runners performed a) a constant-speed running test without previous SS and a maximal incremental treadmill test; b) an anthropometric assessment and a constant-speed running test with previous SS; c) a 3-km time-trial familiarization on an outdoor 400-m track; d and e) two 3-km time-trials, one with SS (experimental situation) and another without (control situation) previous static stretching. The order of the sessions d and e were randomized in a counterbalanced fashion. Sit-and-reach and drop jump tests were performed before the 3-km running time-trial in the control situation and before and after stretching exercises in the SS. Running economy, stride parameters, and electromyographic activity (EMG) of vastus medialis (VM), biceps femoris (BF) and gastrocnemius medialis (GA) were measured during the constant-speed tests. Results: The overall running time did not change with condition (SS 11:35 +/- 00:31 s; control 11:28 +/- 00:41 s, p=0.304), but the first 100 m was completed at a significantly lower velocity after SS. Surprisingly, SS did not modify the running economy, but the iEMG for the BF (+22.6%, p=0.031), stride duration (+2.1%, p=0.053) and range of motion (+11.1%, p = 0.0001) were significantly modified. Drop jump height decreased following SS (-9.2%, p=0.001). Conclusion: Static stretch impaired neuromuscular function, resulting in a slow start during a 3-km running time-trial, thus demonstrating the fundamental role of the neuromuscular system in the self-selected speed during the initial phase of the race.	[Damasceno, Mayara V.; Pasqua, Leonardo A.; Bertuzzi, Romulo] Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil; [Duarte, Marcos] Fed Univ ABC, Sao Paulo, Brazil; [Lima-Silva, Adriano E.] Univ Fed Pernambuco, Dept Phys Educ & Sports Sci, Sports Sci Res Grp, Vitoria De Santo Antao, PE, Brazil; [MacIntosh, Brian R.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade Federal de Pernambuco; University of Calgary	Bertuzzi, R (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Endurance Performance Res Grp, Sao Paulo, Brazil.	bertuzzi@usp.br	Damasceno, Mayara/P-3468-2015; Lima-Silva, Adriano/Y-2404-2019; Lima-Silva, Adriano Eduardo/C-2800-2013; Duarte, Marcos/D-1854-2011; Bertuzzi, Romulo/E-7048-2012	Lima-Silva, Adriano/0000-0002-0613-5104; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104; Duarte, Marcos/0000-0002-0344-7460; 	Sao Paulo Research Foundation [FAPESP: 2011/10742-9, FAPESP: 2011/02769-4, 2010/13913-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation (FAPESP: 2011/10742-9). Mayara Vieira Damasceno and Leonardo Alves Pasqua were supported by a master scholarship from Sao Paulo Research Foundation (FAPESP: 2011/02769-4 and 2010/13913-6), www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Allison SJ, 2008, J SPORT SCI, V26, P1489, DOI 10.1080/02640410802392715; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Baltaci G, 2003, BRIT J SPORT MED, V37, P59, DOI 10.1136/bjsm.37.1.59; Baron B, 2009, EUR J APPL PHYSIOL, V105, P749, DOI 10.1007/s00421-008-0957-6; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Behm DG, 2007, EUR J APPL PHYSIOL, V101, P587, DOI 10.1007/s00421-007-0533-5; Bertuzzi R, 2013, J STRENGTH COND RES; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bradley PS, 2007, J STRENGTH COND RES, V21, P223, DOI 10.1519/00124278-200702000-00040; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Cornwell A, 2001, J HUM MOVEMENT STUD, V40, P307; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Faulkner J, 2008, PSYCHOPHYSIOLOGY, V45, P977, DOI 10.1111/j.1469-8986.2008.00712.x; Fletcher JR, 2009, J APPL PHYSIOL, V107, P1918, DOI 10.1152/japplphysiol.00307.2009; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Hayes PR, 2007, J STRENGTH COND RES, V21, P1227; Higashihara A, 2010, J SPORT SCI, V28, P1085, DOI 10.1080/02640414.2010.494308; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Jones AM, 2002, INT J SPORTS MED, V23, P40, DOI 10.1055/s-2002-19271; Kyrolainen H, 2001, MED SCI SPORT EXER, V33, P1330; Lima-Silva AE, 2010, EUR J APPL PHYSIOL, V108, P1045, DOI 10.1007/s00421-009-1300-6; LOHMAN TG, 1981, HUM BIOL, V53, P181; Lusk G, 1928, SCI NUTR, P177; Marcora SM, 2009, J APPL PHYSIOL, V106, P857, DOI 10.1152/japplphysiol.91324.2008; Mikkola J, 2011, J SPORT SCI, V29, P1359, DOI 10.1080/02640414.2011.589467; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Nelson AG, 2005, J SPORT SCI, V23, P449, DOI 10.1080/02640410410001730205; Nummela AT, 2008, INT J SPORTS MED, V29, P738, DOI 10.1055/s-2007-989404; Nummela AT, 2006, EUR J APPL PHYSIOL, V97, P1, DOI 10.1007/s00421-006-0147-3; Ogura Y, 2007, J STRENGTH COND RES, V21, P788; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Ryan ED, 2009, J SPORT SCI, V27, P957, DOI 10.1080/02640410902998254; Lopes FAS, 2010, J STRENGTH COND RES, V24, P1650, DOI 10.1519/JSC.0b013e3181d32f7b; Sandals LE, 2006, INT J SPORTS MED, V27, P37, DOI 10.1055/s-2005-837468; Sayers AL, 2008, J STRENGTH COND RES, V22, P1416, DOI 10.1519/JSC.0b013e318181a450; Tucker R, 2006, INT J SPORT PHYSIOL, V1, P233, DOI 10.1123/ijspp.1.3.233; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Young W, 2001, RES Q EXERCISE SPORT, V72, P273, DOI 10.1080/02701367.2001.10608960; Young WB., 1995, J STRENGTH CONDITION, V9, P232, DOI DOI 10.1519/00124278-199511000-06005	44	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99238	10.1371/journal.pone.0099238	http://dx.doi.org/10.1371/journal.pone.0099238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905918	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000113
J	Zhao, JY; Yang, YHS; Xi, XQ; Zhang, CB; Sun, SC				Zhao, Jiyan; Yang, Yangheshan; Xi, Xinqiang; Zhang, Changbing; Sun, Shucun			Artificial Warming Facilitates Growth but Not Survival of Plateau Frog (Rana kukunoris) Tadpoles in Presence of Gape-Limited Predatory Beetles	PLOS ONE			English	Article							ESCAPE BEHAVIOR; TEMPERATURE; PLASTICITY; SIZE; LARVAE; SHAPE; METAMORPHOSIS; DRAGONFLIES; POPULATIONS; TEMPORARIA	Background: Global warming has been frequently demonstrated to increase growth rate in larval amphibians that have considerable phenotypic plasticity; this may lead to an increase in larval survival because large larvae are less likely to be captured by gape-limited predators. This study is to test whether warming could improve tadpole growth and thereby enhance the tadpole survival in plateau frog Rana kukunoris. Methodology: We conducted an experiment involving growing tadpoles under two contrasting temperatures, i.e. ambient temperature vs. warming by 3.8 degrees C, with and without their major predators - the gape-limited predaceous diving beetles Agabus sp. in eastern Tibetan Plateau, in a factorial arrangement. We recorded the survival and measured body fresh weight and morphological characteristics of the tadpoles. Principal Findings: Warming significantly increased body fresh weight in the presence of predators after three weeks of treatments. However, the predators imposed significant and similar effects on the survival of tadpoles under both ambient and elevated temperatures, with the effects mostly occurring in the first three weeks of the experiment. Changes in the body form, i.e. the greater whole length at a given fresh weight and the longer tail at a given body length, could have acted as mechanisms of defense and escape for the tadpoles. Conclusions/Significance: Warming did not increase tadpole survival with or without presence of predators. Moreover, an increased growth rate (due to warming in the presence of predators) was not a major factor contributing to the tadpole survival. We postulate that even if warming increases the tadpole growth rate in the plateau frog, it does not necessarily improve their survival in the presence of gape-limited predators.	[Zhao, Jiyan; Yang, Yangheshan; Sun, Shucun] Nanjing Univ, Dept Biol, Nanjing 210008, Jiangsu, Peoples R China; [Xi, Xinqiang; Sun, Shucun] Chinese Acad Sci, Chengdu Inst Biol, ECORES Lab, Chengdu, Peoples R China; [Zhang, Changbing] Sichuan Acad Grassland Sci, Chengdu, Peoples R China	Nanjing University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Sun, SC (corresponding author), Nanjing Univ, Dept Biol, Nanjing 210008, Jiangsu, Peoples R China.	shcs@nju.edu.cn			National Science Foundation of China [31325004]; 973 Program [2013CB956302]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This study was supported by National Science Foundation of China (31325004) and 973 Program (2013CB956302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2002, FUNCT ECOL, V16, P640, DOI 10.1046/j.1365-2435.2002.00658.x; Anderson MT, 2001, CAN J ZOOL, V79, P1834, DOI 10.1139/cjz-79-10-1834; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Benard MF, 2006, ECOLOGY, V87, P340, DOI 10.1890/05-0381; BLAUSTEIN AR, 1990, TRENDS ECOL EVOL, V5, P203, DOI 10.1016/0169-5347(90)90129-2; BRATTSTROM BH, 1963, ECOLOGY, V44, P238, DOI 10.2307/1932171; CALDWELL JP, 1980, OECOLOGIA, V46, P285, DOI 10.1007/BF00346253; CRONIN JT, 1986, HERPETOLOGICA, V42, P171; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Dittman DE, 1997, FUNCT ECOL, V11, P573, DOI 10.1046/j.1365-2435.1997.00127.x; Doherty PA, 1998, J EXP BIOL, V201, P2691; Falster D.S., 2006, USERS GUIDE SMATR ST; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Heyer W.R., 1975, Biotopica, V7, P100; Hoff KV, 2000, AM ZOOL, V40, P62, DOI 10.1668/0003-1569(2000)040[0062:TLAMAT]2.0.CO;2; Jian-hong D, 2005, ZOOL RES, V26, P263; Laurila A, 2008, ECOLOGY, V89, P1399, DOI 10.1890/07-1521.1; Li P, 2010, DIVERSITY AMPHIBIANS, P34; Loman J, 2002, J ZOOL, V258, P115, DOI 10.1017/S0952836902001255; LONSDALE DJ, 1985, ECOLOGY, V66, P1397, DOI 10.2307/1938002; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McCollum SA, 1997, OECOLOGIA, V109, P615, DOI 10.1007/s004420050124; Merila J, 2000, ECOGRAPHY, V23, P457, DOI 10.1034/j.1600-0587.2000.230408.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Qi Yin, 2007, Acta Zoologica Sinica, V53, P974; R Development Core Team, 2007, R LANG ENV STAT COMP; Reading CJ, 1999, OECOLOGIA, V121, P310, DOI 10.1007/s004420050933; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; RICHARDS SJ, 1990, COPEIA, P1041; Shukla P.R., 2022, CLIMATE CHANGE 2013; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; SMITH DC, 1983, ECOLOGY, V64, P501, DOI 10.2307/1939970; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stahlberg F, 2001, J EVOLUTION BIOL, V14, P755, DOI 10.1046/j.1420-9101.2001.00333.x; TEJEDO M, 1993, HERPETOLOGICA, V49, P287; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Teplitsky C, 2005, J EVOLUTION BIOL, V18, P180, DOI 10.1111/j.1420-9101.2004.00790.x; THOMPSON DJ, 1978, J ANIM ECOL, V47, P757, DOI 10.2307/3669; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, 2011, J ANIM ECOL, V80, P79, DOI 10.1111/j.1365-2656.2010.01765.x; TRAVIS J, 1985, OIKOS, V45, P59, DOI 10.2307/3565222; Van Buskirk J, 2003, J HERPETOL, V37, P420, DOI 10.1670/0022-1511(2003)037[0420:TLETTS]2.0.CO;2; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; WILBUR HM, 1987, ECOLOGY, V68, P1437, DOI 10.2307/1939227; Xiang SA, 2009, ECOL ENG, V35, P553, DOI 10.1016/j.ecoleng.2008.02.016; Zhang W, 2011, CHINESE INSECTS ILLU, P263	48	7	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98252	10.1371/journal.pone.0098252	http://dx.doi.org/10.1371/journal.pone.0098252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905846	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000025
J	Equbal, A; Suman, SS; Anwar, S; Singh, KP; Zaidi, A; Sardar, AH; Das, P; Ali, V				Equbal, Asif; Suman, Shashi Shekhar; Anwar, Shadab; Singh, Krishn Pratap; Zaidi, Amir; Sardar, Abul Hasan; Das, Pradeep; Ali, Vahab			Stage-Dependent Expression and Up-Regulation of Trypanothione Synthetase in Amphotericin B Resistant Leishmania donovani	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; CRITHIDIA-FASCICULATA; TRYPANOSOMA-BRUCEI; OXIDATIVE STRESS; ENTAMOEBA-HISTOLYTICA; ESCHERICHIA-COLI; HYDROPEROXIDE METABOLISM; TRYPAREDOXIN PEROXIDASE; ORNITHINE-DECARBOXYLASE; VISCERAL LEISHMANIASIS	Kinetoplastids differ from other organisms in their ability to conjugate glutathione and spermidine to form trypanothione which is involved in maintaining redox homeostasis and removal of toxic metabolites. It is also involved in drug resistance, antioxidant mechanism, and defense against cellular oxidants. Trypanothione synthetase (TryS) of thiol metabolic pathway is the sole enzyme responsible for the biosynthesis of trypanothione in Leishmania donovani. In this study, TryS gene of L. donovani (LdTryS) was cloned, expressed, and fusion protein purified with affinity column chromatography. The purified protein showed optimum enzymatic activity at pH 8.0-8.5. The TryS amino acids sequences alignment showed that all amino acids involved in catalytic and ligands binding of L. major are conserved in L. donovani. Subcellular localization using digitonin fractionation and immunoblot analysis showed that LdTryS is localized in the cytoplasm. Furthermore, RT-PCR coupled with immunoblot analysis showed that LdTryS is overexpressed in Amp B resistant and stationary phase promastigotes (similar to 2.0-folds) than in sensitive strain and logarithmic phase, respectively, which suggests its involvement in Amp B resistance. Also, H2O2 treatment upto 150 mu M for 8 hrs leads to 2-fold increased expression of LdTryS probably to cope up with oxidative stress generated by H2O2. Therefore, this study demonstrates stage-and Amp B sensitivity-dependent expression of LdTryS in L. donovani and involvement of TryS during oxidative stress to help the parasites survival.	[Equbal, Asif; Suman, Shashi Shekhar; Anwar, Shadab; Singh, Krishn Pratap; Zaidi, Amir; Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India; [Sardar, Abul Hasan; Das, Pradeep] Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Ali, V (corresponding author), Rajendra Mem Res Inst Med Sci, Dept Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India.	vahab_ali@yahoo.com	Equbal, Asif/AAJ-7149-2021	Zaidi, Amir/0000-0001-5029-4180	Indian Council of Medical Research (ICMR); Ministry of Health and Family Welfare; Department of Science & Technology, New Delhi, India [DST/INT/JSPSP-117]; ICMR; CSIR; DBT; DST, New Delhi	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Ministry of Health and Family Welfare; Department of Science & Technology, New Delhi, India(Department of Science & Technology (India)); ICMR(Indian Council of Medical Research (ICMR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT(Department of Biotechnology (DBT) India); DST, New Delhi(Department of Science & Technology (India))	This work was supported by a grant from Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, and Department of Science & Technology, (DST/INT/JSPSP-117) New Delhi, India. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript. Asif Equbal (ICMR), Shashi & Amir (CSIR), Shadab (DBT), & K. P. Singh (DST-INSPIRE Fellow) are working as SRF and acknowledged for fellowship support from ICMR & CSIR, DBT, DST, New Delhi respectively.	Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Ali V, 2003, BIOCHEM J, V375, P729, DOI 10.1042/BJ20030630; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budde H, 2003, BIOFACTORS, V17, P83, DOI 10.1002/biof.5520170109; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Carter KC, 2006, ANTIMICROB AGENTS CH, V50, P88, DOI 10.1128/AAC.50.1.88-95.2006; Colotti G, 2011, AMINO ACIDS, V40, P269, DOI 10.1007/s00726-010-0630-3; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2008, J BIOL CHEM, V283, P27785, DOI 10.1074/jbc.M802010200; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; Hausler T, 1996, J CELL BIOL, V132, P311, DOI 10.1083/jcb.132.3.311; Hsu JY, 2008, MOL BIOCHEM PARASIT, V157, P193, DOI 10.1016/j.molbiopara.2007.11.002; JHA TK, 1995, AM J TROP MED HYG, V52, P536, DOI 10.4269/ajtmh.1995.52.536; KELLY JM, 1993, EUR J BIOCHEM, V218, P29, DOI 10.1111/j.1432-1033.1993.tb18348.x; Kim BY, 2001, FREE RADICAL BIO MED, V30, P686, DOI 10.1016/S0891-5849(00)00514-1; Koch O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056788; Koenig K, 1997, J BIOL CHEM, V272, P11908, DOI 10.1074/jbc.272.18.11908; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Manta B, 2013, BBA-GEN SUBJECTS, V1830, P3199, DOI 10.1016/j.bbagen.2013.01.013; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; MEISTER A, 1989, ADV ENZYMOL RAMB, V62, P315; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Muller S, 2001, TRENDS PARASITOL, V17, P242, DOI 10.1016/S1471-4922(01)01908-0; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Reguera RM, 2005, COMP BIOCHEM PHYS C, V140, P151, DOI 10.1016/j.cca.2005.02.006; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Romao S, 2009, INT J PARASITOL, V39, P703, DOI 10.1016/j.ijpara.2008.11.009; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sambrook J, 2001, MOL CLONING LAB MANU; Sardar AH, 2013, J PROTEOMICS, V81, P185, DOI 10.1016/j.jprot.2013.01.011; Saudagar P, 2011, BIOL CHEM, V392, P1113, DOI [10.1515/BC-2011-222, 10.1515/BC.2011.222]; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; SHIM H, 1988, J GEN MICROBIOL, V134, P807; Sinha PK, 2006, J INFECTION, V53, P60, DOI 10.1016/j.jinf.2005.09.011; SMITH K, 1992, PROTEIN SCI, V1, P874, DOI 10.1002/pro.5560010705; TABOR CW, 1970, J BIOL CHEM, V245, P2086; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Wyllie S, 2010, MOL BIOCHEM PARASIT, V173, P162, DOI 10.1016/j.molbiopara.2010.05.015	73	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97600	10.1371/journal.pone.0097600	http://dx.doi.org/10.1371/journal.pone.0097600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901644	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400009
J	Fine, DH; Markowitz, K; Fairlie, K; Tischio-Bereski, D; Ferrandiz, J; Godboley, D; Furgang, D; Gunsolley, J; Best, A				Fine, Daniel H.; Markowitz, Kenneth; Fairlie, Karen; Tischio-Bereski, Debbie; Ferrandiz, Javier; Godboley, Dipti; Furgang, David; Gunsolley, John; Best, Al			Macrophage Inflammatory Protein-1 alpha Shows Predictive Value as a Risk Marker for Subjects and Sites Vulnerable to Bone Loss in a Longitudinal Model of Aggressive Periodontitis	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; SALIVARY BIOMARKER; FILIFACTOR-ALOCIS; ATTACHMENT LOSS; UNITED-STATES; DISEASE; PROGRESSION; DIAGNOSIS; HEALTH; COHORT	Improved diagnostics remains a fundamental goal of biomedical research. This study was designed to assess cytokine biomarkers that could predict bone loss (BL) in localized aggressive periodontitis. 2,058 adolescents were screened. Two groups of 50 periodontally healthy adolescents were enrolled in the longitudinal study. One group had Aggregatibacter actinomycetemcomitans (Aa), the putative pathogen, while the matched cohort did not. Cytokine levels were assessed in saliva and gingival crevicular fluid (GCF). Participants were sampled, examined, and radiographed every 6 months for 2-3 years. Disease was defined as radiographic evidence of BL. Saliva and GCF was collected at each visit, frozen, and then tested retrospectively after detection of BL. Sixteen subjects with Aa developed BL. Saliva from Aa-positive and Aa-negative healthy subjects was compared to subjects who developed BL. GCF was collected from 16 subjects with BL and from another 38 subjects who remained healthy. GCF from BL sites in the 16 subjects was compared to healthy sites in these same subjects and to healthy sites in subjects who remained healthy. Results showed that cytokines in saliva associated with acute inflammation were elevated in subjects who developed BL (i.e., MIP-1 alpha MIP-1 beta IL-alpha, IL-1 beta and IL-8; p<0.01). MIP-1 alpha was elevated 13-fold, 6 months prior to BL. When MIP-1 alpha levels were set at 40 pg/ml, 98% of healthy sites were below that level (Specificity); whereas, 93% of sites with BL were higher (Sensitivity), with comparable Predictive Values of 98%; p<0.0001; 95% C.I. = 42.5-52.7). MIP-1 alpha consistently showed elevated levels as a biomarker for BL in both saliva and GCF, 6 months prior to BL. MIP-1 alpha continues to demonstrate its strong candidacy as a diagnostic biomarker for both subject and site vulnerability to BL.	[Fine, Daniel H.; Markowitz, Kenneth; Fairlie, Karen; Tischio-Bereski, Debbie; Ferrandiz, Javier; Godboley, Dipti; Furgang, David] Rutgers State Univ, Dept Oral Biol, Sch Dent Med, Newark, NJ 07102 USA; [Gunsolley, John; Best, Al] Virginia Commonwealth Virginia, Dept Periodont, Sch Dent, Richmond, VA USA	Rutgers State University Newark; Rutgers State University New Brunswick	Fine, DH (corresponding author), Rutgers State Univ, Dept Oral Biol, Sch Dent Med, Newark, NJ 07102 USA.	finedh@sdm.rutgers.edu		Best, Al/0000-0002-6300-3925	National Institutes of Health [DE 017968]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded in full by a grant from the National Institutes of Health DE 017968 to DHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author accepts full responsibility for all aspects of the study and its resulting manuscript.	Al-Sabbagh M, 2012, J PERIODONTAL RES, V47, P389, DOI 10.1111/j.1600-0765.2011.01445.x; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Aruni AW, 2011, INFECT IMMUN, V79, P3872, DOI 10.1128/IAI.05631-11; BEST AM, 1990, J CLIN PERIODONTOL, V17, P564, DOI 10.1111/j.1600-051X.1990.tb01106.x; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Brown LJ, 1996, J PERIODONTOL, V67, P968, DOI 10.1902/jop.1996.67.10.968; CLEREHUGH V, 1990, J CLIN PERIODONTOL, V17, P702, DOI 10.1111/j.1600-051X.1990.tb01057.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Feghali CA, 1997, FRONT BIOSCI, V2, P12; Fine DH, 2006, PERIODONTOL 2000, V42, P114, DOI 10.1111/j.1600-0757.2006.00189.x; Fine DH, 2013, J CLIN MICROBIOL, V51, P2850, DOI 10.1128/JCM.00729-13; Fine DH, 2009, J PERIODONTOL, V80, P106, DOI [10.1902/jop.2009.080296, 10.1902/jop.2009.080296 ]; Giannobile WV, 2009, PERIODONTOL 2000, V50, P52, DOI 10.1111/j.1600-0757.2008.00288.x; GLAVIND LEIF, 1967, J PERIODONTAL RES, V2, P180, DOI 10.1111/j.1600-0765.1967.tb01887.x; GOLUB L M, 1976, Oral Sciences Reviews, V8, P49; GOODSON JM, 1982, J CLIN PERIODONTOL, V9, P472, DOI 10.1111/j.1600-051X.1982.tb02108.x; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; LISTGARTEN MA, 1980, J CLIN PERIODONTOL, V7, P165, DOI 10.1111/j.1600-051X.1980.tb01960.x; MANDEL ID, 1993, ANN NY ACAD SCI, V694, P1, DOI 10.1111/j.1749-6632.1993.tb18336.x; McCauley LK, 2002, J PERIODONTOL, V73, P1377, DOI 10.1902/jop.2002.73.11.1377; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Ryu OH, 2007, J PERIODONTOL, V78, P1627, DOI 10.1902/jop.2007.070066; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Shaddox L, 2010, J DENT RES, V89, P143, DOI 10.1177/0022034509353397; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064	30	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98541	10.1371/journal.pone.0098541	http://dx.doi.org/10.1371/journal.pone.0098541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901458	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400036
J	Huebert, KB; Peck, MA				Huebert, Klaus B.; Peck, Myron A.			A Day in the Life of Fish Larvae: Modeling Foraging and Growth Using Quirks	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; COD GADUS-MORHUA; ANCHOVY ENGRAULIS-ENCRASICOLUS; HADDOCK MELANOGRAMMUS-AEGLEFINUS; SPRAT SPRATTUS-SPRATTUS; ATLANTIC COD; NORTH-SEA; SELECTIVE PREDATION; FEEDING-BEHAVIOR; ENCOUNTER RATES	This article introduces "Quirks,'' a generic, individual-based model synthesizing over 40 years of empirical and theoretical insights into the foraging behavior and growth physiology of marine fish larvae. In Quirks, different types of larvae are defined by a short list of their biological traits, and all foraging and growth processes (including the effects of key environmental factors) are modeled following one unified set of mechanistic rules. This approach facilitates ecologically meaningful comparisons between different species and environments. We applied Quirks to model young exogenously feeding larvae of four species: 5.5-mm European anchovy (Engraulis encrasicolus), 7-mm Atlantic cod (Gadus morhua), 13-mm Atlantic herring (Clupea harengus), and 7-mm European sprat (Sprattus sprattus). Modeled growth estimates explained the majority of variability among 53 published empirical growth estimates, and displayed very little bias: 0.65%+/- 1.2% d(-1) (mean 6 standard error). Prey organisms of similar to 67% the maximum ingestible prey length were optimal for all larval types, in terms of the expected ingestion per encounter. Nevertheless, the foraging rate integrated over all favorable prey sizes was highest when smaller organisms made up >95% of the prey biomass under the assumption of constant normalized size spectrum slopes. The overall effect of turbulence was consistently negative, because its detrimental influence on prey pursuit success exceeded its beneficial influence on prey encounter rate. Model sensitivity to endogenous traits and exogenous environmental factors was measured and is discussed in depth. Quirks is free software and open source code is provided.	[Huebert, Klaus B.; Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany	University of Hamburg	Huebert, KB (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany.	klaus.huebert@uni-hamburg.de	Huebert, Klaus B./G-2362-2011; Peck, Myron A/H-6164-2011	Huebert, Klaus B./0000-0002-2432-7337; Peck, Myron A/0000-0001-7423-1854	EU [FP7 244966, FP7 266445]	EU(European Commission)	This research was funded through the EU 7th Framework Programs FACTS (Forage Fish Interactions, FP7 244966) and VECTORS (VECTORS of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, FP7 266445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHUTH S, 1988, MEERESFORSCHUNG, V32, P23; [Anonymous], 2005, EGGS LARVAE N SEA FI; [Anonymous], 2013, MAPTOOLS TOOLS READI; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Arrhenius F, 1996, ICES J MAR SCI, V53, P792, DOI 10.1006/jmsc.1996.0100; Baumann H, 2009, J SEA RES, V61, P234, DOI 10.1016/j.seares.2009.01.004; BLAXTER J. H. S., 1965, CALIF COOP OCEANIC FBH INVEST REP, V10, P79; BOEHLERT GW, 1984, J EXP MAR BIOL ECOL, V79, P251, DOI 10.1016/0022-0981(84)90199-0; BRANDER KM, 1994, ICES J MAR SCI, V51, P71, DOI 10.1006/jmsc.1994.1007; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Broughton EA, 2010, NMFSNE217 NOAA; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley LJ, 2006, DEEP-SEA RES PT II, V53, P2758, DOI 10.1016/j.dsr2.2006.08.009; Burchard H, 2002, J SEA RES, V47, P223, DOI 10.1016/S1385-1101(02)00126-0; BUSKEY EJ, 1993, B MAR SCI, V53, P29; Caldarone EM, 2003, MAR ECOL PROG SER, V262, P229, DOI 10.3354/meps262229; Catalan IA, 2010, ESTUAR COAST SHELF S, V86, P299, DOI 10.1016/j.ecss.2009.11.033; CHECKLEY DM, 1984, MAR ECOL PROG SER, V18, P215, DOI 10.3354/meps018215; Chesney EJ, 2008, J EXP MAR BIOL ECOL, V362, P117, DOI 10.1016/j.jembe.2008.06.011; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Daewel U, 2011, CAN J FISH AQUAT SCI, V68, P426, DOI 10.1139/F10-164; Dulcic J, 1998, FISH RES, V36, P117, DOI 10.1016/S0165-7836(98)00108-8; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; ELDRIDGE MB, 1977, T AM FISH SOC, V106, P452, DOI 10.1577/1548-8659(1977)106<452:EOPHCH>2.0.CO;2; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Fiksen O, 1998, FISH OCEANOGR, V7, P355, DOI 10.1046/j.1365-2419.1998.00068.x; Finn RN, 1995, MAR BIOL, V124, P355, DOI 10.1007/BF00363909; Folkvord A, 2004, SARSIA, V89, P297, DOI 10.1080/00364820410002532; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; FRANSZ HG, 1991, NETH J SEA RES, V28, P1, DOI 10.1016/0077-7579(91)90003-J; Galbraith PS, 2004, MAR ECOL PROG SER, V281, P241, DOI 10.3354/meps281241; Garcia A, 1998, MAR ECOL PROG SER, V166, P237, DOI 10.3354/meps166237; Geffen AJ, 2002, J FISH BIOL, V60, P479, DOI [10.1111/j.1095-8649.2002.tb00295.x, 10.1006/jfbi.2001.1859]; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; GOVONI JJ, 1986, ENVIRON BIOL FISH, V16, P59, DOI 10.1007/BF00005160; HAY SJ, 1988, J PLANKTON RES, V10, P431, DOI 10.1093/plankt/10.3.431; HILL PS, 1992, J MAR RES, V50, P643, DOI 10.1357/002224092784797539; HOUDE ED, 1980, ENVIRON BIOL FISH, V5, P315, DOI 10.1007/BF00005186; HOUDE ED, 1983, MAR BIOL, V72, P283, DOI 10.1007/BF00396834; HOUDE ED, 1993, B MAR SCI, V53, P290; Houde ED, 1987, AM FISH SOC S, V2, P17; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; HUNTER JR, 1972, FISH BULL NATL OC AT, V70, P821; ICES, 2013, REP HERR ASS WORK GR; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Johannessen A, 2000, SARSIA, V85, P461, DOI 10.1080/00364827.2000.10414595; Kato Y, 2008, FISHERIES SCI, V74, P48, DOI 10.1111/j.1444-2906.2007.01495.x; Kerr S. R., 2001, COM ECO SYS; Kimura S, 2004, NIPPON SUISAN GAKK, V70, P175, DOI 10.2331/suisan.70.175; Kiorboe T, 1995, J PLANKTON RES, V17, P2319, DOI 10.1093/plankt/17.12.2319; KIORBOE T, 1986, ENVIRON BIOL FISH, V17, P133, DOI 10.1007/BF00001743; KIORBOE T, 1987, MAR ECOL PROG SER, V40, P1, DOI 10.3354/meps040001; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Kooijman B., 2009, DYNAMIC ENERGY BUDGE, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; Kuhn W, 2008, J MARINE SYST, V74, P329, DOI 10.1016/j.jmarsys.2008.02.002; Laurel BJ, 2008, J PLANKTON RES, V30, P1051, DOI 10.1093/plankt/fbn057; LAURENCE GC, 1978, MAR BIOL, V50, P1, DOI 10.1007/BF00390536; Laurence GC, 1985, NMFS NATIONAL OCEANI, P1; Letcher BH, 1996, CAN J FISH AQUAT SCI, V53, P787, DOI 10.1139/cjfas-53-4-787; Lough RG, 2005, FISH OCEANOGR, V14, P241, DOI 10.1111/j.1365-2419.2005.00330.x; MacKenzie BR, 1995, LIMNOL OCEANOGR, V40, P1278, DOI 10.4319/lo.1995.40.7.1278; MACKENZIE BR, 1994, LIMNOL OCEANOGR, V39, P1790, DOI 10.4319/lo.1994.39.8.1790; MacKenzie BR, 2000, LIMNOL OCEANOGR, V45, P1; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miller TJ, 2007, MAR ECOL PROG SER, V347, P127, DOI 10.3354/meps06973; MILLER TJ, 1988, CAN J FISH AQUAT SCI, V45, P1657, DOI 10.1139/f88-197; MUNK P, 1985, MAR ECOL PROG SER, V24, P15, DOI 10.3354/meps024015; MUNK P, 1993, MAR ECOL PROG SER, V99, P17, DOI 10.3354/meps099017; MUNK P, 1992, MAR ECOL PROG SER, V80, P149, DOI 10.3354/meps080149; MUNK P, 1995, MAR BIOL, V122, P205; Oshima M, 2009, J FISH BIOL, V75, P1639, DOI 10.1111/j.1095-8649.2009.02390.x; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; PALOMERA I, 1988, MAR BIOL, V99, P283, DOI 10.1007/BF00391991; Paulsen M, 2014, ICES J MAR SCI, V71, P991, DOI 10.1093/icesjms/fst168; Peck MA, 2007, MAR ECOL PROG SER, V347, P171, DOI 10.3354/meps06976; Peck MA, 2012, ADV ECOL RES, V47, P177, DOI 10.1016/B978-0-12-398315-2.00003-X; Peck MA, 2012, PROG OCEANOGR, V103, P42, DOI 10.1016/j.pocean.2012.04.013; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Peck MA, 2009, SCI MAR, V73, P23, DOI 10.3989/scimar.2009.73s1023; Peck WA, 2005, J FISH BIOL, V66, P882, DOI 10.1111/j.1095-8649.2005.00651.x; Pecseli HL, 2012, PROG OCEANOGR, V101, P14, DOI 10.1016/j.pocean.2011.12.001; Pedersen B.H., 1984, Dana, V3, P21; Pepin P, 2000, MAR ECOL PROG SER, V204, P199, DOI 10.3354/meps204199; PLATT T, 1977, HELGOLAND WISS MEER, V30, P575, DOI 10.1007/BF02207862; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Pope S., 2000, TURBULENT FLOWS, DOI [10.1017/cbo9780511840531.004, DOI 10.1017/CBO9780511840531]; Puvanendran V, 2002, AQUACULTURE, V214, P131, DOI 10.1016/S0044-8486(02)00045-5; R Core Team, 2021, R LANG ENV STAT COMP; Re P, 1987, INVEST PESQ, V51; Record NR, 2013, ECOL MODEL, V260, P11, DOI 10.1016/j.ecolmodel.2013.03.018; Regner S, 1996, SCI MAR, V60, P167; Regner S, 1985, ECOLOGY PLANKTONIC S; ROSENTHAL H, 1969, MAR BIOL, V3, P208, DOI 10.1007/BF00360953; Rosenthal H., 1970, MARINE FOOD CHAINS, P344; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; Ruzicka JJ, 2006, DEEP-SEA RES PT II, V53, P2708, DOI 10.1016/j.dsr2.2006.08.014; Ruzicka JJ, 2006, DEEP-SEA RES PT II, V53, P2735, DOI 10.1016/j.dsr2.2006.09.003; Sabates A, 2007, FISH OCEANOGR, V16, P130, DOI 10.1111/j.1365-2419.2006.00416.x; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; SREENIVASAN KR, 1995, PHYS FLUIDS, V7, P2778, DOI 10.1063/1.868656; Stephens D.W., 1986, pi; Takasuka A, 2003, MAR ECOL PROG SER, V252, P223, DOI 10.3354/meps252223; Takasuka A, 2007, MAR ECOL PROG SER, V350, P99, DOI 10.3354/meps07158; THEILACKER GH, 1987, FISH B-NOAA, V85, P213; Tilseth S., 1984, Flodevigen Rapportserie, V1, P167; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; Tudela S, 2002, J MAR BIOL ASSOC UK, V82, P349, DOI 10.1017/S0025315402005568; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; van der Veer HW, 2003, J SEA RES, V50, P255, DOI 10.1016/j.seares.2003.05.001; von Herbing IH, 2000, MAR BIOL, V136, P591, DOI 10.1007/s002270050719; Voss R, 2003, FISH RES, V63, P97, DOI 10.1016/S0165-7836(02)00282-5; Werner FE, 1996, DEEP-SEA RES PT II, V43, P1793, DOI 10.1016/S0967-0645(96)00042-2; Yeung PK, 1997, PHYS REV E, V56, P1746, DOI 10.1103/PhysRevE.56.1746; YIN MC, 1987, J EXP MAR BIOL ECOL, V107, P279, DOI 10.1016/0022-0981(87)90044-X	115	17	17	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98205	10.1371/journal.pone.0098205	http://dx.doi.org/10.1371/journal.pone.0098205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901937	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400018
J	Kading, RC; Biggerstaff, BJ; Young, G; Komar, N				Kading, Rebekah C.; Biggerstaff, Brad J.; Young, Ginger; Komar, Nicholas			Mosquitoes Used to Draw Blood for Arbovirus Viremia Determinations in Small Vertebrates	PLOS ONE			English	Article							WEST-NILE-VIRUS; EQUINE ENCEPHALITIS-VIRUS; HIGHLANDS J-VIRUS; EXPERIMENTAL-INFECTION; CHICKENS; STRAINS; BIRDS	Serial samples from the same individuals may be required for certain virological studies, however, some small animals cannot easily be blood-sampled. Therefore, we evaluated the use of Culex quinquefasciatus Say and Aedes albopictus Skuse mosquitoes as "biological syringes'' to draw blood for virus titer determinations in small vertebrates. Groups of chicks (Gallus gallus), hamsters (Mesocricetus auratus), and house sparrows (Passer domesticus) were experimentally infected with West Nile virus (WNV) or Highlands J virus (HJV). In general, good correlation was seen between mosquito-and syringe-derived blood samples at titers >= 5.0 log(10) pfu/mL serum as compared with titers < 5.0 log(10) pfu/mL serum for chicks, hamsters, and sparrows. Ninety-two percent (24/26) of sparrows with virus titers > 10(5) pfu/mL serum had mosquito-and syringe-derived titers within one log of each other. Sparrow viremia profiles generated from single mosquito blood meals and syringe were not significantly different (p > 0.05). This technique is valuable for assessing the roles of small vertebrates in the ecologies of arboviruses, and could be used in applications beyond virology and infectious diseases, when < 10 mu L of whole blood is required.	[Kading, Rebekah C.; Biggerstaff, Brad J.; Young, Ginger; Komar, Nicholas] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Kading, RC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	fxk7@cdc.gov	Kading, Rebekah C/E-5633-2017	Kading, Rebekah C/0000-0002-4996-915X; Young, Ginger/0000-0003-2403-8188	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	We would like to thank the late Dr. Andrew Spielman for inspiring this work. Animal care was provided by Verna O'Brien, Andrea Peterson, and Dr. Paul Spurlock. Insectary support was provided by Andrea Peterson and Erin Borland. Permission for sparrow capture was provided by Cozy Cow Dairy, Windsor, CO. This project was financially supported by the Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors only, and do not necessarily reflect the views of the United States Government.	Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Bolker B., 2012, BBMLE TOOLS GEN MAXI; CALISHER CH, 1988, AM J TROP MED HYG, V38, P447, DOI 10.4269/ajtmh.1988.38.447; Centers for Disease Control, 2004, MMWR-MORBID MORTAL W, V53, P1071; Centers for Disease Control, 1985, INT CAT ARB; Centers for Disease Control, 2006, MMWR-MORBID MORTAL W, V55, P1204; Centers for Disease Control, 2005, MMWR-MORBID MORTAL W, V54, P964; Clinis MJ, 1996, VIROLOGY, V218, P343; GUY JS, 1993, AVIAN DIS, V37, P389, DOI 10.2307/1591663; GUY JS, 1994, AVIAN DIS, V38, P572, DOI 10.2307/1592081; Klenk K, 2003, AM J TROP MED HYG, V69, P260, DOI 10.4269/ajtmh.2003.69.260; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422; Mahmood F, 2004, J MED ENTOMOL, V41, P965, DOI 10.1603/0022-2585-41.5.965; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; MORTON DB, 1993, LAB ANIM, V27, P1, DOI 10.1258/002367793780745633; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Ogunrinade A, 1980, Afr J Med Med Sci, V9, P69; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pyle P., 1997, IDENTIFICATION GUI 1; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Sbrana E, 2005, AM J TROP MED HYG, V72, P325, DOI 10.4269/ajtmh.2005.72.325; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; YUILL TM, 1969, T ROY SOC TROP MED H, V63, P407, DOI 10.1016/0035-9203(69)90019-4	29	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99342	10.1371/journal.pone.0099342	http://dx.doi.org/10.1371/journal.pone.0099342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901448	Green Published, gold			2022-12-25	WOS:000336841400120
J	Kleppa, MJ; Erlenwein, SV; Darashchonak, N; von Kaisenberg, CS; von Versen-Hoynck, F				Kleppa, Marc-Jens; Erlenwein, Sarah-Vanessa; Darashchonak, Natallia; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke			Hypoxia and the Anticoagulants Dalteparin and Acetylsalicylic Acid Affect Human Placental Amino Acid Transport	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; SPIRAL ARTERIES; TROPHOBLAST; SYSTEM; HEPARIN; OXYGEN; PREECLAMPSIA; PREGNANCIES; EXPRESSION; PREVENTION	Background: Anticoagulants, e. g. low-molecular weight heparins (LMWHs) and acetylsalicylic acid (ASA) are prescribed to women at risk for pregnancy complications that are associated with impaired placentation and placental hypoxia. Beyond their role as anticoagulants these compounds exhibit direct effects on trophoblast but their impact on placental function is unknown. The amino acid transport systems A and L, which preferably transfer essential amino acids, are well-described models to study placental nutrient transport. We aimed to examine the effect of hypoxia, LMWHs and ASA on the activity of the placental amino acid transport systems A and L and associated signalling mechanisms. Methods: The uptake of C-14-MeAIB (system A) or H-3-leucin (system L) was investigated after incubation of primary villous fragments isolated from term placentas. Villous tissue was incubated at 2% O-2 (hypoxia), 8% O-2 and standard culture conditions (21% O-2) or at 2% O-2 and 21% O-2 with dalteparin or ASA. Activation of the JAK/STAT or mTOR signalling pathways was determined by Western analysis of total and phosphorylated STAT3 or Raptor. Results: Hypoxia decreased system A mediated MeAIB uptake and increased system L mediated leucine uptake compared to standard culture conditions (21% O-2). This was accompanied by an impairment of STAT3 and a stimulation of Raptor signalling. System L activity increased at 8% O-2. Dalteparin treatment reduced system A and system L activity under normoxic conditions and ASA (1 mM) decreased system A and L transporter activity under normoxic and hypoxic conditions. Conclusions: Our data underline the dependency of placental function on oxygen supply. LMWHs and ASA are not able to reverse the effects of hypoxia on placental amino acid transport. These findings and the uncovering of the signalling mechanisms in more detail will help to understand the impact of LMWHs and ASA on placental function and fetal growth.	[Kleppa, Marc-Jens; Erlenwein, Sarah-Vanessa; Darashchonak, Natallia; von Kaisenberg, Constantin S.; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany	Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany.	vonversen-hoeynck.frauke@mh-hannover.de	von Versen-Höynck, Frauke/H-3719-2019; von Kaisenberg, Constantin/AAR-2756-2021	von Versen-Höynck, Frauke/0000-0002-1924-5695; 				Acevedo CG, 1999, EXP PHYSIOL, V84, P1127, DOI 10.1111/j.1469-445X.1999.01875.x; Audette MC, 2010, PLACENTA, V31, P97, DOI 10.1016/j.placenta.2009.11.016; Barbour LA, 1995, AM J OBSTET GYNECOL, V173, P1869, DOI 10.1016/0002-9378(95)90443-3; Bellik L, 2005, BRIT J PHARMACOL, V146, P568, DOI 10.1038/sj.bjp.0706347; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Burton GJ, 2006, METH MOLEC MED, V122, P413; CETIN I, 1988, AM J OBSTET GYNECOL, V158, P120, DOI 10.1016/0002-9378(88)90792-2; CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A; DEKKER GA, 1993, AM J OBSTET GYNECOL, V168, P214, DOI 10.1016/S0002-9378(12)90917-5; Di Nisio M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004734.pub2; Dodd JM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006780.pub2; Drewlo S, 2011, J THROMB HAEMOST, V9, P2486, DOI 10.1111/j.1538-7836.2011.04526.x; Evans RW, 2003, REPRODUCTION, V125, P785, DOI 10.1530/rep.0.1250785; Ganapathy R, 2007, HUM REPROD, V22, P2523, DOI 10.1093/humrep/dem201; Gris JC, 2010, THROMB HAEMOSTASIS, V104, P771, DOI 10.1160/TH10-03-0167; Hills FA, 2006, MOL HUM REPROD, V12, P237, DOI 10.1093/molehr/gal026; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Jansson N, 2003, J CLIN ENDOCR METAB, V88, P1205, DOI 10.1210/jc.2002-021332; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; JOHNSON LW, 1988, AM J PHYSIOL, V254, pC773, DOI 10.1152/ajpcell.1988.254.6.C773; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; Kaushal N, 2006, TOXICOL MECH METHOD, V16, P379, DOI 10.1080/15376520600640040; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Nelson DM, 2003, AM J PHYSIOL-CELL PH, V284, pC310, DOI 10.1152/ajpcell.00253.2002; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Quenby S, 2004, OBSTET GYNECOL, V104, P354, DOI 10.1097/01.AOG.0000128902.84876.d4; Regnault TRH, 2002, ENDOCRINE, V19, P23, DOI 10.1385/ENDO:19:1:23; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Roberge S, 2013, AM J PERINAT; Roos S, 2004, AM J PHYSIOL-REG I, V287, pR886, DOI 10.1152/ajpregu.00232.2004; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Searle J, 2011, ARTERIOSCL THROM VAS, V31, P2972, DOI 10.1161/ATVBAHA.111.237784; SHEPPARD BL, 1981, BRIT J OBSTET GYNAEC, V88, P695, DOI 10.1111/j.1471-0528.1981.tb01268.x; Shibata E, 2008, PLACENTA, V29, P879, DOI 10.1016/j.placenta.2008.07.001; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; von Versen-Hoynck F, 2009, PLACENTA, V30, P361, DOI 10.1016/j.placenta.2009.01.004	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99217	10.1371/journal.pone.0099217	http://dx.doi.org/10.1371/journal.pone.0099217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901243	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400111
J	Lugo, MR; Sharom, FJ				Lugo, Miguel Ramon; Sharom, Frances Jane			Kinetic Validation of the Models for P-Glycoprotein ATP Hydrolysis and Vanadate-Induced Trapping. Proposal for Additional Steps	PLOS ONE			English	Article							HAMSTER OVARY CELLS; OCCLUDED NUCLEOTIDE CONFORMATION; MULTIDRUG TRANSPORTER; CATALYTIC CYCLE; DRUG TRANSPORT; BINDING DOMAINS; RESISTANCE; SITES; STATE; RECONSTITUTION	P-Glycoprotein, a member of the ATP-binding cassette (ABC) superfamily, is a multidrug transporter responsible for cellular efflux of hundreds of structurally unrelated compounds, including natural products, many clinically used drugs and anticancer agents. Expression of P-glycoprotein has been linked to multidrug resistance in human cancers. ABC transporters are driven by ATP hydrolysis at their two cytoplasmic nucleotide-binding domains, which interact to form a closed ATP-bound sandwich dimer. Intimate knowledge of the catalytic cycle of these proteins is clearly essential for understanding their mechanism of action. P-Glycoprotein has been proposed to hydrolyse ATP by an alternating mechanism, for which there is substantial experimental evidence, including inhibition of catalytic activity by trapping of ortho-vanadate at one nucleotide-binding domain, and the observation of an asymmetric occluded state. Despite many studies of P-glycoprotein ATPase activity over the past 20 years, no comprehensive kinetic analysis has yet been carried out, and some puzzling features of its behaviour remain unexplained. In this work, we have built several progressively more complex kinetic models, and then carried out simulations and detailed analysis, to test the validity of the proposed reaction pathway employed by P-glycoprotein for ATP hydrolysis. To establish kinetic parameters for the catalytic cycle, we made use of the large amount of published data on ATP hydrolysis by hamster P-glycoprotein, both purified and in membrane vesicles. The proposed kinetic scheme(s) include a high affinity priming reaction for binding of the first ATP molecule, and an independent pathway for ADP binding outside the main catalytic cycle. They can reproduce to varying degrees the observed behavior of the protein's ATPase activity and its inhibition by ortho-vanadate. The results provide new insights into the mode of action of P-glycoprotein, and some hypotheses about the nature of the occluded nucleotide-bound state.	[Lugo, Miguel Ramon; Sharom, Frances Jane] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Canadian Cancer Society [700248]; Cystic Fibrosis Canada	Canadian Cancer Society(Canadian Cancer Society (CCS)); Cystic Fibrosis Canada	This research was funded by an operating grant from the Canadian Cancer Society to FJS (grant # 700248). MRL currently holds a Kin Canada Fellowship from Cystic Fibrosis Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Buxbaum E, 1999, EUR J BIOCHEM, V265, P54, DOI 10.1046/j.1432-1327.1999.00643.x; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; HAMADA H, 1988, CANCER RES, V48, P4926; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2011, BIOPHYS J, V100, P549; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Scian M, 2014, BIOCHEMISTRY-US, V53, P991, DOI 10.1021/bi401280v; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Sharom FJ, 2005, J BIOENERG BIOMEMBR, V37, P481, DOI 10.1007/s10863-005-9496-6; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Tamaki A, 2011, ESSAYS BIOCHEM, V50, P209, DOI [10.1042/BSE0500209, 10.1042/bse0500209]; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98804	10.1371/journal.pone.0098804	http://dx.doi.org/10.1371/journal.pone.0098804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897122	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700081
J	Sharma, S; Markham, PF; Browning, GF				Sharma, Shukriti; Markham, Philip F.; Browning, Glenn F.			Genes Found Essential in Other Mycoplasmas Are Dispensable in Mycoplasma bovis	PLOS ONE			English	Article							SUBSP MYCOIDES SC; TRANSPOSON MUTAGENESIS; VIRULENCE FACTOR; SURFACE LIPOPROTEIN; MOLECULAR-BIOLOGY; GALLISEPTICUM; AGALACTIAE; IDENTIFICATION; PATHOGENICITY; CONSTRUCTION	Mycoplasmas are regarded to be useful models for studying the minimum genetic complement required for independent survival of an organism. Mycoplasma bovis is a globally distributed pathogen causing pneumonia, mastitis, arthritis, otitis media and reproductive tract disease, and genome sequences of three strains, the type strain PG45 and two strains isolated in China, have been published. In this study, several Tn4001 based transposon constructs were generated and used to create a M. bovis PG45 insertional mutant library. Direct genome sequencing of 319 independent insertions detected disruptions in 129 genes in M. bovis, 48 of which had homologues in Mycoplasma mycoides subspecies mycoides SC and 99 of which had homologues in Mycoplasma agalactiae. Sixteen genes found to be essential in previous studies on other mycoplasma species were found to be dispensable. Five of these genes have previously been predicted to be part of the core set of 153 essential genes in mycoplasmas. Thus this study has extended the list of non-essential genes of mycoplasmas from that previously generated by studies in other species.	[Sharma, Shukriti; Markham, Philip F.; Browning, Glenn F.] Univ Melbourne, Sch Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia	University of Melbourne	Browning, GF (corresponding author), Univ Melbourne, Sch Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	glenfb@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469	Australian Government	Australian Government(Australian GovernmentCGIAR)	These studies were partially supported by financial support from the Australian Government under the AusAID program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; BEHRENS A, 1994, INFECT IMMUN, V62, P5075, DOI 10.1128/IAI.62.11.5075-5084.1994; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chiu CJ, 2006, PROTECTIVE IMMUNE RE; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dybvig K, 1996, ANNU REV MICROBIOL, V50, P25, DOI 10.1146/annurev.micro.50.1.25; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Halbedel S, 2007, INT J MED MICROBIOL, V297, P37, DOI 10.1016/j.ijmm.2006.11.001; Hallamaa KM, 2006, J BACTERIOL, V188, P5393, DOI 10.1128/JB.01819-05; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Janis C, 2008, MICROBIOL-SGM, V154, P2427, DOI 10.1099/mic.0.2008/017640-0; Khan LA, 2005, VET RES COMMUN, V29, P181, DOI 10.1023/B:VERC.0000047506.04096.06; KNUDTSON KL, 1993, GENE, V137, P217, DOI 10.1016/0378-1119(93)90009-R; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lartigue C, 2002, PLASMID, V48, P149, DOI 10.1016/S0147-619X(02)00121-X; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020999; Lin Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00053; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Lysnyansky I, 1999, J BACTERIOL, V181, P5734, DOI 10.1128/JB.181.18.5734-5741.1999; Markham PF, 2003, J BACTERIOL, V185, P2538, DOI 10.1128/JB.185.8.2538-2547.2003; Masukagami Y, 2013, INFECT IMMUN, V81, P3220, DOI 10.1128/IAI.00365-13; McNamara Peter J., 2008, P89; Minion FC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1410, DOI 10.2741/minion; Muneta Y, 2008, VACCINE, V26, P5449, DOI 10.1016/j.vaccine.2008.07.076; Panicker IS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-138; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Pour-El I, 2002, PLASMID, V47, P129, DOI 10.1006/plas.2001.1558; Qi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038239; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Schmidt JA, 2004, J BACTERIOL, V186, P5790, DOI 10.1128/JB.186.17.5790-5798.2004; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Shil PK, 2011, VACCINE, V29, P3197, DOI 10.1016/j.vaccine.2011.02.035; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Skapski A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025291; Szczepanek SM, 2010, INFECT IMMUN, V78, P3475, DOI 10.1128/IAI.00154-10; Thomas A, 2005, FEMS MICROBIOL LETT, V245, P249, DOI 10.1016/j.femsle.2005.03.013; Tseng CW, 2007, IMPROVING MYCOPLASMA; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Whetzel PL, 2003, PLASMID, V49, P34, DOI 10.1016/S0147-619X(02)00114-2; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024	54	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97100	10.1371/journal.pone.0097100	http://dx.doi.org/10.1371/journal.pone.0097100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897538	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700007
J	Leung, JM; Tran, F; Pathak, RB; Poupart, S; Heaslip, AT; Ballif, BA; Westwood, NJ; Ward, GE				Leung, Jacqueline M.; Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Heaslip, Aoife T.; Ballif, Bryan A.; Westwood, Nicholas J.; Ward, Gary E.			Identification of T. gondii Myosin Light Chain-1 as a Direct Target of TachypleginA-2, a Small-Molecule Inhibitor of Parasite Motility and Invasion	PLOS ONE			English	Article							TOXOPLASMA-GONDII; MEMBRANE; GENE; SECRETION; COMPLEX; THIOLS; CELLS; ACIDS	Motility of the protozoan parasite Toxoplasma gondii plays an important role in the parasite's life cycle and virulence within animal and human hosts. Motility is driven by a myosin motor complex that is highly conserved across the Phylum Apicomplexa. Two key components of this complex are the class XIV unconventional myosin, TgMyoA, and its associated light chain, TgMLC1. We previously showed that treatment of parasites with a small-molecule inhibitor of T. gondii invasion and motility, tachypleginA, induces an electrophoretic mobility shift of TgMLC1 that is associated with decreased myosin motor activity. However, the direct target(s) of tachypleginA and the molecular basis of the compound-induced TgMLC1 modification were unknown. We show here by "click" chemistry labelling that TgMLC1 is a direct and covalent target of an alkyne-derivatized analogue of tachypleginA. We also show that this analogue can covalently bind to model thiol substrates. The electrophoretic mobility shift induced by another structural analogue, tachypleginA-2, was associated with the formation of a 225.118 Da adduct on S57 and/or C58, and treatment with deuterated tachypleginA-2 confirmed that the adduct was derived from the compound itself. Recombinant TgMLC1 containing a C58S mutation (but not S57A) was refractory to click labelling and no longer exhibited a mobility shift in response to compound treatment, identifying C58 as the site of compound binding on TgMLC1. Finally, a knock-in parasite line expressing the C58S mutation showed decreased sensitivity to compound treatment in a quantitative 3D motility assay. These data strongly support a model in which tachypleginA and its analogues inhibit the motility of T. gondii by binding directly and covalently to C58 of TgMLC1, thereby causing a decrease in the activity of the parasite's myosin motor.	[Leung, Jacqueline M.; Heaslip, Aoife T.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Leung, Jacqueline M.] Univ Vermont, Program Cellular & Mol Biomed Sci, Burlington, VT USA; [Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Pathak, Ravindra B.; Poupart, Severine; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT USA	University of Vermont; University of Vermont; University of St Andrews; University of St Andrews; University of Vermont	Westwood, NJ (corresponding author), Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland.	njw3@st-andrews.ac.uk; gary.ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Heaslip, Aoife/0000-0002-7838-3617; Westwood, Nicholas/0000-0003-0630-0138	US Public Health Service [AI054961]; University Research Fellowship from the Royal Society; Vermont Genetics Network/NIH from the INBRE program of the NIGMS [8P20GM103449]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496, P20GM103449] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University Research Fellowship from the Royal Society(Royal Society of London); Vermont Genetics Network/NIH from the INBRE program of the NIGMS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Public Health Service grant AI054961 (GEW/NJW), a University Research Fellowship from the Royal Society (NJW) and funding for the mass spectrometry analysis was provided by the Vermont Genetics Network/NIH Grant 8P20GM103449 from the INBRE program of the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Ballif BA, 2013, EMBO MOL MED, V5, P751, DOI 10.1002/emmm.201302466; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Catti F, 2008, TETRAHEDRON, V64, P9561, DOI 10.1016/j.tet.2008.07.063; Claisen L., 1881, BER DTSCH CHEM GES, V14, P2460, DOI [10.1002/cber, DOI 10.1002/CBER.18810140182, 10.1002/cber.188101402192, DOI 10.1002/CBER.188101402192]; Dimmock JR, 2001, J MED CHEM, V44, P586, DOI 10.1021/jm0002580; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hall CI, 2011, P NATL ACAD SCI USA, V108, P10568, DOI 10.1073/pnas.1105622108; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000720; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kortagere S, 2011, J COMPUT AID MOL DES, V25, P403, DOI 10.1007/s10822-011-9420-6; Leung JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085763; LOWEY S, 1995, BIOPHYS J, V68, pS120; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; MUTUS B, 1989, ANAL BIOCHEM, V177, P237, DOI 10.1016/0003-2697(89)90045-6; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pati HN, 2007, MINI-REV MED CHEM, V7, P131, DOI 10.2174/138955707779802642; Pati HN, 2009, EUR J MED CHEM, V44, P54, DOI 10.1016/j.ejmech.2008.03.015; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Polonais V, 2011, TRAFFIC, V12, P287, DOI 10.1111/j.1600-0854.2010.01148.x; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; Ravindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008143; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Salina G, 1964, CHEM IND, V1964, P2053; Salvatore RN, 2005, TETRAHEDRON LETT, V46, P8931, DOI 10.1016/j.tetlet.2005.10.062; Schmidt J.G., 1881, BER DTSCH CHEM GES, V14, P1459, DOI DOI 10.1002/CBER.188101401306; Sensfuss U, 2003, TETRAHEDRON LETT, V44, P2371, DOI 10.1016/S0040-4039(03)00247-8; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sun AM, 2009, BIOORG MED CHEM LETT, V19, P6627, DOI 10.1016/j.bmcl.2009.10.023; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; TRYBUS KM, 1994, J MUSCLE RES CELL M, V15, P587, DOI 10.1007/BF00121066; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105	51	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98056	10.1371/journal.pone.0098056	http://dx.doi.org/10.1371/journal.pone.0098056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892871	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400031
J	Robichaud, N; del Rincon, SV; Huor, B; Alain, T; Petruccelli, LA; Hearnden, J; Goncalves, C; Grotegut, S; Spruck, CH; Furic, L; Larsson, O; Muller, WJ; Miller, WH; Sonenberg, N				Robichaud, N.; del Rincon, S. V.; Huor, B.; Alain, T.; Petruccelli, L. A.; Hearnden, J.; Goncalves, C.; Grotegut, S.; Spruck, C. H.; Furic, L.; Larsson, O.; Muller, W. J.; Miller, W. H.; Sonenberg, N.			Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3	ONCOGENE			English	Article							INITIATION-FACTOR 4E; ACTIVATED PROTEIN-KINASE; HUMAN BREAST-CANCER; MESSENGER-RNA; STAGE-I; DIFFERENTIAL TRANSLATION; SIGNALING PATHWAY; PROSPECTIVE TRIAL; FACTOR EIF-4E; EXPRESSION	The progression of cancers from primary tumors to invasive and metastatic stages accounts for the overwhelming majority of cancer deaths. Understanding the molecular events which promote metastasis is thus critical in the clinic. Translational control is emerging as an important factor in tumorigenesis. The messenger RNA (mRNA) cap-binding protein eIF4E is an oncoprotein that has an important role in cancer initiation and progression. eIF4E must be phosphorylated to promote tumor development. However, the role of eIF4E phosphorylation in metastasis is not known. Here, we show that mice in which eukaryotic translation initiation factor 4E (eIF4E) cannot be phosphorylated are resistant to lung metastases in a mammary tumor model, and that cells isolated from these mice exhibit impaired invasion. We also demonstrate that transforming growth factor-beta (TGF beta) induces eIF4E phosphorylation to promote the translation of Snail and Mmp-3 mRNAs, and the induction of epithelial-to-mesenchymal transition (EMT). Furthermore, we describe a new model wherein EMT induced by TGF beta requires translational activation via the non-canonical TGF beta signaling branch acting through eIF4E phosphorylation.	[Robichaud, N.; Hearnden, J.; Muller, W. J.; Sonenberg, N.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Robichaud, N.; Hearnden, J.; Muller, W. J.; Sonenberg, N.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [del Rincon, S. V.; Huor, B.; Petruccelli, L. A.; Goncalves, C.; Miller, W. H.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst Med Res, Montreal, PQ H3A 1A3, Canada; [Alain, T.] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Grotegut, S.; Spruck, C. H.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA; [Furic, L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Larsson, O.] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	McGill University; McGill University; Lady Davis Institute; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; Sanford Burnham Prebys Medical Discovery Institute; Monash University; Karolinska Institutet	Miller, WH (corresponding author), McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Canc Pavil,1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	wmiller@ldi.jgh.mcgill.ca; nahum.sonenberg@mcgill.ca	Furic, Luc/F-4886-2012	Furic, Luc/0000-0002-1893-9812; Larsson, Ola/0000-0003-1412-1308; Robichaud, Nathaniel/0000-0002-7653-0767	Susan G. Komen Breast Cancer Foundation [IIR12224057]; Canadian Cancer Society [2010-700377]; Cancer Research Society [2012-17280]; PCFA [YI-0310]; Fonds de la Recherche en Sante du Quebec [20874]; Canadian Institutes of Health Research [220151]; Vanier Canada Graduate Scholarship [267839]; Swedish Research Council; Swedish Cancer Society; Wallenberg Academy	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Canadian Cancer Society(Canadian Cancer Society (CCS)); Cancer Research Society; PCFA; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wallenberg Academy	This work was by supported by The Susan G. Komen Breast Cancer Foundation (IIR12224057), and the Canadian Cancer Society (2010-700377) to NS. WHM was supported by the Cancer Research Society (2012-17280). LF was supported by PCFA#YI-0310. NS is a Howard Hughes Medical Institute Senior International Scholar. WHM is a Chercheur National of Fonds de la Recherche en Sante du Quebec (FRSQ). NR was supported by scholarships from the Fonds de la Recherche en Sante du Quebec (20874), the Canadian Institutes of Health Research (220151) and the Vanier Canada Graduate Scholarship (267839). OL is supported by the Swedish Research Council, the Swedish Cancer Society and the Wallenberg Academy Fellows Program. We thank I Topisirovic for advice; C Zakaria, A Sylvestre, S Perreault and C Lister for technical assistance, N Siddiqui for critical reading of the manuscript and S Ramon y Cajal (the Vall d'Hebron University Hospital, Barcelona, Spain) for his support and insights into tumor heterogeneity. We thank the Animal Facility and the Histology Facility at the Goodman Cancer Research Centre for mouse work and tissue processing.	Adesso L, 2013, ONCOGENE, V32, P2848, DOI 10.1038/onc.2012.306; Alain T, 2012, CANCER RES, V72, P6468, DOI 10.1158/0008-5472.CAN-12-2395; ALBINI A, 1987, CANCER RES, V47, P3239; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bakin AV, 2002, J CELL SCI, V115, P3193; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; BYERS HR, 1991, AM J PATHOL, V139, P423; Byrnes K, 2006, ANN SURG, V243, P684, DOI 10.1097/01.sla.0000216770.23642.d8; C.S.H. Laboratory, 2006, COLD SPRING HARBOR P, V2006; Chen CN, 2004, J SURG ONCOL, V86, P22, DOI 10.1002/jso.20037; Crew JP, 2000, BRIT J CANCER, V82, P161; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Heppner KJ, 1996, AM J PATHOL, V149, P273; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; Holm N, 2008, ANN SURG ONCOL, V15, P3207, DOI 10.1245/s10434-008-0086-9; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jia Y, 2012, MED RES REV, V32, P786, DOI 10.1002/med.21260; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee T, 2012, FUTURE MED CHEM, V4, P19, DOI [10.4155/FMC.11.150, 10.4155/fmc.11.150]; Li BDL, 2002, ANN SURG, V235, P732, DOI 10.1097/00000658-200205000-00016; Li BDL, 1998, ANN SURG, V227, P756, DOI 10.1097/00000658-199805000-00016; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Ling C, 2012, CANCER DISCOV, V2, P68, DOI 10.1158/2159-8290.CD-11-0189; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Malina A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012377; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; McClusky DR, 2005, ANN SURG, V242, P584, DOI 10.1097/01.sla.0000184224.55949.90; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; Nathan CA, 1997, ONCOGENE, V15, P1087, DOI 10.1038/sj.onc.1201272; Nathan CAO, 1999, J CLIN ONCOL, V17, P2909, DOI 10.1200/JCO.1999.17.9.2909; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pettersson F, 2011, CLIN CANCER RES, V17, P2874, DOI 10.1158/1078-0432.CCR-10-2334; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramon y Cajal, CLIN TRANSL IN PRESS; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Salehi Z, 2006, CLIN BIOCHEM, V39, P404, DOI 10.1016/j.clinbiochem.2005.11.007; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Scott PAE, 1998, BRIT J CANCER, V77, P2120, DOI 10.1038/bjc.1998.356; Seki N, 2002, CLIN CANCER RES, V8, P3046; Seki N, 2010, LUNG CANCER, V70, P329, DOI 10.1016/j.lungcan.2010.03.006; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Wang XL, 2012, WORLD J GASTROENTERO, V18, P2540, DOI 10.3748/wjg.v18.i20.2540; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wu MY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0400-z; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yin B, 2006, LEUKEMIA, V20, P151, DOI 10.1038/sj.leu.2404033; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220	82	172	175	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2032	2042		10.1038/onc.2014.146	http://dx.doi.org/10.1038/onc.2014.146			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909168	Green Accepted			2022-12-25	WOS:000353173400003
J	Cheng, F; Cappai, R; Lidfeldt, J; Belting, M; Fransson, LA; Mani, K				Cheng, Fang; Cappai, Roberto; Lidfeldt, Jon; Belting, Mattias; Fransson, Lars-Ake; Mani, Katrin			Amyloid Precursor Protein (APP)/APP-like Protein 2 (APLP2) Expression Is Required to Initiate Endosome-Nucleus-Autophagosome Trafficking of Glypican-1-derived Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; A-BETA; NEURODEGENERATIVE DISEASE; DEPENDENT AUTOCLEAVAGE; DEGRADATION-PRODUCTS; DEAMINATIVE CLEAVAGE; APP; LOCALIZATION	Anhydromannose (anMan)-containing heparan sulfate (HS) derived from the proteoglycan glypican-1 is generated in endosomes by an endogenously or ascorbate-induced S-nitrosothiol-catalyzed reaction. Processing of the amyloid precursor protein (APP) and APP-like protein 2 (APLP2) by beta- and gamma-secretases into amyloid beta (A beta) and A beta-like peptides also takes place in these compartments. Moreover, anMan-containing HS suppresses the formation of toxic A beta assemblies in vitro. We showed by using deconvolution immunofluorescence microscopy with an anMan-specific monoclonal antibody as well as S-35 labeling experiments that expression of APP/APLP2 is required for ascorbate-induced transport of HS from endosomes to the nucleus. Nuclear translocation was observed in wild-type mouse embryonic fibroblasts (WT MEFs), Tg2576 MEFs, and N2a neuroblastoma cells but not in APP(-/-) and APLP2(-/-) MEFs. Transfection of APP(-/-) cells with a vector encoding APP restored nuclear import of anMan-containing HS. In WT MEFs and N2a neuroblastoma cells exposed to beta- or gamma-secretase inhibitors, nuclear translocation was greatly impeded, suggesting involvement of APP/APLP2 degradation products. In Tg2576 MEFs, the beta-inhibitor blocked transport, but the gamma-inhibitor did not. During chase in ascorbate-free medium, anMan-containing HS disappeared from the nuclei of WT MEFs. Confocal immunofluorescence microscopy showed that they appeared in acidic, LC3-positive vesicles in keeping with an autophagosomal location. There was increased accumulation of anMan-containing HS in nuclei and cytosolic vesicles upon treatment with chloroquine, indicating that HS was degraded in lysosomes. Manipulations of APP expression and processing may have deleterious effects upon HS function in the nucleus.	[Cheng, Fang; Fransson, Lars-Ake; Mani, Katrin] Lund Univ, Div Neurosci, Dept Expt Med Sci, Glycobiol Grp,Biomed Ctr A13, SE-22184 Lund, Sweden; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lidfeldt, Jon; Belting, Mattias] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, SE-22185 Lund, Sweden; [Belting, Mattias] Skane Oncol Clin, SE-22185 Lund, Sweden	Lund University; University of Melbourne; Lund University	Mani, K (corresponding author), Lund Univ, Div Neurosci, Dept Expt Med Sci, Glycobiol Grp,Biomed Ctr A13, SE-22184 Lund, Sweden.	katrin.mani@med.lu.se	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Lidfeldt, Jon/0000-0002-8440-6512; Belting, Mattias/0000-0003-1585-5434; Mani, Katrin/0000-0002-1821-0634	Swedish Research Council; Alfred Osterlund Foundation; Olle Engkvist Foundation; Kock Foundation; National Health and Medical Research Council of Australia; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Alfred Osterlund Foundation; Olle Engkvist Foundation; Kock Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by grants from the Swedish Research Council; Alfred Osterlund, Kock, and Olle Engkvist Foundations (to F. C., L.-A. F., and K. M.); National Health and Medical Research Council of Australia (to R. C.); and Swedish Cancer Society (to M. B.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; BHAVANANDAN VP, 1975, P NATL ACAD SCI USA, V72, P2032, DOI 10.1073/pnas.72.6.2032; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Cheng F, 2013, GLYCOBIOLOGY, V23, P1510, DOI 10.1093/glycob/cwt079; Cheng F, 2012, GLYCOBIOLOGY, V22, P1480, DOI 10.1093/glycob/cws111; Cheng F, 2011, J BIOL CHEM, V286, P27559, DOI 10.1074/jbc.M111.243345; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P46779, DOI 10.1074/jbc.M105419200; Dudas J., BIOCH J, V350, P245; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; Gouras GK, 2012, LIFE SCI, V91, P1153, DOI 10.1016/j.lfs.2012.06.004; HISCOCK DRR, 1994, J BIOL CHEM, V269, P4539; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 2003, J BIOL CHEM, V278, P38956, DOI 10.1074/jbc.M300394200; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Mani K, 2006, GLYCOBIOLOGY, V16, P1251, DOI 10.1093/glycob/cwl045; Mani K, 2006, GLYCOBIOLOGY, V16, P711, DOI 10.1093/glycob/cwj121; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Regberg Jakob, 2013, Front Biosci (Elite Ed), V5, P509; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Shariati SAM, 2013, FEBS LETT, V587, P2036, DOI 10.1016/j.febslet.2013.05.026; Stewart MD, 2014, MATRIX BIOL, V35, P56, DOI 10.1016/j.matbio.2013.10.009; Svensson G, 2009, GLYCOCONJUGATE J, V26, P1247, DOI 10.1007/s10719-009-9243-z; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215	36	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20871	20878		10.1074/jbc.M114.552810	http://dx.doi.org/10.1074/jbc.M114.552810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898256	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000339396600041
J	He, WX; Hu, JX; Xia, YX; Yan, RQ				He, Wanxia; Hu, Jinxuan; Xia, Yuxing; Yan, Riqiang			beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) Regulates Notch Signaling by Controlling the Cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; SECRETASE BACE1; ALAGILLE-SYNDROME; INTRACELLULAR DOMAIN; ALPHA-SECRETASE; LIGAND JAGGED1; MICE; MYELINATION; GENERATION; RELEASE	BACE1 is a type I transmembrane aspartyl protease that cleaves amyloid precursor protein at the beta-secretase site to initiate the release of beta-amyloid peptide. As a secretase, BACE1 also cleaves additional membrane-bound molecules by exerting various cellular functions. In this study, we showed that BACE1 can effectively shed the membrane-anchored signaling molecule Jagged 1 (Jag1). We also mapped the cleavage sites of Jag1 by ADAM10 and ADAM17. Although Jag1 shares a high degree of homology with Jag2 in the ectodomain region, BACE1 fails to cleave Jag2 effectively, indicating a selective cleavage of Jag1. Abolished cleavage of Jag1 in BACE1-null mice leads to enhanced astrogenesis and, concomitantly, reduced neurogenesis. This characterization provides biochemical evidence that the Jag1-Notch pathway is under the control of BACE1 activity.	[He, Wanxia; Hu, Jinxuan; Xia, Yuxing; Yan, Riqiang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Yan, RQ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617; Xia, Yuxing/0000-0002-8415-8256	National Institutes of Health [AG025493, AG046929, NS074256]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025493, R01AG046929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by National Institutes of Health Grants AG025493, AG046929, and NS074256. To whom correspondence should be addressed: Dept. of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-2690; Fax: 216-444-7927; E-mail: yanr@ccf.org.	Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Parr-Sturgess CA, 2010, BIOCHEM J, V432, P283, DOI 10.1042/BJ20100321; Ponio JBD, 2007, HUM MOL GENET, V16, P2683, DOI 10.1093/hmg/ddm222; Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Turner RT, 2002, BIOCHEMISTRY-US, V41, P8742, DOI 10.1021/bi025926t; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yuan ZR, 1998, HUM MOL GENET, V7, P1363, DOI 10.1093/hmg/7.9.1363	44	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20630	20637		10.1074/jbc.M114.579862	http://dx.doi.org/10.1074/jbc.M114.579862			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907271	Green Published, hybrid			2022-12-25	WOS:000339396600022
J	Mori, Y; Fukuda, M; Henley, JM				Mori, Yasunori; Fukuda, Mitsunori; Henley, Jeremy M.			Small GTPase Rab17 Regulates the Surface Expression of Kainate Receptors but Not alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors in Hippocampal Neurons via Dendritic Trafficking of Syntaxin-4 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECYCLING ENDOSOMES; SYNAPTIC PLASTICITY; EPITHELIAL-CELLS; LOCALIZATION; MORPHOGENESIS; SPINES; LTP	Glutamate receptors are fundamental for control synaptic transmission, synaptic plasticity, and neuronal excitability. However, many of the molecular mechanisms underlying their trafficking remain elusive. We previously demonstrated that the small GTPase Rab17 regulates dendritic trafficking in hippocampal neurons. Here, we investigated the role(s) of Rab17 in AMPA receptor (AMPAR) and kainate receptor (KAR) trafficking. Although Rab17 knockdown did not affect surface expression of the AMPAR subunit GluA1 under basal or chemically induced long term potentiation conditions, it significantly reduced surface expression of the KAR subunit GluK2. Rab17 co-localizes with Syntaxin-4 in the soma, dendritic shaft, the tips of developing hippocampal neurons, and in spines. Rab17 knockdown caused Syntaxin-4 redistribution away from dendrites and into axons in developing hippocampal neurons. Syntaxin-4 knockdown reduced GluK2 but had no effect on GluA1 surface expression. Moreover, overexpression of constitutively active Rab17 promoted dendritic surface expression of GluK2 by enhancing Syntaxin-4 translocation to dendrites. These data suggest that Rab17 mediates the dendritic trafficking of Syntaxin-4 to selectively regulate dendritic surface insertion of GluK2-containing KARs in rat hippocampal neurons.	[Mori, Yasunori; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan	University of Bristol; Tohoku University	Mori, Y (corresponding author), Doshisha Univ, Lab Neural Membrane Biol, Grad Sch Brain Sci, 1-3 Miyakodani, Kyotanabe, Kyoto 6100394, Japan.	yasumori@mail.doshisha.ac.jp; j.m.henley@bristol.ac.uk	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Henley, Jeremy/0000-0003-3589-8335	Uehara Memorial Foundation; Ministry of Education, Culture, Sports, and Technology of Japan; Daiichi-Sankyo Foundation of Life Science; European Research Council; Medical Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/F00723X/1] Funding Source: researchfish; Medical Research Council [MR/L003791/1] Funding Source: researchfish; BBSRC [BB/F00723X/1] Funding Source: UKRI; MRC [MR/L003791/1] Funding Source: UKRI	Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi-Sankyo Foundation of Life Science; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Uehara Memorial Foundation (to Y. M.), grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan, the Daiichi-Sankyo Foundation of Life Science (to M. F.), the European Research Council, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council (to J. M. H.).	Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gonzalez-Gonzalez IM, 2013, TRAFFIC, V14, P810, DOI 10.1111/tra.12071; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Li L, 2001, J BIOL CHEM, V276, P5265, DOI 10.1074/jbc.M003883200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin S, 2008, J BIOL CHEM, V283, P36435, DOI 10.1074/jbc.M806447200; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Monnerie H, 2006, J NEUROSCI RES, V83, P944, DOI 10.1002/jnr.20805; Mori Y, 2013, BIOCHEM BIOPH RES CO, V435, P113, DOI 10.1016/j.bbrc.2013.04.051; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki F, 1997, EXP NEUROL, V145, P203, DOI 10.1006/exnr.1997.6469; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yatsu A, 2013, J INVEST DERMATOL, V133, P2237, DOI 10.1038/jid.2013.156; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20773	20787		10.1074/jbc.M114.550632	http://dx.doi.org/10.1074/jbc.M114.550632			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895134	hybrid, Green Published			2022-12-25	WOS:000339396600033
J	Sinikumpu, SP; Huilaja, L; Jokelainen, J; Koiranen, M; Auvinen, J; Hagg, PM; Wikstrom, E; Timonen, M; Tasanen, K				Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Jokelainen, Jari; Koiranen, Markku; Auvinen, Juha; Hagg, Paivi M.; Wikstrom, Erika; Timonen, Markku; Tasanen, Kaisa			High Prevalence of Skin Diseases and Need for Treatment in a Middle-Aged Population. A Northern Finland Birth Cohort 1966 Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ATOPIC-DERMATITIS; HAND ECZEMA; ANDROGENETIC ALOPECIA; MALIGNANT-MELANOMA; SOCIOECONOMIC-STATUS; SWEDISH POPULATION; RISK-FACTORS; STANDARD CLASSIFICATION; SEVERITY INDEX	To determine the overall prevalence of skin diseases a whole-body skin examination was performed for 1,932 members (46years of age) of the Northern Finland Birth Cohort (NFBC 1966), which is a comprehensive longitudinal research program (N = 12,058). A high prevalence of all skin diseases needing treatment was found (N = 1,158). Half of the cases of skin findings were evaluated to be serious enough to require diagnostic evaluation, treatment or follow-up either in a general health care, occupational health care or a secondary care setting. The remaining half were thought to be slight and selftreatment was advised. Males (70%) had more skin diseases needing treatment than females (52%) (P < 0.001). The most common skin finding was a benign skin tumor, which was found in every cohort member. Skin infections (44%), eczemas (27%) and sebaceous gland diseases (27%) were the most common skin diseases in the cohort. Moreover, skin infections and eczemas were more commonly seen in the group with low education compared to those with high education (P< 0.005). The results strengthen the postulate that skin diseases are common in an adult population.	[Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Hagg, Paivi M.; Wikstrom, Erika; Tasanen, Kaisa] Univ Oulu, Dept Dermatol, Med Res Ctr, SF-90220 Oulu, Finland; [Sinikumpu, Suvi-Paivikki; Huilaja, Laura; Hagg, Paivi M.; Wikstrom, Erika; Tasanen, Kaisa] Oulu Univ Hosp, Oulu, Finland; [Jokelainen, Jari; Koiranen, Markku; Auvinen, Juha; Timonen, Markku] Univ Oulu, Fac Med, Inst Hlth Sci, SF-90220 Oulu, Finland; [Jokelainen, Jari] Oulu Univ Hosp, Unit Gen Practice, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Sinikumpu, SP (corresponding author), Univ Oulu, Dept Dermatol, Med Res Ctr, SF-90220 Oulu, Finland.	suvi-paivikki.sinikumpu@oulu.fi		Tasanen, Kaisa/0000-0001-8056-5949; Jokelainen, Jari/0000-0003-4629-0560	Oulu University Hospital; Northern Finland Cancer Association; Academy of Finland; University of Oulu	Oulu University Hospital; Northern Finland Cancer Association; Academy of Finland(Academy of Finland); University of Oulu	The authors are grateful to Oulu University Hospital, the Northern Finland Cancer Association, the Academy of Finland and the University of Oulu for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram K, 2010, ACTA DERM-VENEREOL, V90, P269, DOI 10.2340/00015555-0856; ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Augustin M, 2011, BRIT J DERMATOL, V165, P865, DOI 10.1111/j.1365-2133.2011.10436.x; AUGUSTSSON A, 1991, BRIT J DERMATOL, V124, P152, DOI 10.1111/j.1365-2133.1991.tb00424.x; BERG M, 1989, ACTA DERM-VENEREOL, V69, P419; Bergmann RL, 2000, CLIN EXP ALLERGY, V30, P1740, DOI 10.1046/j.1365-2222.2000.00927.x; Cash TF, 1999, BRIT J DERMATOL, V141, P398; Crawford GH, 2004, J AM ACAD DERMATOL, V51, P327, DOI 10.1016/j.jaad.2004.03.030; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Dupuy A, 1999, BRIT MED J, V318, P1591, DOI 10.1136/bmj.318.7198.1591; ELEWSKI B, 1995, J AM ACAD DERMATOL, V33, P816, DOI 10.1016/0190-9622(95)91838-8; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gibson GE, 1997, IRISH J MED SCI, V166, P72, DOI 10.1007/BF02944190; Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)70300-2; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Herd RM, 1996, BRIT J DERMATOL, V135, P18; Isohanni I, 2001, SCAND J PUBLIC HEALT, V29, P87, DOI 10.1177/14034948010290020501; Johnson MT, 1978, SKIIN CONDITIONS REL; Julian CG, 1999, BRIT J DERMATOL, V141, P518; Karlsson P, 2000, ACTA DERM-VENEREOL, V80, P335; Krueger G, 2001, ARCH DERMATOL, V137, P280; Lacroix C, 2002, J EUR ACAD DERMATOL, V16, P139, DOI 10.1046/j.1468-3083.2002.00400.x; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Lowell BA, 2001, J AM ACAD DERMATOL, V45, P250, DOI 10.1067/mjd.2001.114598; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; Meding B, 2004, SCAND J WORK ENV HEA, V30, P334, DOI 10.5271/sjweh.804; Meding B, 2004, J INVEST DERMATOL, V122, P873, DOI 10.1111/j.0022-202X.2004.22406.x; MEDING B, 1990, CONTACT DERMATITIS, V22, P13, DOI 10.1111/j.1600-0536.1990.tb01499.x; Montnemery P, 2005, ACTA DERM-VENEREOL, V85, P429, DOI 10.1080/00015550510036658; Muto T, 2003, BRIT J DERMATOL, V148, P117, DOI 10.1046/j.1365-2133.2003.05092.x; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; OSTERLIND A, 1992, ACTA ONCOL, V31, P903, DOI 10.3109/02841869209089727; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Plunkett A, 1999, INT J DERMATOL, V38, P901, DOI 10.1046/j.1365-4362.1999.00856.x; REA JN, 1976, BRIT J PREV SOC MED, V30, P107; Remes ST, 1998, ALLERGY, V53, P682, DOI 10.1111/j.1398-9995.1998.tb03954.x; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Severi G, 2003, BRIT J DERMATOL, V149, P1207, DOI 10.1111/j.1365-2133.2003.05565.x; Shack L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-271; SUSITAIVAL P, 1994, SCAND J WORK ENV HEA, V20, P206, DOI 10.5271/sjweh.1407; SWERDLOW AJ, 1986, BRIT MED J, V292, P1555, DOI 10.1136/bmj.292.6535.1555; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P75, DOI 10.1111/j.1600-0536.2009.01669.x; Wallenhammar LM, 2004, J INVEST DERMATOL, V122, P1381, DOI 10.1111/j.0022-202X.2004.22604.x; White GM, 1998, J AM ACAD DERMATOL, V39, pS34, DOI 10.1016/S0190-9622(98)70442-6; Wilkin J, 2002, J AM ACAD DERMATOL, V46, P584, DOI 10.1067/mjd.2002.120625; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Yi SM, 2012, BRIT J DERMATOL, V167, P306, DOI 10.1111/j.1365-2133.2012.10978.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	52	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99533	10.1371/journal.pone.0099533	http://dx.doi.org/10.1371/journal.pone.0099533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911008	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600100
J	Bennett, DL; Hamberg, LM; Wang, B; Hirsch, JA; Gonzalez, RG; Hunter, GJ				Bennett, Debbie L.; Hamberg, Leena M.; Wang, Bing; Hirsch, Joshua A.; Gonzalez, R. Gilberto; Hunter, George J.			Diagnostic Yield of Delayed Phase Imaging in CT Angiography of the Head and Neck: A Retrospective Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; INTERNAL CAROTID ARTERIES; MANAGEMENT; OCCLUSION	Purpose: To evaluate how often delayed images, obtained during neurovascular CTA, provide unique information relative to early phase imaging alone. Materials and Methods: Informed consent was waived by the institutional review body for this study. Neurovascular CTAs from January through June 2009 were searched to identify those with delayed phase imaging. Reports were reviewed to identify cases where delayed images provided potentially unique information. The studies with potentially unique information were re-interpreted to determine if the information was indeed unique. Results: 645 CTAs with delayed phase imaging were identified. There were 324 men and 310 women (median age 67 years; range 20-96 years). 59 studies (59/645: 9.1%) had findings on the delayed images. There were 13 cases with hemorrhage, with 4 showing progression on delayed views. Of the remaining 46 cases, 28 had occlusion of a vessel that did not reconstitute on the delayed images, 6 had occlusion of a vessel that did reconstitute on the delayed images, 7 had a string sign which was unchanged on the delayed views and 5 had no abnormal findings. Thus in 10 cases the findings were unique to the delayed images (10/645: 1.55%). Four showed active bleeding, three showed proximal occlusion with distal internal carotid filling from ophthalmic collaterals, two showed pial vessels filling distal to proximal MCA occlusion, and one showed retrograde vertebral artery filling due to subclavian steal. 95% confidence limits of the expected incidence of unique information from the delayed phase images are 0.6% - 2.5%. Conclusion: Obtaining delayed phase imaging for neurovascular CTA should be an active decision and not the default protocol. This avoids imaging with little, if any value. If delayed images had not been obtained in our cohort, no detriment in patient management would have occurred.	[Bennett, Debbie L.; Hirsch, Joshua A.; Gonzalez, R. Gilberto; Hunter, George J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hamberg, Leena M.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Wang, Bing] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center	Hunter, GJ (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	gjhunter@partners.org						Almandoz JED, 2010, RADIOL CLIN N AM, V48, P265, DOI 10.1016/j.rcl.2010.02.007; Bartlett ES, 2006, AM J NEURORADIOL, V27, P632; Berne JD, 2004, J TRAUMA, V57, P11, DOI 10.1097/01.TA.0000135499.70048.C7; Brott TG, 2011, STROKE, V42, pE464, DOI 10.1161/STR.0b013e3182112cc2; Chen Y, 2004, SKULL BASE-INTERD AP, V14, P185, DOI 10.1055/s-2004-860946; COUNTEE RW, 1979, J NEUROSURG, V50, P747, DOI 10.3171/jns.1979.50.6.0747; DeLaPaz RL, 2011, J AM COLL RADIOL, V8, P532, DOI 10.1016/j.jacr.2011.05.010; Fox AJ, 2012, AM J NEURORADIOL, V33, P792, DOI 10.3174/ajnr.A3099; Furtado AD, 2010, AM J NEURORADIOL, V31, P1290, DOI 10.3174/ajnr.A2075; Gandhi D, 2009, NEUROIMAG CLIN N AM, V19, P133, DOI 10.1016/j.nic.2009.02.002; Greiner C, 2004, ACTA NEUROCHIR, V146, P237, DOI 10.1007/s00701-004-0216-5; Halliburton SS, 2010, JACC-CARDIOVASC IMAG, V3, P536, DOI 10.1016/j.jcmg.2010.03.004; Han DK, 2010, J VASC SURG, V52, P746, DOI 10.1016/j.jvs.2010.04.028; Hoh BL, 2004, NEUROSURGERY, V54, P1329, DOI 10.1227/01.NEU.0000125325.22576.83; Lev MH, 2012, AM J NEURORADIOL, V33, P790, DOI 10.3174/ajnr.A3098; Lev MH, 2003, AM J NEURORADIOL, V24, P1123; Li YQ, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-64; Niemela M, 2012, WORLD NEUROSURG, V78, P581, DOI 10.1016/j.wneu.2012.01.026; Pantazis G, 2006, SURG NEUROL, V66, P492, DOI 10.1016/j.surneu.2006.05.054; Perkins JA, 2005, INT J PEDIATR OTORHI, V69, P319, DOI 10.1016/j.ijporl.2004.10.008; Romero JM, 2012, EMERG RADIOL, V19, P195, DOI 10.1007/s10140-012-1020-9; SANDOK BA, 1971, ARCH NEUROL-CHICAGO, V24, P462, DOI 10.1001/archneur.1971.00480350096010; Sanelli PC, 2005, AM J ROENTGENOL, V184, P305, DOI 10.2214/ajr.184.1.01840305; Suzuki Y, 2005, NEUROL MED-CHIR, V45, P387, DOI 10.2176/nmc.45.387; Tholen ATR, 2010, RADIOLOGY, V256, P585, DOI 10.1148/radiol.10091157; Wyers MC, 2009, J VASC SURG, V49, P614, DOI 10.1016/j.jvs.2008.10.015	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99020	10.1371/journal.pone.0099020	http://dx.doi.org/10.1371/journal.pone.0099020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905932	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000092
J	Chavarria, NE; Hwang, SM; Cao, SY; Fu, X; Holman, M; Elbanna, D; Rodriguez, S; Arrington, D; Englert, M; Uthandi, S; Soll, D; Maupin-Furlow, JA				Chavarria, Nikita E.; Hwang, Sungmin; Cao, Shiyun; Fu, Xian; Holman, Mary; Elbanna, Dina; Rodriguez, Suzanne; Arrington, Deanna; Englert, Markus; Uthandi, Sivakumar; Soell, Dieter; Maupin-Furlow, Julie A.			Archaeal Tuc1/Ncs6 Homolog Required for Wobble Uridine tRNA Thiolation Is Associated with Ubiquitin-Proteasome, Translation, and RNA Processing System Homologs	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL MODIFICATION; HALOFERAX-VOLCANII; STATISTICAL-MODEL; PROTEINS; TRANSCRIPTION; BIOSYNTHESIS; THIOURIDINE; POSITION; DATABASE; EXOSOME	While cytoplasmic tRNA 2-thiolation protein 1 (Tuc1/Ncs6) and ubiquitin-related modifier-1 (Urm1) are important in the 2-thiolation of 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)U) at wobble uridines of tRNAs in eukaryotes, the biocatalytic roles and properties of Ncs6/Tuc1 and its homologs are poorly understood. Here we present the first report of an Ncs6 homolog of archaea (NcsA of Haloferax volcanii) that is essential for maintaining cellular pools of thiolated tRNA(Lys) UUU and for growth at high temperature. When purified from Hfx. volcanii, NcsA was found to be modified at Lys204 by isopeptide linkage to polymeric chains of the ubiquitin-fold protein SAMP2. The ubiquitin-activating E1 enzyme homolog of archaea (UbaA) was required for this covalent modification. Non-covalent protein partners that specifically associated with NcsA were also identified including UbaA, SAMP2, proteasome activating nucleotidase (PAN)-A/1, translation elongation factor aEF-1 alpha and a beta-CASP ribonuclease homolog of the archaeal cleavage and polyadenylation specificity factor 1 family (aCPSF1). Together, our study reveals that NcsA is essential for growth at high temperature, required for formation of thiolated tRNA(Lys) UUU and intimately linked to homologs of ubiquitin-proteasome, translation and RNA processing systems.	[Chavarria, Nikita E.; Hwang, Sungmin; Cao, Shiyun; Fu, Xian; Holman, Mary; Elbanna, Dina; Rodriguez, Suzanne; Arrington, Deanna; Uthandi, Sivakumar; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Englert, Markus; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Yale University; Yale University	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Uthandi, Sivakumar/C-3277-2018; Maupin-Furlow, Julie/AAW-4035-2020	Uthandi, Sivakumar/0000-0002-7116-1317; Maupin-Furlow, Julie/0000-0001-6105-0923; Fu, Xian/0000-0001-9044-8850	NIGMS NIH HHS [R01 GM057498, R01GM22854, R01 GM022854] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R01GM057498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Aravind L, 1999, In Silico Biol, V1, P69; Auffinger P., 1998, MODIFICATION EDITING; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 1992, TRANSFER RNA PROTEIN; BORK P, 1994, PROTEINS, V20, P347, DOI 10.1002/prot.340200407; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Dominski Z, 2013, BBA-GENE REGUL MECH, V1829, P532, DOI 10.1016/j.bbagrm.2013.01.010; Hepowit NL, 2012, MOL MICROBIOL, V86, P971, DOI 10.1111/mmi.12038; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Jager G, 2004, J BACTERIOL, V186, P750, DOI 10.1128/JB.186.3.750-757.2004; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Liu YC, 2012, J BIOL CHEM, V287, P36683, DOI 10.1074/jbc.M112.405688; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; Miranda HV, 2014, MOL CELL PROTEOMICS, V13, P220, DOI 10.1074/mcp.M113.029652; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Nakagawa H, 2013, PROTEINS, V81, P1232, DOI 10.1002/prot.24273; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nieuwlandt D. T., 1995, P161; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Perez-Fillol M, 1986, Microbiologia, V2, P73; Phung DK, 2013, NUCLEIC ACIDS RES, V41, P1091, DOI 10.1093/nar/gks1237; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Prunetti L, 2014, EXTREMOPHIL IN PRESS; Rawls KS, 2010, J BACTERIOL, V192, P6251, DOI 10.1128/JB.00827-10; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; ROGERS KC, 1995, BIOCHIMIE, V77, P66, DOI 10.1016/0300-9084(96)88106-5; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Shigi N, 2012, J BIOL CHEM, V287, P17568, DOI 10.1074/jbc.M112.359844; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Silva APG, 2011, STRUCTURE, V19, P622, DOI 10.1016/j.str.2011.03.002; Smith DM, 2009, HALOHANDBOOK VERSION, p7.2; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Tomikawa C, 2013, FEBS LETT, V587, P3575, DOI 10.1016/j.febslet.2013.09.021; Vendeix FAP, 2012, J MOL BIOL, V416, P467, DOI 10.1016/j.jmb.2011.12.048; Wilson HL, 1999, J BACTERIOL, V181, P5814, DOI 10.1128/JB.181.18.5814-5824.1999	49	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99104	10.1371/journal.pone.0099104	http://dx.doi.org/10.1371/journal.pone.0099104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906001	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000103
J	Fujisawa, T; Hozumi, H; Kono, M; Enomoto, N; Hashimoto, D; Nakamura, Y; Inui, N; Yokomura, K; Koshimizu, N; Toyoshima, M; Shirai, T; Yasuda, K; Hayakawa, H; Suda, T				Fujisawa, Tomoyuki; Hozumi, Hironao; Kono, Masato; Enomoto, Noriyuki; Hashimoto, Dai; Nakamura, Yutaro; Inui, Naoki; Yokomura, Koshi; Koshimizu, Naoki; Toyoshima, Mikio; Shirai, Toshihiro; Yasuda, Kazumasa; Hayakawa, Hiroshi; Suda, Takafumi			Prognostic Factors for Myositis-Associated Interstitial Lung Disease	PLOS ONE			English	Article							CLINICALLY AMYOPATHIC DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHIES; JAPANESE PATIENTS; SINE MYOSITIS; GENE 5; POLYMYOSITIS; SPECTRUM; FEATURES; SOCIETY	Background: Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM), dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is known about the factors influencing the prognosis for PM/DM/CADM-associated ILD. (PM/DM/CADM-ILD). The aim of the present study is to assess prognostic factors for PM/DM/CADM-ILD. Methods: The clinical features and survival of 114 consecutive patients diagnosed with PM/DM/CADM-ILD (39 men and 75 women; median age, 56 years) were analyzed retrospectively. Results: The study group included 30 PM-associated ILD, 41 DM-associated ILD, and 43 CADM-associated ILD cases. The clinical presentation of ILD was acute/subacute form in 59 patients (51.8%) and chronic form in 55 patients (48.2%). The major pulmonary symptoms were dyspnea, cough, and fever. High-resolution computed tomography frequently revealed ground-glass opacities, traction bronchiectasis, and consolidation. Most of the patients were treated with corticosteroids or corticosteroids in combination with immunosuppressive agents. The all-cause mortality was 27.2%. Acute/subacute form, % forced vital capacity (FVC), age, % of neutrophils in bronchoalveolar lavage (BAL) fluid, and a diagnosis of CADM (vs. PM) were significantly associated with poor outcome in univariate Cox proportional hazards models. Multivariate Cox proportional hazards analysis validated acute/subacute ILD, %FVC, age, and diagnosis of CADM (vs. PM) as significant predictors of overall mortality. Patients with acute/subacute ILD had a much lower survival rate than those with the chronic form (p<0.001). Patients with CADM-ILD had a lower survival rate than those with PM-ILD (p = 0.034). Conclusions: Acute/subacute form, older age, lower level of FVC and diagnosis of CADM predict poor outcome in PM/DM/ CADM-ILD.	[Fujisawa, Tomoyuki; Hozumi, Hironao; Kono, Masato; Enomoto, Noriyuki; Hashimoto, Dai; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4312102, Japan; [Yokomura, Koshi] Seirei Mikatahara Gen Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan; [Koshimizu, Naoki] Fujieda Municipal Gen Hosp, Dept Resp Med, Fujieda, Shizuoka, Japan; [Toyoshima, Mikio] Hamamatsu Rosai Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan; [Shirai, Toshihiro] Shizuoka Prefectural Gen Hosp, Dept Resp Med, Shizuoka, Japan; [Yasuda, Kazumasa] Iwata City Hosp, Dept Resp Med, Iwata, Japan; [Hayakawa, Hiroshi] Natl Hosp Org, Tenryu Hosp, Dept Resp Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Shizuoka General Hospital	Fujisawa, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan.	fujisawa@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264				Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; Cottin V, 2003, EUR RESPIR J, V22, P245, DOI 10.1183/09031936.03.00026703; Ernste FC, 2013, MAYO CLIN PROC, V88, P83, DOI 10.1016/j.mayocp.2012.10.017; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Koga T, 2012, RHEUMATOLOGY, V51, P1278, DOI 10.1093/rheumatology/ker518; Lee CS, 2002, CLIN RHEUMATOL, V21, P391, DOI 10.1007/s100670200104; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Miyazaki E, 2007, CLIN RHEUMATOL, V26, P436, DOI 10.1007/s10067-005-0147-4; Mukae H, 2009, CHEST, V136, P1341, DOI 10.1378/chest.08-2740; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2013, MOD RHEUMATOL, V23, P496, DOI 10.1007/s10165-012-0663-4; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sontheimer RD, 2003, J AM ACAD DERMATOL, V48, P797, DOI 10.1067/mjd.2003.199; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Suda T, 2006, EUR RESPIR J, V28, P1005, DOI 10.1183/09031936.06.00038806; SUDA T, 1995, CHEST, V107, P711, DOI 10.1378/chest.107.3.711; Sun YC, 2013, RHEUMATOL INT, V33, P1295, DOI 10.1007/s00296-012-2545-7; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Ye S, 2007, CLIN RHEUMATOL, V26, P1647, DOI 10.1007/s10067-007-0562-9	27	104	113	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98824	10.1371/journal.pone.0098824	http://dx.doi.org/10.1371/journal.pone.0098824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905449	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000065
J	Kondo, Y; Ninomiya, M; Kimura, O; Machida, K; Funayama, R; Nagashima, T; Kobayashi, K; Kakazu, E; Kato, T; Nakayama, K; Lai, MMC; Shimosegawa, T				Kondo, Yasuteru; Ninomiya, Masashi; Kimura, Osamu; Machida, Keigo; Funayama, Ryo; Nagashima, Takeshi; Kobayashi, Koju; Kakazu, Eiji; Kato, Takanobu; Nakayama, Keiko; Lai, Michael M. C.; Shimosegawa, Tooru			HCV Infection Enhances Th17 Commitment, Which Could Affect the Pathogenesis of Autoimmune Diseases	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; POLYMERASE-CHAIN-REACTION; IN-VIVO; MIXED CRYOGLOBULINEMIA; RHEUMATOID-ARTHRITIS; CELL-LINES; T-CELLS; PROTEIN; INTERFERON; RECEPTOR	Background: Various kinds of autoimmune diseases have been reported to have a significant relationship with persistent hepatitis c virus (HCV) infection and Th17 cells. Previously, our group reported that the existence of HCV in T lymphocytes could affect the development of CD4(+) helper T cells and their proliferation, in addition to the induction of immunoglobulin hyper-mutation. Methods: Therefore, we analyzed the relationship between persistent infection of HCV and the mechanism of Th17 cell induction ex vivo and in vitro. Results: The prevalence of autoimmune-related diseases in chronic hepatitis c patients (CH-C) was significantly higher than in other types of chronic hepatitis (hepatitis B and NASH). A significantly higher frequency of IL6 and TGF-beta double-high patients was detected in CH-C than in other liver diseases. Moreover, these double-high patients had significantly higher positivity of anti-nuclear antibody, cryoglobulinemia, and lymphotropic HCV and higher amounts of IL1-beta, IL21, IL23. In addition to the previously reported lymphotropic SB-HCV strain, we found a novel, genotype 1b lymphotropic HCV (Ly-HCV), by deep sequencing analysis. Lymphotropic-HCV replication could be detected in the lymphoid cells with various kinds of cytokine-conditions including IL1 beta, IL23, IL6 and TGF-beta in vitro. Infection by HCV could significantly enhance the development of Th17 cells. The HCV protein responsible for inducing the Th17 cells was HCV-Core protein, which could enhance the STAT-3 signaling and up-regulate the expression of ROR gamma t as a Th17 master gene. Conclusion: Infection by lymphotropic HCV might enhance the Th17 development and contribute to understanding the pathogenesis of autoimmune-related diseases.	[Kondo, Yasuteru; Ninomiya, Masashi; Kimura, Osamu; Kobayashi, Koju; Kakazu, Eiji; Shimosegawa, Tooru] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan; [Machida, Keigo; Lai, Michael M. C.] Univ So Calif, Keck Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90033 USA; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Cell Proliferat, Sendai, Miyagi 980, Japan; [Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo, Japan; [Lai, Michael M. C.] China Med Univ, Taichung, Taiwan	Tohoku University; University of Southern California; Tohoku University; National Institute of Infectious Diseases (NIID); China Medical University Taiwan	Kondo, Y (corresponding author), Tohoku Univ, Grad Sch Med, Div Gastroenterol, Sendai, Miyagi 980, Japan.	yasuteru@ebony.plala.or.jp	Kondo, Yasuteru/A-6893-2010; Wang, Jing/B-2431-2014	Kondo, Yasuteru/0000-0001-5935-4346; Machida, Keigo/0000-0002-9721-8553	Ministry of Education, Culture, Sport, Science, and Technology of Japan [21790642, 23790761, 25460970]; Japan Society of Hepatology; National Institute on Alcohol Abuse and Alcoholism [R01 AA018857]; American Cancer Society [RSG-12-177-01]; Grants-in-Aid for Scientific Research [26670085] Funding Source: KAKEN; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, R01AA018857] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of Hepatology; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by Grant-in Aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (Y.K. #21790642, #23790761 and #25460970), Grant from the Japan Society of Hepatology (Y.K), the National Institute on Alcohol Abuse and Alcoholism (K.M. #R01 AA018857) and the American Cancer Society (K. M. #RSG-12-177-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassiouny DA, 2011, CLIN EXP DERMATOL, V36, P292, DOI 10.1111/j.1365-2230.2010.03972.x; Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200; Chen XQ, 2010, J CLIN IMMUNOL, V30, P221, DOI 10.1007/s10875-009-9365-x; Dominguez-Villar M, 2007, J LEUKOCYTE BIOL, V82, P1301, DOI 10.1189/jlb.0507335; Ferri C, 2000, CURR OPIN RHEUMATOL, V12, P53, DOI 10.1097/00002281-200001000-00009; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Horie I, 2011, ENDOCRINOLOGY, V152, P4448, DOI 10.1210/en.2011-1356; Horie I, 2011, AUTOIMMUNITY, V44, P159, DOI 10.3109/08916931003777247; Hu Y, 2003, AM J CLIN PATHOL, V119, P95, DOI 10.1309/33TAJLB748KLMXVG; Hu Y, 2012, HUM IMMUNOL, V73, P629, DOI 10.1016/j.humimm.2012.04.015; Ito M, 2010, J INNATE IMMUN, V2, P607, DOI 10.1159/000317690; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Karavattathayyil SJ, 2000, AM J CLIN PATHOL, V113, P391, DOI 10.1309/REV9-FDTM-5NGC-HBWY; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kondo Y, 2011, HEPATOL RES; Kondo Y, 2013, HEPATOLOGY RES OFFIC; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kondo Yasuteru, 2012, Int J Microbiol, V2012, P647581, DOI 10.1155/2012/647581; Kondo Y, 2011, J GASTROENTEROL, V46, P232, DOI 10.1007/s00535-010-0297-2; Kondo Y, 2009, J INFECT DIS, V199, P726, DOI 10.1086/596739; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Machida K, 2006, J VIROL, V80, P866, DOI 10.1128/JVI.80.2.866-874.2006; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; MacParland SA, 2006, J GEN VIROL, V87, P3577, DOI 10.1099/vir.0.81868-0; Mariette X, 1999, LEUKEMIA LYMPHOMA, V33, P93, DOI 10.3109/10428199909093729; Mizukawa Y, 2000, J DERMATOL SCI, V22, P169, DOI 10.1016/S0923-1811(99)00083-3; Negro F, 1999, HEPATOLOGY, V29, P536, DOI 10.1002/hep.510290223; Pal S, 2006, GASTROENTEROLOGY, V130, P1107, DOI 10.1053/j.gastro.2005.12.039; Pan HF, 2012, MOL BIOL REP; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; Shiokawa M, 2010, BIOCHEM BIOPH RES CO, V399, P733, DOI 10.1016/j.bbrc.2010.07.145; Simula MP, 2007, ANN NY ACAD SCI, V1110, P121, DOI 10.1196/annals.1423.014; Stump KL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3329; Sung VMH, 2003, J VIROL, V77, P2134, DOI 10.1128/JVI.77.3.2134-2146.2003; TAKEUCHI K, 1990, NUCLEIC ACIDS RES, V18, P4626, DOI 10.1093/nar/18.15.4626; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Yu CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029742; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018909; Zhou JH, 2009, J SURG RES, V157, P63, DOI 10.1016/j.jss.2008.08.027	41	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98521	10.1371/journal.pone.0098521	http://dx.doi.org/10.1371/journal.pone.0098521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905921	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000036
J	Labrousse, D; Perret, M; Hayez, D; Da Silva, S; Badiou, C; Couzon, F; Bes, M; Chavanet, P; Lina, G; Vandenesch, F; Croisier-Bertin, D; Henry, T				Labrousse, Delphine; Perret, Magali; Hayez, Davy; Da Silva, Sonia; Badiou, Cedric; Couzon, Florence; Bes, Michele; Chavanet, Pascal; Lina, Gerard; Vandenesch, Francois; Croisier-Bertin, Delphine; Henry, Thomas			Kineret (R)/IL-1ra Blocks the IL-1/IL-8 Inflammatory Cascade during Recombinant Panton Valentine Leukocidin-Triggered Pneumonia but Not during S-aureus Infection	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; COMMUNITY-ACQUIRED PNEUMONIA; NLRP3 INFLAMMASOME; NECROTIZING PNEUMONIA; RESISTANT; ACTIVATION; HEMOLYSIN; DISEASES; THERAPY; GENES	Objectives: Community-acquired Staphylococcus aureus necrotizing pneumonia is a life-threatening disease. Panton Valentine Leukocidin (PVL) has been associated with necrotizing pneumonia. PVL triggers inflammasome activation in human macrophages leading to IL-1 beta release. IL-1 beta activates lung epithelial cells to release IL-8. This study aimed to assess the relevance of this inflammatory cascade in vivo and to test the potential of an IL-1 receptor antagonist (IL-1Ra/Kineret) to decrease inflammation-mediated lung injury. Methods: We used the sequential instillation of Heat-killed S. aureus and PVL or S. aureus infection to trigger necrotizing pneumonia in rabbits. In these models, we investigated inflammation in the presence or absence of IL-1Ra/Kineret. Results: We demonstrated that the presence of PVL was associated with IL-1 beta and IL-8 release in the lung. During PVL-mediated sterile pneumonia, Kineret/IL-1Ra reduced IL-8 production indicating the relevance of the PVL/IL-1/IL-8 cascade in vivo and the potential of Kineret/IL-1Ra to reduce lung inflammation. However, Kineret/IL-1Ra was ineffective in blocking IL-8 production during infection with S. aureus. Furthermore, treatment with Kineret increased the bacterial burden in the lung. Conclusions: Our data demonstrate PVL-dependent inflammasome activation during S. aureus pneumonia, indicate that IL-1 signaling controls bacterial burden in the lung and suggest that therapy aimed at targeting this pathway might be deleterious during pneumonia.	[Labrousse, Delphine; Hayez, Davy; Da Silva, Sonia; Croisier-Bertin, Delphine] Vivexia, Dijon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] Univ Lyon, Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] INSERM, U1111, F-69008 Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] CNRS, UMR 5308, Lyon, France; [Perret, Magali; Badiou, Cedric; Couzon, Florence; Bes, Michele; Lina, Gerard; Vandenesch, Francois; Henry, Thomas] Ecole Normale Super Lyon, F-69364 Lyon, France; [Chavanet, Pascal; Croisier-Bertin, Delphine] Univ Hosp, Dept Infect Dis, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); CHU Dijon Bourgogne	Henry, T (corresponding author), Univ Lyon, Lyon, France.	Thomas.henry@inserm.fr	Lina, Gerard J/L-9352-2014; Henry, Thomas/G-3160-2013; Vandenesch, Francois/C-7209-2014	Henry, Thomas/0000-0002-0687-8565; Vandenesch, Francois/0000-0001-9412-7106; Lina, Gerard/0000-0002-9236-7998; Croisier, Delphine/0000-0002-8744-5832	FINOVI	FINOVI	This work was supported by a FINOVI young investigator grant to TH. SOBI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Croisier-Bertin D, 2014, ANTIMICROBIAL AGENTS; Croisier-Bertin D, 2011, ANTIMICROB AGENTS CH, V55, P3557, DOI 10.1128/AAC.01773-09; Day NP, 2012, LANCET INFECT DIS; Diep BA, 2013, J INFECT DIS; Diep BA, 2013, LANCET INFE IN PRESS; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dubin G, 2002, BIOL CHEM, V383, P1075, DOI 10.1515/BC.2002.116; Giampietro C, 2013, ARTHRIT CARE RES, V65, P822, DOI 10.1002/acr.21901; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2011, INT J ANTIMICROB AG, V38, P457, DOI 10.1016/j.ijantimicag.2011.05.003; Herold S, 2011, AM J RESP CRIT CARE, V183, P1380, DOI 10.1164/rccm.201009-1431OC; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Joseph L, 2011, LANCET, V378, P980, DOI 10.1016/S0140-6736(11)61441-4; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; KONIG B, 1994, INFECT IMMUN, V62, P4831; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Li HT, 2011, RESPIRATION, V81, P448, DOI 10.1159/000319557; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Ma XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034970; Malachowa N, 2013, J IMMUNOL, V191, P6022, DOI 10.4049/jimmunol.1301821; MALYAK M, 1994, J CLIN IMMUNOL, V14, P20, DOI 10.1007/BF01541172; McDuffie R S Jr, 2001, Infect Dis Obstet Gynecol, V9, P233, DOI 10.1155/S1064744901000382; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Morgan MS, 2007, INT J ANTIMICROB AG, V30, P289, DOI 10.1016/j.ijantimicag.2007.04.019; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Piroth L, 1999, ANTIMICROB AGENTS CH, V43, P2484, DOI 10.1128/AAC.43.10.2484; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Rouzic N, 2010, J CLIN MICROBIOL, V48, P1952, DOI 10.1128/JCM.01892-09; Schroder AK, 2006, IMMUNOLOGY, V119, P317, DOI 10.1111/j.1365-2567.2006.02435.x; Shallcross LJ, 2012, LANCET INFECT DIS; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Voiriot G, 2011, CHEST, V139, P387, DOI 10.1378/chest.09-3102; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wargo KA, 2005, CLIN INFECT DIS, V40, P1376, DOI 10.1086/429509; Williams MR, 2011, TRENDS IMMUNOL, V32, P461, DOI 10.1016/j.it.2011.06.009	44	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97546	10.1371/journal.pone.0097546	http://dx.doi.org/10.1371/journal.pone.0097546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905099	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000007
J	Mahajan, RV; Kumar, V; Rajendran, V; Saran, S; Ghosh, PC; Saxena, RK				Mahajan, Richi V.; Kumar, Vinod; Rajendran, Vinoth; Saran, Saurabh; Ghosh, Prahlad C.; Saxena, Rajendra Kumar			Purification and Characterization of a Novel and Robust L-Asparaginase Having Low-Glutaminase Activity from Bacillus licheniformis: In Vitro Evaluation of Anti-Cancerous Properties	PLOS ONE			English	Article							ESCHERICHIA-COLI-ASPARAGINASE; CHILDHOOD; RESISTANT; LEUKEMIA; BINDING	L-asparaginase having low glutaminase has been a key therapeutic agent in the treatment of acute lymphpoblastic leukemia (A.L.L). In the present study, an extracellular L-asparaginase with low glutaminase activity, produced by Bacillus licheniformis was purified to homogeneity. Protein was found to be a homotetramer of 134.8 KDa with monomeric size of 33.7 KDa and very specific for its natural substrate i.e. L-asparagine. The activity of purified L-asparaginase enhanced in presence of cations including Na+ and K+, whereas it was moderately inhibited in the presence of divalent cations and thiol group blocking reagents. The purified enzyme was maximally active over the range of pH 6.0 to 10.0 and temperature of 40 degrees C and enzyme was stable maximum at pH 9.0 and -20 degrees C. CD spectra of L-asparaginase predicted the enzyme to consist of 63.05% alpha-helix and 3.29% beta-sheets in its native form with T-222 of 58 degrees C. Fluorescent spectroscopy showed the protein to be stable even in the presence of more than 3 M GdHCl. Kinetic parameters K-m, V-max and k(cat) of purified enzyme were found as 1.4x10(-5) M, 4.03 IU and 2.68x10(3) s(-1), respectively. The purified L-asparaginase had cytotoxic activity against various cancerous cell lines viz. Jurkat clone E6-1, MCF-7 and K-562 with IC50 of 0.22 IU, 0.78 IU and 0.153 IU respectively. However the enzyme had no toxic effect on human erythrocytes and CHO cell lines hence should be considered potential candidate for further pharmaceutical use as an anticancer drug.	[Mahajan, Richi V.; Kumar, Vinod; Saxena, Rajendra Kumar] Univ Delhi South Campus, Dept Microbiol, Delhi, India; [Rajendran, Vinoth; Ghosh, Prahlad C.] Univ Delhi South Campus, Dept Biochem, Delhi, India; [Saran, Saurabh] Univ Delhi South Campus, Delhi, India	University of Delhi; University of Delhi; University of Delhi	Saxena, RK (corresponding author), Univ Delhi South Campus, Dept Microbiol, Delhi, India.	rksmicro@yahoo.co.in	Rajendran, Vinoth/B-1069-2016	Rajendran, Vinoth/0000-0003-1453-1139; Kumar, Vinod/0000-0002-5766-1040				Abakumova OY, 2012, BIOCHEM MOSC-SUPPL S, V6, P307, DOI 10.1134/S1990750812040026; Aghaiypour K, 2001, BBA-PROTEIN STRUCT M, V1550, P117, DOI 10.1016/S0167-4838(01)00270-9; Aung HP, 2000, BBA-PROTEIN STRUCT M, V1481, P349, DOI 10.1016/S0167-4838(00)00179-5; Bansal S, 2012, FASEB J, V26, P1161, DOI 10.1096/fj.11-191254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOME JD, 1967, BIOCHIM BIOPHYS ACTA, V138, P637, DOI 10.1016/0005-2787(67)90569-2; CAMMACK KA, 1972, BIOCHEM J, V126, P361, DOI 10.1042/bj1260361; Dhanam JG, 2013, ADV BIOTECHNOL, V13; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Godfrin Y, 2006, BIOMEDES, V1, P10; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; Kumar S, 2011, BIORESOURCE TECHNOL, V102, P2077, DOI 10.1016/j.biortech.2010.07.114; Leung-Toung R, 2002, CURR MED CHEM, V9, P979, DOI 10.2174/0929867024606704; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; LUBRAN MM, 1989, ANN CLIN LAB SCI, V19, P114; Mahajan RV, 2012, BIORESOURCE TECHNOL, V125, P11, DOI 10.1016/j.biortech.2012.08.086; MASHBURN LT, 1964, ARCH BIOCHEM BIOPHYS, V105, P450, DOI 10.1016/0003-9861(64)90032-3; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Nagarethinam S., 2012, ASIAN J MEDICAL RES, V1, P159; NEUMAN RE, 1956, SCIENCE, V124, P124, DOI 10.1126/science.124.3212.124; OHNUMA T, 1970, CANCER RES, V30, P2297; PETERSON RE, 1969, APPL MICROBIOL, V18, P64, DOI 10.1128/AEM.18.1.64-67.1969; PRAGER MD, 1968, BIOCHEM BIOPH RES CO, V31, P43, DOI 10.1016/0006-291X(68)90028-4; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P72, DOI 10.1007/s12010-009-8679-8; SHIFRIN S, 1974, J BIOL CHEM, V249, P1335; Surolia R, 2012, J BIOMED NANOTECHNOL, V8, P172, DOI 10.1166/jbn.2012.1366; Warangkar Suchita C, 2010, Enzyme Res, V2010, P165878, DOI 10.4061/2010/165878; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; WILLIS RC, 1974, J BACTERIOL, V118, P231, DOI 10.1128/JB.118.1.231-241.1974; WRISTON JC, 1973, ADV ENZYMOL RAMB, V39, P185	31	87	90	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99037	10.1371/journal.pone.0099037	http://dx.doi.org/10.1371/journal.pone.0099037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905227	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000096
J	Ruiz-Sanchez, E; Specht, CD				Ruiz-Sanchez, Eduardo; Specht, Chelsea D.			Ecological Speciation in Nolina parviflora (Asparagaceae): Lacking Spatial Connectivity along of the Trans-Mexican Volcanic Belt	PLOS ONE			English	Article							NICHE CONSERVATISM; LATITUDINAL VARIATION; GENE FLOW; CLIMATE; DIVERSIFICATION; MECHANISMS; SOFTWARE; HISTORY; MAXIMUM; MODELS	The hypothesis of ecological speciation states that as populations diverge in different niches, reproductive isolation evolves as a by-product of adaptation to these different environments. In this context, we used Nolina parviflora as a model to test if this species evolved via ecological speciation and to explore current and historical gene flow among its populations. Nolina parviflora is a montane species endemic to Mexico with its geographical distribution restricted largely to the Trans-Mexican Volcanic Belt. This mountain range is one of the most complex geological regions in Mexico, having undergone volcanism from the mid-Miocene to the present. Ecologically, the Trans-Mexican Volcanic Belt possesses different types of vegetation, including tropical dry forest; oak, pine, pine-oak, and pine-juniper forests; and xerophytic scrub - all of which maintain populations of N. parviflora. Using species distribution models, climatic analyses, spatial connectivity and morphological comparisons, we found significant differences in climatic and morphological variables between populations of N. parviflora in two distinct Trans-Mexican Volcanic Belt regions (east vs. west). This could mean that the geographically isolated populations diverged from one another via niche divergence, indicating ecological speciation. Spatial connectivity analysis revealed no connectivity between these regions under the present or last glacial maximum climate models, indicating a lack of gene flow between the populations of the two regions. The results imply that these populations may encompass more than a single species.	[Ruiz-Sanchez, Eduardo] Inst Ecol AC, Ctr Reg Bajio, Red Biodiversidad & Sistemat, Patzcuaro, Michoacan, Mexico; [Specht, Chelsea D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Specht, Chelsea D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Specht, Chelsea D.] Univ Calif Berkeley, Univ & Jepson Herbaria, Berkeley, CA 94720 USA	Instituto de Ecologia - Mexico; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ruiz-Sanchez, E (corresponding author), Inst Ecol AC, Ctr Reg Bajio, Red Biodiversidad & Sistemat, Patzcuaro, Michoacan, Mexico.	eduardo.ruiz@inecol.mx	Ruiz-Sanchez, Eduardo/P-3539-2019; Ruiz-Sanchez, Eduardo/L-8073-2013	Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; Specht, Chelsea/0000-0001-7746-512X	UC Berkeley College of Natural Resources; University and Jepson Herbaria; UC-MEXUS; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	UC Berkeley College of Natural Resources; University and Jepson Herbaria; UC-MEXUS; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research funding was provided by UC Berkeley College of Natural Resources and the University and Jepson Herbaria. ERS was supported by a joint UC-MEXUS, Consejo Nacional de Ciencia y Tecnologia (CONACyT) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo DF, 2012, EVOL ECOL, V26, P991, DOI 10.1007/s10682-011-9528-0; [Anonymous], 2010, R LANG ENV STAT COMP; Avise JC, 2000, PHYLOGEOGRAPHY; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Bryson RW, 2012, BIOL J LINN SOC, V105, P382, DOI 10.1111/j.1095-8312.2011.01798.x; Bryson RW, 2012, MOL PHYLOGENET EVOL, V62, P447, DOI 10.1016/j.ympev.2011.10.014; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Correa-Metrio A, 2012, J QUATERNARY SCI, V27, P509, DOI 10.1002/jqs.2540; Correa-Metrio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081958; Coyne JA, 2004, SPECIATION; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrari L, 2012, TECTONOPHYSICS, V522, P122, DOI 10.1016/j.tecto.2011.09.018; Ferval M, 2013, S AFR J BOT; Ferval M, 2013, TURK J BOT, V37, P789, DOI 10.3906/bot-1209-51; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gomez-Tuena A, 2007, GEOL SOC AM SPEC PAP, V422, P129, DOI 10.1130/2007.2422(05); Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Hasumi H., 2004, K 1 COUPLED GCM MICR; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hua X, 2010, EVOLUTION, V64, P429, DOI 10.1111/j.1558-5646.2009.00836.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino MV, 2006, BIOGEOGRAPHY; MANTEL N, 1967, CANCER RES, V27, P209; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parra-Olea G, 2012, J BIOGEOGR, V39, P353, DOI 10.1111/j.1365-2699.2011.02593.x; Peterson AT, 2007, ECOL MODEL, V203, P527, DOI 10.1016/j.ecolmodel.2006.12.023; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Rousset F, 1997, GENETICS, V145, P1219; Ruiz-Sanchez E, 2012, ORG DIVERS EVOL, V26, P991; Ruiz-Sanchez E, 2014, ECOL EVOL, V4, P311, DOI 10.1002/ece3.938; Ruiz-Sanchez E, 2013, J BIOGEOGR, V40, P1336, DOI 10.1111/jbi.12073; *STATACORP, 2003, STAT STAT SOFTW; Svensson EI, 2012, ORG DIVERS EVOL, V12, P229, DOI 10.1007/s13127-012-0082-6; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	55	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98754	10.1371/journal.pone.0098754	http://dx.doi.org/10.1371/journal.pone.0098754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905911	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000058
J	Barbieri, C; Vicente, M; Oliveira, S; Bostoen, K; Rocha, J; Stoneking, M; Pakendorf, B				Barbieri, Chiara; Vicente, Mario; Oliveira, Sandra; Bostoen, Koen; Rocha, Jorge; Stoneking, Mark; Pakendorf, Brigitte			Migration and Interaction in a Contact Zone: mtDNA Variation among Bantu-Speakers in Southern Africa	PLOS ONE			English	Article							GENETIC PERSPECTIVES; Y-CHROMOSOME; POPULATIONS; HISTORY; EXPANSION; LANGUAGES; FARMERS; ORIGIN; CLICKS; VIEW	Bantu speech communities expanded over large parts of sub-Saharan Africa within the last 4000-5000 years, reaching different parts of southern Africa 1200-2000 years ago. The Bantu languages subdivide in several major branches, with languages belonging to the Eastern and Western Bantu branches spreading over large parts of Central, Eastern, and Southern Africa. There is still debate whether this linguistic divide is correlated with a genetic distinction between Eastern and Western Bantu speakers. During their expansion, Bantu speakers would have come into contact with diverse local populations, such as the Khoisan hunter-gatherers and pastoralists of southern Africa, with whom they may have intermarried. In this study, we analyze complete mtDNA genome sequences from over 900 Bantu-speaking individuals from Angola, Zambia, Namibia, and Botswana to investigate the demographic processes at play during the last stages of the Bantu expansion. Our results show that most of these Bantu-speaking populations are genetically very homogenous, with no genetic division between speakers of Eastern and Western Bantu languages. Most of the mtDNA diversity in our dataset is due to different degrees of admixture with autochthonous populations. Only the pastoralist Himba and Herero stand out due to high frequencies of particular L3f and L3d lineages; the latter are also found in the neighboring Damara, who speak a Khoisan language and were foragers and small-stock herders. In contrast, the close cultural and linguistic relatives of the Herero and Himba, the Kuvale, are genetically similar to other Bantu-speakers. Nevertheless, as demonstrated by resampling tests, the genetic divergence of Herero, Himba, and Kuvale is compatible with a common shared ancestry with high levels of drift, while the similarity of the Herero, Himba, and Damara probably reflects admixture, as also suggested by linguistic analyses.	[Barbieri, Chiara; Stoneking, Mark] MPI Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Barbieri, Chiara] Univ Bologna, Lab Mol Anthropol, Dept Biol Geol & Environm Sci, Bologna, Italy; [Vicente, Mario; Oliveira, Sandra; Rocha, Jorge] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Vicente, Mario] STAB VIDA, Invest & Serv Ciencias Biol, Oeiras, Portugal; [Oliveira, Sandra; Rocha, Jorge] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Bostoen, Koen] Univ Ghent, KongoKing Res Grp, Dept African Languages & Cultures, B-9000 Ghent, Belgium; [Bostoen, Koen] Univ Libre Bruxelles, Fac Philosophie & Lettres, Brussels, Belgium; [Pakendorf, Brigitte] CNRS, UMR5596, Lab Dynam Langage, Lyon, France; [Pakendorf, Brigitte] Univ Lyon 2, Lyon, France	Max Planck Society; University of Bologna; Universidade do Porto; Universidade do Porto; Ghent University; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Lyon 2	Barbieri, C (corresponding author), MPI Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	barbieri.chiara@gmail.com; brigitte.pakendorf@cnrs.fr		Vicente, Mario/0000-0002-9122-4530; rocha, jorge/0000-0001-5460-7615; Bostoen, Koen/0000-0003-2284-6165; Barbieri, Chiara/0000-0001-8827-5655	Max Planck Society; FCT Project [PTDC/BIA-EVF/2907/2012]; EU FP7 REGPOT grant [CIBIO-New-Gen-28643]; "Genomics and Evolutionary Biology" project; North Portugal Regional Operational Programme (ON.2- O Novo Norte) under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); European Research Council [ERC-2011-AdG 295733]; STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; Portuguese Ministry for Science, Technology and Higher Education [SFRH/BDE/51828/2012, SFRH/BD/85776/2012]	Max Planck Society(Max Planck SocietyFoundation CELLEX); FCT Project(Portuguese Foundation for Science and Technology); EU FP7 REGPOT grant; "Genomics and Evolutionary Biology" project; North Portugal Regional Operational Programme (ON.2- O Novo Norte) under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); European Research Council(European Research Council (ERC)European Commission); STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; Portuguese Ministry for Science, Technology and Higher Education	This work was funded by the Max Planck Society, by FCT Project Grant PTDC/BIA-EVF/2907/2012, by the EU FP7 REGPOT grant CIBIO-New-Gen-28643, and by the "Genomics and Evolutionary Biology" project co-financed by the North Portugal Regional Operational Programme 2007/2013 (ON.2- O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); CB was supported by the European Research Council ERC-2011-AdG 295733 grant (Langelin); MV was supported by STAB VIDA, Investigacao e Servicos em Ciencias Biologicas, Lda; MV and SO were supported by the Portuguese Ministry for Science, Technology and Higher Education through PhD grants SFRH/BDE/51828/2012 and SFRH/BD/85776/2012, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves I, 2011, HUM BIOL, V83, P13, DOI 10.3378/027.083.0102; Ashley CZ, 2010, AFR ARCHAEOL REV, V27, P135, DOI 10.1007/s10437-010-9074-0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbieri C, 2014, AM J PHYS ANTHROPOL, V153, P435, DOI 10.1002/ajpa.22441; Barbieri C, 2013, EUR J HUM GENET, V21, P430, DOI 10.1038/ejhg.2012.192; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Barnard A, 1992, HUNTER HERDERS SO AF; Batai K, 2013, AM J PHYS ANTHROPOL, V150, P482, DOI 10.1002/ajpa.22227; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blench R. M., 2006, ARCHAEOLOGY LANGUAGE; Bostoen K, 2007, J AFR HIST, V48, P173, DOI 10.1017/S002185370700254X; Bostoen K, 2013, CR GEOSCI, V345, P336, DOI 10.1016/j.crte.2013.03.005; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Castri L, 2009, AM J PHYS ANTHROPOL, V140, P302, DOI 10.1002/ajpa.21070; Cerezo M, 2011, PLOS ONE, V6; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Clist B., 1987, MUNTU, V6, P35; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Creissels Denis, 1999, BANTU HIST LINGUISTI, P297; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; de Filippo C, 2010, AM J PHYS ANTHROPOL, V141, P382, DOI 10.1002/ajpa.21155; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fisch M, 2005, MBUKUSHU ANGOLA 1730; Forster P, 1996, AM J HUM GENET, V59, P935; Furrer R., 2012, FIELDS TOOLS SPATIAL; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gowlett D., 2003, BANTU LANGUAGES, P609; Guldemann T, 2008, ANNU REV ANTHROPOL, V37, P93, DOI 10.1146/annurev.anthro.37.081407.085109; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Kinahan J, 2011, BEGINNING ARCHAEOLOG, P15; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer M., 2010, COLD SPRING HARB PRO; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC; Mohlig WJG, 2009, PEOPLE CATTLE LAND T, P119; Nenadic O., 2007, J STAT SOFTW, V20, P3, DOI [DOI 10.18637/JSS.V020.I03, DOI 10.3354/MEPS086063]; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Nurse D., 2003, BANTU LANGUAGES; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pakendorf B, 2011, LANG DYN CHANG, V1, P50, DOI 10.1163/221058211X570349; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PHILLIPSON DW, 2005, AFRICAN ARCHAEOLOGY; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Pour NA, 2013, EUR J HUM GENET, V21, P423, DOI 10.1038/ejhg.2012.176; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; Reid DAM., 1998, DITSWA MMUNG ARCHAEO, P81; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schadeberg Thilo C., 2003, BANTU LANGUAGES, P143; Schlebusch CM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-56; Sikora M, 2011, EUR J HUM GENET, V19, P84, DOI 10.1038/ejhg.2010.141; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Solway JS, 1991, ENCY WORLD CULTURES, P360; SOODYALL H, 1992, ANN HUM GENET, V56, P315, DOI 10.1111/j.1469-1809.1992.tb01159.x; SPURDLE AB, 1994, AM J HUM GENET, V54, P319; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; Venables WN, 2002, MASS MODERN APPL STA; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408	64	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99117	10.1371/journal.pone.0099117	http://dx.doi.org/10.1371/journal.pone.0099117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901532	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400100
J	Beard, PM; Griffiths, SJ; Gonzalez, O; Haga, IR; Jowers, TP; Reynolds, DK; Wildenhain, J; Tekotte, H; Auer, M; Tyers, M; Ghazal, P; Zimmer, R; Haas, J				Beard, Philippa M.; Griffiths, Samantha J.; Gonzalez, Orland; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.; Wildenhain, Jan; Tekotte, Hille; Auer, Manfred; Tyers, Mike; Ghazal, Peter; Zimmer, Ralf; Haas, Juergen			A Loss of Function Analysis of Host Factors Influencing Vaccinia virus Replication by RNA Interference	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WEST-NILE-VIRUS; GENE-EXPRESSION; VIRAL REPLICATION; GENOMIC SCREEN; IFITM PROTEINS; DENGUE VIRUS; EARLY-STAGE; INFECTION; RECEPTOR	Vaccinia virus (VACV) is a large, cytoplasmic, double-stranded DNA virus that requires complex interactions with host proteins in order to replicate. To explore these interactions a functional high throughput small interfering RNA (siRNA) screen targeting 6719 druggable cellular genes was undertaken to identify host factors (HF) influencing the replication and spread of an eGFP-tagged VACV. The experimental design incorporated a low multiplicity of infection, thereby enhancing detection of cellular proteins involved in cell-to-cell spread of VACV. The screen revealed 153 pro-and 149 anti-viral HFs that strongly influenced VACV replication. These HFs were investigated further by comparisons with transcriptional profiling data sets and HFs identified in RNAi screens of other viruses. In addition, functional and pathway analysis of the entire screen was carried out to highlight cellular mechanisms involved in VACV replication. This revealed, as anticipated, that many pro-viral HFs are involved in translation of mRNA and, unexpectedly, suggested that a range of proteins involved in cellular transcriptional processes and several DNA repair pathways possess anti-viral activity. Multiple components of the AMPK complex were found to act as pro-viral HFs, while several septins, a group of highly conserved GTP binding proteins with a role in sequestering intracellular bacteria, were identified as strong anti-viral VACV HFs. This screen has identified novel and previously unexplored roles for cellular factors in poxvirus replication. This advancement in our understanding of the VACV life cycle provides a reliable knowledge base for the improvement of poxvirus-based vaccine vectors and development of anti-viral theraputics.	[Beard, Philippa M.; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Beard, Philippa M.; Haga, Ismar R.; Jowers, Tali Pechenick; Reynolds, Danielle K.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Griffiths, Samantha J.; Ghazal, Peter; Haas, Juergen] Univ Edinburgh, Div Pathway Med, Edinburgh, Midlothian, Scotland; [Gonzalez, Orland; Zimmer, Ralf] Univ Munich, Inst Informat, D-80539 Munich, Germany; [Wildenhain, Jan; Tekotte, Hille; Auer, Manfred; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Tyers, Mike] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Ghazal, Peter] Univ Edinburgh, SynthSys, Ctr Integrat Syst Edinburgh, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Munich; University of Edinburgh; Universite de Montreal; University of Edinburgh	Beard, PM (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.	pip.beard@roslin.ed.ac.uk; juergen.haas@ed.ac.uk	Zimmer, Ralf/L-9295-2019; Tyers, Michael/ABE-3194-2021; Wildenhain, Jan/E-5597-2011; Wildenhain, Jan/Q-6596-2019	Wildenhain, Jan/0000-0002-5461-3828; Wildenhain, Jan/0000-0002-5461-3828; Beard, Pip/0000-0002-2285-810X; Tekotte, Hille/0000-0003-2164-7412; Auer, Manfred/0000-0001-8920-3522; Ghazal, Peter/0000-0003-0035-2228	BBSRC; Wellcome Trust; European Research Council [233457-SCG]; BBSRC [BB/D019621/1]; Wellcome Trust [GR066784]; Scottish Enterprise; EPSRC [BB/D019621/1]; BBSRC [BBS/E/D/20241864, BBS/E/D/20241866] Funding Source: UKRI; MRC [MC_G0802522] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/D019621/1, BBS/E/D/20241866] Funding Source: researchfish; Medical Research Council [MC_G0802522] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Enterprise; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Roslin Institute receives Institute Strategic Grant funding from the BBSRC. This work was supported by grants from the Wellcome Trust and the European Research Council (233457-SCG) (MT, JW and HT), BBSRC (BB/D019621/1), Wellcome Trust (GR066784), and Scottish Enterprise (PG). SynthSys is a Centre for Integrative Systems Biology (CISB) funded by BBSRC and EPSRC, reference BB/D019621/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; BOONE RF, 1978, J VIROL, V26, P554, DOI 10.1128/JVI.26.3.554-569.1978; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown, 2006, APPL MIXED MODELS ME; Broyles SS, 2003, J GEN VIROL, V84, P2293, DOI 10.1099/vir.0.18942-0; Brum LM, 2003, VIROLOGY, V315, P322, DOI 10.1016/S0042-6822(03)00532-4; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Carter GC, 2003, J GEN VIROL, V84, P2443, DOI 10.1099/vir.0.19271-0; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Clemente R, 2010, J VIROL, V84, P3562, DOI 10.1128/JVI.02274-09; Coyne CB, 2011, CELL HOST MICROBE, V9, P70, DOI 10.1016/j.chom.2011.01.001; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; De Braekeleer E, 2011, FUTURE ONCOL, V7, P77, DOI [10.2217/fon.10.158, 10.2217/FON.10.158]; de Magalhaes JC, 2001, J BIOL CHEM, V276, P38353, DOI 10.1074/jbc.M100183200; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gomez CE, 2011, CURR GENE THER, V11, P189; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Haga IR, 2014, J VIROL, V88, P3664, DOI 10.1128/JVI.03013-13; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002; Husain M, 2003, J VIROL, V77, P11754, DOI 10.1128/JVI.77.21.11754-11766.2003; Iwamoto M, 2010, GENES CELLS, V15, P661, DOI 10.1111/j.1365-2443.2010.01415.x; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kiss A, 2003, VIROLOGY, V314, P591, DOI 10.1016/S0042-6822(03)00531-2; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Luc PV, 2004, BIOINFORMATICS, V20, P1413, DOI 10.1093/bioinformatics/bth114; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Panda D, 2011, P NATL ACAD SCI USA, V108, P19036, DOI 10.1073/pnas.1113643108; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Rubins KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015615; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Santos CR, 2006, J VIROL, V80, P7667, DOI 10.1128/JVI.00967-06; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shors T, 1999, J VIROL, V73, P791, DOI 10.1128/JVI.73.1.791-796.1999; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004; Soares JAP, 2009, J VIROL, V83, P6883, DOI 10.1128/JVI.00245-09; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; Wang Y, 2000, GENE DEV, V14, P927; Wenzel M, 2012, J IMMUNOL, V188, P394, DOI 10.4049/jimmunol.1100523; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	73	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98431	10.1371/journal.pone.0098431	http://dx.doi.org/10.1371/journal.pone.0098431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901222	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000336841400027
J	Chen, JF; Ding, ZY; Peng, YH; Pan, F; Li, JJ; Zou, L; Zhang, YL; Liang, HJ				Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie			HIF-1 alpha Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; IN-VITRO; DRUG-RESISTANCE; GASTRIC-CANCER; MDR1 GENE; P-GP; CHEMOTHERAPY; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; CHEMOSENSITIVITY; CHEMORESISTANCE	Background: Multidrug resistance (MDR) is one of the major reasons chemotherapy-based treatments fail. Hypoxia is generally associated with tumor chemoresistance. However, the correlation between the heterodimeric hypoxia-inducible factor-1 (HIF-1) and the multidrug resistance (MDR1) gene/transporter P-glycoprotein (P-gp) remains unclear. This study aims to explore the molecular mechanisms of reversing colon cancer MDR by focusing on the target gene HIF-1 alpha. Methods: A chemotherapeutic sensitivity assay was used to observe the efficiency of MDR reversal in LoVo multicellular spheroids (MCS). The apoptotic level induced by different drugs was examined by flow cytometry (FCM). Binding of HIF-1 alpha to the MDR1 gene promoter was evaluated by Chromatin immunoprecipitation (ChIP). The relationship between HIF-1 alpha/P-gp expression and sensitivity to chemotherapy was analyzed. Results: The sensitivity of LoVo MCS to all four chemotherapy drugs was decreased to varying degrees under hypoxic conditions. After silencing the HIF-1 alpha gene, the sensitivities of LoVo MCS to all four chemotherapy drugs were restored. The apoptotic levels that all the drugs induced were all decreased to various extents in the hypoxic group. After silencing HI-1 alpha, the apoptosis level induced by all four chemotherapy drugs increased. The expression of HIF-1 alpha and P-gp was significantly enhanced in LoVo MCS after treatment with hypoxia. Inhibiting HIF-1 alpha significantly decreased the expression of MDR1/P-gp mRNA or protein in both the LoVo monolayers and LoVo MCS. The ChIP assay showed that HIF-1 alpha was bound to the MDR1 gene promoter. Advanced colon carcinoma patients with expression of both HIF-1 alpha and P-gp were more resistant to chemotherapy than that with non expression. Conclusions: HIF-1 alpha inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-gp. The expression of HIF-1 alpha and MDR1/P-gp can be used as a predictive marker for chemotherapy resistance in colon cancer.	[Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Chen, Jianfang; Ding, Zhenyu; Peng, Yonghai; Pan, Feng; Li, Jianjun; Zou, Lan; Zhang, Yanling; Liang, Houjie] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Ding, Zhenyu] Gen Hosp Shenyang Mil Reg, Dept Oncol, Shenyang, Liaoning, Peoples R China	Army Medical University; Army Medical University	Liang, HJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	lianghoujie@sina.com			National Natural Science Foundation of China [30973430, 81101629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30973430 and No. 81101629).(http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Brown JM, 1998, CANCER RES, V58, P1408; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010; Chen LM, 2004, J PHARM PHARMACOL, V56, P1061, DOI 10.1211/0022357043879; Chen M, 2012, J CELL BIOCHEM, V113, P2474, DOI 10.1002/jcb.24122; Comerford KM, 2002, CANCER RES, V62, P3387; Cuvillier O, 2013, ADV CANCER RES, V117, P117, DOI 10.1016/B978-0-12-394274-6.00005-4; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Ding ZY, 2010, J CANCER RES CLIN, V136, P1697, DOI 10.1007/s00432-010-0828-5; Dong XL, 2012, BIOMED PHARMACOTHER, V66, P70, DOI 10.1016/j.biopha.2011.11.016; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Kamiyama H, 2005, J CANCER RES CLIN, V131, P205, DOI 10.1007/s00432-004-0642-z; Kanagasabai R, 2011, J BIOL CHEM, V286, P33289, DOI 10.1074/jbc.M111.249102; Li J, 2006, BIOCHEM BIOPH RES CO, V342, P1341, DOI 10.1016/j.bbrc.2006.02.094; Liang Shuang, 2012, Genes Cancer, V3, P141, DOI 10.1177/1947601912457025; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Morin PJ, 2003, DRUG RESIST UPDATE, V6, P169, DOI 10.1016/S1368-7646(03)00059-1; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Oktem G, 2006, ONCOL RES, V16, P195; Owen MR, 2011, CANCER RES, V71, P2826, DOI 10.1158/0008-5472.CAN-10-2834; Ramaekers CHMA, 2011, RADIOTHER ONCOL, V101, P190, DOI 10.1016/j.radonc.2011.05.059; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sapra P, 2011, ANGIOGENESIS, V14, P245, DOI 10.1007/s10456-011-9209-1; Sasabe E, 2007, INT J CANCER, V120, P268, DOI 10.1002/ijc.22294; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Westhoff MA, 2009, DRUG RESIST UPDATE, V12, P127, DOI 10.1016/j.drup.2009.08.001; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	36	34	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98882	10.1371/journal.pone.0098882	http://dx.doi.org/10.1371/journal.pone.0098882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901645	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400065
J	Inaba, T; Hisatsune, C; Sasaki, Y; Ogawa, Y; Ebisui, E; Ogawa, N; Matsui, M; Takeuchi, T; Mikoshiba, K; Tsubota, K				Inaba, Takaaki; Hisatsune, Chihiro; Sasaki, Yasumasa; Ogawa, Yoko; Ebisui, Etsuko; Ogawa, Naoko; Matsui, Minoru; Takeuchi, Tsutomu; Mikoshiba, Katsuhiko; Tsubota, Kazuo			Mice Lacking Inositol 1,4,5-Trisphosphate Receptors Exhibit Dry Eye	PLOS ONE			English	Article							LACRIMAL GLAND; SIGNAL-TRANSDUCTION; PROTEIN SECRETION; SJOGRENS-SYNDROME; TYPE-3; ROLES; CA2+	Tear secretion is important as it supplies water to the ocular surface and keeps eyes moist. Both the parasympathetic and sympathetic pathways contribute to tear secretion. Although intracellular Ca2+ elevation in the acinar cells of lacrimal glands is a crucial event for tear secretion in both the pathways, the Ca2+ channel, which is responsible for the Ca2+ elevation in the sympathetic pathway, has not been sufficiently analyzed. In this study, we examined tear secretion in mice lacking the inositol 1,4,5-trisphosphate receptor (IP3R) types 2 and 3 (Itpr2(-/-); Itpr3(-/-) double-knockout mice). We found that tear secretion in both the parasympathetic and sympathetic pathways was abolished in Itpr2(-/-); Itpr3(-/-) mice. Intracellular Ca2+ elevation in lacrimal acinar cells after acetylcholine and epinephrine stimulation was abolished in Itpr2(-/-); Itpr3(-/-) mice. Consequently, Itpr2(-/-); Itpr3(-/-) mice exhibited keratoconjunctival alteration and corneal epithelial barrier disruption. Inflammatory cell infiltration into the lacrimal glands and elevation of serum autoantibodies, a representative marker for Sjogren's syndrome (SS) in humans, were also detected in older Itpr2(-/-); Itpr3(-/-) mice. These results suggested that IP(3)Rs are essential for tear secretion in both parasympathetic and sympathetic pathways and that Itpr2(-/-); Itpr3(-/-) mice could be a new dry eye mouse model with symptoms that mimic those of SS.	[Inaba, Takaaki; Sasaki, Yasumasa; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan; [Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Rheumatol, Shinjuku Ku, Tokyo, Japan; [Inaba, Takaaki; Hisatsune, Chihiro; Ebisui, Etsuko; Ogawa, Naoko; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Matsui, Minoru] Chiba Inst Sci, Dept Pharm, Choshi, Chiba, Japan; [Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Kawaguchi, Saitama, Japan	Keio University; Keio University; RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan.	mikosiba@brain.riken.jp	Hisatsune, Chihiro/C-6661-2017; Takeuchi, Tsutomu/L-2327-2013; Ogawa, Yoko/AAV-1932-2021; Takeuchi, Tsutomu/AFM-8316-2022; Mikoshiba, Katsuhiko/N-7943-2015	Hisatsune, Chihiro/0000-0001-7811-7784; Takeuchi, Tsutomu/0000-0003-1111-8218; Ogawa, Yoko/0000-0002-2906-9621; 	Japanese Ministry of Education, Culture, Sports, Science and Technology [20659272]; Nagao Memorial Fund; Moritani Scholarship Foundation; JSPS KAKENHI [20220007]; Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagao Memorial Fund; Moritani Scholarship Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (No. 20659272) from The Japanese Ministry of Education, Culture, Sports, Science and Technology, the Nagao Memorial Fund, the Moritani Scholarship Foundation (C.H.), JSPS KAKENHI Grant Number 20220007 (K.M.), and the Japan Science and Technology Agency (K.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DARTT DA, 1989, CURR EYE RES, V8, P619, DOI 10.3109/02713688908995762; DARTT DA, 1994, ADV EXP MED BIOL, V350, P1; DARTT DA, 1994, EXP EYE RES, V58, P423, DOI 10.1006/exer.1994.1035; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Fox Robert I., 1995, Current Opinion in Rheumatology, V7, P409, DOI 10.1097/00002281-199509000-00008; Fox Robert I., 1997, Current Opinion in Rheumatology, V9, P393, DOI 10.1097/00002281-199709000-00004; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; GROMADA J, 1995, PFLUG ARCH EUR J PHY, V429, P751, DOI 10.1007/BF00374798; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; HODGES RR, 1992, AM J PHYSIOL, V262, pG1087, DOI 10.1152/ajpgi.1992.262.6.G1087; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	16	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99205	10.1371/journal.pone.0099205	http://dx.doi.org/10.1371/journal.pone.0099205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901844	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400109
J	Sidze, LK; Tekwu, EM; Kuaban, C; Assam, JPA; Tedom, JC; Eyangoh, S; Fouda, FX; Nolna, D; Ntoumi, F; Frank, M; Beng, VNP				Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Kuaban, Christopher; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Eyangoh, Sara; Fouda, Francois-Xavier; Nolna, Desire; Ntoumi, Francine; Frank, Matthias; Beng, Veronique N. Penlap			Strong Decrease in Streptomycin-Resistance and Absence of XDR 12 Years after the Reorganization of the National Tuberculosis Control Program in the Central Region of Cameroon	PLOS ONE			English	Article							ANTITUBERCULOSIS DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; HONG-KONG; SURVEILLANCE; SUSCEPTIBILITY; IMPLEMENTATION; INFECTION; YAOUNDE; WEST	Background: In the 1990s, resistance rates of 15% for streptomycin-resistance and 0.6% for multidrug-resistance (MDR) were reported from the Central Region of Cameroon. This work assesses drug resistant tuberculosis in this region 12 years after reorganization of the National Tuberculosis Control Program (NTCP). Methods: This cross-sectional study was conducted from April 2010 to March 2011 in Jamot Hospital in Yaounde, Cameroon. Only patients with smear positive pulmonary tuberculosis were included. Sputa were cultured and subsequently underwent drug susceptibility testing (DST). All consenting individuals were tested for their HIV status. Results: A total of 665 smear positive pulmonary tuberculosis patients were enrolled. The HIV prevalence was 28.5% (95%CI [25.2-32.1]). Of the 582 sputa that grew Mycobacterium tuberculosis complex species, DST results were obtained for 576. The overall resistance rate was 10.9% (63/576). The overall resistance rates for single drug resistance were: isoniazid-resistance 4.7% (27/576), streptomycin-resistance 3.3% (19/576), rifampicin-resistance 0.2% (1/576), kanamycin-resistance 0.2% (1/576) and ofloxacin-resistance 0.2% (1/576). The MDR rate was 1.1% (6/576) and no extensively drug resistant tuberculosis (XDR) was detected. Conclusions: The data show that reorganization of the NTCP resulted in a strong decrease in streptomycin-resistance and suggest that it prevented the emergence of XDR in the Central Region of Cameroon.	[Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Beng, Veronique N. Penlap] Univ Yaounde I, Biotechnol Ctr BTC, LTR, Yaounde, Cameroon; [Kuaban, Christopher] Jamot Hosp, Pneumol Unit, Yaounde, Cameroon; [Eyangoh, Sara] Ctr Pasteur Cameroon, Mycobacteriol Serv, NTP, Pasteur Inst Int Network,Reference Lab, Yaounde, Cameroon; [Fouda, Francois-Xavier] Mbalmayo Dist Hosp, Mbalmayo, Cameroon; [Nolna, Desire] NTCP, Yaounde, Cameroon; [Ntoumi, Francine] Univ Marien Ngouabi, Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Ntoumi, Francine; Frank, Matthias] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Frank, Matthias] DZIF, Tubingen, Germany; [Sidze, Larissa Kamgue; Tekwu, Emmanuel Mouafo; Assam, Jean-Paul Assam; Tedom, Jean-Claude; Ntoumi, Francine; Frank, Matthias; Beng, Veronique N. Penlap] Cent African Network TB AIDS HIV & Malaria CANTAM, Brazzaville, Rep Congo	University of Yaounde I; Eberhard Karls University of Tubingen; German Center for Infection Research	Frank, M (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	Matthias.Frank@uni-tuebingen.de; v.penlap@yahoo.fr			Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM); European Developing Countries Clinical Trials Partnership (EDCTP) [CB.2007.41700.006]	Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was financially supported by Central Africa Network for Tuberculosis, AIDS/HIV and Malaria (CANTAM), a network sponsored by the European Developing Countries Clinical Trials Partnership (EDCTP) (Grant No CB.2007.41700.006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Bercion R, 1997, INT J TUBERC LUNG D, V1, P110; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cauthen GM, 1996, AM J EPIDEMIOL, V144, P69, DOI 10.1093/oxfordjournals.aje.a008856; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Chaulet P, 1995, TUBERCLE LUNG DIS, V76, P487, DOI 10.1016/0962-8479(95)90523-5; Chode TM, 1989, B INT UNION TUBERC L, V64, P37; DEGOMMIER J, 1957, ANN I PASTEUR PARIS, V92, P692; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; Dolgin E, 2010, NAT MED, V16, P8, DOI 10.1038/nm0110-8a; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Grosset J, 1990, BACTERIOLOGIE MED, P965; Kam KM, 2004, INT J TUBERC LUNG D, V8, P760; Kam KM, 2001, INT J TUBERC LUNG D, V5, P815; Keugoung B, 2013, REV EPIDEMIOL SANTE, V61, P129, DOI 10.1016/j.respe.2012.10.005; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P427; Meriki HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077410; Noeske Jurgen, 2012, BMC Res Notes, V5, P160, DOI 10.1186/1756-0500-5-160; Sangare L, 2010, ANN AFR MED, V9, P15, DOI 10.4103/1596-3519.62619; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Sidze LK, 2013, ADV INFECT DIS, V3, P55; Takiff H, 2011, ANTIMICROB AGENTS CH, V55, P5421, DOI 10.1128/AAC.00695-11; Tantchou J, 2007, EPIDEMIE POLITIQUE A, P267; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2012, WHOHTMTB201262; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P364, DOI 10.1128/AAC.01228-13	28	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98374	10.1371/journal.pone.0098374	http://dx.doi.org/10.1371/journal.pone.0098374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901982	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400026
J	Zhong, C; Li, F; Liu, M; Yang, XN; Zhu, HX; Jia, YY; Jia, SR; Piergiovanni, L				Zhong, Cheng; Li, Fei; Liu, Miao; Yang, Xiao-Ning; Zhu, Hui-Xia; Jia, Yuan-Yuan; Jia, Shi-Ru; Piergiovanni, Luciano			Revealing Differences in Metabolic Flux Distributions between a Mutant Strain and Its Parent Strain Gluconacetobacter xylinus CGMCC 2955	PLOS ONE			English	Article							BACTERIAL CELLULOSE PRODUCTION; CORYNEBACTERIUM-GLUTAMICUM; DEHYDROGENASE; BIOSYNTHESIS; IMPROVEMENT; PATHWAYS	A better understanding of metabolic fluxes is important for manipulating microbial metabolism toward desired end products, or away from undesirable by-products. A mutant strain, Gluconacetobacter xylinus AX2-16, was obtained by combined chemical mutation of the parent strain (G. xylinus CGMCC 2955) using DEC (diethyl sulfate) and LiCl. The highest bacterial cellulose production for this mutant was obtained at about 11.75 g/L, which was an increase of 62% compared with that by the parent strain. In contrast, gluconic acid (the main byproduct) concentration was only 5.71 g/L for mutant strain, which was 55.7% lower than that of parent strain. Metabolic flux analysis indicated that 40.1% of the carbon source was transformed to bacterial cellulose in mutant strain, compared with 24.2% for parent strain. Only 32.7% and 4.0% of the carbon source were converted into gluconic acid and acetic acid in mutant strain, compared with 58.5% and 9.5% of that in parent strain. In addition, a higher flux of tricarboxylic acid (TCA) cycle was obtained in mutant strain (57.0%) compared with parent strain (17.0%). It was also indicated from the flux analysis that more ATP was produced in mutant strain from pentose phosphate pathway (PPP) and TCA cycle. The enzymatic activity of succinate dehydrogenase (SDH), which is one of the key enzymes in TCA cycle, was 1.65-fold higher in mutant strain than that in parent strain at the end of culture. It was further validated by the measurement of ATPase that 3.53-6.41 fold higher enzymatic activity was obtained from mutant strain compared with parent strain.	[Zhong, Cheng; Li, Fei; Liu, Miao; Yang, Xiao-Ning; Zhu, Hui-Xia; Jia, Yuan-Yuan; Jia, Shi-Ru] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin, Peoples R China; [Li, Fei; Piergiovanni, Luciano] Univ Milan, Dept Food Environm & Nutr Sci, DeFENS, Milan, Italy; [Jia, Yuan-Yuan] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China	Tianjin University Science & Technology; University of Milan; Tianjin University	Jia, SR (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Tianjin, Peoples R China.	jiashiru@tust.edu.cn	jia, shi/HHS-4172-2022		National Natural Science Foundation of China [21106105, 20976133]; Foundation of Tianjin Educational Committee [20100602]; National High Technology Research and Development Programme ("863'' Program) of China [2012AA022108]; Changjiang Scholars and Innovative Research Team in University [IRT1166]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Tianjin Educational Committee; National High Technology Research and Development Programme ("863'' Program) of China(National High Technology Research and Development Program of China); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The authors are grateful for the financial support from the National Natural Science Foundation of China (Project No. 21106105, Project No. 20976133), the Foundation of Tianjin Educational Committee (No. 20100602), the National High Technology Research and Development Programme ("863'' Program) of China (No. 2012AA022108), and Changjiang Scholars and Innovative Research Team in University (No. IRT1166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; Bae SO, 2005, APPL MICROBIOL BIOT, V67, P45, DOI 10.1007/s00253-004-1723-2; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BENZIMAN M, 1964, J BACTERIOL, V88, P1010, DOI 10.1128/JB.88.4.1010-1018.1964; BENZIMAN M, 1978, J BACTERIOL, V134, P1; CSONKA LN, 1977, J BIOL CHEM, V252, P3382; Ha JH, 2012, KOREAN J CHEM ENG, V29, P563, DOI 10.1007/s11814-011-0224-0; Hu SY, 2004, SCI CHINA SER B, V47, P206, DOI 10.1360/03yb0204; Ishida T, 2003, BIOTECHNOL BIOENG, V83, P474, DOI 10.1002/bit.10690; Jung HI, 2010, BIORESOURCE TECHNOL, V101, P3602, DOI 10.1016/j.biortech.2009.12.111; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303; Kwon YD, 2007, J APPL MICROBIOL, V103, P2340, DOI 10.1111/j.1365-2672.2007.03485.x; Li YJ, 2012, APPL MICROBIOL BIOT, V96, P1479, DOI 10.1007/s00253-012-4242-6; Marx A, 1996, BIOTECHNOL BIOENG, V49, P111, DOI 10.1002/(SICI)1097-0290(19960120)49:2<111::AID-BIT1>3.0.CO;2-T; Ng RTL, 2012, CHEM ENGINEER TRANS, V29, P1123, DOI 10.3303/CET1229188; Noh K, 2011, APPL MICROBIOL BIOT, V91, P1247, DOI 10.1007/s00253-011-3390-4; Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y; Rauch B, 2010, APPL MICROBIOL BIOT, V88, P711, DOI 10.1007/s00253-010-2779-9; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Sarkar D, 2010, APPL MICROBIOL BIOT, V87, P127, DOI 10.1007/s00253-010-2474-x; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Shang YZ, 2005, PHARMACOL BIOCHEM BE, V82, P67, DOI 10.1016/j.pbb.2005.06.018; Shi HD, 1997, J FERMENT BIOENG, V84, P579, DOI 10.1016/S0922-338X(97)81915-0; Shigematsu T, 2005, J BIOSCI BIOENG, V99, P415, DOI 10.1263/jbb.99.415; SWISSA M, 1980, J BACTERIOL, V143, P1142, DOI 10.1128/JB.143.3.1142-1150.1980; Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; Tonouchi N, 2003, BIOSCI BIOTECH BIOCH, V67, P2648, DOI 10.1271/bbb.67.2648; Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006; VALLINO JJ, 1993, BIOTECHNOL BIOENG, V41, P633, DOI 10.1002/bit.260410606; Velasco-Bedran H, 2007, PROCESS BIOCHEM, V42, P1180, DOI 10.1016/j.procbio.2007.05.017; Venkatesalu V, 2008, PHOTOSYNTHETICA, V46, P622, DOI 10.1007/s11099-008-0105-x; Venkatesh KV, 1997, PROCESS BIOCHEM, V32, P651, DOI 10.1016/S0032-9592(97)00014-9; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yao XL, 2012, FOOD CHEM, V132, P1883, DOI 10.1016/j.foodchem.2011.12.021; Yunzhuan H, 1999, ACTA ENTOMOL SIN, V1; Zeng XB, 2011, CARBOHYD POLYM, V85, P506, DOI 10.1016/j.carbpol.2011.02.034; Zhong C, 2013, APPL MICROBIOL BIOT, V97, P6189, DOI 10.1007/s00253-013-4908-8; Zhong C, 2010, BIOFUEL BIOPROD BIOR, V4, P326, DOI 10.1002/bbb.207; Zhong C, 2009, APPL MICROBIOL BIOT, V84, P667, DOI 10.1007/s00253-009-2001-0; Zhu HX, 2011, BIOTECHNOL BIOTECHNO, V25	42	29	30	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98772	10.1371/journal.pone.0098772	http://dx.doi.org/10.1371/journal.pone.0098772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901455	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400050
J	Ahlstrand, E; Hellmark, B; Svensson, K; Soderquist, B				Ahlstrand, Erik; Hellmark, Bengt; Svensson, Karolina; Soderquist, Bo			Long-Term Molecular Epidemiology of Staphylococcus epidermidis Blood Culture Isolates from Patients with Hematological Malignancies	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; HOSPITAL-ACQUIRED INFECTION; SCCMEC TYPE-IV; GENETIC DIVERSITY; SWEDISH COUNTY; UNITED-STATES; SUSCEPTIBILITY; COLONIZATION; RESISTANCE; SYSTEM	Staphylococcus epidermidis is an important cause of bloodstream infections in patients with hematological malignancies. Knowledge of the long-term epidemiology of these infections is limited. We surveyed all S. epidermidis blood culture isolates from patients treated for hematological malignancies at the University Hospital of Orebro, Sweden from 1980 to 2009. A total of 373 S. epidermidis isolates were identified and multilocus sequence typing, staphylococcal chromosome cassette mec (SCCmec) typing and standard antibiotic susceptibility testing were employed to characterize these isolates. The majority of the isolates 361/373 (97%) belonged to clonal complex 2, and the 373 isolates were divided into 45 sequence types (STs); Simpson's Diversity Index was 0.56. The most prevalent STs were ST2 (243/373, 65%) and ST215 (28/373, 8%). Ninety three percent (226/243) of the ST2 isolates displayed either SCCmec type III or IV. ST2 and 215 were isolated during the entire study period, and together these STs caused temporal peaks in the number of positive blood cultures of S. epidermidis. Methicillin resistance was detected in 213/273 (78%) of all isolates. In the two predominating STs, ST2 and ST215, methicillin resistance was detected in 256/271 isolates (95%), compared with 34/100 (34%) in other STs (p<0.001). In conclusion, in this long-term study of patients with hematological malignancies, we demonstrate a predominance of methicillin-resistant ST2 among S. epidermidis blood culture isolates.	[Ahlstrand, Erik] Orebro Univ Hosp, Dept Med, Div Hematol, Orebro, Sweden; [Hellmark, Bengt; Svensson, Karolina; Soderquist, Bo] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Ahlstrand, Erik; Soderquist, Bo] Univ Orebro, Fac Med & Hlth, SE-70182 Orebro, Sweden	Orebro University; Orebro University; Orebro University	Ahlstrand, E (corresponding author), Orebro Univ Hosp, Dept Med, Div Hematol, Orebro, Sweden.	erik.ahlstrand@orebroll.se		Soderquist, Bo/0000-0001-5939-2932	Orebro county council research committee at the Orebro University Hospital, Sweden	Orebro county council research committee at the Orebro University Hospital, Sweden	The study was supported by grants from the Orebro county council research committee at the Orebro University Hospital, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrand E, 2011, EUR J CLIN MICROBIOL, V30, P1349, DOI 10.1007/s10096-011-1228-8; Beekmann SE, 2005, INFECT CONT HOSP EP, V26, P559, DOI 10.1086/502584; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; Burnie JP, 1997, J CLIN MICROBIOL, V35, P1746, DOI 10.1128/JCM.35.7.1746-1750.1997; Claesson C, 2007, SCAND J INFECT DIS, V39, P1002, DOI 10.1080/00365540701472064; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Gordon RJ, 2012, J INFECT DIS, V205, P1391, DOI 10.1093/infdis/jis218; Hellmark B, 2013, INT J MED MICROBIOL, V303, P32, DOI 10.1016/j.ijmm.2012.11.001; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Kelly S, 2008, J ANTIMICROB CHEMOTH, V61, P901, DOI 10.1093/jac/dkn043; Krediet TG, 2004, J CLIN MICROBIOL, V42, P992, DOI 10.1128/JCM.42.3.992-995.2004; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; Mendes RE, 2012, ANTIMICROB AGENTS CH, V56, P4656, DOI 10.1128/AAC.00279-12; Miragaia M, 2008, J CLIN MICROBIOL, V46, P118, DOI 10.1128/JCM.01685-07; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007722; Muldrew KL, 2008, J CLIN MICROBIOL, V46, P3391, DOI 10.1128/JCM.00115-08; Nouwen JL, 1998, J CLIN MICROBIOL, V36, P2696, DOI 10.1128/JCM.36.9.2696-2702.1998; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Persson L, 2006, EUR J CLIN MICROBIOL, V25, P299, DOI 10.1007/s10096-006-0129-8; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Sanches IS, 2000, MICROB DRUG RESIST, V6, P199, DOI 10.1089/mdr.2000.6.199; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wang XM, 2003, J MED MICROBIOL, V52, P989, DOI 10.1099/jmm.0.05360-0; Widerstrom M, 2006, J HOSP INFECT, V64, P177, DOI 10.1016/j.jhin.2006.06.013; Widerstrom M, 2011, EUROPEAN J CLIN MICR; Widerstrom M, 2012, J CLIN MICROBIOL, V50, P2147, DOI 10.1128/JCM.06456-11; Widerstrom M, 2011, APMIS, V119, P505, DOI 10.1111/j.1600-0463.2011.02757.x; Widerstrom Micael, 2009, Scand J Infect Dis, V41, P642, DOI 10.1080/00365540903146987; Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339; Wisplinghoff H, 2003, ANTIMICROB AGENTS CH, V47, P3574, DOI 10.1128/AAC.47.11.3574-3579.2003; [No title captured]	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99045	10.1371/journal.pone.0099045	http://dx.doi.org/10.1371/journal.pone.0099045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896826	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700108
J	Cocos, R; Sendroiu, A; Schipor, S; Bohiltea, LC; Sendroiu, I; Raicu, F				Cocos, Relu; Sendroiu, Alina; Schipor, Sorina; Bohiltea, Laurentiu Camil; Sendroiu, Ionut; Raicu, Florina			Genotype-Phenotype Correlations in a Mountain Population Community with High Prevalence of Wilson's Disease: Genetic and Clinical Homogeneity	PLOS ONE			English	Article							ATP7B GENE; MUTATION ANALYSIS; MOLECULAR CHARACTERIZATION; CONSECUTIVE GENERATIONS; HAPLOTYPE ANALYSIS; COPPER-METABOLISM; 2 FAMILIES; DIAGNOSIS; IDENTIFICATION; MANIFESTATION	Wilson's disease is an autosomal recessive disorder caused by more than 500 mutations in ATP7B gene presenting considerably clinical manifestations heterogeneity even in patients with a particular mutation. Previous findings suggested a potential role of additional genetic modifiers and environment factors on phenotypic expression among the affected patients. We conducted clinical and genetic investigations to perform genotype-phenotype correlation in two large families living in a socio-culturally isolated community with the highest prevalence of Wilson's disease ever reported of 1:1130. Sequencing of ATP7B gene in seven affected individuals and 43 family members identified a common compound heterozygous genotype, H1069Q/M769H-fs, in five symptomatic and two asymptomatic patients and detected the presence of two out of seven identified single nucleotide polymorphisms in all affected patients. Symptomatic patients had similar clinical phenotype and age at onset (1861 years) showing dysarthria and dysphagia as common clinical features at the time of diagnosis. Moreover, all symptomatic patients presented Kayser-Fleischer rings and lack of dystonia accompanied by unfavourable clinical outcomes. Our findings add value for understanding of genotype-phenotype correlations in Wilson's disease based on a multifamily study in an isolated population with high extent of genetic and environmental homogeneity as opposed to majority of reports. We observed an equal influence of presumed other genetic modifiers and environmental factors on clinical presentation and age at onset of Wilson's disease in patients with a particular genotype. These data provide valuable inferences that could be applied for predicting clinical management in asymptomatic patients in such communities.	[Cocos, Relu; Bohiltea, Laurentiu Camil; Raicu, Florina] Carol Davila Univ Med & Pharm, Chair Med Genet, Bucharest, Romania; [Raicu, Florina] Acad Romana, Francisc I Rainer Anthropol Res Inst, Bucharest, Romania; [Cocos, Relu] Genome Life Res Ctr, Bucharest, Romania; [Schipor, Sorina] Natl Inst Endocrinol CI Parhon, Bucharest, Romania; [Sendroiu, Alina; Sendroiu, Ionut] Family Med Ctr, Rucar, Romania; [Bohiltea, Laurentiu Camil] Sf Pantelimon Clin Emergency Hosp, Bucharest, Romania	Carol Davila University of Medicine & Pharmacy; Romanian Academy of Sciences; National Institute of Endocrinology C.I. Parhon	Raicu, F (corresponding author), Carol Davila Univ Med & Pharm, Chair Med Genet, Bucharest, Romania.	florina_raicu@yahoo.com	Schipor, Sorina/B-5062-2012; Cocoș, Relu/O-4134-2017; Raicu, Florina/A-4531-2011; Cocos, Relu/AAS-3810-2021	Schipor, Sorina/0000-0002-4886-2174; Cocoș, Relu/0000-0002-6209-2305; 	Romanian National Authority for Scientific Research, CNCS-UEFISCDI [2005-CNCSIS-27677, PN-II-ID-PCCE 2011-2-0013]	Romanian National Authority for Scientific Research, CNCS-UEFISCDI	This work was financially supported by two grants of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI, project numbers 2005-CNCSIS-27677 and PN-II-ID-PCCE 2011-2-0013. www.cncs-nrc.ro and http://uefiscdi.gov.ro/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Barada K, 2007, CLIN GENET, V72, P264, DOI 10.1111/j.1399-0004.2007.00853.x; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Brage A, 2007, HEPATOL RES, V37, P18, DOI 10.1111/j.1872-034X.2007.00010.x; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Chabik G, 2014, J INHERIT METAB DIS, V37, P131, DOI 10.1007/s10545-013-9625-z; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; Cox DW, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9358; Czlonkowska A, 2009, MOVEMENT DISORD, V24, P1066, DOI 10.1002/mds.22474; Dedoussis GVZ, 2005, ANN HUM GENET, V69, P268, DOI 10.1046/j.1529-8817.2005.00171.x; Duc HH, 1998, EUR J HUM GENET, V6, P616; Dziezyc K, 2011, PARKINSONISM RELAT D, V17, P577, DOI 10.1016/j.parkreldis.2011.04.013; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; FIGUS A, 1995, AM J HUM GENET, V57, P1318; Firneisz G, 2001, AM J GASTROENTEROL, V96, P2269, DOI 10.1016/S0002-9270(01)02546-1; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frydman F, 1985, P NATL ACAD SCI USA, V82, P1819; Garcia-Villarreal L, 2000, HEPATOLOGY, V32, P1329, DOI 10.1053/jhep.2000.20152; GILMAN PA, 1982, JAMA-J AM MED ASSOC, V248, P467, DOI 10.1001/jama.248.4.467; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Gromadzka G, 2006, MOVEMENT DISORD, V21, P245, DOI 10.1002/mds.20671; Gromadzka G, 2005, CLIN GENET, V68, P524, DOI 10.1111/j.1399-0004.2005.00528.x; Gupta A, 2005, HUM GENET, V118, P49, DOI 10.1007/s00439-005-0007-y; Gupta A, 2007, CLIN CHEM, V53, P1601, DOI 10.1373/clinchem.2007.086066; Iacob R, 2012, J GASTROINTEST LIVER, V21, P181; Lee BH, 2011, LIVER INT, V31, P833, DOI 10.1111/j.1478-3231.2011.02503.x; Lepori MB, 2012, MOL CELL PROBE, V26, P147, DOI 10.1016/j.mcp.2012.03.007; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Merle U., 2010, BMC GASTROENTEROL, V18, P10; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Nicastro E, 2009, J HEPATOL, V50, P555, DOI 10.1016/j.jhep.2008.09.020; Olsson C, 2000, EUR J HUM GENET, V8, P933, DOI 10.1038/sj.ejhg.5200566; Panagiotakaki E, 2004, AM J MED GENET A, V131A, P168, DOI 10.1002/ajmg.a.30345; REILLY M, 1993, J NEUROL NEUROSUR PS, V56, P298, DOI 10.1136/jnnp.56.3.298; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Santhosh S, 2008, WORLD J GASTROENTERO, V14, P4672, DOI 10.3748/wjg.14.4672; SCHEINBERG IH, 1952, SCIENCE, V116, P484, DOI 10.1126/science.116.3018.484; Scheinberg IH, 1984, WILSONS DIS, P23; Simon I, 2008, WORLD J GASTROENTERO, V14, P2383, DOI 10.3748/wjg.14.2383; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STERNLIEB I, 1990, HEPATOLOGY, V12, P1234, DOI 10.1002/hep.1840120526; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Takeshita Y, 2002, J HUM GENET, V47, P543, DOI 10.1007/s100380200082; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; Usta J, 2012, JIMD REP, V4, P129, DOI 10.1007/8904_2011_91; Vrabelova S, 2005, MOL GENET METAB, V86, P277, DOI 10.1016/j.ymgme.2005.05.004; Wang LH, 2011, J HUM GENET, V56, P660, DOI 10.1038/jhg.2011.76; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; Ye S, 2007, WORLD J GASTROENTERO, V13, P5147, DOI 10.3748/wjg.v13.i38.5147	50	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98520	10.1371/journal.pone.0098520	http://dx.doi.org/10.1371/journal.pone.0098520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897373	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700047
J	Fang, BS; Niu, J; Ren, H; Guo, YX; Wang, SZ				Fang, Baishan; Niu, Jin; Ren, Hong; Guo, Yingxia; Wang, Shizhen			Mechanistic Study of Manganese-Substituted Glycerol Dehydrogenase Using a Kinetic and Thermodynamic Analysis	PLOS ONE			English	Article							ACTIVE-SITE METAL; ESCHERICHIA-COLI; STABILITY; BINDING; DESIGN	Mechanistic insights regarding the activity enhancement of dehydrogenase by metal ion substitution were investigated by a simple method using a kinetic and thermodynamic analysis. By profiling the binding energy of both the substrate and product, the metal ion's role in catalysis enhancement was revealed. Glycerol dehydrogenase (GDH) from Klebsiella pneumoniae sp., which demonstrated an improvement in activity by the substitution of a zinc ion with a manganese ion, was used as a model for the mechanistic study of metal ion substitution. A kinetic model based on an ordered Bi-Bi mechanism was proposed considering the noncompetitive product inhibition of dihydroxyacetone (DHA) and the competitive product inhibition of NADH. By obtaining preliminary kinetic parameters of substrate and product inhibition, the number of estimated parameters was reduced from 10 to 4 for a nonlinear regression-based kinetic parameter estimation. The simulated values of time-concentration curves fit the experimental values well, with an average relative error of 11.5% and 12.7% for Mn-GDH and GDH, respectively. A comparison of the binding energy of enzyme ternary complex for Mn-GDH and GDH derived from kinetic parameters indicated that metal ion substitution accelerated the release of dioxyacetone. The metal ion's role in catalysis enhancement was explicated.	[Fang, Baishan; Niu, Jin; Ren, Hong; Guo, Yingxia; Wang, Shizhen] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; [Fang, Baishan; Wang, Shizhen] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen, Peoples R China	Xiamen University; Xiamen University	Wang, SZ (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	szwang@xmu.edu.cn	Guo, Ying/AGH-9666-2022		National Natural Science Foundation of China [41176111, 41306124, 21336009]; Natural Science Foundation of Fujian Province of China [2012J01049]; Fundamental Research Funds for the Central Universities [2013121029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 41176111, No. 41306124), the Key Program of National Natural Science Foundation of China (No. 21336009), the Natural Science Foundation of Fujian Province of China (No. 2012J01049), and the Fundamental Research Funds for the Central Universities (No. 2013121029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 2010, J PHYS CHEM B, V114, P17003, DOI 10.1021/jp107337g; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Arima J, 2009, BIOCHIMIE, V91, P568, DOI 10.1016/j.biochi.2009.01.015; Bogin O, 1997, PROTEIN SCI, V6, P450; BOHACEK RS, 1994, J AM CHEM SOC, V116, P5560, DOI 10.1021/ja00092a006; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; Chen BH, 2008, AICHE J, V54, P2155, DOI 10.1002/aic.11545; Chen HC, 2010, INTEGR SER INFORM SY, V21, P177, DOI 10.1007/978-1-4419-1278-7_13; D'Antonio EL, 2011, BIOCHEMISTRY-US, V50, P8018, DOI 10.1021/bi201101t; Dobson R, 2012, J IND MICROBIOL BIOT, V39, P217, DOI 10.1007/s10295-011-1038-0; Enders D, 2005, ANGEW CHEM INT EDIT, V44, P1304, DOI 10.1002/anie.200400659; Fisher HF, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0001341, DOI 10.1038/NPG.ELS.0001341]; Fisher HF, 2010, EMERGENCY RELIEF SYS, P1, DOI [10.1002/9780470015902.a0001341.pub, DOI 10.1002/9780470015902.A0001341.PUB]; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; Lapenaite I, 2006, CRIT REV ANAL CHEM, V36, P13, DOI 10.1080/10408340500451973; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Leskovac V, 2004, COMPREHENSIVE ENZYME, P141; Martinez-Rodriguez S, 2009, BIOPHYS CHEM, V139, P42, DOI 10.1016/j.bpc.2008.10.003; NISHISE H, 1984, AGR BIOL CHEM TOKYO, V48, P1603, DOI 10.1080/00021369.1984.10866361; Rochu D, 2004, BIOCHEM J, V380, P627, DOI 10.1042/BJ20031861; Ruzheinikov SN, 2001, STRUCTURE, V9, P789, DOI 10.1016/S0969-2126(01)00645-1; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Sokic-Lazic D, 2010, ELECTROANAL, V22, P757, DOI 10.1002/elan.200980010; Sparta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047172; TANG JCT, 1982, J BACTERIOL, V152, P1169; Wang SZ, 2013, BIOTECHNOL BIOPROC E, V18, P796, DOI 10.1007/s12257-013-0125-7; Wang Y, 2014, J BIOL CHEM, V289, P6080, DOI 10.1074/jbc.M113.525535; Zhang K, 2009, MED MICROBIOL IMMUN, V198, P195, DOI 10.1007/s00430-009-0119-4; Zhang Y, 2011, BIORESOURCE TECHNOL, V102, P1837, DOI 10.1016/j.biortech.2010.09.069; Zheng MQ, 2011, BIOCATAL BIOTRANSFOR, V29, P278, DOI 10.3109/10242422.2011.631212	31	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99162	10.1371/journal.pone.0099162	http://dx.doi.org/10.1371/journal.pone.0099162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896258	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700120
J	Marianelli, C; Petrucci, P; Comelli, MC; Calderini, G				Marianelli, Cinzia; Petrucci, Paola; Comelli, Maria Cristina; Calderini, Gabriella			Silver Sucrose Octasulfate (IASOS (TM)) as a Valid Active Ingredient into a Novel Vaginal Gel against Human Vaginal Pathogens: In Vitro Antimicrobial Activity Assessment	PLOS ONE			English	Article							CANDIDA-ALBICANS; BACTERIAL VAGINOSIS; AEROBIC VAGINITIS; NANOPARTICLES; BIOFILMS; ION; MICROSCOPY; ADHESION; THYMOL	This in vitro study assessed the antimicrobial properties of a novel octasilver salt of Sucrose Octasulfate (IASOS) as well as of an innovative vaginal gel containing IASOS (SilSOS Femme), against bacterial and yeast pathogens isolated from human clinical cases of symptomatic vaginal infections. In BHI and LAPT culture media, different ionic silver concentrations and different pHs were tested. IASOS exerted a strong antimicrobial activity towards all the pathogens tested in both culture media. The results demonstrated that salts and organic compounds present in the culture media influenced IASOS efficacy only to a moderate extent. Whereas comparable MBCs (Minimal Bactericidal Concentrations) were observed for G. vaginalis (10 mg/L Ag+), E. coli and E. aerogenes (25 mg/L Ag+) in both media, higher MBCs were found for S. aureus and S. agalactiae in LAPT cultures (50 mg/L Ag+ versus 25 mg/L Ag+). No minimal concentration totally inhibiting the growth of C. albicans was found. Nevertheless, in both media at the highest ionic silver concentrations (50-200 mg/L Ag+), a significant 34-52% drop in Candida growth was observed. pH differently affected the antimicrobial properties of IASOS against bacteria or yeasts; however, a stronger antimicrobial activity at pH higher than the physiological pH was generally observed. It can be therefore concluded that IASOS exerts a bactericidal action against all the tested bacteria and a clear fungistatic action against C. albicans. The antimicrobial activity of the whole vaginal gel SilSOS Femme further confirmed the antimicrobial activity of IASOS. Overall, our findings support IASOS as a valid active ingredient into a vaginal gel.	[Marianelli, Cinzia; Petrucci, Paola] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Comelli, Maria Cristina; Calderini, Gabriella] CM&D Pharma Srl, Padua, Italy	Istituto Superiore di Sanita (ISS)	Marianelli, C (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	cinzia.marianelli@iss.it	MARIANELLI, CINZIA/C-7036-2015	MARIANELLI, CINZIA/0000-0002-5190-4574	CM&D Pharma Limited, UK; Istituto Superiore di Santia	CM&D Pharma Limited, UK; Istituto Superiore di Santia	The study was funded by CM&D Pharma Limited, UK pursuant to a technical and scientific service agreement with Istituto Superiore di Santia. The authors hold the following patents: US 61/715,226 Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia, authors Comelli Maria Cristina, Calderini Gabriella; US 7,183,315 Silver salts of sucrose octasulfate, authors Calderini Gabriella, Prosdocimi Marco, Antico Claudio, Miglierini Giuliana, Casadei Massari Danilo. InterAlia Pharma Srl, Italy (IP owner), kindly supported publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856; Biggs WS, 2009, PRIMARY CARE, V36, P33, DOI 10.1016/j.pop.2008.10.002; Borges S, 2012, ANTON LEEUW INT J G, V101, P677, DOI 10.1007/s10482-011-9666-y; Braga PC, 2010, ARZNEIMITTELFORSCH, V60, P675, DOI 10.1055/s-0031-1296346; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005; Chen MW, 2011, INT J NANOMED, V6, P2873, DOI 10.2147/IJN.S23945; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923; Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467; Donati L, 2010, ARCH GYNECOL OBSTET, V281, P589, DOI 10.1007/s00404-009-1318-3; Donders GGG, 2011, BJOG-INT J OBSTET GY, V118, P1163, DOI 10.1111/j.1471-0528.2011.03020.x; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Donders GGG, 2007, BEST PRACT RES CL OB, V21, P355, DOI 10.1016/j.bpobgyn.2007.01.002; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; Hwang IS, 2012, FEBS J, V279, P1327, DOI 10.1111/j.1742-4658.2012.08527.x; Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1446, DOI 10.1128/AAC.00054-07; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kumar SA, 2007, BIOTECHNOL LETT, V29, P439, DOI 10.1007/s10529-006-9256-7; LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06; Lee JH, 2006, J AGR FOOD CHEM, V54, P8717, DOI 10.1021/jf061603i; Lu L, 2008, ANTIVIR THER, V13, P253; Menard JP, 2011, INT J WOMENS HEALTH, V3, P295, DOI 10.2147/IJWH.S23814; Mendling W, 2002, ARZNEIMITTEL-FORSCH, V52, P8; Monteiro DR, 2013, J APPL MICROBIOL, V114, P1175, DOI 10.1111/jam.12102; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Mumtaz Shamim, 2008, J Ayub Med Coll Abbottabad, V20, P113; Paiva LCF, 2012, MICRON, V43, P497, DOI 10.1016/j.micron.2011.09.013; Rentz Eric J., 2003, Journal of Nutritional & Environmental Medicine (Abingdon), V13, P109, DOI 10.1080/13590840310001594061; Sintubin L, 2011, APPL MICROBIOL BIOT, V91, P153, DOI 10.1007/s00253-011-3225-3; Sobel J D, 1988, Ann N Y Acad Sci, V544, P547, DOI 10.1111/j.1749-6632.1988.tb40450.x; Sobel Jack D, 2006, Curr Infect Dis Rep, V8, P481, DOI 10.1007/s11908-006-0023-7; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD., 2005, MEDICINE, V33, P62; Sosto F, 2011, ARZNEIMITTELFORSCH, V61, P126, DOI 10.1055/s-0031-1296178; SPIEGEL CA, 1991, CLIN MICROBIOL REV, V4, P485, DOI 10.1128/CMR.4.4.485-502.1991; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Tempera G, 2004, INT J ANTIMICROB AG, V24, P85, DOI 10.1016/j.ijantimicag.2003.12.013; Tempera G, 2010, GYNECOL OBSTET INVES, V70, P244, DOI 10.1159/000314013; Togni G, 2011, ANTIMICROB AGENTS CH, V55, P2490, DOI 10.1128/AAC.01623-10; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Weindl G, 2004, SKIN PHARMACOL PHYS, V17, P207, DOI 10.1159/000080213; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; Zhang ST, 2001, APPL ENVIRON MICROB, V67, P4030, DOI 10.1128/AEM.67.9.4030-4035.2001	52	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97791	10.1371/journal.pone.0097791	http://dx.doi.org/10.1371/journal.pone.0097791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897299	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700013
J	Wyshak, G				Wyshak, Grace			Height, Socioeconomic and Subjective Well-Being Factors among US Women, Ages 49-79	PLOS ONE			English	Article							SOCIAL-CLASS; BODY-HEIGHT; SUCCESS; HEALTH; ENVIRONMENT; DISEASE; RISK; LIFE; MEN	Background: A vast literature has associated height with numerous factors, including biological, psychological, socioeconomic, anthropologic, genetic, environmental, and ecologic, among others. The aim of this study is to examine, among U.S. women, height factors focusing on health, income, education, occupation, social activities, religiosity and subjective well-being. Methods/Findings: Data are from the Women's Health Initiative (WHI) Observational Study. Participants are 93,676 relatively healthy women ages 49-79; 83% of whom are White, 17% Non-White. Statistical analyses included descriptive statistics, chi-square and multivariable covariance analyses. The mean height of the total sample is 63.67 inches. White women are significantly taller than Non-White women, mean heights 63.68 vs. 63.63 inches (p = 0.0333). Among both Non-White and White women height is associated with social behavior, i.e. attendance at clubs/lodges/groups. Women who reported attendance 'once a week or more often' were taller than those who reported 'none' and 'once to 3 times a month'. Means in inches are respectively for: White women-63.73 vs. 63.67 and 63.73 vs. 63.67, p = 0.0027. p = 0.0298; Non-White women: 63.77 vs. 63.61 and 63.77 vs. 63.60, p = 0.0050, P = 0.0094. In both White and Non-White women, income, education and subjective well-being were not associated with height. However, other factors differed by race/ethnicity. Taller White women hold or have held managerial/professional jobs-yes vs. no-63.70 vs. 63.66 inches; P = 0.036; and given 'a little' strength and comfort from religion' compared to 'none' and 'a great deal', 63.73 vs. 63.66 P = 0.0418 and 63.73 vs. 63.67, P = 0.0130. Taller Non-White women had better health-excellent or very good vs. good, fair or poor-63.70 vs. 63.59, P = 0.0116. Conclusions: Further research in diverse populations is suggested by the new findings: being taller is associated with social activities -frequent attendance clubs/lodges/groups'', and with 'a little' vs. 'none' or 'great deal' of strength and comfort from religion.	[Wyshak, Grace] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Wyshak, Grace] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wyshak, Grace] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wyshak, G (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	Wyshak@hsph.harvard.edu						Barro RJ, 2003, AM SOCIOL REV, P1; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Beard AS, 2002, PERSPECT BIOL MED, V45, P475, DOI 10.1353/pbm.2002.0064; Beeri MS, 2005, AM J GERIAT PSYCHIAT, V13, P116, DOI 10.1097/00019442-200502000-00005; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Case A, 2009, ECON LETT, V102, P174, DOI 10.1016/j.econlet.2008.12.011; Cavelaars AEJM, 2000, ANN HUM BIOL, V27, P407, DOI 10.1080/03014460050044883; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Fogel R W, 1982, Soc Sci Hist, V6, P401; HENSLEY WE, 1992, PSYCHOL REP, V70, P457, DOI 10.2466/PR0.70.2.457-458; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; HENSLEY WE, 1987, PSYCHOL REP, V60, P843, DOI 10.2466/pr0.1987.60.3.843; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Kortt M, 2010, ECON REC, V86, P71, DOI 10.1111/j.1475-4932.2009.00566.x; KUH DL, 1991, INT J EPIDEMIOL, V20, P1001, DOI 10.1093/ije/20.4.1001; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Mark QJ, 2012, J BIOSOC SCI, P1; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Novak M, 2012, PUBLIC HEALTH, V126, P349, DOI 10.1016/j.puhe.2012.01.012; Ozaltin E, 2012, INT J EPIDEMIOL, V41, P1434, DOI 10.1093/ije/dys144; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Pollet TV, 2008, AM J HUM BIOL, V20, P264, DOI 10.1002/ajhb.20708; Silventoinen K, 1999, INT J EPIDEMIOL, V28, P911, DOI 10.1093/ije/28.5.911; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Smits J, 2012, AM J HUM BIOL, V24, P473, DOI 10.1002/ajhb.22248; Steckel RH, 2008, J ECON PERSPECT, V22, P129, DOI 10.1257/jep.22.1.129; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Tucker-Seeley RD, 2011, ECON HUM BIOL, V9, P194, DOI 10.1016/j.ehb.2010.11.002; WALKER M, 1988, J EPIDEMIOL COMMUN H, V42, P299, DOI 10.1136/jech.42.3.299	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e96061	10.1371/journal.pone.0096061	http://dx.doi.org/10.1371/journal.pone.0096061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896649	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700003
J	Du, N; Peng, H; Chao, XQ; Zhang, Q; Tian, HG; Li, HM				Du, Nan; Peng, Hao; Chao, Xiangqin; Zhang, Qiu; Tian, Honggang; Li, Hongmei			Interaction of Obesity and Central Obesity on Elevated Urinary Albumin-to-Creatinine Ratio	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; WEIGHT-LOSS; MORTALITY; MICROALBUMINURIA; DISEASE	Background: Microalbuminuria was much more common among obese individuals indicating a probable association with obesity. However, association of microalbuminuria with interaction between obesity and central obesity has not yet been studied. Design and Methods: A cross-sectional study was conducted in a 2889 general population aged >= 30 years. Obesity was defined as body mass index >= 28.0 kg/m(2) and central obesity was defined as waist-to-hip ratio >= 0.85 for females and >= 0.90 for males. Both additive and multipliable interactions between obesity and central obesity on elevated urinary albumin-to-creatinine ratio (UACR) were evaluated. Results: After controlling for potential covariates, participants with both obesity and central obesity have significantly increased risk for elevated UACR (OR = 1.82 P<0.001) compared to those with neither. Additive interaction analysis indicated that about 43.9% of the risk of elevated UACR in participants with both obesity and central obesity was attributed to the interaction between obesity and central obesity (the attributable proportion because of the interaction: 0.439; 95% CI: 0.110-0.768). The multipliable interactive effect between obesity and central obesity on elevated UACR was not found significant (OR = 1.82, P = 0.078). Conclusions: Microalbuminuria was significantly associated with the interaction between obesity and central obesity. Our results indicated that individuals with both obesity and central obesity should be intensively managed to prevent renal diseases.	[Du, Nan; Peng, Hao; Zhang, Qiu; Li, Hongmei] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China; [Chao, Xiangqin; Zhang, Qiu; Tian, Honggang] Ctr Dis Prevent & Control GuSu Dist, Suzhou, Peoples R China	Soochow University - China	Li, HM (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China.	lihongmei@suda.edu.cn	Peng, Hao/I-1134-2014; Peng, Hao/AAB-4759-2022	Peng, Hao/0000-0001-6277-662X; 	National Natural Science Foundation of China [81102189]; Suzhou Science and Technology Project [SS0910]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Project; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	The study is supported by Youth Found of the National Natural Science Foundation of China (Grant No. 81102189) and the Suzhou Science and Technology Project (grant NO. SS0910) and partially supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha A, 2009, SAUDI J KIDNEY DIS T, V20, P429; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chen BD, 2010, CLIN CHIM ACTA, V411, P705, DOI 10.1016/j.cca.2010.01.038; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P314, DOI 10.1055/s-2007-976539; Futrakul N, 2009, RENAL FAILURE, V31, P140, DOI 10.1080/08860220802595948; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; GRAY DS, 1991, J CLIN EPIDEMIOL, V44, P545, DOI 10.1016/0895-4356(91)90218-X; Hallqvist T, 1996, J INTERN MED, V239, P377, DOI 10.1046/j.1365-2796.1996.431782000.x; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kalmijn S, 1999, INT J OBESITY, V23, P395, DOI 10.1038/sj.ijo.0800832; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; Morales E, 2003, AM J KIDNEY DIS, V41, P319, DOI 10.1053/ajkd.2003.50039; Naidoo D P, 2002, Cardiovasc J S Afr, V13, P194; Nishida C, 2010, EUR J CLIN NUTR, V64, P2, DOI 10.1038/ejcn.2009.139; Palmer AJ, 2006, DEUT MED WOCHENSCHR, V131, P1721, DOI 10.1055/s-2006-947822; Pedrinelli R, 2002, J HUM HYPERTENS, V16, P79, DOI 10.1038/sj.jhh.1001316; Peng H, 2012, METAB SYNDR RELAT D, V10, P202, DOI 10.1089/met.2011.0119; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Saiki A, 2005, INT J OBESITY, V29, P1115, DOI 10.1038/sj.ijo.0803009; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Solbu MD, 2009, ATHEROSCLEROSIS, V204, P503, DOI 10.1016/j.atherosclerosis.2008.11.002; SWEETING HN, 2007, NUTR J, V6, DOI DOI 10.1186/1475-2891-6-32; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; ZANCHETTI A, 1993, HYPERTENSION, V22, P392	31	15	16	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98926	10.1371/journal.pone.0098926	http://dx.doi.org/10.1371/journal.pone.0098926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892930	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400111
J	Wang, SY; Shiboski, S; Belair, CD; Cooperberg, MR; Simko, JP; Stoppler, H; Cowan, J; Carroll, PR; Blelloch, R				Wang, Siao-Yi; Shiboski, Stephen; Belair, Cassandra D.; Cooperberg, Matthew R.; Simko, Jeffrey P.; Stoppler, Hubert; Cowan, Janet; Carroll, Peter R.; Blelloch, Robert			miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance	PLOS ONE			English	Article							CIRCULATING MICRORNAS; RISK-ASSESSMENT; EXPRESSION; RECURRENCE; DIAGNOSIS; BIOPSY; TARGET; GENE; MEN	Serum microRNAs hold great promise as easily accessible and measurable biomarkers of disease. In prostate cancer, serum miRNA signatures have been associated with the presence of disease as well as correlated with previously validated risk models. However, it is unclear whether miRNAs can provide independent prognostic information beyond current risk models. Here, we focus on a group of low-risk prostate cancer patients who were eligible for active surveillance, but chose surgery. A major criteria for the low risk category is a Gleason score of 6 or lower based on pre-surgical biopsy. However, a third of these patients are upgraded to Gleason 7 on post surgical pathological analysis. Both in a discovery and a validation cohort, we find that pre-surgical serum levels of miR-19, miR-345 and miR-519c-5p can help identify these patients independent of their pre-surgical age, PSA, stage, and percent biopsy involvement. A combination of the three miRNAs increased the area under a receiver operator characteristics curve from 0.77 to 0.94 (p<0.01). Also, when combined with the CAPRA risk model the miRNA signature significantly enhanced prediction of patients with Gleason 7 disease. In-situ hybridizations of matching tumors showed miR-19 upregulation in transformed versus normal-appearing tumor epithelial, but independent of tumor grade suggesting an alternative source for the increase in serum miR-19a/b levels or the release of pre-existing intracellular miR-19a/b upon progression. Together, these data show that serum miRNAs can predict relatively small steps in tumor progression improving the capacity to predict disease risk and, therefore, potentially drive clinical decisions in prostate cancer patients. It will be important to validate these findings in a larger multi-institutional study as well as with independent methodologies.	[Wang, Siao-Yi; Shiboski, Stephen; Belair, Cassandra D.; Cooperberg, Matthew R.; Simko, Jeffrey P.; Stoppler, Hubert; Cowan, Janet; Carroll, Peter R.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685; Wang, Siao-Yi/0000-0001-6741-2024	National Institutes of Health [R21 CA161615]; NATIONAL CANCER INSTITUTE [R21CA161615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health R21 CA161615 and a private donation by John and Donna Shoemaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Conti SL, 2009, J UROLOGY, V181, P1628, DOI 10.1016/j.juro.2008.11.107; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cooperberg MR, 2011, J CLIN ONCOL, V29, P3669, DOI 10.1200/JCO.2011.34.9738; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Dall'Era MA, 2011, BJU INT, V107, P1232, DOI 10.1111/j.1464-410X.2010.09589.x; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Klotz Laurence, 2010, Curr Urol Rep, V11, P165, DOI 10.1007/s11934-010-0110-z; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Scattoni V, 2007, EUR UROL, V52, P1309, DOI 10.1016/j.eururo.2007.08.006; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Suardi N, 2008, CANCER-AM CANCER SOC, V113, P2068, DOI 10.1002/cncr.23827; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98597	10.1371/journal.pone.0098597	http://dx.doi.org/10.1371/journal.pone.0098597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893170	Green Published, gold			2022-12-25	WOS:000336911400073
J	Guignandon, A; Faure, C; Neutelings, T; Rattner, A; Mineur, P; Linossier, MT; Laroche, N; Lambert, C; Deroanne, C; Nusgens, B; Demets, R; Colige, A; Vico, L				Guignandon, Alain; Faure, Celine; Neutelings, Thibaut; Rattner, Aline; Mineur, Pierre; Linossier, Marie-Therese; Laroche, Norbert; Lambert, Charles; Deroanne, Christophe; Nusgens, Betty; Demets, Rene; Colige, Alain; Vico, Laurence			Rac1 GTPase silencing counteracts microgravity-induced effects on osteoblastic cells	FASEB JOURNAL			English	Article						VEGF; spaceflight; MG-63; RhoA; Cdc42	ENDOTHELIAL GROWTH-FACTOR; MATRIX ADHESIONS; MODELED MICROGRAVITY; SIMULATED MICROGRAVITY; FOCAL ADHESIONS; RHO GTPASES; IN-VITRO; VEGF; EXPRESSION; PHOSPHORYLATION	Bone cells exposed to real microgravity display alterations of their cytoskeleton and focal adhesions, two major mechanosensitive structures. These structures are controlled by small GTPases of the Ras homology (Rho) family. We investigated the effects of RhoA, Rac1, and Cdc42 modulation of osteoblastic cells under microgravity conditions. Human MG-63 osteoblast-like cells silenced for RhoGTPases were cultured in the automated Biobox bioreactor (European Space Agency) aboard the Foton M3 satellite and compared to replicate ground-based controls. The cells were fixed after 69 h of microgravity exposure for postflight analysis of focal contacts, F-actin polymerization, vascular endothelial growth factor (VEGF) expression, and matrix targeting. We found that RhoA silencing did not affect sensitivity to microgravity but that Rac1 and, to a lesser extent, Cdc42 abrogation was particularly efficient in counteracting the spaceflight-related reduction of the number of focal contacts [-50% in silenced, scrambled (SiScr) controls vs. -15% for SiRac1], the number of F-actin fibers (-60% in SiScr controls vs. -10% for SiRac1), and the depletion of matrix-bound VEGF (-40% in SiScr controls vs. -8% for SiRac1). Collectively, these data point out the role of the VEGF/Rho GTPase axis in mechanosensing and validate Rac1-mediated signaling pathways as potential targets for counteracting microgravity effects.	[Guignandon, Alain; Faure, Celine; Rattner, Aline; Linossier, Marie-Therese; Laroche, Norbert; Vico, Laurence] Univ Lyon 1, INSERM, Lab Biol Integree Tissu Osseux, U 1059, F-42023 St Etienne 2, France; [Neutelings, Thibaut; Mineur, Pierre; Lambert, Charles; Deroanne, Christophe; Nusgens, Betty; Colige, Alain] Univ Liege, Lab Connect Tissues Biol, GIGA, Sart Tilman Par Liege, Belgium; [Demets, Rene] ESTEC, HSO, BSU, Noordwijk, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Liege; European Space Agency	Guignandon, A (corresponding author), Univ Lyon 1, Fac Med, INSERM U1059, LBTO, 15 Rue Ambroise PARE, F-42023 St Etienne 2, France.	alain.guignandon@univ-st-etienne.fr	Vico, Laurence/O-1927-2018; Vico, Laurence/ABG-7239-2020	Vico, Laurence/0000-0002-2110-287X; Vico, Laurence/0000-0002-2110-287X; GUIGNANDON, Alain/0000-0002-0745-5417	ESA; European Research in Space and Terrestrial Osteoporosis (ERISTO) [14232/NL/SH, CCN3]; Microgravity Application Program (MAP) [AO-99-122, 14426]; Centre National d'Etudes Spatiales (CNES); Centre National d'Etudes Spatiales (the French space agency); Institut National de la Sant et de la Recherche Medicale (INSERM); University Jean Monnet; Institute for Science and Engineering (IFRESIS; Institute for Science and Engineering (St-Etienne); Institute for Science and Engineering (France); Center for Concepts in Mechatronics (CCM; Nuenen, The Netherlands)	ESA(European Space Agency); European Research in Space and Terrestrial Osteoporosis (ERISTO); Microgravity Application Program (MAP); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National d'Etudes Spatiales (the French space agency)(Centre National D'etudes Spatiales); Institut National de la Sant et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Jean Monnet; Institute for Science and Engineering (IFRESIS; Institute for Science and Engineering (St-Etienne); Institute for Science and Engineering (France); Center for Concepts in Mechatronics (CCM; Nuenen, The Netherlands)	The spaceflight opportunity on Foton-M3 was provided by the ESA. The authors acknowledge the support of the ESA and the Center for Concepts in Mechatronics (CCM; Nuenen, The Netherlands) for providing help during the preparation and integration of the Obadis experiment in the Biobox. This study received financial support from the ESA, European Research in Space and Terrestrial Osteoporosis (ERISTO; contract 14232/NL/SH; CCN3), the Microgravity Application Program (MAP; AO-99-122, contract 14426), and the Centre National d'Etudes Spatiales (CNES; the French space agency). Moreover, this work was supported in part by the Institut National de la Sant et de la Recherche Medicale (INSERM), the University Jean Monnet, and the Institute for Science and Engineering (IFRESIS; St-Etienne, France). The authors declare no conflicts of interest.	Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c; Anderson SM, 2009, BIOMATERIALS, V30, P4618, DOI 10.1016/j.biomaterials.2009.05.030; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Blaber EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061372; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Buravkova LB, 2010, ACTA NATURAE, V2, P28, DOI 10.32607/20758251-2010-2-1-28-35; Burger EH, 1998, BONE, V22, p127S, DOI 10.1016/S8756-3282(98)00010-6; Capulli M, 2009, J CELL BIOCHEM, V107, P240, DOI 10.1002/jcb.22120; Carmeliet G, 1997, J BONE MINER RES, V12, P786, DOI 10.1359/jbmr.1997.12.5.786; Carmeliet G, 1999, FASEB J, V13, pS129, DOI 10.1096/fasebj.13.9001.s129; Carroll B, 2013, DEV CELL, V25, P15, DOI 10.1016/j.devcel.2013.03.005; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DEGROOT RP, 1991, EXP CELL RES, V197, P87, DOI 10.1016/0014-4827(91)90483-B; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Dieriks B, 2011, MOL MED REP, V4, P17, DOI 10.3892/mmr.2010.405; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Faure C, 2008, BONE, V42, P1092, DOI 10.1016/j.bone.2008.02.011; Faure C, 2010, BIOMATERIALS, V31, P6477, DOI 10.1016/j.biomaterials.2010.05.011; Goel HL, 2012, CELL ADHES MIGR, V6, P554, DOI 10.4161/cam.22419; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; GUIGNANDON A, 1995, CELL STRUCT FUNCT, V20, P369, DOI 10.1247/csf.20.369; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Higashibata Akira, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-19; Ho TTG, 2008, J BIOL CHEM, V283, P21588, DOI 10.1074/jbc.M710033200; Ho TTG, 2011, MOL BIOL CELL, V22, P3263, DOI 10.1091/mbc.E11-01-0020; Hoang MV, 2011, BLOOD, V117, P1751, DOI 10.1182/blood-2010-05-286831; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford M, 1999, FASEB J, V13, pS121; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Ingber DE, 2008, J BODYW MOV THER, V12, P198, DOI 10.1016/j.jbmt.2008.04.038; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Kumei Y, 1999, Biol Sci Space, V13, P142; Kumei Y, 2007, ANN NY ACAD SCI, V1095, P292, DOI 10.1196/annals.1397.032; Lin LJ, 2013, BIOMATERIALS, V34, P3807, DOI 10.1016/j.biomaterials.2013.01.092; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rijken P J, 1994, Adv Space Biol Med, V4, P159; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Sun Y, 2013, OSTEOPOROSIS INT, V24, P969, DOI 10.1007/s00198-012-2028-4; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	52	22	22	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4077	4087		10.1096/fj.14-249714	http://dx.doi.org/10.1096/fj.14-249714			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24903274	Green Published			2022-12-25	WOS:000340845900025
J	Furtner, J; Bender, B; Braun, C; Schittenhelm, J; Skardelly, M; Ernemann, U; Bisdas, S				Furtner, Julia; Bender, Benjamin; Braun, Christian; Schittenhelm, Jens; Skardelly, Marco; Ernemann, Ulrike; Bisdas, Sotirios			Prognostic Value of Blood Flow Measurements Using Arterial Spin Labeling in Gliomas	PLOS ONE			English	Article							GRADE GLIOMAS; PERFUSION; PREDICTION; SURVIVAL; BRAIN	The period of event-free survival (EFS) within the same histopathological glioma grades may have high variability, mainly without a known cause. The purpose of this study was to reveal the prognostic value of quantified tumor blood flow (TBF) values obtained by arterial spin labeling (ASL) for EFS in patients with histopathologically proven astrocytomas independent of WHO (World Health Organization) grade. Twenty-four patients with untreated gliomas underwent tumor perfusion quantification by means of pulsed ASL in 3T. The clinical history of the patients was retrospectively extracted from the local database. Six patients had to be excluded due to insufficent follow-up data for further evaluation or histopathologically verified oligodendroglioma tumor components. Receiver operating characteristic (ROC) curves were used to define an optimal cut-off value of maximum TBF (mTBF) values for subgrouping in low-perfused and high-perfused gliomas. KaplanMeier curves and Cox proportional hazard regression model were used to determine the prognostic value of mTBF for EFS. An optimal mTBF cut-off value of 182 ml/100 g/min (sensitivity =83%, specificity =100%) was determined. Patients with low-perfused gliomas had significantly longer EFS compared to patients with high-perfused gliomas (p =0.0012) independent of the WHO glioma grade. Quantified mTBF values obtained by ASL offer a new and totally non-invasive marker to prognosticate the EFS, independently on histopathological tumor grading, in patients with gliomas.	[Furtner, Julia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Furtner, Julia; Bender, Benjamin; Ernemann, Ulrike; Bisdas, Sotirios] Univ Tubingen, Dept Neuroradiol, Tubingen, Germany; [Braun, Christian] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Schittenhelm, Jens] Univ Tubingen, Dept Neuropathol, Tubingen, Germany; [Skardelly, Marco] Univ Tubingen, Dept Neurosurg, Tubingen, Germany	Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Bisdas, S (corresponding author), Univ Tubingen, Dept Neuroradiol, Tubingen, Germany.	sotirios.bisdas@uni-tuebingen.de	Bisdas, Sotirios/P-2549-2016; Skardelly, Marco/AAF-8680-2021	Bisdas, Sotirios/0000-0001-9930-5549; Bender, Benjamin/0000-0002-3205-4631; Furtner, Julia/0000-0001-8258-3681	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University.	Bisdas S, 2009, AM J NEURORADIOL, V30, P681, DOI 10.3174/ajnr.A1465; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cao Y, 2006, INT J RADIAT ONCOL, V64, P876, DOI 10.1016/j.ijrobp.2005.09.001; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Golay X, 2006, NEUROIMAG CLIN N AM, V16, P259, DOI 10.1016/j.nic.2006.02.003; Hirai T, 2008, AM J NEURORADIOL, V29, P1505, DOI 10.3174/ajnr.A1121; Hirai T, 2011, AM J NEURORADIOL, V32, P2073, DOI 10.3174/ajnr.A2725; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Jarnum H, 2010, NEURORADIOLOGY, V52, P307, DOI 10.1007/s00234-009-0616-6; Kuo PH, 2010, RADIOLOGY, V3, P647; Law M, 2006, RADIOLOGY, V238, P658, DOI 10.1148/radiol.2382042180; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Lev MH, 2004, AM J NEURORADIOL, V25, P214; Mangla R, 2014, J NEURO-ONCOL, V116, P325, DOI 10.1007/s11060-013-1298-9; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Seeger A, 2013, ACAD RADIOL, p[12, 1557]; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; The WHO, 2020, CLASSIFICATION TUMOU; Walker C, 2003, CLIN CANCER RES, V9, P4841; Warmuth C, 2003, RADIOLOGY, V228, P523, DOI 10.1148/radiol.2282020409; Weber MA, 2003, INVEST RADIOL, V38, P712, DOI 10.1097/01.rli.0000084890.57197.54; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong EC, 1997, NMR BIOMED, V10, P237, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<237::AID-NBM475>3.0.CO;2-X; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506	29	23	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99616	10.1371/journal.pone.0099616	http://dx.doi.org/10.1371/journal.pone.0099616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911025	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600110
J	Noah, TL; Zhang, HT; Zhou, HB; Glista-Baker, E; Muller, L; Bauer, RN; Meyer, M; Murphy, PC; Jones, S; Letang, B; Robinette, C; Jaspers, I				Noah, Terry L.; Zhang, Hongtao; Zhou, Haibo; Glista-Baker, Ellen; Mueller, Loretta; Bauer, Rebecca N.; Meyer, Megan; Murphy, Paula C.; Jones, Shannon; Letang, Blanche; Robinette, Carole; Jaspers, Ilona			Effect of Broccoli Sprouts on Nasal Response to Live Attenuated Influenza Virus in Smokers: A Randomized, Double-Blind Study	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER CHEMOPREVENTION; CIGARETTE-SMOKING; RISK-FACTORS; H1N1 2009; SULFORAPHANE; INFECTION; EXPOSURE; EXPRESSION; NRF2	Background: Smokers have increased susceptibility and altered innate host defense responses to influenza virus infection. Broccoli sprouts are a source of the Nrf2 activating agentsulforaphane, and short term ingestion of broccoli sprout homogenates (BSH) has been shown to reduce nasal inflammatory responses to oxidant pollutants. Objectives: Assess the effects of BSH on nasal cytokines, virus replication, and Nrf2-dependent enzyme expression in smokers and nonsmokers. Methods: We conducted a randomized, double-blind, placebo-controlled trial comparing the effects of BSH on serially sampled nasal lavage fluid (NLF) cytokines, viral sequence quantity, and Nrf2-dependent enzyme expression in NLF cells and biopsied epithelium. Healthy young adult smokers and nonsmokers ingested BSH or placebo (alfalfa sprout homogenate) for 4 days, designated Days -1, 0, 1, 2. On Day 0 they received standard vaccine dose of live attenuated influenza virus (LAIV) intranasally. Nasal lavage fluids and nasal biopsies were collected serially to assess response to LAIV. Results: In area under curve analyses, post-LAIV IL-6 responses (P =0.03) and influenza sequences (P =0.01) were significantly reduced in NLF from BSH-treated smokers, whileNAD(P) H: quinoneoxidoreductasein NLF cells was significantly increased. In nonsmokers, a similar trend for reduction in virus quantity with BSH did not reach statistical significance. Conclusions: In smokers, short term ingestion of broccoli sprout homogenates appears to significantly reduce some virus-induced markers of inflammation, as well as reducing virus quantity. Nutritional antioxidant interventions have promise as a safe, low-cost strategy for reducing influenza risk among smokers and other at risk populations.	[Noah, Terry L.; Glista-Baker, Ellen; Jones, Shannon; Robinette, Carole; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA; [Noah, Terry L.; Murphy, Paula C.; Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Zhang, Hongtao; Zhou, Haibo] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bauer, Rebecca N.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA; [Meyer, Megan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Letang, Blanche] Univ N Carolina, Biol & Biomed Sci Program, Chapel Hill, NC USA; [Mueller, Loretta] Univ Childrens Hosp Basel, Basel, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Basel	Noah, TL (corresponding author), Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA.	terry_noah@med.unc.edu	Jaspers, Ilona/AAZ-5035-2020; ZHOU, Haibo/M-7373-2017		NIEHS NIH HHS [R01 ES013611, T32 ES007126, P30 ES010126] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013611, T32ES007126, P30ES010126] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Cantin AM, 2012, CURR MOL MED, V12, P836; Cheung KL, 2010, AAPS J, V12, P87, DOI 10.1208/s12248-009-9162-8; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; Cohen HA, 2004, ARCH PEDIAT ADOL MED, V158, P217, DOI 10.1001/archpedi.158.3.217; Dinkova-Kostova AT, 2007, CANCER EPIDEM BIOMAR, V16, P847, DOI 10.1158/1055-9965.EPI-06-0934; Guerrero-Beltran CE, 2012, EXP TOXICOL PATHOL, V64, P503, DOI 10.1016/j.etp.2010.11.005; Gerhauser C, 2013, CURR OPIN CLIN NUTR, V16, P405, DOI 10.1097/MCO.0b013e328362014e; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Huttunen R, 2011, J INTERN MED, V269, P258, DOI 10.1111/j.1365-2796.2010.02332.x; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Jaspers I, 1999, J BIOL CHEM, V274, P31025, DOI 10.1074/jbc.274.43.31025; Jaspers I, 2010, AM J RESP CELL MOL, V43, P368, DOI 10.1165/rcmb.2009-0254OC; KARK JD, 1981, AM J PUBLIC HEALTH, V71, P530, DOI 10.2105/AJPH.71.5.530; KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; LEBIUSH M, 1982, MIL MED, V147, P43, DOI 10.1093/milmed/147.1.43; Lenzi L, 2012, J BRAS PNEUMOL, V38, P57, DOI 10.1590/S1806-37132012000100009; Li CKF, 2013, CURR OPIN IMMUNOL, V25, P470, DOI 10.1016/j.coi.2013.07.005; Macchia I, 1999, INT J IMMUNOPHARMACO, V21, P185, DOI 10.1016/S0192-0561(98)00080-0; Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15; Nantz MP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-161; Negishi H, 2013, J NUTR, V143, P1794, DOI 10.3945/jn.113.179036; Noah TL, 2012, AM J RESP CRIT CARE, V185, P179, DOI 10.1164/rccm.201103-0465OC; Noah TL, 2011, ENVIRON HEALTH PERSP, V119, P78, DOI 10.1289/ehp.1002258; Rager JE, 2013, AM J PHYSIOL-LUNG C, V305, pL432, DOI 10.1152/ajplung.00116.2013; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Ritz SA, 2007, AM J PHYSIOL-LUNG C, V292, pL33, DOI 10.1152/ajplung.00170.2006; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; Wilson KM, 2013, J PEDIATR-US, V162, P16, DOI 10.1016/j.jpeds.2012.06.043; Wong CM, 2013, INFLUENZA OTHER RESP, V7, P531, DOI 10.1111/j.1750-2659.2012.00411.x; Woolson RFC., 2002, STAT METHODS ANAL BI, Ved 2; Yageta Y, 2013, AM J RESP CELL MOL B	38	28	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98671	10.1371/journal.pone.0098671	http://dx.doi.org/10.1371/journal.pone.0098671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910991	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600009
J	Pritchard, AJ; Mir, AK; Dev, KK				Pritchard, Adam J.; Mir, Anis K.; Dev, Kumlesh K.			Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; IN-VITRO; SIGNALING PATHWAYS; TRANSGENIC MICE; FTY720; ACTIVATION	The family of sphingosine-1-phosphate receptors (S1PRs) is G-protein-coupled, comprised of subtypes S1PR1-S1PR5 and activated by the endogenous ligand S1P. The phosphorylated version of Fingolimod (pFTY720), an oral therapy for multiple sclerosis (MS), induces S1PR1 internalisation in T cells, subsequent insensitivity to S1P gradients and sequestering of these cells within lymphoid organs, thus limiting immune response. S1PRs are also expressed in neuronal and glial cells where pFTY720 is suggested to directly protect against lysolecithin-induced deficits in myelination state in organotypic cerebellar slices. Of note, the effect of pFTY720 on immune cells already migrated into the CNS, prior to treatment, has not been well established. We have previously found that organotypic slice cultures do contain immune cells, which, in principle, could also be regulated by pFTY720 to maintain levels of myelin. Here, a mouse organotypic cerebellar slice and splenocyte co-culture model was thus used to investigate the effects of pFTY720 on splenocyte-induced demyelination. Spleen cells isolated from myelin oligodendrocyte glycoprotein immunised mice (MOG-splenocytes) or from 2D2 transgenic mice (2D2splenocytes) both induced demyelination when co-cultured with mouse organotypic cerebellar slices, to a similar extent as lysolecithin. As expected, in vivo treatment of MOG-immunised mice with FTY720 inhibited demyelination induced by MOG-splenocytes. Importantly, in vitro treatment of MOG- and 2D2-splenocytes with pFTY720 also attenuated demyelination caused by these cells. In addition, while in vitro treatment of 2D2-splenocytes with pFTY720 did not alter cell phenotype, pFTY720 inhibited the release of the pro-inflammatory cytokines such as interferon gamma (IFN gamma) and interleukin 6 (IL6) from these cells. This work suggests that treatment of splenocytes by pFTY720 attenuates demyelination and reduces pro-inflammatory cytokine release, which likely contributes to enhanced myelination state induced by pFTY720 in organotypic cerebellar slices.	[Pritchard, Adam J.; Dev, Kumlesh K.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Mir, Anis K.] Novartis Pharma AG, Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammatory Dis, Basel, Switzerland	Trinity College Dublin; Novartis	Dev, KK (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.	devk@tcd.ie		Dev, Kumlesh/0000-0003-4274-9119	Trinity College Dublin Ireland; Novartis Pharma Basel Switerland	Trinity College Dublin Ireland; Novartis Pharma Basel Switerland	This work was supported in part by research grants from Trinity College Dublin Ireland and Novartis Pharma Basel Switerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Note, however, that AKM is an employee of Novartis Pharma Basel and had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials under relevant material transfer agreements.	Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bin JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041237; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Buntinx M, 2002, J NEUROIMMUNOL, V124, P70, DOI 10.1016/S0165-5728(01)00495-7; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Dorsam G, 2003, J IMMUNOL, V171, P3500, DOI 10.4049/jimmunol.171.7.3500; Fantini MC, 2007, NAT PROTOC, V2, P1789, DOI 10.1038/nprot.2007.258; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Healy LM, 2013, BRIT J PHARMACOL, V169, P1114, DOI 10.1111/bph.12207; Hu YH, 2011, MOL CELL NEUROSCI, V48, P72, DOI 10.1016/j.mcn.2011.06.007; Hwang SJ, 2010, LAB INVEST, V90, P9, DOI 10.1038/labinvest.2009.109; Idzko M, 2002, FASEB J, V16, P625, DOI 10.1096/fj.01-0625fje; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Jackson SJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-76; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim HJ, 2011, FASEB J, V25, P1509, DOI 10.1096/fj.10-173203; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Ling CY, 2008, J IMMUNOL, V180, P8393, DOI 10.4049/jimmunol.180.12.8393; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okamoto H, 1999, BIOCHEM BIOPH RES CO, V260, P203, DOI 10.1006/bbrc.1999.0886; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Oz-Arslan D, 2006, J LEUKOCYTE BIOL, V80, P287, DOI 10.1189/jlb.1205751; Ozenci V, 1999, SCAND J IMMUNOL, V49, P554; PANITCH HS, 1987, LANCET, V1, P893; Poti F, 2013, ARTERIOSCL THROM VAS, V33, P1505, DOI 10.1161/ATVBAHA.113.301347; Pritchard AJ, 2013, FUTURE NEUROLOGY, V8, P487; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Sepulcre J, 2005, CYTOKINE, V32, P111, DOI 10.1016/j.cyto.2005.08.005; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Shrestha R, 2014, NEUROPHARMACOLOGY, V76, P184, DOI 10.1016/j.neuropharm.2013.06.025; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Stelmasiak Z, 2000, MED SCI MONITOR, V6, P1108; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Wolf AM, 2009, J IMMUNOL, V183, P3751, DOI 10.4049/jimmunol.0901011; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yang Y, 2011, DEV BIOL, V350, P127, DOI 10.1016/j.ydbio.2010.11.028; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	59	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99444	10.1371/journal.pone.0099444	http://dx.doi.org/10.1371/journal.pone.0099444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911000	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600089
J	Qin, LX; Zhou, Q				Qin, Li-Xuan; Zhou, Qin			MicroRNA Array Normalization: An Evaluation Using a Randomized Dataset as the Benchmark	PLOS ONE			English	Article							MICROARRAYS; SUMMARIES; VARIANCE	MicroRNA arrays possess a number of unique data features that challenge the assumption key to many normalization methods. We assessed the performance of existing normalization methods using two microRNA array datasets derived from the same set of tumor samples: one dataset was generated using a blocked randomization design when assigning arrays to samples and hence was free of confounding array effects; the second dataset was generated without blocking or randomization and exhibited array effects. The randomized dataset was assessed for differential expression between two tumor groups and treated as the benchmark. The non-randomized dataset was assessed for differential expression after normalization and compared against the benchmark. Normalization improved the true positive rate significantly in the non-randomized data but still possessed a false discovery rate as high as 50%. Adding a batch adjustment step before normalization further reduced the number of false positive markers while maintaining a similar number of true positive markers, which resulted in a false discovery rate of 32% to 48%, depending on the specific normalization method. We concluded the paper with some insights on possible causes of false discoveries to shed light on how to improve normalization for microRNA arrays.	[Qin, Li-Xuan; Zhou, Qin] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Qin, LX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.	qinl@mskcc.org			National Institutes of Health [CA151947, CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA151947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health [CA151947 and CA008748 to LXQ and QZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan JQ, 2004, P NATL ACAD SCI USA, V101, P1135, DOI 10.1073/pnas.0307557100; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Pepe M. S., 2003, STAT EVALUATION MED; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Qin LX, 2013, CANCER INFORM, V12, P83, DOI 10.4137/CIN.S11384; Qin LX, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1339; Qin LX, 2014, CLIN CANCER RES, V20, P1; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Sharma S, 2009, CARCINOGENESIS; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Speed T., 2003, STAT ANAL GENE EXPRE; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98879	10.1371/journal.pone.0098879	http://dx.doi.org/10.1371/journal.pone.0098879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905456	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000076
J	Clauzure, M; Valdivieso, AG; Copiz, MMM; Schulman, G; Teiber, ML; Santa-Coloma, TA				Clauzure, Mariangeles; Valdivieso, Angel G.; Massip Copiz, Maria M.; Schulman, Gustavo; Luz Teiber, Maria; Santa-Coloma, Tomas A.			Disruption of Interleukin-1 beta Autocrine Signaling Rescues Complex I Activity and Improves ROS Levels in Immortalized Epithelial Cells with Impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function	PLOS ONE			English	Article							NF-KAPPA-B; MITOCHONDRIAL NADH DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; TNF-ALPHA; TGF-BETA; OXIDATIVE STRESS; CHLORIDE CHANNEL; MESSENGER-RNA; CYTOCHROME-C	Patients with cystic fibrosis (CF) have elevated concentration of cytokines in sputum and a general inflammatory condition. In addition, CF cells in culture produce diverse cytokines in excess, including IL-1 beta. We have previously shown that IL-1 beta, at low doses (similar to 30 pM), can stimulate the expression of CFTR in T84 colon carcinoma cells, through NF-kappa B signaling. However, at higher doses (similar to 2.5 ng/ml, similar to 150 pM), IL-1 beta inhibit CFTR mRNA expression. On the other hand, by using differential display, we found two genes with reduced expression in CF cells, corresponding to the mitochondrial proteins CISD1 and MTND4. The last is a key subunit for the activity of mitochondrial Complex I (mCx-I); accordingly, we later found a reduced mCx-I activity in CF cells. Here we found that IB3-1 cells (CF cells), cultured in serum-free media, secrete 323 +/- 5 pg/ml of IL-1 beta in 24 h vs 127 +/- 3 pg/ml for S9 cells (CFTR-corrected IB3-1 cells). Externally added IL-1 beta (5 ng/ml) reduces the mCx-I activity and increases the mitochondrial (MitoSOX probe) and cellular (DCFH-DA probe) ROS levels of S9 (CFTR-corrected IB3-1 CF cells) or Caco-2/pRSctrl cells (shRNA control cells) to values comparable to those of IB3-1 or Caco-2/pRS26 cells (shRNA specific for CFTR). Treatments of IB3-1 or Caco-2/pRS26 cells with either IL-1b blocking antibody, IL-1 receptor antagonist, IKK inhibitor III (NF-kappa B pathway) or SB203580 (p38 MAPK pathway), restored the mCx-I activity. In addition, in IB3-1 or Caco-2/pRS26 cells, IL-1b blocking antibody, IKK inhibitor III or SB203580 reduced the mitochondrial ROS levels by,50% and the cellular ROS levels near to basal values. The AP-1 inhibitors U0126 (MEK1/2) or SP600125 (JNK1/2/3 inhibitor) had no effects. The results suggest that in these cells IL-1 beta, through an autocrine effect, acts as a bridge connecting the CFTR with the mCx-I activity and the ROS levels.	[Santa-Coloma, Tomas A.] Pontifical Catholic Univ Argentina UCA, Sch Med Sci, Inst Biomed Res BIOMED, Lab Cellular & Mol Biol, Buenos Aires, DF, Argentina; Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina	Pontifical Catholic University of Argentina; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Santa-Coloma, TA (corresponding author), Pontifical Catholic Univ Argentina UCA, Sch Med Sci, Inst Biomed Res BIOMED, Lab Cellular & Mol Biol, Buenos Aires, DF, Argentina.	tsantacoloma@gmail.com	Santa-Coloma, Tomas/I-1254-2019; Valdivieso, Ángel/AAP-3888-2020	Santa-Coloma, Tomas/0000-0002-3266-1095; Clauzure, Mariangeles/0000-0002-8490-6197	National Agency for the Promotion of Science and Technology of Argentina (ANPCYT) [BID OC-AR 1728, PICT 2004-13970, PICT 2007-00628]; National Research Council of Argentina (CONICET) [PIP 11220080 102551]; Pontifical Catholic University of Argentina (UCA)	National Agency for the Promotion of Science and Technology of Argentina (ANPCYT)(ANPCyT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Pontifical Catholic University of Argentina (UCA)	This work was supported by the National Agency for the Promotion of Science and Technology of Argentina (ANPCYT;www.agencia.mincyt.gob.ar), grants BID OC-AR 1728, PICT 2004-13970 and PICT 2007-00628 to TASC and fellowship to MG; The National Research Council of Argentina (CONICET;www.conicet.gov.ar), grant PIP 11220080 102551, 2009-2011 to TASC and research fellowships to MC, AGV, MMMC and GS; and The Pontifical Catholic University of Argentina (UCA; www.uca.edu.ar), grant to TASC and fellowships to AGV and MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-33; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bartling TR, 2009, AM J RESP CELL MOL, V40, P58, DOI 10.1165/rcmb.2007-0464OC; Becker MN, 2004, AM J RESP CRIT CARE, V169, P645, DOI 10.1164/rccm.200207-765OC; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Black JP, 2000, BIOMATERIALS, V21, P2287, DOI 10.1016/S0142-9612(00)00155-1; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cafferata E.G., 1995, 31 ANN M ARG SOC BIO; Cafferata E.G.A., 2002, THESIS, P99; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; Cafferata EGA, 2001, J BIOL CHEM, V276, P15441, DOI 10.1074/jbc.M010061200; Cafferata EGA, 1997, PEDIAT PULMONOLOGY, V14, P71; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Carrillo C, 1998, CELL MOL BIOL, V44, P543; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clauzure M, 2010, MEDICINA-BUENOS AIRE, V70, P107, DOI DOI 10.13140/RG.2.1.1240.8561; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; DUPONT H, 1990, J IMMUNOL METHODS, V128, P287, DOI 10.1016/0022-1759(90)90222-H; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FEIGAL RJ, 1982, LIFE SCI, V30, P93, DOI 10.1016/0024-3205(82)90640-3; FEIGAL RJ, 1979, NATURE, V278, P276, DOI 10.1038/278276a0; Valdivieso AG, 2013, REDOX BIOL, V1, P190, DOI 10.1016/j.redox.2012.11.007; Galvin Paul, 2004, J Cyst Fibros, V3 Suppl 2, P29, DOI 10.1016/j.jcf.2004.05.006; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Gillette DD, 2013, J BIOL CHEM, V288, P3691, DOI 10.1074/jbc.C112.430298; Gonzalez-Guerrico AM, 2002, J BIOL CHEM, V277, P17239, DOI 10.1074/jbc.M112456200; GRASSO P, 1993, ENDOCRINOLOGY, V132, P1745, DOI 10.1210/en.132.4.1745; Hayashi Hidetoshi, 2005, Nihon Rinsho, V63 Suppl 8, P60; Howe K, 2002, AM J PHYSIOL-CELL PH, V283, pC1667, DOI 10.1152/ajpcell.00414.2001; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Jacquot J, 2008, INT J BIOCHEM CELL B, V40, P1703, DOI 10.1016/j.biocel.2008.02.002; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Joshi AKR, 2011, ANAL BIOCHEM, V415, P209, DOI 10.1016/j.ab.2011.04.014; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knorre A, 2002, BIOL CHEM, V383, P271, DOI 10.1515/BC.2002.029; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li JD, 1998, P NATL ACAD SCI USA, V95, P5718, DOI 10.1073/pnas.95.10.5718; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Marcucci F, 2001, BIOCELL S2, V25, P49; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; Moss RB, 2000, CLIN EXP IMMUNOL, V120, P518, DOI 10.1046/j.1365-2249.2000.01232.x; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; NAKAMURA H, 1992, FEBS LETT, V314, P366, DOI 10.1016/0014-5793(92)81507-I; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Nogrady N, 1998, J BIOTECHNOL, V60, P15, DOI 10.1016/S0168-1656(97)00156-9; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Osika E, 1999, EUR RESPIR J, V14, P339, DOI 10.1034/j.1399-3003.1999.14b17.x; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Pongnimitprasert N, 2008, ANN BIOL CLIN-PARIS, V66, P621, DOI 10.1684/abc.2008.0285; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; SHAPIRO BL, 1982, AM J HUM GENET, V34, P846; SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5; SHAPIRO BL, 1988, LANCET, V2, P290; SHAPIRO BL, 1973, P SOC EXP BIOL MED, V144, P181; SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979; SPORN MB, 1985, CANCER SURV, V4, P627; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Srivastava M, 1999, MOL MED, V5, P753, DOI 10.1007/BF03402099; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Sun HX, 2008, CANCER PREV RES, V1, P316, DOI 10.1158/1940-6207.CAPR-07-0002; Tabary O, 2000, J IMMUNOL, V164, P3377, DOI 10.4049/jimmunol.164.6.3377; Tabary O, 2001, PFLUG ARCH EUR J PHY, V443, pS40, DOI 10.1007/s004240100642; Taminelli GL, 2008, BIOCHEM BIOPH RES CO, V365, P856, DOI 10.1016/j.bbrc.2007.11.076; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Teiber ML, 2010, MEDICINA BUENOS A S2, V70, P109; TURNER M, 1991, EUR J IMMUNOL, V21, P1635, DOI 10.1002/eji.1830210708; Valdivieso AG, 2007, BIOCHEM BIOPH RES CO, V356, P805, DOI 10.1016/j.bbrc.2007.03.057; Valdivieso AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048059; Van Seuningen I, 2001, FRONT BIOSCI-LANDMRK, V6, pD1216; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Wier EM, 2012, J BIOL CHEM, V287, P43019, DOI 10.1074/jbc.M112.388694; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	104	30	31	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99257	10.1371/journal.pone.0099257	http://dx.doi.org/10.1371/journal.pone.0099257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901709	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400115
J	Kim, EJ; Kim, BH; Seo, HS; Lee, YJ; Kim, HH; Son, HH; Choi, MH				Kim, Eung Ju; Kim, Baek-hui; Seo, Hong Seog; Lee, Yong Jik; Kim, Hyun Hee; Son, Hyun-Hwa; Choi, Man Ho			Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; DIETARY-CHOLESTEROL; LIPID-ACCUMULATION; METABOLIC SYNDROME; RISK; STEATOHEPATITIS; ASSOCIATION	Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet. Moreover, it is unclear whether systemic inflammation can exacerbate both pathologies in the same model. Accordingly, this study investigated the effect of additional systemic inflammation on NAFLD and atherosclerosis induced by cholesterol overload in wild animals. New Zealand white rabbits were divided into 4 groups: groups I (control) and II received normal chow, and groups III and IV received a 1% cholesterol diet. To induce inflammation via toll-like receptor (TLR)-4 signaling, groups II and IV received subcutaneous injections of 0.5 mL of 1% carrageenan every 3 weeks. After 3 months, total cholesterol markedly increased in groups III and IV, and the serum expressions of systemic inflammatory markers were elevated in the groups II-IV. Early NAFLD lesions (e. g., mild fatty changes in the liver with sporadic fibrosis) and atherosclerosis (e. g., intimal hyperplasia composed of foam cells) were observed in both the liver and aorta specimens from group III, and advanced lesions were observed in group IV. The expressions of inflammatory cellular receptors, TLR-2 and TLR-4, in the aorta gradually increased from group I to IV but were similar in the liver in groups II-IV. Cholesteryl ester (CE) levels were higher in group IV than in group III, although the difference was not significant. CE levels in the aorta were similar between groups III and IV. Systemic inflammation can simultaneously exacerbate existing early lesions due to cholesterol overload in both the liver and aorta of rabbits. However, the cellular response of inflammatory receptors and expression of cholesterol metabolites differ between these organs.	[Kim, Eung Ju; Seo, Hong Seog; Lee, Yong Jik; Kim, Hyun Hee] Korea Univ, Coll Med, Guro Hosp, Cardiovasc Ctr,Div Cardiol,Dept Internal Med, Seoul 136705, South Korea; [Kim, Baek-hui] Korea Univ, Coll Med, Guro Hosp, Dept Pathol, Seoul 136705, South Korea; [Seo, Hong Seog] Korea Inst Sci & Technol, Korea Univ Korea Inst Sci & Technol KU KIST Grad, Seoul, South Korea; [Son, Hyun-Hwa; Choi, Man Ho] Korea Inst Sci & Technol, Future Convergence Res Div, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST)	Seo, HS (corresponding author), Korea Univ, Coll Med, Guro Hosp, Cardiovasc Ctr,Div Cardiol,Dept Internal Med, Seoul 136705, South Korea.	mdhsseo@korea.ac.kr; mh_choi@kist.re.kr		Lee, Yong-Jik/0000-0001-8814-0099; Seo, Hong Seog/0000-0002-3228-7988; Kim, Eung Ju/0000-0003-2322-6267	Korea Institute of Science and Technology Institutional Program [2E24080]; Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea [A070001]; Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology [R1307921]	Korea Institute of Science and Technology Institutional Program; Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea; Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology	This study was partly supported by the Korea Institute of Science and Technology Institutional Program (Project No. 2E24080); a grant from the Korean Health Technology R&D Project of the Ministry for Health, Welfare & Family Affairs of the Republic of Korea (A070001); and a grant from the Korea University-Korea Institute of Science and Technology Graduate School Converging Science and Technology(R1307921). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Sarmiento-Monroy JC, 2012, ARTHRITIS, DOI 10.1155/2012/371909; Chowdhary VR, 2008, J RHEUMATOL, V35, P2159, DOI 10.3899/jrheum.080336; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dick TJM, 2013, ATHEROSCLEROSIS, V226, P208, DOI 10.1016/j.atherosclerosis.2012.10.040; Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1, DOI 10.1152/ajpgi.00384.2001; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; El Fadl KA, 2011, ANGIOLOGY, V62, P62, DOI 10.1177/0003319710371617; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; FREDRICK.DS, 1965, CIRCULATION, V31, P321, DOI 10.1161/01.CIR.31.3.321; Furuta M, 2010, ACTA ODONTOL SCAND, V68, P27, DOI 10.3109/00016350903291913; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Gisondi P, 2010, ACTA DERMATOVENER CR, V18, P297; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Jung HJ, 2010, CLIN CHIM ACTA, V411, P818, DOI 10.1016/j.cca.2010.02.068; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolodgie FD, 1996, ARTERIOSCL THROM VAS, V16, P1454, DOI 10.1161/01.ATV.16.12.1454; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kuipers F, 1996, HEPATOLOGY, V24, P241; KWITEROVICH PO, 1987, ARTERIOSCLEROSIS, V7, P211, DOI 10.1161/01.ATV.7.3.211; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Lehr HA, 2001, CIRCULATION, V104, P914, DOI 10.1161/hc3401.093153; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Ohnishi S, 2008, PROTEIN SCI, V17, P1531, DOI 10.1110/ps.035329.108; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schoenfeld SR, 2013, SEMIN ARTHRITIS RHEU, V43, P77, DOI 10.1016/j.semarthrit.2012.12.002; Son HH, 2014, J LIPID RES, V55, P155, DOI 10.1194/jlr.D040790; Sung KC, 2009, ATHEROSCLEROSIS, V203, P581, DOI 10.1016/j.atherosclerosis.2008.07.024; Sung KC, 2012, DIABETES CARE, V35, P2359, DOI 10.2337/dc12-0515; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0; Tsuji RF, 2003, CLIN EXP ALLERGY, V33, P249, DOI 10.1046/j.1365-2222.2003.01575.x; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wobser H, 2009, CELL RES, V19, P996, DOI 10.1038/cr.2009.73; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang X, 2005, ARTERIOSCL THROM VAS, V25, P2308, DOI 10.1161/01.ATV.0000187468.00675.a3; Yanni AE, 2004, LAB ANIM-UK, V38, P246, DOI 10.1258/002367704323133628; Zhang YQ, 2010, VACCINE, V28, P5212, DOI 10.1016/j.vaccine.2010.05.068	46	41	41	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97841	10.1371/journal.pone.0097841	http://dx.doi.org/10.1371/journal.pone.0097841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901254	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400013
J	Ratnoglik, SL; Jiang, DP; Aoki, C; Sudarmono, P; Shoji, I; Deng, L; Hotta, H				Ratnoglik, Suratno Lulut; Jiang, Da-Peng; Aoki, Chie; Sudarmono, Pratiwi; Shoji, Ikuo; Deng, Lin; Hotta, Hak			Induction of Cell-Mediated Immune Responses in Mice by DNA Vaccines That Express Hepatitis C Virus NS3 Mutants Lacking Serine Protease and NTPase/RNA Helicase Activities	PLOS ONE			English	Article							VIRAL CLEARANCE; RNA HELICASES; T-CELLS; NONSTRUCTURAL PROTEIN-3; HCV INFECTION; CORE PROTEIN; CD4(+); REPLICATION; CANCER; EPITOPES	Effective therapeutic vaccines against virus infection must induce sufficient levels of cell-mediated immune responses against the target viral epitopes and also must avoid concomitant risk factors, such as potential carcinogenic properties. The nonstructural protein 3 (NS3) of hepatitis C virus (HCV) carries a variety of CD4(+) and CD8(+) T cell epitopes, and induces strong HCV-specific T cell responses, which are correlated with viral clearance and resolution of acute HCV infection. On the other hand, NS3 possesses serine protease and nucleoside triphosphatase (NTPase)/RNA helicase activities, which not only play important roles in viral life cycle but also concomitantly interfere with host defense mechanisms by deregulating normal cellular functions. In this study, we constructed a series of DNA vaccines that express NS3 of HCV. To avoid the potential harm of NS3, we introduced mutations to the catalytic triad of the serine protease (H57A, D81A and S139A) and the NTPase/RNA helicase domain (K210N, F444A, R461Q and W501A) to eliminate the enzymatic activities. Immunization of BALB/c mice with each of the DNA vaccine candidates (pNS3[S139A/K210N], pNS3[S139A/F444A], pNS3[S139A/R461Q] and pNS3[S139A/W501A]) that expresses an NS3 mutant lacking both serine protease and NTPase/helicase activities induced T cell immune responses to the degree comparable to that induced by the wild type NS3 and the NS3/4A complex, as demonstrated by interferon-gamma production and cytotoxic T lymphocytes activities against NS3. The present study has demonstrated that plasmids expressing NS3 mutants, NS3(S139A/K210N), NS3(S139A/F444A), NS3(S139A/R461Q) and NS3(S139A/W501A), which lack both serine protease and NTPase/RNA helicase activities, would be good candidates for safe and efficient therapeutic DNA vaccines against HCV infection.	[Ratnoglik, Suratno Lulut; Jiang, Da-Peng; Aoki, Chie; Shoji, Ikuo; Deng, Lin; Hotta, Hak] Kobe Univ Grad Sch Med, Div Microbiol, Kobe, Hyogo, Japan; [Aoki, Chie] Univ Indonesia, JST JICA SATREPS Lab, Fac Med, Kobe Univ, Jakarta, Indonesia; [Ratnoglik, Suratno Lulut; Sudarmono, Pratiwi] Univ Indonesia, Fac Med, Jakarta, Indonesia	Kobe University; University of Indonesia; University of Indonesia	Hotta, H (corresponding author), Kobe Univ Grad Sch Med, Div Microbiol, Kobe, Hyogo, Japan.	hotta@kobe-u.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379	SATREPS Grant from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan; Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [26461003] Funding Source: KAKEN	SATREPS Grant from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a SATREPS Grant from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), a grant from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan. This study was also carried out as part of the Global Center of Excellence (G-COE) Program at Kobe University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Alaoui-Ismaili MH, 2000, ANTIVIR RES, V46, P181, DOI 10.1016/S0166-3542(00)00085-1; Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Castelli FA, 2007, EUR J IMMUNOL, V37, P1513, DOI 10.1002/eji.200636783; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; Deng L, 2006, J GEN VIROL, V87, P1703, DOI 10.1099/vir.0.81735-0; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Diepolder HM, 1997, J VIROL, V71, P6011, DOI 10.1128/JVI.71.8.6011-6019.1997; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hegde R, 2005, J VIROL, V79, P14688, DOI 10.1128/JVI.79.23.14688-14697.2005; Hidajat R, 2005, J GEN VIROL, V86, P2197, DOI 10.1099/vir.0.80862-0; JARVIS TC, 1991, TRENDS GENET, V7, P186, DOI 10.1016/0168-9525(91)90434-R; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Kuang WF, 2004, BIOCHEM BIOPH RES CO, V317, P211, DOI 10.1016/j.bbrc.2004.03.032; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; MacDonald AJ, 2002, J INFECT DIS, V185, P720, DOI 10.1086/339340; Martinez MA, 2003, ANTIMICROB AGENTS CH, V47, P1760, DOI 10.1128/AAC.47.5.1760-1765.2003; Mashiba T, 2007, IMMUNOGENETICS, V59, P197, DOI 10.1007/s00251-006-0185-3; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Penna A, 2002, HEPATOLOGY, V35, P1225, DOI 10.1053/jhep.2002.33153; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Raviprakash Kanakatte, 2006, V127, P83; Robert F, 2013, WIRES RNA, V4, P333, DOI 10.1002/wrna.1163; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Vlachakis D, 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.275., DOI 10.1038/PROTEX.2011.275]; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98877	10.1371/journal.pone.0098877	http://dx.doi.org/10.1371/journal.pone.0098877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901478	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400064
J	Baudier, KM; Kaschock-Marenda, SD; Patel, N; Diangelus, KL; O'Donnell, S; Marenda, DR				Baudier, Kaitlin M.; Kaschock-Marenda, Simon D.; Patel, Nirali; Diangelus, Katherine L.; O'Donnell, Sean; Marenda, Daniel R.			Erythritol, a Non-Nutritive Sugar Alcohol Sweetener and the Main Component of Truvia (R), Is a Palatable Ingested Insecticide	PLOS ONE			English	Article							MANNOSE TOXICITY; DROSOPHILA; TOLERANCE	Insecticides have a variety of commercial applications including urban pest control, agricultural use to increase crop yields, and prevention of proliferation of insect-borne diseases. Many pesticides in current use are synthetic molecules such as organochlorine and organophosphate compounds. Some synthetic insecticides suffer drawbacks including high production costs, concern over environmental sustainability, harmful effects on human health, targeting non-intended insect species, and the evolution of resistance among insect populations. Thus, there is a large worldwide need and demand for environmentally safe and effective insecticides. Here we show that Erythritol, a non-nutritive sugar alcohol, was toxic to the fruit fly Drosophila melanogaster. Ingested erythritol decreased fruit fly longevity in a dose-dependent manner, and erythritol was ingested by flies that had free access to control (sucrose) foods in choice and CAFE studies. Erythritol was US FDA approved in 2001 and is used as a food additive in the United States. Our results demonstrate, for the first time, that erythritol may be used as a novel, environmentally sustainable and human safe approach for insect pest control.	[Baudier, Kaitlin M.; Kaschock-Marenda, Simon D.; Patel, Nirali; Diangelus, Katherine L.; O'Donnell, Sean; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Baudier, Kaitlin M.; O'Donnell, Sean] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Drexel University; Drexel University	O'Donnell, S (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	so356@drexel.edu; Daniel.Marenda@drexel.edu	Baudier, Kaitlin/I-4138-2019	Baudier, Kaitlin/0000-0001-8450-3788	NSF IOS [1256114, 1209072]; Direct For Biological Sciences [1209072] Funding Source: National Science Foundation	NSF IOS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by NSF IOS 1256114 (to DRM); NSF IOS 1209072 (to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUST JG, 1979, PHYSIOL ENTOMOL, V4, P1, DOI 10.1111/j.1365-3032.1979.tb00171.x; Bornet FRJ, 1996, REGUL TOXICOL PHARM, V24, pS296, DOI 10.1006/rtph.1996.0111; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Danks HV, 2004, INTEGR COMP BIOL, V44, P85, DOI 10.1093/icb/44.2.85; DELAFUENTE M, 1986, BIOCHEM BIOPH RES CO, V140, P51, DOI 10.1016/0006-291X(86)91056-9; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; LEBOURG E, 1992, GERONTOLOGY, V38, P71; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Moon HJ, 2010, APPL MICROBIOL BIOT, V86, P1017, DOI 10.1007/s00253-010-2496-4; Oku T, 1996, NUTR RES, V16, P577, DOI 10.1016/0271-5317(96)00036-X; Pimentel David, 2005, Environment Development and Sustainability, V7, P229, DOI 10.1007/s10668-005-7314-2; SILVA CP, 1995, INSECT BIOCHEM MOLEC, V25, P487, DOI 10.1016/0965-1748(94)00088-G; SOLS A, 1960, SCIENCE, V131, P297, DOI 10.1126/science.131.3396.297; Storey D, 2007, EUR J CLIN NUTR, V61, P349, DOI 10.1038/sj.ejcn.1602532; Subramanian Meera, 2013, NY TIMES; Tetzloff W, 1996, REGUL TOXICOL PHARM, V24, pS286, DOI 10.1006/rtph.1996.0110; TOKUOKA K, 1992, J GEN APPL MICROBIOL, V38, P145, DOI 10.2323/jgam.38.145; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	19	42	44	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98949	10.1371/journal.pone.0098949	http://dx.doi.org/10.1371/journal.pone.0098949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896294	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700099
J	Kougioumtzi, A; Tsaparas, P; Magklara, A				Kougioumtzi, Anastasia; Tsaparas, Panayiotis; Magklara, Angeliki			Deep Sequencing Reveals New Aspects of Progesterone Receptor Signaling in Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED LEUCINE-ZIPPER; FOCAL ADHESION KINASE; MAMMARY-GLAND; GENE-REGULATION; RNA-SEQ; ESTROGEN-RECEPTOR; EMERGING ROLES; GENOMIC DATA; EXPRESSION	Despite the pleiotropic effects of the progesterone receptor in breast cancer, the molecular mechanisms in play remain largely unknown. To gain a global view of the PR-orchestrated networks, we used next-generation sequencing to determine the progestin-regulated transcriptome in T47D breast cancer cells. We identify a large number of PR target genes involved in critical cellular programs, such as regulation of transcription, apoptosis, cell motion and angiogenesis. Integration of the transcriptomic data with the PR-binding profiling of hormonally treated cells identifies numerous components of the small-GTPases signaling pathways as direct PR targets. Progestin-induced deregulation of the small GTPases may contribute to the PR's role in mammary tumorigenesis. Transcript expression analysis reveals significant expression changes of specific transcript variants in response to the extracellular hormonal stimulus. Using the NET1 gene as an example, we show that the PR can dictate alternative promoter usage leading to the upregulation of an isoform that may play a role in metastatic breast cancer. Future studies should aim to characterize these selectively regulated variants and evaluate their clinical utility in prognosis and targeted therapy of hormonally responsive breast tumors.	[Kougioumtzi, Anastasia] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece; [Tsaparas, Panayiotis] Univ Ioannina, Dept Comp Sci & Engn, GR-45110 Ioannina, Greece; [Magklara, Angeliki] Univ Ioannina, Sch Med, Clin Chem Lab, GR-45110 Ioannina, Greece; [Magklara, Angeliki] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Ioannina, Greece	University of Ioannina; University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH)	Magklara, A (corresponding author), Univ Ioannina, Sch Med, Clin Chem Lab, GR-45110 Ioannina, Greece.	magklara@cc.uoi.gr	Magklara, Angeliki/AAK-8347-2020	Magklara, Angeliki/0000-0003-3408-6722; Tsaparas, Panayiotis/0000-0002-3490-1507	Marie Curie Career Integration Grant [PCIG10-GA-2011-303519]; internal IMBB grant	Marie Curie Career Integration Grant; internal IMBB grant	This work was supported by a Marie Curie Career Integration Grant (PCIG10-GA-2011-303519) and an internal IMBB grant to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bhat-Nakshatri P, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-21; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chatterton RT, 2002, CANCER LETT, V188, P47, DOI 10.1016/S0304-3835(02)00461-5; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Croce MV, 2003, BREAST CANCER RES TR, V81, P195, DOI 10.1023/A:1026110417294; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dutertre M, 2010, RNA BIOL, V7, P403, DOI 10.4161/rna.7.4.12152; Dutertre M, 2010, CANCER RES, V70, P3760, DOI 10.1158/0008-5472.CAN-09-3988; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Fritzsche FR, 2006, CLIN CANCER RES, V12, P1728, DOI 10.1158/1078-0432.CCR-05-2057; Fu XD, 2010, ENDOCR-RELAT CANCER, V17, P431, DOI 10.1677/ERC-09-0258; Fu XD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002790; Garcia-Murillas I, 2013, ONCOGENE; Ghatge RP, 2005, BREAST CANCER RES, V7, pR1036, DOI 10.1186/bcr1340; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hyder SM, 2009, ENDOCR-RELAT CANCER, V16, P809, DOI 10.1677/ERC-08-0311; Hyder SM, 1998, CANCER RES, V58, P392; Hyder SM, 2001, INT J CANCER, V92, P469, DOI 10.1002/ijc.1236; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kato S, 2005, J CLIN ENDOCR METAB, V90, P1181, DOI 10.1210/jc.2004-0857; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Knutson TP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3211; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Lange CA, 1999, MOL ENDOCRINOL, V13, P829, DOI 10.1210/me.13.6.829; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang YY, 2006, ENDOCR-RELAT CANCER, V13, P905, DOI 10.1677/erc.1.01221; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lydon JP, 1999, CANCER RES, V59, P4276; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Meyer CA, 2012, MOL ENDOCRINOL, V26, P1651, DOI 10.1210/me.2012-1150; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Omenn GS, 2013, J PROTEOMICS, V90, P28, DOI 10.1016/j.jprot.2013.04.007; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wan YH, 2002, MOL ENDOCRINOL, V16, P1204, DOI 10.1210/me.16.6.1204; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang Y, 2005, BIOCHEM BIOPH RES CO, V330, P1247, DOI 10.1016/j.bbrc.2005.03.106; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Whitman S, 2000, MOL CELL BIOL, V20, P583, DOI 10.1128/MCB.20.2.583-593.2000; Wu JB, 2004, CANCER RES, V64, P2238, DOI 10.1158/0008-5472.CAN-03-3044; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yee KO, 2009, BREAST CANCER RES TR, V114, P85, DOI 10.1007/s10549-008-9992-6; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	76	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98404	10.1371/journal.pone.0098404	http://dx.doi.org/10.1371/journal.pone.0098404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897521	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700042
J	Seth, I; Schwartz, JL; Stewart, RD; Emery, R; Joiner, MC; Tucker, JD				Seth, Isheeta; Schwartz, Jeffrey L.; Stewart, Robert D.; Emery, Robert; Joiner, Michael C.; Tucker, James D.			Neutron Exposures in Human Cells: Bystander Effect and Relative Biological Effectiveness	PLOS ONE			English	Article							SERUM SEROTONIN LEVELS; INDUCED GENOMIC INSTABILITY; COSMIC-RADIATION; IONIZING-RADIATION; SIGNALING PATHWAYS; SECONDARY NEUTRONS; HUMAN-LYMPHOCYTES; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; CAPTURE THERAPY	Bystander effects have been observed repeatedly in mammalian cells following photon and alpha particle irradiation. However, few studies have been performed to investigate bystander effects arising from neutron irradiation. Here we asked whether neutrons also induce a bystander effect in two normal human lymphoblastoid cell lines. These cells were exposed to fast neutrons produced by targeting a near-monoenergetic 50.5 MeV proton beam at a Be target (17 MeV average neutron energy), and irradiated-cell conditioned media (ICCM) was transferred to unirradiated cells. The cytokinesis-block micronucleus assay was used to quantify genetic damage in radiation-naive cells exposed to ICCM from cultures that received 0 (control), 0.5, 1, 1.5, 2, 3 or 4 Gy neutrons. Cells grown in ICCM from irradiated cells showed no significant increase in the frequencies of micronuclei or nucleoplasmic bridges compared to cells grown in ICCM from sham irradiated cells for either cell line. However, the neutron beam has a photon dose-contamination of 5%, which may modulate a neutron-induced bystander effect. To determine whether these low doses of contaminating photons can induce a bystander effect, cells were irradiated with cobalt-60 at doses equivalent to the percent contamination for each neutron dose. No significant increase in the frequencies of micronuclei or bridges was observed at these doses of photons for either cell line when cultured in ICCM. As expected, high doses of photons induced a clear bystander effect in both cell lines for micronuclei and bridges (p<0.0001). These data indicate that neutrons do not induce a bystander effect in these cells. Finally, neutrons had a relative biological effectiveness of 2.0 +/- 0.13 for micronuclei and 5.8 +/- 2.9 for bridges compared to cobalt-60. These results may be relevant to radiation therapy with fast neutrons and for regulatory agencies setting standards for neutron radiation protection and safety.	[Seth, Isheeta; Tucker, James D.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Schwartz, Jeffrey L.; Stewart, Robert D.; Emery, Robert] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA; [Joiner, Michael C.] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA	Wayne State University; University of Washington; University of Washington Seattle; Wayne State University	Tucker, JD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	jtucker@biology.biosci.wayne.edu	Stewart, Robert/A-3609-2013; seth, isheeta/AIB-4204-2022	Stewart, Robert/0000-0001-5946-0595; 	Wayne State University	Wayne State University	This work was in part supported by Wayne State University Graduate Enhancement Research Funds to Isheeta Seth. The remaining funds came from Dr. Tucker's Wayne State University Indirect Cost Account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dagrosa MA, 2011, INT J RADIAT ONCOL, V79, P262, DOI 10.1016/j.ijrobp.2010.07.020; Asur RS, 2009, MUTAT RES-GEN TOX EN, V676, P11, DOI 10.1016/j.mrgentox.2009.02.012; Azzam EI, 2004, HUM EXP TOXICOL, V23, P61, DOI 10.1191/0960327104ht418oa; Baskar Rajamanickam, 2010, Genome Integr, V1, P13, DOI 10.1186/2041-9414-1-13; Belloni P, 2011, MUTAT RES-FUND MOL M, V713, P32, DOI 10.1016/j.mrfmmm.2011.05.010; Belyakov OV, 2001, BRIT J CANCER, V84, P674, DOI 10.1054/bjoc.2000.1665; Brooks AL, 2004, HUM EXP TOXICOL, V23, P67, DOI 10.1191/0960327104ht419oa; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; CARNES BA, 1989, RADIAT RES, V119, P39, DOI 10.2307/3577366; Chapman KL, 2012, INT J RADIAT BIOL, V88, P781, DOI 10.3109/09553002.2012.710926; Chen S, 2011, MUTAT RES-FUND MOL M, V706, P59, DOI 10.1016/j.mrfmmm.2010.10.011; Chen SP, 2009, MUTAT RES-FUND MOL M, V666, P68, DOI 10.1016/j.mrfmmm.2009.04.006; Cheong HSJ, 2013, MUTAGENESIS, V28, P433, DOI 10.1093/mutage/get020; Chiba S, 2002, BONE MARROW TRANSPL, V29, P935, DOI 10.1038/sj.bmt.1703568; Dale Walter M., 1942, BIOCHEM JOUR, V36, P80; Dale WM, 1940, BIOCHEM J, V34, P1367, DOI 10.1042/bj0341367; DUNCAN W, 1987, RADIOTHER ONCOL, V8, P97, DOI 10.1016/S0167-8140(87)80162-7; EASTMOND DA, 1989, ENVIRON MOL MUTAGEN, V13, P34, DOI 10.1002/em.2850130104; Edwards GO, 2004, BRIT J CANCER, V90, P1450, DOI 10.1038/sj.bjc.6601686; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fowler J F, 1975, J Can Assoc Radiol, V26, P40; Geard CR, 2002, RADIAT PROT DOSIM, V99, P233, DOI 10.1093/oxfordjournals.rpd.a006771; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Han W, 2007, BRIT J RADIOL, V80, pS7, DOI 10.1259/bjr/44550200; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Heilbronn L, 2005, RADIAT PROT DOSIM, V116, P140, DOI 10.1093/rpd/nci033; Hu BR, 2006, CARCINOGENESIS, V27, P245, DOI 10.1093/carcin/bgi224; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Kalanxhi E, 2012, INT J RADIAT BIOL, V88, P773, DOI 10.3109/09553002.2012.711919; Kinashi Y, 2007, INT J RADIAT ONCOL, V68, P508, DOI 10.1016/j.ijrobp.2007.02.002; Lennox AJ, INT C ADV NEUTR SOUR; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Liu ZF, 2007, RADIAT RES, V168, P627, DOI 10.1667/RR1014.1; Lukina Ye Yu, 2010, Voprosy Onkologii (St. Petersburg), V56, P413; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Morgan WF, 2013, CANC LETT, DOI 101016/jcanlet201309009; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2003, ONCOGENE, V22, P7028, DOI 10.1038/sj.onc.1206882; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2013, RAD ENV BIOPHYS; Mothersill C, 2013, J ENV RADIOACT; Mothersill C, 2012, INT J RADIAT BIOL, V88, P763, DOI 10.3109/09553002.2012.715795; Mothersill C, 2012, INT J RADIAT BIOL, V88, P583, DOI 10.3109/09553002.2012.698366; Mothersill C, 2011, INT J RADIAT BIOL, V87, P1120, DOI 10.3109/09553002.2011.610866; Mothersill C, 2010, RADIAT RES, V174, P119, DOI 10.1667/RR2036.1; NAGASAWA H, 1992, CANCER RES, V52, P6394; *NAT TOX PROGR, 2004, REP CARC; Ohnishi T, 2002, J RADIAT RES, V43, pS7; Perez-Andujar A, 2013, MED PHYS, V40, DOI 10.1118/1.4829512; Pinho C, 2012, INT J RADIAT BIOL, V88, P791, DOI 10.3109/09553002.2012.715794; Poon RCC, 2007, ENVIRON RES, V105, P200, DOI 10.1016/j.envres.2006.12.003; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Rajendran S, 2011, RADIAT RES, V175, P159, DOI 10.1667/RR2296.1; Resat MBS, 2004, J CELL BIOCHEM, V92, P1013, DOI 10.1002/jcb.20149; Ruhm W, 2009, RADIAT PROT DOSIM, V136, P256, DOI 10.1093/rpd/ncp161; Ruhm W, 2009, RADIAT ENVIRON BIOPH, V48, P125, DOI 10.1007/s00411-009-0219-y; Ryan LA, 2006, HEALTH PHYS, V91, P68, DOI 10.1097/01.HP.0000200339.91550.6b; Schettino G, 2005, RADIAT RES, V163, P332, DOI 10.1667/RR3319; Schmid E, 2003, RADIAT ENVIRON BIOPH, V42, P87, DOI 10.1007/s00411-003-0200-0; Schwartz JL, 2007, MUTAT RES-FUND MOL M, V616, P196, DOI 10.1016/j.mrfmmm.2006.11.016; Scott AH, 2013, DMSO HDB DOCTORS; Shao CL, 2004, J RADIAT RES, V45, P97, DOI 10.1269/jrr.45.97; Sokolov MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014195; Stannard C, 2013, RADIOTHER ONCOL, V109, P262, DOI 10.1016/j.radonc.2013.08.013; Task Group on Radiation Protection in Space ICRP Committee 2, 2013, Ann ICRP, V42, P1, DOI 10.1016/j.icrp.2013.05.004; Vukovic B, 2007, J ENVIRON RADIOACTIV, V98, P264, DOI 10.1016/j.jenvrad.2007.05.002; Vukovic B, 2010, APPL RADIAT ISOTOPES, V68, P2398, DOI 10.1016/j.apradiso.2010.06.017; Wang C, 2011, INT J RADIAT BIOL, V87, P964, DOI 10.3109/09553002.2011.584939; Wang H, 2013, CANC LETT, DOI 101016/jcanlet201309031; Watson GE, 2000, CANCER RES, V60, P5608; Yang M, 2011, RADIAT RES, V176, P303, DOI 10.1667/RR2589.1; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	76	27	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98947	10.1371/journal.pone.0098947	http://dx.doi.org/10.1371/journal.pone.0098947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896095	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700098
J	Wang, GD; Wang, JL; Luo, XM; Ansari, GAS; Khan, MF				Wang, Gangduo; Wang, Jianling; Luo, Xuemei; Ansari, G. A. Shakeel; Khan, M. Firoze			Nitrosative Stress and Nitrated Proteins in Trichloroethene-Mediated Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; N-ACETYLCYSTEINE; DISEASE-ACTIVITY; LIPID-PEROXIDATION; OXIDATIVE STRESS; CHRONIC EXPOSURE; REACTIVE OXYGEN; UNITED-STATES	Exposure to trichloroethene (TCE), a ubiquitous environmental contaminant, has been linked to a variety of autoimmune diseases (ADs) including SLE, scleroderma and hepatitis. Mechanisms involved in the pathogenesis of ADs are largely unknown. Earlier studies from our laboratory in MRL+/+ mice suggested the contribution of oxidative/nitrosative stress in TCE-induced autoimmunity, and N-acetylcysteine (NAC) supplementation provided protection by attenuating oxidative stress. This study was undertaken to further evaluate the contribution of nitrosative stress in TCE-mediated autoimmunity and to identify proteins susceptible to nitrosative stress. Groups of female MRL+/+ mice were given TCE, NAC or TCE + NAC for 6 weeks (TCE, 10 mmol/kg, i.p., every 4th day; NAC, similar to 250 mg/kg/day via drinking water). TCE exposure led to significant increases in serum anti-nuclear and anti-histone antibodies together with significant induction of iNOS and increased formation of nitrotyrosine (NT) in sera and livers. Proteomic analysis identified 14 additional nitrated proteins in the livers of TCE-treated mice. Furthermore, TCE exposure led to decreased GSH levels and increased activation of NF-kappa B. Remarkably, NAC supplementation not only ameliorated TCE-induced nitrosative stress as evident from decreased iNOS, NT, nitrated proteins, NF-kappa B p65 activation and increased GSH levels, but also the markers of autoimmunity, as evident from decreased levels of autoantibodies in the sera. These findings provide support to the role of nitrosative stress in TCE-mediated autoimmune response and identify specific nitrated proteins which could have autoimmune potential. Attenuation of TCE-induced autoimmunity in mice by NAC provides an approach for designing therapeutic strategies.	[Wang, Gangduo; Wang, Jianling; Ansari, G. A. Shakeel; Khan, M. Firoze] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Luo, Xuemei] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Khan, MF (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	mfkhan@utmb.edu			National Institute of Environmental Health Sciences (NIEHS), NIH [ES016302]; NIEHS center grant [P30ES06676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES016302] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES016302 from the National Institute of Environmental Health Sciences (NIEHS), NIH and P30ES06676 (NIEHS center grant). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS, NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Ashtiani H, 2012, J NAT MED-TOKYO, V66, P85, DOI 10.1007/s11418-011-0554-6; Aktunc E, 2010, CLIN EXP DERMATOL, V35, P902, DOI 10.1111/j.1365-2230.2010.03823.x; Al-Shobaili HA, 2013, LUPUS, V22, P1024, DOI 10.1177/0961203313498803; Al-Shobaili HA, 2013, IMMUNOL INVEST, V42, P191, DOI 10.3109/08820139.2012.751396; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Cai P, 2008, TOXICOL APPL PHARM, V228, P68, DOI 10.1016/j.taap.2007.11.031; Channel SR, 1998, TOXICOL SCI, V43, P145; de Andres MC, 2013, ARTHRITIS RHEUM-US, V65, P732, DOI 10.1002/art.37806; Downs I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038051; Egner W, 2000, J CLIN PATHOL, V53, P424, DOI 10.1136/jcp.53.6.424; Fan XZ, 2011, TOXICOL APPL PHARM, V255, P103, DOI 10.1016/j.taap.2011.06.005; Frostegard J, 2005, ARTHRITIS RHEUM-US, V52, P192, DOI 10.1002/art.20780; Griffin JM, 2000, IMMUNOPHARMACOLOGY, V46, P123, DOI 10.1016/S0162-3109(99)00164-2; Griffiths HR, 2008, AUTOIMMUN REV, V7, P544, DOI 10.1016/j.autrev.2008.04.013; Hill BG, 2010, J BIOL CHEM, V285, P19699, DOI 10.1074/jbc.R110.101618; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; KHAN MF, 1995, TOXICOL APPL PHARM, V134, P155, DOI 10.1006/taap.1995.1179; Khan MF, 2001, TOXICOL APPL PHARM, V170, P88, DOI 10.1006/taap.2000.9086; KILBURN KH, 1992, ENVIRON RES, V57, P1, DOI 10.1016/S0013-9351(05)80014-3; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kurien BT, 2008, AUTOIMMUN REV, V7, P567, DOI 10.1016/j.autrev.2008.04.019; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Li Y, 2013, NEUROSCIENCE, V248, P681, DOI 10.1016/j.neuroscience.2013.06.030; Morgan PE, 2009, FREE RADICAL RES, V43, P117, DOI 10.1080/10715760802623896; Nagareddy PR, 2006, J CARDIOVASC PHARM, V47, P513, DOI 10.1097/01.fjc.0000211744.93701.25; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Niwano S, 2011, CIRC J, V75, P662, DOI 10.1253/circj.CJ-10-0673; Nur E, 2012, ANN HEMATOL, V91, P1097, DOI 10.1007/s00277-011-1404-z; Oates JC, 1999, P ASSOC AM PHYSICIAN, V111, P611, DOI 10.1046/j.1525-1381.1999.99110.x; Oates JC, 2010, AUTOIMMUNITY, V43, P56, DOI 10.3109/08916930903374683; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; Perricone C, 2009, AUTOIMMUN REV, V8, P697, DOI 10.1016/j.autrev.2009.02.020; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Reveille J, 2004, LUPUS, V13, P290, DOI 10.1191/0961203303lu1015oa; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shah D, 2010, IMMUNOL LETT, V129, P7, DOI 10.1016/j.imlet.2010.01.005; Suwannaroj S, 2001, LUPUS, V10, P258, DOI 10.1191/096120301680416940; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Wanchu A, 1998, RHEUMATOL INT, V18, P41, DOI 10.1007/s002960050055; Wang GD, 2008, FREE RADICAL BIO MED, V44, P1475, DOI 10.1016/j.freeradbiomed.2008.01.012; Wang GD, 2007, TOXICOLOGY, V229, P186, DOI 10.1016/j.tox.2006.10.014; Wang GD, 2013, TOXICOL APPL PHARM, V273, P189, DOI 10.1016/j.taap.2013.08.020; Wang GD, 2012, TOXICOLOGY, V292, P113, DOI 10.1016/j.tox.2011.12.001; Wang GD, 2010, ARTHRITIS RHEUM-US, V62, P2064, DOI 10.1002/art.27442; Wang GD, 2009, TOXICOL APPL PHARM, V237, P188, DOI 10.1016/j.taap.2009.03.010; Wang JL, 2008, TOXICOL APPL PHARM, V230, P227, DOI 10.1016/j.taap.2008.02.022; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhu QX, 2005, TOXICOLOGY, V209, P55, DOI 10.1016/j.tox.2004.12.006	55	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98660	10.1371/journal.pone.0098660	http://dx.doi.org/10.1371/journal.pone.0098660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892995	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400082
J	Wang, W; Yao, XF; Zhai, JP; Ji, MH				Wang, Wei; Yao, Xinfeng; Zhai, Junpeng; Ji, Minhe			A Tetrahedron-Based Endmember Selection Approach for Urban Impervious Surface Mapping	PLOS ONE			English	Article							SPECTRAL MIXTURE ANALYSIS; MULTIOBJECTIVE OPTIMIZATION; PIXEL CLASSIFICATION; LAND-USE; MODEL; EXTRACTION; ALGORITHM; INDIANAPOLIS; INDEX	The pixel purity index (PPI) and two-dimensional (2-D) scatter plots are two popular techniques for endmember extraction in remote sensing spectral mixture analysis, yet both suffer from one major drawback, that is, the selection of a final set of endmembers has to endure a cumbersome process of iterative visual inspection and human intervention, especially when a spectrally-complex urban scene is involved. Within the conceptual framework of a V-H-L-S (vegetation-high albedo-low albedo-soil) model, which is expanded from the classic V-I-S (vegetation-impervious surface-soil) model, a tetrahedron-based endmember selection approach combined with a multi-objective optimization genetic algorithm (MOGA) was designed to identify urban endmembers from multispectral imagery. The tetrahedron defining the enclosing volume of MNF-transformed pixels in a three-dimensional (3-D) space was algorithmically sought, so that the tetrahedral vertices can ideally match the four components of the adopted model. A case study with Landsat Enhanced Thematic Mapper Plus (ETM+) satellite imagery in Shanghai, China was conducted to verify the validity of the method. The method performance was compared with those of the traditional PPI and 2-D scatter plots approaches. The results indicated that the tetrahedron-based endmember selection approach performed better in both accuracy and ease of identification for urban surface endmembers owing to the 3-D visualization analysis and use of the MOGA.	[Wang, Wei; Zhai, Junpeng; Ji, Minhe] E China Normal Univ, Key Lab GISci, Educ Minist China, Shanghai 200062, Peoples R China; [Yao, Xinfeng] Shanghai Acad Agr Sci, Agr Informat Inst Sci & Technol, Shanghai, Peoples R China	East China Normal University; Shanghai Academy of Agricultural Sciences	Ji, MH (corresponding author), E China Normal Univ, Key Lab GISci, Educ Minist China, Shanghai 200062, Peoples R China.	mhji@geo.ecnu.edu.cn			National Basic Research Program of China [2010CB951603]; Shanghai Natural Science Foundation [13ZR1436900]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This work was supported by National Basic Research Program of China (No. 2010CB951603) and the Shanghai Natural Science Foundation (No. 13ZR1436900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1995, REMOTE SENS ENVIRON, V52, P137, DOI 10.1016/0034-4257(94)00098-8; Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Asner GP, 2000, REMOTE SENS ENVIRON, V74, P99, DOI 10.1016/S0034-4257(00)00126-7; Awad MM, 2012, INT J REMOTE SENS, V33, P5819, DOI 10.1080/01431161.2012.674228; Boardman J.W., 1993, AVIRIS WORKSH, V1, P11; Boardman J. W., 1995, JPL PUBLICATION, V951, P23; Chang CI, 2006, IEEE GEOSCI REMOTE S, V3, P63, DOI 10.1109/LGRS.2005.856701; Dai XY, 2010, INT J REMOTE SENS, V31, P6095, DOI 10.1080/01431160903376407; Dare PM, 2005, PHOTOGRAMM ENG REM S, V71, P169, DOI 10.14358/PERS.71.2.169; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Eschenauer H., 1990, MULTICRITERIA DESIGN; FOODY GM, 1994, INT J REMOTE SENS, V15, P619, DOI 10.1080/01431169408954100; Ghoggali N, 2009, IEEE T GEOSCI REMOTE, V47, P1707, DOI 10.1109/TGRS.2008.2007128; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Hendrix EMT, 2010, INT GEOSCI REMOTE SE, P193, DOI 10.1109/IGARSS.2010.5649694; JI M, 1999, GEOCARTO INT, V14, P33, DOI DOI 10.1080/10106049908542126; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; Lu D, 2004, INT J REMOTE SENS, V25, P5345, DOI 10.1080/01431160412331269733; Lu DS, 2006, REMOTE SENS ENVIRON, V102, P146, DOI 10.1016/j.rse.2006.02.010; Lu DS, 2006, INT J REMOTE SENS, V27, P3553, DOI 10.1080/01431160600617202; Lu DS, 2011, INT J REMOTE SENS, V32, P2519, DOI 10.1080/01431161003698393; Lu DS, 2009, INT J REMOTE SENS, V30, P1297, DOI 10.1080/01431160802508985; Lu DS, 2004, PHOTOGRAMM ENG REM S, V70, P1053, DOI 10.14358/PERS.70.9.1053; M Kasprzak E., 2000, J ENG VALUAT COST AN, V3, P173; Phinn S, 2002, INT J REMOTE SENS, V23, P4131, DOI 10.1080/01431160110114998; Plaza A, 2002, IEEE T GEOSCI REMOTE, V40, P2025, DOI 10.1109/TGRS.2002.802494; Powell RL, 2007, REMOTE SENS ENVIRON, V106, P253, DOI 10.1016/j.rse.2006.09.005; Rashed T., 2001, GEOCARTO INT, V16, P5, DOI [10.1080/10106040108542210, DOI 10.1080/10106040108542210]; Rassafi AA, 2012, INT J TRANSPORTATION, V1, P47; RIDD MK, 1995, INT J REMOTE SENS, V16, P2165, DOI 10.1080/01431169508954549; Rogge DM, 2007, REMOTE SENS ENVIRON, V110, P287, DOI 10.1016/j.rse.2007.02.019; Saha S, 2010, INT J REMOTE SENS, V31, P5751, DOI 10.1080/01431161.2010.512302; Small C, 2001, INT J REMOTE SENS, V22, P1305, DOI 10.1080/01431160151144369; SMITH MO, 1985, J GEOPHYS RES, V90, pC797, DOI 10.1029/JB090iS02p0C797; Somers B, 2011, REMOTE SENS ENVIRON, V115, P1603, DOI 10.1016/j.rse.2011.03.003; Van de Voorde T, 2009, INT J REMOTE SENS, V30, P4785, DOI 10.1080/01431160802665918; Weng QH, 2008, INT J APPL EARTH OBS, V10, P68, DOI 10.1016/j.jag.2007.05.002; Weng QH, 2012, REMOTE SENS ENVIRON, V117, P34, DOI 10.1016/j.rse.2011.02.030; Weng QH, 2009, INT J REMOTE SENS, V30, P4807, DOI 10.1080/01431160802665926; Winter ME, 1999, P SOC PHOTO-OPT INS, V3753, P266, DOI 10.1117/12.366289; Wu CS, 2009, INT J REMOTE SENS, V30, P2915, DOI 10.1080/01431160802558634; Wu CS, 2003, REMOTE SENS ENVIRON, V84, P493, DOI 10.1016/S0034-4257(02)00136-0; Wu CS, 2004, REMOTE SENS ENVIRON, V93, P480, DOI 10.1016/j.rse.2004.08.003; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	46	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e93479	10.1371/journal.pone.0093479	http://dx.doi.org/10.1371/journal.pone.0093479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892938	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400002
J	Yan, Y; Hein, AL; Greer, PM; Wang, Z; Kolb, RH; Batra, SK; Cowan, KH				Yan, Y.; Hein, A. L.; Greer, P. M.; Wang, Z.; Kolb, R. H.; Batra, S. K.; Cowan, K. H.			A novel function of HER2/Neu in the activation of G2/M checkpoint in response to gamma-irradiation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; DNA-DAMAGE CHECKPOINT; TYROSINE KINASE INHIBITION; CELL-CYCLE CHECKPOINTS; SIGNALING PATHWAY; CANCER-CELLS; PHOSPHORYLATION; RADIATION; EGFR; PROTEIN	In response to gamma-irradiation (IR)-induced DNA damage, activation of cell cycle checkpoints results in cell cycle arrest, allowing time for DNA repair before cell cycle re-entry. Human cells contain G1 and G2 cell cycle checkpoints. While G1 checkpoint is defective in most cancer cells, commonly due to mutations and/or alterations in the key regulators of G1 checkpoint (for example, p53, cyclin D), G2 checkpoint is rarely impaired in cancer cells, which is important for cancer cell survival. G2 checkpoint activation involves activation of ataxia telangiectasia-mutated (ATM)/ATM- and rad3-related (ATR) signalings, which leads to the inhibition of Cdc2 kinase and subsequent G2/M cell cycle arrest. Previous studies from our laboratory show that G2 checkpoint activation following IR exposure of MCF-7 breast cancer cells is dependent on the activation of extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) signaling. As HER receptor tyrosine kinases (RTKs), which have important roles in cell proliferation and survival, have been shown to activate ERK1/2 signaling in response to various stimuli, we investigated the role of HER RTKs in IR-induced G2/M checkpoint response in breast cancer cells. Results of the present studies indicate that IR exposure resulted in a striking increase in the phosphorylation of HER1, HER2, HER3 and HER4 in MCF-7 cells, indicative of activation of these proteins. Furthermore, specific inhibition of HER2 using an inhibitor, short hairpin RNA and dominant-negative mutant HER2 abolished IR-induced activation of ATM/ATR signaling, phosphorylation of Cdc2-Y15 and subsequent induction of G2/M arrest. Moreover, the inhibition of HER2 also abrogated IR-induced ERK1/2 phosphorylation. In contrast, inhibition of HER1 using specific inhibitors or decreasing expression of HER3 or HER4 using short hairpin RNAs did not block the induction of G2/M arrest following IR. These results suggest an important role of HER2 in the activation of G2/M checkpoint response following IR.	[Yan, Y.; Hein, A. L.; Greer, P. M.; Wang, Z.; Kolb, R. H.; Cowan, K. H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Batra, S. K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Yan, Y (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	yyan@unmc.edu; kcowan@unmc.edu		Hein, Ashley/0000-0002-3309-2218	Nebraska [DHHS-LB506]; NCI [NCI T32 CA009476]; NCI Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476] Funding Source: NIH RePORTER	Nebraska; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Helen Piwnica-Worms for the GST-Cdc25C construct, Dr Ming-Fong Lin for the HER2-mut, wild-type HER2 and control constructs, Victoria Smith and Dr Charles Kuzynski for assistance with FACS analysis and Dr Janina Baranowska-Kortylewicz for assistance with the Mark I 68A Cesium-137 Irradiator. This work was supported by Nebraska DHHS-LB506 Grant 2010-40 to YY, NCI Training Grant (NCI T32 CA009476) to RK and NCI Cancer Center Support Grant (P30CA036727) to KC.	Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Geoerger B, 2008, INT J CANCER, V123, P209, DOI 10.1002/ijc.23488; Goldkorn T, 1997, BBA-MOL CELL RES, V1358, P289, DOI 10.1016/S0167-4889(97)00063-3; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Jani JP, 2007, CANCER RES, V67, P9887, DOI 10.1158/0008-5472.CAN-06-3559; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KHARBANDA S, 1994, CANCER RES, V54, P1412; Kiyozuka M, 2013, ANTICANCER RES, V33, P4337; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Leach JK, 2001, CANCER RES, V61, P3894; Lee HC, 2008, MOL CANCER RES, V6, P996, DOI 10.1158/1541-7786.MCR-08-0113; Lee MS, 2003, ONCOGENE, V22, P781, DOI 10.1038/sj.onc.1206066; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liang K, 2003, MOL CANCER THER, V2, P1113; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Navolanic PM, 2003, INT J ONCOL, V22, P237; Nyati MK, 2004, CLIN CANCER RES, V10, P691, DOI 10.1158/1078-0432.CCR-1041-03; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; SchmidtUllrich RK, 1997, ONCOGENE, V15, P1191, DOI 10.1038/sj.onc.1201275; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu Bo, 2004, Methods Mol Biol, V281, P283; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yan Y, 2002, J BIOL CHEM, V277, P33422, DOI 10.1074/jbc.M201147200; Yan Y, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3164	51	23	26	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2215	2226		10.1038/onc.2014.167	http://dx.doi.org/10.1038/onc.2014.167			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24909175	Green Accepted			2022-12-25	WOS:000353473000007
J	Buscetta, M; Papasergi, S; Firon, A; Pietrocola, G; Biondo, C; Mancuso, G; Midiri, A; Romeo, L; Teti, G; Speziale, P; Trieu-Cuot, P; Beninati, C				Buscetta, Marco; Papasergi, Salvatore; Firon, Arnaud; Pietrocola, Giampiero; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Romeo, Letizia; Teti, Giuseppe; Speziale, Pietro; Trieu-Cuot, Patrick; Beninati, Concetta			FbsC, a Novel Fibrinogen-binding Protein, Promotes Streptococcus agalactiae-Host Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; HUMAN EPITHELIAL-CELLS; MICROVASCULAR ENDOTHELIAL-CELLS; REGULATORY SYSTEM; HUMAN FIBRONECTIN; NEONATAL SEPSIS; GROUP-A; INVASION; ADHERENCE; COLONIZATION	Streptococcus agalactiae (group B Streptococcus or GBS) is a common cause of invasive infections in newborn infants and adults. The ability of GBS to bind human fibrinogen is of crucial importance in promoting colonization and invasion of host barriers. We characterized here a novel fibrinogen-binding protein of GBS, designated FbsC (Gbs0791), which is encoded by the prototype GBS strain NEM316. FbsC, which bears two bacterial immunoglobulin-like tandem repeat domains and a C-terminal cell wall-anchoring motif (LPXTG), was found to be covalently linked to the cell wall by the housekeeping sortase A. Studies using recombinant FbsC indicated that it binds fibrinogen in a dose-dependent and saturable manner, and with moderate affinity. Expression of FbsC was detected in all clinical GBS isolates, except those belonging to the hypervirulent lineage ST17. Deletion of fbsC decreases NEM316 abilities to adhere to and invade human epithelial and endothelial cells, and to form biofilm in vitro. Notably, bacterial adhesion to fibrinogen and fibrinogen binding to bacterial cells were abolished following fbsC deletion in NEM316. Moreover, the virulence of the fbsC deletion mutant and its ability to colonize the brain were impaired in murine models of infection. Finally, immunization with recombinant FbsC significantly protected mice from lethal GBS challenge. In conclusion, FbsC is a novel fibrinogen-binding protein expressed by most GBS isolates that functions as a virulence factor by promoting invasion of epithelial and endothelial barriers. In addition, the protein has significant immunoprotective activity and may be a useful component of an anti-GBS vaccine.	[Buscetta, Marco; Papasergi, Salvatore; Biondo, Carmelo; Mancuso, Giuseppe; Midiri, Angelina; Romeo, Letizia; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Metchnikoff Lab, Dipartimento Sci Pediat Ginecol Microbiol & Biome, I-98125 Messina, Italy; [Firon, Arnaud; Trieu-Cuot, Patrick] Inst Pasteur, CNRS, Unite Biol Bacteries Pathogenes Gram Positif, ERL3526, F-75015 Paris, France; [Pietrocola, Giampiero; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, I-27100 Pavia, Italy	University of Messina; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pavia	Teti, G (corresponding author), Policlin Univ, Torre Biol 2 P,Via Consolare Valeria 1, I-98125 Messina, Italy.	gteti@unime.it	Romeo, Letizia/Z-4819-2019; Romeo, Letizia/Z-2735-2019; papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019	Romeo, Letizia/0000-0002-7460-8815; Midiri, Angelina/0000-0002-4128-9678; Mancuso, Giuseppe/0000-0001-5454-3228; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; BENINATI, Concetta/0000-0001-8305-1337; Buscetta, Marco/0000-0001-8313-2647; TRIEU-CUOT, Patrick/0000-0002-2768-9587; FIRON, Arnaud/0000-0002-5323-5212	CLUSTER MEDINTECH [CTN01_00177_962865]; Ministero dell'Istruzione [PON01_00117]; dell'Universita e della Ricerca of Italy; Institut Pasteur; CNRS; French Government's Investissement d'Avenir program; Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fondation pour la Recherche Medicale [DEQ20130326538]	CLUSTER MEDINTECH; Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by CLUSTER MEDINTECH Project CTN01_00177_962865 and Ministero dell'Istruzione Grant PON01_00117, the dell'Universita e della Ricerca of Italy.; Supported by the Institut Pasteur, CNRS, French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID, and Fondation pour la Recherche Medicale Grant DEQ20130326538.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Brega S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065832; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; CAREY RB, 1980, INFECT IMMUN, V28, P195, DOI 10.1128/IAI.28.1.195-203.1980; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; CHHATWAL GS, 1985, MICROBIOL IMMUNOL, V29, P973, DOI 10.1111/j.1348-0421.1985.tb02961.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Danne C, 2013, RES MICROBIOL, V164, P973, DOI 10.1016/j.resmic.2013.09.002; Dombek PE, 1999, MOL MICROBIOL, V31, P859, DOI 10.1046/j.1365-2958.1999.01223.x; Dramsi S, 2012, MICROB DRUG RESIST, V18, P286, DOI 10.1089/mdr.2012.0005; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Firon A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003179; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Guadiz G, 1997, AM J RESP CELL MOL, V17, P60, DOI 10.1165/ajrcmb.17.1.2730; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Jiang SM, 2014, INFECT IMMUN, V82, P1007, DOI 10.1128/IAI.01014-13; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Papasergi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075266; Papasergi S, 2013, J PROTEOMICS, V89, P154, DOI 10.1016/j.jprot.2013.06.003; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Park SE, 2012, INFECT IMMUN, V80, P3975, DOI 10.1128/IAI.00699-12; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; RUBENS CE, 1992, INFECT IMMUN, V60, P5157, DOI 10.1128/IAI.60.12.5157-5163.1992; RUBENS CE, 1991, J INFECT DIS, V164, P320, DOI 10.1093/infdis/164.2.320; SCHONBECK C, 1981, INFECT IMMUN, V31, P856; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Seo HS, 2013, J BIOL CHEM, V288, P35982, DOI 10.1074/jbc.M113.513358; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje	55	44	49	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21003	21015		10.1074/jbc.M114.553073	http://dx.doi.org/10.1074/jbc.M114.553073			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904056	hybrid, Green Published			2022-12-25	WOS:000339396600053
J	Rosenberger, A; Liphardt, AM; Bargmann, A; Muller, K; Beck, L; Mester, J; Zange, J				Rosenberger, Andre; Liphardt, Anna-Maria; Bargmann, Arne; Mueller, Klaus; Beck, Luis; Mester, Joachim; Zange, Jochen			EMG and Heart Rate Responses Decline within 5 Days of Daily Whole-Body Vibration Training with Squatting	PLOS ONE			English	Article							BED-REST; MUSCLE-ACTIVITY; OXYGEN-UPTAKE; EXERCISE; FREQUENCY; SYNCHRONIZATION; RECRUITMENT; AMPLITUDE; EXPOSURE; BENEFITS	In this study, we examined the acute effects of a 5-day daily whole-body vibration (WBV) training on electromyography (EMG) responses of the m. rectus femoris and m. gastrocnemius lateralis, heart rate (HR, continuously recorded), and blood lactate levels. The purpose of the study was to investigate the adaptation of muscle activity, heart rate and blood lactate levels during 5 days of daily training. Two groups of healthy male subjects performed either squat exercises with vibration at 20 Hz on a side alternating platform (SE+V, n = 20, age = 31.9 +/- 7.5 yrs., height = 178.8 +/- 6.2 cm, body mass = 79.2 +/- 11.4 kg) or squat exercises alone (SE, n = 21, age = 28.4 +/- 7.3 years, height = 178.9 +/- 7.4 cm, body mass = 77.2 +/- 9.7 kg). On training day 1, EMG amplitudes of the m. rectus femoris were significantly higher (P<0.05) during SE+V than during SE. However, this difference was no longer statistically significant on training days 3 and 5. The heart rate (HR) response was significantly higher (P<0.05) during SE+V than during SE on all training days, but showed a constant decline throughout the training days. On training day 1, blood lactate increased significantly more after SE+V than after SE (P<0.05). On the following training days, this difference became much smaller but remained significantly different. The specific physiological responses to WBV were largest on the initial training day and most of them declined during subsequent training days, showing a rapid neuromuscular and cardiovascular adaptation to the vibration stimulus.	[Rosenberger, Andre; Liphardt, Anna-Maria; Bargmann, Arne; Mueller, Klaus; Beck, Luis; Zange, Jochen] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Rosenberger, Andre; Liphardt, Anna-Maria; Mester, Joachim] German Sport Univ Cologne, Inst Training Sci & Sport Informat, Cologne, Germany; [Bargmann, Arne; Zange, Jochen] Univ Cologne, Fac Med, D-50931 Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR); German Sport University Cologne; University of Cologne	Rosenberger, A (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany.	andre.rosenberger@dlr.de		Liphardt, Anna-Maria/0000-0003-0739-1959; Zange, Jochen/0000-0003-1822-0952				Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1794, DOI 10.1249/mss.0b013e3181238a0f; Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1642, DOI 10.1249/mss.0b013e318093f551; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Cardinale Marco, 2006, J Br Menopause Soc, V12, P12, DOI 10.1258/136218006775997261; Cardinale M, 2006, CLIN PHYSIOL FUNCT I, V26, P380, DOI 10.1111/j.1475-097X.2006.00706.x; Cochrane DJ, 2008, EUR J APPL PHYSIOL, V103, P441, DOI 10.1007/s00421-008-0736-4; Cochrane DJ, 2011, INT J SPORTS MED, V32, P75, DOI 10.1055/s-0030-1268010; Desmedt J E, 1983, Adv Neurol, V39, P671; Eckhardt H, 2011, J STRENGTH COND RES, V25, P1120, DOI 10.1519/JSC.0b013e3181d09e0e; EKLUND G, 1966, EXP NEUROL, V16, P80, DOI 10.1016/0014-4886(66)90088-4; Fratini A, 2009, J ELECTROMYOGR KINES, V19, P710, DOI 10.1016/j.jelekin.2008.04.005; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Martin BJ, 1997, EUR J APPL PHYSIOL, V75, P504, DOI 10.1007/s004210050196; Mester J, 2006, J BIOMECH, V39, P1056, DOI 10.1016/j.jbiomech.2005.02.015; Mester J, 1999, J Sci Med Sport, V2, P211, DOI 10.1016/S1440-2440(99)80174-1; Mulder ER, 2009, J APPL PHYSIOL, V107, P1789, DOI 10.1152/japplphysiol.00230.2009; Pollock RD, 2012, J APPL PHYSIOL, V112, P388, DOI 10.1152/japplphysiol.01223.2010; Pollock RD, 2010, CLIN BIOMECH, V25, P840, DOI 10.1016/j.clinbiomech.2010.05.004; Randall JM, 1997, ERGONOMICS, V40, P879, DOI 10.1080/001401397187711; Rittweger J, 2003, CLIN PHYSIOL FUNCT I, V23, P81, DOI 10.1046/j.1475-097X.2003.00473.x; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Ritzmann R, 2013, EUR J APPL PHYSIOL, V113, P1, DOI 10.1007/s00421-012-2402-0; Ritzmann R, 2010, EUR J APPL PHYSIOL, V110, P143, DOI 10.1007/s00421-010-1483-x; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Torvinen S, 2002, CLIN PHYSIOL FUNCT I, V22, P145, DOI 10.1046/j.1365-2281.2002.00410.x; VIITASALO JHT, 1977, EUR J APPL PHYSIOL, V37, P111, DOI 10.1007/BF00421697; Wakeling JM, 2002, J APPL PHYSIOL, V93, P1093, DOI 10.1152/japplphysiol.00142.2002; Zange J, 2009, EUR J APPL PHYSIOL, V105, P265, DOI 10.1007/s00421-008-0898-0; Zange J, 2009, EUR J APPL PHYSIOL, V105, P271, DOI 10.1007/s00421-008-0899-z	35	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99060	10.1371/journal.pone.0099060	http://dx.doi.org/10.1371/journal.pone.0099060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905721	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341869000100
J	Szwarc, MM; Kommagani, R; Jeong, JW; Wu, SP; Tsai, SY; Tsai, MJ; O'Malley, BW; DeMayo, FJ; Lydon, JP				Szwarc, Maria M.; Kommagani, Ramakrishna; Jeong, Jae-Wook; Wu, San-Pin; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.; DeMayo, Francesco J.; Lydon, John P.			Perturbing the Cellular Levels of Steroid Receptor Coactivator-2 Impairs Murine Endometrial Function	PLOS ONE			English	Article							MAMMARY-GLAND; EMBRYO IMPLANTATION; EXPRESSION; PROGESTERONE; ANDROGEN; MICE; PROLIFERATION; COREGULATORS; SRC-1; AIB1	As pleiotropic coregulators, members of the p160/steroid receptor coactivator (SRC) family control a broad spectrum of transcriptional responses that underpin a diverse array of physiological and pathophysiological processes. Because of their potent coregulator properties, strict controls on SRC expression levels are required to maintain normal tissue functionality. Accordingly, an unwarranted increase in the cellular levels of SRC members has been causally linked to the initiation and/or progression of a number of clinical disorders. Although knockout mouse models have underscored the critical non-redundant roles for each SRC member in vivo, there are surprisingly few mouse models that have been engineered to overexpress SRCs. This deficiency is significant since SRC involvement in many of these disorders is based on unscheduled increases in the levels (rather than the absence) of SRC expression. To address this deficiency, we used recent mouse technology that allows for the targeted expression of human SRC-2 in cells which express the progesterone receptor. Through cre-loxP recombination driven by the endogenous progesterone receptor promoter, a marked elevation in expression levels of human SRC-2 was achieved in endometrial cells that are positive for the progesterone receptor. As a result of this increase in coregulator expression, female mice are severely subfertile due to a dysfunctional uterus, which exhibits a hypersensitivity to estrogen exposure. Our findings strongly support the proposal from clinical observations that increased levels of SRC-2 are causal for a number of endometrial disorders which compromise fertility. Future studies will use this mouse model to decipher the molecular mechanisms that underpin the endometrial defect. We believe such mechanistic insight may provide new molecular descriptors for diagnosis, prognosis, and/or therapy in the clinical management of female infertility.	[Szwarc, Maria M.; Kommagani, Ramakrishna; Wu, San-Pin; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.; DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jeong, Jae-Wook] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA	Baylor College of Medicine; Michigan State University; Michigan State University College of Human Medicine	Lydon, JP (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	jlydon@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019; , San Pin Wu/AAF-8371-2020	DeMayo, Francesco/0000-0002-9480-7336; , San Pin Wu/0000-0001-9626-784X; Kommagani, Ramakrishna/0000-0003-0403-0971	National Institutes of Health [U19DK062434, HD-07857, U54 HD-07495, CA-077530]; Baylor College of Medicine Genetically Engineered Mouse Shared Resource [NH/NCI 5 P30 CA125123]; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core - (Eunice Kennedy Shriver NICHD/NIH (SCCPIR)) [U54-HD28934]; Cancer Prevention Research Institute of Texas pre-doctoral training fellowship [CPRIT RP101499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311, U54HD028934, R01HD008188, P50HD028934, R01HD007857, U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD007857, U01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, R29CA077530, R01CA077530] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Genetically Engineered Mouse Shared Resource; University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core - (Eunice Kennedy Shriver NICHD/NIH (SCCPIR)); Cancer Prevention Research Institute of Texas pre-doctoral training fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by National Institutes of Health grants: U19DK062434 to M.J.T., S.Y.T., B.W.O, and F.J.D. and HD-07857; U54 HD-07495; and CA-077530 to B.W.O.; F.J.D.; and J.P.L. respectively. These studies also were supported by the Baylor College of Medicine Genetically Engineered Mouse Shared Resource (NH/NCI 5 P30 CA125123) and the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core (supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) Grant U54-HD28934). M. M. S. is supported by Cancer Prevention Research Institute of Texas pre-doctoral training fellowship (CPRIT RP101499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Balmer NN, 2006, MODERN PATHOL, V19, P1593, DOI 10.1038/modpathol.3800696; Brinton LA, 2010, FERTIL STERIL, V94, P1787, DOI 10.1016/j.fertnstert.2009.10.012; Carretero J, 2013, ANN ANAT, V195, P253, DOI 10.1016/j.aanat.2013.01.009; Chen XA, 2010, MOL ENDOCRINOL, V24, P1917, DOI 10.1210/me.2010-0201; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; COULAM CB, 1983, OBSTET GYNECOL, V61, P403; Dasgupta S, 2014, ANNU REV MED, V65, P279, DOI 10.1146/annurev-med-051812-145316; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fernandez-Valdivia R, 2008, ENDOCRINOLOGY, V149, P6236, DOI 10.1210/en.2008-0768; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; FOSSUM GT, 1989, J IN VITRO FERTIL EM, V6, P7, DOI 10.1007/BF01134574; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gregory CW, 2002, J CLIN ENDOCR METAB, V87, P2960, DOI 10.1210/jc.87.6.2960; Gregory CW, 2001, CANCER RES, V61, P4315; Ha Cole, 1933, P R SOC B, V114; Han SJ, 2012, NAT MED, V18, P1102, DOI 10.1038/nm.2826; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; He B, 2011, ENDOCRINOLOGY, V152, P1047, DOI 10.1210/en.2010-0732; Ismail PM, 2002, MOL ENDOCRINOL, V16, P2475, DOI 10.1210/me.2002-0169; Jeong JW, 2007, ENDOCRINOLOGY, V148, P4238, DOI 10.1210/en.2007-0122; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; Kefalopoulou Z, 2012, J NEURO-ONCOL, V106, P23, DOI 10.1007/s11060-011-0637-y; Kershah SM, 2004, GYNECOL ONCOL, V92, P304, DOI 10.1016/j.ygyno.2003.10.007; Kim JY, 2009, J CLIN ENDOCR METAB, V94, P1416, DOI 10.1210/jc.2008-1612; Kommagani R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003900; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Markey CM, 2001, ENVIRON HEALTH PERSP, V109, P55, DOI 10.2307/3434921; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Park S, 2012, ENDOCRINOLOGY, V153, P3982, DOI 10.1210/en.2012-1044; PARR EL, 1987, BIOL REPROD, V36, P211, DOI 10.1095/biolreprod36.1.211; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Quezada S, 2006, FERTIL STERIL, V85, P1017, DOI 10.1016/j.fertnstert.2005.09.053; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; Sakaguchi H, 2007, J STEROID BIOCHEM, V104, P237, DOI 10.1016/j.jsbmb.2007.03.007; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Stashi E, 2014, CELL REP; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tien JCY, 2013, CANCER RES, V73, P3997, DOI 10.1158/0008-5472.CAN-12-3929; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uchikawa J, 2003, CANCER, V98, P2207, DOI 10.1002/cncr.11760; Villavicencio A, 2006, GYNECOL ONCOL, V103, P307, DOI 10.1016/j.ygyno.2006.03.029; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Ye XC, 2005, P NATL ACAD SCI USA, V102, P9487, DOI 10.1073/pnas.0503577102; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076	66	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98664	10.1371/journal.pone.0098664	http://dx.doi.org/10.1371/journal.pone.0098664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905738	Green Submitted, gold, Green Published			2022-12-25	WOS:000341869000045
J	Xiao, DL; Huang, XH; Xue, Q; Zhang, LB				Xiao, DaLiao; Huang, Xiaohui; Xue, Qin; Zhang, Lubo			Antenatal Hypoxia Induces Programming of Reduced Arterial Blood Pressure Response in Female Rat Offspring: Role of Ovarian Function	PLOS ONE			English	Article							PRENATAL HYPOXIA; ADULT MALE; DEVELOPMENTAL ORIGINS; HEART SUSCEPTIBILITY; PROTEIN RESTRICTION; REPERFUSION INJURY; ANGIOTENSIN-II; IN-UTERO; FETAL; PREGNANCY	In utero exposure to adverse environmental factors increases the risk of cardiovascular disease in adulthood. The present study tested the hypothesis that antenatal hypoxia causes a gender-dependent programming of altered arterial blood pressure response (BP) in adult offspring. Time-dated pregnant rats were divided into normoxic and hypoxic (10.5% O-2 from days 15 to 21 of gestation) groups. The experiments were conducted in adult offspring. Antenatal hypoxia caused intrauterine growth restriction, and resulted in a gender-dependent increase Angiotensin II (Ang II)-induced BP response in male offspring, but significant decrease in BP response in female offspring. The baroreflex sensitivity was not significantly altered. Consistent with the reduced blood pressure response, antenatal hypoxia significantly decreased Ang II-induced arterial vasoconstriction in female offspring. Ovariectomy had no significant effect in control animals, but significantly increased Ang II-induced maximal BP response in prenatally hypoxic animals and eliminated the difference of BP response between the two groups. Estrogen replacement in ovariectomized animals significantly decreased the BP response to angiotensin II I only in control, but not in hypoxic animals. The result suggests complex programming mechanisms of antenatal hypoxia in regulation of ovary function. Hypoxia-mediated ovary dysfunction results in the phenotype of reduced vascular contractility and BP response in female adult offspring.	[Xiao, DaLiao; Huang, Xiaohui; Xue, Qin; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA	Loma Linda University	Zhang, LB (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol,Div Pharmacol, Loma Linda, CA 92354 USA.	lzhang@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HD082779, HL083966, DA032510]; Regents of the University of California TRDRP [22XT-0022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083966, R01HL110125, R01HL118861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California TRDRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health grants HD082779 (to L. Zhang), HL083966 (to L. Zhang) and DA032510 (to D. Xiao), and by the Regents of the University of California TRDRP grant 22XT-0022 (to D. Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-17; Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1986, LANCET, V1, P1077; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Dias DPM, 2010, BRAZ J MED BIOL RES, V43, P969, DOI 10.1590/S0100-879X2010001000008; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dumesic DA, 2007, REV ENDOCR METAB DIS, V8, P127, DOI 10.1007/s11154-007-9046-0; El-Seweidy MM, 2012, J PHARM PHARMACOL, V64, P108, DOI 10.1111/j.2042-7158.2011.01377.x; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; Hawkins P, 2000, AM J PHYSIOL-REG I, V279, pR340, DOI 10.1152/ajpregu.2000.279.1.R340; Hemmings DG, 2005, AM J PHYSIOL-HEART C, V289, pH674, DOI 10.1152/ajpheart.00191.2005; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; LAUNER LJ, 1993, BMJ-BRIT MED J, V307, P1451, DOI 10.1136/bmj.307.6917.1451; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; Louey S., 2003, Archives of Physiology and Biochemistry, V111, P53, DOI 10.1076/apab.111.1.53.15137; Louey S, 2000, PEDIATR RES, V48, P808, DOI 10.1203/00006450-200012000-00018; Martin DS, 2008, AM J HYPERTENS, V21, P983, DOI 10.1038/ajh.2008.237; Matys T, 2000, J PHYSIOL PHARMACOL, V51, P161; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miner JA, 2011, AM J PHYSIOL-HEART C, V301, pH1716, DOI 10.1152/ajpheart.00405.2011; NEWBOLD RR, 1983, BIOL REPROD, V28, P735, DOI 10.1095/biolreprod28.3.735; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; OSullivan MJ, 1996, ACTA PAEDIATR, V85, P849, DOI 10.1111/j.1651-2227.1996.tb14166.x; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Peyronnet J, 2002, PFLUG ARCH EUR J PHY, V443, P858, DOI 10.1007/s00424-001-0766-9; Ribeiro RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053226; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Sathishkumar K, 2012, BRIT J NUTR, V107, P665, DOI 10.1017/S0007114511003448; Tong WN, 2011, AM J PHYSIOL-HEART C, V301, pH2113, DOI 10.1152/ajpheart.00356.2011; VAHAKANGAS K, 1985, TOXICOL LETT, V25, P75, DOI 10.1016/0378-4274(85)90103-1; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR1131, DOI 10.1152/ajpregu.00037.2003; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2013, HYPERTENSION, V61, P1246, DOI 10.1161/HYPERTENSIONAHA.113.01152; Xiao DL, 2009, HYPERTENSION, V53, P937, DOI 10.1161/HYPERTENSIONAHA.108.121830; Xiao DL, 2000, J SOC GYNECOL INVEST, V7, P279, DOI 10.1016/S1071-5576(00)00066-6; Xu X, 2008, INT J CARDIOL, V130, P196, DOI 10.1016/j.ijcard.2007.08.041; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zemunik T, 2003, BRAZ J MED BIOL RES, V36, P871, DOI 10.1590/S0100-879X2003000700007	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98743	10.1371/journal.pone.0098743	http://dx.doi.org/10.1371/journal.pone.0098743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905716	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000056
J	Mambelli, LI; Mattos, RC; Winter, GHZ; Madeiro, DS; Morais, BP; Malschitzky, E; Miglino, MA; Kerkis, A; Kerkis, I				Mambelli, Lisley I.; Mattos, Rodrigo C.; Winter, Gustavo H. Z.; Madeiro, Dener S.; Morais, Bruna P.; Malschitzky, Eduardo; Miglino, Maria Angelica; Kerkis, Alexandre; Kerkis, Irina			Changes in Expression Pattern of Selected Endometrial Proteins following Mesenchymal Stem Cells Infusion in Mares with Endometrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; IN-VITRO; COEXPRESSION; CYTOKERATIN; VIMENTIN; BIOPSY	Mesenchymal stem cells (MSCs) due to their self-renewal potential and differentiation capacity are useful for tissue regeneration. Immunomodulatory and trophic properties of MSCs were demonstrated suggesting their use as medicinal signaling cells able to positively change local environment in injured tissue. Equine endometrosis is a progressive degenerative disease responsible for glandular alterations and endometrial fibrosis which causes infertility in mares. More precisely, this disease is characterized by phenotypic changes in the expression pattern of selected endometrial proteins. Currently, no effective treatment is available for endometrosis. Herein, we aimed at the evaluation of expression pattern of these proteins after allogeneic equine adipose tissue-derived multipotent mesenchymal stem cells (eAT-MSCs) infusion as well as at testing the capacity of these cells to promote endometrial tissue remodeling in mares with endometrosis. eAT-MSC (2x10(7)/animal) were transplanted into mares' uterus and control animals received only placebo. Uterine biopsies were collected before (day 0) and after (days 7, 21 and 60) cells transplantation. Conventional histopathology as well as expression analysis of such proteins as laminin, vimentin, Ki-67-antigen, alpha-smooth muscle actin (alpha-SMA) and cytokeratin 18 (CK18) have been performed before and after eAT-MSCs transplantation. We demonstrated that eAT-MSCs induced early (at day 7) remodeling of endometrial tissue microenvironment through changes observed in intra cellular and intra glandular localization of aforementioned proteins. We demonstrated that eAT-MSCs were able to positively modulate the expression pattern of studied secretory proteins as well as, to promote the induction of glandular epithelial cells proliferation suggesting local benefits to committed endometrial tissue environment after eAT-MSCs transplantation.	[Mambelli, Lisley I.; Madeiro, Dener S.; Morais, Bruna P.; Kerkis, Alexandre; Kerkis, Irina] Inst Butantan, Genet Lab, Sao Paulo, Brazil; [Mambelli, Lisley I.; Miglino, Maria Angelica] Univ Sao Paulo, Programa Posgrad Anat Anim Domest & Silvestres, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Mattos, Rodrigo C.; Winter, Gustavo H. Z.] Univ Fed Rio Grande do Sul, Fac Med Vet, Reprolab, Porto Alegre, RS, Brazil; [Malschitzky, Eduardo] Univ Luterana Brasil, Curso Med Vet, Canoas, RS, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil	Kerkis, I (corresponding author), Inst Butantan, Genet Lab, Sao Paulo, Brazil.	irina.kerkis@butantan.gov.br	Miglino, Maria Angelica/B-9519-2012; Kerkis, Irina/AAD-1006-2019; Winter, Gustavo H Z/M-3617-2014	Miglino, Maria Angelica/0000-0003-4979-115X; 	Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP) [2006/51839-7, 2007/50212-3, 2009/06764-7]; Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES)	Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES)	This work was supported by the Sao Paulo Research Foundations (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP. Grant numbers: 2006/51839-7(PIPE); 2007/50212-3 (BP.IC); 2009/06764-7 (BP.MS)) and Coordination of Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES) - fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aupperle H, 2000, EQUINE VET J, V32, P228, DOI 10.2746/042516400776563554; Aupperle H, 2004, RES VET SCI, V76, P249, DOI 10.1016/j.rvsc.2003.11.003; Bader H, 1997, PFERDEHEILKUNDE, V5, P544; Brunckhorst D., 1991, FERTILITAT, V7, P44; Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI 10.1089/ten.TEA.2010.0216; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; CZERNOBILSKY B, 1993, VIRCHOWS ARCH A, V422, P313, DOI 10.1007/BF01608341; DABBS DJ, 1986, AM J SURG PATHOL, V10, P568, DOI 10.1097/00000478-198608000-00007; FRANKE WW, 1979, EUR J CELL BIOL, V19, P255; Gerstenberg C, 1999, MOL REPROD DEV, V53, P255, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;255::AID-MRD1&gt;3.0.CO;2-D; Hoffmann C, 2009, ANIM REPROD SCI, V111, P261, DOI 10.1016/j.anireprosci.2008.03.019; Kenney R.M., 1986, CURRENT THERAPY THER, P723; KENNEY RM, 1978, J AM VET MED ASSOC, V172, P241; Kenney RM, 1992, EQUINE VET J, V25, P186; Kozubenko N, 2010, CELL TRANSPLANT, V19, P471, DOI 10.3727/096368909X484707; Lehmann J, 2011, THERIOGENOLOGY, V76, P1326, DOI 10.1016/j.theriogenology.2011.06.001; Mambelli LI, 2013, THERIOGENOLOGY, V79, P744, DOI 10.1016/j.theriogenology.2012.11.030; Mambelli LI, 2009, TISSUE ENG PART C-ME, V15, P87, DOI 10.1089/ten.tec.2008.0186; MCNUTT MA, 1985, ULTRASTRUCT PATHOL, V9, P31, DOI 10.3109/01913128509055483; NISOLLE M, 1995, FERTIL STERIL, V64, P69, DOI 10.1016/S0015-0282(16)57657-2; NORWITZ ER, 1991, HUM REPROD, V6, P1470; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schoon H A, 2000, J Reprod Fertil Suppl, P381; Schoon H. A., 1992, Pferdeheilkunde, V8, P355; Schoon HA, 1997, PFERDEHEILKUNDE, V13, P453, DOI 10.21836/PEM19970506; Semont A, 2010, CELL DEATH DIFFER, V17, P952, DOI 10.1038/cdd.2009.187; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; TABIBZADEH S, 1991, ENDOCR REV, V12, P272, DOI 10.1210/edrv-12-3-272; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Walter I, 2001, REPRODUCTION, V121, P581, DOI 10.1530/rep.0.1210581	34	28	28	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97889	10.1371/journal.pone.0097889	http://dx.doi.org/10.1371/journal.pone.0097889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901368	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400014
J	Finegersh, A; Homanics, GE				Finegersh, Andrey; Homanics, Gregg E.			Paternal Alcohol Exposure Reduces Alcohol Drinking and Increases Behavioral Sensitivity to Alcohol Selectively in Male Offspring	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; MESSENGER-RNA; FEMALE RATS; BDNF; CONSUMPTION; ETHANOL; GENE; INHERITANCE; ANXIETY	Alcohol use disorder (AUD) is heritable, but the genetic basis for this disease remains poorly understood. Although numerous gene variants have been associated with AUD, these variants account for only a small fraction of the total risk. The idea of inheritance of acquired characteristics, i.e. "epigenetic inheritance,'' is re-emerging as a proven adjunct to traditional modes of genetic inheritance. We hypothesized that alcohol drinking and neurobiological sensitivity to alcohol are influenced by ancestral alcohol exposure. To test this hypothesis, we exposed male mice to chronic vapor ethanol or control conditions, mated them to ethanol-naive females, and tested adult offspring for ethanol drinking, ethanol-induced behaviors, gene expression, and DNA methylation. We found that ethanol-sired male offspring had reduced ethanol preference and consumption, enhanced sensitivity to the anxiolytic and motor-enhancing effects of ethanol, and increased Bdnf expression in the ventral tegmental area (VTA) compared to control-sired male offspring. There were no differences among ethanol-and control-sired female offspring on these assays. Ethanol exposure also decreased DNA methylation at the Bdnf promoter of sire's germ cells and hypomethylation was maintained in the VTA of both male and female ethanol-sired offspring. Our findings show that paternal alcohol exposure is a previously unrecognized regulator of alcohol drinking and behavioral sensitivity to alcohol in male, but not female, offspring. Paternal alcohol exposure also induces epigenetic alterations (DNA hypomethylation) and gene expression changes that persist in the VTA of offspring. These results provide new insight into the inheritance and development of alcohol drinking behaviors.	[Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Homanics, GE (corresponding author), Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA.	homanicsge@anes.upmc.edu	; Burne, Thomas/C-5656-2009	Finegersh, Andrey/0000-0002-2639-2132; Burne, Thomas/0000-0003-3502-9789	National Institute on Alcohol Abuse and Alcoholism [R37AA10422, F30AA021632]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA010422, F30AA021632] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants R37AA10422 (GEH) and F30AA021632 (AF) from the National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1990, PSYCHOPHARMACOLOGY, V100, P159, DOI 10.1007/BF02244399; ABEL EL, 1991, ALCOHOL, V8, P21, DOI 10.1016/0741-8329(91)91168-2; ABEL EL, 1989, ALCOHOL CLIN EXP RES, V13, P533, DOI 10.1111/j.1530-0277.1989.tb00373.x; ABEL EL, 1993, ALCOHOL, V10, P237, DOI 10.1016/0741-8329(93)90042-M; Adler ID, 1996, MUTAT RES-FUND MOL M, V352, P169, DOI 10.1016/0027-5107(95)00223-5; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Bielawski DM, 2002, ALCOHOL CLIN EXP RES, V26, P347, DOI 10.1097/00000374-200203000-00007; Bienkowski P, 1999, ALCOHOL, V18, P131, DOI 10.1016/S0741-8329(98)00075-5; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Blakley G, 2006, PHARMACOL BIOCHEM BE, V84, P51, DOI 10.1016/j.pbb.2006.04.005; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Byrnes EM, 2005, PSYCHOPHARMACOLOGY, V182, P537, DOI 10.1007/s00213-005-0122-4; Byrnes JJ, 2011, BEHAV BRAIN RES, V218, P200, DOI 10.1016/j.bbr.2010.11.059; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Conner JM, 1997, J NEUROSCI, V17, P2295; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Ferron SR, 2011, NATURE, V475, P381, DOI 10.1038/nature10229; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Griffin WC, 2009, PSYCHOPHARMACOLOGY, V201, P569, DOI 10.1007/s00213-008-1324-3; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Jamerson PA, 2004, DEV BRAIN RES, V149, P103, DOI 10.1016/j.devbrainres.2003.12.010; Jeanblanc J, 2013, EUR J NEUROSCI, V37, P607, DOI 10.1111/ejn.12067; Jeanblanc J, 2009, J NEUROSCI, V29, P13494, DOI 10.1523/JNEUROSCI.2243-09.2009; Jenkins TG, 2012, REPRODUCTION, V143, P727, DOI 10.1530/REP-11-0450; Jensen CH, 2001, NEUROREPORT, V12, P3959, DOI 10.1097/00001756-200112210-00021; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Ledig M, 1998, NEUROPHARMACOLOGY, V37, P57, DOI 10.1016/S0028-3908(97)00185-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Logrip ML, 2009, J NEUROCHEM, V109, P1459, DOI 10.1111/j.1471-4159.2009.06073.x; Lopez MF, 2003, ADDICT BIOL, V8, P419, DOI 10.1080/13556210310001648176; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Nueda M-L, J MOL BIO, V367, P1281; Ouko LA, 2009, ALCOHOL CLIN EXP RES, V33, P1615, DOI 10.1111/j.1530-0277.2009.00993.x; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Purohit V, 2007, AM J CLIN NUTR, V86, P14, DOI 10.1093/ajcn/86.1.14; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; TANAKA H, 1982, BRAIN DEV-JPN, V4, P1; Treutlein J, 2011, CURR PSYCHIAT REP, V13, P147, DOI 10.1007/s11920-011-0176-4; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; WOZNIAK DF, 1991, PSYCHOPHARMACOLOGY, V105, P289, DOI 10.1007/BF02244324	58	79	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99078	10.1371/journal.pone.0099078	http://dx.doi.org/10.1371/journal.pone.0099078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896617	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700114
J	Jacques, JF; Mercier, A; Brault, A; Mourer, T; Labbe, S				Jacques, Jean-Francois; Mercier, Alexandre; Brault, Ariane; Mourer, Thierry; Labbe, Simon			Fra2 Is a Co-Regulator of Fep1 Inhibition in Response to Iron Starvation	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR FEP1; BINDING FACTOR PHP4; MONOTHIOL GLUTAREDOXINS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SULFUR CLUSTER; MOLECULAR-GENETICS; DNA-BINDING	Iron is required for several metabolic functions involved in cellular growth. Although several players involved in iron transport have been identified, the mechanisms by which iron-responsive transcription factors are controlled are still poorly understood. In Schizosaccharomyces pombe, the Fep1 transcription factor represses genes involved in iron acquisition in response to high levels of iron. In contrast, when iron levels are low, Fep1 becomes inactive and loses its ability to associate with chromatin. Although the molecular basis by which Fep1 is inactivated under iron starvation remains unknown, this process requires the monothiol glutaredoxin Grx4. Here, we demonstrate that Fra2 plays a role in the negative regulation of Fep1 activity. Disruption of fra2(+) (fra2 Delta) led to a constitutive repression of the fio1(+) gene transcription. Fep1 was consistently active and constitutively bound to its target gene promoters in cells lacking fra2+. A constitutive activation of Fep1 was also observed in a php4 Delta fra2 Delta double mutant strain in which the behavior of Fep1 is freed of its transcriptional regulation by Php4. Microscopic analyses of cells expressing a functional Fra2-Myc(13) protein revealed that Fra2 localized throughout the cells with a significant proportion of Fra2 being observed within the nuclei. Further analysis by coimmunoprecipitation showed that Fra2, Fep1 and Grx4 are associated in a heteroprotein complex. Bimolecular fluorescence complementation experiments brought further evidence that an interaction between Fep1 and Fra2 occurs in the nucleus. Taken together, results reported here revealed that Fra2 plays a role in the Grx4-mediated pathway that inactivates Fep1 in response to iron deficiency.	[Jacques, Jean-Francois; Mercier, Alexandre; Brault, Ariane; Mourer, Thierry; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Mourer, Thierry/0000-0003-1651-6768	Faculty of Medicine and Health Sciences of the Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada [MOP-238238-01]	Faculty of Medicine and Health Sciences of the Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	A.B. is the recipient of a studentship from the Faculty of Medicine and Health Sciences of the Universite de Sherbrooke. This work was supported by the Natural Sciences and Engineering Research Council of Canada (Grant no. MOP-238238-01) to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Haas H, 2003, APPL MICROBIOL BIOT, V62, P316, DOI 10.1007/s00253-003-1335-2; Haas H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00028; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Herrero E, 2010, CURR PROTEIN PEPT SC, V11, P659, DOI 10.2174/138920310794557637; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaplan J, 2013, CURR BIOL, V23, pR642, DOI 10.1016/j.cub.2013.05.033; Kim KD, 2011, BIOCHEM BIOPH RES CO, V408, P609, DOI 10.1016/j.bbrc.2011.04.069; Kronstad JW, 2013, CURR OPIN MICROBIOL, V16, P659, DOI 10.1016/j.mib.2013.08.009; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Poor CB, 2014, P NATL ACAD SCI US, V3; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	47	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98959	10.1371/journal.pone.0098959	http://dx.doi.org/10.1371/journal.pone.0098959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897379	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700103
J	Hoffmann, J; Ospelt, M; Troidl, C; Voss, S; Liebetrau, C; Kim, WK; Rolf, A; Wietelmann, A; Braun, T; Troidl, K; Sadayappan, S; Barefield, D; Hamm, C; Nef, H; Mollmann, H				Hoffmann, Jedrzej; Ospelt, Manuel; Troidl, Christian; Voss, Sandra; Liebetrau, Christoph; Kim, Won-Keun; Rolf, Andreas; Wietelmann, Astrid; Braun, Thomas; Troidl, Kerstin; Sadayappan, Sakthivel; Barefield, David; Hamm, Christian; Nef, Holger; Moellmann, Helge			Sham Surgery and Inter-Individual Heterogeneity Are Major Determinants of Monocyte Subset Kinetics in a Mouse Model of Myocardial Infarction	PLOS ONE			English	Article							SPLENIC RESERVOIR; BONE-MARROW; MICE; BLOOD; MACROPHAGE; IDENTIFICATION; INFLAMMATION; INHIBITION; CONTRIBUTE; CELLS	Aims: Mouse models of myocardial infarction (MI) are commonly used to explore the pathophysiological role of the monocytic response in myocardial injury and to develop translational strategies. However, no study thus far has examined the potential impact of inter-individual variability and sham surgical procedures on monocyte subset kinetics after experimental MI in mice. Our goal was to investigate determinants of systemic myeloid cell subset shifts in C57BL/6 mice following MI by developing a protocol for sequential extensive flow cytometry (FCM). Methods and Results: Following cross-sectional multiplex FCM analysis we provide for the first time a detailed description of absolute quantities, relative subset composition, and biological variability of circulating classical, intermediate, and non-classical monocyte subsets in C57BL/6 mice. By using intra-individual longitudinal measurements after MI induction, a time course of classical and non-classical monocytosis was recorded. This approach disclosed a significant reduction of monocyte subset dispersion across all investigated time points following MI. We found that in the current invasive model of chronic MI the global pattern of systemic monocyte kinetics is mainly determined by a nonspecific inflammatory response to sham surgery and not by the extent of myocardial injury. Conclusions: Application of sequential multiplexed FCM may help to reduce the impact of biological variability in C57BL/6 mice. Furthermore, the confounding influence of sham surgical procedures should always be considered when measuring monocyte subset kinetics in a murine model of MI.	[Hoffmann, Jedrzej; Ospelt, Manuel; Troidl, Christian; Voss, Sandra; Liebetrau, Christoph; Kim, Won-Keun; Rolf, Andreas; Hamm, Christian; Nef, Holger; Moellmann, Helge] Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany; [Liebetrau, Christoph; Rolf, Andreas; Hamm, Christian; Nef, Holger; Moellmann, Helge] Univ Giessen, Dept Cardiol, Med Clin 1, D-35390 Giessen, Germany; [Wietelmann, Astrid; Braun, Thomas; Troidl, Kerstin] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Sadayappan, Sakthivel; Barefield, David] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL USA	Kerckhoff Clinic; Justus Liebig University Giessen; Max Planck Society; Loyola University Chicago	Hoffmann, J (corresponding author), Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany.	j.hoffmann@kerckhoff-fgi.de	Hamm, Christian W./I-3155-2017; Kim, Won-Keun/AAS-8945-2021; Rolf, Andreas/ABH-4255-2020	Hamm, Christian W./0000-0001-6763-4161; Kim, Won-Keun/0000-0002-0799-7478; Braun, Thomas/0000-0002-6165-4804; Rolf, Andreas/0000-0002-8771-297X; Barefield, David/0000-0002-6166-640X; Sadayappan, Sakthivel/0000-0003-2006-7678; Hoffmann, Jedrzej/0000-0003-0487-4373	William G. Kerckhoff-Stiftung, Bad Nauheim, Germany	William G. Kerckhoff-Stiftung, Bad Nauheim, Germany	Research funding was received from William G. Kerckhoff-Stiftung, Bad Nauheim, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hoff J, 2000, LAB ANIMAL, V29, P47; Hoffmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047155; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Jensen CJ, 2009, CLIN RES CARDIOL, V98, P651, DOI 10.1007/s00392-009-0051-z; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Mollmann H, 2006, CARDIOVASC RES, V71, P661, DOI 10.1016/j.cardiores.2006.06.013; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nossuli TO, 2000, AM J PHYSIOL-HEART C, V278, pH1049, DOI 10.1152/ajpheart.2000.278.4.H1049; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Schneider JE, 2006, J CARDIOVASC MAGN R, V8, P693, DOI 10.1080/10976640600723664; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98456	10.1371/journal.pone.0098456	http://dx.doi.org/10.1371/journal.pone.0098456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893162	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400053
J	Tajrishi, MM; Shin, J; Hetman, M; Kumar, A				Tajrishi, Marjan M.; Shin, Jonghyun; Hetman, Michal; Kumar, Ashok			DNA Methyltransferase 3a and Mitogen-activated Protein Kinase Signaling Regulate the Expression of Fibroblast Growth Factor-inducible 14 (Fn14) during Denervation-induced Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; METHYLATION PATTERNS; TARGETED ABLATION; TWEAK-FN14 SYSTEM; EARLY RESPONSE; UBIQUITIN; REGENERATION; MICE; CYTOKINE; PATHWAYS	The TWEAK-fibroblast growth factor-inducible 14 (Fn14) system is a critical regulator of denervation-induced skeletal muscle atrophy. Although the expression of Fn14 is a rate-limiting step in muscle atrophy on denervation, mechanisms regulating gene expression of Fn14 remain unknown. Methylation of CpG sites within promoter region is an important epigenetic mechanism for gene silencing. Our study demonstrates that Fn14 promoter contains a CpG island close to transcription start site. Fn14 promoter also contains multiple consensus DNA sequence for transcription factors activator protein 1 (AP1) and specificity protein 1 (SP1). Denervation diminishes overall genomic DNA methylation and causes hypomethylation at specific CpG sites in Fn14 promoter leading to the increased gene expression of Fn14 in skeletal muscle. Abundance of DNA methyltransferase 3a (Dnmt3a) and its interaction with Fn14 promoter are repressed in denervated skeletal muscle of mice. Overexpression of Dnmt3a inhibits the gene expression of Fn14 and attenuates skeletal muscle atrophy upon denervation. Denervation also causes the activation of ERK1/2, JNK1/2, and ERK5 MAPKs and AP1 and SP1, which stimulate the expression of Fn14 in skeletal muscle. Collectively, our study provides novel evidence that Dnmt3a and MAPK signaling regulate the levels of Fn14 in skeletal muscle on denervation.	[Tajrishi, Marjan M.; Shin, Jonghyun; Kumar, Ashok] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Hetman, Michal] Univ Louisville, Dept Neurol Surg, Sch Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Kumar, A (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [R01 AG029623, R01 AR059810, R01 NS073584]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG029623 and R01 AR059810 (to A. K.) and R01 NS073584 (to M. H.).	Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Casaccia-Bonnefil P, 2008, PROG NEUROBIOL, V86, P368, DOI 10.1016/j.pneurobio.2008.09.012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Choi MC, 2012, MOL CELL, V47, P122, DOI 10.1016/j.molcel.2012.04.025; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Guasconi V, 2008, CURR OPIN CLIN NUTR, V11, P233, DOI 10.1097/MCO.0b013e3282fa1810; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Mastroeni D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006617; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ordway JM, 2002, CELL GROWTH DIFFER, V13, P149; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Proserpio V, 2013, GENE DEV, V27, P1299, DOI 10.1101/gad.217240.113; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	51	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19985	19999		10.1074/jbc.M114.568626	http://dx.doi.org/10.1074/jbc.M114.568626			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895120	Green Published, hybrid			2022-12-25	WOS:000339395200015
J	Li, LL; Zhou, HF; Yang, X; Zhao, L; Yu, XD				Li, Luanluan; Zhou, Huafei; Yang, Xin; Zhao, Li; Yu, Xiaodan			Relationships between 25-Hydroxyvitamin D and Nocturnal Enuresis in Five- to Seven-Year-Old Children	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; SLEEP FRAGMENTATION; D-RECEPTOR; MYOPATHY; EPIDEMIOLOGY; SOCIETY; DISEASE; SYSTEM; HEALTH	Background: Vitamin D has been recognized to contribute to various physiological processes. However, no study has investigated serum 25-hydroxyvitamin D [25(OH) D] concentrations in children with nocturnal enuresis (NE) in the English literature. Objective: In the present study, serum 25(OH) D concentrations were measured in five-to seven-year-old children with NE and compared with those in non-enuretic children to investigate whether there was any relationship between 25(OH) D and NE as the first time in the literature. Design: Two hundred forty-seven five-to seven-year-old children were recruited from Taizhou, Zhejiang Province, China. Serum 25(OH) D concentrations were measured, and the structured questionnaire was administered to the parents of all children. Low 25(OH) D was defined as serum 25(OH) D concentrations below 20 ng/ml. Results: The prevalence of NE was 7.3% in the group of children with 25(OH) D concentrations that exceeded 20 ng/ml; this prevalence was much lower than the 17.5% observed in the group of children with 25(OH) D concentrations below 20 ng/ml (p, 0.05). After adjusting for potential confounders, serum 25(OH) D (>= 20 ng/ml) was significantly associated with NE and represented a protective factor against NE (OR = 0.31, 95% CI = 0.092, 1.0, P,<0.05). A nonlinear relationship between 25(OH) D and NE was observed. The prevalence of NE decreased with increasing 25(OH) D concentrations above 19 ng/ml. Additionally, children exhibiting higher frequencies of bedwetting had lower 25(OH) D concentrations [5-7 times/week: 18.3 +/- 4.8; 2-4 times/week: 20.9 +/- 4.1; 0-1 times/week: 23.666.4 (ng/ml), P< 0.05)]. Conclusions: Low 25(OH) D was associated with an increased risk of NE in children aged five to seven years.	[Li, Luanluan; Yang, Xin; Zhao, Li; Yu, Xiaodan] Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai Inst Pediat Res,Xinhua Hosp, Shanghai 200030, Peoples R China; [Zhou, Huafei] Taizhou Hosp Luqiao, Taizhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University	Yu, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai Inst Pediat Res,Xinhua Hosp, Shanghai 200030, Peoples R China.	xd_yu2003@126.com			Shanghai Committee of Science and Technology, China [114119a1600]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This study was funded by the Shanghai Committee of Science and Technology, China (No. 114119a1600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2012, CURR OPIN ALLERGY CL, V12, P13, DOI 10.1097/ACI.0b013e32834eccdb; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Butler RJ, 2004, CLIN PSYCHOL REV, V24, P909, DOI 10.1016/j.cpr.2004.07.001; Butler RJ, 2000, SCAND J UROL NEPHROL, V34, P270, DOI 10.1080/003655900750042022; Cohen-Zrubavel V, 2011, SLEEP, V34, P191, DOI 10.1093/sleep/34.2.191; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Glerup H, 2000, CALCIFIED TISSUE INT, V66, P419, DOI 10.1007/s002230010085; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Gumus B, 1999, ACTA PAEDIATR, V88, P1369, DOI 10.1080/080352599750030103; Gunes A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-357; Hjalmas K, 2004, J UROLOGY, V171, P2545, DOI 10.1097/01.ju.0000111504.85822.b2; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Kiddoo DA, 2006, AM J PHYSIOL-REG I, V290, pR1697, DOI 10.1152/ajpregu.00742.2005; Kong J, 2008, J AM SOC NEPHROL, V19, P2396, DOI 10.1681/ASN.2008010011; Krueger James M, 2011, Handb Clin Neurol, V98, P229, DOI 10.1016/B978-0-444-52006-7.00015-0; Leiberman A, 2006, INT J PEDIATR OTORHI, V70, P1675, DOI 10.1016/j.ijporl.2006.06.002; McCarty DE, 2012, J CLIN SLEEP MED, V8, P693, DOI 10.5664/jcsm.2266; McCarty DE, 2010, J CLIN SLEEP MED, V6, P605; Neveus T, 2008, PEDIATR NEPHROL, V23, P1201, DOI 10.1007/s00467-008-0859-1; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; NUNN JD, 1986, IMMUNOLOGY, V59, P479; Ozden Cuneyt, 2007, Int. braz j urol., V33, P216, DOI 10.1590/S1677-55382007000200013; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; PHILIP P, 1994, SLEEP, V17, P242; Prabhala A, 2000, ARCH INTERN MED, V160, P1199, DOI 10.1001/archinte.160.8.1199; Reid D, 2011, INT J PEDIATR OTORHI, V75, P261, DOI 10.1016/j.ijporl.2010.11.012; ROEHRS T, 1994, SLEEP, V17, P438, DOI 10.1093/sleep/17.5.438; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; RUSSELL JA, 1994, MUSCLE NERVE, V17, P578, DOI 10.1002/mus.880170603; Saintonge S, 2009, PEDIATRICS, V123, P797, DOI 10.1542/peds.2008-1195; Suzuki Y, 2009, J STEROID BIOCHEM, V113, P134, DOI 10.1016/j.jsbmb.2008.12.004; Umlauf Mary Grace, 2003, J Spec Pediatr Nurs, V8, P22, DOI 10.1111/j.1744-6155.2003.tb00180.x; van den Ouweland JMW, 2013, REV ENDOCR METAB DIS, V14, P159, DOI 10.1007/s11154-013-9241-0; Van der Schueren BJ, 2012, CURR OPIN LIPIDOL, V23, P17, DOI 10.1097/MOL.0b013e32834d7357; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200	42	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99316	10.1371/journal.pone.0099316	http://dx.doi.org/10.1371/journal.pone.0099316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911026	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600070
J	Ochiai-Shino, H; Kato, H; Sawada, T; Onodera, S; Saito, A; Takato, T; Shibahara, T; Muramatsu, T; Azuma, T				Ochiai-Shino, Hiromi; Kato, Hiroshi; Sawada, Takashi; Onodera, Shoko; Saito, Akiko; Takato, Tsuyoshi; Shibahara, Takahiko; Muramatsu, Takashi; Azuma, Toshifumi			A Novel Strategy for Enrichment and Isolation of Osteoprogenitor Cells from Induced Pluripotent Stem Cells Based on Surface Marker Combination	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; IN-VITRO; OSTERIX; TRANSCRIPTION; PROGENITORS; GENERATION; INHIBITION; DERIVATION	In this study, we developed a new method to stimulate osteogenic differentiation in tissue-nonspecific alkaline phosphatase (TNAP)-positive cells liberated from human induced pluripotent stem cells (hiPSCs)-derived embryoid bodies (EBs) with 14 days long TGF-beta/IGF-1/FGF-2 treatment. TNAP is a marker protein of osteolineage cells. We analyzed and isolated TNAP-positive and E-cadherin-negative nonepithelial cells by fluorescence-activated cell sorting. Treating the cells with a combination of transforming growth factor (TGF)-beta, insulin-like growth factor (IGF)-1, and fibroblast growth factor (FGF)-2 for 14 days greatly enhanced TNAP expression and maximized expression frequency up to 77.3%. The isolated cells expressed high levels of osterix, which is an exclusive osteogenic marker. Culturing these TNAP-positive cells in osteoblast differentiation medium (OBM) led to the expression of runt-related transcription factor 2, type I collagen, bone sialoprotein, and osteocalcin (OCN). These cells responded to treatment with activated vitamin D3 by upregulating OCN. Furthermore, in OBM they were capable of generating many mineralized nodules with strong expression of receptor activator of NF-kappaB ligand and sclerostin (SOST). Real-time RT-PCR showed a significant increase in the expression of osteocyte marker genes, including SOST, neuropeptide Y, and reelin. Scanning electron microscopy showed dendritic morphology. Examination of semi-thin toluidine blue-stained sections showed many interconnected dendrites. Thus, TNAP-positive cells cultured in OBM may eventually become terminally differentiated osteocyte-like cells. In conclusion, treating hiPSCs-derived cells with a combination of TGF-beta, IGF-1, and FGF-2 generated TNAP-positive cells at high frequency. These TNAP-positive cells had a high osteogenic potential and could terminally differentiate into osteocyte-like cells. The method described here may reveal new pathways of osteogenesis and provide a novel tool for regenerative medicine and drug development.	[Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Kato, Hiroshi; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Sawada, Takashi] Tokyo Dent Coll, Dept Ultrastruct Sci, Tokyo, Japan; [Takato, Tsuyoshi] Univ Tokyo, Fac Med, Grad Sch Med, Dept Oral & Maxillofacial Surg,Div Tissue Engn, Tokyo 113, Japan; [Muramatsu, Takashi] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; University of Tokyo; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.	tazuma@tdc.ac.jp	Muramatsu, Takashi/AAW-2646-2020	Onodera, Shoko/0000-0003-0673-3400	JSPS KAKENHI [25861761]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25861761. The URL is "http://www.jsps.go.jp/j-grantsinaid/". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566; Goudenege S, 2012, MOL THER, V20, P2153, DOI 10.1038/mt.2012.188; Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023; Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383; Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neve A, 2011, CELL TISSUE RES, V343, P289, DOI 10.1007/s00441-010-1086-1; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Sakurai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047078; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Tashiro K, 2009, STEM CELLS, V27, P1802, DOI 10.1002/stem.108; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Woll Nicole L., 2006, V330, P149; Woll NL, 2006, STEM CELLS DEV, V15, P865, DOI 10.1089/scd.2006.15.865; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	24	35	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99534	10.1371/journal.pone.0099534	http://dx.doi.org/10.1371/journal.pone.0099534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911063	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600101
J	Cheah, KY; Howarth, GS; Bindon, KA; Kennedy, JA; Bastian, SEP				Cheah, Ker Y.; Howarth, Gordon S.; Bindon, Keren A.; Kennedy, James A.; Bastian, Susan E. P.			Low Molecular Weight Procyanidins from Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Caco-2 Human Colon Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROANTHOCYANIDINS; ANTIOXIDANT; APOPTOSIS; ANGIOGENESIS; POLYPHENOLS; EXPRESSION; FRACTIONS; PATHWAYS; RECEPTOR	Objective: Grape seed procyanidins (PC) are flavan-3-ol oligomers and polymers known for their biological activity in the gut. Grape seed extract (GSE) have been reported to reduce intestinal injury in a rat model of mucositis. We sought to investigate effects of purified PC fractions differing in mean degree of polymerization (mDP) combined with 5-Fluorouracil (5-FU) chemotherapy on the viability of colon cancer cells (Caco-2). Design: SixPC fractions (F1-F6) were isolated from Cabernet Sauvignon seeds at two ripeness stages: pre-veraison unripe (immature) and ripe (mature), utilizing step gradient, low-pressure chromatography on a Sephadex LH-20 resin. Fractions were tested on Caco-2 cells, alone and in combination with 5-FU. Eluted fractions were characterized by phloroglucinolysis and gel permeation chromatography. Cell viability was determined by the 3-(4,5-Dimethylthiazol-2yl)-2,5-diphenyl-tetrazolium bromide) (MTT) assay. Results: All isolated fractions significantly reduced Caco-2 cell viability compared to the control (P<0.05), but F2 and F3 (mDP 2-6) were the most active fractions (immature F2 = 32% mDP 2.4, F3 = 35% mDP 5.8 and mature F2 = 13% mDP 3.6 and F3 = 17% mDP 5.9; percentage of viable cells remaining) on Caco-2 cells. When combined with 5-FU, immature fractions F1-F3 enhanced the cell toxicity effects of 5-FU by 27-73% (P<0.05). Mature seed PC fractions (F1-F4) significantly enhanced the toxicity of 5-FU by 60-83% against Caco-2 cells (P<0.05). Moreover, some fractions alone were more potent at decreasing viability in Caco-2 cells (P<0.05; immature fractions = 65-68% and mature fractions = 83-87%) compared to 5-FU alone (37%). Conclusions: PCs of mDP 2-6 (immature F1-F3 and mature F1 and F4) not only enhanced the impact of 5-FU in killing Caco-2 cells, but also surpassed standard 5-FU chemotherapy as an anti-cancer agent. The bioactivity of PC is therefore attributed primarily to lower molecular weight PCs.	[Cheah, Ker Y.; Bastian, Susan E. P.] Sch Agr Food & Wine, Wine Sci & Business Grp, Glen Osmond, SA, Australia; [Cheah, Ker Y.; Howarth, Gordon S.] Children Youth & Womens Hlth Serv, Ctr Paediat & Adolescent Gastroenterol, Adelaide, SA, Australia; [Howarth, Gordon S.] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA 5005, Australia; [Bindon, Keren A.; Kennedy, James A.] Australian Wine Res Inst, Adelaide, SA, Australia; [Kennedy, James A.] Calif State Univ Fresno, Dept Viticulture & Enol, Fresno, CA 93740 USA	University of Adelaide; Australian Wine Research Institute; California State University System; California State University Fresno	Bastian, SEP (corresponding author), Sch Agr Food & Wine, Wine Sci & Business Grp, Waite Campus,PMB 1, Glen Osmond, SA, Australia.	sue.bastian@adelaide.edu.au	Kennedy, James A/A-1636-2012; Howarth, Gordon/AAM-8699-2020	Kennedy, James A/0000-0002-5453-8469; Howarth, Gordon/0000-0001-6979-6084; Bastian, Susan/0000-0002-8790-2044	South Australian Health and Medical Research Institute Cancer Council	South Australian Health and Medical Research Institute Cancer Council	Professor Gordon Howarth is supported by a South Australian Health and Medical Research Institute Cancer Council Senior Research Fellowship. The current study was performed under the collaboration between Wine Science and Business Group, The University of Adelaide and Australian Wine Research Institute (AWRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis-Goretta L, 2008, J NUTR BIOCHEM, V19, P797, DOI 10.1016/j.jnutbio.2007.10.004; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Bindon KA, 2011, J AGR FOOD CHEM, V59, P2696, DOI 10.1021/jf1047207; Bindon KA, 2010, J AGR FOOD CHEM, V58, P2520, DOI 10.1021/jf9037453; Cheah KY, 2013, DIGEST DIS SCI, V58, P970, DOI 10.1007/s10620-012-2464-1; Cheah KY, 2009, CANCER BIOL THER, V8, P382, DOI 10.4161/cbt.8.4.7453; Cheah KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085184; Choi KC, 2011, BIOCHEM J, V433, P235, DOI 10.1042/BJ20100980; Choy YY, 2013, J AGR FOOD CHEM, V61, P121, DOI 10.1021/jf301939e; Deprez S, 2001, ANTIOXID REDOX SIGN, V3, P957, DOI 10.1089/152308601317203503; Dinicola S, 2012, INT J MOL SCI, V13, P651, DOI 10.3390/ijms13010651; Dinicola S, 2010, BRIT J NUTR, V104, P824, DOI 10.1017/S0007114510001522; Du Y, 2007, J AGR FOOD CHEM, V55, P1695, DOI 10.1021/jf063071b; Engelbrecht AM, 2007, CANCER LETT, V258, P144, DOI 10.1016/j.canlet.2007.08.020; Faria A, 2006, J AGR FOOD CHEM, V54, P2392, DOI 10.1021/jf0526487; Huang SS, 2012, INT J MOL MED, V30, P1410, DOI 10.3892/ijmm.2012.1147; Huang SS, 2012, NUTR RES, V32, P530, DOI 10.1016/j.nutres.2012.05.012; Huynh-Delerme C, 2005, TOXICOL IN VITRO, V19, P439, DOI 10.1016/j.tiv.2004.08.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaur M, 2008, NUTR CANCER, V60, P2, DOI 10.1080/01635580802381295; Keefe DM, 2008, EXPERT OPIN EMERG DR, V13, P511, DOI 10.1517/14728214.13.3.511 ; Kennedy JA, 2003, J CHROMATOGR A, V995, P99, DOI 10.1016/S0021-9673(03)00420-5; Kern M, 2005, MOL NUTR FOOD RES, V49, P317, DOI 10.1002/mnfr.200400086; Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x; Nomoto H, 2004, NUTR CANCER, V49, P81, DOI 10.1207/s15327914nc4901_11; Park SY, 2011, J MED FOOD, V14, P9, DOI 10.1089/jmf.2010.1264; Pierini R, 2008, MOL NUTR FOOD RES, V52, P1399, DOI 10.1002/mnfr.200700513; Poncet-Legrand C, 2003, LANGMUIR, V19, P10563, DOI 10.1021/la034927z; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Spencer JPE, 2001, BIOCHEM BIOPH RES CO, V285, P588, DOI 10.1006/bbrc.2001.5211; Torres JL, 2002, J AGR FOOD CHEM, V50, P7548, DOI 10.1021/jf025868i; Ugartondo V, 2007, CHEM RES TOXICOL, V20, P1543, DOI 10.1021/tx700253y; Van Cutsem EJD, 2005, ANN ONCOL, V16, P16, DOI 10.1093/annonc/mdi808; Wang YH, 2011, INT IMMUNOPHARMACOL, V11, P1620, DOI 10.1016/j.intimp.2011.05.024	35	37	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98921	10.1371/journal.pone.0098921	http://dx.doi.org/10.1371/journal.pone.0098921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905821	Green Submitted, gold, Green Published			2022-12-25	WOS:000341869000079
J	Weitkamp, JH; Rosen, MJ; Zhao, ZG; Koyama, T; Geem, D; Denning, TL; Rock, MT; Moore, DJ; Halpern, MD; Matta, P; Denning, PW				Weitkamp, Joern-Hendrik; Rosen, Michael J.; Zhao, Zhiguo; Koyama, Tatsuki; Geem, Duke; Denning, Timothy L.; Rock, Michael T.; Moore, Daniel J.; Halpern, Melissa D.; Matta, Pranathi; Denning, Patricia W.			Small Intestinal Intraepithelial TCR gamma delta(+) T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis	PLOS ONE			English	Article							GAMMA-DELTA; TIGHT JUNCTIONS; DEFICIENT MICE; IMMUNE-SYSTEM; EXPRESSION; EPIDEMIOLOGY; GROWTH; CELLS; MODEL; PROTECTION	Background: Gastrointestinal barrier immaturity predisposes preterm infants to necrotizing enterocolitis (NEC). Intraepithelial lymphocytes (IEL) bearing the unconventional T cell receptor (TCR) gamma delta (gamma delta IEL) maintain intestinal integrity and prevent bacterial translocation in part through production of interleukin (IL) 17. Objective: We sought to study the development of gamma delta IEL in the ileum of human infants and examine their role in NEC pathogenesis. We defined the ontogeny of gamma delta IEL proportions in murine and human intestine and subjected tc delta(-/-) mice to experimental gut injury. In addition, we used polychromatic flow cytometry to calculate percentages of viable IEL (defined as CD3(+) CD8(+) CD103(+) lymphocytes) and the fraction of gamma delta IEL in surgically resected tissue from infants with NEC and gestational age matched non-NEC surgical controls. Results: In human preterm infants, the proportion of IEL was reduced by 66% in 11 NEC ileum resections compared to 30 non-NEC controls (p<0.001). While gamma delta IEL dominated over conventional alpha beta IEL early in gestation in mice and in humans, gamma delta IEL were preferential decreased in the ileum of surgical NEC patients compared to non-NEC controls (50% reduction, p<0.05). Loss of IEL in human NEC was associated with downregulation of the Th17 transcription factor retinoic acid-related orphan nuclear hormone receptor C (RORC, p<0.001). TCRd-deficient mice showed increased severity of experimental gut injury (p<0.05) with higher TNF alpha expression but downregulation of IL17A. Conclusion: Complimentary mouse and human data suggest a role of gamma delta IEL in IL17 production and intestinal barrier production early in life. Specific loss of the gamma delta IEL fraction may contribute to NEC pathogenesis. Nutritional or pharmacological interventions to support gamma delta IEL maintenance in the developing small intestine could serve as novel strategies for NEC prevention.	[Weitkamp, Joern-Hendrik; Rock, Michael T.; Moore, Daniel J.; Matta, Pranathi] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Weitkamp, Joern-Hendrik; Rock, Michael T.; Moore, Daniel J.; Matta, Pranathi] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Rosen, Michael J.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Zhao, Zhiguo; Koyama, Tatsuki] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA; [Geem, Duke; Denning, Timothy L.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Halpern, Melissa D.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Halpern, Melissa D.] Univ Arizona, Steele Childrens Res Ctr, Tucson, AZ USA; [Denning, Patricia W.] Emory Univ Sch Med, Dept Pediat, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Cincinnati Children's Hospital Medical Center; Vanderbilt University; University System of Georgia; Georgia State University; University of Arizona; University of Arizona; Emory University	Weitkamp, JH (corresponding author), Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN 37232 USA.	weitkamp@Vanderbilt.Edu; pllin@emory.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020; Moore, Daniel J/A-4924-2008; Denning, Patricia W/G-4485-2011; Moore, Daniel/V-6145-2019	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Denning, Timothy/0000-0002-1072-7444; Rosen, Michael/0000-0002-5149-718X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059122, K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146, P30DK058404, P30DK020593, R24DK064399, K23DK094832, R21DK102058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NCATS NIH HHS [2 UL1 TR000445-06, UL1 TR000445] Funding Source: Medline; NCRR NIH HHS [UL1 RR024975, UL1 RR024975-01] Funding Source: Medline; NICHD NIH HHS [R01 HD059122, R01HD05922, K08HD061607, K08 HD061607] Funding Source: Medline; NIDDK NIH HHS [P30DK058404, K08 DK090146, 5K08DK090146-03, P30DK20593, R24 DK064399, R21 DK102058, P30 DK058404, K23DK094832, K23 DK094832, DK 063399, P30 DK020593] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asigbetse KE, 2010, J INVEST ALLERG CLIN, V20, P391; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Bhagat G, 2008, J CLIN INVEST, V118, P281, DOI 10.1172/JCI30989; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; CAMERINI V, 1993, J IMMUNOL, V151, P1765; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Dalton JE, 2006, GASTROENTEROLOGY, V131, P818, DOI 10.1053/j.gastro.2006.06.003; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Edelblum KL, 2012, P NATL ACAD SCI USA, V109, P7097, DOI 10.1073/pnas.1112519109; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; FU YX, 1994, J IMMUNOL, V153, P3101; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gibbons DL, 2009, EUR J IMMUNOL, V39, P1794, DOI 10.1002/eji.200939222; Gordon PV, 2012, EJ NEONATOL RES, V2, P145; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Istvanic S, 2007, AM J CLIN PATHOL, V127, P816, DOI 10.1309/V1GCW4DHTHM9WVXJ; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KLIEGMAN RM, 1981, AM J DIS CHILD, V135, P603, DOI 10.1001/archpedi.1981.02130310009005; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kuo S, 2001, PEDIATR RES, V49, P543, DOI 10.1203/00006450-200104000-00017; Li ZY, 2012, INFECT IMMUN, V80, P565, DOI 10.1128/IAI.05078-11; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Llanos AR, 2002, PAEDIATR PERINAT EP, V16, P342, DOI 10.1046/j.1365-3016.2002.00445.x; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McElroy Steven J, 2011, Neoreviews, V12, pe517; Mirpuri J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051955; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; MUSEMECHE C, 1991, J PEDIATR SURG, V26, P1047, DOI 10.1016/0022-3468(91)90671-F; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG167, DOI 10.1152/ajpgi.00141.2012; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Romano-Keeler J, 2014, GUT MICROBES, V5, P192, DOI 10.4161/gmic.28442; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah TA, 2012, J PERINATOL, V32, P552, DOI 10.1038/jp.2011.176; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Shibahara T, 2000, GASTROENTEROLOGY, V118, P289, DOI 10.1016/S0016-5085(00)70211-3; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Sun XM, 1997, AM J PHYSIOL-GASTR L, V273, pG56, DOI 10.1152/ajpgi.1997.273.1.G56; Suzuki R, 2002, INT IMMUNOL, V14, P339, DOI 10.1093/intimm/14.4.339; Tian RL, 2010, INT J CLIN EXP MED, V3, P293; Unutmaz D, 2009, EUR J IMMUNOL, V39, P1452, DOI 10.1002/eji.200939540; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Yang H, 2004, J IMMUNOL, V172, P4151, DOI 10.4049/jimmunol.172.7.4151; Zhang F, 2014, MUCOSAL IMMUNOL, V7, P521, DOI 10.1038/mi.2013.69	62	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99042	10.1371/journal.pone.0099042	http://dx.doi.org/10.1371/journal.pone.0099042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905458	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000098
J	Giles, JT; Darrah, E; Danoff, S; Johnson, C; Andrade, F; Rosen, A; Bathon, JM				Giles, Jon T.; Darrah, Erika; Danoff, Sonye; Johnson, Cheilonda; Andrade, Felipe; Rosen, Antony; Bathon, Joan M.			Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; ATHEROSCLEROSIS MESA; CARDIAC CT; CITRULLINATION; MORTALITY; FIBROSIS; GENES; PAD	Background: A subset of rheumatoid arthritis (RA) patients have detectable antibodies directed against the peptidylarginine deiminase (PAD) enzyme isoforms 3 and 4. Anti-PAD3/4 cross-reactive antibodies (anti-PAD3/4XR) have been shown to lower the calcium threshold required for PAD4 activation, an effect potentially relevant to the pathogenesis of RA-associated interstitial lung disease (ILD). Methods: RA patients underwent multi-detector computed tomography (MDCT) of the chest with interpretation by a pulmonary radiologist for ILD features. A semi-quantitative ILD Score (range 0-32) was calculated. Concurrent serum samples were assessed for antibodies against PAD by immunoprecipitation with radiolabeled PAD3 and PAD4. Results: Among the 176 RA patients studied, any ILD was observed in 58 (33%) and anti-PAD3/4XR was detected in 19 (11%). The frequency of any ILD among those with anti-PAD3/4XR was 68% vs. 29% among those with no anti-PAD (crude OR = 5.39; p = 0.002) and vs. 27% among those with anti-PAD4 that was not cross-reactive with PAD3 (crude OR = 5.74; p = 0.001). Both associations were stronger after adjustment for relevant confounders (adjusted ORs = 7.22 and 6.61, respectively; both p-values<0.01). Among ever smokers with anti-PAD3/4XR, the adjusted frequency of any ILD was 93% vs. 17% for never smokers without the antibody (adjusted OR = 61.4; p = 0.001, p-value for the interaction of smoking with anti-PAD3/4XR<0.05). Conclusions: The prevalence and extent of ILD was markedly higher among RA patients with anti-PAD3/4 cross-reactive antibodies, even after accounting for relevant confounders, particularly among ever smokers. These findings may suggest etiopathologic mechanisms of RA-ILD, and their clinical utility for predicting ILD warrants additional study.	[Giles, Jon T.; Bathon, Joan M.] Columbia Univ, Coll Phys & Surg, Div Rheumatol, New York, NY 10027 USA; [Darrah, Erika; Andrade, Felipe; Rosen, Antony] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [Danoff, Sonye; Johnson, Cheilonda] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins University	Giles, JT (corresponding author), Columbia Univ, Coll Phys & Surg, Div Rheumatol, New York, NY 10027 USA.	jtg2122@columbia.edu	Johnson, Cheilonda/AAB-4555-2020	Johnson, Cheilonda/0000-0003-3040-4981; Danoff, Sonye K./0000-0001-9172-8977; Darrah, Erika/0000-0003-1119-0279	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR050026-01]; Stabler Family Foundation; Mackley Fund from Sibley Memorial Hospital; NIH [P30 AR053503]; American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign; Johns Hopkins Bayview Medical Center General Clinical Research Center [M01RR02719]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR050026, P30AR053503, R01AR050026] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stabler Family Foundation; Mackley Fund from Sibley Memorial Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign; Johns Hopkins Bayview Medical Center General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR050026-01 (JMB), grant support from the Stabler Family Foundation, the Mackley Fund from Sibley Memorial Hospital, and NIH grant P30 AR053503 (AR, ED, FA), and awards from the American College of Rheumatology Research and Education Foundation Within-Our-Reach Campaign (SKD, JTG). Additional support was provided by the Johns Hopkins Bayview Medical Center General Clinical Research Center (Grant Number M01RR02719). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baumgartner KB, 2000, AM J EPIDEMIOL, V152, P307, DOI 10.1093/aje/152.4.307; Bongartz T, 2007, RHEUMATOLOGY, V46, P70, DOI 10.1093/rheumatology/kel202; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Dawson JK, 2001, THORAX, V56, P622, DOI 10.1136/thorax.56.8.622; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Giles JT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2641; Giles JT, 2013, ANN RHEUM DIS, DOI 10.1136; Goldin JG, 2008, CHEST, V134, P358, DOI 10.1378/chest.07-2444; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Kallberg H, 2011, ANN RHEUM DIS, V70, P508, DOI 10.1136/ard.2009.120899; Kobayashi H, 2010, J RHEUMATOL, V37, P730, DOI 10.3899/jrheum.090670; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; MCDONAGH J, 1994, BRIT J RHEUMATOL, V33, P118; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Ordonez A, 2009, FEBS J, V276, P6763, DOI 10.1111/j.1742-4658.2009.07391.x; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; ROBERTSON WG, 1981, CRC CR REV CL LAB SC, V15, P85, DOI 10.3109/10408368109105869; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Shelef MA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4083; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Solomon JJ, 2013, RESP MED, V107, P1247, DOI 10.1016/j.rmed.2013.05.002; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Willis VC, 2013, ARTHRITIS RHEUM-US, V65, P2545, DOI 10.1002/art.38066; WOLFE F, 1988, J RHEUMATOL, V15, P1480; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253	34	45	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98794	10.1371/journal.pone.0098794	http://dx.doi.org/10.1371/journal.pone.0098794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901704	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400052
J	Tran, HB; Ahern, J; Hodge, G; Holt, P; Dean, MM; Reynolds, PN; Hodge, S				Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Dean, Melinda M.; Reynolds, Paul N.; Hodge, Sandra			Oxidative Stress Decreases Functional Airway Mannose Binding Lectin in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGE SCAVENGER RECEPTOR; SURFACTANT PROTEIN-A; ALVEOLAR MACROPHAGES; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; PHAGOCYTOSIS; MBL; RECOGNITION; EXPRESSION	We have previously established that a defect in the ability of alveolar macrophages (AM) to phagocytose apoptotic cells (efferocytosis) and pathogens is a potential therapeutic target in COPD. We further showed that levels of mannose binding lectin (MBL; required for effective macrophage phagocytic function) were reduced in the airways but not circulation of COPD patients. We hypothesized that increased oxidative stress in the airway could be a cause for such disturbances. We therefore studied the effects of oxidation on the structure of the MBL molecule and its functional interactions with macrophages. Oligomeric structure of plasma derived MBL (pdMBL) before and after oxidation (oxMBL) with 2,2'-azobis(2-methylpropionamidine) dihydrochroride (AAPH) was investigated by blue native PAGE. Macrophage function in the presence of pd/oxMBL was assessed by measuring efferocytosis, phagocytosis of non-typeable Haemophilus influenzae (NTHi) and expression of macrophage scavenger receptors. Oxidation disrupted higher order MBL oligomers. This was associated with changed macrophage function evident by a significantly reduced capacity to phagocytose apoptotic cells and NTHi in the presence of oxMBL vs pdMBL (eg, NTHi by 55.9 and 27.0% respectively). Interestingly, oxidation of MBL significantly reduced macrophage phagocytic ability to below control levels. Flow cytometry and immunofluorescence revealed a significant increase in expression of macrophage scavenger receptor (SRA1) in the presence of pdMBL that was abrogated in the presence of oxMBL. We show the pulmonary macrophage dysfunction in COPD may at least partially result from an oxidative stress-induced effect on MBL, and identify a further potential therapeutic strategy for this debilitating disease.	[Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Hanson Inst, Adelaide, SA 5000, Australia; [Tran, Hai B.; Ahern, Jessica; Hodge, Greg; Holt, Phillip; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Hodge, Greg; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Dean, Melinda M.] Australian Red Cross Blood Serv, Brisbane, Qld, Australia	Hanson Institute; Royal Adelaide Hospital; Royal Adelaide Hospital; University of Adelaide; Australian Red Cross Blood Service	Tran, HB (corresponding author), Royal Adelaide Hosp, Hanson Inst, Adelaide, SA 5000, Australia.	hai.tran@health.sa.gov.au		Holt, Phillip/0000-0003-1999-1927	Hanson Institute Brine Bequest for Emphysema Research	Hanson Institute Brine Bequest for Emphysema Research	The work was supported by a Hanson Institute Brine Bequest for Emphysema Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang P, 2008, SCAND J INFECT DIS, V40, P44, DOI 10.1080/00365540701522959; Butler GS, 2002, J BIOL CHEM, V277, P17511, DOI 10.1074/jbc.M201461200; Dehle FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061573; Fidler KJ, 2009, THORAX, V64, P150, DOI 10.1136/thx.2008.100073; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2011, J HEART LUNG TRANSPL, V30, P589, DOI 10.1016/j.healun.2011.01.710; Hodge S, 2010, AM J RESP CELL MOL, V42, P235, DOI 10.1165/rcmb.2008-0486OC; Hoenderdos K, 2013, AM J RESP CELL MOL, V48, P531, DOI 10.1165/rcmb.2012-0492TR; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Kuzmenko AI, 2005, J BIOL CHEM, V280, P25913, DOI 10.1074/jbc.M411344200; LIPSCOMBE RJ, 1995, IMMUNOLOGY, V85, P660; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; Mukaro VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056147; Nakanishi Y, 2009, AM J RESP CRIT CARE, V179, P271, DOI 10.1164/rccm.200806-905OC; Nauta AJ, 2003, EUR J IMMUNOL, V33, P2853, DOI 10.1002/eji.200323888; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Ozment TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002967; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Shimizu T, 2009, BBA-GEN SUBJECTS, V1790, P1705, DOI 10.1016/j.bbagen.2009.10.006; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; Starosta V, 2006, FREE RADICAL RES, V40, P419, DOI 10.1080/10715760600571248; Starosta V, 2006, PEDIATR PULM, V41, P67, DOI 10.1002/ppul.20289; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Terai I, 2003, EUR J IMMUNOL, V33, P2755, DOI 10.1002/eji.200323955; Theakston F, 2008, WORLD HLTH STAT; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; Valdimarsson H, 2003, BIOCHEM SOC T, V31, P768, DOI 10.1042/bst0310768; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083517; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	44	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98571	10.1371/journal.pone.0098571	http://dx.doi.org/10.1371/journal.pone.0098571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901869	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400039
J	Wu, WX; Cheng, ZW; Liu, MJ; Yang, XF; Qiu, DW				Wu, Wenxian; Cheng, Zhiwei; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen			C3HC4-Type RING Finger Protein NbZFP1 Is Involved in Growth and Fruit Development in Nicotiana benthamiana	PLOS ONE			English	Article							S-TYPE ANION; ARABIDOPSIS; GENE; EXPRESSION; LIGASE; RESISTANCE; CHANNELS; ELEMENTS; DROUGHT; BINDING	C3HC4-type RING finger proteins constitute a large family in the plant kingdom and play important roles in various physiological processes of plant life. In this study, a C3HC4-type zinc finger gene was isolated from Nicotiana benthamiana. Sequence analysis indicated that the gene encodes a 24-kDa protein with 191 amino acids containing one typical C3HC4-type zinc finger domain; this gene was named NbZFP1. Transient expression of pGDG-NbZFP1 demonstrated that NbZFP1 was localized to the chloroplast, especially in the chloroplasts of cells surrounding leaf stomata. Virus-induced gene silencing (VIGS) analysis indicated that silencing of NbZFP1 hampered fruit development, although the height of the plants was normal. An overexpression construct was then designed and transferred into Nicotiana benthamiana, and PCR and Southern blot showed that the NbZFP1 gene was successfully integrated into the Nicotiana benthamiana genome. The transgenic lines showed typical compactness, with a short internode length and sturdy stems. This is the first report describing the function of a C3HC4-type RING finger protein in tobacco.	[Wu, Wenxian; Cheng, Zhiwei; Liu, Mengjie; Yang, Xiufen; Qiu, Dewen] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Qiu, DW (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	qiudewen@caas.cn			National Science Foundation of China [31371984]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (31371984). The website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; An G, 1989, BINARY VECTORS, P29; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Crawford BCW, 2007, CURR BIOL, V17, P1101, DOI 10.1016/j.cub.2007.05.079; De Smet I, 2003, PLANT J, V33, P543, DOI 10.1046/j.1365-313X.2003.01652.x; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Kobayashi A, 1998, PLANT J, V13, P571, DOI 10.1046/j.1365-313X.1998.00043.x; Kulye M, 2012, PLANT CELL ENVIRON, V35, P2104, DOI 10.1111/j.1365-3040.2012.02539.x; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Levchenko V, 2005, P NATL ACAD SCI USA, V102, P4203, DOI 10.1073/pnas.0500146102; Liu KM, 2007, PLANTA, V226, P1007, DOI 10.1007/s00425-007-0548-5; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Ma K, 2009, GENE, V444, P33, DOI 10.1016/j.gene.2009.05.018; Matsuda N, 2001, J CELL SCI, V114, P1949; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Pepper AE, 1997, GENETICS, V145, P1125; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Sakai H, 1995, ROLE SUPERMAN MAINTA; Schumann U, 2003, P NATL ACAD SCI USA, V100, P9626, DOI 10.1073/pnas.1633697100; Siegel RS, 2009, PLANT J, V59, P207, DOI 10.1111/j.1365-313X.2009.03872.x; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; VONARNIM AG, 1993, J BIOL CHEM, V268, P19626; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Zhang SS, 2009, P NATL ACAD SCI USA, V106, P4543, DOI 10.1073/pnas.0900349106; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	41	24	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99352	10.1371/journal.pone.0099352	http://dx.doi.org/10.1371/journal.pone.0099352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901716	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400122
J	Kelly, SBA; Kelly, DJ; Cooper, N; Bahrun, A; Analuddin, K; Marples, NM				Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Bahrun, Andi; Analuddin, Kangkuso; Marples, Nicola M.			Molecular and Phenotypic Data Support the Recognition of the Wakatobi Flowerpecker (Dicaeum kuehni) from the Unique and Understudied Sulawesi Region	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; BODY-SIZE; BIRDS; DNA	Accurate estimates of species richness are essential to macroecological and macroevolutionary research, as well as to the effective management and conservation of biodiversity. The resolution of taxonomic relationships is therefore of vital importance. While molecular methods have revolutionised taxonomy, contemporary species delimitation requires an integrative, multi-disciplinary approach. Despite boasting a remarkably high level of endemism, the avifauna of the Sulawesi region of Indonesia remains poorly studied. Previous studies of avian diversity in Sulawesi have focussed predominantly on phenotypic characteristics, thus potentially overlooking any genetically distinct lineages. Grey-sided Flowerpecker Dicaeum celebicum populations from the Wakatobi archipelago were originally described as a separate species from those on nearby mainland Sulawesi. However, for reasons that remain unknown, the Wakatobi populations were reclassified as a subspecies of the mainland form. Combining estimates of genetic divergence with phylogenetic and morphological analyses, we reassessed the status of Wakatobi populations. Our results describe the Wakatobi populations as a separate species to those on mainland Sulawesi; reproductively isolated, genetically and morphologically distinct. We therefore recommend the reclassification of these populations to their original status of Dicaeum kuehni and propose the vernacular name 'Wakatobi Flowerpecker'. In consideration of our findings and the lack of integrative ornithological research within the Sulawesi region, we believe species richness and avian endemism within the region are underestimated.	[Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Marples, Nicola M.] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Kelly, Sean B. A.; Kelly, David J.; Cooper, Natalie; Marples, Nicola M.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Bahrun, Andi] Univ Haluoleo, Dept Agrotechnol, Kendari, Southeast Sulaw, Indonesia; [Analuddin, Kangkuso] Univ Haluoleo, Dept Biol, Kendari, Southeast Sulaw, Indonesia	Trinity College Dublin; Trinity College Dublin; Universitas Halu Oleo; Universitas Halu Oleo	Kelly, SBA (corresponding author), Trinity Coll Dublin, Dept Zool, Dublin, Ireland.	kellys17@tcd.ie	Cooper, Natalie/I-7976-2012; Analuddin, Kangkuso/ABD-6036-2020; Kelly, David/AAE-8278-2019	Cooper, Natalie/0000-0003-4919-8655; Analuddin, Kangkuso/0000-0003-0258-9376; Marples, Nicola/0000-0003-4693-2607; Kelly, David/0000-0002-5880-4162; Kelly, Sean/0000-0002-3078-8404	Trinity College Dublin; Operation Wallacea	Trinity College Dublin; Operation Wallacea	This research was primarily funded by Trinity College Dublin and partially funded by Operation Wallacea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2008, ZOOL J LINN SOC, V154; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BirdLife International, 2013, END BIRD AR FACTSH K; BirdLife International, 2013, DAT ZON TAX; Blair CP, 2005, EVOLUTION, V59, P304; Cheke R.A., 2008, P350; Cheke R. A., 2008, HDB BIRDS WORLD, P196; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; Coates B.J., 1997, GUIDE BIRDS WALLACEA; Dennis AB, 2010, MOL ECOL, V19, P3206, DOI 10.1111/j.1365-294X.2010.04689.x; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fjeldsa J, 2010, IBIS, V152, P747, DOI 10.1111/j.1474-919X.2010.01053.x; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; GRANT PR, 1968, SYST ZOOL, V17, P319, DOI 10.2307/2412010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartert E., 1903, NOVITATES ZOOLOGICAE, V10, P18; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HOLM S, 1979, SCAND J STAT, V6, P65; Indrawan M., 2004, Bulletin of the British Ornithologists' Club, V124, P160; Indrawan M, 2008, WILSON J ORNITHOL, V120, P1, DOI 10.1676/06-051.1; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Lambert FR, 1998, NEW SPECIES GYMNOCRE, V13, P1; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P67; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Lohman DJ, 2009, MOL ECOL RESOUR, V9, P37, DOI 10.1111/j.1755-0998.2008.02221.x; Luo A-Rong, 2010, Acta Entomologica Sinica, V53, P192; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr E., 1942, P1; Mayr E., 1947, Araer Mus Nov, P1; Mckay BD, 2010, AUK, V127, P932, DOI 10.1525/auk.2010.09093; Melo M, 2010, J ZOOL, V282, P120, DOI 10.1111/j.1469-7998.2010.00720.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nyari AS, 2009, MOL PHYLOGENET EVOL, V53, P613, DOI 10.1016/j.ympev.2009.06.014; R Core Team, 2021, R LANG ENV STAT COMP; Rasmussen P.C., 2000, Forktail, V16, P69; Rasmussen PC, 1999, WILSON BULL, V111, P457; Redfern C. P. F, 2001, RINGERS MANUAL; Robinson-Wolrath SI, 2003, J EVOLUTION BIOL, V16, P1106, DOI 10.1046/j.1420-9101.2003.00615.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Scott SN, 2003, EVOLUTION, V57, P2147; SMITH RB, 1991, GEOL SOC AM BULL, V103, P660, DOI 10.1130/0016-7606(1991)103<0660:GOAMCC>2.3.CO;2; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	53	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98694	10.1371/journal.pone.0098694	http://dx.doi.org/10.1371/journal.pone.0098694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896822	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700066
J	Park, CY; Hong, JH; Lee, JH; Lee, KE; Cho, HS; Lim, SJ; Kwak, JW; Kim, KS; Kim, HJ				Park, Chong Yoon; Hong, Joon Hyeong; Lee, Jae Heon; Lee, Kyu Eun; Cho, Hyun Sang; Lim, Su Jin; Kwak, Jin Wook; Kim, Kyung Soo; Kim, Hyun Jik			Clinical Effect of Surgical Correction for Nasal Pathology on the Treatment of Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							UPPER AIRWAY; SURGERY; RESISTANCE; PATHOGENESIS; PRESSURE	Objectives: This study aimed to evaluate the hypothesis that relief of nasal obstruction in subjects with obstructive sleep apnea (OSA) would lead to reduce OSA severity and to discuss the available evidence on the clinical efficacy of nasal surgery as a treatment modality for OSA. Study Design: Twenty-five subjects who had reduced patency of nasal cavity and narrowing of retroglossal or retropalatal airways were diagnosed with OSA and underwent nasal surgery, such as septoplasty or turbinoplasty to correct nasal pathologies. The effect of the surgery on nasal patency was quantified by measuring minimal cross-sectional area (MCA) using acoustic rhinometry. The watch-PAT-derived respiratory disturbance index (RDI), apnea and hypopnea index (AHI), lowest oxygen saturation, and valid sleep time were measured before and after nasal surgery. Results: The present study shows that the AHI and RDI decreased significantly and the lowest oxygen saturation and valid sleep time rose after nasal surgery in 25 OSA subjects. In addition, a reduction in subjective symptoms was observed in subjects and mean MCA increased after nasal surgery. Fourteen subjects were classified as responders and 11 subjects as non-responders. Responders showed considerable improvement of their subjective symptoms and the AHI and RDI were significantly lower after surgery. We found that the changes between pre- and post-operative AHI and RDI values were minimal in 11 non-responders. However, daytime somnolence and REM sleep time improved after nasal surgery in non-responders. Conclusions: Our study provides evidence that the surgical treatment of nasal pathology improves nasal airway patency and reduces OSA severity in 56% subjects. Furthermore, correction of nasal pathology appears to result in improved sleep quality in both responder and non-responders OSA subjects.	[Park, Chong Yoon; Hong, Joon Hyeong; Lee, Jae Heon; Lee, Kyu Eun; Cho, Hyun Sang; Lim, Su Jin; Kwak, Jin Wook; Kim, Kyung Soo; Kim, Hyun Jik] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol & Head & Neck Surg, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, HJ (corresponding author), Chung Ang Univ, Coll Med, Dept Otorhinolaryngol & Head & Neck Surg, Seoul 156756, South Korea.	hyunjk@cau.ac.kr						ATKINS M, 1994, CHEST, V105, P1133, DOI 10.1378/chest.105.4.1133; BRAVER HM, 1994, SLEEP, V17, P516, DOI 10.1093/sleep/17.6.516; Craig TJ, 2003, ALLERGY ASTHMA PROC, V24, P53; FERRIS BG, 1964, J APPL PHYSIOL, V19, P653, DOI 10.1152/jappl.1964.19.4.653; Friedman M, 2000, OTOLARYNG HEAD NECK, V122, P71, DOI 10.1016/S0194-5998(00)70147-1; Georgalas C, 2011, EUR ARCH OTO-RHINO-L, V268, P1365, DOI 10.1007/s00405-010-1469-7; HOFFSTEIN V, 1992, AM REV RESPIR DIS, V145, P841, DOI 10.1164/ajrccm/145.4_Pt_1.841; HOIJER U, 1992, ARCH OTOLARYNGOL, V118, P281; KERR P, 1992, J OTOLARYNGOL, V21, P189; Kim ST, 2004, ACTA OTO-LARYNGOL, V124, P297, DOI 10.1080/00016480410016252; Kohler M, 2007, EUR RESPIR J, V30, P1208, DOI 10.1183/09031936.00032007; Koutsourelakis I, 2008, EUR RESPIR J, V31, P110, DOI 10.1183/09031936.00087607; McLean HA, 2005, EUR RESPIR J, V25, P521, DOI 10.1183/09031936.05.00045004; Nakata S, 2005, RHINOLOGY, V43, P296; Nakata S, 2008, AM J RHINOL, V22, P59, DOI 10.2500/ajr.2008.22.3120; Park SS, 1993, LUNG, V64, P311; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; SERIES F, 1993, THORAX, V48, P360, DOI 10.1136/thx.48.4.360; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; SMITH PL, 1988, J APPL PHYSIOL, V64, P789, DOI 10.1152/jappl.1988.64.2.789; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Verse T, 2002, LARYNGOSCOPE, V112, P64, DOI 10.1097/00005537-200201000-00012; Virkkula P, 2006, CHEST, V129, P81, DOI 10.1378/chest.129.1.81	24	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98765	10.1371/journal.pone.0098765	http://dx.doi.org/10.1371/journal.pone.0098765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896824	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700073
J	Takano, S; Fukasawa, M; Maekawa, S; Kadokura, M; Miura, M; Shindo, H; Takahashi, E; Sato, T; Enomoto, N				Takano, Shinichi; Fukasawa, Mitsuharu; Maekawa, Shinya; Kadokura, Makoto; Miura, Mika; Shindo, Hiroko; Takahashi, Ei; Sato, Tadashi; Enomoto, Nobuyuki			Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic Duct Dilation	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS GUIDELINES; STIMULATORY G-PROTEIN; K-RAS; FREQUENT GNAS; SOMATIC MUTATIONS; JUICE; CARCINOMA; IPMN; P53; MANAGEMENT	Background: To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related gene profiling analyses using pure pancreatic juice and resected pancreatic tissues. Methods: Pure pancreatic juice was collected from 152 patients [nine with a normal pancreas, 22 with chronic pancreatitis (CP), 39 with pancreatic ductal adenocarcinoma (PDAC), and 82 with IPMN], and resected tissues from the pancreas were collected from 48 patients (six IPMNs and 42 PDACs). The extracted DNA was amplified by multiplexed polymerase chain reaction (PCR) targeting 46 cancer-related genes containing 739 mutational hotspots. The mutations were analysed using a semiconductor-based DNA sequencer. Results: Among the 46 cancer-related genes, KRAS and GNAS mutations were most frequently detected in both PDAC and IPMN cases. In pure pancreatic juice, GNAS mutations were detected in 7.7% of PDAC cases and 41.5% of IPMN cases (p<0.001 vs. others). All PDAC cases with GNAS mutations (n = 3) were accompanied by IPMN. Multivariate analysis revealed that GNAS mutations in IPMN cases were associated with dilated main pancreatic ducts (MPD, p = 0.016), while no statistically independent associations with clinical variables were observed for KRAS mutations. In the resected pancreatic tissues, GNAS mutations were detected in 50% of PDAC cases concomitant with IPMN, 33.3% of PDAC cases derived from IPMN, and 66.7% of IPMN cases, while no GNAS mutations were detected in cases of PDAC without IPMN. Conclusions: The GNAS mutation was specifically found in the cases with IPMN and it was speculated that some PDACs might be influenced by the concomitant but separately-located IPMN in their pathogenic mechanism. Furthermore, the GNAS mutation was significantly associated with MPD dilatation in IPMN cases, suggesting its role in mucus hypersecretion.	[Takano, Shinichi; Fukasawa, Mitsuharu; Maekawa, Shinya; Kadokura, Makoto; Miura, Mika; Shindo, Hiroko; Takahashi, Ei; Sato, Tadashi; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Fac Med, Chuo Ku, Yamanashi, Japan	University of Yamanashi	Takano, S (corresponding author), Univ Yamanashi, Dept Internal Med 1, Fac Med, Chuo Ku, Yamanashi, Japan.	stakano@yamanashi.ac.jp	Seco-Granados, Gonzalo/C-7058-2008; Morell, Antoni/AFP-3174-2022; Maekawa, Shinya/AAF-1349-2019	Seco-Granados, Gonzalo/0000-0003-2494-6872; Morell, Antoni/0000-0003-2249-8594; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [25860527]; Foundation for Advancement of International Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Advancement of International Science(Foundation for Advancement of International Science (FAIS))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25860527, http://www.jsps.go.jp/j-grantsinaid/) and by grants from the Foundation for Advancement of International Science (http://www.fais.or.jp/grant/fy25/01_file/2013_01members.pdf). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadling C, 2013, J MOL DIAGN, V15, P171, DOI 10.1016/j.jmoldx.2012.09.003; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Dal Molin M, 2013, ANN SURG ONCOL, V20, P3802, DOI 10.1245/s10434-013-3096-1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaino M, 1999, PANCREAS, V18, P294, DOI 10.1097/00006676-199904000-00011; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kawakubo K, 2013, PANCREAS, V42, P687, DOI 10.1097/MPA.0b013e318270ea97; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087875; KONDO H, 1994, CANCER, V73, P1589, DOI 10.1002/1097-0142(19940315)73:6<1589::AID-CNCR2820730609>3.0.CO;2-7; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; Sasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081706; TADA M, 1993, CANCER RES, V53, P2472; Tada M, 2006, CLIN GASTROENTEROL H, V4, P1265, DOI 10.1016/j.cgh.2006.07.013; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tanno S, 2010, PANCREATOLOGY, V10, P173, DOI 10.1159/000231982; Tateishi K, 1999, GUT, V45, P737, DOI 10.1136/gut.45.5.737; Tsai JH, 2013, AM J SURG PATHOL, V37, P1862, DOI 10.1097/PAS.0b013e3182986bb5; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wang Y, 2004, PANCREAS, V28, P13, DOI 10.1097/00006676-200401000-00002; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c	37	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98718	10.1371/journal.pone.0098718	http://dx.doi.org/10.1371/journal.pone.0098718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897499	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700069
J	Wu, JR; Yu, MZ; Xu, JH; Du, J; Ji, F; Dong, F; Li, XH; Shi, JR				Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Li, Xinhai; Shi, Jianrong			Impact of Transgenic Wheat with wheat yellow mosaic virus Resistance on Microbial Community Diversity and Enzyme Activity in Rhizosphere Soil	PLOS ONE			English	Article							GENETICALLY-MODIFIED CROPS; COAT PROTEIN; FUNCTIONAL DIVERSITY; RISK-ASSESSMENT; BT COTTON; PLANTS; MICROORGANISMS; PERSISTENCE; LOCATION; BACTERIA	The transgenic wheat line N12-1 containing the WYMV-Nib8 gene was obtained previously through particle bombardment, and it can effectively control the wheat yellow mosaic virus (WYMV) disease transmitted by Polymyxa graminis at turngreen stage. Due to insertion of an exogenous gene, the transcriptome of wheat may be altered and affect root exudates. Thus, it is important to investigate the potential environmental risk of transgenic wheat before commercial release because of potential undesirable ecological side effects. Our 2-year study at two different experimental locations was performed to analyze the impact of transgenic wheat N12-1 on bacterial and fungal community diversity in rhizosphere soil using polymerase chain reaction-denaturing gel gradient electrophoresis (PCR-DGGE) at four growth stages (seeding stage, turngreen stage, grain-filling stage, and maturing stage). We also explored the activities of urease, sucrase and dehydrogenase in rhizosphere soil. The results showed that there was little difference in bacterial and fungal community diversity in rhizosphere soil between N12-1 and its recipient Y158 by comparing Shannon's, Simpson's diversity index and evenness (except at one or two growth stages). Regarding enzyme activity, only one significant difference was found during the maturing stage at Xinxiang in 2011 for dehydrogenase. Significant growth stage variation was observed during 2 years at two experimental locations for both soil microbial community diversity and enzyme activity. Analysis of bands from the gel for fungal community diversity showed that the majority of fungi were uncultured. The results of this study suggested that virus-resistant transgenic wheat had no adverse impact on microbial community diversity and enzyme activity in rhizosphere soil during 2 continuous years at two different experimental locations. This study provides a theoretical basis for environmental impact monitoring of transgenic wheat when the introduced gene is derived from a virus.	[Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] Jiangsu Acad Agr Sci, Inst Food Safety & Detect, Nanjing, Jiangsu, Peoples R China; [Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Jirong; Yu, Mingzheng; Xu, Jianhong; Du, Juan; Ji, Fang; Dong, Fei; Shi, Jianrong] Jiangsu Ctr GMO Evaluat & Detect, Nanjing, Jiangsu, Peoples R China; [Li, Xinhai] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Jiangsu Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, XH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China.	lixinhai@caas.cn; shiji@jaas.ac.cn	Shi, Jianrong/AAQ-1805-2020; xu, jianhong/AAQ-4773-2021; Shi, Jianrong/AAQ-3456-2020	Shi, Jianrong/0000-0003-3818-5074; shi, jianrong/0000-0001-8650-248X	National Special Transgenic Project [2014ZX08011-003]; Natural Science Foundation of Jiangsu Province, China [BK20130721]; Jiangsu Agriculture Science and Technology Innovation Fund [cx(11)4064]	National Special Transgenic Project; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Jiangsu Agriculture Science and Technology Innovation Fund	This work was supported by the National Special Transgenic Project (2014ZX08011-003), Natural Science Foundation of Jiangsu Province, China (BK20130721) and Jiangsu Agriculture Science and Technology Innovation Fund [cx(11)4064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL PP, 1986, SCIENCE, V232, P738, DOI 10.1126/science.3457472; Alef K., 1995, METHODS APPL SOIL MI, P350; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakke I, 2011, J MICROBIOL METH, V84, P349, DOI 10.1016/j.mimet.2010.12.015; BEACHY RN, 1990, ANNU REV PHYTOPATHOL, V28, P451, DOI 10.1146/annurev.py.28.090190.002315; Blackwood CB, 2004, J ENVIRON QUAL, V33, P832, DOI 10.2134/jeq2004.0832; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; CHEN JP, 1993, ANN APPL BIOL, V123, P55, DOI 10.1111/j.1744-7348.1993.tb04072.x; Chen ZH, 2011, PLANT SOIL ENVIRON, V57, P67, DOI 10.17221/237/2010-PSE; Chun YJ, 2011, APPL SOIL ECOL, V51, P130, DOI 10.1016/j.apsoil.2011.09.008; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Coz I, 2008, J ENVIRON QUAL, V37, P647, DOI 10.2134/jeq2007.0352; Das M, 2007, APPL ENVIRON MICROB, V73, P756, DOI 10.1128/AEM.01170-06; Devare MH, 2004, J ENVIRON QUAL, V33, P837, DOI 10.2134/jeq2004.0837; Dick R.P., 1996, METHODS ASSESSING SO, P247, DOI DOI 10.2136/SSSASPECPUB49.C15; DONEGAN KK, 1995, APPL SOIL ECOL, V2, P111, DOI 10.1016/0929-1393(94)00043-7; Donegan KK, 1999, J APPL ECOL, V36, P920, DOI 10.1046/j.1365-2664.1999.00448.x; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Fang M, 2005, APPL ENVIRON MICROB, V71, P4132, DOI 10.1128/AEM.71.7.4132-4136.2005; Faragova N, 2011, BIOLOGIA, V66, P768, DOI 10.2478/s11756-011-0082-6; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fuchs M, 2007, ANNU REV PHYTOPATHOL, V45, P173, DOI 10.1146/annurev.phyto.45.062806.094434; Graef F, 2005, ENVIRON MONIT ASSESS, V111, P1, DOI 10.1007/s10661-005-8044-5; Guan SY, 1986, SOIL ENZYME ITS RES, P62; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hen CG, 2000, PLANT DIS, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Hirsch PR, 2010, SOIL BIOL BIOCHEM, V42, P878, DOI 10.1016/j.soilbio.2010.02.019; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Kent AD, 2002, ANNU REV MICROBIOL, V56, P211, DOI 10.1146/annurev.micro.56.012302.161120; Kowalchuk GA, 2003, TRENDS ECOL EVOL, V18, P403, DOI 10.1016/S0169-5347(03)00187-3; Li YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055555; Lin CH, 2010, APPL ENVIRON MICROB, V76, P3370, DOI 10.1128/AEM.00018-10; Lindfeld Andreas, 2012, Open Ecology Journal, V5, P45, DOI 10.2174/1874213001205010045; Liu B, 2005, PLANT SOIL, V271, P1, DOI 10.1007/s11104-004-1610-8; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lu HH, 2010, PLANT SOIL, V336, P279, DOI 10.1007/s11104-010-0476-1; Lu R.K, 1999, SOIL AGROCHEMISTRY A; Lupwayi NZ, 2007, SOIL BIOL BIOCHEM, V39, P1418, DOI 10.1016/j.soilbio.2006.12.038; MCGREGOR AN, 2000, NZ SOIL NEWS, V48, P166; Meyer JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053825; O'Callaghan M, 2001, N Z PLANT PROTECT-SE, V54, P105, DOI 10.30843/nzpp.2001.54.3725; Raybould A, 2012, TRANSGENIC RES, V21, P655, DOI 10.1007/s11248-011-9560-4; Robinson DJ, 1996, TRANSGENIC RES, V5, P359, DOI 10.1007/BF01968945; Romeis J, 2003, PEDOBIOLOGIA, V47, P141, DOI 10.1078/0031-4056-00177; Saxena D, 1999, NATURE, V402, P480, DOI 10.1038/44997; Sengelov G, 2001, CURR MICROBIOL, V42, P160, DOI 10.1007/s002840010197; SERRAWITTLING C, 1995, BIOL FERT SOILS, V20, P226, DOI 10.1007/BF00336082; Shen RF, 2006, PLANT SOIL, V285, P149, DOI 10.1007/s11104-006-9000-z; Sun CX, 2007, BIOL FERT SOILS, V43, P617, DOI 10.1007/s00374-006-0158-6; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Tepfer M, 2002, ANNU REV PHYTOPATHOL, V40, P467, DOI 10.1146/annurev.phyto.40.120301.093728; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Weaver R.W., 1994, METHODS SOIL ANAL 2; Wei XD, 2006, PLANT SOIL, V285, P347, DOI 10.1007/s11104-006-9020-8; Weinert N, 2010, PLANT SOIL, V326, P437, DOI 10.1007/s11104-009-0024-z; Wu HongYa, 2006, Journal of Triticeae Crops, V26, P11; Xu H, 2001, ACTA AGRONOMICA SINI, V27, P688; Yi H, 2009, J PLANT BIOL, V52, P577, DOI 10.1007/s12374-009-9075-1; Zughart W, 2008, EUPHYTICA, V164, P845, DOI 10.1007/s10681-007-9475-6	62	23	28	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98394	10.1371/journal.pone.0098394	http://dx.doi.org/10.1371/journal.pone.0098394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897124	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700040
J	Randrianambinintsoa, FJ; Leger, N; Robert, V; Depaquit, J				Randrianambinintsoa, Fano Jose; Leger, Nicole; Robert, Vincent; Depaquit, Jerome			Paraphyly of the Subgenus Sintonius (Diptera, Psychodidae, Sergentomyia): Status of the Malagasy Species. Creation of a New Subgenus and Description of a New Species	PLOS ONE			English	Article							WORLD PHLEBOTOMINAE DIPTERA; MADAGASCAR DIPTERA; NUMERICAL TAXONOMY; N. SP; SANDFLIES; FEMALE	During an inventory of Phlebotomine sand flies carried out in Madagascar, we have identified some specimens showing morphological characters related to the subgenus Sintonius of the genus Sergentomyia. We started a molecular study based on cytochrome b mtDNA and on D1-D2 and D8 domains of the rDNA. The sampling includes all the Sergentomyia species available and also S. (Sergentomyia) schwetzi, S. (Parrotomyia) magna, and the following species belonging to the subgenus Sintonius: S. clydei, S. christophersi, S. affinis vorax, S. adleri and S. meilloni. The Sintonius subgenus (sensu Theodor) is paraphyletic. The Malagasy specimens morphologically Sintonius-like are never clustered with the continental Sintonius. We propose a new subgenus to include them: Trouilletomyia subg. nov. Due to the lack of mesanepisternal setae, the species huberti is removed from the genus Phlebotomus and we propose here a new combination: Sergentomyia huberti comb. nov. The male of S. huberti is pinpointed and described for the first time. Lastly, a new species for Science is described on one female: Sergentomyia (Trouilletomyia) boironis n. sp.	[Randrianambinintsoa, Fano Jose] Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo, Madagascar; [Randrianambinintsoa, Fano Jose; Leger, Nicole; Depaquit, Jerome] Univ Reims, ANSES, SFR Cap Sante, USC Transmiss Vectorielle & Epidemiosurveillance, Reims, France; [Randrianambinintsoa, Fano Jose; Robert, Vincent] MIVEGEC, UMR IRD CNRS UM1 UM2 224 5290, Montpellier, France; [Randrianambinintsoa, Fano Jose] Inst Pasteur Madagascar, Antananarivo, Madagascar	University Antananarivo; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Universite de Reims Champagne-Ardenne; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Randrianambinintsoa, FJ (corresponding author), Univ Antananarivo, Fac Sci, Dept Biol Anim, Antananarivo, Madagascar.	fanoujo@yahoo.fr	Randrianambinintsoa, Fano José/G-1198-2014; Depaquit, Jérôme/AAT-7586-2021; Randrianambinintsoa, Fano José/M-3737-2019	Randrianambinintsoa, Fano José/0000-0002-9654-1850; Depaquit, Jérôme/0000-0001-6995-0088; Randrianambinintsoa, Fano José/0000-0002-9654-1850	Institute of Research for Development; Institut Pasteur de Madagascar; Volkswagen Stiftung; Program of Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien; GDRI "Biodiversite et Developpement Durable a Madagascar"; Universite de Reims Champagne - Ardenne; Robert S. McNamara Fellowship Program of the World Bank	Institute of Research for Development; Institut Pasteur de Madagascar; Volkswagen Stiftung(Volkswagen); Program of Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien; GDRI "Biodiversite et Developpement Durable a Madagascar"; Universite de Reims Champagne - Ardenne; Robert S. McNamara Fellowship Program of the World Bank	The fieldwork received funding from the Institute of Research for Development, Institut Pasteur de Madagascar, and Volkswagen Stiftung. Laboratory work received funding from: (i) the Program of "Institut Francais de la biodiversite/CNRS/AIRD Biodiversite dans les iles de l'Ocean Indien"' itself included in the Regional Project "Insectes vecteurs (phlebotomes et moustiques) dans les iles de l'Ocean Indien: Madagascar, Seychelles et Comores", the GDRI "Biodiversite et Developpement Durable a Madagascar"; (ii) "Universite de Reims Champagne - Ardenne"; and (iii) the Robert S. McNamara Fellowship Program of the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P69; Abonnenc E, 1972, SER ENT MED PARASITO, V55; Aransay AM, 2000, INSECT MOL BIOL, V9, P157, DOI 10.1046/j.1365-2583.2000.00168.x; Berdjane-Brouk Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028266; Bonfield JK, 1996, DNA SEQUENCE, V6, P109, DOI 10.3109/10425179609010197; Charrel RN, 2006, EMERG INFECT DIS, V12, P1299, DOI 10.3201/eid1708.060345; Depaquit J, 2008, PARASITE, V15, P15, DOI 10.1051/parasite/2008151015; Depaquit J, 2007, PARASITE, V14, P219, DOI 10.1051/parasite2007143219; Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Depaquit J, 2004, PARASITE, V11, P261, DOI 10.1051/parasite/2004113261; Depaquit J, 2004, PARASITE, V11, P201, DOI 10.1051/parasite/2004112201; Depaquit J, 1998, CR ACAD SCI III-VIE, V321, P849, DOI 10.1016/S0764-4469(99)80025-0; Depaquit J, 2002, PARASITE, V9, P325, DOI 10.1051/parasite/2002094325; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; FRANCA C., 1920, Bulletin de la Societe de Pathologie Exotique, V13, P695; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jung H. F., 1958, P1; Leger N, 2005, PARASITE, V12, P51, DOI 10.1051/parasite/2005121051; LEGER N, 1978, B SOC PATHOL EXOT, V71, P476; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; NITZULESCU VIRGIL, 1931, ANN PARASITOL HUMAINE ET COMP, V9, P271; Perfiliev P., 1968, FAUNA USSR DIPTERA P; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randrianambinintsoa F.J., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P206, DOI 10.1007/s13149-013-0305-x; Randrianambinintsoa FJ, 2013, PARASITE, V20, DOI 10.1051/parasite/2013005; Rispail P, 1998, MEM I OSWALDO CRUZ, V93, P787, DOI 10.1590/S0074-02761998000600016; Rispail P, 1998, MEM I OSWALDO CRUZ, V93, P773, DOI 10.1590/S0074-02761998000600015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Senghor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014773; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; THEODOR O, 1948, B ENTOMOL RES, V39, P85, DOI 10.1017/S0007485300024305; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98065	10.1371/journal.pone.0098065	http://dx.doi.org/10.1371/journal.pone.0098065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893009	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400033
J	Saiki, A; Kimura, R; Samura, T; Fujiwara-Tsukamoto, Y; Sakai, Y; Isomura, Y				Saiki, Akiko; Kimura, Rie; Samura, Toshikazu; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu			Different Modulation of Common Motor Information in Rat Primary and Secondary Motor Cortices	PLOS ONE			English	Article							MEDIAL AGRANULAR CORTEX; CONTRASTING NEURONAL-ACTIVITY; SKILLED FORELIMB MOVEMENTS; LABELED PYRAMIDAL NEURONS; PREFRONTAL UNIT-ACTIVITY; GO/NO-GO DISCRIMINATION; VOLUNTARY MOVEMENT; INTRACORTICAL MICROSTIMULATION; CORTICOCORTICAL CONNECTIONS; SENSORIMOTOR CORTEX	Rodents have primary and secondary motor cortices that are involved in the execution of voluntary movements via their direct and parallel projections to the spinal cord. However, it is unclear whether the rodent secondary motor cortex has any motor function distinct from the primary motor cortex to properly control voluntary movements. In the present study, we quantitatively examined neuronal activity in the caudal forelimb area (CFA) of the primary motor cortex and rostral forelimb area (RFA) of the secondary motor cortex in head-fixed rats performing forelimb movements (pushing, holding, and pulling a lever). We found virtually no major differences between CFA and RFA neurons, regardless of neuron subtypes, not only in their basal spiking properties but also in the time-course, amplitude, and direction preference of their functional activation for simple forelimb movements. However, the RFA neurons, as compared with the CFA neurons, showed obviously a greater susceptibility of their functional activation to an alteration in a behavioral situation, a 'rewarding' response that leads to reward or a 'consummatory' response that follows reward water, which might be accompanied by some internal adaptations without affecting the motor outputs. Our results suggest that, although the CFA and RFA neurons commonly process fundamental motor information to properly control forelimb movements, the RFA neurons may be functionally differentiated to integrate motor information with internal state information for an adaptation to goal-directed behaviors.	[Saiki, Akiko; Kimura, Rie; Samura, Toshikazu; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Saiki, Akiko; Sakai, Yutaka; Isomura, Yoshikazu] Tamagawa Univ, Grad Sch Brain Sci, Machida, Tokyo, Japan; [Saiki, Akiko; Kimura, Rie; Fujiwara-Tsukamoto, Yoko; Sakai, Yutaka; Isomura, Yoshikazu] JST CREST, Chiyoda Ku, Tokyo, Japan; [Samura, Toshikazu] Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Samura, Toshikazu] Doshisha Univ, Grad Sch Brain Sci, Lab Neural Circuitry, Kyoto 602, Japan	Yamaguchi University; Doshisha University	Isomura, Y (corresponding author), Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan.	isomura@lab.tamagawa.ac.jp		Kimura, Rie/0000-0003-1798-5400	JST CREST; MEXT [22120520, 24120715, 24300143]; Uehara Memorial Foundation; Brain Science Foundation; Grants-in-Aid for Scientific Research [26119526] Funding Source: KAKEN	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Brain Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST (Y.I.), Grants-in-Aid for Scientific Research on Innovative Areas (Y.I., 22120520, 24120715) and for Scientific Research (B) (Y.I., 24300143) from MEXT, and research grants from the Uehara Memorial Foundation (Y.I.) and Brain Science Foundation (Y.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Bonazzi L, 2013, J NEUROSCI, V33, P2097, DOI 10.1523/JNEUROSCI.3454-12.2013; Brasted PJ, 2000, BEHAV BRAIN RES, V111, P139, DOI 10.1016/S0166-4328(00)00147-9; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; BROWN VJ, 1991, BEHAV NEUROSCI, V105, P567, DOI 10.1037/0735-7044.105.4.567; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHAPIN JK, 1986, EXP NEUROL, V91, P502, DOI 10.1016/0014-4886(86)90048-8; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Cho RH, 2004, NEUROSCI RES, V50, P395, DOI 10.1016/j.neures.2004.08.007; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1985, BRAIN RES, V333, P173, DOI 10.1016/0006-8993(85)90141-6; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gharbawie OA, 2007, EUR J NEUROSCI, V26, P3309, DOI 10.1111/j.1460-9568.2007.05874.x; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hermer-Vazquez L, 2004, BEHAV BRAIN RES, V150, P93, DOI 10.1016/S0166-4328(03)00226-2; Hira R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00055; Hira R, 2013, J NEUROSCI, V33, P1377, DOI 10.1523/JNEUROSCI.2550-12.2013; Hyland B, 1998, BEHAV BRAIN RES, V94, P255, DOI 10.1016/S0166-4328(97)00157-5; Igarashi J, 2013, J NEUROSCI, V33, P18515, DOI 10.1523/JNEUROSCI.2126-13.2013; Isomura Y, 2003, J NEUROSCI, V23, P8002; Isomura Y, 2013, J NEUROSCI, V33, P10209, DOI 10.1523/JNEUROSCI.0381-13.2013; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; Kimura R, 2012, J NEUROPHYSIOL, V108, P1781, DOI 10.1152/jn.00356.2012; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; KURATA K, 1985, J NEUROPHYSIOL, V53, P142, DOI 10.1152/jn.1985.53.1.142; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; LIANG FY, 1993, SOMATOSENS MOT RES, V10, P51, DOI 10.3109/08990229309028823; Mansoori BK, 2014, EXP NEUROL, V254, P18, DOI 10.1016/j.expneurol.2014.01.010; MILLER MW, 1987, EXP BRAIN RES, V67, P339; Morishima M, 2011, J NEUROSCI, V31, P10380, DOI 10.1523/JNEUROSCI.0772-11.2011; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; OKANO K, 1987, EXP BRAIN RES, V66, P155; Ostlund SB, 2009, J NEUROSCI, V29, P8280, DOI 10.1523/JNEUROSCI.1176-09.2009; PASSINGHAM RE, 1988, BEHAV NEUROSCI, V102, P101, DOI 10.1037/0735-7044.102.1.101; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; Smith NJ, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00124; Sul JH, 2011, NAT NEUROSCI, V14, P1202, DOI 10.1038/nn.2881; Takekawa T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00005; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; TANJI J, 1985, J NEUROPHYSIOL, V53, P129, DOI 10.1152/jn.1985.53.1.129; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Umeda T, 2011, EUR J NEUROSCI, V34, P1453, DOI 10.1111/j.1460-9568.2011.07866.x; VandenBerg PM, 2002, BRAIN RES BULL, V59, P197, DOI 10.1016/S0361-9230(02)00865-1; VANKAN PLE, 1985, EXP BRAIN RES, V60, P559, DOI 10.1007/BF00236942; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8; Zeiler SR, 2013, STROKE, V44, P483, DOI 10.1161/STROKEAHA.112.676940; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	63	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98662	10.1371/journal.pone.0098662	http://dx.doi.org/10.1371/journal.pone.0098662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893154	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400083
J	Wang, J; Mikse, O; Liao, RG; Li, Y; Tan, L; Janne, PA; Gray, NS; Wong, KK; Hammerman, PS				Wang, J.; Mikse, O.; Liao, R. G.; Li, Y.; Tan, L.; Janne, P. A.; Gray, N. S.; Wong, K-k; Hammerman, P. S.			Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR-3; SENSITIVE FGFR2; BREAST-CANCER; GENE FUSIONS; LUNG-CANCER; MUTATIONS; IDENTIFICATION; PROGRESSION; NVP-BGJ398	Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are currently under investigation in clinical trials for subjects with FGFR gene amplifications, mutations and translocations. Here, we develop cell line models of acquired resistance to FGFR inhibition by exposure of cell lines harboring FGFR3 gene amplification and translocation to the selective FGFR inhibitor BGJ398 and multitargeted FGFR inhibitor ponatinib. We show that the acquisition of resistance is rapid, reversible and characterized by an epithelial to mesenchymal transition and a switch from dependency on FGFR3 to ERBB family members. Acquired resistance was associated with demonstrable changes in gene expression including increased production of ERBB2/3 ligands, which were sufficient to drive resistance in the setting of FGFR3 dependency but not dependency on other FGFR family members. These data support the concept that activation of ERBB family members is sufficient to bypass dependency on FGFR3 and suggest that concurrent inhibition of these two pathways may be desirable when targeting FGFR3-dependent cancers.	[Wang, J.; Mikse, O.; Liao, R. G.; Li, Y.; Janne, P. A.; Wong, K-k; Hammerman, P. S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Wang, J.] Fudan Univ, Shanghai Med Coll, Dept Integrat Med & Neurobiol, Shanghai 200433, Peoples R China; [Liao, R. G.; Li, Y.; Hammerman, P. S.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Tan, L.; Gray, N. S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Janne, P. A.; Wong, K-k] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Fudan University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hammerman, PS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Dana 810A, Boston, MA 02215 USA.	phammerman@partners.org		Tan, Li/0000-0002-1199-9046; Liao, Rachel/0000-0002-7830-1976	NCI [K08 CA163677]; V Foundation the Stephen D; Alice Cutler Fund; NSFC [81202746]; CSC; NATIONAL CANCER INSTITUTE [R01CA166480, K08CA163677, P01CA154303, R01CA140594] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation the Stephen D; Alice Cutler Fund; NSFC(National Natural Science Foundation of China (NSFC)); CSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	PSH is supported by NCI K08 CA163677, the V Foundation the Stephen D and Alice Cutler Fund. We thank M Meyerson for assisting with the planning of this study. JW is supported by NSFC 81202746 and CSC.	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Andre F, 2013, CLIN CANCER RES, V19, P3693, DOI 10.1158/1078-0432.CCR-13-0190; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Chell V, 2013, ONCOGENE, V32, P3059, DOI 10.1038/onc.2012.319; Cheng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057284; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Courjal F, 1997, CANCER RES, V57, P4360; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbinski F, 2012, CANCER DISCOV, V2, P948, DOI 10.1158/2159-8290.CD-12-0237; Herrera-Abreu MT, 2013, CANCER DISCOV, V3, P1058, DOI 10.1158/2159-8290.CD-12-0569; Jenndahl LE, 2005, INT J ONCOL, V27, P439; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-383; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Lemieux S, 2013, ANTI-CANCER AGENT ME, V13, P748, DOI 10.2174/18715206113139990080; Liao RG, 2013, CANCER RES, V73, P5195, DOI 10.1158/0008-5472.CAN-12-3950; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Winter SF, 2007, ONCOGENE, V26, P4897, DOI 10.1038/sj.onc.1210288; Wolf J, 2012, CANC RES, V72; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	46	46	60	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 23	2015	34	17					2167	2177		10.1038/onc.2014.161	http://dx.doi.org/10.1038/onc.2014.161			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG7HG	24909170	Green Accepted			2022-12-25	WOS:000353473000003
J	Malhotra, P; Soni, V; Kumar, A; Anbazhagan, AN; Dudeja, A; Saksena, S; Gill, RK; Dudeja, PK; Alrefai, WA				Malhotra, Pooja; Soni, Vinay; Kumar, Anoop; Anbazhagan, Arivarasu N.; Dudeja, Amish; Saksena, Seema; Gill, Ravinder K.; Dudeja, Pradeep K.; Alrefai, Waddah A.			Epigenetic Modulation of Intestinal Cholesterol Transporter Niemann-Pick C1-like 1 (NPC1L1) Gene Expression by DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; HUMAN CANCER-CELLS; ABSORPTION; REVEALS; DIETARY; PROTEIN; DNMT1; GATA4; MICE	Intestinal NPC1L1 transporter is essential for cholesterol absorption and the maintenance of cholesterol homeostasis in the body. NPC1L1 is differentially expressed along the gastrointestinal tract with very low levels in the colon as compared with the small intestine. This study was undertaken to examine whether DNA methylation was responsible for segment-specific expression of NPC1L1. Treatment of mice with 5-azacytidine (i.p.) resulted in a significant dose-dependent increase in NPC1L1 mRNA expression in the colon. The lack of expression of NPC1L1 in the normal colon was associated with high levels of methylation in the area flanking the 3-kb fragment upstream of the initiation site of the mouse NPC1L1 gene in mouse colon as analyzed by EpiTYPER (R) Mass-ARRAY (R). The high level of methylation in the colon was observed in specific CpG dinucleotides and was significantly decreased in response to 5-azacytidine. Similar to mouse NPC1L1, 5-azacytidine treatment also increased the level of human NPC1L1 mRNA expression in the intestinal HuTu-80 cell line in a dose-and time-dependent manner. Silencing the expression of DNA methyltransferase DNMT1, -2, -3A, and -3B alone by siRNA did not affect NPC1L1 expression in HuTu-80 cells. However, the simultaneous attenuation of DNMT1 and -3B expression caused a significant increase in NPC1L1 mRNA expression as compared with control. Also, in vitro methylation of the human NPC1L1 promoter significantly decreased NPC1L1 promoter activity in human intestinal Caco2 cells. In conclusion, our data demonstrated for the first time that DNA methylation in the promoter region of the NPC1L1 gene appears to be a major mechanism underlying differential expression of NPC1L1 along the length of the gastrointestinal tract.	[Dudeja, Pradeep K.; Alrefai, Waddah A.] Univ Illinois, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA; [Malhotra, Pooja; Soni, Vinay; Kumar, Anoop; Anbazhagan, Arivarasu N.; Dudeja, Amish; Saksena, Seema; Gill, Ravinder K.; Dudeja, Pradeep K.; Alrefai, Waddah A.] Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alrefai, WA (corresponding author), Univ Illinois, Jesse Brown VA Med Ctr, Med Res Serv 600 151, 820 South Damen Ave, Chicago, IL 60612 USA.	walrefai@uic.edu		Gill, Ravinder/0000-0002-5337-2567	National Institutes of Health from NIDDK [DK54016, DK81858, DK92441, DK96258, DK96245, DK71596]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081858, R56DK071596, R03DK096258, R21DK096254, R01DK092441, R01DK071596, R01DK054016] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000152] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK54016, DK81858, and DK92441 (to P. K. D.), DK96258 (to R. K. G.), DK96245 (to S. S.), and DK71596 (to W. A. A.) from NIDDK. This work was also supported by the Department of Veterans Affairs (to W. A. A. and P. K. D.).	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V292, pG369, DOI 10.1152/ajpgi.00306.2006; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Berger J, 2007, MOL CELL BIOL, V27, P4049, DOI 10.1128/MCB.02023-06; Beuling E, 2010, GUT, V59, P888, DOI 10.1136/gut.2009.204990; Bird LM, 2011, AM J MED GENET A, V155A, P2956, DOI 10.1002/ajmg.a.34297; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Engelking LJ, 2012, J LIPID RES, V53, P1359, DOI 10.1194/jlr.M027599; Fernandez A. Z., INT J VASC MED, DOI [10.1155/2010/437809, DOI 10.1155/2010/437809]; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Iwayanagi Y, 2008, PHARM RES, V25, P1134, DOI 10.1007/s11095-007-9496-9; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lally S, 2006, DIABETOLOGIA, V49, P1008, DOI 10.1007/s00125-006-0177-8; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Saetrom P, 2007, PEDIATR RES, V61, p17R, DOI 10.1203/pdr.0b013e318045760e; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Ting AH, 2006, CANCER RES, V66, P729, DOI 10.1158/0008-5472.CAN-05-1537; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; WILSON MD, 1994, J LIPID RES, V35, P943; Wong WK, 2003, J BIOL CHEM, V278, P36227, DOI 10.1074/jbc.M305549200; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155	32	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2014	289	33					23132	23140		10.1074/jbc.M113.546283	http://dx.doi.org/10.1074/jbc.M113.546283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO0QV	24904062	Green Published, hybrid			2022-12-25	WOS:000341017200050
J	Zach, L; Braunstein, I; Stanhill, A				Zach, Lolita; Braunstein, Ilana; Stanhill, Ariel			Stress-induced Start Codon Fidelity Regulates Arsenite-inducible Regulatory Particle-associated Protein (AIRAP) Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							40S RIBOSOMAL-SUBUNIT; INITIATION-FACTORS; MODULATES AUTOREGULATION; MESSENGER-RNAS; SITE SELECTION; EIF1; PHOSPHORYLATION; COMPLEX; GENE; REINITIATION	Initial steps in protein synthesis are highly regulated processes as they define the reading frame of the translation machinery. Eukaryotic translation initiation is a process facilitated by numerous factors (eIFs), aimed to form a "scanning" mechanism toward the initiation codon. Translation initiation of the main open reading frame (ORF) in an mRNA transcript has been reported to be regulated by upstream open reading frames (uORFs) in a manner of re-initiation. This mode of regulation is governed by the phosphorylation status of eIF2 alpha and controlled by cellular stresses. Another mode of translational initiation regulation is leaky scanning, and this regulatory process has not been extensively studied. We have identified arsenite-inducible regulatory particle-associated protein (AIRAP) transcript to be translationally induced during arsenite stress conditions. AIRAP transcript contains a single uORF in a poor-kozak context. AIRAP translation induction is governed by means of leaky scanning and not re-initiation. This induction of AIRAP is solely dependent on eIF1 and the uORF kozak context. We show that eIF1 is phosphorylated under specific conditions that induce protein misfolding and have biochemically characterized this site of phosphorylation. Our data indicate that leaky scanning like re-initiation is responsive to stress conditions and that leaky scanning can induce ORF translation by bypassing poor kozak context of a single uORF transcript.	[Zach, Lolita; Braunstein, Ilana; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	stanhill@tx.technion.ac.il		stanhill, ariel/0000-0002-0318-2212	John Hopkins-Technion grant foundation; Israeli Science Foundation [168/12]	John Hopkins-Technion grant foundation; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the John Hopkins-Technion grant foundation and the Israeli Science Foundation Grant 168/12.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Elfakess R, 2011, NUCLEIC ACIDS RES, V39, P7598, DOI 10.1093/nar/gkr484; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Glinka Tal, 2014, Biochem J, V457, P253, DOI 10.1042/BJ20130710; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	35	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20706	20716		10.1074/jbc.M114.547828	http://dx.doi.org/10.1074/jbc.M114.547828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898249	hybrid, Green Published			2022-12-25	WOS:000339396600028
J	Lee, YK; Lee, KS; Kim, WM; Sohn, YS				Lee, Yeon Kyung; Lee, Kyeong-Seok; Kim, Won Mok; Sohn, Young-Soo			Detection of Amyloid-beta 42 Using a Waveguide-Coupled Bimetallic Surface Plasmon Resonance Sensor Chip in the Intensity Measurement Mode	PLOS ONE			English	Article							AMYLOID-BETA; OPTICAL BIOSENSORS; SENSITIVITY; BIOMARKERS; FILM; ENHANCEMENT	The waveguide-coupled bimetallic (WcBiM) surface plasmon resonance (SPR) chip had been utilized in the intensity interrogation detection mode to detect amyloid-beta 42 (A beta 42), a biomarker of the Alzheimer disease. The SPR reflectance curve of the WcBiM chip has the narrower full-width-at-half-maximum (FWHM) compared with the SPR reflectance curve of the conventional gold (Au) chip, resulting in the steeper gradient. For the enhancement of resolution, the light source was fixed at an angle where the slope of the reflectance curve is the steepest, and the change in the reflectance was monitored. For the detection of A beta 42, the antibody of A beta 42 (anti-A beta 42) was immobilized on the WcBiM SPR chip using the self-assembled monolayer. The SPR responses, the average changes in the reflectance to the A beta 42 at the concentrations of 100 pg/ml, 250 pg/ml, 500 pg/ml, 750 pg/ml, 1,000 pg/ml, and 2,000 pg/ml were 0.0111%, 0.0305%, 0.0867%, 0.1712%, 0.3021%, and 0.5577%, respectively, for the three replicates. From linear regression analysis, the calibration curve indicated that the SPR response had a linear relation with A beta 42 with the concentration in the range of 100 pg/ml to 2,000 pg/ml. A control experiment showed the anti-A beta 42-modified surface of the WcBiM chip had a high specificity to A beta 42. Thus, the enhanced resolution by utilizing the WcBiM SPR chip in the intensity interrogation detection mode aids the diagnosis of the Alzheimer disease by detecting the A beta 42 around the criteria concentration (500 pg/ml) without any labeling.	[Lee, Yeon Kyung; Sohn, Young-Soo] Catholic Univ Daegu, Dept Biomed Engn, Gyongsan, Gyeongbuk, South Korea; [Lee, Kyeong-Seok; Kim, Won Mok] Korea Inst Sci & Technol, Elect Mat Res Ctr, Seoul, South Korea	Catholic University of Daegu; Korea Institute of Science & Technology (KIST)	Sohn, YS (corresponding author), Catholic Univ Daegu, Dept Biomed Engn, Gyongsan, Gyeongbuk, South Korea.	sohnys@cu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2010028]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2010028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohunicky B, 2011, NANOTECHNOL SCI APPL, V4, P1, DOI 10.2147/NSA.S13465; Butterfield DA, 2004, NEUROBIOL AGING, V25, P563, DOI 10.1016/j.neurobiolaging.2003.12.027; Chen Y, 2011, APPL OPTICS, V50, P387, DOI 10.1364/AO.50.000387; Chien FC, 2004, BIOSENS BIOELECTRON, V20, P633, DOI 10.1016/j.bios.2004.03.014; Choi S, 2008, BIOSENS BIOELECTRON, V24, P893, DOI 10.1016/j.bios.2008.07.036; Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y; Englebienne P, 2003, SPECTROSC-INT J, V17, P255, DOI 10.1155/2003/372913; Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022; Grober E, 2008, J INT NEUROPSYCH SOC, V14, P266, DOI 10.1017/S1355617708080302; Hampel H, 2008, ALZHEIMERS DEMENT, V4, P38, DOI 10.1016/j.jalz.2007.08.006; Hegnerova K, 2009, SENSOR ACTUAT B-CHEM, V139, P69, DOI 10.1016/j.snb.2008.09.006; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Humpel C, 2011, TRENDS BIOTECHNOL, V29, P26, DOI 10.1016/j.tibtech.2010.09.007; Kang DY, 2009, BIOSENS BIOELECTRON, V24, P1431, DOI 10.1016/j.bios.2008.08.018; Lame ME, 2011, ANAL BIOCHEM, V419, P133, DOI 10.1016/j.ab.2011.08.010; Lee KS, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/12/125302; Lee KS, 2010, SENSORS-BASEL, V10, P11390, DOI 10.3390/s101211390; Lee YK, 2013, J KOREAN PHYS SOC, V62, P475, DOI 10.3938/jkps.62.475; Li CT, 2012, BIOSENS BIOELECTRON, V36, P192, DOI 10.1016/j.bios.2012.04.016; Mascini M, 2008, BIOMARKERS, V13, P637, DOI [10.1080/13547500802645905, 10.1080/13547500802645905 ]; Mehta PD, 2007, J NEUROL SCI, V254, P22, DOI 10.1016/j.jns.2006.12.010; Moskovitz J, 2011, BIOCHEMISTRY-US, V50, P10687, DOI 10.1021/bi201426b; Oh ES, 2010, J ALZHEIMERS DIS, V21, P769, DOI 10.3233/JAD-2010-100456; Ong BH, 2006, SENSOR ACTUAT B-CHEM, V114, P1028, DOI 10.1016/j.snb.2005.07.064; Pejcic B, 2006, ANALYST, V131, P1079, DOI 10.1039/b603402k; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Ryu J, 2008, ANAL CHEM, V80, P2400, DOI 10.1021/ac7019514; Sharma AK, 2005, OPT COMMUN, V245, P159, DOI 10.1016/j.optcom.2004.10.013; Sharma AK, 2007, J APPL PHYS, V101, DOI 10.1063/1.2721779; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tothill IE, 2009, SEMIN CELL DEV BIOL, V20, P55, DOI 10.1016/j.semcdb.2009.01.015; Ukraintseva S, 2006, STROKE, V37, P1155, DOI 10.1161/01.STR.0000217971.88034.e9; Viswanathan S, 2012, BIOSENS BIOELECTRON, V33, P179, DOI 10.1016/j.bios.2011.12.049; Wan YH, 2012, SENSOR ACTUAT B-CHEM, V162, P35, DOI 10.1016/j.snb.2011.12.019; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Yuk JS, 2011, BIOSENS BIOELECTRON, V26, P3213, DOI 10.1016/j.bios.2010.12.028; Zynio SA, 2002, SENSORS-BASEL, V2, P62, DOI 10.3390/s20200062	40	18	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98992	10.1371/journal.pone.0098992	http://dx.doi.org/10.1371/journal.pone.0098992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911167	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600032
J	Illarionava, NB; Brismar, H; Aperia, A; Gunnarson, E				Illarionava, Nina B.; Brismar, Hjalmar; Aperia, Anita; Gunnarson, Eli			Role of Na,K-ATPase alpha 1 and alpha 2 Isoforms in the Support of Astrocyte Glutamate Uptake	PLOS ONE			English	Article							NEURONAL-ACTIVITY; NA+; TRANSPORTERS; GLT-1; SUBUNIT; DYNAMICS; KINETICS; SIGNALS; GLAST; MICE	Glutamate released during neuronal activity is cleared from the synaptic space via the astrocytic glutamate/Na+ co-transporters. This transport is driven by the transmembrane Na+ gradient mediated by Na,K-ATPase. Astrocytes express two isoforms of the catalytic Na, K-ATPase alpha subunits; the ubiquitously expressed alpha 1 subunit and the alpha 2 subunit that has a more specific expression profile. In the brain alpha 2 is predominantly expressed in astrocytes. The isoforms differ with regard to Na+ affinity, which is lower for alpha 2. The relative roles of the alpha 1 and alpha 2 isoforms in astrocytes are not well understood. Here we present evidence that the presence of the alpha 2 isoform may contribute to a more efficient restoration of glutamate triggered increases in intracellular sodium concentration [Na+](i). Studies were performed on primary astrocytes derived from E17 rat striatum expressing Na, K-ATPase alpha 1 and alpha 2 and the glutamate/Na+ co-transporter GLAST. Selective inhibition of alpha 2 resulted in a modest increase of [Na+](i) accompanied by a disproportionately large decrease in uptake of aspartate, an indicator of glutamate uptake. To compare the capacity of alpha 1 and alpha 2 to handle increases in [Na+](i) triggered by glutamate, primary astrocytes overexpressing either alpha 1 or alpha 2 were used. Exposure to glutamate 200 mM caused a significantly larger increase in [Na+](i) in alpha 1 than in alpha 2 overexpressing cells, and as a consequence restoration of [Na+](i), after glutamate exposure was discontinued, took longer time in alpha 1 than in alpha 2 overexpressing cells. Both alpha 1 and alpha 2 interacted with astrocyte glutamate/Na+ co-transporters via the 1st intracellular loop.	[Illarionava, Nina B.; Brismar, Hjalmar; Aperia, Anita; Gunnarson, Eli] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, Dept Cell Phys, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Gunnarson, E (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	eli.gunnarson@ki.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003	Swedish Research Council; Erling-Persson Family Foundation; Stockholm County Council; Karolinska Institutet; Sallskapet Barnavard	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erling-Persson Family Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Sallskapet Barnavard	This study has been supported by grants from the Swedish Research Council (AA), the Erling-Persson Family Foundation, the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet (EG) and Sallskapet Barnavard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aperia A, 2012, J AM SOC NEPHROL, V23, P1283, DOI 10.1681/ASN.2012010102; Azarias G, 2012, J BIOL CHEM; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Barcroft LC, 2004, MECH DEVELOP, V121, P417, DOI 10.1016/j.mod.2004.04.005; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bernardinelli Y, 2004, P NATL ACAD SCI USA, V101, P14937, DOI 10.1073/pnas.0405315101; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; Chatton JY, 2000, EUR J NEUROSCI, V12, P3843, DOI 10.1046/j.1460-9568.2000.00269.x; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Genda EN, 2011, J NEUROSCI, V31, P18275, DOI 10.1523/JNEUROSCI.3305-11.2011; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HOYER J, 1991, J GEN PHYSIOL, V97, P1073, DOI 10.1085/jgp.97.5.1073; Ikeda K, 2004, J NEUROSCI, V24, P10693, DOI 10.1523/JNEUROSCI.2909-04.2004; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Langer J, 2009, J PHYSIOL-LONDON, V587, P5859, DOI 10.1113/jphysiol.2009.182279; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Liebmann T, 2012, J NEUROSCI, V32, P17998, DOI 10.1523/JNEUROSCI.1804-12.2012; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Longuemare MC, 1999, NEUROSCIENCE, V93, P285, DOI 10.1016/S0306-4522(99)00152-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; Pellerin L, 1997, J NEUROCHEM, V69, P2132; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sambrook J, 2001, MOL CLONING LAB MANU; Tanaka K, 2000, NEUROSCI RES, V37, P15, DOI 10.1016/S0168-0102(00)00104-8; TURNER RJ, 1982, J MEMBRANE BIOL, V70, P37, DOI 10.1007/BF01871587; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	38	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98469	10.1371/journal.pone.0098469	http://dx.doi.org/10.1371/journal.pone.0098469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901986	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400033
J	Nozawa, T; Sugiura, M; Yokoyama, R; Ihara, M; Kotozaki, Y; Miyauchi, CM; Kanno, A; Kawashima, R				Nozawa, Takayuki; Sugiura, Motoaki; Yokoyama, Ryoichi; Ihara, Mizuki; Kotozaki, Yuka; Miyauchi, Carlos Makoto; Kanno, Akitake; Kawashima, Ryuta			Ongoing Activity in Temporally Coherent Networks Predicts Intra-Subject Fluctuation of Response Time to Sporadic Executive Control Demands	PLOS ONE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; EVENT-RELATED FMRI; TOP-DOWN CONTROL; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE; DEFAULT-MODE; INDEPENDENT COMPONENTS; NEURAL PREDICTORS; VISUAL-CORTEX	Can ongoing fMRI BOLD signals predict fluctuations in swiftness of a person's response to sporadic cognitive demands? This is an important issue because it clarifies whether intrinsic brain dynamics, for which spatio-temporal patterns are expressed as temporally coherent networks (TCNs), have effects not only on sensory or motor processes, but also on cognitive processes. Predictivity has been affirmed, although to a limited extent. Expecting a predictive effect on executive performance for a wider range of TCNs constituting the cingulo-opercular, fronto-parietal, and default mode networks, we conducted an fMRI study using a version of the color-word Stroop task that was specifically designed to put a higher load on executive control, with the aim of making its fluctuations more detectable. We explored the relationships between the fluctuations in ongoing pre-trial activity in TCNs and the task response time (RT). The results revealed the existence of TCNs in which fluctuations in activity several seconds before the onset of the trial predicted RT fluctuations for the subsequent trial. These TCNs were distributed in the cingulo-opercular and fronto-parietal networks, as well as in perceptual and motor networks. Our results suggest that intrinsic brain dynamics in these networks constitute "cognitive readiness,'' which plays an active role especially in situations where information for anticipatory attention control is unavailable. Fluctuations in these networks lead to fluctuations in executive control performance.	[Nozawa, Takayuki; Ihara, Mizuki; Kotozaki, Yuka; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Yokoyama, Ryoichi; Miyauchi, Carlos Makoto; Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokoyama, Ryoichi] Japan Soc Promot Sci, Tokyo, Japan	Tohoku University; Tohoku University; Japan Society for the Promotion of Science	Nozawa, T (corresponding author), Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	nozawa@idac.tohoku.ac.jp	Kotozaki, Yuka/ABA-2267-2020; Nozawa, Takayuki/Y-9610-2019; Kotozaki, Yuka/ABA-2922-2020	Nozawa, Takayuki/0000-0001-6300-4373; Kotozaki, Yuka/0000-0002-4659-1200	System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST); MEXT/JSPS [23700137, 26330171]	System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by System Development Program for Advanced Measurement and Analysis, Japan Science and Technology Agency (JST; http://www.jst.go.jp/), and also by MEXT/JSPS (http://www.jsps.go.jp/) KAKENHI Grant Number 23700137 and 26330171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cheyne JA, 2011, COGNITION, V121, P437, DOI 10.1016/j.cognition.2011.07.010; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Hasson U, 2009, P NATL ACAD SCI USA, V106, P10841, DOI 10.1073/pnas.0903253106; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Hesselmann G, 2008, J NEUROSCI, V28, P14481, DOI 10.1523/JNEUROSCI.4398-08.2008; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; R Core Team, 2022, R LANG ENV STAT COMP; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	80	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99166	10.1371/journal.pone.0099166	http://dx.doi.org/10.1371/journal.pone.0099166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901995	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400103
J	Tang, YL; Cao, Y; Qiu, JB; Gao, Z; Ou, ZH; Wang, YJ; Zheng, YZ				Tang, Yulin; Cao, Yan; Qiu, Jianbin; Gao, Zhan; Ou, Zhonghua; Wang, Yajing; Zheng, Yizhi			Expression of a Vacuole-Localized BURP-Domain Protein from Soybean (SALI3-2) Enhances Tolerance to Cadmium and Copper Stresses	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; ARABIDOPSIS-THALIANA; DIFFERENTIAL EXPRESSION; TRANSPORTING ATPASES; CONTAINING GENES; HIGHER-PLANTS; IDENTIFICATION; METALLOTHIONEINS; PHYTOCHELATINS; FRUIT	The plant-specific BURP family proteins play diverse roles in plant development and stress responses, but the function mechanism of these proteins is still poorly understood. Proteins in this family are characterized by a highly conserved BURP domain with four conserved Cys-His repeats and two other Cys, indicating that these proteins potentially interacts with metal ions. In this paper, an immobilized metal affinity chromatography (IMAC) assay showed that the soybean BURP protein SALI3-2 could bind soft transition metal ions (Cd2+, Co2+, Ni2+, Zn2+ and Cu2+) but not hard metal ions (Ca2+ and Mg2+) in vitro. A subcellular localization analysis by confocal laser scanning microscopy revealed that the SALI3-2-GFP fusion protein was localized to the vacuoles. Physiological indexes assay showed that Sali3-2-transgenic Arabidopsis thaliana seedlings were more tolerant to Cu2+ or Cd2+ stresses than the wild type. An inductively coupled plasma optical emission spectrometry (ICP-OES) analysis illustrated that, compared to the wild type seedlings the Sali3-2-transgenic seedlings accumulated more cadmium or copper in the roots but less in the upper ground tissues when the seedlings were exposed to excessive CuCl2 or CdCl2 stress. Therefore, our findings suggest that the SALI3-2 protein may confer cadmium (Cd2+) and copper (Cu2+) tolerance to plants by helping plants to sequester Cd2+ or Cu2+ in the root and reduce the amount of heavy metals transported to the shoots.	[Tang, Yulin; Gao, Zhan; Ou, Zhonghua; Wang, Yajing; Zheng, Yizhi] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial & Gene Engn, Shenzhen, Guangdong, Peoples R China; [Cao, Yan; Qiu, Jianbin] Shenzhen Univ, Coll Life Sci, Key Lab Marine Bioresource & Ecoenvironm Sci, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Shenzhen University	Tang, YL (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial & Gene Engn, Shenzhen, Guangdong, Peoples R China.	yltang@szu.edu.cn; yzzheng@szu.edu.cn	Tang, Yulin/F-7201-2012		National Natural Science Foundation of China [30770184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30770184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Batchelor AK, 2002, PLANTA, V215, P523, DOI 10.1007/s00425-002-0798-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Ding XP, 2009, PLANTA, V230, P149, DOI 10.1007/s00425-009-0929-z; Fernandez L, 2007, PLANT MOL BIOL, V63, P307, DOI 10.1007/s11103-006-9090-2; Gan DF, 2011, MOL BIOL REP, V38, P4553, DOI 10.1007/s11033-010-0587-z; Granger C, 2002, GENOME, V45, P693, DOI [10.1139/g02-032, 10.1139/G02-032]; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hattori J, 1998, MOL GEN GENET, V259, P424, DOI 10.1007/s004380050832; Huang J, 2012, PLANT PHYSIOL, V158, P1779, DOI 10.1104/pp.111.192872; Liu H., 2013, PLANT CELL ENV; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Malik MR, 2008, J EXP BOT, V59, P2857, DOI 10.1093/jxb/ern149; Memon AR, 2009, ENVIRON SCI POLLUT R, V16, P162, DOI 10.1007/s11356-008-0079-z; Mendoza-Cozatl DG, 2011, CURR OPIN PLANT BIOL, V14, P554, DOI 10.1016/j.pbi.2011.07.004; Murphy A, 1997, PLANT PHYSIOL, V113, P1293, DOI 10.1104/pp.113.4.1293; Narukawa T, 2014, ANAL SCI, V30, P245, DOI 10.2116/analsci.30.245; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Romero-Isart N, 2002, J INORG BIOCHEM, V88, P388, DOI 10.1016/S0162-0134(01)00347-6; Shao YH, 2011, J INTEGR PLANT BIOL, V53, P743, DOI 10.1111/j.1744-7909.2011.01068.x; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Tang YL, 2013, CHEM J CHINESE U, V34, P128, DOI 10.7503/cjcu20120184; Teerawanichpan P, 2009, PLANT MOL BIOL, V71, P331, DOI 10.1007/s11103-009-9541-7; Van Son L, 2009, PLANT MOL BIOL, V71, P319, DOI 10.1007/s11103-009-9526-6; Wang AM, 2003, P NATL ACAD SCI USA, V100, P14487, DOI 10.1073/pnas.2231254100; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; Wang JA, 2010, PLANT CELL, V22, P4009, DOI 10.1105/tpc.110.080697; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu HL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-197; Yu W, 1996, MOL CELL BIOL, V16, P2464; Yue YS, 2012, J EXP BOT, V63, P3741, DOI 10.1093/jxb/ers069; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2; ZHENG LS, 1994, PLANT PHYSIOL, V105, P1189, DOI 10.1104/pp.105.4.1189; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875; 唐玉林, 2009, [自然科学进展, Progress in Natural Science], V19, P241	42	15	18	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98830	10.1371/journal.pone.0098830	http://dx.doi.org/10.1371/journal.pone.0098830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901737	Green Submitted, gold, Green Published			2022-12-25	WOS:000336841400059
J	Wang, H; Zhang, HD; Zou, Y; Mi, YL; Lin, SJ; Xie, ZX; Yan, YJ; Zhang, HJ				Wang, Hua; Zhang, Huaidong; Zou, Yi; Mi, Yanling; Lin, Shuangjun; Xie, Zhixiong; Yan, Yunjun; Zhang, Houjin			Structural Insight into the Tetramerization of an Iterative Ketoreductase SiaM through Aromatic Residues in the Interfaces	PLOS ONE			English	Article							CARRIER PROTEIN REDUCTASE; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; STACKING INTERACTIONS; POLYKETIDE; STEREOCHEMISTRY; CATALYSIS; DOMAINS; BIOSYNTHESIS; SCATTERING	In the biosynthesis of polyketides, ketoreductases (KRs) are an important group of enzymes that determine the chiralities of the carbon backbones. SiaM is a special member of this group that can recognize substrates with different lengths and can be used iteratively. Here we report the crystal structure of SiaM. Structural analysis indicates that the overall structure resembles those of other KRs. However, significant disparity can be found in the conserved LDD motif that is replaced with IRD motif in SiaM. The isoleucine and aspartic acid residues take similar orientations as leucine and aspartic acid in the conserved LDD motif, while the arginine residue points out towards the solvent. PISA analysis shows that SiaM forms a tetramer. Several aromatic residues are found in the interfaces, which have aromatic stacking interactions with the aromatic residues in the neighboring protomers. Mutagenesis studies performed on the aromatic residues show that these sites are important for maintaining the structural integrity of SiaM. However, the aromatic residues contribute differently to the enzymatic activity. In the N-terminal interface, the aromatic residues can be replaced with leucine without affecting the enzymatic activity while, in the other interface, such mutations abolish the enzymatic activity.	[Wang, Hua; Zhang, Huaidong; Mi, Yanling; Yan, Yunjun; Zhang, Houjin] Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China; [Wang, Hua; Zhang, Huaidong; Mi, Yanling; Yan, Yunjun; Zhang, Houjin] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biotechnol, Wuhan 430074, Hubei, Peoples R China; [Zou, Yi; Lin, Shuangjun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xie, Zhixiong] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Wuhan University	Zhang, HJ (corresponding author), Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hjzhang@hust.edu.cn		Zhang, Huaidong/0000-0001-6572-4737; Zou, Yi/0000-0002-1742-9650	National Key Basic Research Program of China [2013CB933900]; National Natural Science Foundation of China [31000326, 31070057]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National Key Basic Research Program of China (No. 2013CB933900) and National Natural Science Foundation of China (No. 31000326 & No. 31070057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand S, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-10; Baerga-Ortiz A, 2006, CHEM BIOL, V13, P277, DOI 10.1016/j.chembiol.2006.01.004; Bobeck MJ, 2007, BIOCHEMISTRY-US, V46, P6753, DOI 10.1021/bi700212s; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Caffrey P, 2005, CHEM BIOL, V12, P1060, DOI 10.1016/j.chembiol.2005.10.002; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dutta D, 2012, PROTEINS, V80, P1250, DOI 10.1002/prot.24024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza-Fonseca LM, 2005, BIOCHEM BIOPH RES CO, V328, P922, DOI 10.1016/j.bbrc.2005.01.043; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; Gullo VP, 2006, J IND MICROBIOL BIOT, V33, P523, DOI 10.1007/s10295-006-0107-2; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Javidpour P, 2011, BIOCHEMISTRY-US, V50, P4638, DOI 10.1021/bi200335f; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korman TP, 2004, BIOCHEMISTRY-US, V43, P14529, DOI 10.1021/bi048133a; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwan DH, 2011, MOLECULES, V16, P6092, DOI 10.3390/molecules16076092; Li RH, 2002, BIOCHEMISTRY-US, V41, P2246, DOI 10.1021/bi0116947; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; MOROKUMA K, 1977, ACCOUNTS CHEM RES, V10, P294, DOI 10.1021/ar50116a004; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Ostergaard LH, 2002, BIOCHEMISTRY-US, V41, P2719, DOI 10.1021/bi0117605; PERUTZ MF, 1993, PHILOS T R SOC A, V345, P105, DOI 10.1098/rsta.1993.0122; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Rutledge LR, 2007, CHEM PHYS LETT, V444, P167, DOI 10.1016/j.cplett.2007.06.090; Schrodinger L., 2020, PYMOL; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Sutch BT, 2009, J CHEM INF MODEL, V49, P2139, DOI 10.1021/ci900154a; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tellez-Valencia A, 2004, J MOL BIOL, V341, P1355, DOI 10.1016/j.jmb.2004.06.056; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yin YF, 2001, BIOORG MED CHEM LETT, V11, P1477, DOI 10.1016/S0960-894X(00)00529-1; You YO, 2013, J AM CHEM SOC, V135, P7406, DOI 10.1021/ja4014776; Zaccai NR, 2008, PROTEINS, V70, P562, DOI 10.1002/prot.21624; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zheng JT, 2010, STRUCTURE, V18, P913, DOI 10.1016/j.str.2010.04.015; Zou Y, 2013, CHEMBIOCHEM, V14, P679, DOI 10.1002/cbic.201300068	54	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97996	10.1371/journal.pone.0097996	http://dx.doi.org/10.1371/journal.pone.0097996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901639	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400016
J	Babu, VMP; Sutton, MD				Babu, Vignesh M. P.; Sutton, Mark D.			A dnaN Plasmid Shuffle Strain for Rapid In Vivo Analysis of Mutant Escherichia coli beta Clamps Provides Insight Into the Role of Clamp in umuDC-Mediated Cold Sensitivity	PLOS ONE			English	Article							POLYMERASE-III HOLOENZYME; AMINO-ACID-RESIDUES; SLIDING-CLAMP; PROCESSIVITY CLAMP; SOS MUTAGENESIS; RECA PROTEIN; LEXA PROTEIN; POL IV; REPLICATION; REPAIR	The E. coli umuDC gene products participate in two temporally distinct roles: UmuD(2)C acts in a DNA damage checkpoint control, while UmuD'C-2, also known as DNA polymerase V (Pol V), catalyzes replication past DNA lesions via a process termed translesion DNA synthesis. These different roles of the umuDC gene products are managed in part by the dnaN-encoded beta sliding clamp protein. Co-overexpression of the beta clamp and Pol V severely blocked E. coli growth at 30 degrees C. We previously used a genetic assay that was independent of the ability of beta clamp to support E. coli viability to isolate 8 mutant clamp proteins (beta(Q61K), beta(S107L), beta(D150N), beta(G157S), beta(V170M), beta(E202K), beta(M204K) and beta(P363S)) that failed to block growth at 30 degrees C when co-overexpressed with Pol V. It was unknown whether these mutant clamps were capable of supporting E. coli viability and normal umuDC functions in vivo. The goals of this study were to answer these questions. To this end, we developed a novel dnaN plasmid shuffle assay. Using this assay, beta(D150N) and beta(P363S) were unable to support E. coli viability. The remaining 6 mutant clamps, each of which supported viability, were indistinguishable from beta(+) with respect to umuDC functions in vivo. In light of these findings, we analyzed phenotypes of strains overexpressing either beta clamp or Pol V alone. The strain overexpressing beta(+), but not those expressing mutant beta clamps, displayed slowed growth irrespective of the incubation temperature. Moreover, growth of the Pol V-expressing strain was modestly slowed at 30 degrees, but not 42 degrees C. Taken together, these results suggest the mutant clamps were identified due to their inability to slow growth rather than an inability to interact with Pol V. They further suggest that cold sensitivity is due, at least in part, to the combination of their individual effects on growth at 30 degrees C.	[Babu, Vignesh M. P.; Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Babu, Vignesh M. P.; Sutton, Mark D.] SUNY Buffalo, Sch Med & Biomed Sci, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA; [Sutton, Mark D.] SUNY Buffalo, Sch Med & Biomed Sci, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sutton, MD (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	mdsutton@buffalo.edu	Babu, Vignesh/X-1443-2019	Babu, Vignesh/0000-0003-2603-7605	United States National Institutes of Health, National Institute of General Medical Sciences [GM066094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066094, R01GM066094] Funding Source: NIH RePORTER	United States National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health, National Institute of General Medical Sciences grant GM066094 (http://www.nigms.nih.gov/) awarded to MDS. The sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuning PJ, 2009, J BACTERIOL, V191, P5910, DOI 10.1128/JB.00292-09; Beuning PJ, 2006, MOL MICROBIOL, V59, P460, DOI 10.1111/j.1365-2958.2005.04959.x; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Courcelle J, 2001, GENETICS, V158, P41; COYLE MB, 1970, CANCER RES, V30, P2314; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, ENVIRON MOL MUTAGEN, V38, P105, DOI 10.1002/em.1059; Furukohri A, 2008, J BIOL CHEM, V283, P11260, DOI 10.1074/jbc.M709689200; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Grigorian AV, 2003, J BACTERIOL, V185, P630, DOI 10.1128/JB.185.2.630-644.2003; Heltzel JMH, 2012, J BACTERIOL, V194, P3589, DOI 10.1128/JB.00520-12; Heltzel JMH, 2009, P NATL ACAD SCI USA, V106, P12664, DOI 10.1073/pnas.0903460106; Heltzel JMH, 2009, J MOL BIOL, V387, P74, DOI 10.1016/j.jmb.2009.01.050; HO C, 1993, J BACTERIOL, V175, P5411, DOI 10.1128/JB.175.17.5411-5419.1993; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; MARSH L, 1991, MUTAT RES, V250, P183, DOI 10.1016/0027-5107(91)90175-N; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; Miller JH, 1999, SHORT COURSE BACTERI; Neuwald AF, 2003, NUCLEIC ACIDS RES, V31, P4503, DOI 10.1093/nar/gkg486; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; OHMORI H, 1984, GENE, V28, P159, DOI 10.1016/0378-1119(84)90253-1; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Opperman T, 1996, J BACTERIOL, V178, P4400, DOI 10.1128/jb.178.15.4400-4411.1996; PEREZROGER I, 1991, BIOCHIMIE, V73, P329, DOI 10.1016/0300-9084(91)90220-U; PHIZICKY EM, 1981, CELL, V25, P259, DOI 10.1016/0092-8674(81)90251-8; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Reuven NB, 1998, MOL CELL, V2, P191, DOI 10.1016/S1097-2765(00)80129-X; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; SHINAGAWA H, 1988, P NATL ACAD SCI USA, V85, P1806, DOI 10.1073/pnas.85.6.1806; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Sutton MD, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-102; Sutton MD, 2010, BBA-PROTEINS PROTEOM, V1804, P1167, DOI 10.1016/j.bbapap.2009.06.010; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Sutton MD, 2005, MOL MICROBIOL, V55, P1751, DOI 10.1111/j.1365-2958.2005.04500.x; Sutton MD, 2006, DNA REPAIR, V5, P312, DOI 10.1016/j.dnarep.2005.10.011; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; SUTTON MD, 1995, J BACTERIOL, V177, P6657, DOI 10.1128/jb.177.22.6657-6665.1995; Sutton MD, 2001, J BACTERIOL, V183, P2897, DOI 10.1128/JB.183.9.2897-2909.2001; Sutton MD, 2001, J BACTERIOL, V183, P1215, DOI 10.1128/JB.183.4.1215-1224.2001; Sutton MD, 2001, J BACTERIOL, V183, P1085, DOI 10.1128/JB.183.3.1085-1089.2001; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Villarroya M, 1998, EMBO J, V17, P1829, DOI 10.1093/emboj/17.6.1829; Wagner J, 2009, MOL MICROBIOL, V74, P1143, DOI 10.1111/j.1365-2958.2009.06920.x; WALKER GC, 1979, MOL GEN GENET, V172, P17, DOI 10.1007/BF00276210; WARNER HR, 1969, J VIROL, V3, P331, DOI 10.1128/JVI.3.3.331-336.1969	66	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98791	10.1371/journal.pone.0098791	http://dx.doi.org/10.1371/journal.pone.0098791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896652	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700079
J	Carl, C; de Nys, R; Paul, NA				Carl, Christina; de Nys, Rocky; Paul, Nicholas A.			The Seeding and Cultivation of a Tropical Species of Filamentous Ulva for Algal Biomass Production	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; MASS CULTIVATION; NITROGEN UPTAKE; WATER MOTION; FRESH-WATER; ENTEROMORPHA; CHLOROPHYTA; SALINITY; MARINE; RHODOPHYTA	Filamentous species of Ulva are ideal for cultivation because they are robust with high growth rates and maintained across a broad range of environments. Temperate species of filamentous Ulva are commercially cultivated on nets which can be artificially 'seeded' under controlled conditions allowing for a high level of control over seeding density and consequently biomass production. This study quantified for the first time the seeding and culture cycle of a tropical species of filamentous Ulva (Ulva sp. 3) and identified seeding density and nursery period as key factors affecting growth and biomass yield. A seeding density of 621,000 swarmers m(-1) rope in combination with a nursery period of five days resulted in the highest growth rate and correspondingly the highest biomass yield. A nursery period of five days was optimal with up to six times the biomass yield compared to ropes under either shorter or longer nursery periods. These combined parameters of seeding density and nursery period resulted in a specific growth rate of more than 65% day(-1) between 7 and 10 days of outdoor cultivation post-nursery. This was followed by a decrease in growth through to 25 days. This study also demonstrated that the timing of harvest is critical as the maximum biomass yield of 23.0 +/- 8.8 g dry weight m(-1) (228.7 +/- 115.4 g fresh weight m(-1)) was achieved after 13 days of outdoor cultivation whereas biomass degraded to 15.5 +/- 7.3 g dry weight m(-1) (120.2 +/- 71.8 g fresh weight m(-1)) over a longer outdoor cultivation period of 25 days. Artificially seeded ropes of Ulva with high biomass yields over short culture cycles may therefore be an alternative to unattached cultivation in integrated pond-based aquaculture systems.	[Carl, Christina; de Nys, Rocky; Paul, Nicholas A.] James Cook Univ, Sch Marine & Trop Biol, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia	James Cook University	Carl, C (corresponding author), James Cook Univ, Sch Marine & Trop Biol, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	tine.carl@jcu.edu.au	Praeger, Christina/A-7224-2013; de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	Praeger, Christina/0000-0002-1947-122X; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC) through Australian Government's Cooperative Research Centre	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC) through Australian Government's Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alveal K, 1997, AQUACULTURE, V148, P77, DOI 10.1016/S0044-8486(96)01415-9; Angell AR, 2014, J PHYCOL, V50, P216, DOI 10.1111/jpy.12154; Bolton JJ, 2009, J APPL PHYCOL, V21, P575, DOI 10.1007/s10811-008-9385-6; Bruhn A, 2011, BIORESOURCE TECHNOL, V102, P2595, DOI 10.1016/j.biortech.2010.10.010; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; Carl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097396; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Conitz JM, 2013, BOT MAR, V56, P525, DOI 10.1515/bot-2013-0067; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; Demetropoulos CL, 2004, AQUACULTURE, V235, P471, DOI 10.1016/j.aquaculture.2003.09.012; Cruz-Suarez LE, 2010, AQUACULTURE, V301, P64, DOI 10.1016/j.aquaculture.2010.01.021; Finlay JA, 2002, BIOFOULING, V18, P251, DOI 10.1080/08927010290029010; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gamboa-Delgado J, 2011, J SHELLFISH RES, V30, P969, DOI 10.2983/035.030.0340; Handa A, 2013, AQUACULTURE, V414, P191, DOI 10.1016/j.aquaculture.2013.08.006; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2004.tb00311.x; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Hwang EK, 2006, J APPL PHYCOL, V18, P251, DOI 10.1007/s10811-006-9021-2; Ichihara K, 2013, PHYCOL RES, V61, P52, DOI 10.1111/j.1440-1835.2012.00668.x; Kawashima Y, 2013, FISHERIES SCI, V79, P521, DOI 10.1007/s12562-013-0610-0; Kim JK, 2007, J APPL PHYCOL, V19, P431, DOI 10.1007/s10811-006-9150-7; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Kregting LT, 2008, J PHYCOL, V44, P320, DOI 10.1111/j.1529-8817.2008.00484.x; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Luning K, 2003, J APPL PHYCOL, V15, P115, DOI 10.1023/A:1023807503255; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; MAIRH OP, 1986, INDIAN J MAR SCI, V15, P212; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; MOLL B, 1995, BIORESOURCE TECHNOL, V52, P255, DOI 10.1016/0960-8524(95)00036-E; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Neveux N, 2014, BIORESOURCE TECHNOL, V155, P334, DOI 10.1016/j.biortech.2013.12.083; Ohno M, 1981, REP USA MAR BIOL I, V3, P51; Ohno M, 2006, ADV SEAWEED CULTIVAT, P1; Pandey RS, 1985, REP US MAR BIOL I, V7, P21; Pang SJ, 2009, J APPL PHYCOL, V21, P413, DOI 10.1007/s10811-008-9386-5; Paul NA, 2008, AQUACULTURE, V281, P49, DOI 10.1016/j.aquaculture.2008.05.024; Paul NA, 2012, AQUACULTURE: FARMING AQUATIC ANIMALS AND PLANTS, 2ND EDITION, P268; Peteiro C, 2013, J APPL PHYCOL, V25, P205, DOI 10.1007/s10811-012-9854-9; Peteiro C, 2012, J APPL PHYCOL, V24, P1361, DOI 10.1007/s10811-012-9788-2; Sanderson JC, 2012, AQUACULTURE, V354, P128, DOI 10.1016/j.aquaculture.2012.03.019; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Steen H, 2003, BOT MAR, V46, P36, DOI 10.1515/BOT.2003.006; van der Wal H, 2013, BIORESOURCE TECHNOL, V128, P431, DOI 10.1016/j.biortech.2012.10.094; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018; Zhang C, 2012, FOOD SCI BIOTECHNOL, V21, P625, DOI 10.1007/s10068-012-0081-6; Zhang QS, 2012, J APPL PHYCOL, V24, P707, DOI 10.1007/s10811-011-9689-9	51	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98700	10.1371/journal.pone.0098700	http://dx.doi.org/10.1371/journal.pone.0098700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897115	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700067
J	Suthar, N; Roy, S; Call, DR; Besser, TE; Davis, MA				Suthar, Neeraj; Roy, Sandip; Call, Douglas R.; Besser, Thomas E.; Davis, Margaret A.			An Individual-Based Model of Transmission of Resistant Bacteria in a Veterinary Teaching Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; NONINHERITED ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL DRUG-USE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; RISK-FACTORS; NOSOCOMIAL INFECTIONS; PET ANIMALS; DOGS; IMPACT	Veterinary nosocomial infections caused by antibiotic resistant bacteria cause increased morbidity, higher cost and length of treatment and increased zoonotic risk because of the difficulty in treating them. In this study, an individual-based model was developed to investigate the effects of movements of canine patients among ten areas (transmission points) within a veterinary teaching hospital, and the effects of these movements on transmission of antibiotic susceptible and resistant pathogens. The model simulates contamination of transmission points, healthcare workers, and patients as well as the effects of decontamination of transmission points, disinfection of healthcare workers, and antibiotic treatments of canine patients. The model was parameterized using data obtained from hospital records, information obtained by interviews with hospital staff, and the published literature. The model suggested that transmission resulting from contact with healthcare workers was common, and that certain transmission points (housing wards, diagnostics room, and the intensive care unit) presented higher risk for transmission than others (lobby and surgery). Sensitivity analyses using a range of parameter values demonstrated that the risk of acquisition of colonization by resistant pathogens decreased with shorter patient hospital stays (P<0.0001), more frequent decontamination of transmission points and disinfection of healthcare workers (P<0.0001) and better compliance of healthcare workers with hygiene practices (P<0.0001). More frequent decontamination of heavily trafficked transmission points was especially effective at reducing transmission of the model pathogen.	[Suthar, Neeraj; Roy, Sandip; Call, Douglas R.; Besser, Thomas E.; Davis, Margaret A.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Roy, Sandip] Washington State Univ, Coll Vet Med, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Call, Douglas R.; Besser, Thomas E.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Davis, Margaret A.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University; Washington State University	Davis, MA (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	madavis@vetmed.wsu.edu			Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington	Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington	This work was entirely supported by the Paul G. Allen School for Global Animal Health, Washington State University, Pullman Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S., 2014, J ANTIMICROB CHEMOTH; Ahmed MO, 2012, MICROB DRUG RESIST, V18, P161, DOI 10.1089/mdr.2011.0213; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Banu A, 2012, J CLIN DIAGN RES, V6, P1381, DOI 10.7860/JCDR/2012/4286.2364; Boerlin Patrick, 2004, Animal Health Research Reviews, V5, P95, DOI 10.1079/AHR200465; Bootsma MCJ, 2012, B MATH BIOL, V74, P1691, DOI 10.1007/s11538-012-9731-3; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; D'Agata EMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030170; Frieden DT, 2013, ANTIBIOTIC RESISTANC; Gastmeier P, 2006, J HOSP INFECT, V62, P181, DOI 10.1016/j.jhin.2005.08.010; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Ghosh A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00062; Gibson JS, 2011, EPIDEMIOL INFECT, V139, P1511, DOI 10.1017/S0950268810002785; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Guardabassi L, 2004, J ANTIMICROB CHEMOTH, V54, P321, DOI 10.1093/jac/dkh332; Hamilton E, 2013, JAVMA-J AM VET MED A, V243, P990, DOI 10.2460/javma.243.7.990; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Heuer OE, 2005, EMERG INFECT DIS, V11, P344; Howard DH, 2003, CLIN INFECT DIS, V36, pS4, DOI 10.1086/344656; Johnson JA, 2002, VET CLIN N AM-SMALL, V32, P1101, DOI 10.1016/S0195-5616(02)00038-4; Kouyos R., 2011, PLOS PATHOGENS, V7; KuKanich KS, 2012, JAVMA-J AM VET MED A, V240, P437, DOI 10.2460/javma.240.4.437; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lloyd DH, 2007, CLIN INFECT DIS, V45, pS148, DOI 10.1086/519254; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Murphy C, 2009, CAN VET J, V50, P1047; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Ogeer-Gyles J, 2006, JAVMA-J AM VET MED A, V229, P694, DOI 10.2460/javma.229.5.694; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Orsini JA, 2005, CAN J VET RES, V69, P278; Prescott JF, 2002, CAN VET J, V43, P107; Raboud J, 2005, INFECT CONT HOSP EP, V26, P607, DOI 10.1086/502589; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stolle I, 2013, J ANTIMICROB CHEMOTH, V68, P2802, DOI 10.1093/jac/dkt259; van den Bogaard AE, 1999, LANCET, V354, P163, DOI 10.1016/S0140-6736(05)75297-1; Vatopoulos AC, 1996, J HOSP INFECT, V34, P11, DOI 10.1016/S0195-6701(96)90121-8; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Webb GF, 2009, J BIOL DYNAM, V48, P271	44	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98589	10.1371/journal.pone.0098589	http://dx.doi.org/10.1371/journal.pone.0098589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893006	gold, Green Submitted, Green Published			2022-12-25	WOS:000336911400072
J	Robichaux, JP; Hallett, RM; Fuseler, JW; Hassell, JA; Ramsdell, AF				Robichaux, J. P.; Hallett, R. M.; Fuseler, J. W.; Hassell, J. A.; Ramsdell, A. F.			Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice	ONCOGENE			English	Article							MESSENGER-RNA EXPRESSION; BREAST-CANCER PATIENTS; NEOADJUVANT CHEMOTHERAPY; CANDIDATE BIOMARKERS; KINASE-1 PLK1; RESISTANCE; CELLS; STATHMIN; SURVIVIN; FOXM1	Significant left-right (L-R) differences in tumor incidence and disease outcome occur for cancers of paired organs, including the breasts; however, the basis for this laterality is unknown. Here, we show that despite their morphologic symmetry, left versus right mammary glands in wild-type mice have baseline differences in gene expression that are L-R independently regulated during pubertal development, including genes that regulate luminal progenitor cell renewal, luminal cell differentiation, mammary tumorigenesis, tamoxifen sensitivity and chemotherapeutic resistance. In MMTV-cNeu(Tg/Tg) mice, which model HER2/Neu-amplified breast cancer, baseline L-R differences in mammary gene expression are amplified, sustained or inverted in a gene-specific manner and the mammary ductal epithelium undergoes L-R asymmetric growth and patterning. Comparative genomic analysis of mouse L-R mammary gene expression profiles with gene expression profiles of human breast tumors revealed significant linkage between right-sided gene expression and decreased breast cancer patient survival. Collectively, these findings are the first to demonstrate that mammary glands are lateralized organs, and, moreover, that mammary glands have L-R differential susceptibility to HER2/Neu oncogene-mediated effects on ductal epithelial growth and differentiation. We propose that intrinsic molecular laterality may have a role in L-R asymmetric breast tumor incidence and, furthermore, that interplay between the L-R molecular landscape and oncogene activity may contribute to the differential disease progression and patient outcome that are associated with tumor situs.	[Robichaux, J. P.; Ramsdell, A. F.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Robichaux, J. P.; Ramsdell, A. F.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Hallett, R. M.; Hassell, J. A.] McMaster Univ, Ctr Funct Genom, Dept Biochem Biomed Sci, Hamilton, ON, Canada; [Fuseler, J. W.; Ramsdell, A. F.] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA; [Ramsdell, A. F.] Univ S Carolina, Coll Arts & Sci, Program Womens & Gender Studies, Columbia, SC 29208 USA	Medical University of South Carolina; Medical University of South Carolina; McMaster University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ramsdell, AF (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, 6439 Garners Ferry Rd,Bldg 1,RM C-36, Columbia, SC 29208 USA.	ramsdell@musc.edu		Ramsdell, Ann F/0000-0003-2469-7079; Robichaux, Jacqulyne/0000-0001-8812-7054	National Institutes of Health [K02HL086737, R21HD068993]; Cancer Center Support Grant [P30CA138313]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068993] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL086737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Scott Argraves, Dr Jeremey Barth and Mr Victor Fresco of the MUSC Proteogenomics Facility for performing the DNA microarray and Dr Caroline Alexander and Dr Elizabeth Yeh for helpful discussion. This work was supported by National Institutes of Health K02HL086737 (AFR), R21HD068993 (AFR) and conducted in facilities supported, in part, by Cancer Center Support Grant P30CA138313 to the Hollings Cancer Center, MUSC.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Baquero MT, 2012, CANCER-AM CANCER SOC, V118, P4660, DOI 10.1002/cncr.27453; Biro FM, 2013, J ADOLESCENT HEALTH, V52, pS15, DOI 10.1016/j.jadohealth.2012.09.019; Boudreau A, 2013, P NATL ACAD SCI USA, V110, pE3937, DOI 10.1073/pnas.1315022110; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brill B, 2008, LAB ANIM-UK, V42, P104, DOI 10.1258/la.2007.06003e; Cao XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056735; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Cheng Y, 2014, MOL CANCER THER, V13, P675, DOI 10.1158/1535-7163.MCT-13-0416; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Colas E, 2011, INT J CANCER, V129, P2435, DOI 10.1002/ijc.25901; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; de Wit M, 2014, J PROTEOMICS, V99, P26, DOI 10.1016/j.jprot.2014.01.001; DELAHUNT B, 1994, UROLOGY, V43, P300, DOI 10.1016/0090-4295(94)90070-1; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; El Hajj P, 2013, BRIT J CANCER, V108, P1641, DOI 10.1038/bjc.2013.115; Falkenius J, 2013, MELANOMA RES, V23, P452, DOI 10.1097/CMR.0000000000000027; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fatima N, 2013, ASIAN PAC J CANCER P, V14, P43, DOI 10.7314/APJCP.2013.14.1.43; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Fenton SE, 2012, ANNU REV PHARMACOL, V52, P455, DOI 10.1146/annurev-pharmtox-010611-134659; Flanagan JM, 2013, ANN ONCOL, V24, P2813, DOI 10.1093/annonc/mdt370; Fuseler JW, 2014, ANTICANCER RES, V34, P1171; Gakiopoulou H, 2007, BRIT J CANCER, V97, P1124, DOI 10.1038/sj.bjc.6603992; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Gheibi A, 2012, Adv Biomed Res, V1, P80, DOI 10.4103/2277-9175.102990; Golding JP, 2004, GENE EXPR PATTERNS, V5, P3, DOI 10.1016/j.modgep.2004.08.004; Golding JP, 2004, DEV DYNAM, V231, P795, DOI 10.1002/dvdy.20176; Hallett RM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-16; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Han ZX, 2013, CANCER BIOTHER RADIO, V28, P398, DOI 10.1089/cbr.2012.1323; HARTVEIT F, 1984, ONCOLOGY, V41, P149, DOI 10.1159/000225812; Hatzis C, JAMA, V305, P1873; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Hu KJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3107; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; Hwang JE, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-431; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Journe F, 2011, BRIT J CANCER, V105, P1726, DOI 10.1038/bjc.2011.451; Kaneko N, 2013, BIOL PHARM BULL, V36, P1921, DOI 10.1248/bpb.b13-00515; King SI, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3136; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Li A, 2013, ONCOL REP, V29, P535, DOI 10.3892/or.2012.2144; Li WJ, 2013, MOL BIOL REP, V40, P6143, DOI 10.1007/s11033-013-2725-x; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Liu WJ, 2012, MOL MED REP, V6, P607, DOI 10.3892/mmr.2012.966; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Maynadier M, 2012, MOL CELL ENDOCRINOL, V364, P126, DOI 10.1016/j.mce.2012.08.016; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Meng XL, 2012, GENET TEST MOL BIOMA, V16, P689, DOI 10.1089/gtmb.2011.0298; Miceli C, 2013, CANCER GENE THER, V20, P298, DOI 10.1038/cgt.2013.21; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Mobasheri A, 2014, J MAMMARY GLAND BIOL, V19, P91, DOI 10.1007/s10911-013-9312-6; Mohanan S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/895343; Mukherjee S, 2000, ONCOGENE, V19, P5982, DOI 10.1038/sj.onc.1203964; Pasini A, 2012, TRANSL ONCOL, V5, P461, DOI 10.1593/tlo.12256; Petrarca CR, 2011, CLIN BREAST CANCER, V11, P129, DOI 10.1016/j.clbc.2011.03.002; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Roychoudhuri R, 2006, CANCER CAUSE CONTROL, V17, P655, DOI 10.1007/s10552-005-0615-9; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Su D, 2009, CANCER-AM CANCER SOC, V115, P2453, DOI 10.1002/cncr.24282; Teh MT, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00146; Valladares-Ayerbes M, 2010, CANCER EPIDEM BIOMAR, V19, P1432, DOI 10.1158/1055-9965.EPI-10-0123; Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang QP, 2013, INT J BIOCHEM CELL B, V45, P2036, DOI 10.1016/j.biocel.2013.06.026; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wierer M, 2013, CELL REP, V3, P2021, DOI 10.1016/j.celrep.2013.05.024; Wilting J, 2011, CURR MED CHEM, V18, P5519, DOI 10.2174/092986711798347252; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Yoruk O, 2009, INT J NEUROSCI, V119, P815, DOI 10.1080/00207450802329639; Zhang EY, 2013, J PROTEOME RES, V12, P2805, DOI 10.1021/pr4001527; Zhang M, TARGET ONCOL; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao YC, 2014, MOL MED REP, V9, P614, DOI 10.3892/mmr.2013.1842; Zou J, 2013, CELL CYCLE, V12, P14; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	87	13	14	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					2003	2010		10.1038/onc.2014.149	http://dx.doi.org/10.1038/onc.2014.149			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24909172	Green Accepted			2022-12-25	WOS:000352725600014
J	Canver, MC; Bauer, DE; Dass, A; Yien, YY; Chung, J; Masuda, T; Maeda, T; Paw, BH; Orkin, SH				Canver, Matthew C.; Bauer, Daniel E.; Dass, Abhishek; Yien, Yvette Y.; Chung, Jacky; Masuda, Takeshi; Maeda, Takahiro; Paw, Barry H.; Orkin, Stuart H.			Characterization of Genomic Deletion Efficiency Mediated by Clustered Regularly Interspaced Palindromic Repeats (CRISPR)/Cas9 Nuclease System in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE ERYTHROLEUKEMIA-CELLS; CHROMOSOMAL DELETIONS; CRISPR-CAS9 SYSTEM; CAS9; SPECIFICITY; CRISPR/CAS; DNA; ENDONUCLEASE; MUTAGENESIS; INVERSIONS	The clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 nuclease system has provided a powerful tool for genome engineering. Double strand breaks may trigger nonhomologous end joining repair, leading to frameshift mutations, or homology-directed repair using an extrachromosomal template. Alternatively, genomic deletions may be produced by a pair of double strand breaks. The efficiency of CRISPR/Cas9-mediated genomic deletions has not been systematically explored. Here, we present a methodology for the production of deletions in mammalian cells, ranging from 1.3 kb to greater than 1 Mb. We observed a high frequency of intended genomic deletions. Nondeleted alleles are nonetheless often edited with inversions or small insertion/deletions produced at CRISPR recognition sites. Deleted alleles also typically include small insertion/deletions at predicted deletion junctions. We retrieved cells with biallelic deletion at a frequency exceeding that of probabilistic expectation. We demonstrate an inverse relationship between deletion frequency and deletion size. This work suggests that CRISPR/Cas9 is a robust system to produce a spectrum of genomic deletions to allow investigation of genes and genetic elements.	[Canver, Matthew C.; Bauer, Daniel E.; Yien, Yvette Y.; Chung, Jacky; Maeda, Takahiro; Paw, Barry H.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bauer, Daniel E.; Dass, Abhishek; Paw, Barry H.; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Paw, Barry H.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yien, Yvette Y.; Chung, Jacky; Masuda, Takeshi; Maeda, Takahiro; Paw, Barry H.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	Stuart_Orkin@dfci.harvard.edu	Maeda, Takahiro/AAC-4563-2019	Maeda, Takahiro/0000-0003-4530-6460; Paw, Barry/0000-0002-0492-1419; Canver, Matthew/0000-0002-8146-3992	National Institutes of Health [R01HL032259, P30DK049216]; NIDDK [K08DK093705]; NIAID [R01AI084905]; Canadian Institutes of Health Research fellowship;  [T32HL007574];  [F32DK098866];  [R01DK070838];  [P01HL032262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007574, R01HL032259, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, P30DK049216, K08DK093705, F32DK098866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL032259 and P30DK049216 (Center of Excellence in Molecular Hematology to S. H. O.), Grant K08DK093705 from NIDDK (to D. E. B.), Grant R01AI084905 from NIAID (to T. M.), Grants T32HL007574 and F32DK098866 (to Y. Y. Y.), and Grants R01DK070838 and P01HL032262 (to B. H. P.).; Supported by a Canadian Institutes of Health Research fellowship.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MAMAEVA SE, 1985, CANCER GENET CYTOGEN, V16, P199, DOI 10.1016/0165-4608(85)90046-9; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MILLER DA, 1979, CANCER GENET CYTOGEN, V1, P103, DOI 10.1016/0165-4608(79)90016-5; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	35	210	229	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21312	21324		10.1074/jbc.M114.564625	http://dx.doi.org/10.1074/jbc.M114.564625			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24907273	hybrid, Green Published			2022-12-25	WOS:000340558300012
J	Gumuscu, B; Erdogan, Z; Guler, MO; Tekinay, T				Gumuscu, Burcu; Erdogan, Zeynep; Guler, Mustafa O.; Tekinay, Turgay			Highly Sensitive Determination of 2,4,6-Trinitrotoluene and Related Byproducts Using a Diol Functionalized Column for High Performance Liquid Chromatography	PLOS ONE			English	Article							SELECTIVE SPECTROPHOTOMETRIC DETERMINATION; EPA METHOD 8330; COMPLETE SEPARATION; EXPLOSIVES; IDENTIFICATION; DEGRADATION; METABOLITES; VALIDATION; WATERS; ARRAY	In this work a new detection method for complete separation of 2,4,6-trinitrotoluene (TNT); 2,4-dinitrotoluene (2,4-DNT); 2,6-dinitrotoluene (2,6-DNT); 2-aminodinitrotoluene (2-ADNT) and 4-aminodinitrotoluene (4-ADNT) molecules in high-performance liquid-chromatography (HPLC) with UV sensor has been developed using dial column. This approach improves on cost, time, and sensitivity over the existing methods, providing a simple and effective alternative. Total analysis time was less than 13 minutes including column re-equilibration between runs, in which water and acetonitrile were used as gradient elution solvents. Under optimized conditions, the minimum resolution between 2,4-DNT and 2,6-DNT peaks was 2.06. The recovery rates for spiked environmental samples were between 95-98%. The detection limits for diol column ranged from 0.78 to 1.17 mu g/L for TNT and its byproducts. While the solvent consumption was 26.4 mL/min for two-phase EPA and 30 mL/min for EPA 8330 methods, it was only 8.8 mL/min for dial column. The resolution was improved up to 49% respect to two-phase EPA and EPA 8330 methods. When compared to C-18 and phenyl-3 columns, solvent usage was reduced up to 64% using diol column and resolution was enhanced approximately two-fold. The sensitivity of diol column was afforded by the hydroxyl groups on polyol layer, joining the formation of charge-transfer complexes with nitroaromatic compounds according to acceptor-donor interactions. Having compliance with current requirements, the proposed method demonstrates sensitive and robust separation.	[Gumuscu, Burcu; Erdogan, Zeynep; Guler, Mustafa O.; Tekinay, Turgay] Bilkent Univ, Inst Mat Sci & Nanotechnol, UNAM, Ankara, Turkey; [Gumuscu, Burcu] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tekinay, Turgay] Gazi Univ, Life Sci Applicat & Res Ctr, Ankara, Turkey; [Tekinay, Turgay] Gazi Univ, Fac Med, Dept Med Biol & Genet, Ankara, Turkey	Ihsan Dogramaci Bilkent University; University of Twente; Gazi University; Gazi University	Tekinay, T (corresponding author), Bilkent Univ, Inst Mat Sci & Nanotechnol, UNAM, Ankara, Turkey.	ttekinay@gazi.edu.tr	Guler, Mustafa/C-9453-2011; Gumuscu, Burcu/Q-6602-2018	Guler, Mustafa/0000-0003-1168-202X; Gumuscu, Burcu/0000-0003-4843-4724	Republic of Turkey, Ministry of Science Industry and Technology [STZ-00480-2009-2]	Republic of Turkey, Ministry of Science Industry and Technology(Ministry of Science, Industry & Technology - Turkey)	This work is supported by the Republic of Turkey, Ministry of Science Industry and Technology under the Project No. STZ-00480-2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FQ, 2009, J HAZARD MATER, V166, P757, DOI 10.1016/j.jhazmat.2008.11.116; Batlle R, 2002, J CHROMATOGR A, V963, P73, DOI 10.1016/S0021-9673(02)00136-X; Becanova J, 2010, INT J MASS SPECTROM, V291, P133, DOI 10.1016/j.ijms.2010.01.016; Borch T, 2004, J CHROMATOGR A, V1022, P83, DOI 10.1016/j.chroma.2003.09.067; Cenas N, 2001, BBA-GEN SUBJECTS, V1528, P31, DOI 10.1016/S0304-4165(01)00169-6; Craig HD, 2011, MAR TECHNOL SOC J, V45, P35, DOI 10.4031/MTSJ.45.6.10; DWIVEDY AK, 1967, J CHROMATOGR, V29, P120, DOI 10.1016/S0021-9673(00)92636-0; Environmental Protection Agency, 1989, HLTH ADV TNT CRIT ST; EPA, 2006, 8330 EPA; Esteve-Nunez A, 2001, MICROBIOL MOL BIOL R, V65, P335, DOI 10.1128/MMBR.65.3.335-352.2001; Gaurav, 2009, J HAZARD MATER, V172, P1652, DOI 10.1016/j.jhazmat.2009.08.039; Gumuscu B, 2013, INT BIODETER BIODEGR, V85, P35, DOI 10.1016/j.ibiod.2013.06.007; Holmgren E, 2012, J CHROM A, V1222, P109; ICH harmonised tripartite guidelines, 2005, ICH VAL AN PROC METH; Jiang Y, 2008, ANGEW CHEM, V120, P8663; Knackmuss HJ, 1996, BASIC KNOWLEDGE PERS, P1; Lang MJ, 1999, J CHROMATOGR A, V849, P381, DOI 10.1016/S0021-9673(99)00591-9; Lima Debora R. S., 2011, Reviews on Environmental Health, V26, P101, DOI 10.1515/REVEH.2011.014; Maeda T, 2006, J CHROMATOGR SCI, V44, P96, DOI 10.1093/chromsci/44.2.96; Monteil-Rivera F, 2004, J CHROMATOGR A, V1048, P213, DOI 10.1016/j.chroma.2004.07.054; Ozokwelu ED, 1997, KIRK OTHMER ENCY CHE; Preiss A, 2009, J CHROMATOGR A, V1216, P4968, DOI 10.1016/j.chroma.2009.04.055; Rahimi-Nasrabadi M, 2012, MICROCHIM ACTA, V177, P145, DOI 10.1007/s00604-012-0762-0; Schmidt AC, 2006, CHROMATOGRAPHIA, V63, P1, DOI 10.1365/s10337-005-0703-8; Shabir GA, 2003, J CHROMATOGR A, V987, P57, DOI 10.1016/S0021-9673(02)01536-4; Spain J.C., 2000, BIODEGRADATION NITRO; Sunahara GI, 2010, ECOTOXICOLOGY EXPLOS; Uzer A, 2004, ANAL CHIM ACTA, V505, P83, DOI 10.1016/S0003-2670(03)00674-3; Uzer AE, 2005, ANAL CHIM ACTA, V534, P307, DOI 10.1016/j.aca.2004.11.045; Vijayakumar C, 2010, CHEM COMMUN, V46, P874, DOI 10.1039/b921520d; Xu XM, 2014, SCI JUSTICE, V54, P3, DOI 10.1016/j.scijus.2013.08.003; YANG NC, 1964, J AM CHEM SOC, V86, P5022, DOI 10.1021/ja01076a070; Yildiz A, 1997, ENSTRUMENTAL ANALIZ	33	13	13	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99230	10.1371/journal.pone.0099230	http://dx.doi.org/10.1371/journal.pone.0099230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905826	Green Published, gold			2022-12-25	WOS:000341869000112
J	Sun, QR; Jia, N; Wang, WX; Jin, H; Xu, JH; Hu, HT				Sun, Qinru; Jia, Ning; Wang, Weixi; Jin, Hui; Xu, Jiehua; Hu, Haitao			Protective Effects of Astragaloside IV against Amyloid Beta1-42 Neurotoxicity by Inhibiting the Mitochondrial Permeability Transition Pore Opening	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CELL-DEATH; OVEREXPRESSION; DYSFUNCTION; PATHWAYS; CALCIUM; NEURONS; KINASE; INJURY	Mitochondrial dysfunction caused by amyloid beta-peptide (A beta) plays an important role in the pathogenesis of Alzheimer disease (AD). Substantial evidence has indicated that the mitochondrial permeability transition pore (mPTP) opening is involved in A beta-induced neuronal death and reactive oxygen species (ROS) generation. Astragaloside IV (AS-IV), one of the major active constituents of Astragalus membranaceus, has been reported as an effective anti-oxidant for treating neurodegenerative diseases. However, the molecular mechanisms still need to be clarified. In this study, we investigated whether AS-IV could prevent A beta 1-42-induced neurotoxicity in SK-N-SH cells via inhibiting the mPTP opening. The results showed that pretreatment of AS-IV significantly increased the viability of neuronal cells, reduced apoptosis, decreased the generation of intracellular reactive oxygen species (ROS) and decreased mitochondrial superoxide in the presence of A beta 1-42. In addition, pretreatment of AS-IV inhibited the mPTP opening, rescued mitochondrial membrane potential (Delta Psi m), enhanced ATP generation, improved the activity of cytochrome c oxidase and blocked cytochrome c release from mitochondria in A beta 1-42 rich milieu. Moreover, pretreatment of AS-IV reduced the expression of Bax and cleaved caspase-3 and increased the expression of Bcl-2 in an A beta 1-42 rich environment. These data indicate that AS-IV prevents A beta 1-42-induced SK-N-SH cell apoptosis via inhibiting the mPTP opening and ROS generation. These results provide novel insights of AS-IV for the prevention and treatment of neurodegenerative disorders such as AD.	[Sun, Qinru; Jia, Ning; Wang, Weixi; Jin, Hui; Xu, Jiehua; Hu, Haitao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Human Anat & Histoembryol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Jia, N (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Human Anat & Histoembryol, Xian, Shaanxi, Peoples R China.	jianing@mail.xjtu.edu.cn; huht1944@163.com	Sun, Qinru/H-7767-2014					Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bartley MG, 2012, J ALZHEIMERS DIS, V28, P855, DOI 10.3233/JAD-2011-111172; Brustovetsky T, 2010, BBA-BIOENERGETICS, V1797, P1795, DOI 10.1016/j.bbabio.2010.07.006; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chan WS, 2009, NEUROCHEM INT, V55, P414, DOI 10.1016/j.neuint.2009.04.012; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Cheng CY, 2006, J BIOMED MATER RES A, V76A, P463, DOI 10.1002/jbm.a.30249; Dartigues JF, 2009, LANCET NEUROL, V8, P1082, DOI 10.1016/S1474-4422(09)70298-4; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Du H, 2010, BBA-MOL BASIS DIS, V1802, P198, DOI 10.1016/j.bbadis.2009.07.005; Ebenezer PJ, 2010, J ALZHEIMERS DIS, V22, P839, DOI 10.3233/JAD-2010-101161; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fernandez-Morales JC, 2012, ACS CHEM NEUROSCI, V3, P873, DOI 10.1021/cn3001069; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Horiuchi M, 2012, NEUROBIOL AGING, V33, P499, DOI 10.1016/j.neurobiolaging.2010.05.007; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Liu T, 2010, BRAIN RES, V1347, P149, DOI 10.1016/j.brainres.2010.05.079; Martin LJ, 2012, PROG MOL BIOL TRANSL, V107, P355, DOI 10.1016/B978-0-12-385883-2.00005-9; Nam JH, 2012, ANTIOXID REDOX SIGN, V16, P1369, DOI 10.1089/ars.2011.4175; Polat E, 2010, PHYTOCHEMISTRY, V71, P658, DOI 10.1016/j.phytochem.2009.11.013; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Ren R, 2011, J CELL BIOCHEM, V112, P1450, DOI 10.1002/jcb.23062; Ren S, 2013, J TRADIT CHIN MED, V33, P413, DOI 10.1016/S0254-6272(13)60189-2; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang-Dietrich L, 2013, J ALZHEIMERS DIS, V34, P985, DOI 10.3233/JAD-122047; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zhang DW, 2012, PHARMACOLOGY, V90, P95, DOI 10.1159/000339476; Zhang N, 2011, MOLECULES, V16, P3896, DOI 10.3390/molecules16053896; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	44	96	108	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98866	10.1371/journal.pone.0098866	http://dx.doi.org/10.1371/journal.pone.0098866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905226	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000074
J	Clement, G				Clement, Gilles			Effects of Varying Gravity Levels in Parabolic Flight on the Size-Mass Illusion	PLOS ONE			English	Article							WEIGHT; DISCRIMINATION; PERCEPTION; OBJECTS	When an observer lifts two objects with the same weight but different sizes, the smaller object is consistently reported to feel heavier than the larger object even after repeated trials. Here we explored the effect of reduced and increased gravity on this perceptual size-mass illusion. Experiments were performed on board the CNES Airbus A300 Zero-G during parabolic flights eliciting repeated exposures to short periods of zero g, 0.16 g, 0.38 g, one g, and 1.8 g. Subjects were asked to assess perceived heaviness by actively oscillating objects with various sizes and masses. The results showed that a perceptual size-mass illusion was clearly present at all gravity levels. During the oscillations, the peak arm acceleration varied as a function of the gravity level, irrespective of the mass and size of the objects. In other words we did not observe a sensorimotor size-mass illusion. These findings confirm dissociation between the sensorimotor and perceptual systems for determining object mass. In addition, they suggest that astronauts on the Moon or Mars with the eyes closed will be able to accurately determine the relative difference in mass between objects.	Int Space Univ, Illkirch Graffenstaden, France		Clement, G (corresponding author), Int Space Univ, Illkirch Graffenstaden, France.	gilles.clement@isunet.edu	Clement, Gilles/I-1973-2017		Centre National d'Etudes Spatiales (CNES); European Space Agency (ESA)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); European Space Agency (ESA)(European Space Agency)	Sources of funding are the Centre National d'Etudes Spatiales (CNES) and the European Space Agency (ESA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERY W, 1992, ACTA ASTRONAUT, V26, P119, DOI 10.1016/0094-5765(92)90052-K; ALBERY WB, 1989, AVIAT SPACE ENVIR MD, V60, P943; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; DARWOOD JJ, 1991, AVIAT SPACE ENVIR MD, V62, P319; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Gazenko O, 1980, P 6 INT S MAN SPAC B; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Kawai S, 2002, EXP BRAIN RES, V147, P23, DOI 10.1007/s00221-002-1210-x; Lackner JR, 1996, CURR OPIN NEUROBIOL, V6, P744, DOI 10.1016/S0959-4388(96)80023-7; Murray DJ, 1999, PERCEPT PSYCHOPHYS, V61, P1681, DOI 10.3758/BF03213127; Plaisier MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042518; Platkiewicz J, 2014, J NEUROPHYS IN PRESS; ROSS H, 1984, SCIENCE, V225, P219, DOI 10.1126/science.6729479; ROSS HE, 1987, AVIAT SPACE ENVIR MD, V58, pA148; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS HE, 1987, Q J EXP PSYCHOL-A, V39, P77, DOI 10.1080/02724988743000042; ROSS HE, 1986, NATURWISSENSCHAFTEN, V73, P453, DOI 10.1007/BF00367296; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Ross HE, 1987, P 3 EUR S LIF SCI RE, P142; Tiest WMB, 2010, ATTEN PERCEPT PSYCHO, V72, P1144, DOI 10.3758/APP.72.4.1144; Zhu Q, 2011, EVOL HUM BEHAV, V32, P288, DOI 10.1016/j.evolhumbehav.2010.11.005	25	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99188	10.1371/journal.pone.0099188	http://dx.doi.org/10.1371/journal.pone.0099188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901519	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400107
J	Little, SJ; Pond, SLK; Anderson, CM; Young, JA; Wertheim, JO; Mehta, SR; May, S; Smith, DM				Little, Susan J.; Pond, Sergei L. Kosakovsky; Anderson, Christy M.; Young, Jason A.; Wertheim, Joel O.; Mehta, Sanjay R.; May, Susanne; Smith, Davey M.			Using HIV Networks to Inform Real Time Prevention Interventions	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION NETWORK; INFECTION; SEX; EPIDEMIOLOGY; AFRICA; RATES; RISK; MEN; ACT	Objective: To reconstruct the local HIV-1 transmission network from 1996 to 2011 and use network data to evaluate and guide efforts to interrupt transmission. Design: HIV-1 pol sequence data were analyzed to infer the local transmission network. Methods: We analyzed HIV-1 pol sequence data to infer a partial local transmission network among 478 recently HIV-1 infected persons and 170 of their sexual and social contacts in San Diego, California. A transmission network score (TNS) was developed to estimate the risk of HIV transmission from a newly diagnosed individual to a new partner and target prevention interventions. Results: HIV-1 pol sequences from 339 individuals (52.3%) were highly similar to sequences from at least one other participant (i.e., clustered). A high TNS (top 25%) was significantly correlated with baseline risk behaviors (number of unique sexual partners and insertive unprotected anal intercourse (p = 0.014 and p = 0.0455, respectively) and predicted risk of transmission (p<0.0001). Retrospective analysis of antiretroviral therapy (ART) use, and simulations of ART targeted to individuals with the highest TNS, showed significantly reduced network level HIV transmission (p<0.05). Conclusions: Sequence data from an HIV-1 screening program focused on recently infected persons and their social and sexual contacts enabled the characterization of a highly connected transmission network. The network-based risk score (TNS) was highly correlated with transmission risk behaviors and outcomes, and can be used identify and target effective prevention interventions, like ART, to those at a greater risk for HIV-1 transmission.	[Little, Susan J.; Pond, Sergei L. Kosakovsky; Anderson, Christy M.; Young, Jason A.; Wertheim, Joel O.; Mehta, Sanjay R.; Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Little, SJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	slittle@ucsd.edu	Little, Susan/AAA-6116-2019; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Smith, Davey/0000-0003-3603-1733	National Institutes of Health [AI43638, AI74621, AI106039, GM093939, AI093163, MH083552, AI090970, AI96189, DA034978, AI067039, AI097061, AI100665, AI080353, MH097520, AI36214, MH62512, TW008908, AI69432, AI096113, AI47745]; California HIV-1 Research Program (CHRP) [RN07-SD-702]; FOGARTY INTERNATIONAL CENTER [R24TW008908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069432, R24AI067039, P30AI036214, R56AI047745, U19AI090970, K24AI100665, K23AI093163, U01AI043638, R21AI080353, K01AI110181, P01AI074621, U01AI069432, R01AI047745, R24AI106039, R21AI097061, U19AI096113, R21AI047745, R01AI096189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097520, R01MH100974, R01MH083552, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV-1 Research Program (CHRP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funds from the following: National Institutes of Health grants AI43638, AI74621, AI106039, AI47745, GM093939, AI093163, MH083552, AI090970, AI96189, DA034978, AI067039, AI097061, AI100665, AI080353, MH097520, AI36214, MH62512, TW008908, AI69432, AI096113, AI47745 and California HIV-1 Research Program (CHRP) RN07-SD-702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2013, AM J PUBLIC HEALTH, V103, P322, DOI 10.2105/AJPH.2012.300908; Althaus CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051438; Armstrong MP, 1999, STAT MED, V18, P497, DOI 10.1002/(SICI)1097-0258(19990315)18:5<497::AID-SIM45>3.3.CO;2-R; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208; Gandhi NR, 2013, J INFECT DIS, V207, P9, DOI 10.1093/infdis/jis631; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kassanjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020027; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Morris SR, 2010, ANN INTERN MED, V152, P778, DOI 10.7326/0003-4819-152-12-201006150-00005; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rivas AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039778; Rodriguez K, 2013, AIDS CARE, V25, P828, DOI 10.1080/09540121.2012.748164; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Smith D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001473; Smith DA, 2009, AIDS, V23, P225, DOI 10.1097/QAD.0b013e32831d2a81; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Wertheim JO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027775	36	120	135	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98443	10.1371/journal.pone.0098443	http://dx.doi.org/10.1371/journal.pone.0098443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901437	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400029
J	Yin, R; Gu, L; Li, M; Jiang, CZ; Cao, TC; Zhang, XB				Yin, Rong; Gu, Liang; Li, Min; Jiang, Cizhong; Cao, Tongcheng; Zhang, Xiaobai			Gene Expression Profiling Analysis of Bisphenol A-Induced Perturbation in Biological Processes in ER-Negative HEK293 Cells	PLOS ONE			English	Article							BREAST-CANCER; DNA-DAMAGE; RNA-SEQ; EXPOSURE; RECEPTOR; POPULATION; APOPTOSIS; REVEALS; RISK	Bisphenol A (BPA) is an environmental endocrine disruptor which has been detected in human bodies. Many studies have implied that BPA exposure is harmful to human health. Previous studies mainly focused on BPA effects on estrogen receptor (ER)-positive cells. Genome-wide impacts of BPA on gene expression in ER-negative cells is unclear. In this study, we performed RNA-seq to characterize BPA-induced cellular and molecular impacts on ER-negative HEK293 cells. The microscopic observation showed that low-dose BPA exposure did not affect cell viability and morphology. Gene expression profiling analysis identified a list of differentially expressed genes in response to BPA exposure in HEK293 cells. These genes were involved in variable important biological processes including ion transport, cysteine metabolic process, apoptosis, DNA damage repair, etc. Notably, BPA up-regulated the expression of ERCC5 encoding a DNA endonuclease for nucleotide-excision repair. Further electrochemical experiment showed that BPA induced significant DNA damage in ER-positive MCF-7 cells but not in ER-negative HEK293 cells. Collectively, our study revealed that ER-negative HEK293 cells employed mechanisms in response to BPA exposure different from ER-positive cells.	[Yin, Rong; Cao, Tongcheng] Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China; [Gu, Liang; Li, Min; Jiang, Cizhong; Zhang, Xiaobai] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Jiang, CZ (corresponding author), Tongji Univ, Dept Chem, Shanghai 200092, Peoples R China.	czjiang@tongji.edu.cn; ctc@tongji.edu.cn; zhangxb@tongji.edu.cn			Ministry of Science and Technology of China [2010CB944901, 2011CB965104, 2012AA020405]; National Natural Science Foundation of China [91019017, 31271373, 31200952]; China Postdoctoral Science Foundation [2013M531207]; Shanghai Postdoctoral Sustentation Fund [13R21416700]; Aurora Talent Project of Shanghai [10SG24]; program for Eastern Scholar of Shanghai; Fundamental Research Funds for the Central Universities [20113048, 20113109]; Ministry of Education, China [IRT1168]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund; Aurora Talent Project of Shanghai; program for Eastern Scholar of Shanghai; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education, China(Ministry of Education, China)	This study was supported in part by grants from the Ministry of Science and Technology of China (2010CB944901, 2011CB965104, 2012AA020405); and the National Natural Science Foundation of China (91019017, 31271373, 31200952); China Postdoctoral Science Foundation (2013M531207); the Shanghai Postdoctoral Sustentation Fund (13R21416700); Aurora Talent Project of Shanghai (10SG24); the program for Eastern Scholar of Shanghai; the Fundamental Research Funds for the Central Universities (20113048, 20113109); and IRT1168 from the Ministry of Education, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Bhandari R, 2013, AM J EPIDEMIOL, V177, P1263, DOI 10.1093/aje/kws391; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Chepelev NL, 2013, CHEM RES TOXICOL, V26, P498, DOI 10.1021/tx400036v; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Diel P, 2002, J STEROID BIOCHEM, V80, P61, DOI 10.1016/S0960-0760(01)00173-X; Erler C, 2010, J PEDIATR NURS, V25, P400, DOI 10.1016/j.pedn.2009.05.006; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Foster Warren G, 2008, Fertil Steril, V89, pe53, DOI 10.1016/j.fertnstert.2007.12.028; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Gentilcore D, 2013, TOXICOLOGY, V304, P21, DOI 10.1016/j.tox.2012.12.001; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Huang YQ, 2012, ENVIRON INT, V42, P91, DOI 10.1016/j.envint.2011.04.010; Iso T, 2006, BIOL PHARM BULL, V29, P206, DOI 10.1248/bpb.29.206; Krieter DH, 2013, ARTIF ORGANS, V37, P283, DOI 10.1111/j.1525-1594.2012.01556.x; Li DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065399; Lozada KW, 2011, BIOL REPROD, V85, P490, DOI 10.1095/biolreprod.110.090431; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajapandi T, 2000, J BIOL CHEM, V275, P22597, DOI 10.1074/jbc.M002035200; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai WT, 2006, J ENVIRON SCI HEAL C, V24, P225, DOI 10.1080/10590500600936482; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wang TG, 2013, EPIDEMIOLOGY, V24, P295, DOI 10.1097/EDE.0b013e318280e02f; Xu JP, 2002, BIOCHEM BIOPH RES CO, V292, P456, DOI 10.1006/bbrc.2002.6644; Zhou LP, 2003, J AM CHEM SOC, V125, P1431, DOI 10.1021/ja0290274	30	13	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98635	10.1371/journal.pone.0098635	http://dx.doi.org/10.1371/journal.pone.0098635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901218	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400041
J	Alsmadi, O; John, SE; Thareja, G; Hebbar, P; Antony, D; Behbehani, K; Thanaraj, TA				Alsmadi, Osama; John, Sumi E.; Thareja, Gaurav; Hebbar, Prashantha; Antony, Dinu; Behbehani, Kazem; Thanaraj, Thangavel Alphonse			Genome at Juncture of Early Human Migration: A Systematic Analysis of Two Whole Genomes and Thirteen Exomes from Kuwaiti Population Subgroup of Inferred Saudi Arabian Tribe Ancestry	PLOS ONE			English	Article							METACHROMATIC LEUKODYSTROPHY; STRUCTURAL VARIATION; GENOTYPE IMPUTATION; GENETIC-STRUCTURE; SHORT-READ; SEQUENCE; VARIANTS; MUTATIONS; COMMON; DATABASE	Population of the State of Kuwait is composed of three genetic subgroups of inferred Persian, Saudi Arabian tribe and Bedouin ancestry. The Saudi Arabian tribe subgroup traces its origin to the Najd region of Saudi Arabia. By sequencing two whole genomes and thirteen exomes from this subgroup at high coverage (> 40X), we identify 4,950,724 Single Nucleotide Polymorphisms (SNPs), 515,802 indels and 39,762 structural variations. Of the identified variants, 10,098 (8.3%) exomic SNPs, 139,923 (2.9%) non-exomic SNPs, 5,256 (54.3%) exomic indels, and 374,959 (74.08%) non-exomic indels are 'novel'. Up to 8,070 (79.9%) of the reported novel biallelic exomic SNPs are seen in low frequency (minor allele frequency < 5%). We observe 5,462 known and 1,004 novel potentially deleterious nonsynonymous SNPs. Allele frequencies of common SNPs from the 15 exomes is significantly correlated with those from genotype data of a larger cohort of 48 individuals (Pearson correlation coefficient, 0.91; p < 2.2x10(-16)). A set of 2,485 SNPs show significantly different allele frequencies when compared to populations from other continents. Two notable variants having risk alleles in high frequencies in this subgroup are: a nonsynonymous deleterious SNP (rs2108622 [19: g. 15990431C > T] from CYP4F2 gene [MIM:* 604426]) associated with warfarin dosage levels [MIM:# 122700] required to elicit normal anticoagulant response; and a 39 UTR SNP (rs6151429 [22: g. 51063477 > C]) from ARSA gene [MIM:* 607574]) associated with Metachromatic Leukodystrophy [MIM:# 250100]. Hemoglobin Riyadh variant (identified for the first time in a Saudi Arabian woman) is observed in the exome data. The mitochondrial haplogroup profiles of the 15 individuals are consistent with the haplogroup diversity seen in Saudi Arabian natives, who are believed to have received substantial gene flow from Africa and eastern provenance. We present the first genome resource imperative for designing future genetic studies in Saudi Arabian tribe subgroup. The fulllength genome sequences and the identified variants are available at ftp://dgr. dasmaninstitute. org and http://dgr. dasmaninstitute. org/DGR/gb. html.	[Alsmadi, Osama; John, Sumi E.; Thareja, Gaurav; Hebbar, Prashantha; Antony, Dinu; Behbehani, Kazem; Thanaraj, Thangavel Alphonse] Dasman Diabet Inst, Dasman, Kuwait		Alsmadi, O (corresponding author), Dasman Diabet Inst, Dasman, Kuwait.	osama.alsmadi@dasmaninstitute.org; alphonse.thangavel@dasmaninsitute.org	Hebbar, Prashantha/S-8748-2019; Thareja, Gaurav/GRE-8285-2022		Kuwait Foundation for the Advancement of Sciences (KFAS)	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS))	The Kuwait Foundation for the Advancement of Sciences (KFAS) is acknowledged for funding the activities at our institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed F, 2011, INT J FOOD SCI NUTR, V62, P585, DOI 10.3109/09637486.2011.566848; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alsmadi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074913; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2006, NAT GENET, V38, P851; [Anonymous], SNP VAR SUIT VERS 7; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Carter R, 2006, ANTIQUITY, V80, P52, DOI 10.1017/S0003598X0009325X; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; De La Vega F, 2009, FUNCTIONAL ANAL GENE; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; ELHAZMI MAF, 1977, HEMOGLOBIN, V1, P59, DOI 10.3109/03630267609031022; ELKHATEEB I, 1988, BRAIN DEV-JPN, V10, P243; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gao Xiaoyi, 2012, Frontiers in Genetics, V3, P117, DOI 10.3389/fgene.2012.00117; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; Hardison R, 1998, GENOMICS, V47, P429, DOI 10.1006/geno.1997.5147; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; HEINISCH U, 1995, AM J HUM GENET, V56, P51; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Kenna KP, 2013, J MED GENET, V50, P776, DOI 10.1136/jmedgenet-2013-101795; Kennet D., 2011, P SEMINAR ARABIAN ST, V41, P161; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Koul R L, 1994, Indian Pediatr, V31, P694; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Marouf R, 2002, MED PRIN PRACT, V11, P38, DOI 10.1159/000048659; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; McKusick V.A., 1998, MENDELIAN INHERITANC; Mehdi Syed Riaz, 2011, Indian J Hum Genet, V17, P207, DOI 10.4103/0971-6866.92106; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moore B, 2011, GENET MED, V13, P210, DOI 10.1097/GIM.0b013e31820ed321; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Niida Y, 1999, HUM MUTAT, V14, P412, DOI 10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Rajab A, 2005, COMMUNITY GENET, V8, P27, DOI 10.1159/000083334; Regis S, 2002, HUM GENET, V110, P351, DOI 10.1007/s00439-002-0701-y; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rodriguez-Flores JL, 2014, HUM MUTAT, V35, P105, DOI 10.1002/humu.22460; Rodriguez-Flores JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047614; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059494; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sung YJ, 2012, GENET EPIDEMIOL, V36, P508, DOI 10.1002/gepi.21647; Tadmouri GO, 2006, NUCLEIC ACIDS RES, V34, pD602, DOI 10.1093/nar/gkj015; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teebi AS, 2010, GENETIC DISORDERS AMONG ARAB POPULATIONS, SECOND EDITION, P3, DOI 10.1007/978-3-642-05080-0_1; Theyab JB, 2012, HUM BIOL, V84, P379, DOI 10.3378/027.084.0403; Triki-Fendri S, 2010, ANN HUM BIOL, V37, P827, DOI 10.3109/03014461003720296; Van Geystelen A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-101; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westesson O, 2013, BRIEF BIOINFORM, V14, P172, DOI 10.1093/bib/bbr078; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong LP, 2013, AM J HUM GENET, V92, P52, DOI 10.1016/j.ajhg.2012.12.005; Wu JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-305; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang H, 2008, MOL PSYCHIATR, V13, P531, DOI 10.1038/sj.mp.4002035; ZLOTOGORA J, 1994, J MED GENET, V31, P672, DOI 10.1136/jmg.31.9.672; Zubaid M, 2013, HELL J CARDIOL, V54, P102	114	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99069	10.1371/journal.pone.0099069	http://dx.doi.org/10.1371/journal.pone.0099069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896259	Green Published, gold			2022-12-25	WOS:000338430700113
J	Gredzens, C; Marsh, H; Fuentes, MMPB; Limpus, CJ; Shimada, T; Hamann, M				Gredzens, Christian; Marsh, Helene; Fuentes, Mariana M. P. B.; Limpus, Colin J.; Shimada, Takahiro; Hamann, Mark			Satellite Tracking of Sympatric Marine Megafauna Can Inform the Biological Basis for Species Co-Management	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PROTECTED AREA DESIGN; HOME-RANGE; CHELONIA-MYDAS; GREEN TURTLES; RESERVE DESIGN; TORRES STRAIT; FORAGING AREA; DUGONG-DUGON; SAMPLE-SIZE	Context: Systematic conservation planning is increasingly used to identify priority areas for protection in marine systems. However, ecosystem-based approaches typically use density estimates as surrogates for animal presence and spatial modeling to identify areas for protection and may not take into account daily or seasonal movements of animals. Additionally, sympatric and inter-related species are often managed separately, which may not be cost-effective. This study aims to demonstrate an evidence-based method to inform the biological basis for co-management of two sympatric species, dugongs and green sea turtles. This approach can then be used in conservation planning to delineate areas to maximize species protection. Methodology/Results: Fast-acquisition satellite telemetry was used to track eleven dugongs and ten green turtles at two geographically distinct foraging locations in Queensland, Australia to evaluate the inter-and intra-species spatial relationships and assess the efficacy of existing protection zones. Home-range analysis and bathymetric modeling were used to determine spatial use and compared with existing protection areas using GIS. Dugong and green turtle home-ranges significantly overlapped in both locations. However, both species used different core areas and differences existed between regions in depth zone use and home-range size, especially for dugongs. Both species used existing protection areas in Shoalwater Bay, but only a single tracked dugong used the existing protection area in Torres Strait. Conclusions/Significance:: Fast-acquisition satellite telemetry can provide evidence-based information on individual animal movements to delineate relationships between dugongs and green turtles in regions where they co-occur. This information can be used to increase the efficacy of conservation planning and complement more broadly based survey information. These species also use similar habitats, making complimentary co-management possible, but important differences exist between locations making it essential to customize management. This methodology could be applied on a broader scale to include other sympatric and inter-related species.	[Gredzens, Christian; Marsh, Helene; Shimada, Takahiro; Hamann, Mark] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Gredzens, Christian] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Marsh, Helene; Hamann, Mark] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld 4811, Australia; [Fuentes, Mariana M. P. B.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Limpus, Colin J.] Queensland Dept Environm & Heritage Protect, Aquat Threatened Species Unit, Brisbane, Qld, Australia	James Cook University; James Cook University; James Cook University; James Cook University	Gredzens, C (corresponding author), James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia.	Christian.Gredzens@my.jcu.edu.au	Shimada, Takahiro/F-9876-2017	Shimada, Takahiro/0000-0002-3364-5169; Gredzens, Christian/0000-0002-9366-6623; Marsh, Helene/0000-0003-3492-4992; Hamann, Mark/0000-0003-4588-7955	Australian National Environment Research Program scholarship; Australian Government's Australian Marine Mammal Centre; Marine and Tropical Science Research Facility and National Environment Research Program; Torres Strait Regional Authority; Great Barrier Reef Marine Park Authority; Queensland Department of Environment and Heritage Protection	Australian National Environment Research Program scholarship; Australian Government's Australian Marine Mammal Centre(Australian Government); Marine and Tropical Science Research Facility and National Environment Research Program; Torres Strait Regional Authority; Great Barrier Reef Marine Park Authority; Queensland Department of Environment and Heritage Protection	The Torres Strait field work was funded by an Australian National Environment Research Program scholarship. The project was funded by the Australian Government's Australian Marine Mammal Centre, Marine and Tropical Science Research Facility and National Environment Research Program, the Torres Strait Regional Authority, the Great Barrier Reef Marine Park Authority, the Queensland Department of Environment and Heritage Protection, and an anonymous donor with a passion for dugongs. The identity of the donor is not considered relevant to the editors or reviewers' assessment of the validity of the work. None of the research was funded, in whole or in part, by a tobacco company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2005, WILDLIFE RES, V32, P53, DOI 10.1071/WR04015; Bailey H, 2012, ECOL APPL, V22, P735, DOI 10.1890/11-0633; Beaman R., 2010, 25I1A MTSRF REEF RAI, P13; Beyer H. L, 2012, GEOSPATIAL MODELLING; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Bolten Alan B., 1999, P110; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Christie P, 2003, FISHERIES, V28, P22; Coles R., 2003, WORLD ATLAS SEAGRASS, P119; Cuevas E, 2007, AMPHIBIA-REPTILIA, V28, P337, DOI 10.1163/156853807781374683; Daniell JJ, 2008, J GEOPHYS RES EARTH, V113; De Iongh HH, 1998, MAR ECOL-P S Z N I, V19, P179; Dobbs K., 2007, MARINE TURTLE DUGONG; Dobbs K, 2008, OCEAN COAST MANAGE, V51, P368, DOI 10.1016/j.ocecoaman.2007.08.001; Dobbs Kirstin, 2007, Pacific Conservation Biology, V13, P293; Dryden J, 2008, WILDLIFE RES, V35, P477, DOI 10.1071/WR07087; ESRI, 2011, ARCGIS DESKT V 10 0; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fuentes MMPB, 2013, MAR MAMMAL SCI, V29, P159, DOI 10.1111/j.1748-7692.2011.00531.x; Gerber LR, 2003, ECOL APPL, V13, pS47; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grech A, 2008, AQUAT CONSERV, V18, P1127, DOI 10.1002/aqc.943; Grech A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017993; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Hazel J, 2013, MAR BIOL, V160, P617, DOI 10.1007/s00227-012-2117-0; Hazen EL, 2012, MAR ECOL PROG SER, V457, P221, DOI 10.3354/meps09857; Heithaus MR, 2002, MAR BIOL, V140, P229, DOI 10.1007/s00227-001-0712-6; Hemson G, 2005, J ANIM ECOL, V74, P455, DOI 10.1111/j.1365-2656.2005.00944.x; Hoelzel AR., 2009, MARINE MAMMAL BIOL E; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Horne JS, 2006, J WILDLIFE MANAGE, V70, P641, DOI 10.2193/0022-541X(2006)70[641:LCVLSC]2.0.CO;2; IUCN, 2022, IUCN RED LIST THREAT; Lanyon Janet M., 2006, Aquatic Mammals, V32, P196, DOI 10.1578/AM.32.2.2006.196; Lee KA, 2014, AQUAT CONSERV; Limpus C.J., 1978, EXPLORATION N AUSTR, P187; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Long BG, 1997, TORRES STRAIT REEF R; Lutz P.L., 1997, BIOL SEA TURTLES; Lynch TP, 2013, ENVIRON MANAGE, V52, P1341, DOI 10.1007/s00267-013-0174-x; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; MARSH H, 1990, AUST WILDLIFE RES, V17, P83; Marsh H, 2000, MAR MAMMAL SCI, V16, P684, DOI 10.1111/j.1748-7692.2000.tb00965.x; MARSH H, 1981, BIOL CONSERV, V19, P255, DOI 10.1016/0006-3207(81)90002-1; Marsh H., 2011, ECOLOGY CONSERVATION, DOI DOI 10.1017/CBO9781139013277; Marsh H., 2011, AERIAL SURVEY TORRES; McKenzie L, 2010, QUEENSLAND SEAGRASSE; NIETSCHMANN B, 1981, NAT HIST, V90, P54; O'Neill P, 2009, STATE ENV REPORT SHO, P180; Parnell PE, 2006, ECOL APPL, V16, P945, DOI 10.1890/1051-0761(2006)016[0945:MRDOSH]2.0.CO;2; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Poiner IR, 1996, SEAGRASSES; Preen A., 1992, THESIS J COOK U TOWN; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; R Core Team, 2012, R LANG ENV STAT COMP; Rasheed MA, 2008, CONT SHELF RES, V28, P2292, DOI 10.1016/j.csr.2008.03.026; Roberts C.M., 2001, CONSERV PRACT, V2, P10, DOI [DOI 10.1111/J.1526-4629.2001.TB00012.X, 10.1111/j.1526-4629.2001.tb00012.x]; ROBERTS CM, 2006, ROADMAP RECOVERY GLO; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Sheppard JK, 2009, J WILDLIFE MANAGE, V73, P45, DOI 10.2193/2007-468; Shimada T, 2012, MAR ECOL PROG SER, V457, P171, DOI 10.3354/meps09747; Silverman B. W., 1986, MONOGRAPHS STAT APPL, P176; Taylor H. A, 2010, TORRES STRAITS DUGON; Telonics, 2012, GEN4 GPS SYST MAN; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; [No title captured]	79	40	40	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98944	10.1371/journal.pone.0098944	http://dx.doi.org/10.1371/journal.pone.0098944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893163	gold, Green Accepted, Green Published			2022-12-25	WOS:000336911400113
J	Wang, YY; Hu, CS; Ming, H; Oenema, O; Schaefer, DA; Dong, WX; Zhang, YM; Li, XX				Wang, Yuying; Hu, Chunsheng; Ming, Hua; Oenema, Oene; Schaefer, Douglas A.; Dong, Wenxu; Zhang, Yuming; Li, Xiaoxin			Methane, Carbon Dioxide and Nitrous Oxide Fluxes in Soil Profile under a Winter Wheat-Summer Maize Rotation in the North China Plain	PLOS ONE			English	Article							CO2 EFFLUX; GAS EMISSIONS; N2O FLUXES; CH4; RESPIRATION; MITIGATION; DIFFUSION; WATER; TEMPERATURE; TRANSPORT	The production and consumption of the greenhouse gases (GHGs) methane (CH4), carbon dioxide (CO2) and nitrous oxide (N2O) in soil profile are poorly understood. This work sought to quantify the GHG production and consumption at seven depths (0-30, 30-60, 60-90, 90-150, 150-200, 200-250 and 250-300 cm) in a long-term field experiment with a winter wheat-summer maize rotation system, and four N application rates (0; 200; 400 and 600 kg N ha(-1) year(-1)) in the North China Plain. The gas samples were taken twice a week and analyzed by gas chromatography. GHG production and consumption in soil layers were inferred using Fick's law. Results showed nitrogen application significantly increased N2O fluxes in soil down to 90 cm but did not affect CH4 and CO2 fluxes. Soil moisture played an important role in soil profile GHG fluxes; both CH4 consumption and CO2 fluxes in and from soil tended to decrease with increasing soil water filled pore space (WFPS). The top 0-60 cm of soil was a sink of atmospheric CH4, and a source of both CO2 and N2O, more than 90% of the annual cumulative GHG fluxes originated at depths shallower than 90 cm; the subsoil (>90 cm) was not a major source or sink of GHG, rather it acted as a 'reservoir'. This study provides quantitative evidence for the production and consumption of CH4, CO2 and N2O in the soil profile.	[Wang, Yuying; Hu, Chunsheng; Ming, Hua; Dong, Wenxu; Zhang, Yuming; Li, Xiaoxin] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China; [Oenema, Oene] Wageningen Univ, Dept Soil Qual, Alterra, Wageningen, Netherlands; [Schaefer, Douglas A.] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Wageningen University & Research; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Hu, CS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Hebei, Peoples R China.	cshu@sjziam.ac.cn			Strategic Priority Research Program of Chinese Academy of Sciences [XDA0505050202, XDA05050601]; National Science & Technology Pillar Program [2012BAD14B07-5]; National Basic Research Program of China [2010CB833501]; National Natural Science Foundation of China [30970534]; Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KSCX2-EW-J-5]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Science & Technology Pillar Program; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This research is supported by the "Strategic Priority Research Program of Chinese Academy of Sciences" (Grant No. XDA0505050202 and XDA05050601) and the "National Science & Technology Pillar Program" (Grant No. 2012BAD14B07-5). It is also supported by the "National Basic Research Program of China" (Grant No. 2010CB833501); the "National Natural Science Foundation of China" (Grant No. 30970534) and the "Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences" (Grant No. KSCX2-EW-J-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajracharya RM, 2000, SOIL SCI SOC AM J, V64, P694, DOI 10.2136/sssaj2000.642694x; Banger K, 2012, GLOBAL CHANGE BIOL, V18, P3259, DOI 10.1111/j.1365-2486.2012.02762.x; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; BOWDEN WB, 1986, SCIENCE, V233, P867, DOI 10.1126/science.233.4766.867; Campbell GS, 1985, SOIL SCIENCE SOCIETY; Chu H, 2004, SOIL SCI PLANT NUTR, V50, P287, DOI 10.1080/00380768.2004.10408480; Clough TJ, 2004, SOIL SCI SOC AM J, V68, P1600, DOI 10.2136/sssaj2004.1600; Clough TJ, 2003, AUST J SOIL RES, V41, P439, DOI 10.1071/SR02079; DAVIDSON EA, 1992, SOIL SCI SOC AM J, V56, P95, DOI 10.2136/sssaj1992.03615995005600010015x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Ding WX, 2013, SCI TOTAL ENVIRON, V465, P115, DOI 10.1016/j.scitotenv.2012.11.020; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fang YT, 2009, PLANT SOIL, V319, P37, DOI 10.1007/s11104-008-9847-2; Fierer N, 2005, ECOSYSTEMS, V8, P412, DOI 10.1007/s10021-003-0151-y; Flessa H, 2000, J ENVIRON QUAL, V29, P262, DOI 10.2134/jeq2000.00472425002900010033x; Gebert J, 2011, WASTE MANAGE, V31, P987, DOI 10.1016/j.wasman.2010.10.008; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; GILLILAND ER, 1974, IND ENG CHEM FUND, V13, P95, DOI 10.1021/i160050a001; Grandy AS, 2006, GLOBAL CHANGE BIOL, V12, P1507, DOI 10.1111/j.1365-2486.2006.01166.x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Jassal RS, 2010, GEODERMA, V157, P118, DOI 10.1016/j.geoderma.2010.04.002; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Jury WA, 1991, SOIL PHYSICS; Kelting DL, 1998, SOIL BIOL BIOCHEM, V30, P961, DOI 10.1016/S0038-0717(97)00186-7; Kim Y, 2007, TELLUS B, V59, P223, DOI 10.1111/j.1600-0889.2006.00233.x; KOSCHORRECK M, 1993, GLOBAL BIOGEOCHEM CY, V7, P109, DOI 10.1029/92GB02814; Kravchenko I, 2002, SOIL BIOL BIOCHEM, V34, P669, DOI 10.1016/S0038-0717(01)00232-2; Li XX, 2007, AGR WATER MANAGE, V89, P137, DOI 10.1016/j.agwat.2006.12.012; MARSHALL TJ, 1959, J SOIL SCI, V10, P79, DOI 10.1111/j.1365-2389.1959.tb00667.x; MILLINGTON R, 1961, T FARADAY SOC, V57, P1200, DOI 10.1039/tf9615701200; Reth S., 2008, FOCUS, V8, P129, DOI DOI 10.1007/S11267-007-9165-3; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Rolston D.E., 1986, METHODS SOIL ANAL 1, P1103, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C47; SALLAM A, 1984, SOIL SCI SOC AM J, V48, P3, DOI 10.2136/sssaj1984.03615995004800010001x; Sanz-Cobena A, 2014, SCI TOTAL ENVIRON, V466, P164, DOI 10.1016/j.scitotenv.2013.07.023; Sanz-Cobena A, 2012, AGR ECOSYST ENVIRON, V149, P64, DOI 10.1016/j.agee.2011.12.016; Sherlock RR, 2002, J ENVIRON QUAL, V31, P1491, DOI 10.2134/jeq2002.1491; Shrestha BM, 2004, NUTR CYCL AGROECOSYS, V68, P155, DOI 10.1023/B:FRES.0000019044.52811.11; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEUDLER PA, 1989, NATURE, V341, P314, DOI 10.1038/341314a0; Stiehl-Braun PA, 2011, SOIL BIOL BIOCHEM, V43, P1034, DOI 10.1016/j.soilbio.2011.01.020; Tang JW, 2003, AGR FOREST METEOROL, V118, P207, DOI 10.1016/S0168-1923(03)00112-6; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wang Y, 2010, PLANT SOIL ENVIRON, V56, P16, DOI 10.17221/144/2009-PSE; Wang YY, 2013, AGR ECOSYST ENVIRON, V164, P260, DOI 10.1016/j.agee.2012.10.004; Wu X, 2010, SOIL BIOL BIOCHEM, V42, P773, DOI 10.1016/j.soilbio.2010.01.013; Zhu B, 2009, SOIL SCI SOC AM J, V73, P1419, DOI 10.2136/sssaj2008.0259; Zhu H.J., 1992, SOIL GEOGRAPHY; Zou GY, 2001, SOIL ENV SCI, V10, P273	53	24	30	6	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98445	10.1371/journal.pone.0098445	http://dx.doi.org/10.1371/journal.pone.0098445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892931	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400051
J	Tuthill, MH; Montinaro, A; Zinngrebe, J; Prieske, K; Draber, P; Prieske, S; Newsom-Davis, T; von Karstedt, S; Graves, J; Walczak, H				Tuthill, M. H.; Montinaro, A.; Zinngrebe, J.; Prieske, K.; Draber, P.; Prieske, S.; Newsom-Davis, T.; von Karstedt, S.; Graves, J.; Walczak, H.			TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells	ONCOGENE			English	Article							OVARIAN-CANCER; TUMORICIDAL ACTIVITY; PANCREATIC-CANCER; INDUCED APOPTOSIS; LUNG-CANCER; IN-VIVO; CONATUMUMAB; RESISTANCE; COMBINATION; INHIBITION	Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in cancer cells while sparing normal tissues. Despite promising preclinical results, few patients responded to treatment with recombinant TRAIL (Apo2L/Dulanermin) or TRAIL-R2-specific antibodies, such as conatumumab (AMG655). It is unknown whether this was due to intrinsic TRAIL resistance within primary human cancers or insufficient agonistic activity of the TRAIL-receptor (TRAIL-R)-targeting drugs. Fc gamma receptors (Fc gamma R)-mediated crosslinking increases the cancer-cell-killing activity of TRAIL-R2-specific antibodies in vivo. We tested this phenomenon using Fc gamma R-expressing immune cells from patients with ovarian cancer. However, even in the presence of high numbers of Fc gamma R-expressing immune cells, as found in ovarian cancer ascites, AMG655-induced apoptosis was not enabled to any significant degree, indicating that this concept may not translate into clinical use. On the basis of these results, we next set out to determine whether AMG655 possibly interferes with apoptosis induction by endogenous TRAIL, which could be expressed by immune cells. To do so, we tested how AMG655 affected apoptosis induction by recombinant TRAIL. This, however, resulted in the surprising discovery of a striking synergy between AMG655 and non-tagged TRAIL (Apo2L/TRAIL) in killing cancer cells. This combination was as effective in killing cancer cells as highly active recombinant isoleucine-zipper-tagged TRAIL (iz-TRAIL). The increased killing efficiency was due to enhanced formation of the TRAIL death-inducing signalling complex, enabled by concomitant binding of Apo2L/TRAIL and AMG655 to TRAIL-R2. The synergy of AMG655 with Apo2L/TRAIL extended to primary ovarian cancer cells and was further enhanced by combination with the proteasome inhibitor bortezomib or a second mitochondrial-derived activator of caspases (SMAC) mimetic. Importantly, primary human hepatocytes were not killed by the AMG655-Apo2L/TRAIL combination, also not when further combined with bortezomib or a SMAC mimetic. We therefore propose that clinical-grade non-tagged recombinant forms of TRAIL, such as dulanermin, could be combined with antibodies such as AMG655 to introduce a highly active TRAIL-R2-agonistic therapy into the cancer clinic.	[Tuthill, M. H.; Montinaro, A.; Zinngrebe, J.; Prieske, K.; Draber, P.; Prieske, S.; Newsom-Davis, T.; von Karstedt, S.; Walczak, H.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London, England; [Tuthill, M. H.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London, England; [Graves, J.] Amgen Inc, Seattle, WA USA	Imperial College London; Imperial College London; Amgen	Walczak, H (corresponding author), UCL, Inst Canc, Room 416,Paul OGorman Bldg,72 Huntley St, London WC1E 6DD, England.	h.walczak@ucl.ac.uk	Walczak, Henning/AAV-2214-2020; Draber, Peter/G-3141-2014	Walczak, Henning/0000-0002-6312-4591; Draber, Peter/0000-0001-8658-4614	Medical Research Council [MC_EX_G0802342]; Cancer Research UK [C33499/A10950]; Ovarian Cancer Action; Association for International Cancer Research; Cancer Research UK [10950] Funding Source: researchfish; MRC [MC_EX_G0802342] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Ovarian Cancer Action(Ovarian Cancer Action); Association for International Cancer Research; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and the staff at Imperial College Healthcare NHS Trust for providing and collecting the ovarian cancer ascites samples for this research. AMG655 was kindly provided by AMGEN Inc. (Thousand Oaks, CA, USA). We thank B Vogelstein and R Youle for providing cell lines. We also thank Dr C Kantari for technical advice and helpful discussions. This work has been funded by the Medical Research Council by providing a Clinical Research Training Fellowship for MHT (MC_EX_G0802342), Cancer Research UK, (C33499/A10950), Ovarian Cancer Action, and the Association for International Cancer Research. The SMAC mimetic compound SM083 (also known as SM 9a) was synthesised and kindly provided by P Seneci and L Manzoni.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Gieffers C, 2013, MOL CANCER THER, V12, P2735, DOI 10.1158/1535-7163.MCT-13-0323; Gillissen B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.67; Goncharenko-Khaider N, 2010, ONCOGENE, V29, P5523, DOI 10.1038/onc.2010.288; Haynes NM, 2010, J IMMUNOL, V185, P532, DOI 10.4049/jimmunol.0903624; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Kaplan-Lefko PJ, 2010, CANCER BIOL THER, V9, P618, DOI 10.4161/cbt.9.8.11264; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Koschny R, 2007, HEPATOLOGY, V45, P649, DOI 10.1002/hep.21555; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lecis D, 2012, BIOORGAN MED CHEM, V20, P6709, DOI 10.1016/j.bmc.2012.09.041; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Newsom-Davis T, 2009, APOPTOSIS, V14, P607, DOI 10.1007/s10495-009-0321-2; Paz-Ares L, 2013, J THORAC ONCOL, V8, P329, DOI 10.1097/JTO.0b013e31827ce554; Petrucci E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035073; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012	27	48	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2138	2144		10.1038/onc.2014.156	http://dx.doi.org/10.1038/onc.2014.156			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909167	Green Accepted			2022-12-25	WOS:000353173400013
J	Bianchi, R; Fischer, E; Yuen, D; Ernst, E; Ochsenbein, AM; Chen, L; Otto, VI; Detmar, M				Bianchi, Roberta; Fischer, Eliane; Yuen, Don; Ernst, Ellen; Ochsenbein, Alexandra M.; Chen, Lu; Otto, Vivianne I.; Detmar, Michael			Mutation of Threonine 34 in Mouse Podoplanin-Fc Reduces CLEC-2 Binding and Toxicity in Vivo While Retaining Anti-lymphangiogenic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; AGGREGATION-INDUCING FACTOR; ACTIVATION RECEPTOR CLEC-2; LECTIN-LIKE RECEPTORS; PLATELET-AGGREGATION; BLOOD; SEPARATION; MIGRATION; PROTEIN; IDENTIFICATION	The lymphatic system plays an important role in cancer metastasis and inhibition of lymphangiogenesis could be valuable in fighting cancer dissemination. Podoplanin (Pdpn) is a small, transmembrane glycoprotein expressed on the surface of lymphatic endothelial cells (LEC). During mouse development, binding of Pdpn to the C-type lectin-like receptor 2 (CLEC-2) on platelets is critical for the separation of the lymphatic and blood vascular systems. Competitive inhibition of Pdpn functions with a soluble form of the protein, Pdpn-Fc, leads to reduced lymphangiogenesis in vitro and in vivo. However, the transgenic overexpression of human Pdpn-Fc in mouse skin causes disseminated intravascular coagulation due to platelet activation via CLEC-2. In the present study, we produced and characterized a mutant form of mouse Pdpn-Fc, in which threonine 34, which is considered essential for CLEC-2 binding, was mutated to alanine (PdpnT34A-Fc). Indeed, PdpnT34A-Fc displayed a 30-fold reduced binding affinity for CLEC-2 compared with Pdpn-Fc. This also translated into fewer side effects due to platelet activation in vivo. Mice showed less prolonged bleeding time and fewer embolized vessels in the liver, when PdpnT34A-Fc was injected intravenously. However, PdpnT34A-Fc was still as active as wild-type Pdpn-Fc in inhibiting lymphangiogenesis in vitro and also inhibited lymphangiogenesis in vivo. These data suggest that the function of Pdpn in lymphangiogenesis does not depend on threonine 34 in the CLEC-2 binding domain and that PdpnT34A-Fc might be an improved inhibitor of lymphangiogenesis with fewer toxic side effects.	[Bianchi, Roberta; Ernst, Ellen; Ochsenbein, Alexandra M.; Otto, Vivianne I.; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland; [Fischer, Eliane] Paul Scherrer Inst, Ctr Radiopharmaceut Sci, CH-5232 Villigen, Switzerland; [Yuen, Don; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Berkeley, CA 94720 USA; [Yuen, Don; Chen, Lu] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Detmar, M (corresponding author), ETH, Vladimir Prelog Weg 3,HCI H303, CH-8093 Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Fischer, Eliane/M-2590-2013	Fischer, Eliane/0000-0002-3399-3737; Otto, Vivianne/0000-0002-1157-0186	National Institutes of Health; Swiss National Science Foundation [31003A-130627]; European Research Council Grant LYVICAM; Oncosuisse; Leducq Foundation; Krebsliga Zurich; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council Grant LYVICAM; Oncosuisse; Leducq Foundation(Leducq Foundation); Krebsliga Zurich; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, Swiss National Science Foundation Grant 31003A-130627, European Research Council Grant LYVICAM, Oncosuisse, Krebsliga Zurich, and the Leducq Foundation.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Colonna M, 2000, EUR J IMMUNOL, V30, P697; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kaneko M, 2004, J BIOL CHEM, V279, P38838, DOI 10.1074/jbc.M407210200; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerrigan AM, 2012, J THROMB HAEMOST, V10, P484, DOI 10.1111/j.1538-7836.2011.04614.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; NOVAKHOFER I, 1992, J NUCL MED, V33, P231; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; Pyz E, 2011, METHODS MOL BIOL, V748, P1, DOI 10.1007/978-1-61779-139-0_1; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Scholl FG, 1999, J CELL SCI, V112, P4601; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, PLATELETS, V22, P380, DOI 10.3109/09537104.2011.556274; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Valtcheva N, 2013, J BIOL CHEM, V288, P35736, DOI 10.1074/jbc.M113.512954; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Williams MC, 1996, AM J RESP CELL MOL, V14, P577, DOI 10.1165/ajrcmb.14.6.8652186; Zhang H, 2011, INVEST OPHTH VIS SCI, V52, P6529, DOI 10.1167/iovs.11-7454; Zuberbuhler K, 2009, PROTEIN ENG DES SEL, V22, P169, DOI 10.1093/protein/gzn068	41	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21016	21027		10.1074/jbc.M114.550525	http://dx.doi.org/10.1074/jbc.M114.550525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907275	Green Published, hybrid			2022-12-25	WOS:000339396600054
J	Jensen, DD; Halls, ML; Murphy, JE; Canals, M; Cattaruzza, F; Poole, DP; Lieu, T; Koon, HW; Pothoulakis, C; Bunnett, NW				Jensen, Dane D.; Halls, Michelle L.; Murphy, Jane E.; Canals, Meritxell; Cattaruzza, Fiore; Poole, Daniel P.; Lieu, TinaMarie; Koon, Hon-Wai; Pothoulakis, Charalabos; Bunnett, Nigel W.			Endothelin-converting Enzyme 1 and beta-Arrestins Exert Spatiotemporal Control of Substance P-induced Inflammatory Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INTERLEUKIN-8 EXPRESSION; PROTEIN-COUPLED RECEPTORS; COLONIC EPITHELIAL-CELLS; NEUTRAL ENDOPEPTIDASE; NEUROKININ RECEPTORS; TRAFFICKING; ENDOSOMES; BETA-ARRESTIN-1; COLITIS; RESENSITIZATION	Although the intracellular trafficking of G protein-coupled receptors controls specific signaling events, it is unclear how the spatiotemporal control of signaling contributes to complex pathophysiological processes such as inflammation. By using bioluminescence resonance energy transfer and superresolution microscopy, we found that substance P (SP) induces the association of the neurokinin 1 receptor(NK1R) with two classes of proteins that regulate SP signaling from plasma and endosomal membranes: the scaffolding proteins beta-arrestin (beta ARRs) 1 and 2 and the transmembrane metallopeptidases ECE-1c and ECE-1d. In HEK293 cells and non-transformed human colonocytes, we observed that G protein-coupled receptor kinase 2 and beta ARR1/2 terminate plasma membrane Ca2+ signaling and initiate receptor trafficking to endosomes that is necessary for sustained activation of ERKs in the nucleus. beta ARRs deliver the SP-NK1R endosomes, where ECE-1 associates with the complex, degrades SP, and allows the NK1R, freed from beta ARRs, to recycle. Thus, both ECE-1 and beta ARRs mediate the resensitization of NK1R Ca2+ signaling at the plasma membrane. Sustained exposure of colonocytes to SP activates NF-kappa B and stimulates IL-8 secretion. This proinflammatory signaling is unaffected by inhibition of the endosomal ERK pathway but is suppressed by ECE-1 inhibition or beta ARR2 knockdown. Inhibition of protein phosphatase 2A, which also contributes to sustained NK1R signaling at the plasma membrane, similarly attenuates IL-8 secretion. Thus, the primary function of beta ARRs and ECE-1 in SP-dependent inflammatory signaling is to promote resensitization, which allows the sustained NK1R signaling from the plasma membrane that drives inflammation.	[Jensen, Dane D.; Halls, Michelle L.; Canals, Meritxell; Poole, Daniel P.; Lieu, TinaMarie; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Murphy, Jane E.; Cattaruzza, Fiore] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Koon, Hon-Wai; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Inflammatory Bowel Dis Res Ctr, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	Nigel.Bunnett@Monash.edu	Poole, Daniel/AET-6645-2022; Lieu, TinaMarie/AAM-7691-2020	Poole, Daniel/0000-0002-6168-8422; Canals, Meritxell/0000-0002-7942-5006; Bunnett, Nigel W./0000-0003-3367-0644; Jensen, Dane D./0000-0001-6540-2375; Halls, Michelle/0000-0001-8555-8959	National Institutes of Health [DK47343]; National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47343 (to C. P.). This work was also supported by National Health and Medical Research Council Grants 63303, 1049682, and 1031886 and by Monash University (to N. W. B.).	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DRAPEAU G, 1987, NEUROPEPTIDES, V10, P43, DOI 10.1016/0143-4179(87)90088-6; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jorgensen R, 2008, MOL PHARMACOL, V73, P349, DOI 10.1124/mol.107.038877; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lee S, 2009, INFLAMM BOWEL DIS, V15, P1007, DOI 10.1002/ibd.20877; Lee T, 2013, AM J PATHOL, V182, P1114, DOI 10.1016/j.ajpath.2012.12.025; Lu B, 1997, NAT MED, V3, P904, DOI 10.1038/nm0897-904; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; OKAMOTO A, 1994, BIOCHEM J, V299, P683, DOI 10.1042/bj2990683; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Wang HY, 2010, FASEB J, V24, P1971, DOI 10.1096/fj.09-137646; Zhao DZ, 2002, BIOCHEM J, V368, P665, DOI 10.1042/BJ20020950; Zhao PS, 2013, J BIOL CHEM, V288, P25689, DOI 10.1074/jbc.M113.496414	31	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20283	20294		10.1074/jbc.M114.578179	http://dx.doi.org/10.1074/jbc.M114.578179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898255	hybrid, Green Published			2022-12-25	WOS:000339395200040
J	Yabas, M; Coupland, LA; Cromer, D; Winterberg, M; Teoh, NC; D'Rozario, J; Kirk, K; Broer, S; Parish, CR; Enders, A				Yabas, Mehmet; Coupland, Lucy A.; Cromer, Deborah; Winterberg, Markus; Teoh, Narci C.; D'Rozario, James; Kirk, Kiaran; Broeer, Stefan; Parish, Christopher R.; Enders, Anselm			Mice Deficient in the Putative Phospholipid Flippase ATP11C Exhibit Altered Erythrocyte Shape, Anemia, and Reduced Erythrocyte Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; BIOLOGICAL-MEMBRANES; PHOSPHATIDYLSERINE; IDENTIFICATION; ASYMMETRY; ATPASE; TRANSLOCATION; PURIFICATION; DISEASE; GENE	Transmembrane lipid transporters are believed to establish and maintain phospholipid asymmetry in biological membranes; however, little is known about the in vivo function of the specific transporters involved. Here, we report that developing erythrocytes from mice lacking the putative phosphatidylserine flippase ATP11Cshowed a lower rate of PS translocation in vitro compared with erythrocytes from wild-type littermates. Furthermore, the mutant mice had an elevated percentage of phosphatidylserine exposing mature erythrocytes in the periphery. Although erythro-cyte development in ATP11C-deficient mice was normal, the mature erythrocytes had an abnormal shape ( stomatocytosis), and the life span of mature erythrocytes was shortened relative to that in control littermates, resulting in anemia in the mutant mice. Thus, our findings uncover an essential role for ATP11C in erythrocyte morphology and survival and provide a new candidate for the rare inherited blood disorder stomatocytosis with uncompensated anemia.	[Yabas, Mehmet; Enders, Anselm] Australian Natl Univ, John Curtin Sch Med Res, Ramaciotti Immunizat Genom Lab, Canberra, ACT 2601, Australia; [Coupland, Lucy A.; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, Canc & Vasc Biol Grp, Dept Immunol, Canberra, ACT 2601, Australia; [Winterberg, Markus; Kirk, Kiaran; Broeer, Stefan] Australian Natl Univ, Div Biomed Sci & Biochem, Res Sch Biol, Canberra, ACT 2601, Australia; [Coupland, Lucy A.; D'Rozario, James] Canberra Hosp, Clin Haematol Unit, Canberra, ACT 2605, Australia; [Cromer, Deborah] Univ New S Wales, Complex Syst Biol Grp, Ctr Vasc Res, Kensington, NSW 2052, Australia; [Teoh, Narci C.] Australian Natl Univ, Sch Med, Canberra Hosp, Liver Res Grp, Canberra, ACT 2605, Australia	Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Australian National University; Australian National University; Canberra Hospital; University of New South Wales Sydney; Australian National University; Canberra Hospital	Enders, A (corresponding author), Australian Natl Univ, Dept Immunol, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2601, Australia.	anselm.enders@anu.edu.au	Kirk, Kiaran/C-8299-2009; Yabas, Mehmet/D-9513-2012; Broer, Stefan/A-1286-2008; Enders, Anselm/B-1165-2011; Coupland, Lucy/W-2001-2019	Kirk, Kiaran/0000-0002-5613-2622; Yabas, Mehmet/0000-0002-3462-5389; Broer, Stefan/0000-0002-8040-1634; Enders, Anselm/0000-0001-5933-6463; Cromer, Deborah/0000-0002-5276-5094; Coupland, Lucy/0000-0002-8912-9534; Parish, Christopher/0000-0001-7740-0430; Winterberg, Markus/0000-0002-8529-9317	National Health and Medical Research Council [GNT1061288, GNT1035858]; Ministry of National Education, Republic of Turkey; University of New South Wales; Ramaciotti Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ministry of National Education, Republic of Turkey(Ministry of National Education - Turkey); University of New South Wales; Ramaciotti Foundation	This work was supported in part by National Health and Medical Research Council Grant GNT1061288.; Supported by a postgraduate award from the Ministry of National Education, Republic of Turkey.; Supported by National Health and Medical Research Council program grants.; Supported by a University of New South Wales Vice-Chancellor's postdoctoral fellowship.; Supported by National Health and Medical Research Council Career Development Fellowship GNT1035858 and by the Ramaciotti Foundation. To whom correspondence should be addressed: Ramaciotti Immunization Genomics Laboratory, Dept. of Immunology, The John Curtin School of Medical Research, Australian National University, GPO Box 334, Canberra, ACT 2601, Australia. Tel.: 61-2-6125-7605; Fax: 61-2-6125-8512; E-mail: anselm.enders@anu.edu.au.	An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; AULAND ME, 1994, ARCH BIOCHEM BIOPHYS, V312, P272, DOI 10.1006/abbi.1994.1309; Bruce LJ, 2009, BLOOD CELL MOL DIS, V42, P216, DOI 10.1016/j.bcmd.2009.01.014; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cacciagli P, 2010, EUR J HUM GENET, V18, P1360, DOI 10.1038/ejhg.2010.126; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Coupland LA, 2010, EXP HEMATOL, V38, P453, DOI 10.1016/j.exphem.2010.03.003; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; DALEKE DL, 1992, ANN NY ACAD SCI, V671, P468, DOI 10.1111/j.1749-6632.1992.tb43832.x; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; DUCROU W, 1969, MED J AUSTRALIA, V2, P1087, DOI 10.5694/j.1326-5377.1969.tb107626.x; Kean LS, 2002, EXP HEMATOL, V30, P394, DOI 10.1016/S0301-472X(02)00780-4; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuypers FA, 1998, BLOOD, V91, P3044, DOI 10.1182/blood.V91.8.3044.3044_3044_3051; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MCEVOY L, 1986, P NATL ACAD SCI USA, V83, P3311, DOI 10.1073/pnas.83.10.3311; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; MORIYAMA Y, 1988, J BIOL CHEM, V263, P8521; MORROT G, 1990, FEBS LETT, V266, P29, DOI 10.1016/0014-5793(90)81498-D; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Winterberg M, 2012, BLOOD, V119, P3604, DOI 10.1182/blood-2011-10-386003; Wood BL, 1996, BLOOD, V88, P1873; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yasin Z, 2003, BLOOD, V102, P365, DOI 10.1182/blood-2002-11-3416; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	42	46	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19531	19537		10.1074/jbc.C114.570267	http://dx.doi.org/10.1074/jbc.C114.570267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24898253	hybrid, Green Published			2022-12-25	WOS:000339326800028
J	Sriurairatana, S; Boonyawiwat, V; Gangnonngiw, W; Laosutthipong, C; Hiranchan, J; Flegel, TW				Sriurairatana, Siriporn; Boonyawiwat, Visanu; Gangnonngiw, Warachin; Laosutthipong, Chaowanee; Hiranchan, Jindanan; Flegel, Timothy W.			White Feces Syndrome of Shrimp Arises from Transformation, Sloughing and Aggregation of Hepatopancreatic Microvilli into Vermiform Bodies Superficially Resembling Gregarines	PLOS ONE			English	Article							SURFACE-MORPHOLOGY; MARINE GREGARINES; N. SP.; LITOPENAEUS-VANNAMEI; MOLECULAR PHYLOGENY; SEPTATE GREGARINE; SELENIDIUM SPP.; APICOMPLEXA; EUGREGARINORIDA; PTEROSPORA	Accompanying acute hepatopancreatic necrosis disease (AHPND) in cultivated Asian shrimp has been an increasing prevalence of vermiform, gregarine-like bodies within the shrimp hepatopancreas (HP) and midgut. In high quantity they result in white fecal strings and a phenomenon called white feces syndrome (WFS). Light microscopy (LM) of squash mounts and stained smears from fresh HP tissue revealed that the vermiform bodies are almost transparent with widths and diameters proportional to the HP tubule lumens in which they occur. Despite vermiform appearance, they show no cellular structure. At high magnification (LM with 40-100x objectives), they appear to consist of a thin, outer membrane enclosing a complex of thicker, inter-folded membranes. Transmission electron microscopy (TEM) revealed that the outer non-laminar membrane of the vermiform bodies bore no resemblance to a plasma membrane or to the outer layer of any known gregarine, other protozoan or metazoan. Sub-cellular organelles such as mitochondria, nuclei, endoplasmic reticulum and ribosomes were absent. The internal membranes had a tubular sub-structure and occasionally enclosed whole B-cells, sloughed from the HP tubule epithelium. These internal membranes were shown to arise from transformed microvilli that peeled away from HP tubule epithelial cells and then aggregated in the tubule lumen. Stripped of microvilli, the originating cells underwent lysis. By contrast, B-cells remained intact or were sloughed independently and whole from the tubule epithelium. When sometimes engulfed by the aggregated, transformed microvilli (ATM) they could be misinterpreted as cyst-like structures by light microscopy, contributing to gregarine-like appearance. The cause of ATM is currently unknown, but formation by loss of microvilli and subsequent cell lysis indicate that their formation is a pathological process. If sufficiently severe, they may retard shrimp growth and may predispose shrimp to opportunistic pathogens. Thus, the cause of ATM and their relationship (if any) to AHPND should be determined.	[Sriurairatana, Siriporn; Laosutthipong, Chaowanee; Hiranchan, Jindanan; Flegel, Timothy W.] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand; [Boonyawiwat, Visanu] Kasetsart Univ, Fac Vet Med, Dept Farm Resources & Prod Med, Bangkok, Thailand; [Gangnonngiw, Warachin; Flegel, Timothy W.] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pratum Thani, Thailand; [Laosutthipong, Chaowanee; Hiranchan, Jindanan] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand	Mahidol University; Kasetsart University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Flegel, TW (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand.	sctwf@mahidol.ac.th		laosutthipong, chaowanee/0000-0001-5586-797X; Flegel, Timothy W./0000-0002-1913-213X	Surathani Shrimp Farmers Club; Frozen Food Association of Thailand; Charoen Pokphand Company Ltd.; Thai Commission for Higher Education; National Research Council of Thailand; Mahidol University	Surathani Shrimp Farmers Club; Frozen Food Association of Thailand; Charoen Pokphand Company Ltd.; Thai Commission for Higher Education; National Research Council of Thailand(National Research Council of Thailand (NRCT)); Mahidol University	Partial funding for this work was obtained from the Surathani Shrimp Farmers Club, the Frozen Food Association of Thailand, Charoen Pokphand Company Ltd., the Thai Commission for Higher Education, the National Research Council of Thailand and Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell T.A., 1988, HDB NORMAL PENAEID S; Dilokkiet S, 2010, AQUABIZ, V36, P37; Ha NTH, 2010, AGR RURAL DEV SCI TE, V12, P45; Jimenez R, 2002, AQUAC RES, V33, P231, DOI 10.1046/j.1355-557x.2002.00647.x; Johnson P.T., 1980, HISTOLOGY BLUE CRAB; JONES TC, 1994, DIS AQUAT ORGAN, V19, P67, DOI 10.3354/dao019067; Landers SC, 2005, J EUKARYOT MICROBIOL, V52, P23, DOI 10.1111/j.1550-7408.2005.3277rrr.x; Leander BS, 2008, TRENDS PARASITOL, V24, P60, DOI 10.1016/j.pt.2007.11.005; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; Leander BS, 2003, J PARASITOL, V89, P1191, DOI 10.1645/GE-3155; Lightner DV, 1996, HDB PATHOLOGY DIAGNO; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Poulpanich N, 2009, DIS AQUAT ORGAN, V86, P57, DOI 10.3354/dao02094; Rueckert S, 2008, ZOOL SCR, V37, P637, DOI 10.1111/j.1463-6409.2008.00346.x; Rueckert S, 2013, J EUKARYOT MICROBIOL, V60, P121, DOI 10.1111/jeu.12015; Rueckert S, 2009, J EUKARYOT MICROBIOL, V56, P428, DOI 10.1111/j.1550-7408.2009.00422.x; Tangprasittipap A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-139; Tangtrongpiros J, 2010, PUBL SEM VET MED AQ	18	51	54	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99170	10.1371/journal.pone.0099170	http://dx.doi.org/10.1371/journal.pone.0099170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911022	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600050
J	Cho, H; Noh, KH; Chung, JY; Takikita, M; Chung, EJ; Kim, BW; Hewitt, SM; Kim, TW; Kim, JH				Cho, Hanbyoul; Noh, Kyung Hee; Chung, Joon-Yong; Takikita, Mikiko; Chung, Eun Joo; Kim, Bo Wook; Hewitt, Stephen M.; Kim, Tae Woo; Kim, Jae-Hoon			Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; ACTIVATION; GENE; EXPRESSION; RESISTANCE; CHEMOTHERAPY; SURVIVAL; PATHWAY; FAMILY; DEATH	Synaptonemal complex protein 3 (SCP3), a member of Cor1 family, is up-regulated in various cancer cells; however, its oncogenic potential and clinical significance has not yet been characterized. In the present study, we investigated the oncogenic role of SCP3 and its relationship with phosphorylated AKT (pAKT) in cervical neoplasias. The functional role of SCP3 expression was investigated by overexpression or knockdown of SCP3 in murine cell line NIH3T3 and human cervical cancer cell lines CUMC6, SiHa, CaSki, and HeLa both in vitro and in vivo. Furthermore, we examined SCP3 expression in tumor specimens from 181 cervical cancer and 400 cervical intraepithelial neoplasia (CIN) patients by immunohistochemistry and analyzed the correlation between SCP3 expression and clinicopathologic factors or survival. Overexpression of SCP3 promoted AKT-mediated tumorigenesis both in vitro and in vivo. Functional studies using NIH3T3 cells demonstrated that the C-terminal region of human SCP3 is important for AKT activation and its oncogenic potential. High expression of SCP3 was significantly associated with tumor stage (P = 0.002) and tumor grade (P<0.001), while SCP3 expression was positively associated with pAKT protein level in cervical neoplasias. Survival times for patients with cervical cancer overexpressing both SCP3 and pAKT (median, 134.0 months, n = 68) were significantly shorter than for patients with low expression of either SCP3 or pAKT (161.5 months, n = 108) as determined by multivariate analysis (P = 0.020). Our findings suggest that SCP3 plays an important role in the progression of cervical cancer through the AKT signaling pathway, supporting the possibility that SCP3 may be a promising novel cancer target for cervical cancer therapy.	[Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Grad Sch Med, Lab Infect & Immunol, Ansan, Gyeonggi Do, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea; [Chung, Joon-Yong; Takikita, Mikiko; Kim, Bo Wook; Hewitt, Stephen M.] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chung, Eun Joo] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kim, TW (corresponding author), Korea Univ, Grad Sch Med, Lab Infect & Immunol, Ansan, Gyeonggi Do, South Korea.	twkim0421@korea.com; jaehoonkim@yuhs.ac	Chung, Joon-Yong/J-9177-2017	Chung, Joon-Yong/0000-0001-5041-5982; Hewitt, Stephen/0000-0001-8283-1788; Cho, Hanbyoul/0000-0002-6177-1648; Jae-Hoon, Kim/0000-0001-6599-7065	National Research Foundation of Korea [2012R1A2A2A01007527, 2012R1A6A3A01010537, 2011-0005230, 2011-0010286, 2011-0007146]; Korea Healthcare Technology RD Project [A121387, A110057, A062260]; Yonsei University College of Medicine [3-2010-0072, 6-2011-0073, 6-2013-0106]; NIH, National Cancer Institute, Center for Cancer research; NATIONAL CANCER INSTITUTE [ZICBC010923] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology RD Project; Yonsei University College of Medicine(General Electric); NIH, National Cancer Institute, Center for Cancer research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Research Foundation of Korea (2012R1A2A2A01007527, 2012R1A6A3A01010537, 2011-0005230, 2011-0010286, and 2011-0007146), the Korea Healthcare Technology R&D Project (A121387, A110057 and A062260), and faculty research grants from Yonsei University College of Medicine (3-2010-0072, 6-2011-0073, and 6-2013-0106). This research was supported, in part, by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bansal N, 2012, J GYNECOL ONCOL, V23, P35, DOI 10.3802/jgo.2012.23.1.35; Botelho RJ, 2001, BBA-GENE STRUCT EXPR, V1518, P294, DOI 10.1016/S0167-4781(01)00171-3; Brognard J, 2001, CANCER RES, V61, P3986; Chung JY, 2013, HUM PATHOL, V44, P472, DOI 10.1016/j.humpath.2012.06.018; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Goodwin Scott C, 2003, J Vasc Interv Radiol, V14, pS467; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; Kang TH, 2010, CANCER RES, V70, P3062, DOI 10.1158/0008-5472.CAN-09-3856; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Lim SH, 1999, BRIT J CANCER, V81, P1162, DOI 10.1038/sj.bjc.6690824; Miemeyer P, 2003, LEUKEMIA RES, V27, P655, DOI 10.1016/S0145-2126(02)00230-8; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Parmigiani RB, 2006, P NATL ACAD SCI USA, V103, P18066, DOI 10.1073/pnas.0608853103; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Smith HA, 2011, CANCER RES, V71, P6785, DOI 10.1158/0008-5472.CAN-11-2127; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98712	10.1371/journal.pone.0098712	http://dx.doi.org/10.1371/journal.pone.0098712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905095	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000051
J	Kim, MJ; Lim, NK; Choi, YM; Kim, JJ; Hwang, KR; Chae, SJ; Park, CW; Choi, DS; Kang, BM; Lee, BS; Kim, T; Park, HY				Kim, Min-Ju; Lim, Nam-Kyoo; Choi, Young-Min; Kim, Jin-Ju; Hwang, Kyu-Ri; Chae, Soo-Jin; Park, Chan-Woo; Choi, Doo-Seok; Kang, Byung-Moon; Lee, Byung-Seok; Kim, Tak; Park, Hyun-Young			Prevalence of Metabolic Syndrome Is Higher among Non-Obese PCOS Women with Hyperandrogenism and Menstrual Irregularity in Korea	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INSULIN-RESISTANCE; CRITERIA; HEALTH; SAMPLE; RISK	Background: Hyperandrogenism (HA) has been linked with several components of metabolic syndrome (MetS). Few studies in Asian women have evaluated the important risk factors for and prevalence of MetS according to PCOS subtype. In this study, we investigated differences in metabolic parameters and the prevalence of MetS in two major phenotypic subgroups of PCOS in Korea. Furthermore, we investigated the relationship between HA-associated parameters and MetS. Materials and Methods: This cross-sectional observational study was conducted from May 2010 to December 2011 in Korea. A total of 837 females with PCOS, aged 15-40, were recruited from Departments of Obstetrics and Gynecology at 13 hospitals. Of those, 700 subjects with either polycystic ovaries (PCO)+HA+oligomenorrhea/amenorrhea (O) or PCO+O were eligible for this study. MetS was diagnosed according to the modified National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines and the International Diabetes Federation (IDF) criteria. Results: MetS was more prevalent in the PCO+HA+O group (19.7%) than in the PCO+O (11.9%) group. There were statistically significant trends for an increased risk of MetS in the PCO+HA+O group compared to the PCO+O group. After adjustment for age, the odds ratio of MetS was 2.192 in non-obese subjects with PCO+HA+O compared to those with PCO+O, whereas the risk of MetS was not different in obese patients. Multivariate logistic regression analysis showed that high free androgen index and low sex hormone-binding globulin were significantly associated with MetS in non-obese women with PCOS, with odds ratios of 4.234 (95% CI, 1.893-9.474) and 4.612 (95% CI, 1.978-10.750), respectively. However, no associations were detected between MetS and SHBG and FAI in obese PCOS subjects. Conclusions: Our results indicate that HA and its associated parameters (FAI and SHBG) are significantly associated with MetS in non-obese PCOS subjects, whereas this association was not observed in obese subjects.	[Kim, Min-Ju; Lim, Nam-Kyoo; Park, Hyun-Young] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea; [Choi, Young-Min; Kim, Jin-Ju; Hwang, Kyu-Ri] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Choi, Young-Min] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea; [Kim, Jin-Ju] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul 110744, South Korea; [Hwang, Kyu-Ri] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea; [Chae, Soo-Jin] Maria Fertil Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Chan-Woo] Cheil Gen Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Chan-Woo] Womens Healthcare Ctr, Seoul, South Korea; [Choi, Doo-Seok] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Seoul Samsung Hosp, Seoul, South Korea; [Kang, Byung-Moon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Byung-Seok] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea; [Kim, Tak] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Park, HY (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Cardiovasc & Rare Dis, Chungbuk, South Korea.	mdhypark@gmail.com		Park, Hyun-Young/0000-0002-6698-7368; Chae, Soojin/0000-0002-3376-0167; Kim, Tak/0000-0003-1514-3576	Korea National Institute of Health [4800-4861-303 (2012-N63001-00), 4800-4845-302 (2010-N63001-00)]	Korea National Institute of Health	This work was supported by the Korea National Institute of Health intramural research grant, 4800-4861-303 (2012-N63001-00) and 4800-4845-302 (2010-N63001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Chae SJ, 2008, HUM REPROD, V23, P1924, DOI 10.1093/humrep/den239; Christakou CD, 2008, WOMENS HEALTH, V4, P583, DOI 10.2217/17455057.4.6.583; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Cussons AJ, 2008, HUM REPROD, V23, P2352, DOI 10.1093/humrep/den263; Dieudonne MN, 1998, AM J PHYSIOL-CELL PH, V274, pC1645, DOI 10.1152/ajpcell.1998.274.6.C1645; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Essah PA, 2006, J ENDOCRINOL INVEST, V29, P270, DOI 10.1007/BF03345554; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fruzzetti F, 2009, GYNECOL ENDOCRINOL, V25, P335, DOI 10.1080/09513590802630146; Glueck CJ, 2003, METABOLISM, V52, P908, DOI 10.1016/S0026-0495(03)00104-5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Holte J, 1996, BAILLIERE CLIN ENDOC, V10, P221, DOI 10.1016/S0950-351X(96)80085-1; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Kim JJ, 2011, HUM REPROD, V26, P214, DOI 10.1093/humrep/deq303; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Korhonen S, 2003, FERTIL STERIL, V79, P1327, DOI 10.1016/S0015-0282(03)00347-9; Mehrabian F, 2011, J RES MED SCI, V16, P763; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Park HR, 2007, DIABETES RES CLIN PR, V77, pS243, DOI 10.1016/j.diabres.2007.01.065; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Weerakiet S, 2007, GYNECOL ENDOCRINOL, V23, P153, DOI 10.1080/09513590701214158; Yilmaz M, 2011, J OBSTET GYNAECOL RE, V37, P1020, DOI 10.1111/j.1447-0756.2010.01478.x	27	16	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99252	10.1371/journal.pone.0099252	http://dx.doi.org/10.1371/journal.pone.0099252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901345	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400112
J	Yan, TL; Li, L; Sun, BY; Liu, F; Yang, P; Chen, T; Li, T; Liu, XS				Yan, Tinglin; Li, Lu; Sun, Baiyu; Liu, Fei; Yang, Peng; Chen, Teng; Li, Tao; Liu, Xinshe			Luteolin Inhibits Behavioral Sensitization by Blocking Methamphetamine-Induced MAPK Pathway Activation in the Caudate Putamen in Mice	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; GENE-EXPRESSION; DELTA-FOSB; PROTEIN-KINASES; COCAINE; RAT; AMPHETAMINE; MECHANISMS; PLASTICITY; APOPTOSIS	Goal: To investigate the effect of luteolin on methamphetamine (MA)-induced behavioral sensitization and mitogen-activated protein kinase (MAPK) signal transduction pathway activation in mice. Methods: Mice received a single dose of MA to induce hyperactivity or repeated intermittent intraperitoneal injections of MA to establish an MA-induced behavioral sensitization mouse model. The effect of luteolin on the development and expression of MA-induced hyperactivity and behavioral sensitization was examined. The expression and activity of Delta FosB and the levels of phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2), phosphorylated c-Jun N-terminal kinase (pJNK), and phosphorylated p38 mitogen-activated protein kinase (pp38) in the caudate putamen (CPu) were measured by western blot. Results: Luteolin significantly decreased hyperactivity as well as the development and expression of MA-induced behavioral sensitization in mice. Delta FosB, pERK1/2, and pJNK levels in the CPu were higher in MA-treated mice than in control mice, whereas the pp38 level did not change. Injection of luteolin inhibited the MA-induced increase in Delta FosB, pERK1/2, and pJNK levels, but did not affect the pp38 level. Conclusions: Luteolin inhibits MA-induced hyperactivity and behavioral sensitization in mice through the ERK1/2/Delta FosB pathway. Furthermore, the JNK signaling pathway might be involved in MA-induced neurodegeneration in the CPu, and luteolin inhibits this process.	[Yan, Tinglin; Li, Lu; Sun, Baiyu; Liu, Fei; Yang, Peng; Chen, Teng; Li, Tao; Liu, Xinshe] Xi An Jiao Tong Univ, Sch Med, Dept Forens Med, Xian 710049, Shaanxi, Peoples R China; [Chen, Teng; Li, Tao; Liu, Xinshe] Xi An Jiao Tong Univ, Hlth Minist Forens Sci, Key Lab, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Li, T (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Forens Med, Xian 710049, Shaanxi, Peoples R China.	litao@mail.xjtu.edu.cn; lxins@mail.xjtu.edu.cn			National Natural Science Foundation of China [81273351, 81373253]; Key Program for International S&T Cooperation Projects of Shaanxi Province [2012kw-36-02]; Fundamental Research Funds for the Central Universities; Shaanxi Key Project on Science and Technology [2013K12-01-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for International S&T Cooperation Projects of Shaanxi Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shaanxi Key Project on Science and Technology	National Natural Science Foundation of China (No. 81273351), National Natural Science Foundation of China (No. 81373253; http://www.nsfc.gov.cn). 2012 Key Program for International S&T Cooperation Projects of Shaanxi Province (2012kw-36-02; http://www.sninfo.gov.cn). The Fundamental Research Funds for the Central Universities, Shaanxi Key Project on Science and Technology (2013K12-01-09; http://www.xjtu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai IN, 2007, BRAIN RES, V1143, P22, DOI 10.1016/j.brainres.2007.01.069; Besnard A, 2011, J NEUROSCI, V31, P14296, DOI 10.1523/JNEUROSCI.2890-11.2011; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Buchanan JB, 2010, BRAIN BEHAV IMMUN, V24, P502, DOI 10.1016/j.bbi.2009.12.008; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; CHAN P, 1994, J NEUROCHEM, V62, P2484, DOI 10.1046/j.1471-4159.1994.62062484.x; Chapman DE, 2001, J PHARMACOL EXP THER, V296, P520; CHEN JS, 1995, MOL PHARMACOL, V48, P880; Chinen CC, 2006, NEUROPSYCHOPHARMACOL, V31, P151, DOI 10.1038/sj.npp.1300789; Cohen-Matsliah SI, 2007, J NEUROSCI, V27, P12584, DOI 10.1523/JNEUROSCI.3728-07.2007; Crozier SJ, 2010, AM J PHYSIOL-GASTR L, V299, pG1154, DOI 10.1152/ajpgi.00445.2009; Do H, 2013, CELL BIOL TOXICOL, V29, P365, DOI 10.1007/s10565-013-9260-3; Fan XL, 2003, NEUROSCIENCE, V122, P997, DOI 10.1016/j.neuroscience.2003.08.062; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Han SH, 2010, J CELL BIOCHEM, V111, P1493, DOI 10.1002/jcb.22879; Hiroi N, 1998, J NEUROSCI, V18, P6952; HOTCHKISS AJ, 1980, J PHARMACOL EXP THER, V214, P257; Huang GH, 2014, ONCOL REP, V31, P2377, DOI 10.3892/or.2014.3099; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jung DH, 2010, INT IMMUNOPHARMACOL, V10, P1047, DOI 10.1016/j.intimp.2010.06.004; Kaplan GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023574; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Li JX, 2008, J CHINESE PHARM SCI, V17, P1; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Mendez IA, 2009, BEHAV BRAIN RES, V201, P74, DOI 10.1016/j.bbr.2009.01.034; Mierzejewska K, 2013, INT J MOL MED, V32, P281, DOI 10.3892/ijmm.2013.1389; Mitew S, 2013, NEUROSCIENCE; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nikaido T, 2001, MOL PHARMACOL, V59, P894, DOI 10.1124/mol.59.4.894; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Perez-Otano I, 1998, MOL BRAIN RES, V53, P41, DOI 10.1016/S0169-328X(97)00269-6; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rangaswami H, 2009, J BIOL CHEM, V284, P14796, DOI 10.1074/jbc.M806486200; Robinson TE, 2000, ADDICTION, V95, pS91; Ryu SY, 2013, EUR J PHARMACOL, V720, P391, DOI 10.1016/j.ejphar.2013.09.064; Scibelli AC, 2011, PSYCHOPHARMACOLOGY, V214, P791, DOI 10.1007/s00213-010-2086-2; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Skalnikova HK, 2013, J PROTEOMICS, V91, P41, DOI 10.1016/j.jprot.2013.06.028; SONSALLA PK, 1986, J PHARMACOL EXP THER, V238, P932; Stark F, 2011, CELL SIGNAL, V23, P876, DOI 10.1016/j.cellsig.2011.01.013; Sueyoshi N, 2009, ARCH BIOCHEM BIOPHYS, V488, P48, DOI 10.1016/j.abb.2009.06.003; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Ujike Hiroshi, 2002, Curr Psychiatry Rep, V4, P177, DOI 10.1007/s11920-002-0024-7; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Valjent E, 2000, J NEUROSCI, V20, P8701; van der Schaaf ME, 2013, NEUROPSYCHOPHARMACOL, V38, P2011, DOI 10.1038/npp.2013.100; Wang JQ, 2004, MOL NEUROBIOL, V29, P1, DOI 10.1385/MN:29:1:01; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Yim DG, 2014, ONCOGENE; Zhao N, 2014, NEUROSCIENCE, V258, P101, DOI 10.1016/j.neuroscience.2013.11.025	55	20	22	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98981	10.1371/journal.pone.0098981	http://dx.doi.org/10.1371/journal.pone.0098981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901319	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400084
J	Coggins, NL; Trakimas, D; Chang, SL; Ehrlich, A; Ray, P; Luker, KE; Linderman, JJ; Luker, GD				Coggins, Nathaniel L.; Trakimas, Danielle; Chang, S. Laura; Ehrlich, Anna; Ray, Paramita; Luker, Kathryn E.; Linderman, Jennifer J.; Luker, Gary D.			CXCR7 Controls Competition for Recruitment of beta-Arrestin 2 in Cells Expressing Both CXCR4 and CXCR7	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; G-PROTEIN; LIGAND; CXCL12; MIGRATION; BINDING; ACTIVATION; BREAST; SDF-1; INTERNALIZATION	Chemokine CXCL12 promotes growth and metastasis of more than 20 different human cancers, as well as pathogenesis of other common diseases. CXCL12 binds two different receptors, CXCR4 and CXCR7, both of which recruit and signal through the cytosolic adapter protein beta-arrestin 2. Differences in CXCL12-dependent recruitment of beta-arrestin 2 in cells expressing one or both receptors remain poorly defined. To quantitatively investigate parameters controlling association of beta-arrestin 2 with CXCR4 or CXCR7 in cells co-expressing both receptors, we used a systems biology approach combining real-time, multi-spectral luciferase complementation imaging with computational modeling. Cells expressing only CXCR4 maintain low basal association with beta-arrestin 2, and CXCL12 induces a rapid, transient increase in this interaction. In contrast, cells expressing only CXCR7 have higher basal association with beta-arrestin 2 and exhibit more gradual, prolonged recruitment of beta-arrestin 2 in response to CXCL12. We developed and fit a data-driven computational model for association of either CXCR4 or CXCR7 with beta-arrestin 2 in cells expressing only one type of receptor. We then experimentally validated model predictions that co-expression of CXCR4 and CXCR7 on the same cell substantially decreases both the magnitude and duration of CXCL12-regulated recruitment of beta-arrestin 2 to CXCR4. Co-expression of both receptors on the same cell only minimally alters recruitment of beta-arrestin 2 to CXCR7. In silico experiments also identified beta-arrestin 2 as a limiting factor in cells expressing both receptors, establishing that CXCR7 wins the "competition'' with CXCR4 for CXCL12 and recruitment of beta-arrestin 2. These results reveal how competition for beta-arrestin 2 controls integrated responses to CXCL12 in cells expressing both CXCR4 and CXCR7. These results advance understanding of normal and pathologic functions of CXCL12, which is critical for developing effective strategies to target these pathways therapeutically.	[Coggins, Nathaniel L.; Ehrlich, Anna; Ray, Paramita; Luker, Kathryn E.; Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Dept Radiol, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Trakimas, Danielle; Chang, S. Laura; Linderman, Jennifer J.] Univ Michigan, Dept Microbiol & Immunol, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Linderman, Jennifer J.; Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Luker, Gary D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Linderman, JJ (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Dept Chem Engn, Ann Arbor, MI 48109 USA.	linderma@umich.edu; gluker@umich.edu		luker, gary/0000-0001-6832-2581	United States National Institutes of Health National Cancer Institute [R01CA136553, R01CA136829, R01CA142750, P50CA093990, R01GM096040, R01EB012579]; NATIONAL CANCER INSTITUTE [P50CA093990, R01CA142750, R01CA136829, R01CA136553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096040] Funding Source: NIH RePORTER	United States National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health National Cancer Institute Grants for G. D. L.: R01CA136553, R01CA136829, R01CA142750 and P50CA093990, and for J. J. L.: R01GM096040 and R01EB012579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Fallahi-Sichani M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000778; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kinzer-Ursem TL, 2007, PLOS COMPUT BIOL, V3, P84, DOI 10.1371/journal.pcbi.0030006; Kinzer-Ursem TL, 2006, CELL SIGNAL, V18, P1732, DOI 10.1016/j.cellsig.2006.01.014; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Linderman JJ, 2009, J BIOL CHEM, V284, P5427, DOI 10.1074/jbc.R800028200; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2008, ANAL CHEM, V80, P5565, DOI 10.1021/ac8005457; Luker KE, 2012, NAT MED, V18, P172, DOI 10.1038/nm.2590; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Ma WS, 2013, J BIOL CHEM, V288, P15481, DOI 10.1074/jbc.M112.445510; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rath D, 2013, EUR HEART J; Santiago B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1900; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Villalobos V, 2010, CHEM BIOL, V17, P1018, DOI 10.1016/j.chembiol.2010.06.018; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vrecl M, 2000, PFLUG ARCH EUR J PHY, V439, pR19, DOI 10.1007/s004240000075; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; WYMAN J, 1975, P NATL ACAD SCI USA, V72, P3983, DOI 10.1073/pnas.72.10.3983; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; ZIGMOND SH, 1982, J CELL BIOL, V92, P34, DOI 10.1083/jcb.92.1.34; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98328	10.1371/journal.pone.0098328	http://dx.doi.org/10.1371/journal.pone.0098328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896823	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700032
J	Eby, LA; Helmy, O; Holsinger, LM; Young, MK				Eby, Lisa A.; Helmy, Olga; Holsinger, Lisa M.; Young, Michael K.			Evidence of Climate-Induced Range Contractions in Bull Trout Salvelinus confluentus in a Rocky Mountain Watershed, USA	PLOS ONE			English	Article							BROOK TROUT; POPULATION-STRUCTURE; STREAM TEMPERATURES; LIFE-HISTORY; RIVER-BASIN; WILDFIRE; TRENDS; DISTRIBUTIONS; CONSERVATION; ABUNDANCE	Many freshwater fish species are considered vulnerable to stream temperature warming associated with climate change because they are ectothermic, yet there are surprisingly few studies documenting changes in distributions. Streams and rivers in the U.S. Rocky Mountains have been warming for several decades. At the same time these systems have been experiencing an increase in the severity and frequency of wildfires, which often results in habitat changes including increased water temperatures. We resampled 74 sites across a Rocky Mountain watershed 17 to 20 years after initial samples to determine whether there were trends in bull trout occurrence associated with temperature, wildfire, or other habitat variables. We found that site abandonment probabilities (0.36) were significantly higher than colonization probabilities (0.13), which indicated a reduction in the number of occupied sites. Site abandonment probabilities were greater at low elevations with warm temperatures. Other covariates, such as the presence of wildfire, nonnative brook trout, proximity to areas with many adults, and various stream habitat descriptors, were not associated with changes in probability of occupancy. Higher abandonment probabilities at low elevation for bull trout provide initial evidence validating the predictions made by bioclimatic models that bull trout populations will retreat to higher, cooler thermal refuges as water temperatures increase. The geographic breadth of these declines across the region is unknown but the approach of revisiting historical sites using an occupancy framework provides a useful template for additional assessments.	[Eby, Lisa A.; Helmy, Olga] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Eby, Lisa A.; Helmy, Olga] Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT USA; [Holsinger, Lisa M.] US Forest Serv, USDA, Rocky Mt Res Stn, Fire Sci Lab, Missoula, MT USA; [Young, Michael K.] US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Missoula, MT USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Young, MK (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Missoula, MT USA.	mkyoung@fs.fed.us			Joint Fire Sciences Project [JFSP-09-1002-9]; MT NSF EPSCoR [EPS-0701906]; Longwell Foundation	Joint Fire Sciences Project; MT NSF EPSCoR; Longwell Foundation	This project was primarily funded by the Joint Fire Sciences Project (JFSP-09-1002-9). MT NSF EPSCoR (EPS-0701906) and the Longwell Foundation also provided fellowship support to O.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chokhachy R, 2008, T AM FISH SOC, V137, P1709, DOI 10.1577/T07-247.1; Al-Chokhachy R, 2009, CAN J FISH AQUAT SCI, V66, P649, DOI 10.1139/F09-026; Almodovar A, 2012, GLOBAL CHANGE BIOL, V18, P1549, DOI 10.1111/j.1365-2486.2011.02608.x; Altwegg R, 2008, BIOL LETTERS, V4, P581, DOI 10.1098/rsbl.2008.0051; Arismendi I, 2013, FRESHWATER BIOL, V58, P880, DOI 10.1111/fwb.12094; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Beer WN, 2013, GLOBAL CHANGE BIOL, V19, P2547, DOI 10.1111/gcb.12242; BJORNN TED C, 1964, TRANS AMER FISH SOC, V93, P70, DOI 10.1577/1548-8659(1964)93[70:MOPAWT]2.0.CO;2; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Comte L, 2013, ECOGRAPHY, V36, P1236, DOI 10.1111/j.1600-0587.2013.00282.x; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Copeland T, 2011, T AM FISH SOC, V140, P928, DOI 10.1080/00028487.2011.599261; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Donovan T.M., 2007, EXERCISES OCCUPANCY; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dunham J, 2003, N AM J FISH MANAGE, V23, P894, DOI 10.1577/M02-028; Dunham JB, 2007, ECOSYSTEMS, V10, P335, DOI 10.1007/s10021-007-9029-8; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Gresswell RE, 1999, T AM FISH SOC, V128, P193, DOI 10.1577/1548-8659(1999)128&lt;0193:FAAEIF&gt;2.0.CO;2; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; High B, 2008, N AM J FISH MANAGE, V28, P1687, DOI 10.1577/M06-164.1; Hines JE, 2006, PRESENCE2 V4 1 SOFTW; Howell PJ, 2010, ECOL FRESHW FISH, V19, P96, DOI 10.1111/j.1600-0633.2009.00393.x; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Isaak DJ, 2012, FISHERIES, V37, P542, DOI 10.1080/03632415.2012.742808; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Keane RE, 2008, INT J WILDLAND FIRE, V17, P696, DOI 10.1071/WF07148; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Leppi JC, 2012, CLIMATIC CHANGE, V112, P997, DOI 10.1007/s10584-011-0235-1; Luce CH, 2013, SCIENCE, V342, P1360, DOI 10.1126/science.1242335; Mahlum SK, 2011, INT J WILDLAND FIRE, V20, P240, DOI 10.1071/WF09132; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Maxwell D, 2005, J APPL ECOL, V42, P25, DOI 10.1111/j.1365-2664.2005.01000.x; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; McMahon TE, 2007, T AM FISH SOC, V136, P1313, DOI 10.1577/T06-217.1; Meyer KA, 2014, N AM J FISH MANAGE, V34, P202, DOI 10.1080/02755947.2013.869280; Montana Bull Trout Restoration Team, 2000, REST PLAN B TROUT CL; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nelson ML, 2002, ENVIRON BIOL FISH, V64, P321, DOI 10.1023/A:1016062708588; Nyce LG, 2013, N AM J FISH MANAGE, V33, P432, DOI 10.1080/02755947.2013.768565; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Rich CF, 2003, T AM FISH SOC, V132, P1053, DOI 10.1577/T02-109; Rieman BE, 2006, CAN J FISH AQUAT SCI, V63, P63, DOI 10.1139/F05-206; Rieman BE, 2000, ECOL FRESHW FISH, V9, P51, DOI 10.1034/j.1600-0633.2000.90106.x; Rieman BE, 2007, T AM FISH SOC, V136, P1552, DOI 10.1577/T07-028.1; Ruesch AS, 2012, CONSERV BIOL, V26, P873, DOI 10.1111/j.1523-1739.2012.01897.x; Selong JH, 2001, T AM FISH SOC, V130, P1026, DOI 10.1577/1548-8659(2001)130<1026:EOTOGA>2.0.CO;2; Sestrich CM, 2011, T AM FISH SOC, V140, P136, DOI 10.1080/00028487.2011.557019; Starcevich SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037257; Tarboton D. G., 2008, TERRAIN ANAL USING D; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; *US GEOL SURV, 2006, NAT EL DAT; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2011, CAN J FISH AQUAT SCI, V68, P988, DOI [10.1139/F2011-034, 10.1139/f2011-034]; Williams JE, 2011, FISHERIES, V36, P267, DOI 10.1080/03632415.2011.582398; Winfield IJ, 2010, HYDROBIOLOGIA, V650, P55, DOI 10.1007/s10750-009-0078-1	66	59	63	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98812	10.1371/journal.pone.0098812	http://dx.doi.org/10.1371/journal.pone.0098812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897341	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700082
J	Yednock, BK; Neigel, JE				Yednock, Bree K.; Neigel, Joseph E.			Detecting Selection in the Blue Crab, Callinectes sapidus, Using DNA Sequence Data from Multiple Nuclear Protein-Coding Genes	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; NATURAL-POPULATIONS; STATISTICAL TESTS; HAPLOTYPE RECONSTRUCTION; PARASITIC DINOFLAGELLATE; POSITIVE SELECTION; ESCAPE MUTATIONS; NEUTRAL MODEL; NULL ALLELES; C-SIMILIS	The identification of genes involved in the adaptive evolution of non-model organisms with uncharacterized genomes constitutes a major challenge. This study employed a rigorous and targeted candidate gene approach to test for positive selection on protein-coding genes of the blue crab, Callinectes sapidus. Four genes with putative roles in physiological adaptation to environmental stress were chosen as candidates. A fifth gene not expected to play a role in environmental adaptation was used as a control. Large samples (n > 800) of DNA sequences from C. sapidus were used in tests of selective neutrality based on sequence polymorphisms. In combination with these, sequences from the congener C. similis were used in neutrality tests based on interspecific divergence. In multiple tests, significant departures from neutral expectations and indicative of positive selection were found for the candidate gene trehalose 6-phosphate synthase (tps). These departures could not be explained by any of the historical population expansion or bottleneck scenarios that were evaluated in coalescent simulations. Evidence was also found for balancing selection at ATP-synthase subunit 9 (atps) using a maximum likelihood version of the Hudson, Kreitmen, and Aguade test, and positive selection favoring amino acid replacements within ATP/ADP translocase (ant) was detected using the McDonald-Kreitman test. In contrast, test statistics for the control gene, ribosomal protein L12 (rpl), which presumably has experienced the same demographic effects as the candidate loci, were not significantly different from neutral expectations and could readily be explained by demographic effects. Together, these findings demonstrate the utility of the candidate gene approach for investigating adaptation at the molecular level in a marine invertebrate for which extensive genomic resources are not available.	[Yednock, Bree K.; Neigel, Joseph E.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	University of Louisiana Lafayette	Yednock, BK (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	breeyednock@gmail.com			Gulf of Mexico Research Initiative; National Science Foundation [OCE-0315995]; NSF [PFUND-214]; Louisiana Board of Regents [ENH_2008-09]	Gulf of Mexico Research Initiative; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Louisiana Board of Regents	This research was made possible by grants from The Gulf of Mexico Research Initiative, the National Science Foundation (OCE-0315995 and NSF (2010)-PFUND-214), and the Louisiana Board of Regents (ENH_2008-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; ALLENDORF FW, 1982, GENETICS, V100, P497; Andolfatto P, 2000, GENETICS, V156, P257; Andolfatto P, 2008, GENETICS, V180, P1767, DOI 10.1534/genetics.108.091850; [Anonymous], 1981, ECOLOGIC ATLAS BENTH; BARNWELL FH, 1984, ZOOL J LINN SOC-LOND, V81, P23, DOI 10.1111/j.1096-3642.1984.tb02558.x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Biswas S, 2006, GENOMIC INSIGHTS POS; BRUNNER CA, 1982, QUATERNARY RES, V17, P105, DOI 10.1016/0033-5894(82)90048-5; Calderon I, 2010, MAR ECOL PROG SER, V408, P149, DOI 10.3354/meps08576; Calderon I, 2009, J MOL EVOL, V68, P366, DOI 10.1007/s00239-009-9219-4; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Chung J Sook, 2008, Saline Syst, V4, P18, DOI 10.1186/1746-1448-4-18; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; DAS T, 1993, MAR ECOL PROG SER, V98, P263, DOI 10.3354/meps098263; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; ENGEL DW, 1977, MAR BIOL, V41, P275, DOI 10.1007/BF00394915; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Eyre-Walker A, 2002, GENETICS, V162, P2017; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Fay JC, 2000, GENETICS, V155, P1405; Foxe JP, 2009, GENETICS, V183, P663, DOI 10.1534/genetics.109.104778; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; GUERIN JL, 1992, MAR BIOL, V114, P391, DOI 10.1007/BF00350029; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Hey J, 1997, GENETICS, V145, P833; HSUEH PW, 1993, PSZNI MAR ECOL, V14, P239, DOI 10.1111/j.1439-0485.1993.tb00482.x; HSUEH PW, 1992, J CRUSTACEAN BIOL, V12, P615, DOI 10.2307/1548842; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399; Issartel J, 2005, J EXP BIOL, V208, P2923, DOI 10.1242/jeb.01737; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KAPLAN NL, 1989, GENETICS, V123, P887; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kohn MH, 2004, MOL BIOL EVOL, V21, P374, DOI 10.1093/molbev/msh026; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Messick GA, 2000, DIS AQUAT ORGAN, V43, P139, DOI 10.3354/dao043139; Metcalf KS, 1995, B MAR SCI, V57, P781; Mosca E, 2012, EVOL APPL, V5, P762, DOI 10.1111/j.1752-4571.2012.00256.x; Nei M., 1987, MOL EVOLUTIONARY GEN; NEWMAN MW, 1975, J PARASITOL, V61, P554, DOI 10.2307/3279346; Nielsen EE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-276; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Otterson GA, 1997, GENE, V199, P287, DOI 10.1016/S0378-1119(97)00383-1; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; PILLER SC, 1995, J EXP BIOL, V198, P349; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robles R, 2007, MAR BIOL, V150, P1265, DOI 10.1007/s00227-006-0437-7; ROSAS C, 1994, J CRUSTACEAN BIOL, V14, P371, DOI 10.2307/1548915; Rozas J, 2001, GENETICS, V158, P1147; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SIEBERS D, 1972, MAR BIOL, V17, P291, DOI 10.1007/BF00366739; SIMONSEN KL, 1995, GENETICS, V141, P413; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; TAJIMA F, 1989, GENETICS, V123, P585; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VOELKER RA, 1980, P NATL ACAD SCI-BIOL, V77, P1091, DOI 10.1073/pnas.77.2.1091; Wall JD, 2002, GENETICS, V162, P203; Wang B, 2006, MAR BIOTECHNOL, V8, P491, DOI 10.1007/s10126-005-6136-4; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; WILLIAMS AB, 1974, FISH B-NOAA, V72, P685; Wright SI, 2004, GENETICS, V168, P1071, DOI 10.1534/genetics.104.026500; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yednock BK, 2014, MAR BIOL, V161, P871, DOI 10.1007/s00227-013-2387-1; Zeng K, 2007, MOL BIOL EVOL, V24, P1562, DOI 10.1093/molbev/msm078; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231	94	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99081	10.1371/journal.pone.0099081	http://dx.doi.org/10.1371/journal.pone.0099081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896825	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700115
J	Yokogawa, N; Murakami, H; Demura, S; Kato, S; Yoshioka, K; Hayashi, H; Ishii, T; Igarashi, T; Fang, X; Tsuchiya, H				Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Igarashi, Takashi; Fang, Xiang; Tsuchiya, Hiroyuki			Perioperative Complications of Total En Bloc Spondylectomy: Adverse Effects of Preoperative Irradiation	PLOS ONE			English	Article							SPINAL TUMORS; SURGERY; HEAD	Background: Total en bloc spondylectomy (TES) is associated with a high complication rate because it is technically demanding and involves patients compromised by cancer. Specifically, perioperative complications are more likely to occur in patients receiving preoperative irradiation. We examined the perioperative complications associated with TES in patients receiving preoperative irradiation. Methods: Seventy-seven patients underwent TES between May 2010 and April 2013. We performed a retrospective review of prospectively collected data for 50 patients with metastatic tumors of the thoracic spine, excluding patients with primary spinal tumors, lumbar spinal metastasis, and combined anterior and posterior approach TES. Patients were divided into 2 groups: those with preoperative irradiation (RT-TES group, 18 patients) and those without preoperative irradiation (TES group, 32 patients). The following perioperative complications, occurring within 2 months of surgery, were compared between the groups: intraoperative dural injuries, epidural hematomas, deep surgical-site infections, postoperative cerebrospinal fluid leakage, wound dehiscence, pleural effusions, and neurological deficits. Results: Significant differences in patient characteristics were not observed between the RT-TES and TES groups. Perioperative TES complications occurred in 20/50 patients (40.0%). The complication rate in the RT-TES group was 77.8% (14 out of 18), threefold higher than the 18.8% (6 out of 32) in the TES group (P<0.01). The incidence of complications, including intraoperative dural injuries, postoperative cerebrospinal fluid leakage, wound dehiscence, and pleural effusions, was significantly higher in the RT-TES group (P<0.01). Conclusion: The perioperative complication rate associated with TES for spinal metastasis was significantly higher among patients receiving preoperative irradiation than among those not receiving preoperative irradiation.	[Yokogawa, Noriaki; Murakami, Hideki; Demura, Satoru; Kato, Satoshi; Yoshioka, Katsuhito; Hayashi, Hiroyuki; Ishii, Takayoshi; Igarashi, Takashi; Fang, Xiang; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Dept Orthoped Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	chakkun1981chakkun@yahoo.co.jp	DEMURA, Satoru/X-8589-2019	Kato, Satoshi/0000-0003-4762-5932	Grants-in-Aid for Scientific Research [26293333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Boriani S, 2010, EUR SPINE J, V19, P231, DOI 10.1007/s00586-009-1137-z; Demura S, 2009, SPINE, V34, P635, DOI 10.1097/BRS.0b013e31819712ca; Devalia HL, 2008, INT WOUND J, V5, P40, DOI 10.1111/j.1742-481X.2007.00351.x; Dormand Emma-Louise, 2005, Int Wound J, V2, P112, DOI 10.1111/j.1742-4801.2005.00079.x; Ghogawala Z, 2001, SPINE, V26, P818, DOI 10.1097/00007632-200104010-00025; JOSEPH DL, 1973, ARCH OTOLARYNGOL, V97, P381; Kawahara N, 2009, ORTHOP CLIN N AM, V40, P47, DOI 10.1016/j.ocl.2008.09.004; Murakami Hideki, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100129-10; Murakami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064818; Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036; TAYLOR JMG, 1992, INT J RADIAT ONCOL, V23, P41, DOI 10.1016/0360-3016(92)90541-O; TERZ JJ, 1981, SURGERY, V89, P449; TOMITA K, 1994, INT ORTHOP, V18, P291; Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3; Wang Junru, 2006, Hernia, V10, P502, DOI 10.1007/s10029-006-0150-y	17	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98797	10.1371/journal.pone.0098797	http://dx.doi.org/10.1371/journal.pone.0098797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893004	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400093
J	DeBord, JD; Smith, DF; Anderton, CR; Heeren, RMA; Pasa-Tolic, L; Gomer, RH; Fernandez-Lima, FA				DeBord, John Daniel; Smith, Donald F.; Anderton, Christopher R.; Heeren, Ron M. A.; Pasa-Tolic, Ljiljana; Gomer, Richard H.; Fernandez-Lima, Francisco A.			Secondary Ion Mass Spectrometry Imaging of Dictyostelium discoideum Aggregation Streams	PLOS ONE			English	Article							TOF-SIMS; LIPID-COMPOSITION; PLASMA-MEMBRANES; ACCURACY; SURFACES; ENERGY; BEAMS	High resolution imaging mass spectrometry could become a valuable tool for cell and developmental biology, but both, high spatial and mass spectral resolution are needed to enable this. In this report, we employed Bi-3 bombardment time-off-light (Bi-3 ToF-SIMS) and C-60 bombardment Fourier transform ion cyclotron resonance secondary ion mass spectrometry (C-60 FTICR-SIMS) to image Dictyostelium discoideum aggregation streams. Nearly 300 lipid species were identified from the aggregation streams. High resolution mass spectrometry imaging (FTICR-SIMS) enabled the generation of multiple molecular ion maps at the nominal mass level and provided good coverage for fatty acyls, prenol lipids, and sterol lipids. The comparison of Bi-3 ToF-SIMS and C-60 FTICR-SIMS suggested that while the first provides fast, high spatial resolution molecular ion images, the chemical complexity of biological samples warrants the use of high resolution analyzers for accurate ion identification.	[DeBord, John Daniel; Fernandez-Lima, Francisco A.] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Smith, Donald F.; Heeren, Ron M. A.] FOM Inst AMOLF, Amsterdam, Netherlands; [Anderton, Christopher R.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	State University System of Florida; Florida International University; AMOLF; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Texas A&M University System; Texas A&M University College Station	Fernandez-Lima, FA (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	fernandf@fiu.edu	Heeren, Ron/ABA-4858-2020; Smith, Donald F/K-3939-2013	Heeren, Ron/0000-0002-6533-7179; Anderton, Christopher/0000-0002-6170-1033; Smith, Donald/0000-0003-3331-0526; Fernandez-Lima, Francisco/0000-0002-1283-4390; Gomer, Richard/0000-0003-2361-4307	NIGMS [R00GM106414, GM102280]; Department of Energy's Office of Biological and Environmental Research (DOE-BER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM106414, R01GM102280] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy's Office of Biological and Environmental Research (DOE-BER)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIGMS grants R00GM106414 to FF-L and GM102280 to RHG. A portion of this research was performed at the W. R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research (DOE-BER) and located at Pacific Northwest National Laboratory (PNNL). This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of The Netherlands Organization for Scientific Research (NWO).	Benabdellah F, 2010, ANAL BIOANAL CHEM, V396, P151, DOI 10.1007/s00216-009-3031-2; Beu SC, 2011, J AM SOC MASS SPECTR, V22, P591, DOI 10.1007/s13361-010-0057-9; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Birch GL, 2011, LIPIDOMIC PROFILING; Bouneau S, 2004, NUCL INSTRUM METH B, V225, P579, DOI 10.1016/j.nimb.2004.06.005; Brison J, 2010, J PHYS CHEM C, V114, P5565, DOI 10.1021/jp9066179; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Brunelle A, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.022902; Cheng J, 2005, ANAL CHEM, V77, P3651, DOI 10.1021/ac048131w; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Delcorte A, 2013, J PHYS CHEM C, V117, P2740, DOI 10.1021/jp308411r; Della-Negra S, 2011, SURF INTERFACE ANAL, V43, P62, DOI 10.1002/sia.3416; Ellis S, 2013, ANAL BIOANAL CHEM, P1; Fernandez-Lima FA, 2013, SURF INTERFACE ANAL, V45, P294, DOI 10.1002/sia.4901; Fernandez-Lima FA, 2011, ANAL CHEM, V83, P8448, DOI 10.1021/ac201481r; Ferreri C, 2005, CHEMBIOCHEM, V6, P1722, DOI 10.1002/cbic.200500109; Fhaner CJ, 2012, ANAL CHEM, V84, P8917, DOI 10.1021/ac302154g; Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u; Fletcher JS, 2011, MASS SPECTROM REV, V30, P142, DOI 10.1002/mas.20275; Fletcher JS, 2008, ANAL CHEM, V80, P9058, DOI 10.1021/ac8015278; Fletcher JS, 2006, ANAL CHEM, V78, P1827, DOI 10.1021/ac051624w; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gilmore IS, 2013, J VAC SCI TECHNOL A, V31, DOI 10.1116/1.4816935; Gormanns P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030576; Green FM, 2011, ANAL CHEM, V83, P3239, DOI 10.1021/ac200067s; HASE A, 1981, Journal of the Faculty of Science Hokkaido University Series V Botany, V12, P183; Jang W, 2011, EUKARYOT CELL, V10, P150, DOI 10.1128/EC.00219-10; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; LONG BH, 1974, J BIOL CHEM, V249, P521; Muramoto S, 2012, ANAL CHEM, V84, P365, DOI 10.1021/ac202713k; Novikov A, 2005, RAPID COMMUN MASS SP, V19, P1851, DOI 10.1002/rcm.1995; Ostrowski SG, 2005, ANAL CHEM, V77, P6190, DOI 10.1021/ac0508189; Paquet VE, 2013, EUKARYOT CELL, V12, P1326, DOI 10.1128/EC.00107-13; Petkovic M, 2001, ANAL BIOCHEM, V289, P202, DOI 10.1006/abio.2000.4926; Piehowski PD, 2008, ANAL CHEM, V80, P8662, DOI 10.1021/ac801591r; Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v; SINGH SB, 1991, TETRAHEDRON LETT, V32, P5279, DOI 10.1016/S0040-4039(00)92364-5; Smith DF, 2013, ANAL BIOANAL CHEM, V405, P6069, DOI 10.1007/s00216-013-7048-1; Smith DF, 2011, ANAL CHEM, V83, P9552, DOI 10.1021/ac2023348; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; TAKEDA N, 1987, CLIN CHEM, V33, P682; Touboul D, 2011, BIOCHIMIE, V93, P113, DOI 10.1016/j.biochi.2010.05.013; VanStipdonk MJ, 1996, RAPID COMMUN MASS SP, V10, P1987; WEEKS G, 1980, J LIPID RES, V21, P681; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; YOSHIOKA S, 1985, J LIPID RES, V26, P1134	47	12	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99319	10.1371/journal.pone.0099319	http://dx.doi.org/10.1371/journal.pone.0099319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911189	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600073
J	Wu, JQ; Xu, JH; Zhang, ZF; Ren, JC; Li, YY; Wang, J; Cao, YL; Rong, F; Zhao, R; Huang, XL; Du, J				Wu, Junqing; Xu, Jianhua; Zhang, Zhaofeng; Ren, Jingcao; Li, Yuyan; Wang, Jian; Cao, Yunlei; Rong, Fen; Zhao, Rui; Huang, Xianliang; Du, Jing			Association of FTO Polymorphisms with Obesity and Metabolic Parameters in Han Chinese Adolescents	PLOS ONE			English	Article							BIRTH-WEIGHT; FAT MASS; GENE; VARIANTS; CHILDHOOD; CHILDREN; RISK	Background: Previous studies have suggested that fat mass-and obesity-associated (FTO) gene is associated with body mass index (BMI) and the risk of obesity. This study aims to assess the association of five FTO polymorphisms (rs9939609, rs8050136, rs1558902, rs3751812 and rs6499640) with obesity and relative parameters in Han Chinese adolescents. Methods: We examined a total of 401 adolescents, 223 normal weights (58.7% boys, 41.3% girls), 178 overweight (60.1% boys, 39.9% girls), aging from 14 to 18-years-old, recruited randomly from public schools in the central region of Wuxi, a southern city of China. DNA samples were genotyped for the five polymorphisms by Sequenom Plex MassARRAY. Association of the FTO polymorphisms with BMI, serum fasting plasm glucose (FPG), fasting insulin (FIns), triglyceride (TG) and cholesterol (TC) were investigated. Results: 1) Serum FPG, FIns, TG and TC were statistically significant higher than that in normal control group. 2) We found that BMI was higher in the rs9939609 TA+AA, rs8050136 AC+AA, rs1558902 TA+AA and rs3751812 GT+TT genotypes than in wild TT genotypes (rs9939609: P = 0.038; rs1558902: P = 0.038;), CC genotypes(rs8050136: P = 0.024) and GG genotypes (rs3751812: P = 0.024), which were not significant on adjusting for multiple testing. 3) In case-control studies, five polymorphisms were not significantly associated with overweight (p > 0.05), haplotype analyses showed non-haplotype is significantly associated with a higher risk of being overweight (p > 0.05). 4) There existed no significant statistical difference about FPG, FIns, TG and TC in genotype model for any SNP. Conclusions: Our study has conducted a genetic association study of the FTO polymorphisms with BMI, serum fasting plasm glucose (FPG), fasting insulin (FIns), triglyceride (TG) and cholesterol (TC). Our study found BMI of subjects with A allele of FTO rs9939609 is higher than that with T allele. Further studies on other polymorphisms from FTO and increasing the sample size are needed.	[Wu, Junqing; Li, Yuyan; Rong, Fen; Zhao, Rui] Shanghai Inst Planned Parenthood Res, WHO Collaborating Ctr Human Res, Shanghai, Peoples R China; [Wu, Junqing; Xu, Jianhua; Zhang, Zhaofeng; Li, Yuyan; Wang, Jian; Cao, Yunlei; Rong, Fen; Zhao, Rui; Huang, Xianliang; Du, Jing] Shanghai Inst Planned Parenthood Res, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China; [Xu, Jianhua; Zhang, Zhaofeng; Wang, Jian; Cao, Yunlei; Huang, Xianliang; Du, Jing] Fudan Univ, Shanghai Med Coll, Inst Reprod & Dev, Shanghai 200433, Peoples R China; [Ren, Jingcao] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang City, Henan, Peoples R China	Fudan University; Xinxiang Medical University	Wu, JQ (corresponding author), Shanghai Inst Planned Parenthood Res, WHO Collaborating Ctr Human Res, Shanghai, Peoples R China.	wujq1688@163.com; dujing42@126.com	Du, Jing/AAY-4092-2021	Du, Jing/0000-0002-6767-2763; Zhao, Rui/0000-0001-6445-3461	National Nature Science Foundation of China [81072364]; Knowledge Innovation Program in Chinese Academy of Sciences [KSCX2-EW-R-06]; Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning [2011GJ02]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program in Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning	This work was supported by National Nature Science Foundation of China (No. 81072364), the Knowledge Innovation Program in Chinese Academy of Sciences (No. KSCX2-EW-R-06) to YLW, and Science and Technology Development Fund of Shanghai Municipal Commission of Health & Family Planning (2011GJ02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bressler J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010521; [曹凌峰 CAO Ling-feng], 2010, [中国循证儿科杂志, Chinese JOurnal of Evidence Based Pediatrics], V5, P46; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Groop L, 2007, NAT GENET, V39, P706, DOI 10.1038/ng0607-706; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Hetherington MM, 2010, FORUM NUTR, V63, P195, DOI 10.1159/000264407; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li Y, 2013, J HUM HYPERTENS, V27, P686, DOI 10.1038/jhh.2013.31; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Ma L, 2014, EUR J PEDIA IN PRESS; Mei H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031470; Moore SC, 2012, OBESITY, V20, P1902, DOI 10.1038/oby.2011.238; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Olza J, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-123; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Ren JC, 2013, SAUDI MED J, V34, P623; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wang LN, 2013, OBES RES CLIN PRACT, V7, pE14, DOI 10.1016/j.orcp.2011.12.007; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu JQ, 2013, IRAN J PUBLIC HEALTH, V42, P480	29	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98984	10.1371/journal.pone.0098984	http://dx.doi.org/10.1371/journal.pone.0098984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911064	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600031
J	Bruns, H; Lozanovski, VJ; Schultze, D; Hillebrand, N; Hinz, U; Buchler, MW; Schemmer, P				Bruns, Helge; Lozanovski, Vladimir J.; Schultze, Daniel; Hillebrand, Norbert; Hinz, Ulf; Buechler, Markus W.; Schemmer, Peter			Prediction of Postoperative Mortality in Liver Transplantation in the Era of MELD-Based Liver Allocation: A Multivariate Analysis	PLOS ONE			English	Article							DONOR-RISK-INDEX; SINGLE-CENTER EXPERIENCE; CORONARY-ARTERY-DISEASE; COLD ISCHEMIA TIME; BILIARY COMPLICATIONS; GRAFT-SURVIVAL; SERUM SODIUM; CANDIDATES; MODEL; IMPACT	Background and Aims: Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list mortality can be predicted by the MELD-score, reliable scoring systems for the postoperative period do not exist. This study's objective was to identify risk factors that contribute to postoperative mortality. Methods: Between December 2006 and March 2011, 429 patients underwent liver transplantation in our department. Risk factors for postoperative mortality in 266 consecutive liver transplantations were identified using univariate and multivariate analyses. Patients who were <18 years, HU-listings, and split-, living related, combined or re-transplantations were excluded from the analysis. The correlation between number of risk factors and mortality was analyzed. Results: A labMELD >= 20, female sex, coronary heart disease, donor risk index >1.5 and donor Na+>145 mmol/L were identified to be independent predictive factors for postoperative mortality. With increasing number of these risk-factors, postoperative 90-day and 1-year mortality increased (0-1: 0 and 0%; 2: 2.9 and 17.4%; 3: 5.6 and 16.8%; 4: 22.2 and 33.3%; 5-6: 60.9 and 66.2%). Conclusions: In this analysis, a simple score was derived that adequately identified patients at risk after liver transplantation. Opening a discussion on the inclusion of these parameters in the process of organ allocation may be a worthwhile venture.	[Bruns, Helge; Lozanovski, Vladimir J.; Schultze, Daniel; Hillebrand, Norbert; Hinz, Ulf; Buechler, Markus W.; Schemmer, Peter] Heidelberg Univ, Dept Gen & Transplant Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Bruns, H (corresponding author), Heidelberg Univ, Dept Gen & Transplant Surg, Heidelberg, Germany.	helge.bruns@med.uni-heidelberg.de	Bruns, Helge/N-6013-2014; Lozanovski, Vladimir J/AAP-9781-2020	Bruns, Helge/0000-0003-1010-1043; Lozanovski, Vladimir J/0000-0002-7332-3973				Afonso RC, 2008, TRANSPL P, V40, P800, DOI 10.1016/j.transproceed.2008.03.017; Annicchiarico BE, 2008, TRANSPL P, V40, P1918, DOI 10.1016/j.transproceed.2008.05.070; AVOLIO AW, 1991, TRANSPLANT P, V23, P2451; Benckert C, 2011, SCAND J GASTROENTERO, V46, P941, DOI 10.3109/00365521.2011.568521; Boin IFSF, 2008, TRANSPL P, V40, P789, DOI 10.1016/j.transproceed.2008.02.058; Bonney GK, 2009, TRANSPLANTATION, V87, P1858, DOI 10.1097/TP.0b013e3181a75b37; Brooks BK, 1996, TRANSPLANTATION, V62, P1784, DOI 10.1097/00007890-199612270-00017; Bruns H, 2011, CLIN TRANSPLANT, V25, pE558, DOI 10.1111/j.1399-0012.2011.01483.x; Bruns H, 2011, MICROCIRCULATION, V18, P205, DOI 10.1111/j.1549-8719.2010.00078.x; Buenadicha AL, 2005, TRANSPL P, V37, P3881, DOI 10.1016/j.transproceed.2005.09.165; Carbo J, 1998, REV ESP ENFERM DIG, V90, P109; CAREY WD, 1995, TRANSPLANTATION, V59, P859, DOI 10.1097/00007890-199503270-00010; Cywinski JB, 2008, LIVER TRANSPLANT, V14, P59, DOI 10.1002/lt.21305; David AI, 2012, EINSTEIN-SAO PAULO, V10, P57, DOI 10.1590/S1679-45082012000100012; Desschans B, 2008, ACTA CHIR BELG, V108, P31, DOI 10.1080/00015458.2008.11680171; Donovan CL, 1996, TRANSPLANTATION, V61, P1180, DOI 10.1097/00007890-199604270-00011; Edwards E, 2004, LIVER TRANSPLANT, V10, pS10, DOI 10.1002/lt.20271; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Filippone EJ, 2012, CARDIOL REV, V20, P253, DOI 10.1097/CRD.0b013e3182564a34; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Garg A, 2013, JACC-CARDIOVASC IMAG, V6, P105, DOI 10.1016/j.jcmg.2012.11.002; Gastaca M, 2012, TRANSPL P, V44, P1554, DOI [10.1016/j.transproceed.2012.05.025, 10.1016/j.transproceed.2012.05.008]; Halldorson JB, 2009, AM J TRANSPLANT, V9, P318, DOI 10.1111/j.1600-6143.2008.02491.x; JENKINS RL, 1989, SURG CLIN N AM, V69, P371; Jin B, 2008, HEPATO-GASTROENTEROL, V55, P207; KAHN D, 1989, HEPATOLOGY, V10, P861, DOI 10.1002/hep.1840100519; KAHN D, 1993, DIGEST DIS SCI, V38, P1485, DOI 10.1007/BF01308608; Kaseje N, 2013, EUR J PEDIATR SURG, V23, P8, DOI 10.1055/s-0032-1329703; Kim HJ, 2010, AM J TRANSPLANT, V10, P2652, DOI 10.1111/j.1600-6143.2010.03315.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1016/0270-9139(95)90202-3; Mateo R, 2006, AM J TRANSPLANT, V6, P791, DOI 10.1111/j.1600-6143.2006.01243.x; Merion RM, 2010, SEMIN LIVER DIS, V30, P411, DOI 10.1055/s-0030-1267541; Mieth M., 2006, HEIDELBERGER MANUAL; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; Plotkin J S, 1996, Liver Transpl Surg, V2, P426, DOI 10.1002/lt.500020604; Porte R J, 1998, Transpl Int, V11 Suppl 1, pS164, DOI 10.1007/s001470050452; PORTE RJ, 1993, SEMIN THROMB HEMOST, V19, P191, DOI 10.1055/s-2007-994025; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Rahimi RS, 2013, CURR OPIN GASTROENTE; Rossi Elsabetta, 1997, Rays (Rome), V22, P595; Schmidt J, 2008, CHIRURG, V79, P112, DOI 10.1007/s00104-007-1452-z; Schmied BM, 2005, TRANSPLANTATION, V80, pS147, DOI 10.1097/01.tp.0000186907.58294.d1; Schrem H, 2012, ANN TRANSPL, V17, P5; SCOTTE M, 1994, J HEPATOL, V21, P340, DOI 10.1016/S0168-8278(05)80311-3; STAHL RL, 1990, HEPATOLOGY, V12, P553, DOI 10.1002/hep.1840120317; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Tiukinhoy-Laing SD, 2006, AM J CARDIOL, V98, P178, DOI 10.1016/j.amjcard.2006.01.089; Togashi J, 2013, HEPATOL RES; Totsuka E, 2002, SURG TODAY, V32, P792, DOI 10.1007/s005950200152; Tsui TY, 2009, LANGENBECK ARCH SURG, V394, P235, DOI 10.1007/s00423-008-0348-9; TURNER TB, 1981, JOHNS HOPKINS MED J, V148, P53; Venettoni S, 2004, TRANSPL INT, V17, P402, DOI 10.1007/s00147-004-0718-3; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Weiss KH, 2007, NEPHROL DIAL TRANSPL, V22, P9, DOI 10.1093/ndt/gfm658; Wheeler MD, 1999, CELL MOL LIFE SCI, V56, P843, DOI 10.1007/s000180050030; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005; Yong CM, 2010, LIVER TRANSPLANT, V16, P1242, DOI 10.1002/lt.22152; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x	62	48	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98782	10.1371/journal.pone.0098782	http://dx.doi.org/10.1371/journal.pone.0098782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905210	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000063
J	Du, MJ; Chen, XD; Zhou, XL; Wan, YJ; Lan, B; Zhang, CZ; Cao, YJ				Du, Ming-juan; Chen, Xiang-dong; Zhou, Xiao-li; Wan, Ya-juan; Lan, Bei; Zhang, Cui-zhu; Cao, Youjia			Estrogen Induces Vav1 Expression in Human Breast Cancer Cells	PLOS ONE			English	Article							SIGNAL TRANSDUCER VAV1; EXCHANGE FACTOR VAV1; CYCLE PROGRESSION; TRANSCRIPTION FACTOR; RECEPTOR INTERACTION; MECHANISMS; PROTEIN; IDENTIFICATION; APOPTOSIS; DISEASE	Vav1, a guanine nucleotide exchange factor (GEF) for Rho family GTPases, is a hematopoietic protein involved in a variety of cellular events. In recent years, aberrant expression of Vav1 has been reported in non-hematopoietic cancers including human breast cancer. It remains to be answered how Vav1 is expressed and what Vav1 does in its non-resident tissues. In this study, we aimed to explore the mechanism for Vav1 expression in breast cancer cells in correlation with estrogen-ER pathway. We not only verified the ectopic expression of Vav1 in human breast cancer cell lines, but also observed that Vav1 expression was induced by 17 beta-estradiol (E-2), a typical estrogen receptor (ER) ligand, in ER-positive cell lines. On the other hand, Tamoxifen, a selective estrogen receptor modulator (SERM), and ICI 182,780, an ER antagonist, suppressed the expression of Vav1. The estrogen receptor modulating Vav1 expression was identified to be alpha form, not beta. Furthermore, treatment of E-2 increased the transcription of vav1 gene by enhancing the promoter activity, though there was no recognizable estrogen response element (ERE). Nevertheless, two regions at the vav1 gene promoter were defined to be responsible for E-2-induced activation of vav1 promoter. Chromatin immunoprecipitation (ChIP) and co-immunoprecipitation (Co-IP) analyses suggested that ER alpha might access to the vav1 promoter via interacting with transcription factors, c-Myb and ELF-1. Consequently, the enhanced expression of Vav1 led to the elevation of Cyclin D1 and the progression of cell cycle. The present study implies that estrogen-ER modulates the transcription and expression of Vav1, which may contribute to the proliferation of cancerous cells.	[Du, Ming-juan; Chen, Xiang-dong; Zhou, Xiao-li; Wan, Ya-juan; Cao, Youjia] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China; [Lan, Bei; Zhang, Cui-zhu; Cao, Youjia] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Cao, YJ (corresponding author), Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn						BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Gerloff A, 2011, ONCOL REP, V26, P1121, DOI 10.3892/or.2011.1409; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hornstein I, 2003, J PATHOL, V199, P526, DOI 10.1002/path.1314; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Huynh KT, 2012, EXPERT REV MOL DIAGN, V12, P371, DOI [10.1586/erm.12.26, 10.1586/ERM.12.26]; Ilan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029939; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordan VC, 2009, CANCER RES, V69, P1243, DOI 10.1158/0008-5472.CAN-09-0029; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Koehler KF, 2005, ENDOCR REV, V26, P465, DOI 10.1210/er.2004-0027; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lane Jane, 2008, Int Semin Surg Oncol, V5, P23, DOI 10.1186/1477-7800-5-23; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lazer G, 2009, J PATHOL, V219, P25, DOI 10.1002/path.2579; Li SY, 2013, J BIOL CHEM, V288, P3777, DOI 10.1074/jbc.M112.426221; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Parl FF, 2009, ANN NY ACAD SCI, V1155, P68, DOI 10.1111/j.1749-6632.2008.03676.x; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Petz LN, 2002, ENDOCRINOLOGY, V143, P4583, DOI 10.1210/en.2002-220369; Poelzl G, 2000, P NATL ACAD SCI USA, V97, P2836, DOI 10.1073/pnas.050580997; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Sebban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054321; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shigekawa Takashi, 2011, Hormones & Cancer, V2, P286, DOI 10.1007/s12672-011-0082-6; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Swaby RF, 2007, REV ENDOCR METAB DIS, V8, P229, DOI 10.1007/s11154-007-9034-4; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang X, 2009, JOVE-J VIS EXP, V32, pe1499, DOI DOI 10.3791/1499; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185; Zhou Z, 2007, J BIOL CHEM, V282, P23737, DOI 10.1074/jbc.M702975200	49	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99052	10.1371/journal.pone.0099052	http://dx.doi.org/10.1371/journal.pone.0099052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905577	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000099
J	Hassan, AKM; Dimitry, SR; Agban, GW				Hassan, Ayman K. M.; Dimitry, Salwa R.; Agban, George W.			Can Exercise Capacity Assessed by the 6 Minute Walk Test Predict the Development of Major Adverse Cardiac Events in Patients with STEMI after Fibrinolysis?	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; 6-MINUTE WALK; HEART-FAILURE; RISK SCORE; ELDERLY-PATIENTS; MORTALITY; ELEVATION; DISEASE; TRIAL	Background: To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis. Methodology/Principal Findings: This is a prospective cohort study of one hundred consecutive patients with STEMI, who had received fibrinolysis, at Assuit University Hospital. All patients underwent 6MWT pre-discharge and were followed up for 3 months to monitor the incidence of major adverse cardiac events (MACE). Patients were divided into 3 groups according to the level of 6MWTD (level I>450 m, level II = 300-450 m and level III<300 m). Among the study population, the median 6MWT distance was 370 meters (interquartile range 162-462). The mean age was 60.9 +/- 10.7 years, 71.9% of them were males, 2/3 had anterior MI. only 10.5% had successful thrombolysis. Compared to patients in level I (>450 m), patients in level III (<300 m) were more likely to have clinical risk factors as hypertension, diabetes and impaired renal function. The patient's mean TIMI score was 3.4 +/- 2.2, the mean GRACE score was 150.5 +/- 27.7. There was a significant negative correlation between the 6 MWTD and GRACE risk score (r = -0.80, p<0.001). At 3 months of follow-up, 51% had MACE including 16% were dead. Multivariate logistic regression analysis identified that the GRACE risk score and 6MWT distance levels were the best predictors of the MACE at 3 month of follow up. The incidence of MACE was 4 times higher in patients with high GRACE risk score who couldn't walk more than 300 meters (OR = 4.66, 95% CI = 1.1-14.5, p = 0.006). Conclusions/Significance: In patients with STEMI treated with fibrinolysis, the addition of 6MWTD assessment pre-discharge to the traditional GRACE risk score improved the risk prediction of cardiovascular events at 3 month follow up.	[Hassan, Ayman K. M.; Dimitry, Salwa R.; Agban, George W.] Assiut Univ, Fac Med, Dept Cardiovasc Med, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Assiut University	Hassan, AKM (corresponding author), Assiut Univ, Fac Med, Dept Cardiovasc Med, Assiut, Egypt.	aymankhairy11@gmail.com	HASSAN, AYMAN K.M./ABC-5219-2021	HASSAN, AYMAN K.M./0000-0002-7719-0805				Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; Beatty AL, 2012, ARCH INTERN MED, V172, P1096, DOI 10.1001/archinternmed.2012.2198; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; Boden WE, 2013, JAMA-J AM MED ASSOC, V309, P143, DOI 10.1001/jama.2012.128367; Bonnefoy E, 2011, ANN CARDIOL ANGEIOL, V60, P311, DOI 10.1016/j.ancard.2011.10.001; BRUSCHKE AVG, 1990, CLEV CLIN J MED, V57, P547, DOI 10.3949/ccjm.57.6.547; bu-Assi E, 2010, REV ESP CARDIOL, V63, P640; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Cahalin LP, 1996, CHEST, V110, P325, DOI 10.1378/chest.110.2.325; Capodanno D, 2010, AM HEART J, V159, P103, DOI 10.1016/j.ahj.2009.10.021; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Guazzi M, 2009, CIRC-HEART FAIL, V2, P549, DOI 10.1161/CIRCHEARTFAILURE.109.881326; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Hassan AKM, 2009, CATHETER CARDIO INTE, V74, P335, DOI 10.1002/ccd.21980; Ingle L, 2005, EUR HEART J, V26, P1742, DOI 10.1093/eurheartj/ehi259; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Rasekaba T, 2009, INTERN MED J, V39, P495, DOI 10.1111/j.1445-5994.2008.01880.x; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Selvarajah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040249; Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stevens D, 1999, AM J RESP CRIT CARE, V160, P1540, DOI 10.1164/ajrccm.160.5.9808139; Swiston JR, 2010, RESP MED, V104, P1588, DOI 10.1016/j.rmed.2010.08.003; Taher T, 2004, J AM COLL CARDIOL, V44, P38, DOI 10.1016/j.jacc.2004.03.041	31	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99035	10.1371/journal.pone.0099035	http://dx.doi.org/10.1371/journal.pone.0099035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905094	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000095
J	Lai, CK; Saxena, V; Tseng, CH; Jeng, KS; Kohara, M; Lai, MMC				Lai, Chao-Kuen; Saxena, Vikas; Tseng, Chung-Hsin; Jeng, King-Song; Kohara, Michinori; Lai, Michael M. C.			Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport	PLOS ONE			English	Article							IN-VITRO MODEL; RNA REPLICATION; HCV RNA; GRADIENT CENTRIFUGATION; BUOYANT DENSITY; LIPID DROPLET; IDENTIFICATION; CULTURE; MEMBRANE; RELEASE	Nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) serves dual functions in viral RNA replication and virus assembly. Here, we demonstrate that HCV replication complex along with NS5A and Core protein was transported to the lipid droplet (LD) through microtubules, and NS5A-Core complexes were then transported from LD through early-to-late endosomes to the plasma membrane via microtubules. Further studies by cofractionation analysis and immunoelectron microscopy of the released particles showed that NS5A-Core complexes, but not NS4B, were present in the low-density fractions, but not in the high-density fractions, of the HCV RNA-containing virions and associated with the internal virion core. Furthermore, exosomal markers CD63 and CD81 were also detected in the low-density fractions, but not in the high-density fractions. Overall, our results suggest that HCV NS5A is associated with the core of the low-density virus particles which exit the cell through a preexisting endosome/exosome pathway and may contribute to HCV natural infection.	[Lai, Chao-Kuen; Saxena, Vikas; Jeng, King-Song; Lai, Michael M. C.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Michael M. C.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Tseng, Chung-Hsin; Lai, Michael M. C.] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Tseng, Chung-Hsin; Lai, Michael M. C.] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Lai, Chao-Kuen] Natl Taiwan Univ, Grad Inst Toxicol, Taipei 10764, Taiwan; [Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 113, Japan	Academia Sinica - Taiwan; University of Southern California; National Cheng Kung University; National Cheng Kung University; National Taiwan University; Tokyo Metropolitan Institute of Medical Science	Lai, MMC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	michlai@gate.sinica.edu.tw	Saxena, Vikas/A-9472-2016	Saxena, Vikas/0000-0003-4816-4875				Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ariumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014517; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Cho NJ, 2009, ACS CHEM BIOL, V4, P1061, DOI 10.1021/cb900149b; Cho NJ, 2009, ANAL CHEM, V81, P4752, DOI 10.1021/ac900242s; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Grove J, 2008, J VIROL, V82, P12020, DOI 10.1128/JVI.01569-08; Heller T, 2005, P NATL ACAD SCI USA, V102, P2579, DOI 10.1073/pnas.0409666102; Ishida S, 2001, HEPATOL RES, V20, P335, DOI 10.1016/S1386-6346(01)00080-8; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; KAITO M, 1994, J GEN VIROL, V75, P1755, DOI 10.1099/0022-1317-75-7-1755; KANTO T, 1994, HEPATOLOGY, V19, P296; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lai CK, 2010, J VIROL, V84, P11590, DOI 10.1128/JVI.00587-10; Li X, 1995, J VIRAL HEPATITIS, V2, P227, DOI 10.1111/j.1365-2893.1995.tb00034.x; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1996, J HEPATOL, V24, P11; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; MIYAMOTO H, 1992, J GEN VIROL, V73, P715, DOI 10.1099/0022-1317-73-3-715; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; PATERSON RG, 1995, VIROLOGY, V208, P121, DOI 10.1006/viro.1995.1135; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Prince AM, 1996, J VIRAL HEPATITIS, V3, P11, DOI 10.1111/j.1365-2893.1996.tb00075.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Roohvand F, 2009, J BIOL CHEM, V284, P13778, DOI 10.1074/jbc.M807873200; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11; Sette P, 2011, STRUCTURE, V19, P1485, DOI 10.1016/j.str.2011.07.016; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Shimoike T, 1999, J VIROL, V73, P9718, DOI 10.1128/JVI.73.12.9718-9725.1999; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WU XY, 1994, J VIROL, V68, P6161, DOI 10.1128/JVI.68.10.6161-6169.1994	63	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99022	10.1371/journal.pone.0099022	http://dx.doi.org/10.1371/journal.pone.0099022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905011	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000094
J	Mannelqvist, M; Wik, E; Stefansson, IM; Akslen, LA				Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.			An 18-Gene Signature for Vascular Invasion Is Associated with Aggressive Features and Reduced Survival in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; PROGNOSTIC IMPORTANCE; MOLECULAR SUBTYPES; CHEMOTHERAPY; THERAPY; TRANSCRIPTOME; RECURRENCE; PREDICTOR; TRIAL	Aims: Vascular invasion by tumor cells is known to be important for cancer progression. By microarray and qPCR analyses, we earlier identified an 18-gene signature associated with vascular involvement in endometrial cancer. Here, we explored the significance of this vascular invasion signature in multiple series of breast cancer patients. Methods and Results: The study includes 11 open access gene expression data sets which collectively provide information on 2423 breast cancer patients. The 18-gene signature showed consistent associations with aggressive features of breast cancer, like high tumor grade, hormone receptor negativity, HER2 positivity, a basal-like phenotype, reduced patient survival, and response to neoadjuvant chemotherapy. Also, the vascular invasion signature was associated with several other gene expression profiles related to vascular biology and tumor progression, including the Oncotype DX breast cancer recurrence signature. Conclusions: The 18-gene vascular invasion signature showed strong and consistent associations with aggressive features of breast cancer and reduced survival.	[Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway; [Wik, Elisabeth; Stefansson, Ingunn M.; Akslen, Lars A.] Haukeland Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Akslen, LA (corresponding author), Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers CCBIO, N-5020 Bergen, Norway.	lars.akslen@gades.uib.no	Akslen, Lars A./AAG-6097-2021; Wik, E./AAA-9105-2020; Akslen, Lars A/C-1202-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543	Norwegian Cancer Society; Research Council of Norway; University of Bergen; Helse Vest	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); University of Bergen; Helse Vest	The study is funded by the Norwegian Cancer Society, the Research Council of Norway, Helse Vest research and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Anders CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001373; Borgan E, 2013, MOL ONCOL, V7, P130, DOI 10.1016/j.molonc.2012.10.005; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; de Cremoux P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-215; Gardner RE, 2000, ARCH OTOLARYNGOL, V126, P309, DOI 10.1001/archotol.126.3.309; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gluck S, 2011, BREAST CANC RES TREA; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Kadivar M, 2012, ASIAN PAC J CANCER P, V13, P1881, DOI 10.7314/APJCP.2012.13.5.1881; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Mannelqvist M, 2011, AM J PATHOL, V178, P861, DOI 10.1016/j.ajpath.2010.10.040; Mannelqvist M, 2009, HISTOPATHOLOGY, V54, P174, DOI 10.1111/j.1365-2559.2008.03201.x; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PINDER SE, 1994, HISTOPATHOLOGY, V24, P41, DOI 10.1111/j.1365-2559.1994.tb01269.x; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Straume O, 1996, CANCER, V78, P1211, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.3.CO;2-O; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	27	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98787	10.1371/journal.pone.0098787	http://dx.doi.org/10.1371/journal.pone.0098787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905342	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000064
J	Vanroy, C; Vanlandewijck, Y; Cras, P; Feys, H; Truijen, S; Michielsen, M; Vissers, D				Vanroy, Christel; Vanlandewijck, Yves; Cras, Patrick; Feys, Hilde; Truijen, Steven; Michielsen, Marc; Vissers, Dirk			Is a Coded Physical Activity Diary Valid for Assessing Physical Activity Level and Energy Expenditure in Stroke Patients?	PLOS ONE			English	Article							DOUBLY LABELED WATER; AMBULATORY ACTIVITY; AMERICAN-COLLEGE; ACCELEROMETRY; PREVENTION; REHABILITATION; DISABILITIES; INDIVIDUALS; PEDOMETERS; SURVIVORS	Objectives: to determine the concurrent validity of a physical activity diary for measuring physical activity level and total energy expenditure in hospitalized stroke patients. Method: Sixteen stroke patients kept coded activity diaries and wore SenseWear Pro2 multi-sensor activity monitors during daytime hours for one day. A researcher observed the patients and completed a diary. Data from the patients' diaries were compared with observed and measured data to determine total activity (METs*minutes), activity level and total energy expenditure. Results: Spearman correlations between the patients' and researchers' diaries revealed a high correlation for total METs*minutes (r(s) = 0.75, p<0.01) for sedentary (r(s) = 0.74, p<0.01) and moderate activities (r(s) = 0.71, p<0.01) and a very high correlation (r(s) = 0.92, p<0.01) for the total energy expenditure. Comparisons between the patients' diaries and activity monitor data revealed a low correlation (r(s) 0.29) for total METs*minutes and energy expenditure. Conclusion: Coded self-monitoring activity diaries appear feasible as a low-tech alternative to labor-intensive observational diaries for determining sedentary, moderate, and total physical activity and for quantifying energy expenditure in hospitalized stroke patients. Given the poor correlation with objective measurements of physical activity, however, further research is needed to validate its use against a gold-standard measure of physical activity intensity and energy expenditure.	[Vanroy, Christel; Truijen, Steven; Vissers, Dirk] Univ Antwerp, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-2020 Antwerp, Belgium; [Vanroy, Christel; Cras, Patrick] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Vanroy, Christel; Vanlandewijck, Yves; Feys, Hilde] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Cras, Patrick] Univ Antwerp Hosp, Dept Neurol, Antwerp, Belgium; [Cras, Patrick] Born Bunge Inst, Dept Neurol, Antwerp, Belgium; [Michielsen, Marc] Jessa Hosp, Herk De Stad, Belgium	University of Antwerp; University of Antwerp; KU Leuven; University of Antwerp	Vanroy, C (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Rehabil Sci & Physiotherapy, B-2020 Antwerp, Belgium.	christel.vanroy@uantwerpen.be	truijen, steven/G-4179-2016	truijen, steven/0000-0002-0604-1431; Vanlandewijck, Yves/0000-0003-2982-0849; Vanroy, Christel/0000-0002-3228-8913; Vissers, Dirk/0000-0001-5901-6515	Artesis University College Antwerp, Belgium [G841]	Artesis University College Antwerp, Belgium	This research is funded by a research grant (G841) from the Artesis University College Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alzahrani MA, 2011, J PHYSIOTHER, V57, P47, DOI 10.1016/S1836-9553(11)70007-8; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baert I, 2012, DISABIL REHABIL, V34, P1835, DOI 10.3109/09638288.2012.665130; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Borms J, 1999, BLOSO BRUSSEL, P239; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Carroll SL, 2012, ARCH PHYS MED REHAB, V93, P466, DOI 10.1016/j.apmr.2011.08.047; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Conway JM, 2002, AM J CLIN NUTR, V75, P519, DOI 10.1093/ajcn/75.3.519; De Wit L, 2005, STROKE, V36, P1977, DOI 10.1161/01.STR.0000177871.59003.e3; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Green LB, 2007, TOP STROKE REHABIL, V14, P9, DOI 10.1310/tsr1406-9; Haeuber E, 2004, ARCH PHYS MED REHAB, V85, P1997, DOI 10.1016/j.apmr.2003.11.035; Hale LA, 2008, ARCH PHYS MED REHAB, V89, P1765, DOI 10.1016/j.apmr.2008.02.027; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hinkle DE, 1988, APPL STAT BEHAV SCI, P117; Koebnick C, 2005, INT J OBESITY, V29, P302, DOI 10.1038/sj.ijo.0802882; Kramer SF, 2013, BIOMED RES INT, V2013, P1; Lincoln N, 1979, Physiotherapy, V65, P48; Machado-Rodrigues AM, 2012, SCAND J MED SCI SPOR, V22, P259, DOI 10.1111/j.1600-0838.2010.01155.x; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Meeus M, 2011, DISABIL REHABIL, V33, P9, DOI 10.3109/09638288.2010.483307; Melanson EL, 2004, PREV MED, V39, P361, DOI 10.1016/j.ypmed.2004.01.032; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rush EC, 2008, ANN HUM BIOL, V35, P416, DOI 10.1080/03014460802089825; Speck BJ, 2006, PUBLIC HEALTH NURS, V23, P88, DOI 10.1111/j.0737-1209.2006.230112.x; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Stoller O, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-45; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Vanroy C, 2013, DISABIL REHABIL, P1; Wannamethee SG, 1999, J CARDIOVASC RISK, V6, P213; Washburn RA, 2002, ARCH PHYS MED REHAB, V83, P193, DOI 10.1053/apmr.2002.27467; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; Wetten AA, 2013, J PHYS ACT HLTH; Wickel EE, 2006, MED SCI SPORT EXER, V38, P373, DOI 10.1249/01.mss.0000183344.46077.bb	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98735	10.1371/journal.pone.0098735	http://dx.doi.org/10.1371/journal.pone.0098735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905345	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000053
J	Wang, HJ; Xu, CY; Kong, XL; Li, XY; Kong, XN; Wang, Y; Ding, X; Yang, QF				Wang, Haiji; Xu, Chunyuan; Kong, Xiaoli; Li, Xiaoyan; Kong, Xiangnan; Wang, Yu; Ding, Xia; Yang, Qifeng			Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer	PLOS ONE			English	Article							INDUCED APOPTOSIS; OVARIAN-CANCER; CELLS; OVERCOME; RECEPTOR; SURVIVAL; CHEMORESISTANCE; SENSITIVITY; METASTASIS; ACTIVATION	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively induce apoptosis of cancer cells and is verified effective to various cancers. However, a variety of breast cancer cell lines are resistant to TRAIL and the mechanisms of resistance are largely unknown. In our present experiment, we successfully utilized breast cancer cell line MDA-MB-231 to establish TRAIL-resistant cell line. We found resistance to TRAIL could induce epithelial-mesenchymal transition (EMT) and enhance invasiveness. We further demonstrated PTEN was down-regulated in TRAIL-resistant cells. Silencing miR-221, PTEN expression was up-regulated, the process of EMT could be reversed, and the ability of migration and invasion were correspondingly weakened. We also demonstrated knockdown of miR-221 could reverse resistance to TRAIL partially by targeting PTEN. Our findings suggest that resistance to TRAIL could induce EMT and enhance invasiveness by suppressing PTEN via miR-221. Re-expression of miR-221 or targeting PTEN might serve as potential therapeutic approaches for the treatment of Trail-resistant breast cancer.	[Wang, Haiji; Xu, Chunyuan; Ding, Xia] Shandong Univ, Dept Oncol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Haiji] Qingdao Univ, Dept Oncol, Affiliated Hosp, Coll Med, Qingdao, Shandong, Peoples R China; [Wang, Haiji; Kong, Xiaoli; Li, Xiaoyan; Kong, Xiangnan; Yang, Qifeng] Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Xu, Chunyuan] Qingdao Municipal Hosp, Dept Oncol, Qingdao, Shandong, Peoples R China; [Wang, Yu] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Qingdao University; Shandong University; Qingdao Municipal Hospital; Shandong University	Yang, QF (corresponding author), Shandong Univ, Dept Breast Surg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022	Yang, Qifeng/0000-0003-0576-8513				Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bonavida Benjamin, 2011, Critical Reviews in Oncogenesis, V16, P211; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; de Jong S, 2001, CANCER METAST REV, V20, P51, DOI 10.1023/A:1013112624971; Ding J, 2012, J BIOL CHEM, V287, P641, DOI 10.1074/jbc.M111.286526; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Germano S, 2009, CURR CANCER DRUG TAR, V9, P398, DOI 10.2174/156800909788166529; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kim SH, 2004, J BIOL CHEM, V279, P40044, DOI 10.1074/jbc.M404541200; Lagadec C, 2008, ONCOGENE, V27, P1472, DOI 10.1038/sj.onc.1210749; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Metwalli AR, 2010, CANCER BIOL THER, V10, P889, DOI 10.4161/cbt.10.9.13237; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Rahman M, 2009, ADV CANCER RES, V103, P43, DOI 10.1016/S0065-230X(09)03003-6; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Shin EC, 2002, EXP MOL MED, V34, P114, DOI 10.1038/emm.2002.17; Srivastava RK, 2010, MOL CANCER THER, V9, P3254, DOI 10.1158/1535-7163.MCT-10-0582; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Tanic N, 2012, CANCER BIOL THER, V13, P1165, DOI 10.4161/cbt.21346; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomek S, 2004, GYNECOL ONCOL, V94, P107, DOI 10.1016/j.ygyno.2004.04.012; Voelkel-Johnson C, 2002, CANCER GENE THER, V9, P164, DOI 10.1038/sj.cgt.7700420; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Xu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010226; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Ye X, 2013, BMB REPORTS; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203; Zhang A-Li, 2005, Ai Zheng, V24, P1301; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang XD, 1999, CANCER RES, V59, P2747; Zhuang H, 2012, J MOL MED BERL	44	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99067	10.1371/journal.pone.0099067	http://dx.doi.org/10.1371/journal.pone.0099067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905916	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000102
J	Dimitrieva, S; Anisimova, M				Dimitrieva, Slavica; Anisimova, Maria			Unraveling Patterns of Site-to-Site Synonymous Rates Variation and Associated Gene Properties of Protein Domains and Families	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; CODON USAGE; PURIFYING SELECTION; ADAPTIVE EVOLUTION; SILENT SITES; TRANSLATIONAL SELECTION; STATISTICAL-METHODS; SPLICING ENHANCERS; BASE COMPOSITION; MUTATIONS	In protein-coding genes, synonymous mutations are often thought not to affect fitness and therefore are not subject to natural selection. Yet increasingly, cases of non-neutral evolution at certain synonymous sites were reported over the last decade. To evaluate the extent and the nature of site-specific selection on synonymous codons, we computed the site-to-site synonymous rate variation (SRV) and identified gene properties that make SRV more likely in a large database of protein-coding gene families and protein domains. To our knowledge, this is the first study that explores the determinants and patterns of the SRV in real data. We show that the SRV is widespread in the evolution of protein-coding sequences, putting in doubt the validity of the synonymous rate as a standard neutral proxy. While protein domains rarely undergo adaptive evolution, the SRV appears to play important role in optimizing the domain function at the level of DNA. In contrast, protein families are more likely to evolve by positive selection, but are less likely to exhibit SRV. Stronger SRV was detected in genes with stronger codon bias and tRNA reusage, those coding for proteins with larger number of interactions or forming larger number of structures, located in intracellular components and those involved in typically conserved complex processes and functions. Genes with extreme SRV show higher expression levels in nearly all tissues. This indicates that codon bias in a gene, which often correlates with gene expression, may often be a site-specific phenomenon regulating the speed of translation along the sequence, consistent with the co-translational folding hypothesis. Strikingly, genes with SRV were strongly overrepresented for metabolic pathways and those associated with several genetic diseases, particularly cancers and diabetes.	[Dimitrieva, Slavica] Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Dimitrieva, Slavica] Swiss Fed Inst Technol Lausanne EPFL, Lausanne, Switzerland; [Dimitrieva, Slavica; Anisimova, Maria] Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Dimitrieva, Slavica; Anisimova, Maria] SIB, Lausanne, Switzerland	Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Anisimova, M (corresponding author), Zurich Univ Appl Sci ZHAW, Inst Appl Simulat, Wadenswil, Switzerland.	maria.anisimova@zhaw.ch		Anisimova, Maria/0000-0001-8145-7966	Swiss State Secretariat for Education and Research; Swiss National Science Foundation [31003A_127325/1]; ETH Zurich	Swiss State Secretariat for Education and Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	SD was supported by the Swiss State Secretariat for Education and Research and has received an ETH medal for her Master thesis (including some work presented in this article). MA is supported by the ETH Zurich and is receiving funding from Swiss National Science Foundation (31003A_127325/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2012, CODON EVOLUTION MECH; Aris-Brosou S, 2005, MOL BIOL EVOL, V22, P200, DOI 10.1093/molbev/msi006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balakirev ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022613; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chamary JV, 2005, TRENDS GENET, V21, P256, DOI 10.1016/j.tig.2005.03.001; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; CLARKE B, 1970, SCIENCE, V168, P1009, DOI 10.1126/science.168.3934.1009; Dimitrieva S, 2010, TRENDS EVOL BIOL, V2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Eskesen ST, 2004, GENETICS, V167, P543, DOI 10.1534/genetics.167.1.543; Eyre-Walker A, 1999, GENETICS, V152, P675; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Friberg MT, 2006, LECT NOTES COMPUT SC, V4175, P1; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hughes AL, 1997, J MOL EVOL, V45, P125, DOI 10.1007/PL00006211; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Iida K, 2000, GENE, V261, P93, DOI 10.1016/S0378-1119(00)00482-0; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kandasamy K, 2009, NUCLEIC ACIDS RES, V37, pD773, DOI 10.1093/nar/gkn701; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Komar AA, 2007, SCIENCE, V315, P466, DOI 10.1126/science.1138239; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lu HC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000608; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Najafabadi HS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r87; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Orban TI, 2001, TRENDS GENET, V17, P252; Oresic M, 1998, J MOL BIOL, V281, P31, DOI 10.1006/jmbi.1998.1921; Park SG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-241; PEDEN JF, 1999, THESIS U NOTTINGHAM; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Resch AM, 2007, MOL BIOL EVOL, V24, P1821, DOI 10.1093/molbev/msm100; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Shah JH, 2008, ADV EXP MED BIOL, V614, P145, DOI 10.1007/978-0-387-74911-2_17; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	79	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e95034	10.1371/journal.pone.0095034	http://dx.doi.org/10.1371/journal.pone.0095034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896293	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700002
J	Gomes-Giacoia, E; Miyake, M; Goodison, S; Sriharan, A; Zhang, G; You, LJ; Egan, JO; Rhode, PR; Parker, AS; Chai, KX; Wong, HC; Rosser, CJ				Gomes-Giacoia, Evan; Miyake, Makito; Goodison, Steve; Sriharan, Aravindhan; Zhang, Ge; You, Lijing; Egan, Jack O.; Rhode, Peter R.; Parker, Alexander S.; Chai, Karl X.; Wong, Hing C.; Rosser, Charles J.			Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; GENE-THERAPY; N-BUTYL-N-(4-HYDROXYBUTYL) NITROSAMINE; MITOMYCIN-C; STAGE-TA; IMMUNOTHERAPY; INTERLEUKIN-15; IL-15; EXPRESSION	Intravesical Bacillus Calmette-Guerin (BCG) has been shown to induce a specific immunologic response (i.e., activation of IL-2 and effector T-cells), while preclinical studies using ALT-803 (mutated IL-15 analogue combined with IL-15R alpha-Fc fusion) have shown promising results by prolonging the agent's half-life and stimulating CD8+ T-cells. Based on these results, we hypothesized that the intravesical administration of ALT-803 along with BCG will generate an immunologic response leading to significant bladder tumor burden reduction. Using a well-established carcinogen induced rat non-muscle invasive bladder cancer (NMIBC) model, we studied the effects of intravesical ALT-803 with and without BCG. Rat tissues were evaluated to document treatment response. Intravesical ALT-803 was safe and well tolerated alone and in combination with BCG. As a single treatment agent, ALT-803 reduced tumor burden by 35% compared to control whereas BCG alone only reduced tumor burden by 15%. However, the combination of ALT-803 plus BCG reduced tumor burden by 46% compared to control. Immune monitoring suggested that the antitumor response was linked to the production and secretion of IL-1 alpha, IL-1 beta and RANTES, which in turn, induced the proliferation and activation of NK cells. Lastly, tumoral responses of the combinational treatment were associated with 76% reduction in angiogenesis, which is significantly higher than when assessed with either agent alone. The enhanced therapeutic index seen with this duplet provides justification for the development of this regimen for future clinical trials.	[Gomes-Giacoia, Evan; Miyake, Makito; Goodison, Steve; Zhang, Ge; Rosser, Charles J.] MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL 32806 USA; [Goodison, Steve; Parker, Alexander S.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Sriharan, Aravindhan] MD Anderson Canc Ctr Orlando, Dept Pathol, Orlando, FL USA; [You, Lijing; Egan, Jack O.; Rhode, Peter R.; Wong, Hing C.] Altor Biosci Corp, Miramar, FL USA; [Chai, Karl X.] Univ Cent Florida, Burnett Coll Biomed Sci, Orlando, FL 32816 USA; [Rosser, Charles J.] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Central Florida; Cancer Research Center of Hawaii; University of Hawaii System	Rosser, CJ (corresponding author), MD Anderson Canc Ctr Orlando, Canc Res Inst, Orlando, FL 32806 USA.	cjrosser@hawaii.edu		Wong, Hing C./0000-0002-6865-4313	James and Esther King Biomedical Team Science Project [1KT-01]; NATIONAL CANCER INSTITUTE [R01CA116161, R43CA156740] Funding Source: NIH RePORTER	James and Esther King Biomedical Team Science Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the James and Esther King Biomedical Team Science Project 1KT-01 (C.J. Rosser). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askeland EJ, 2012, ADV UROL, V2012, DOI 10.1155/2012/181987; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; BECICH MJ, 1991, J UROLOGY, V145, P1316, DOI 10.1016/S0022-5347(17)38622-6; Bevers RFM, 2004, BRIT J CANCER, V91, P607, DOI 10.1038/sj.bjc.6602026; BOHLE A, 1990, J UROLOGY, V144, P53, DOI 10.1016/S0022-5347(17)39365-5; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Clark PE, 2013, J NATL COMPR CANC NE, V11, P446, DOI 10.6004/jnccn.2013.0059; Cobb D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/924023; de Reijke TM, 1999, J UROLOGY, V161, P67, DOI 10.1016/S0022-5347(01)62065-2; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Greco O, 2002, FRONT BIOSCI-LANDMRK, V7, pD1516, DOI 10.2741/greco; Grubbs CJ, 2000, CANCER RES, V60, P5599; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Herr HW, 2012, J UROLOGY, V187, P435, DOI 10.1016/j.juro.2011.10.032; Herr HW, 2000, J UROLOGY, V163, P60, DOI 10.1016/S0022-5347(05)67972-4; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Kaempfer R, 1996, J CLIN ONCOL, V14, P1778, DOI 10.1200/JCO.1996.14.6.1778; Kandasamy M, 2011, CELL IMMUNOL, V271, P89, DOI 10.1016/j.cellimm.2011.06.004; Kitamura H, 2006, CLIN CANCER RES, V12, P4641, DOI 10.1158/1078-0432.CCR-06-0595; Krege S, 1996, J UROLOGY, V156, P962, DOI 10.1016/S0022-5347(01)65673-8; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Kresowik TP, 2009, IMMUNOTHERAPY-UK, V1, P281, DOI 10.2217/1750743X.1.2.281; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; LeBlanc F, 2012, FUTURE ONCOL, V8, P787, DOI [10.2217/fon.12.75, 10.2217/FON.12.75]; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Matsumoto K, 2011, HUM GENE THER, V22, P1423, DOI 10.1089/hum.2011.013; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Nepple KG, 2010, J UROLOGY, V184, P1915, DOI 10.1016/j.juro.2010.06.147; Okamura T, 1999, CANCER LETT, V140, P129, DOI 10.1016/S0304-3835(99)00060-9; Oliveira PA, 2006, ANTICANCER RES, V26, P2995; PRESCOTT S, 1990, J UROLOGY, V144, P1248, DOI 10.1016/S0022-5347(17)39713-6; Saint F, 2003, INT J CANCER, V107, P434, DOI 10.1002/ijc.11352; Saint F, 2002, J UROLOGY, V167, P364, DOI 10.1016/S0022-5347(05)65469-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Suttmann H, 2003, INFECT IMMUN, V71, P4647, DOI 10.1128/IAI.71.8.4647-4656.2003; Sylvester RJ, 2010, EUR UROL, V57, P766, DOI 10.1016/j.eururo.2009.12.024; Tang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076292; Thalmann GN, 2000, J UROLOGY, V164, P2129, DOI 10.1016/S0022-5347(05)66983-2; Tyagi A, 2007, MOL CANCER THER, V6, P3248, DOI 10.1158/1535-7163.MCT-07-2006; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weidner N, 1998, J PATHOL, V184, P119, DOI 10.1002/(SICI)1096-9896(199802)184:2<119::AID-PATH17>3.0.CO;2-D; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Wong HC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26442; Xu WZ, 2012, SCI TECHNOL ENERG MA, V73, P15; YAGISAWA M, 1995, EXP HEMATOL, V23, P603; Yamashita M, 2002, CANCER GENE THER, V9, P687, DOI 10.1038/sj.cgt.7700488; Zhu XY, 2009, J IMMUNOL, V183, P3598, DOI 10.4049/jimmunol.0901244	52	67	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e96705	10.1371/journal.pone.0096705	http://dx.doi.org/10.1371/journal.pone.0096705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896845	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700004
J	Lonsdorf, EV; Markham, AC; Heintz, MR; Anderson, KE; Ciuk, DJ; Goodall, J; Murray, CM				Lonsdorf, Elizabeth V.; Markham, A. Catherine; Heintz, Matthew R.; Anderson, Karen E.; Ciuk, David J.; Goodall, Jane; Murray, Carson M.			Sex Differences in Wild Chimpanzee Behavior Emerge during Infancy	PLOS ONE			English	Article							PAN-TROGLODYTES; LIFE-HISTORY; REPRODUCTIVE SUCCESS; GENDER DIFFERENCES; BIASED INVESTMENT; DOMINANCE RANK; SOCIALIZATION; PATTERNS; MILK	The role of biological and social influences on sex differences in human child development is a persistent topic of discussion and debate. Given their many similarities to humans, chimpanzees are an important study species for understanding the biological and evolutionary roots of sex differences in human development. In this study, we present the most detailed analyses of wild chimpanzee infant development to date, encompassing data from 40 infants from the long-term study of chimpanzees at Gombe National Park, Tanzania. Our goal was to characterize age-related changes, from birth to five years of age, in the percent of observation time spent performing behaviors that represent important benchmarks in nutritional, motor, and social development, and to determine whether and in which behaviors sex differences occur. Sex differences were found for indicators of social behavior, motor development and spatial independence with males being more physically precocious and peaking in play earlier than females. These results demonstrate early sex differentiation that may reflect adult reproductive strategies. Our findings also resemble those found in humans, which suggests that biologically based sex differences may have been present in the common ancestor and operated independently from the influences of modern sex-biased parental behavior and gender socialization.	[Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA; [Lonsdorf, Elizabeth V.] Franklin & Marshall Coll, Biol Fdn Behav Program, Lancaster, PA 17604 USA; [Lonsdorf, Elizabeth V.; Heintz, Matthew R.; Anderson, Karen E.] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL USA; [Markham, A. Catherine; Murray, Carson M.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Heintz, Matthew R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Ciuk, David J.] Franklin & Marshall Coll, Dept Govt, Lancaster, PA 17604 USA; [Goodall, Jane] Jane Goodall Inst, Vienna, VA USA	Franklin & Marshall College; Franklin & Marshall College; George Washington University; University of Chicago; Franklin & Marshall College	Lonsdorf, EV (corresponding author), Franklin & Marshall Coll, Dept Psychol, Lancaster, PA 17604 USA.	Elizabeth.lonsdorf@fandm.edu		Ciuk, David/0000-0002-5366-683X	Leo S. Guthman Foundation; National Geographic Society; National Institutes of Health [5R00HD057992]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD057992] Funding Source: NIH RePORTER	Leo S. Guthman Foundation; National Geographic Society(National Geographic Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Leo S. Guthman Foundation, the National Geographic Society, and the National Institutes of Health (5R00HD057992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2001, DEV PSYCHOBIOL, V38, P252, DOI 10.1002/dev.1019; BERMAN PW, 1977, CHILD DEV, V48, P711, DOI 10.1111/j.1467-8624.1977.tb01225.x; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Brent L, 1997, BEHAVIOUR, V134, P1189, DOI 10.1163/156853997X00124; Brown GR, 2000, PRIMATES, V41, P63, DOI 10.1007/BF02557462; Campbell DW, 1999, INFANT CHILD DEV, V8, P1, DOI 10.1002/(SICI)1522-7219(199903)8:1<1::AID-ICD186>3.0.CO;2-O; Clark C. B., 1977, P235; Connellan J, 2000, INFANT BEHAV DEV, V23, P113, DOI 10.1016/S0163-6383(00)00032-1; Edwards C.P., 1993, JUVENILE PRIMATES LI, P327; Forster S, 2005, BEHAVIOUR, V142, P869, DOI 10.1163/1568539055010138; Garza C, 2006, ACTA PAEDIATR, V95, P66, DOI 10.1080/08035320500495530; Gilby IC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1831, DOI 10.1007/s00265-008-0612-6; Gilby IC, 2006, ANIM BEHAV, V72, P169, DOI 10.1016/j.anbehav.2006.01.013; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; GOLDBERG S, 1982, CHILD DEV, V53, P1544, DOI 10.1111/j.1467-8624.1982.tb03477.x; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J, 1967, PRIMATE ETHOLOGY, P287; Hasegawa T, 1990, CHIMPANZEES MAHALE, P100; Haviland J. J., 1981, GENDER NONVERBAL BEH, P183, DOI [10.1007/978-1-4612-5953-4_10, DOI 10.1007/978-1-4612-5953-4_10]; Hinde K, 2009, AM J HUM BIOL, V21, P512, DOI 10.1002/ajhb.20917; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hiraiwa-Hasegawa M., 1990, P257; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lonsdorf EV, 2014, ANIM BEHAV, V88, P79, DOI 10.1016/j.anbehav.2013.11.015; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; MACCOBY EE, 1988, DEV PSYCHOL, V24, P755, DOI 10.1037/0012-1649.24.6.755; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; McGrew W.C., 1979, Perspectives on Human Evolution, V5, P441; McIntyre MH, 2009, ANNU REV ANTHROPOL, V38, P83, DOI 10.1146/annurev-anthro-091908-164338; Meredith S. L., 2013, BUILDING BABIES PRIM, P411; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muller MN, 2005, ADV STUD BEHAV, V35, P275, DOI 10.1016/S0065-3454(05)35007-8; Murray CM, 2007, ANIM BEHAV, V74, P1795, DOI 10.1016/j.anbehav.2007.03.024; Nicholson NA, 1977, PRIMATE BIOSOCIAL DE, P592; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; OWENS NW, 1975, ANIM BEHAV, V23, P387, DOI 10.1016/0003-3472(75)90087-1; Plooij FX., 1984, BEHAV DEV FREE LIVIN; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; PUSEY AE, 1990, BEHAVIOUR, V115, P203, DOI 10.1163/156853990X00581; Pusey AE, 2005, INT J PRIMATOL, V26, P3, DOI 10.1007/s10764-005-0721-2; PUSEY AE, 1983, ANIM BEHAV, V31, P363, DOI 10.1016/S0003-3472(83)80055-4; Roney James R., 2003, P171; Smith BH, 1992, EVOL ANTHROPOL, V1, P134, DOI DOI 10.1002/EVAN.1360010406; Smith TM, 2013, P NATL ACAD SCI USA, V110, P2787, DOI 10.1073/pnas.1218746110; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; van Lawick-Goodall J., 1968, Animal Behaviour Monographs, V1, P161; VANDERIJTPLOOIJ HHC, 1987, BEHAVIOUR, V101, P1, DOI 10.1163/156853987X00378; Whiting B. B., 1988, CHILDREN DIFFERENT W; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Witt SD, 1997, ADOLESCENCE, V32, P253; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wrangham R W, 1980, J Reprod Fertil Suppl, VSuppl 28, P13; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101	55	53	53	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99099	10.1371/journal.pone.0099099	http://dx.doi.org/10.1371/journal.pone.0099099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911160	Green Published, gold			2022-12-25	WOS:000337165600042
J	Lee, YH; Hsu, CY; Chu, CW; Liu, PH; Hsia, CY; Huang, YH; Su, CW; Chiou, YY; Lin, HC; Huo, TI				Lee, Yun-Hsuan; Hsu, Chia-Yang; Chu, Chen-Wei; Liu, Po-Hong; Hsia, Cheng-Yuan; Huang, Yi-Hsiang; Su, Chien-Wei; Chiou, Yi-You; Lin, Han-Chieh; Huo, Teh-Ia			A New Child-Turcotte-Pugh Class 0 for Patients with Hepatocellular Carcinoma: Determinants, Prognostic Impact and Ability to Improve the Current Staging Systems	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; LIVER RESECTION; HEPATIC RESECTION; RISK-FACTORS; CLASS-B; MANAGEMENT; SURVIVAL; THERAPY; MODEL; RECURRENCE	Background/Aim: Majority of patients with hepatocellular carcinoma (HCC) belonged to Child-Turcotte-Pugh (CTP) class A. We aimed to identify a new class of patients with very well-preserved liver function and analyze its impact on outcome prediction, tumor staging and treatment allocation. Methods: A total of 2654 HCC patients were retrospectively analyzed. The prognostic ability was compared by the Akaike information criterion (AIC). Results: The CTP class 0 was defined by fulfilling all criteria of albumin >= 4 g/dL, bilirubin <= 0.8 mg/dL, prothrombin time prolongation <0 seconds, no ascites and encephalopathy. A total of 23% of patients of CTP class A were reclassified as CTP class 0. Patients with CTP class 0 had a higher serum sodium level, lower serum creatinine, alanine aminotransferase, afetoprotein levels, shorter prothrombin time, better general well-being, smaller tumor burden with more solitary nodules, lower rates of vascular invasion, ascites formation, hepatic encephalopathy, more frequently treated with curative interventions and better Barcelona Clinic Liver Cancer (BCLC) stages (all p<0.001). In the Cox proportional hazards model, the adjusted hazard ratios for CTP class A, B and C were 1.739, 3.120 and 5.107, respectively, compared to class 0 (all p<0.001). Reassigning patients with CTP class 0, A, B, B and C to stage 0, A, B, C and D, respectively, provided the lowest AIC score among all BCLC-based models. Conclusions: The proposal of CTP class 0 independently predicted better survival in HCC patients. Modification of tumor staging systems according to the modified CTP classification further enhances their prognostic ability.	[Lee, Yun-Hsuan; Hsu, Chia-Yang; Chu, Chen-Wei; Liu, Po-Hong; Hsia, Cheng-Yuan; Su, Chien-Wei; Chiou, Yi-You; Lin, Han-Chieh; Huo, Teh-Ia] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Hsu, Chia-Yang; Liu, Po-Hong; Huang, Yi-Hsiang; Su, Chien-Wei; Lin, Han-Chieh; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lee, Yun-Hsuan; Chu, Chen-Wei] Taipei Vet Gen Hosp, Dept Med, Yuanshan Branch, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of California System; University of California Los Angeles	Huo, TI (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/G-8459-2015; Su, Chien-Wei/AHC-8307-2022; Liu, Po-Hong/HGB-9015-2022; Su, Chien-Wei/C-1521-2012	Liu, Po-Hong/0000-0001-6205-3704; Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425				Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabibbo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070016; Cabrera R, 2010, ALIMENT PHARM THER, V31, P461, DOI 10.1111/j.1365-2036.2009.04200.x; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chen X, 2012, BRIT J SURG, V99, P1701, DOI 10.1002/bjs.8951; Child CG, 1964, LIVER PORTAL HYPERTE, P50; FEINSTEIN AR, 1972, CLIN PHARMACOL THER, V13, P609; Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284; GRANT BF, 1988, SEMIN LIVER DIS, V8, P12, DOI 10.1055/s-2008-1040525; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Harada N, 2012, ANN TRANSPL, V17, P11; Hosmer DW, 1997, STAT MED, V16, P965; Hsu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089373; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Hsu KF, 2012, EUR J RADIOL, V81, P466, DOI 10.1016/j.ejrad.2010.12.058; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Ikeda K, 2011, LIVER INT, V31, P692, DOI 10.1111/j.1478-3231.2011.02480.x; Komorizono Y, 2003, CANCER-AM CANCER SOC, V97, P1253, DOI 10.1002/cncr.11168; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lee YH, 2014, J CLIN GAST IN PRESS; Lee YH, 2012, DIGEST LIVER DIS, V44, P868, DOI 10.1016/j.dld.2012.04.018; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Manghisi G, 1998, HEPATOLOGY, V28, P751; Nagasue N, 1999, ANN SURG, V229, P84, DOI 10.1097/00000658-199901000-00011; Okuwaki Y, 2009, AM J GASTROENTEROL, V104, P2747, DOI 10.1038/ajg.2009.414; Pompili M, 2013, J HEPATOL, V59, P89, DOI 10.1016/j.jhep.2013.03.009; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Silva MF, 2013, EJSO-EUR J SURG ONC, V39, P386, DOI 10.1016/j.ejso.2012.12.011; Song PP, 2012, LIVER INT, V32, P1053, DOI 10.1111/j.1478-3231.2012.02792.x; Takahashi S, 2007, DIGEST DIS, V25, P303, DOI 10.1159/000106909; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99115	10.1371/journal.pone.0099115	http://dx.doi.org/10.1371/journal.pone.0099115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906132	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000104
J	Nardella, A; Rocchi, L; Conte, A; Bologna, M; Suppa, A; Berardelli, A				Nardella, Andrea; Rocchi, Lorenzo; Conte, Antonella; Bologna, Matteo; Suppa, Antonio; Berardelli, Alfredo			Inferior Parietal Lobule Encodes Visual Temporal Resolution Processes Contributing to the Critical Flicker Frequency Threshold in Humans	PLOS ONE			English	Article							THETA-BURST-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; PHOSPHENE THRESHOLDS; EVOKED-POTENTIALS; FUSION THRESHOLD; PREFRONTAL CORTEX; MOTOR CORTEX; BLOOD-FLOW; MOTION; BRAIN	The measurement of the Critical Flicker Frequency threshold is used to study the visual temporal resolution in healthy subjects and in pathological conditions. To better understand the role played by different cortical areas in the Critical Flicker Frequency threshold perception we used continuous Theta Burst Stimulation (cTBS), an inhibitory plasticity-inducing protocol based on repetitive transcranial magnetic stimulation. The Critical Flicker Frequency threshold was measured in twelve healthy subjects before and after cTBS applied over different cortical areas in separate sessions. cTBS over the left inferior parietal lobule altered the Critical Flicker Frequency threshold, whereas cTBS over the left mediotemporal cortex, primary visual cortex and right inferior parietal lobule left the Critical Flicker Frequency threshold unchanged. No statistical difference was found when the red or blue lights were used. Our findings show that left inferior parietal lobule is causally involved in the conscious perception of Critical Flicker Frequency and that Critical Flicker Frequency threshold can be modulated by plasticity-inducing protocols.	[Nardella, Andrea; Conte, Antonella; Bologna, Matteo; Suppa, Antonio; Berardelli, Alfredo] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Rocchi, Lorenzo; Conte, Antonella; Berardelli, Alfredo] Univ Rome, Dept Neurol & Psychiat, Rome, Italy	IRCCS Neuromed; Sapienza University Rome	Berardelli, A (corresponding author), IRCCS Neuromed, Pozzilli, Isernia, Italy.	alfredo.berardelli@uniroma1.it	Suppa, Antonio/K-4803-2016; Conte, Antonella/J-4508-2012; Rocchi, Lorenzo/K-7983-2016; Bologna, Matteo/K-7886-2016	Suppa, Antonio/0000-0001-9903-5550; Rocchi, Lorenzo/0000-0003-3979-156X; Bologna, Matteo/0000-0003-0165-0833; Conte, Antonella/0000-0002-6338-2961; BERARDELLI, Alfredo/0000-0003-3598-3142				Aglioti SM, 2003, NEUROLOGY, V60, P782, DOI 10.1212/01.WNL.0000046528.24693.5B; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Beck DM, 2006, CEREB CORTEX, V16, P712, DOI 10.1093/cercor/bhj017; BECKERS G, 1992, P ROY SOC B-BIOL SCI, V249, P173, DOI 10.1098/rspb.1992.0100; Bernardi Luciana, 2007, Arq. Bras. Oftalmol., V70, P91, DOI 10.1590/S0004-27492007000100017; Bestmann S, 2008, TRENDS COGN SCI, V12, P81, DOI 10.1016/j.tics.2007.12.002; BLACK S, 1975, NEW ZEAL MED J, V81, P244; Bolognini N, 2009, EXP BRAIN RES, V195, P509, DOI 10.1007/s00221-009-1820-7; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bosco G, 2008, J NEUROSCI, V28, P12071, DOI 10.1523/JNEUROSCI.2869-08.2008; Bowles KE, 2012, ADV EXP MED BIOL, V723, P503, DOI 10.1007/978-1-4614-0631-0_63; Bradley D, 2012, J NEUROL, V259, P77, DOI 10.1007/s00415-011-6125-7; Brighina F, 2003, EUR J NEUROSCI, V17, P2469, DOI 10.1046/j.1460-9568.2003.02679.x; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; Connolly D, 2007, OPTOMETRY VISION SCI, V84, P529, DOI 10.1097/OPX.0b013e318073c65b; Conte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032979; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Curran S, 2004, INT J GERIATR PSYCH, V19, P575, DOI 10.1002/gps.1134; Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Fiesta MP, 2008, J NEUROSCI METH, V174, P103, DOI 10.1016/j.jneumeth.2008.06.020; Fiorio M, 2003, ANN NEUROL, V53, P630, DOI 10.1002/ana.10525; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gregori B, 2011, J NEUROL SCI, V300, P130, DOI 10.1016/j.jns.2010.09.002; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hagenbeek RE, 2002, HUM BRAIN MAPP, V17, P244, DOI 10.1002/hbm.10067; Hecht S, 1933, P NATL ACAD SCI USA, V19, P522, DOI 10.1073/pnas.19.5.522; Herwig U, 2001, PSYCHIAT RES-NEUROIM, V108, P123, DOI 10.1016/S0925-4927(01)00121-4; Hong KS, 2000, J NEUROL SCI, V181, P50, DOI 10.1016/S0022-510X(00)00412-3; Hotson JR, 1999, NEUROPSYCHOLOGIA, V37, P169; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iezzi E, 2010, EUR J NEUROSCI, V31, P585, DOI 10.1111/j.1460-9568.2010.07090.x; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Kagi G, 2013, MOVEMENT DISORD, V28, P356, DOI 10.1002/mds.25305; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2010, CLIN NEUROPHYSIOL, V121, P376, DOI 10.1016/j.clinph.2009.12.002; Koivisto M, 2010, NEUROIMAGE, V51, P828, DOI 10.1016/j.neuroimage.2010.02.042; KOOI KA, 1958, NEUROLOGY, V8, P764, DOI 10.1212/WNL.8.10.764; Kowacs PA, 2005, CEPHALALGIA, V25, P339, DOI 10.1111/j.1468-2982.2004.00861.x; Krolak-Salmon P, 2003, ANN NEUROL, V53, P73, DOI 10.1002/ana.10403; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lyskov E, 1998, INT J PSYCHOPHYSIOL, V28, P285, DOI 10.1016/S0167-8760(97)00074-3; MECACCI L, 1987, INT J PSYCHOPHYSIOL, V4, P325, DOI 10.1016/0167-8760(87)90045-6; Midena E, 1989, Metab Pediatr Syst Ophthalmol (1985), V12, P28; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nicholls M E, 1996, Laterality, V1, P97; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Petukhov IV, 2007, B EXP BIOL MED+, V144, P267, DOI 10.1007/s10517-007-0306-5; Puzzo I, 2013, BRAIN RES, V1541, P33, DOI 10.1016/j.brainres.2013.10.016; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; REBAI M, 1986, PERCEPTION, V15, P589, DOI 10.1068/p150589; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schrupp LE, 2009, OPTOMETRY, V80, P642, DOI 10.1016/j.optm.2009.04.097; Seitz AR, 2005, HUM PSYCHOPHARM CLIN, V20, P55, DOI 10.1002/hup.661; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; SIMONSON E, 1952, PHYSIOL REV, V32, P349, DOI 10.1152/physrev.1952.32.3.349; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Talairach J., 1988, COPLANAR STEREOTAXIC; Teo JTH, 2007, CLIN NEUROPHYSIOL, V118, P1649, DOI 10.1016/j.clinph.2007.04.010; Thickbroom GW, 1998, ELECTROMYOGR MOTOR C, V109, P79, DOI 10.1016/S0924-980X(98)00006-X; Toman J, 1941, J NEUROPHYSIOL, V4, P51, DOI 10.1152/jn.1941.4.1.51; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; TYLER CW, 1989, J OPT SOC AM A, V6, P481, DOI 10.1364/JOSAA.6.000481; Walker AE, 1944, ARCH NEURO PSYCHIATR, V52, P117, DOI 10.1001/archneurpsyc.1944.02290320032004; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038	82	13	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98948	10.1371/journal.pone.0098948	http://dx.doi.org/10.1371/journal.pone.0098948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905987	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000081
J	Nascimento, FX; Rossi, MJ; Soares, CRFS; McConkey, BJ; Glick, BR				Nascimento, Francisco X.; Rossi, Marcio J.; Soares, Claudio R. F. S.; McConkey, Brendan J.; Glick, Bernard R.			New Insights into 1-Aminocyclopropane-1-Carboxylate (ACC) Deaminase Phylogeny, Evolution and Ecological Significance	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; BURKHOLDERIA-CEPACIA COMPLEX; D-CYSTEINE DESULFHYDRASE; PSEUDOMONAS-PUTIDA UW4; PLANT-GROWTH; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; AGROBACTERIUM-TUMEFACIENS; SEQUENCE ALIGNMENT; CONFER RESISTANCE	The main objective of this work is the study of the phylogeny, evolution and ecological importance of the enzyme 1-aminocyclopropane-1-carboxylate (ACC) deaminase, the activity of which represents one of the most important and studied mechanisms used by plant growth promoting microorganisms. The ACC deaminase gene and its regulatory elements presence in completely sequenced organisms was verified by multiple searches in diverse databases, and based on the data obtained a comprehensive analysis was conducted. Strain habitat, origin and ACC deaminase activity were taken into account when analyzing the results. In order to unveil ACC deaminase origin, evolution and relationships with other closely related pyridoxal phosphate (PLP) dependent enzymes a phylogenetic analysis was also performed. The data obtained show that ACC deaminase is mostly prevalent in some Bacteria, Fungi and members of Stramenopiles. Contrary to previous reports, we show that ACC deaminase genes are predominantly vertically inherited in various bacterial and fungal classes. Still, results suggest a considerable degree of horizontal gene transfer events, including interkingdom transfer events. A model for ACC deaminase origin and evolution is also proposed. This study also confirms the previous reports suggesting that the Lrp-like regulatory protein AcdR is a common mechanism regulating ACC deaminase expression in Proteobacteria, however, we also show that other regulatory mechanisms may be present in some Proteobacteria and other bacterial phyla. In this study we provide a more complete view of the role for ACC deaminase than was previously available. The results show that ACC deaminase may not only be related to plant growth promotion abilities, but may also play multiple roles in microorganism's developmental processes. Hence, exploring the origin and functioning of this enzyme may be the key in a variety of important agricultural and biotechnological applications.	[Nascimento, Francisco X.; Rossi, Marcio J.; Soares, Claudio R. F. S.] Univ Fed Santa Catarina, Dept Microbiol, Lab Microbiol Solo, Florianopolis, SC, Brazil; [McConkey, Brendan J.; Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Universidade Federal de Santa Catarina (UFSC); University of Waterloo	Nascimento, FX (corresponding author), Univ Fed Santa Catarina, Dept Microbiol, Lab Microbiol Solo, Florianopolis, SC, Brazil.	fxnascimento@gmail.com	Nascimento, Francisco X./F-6537-2016; Jose Rossi, Marcio/M-3979-2014	Nascimento, Francisco X./0000-0003-1184-3794; Jose Rossi, Marcio/0000-0003-1062-5269; Sousa Soares, Claudio Roberto Fonseca/0000-0002-5443-6614	Fundacao de Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/86954/2012]	Fundacao de Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	Francisco X. Nascimento acknowledges a PhD fellowship (SFRH/BD/86954/2012) from Fundacao de Ciencia e Tecnologia (FCT), Portugal. We thank Michael D.J. Lynch (University of Waterloo) for all the help in the phylogenetic analysis, and Clarisse Brigido (Universidade de Evora) for the suggestions provided for the elaboration of this manuscript.	Ali S, 2012, J APPL MICROBIOL, V113, P1139, DOI 10.1111/j.1365-2672.2012.05409.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baldwin A, 2007, EMERG INFECT DIS, V13, P458, DOI 10.3201/eid1303.060403; Belimov AA, 2005, SOIL BIOL BIOCHEM, V37, P241, DOI 10.1016/j.soilbio.2004.07.033; Bharath SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036267; Blaha D, 2006, FEMS MICROBIOL ECOL, V56, P455, DOI 10.1111/j.1574-6941.2006.00082.x; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Brotman Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003221; Burd GI, 1998, APPL ENVIRON MICROB, V64, P3663; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chen SC, 2013, FUNGAL ECOL, V6, P110, DOI 10.1016/j.funeco.2012.08.003; Cheng ZY, 2008, CAN J MICROBIOL, V54, P128, DOI 10.1139/w07-128; Conforte VP, 2010, J GEN APPL MICROBIOL, V56, P331; Contesto C, 2008, PLANT SCI, V175, P178, DOI 10.1016/j.plantsci.2008.01.020; Cooper VS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000732; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dastager SG, 2010, PLANT PHYSIOL BIOCH, V48, P987, DOI 10.1016/j.plaphy.2010.09.006; Dell'Amico E, 2008, SOIL BIOL BIOCHEM, V40, P74, DOI 10.1016/j.soilbio.2007.06.024; Destino Lauren, 2006, Ann Clin Microbiol Antimicrob, V5, P21, DOI 10.1186/1476-0711-5-21; Dobrindt U, 2010, MED MICROBIOL IMMUN, V199, P145, DOI 10.1007/s00430-010-0161-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Tarabily KA, 2008, PLANT SOIL, V308, P161, DOI 10.1007/s11104-008-9616-2; Fedorov DN, 2013, FEMS MICROBIOL LETT, V343, P70, DOI 10.1111/1574-6968.12133; Fiore A, 2001, ENVIRON MICROBIOL, V3, P137, DOI 10.1046/j.1462-2920.2001.00175.x; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gandhi PM, 2009, J MICROBIOL BIOTECHN, V19, P99, DOI 10.4014/jmb.0803.173; Ghosh S, 2003, PLANT PHYSIOL BIOCH, V41, P277, DOI 10.1016/S0981-9428(03)00019-6; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; GLICK BR, 1994, CAN J MICROBIOL, V40, P911, DOI 10.1139/m94-146; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P11, DOI 10.1016/S0981-9428(00)01212-2; Grichko VP, 2000, J BIOTECHNOL, V81, P45, DOI 10.1016/S0168-1656(00)00270-4; Grichko VP, 2000, CAN J MICROBIOL, V46, P1159, DOI 10.1139/cjm-46-12-1159; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2007, J MOL EVOL, V64, P90, DOI 10.1007/s00239-006-0082-2; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Gupta RS, 2000, CRIT REV MICROBIOL, V26, P111, DOI 10.1080/10408410091154219; Hao YU, 2007, CAN J MICROBIOL, V53, P1291, DOI 10.1139/W07-099; Hao YA, 2011, CAN J MICROBIOL, V57, P278, DOI [10.1139/W11-006, 10.1139/w11-006]; HONMA M, 1978, AGR BIOL CHEM TOKYO, V42, P1825, DOI 10.1080/00021369.1978.10863261; Hontzeas N, 2005, APPL ENVIRON MICROB, V71, P7556, DOI 10.1128/AEM.71.11.7556-7558.2005; Hontzeas N, 2004, BBA-PROTEINS PROTEOM, V1703, P11, DOI 10.1016/j.bbapap.2004.09.015; Hyodo H, 1991, PLANT HORMONE ETHYLE, P65; Jia YJ, 1999, BIOSCI BIOTECH BIOCH, V63, P542, DOI 10.1271/bbb.63.542; Jia YJ, 2000, BIOSCI BIOTECH BIOCH, V64, P299, DOI 10.1271/bbb.64.299; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; KLEE HJ, 1991, PLANT CELL, V3, P1187, DOI 10.1105/tpc.3.11.1187; Klich MA, 2002, MYCOLOGIA, V94, P21, DOI 10.2307/3761842; Li JP, 2001, CAN J MICROBIOL, V47, P359, DOI 10.1139/cjm-47-4-359; Li JP, 2000, CURR MICROBIOL, V41, P101, DOI 10.1007/s002840010101; Ludwig W., 2005, BERGEYS MANUAL SYSTE, P49, DOI DOI 10.1007/0-387-28021-9_; Ma WB, 2004, APPL ENVIRON MICROB, V70, P5891, DOI 10.1128/AEM.70.10.5891-5897.2004; Ma WB, 2003, APPL ENVIRON MICROB, V69, P4396, DOI 10.1128/AEM.69.8.4396-4402.2003; Maimaiti J, 2007, ENVIRON MICROBIOL, V9, P435, DOI 10.1111/j.1462-2920.2006.01155.x; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; Massey RC, 2002, TRENDS MICROBIOL, V10, P580, DOI 10.1016/S0966-842X(02)02475-7; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McDonnell L, 2009, PHYSIOL PLANTARUM, V136, P94, DOI 10.1111/j.1399-3054.2009.01208.x; Minami R, 1998, J BIOCHEM, V123, P1112; Murset V, 2012, SYMBIOSIS, V57, P43, DOI 10.1007/s13199-012-0177-z; Nadeem SM, 2009, CAN J MICROBIOL, V55, P1302, DOI [10.1139/W09-092, 10.1139/w09-092]; NAGASAWA T, 1985, EUR J BIOCHEM, V153, P541, DOI 10.1111/j.1432-1033.1985.tb09335.x; Nandasena KG, 2007, ENVIRON MICROBIOL, V9, P2496, DOI 10.1111/j.1462-2920.2007.01368.x; Nascimento F, 2012, PLANT SOIL, V353, P221, DOI 10.1007/s11104-011-1025-2; Nascimento FX, 2012, LETT APPL MICROBIOL, V55, P15, DOI 10.1111/j.1472-765X.2012.03251.x; Nascimento FX, 2013, BIOCONTROL, V58, P427, DOI 10.1007/s10526-012-9500-0; Nascimento FX, 2012, FEMS MICROBIOL LETT, V336, P26, DOI 10.1111/j.1574-6968.2012.02648.x; Nie L, 2002, PLANT PHYSIOL BIOCH, V40, P355, DOI 10.1016/S0981-9428(02)01375-X; Nikolic B, 2011, ARCH MICROBIOL, V193, P665, DOI 10.1007/s00203-011-0703-z; Nukui N, 2006, APPL ENVIRON MICROB, V72, P4964, DOI 10.1128/AEM.02745-05; Onofre-Lemus J, 2009, APPL ENVIRON MICROB, V75, P6581, DOI 10.1128/AEM.01240-09; Prigent-Combaret C, 2008, FEMS MICROBIOL ECOL, V65, P202, DOI 10.1111/j.1574-6941.2008.00474.x; Reed MLE, 2005, CURR MICROBIOL, V51, P425, DOI 10.1007/s00284-005-4584-8; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Robison MM, 2001, MOL PLANT PATHOL, V2, P135, DOI 10.1046/j.1364-3703.2001.00060.x; Rothballer M, 2008, FEMS MICROBIOL ECOL, V66, P85, DOI 10.1111/j.1574-6941.2008.00582.x; Sergeeva E, 2006, WORLD J MICROB BIOT, V22, P277, DOI 10.1007/s11274-005-9032-1; Sharma M, 2011, PLANT SOIL, V341, P447, DOI 10.1007/s11104-010-0657-y; Siddikee MA, 2010, J MICROBIOL BIOTECHN, V20, P1577, DOI 10.4014/jmb.1007.07011; Singh N, 2012, J MOL MODEL, V18, P4101, DOI 10.1007/s00894-012-1389-0; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Soutourina J, 2001, J BIOL CHEM, V276, P40864, DOI 10.1074/jbc.M102375200; Stearns JC, 2012, MOL PLANT MICROBE IN, V25, P668, DOI 10.1094/MPMI-08-11-0213; Stiens M, 2006, APPL ENVIRON MICROB, V72, P3662, DOI 10.1128/AEM.72.5.3662-3672.2006; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Sziderics AH, 2007, CAN J MICROBIOL, V53, P1195, DOI 10.1139/W07-082; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmusk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017968; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toklikishvili N, 2010, PLANT PATHOL, V59, P1023, DOI 10.1111/j.1365-3059.2010.02326.x; Uchiumi T, 2004, J BACTERIOL, V186, P2439, DOI 10.1128/JB.186.8.2439-2448.2004; URAKAMI T, 1994, INT J SYST BACTERIOL, V44, P235, DOI 10.1099/00207713-44-2-235; Viallard V, 1998, INT J SYST BACTERIOL, V48, P549, DOI 10.1099/00207713-48-2-549; Viterbo A, 2010, FEMS MICROBIOL LETT, V305, P42, DOI 10.1111/j.1574-6968.2010.01910.x; WALSH C, 1981, BIOCHEMISTRY-US, V20, P7509, DOI 10.1021/bi00529a028; Wang CX, 2000, CAN J MICROBIOL, V46, P898, DOI 10.1139/cjm-46-10-898; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	105	142	149	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99168	10.1371/journal.pone.0099168	http://dx.doi.org/10.1371/journal.pone.0099168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905353	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000108
J	Yamamoto, T; Byun, J; Zhai, PY; Ikeda, Y; Oka, S; Sadoshima, J				Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong; Ikeda, Yoshiyuki; Oka, Shinichi; Sadoshima, Junichi			Nicotinamide Mononucleotide, an Intermediate of NAD(+) Synthesis, Protects the Heart from Ischemia and Reperfusion	PLOS ONE			English	Article							POSSIBLE INVOLVEMENT; CALORIC RESTRICTION; CELL-SURVIVAL; SIRT1; ISCHEMIA/REPERFUSION; DEACETYLATION; METABOLISM; AUTOPHAGY; DISEASE; AMPK	Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD(+)) synthesis, and Sirt1, an NAD(+)-dependent histone deacetylase, protect the heart against ischemia/reperfusion (I/R). It remains unknown whether Nampt mediates the protective effect of ischemic preconditioning (IPC), whether nicotinamide mononucleotide (NMN, 500 mg/kg), a product of Nampt in the NAD(+) salvage pathway, mimics the effect of IPC, or whether caloric restriction (CR) upregulates Nampt and protects the heart through a Sirt1-dependent mechanism. IPC upregulated Nampt protein, and the protective effect of IPC against ischemia (30 minutes) and reperfusion (24 hours) was attenuated at both early and late phases in Nampt +/- mice, suggesting that Nampt plays an essential role in mediating the protective effect of IPC. In order to mimic the effect of Nampt, NMN was administered by intraperitoneal injection. NMN significantly increased the level of NAD(+) in the heart at baseline and prevented a decrease in NAD(+) during ischemia. NMN protected the heart from I/R injury when it was applied once 30 minutes before ischemia or 4 times just before and during reperfusion, suggesting that exogenous NMN protects the heart from I/R injury in both ischemic and reperfusion phases. The protective effect of NMN was accompanied by decreases in acetylation of FoxO1, but it was not obvious in Sirt1 KO mice, suggesting that the effect of NMN is mediated through activation of Sirt1. Compared to control diet (90% calories), CR (60% calories for 6 weeks) in mice led to a significant reduction in I/R injury, accompanied by upregulation of Nampt. The protective effect of CR against I/R injury was not significant in cardiac-specific Sirt1 KO mice, suggesting that the protective effect of CR is in part mediated through the Nampt-Sirt1 pathway. In conclusion, exogenous application of NMN and CR protects the heart by both mimicking IPC and activating Sirt1.	[Yamamoto, Takanobu; Byun, Jaemin; Zhai, Peiyong; Ikeda, Yoshiyuki; Oka, Shinichi; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA.	sadoshju@njms.rutgers.edu		Sadoshima, Junichi/0000-0003-3724-4132	United States Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, P01HL069020, R01HL067724, R01HL112330, R01HL102738, P01HL059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039, P01AG027211] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fondation Leducq Transatlantic Networks of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants HL59139, HL67724, HL69020, HL91469, HL102738, and AG27211, and by the Fondation Leducq Transatlantic Networks of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mayi TH, 2011, BIOCHEM BIOPH RES CO, V404, P458, DOI 10.1016/j.bbrc.2010.12.002; Montecucco F, 2013, ANTIOXID REDOX SIGN, V18, P630, DOI 10.1089/ars.2011.4487; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Pillai VB, AM J PHYSL HEART CIR, V304, pH415; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Shinmura K, 2013, TRENDS CARDIOVAS MED, V23, P18, DOI 10.1016/j.tcm.2012.08.006; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Yamamoto T, 2011, TRENDS CARDIOVAS MED, V21, P27, DOI 10.1016/j.tcm.2012.01.005; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	29	169	174	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98972	10.1371/journal.pone.0098972	http://dx.doi.org/10.1371/journal.pone.0098972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905194	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000085
J	Dimopoulou, M; Vuillemin, M; Campbell-Sills, H; Lucas, PM; Ballestra, P; Miot-Sertier, C; Favier, M; Coulon, J; Moine, V; Doco, T; Roques, M; Williams, P; Petrel, M; Gontier, E; Moulis, C; Remaud-Simeon, M; Dols-Lafargue, M				Dimopoulou, Maria; Vuillemin, Marlene; Campbell-Sills, Hugo; Lucas, Patrick M.; Ballestra, Patricia; Miot-Sertier, Cecile; Favier, Marion; Coulon, Joana; Moine, Virginie; Doco, Thierry; Roques, Maryline; Williams, Pascale; Petrel, Melina; Gontier, Etienne; Moulis, Claire; Remaud-Simeon, Magali; Dols-Lafargue, Marguerite			Exopolysaccharide (EPS) Synthesis by Oenococcus oeni: From Genes to Phenotypes	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STREPTOCOCCUS-THERMOPHILUS; LEUCONOSTOC-MESENTEROIDES; MALOLACTIC FERMENTATION; PEDIOCOCCUS-PARVULUS; LACTOCOCCUS-LACTIS; FUNCTIONAL-CHARACTERIZATION; BIOSYNTHESIS; POLYSACCHARIDE; DIVERSITY	Oenococcus oeni is the bacterial species which drives malolactic fermentation in wine. The analysis of 50 genomic sequences of O. oeni (14 already available and 36 newly sequenced ones) provided an inventory of the genes potentially involved in exopolysaccharide (EPS) biosynthesis. The loci identified are: two gene clusters named eps1 and eps2, three isolated glycoside-hydrolase genes named dsrO, dsrV and levO, and three isolated glycosyltransferase genes named gtf, it3, it4. The isolated genes were present or absent depending on the strain and the eps gene clusters composition diverged from one strain to another. The soluble and capsular EPS production capacity of several strains was examined after growth in different culture media and the EPS structure was determined. Genotype to phenotype correlations showed that several EPS biosynthetic pathways were active and complementary in O. oeni. Can be distinguished: (i) a Wzy -dependent synthetic pathway, allowing the production of heteropolysaccharides made of glucose, galactose and rhamnose, mainly in a capsular form, (ii) a glucan synthase pathway (Gtf), involved in beta-glucan synthesis in a free and a cell-associated form, giving a ropy phenotype to growth media and (iii) homopolysaccharide synthesis from sucrose (alpha-glucan or beta-fructan) by glycoside-hydrolases of the GH70 and GH68 families. The eps gene distribution on the phylogenetic tree was examined. Fifty out of 50 studied genomes possessed several genes dedicated to EPS metabolism. This suggests that these polymers are important for the adaptation of O. oeni to its specific ecological niche, wine and possibly contribute to the technological performance of malolactic starters.	[Dimopoulou, Maria; Campbell-Sills, Hugo; Lucas, Patrick M.; Ballestra, Patricia; Miot-Sertier, Cecile; Dols-Lafargue, Marguerite] Univ Bordeaux, Inst Polytech Bordeaux, Unite Rech Oenol, ISVV,EA 4577,INRA USC 1366, Villenave Dornon, France; [Vuillemin, Marlene; Moulis, Claire; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,INRA,CNRS,LISBP, Toulouse, France; [Favier, Marion; Coulon, Joana; Moine, Virginie] BioLaffort, Res Subsidiary Laffort Grp, Bordeaux, France; [Doco, Thierry; Roques, Maryline; Williams, Pascale] INRA, UMR1083, F-34060 Montpellier, France; [Petrel, Melina; Gontier, Etienne] Univ Bordeaux, Bordeaux Imaging Ctr, UMS CNRS INSERM 34220 US4, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Dols-Lafargue, M (corresponding author), Univ Bordeaux, Inst Polytech Bordeaux, Unite Rech Oenol, ISVV,EA 4577,INRA USC 1366, Villenave Dornon, France.	dols@enscbp.fr	Vuillemin, Marlène/Q-6203-2016	Vuillemin, Marlène/0000-0002-1776-7844; Doco, Thierry/0000-0002-1453-8683; Lucas, Patrick/0000-0002-9054-5439; MIOT-SERTIER, Cecile/0000-0002-5158-3803; Dimopoulou, Maria/0000-0003-4883-7697; MOULIS, Claire/0000-0002-1937-9052	 [ANR-10-ALIA-003]		ANR-10-ALIA-003 (www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Boels IC, 2001, INT DAIRY J, V11, P723, DOI 10.1016/S0958-6946(01)00116-9; Borneman AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-373; Borneman AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029626; Borneman AR, 2010, APPL MICROBIOL BIOT, V86, P681, DOI 10.1007/s00253-009-2425-6; Bourdineaud JP, 2003, APPL ENVIRON MICROB, V69, P2512, DOI 10.1128/AEM.69.5.2512-2520.2003; Bridier J, 2010, APPL ENVIRON MICROB, V76, P7754, DOI 10.1128/AEM.01544-10; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Ciezack G, 2010, J APPL MICROBIOL, V108, P499, DOI 10.1111/j.1365-2672.2009.04449.x; Coulon J, 2012, INT J FOOD MICROBIOL, V159, P25, DOI 10.1016/j.ijfoodmicro.2012.07.024; DAVIS CR, 1986, APPL ENVIRON MICROB, V51, P539, DOI 10.1128/AEM.51.3.539-545.1986; DAVIS CR, 1985, AM J ENOL VITICULT, V36, P290; De Vuyst L, 1999, FEMS MICROBIOL REV, V23, P153, DOI 10.1016/S0168-6445(98)00042-4; Degeest B, 2001, J APPL MICROBIOL, V91, P470, DOI 10.1046/j.1365-2672.2001.01404.x; Degeest B, 2000, APPL ENVIRON MICROB, V66, P3519, DOI 10.1128/AEM.66.8.3519-3527.2000; Dertli E, 2013, J BIOL CHEM, V288, P31938, DOI 10.1074/jbc.M113.507418; Dimopoulou M, 2012, INT J FOOD MICROBIOL, V153, P114, DOI 10.1016/j.ijfoodmicro.2011.10.024; Dols-Lafargue M, 2008, APPL ENVIRON MICROB, V74, P4079, DOI 10.1128/AEM.00673-08; Dols-Lafargue M, 2007, J AGR FOOD CHEM, V55, P9592, DOI 10.1021/jf071677+; Doria F, 2013, APPL ENVIRON MICROB, V79, P4799, DOI 10.1128/AEM.01307-13; Favier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049082; Forde A, 2003, PLASMID, V49, P130, DOI 10.1016/S0147-619X(02)00156-7; FUNANE K, 1993, BIOCHEMISTRY-US, V32, P13696, DOI 10.1021/bi00212a039; Gammacurta M, 2011, P 9 INT S OEN 15 17; Ganzle MG, 2009, BACTERIAL POLYSACCHA; Golubchik T, 2012, NAT GENET, V44, P352, DOI 10.1038/ng.1072; Gorska S, 2010, CARBOHYD RES, V345, P108, DOI 10.1016/j.carres.2009.09.015; Grandvalet C, 2005, J BACTERIOL, V187, P5614, DOI 10.1128/JB.187.16.5614-5623.2005; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; HARRIS PJ, 1984, CARBOHYD RES, V127, P59, DOI 10.1016/0008-6215(84)85106-X; HENICKKLING T, 1989, APPL ENVIRON MICROB, V55, P2010, DOI 10.1128/AEM.55.8.2010-2016.1989; Hidalgo-Cantabrana C, 2014, APPL ENVIRON MICROB, V80, P9, DOI 10.1128/AEM.02977-13; Hocine B, 2010, J INT SCI VIGNE VIN, V44, P31; Hong SH, 2001, J DAIRY SCI, V84, P1367, DOI 10.3168/jds.S0022-0302(01)70167-1; Jaomanjaka F, 2013, INT J FOOD MICROBIOL, V166, P331, DOI 10.1016/j.ijfoodmicro.2013.06.032; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; Lbarburu I, 2007, J APPL MICROBIOL, V103, P477, DOI 10.1111/j.1365-2672.2006.03266.x; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Lonvaud-Funel A, 1999, ANTON LEEUW INT J G, V76, P317, DOI 10.1023/A:1002088931106; Looijesteijn PJ, 2001, INT J FOOD MICROBIOL, V64, P71, DOI 10.1016/S0168-1605(00)00437-2; LUDWIG THOMAS G., 1956, JOUR DENTAL RES, V35, P90, DOI 10.1177/00220345560350012301; Martins G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073013; Mills DA, 2005, FEMS MICROBIOL REV, V29, P465, DOI 10.1016/j.femsre.2005.04.011; Morales-Arrieta S, 2006, GENE, V376, P59, DOI 10.1016/j.gene.2006.02.007; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; MUKASA H, 1973, INFECT IMMUN, V8, P555, DOI 10.1128/IAI.8.4.555-562.1973; MURCHISON H, 1981, INFECT IMMUN, V34, P1044, DOI 10.1128/IAI.34.3.1044-1055.1981; Olvera C, 2007, MICROBIOL-SGM, V153, P3994, DOI 10.1099/mic.0.2007/008854-0; Peant B, 2005, MICROBIOL-SGM, V151, P1839, DOI 10.1099/mic.0.27852-0; Peynaud E, 1959, CR ACAD AGR FR, V45, P355; Pluvinet A, 2004, INT DAIRY J, V14, P627, DOI 10.1016/j.idairyj.2003.12.009; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rodriguez C, 2008, LETT APPL MICROBIOL, V46, P462, DOI 10.1111/j.1472-765X.2008.02341.x; Ruas-Madiedo P, 2002, INT DAIRY J, V12, P689, DOI 10.1016/S0958-6946(01)00161-3; Stingele F, 1999, MOL MICROBIOL, V32, P1287, DOI 10.1046/j.1365-2958.1999.01441.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torriani S, 2011, ANN MICROBIOL, V61, P33, DOI 10.1007/s13213-010-0072-x; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; Versari A, 1999, J IND MICROBIOL BIOT, V23, P447, DOI 10.1038/sj.jim.2900733; Walling E, 2005, INT J FOOD MICROBIOL, V98, P53, DOI 10.1016/j.ijfoodmicro.2004.05.016; Walling E, 2005, FOOD MICROBIOL, V22, P71, DOI 10.1016/j.fm.2004.04.003; Werning ML, 2006, J FOOD PROTECT, V69, P161, DOI 10.4315/0362-028X-69.1.161; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wilson BA, 2002, CURR OPIN BIOTECH, V13, P267, DOI 10.1016/S0958-1669(02)00312-9; Wyres KL, 2013, J INFECT DIS, V207, P439, DOI 10.1093/infdis/jis703	70	46	48	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98898	10.1371/journal.pone.0098898	http://dx.doi.org/10.1371/journal.pone.0098898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901216	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400069
J	Talarico, JA; Carter, RL; Grisanti, LA; Yu, JE; Repas, AA; Tilley, DG				Talarico, Jennifer A.; Carter, Rhonda L.; Grisanti, Laurel A.; Yu, Justine E.; Repas, Ashley A.; Tilley, Douglas G.			beta-Adrenergic Receptor-Dependent Alterations in Murine Cardiac Transcript Expression Are Differentially Regulated by Gefitinib In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; BETA(2)-ADRENERGIC RECEPTOR; INDUCED APOPTOSIS; SEMAPHORIN 3A; HYPERTROPHY; THROMBOSPONDIN-1; TRANSACTIVATION; PATHWAY; HEART	beta-adrenergic receptor (bAR)-mediated transactivation of epidermal growth factor receptor (EGFR) has been shown to promote cardioprotection in a mouse model of heart failure and we recently showed that this mechanism leads to enhanced cell survival in part via regulation of apoptotic transcript expression in isolated primary rat neonatal cardiomyocytes. Thus, we hypothesized that this process could regulate cardiac transcript expression in vivo. To comprehensively assess cardiac transcript alterations in response to acute bAR-dependent EGFR transactivation, we performed whole transcriptome analysis of hearts from C57BL/6 mice given i.p. injections of the bAR agonist isoproterenol in the presence or absence of the EGFR antagonist gefitinib for 1 hour. Total cardiac RNA from each treatment group underwent transcriptome analysis, revealing a substantial number of transcripts regulated by each treatment. Gefitinib alone significantly altered the expression of 405 transcripts, while isoproterenol either alone or in conjunction with gefitinib significantly altered 493 and 698 distinct transcripts, respectively. Further statistical analysis was performed, confirming 473 transcripts whose regulation by isoproterenol were significantly altered by gefitinib (isoproterenol-induced up/downregulation antagonized/promoted by gefinitib), including several known to be involved in the regulation of numerous processes including cell death and survival. Thus, bAR-dependent regulation of cardiac transcript expression in vivo can be modulated by the EGFR antagonist gefitinib.	[Talarico, Jennifer A.] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Carter, Rhonda L.; Grisanti, Laurel A.; Yu, Justine E.; Repas, Ashley A.; Tilley, Douglas G.] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA; [Tilley, Douglas G.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Tilley, DG (corresponding author), Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA.	douglas.tilley@temple.edu		Tilley, Douglas/0000-0002-9681-3377	National Institutes of Health [HL105414]; WW Smith Charitable Trust [H1206]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WW Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by the National Institutes of Health (HL105414) and the WW Smith Charitable Trust (H1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2009, CANCER PREV RES, V2, P175, DOI 10.1158/1940-6207.CAPR-08-0104; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Carter BD, 2010, AM J PHYSIOL-HEART C, V298, pH1633, DOI 10.1152/ajpheart.00253.2010; Carter RL, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.24; Chen H, 2012, CELL BIOL INT, V36, P237, DOI 10.1042/CBI20110162; Chen Y, 2013, LUNG CANCER, V82, P313, DOI 10.1016/j.lungcan.2013.08.013; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gonzalez-Quesada C, 2013, CIRC RES, V113, P1331, DOI 10.1161/CIRCRESAHA.113.302593; Grisanti LA, 2014, J MOL CELLU IN PRESS; Guo HF, 2013, BIOCHEMISTRY-US, V52, P7551, DOI 10.1021/bi401034q; Ieda M, 2004, J CLIN INVEST, V113, P876, DOI 10.1172/JCI200419480; Inoue R, 2006, ANTICANCER RES, V26, P4195; Irwin DM, 2014, MOL PHYLOGENET EVOL, V70, P195, DOI 10.1016/j.ympev.2013.09.016; Jin Z, 2006, DEV DYNAM, V235, P163, DOI 10.1002/dvdy.20614; Kawasaki Y, 2007, J MEMBRANE BIOL, V217, P53, DOI 10.1007/s00232-007-9051-y; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Lee KS, 2011, CELL SIGNAL, V23, P1100, DOI 10.1016/j.cellsig.2011.01.006; Leggas M, 2006, CANCER RES, V66, P4802, DOI 10.1158/0008-5472.CAN-05-2915; Lewin G, 2009, CIRCULATION, V119, P79, DOI 10.1161/CIRCULATIONAHA.108.786533; Li JW, 2012, J VIROL, V86, P3200, DOI 10.1128/JVI.06699-11; Lu QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064265; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Ma YG, 2013, CIRC RES, V113, P1272, DOI 10.1161/CIRCRESAHA.113.302749; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Mani SK, 2010, J MOL CELL CARDIOL, V48, P342, DOI 10.1016/j.yjmcc.2009.11.007; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Molojavyi A, 2010, PHYSIOL GENOMICS, V41, P137, DOI 10.1152/physiolgenomics.90297.2008; Mustonen E, 2013, BASIC CLIN PHARMACOL, V112, P4, DOI 10.1111/bcpt.12026; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Orphanos GS, 2009, ACTA ONCOL, V48, P964, DOI 10.1080/02841860903229124; Parnes D, 2007, BBA-GENE STRUCT EXPR, V1769, P586, DOI 10.1016/j.bbaexp.2007.06.001; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Soker T, 2013, GENE, V512, P517, DOI 10.1016/j.gene.2012.10.002; Solmi R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-227; Sun SQ, 2011, CHINESE MED J-PEKING, V124, P2173, DOI 10.3760/cmaj.issn.0366-6999.2011.14.017; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Wang Q, 2010, AM J PHYSIOL-REG I, V299, pR1013, DOI 10.1152/ajpregu.00241.2010; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Wen HZ, 2011, TOHOKU J EXP MED, V225, P51, DOI 10.1620/tjem.225.51; Xia Y, 2011, HYPERTENSION, V58, P902, DOI 10.1161/HYPERTENSIONAHA.111.175323; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zhang BH, 2013, HEART VESSELS; Zhang XY, 2013, CIRC RES, V112, P498, DOI 10.1161/CIRCRESAHA.112.273896	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99195	10.1371/journal.pone.0099195	http://dx.doi.org/10.1371/journal.pone.0099195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901703	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400108
J	Darnell, AM; Graf, JA; Somers, MJ; Slotow, R; Gunther, MS				Darnell, Angela M.; Graf, Jan A.; Somers, Michael J.; Slotow, Rob; Gunther, Micaela Szykman			Space Use of African Wild Dogs in Relation to Other Large Carnivores	PLOS ONE			English	Article							HLUHLUWE-UMFOLOZI PARK; LYCAON-PICTUS; INTERSPECIFIC COMPETITION; HUNTING BEHAVIOR; SPOTTED HYAENAS; IMFOLOZI-PARK; NATIONAL-PARK; PANTHERA-LEO; PACK SIZE; POPULATION	Interaction among species through competition is a principle process structuring ecological communities, affecting behavior, distribution, and ultimately the population dynamics of species. High competition among large African carnivores, associated with extensive diet overlap, manifests in interactions between subordinate African wild dogs (Lycaon pictus) and dominant lions (Panthera leo) and spotted hyenas (Crocuta crocuta). Using locations of large carnivores in Hluhluwe-iMfolozi Park, South Africa, we found different responses from wild dogs to their two main competitors. Wild dogs avoided lions, particularly during denning, through a combination of spatial and temporal avoidance. However, wild dogs did not exhibit spatial or temporal avoidance of spotted hyenas, likely because wild dog pack sizes were large enough to adequately defend their kills. Understanding that larger carnivores affect the movements and space use of other carnivores is important for managing current small and fragmented carnivore populations, especially as reintroductions and translocations are essential tools used for the survival of endangered species, as with African wild dogs.	[Darnell, Angela M.; Gunther, Micaela Szykman] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Graf, Jan A.; Slotow, Rob] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, Ctr Invas Biol, ZA-0002 Pretoria, South Africa; [Gunther, Micaela Szykman] Smithsonian Conservat Biol Inst, Front Royal, VA USA	California State University System; California State Polytechnic University, Humboldt; University of Kwazulu Natal; University of Pretoria; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Darnell, AM (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	ange.darnell@gmail.com	Slotow, Rob/AAM-9053-2020; /A-1523-2008	Slotow, Rob/0000-0001-9469-1508; /0000-0002-5836-8823; Darnell Baker, Ange/0000-0003-1419-3248	Smithsonian Institution Undersecretary for Science Endowment Funds; American Zoo and Aquarium Association Conservation Endowment Fund; Humboldt State University Sponsored Program Foundation; University of Pretoria, Green Trust; Bateleurs and Wildlife Conservation Trust; NRF, NSF; University of KwaZulu-Natal; Walt Disney Foundation and MGM; Wild about Cats; Hluhluwe Tourism Association; THRIP; Grand Hotel grants	Smithsonian Institution Undersecretary for Science Endowment Funds; American Zoo and Aquarium Association Conservation Endowment Fund; Humboldt State University Sponsored Program Foundation; University of Pretoria, Green Trust; Bateleurs and Wildlife Conservation Trust; NRF, NSF; University of KwaZulu-Natal; Walt Disney Foundation and MGM; Wild about Cats; Hluhluwe Tourism Association; THRIP; Grand Hotel grants	Funding for this project was provided by the Smithsonian Institution Undersecretary for Science Endowment Funds, the American Zoo and Aquarium Association Conservation Endowment Fund, and Humboldt State University Sponsored Program Foundation (MSG); University of Pretoria, The Green Trust (WWF-SA), and Bateleurs and Wildlife Conservation Trust (KZN) (MS); NRF, NSF, University of KwaZulu-Natal, Walt Disney Foundation and MGM, Wild about Cats, and Hluhluwe Tourism Association (RS); and THRIP (N. Ferguson) and Grand Hotel grants (C. Packer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acocks JPH., 1988, MEMOIRS BOT SURVEY S, P1, DOI DOI 10.2307/212246; Andreka G, 1999, S AFR J WILDL RES, V29, P1; Ballard Warren B., 2003, P259; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Celesia GG, 2010, AFR J ECOL, V48, P58, DOI 10.1111/j.1365-2028.2009.01082.x; COOPER SM, 1990, AFR J ECOL, V28, P131, DOI 10.1111/j.1365-2028.1990.tb01145.x; Courchamp F, 2000, OIKOS, V91, P311, DOI 10.1034/j.1600-0706.2000.910212.x; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2001, CONSERV BIOL SER, V5, P35; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; ESTES RD, 1967, J WILDLIFE MANAGE, V31, P52, DOI 10.2307/3798360; ESTES RD, 1991, BEHAV GUIDE AFRICAN; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Gorman TA, 2006, J MAMMAL, V87, P740, DOI 10.1644/05-MAMM-A-337R1.1; Graf JA, 2009, ACTA THERIOL, V54, P333, DOI 10.4098/j.at.0001-7051.095.2008; Greyling T, 1984, DIRECTOR SO AFRICAN; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2010, ANIM BEHAV, V79, P425, DOI 10.1016/j.anbehav.2009.11.021; Hampton SE, 2004, OECOLOGIA, V138, P475, DOI 10.1007/s00442-003-1446-6; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hopcraft JGC, 2002, THESIS U BRIT COLUMB; Johnson WE, 1996, CARNIVORE BEHAV ECOL, P125; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Kruuk H., 1972, SPOTTED HYENA STUDY; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Maddock A., 1996, Lammergeyer, V44, P6; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; MCDOUGAL C, 1988, Journal of the Bombay Natural History Society, V85, P609; MILLS MGL, 1982, S AFR J WILDL RES, V12, P111; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; MILLS MGL, 1993, SYM ZOOL S, P253; MILLS MGL, 1998, POPULATION HABITAT V; Mills Michael G.L., 2003, P370; MINTA SC, 1992, ECOL APPL, V2, P178, DOI 10.2307/1941774; Nelson JL, 2007, J WILDLIFE MANAGE, V71, P1467, DOI 10.2193/2006-234; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Palomares F, 1996, J APPL ECOL, V33, P5, DOI 10.2307/2405010; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; Saleni P, 2007, CANID NEWS, V10, P2; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Spiering PA, 2011, CONSERV GENET, V12, P401, DOI 10.1007/s10592-010-0147-z; Spiering PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P583, DOI 10.1007/s00265-009-0875-6; Spong G, 2002, BEHAV ECOL SOCIOBIOL, V52, P303, DOI 10.1007/s00265-002-0515-x; Terborgh J., 1999, WILD EARTH, P42; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Trinkel M, 2005, AFR J ECOL, V43, P220, DOI 10.1111/j.1365-2028.2005.00574.x; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; van Dyk G, 2003, AFR ZOOL, V38, P79; Vanak AT, 2013, ECOLOGY IN PRESS; Vucetich JA, 1999, CONSERV BIOL, V13, P1172, DOI 10.1046/j.1523-1739.1999.98366.x; Webster H, 2012, ETHOLOGY, V118, P147, DOI 10.1111/j.1439-0310.2011.01992.x; WHATELEY A, 1983, Bothalia, V14, P745; Whateley A, 1978, LAMMERGEYER, V35, P1; WOODROFFE R, 2004, CANIDS FOXES WOLVES; Woodroffe R, 2007, ORYX, V41, P215, DOI 10.1017/S0030605307001809; Woodroffe Rosie, 1997, P58; Zar JH, 1999, BIOSTATISTICAL ANAL	78	33	34	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98846	10.1371/journal.pone.0098846	http://dx.doi.org/10.1371/journal.pone.0098846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896638	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700086
J	Mindur, JE; Ito, N; Dhib-Jalbut, S; Ito, K				Mindur, John E.; Ito, Naoko; Dhib-Jalbut, Suhayl; Ito, Kouichi			Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b(+)CD4(+) T Cells in the CNS during Progressive EAE	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ALPHA-4 INTEGRIN; CONTROLLED TRIAL; CD11B MAC-1; P-SELECTIN; RECEPTOR 2; GM-CSF; NATALIZUMAB	Natalizumab is a humanized monoclonal antibody against the leukocyte adhesion molecule very late antigen (VLA)-4, and is currently an approved therapy for patients with relapsing-remitting multiple sclerosis (RRMS). However, it is unknown whether natalizumab is beneficial for progressive forms of MS. Therefore, we assessed the effects of anti-VLA-4 monoclonal antibody (mAb) therapy in a progressive experimental autoimmune encephalomyelitis (EAE) mouse model. Notably, we found that early therapy could significantly reduce the severity of progressive EAE, while treatment initiated at an advanced stage was less efficient. Furthermore, we observed the accumulation of a novel subset of GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS throughout disease progression. Importantly, early therapeutic anti-VLA-4 mAb treatment suppressed the accumulation of these GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS along with activated microglia/macrophages populations, and also conferred a protective effect against inflammation-mediated neurodegeneration, including demyelination and axonal loss. Collectively, our data suggest that early treatment with anti-VLA-4 mAb can provide neuroprotection against progressive CNS autoimmune disease by preventing the accumulation of pathogenic GM-CSF-producing CD11b(+)CD4(+) T cells in the CNS.	[Mindur, John E.; Ito, Naoko; Dhib-Jalbut, Suhayl; Ito, Kouichi] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ito, K (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Piscataway, NJ 08854 USA.	itoko@rwjms.rutgers.edu	Mindur, John E./L-3299-2019	Mindur, John E./0000-0002-2212-3904	Biogen Idec; Elan [TYS-09-10003]	Biogen Idec(Biogen); Elan	This study was supported by an investigator initiated grant to Drs. Ito and Dhib-Jalbut from Biogen Idec and Elan (Grant# TYS-09-10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Bauer J, 1998, AM J PATHOL, V153, P715, DOI 10.1016/S0002-9440(10)65615-5; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Bullard DC, 2005, J IMMUNOL, V175, P6327, DOI 10.4049/jimmunol.175.10.6327; Cannella B, 2003, J NEUROSCI RES, V71, P407, DOI 10.1002/jnr.10487; Chen XC, 2009, J INFECT DIS, V200, P399, DOI 10.1086/600075; Christensen JE, 2001, INT IMMUNOL, V13, P593, DOI 10.1093/intimm/13.4.593; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Engelhardt B, 1998, J CLIN INVEST, V102, P2096, DOI 10.1172/JCI4271; Fitzner D, 2010, CURR NEUROPHARMACOL, V8, P305, DOI 10.2174/157015910792246218; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Hiraki K, 2009, J NEUROSCI RES, V87, P1175, DOI 10.1002/jnr.21924; HOSHINO T, 1993, J IMMUNOL, V151, P2237; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Issazadeh S, 2000, J CLIN INVEST, V105, P1109, DOI 10.1172/JCI8607; Ji NN, 2011, J IMMUNOL, V186, P2750, DOI 10.4049/jimmunol.1000907; Kanwar JR, 2000, IMMUNOL CELL BIOL, V78, P641, DOI 10.1046/j.1440-1711.2000.00947.x; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kerfoot SM, 2006, J IMMUNOL, V176, P6225, DOI 10.4049/jimmunol.176.10.6225; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kotsougiani D, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/526740; Lin YL, 2003, EUR J IMMUNOL, V33, P2736, DOI 10.1002/eji.200324087; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MCFARLAND HI, 1992, J IMMUNOL, V149, P1326; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Peferoen L, 2013, IMMUNOLOGY; Peguillet I, 2014, CANC RES; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ponomarev EA, 2006, J IMMUNOL, V176, P1402, DOI 10.4049/jimmunol.176.3.1402; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Quandt JA, 2012, J IMMUNOL, V189, P2897, DOI 10.4049/jimmunol.1103087; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Rinaldi F, 2011, NEUROL SCI, V31, pS317, DOI 10.1007/s10072-010-0346-x; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Theien BE, 2003, BLOOD, V102, P4464, DOI 10.1182/blood-2003-03-0974; Theien BE, 2001, J CLIN INVEST, V107, P995, DOI 10.1172/JCI11717; Tuohy VK, 1998, IMMUNOL REV, V164, P93, DOI 10.1111/j.1600-065X.1998.tb01211.x; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wright E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070954; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99068	10.1371/journal.pone.0099068	http://dx.doi.org/10.1371/journal.pone.0099068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896098	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700112
J	Poongavanam, V; Steinmann, C; Kongsted, J				Poongavanam, Vasanthanathan; Steinmann, Casper; Kongsted, Jacob			Inhibitor Ranking through QM Based Chelation Calculations for Virtual Screening of HIV-1 RNase H Inhibition	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHOD; POLARIZABLE CONTINUUM MODEL; PROTEIN-LIGAND INTERACTIONS; SCORING FUNCTIONS; REVERSE-TRANSCRIPTASE; BINDING-AFFINITY; 2ND-ROW ELEMENTS; RIBONUCLEASE-H; BASIS-SET; DOCKING	Quantum mechanical (QM) calculations have been used to predict the binding affinity of a set of ligands towards HIV-1 RT associated RNase H (RNH). The QM based chelation calculations show improved binding affinity prediction for the inhibitors compared to using an empirical scoring function. Furthermore, full protein fragment molecular orbital (FMO) calculations were conducted and subsequently analysed for individual residue stabilization/destabilization energy contributions to the overall binding affinity in order to better understand the true and false predictions. After a successful assessment of the methods based on the use of a training set of molecules, QM based chelation calculations were used as filter in virtual screening of compounds in the ZINC database. By this, we find, compared to regular docking, QM based chelation calculations to significantly reduce the large number of false positives. Thus, the computational models tested in this study could be useful as high throughput filters for searching HIV-1 RNase H active-site molecules in the virtual screening process.	[Poongavanam, Vasanthanathan; Steinmann, Casper; Kongsted, Jacob] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark	University of Southern Denmark	Poongavanam, V (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark.	nathan@sdu.dk	Kongsted, Jacob/AAD-3458-2022; Poongavanam, Vasanthanathan/O-3945-2017; Svendsen, Casper/T-6775-2018	Poongavanam, Vasanthanathan/0000-0002-8880-9247; Svendsen, Casper/0000-0002-5638-1346; Kongsted, Jacob/0000-0002-7725-2164	Danish Councils for Independent Research; Villum Foundation	Danish Councils for Independent Research; Villum Foundation(Villum Fonden)	Support was provided by the Danish Councils for Independent Research and the Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HC, 2001, MOL CELLS, V12, P127; [Anonymous], 2013, SMALL MOL DRUG DISC; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barone V, 1998, J COMPUT CHEM, V19, P404, DOI 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Budihas SR, 2005, NUCLEIC ACIDS RES, V33, P1249, DOI 10.1093/nar/gki268; Butina D, 2002, DRUG DISCOV TODAY, V7, pS83, DOI 10.1016/S1359-6446(02)02288-2; Cossi M, 2003, J COMPUT CHEM, V24, P669, DOI 10.1002/jcc.10189; de Ruiter A, 2011, CURR OPIN CHEM BIOL, V15, P547, DOI 10.1016/j.cbpa.2011.05.021; Didierjean J, 2005, ANTIMICROB AGENTS CH, V49, P4884, DOI 10.1128/AAC.49.12.4884-4894.2005; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2006, J COMPUT CHEM, V27, P976, DOI 10.1002/jcc.20406; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Felts AK, 2011, J CHEM INF MODEL, V51, P1986, DOI 10.1021/ci200194w; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GORDON MS, 1982, J AM CHEM SOC, V104, P2797, DOI 10.1021/ja00374a017; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Himmel DM, 2009, STRUCTURE, V17, P1625, DOI 10.1016/j.str.2009.09.016; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Ilina Tatiana, 2012, Biology (Basel), V1, P521, DOI 10.3390/biology1030521; Jain AN, 2006, CURR PROTEIN PEPT SC, V7, P407, DOI 10.2174/138920306778559395; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Klumpp K, 2003, NUCLEIC ACIDS RES, V31, P6852, DOI 10.1093/nar/gkg881; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; Langdon SR, 2013, J CHEM INF MODEL, V53, P1100, DOI 10.1021/ci400100c; Lansdon EB, 2011, ANTIMICROB AGENTS CH, V55, P2905, DOI 10.1128/AAC.01594-10; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li HL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-58; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Nienhaus G.U., 2005, PROTEIN LIGAND INTER; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger scientist(s), 2013, SMALL MOL DRUG DISC; Stahl M, 2001, J MED CHEM, V44, P1035, DOI 10.1021/jm0003992; Steinmann C., 2012, PLOS ONE, V7; STEPHENS PJ, 1994, CHEM PHYS LETT, V225, P247, DOI 10.1016/0009-2614(94)00605-9; Stjernschantz E, 2010, BIOPHYS J, V98, P2682, DOI 10.1016/j.bpj.2010.02.034; Tanaka R, 2009, BIOORGAN MED CHEM, V17, P5238, DOI 10.1016/j.bmc.2009.05.049; Tramontano E, 2010, CURR MED CHEM, V17, P2837, DOI 10.2174/092986710792065045; Vasanthanathan P, 2009, J CHEM INF MODEL, V49, P43, DOI 10.1021/ci800371f; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n	50	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98659	10.1371/journal.pone.0098659	http://dx.doi.org/10.1371/journal.pone.0098659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897431	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700062
J	Tang, QC; Wang, YH; Huang, R; You, Q; Wang, GY; Chen, YG; Jiang, Z; Liu, Z; Yu, L; Muhammad, S; Wang, XS				Tang, Qingchao; Wang, Yihui; Huang, Rui; You, Qi; Wang, Guiyu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Yu, Lei; Muhammad, Shan; Wang, Xishan			Preparation of Anti-Tumor Nanoparticle and Its Inhibition to Peritoneal Dissemination of Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; TARGETED DELIVERY; GASTRIC-CANCER; CARCINOMATOSIS; 5-FU; SENSITIVITY; THERAPY; GROWTH; CELLS	Background: 5-Fluorouracil (5-FU) is one of the most classic chemotherapy drugs. Nanoparticle drug delivery vehicles offer superiority over target effect enhancement and abatement of side effects. Little is known however as to the specific effect of nanoparticle on peritoneal dissemination of colon cancer. The aim of this study is to prepare one NPs (nanoparticles) loaded with 5-FU and investigate the characteristic of NPs and the role of it in peritoneal metastasis nodules formation of human colon cancer. Methodology/Principal Findings: Prepared the NPs (nanoparticles) loaded with 5-FU (5-Fluorouracil) by PEG-PLGA with the method of double emulsion. Then evaluate the characteristics of the NPs by scanning electron microscopy, analyzing the particle diameter distribution and determining the loading efficiency. Detect the release features of NPs in vitro and in vivo. Nude mice with peritoneal metastases were treated with 5-FU solution or 5-FU-NPs through peritoneal cavity. Count the nodules on peritoneum and mesenterium and survey the size of them. We got NPs with average-diameter of 310 nm. In vitro release test shows NPs can release equably for 5 days with release rate of 99.2%. In vivo, NPs group can keep higher plasma concentration of 5-FU longer than it in solution group. The number of peritoneal dissemination nodule below 1 mm in 5-FU-sol group(17.3 +/- 3.5) and 5-FU-NP group(15.2 +/- 3.2) is less than control group(27.2 +/- 4.7)(P<0.05). The total number of nodules in 5-FU-NP group(28.7 +/- 4.2) is significantly smaller than in 5-FU-sol group(37.7 +/- 6.3) (P<0.05). Conclusions/Significance: The novel anti-tumor nanoparticles loaded with 5-FU by PEG-PLGA can release maintain 5 days and have inhibitory action to peritoneal dissemination of colon cancer in mice.	[Tang, Qingchao; Huang, Rui; Wang, Guiyu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Yu, Lei; Muhammad, Shan; Wang, Xishan] Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Ctr Canc, Harbin, Peoples R China; [Wang, Yihui; You, Qi] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, XS (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Colorectal Canc Surg, Ctr Canc, Harbin, Peoples R China.	wxshan1208@126.com			"Wu Jie-ping'' Medicine Foundation of China [04102303]; Special Foundation of Harbin Technical Innovation [2006RFQXS075]; Heilongjiang Province of China [JC04-02]	"Wu Jie-ping'' Medicine Foundation of China; Special Foundation of Harbin Technical Innovation; Heilongjiang Province of China	This work was supported by the "Wu Jie-ping'' Medicine Foundation of China, (No. 04102303) and the Special Foundation of Harbin Technical Innovation for Talented Person (No. 2006RFQXS075) and the Science Fund for Distinguished Young Scholars of Heilongjiang Province of China under Grant No. JC04-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botella P, 2011, J CONTROL RELEASE, V156, P246, DOI 10.1016/j.jconrel.2011.06.039; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Burke AR, 2012, BIOMATERIALS, V33, P2961, DOI 10.1016/j.biomaterials.2011.12.052; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Chaturvedi K, 2013, J CONTROL RELEASE, V165, P129, DOI 10.1016/j.jconrel.2012.11.005; Chester JD, 2000, ANN ONCOL, V11, P235, DOI 10.1023/A:1008356017611; Couvreur P, 2013, ADV DRUG DELIVER REV, V65, P21, DOI 10.1016/j.addr.2012.04.010; de Cuba EMV, 2012, VIRCHOWS ARCH, V461, P231, DOI 10.1007/s00428-012-1287-y; Drecoll E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005715; Emoto S, 2012, CANCER SCI, V103, P1304, DOI 10.1111/j.1349-7006.2012.02274.x; Gomez-Portilla Alberto, 2005, Cir Esp, V77, P6; Hasegawa S, 2006, ONCOL REP, V15, P1185; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Koppe MJ, 2006, ANN SURG, V243, P212, DOI 10.1097/01.sla.0000197702.46394.16; Lamppa JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017042; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-103; Lin H, 2008, CHEM RES CHINESE U, V24, P805; Lu HX, 2007, CANCER CHEMOTH PHARM, V59, P175, DOI 10.1007/s00280-006-0256-z; Pera M, 2012, ANN ONCOL, V23, P664, DOI 10.1093/annonc/mdr291; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Soma D, 2009, CANCER SCI, V100, P1979, DOI 10.1111/j.1349-7006.2009.01265.x; Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544; Wang YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-402; Wohlfart S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019121; Yang SH, 2004, J SURG ONCOL, V87, P167, DOI 10.1002/jso.20109	26	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98455	10.1371/journal.pone.0098455	http://dx.doi.org/10.1371/journal.pone.0098455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896096	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700043
J	van den Borne, P; Rygiel, TP; Hoogendoorn, A; Westerlaken, GHA; Boon, L; Quax, PHA; Pasterkamp, G; Hoefer, IE; Meyaard, L				van den Borne, Pleunie; Rygiel, Tomasz P.; Hoogendoorn, Ayla; Westerlaken, Geertje H. A.; Boon, Louis; Quax, Paul H. A.; Pasterkamp, Gerard; Hoefer, Imo E.; Meyaard, Linde			The CD200-CD200 Receptor Inhibitory Axis Controls Arteriogenesis and Local T Lymphocyte Influx	PLOS ONE			English	Article							VESSEL DEVELOPMENT; CD200; EXPRESSION; CELLS; MECHANISMS; MONOCYTES; ANGIOGENESIS; ACTIVATION; ISCHEMIA; GROWTH	The role of the CD200 ligand-CD200 receptor (CD200-CD200R) inhibitory axis is highly important in controlling myeloid cell function. Since the activation of myeloid cells is crucial in arteriogenesis, we hypothesized that disruption of the CD200-CD200R axis promotes arteriogenesis in a murine hindlimb ischemia model. Female Cd200(-/-) and wildtype (C57Bl/6J) mice underwent unilateral femoral artery ligation. Perfusion recovery was monitored over 7 days using Laser-Doppler analysis and was increased in Cd200(-/-) mice at day 3 and 7 after femoral artery ligation, compared to wildtype. Histology was performed on hindlimb muscles at baseline, day 3 and 7 to assess vessel geometry and number and inflammatory cell influx. Vessel geometry in non-ischemic muscles was larger, and vessel numbers in ischemic muscles were increased in Cd200(-/-) mice compared to wildtype. Furthermore, T lymphocyte influx was increased in Cd200(-/-) compared to wildtype. CD200R agonist treatment was performed in male C57Bl/6J mice to validate the role of the CD200-CD200R axis in arteriogenesis. CD200R agonist treatment after unilateral femoral artery ligation resulted in a significant decrease in vessel geometry, perfusion recovery and T lymphocyte influx at day 7 compared to isotype treatment. In this study, we show a causal role for the CD200-CD200R inhibitory axis in arteriogenesis in a murine hindlimb ischemia model. Lack of CD200R signaling is accompanied by increased T lymphocyte recruitment to the collateral vasculature and results in enlargement of preexisting collateral arteries.	[van den Borne, Pleunie; Hoogendoorn, Ayla; Pasterkamp, Gerard; Hoefer, Imo E.] Univ Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands; [Rygiel, Tomasz P.; Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Rygiel, Tomasz P.] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Warsaw, Poland; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Pasterkamp, Gerard; Hoefer, Imo E.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical University of Warsaw; Bioceros B.V.; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Hoefer, IE (corresponding author), Univ Med Ctr, Lab Expt Cardiol, Utrecht, Netherlands.	I.Hoefer@umcutrecht.nl	Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; Boon, Laurence/HCI-3629-2022	Quax, Paul/0000-0002-6853-5760; Rygiel, Tomasz/0000-0003-4746-6505; Boon, Louis/0000-0002-0937-9171; Meyaard, Linde/0000-0003-0707-4793	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation; Association for International Cancer Research [AICR 07-0086]; Foundation for Polish Science [HOMING PLUS/2011-4/10]	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart Foundation(Netherlands Heart Foundation); Association for International Cancer Research; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This research forms part of the Project P1.03 PENT of the research program of the Biomedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Dutch Heart Foundation is gratefully acknowledged. This work was supported by grants from Association for International Cancer Research (AICR 07-0086) and the Foundation for Polish Science (HOMING PLUS/2011-4/10) to L.M. and T.P.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Buschmann IR, 2001, ATHEROSCLEROSIS, V159, P343, DOI 10.1016/S0021-9150(01)00637-2; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Costello DA, 2011, J BIOL CHEM, V286, P34722, DOI 10.1074/jbc.M111.280826; de Groot D, 2011, J MOL CELL CARDIOL, V50, P25, DOI 10.1016/j.yjmcc.2010.08.006; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; Gorczynski RM, 2011, TRANSPL IMMUNOL, V25, P187, DOI 10.1016/j.trim.2011.07.006; Grundmann S, 2007, EUR J CLIN INVEST, V37, P755, DOI 10.1111/j.1365-2362.2007.01861.x; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Herold J, 2004, HUM GENE THER, V15, P1, DOI 10.1089/10430340460732517; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P12; Horie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03072; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Ko YC, 2009, J ANAT, V214, P183, DOI 10.1111/j.1469-7580.2008.00986.x; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krejsek J, 2010, PERFUSION-UK, V25, P389, DOI 10.1177/0267659110381451; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Peng XZ, 2011, AM J PHYSIOL-HEART C, V300, pH2027, DOI 10.1152/ajpheart.00004.2011; Rijkers ESK, 2007, EUR J HAEMATOL, V79, P410, DOI 10.1111/j.1600-0609.2007.00920.x; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Rygiel TP, 2012, ONCOGENE, V31, P2979, DOI 10.1038/onc.2011.477; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Wang LX, 2010, EUR J IMMUNOL, V40, P2569, DOI 10.1002/eji.201040472; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98820	10.1371/journal.pone.0098820	http://dx.doi.org/10.1371/journal.pone.0098820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897500	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700083
J	Yan, DF; Yan, SX; Lu, ZJ; Xie, C; Chen, W; Xu, X; Li, XK; Yu, HG; Zhu, XL; Zheng, LY				Yan, DanFang; Yan, SenXiang; Lu, ZhongJie; Xie, Cong; Chen, Wei; Xu, Xing; Li, Xinke; Yu, Haogang; Zhu, Xinli; Zheng, LingYan			Postoperative Radiotherapy for Glioma: Improved Delineation of the Clinical Target Volume Using the Geodesic Distance Calculation	PLOS ONE			English	Article							INTEROBSERVER VARIABILITY; COMPUTATION; IMAGES; TRIAL	Objects: To introduce a new method for generating the clinical target volume (CTV) from gross tumor volume (GTV) using the geodesic distance calculation for glioma. Methods: One glioblastoma patient was enrolled. The GTV and natural barriers were contoured on each slice of the computer tomography (CT) simulation images. Then, a graphic processing unit based on a parallel Euclidean distance transform was used to generate the CTV considering natural barriers. Three-dimensional (3D) visualization technique was applied to show the delineation results. Speed of operation and precision were compared between this new delineation method and the traditional method. Results: In considering spatial barriers, the shortest distance from the point sheltered from these barriers equals the sum of the distance along the shortest path between the two points; this consists of several segments and evades the spatial barriers, rather than being the direct Euclidean distance between two points. The CTV was generated irregularly rather than as a spherical shape. The time required to generate the CTV was greatly reduced. Moreover, this new method improved inter- and intra-observer variability in defining the CTV. Conclusions: Compared with the traditional CTV delineation, this new method using geodesic distance calculation not only greatly shortens the time to modify the CTV, but also has better reproducibility.	[Yan, DanFang; Yan, SenXiang; Lu, ZhongJie; Li, Xinke; Yu, Haogang; Zhu, Xinli; Zheng, LingYan] Zhejiang Univ, Dept Radiat Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Cong; Chen, Wei; Xu, Xing] Zhejiang Univ, State Key Lab CAD & CG, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yan, SX (corresponding author), Zhejiang Univ, Dept Radiat Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	yansenxiang@zju.edu.cn		Xie, Cong/0000-0001-5760-7522	National Science Foundation of China [81172124]; Welfare and Social Development Projects of Zhejiang Province Technology [2013C33121]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Welfare and Social Development Projects of Zhejiang Province Technology	This work was supported by the National Science Foundation of China Fund: 2011 Project 81172124 and Welfare and Social Development Projects of Zhejiang Province Technology Research: 2013C33121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman F, 2004, EUR J CANCER, V40, P1724, DOI 10.1016/j.ejca.2004.03.026; Breen SL, 2007, INT J RADIAT ONCOL, V68, P763, DOI 10.1016/j.ijrobp.2006.12.039; Cattaneo GM, 2005, RADIOTHER ONCOL, V75, P217, DOI 10.1016/j.radonc.2005.03.012; Hayashi T, 1998, IEEE T PARALL DISTR, V9, P1153, DOI 10.1109/71.737693; Iuchi T, 2006, INT J RADIAT ONCOL, V64, P1317, DOI 10.1016/j.ijrobp.2005.12.005; Jena R, 2005, CLIN ONCOL-UK, V17, P581, DOI 10.1016/j.clon.2005.04.012; Karim ABMF, 2002, INT J RADIAT ONCOL, V52, P316, DOI 10.1016/S0360-3016(01)02692-X; KOLOUNTZAKIS MN, 1992, INFORM PROCESS LETT, V43, P181, DOI 10.1016/0020-0190(92)90197-4; Lee YH, 2003, IEEE T PARALL DISTR, V14, P203, DOI 10.1109/TPDS.2003.1189579; LEUNENS G, 1993, RADIOTHER ONCOL, V29, P169, DOI 10.1016/0167-8140(93)90243-2; Nakamatsu K, 2008, INT J CLIN ONCOL, V13, P48, DOI 10.1007/s10147-007-0722-6; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545; Rong G, 2006, P 2006 S INTERACTIVE, P109, DOI DOI 10.1145/1111411.1111431; Rong GD, 2007, ISVD 2007: THE 4TH INTERNATIONAL SYMPOSIUM ON VORONOI DIAGRAMS IN SCIENCE AND ENGINEERING 2007, PROCEEDINGS, P176; Shaw E. G., 2002, International Journal of Radiation Oncology Biology Physics, V54, P206, DOI 10.1016/S0360-3016(02)03413-2; Struikmans H, 2005, RADIOTHER ONCOL, V76, P293, DOI 10.1016/j.radonc.2005.03.029; Sud A, 2004, COMPUT GRAPH FORUM, V23, P557, DOI 10.1111/j.1467-8659.2004.00787.x; Wang Y. C., 2001, P 8 AIAA AM I AER AS, P1	19	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98616	10.1371/journal.pone.0098616	http://dx.doi.org/10.1371/journal.pone.0098616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896082	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700056
J	Srivathsa, A; Karanth, KK; Jathanna, D; Kumar, NS; Karanth, KU				Srivathsa, Arjun; Karanth, Krithi K.; Jathanna, Devcharan; Kumar, N. Samba; Karanth, K. Ullas			On a Dhole Trail: Examining Ecological and Anthropogenic Correlates of Dhole Habitat Occupancy in the Western Ghats of India	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; CUON-ALPINUS CANIDAE; PROTECTED AREAS; DETECTION PROBABILITIES; FRAGMENTED LANDSCAPE; MAMMAL CONSERVATION; TROPICAL FORESTS; POPULATION-SIZE; EXTINCTION RISK; PREY SELECTION	Although they play a critical role in shaping ecological communities, many threatened predator species are data-deficient. The Dhole Cuon alpinus is one such rare canid with a global population thought to be <2500 wild individuals. We assessed habitat occupancy patterns of dholes in the Western Ghats of Karnataka, India, to understand ecological and anthropogenic determinants of their distribution and habitat-use. We conducted spatially replicated detection/non-detection surveys of dhole signs along forest trails at two appropriate scales: the entire landscape and a single wildlife reserve. Landscape-scale habitat occupancy was assessed across 38,728 km(2) surveying 206 grid cells of 188-km(2) each. Finer scale habitat-use within 935 km(2) Bandipur Reserve was studied surveying 92 grid cells of 13-km(2) km each. We analyzed the resulting data of dhole signs using likelihood-based habitat occupancy models. The models explicitly addressed the problematic issue of imperfect detection of dhole signs during field surveys as well as potential spatial auto-correlation between sign detections made on adjacent trail segments. We show that traditional 'presence versus absence' analyses underestimated dhole habitat occupancy by 60% or 8682 km(2) [naive = 0.27; psi(L)(SE) = 0.68 (0.08)] in the landscape. Addressing imperfect sign detections by estimating detection probabilities [<(p)over cap>(t(L))(SE) = 0.12 (0.11)] was critical for reliable estimation. Similar underestimation occurred while estimating habitat-use probability at reserve-scale [naive = 0.39; (Psi) over cap (s)(SE) = 0.71 (0.06)]. At landscape scale, relative abundance of principal ungulate prey primarily influenced dhole habitat occupancy. Habitat-use within a reserve, however, was predominantly and negatively influenced by anthropogenic disturbance. Our results are the first rigorous assessment of dhole occupancy at multiple spatial scales with potential conservation value. The approach used in this study has potential utility for cost-effectively assessing spatial distribution and habitat-use in other species, landscapes and reserves.	[Srivathsa, Arjun] Tata Inst Fundamental Res, Natl Ctr Biol Sci, India Program, Postgrad Programme Wildlife Biol & Conservat,Wild, Bangalore, Karnataka, India; [Srivathsa, Arjun; Karanth, Krithi K.; Jathanna, Devcharan; Kumar, N. Samba; Karanth, K. Ullas] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Karanth, Krithi K.; Karanth, K. Ullas] Wildlife Conservat Soc, Bronx, NY USA; [Kumar, N. Samba] India Program, Wildlife Conservat Soc, Bangalore, Karnataka, India; [Karanth, K. Ullas] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Wildlife Conservation Society; Duke University	Srivathsa, A (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, India Program, Postgrad Programme Wildlife Biol & Conservat,Wild, Bangalore, Karnataka, India.	arjuns.cws@gmail.com	Kumar, Samba/ADR-7829-2022; Jathanna, Devcharan/AAL-9107-2020	Kumar, Samba/0000-0002-1226-8552; Jathanna, Devcharan/0000-0002-7962-4582; Srivathsa, Arjun/0000-0003-2935-3857	Department of Science and Technology, Government of India; Save the Tiger Fund of National Fish and Wildlife Foundation; Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Save the Tiger Fund of National Fish and Wildlife Foundation; Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC	Department of Science and Technology, Government of India. (URL: http://www.dst.gov.in). Save the Tiger Fund of National Fish and Wildlife Foundation (URL: http://www.nfwf.org/Pages/default.aspx). Rhino & Tiger Conservation Fund of US Fish and Wildlife Service, Washington, DC. (URL: http://www.fws.gov/international/wildlife-without-borders/rhino-and-tiger-conservation-fund.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; COHEN J A, 1978, Mammalian Species, P1, DOI 10.2307/3503800; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Durbin LS, 2008, IUCN RED LIST THREAT; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Grassman LI, 2005, MAMMALIA, V69, P11, DOI 10.1515/mamm.2005.002; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; He F., 2007, SCALING BIODIVERSITY; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines JE., 2006, PRESENCESOFTWARE EST; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Jenks KE, 2012, MAMMALIA, V76, P175, DOI 10.1515/mammalia-2011-0063; JOHNSINGH AJT, 1982, J ZOOL, V198, P443, DOI 10.1111/jzo.1982.198.4.443; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kamler JF, 2012, J MAMMAL, V93, P627, DOI 10.1644/11-MAMM-A-241.1; KARANTH K U, 1986, Journal of the Bombay Natural History Society, V83, P166; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; KARANTH KU, 1992, J TROP ECOL, V8, P21, DOI 10.1017/S0266467400006040; Karanth KU, 2000, J ZOOL, V250, P255; Karwanishi Kae, 2008, Mammal Study, V33, P173; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; Kumar NS, 2010, THESIS MANIPAL U IND; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Magoun AJ, 2007, J WILDLIFE MANAGE, V71, P2221, DOI 10.2193/2006-372; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Narain S.P., 2005, JOINING DOTS REPORT; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; Rangarajan M., 2006, CONSERV SOC, V4, P359; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robert A, 2009, OIKOS, V118, P1590, DOI 10.1111/j.1600-0706.2009.17818.x; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Sankar K, 2010, TELEM WILDL SCI, V13, P69; Sargeant GA, 2005, J WILDLIFE MANAGE, V69, P483, DOI 10.2193/0022-541X(2005)069[0483:MCMCEO]2.0.CO;2; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Stanley TR, 2005, J WILDLIFE MANAGE, V69, P874, DOI 10.2193/0022-541X(2005)069[0874:ESOAAU]2.0.CO;2; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Thinley P, 2011, MAMM BIOL, V76, P518, DOI 10.1016/j.mambio.2011.02.003; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Trainor AM, 2014, ECOL APPL, V24, P204, DOI 10.1890/13-0336.1; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Velho N, 2012, BIOL CONSERV, V148, P210, DOI 10.1016/j.biocon.2012.01.022; Venkataraman AB, 1995, J ZOOL, V237, P543, DOI 10.1111/j.1469-7998.1995.tb05014.x; Wang SW, 2009, J ZOOL, V277, P275, DOI 10.1111/j.1469-7998.2008.00537.x; Wibisono HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025931; Wikramanayake ED, 1998, CONSERV BIOL, V12, P865, DOI 10.1046/j.1523-1739.1998.96428.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Witmer GW, 2005, WILDLIFE RES, V32, P259, DOI 10.1071/WR04003; Woodroffe R, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P123; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	85	41	43	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98803	10.1371/journal.pone.0098803	http://dx.doi.org/10.1371/journal.pone.0098803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893166	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400094
J	Shimizu, E; Nakatani, T; He, ZM; Partridge, NC				Shimizu, Emi; Nakatani, Teruyo; He, Zhiming; Partridge, Nicola C.			Parathyroid Hormone Regulates Histone Deacetylase (HDAC) 4 through Protein Kinase A-mediated Phosphorylation and Dephosphorylation in Osteoblastic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; GENE-EXPRESSION; IN-VIVO; HYPERTROPHY; REPRESSION; SKELETOGENESIS; IDENTIFICATION	Histone deacetylases (HDACs) are crucial regulators of gene expression in transcriptional co-repressor complexes. Previously, we reported that HDAC4 was a basal repressor of matrix metalloproteinase-13 (MMP-13) transcription and parathyroid hormone (PTH) regulates HDAC4 to control MMP-13 promoter activity through dissociation from Runx2. Here, we show that PTH induces the protein kinase A (PKA)-dependent phosphorylation of HDAC4 in the nucleus of the rat osteoblastic cell line, UMR 106-01. We demonstrate that PKA-dependent phosphorylated HDAC4 is released from Runx2 bound to the MMP-13 promoter in these cells. Point mutation of Ser-740 in rHDAC4 prevents the release of HDAC4 from Runx2 on the MMP-13 promoter and also prevents the PTH stimulation of MMP-13 transcription. Thus, PTH-induced phosphorylation of rHDAC4 at Ser-740 is crucial for regulating MMP-13 transcription in osteoblasts. PTH causes degradation of HDAC4, and this product appears in the cytoplasm. The cytoplasmic degradation of HDAC4 is blocked by PKA and lysosomal inhibitors, but is not affected by proteasome, caspase-3, or serine and aspartic protease inhibitors. In addition, the phosphatase inhibitor, okadaic acid, prevents degradation indicating that dephosphorylation is associated with degradation. These mechanisms regulating HDAC4 and their roles in such processes are crucial for bone and chondrocyte development. Our data support a link between PTH regulating HDAC4 phosphorylation by PKA, trafficking, partial degradation, and the control of MMP-13 transcription through association with Runx2.	[Shimizu, Emi; Nakatani, Teruyo; He, Zhiming; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Shimizu, Emi] NYU, Coll Dent, Dept Endodont, New York, NY 10010 USA	New York University; New York University	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 East 24th St, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047420, R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 (to N. C. P.).	Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gao CZ, 2006, FEBS LETT, V580, P5096, DOI 10.1016/j.febslet.2006.08.038; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	30	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21340	21350		10.1074/jbc.M114.550699	http://dx.doi.org/10.1074/jbc.M114.550699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24904057	hybrid, Green Published			2022-12-25	WOS:000340558300014
J	De Marchi, U; Santo-Domingo, J; Castelbou, C; Sekler, I; Wiederkehr, A; Demaurex, N				De Marchi, Umberto; Santo-Domingo, Jaime; Castelbou, Cyril; Sekler, Israel; Wiederkehr, Andreas; Demaurex, Nicolas			NCLX Protein, but Not LETM1, Mediates Mitochondrial Ca2+ Extrusion, Thereby Limiting Ca2+-induced NAD(P)H Production and Modulating Matrix Redox State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; PERMEABILITY TRANSITION PORE; RAT KIDNEY MITOCHONDRIA; INDUCED CELL-DEATH; ESSENTIAL COMPONENT; CALCIUM UNIPORTER; HEART-MITOCHONDRIA; ATP SYNTHASE; METABOLISM; CHANNELS	Mitochondria capture and subsequently release Ca2+ ions, thereby sensing and shaping cellular Ca2+ signals. The Ca2+ uniporter MCU mediates Ca2+ uptake, whereas NCLX (mitochondrial Na/Ca exchanger) and LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) were proposed to exchange Ca2+ against Na+ or H+, respectively. Here we study the role of these ion exchangers in mitochondrial Ca2+ extrusion and in Ca2+-metabolic coupling. Both NCLX and LETM1 proteins were expressed in HeLa cells mitochondria. The rate of mitochondrial Ca2+ efflux, measured with a genetically encoded indicator during agonist stimulations, increased with the amplitude of mitochondrial Ca2+ ([Ca2+](mt)) elevations. NCLX overexpression enhanced the rates of Ca2+ efflux, whereas increasing LETM1 levels had no impact on Ca2+ extrusion. The fluorescence of the redox-sensitive probe roGFP increased during [Ca2+](mt) elevations, indicating a net reduction of the matrix. This redox response was abolished by NCLX overexpression and restored by the Na+/Ca2+ exchanger inhibitor CGP37157. The [Ca2+](mt) elevations were associated with increases in the autofluorescence of NAD(P)H, whose amplitude was strongly reduced by NCLX overexpression, an effect reverted by Na+/Ca2+ exchange inhibition. We conclude that NCLX, but not LETM1, mediates Ca2+ extrusion from mitochondria. By controlling the duration of matrix Ca2+ elevations, NCLX contributes to the regulation of NAD(P)H production and to the conversion of Ca2+ signals into redox changes.	[De Marchi, Umberto; Santo-Domingo, Jaime; Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [De Marchi, Umberto; Santo-Domingo, Jaime; Castelbou, Cyril; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Sekler, Israel] Ben Gurion Univ Negev, Dept Physiol, IL-84105 Beer Sheva, Israel	Nestle SA; University of Geneva; Ben Gurion University	De Marchi, U (corresponding author), Nestle Inst Hlth Sci, EPFL Innovat Pk,Bldg G, CH-1015 Lausanne, Switzerland.	Umberto.DeMarchi@rd.nestle.com; Nicolas.Demaurex@unige.ch	Domingo, Jaime Santo/AAA-4995-2020	Domingo, Jaime Santo/0000-0001-5501-0482; De Marchi, Umberto/0000-0002-6011-5446; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [310030B_133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B_133126 (to N. D.).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; Leloup C, 2011, ANTIOXID REDOX SIGN, V14, P519, DOI 10.1089/ars.2010.3424; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; Morris BJ, 2013, FREE RADICAL BIO MED, V56, P133, DOI 10.1016/j.freeradbiomed.2012.10.525; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Nowikovsky K, 2012, J GEN PHYSIOL, V139, P445, DOI 10.1085/jgp.201110757; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pizzo P, 2012, PFLUG ARCH EUR J PHY, V464, P3, DOI 10.1007/s00424-012-1122-y; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; POZZAN T, 1977, BIOCHEMISTRY-US, V16, P5618, DOI 10.1021/bi00644a036; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Voronina S, 2002, J PHYSIOL-LONDON, V539, P41, DOI 10.1113/jphysiol.2001.013134; Wang SB, 2013, TRENDS CARDIOVAS MED, V23, P14, DOI 10.1016/j.tcm.2012.08.005; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006; Zoratti M, 2010, FEBS LETT, V584, P1997, DOI 10.1016/j.febslet.2010.01.012	70	80	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20377	20385		10.1074/jbc.M113.540898	http://dx.doi.org/10.1074/jbc.M113.540898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898248	Green Published, hybrid			2022-12-25	WOS:000339395200048
J	Zhu, BK; Ferry, CH; Markell, LK; Blazanin, N; Glick, AB; Gonzalez, FJ; Peters, JM				Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Gonzalez, Frank J.; Peters, Jeffrey M.			The Nuclear Receptor Peroxisome Proliferator-activated Receptor-beta/delta (PPAR beta/delta) Promotes Oncogene-induced Cellular Senescence through Repression of Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED SKIN TUMORIGENESIS; LIGAND ACTIVATION; SIGNALING NETWORK; CELLS; CARCINOGENESIS; EXPRESSION; CANCER; DIFFERENTIATION; TRANSCRIPTION; INHIBITION	Endoplasmic reticulum (ER) stress and ER stress-associated unfolded protein response (UPR) can promote cancer cell survival, but it remains unclear whether they can influence oncogene-induced senescence. The present study examined the role of ER stress in senescence using oncogene-dependent models. Increased ER stress attenuated senescence in part by up-regulating phosphorylated protein kinase B (p-AKT) and decreasing phosphorylated extracellular signal-regulated kinase (p-ERK). A positive feed forward loop between p-AKT, ER stress, and UPR was discovered whereby a transient increase of ER stress caused reduced senescence and promotion of tumorigenesis. Decreased ER stress was further correlated with increased senescence in both mouse and human tumors. Interestingly, H-RAS-expressing Ppar beta/delta null cells and tumors having increased cell proliferation exhibited enhanced ER stress, decreased cellular senescence, and/or enhanced tumorigenicity. Collectively, these results demonstrate a new role for ER stress and UPR that attenuates H-RAS-induced senescence and suggest that PPAR beta/delta can repress this oncogene-induced ER stress to promote senescence in accordance with its role as a tumor modifier that suppresses carcinogenesis.	[Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Zhu, Bokai; Ferry, Christina H.; Markell, Lauren K.; Blazanin, Nicholas; Glick, Adam B.; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	jmp21@psu.edu	Zhu, Bokai/AAF-7502-2020	Zhu, Bokai/0000-0003-0827-5757; Peters, Jeffrey/0000-0003-2782-2998	National Institutes of Health [CA124533, CA141029, CA140369, AA018863, CA122109, CA117957, ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [ZIABC005562, R01CA117957, ZIABC005561, R01CA140369, ZIABC005708, R01CA141029, R01CA122109, R01CA124533, R01CA126826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124533, CA141029, CA140369, and AA018863 (to J. M. P.), CA122109 and CA117957 (to A. B. G.), and ZIABC005561, ZIABC005562, and ZIABC005708 (NCI Intramural Research Program; to F. J. G.).	Bility MT, 2010, TOXICOL SCI, V113, P27, DOI 10.1093/toxsci/kfp212; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; DLUGOSZ AA, 1995, METHOD ENZYMOL, V254, P3; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Horiguchi M, 2012, CANCER RES, V72, P395, DOI 10.1158/0008-5472.CAN-11-1891; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Kennedy AL, 2011, MOL CELL, V42, P36, DOI 10.1016/j.molcel.2011.02.020; Kim DJ, 2006, CARCINOGENESIS, V27, P1105, DOI 10.1093/carcin/bgi346; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MORGAN D, 1992, CANCER RES, V52, P3145; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Seufferlein T, 1996, CANCER RES, V56, P3895; STRICKLAND JE, 1988, CANCER RES, V48, P165; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vijayachandra K, 2003, CANCER RES, V63, P3447; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zhu BK, 2012, MOL CELL BIOL, V32, P2065, DOI 10.1128/MCB.00092-12; Zhu BK, 2010, MOL CANCER THER, V9, P3267, DOI 10.1158/1535-7163.MCT-10-0820	40	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20102	20119		10.1074/jbc.M114.551069	http://dx.doi.org/10.1074/jbc.M114.551069			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24898257	Green Published, hybrid			2022-12-25	WOS:000339395200024
J	Nubling, GS; Levin, J; Bader, B; Lorenzl, S; Hillmer, A; Hogen, T; Kamp, F; Giese, A				Nuebling, Georg Sebastian; Levin, Johannes; Bader, Benedikt; Lorenzl, Stefan; Hillmer, Andreas; Hoegen, Tobias; Kamp, Frits; Giese, Armin			Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers	PLOS ONE			English	Article							PARKINSONS-DISEASE; NEURONAL DYSFUNCTION; INCLUSION FORMATION; METAL-IONS; PROTEIN; IRON; BRAIN; VESICLES; NEURODEGENERATION; COAGGREGATION	Background: In several neurodegenerative diseases, hyperphosphorylation at position Ser129 is found in fibrillar deposits of alpha-synuclein (asyn), implying a pathophysiological role of asyn phosphorylation in neurodegeneration. However, recent animal models applying asyn phosphorylation mimics demonstrated a protective effect of phosphorylation. Since metal-ion induced asyn oligomers were identified as a potential neurotoxic aggregate species with membrane pore-forming abilities, the current study was undertaken to determine effects of asyn phosphorylation on oligomer membrane binding. Methods: We investigated the influence of S129 phosphorylation on interactions of metal-ion induced asyn oligomers with small unilamellar lipid vesicles (SUV) composed of POPC and DPPC applying the phosphorylation mimic asyn129E. Confocal single-particle fluorescence techniques were used to monitor membrane binding at the single-particle level. Results: Binding of asyn129E monomers to gel-state membranes (DPPC-SUV) is slightly reduced compared to wild-type asyn, while no interactions with membranes in the liquid-crystalline state (POPC-SUV) are seen for both asyn and asyn129E. Conversely, metal-ion induced oligomer formation is markedly increased in asyn129E. Surprisingly, membrane binding to POPC-SUV is nearly absent in Fe3+ induced asyn129E oligomers and markedly reduced in Al3+ induced oligomers. Conclusion: The protective effect of pseudophosphorylation seen in animal models may be due to impeded oligomer membrane binding. Phosphorylation at Ser129 may thus have a protective effect against neurotoxic asyn oligomers by preventing oligomer membrane binding and disruption of the cellular electrophysiological equilibrium. Importantly, these findings put a new complexion on experimental pharmaceutical interventions against POLO-2 kinase.	[Nuebling, Georg Sebastian; Levin, Johannes; Bader, Benedikt; Lorenzl, Stefan; Hoegen, Tobias] Univ Munich, Dept Neurol, Klinikum Univ Munchen, D-80539 Munich, Germany; [Nuebling, Georg Sebastian; Hillmer, Andreas; Giese, Armin] Univ Munich, Ctr Neuropathol & Prion Res, D-80539 Munich, Germany; [Nuebling, Georg Sebastian; Lorenzl, Stefan] Univ Munich, Dept Palliat Med, Klinikum Univ Munchen, D-80539 Munich, Germany; [Lorenzl, Stefan] Paracelsus Med Univ, Inst Nursing Sci & Practice, Endowed Professorship Interdisciplinary Res Palli, Salzburg, Austria; [Kamp, Frits] Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich; University of Munich; Paracelsus Private Medical University; University of Munich	Nubling, GS (corresponding author), Univ Munich, Dept Neurol, Klinikum Univ Munchen, D-80539 Munich, Germany.	georg.nuebling@med.uni-muenchen.de	Giese, Armin/F-3271-2010; Levin, Johannes/E-4052-2010	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306; Nubling, Georg/0000-0003-4492-7302				Aubele DL, 2013, CHEMMEDCHEM, V8, P1295, DOI 10.1002/cmdc.201300166; Bader B, 2011, BIOCHEM BIOPH RES CO, V411, P190, DOI 10.1016/j.bbrc.2011.06.135; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bieschke J, 2000, P NATL ACAD SCI USA, V97, P5468, DOI 10.1073/pnas.97.10.5468; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Castellani RJ, 2000, ACTA NEUROPATHOL, V100, P111, DOI 10.1007/s004010050001; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giese A, 2005, BIOCHEM BIOPH RES CO, V333, P1202, DOI 10.1016/j.bbrc.2005.06.025; Giese A, 2000, ARCH VIROL, P161; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hogen T, 2012, BIOPHYS J, V102, P1646, DOI 10.1016/j.bpj.2012.01.059; Huls S, 2011, J NEUROCHEM, V117, P868, DOI 10.1111/j.1471-4159.2011.07254.x; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Kuwahara T, 2012, J BIOL CHEM, V287, P7098, DOI 10.1074/jbc.M111.237131; Levin J, 2011, J PARKINSON DIS, V1, P205, DOI 10.3233/JPD-2011-11040; Li W, 1998, NEUROCHEM; Logroscino G, 2008, AM J EPIDEMIOL, V168, P1381, DOI 10.1093/aje/kwn273; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nubling G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-35; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Schmidt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042545; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Stockl M, 2012, MOL BIOSYST, V8, P338, DOI 10.1039/c1mb05293d; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174	44	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98906	10.1371/journal.pone.0098906	http://dx.doi.org/10.1371/journal.pone.0098906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911099	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600021
J	Wang, SL; Shi, XH; Yang, Z; Zhang, YM; Shen, LR; Lei, ZY; Zhang, ZQ; Cao, C; Fan, DL				Wang, Shao-liang; Shi, Xiao-hua; Yang, Zhi; Zhang, Yi-ming; Shen, Li-ru; Lei, Ze-yuan; Zhang, Zhi-qing; Cao, Cong; Fan, Dong-li			Osteopontin (OPN) Is an Important Protein to Mediate Improvements in the Biocompatibility of C Ion-Implanted Silicone Rubber	PLOS ONE			English	Article							PLASMA-SURFACE MODIFICATION; IN-VITRO; HORSERADISH-PEROXIDASE; BREAST IMPLANTS; TITANIUM-ALLOY; CANCER-CELLS; FUNCTIONALIZATION; ADHESION; BIOMATERIALS; ACTIVATION	Medical device implants are drawing increasing amounts of interest from modern medical practitioners. However, this attention is not evenly spread across all such devices; most of these implantable devices can cause adverse reactions such as inflammation, fibrosis, thrombosis, and infection. In this work, the biocompatibility of silicone rubber (SR) was improved through carbon (C) ion implantation. Scanning electron microscopy (SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), and X-ray diffraction (XRD) results confirmed that these newly generated carbon-implanted silicone rubbers (C-SRs) had large, irregular peaks and deep valleys on their surfaces. The water contact angle of the SR surface decreased significantly after C ion implantation. C ion implantation also changed the surface charge distribution, silicone oxygen rate, and chemical-element distribution of SR to favor cell attachment. The dermal fibroblasts cultured on the surface C-SR grew faster and showed more typical fibroblastic shapes. The expression levels of major adhesion proteins, including talin-1, zyxin, and vinculin, were significantly higher in dermal fibroblasts cultured on C-SR coated plates than in dermal fibroblasts cultured on SR. Those same dermal fibroblasts on C-SRs showed more pronounced adhesion and migration abilities. Osteopontin (OPN), a critical extracellular matrix (ECM) protein, was up-regulated and secreted from dermal fibroblasts cultured on C-SR. Matrix metalloproteinase-9 (MMP-9) activity was also increased. These cells were highly mobile and were able to adhere to surfaces, but these abilities were inhibited by the monoclonal antibody against OPN, or by shRNA-mediated MMP-9 knockdown. Together, these results suggest that C ion implantation significantly improves SR biocompatibility, and that OPN is important to promote cell adhesion to the C-SR surface.	[Wang, Shao-liang; Shi, Xiao-hua; Yang, Zhi; Zhang, Yi-ming; Lei, Ze-yuan; Fan, Dong-li] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China; [Shen, Li-ru] Southwestern Inst Phys, Chengdu, Sichuan, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China	Army Medical University; Southwestern Institute of Physics - China; Soochow University - China	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; fdltmmu@sina.com			National Natural Science Foundation of China [81071574]; Third Military Medical University [2012XZH05]; research start-up funds of Soochow University [Q321506612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University; research start-up funds of Soochow University	This work was funded by a grant from National Natural Science Foundation of China (81071574) (http://www.nsfc.gov.cn/publish/portal0/default.htm), a grant for Transformation of Scientific and Technological Achievements from Third Military Medical University (2012XZH05) (http://www.tmmu.edu.cn/), and the research start-up funds of Soochow University to Cong Cao (Q321506612)(http://www.suda.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Beck H, 2010, AM J CARDIOL, V106, P810, DOI 10.1016/j.amjcard.2010.04.043; Berry MG, 2012, J PLAST RECONSTR AES, V65, P697, DOI 10.1016/j.bjps.2012.02.019; Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009; Borschel C, 2009, SMALL, V5, P2576, DOI 10.1002/smll.200900562; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Cao C, 2006, BIOCHEM J, V400, P225, DOI 10.1042/BJ20060816; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9; Cooper L, 2005, GENOME BIOL, V6; Cordeiro AL, 2009, LANGMUIR, V25, P1509, DOI 10.1021/la803054s; Coyer SR, 2012, J CELL SCI, V125, P5110, DOI 10.1242/jcs.108035; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Feng XJ, 2004, J AM CHEM SOC, V126, P62, DOI 10.1021/ja038636o; Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010; Gan BK, 2008, J BIOMED MATER RES A, V85A, P605, DOI 10.1002/jbm.a.31612; Hunter C, 2012, J SURG RES, V176, P348, DOI 10.1016/j.jss.2011.07.054; Ito K, 2009, MATRIX BIOL, V28, P11, DOI 10.1016/j.matbio.2008.10.002; Jun K, 2009, J VAC SCI TECHNOL B, V27, P3043, DOI 10.1116/1.3259919; Jung DH, 2007, PLAST RECONSTR SURG, V120, P1997, DOI 10.1097/01.prs.0000287323.71630.e6; Kondyurin A, 2008, ACTA BIOMATER, V4, P1218, DOI 10.1016/j.actbio.2008.04.017; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0; Li WQ, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-175; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013; Matsuoka M, 2009, BIO-MED MATER ENG, V19, P155, DOI 10.3233/BME-2009-0575; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Miyauchi T, 2010, BIOMATERIALS, V31, P3827, DOI 10.1016/j.biomaterials.2010.01.133; Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293; Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus; Ren TB, 2008, J BIOMED MATER RES A, V86A, P209, DOI 10.1002/jbm.a.31508; Roth J, 2008, LANGMUIR, V24, P12603, DOI 10.1021/la801970s; Rullo OJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4150; Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010; Seyhan H, 2011, J PLAST RECONSTR AES, V64, pE60, DOI 10.1016/j.bjps.2010.08.016; Thein-Han WW, 2009, ACTA BIOMATER, V5, P2668, DOI 10.1016/j.actbio.2009.04.029; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Tuboltsev V, 2009, SMALL, V5, P2687, DOI 10.1002/smll.200901424; Wang HY, 2012, ACS APPL MATER INTER, V4, P4380, DOI 10.1021/am301033t; Wu GS, 2012, SURF COAT TECH, V206, P3186, DOI 10.1016/j.surfcoat.2012.01.001; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Zeplin PH, 2010, PLAST RECONSTR SURG, V126, P266, DOI 10.1097/PRS.0b013e3181dbc313; Zhang RH, 2011, ANAT REC, V294, P406, DOI 10.1002/ar.21324; Zhang YM, 2009, AESTHET PLAST SURG, V33, P760, DOI 10.1007/s00266-009-9363-7; Zhang YM, 2012, MATER LETT, V66, P203, DOI 10.1016/j.matlet.2011.08.060; Zhao Y, 2013, ACS APPL MATER INTER, V5, P1510, DOI 10.1021/am302961h; Zou CY, 2013, CELL BIOCHEM BIOPHYS, V65, P455, DOI 10.1007/s12013-012-9449-8	51	14	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98320	10.1371/journal.pone.0098320	http://dx.doi.org/10.1371/journal.pone.0098320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911051	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600002
J	Nakaoka, S; Ishizaki, T; Urushihara, H; Satoh, T; Ikeda, S; Yamamoto, M; Nakayama, T				Nakaoka, Sachiko; Ishizaki, Tatsuro; Urushihara, Hisashi; Satoh, Toshihiko; Ikeda, Shunya; Yamamoto, Mitsutoshi; Nakayama, Takeo			Prescribing Pattern of Anti-Parkinson Drugs in Japan: A Trend Analysis from 2005 to 2010	PLOS ONE			English	Article							DOPAMINE AGONISTS; DISEASE; IMPACT; PREVALENCE; MANAGEMENT; CISAPRIDE; PRESCRIPTION; VALVULOPATHY; DATABASE; COHORT	Objective: Therapeutic options for Parkinson's disease mainly consist of L-dopa and dopamine agonists. However, in Japan, the product labeling of the ergot dopamine agonists, cabergoline and pergolide, was revised in April 2007 due to the risk of developing cardiac valvulopathy. Here, we describe the prescribing trends of anti-Parkinson drugs from 2005 through 2010 in Japan, and examined whether these trends changed after the drug safety measures in 2007. Methods and Patients: We used medical claim data from January 2005 to December 2010 for Parkinson's disease patients older than 30 years who were prescribed anti-Parkinson drugs. We calculated the proportion of patients prescribed each drug for each year, and compared the proportions of first-line drugs prescribed before and after April 2007. We also examined the prescription variations of cabergoline/pergolide users one year before or after April 2007. Results: L-dopa was the most frequently prescribed drug for Parkinson's disease (2005, 58%; 2010, 51%). The proportion of patients prescribed ergot dopamine agonists markedly decreased and non-ergot dopamine agonists increased after 2007. Among first-line drugs, the proportion of non-ergot agents increased after April 2007. Among 54 cabergoline/pergolide users, 24 (44%) discontinued these drugs, nine of whom switched to non-ergot agents. Conclusion: L-dopa was the mainstay of Parkinson's disease treatment between 2005 and 2010 in Japan. There was a decrease in ergot agents and an increase in non-ergot agents prescribed after the regulatory actions in 2007.	[Nakaoka, Sachiko; Ishizaki, Tatsuro; Nakayama, Takeo] Kyoto Univ Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Inst Gerontol, Human Care Res Team, Tokyo, Japan; [Urushihara, Hisashi] Keio Univ, Div Drug Dev & Regulatory Sci, Fac Pharm, Tokyo, Japan; [Satoh, Toshihiko] Aoyama Gakuin Univ, Sch Social Informat, Tokyo, Kanagawa 150, Japan; [Ikeda, Shunya] Int Univ Hlth & Welf, Sch Pharm, Dept Pharmaceut Sci, Otawara, Tochigi, Japan; [Yamamoto, Mitsutoshi] Takamatsu Neurol Clin, Kagawa, Japan	Kyoto University; Tokyo Metropolitan Institute of Gerontology; Keio University; Aoyama Gakuin University; International University of Health & Welfare	Nakayama, T (corresponding author), Kyoto Univ Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan.	nakayama.takeo.4a@kyoto-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022	Urushihara, Hisashi/0000-0001-6913-9930; Nakayama, Takeo/0000-0002-7918-6252				ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Askmark H, 2003, PARKINSONISM RELAT D, V9, P271, DOI 10.1016/S1353-8020(02)00117-7; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; European Pharmaceutical Market Research Association, AN CLASS; Hallas J, 2005, PHARMACOEPIDEM DR S, V14, P455, DOI 10.1002/pds.1063; Higashi Takahiro, 2012, Glob J Health Sci, V4, P197, DOI 10.5539/gjhs.v4n6p197; Hollingworth SA, 2011, PHARMACOEPIDEM DR S, V20, P450, DOI 10.1002/pds.2114; Hubner-Liebermann B, 2005, INT J SOC PSYCHIATR, V51, P83, DOI 10.1177/0020764005050337; Japanese Society of Neurology, 2011, GUID TREATM PARK DIS; Jones JK, 2001, JAMA-J AM MED ASSOC, V286, P1607, DOI 10.1001/jama.286.13.1607; Katada H, 2014, CLIN RHEUMA IN PRESS; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Kirigaya D, 2011, INTERNAL MED, V50, P2793, DOI 10.2169/internalmedicine.50.5266; Kohro T, 2013, INT HEART J, V54, P93, DOI 10.1536/ihj.54.93; Lee D, 2007, TXB PHARMACOEPIDEMIO, P399; Leoni O, 2002, PHARMACOEPIDEM DR S, V11, P149, DOI 10.1002/pds.682; Ministor of Health Labour and Welfare, 2007, REV PRECAUTIONS; Ministry of Health Labour and Welfare, 2011, HLTH INS; Miyasaki JM, 2002, NEUROLOGY, V58, P11, DOI 10.1212/WNL.58.1.11; Miziuno Yoshikuni, 2002, Rinsho Shinkeigaku, V42, P421; Nakaoka S, 2011, INTERNAL MED, V50, P687, DOI 10.2169/internalmedicine.50.4344; Nakayama T, 2012, YAKUGAKU ZASSHI, V132, P549, DOI 10.1248/yakushi.132.549; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; Nemeroff CB, 2007, ARCH GEN PSYCHIAT, V64, P466, DOI 10.1001/archpsyc.64.4.466; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Ogino S, 2011, PROG NEURO-PSYCHOPH, V35, P78, DOI 10.1016/j.pnpbp.2010.08.030; Ooba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066116; Ooba N, 2011, DRUG SAFETY, V34, P329, DOI 10.2165/11588230-000000000-00000; Osaki Y, 2011, ACTA NEUROL SCAND, V124, P182, DOI 10.1111/j.1600-0404.2010.01442.x; Rosa MM, 2010, MOVEMENT DISORD, V25, P1053, DOI 10.1002/mds.23038; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Shatin D, 2005, PHARMACOEPIDEM DR S, V14, P149, DOI 10.1002/pds.961; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; Steiger M, 2009, J NEURAL TRANSM, V116, P179, DOI 10.1007/s00702-008-0179-4; Swarztrauber K, 2006, NEUROLOGY, V66, P1425, DOI 10.1212/01.wnl.0000210433.49727.40; Taniguchi A, 2008, CLIN NEUROL, V48, P106; Trifiro G, 2008, PARKINSONISM RELAT D, V14, P420, DOI 10.1016/j.parkreldis.2007.10.010; U.S. Department of Health and Human Services Food and Drug Administration, 2011, GUID IND MED GUID DI; Urushihara H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028483; Wada M, 2013, INT J GEN MED, V6, P597, DOI 10.2147/IJGM.S44190; Weatherby LB, 2001, PHARMACOEPIDEM DR S, V10, P211, DOI 10.1002/pds.592; Yamamoto M, 2006, NEUROLOGY, V67, P1225, DOI 10.1212/01.wnl.0000238508.68593.1d; Yamanaka H, 2014, MOD RHEUMATOL, V24, P33, DOI 10.3109/14397595.2013.854059; Yamashiro K, 2008, MOVEMENT DISORD, V23, P935, DOI 10.1002/mds.22036; Yamawaki M, 2009, NEUROEPIDEMIOLOGY, V32, P263, DOI 10.1159/000201565	45	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99021	10.1371/journal.pone.0099021	http://dx.doi.org/10.1371/journal.pone.0099021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906013	gold, Green Published			2022-12-25	WOS:000341869000093
J	Naspi, A; Panasiti, V; Abbate, F; Roberti, V; Devirgiliis, V; Curzio, M; Borghi, M; Lozupone, F; Carotti, S; Morini, S; Gaudio, E; Calvieri, S; Londei, P				Naspi, Antimo; Panasiti, Vincenzo; Abbate, Franco; Roberti, Vincenzo; Devirgiliis, Valeria; Curzio, Michela; Borghi, Martina; Lozupone, Francesco; Carotti, Simone; Morini, Sergio; Gaudio, Eugenio; Calvieri, Stefano; Londei, Paola			Insulin-Like-Growth-Factor-Binding-Protein-3 (IGFBP-3) Contrasts Melanoma Progression In Vitro and In Vivo	PLOS ONE			English	Article							IGF-BINDING PROTEIN-3; GROWTH-FACTOR (IGF)-I; CANCER-RISK; COLORECTAL-CANCER; PROSTATE-CANCER; PLASMA-LEVELS; TUMOR-GROWTH; CELLS	Insulin-like-factor-binding-protein 3 (IGFBP-3) is known to modulate the activity of insulin-like growth factors (IGFs) besides having a number of IGF-independent effects on cell growth and survival. IGFBP-3 has been reported to decrease significantly in the blood serum of patients affected by certain cancers. In the present work, we have evaluated the levels of IGFBP-3 in the blood serum and tissues of patients affected by cutaneous melanoma, showing that loss of IGFBP-3 from both is strongly correlated with disease progression and reduced survival. In vitro treatment with IGFBP-3 of human and murine metastatic melanoma cell lines specifically inhibited the cells' migratory and invasive behaviour, inducing up-regulation of melanocytic differentiation markers such as tyrosinase activity and melanin content. A molecular analysis of the cellular pathways transducing the effect of IGFBP-3 implicated the Akt-GSK3 beta axis. Moreover, administration of IGFBP-3 in vivo to SCID mice inoculated with human metastatic melanoma cells strongly reduced or completely inhibited tumor growth. In summary, IGFBP-3 appears to exert a specific inhibitory effect on melanoma growth and dissemination, suggesting that it may qualify as a useful therapeutic agent in melanomas and perhaps other cancers, at the least as a valid adjuvant therapy during treatment with conventional anti-tumoral drugs.	[Naspi, Antimo; Abbate, Franco; Londei, Paola] Univ Roma La Sapienza, Dept Biotecnol Cellulari & Ematol, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Panasiti, Vincenzo; Devirgiliis, Valeria] Campus Biomed Univ Rome, Plast Surg Unit, Rome, Italy; [Roberti, Vincenzo; Curzio, Michela; Calvieri, Stefano] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Borghi, Martina; Lozupone, Francesco] Ist Super Sanita, Unit Antitumor Drugs, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Carotti, Simone; Morini, Sergio] Univ Campus Biomed Rome, Dept Human Anat CIR, Rome, Italy; [Gaudio, Eugenio] Univ Roma La Sapienza, Dept Human Anat, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; University Campus Bio-Medico - Rome Italy; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University Campus Bio-Medico - Rome Italy; Sapienza University Rome	Naspi, A (corresponding author), Univ Roma La Sapienza, Dept Biotecnol Cellulari & Ematol, Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	naspi@bce.uniroma1.it	Carotti, Simone/G-7822-2012; Lozupone, Francesco/H-2998-2016; Panasiti, Vincenzo/GPF-5731-2022; BORGHI, MARTINA/M-4355-2015; Morini, Sergio/AAB-8540-2022	Carotti, Simone/0000-0002-3164-1500; Lozupone, Francesco/0000-0002-4959-9400; BORGHI, MARTINA/0000-0001-6313-0273; Morini, Sergio/0000-0001-6137-2404; Panasiti, Vincenzo/0000-0003-1589-867X; calvieri, stefano/0000-0003-3735-4585	University of Rome	University of Rome	The study was financed by the following grants (2010-2011) from the University of Rome (www.uniroma1.it): "Role of IGF-binding proteins and other molecular markers in melanoma progression" and "Molecular markers in melanoma progression". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2003, HORM METAB RES, V35, P726; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baldini PM, 2006, MELANOMA RES, V16, P501, DOI 10.1097/01.cmr.0000232296.99160.d7; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Dar AA, 2010, J INVEST DERMATOL, V130, P2071, DOI 10.1038/jid.2010.70; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gribben L, 2012, CANCER LETT, V317, P41, DOI 10.1016/j.canlet.2011.11.011; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Lal G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073953; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lomas J, 2008, FRONT BIOSCI-LANDMRK, V13, P5071, DOI 10.2741/3065; Lozupone F, 2000, INT J CANCER, V87, P569, DOI 10.1002/1097-0215(20000815)87:4<569::AID-IJC17>3.0.CO;2-U; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782; Mattei F, 2014, J IMMUNOTOXICOL, V11, P337, DOI 10.3109/1547691X.2014.891677; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Panasiti V, 2011, J AM ACAD DERMATOL, V64, P865, DOI 10.1016/j.jaad.2010.03.035; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P285, DOI 10.1136/mp.54.5.285	27	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98641	10.1371/journal.pone.0098641	http://dx.doi.org/10.1371/journal.pone.0098641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905466	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000043
J	Wang, HH; Reitz, SR; Xiang, JC; Smagghe, G; Lei, ZR				Wang, Haihong; Reitz, Stuart R.; Xiang, Juncheng; Smagghe, Guy; Lei, Zhongren			Does Temperature-Mediated Reproductive Success Drive the Direction of Species Displacement in Two Invasive Species of Leafminer Fly?	PLOS ONE			English	Article							LIRIOMYZA-SATIVAE DIPTERA; TRIFOLII BURGESS DIPTERA; INTRASPECIFIC COMPETITION; CLIMATE-CHANGE; L-BRYONIAE; AGROMYZIDAE; DROSOPHILA; HUIDOBRENSIS; COEXISTENCE; ADAPTATION	Liriomyza sativae and L. trifolii (Diptera: Agromyzidae) are two highly invasive species of leafmining flies, which have become established as pests of horticultural crops throughout the world. In certain regions where both species have been introduced, L. sativae has displaced L. trifolii, whereas the opposite has occurred in other regions. These opposing outcomes suggest that neither species is an inherently superior competitor. The regions where these displacements have been observed (southern China, Japan and western USA) are climatically different. We determined whether temperature differentially affects the reproductive success of these species and therefore if climatic differences could affect the outcome of interspecific interactions where these species are sympatric. The results of life table parameters indicate that both species can develop successfully at all tested temperatures (20, 25, 31, 33 degrees C). L. sativae had consistently higher fecundities at all temperatures, but L. trifolii developed to reproductive age faster. Age-stage specific survival rates were higher for L. sativae at low temperatures, but these were higher for L. trifolii at higher temperatures. We then compared the net reproductive rates (R-0) for both species in pure and mixed cultures maintained at the same four constant temperatures. Both species had significantly lower net reproductive rates in mixed species cultures compared with their respective pure species cultures, indicating that both species are subject to intense interspecific competition. Net reproductive rates were significantly greater for L. sativae than for L. trifolii in mixed species groups at the lower temperatures, whereas the opposite occurred at the higher temperature. Therefore, interactions between the species are temperature dependent and small differences could shift the competitive balance between the species. These temperature mediated effects may contribute to the current ongoing displacement of L. sativae by the more recent invader L. trifolii in warm climatic areas of China.	[Wang, Haihong; Xiang, Juncheng; Lei, Zhongren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Reitz, Stuart R.] Oregon State Univ, Dept Crop & Soil Sci, Ontario, OR USA; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Oregon State University; Ghent University	Lei, ZR (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zrlei@ippcaas.cn	Reitz, Stuart/AAC-4467-2019; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313	China Agriculture Research System [CARS-25-B-07]; National Natural Science Foundation of China [31201526]; Beijing Municipal Natural Science Foundation [6122026]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported in part by the China Agriculture Research System (CARS-25-B-07), the National Natural Science Foundation of China (31201526), and Beijing Municipal Natural Science Foundation (6122026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, APPL ENTOMOL ZOOL, V36, P277, DOI 10.1303/aez.2001.277; Abe Y, 2008, BIOL INVASIONS, V10, P951, DOI 10.1007/s10530-007-9173-2; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; CARRACEDO MC, 1986, GENETICA, V69, P97, DOI 10.1007/BF00115128; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2009, TWOSEX MSCHART COMPU; DEBACH P, 1966, ANNU REV ENTOMOL, V11, P183, DOI 10.1146/annurev.en.11.010166.001151; DESTASO J, 1994, T AM FISH SOC, V123, P289, DOI 10.1577/1548-8659(1994)123<0289:IOWTOI>2.3.CO;2; Efron B., 1994, INTRO BOOTSTRAP; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Lanzoni A, 2002, ENVIRON ENTOMOL, V31, P797, DOI 10.1603/0046-225X-31.5.797; Lei ZR, 1997, ANN AGR SCI CHINA YO, P495; Lei ZR, 2005, BIOL MANAGEMENT INVA, P177; Minkenberg OPJM, 1998, B OEPP, V18, P173; ORENGO DJ, 1994, Z ZOOL SYST EVOL, V32, P44; PARRELLA MP, 1983, ENVIRON ENTOMOL, V12, P1412, DOI 10.1093/ee/12.5.1412; PARRELLA MP, 1987, ANNU REV ENTOMOL, V32, P201, DOI 10.1146/annurev.en.32.010187.001221; PARRELLA MP, 1988, PAN-PAC ENTOMOL, V64, P17; PETITT FL, 1992, ENVIRON ENTOMOL, V21, P136, DOI 10.1093/ee/21.1.136; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Reitz SR, 2002, ENTOMOL EXP APPL, V102, P101, DOI 10.1023/A:1015861716270; Reitz SR, 2013, INSECTICIDES DEV SAF; Scheffer SJ, 2005, ANN ENTOMOL SOC AM, V98, P181, DOI 10.1603/0013-8746(2005)098[0181:MPOVPL]2.0.CO;2; Sokal RR, 1995, BIOMETRY PRINCIPLES, V3, P1995; Spencer KA, 1973, SERIES ENTOMOLOGICA, V9; Taniguchi Y, 1998, CAN J FISH AQUAT SCI, V55, P1894, DOI 10.1139/cjfas-55-8-1894; Tantowijoyo W, 2010, ENTOMOL EXP APPL, V135, P141, DOI 10.1111/j.1570-7458.2010.00984.x; Tokumaru S, 2005, APPL ENTOMOL ZOOL, V40, P551, DOI 10.1303/aez.2005.551; Tokumaru S, 2003, JPN J APPL ENTOMOL Z, V47, P143, DOI 10.1303/jjaez.2003.143; Tokumaru S, 2007, APPL ENTOMOL ZOOL, V42, P317, DOI 10.1303/aez.2007.317; TRUMBLE JT, 1983, ENVIRON ENTOMOL, V12, P810, DOI 10.1093/ee/12.3.810; Wang SY, 2014, MITOCHONDR DNA, V25, P104, DOI 10.3109/19401736.2013.786706; Wang SY, 2011, MOL BIOL REP, V38, P687, DOI 10.1007/s11033-010-0155-6; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; [相君成 Xiang Juncheng], 2012, [生态学报, Acta Ecologica Sinica], V32, P1616	41	19	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98761	10.1371/journal.pone.0098761	http://dx.doi.org/10.1371/journal.pone.0098761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906119	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000060
J	Belo, L; Nascimento, H; Kohlova, M; Bronze-da-Rocha, E; Fernandes, J; Costa, E; Catarino, C; Aires, L; Mansilha, HF; Rocha-Pereira, P; Quintanilha, A; Rego, C; Santos-Silva, A				Belo, Luis; Nascimento, Henrique; Kohlova, Michaela; Bronze-da-Rocha, Elsa; Fernandes, Joao; Costa, Elisio; Catarino, Cristina; Aires, Luisa; Mansilha, Helena Ferreira; Rocha-Pereira, Petronila; Quintanilha, Alexandre; Rego, Carla; Santos-Silva, Alice			Body Fat Percentage Is a Major Determinant of Total Bilirubin Independently of UGT1A1*28 Polymorphism in Young Obese	PLOS ONE			English	Article							SERUM BILIRUBIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; INVERSE RELATIONSHIP; RACIAL VARIABILITY; CLINICAL-PRACTICE; MASS INDEX; GENE	Objectives: Bilirubin has potential antioxidant and anti-inflammatory properties. The UGT1A1*28 polymorphism (TA repeats in the promoter region) is a major determinant of bilirubin levels and recent evidence suggests that raised adiposity may also be a contributing factor. We aimed to study the interaction between UGT1A1 polymorphism, hematological and anthropometric variables with total bilirubin levels in young individuals. Methods: 350 obese (mean age of 11.6 years; 52% females) and 79 controls (mean age of 10.5 years; 59% females) were included. Total bilirubin and C-reactive protein (CRP) plasma levels, hemogram, anthropometric data and UGT1A1 polymorphism were determined. In a subgroup of 74 obese and 40 controls body composition was analyzed by dual-energy X-ray absorptiometry. Results: The UGT1A1 genotype frequencies were 49.9%, 42.7% and 7.5% for 6/6, 6/7 and 7/7 genotypes, respectively. Patients with 7/7 genotype presented the highest total bilirubin levels, followed by 6/7 and 6/6 genotypes. Compared to controls, obese patients presented higher erythrocyte count, hematocrit, hemoglobin and CRP levels, but no differences in bilirubin or in UGT1A1 genotype distribution. Body fat percentage was inversely correlated with bilirubin in obese patients but not in controls. This inverse association was observed either in 6/7 or 6/6 genotype obese patients. UGT1A1 polymorphism and body fat percentage were the main factors affecting bilirubin levels within obese patients (linear regression analysis). Conclusion: In obese children and adolescents, body fat composition and UGT1A1 polymorphism are independent determinants of total bilirubin levels. Obese individuals with 6/6 UGT1A1 genotype and higher body fat mass may benefit from a closer clinical follow-up.	[Belo, Luis; Nascimento, Henrique; Bronze-da-Rocha, Elsa; Fernandes, Joao; Costa, Elisio; Catarino, Cristina; Santos-Silva, Alice] Univ Porto, Fac Farm, Dept Ciencias Biol, P-4100 Oporto, Portugal; [Belo, Luis; Nascimento, Henrique; Bronze-da-Rocha, Elsa; Costa, Elisio; Catarino, Cristina; Quintanilha, Alexandre; Santos-Silva, Alice] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Kohlova, Michaela; Fernandes, Joao] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci IBILI, Coimbra, Portugal; [Aires, Luisa] Univ Porto, Ctr Invest Actividade Fis Saude & Lazer CIAFEL, Fac Desporto, P-4100 Oporto, Portugal; [Aires, Luisa] Inst Univ Maia ISMAI, Maia, Portugal; [Mansilha, Helena Ferreira] Ctr Hosp Porto, Dept Infancia & Adolescencia, Serv Pediat, Oporto, Portugal; [Rocha-Pereira, Petronila] Univ Beira Interior, Ctr Invest Ciencias Saude, Covilha, Portugal; [Quintanilha, Alexandre] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Rego, Carla] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Hosp CUF Porto,Ctr Crianca & Adolescente, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Instituto Universitario da Maia (ISMAI); Universidade da Beira Interior; Universidade do Porto; Universidade do Porto	Belo, L (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	luisbelo@ff.up.pt	Fernandes, Joao C/AAF-2091-2019; Santos-Silva, Alice/AAC-7082-2020; Costa, Elisio MS/K-1990-2013; Belo, Luís FBA/K-5878-2013; Santos-Silva, Alice/K-2326-2013; Aires, Luisa/L-7528-2013; Bronze-da-Rocha, Elsa M R/K-2723-2013; Fernandes, João/K-3126-2013; Catarino, Cristina/K-5492-2013; Kohlova, Michaela/T-3587-2017; Rocha-Pereira, Petronila/K-3102-2013; Quintanilha, Alexandre/L-5371-2013	Fernandes, Joao C/0000-0003-1556-1698; Santos-Silva, Alice/0000-0002-2565-3169; Costa, Elisio MS/0000-0003-1158-1480; Belo, Luís FBA/0000-0002-3941-6850; Santos-Silva, Alice/0000-0002-2565-3169; Bronze-da-Rocha, Elsa M R/0000-0002-3571-2513; Fernandes, João/0000-0003-1556-1698; Catarino, Cristina/0000-0002-3229-1434; Kohlova, Michaela/0000-0002-9411-3449; Rocha-Pereira, Petronila/0000-0002-7985-1494; Aires, Luisa/0000-0001-9717-4186; Rego, Carla/0000-0003-1229-8775; Nascimento, Henrique/0000-0002-9105-018X; Quintanilha, Alexandre/0000-0001-8544-0061	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-028613 (PTDC/DTP-DES/0393/2012)]; FCT [SFRH/BD/48060/2008]; Fundação para a Ciência e a Tecnologia [PTDC/DTP-DES/0393/2012] Funding Source: FCT	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-028613 (PTDC/DTP-DES/0393/2012). A PhD grant was attributed to H. Nascimento by FCT (SFRH/BD/48060/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, CURR PHARM DESIGN, V14, P412, DOI 10.2174/138161208783597371; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Chauhan Alia, 2013, FP Essent, V410, P25; Clementi M, 2007, DIGEST LIVER DIS, V39, P351, DOI 10.1016/j.dld.2006.12.019; Coimbra S, 2013, OBES REV, V14, P771, DOI 10.1111/obr.12057; D'Archivio M, 2012, EUR J CLIN INVEST, V42, P70, DOI 10.1111/j.1365-2362.2011.02558.x; Devries MC, 2008, OBESITY, V16, P2281, DOI 10.1038/oby.2008.358; Fevery J, 2008, LIVER INT, V28, P592, DOI 10.1111/j.1478-3231.2008.01716.x; GAFFNEY D, 1994, J MED GENET, V31, P248, DOI 10.1136/jmg.31.3.248; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Gourley G R, 1997, Adv Pediatr, V44, P173; Greco EA, 2013, WORLD J DIABETES, V4, P31, DOI 10.4239/wjd.v4.i2.31; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Hwang HJ, 2011, CLIN CHEM LAB MED, V49, P1823, DOI 10.1515/CCLM.2011.662; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jenko-Praznikar Z, 2013, METABOLISM, V62, P976, DOI 10.1016/j.metabol.2013.01.011; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kaniwa N, 2005, DRUG METAB DISPOS, V33, P458, DOI 10.1124/dmd.104.001800; Karatzas A, 2010, CANCER EPIDEMIOL, V34, P345, DOI 10.1016/j.canep.2010.02.009; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Maruhashi T, 2012, CIRCULATION, V126, P598, DOI 10.1161/CIRCULATIONAHA.112.105775; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nascimento Henrique, 2012, Open Biochem J, V6, P43, DOI 10.2174/1874091X01206010043; Nascimento H, 2009, ARCH PEDIAT ADOL MED, V163, P1030, DOI 10.1001/archpediatrics.2009.190; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Ohnaka K, 2010, DIABETES RES CLIN PR, V88, P103, DOI 10.1016/j.diabres.2009.12.022; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ostanek B, 2007, BLOOD CELL MOL DIS, V38, P78, DOI 10.1016/j.bcmd.2006.10.160; Padez C, 2004, AM J HUM BIOL, V16, P670, DOI 10.1002/ajhb.20080; Rocha S, 2010, BLOOD CELL MOL DIS, V44, P117, DOI 10.1016/j.bcmd.2009.10.012; Rodrigues C, 2012, BLOOD CELL MOL DIS, V48, P166, DOI 10.1016/j.bcmd.2012.01.004; Swift DL, 2012, MED SCI SPORT EXER, V44, P569, DOI 10.1249/MSS.0b013e3182357dd4; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Weinberger B, 2013, NEONATOLOGY, V103, P105, DOI 10.1159/000343097; Wonisch W, 2012, AGING MALE, V15, P159, DOI 10.3109/13685538.2012.669436; Wu TW, 1996, BIOCHEM PHARMACOL, V51, P859, DOI 10.1016/0006-2952(95)02395-X; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427; Yoshino S, 2011, J ATHEROSCLER THROMB, V18, P403, DOI 10.5551/jat.6346; Yu K, 2011, KOREAN J FAM MED, V32, P327, DOI 10.4082/kjfm.2011.32.6.327	49	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98467	10.1371/journal.pone.0098467	http://dx.doi.org/10.1371/journal.pone.0098467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901842	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400032
J	Tang, HJ; Liu, WL; Lin, HL; Lai, CC				Tang, Hung-Jen; Liu, Wei-Lun; Lin, Hsin-Lan; Lai, Chih-Cheng			Epidemiology and Prognostic Factors of Candidemia in Cancer Patients	PLOS ONE			English	Article							INVASIVE FUNGAL-INFECTIONS; BLOOD-STREAM INFECTIONS; HEMATOLOGICAL MALIGNANCIES; CHANGING EPIDEMIOLOGY; RISK-FACTORS; SUSCEPTIBILITY; SURVEILLANCE; FLUCONAZOLE; CANDIDAEMIA; CANDIDIASIS	Aim: The study of candidemia in cancer patients has been limited. This retrospective study aims to investigate the epidemiologic characteristics and prognostic factors of candidemia among cancer patients. Materials and Methods: From 2009 to 2012, cancer patients with candidemia were identified at a hospital in Taiwan. The medical records of all patients with bloodstream infections due to Candida species were retrospectively reviewed. Results: During the four-year period, a total of 242 episodes of candidemia were identified among cancer patients. Half of these patients were classified as elderly (>= 65 years old), and more than 95% of the candidemia episodes were classified as healthcare-associated infections. Among the 242 cancer patients with candidemia, head and neck cancer was the most common, followed by gastrointestinal tract and lung cancer. Additionally, most of the patients had variable underlying conditions, such as the presence of CVC (99%) or prior exposure to broad-spectrum antibiotics (93%) and were receiving an immunosuppressant (86%). Overall, C. albicans (n = 132, 54.5%) was the most common pathogen, followed by C. tropicalis (n = 52, 21.5%), C. parapsilosis (n = 38, 15.7%), and C. glabrata (n = 29, 12.0%). Seventeen patients had polycandidal candidemia, and 77 patients had concomitant bacteremia. Approximately one-third of the patients required admission to the intensive care unit (ICU) or mechanical ventilation, and the overall in-hospital mortality was 50.8%. Multivariable analysis showed that the in-hospital mortality was significantly associated with only the non-use of antifungal agents and acute respiratory failure (P<.001). Conclusions: Candidemia can develop in patients with both solid cancer and hematological malignancy, especially for patients with underlying conditions. Overall, the associated morbidity and mortality due to Candidemia remain high. It was also determined that the non-use of antifungal agents and acute respiratory failure conditions were associated with in-hospital mortality.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Liu, Wei-Lun; Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Lin, Hsin-Lan] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com						Bergamasco MD, 2013, MYCOSES, V56, P256, DOI 10.1111/myc.12013; Chen YC, 2003, J ANTIMICROB CHEMOTH, V52, P71, DOI 10.1093/jac/dkg275; Cheng MF, 2004, DIAGN MICR INFEC DIS, V48, P33, DOI 10.1016/j.diagmicrobio.2003.08.002; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Hachem R, 2008, CANCER, V112, P2493, DOI 10.1002/cncr.23466; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hsueh PR, 2002, MICROB DRUG RESIST, V8, P311, DOI 10.1089/10766290260469570; Lai CC, 2012, INT J ANTIMICROB AG, V40, P349, DOI 10.1016/j.ijantimicag.2012.05.024; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Li D, 2013, MED MYCOL, V51, P378, DOI 10.3109/13693786.2012.727481; Lu Jang-Jih, 2004, Journal of Microbiology Immunology and Infection, V37, P335; Megalakaki C, 2006, J BUON, V11, P191; Montagna MT, 2013, INFECTION, V41, P645, DOI 10.1007/s15010-013-0432-0; Mor M, 2011, PEDIATR BLOOD CANCER, V56, P1092, DOI 10.1002/pbc.23005; Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x; Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026; Ruan SY, 2009, J FORMOS MED ASSOC, V108, P443, DOI 10.1016/S0929-6646(09)60091-7; Sabino R, 2010, MED MYCOL, V48, P346, DOI [10.3109/13693780903161216, 10.1080/13693780903161216]; Schuster MG, 2013, J INFECTION, V66, P278, DOI 10.1016/j.jinf.2012.11.002; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Tragiannidis A, 2012, CLIN MICROBIOL INFEC, V18, pE27, DOI 10.1111/j.1469-0691.2011.03720.x; Velasco E, 2008, EUR J CLIN MICROBIOL, V27, P1071, DOI 10.1007/s10096-008-0546-y; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yang YL, 2008, DIAGN MICR INFEC DIS, V61, P175, DOI 10.1016/j.diagmicrobio.2008.01.011; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	27	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99103	10.1371/journal.pone.0099103	http://dx.doi.org/10.1371/journal.pone.0099103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901336	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400098
J	Wang, L; Zhou, L; Zhang, H; Li, Y; Ge, XN; Guo, X; Yu, KZ; Yang, HC				Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun			Interactome Profile of the Host Cellular Proteins and the Nonstructural Protein 2 of Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							CYSTEINE PROTEASE DOMAIN; MOLECULAR-BIOLOGY; ECONOMIC-IMPACT; PAPAIN-LIKE; NSP2; APOPTOSIS; REPLICATION; ANTIGEN; INNATE; STRAIN	The nonstructural protein 2 (NSP2) is considered to be one of crucial viral proteins in the replication and pathogenesis of porcine reproductive and respiratory syndrome virus (PRRSV). In the present study, the host cellular proteins that interact with the NSP2 of PRRSV were immunoprecipitated with anti-Myc antibody from the MARC-145 cells infected by a recombinant PRRSV with 3xMyc tag insertion in its NSP2-coding region, and then 285 cellular proteins interacting with NSP2 were identified by LC-MS/ MS. The Gene Ontology and enriched KEGG Pathway bioinformatics analyses indicated that the identified proteins could be assigned to different subcellular locations and functional classes. Functional analysis of the interactome profile highlighted cellular pathways associated with infectious disease, translation, immune system, nervous system and signal transduction. Two interested cellular proteins-BCL2-associated athanogene 6 (BAG6) and apoptosis-inducing factor 1 (AIF1) which may involve in transporting of NSP2 to Endoplasmic reticulum (ER) or PRRSV-driven apoptosis were validated by Western blot. The interactome data between PRRSV NSP2 and cellular proteins contribute to the understanding of the roles of NSP2 in the replication and pathogenesis of PRRSV, and also provide novel cellular target proteins for elucidating the associated molecular mechanisms of the interaction of host cellular proteins with viral proteins in regulating the viral replication.	[Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China; [Wang, Li; Zhou, Lei; Zhang, Han; Li, Yan; Ge, Xinna; Guo, Xin; Yu, Kangzhen; Yang, Hanchun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Yu, Kangzhen] Minist Agr Peoples Republ China, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Yang, HC (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China.	yanghanchun1@cau.edu.cn		Zhou, Lei/0000-0002-8837-3965	Chinese Ministry of Science and Technology [2014CB542700]; National Natural Science Foundation of China [31330077]; Ministry of Agriculture of People's Republic of China [CARS-36]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of People's Republic of China	This work was supported by National Key Basic Research Plan Grant (2014CB542700) from the Chinese Ministry of Science and Technology (http://www.most.gov.cn/) and Key project of National Natural Science Funds from National Natural Science Foundation of China (31330077) (http://www.nsfc.gov.cn/), and the earmarked fund for Modern Agro-industry Technology Research System of China (CARS-36) from the Ministry of Agriculture of People's Republic of China (http://119.253.58.231/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET RES, V28, P305; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Beura LK, 2011, J VIROL, V85, P12939, DOI 10.1128/JVI.05177-11; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Cao JB, 2012, J VET DIAGN INVEST, V24, P767, DOI 10.1177/1040638712445764; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang AC, 2012, J VIROL, V80, P8705; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Fang Y, 2006, J VIROL, V80, P11447, DOI 10.1128/JVI.01032-06; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Garner MG, 2001, REV SCI TECH OIE, V20, P671, DOI 10.20506/rst.20.3.1303; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Halbur PG, 1996, VET PATHOL, V33, P159, DOI 10.1177/030098589603300205; Han J, 2007, J VIROL, V81, P9878, DOI 10.1128/JVI.00562-07; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Han J, 2010, J VIROL, V84, P10102, DOI 10.1128/JVI.01208-10; Han J, 2009, J VIROL, V83, P9449, DOI 10.1128/JVI.00834-09; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Jourdan SS, 2012, PROTEOMICS, V12, P1015, DOI 10.1002/pmic.201100469; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; Kim DY, 2007, VIRUS RES, V128, P106, DOI 10.1016/j.virusres.2007.04.019; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Knoops K, 2012, J VIROL, V86, P2474, DOI 10.1128/JVI.06677-11; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Leznicki P, 2012, P NATL ACAD SCI USA, V109, P19214, DOI 10.1073/pnas.1209997109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li LM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-203; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Ma ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069387; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Miller LC, 2004, VET IMMUNOL IMMUNOP, V102, P131, DOI 10.1016/j.vetimm.2004.09.004; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Molitor TW, 1997, VET MICROBIOL, V55, P265, DOI 10.1016/S0378-1135(96)01327-2; Music Nedzad, 2010, Animal Health Research Reviews, V11, P135, DOI 10.1017/S1466252310000034; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Pedersen KW, 1999, J VIROL, V73, P2016, DOI 10.1128/JVI.73.3.2016-2026.1999; Posthuma CC, 2008, J VIROL, V82, P4480, DOI 10.1128/JVI.02756-07; Preta G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047328; ROSSOW KD, 1995, VET PATHOL, V32, P361, DOI 10.1177/030098589503200404; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SNIJDER EJ, 1995, J BIOL CHEM, V270, P16671, DOI 10.1074/jbc.270.28.16671; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Snijder EJ, 2001, J GEN VIROL, V82, P985, DOI 10.1099/0022-1317-82-5-985; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sun Z, 2012, J VIROL, V86, P3839, DOI 10.1128/JVI.06466-11; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tanaka S, 2005, J NEUROCHEM, V95, P179, DOI 10.1111/j.1471-4159.2005.03353.x; Thanawongnuwech R, 1997, J VET DIAGN INVEST, V9, P334, DOI 10.1177/104063879700900323; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; van Kasteren PB, 2012, J VIROL, V86, P773, DOI 10.1128/JVI.06277-11; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Wassenaar ALM, 1997, J VIROL, V71, P9313, DOI 10.1128/JVI.71.12.9313-9322.1997; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Yan YL, 2007, VIRUS RES, V126, P207, DOI 10.1016/j.virusres.2007.03.002; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang HM, 2009, J PROTEOME RES, V8, P3091, DOI 10.1021/pr900002f; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016; Zhou L, 2009, VIRUS RES, V145, P97, DOI 10.1016/j.virusres.2009.06.014; Zhou L, 2009, J VIROL, V83, P5156, DOI 10.1128/JVI.02678-08	75	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99176	10.1371/journal.pone.0099176	http://dx.doi.org/10.1371/journal.pone.0099176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901321	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400105
J	Zelnikar, M; Bencina, M; Jerala, R; Mancek-Keber, M				Zelnikar, Mojca; Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja			Vanadate from Air Pollutant Inhibits Hrs-Dependent Endosome Fusion and Augments Responsiveness to Toll-Like Receptors	PLOS ONE			English	Article							OIL FLY-ASH; EPITHELIAL-CELLS; TYROSINE PHOSPHORYLATION; INFLAMMATORY RESPONSES; CYTOKINE PRODUCTION; EXPOSURE; TOLL-LIKE-RECEPTOR-4; SUSCEPTIBILITY; INCREASES; MORTALITY	There is a well-established association between exposure to air pollutants and pulmonary injuries. For example, metals found in ROFA (residual oil fly ash) increase susceptibility of mice as well as humans to microbial infections. In our research, we have found that vanadate substantially increased the response of several Toll-like receptors (TLRs) to stimulation with their ligands. Although vanadate caused generation of reactive oxygen species (ROS), the addition of ROS scavenger N-acetyl cysteine (NAC) had no effect on augmented lipopolysaccharide (LPS) stimulation. We further showed that vanadate inhibits endosome fusion. This effect was determined by measuring the size of endosomes, NF-kappa B activity and TLR4 degradation in Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate) overexpressed cells. Moreover, we identified the role of Hrs phosphorylation in these processes. Based on our findings, we can conclude that vanadate potentiates TLR4 activity by increasing Hrs phosphorylation status, reducing the size of Hrs/TLR4-positive endosomes and impacting TLR4 degradation, thus contributing to the detrimental effects of air pollutants on human health.	[Zelnikar, Mojca; Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja] Natl Inst Chem, Biotechnol Lab, Ljubljana, Slovenia; [Bencina, Mojca; Jerala, Roman; Mancek-Keber, Mateja] EN FIST Ctr Excellence, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Mancek-Keber, M (corresponding author), Natl Inst Chem, Biotechnol Lab, Ljubljana, Slovenia.	mateja.mancek@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency; Ministry of Science and Technology at the Centre of Excellence EN-FIST	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Science and Technology at the Centre of Excellence EN-FIST	This work was supported by programs and projects from the Slovenian Research Agency and by the Ministry of Science and Technology at the Centre of Excellence EN-FIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Antonini JM, 2002, TOXICOL SCI, V70, P110, DOI 10.1093/toxsci/70.1.110; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Carter JD, 1997, TOXICOL APPL PHARM, V146, P180, DOI 10.1006/taap.1997.8254; Cho HY, 2005, PHYSIOL GENOMICS, V22, P108, DOI 10.1152/physiolgenomics.00037.2005; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dye JA, 1997, AM J RESP CELL MOL, V17, P625, DOI 10.1165/ajrcmb.17.5.2749; Gamero AM, 2001, J BIOL CHEM, V276, P13547, DOI 10.1074/jbc.M007948200; Gasparrini F, 2012, EUR J IMMUNOL, V42, P2744, DOI 10.1002/eji.201142278; Ghio AJ, 2002, ENVIRON HEALTH PERSP, V110, P89, DOI 10.1289/ehp.02110s1189; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; HAUSER R, 1995, OCCUP ENVIRON MED, V52, P353, DOI 10.1136/oem.52.5.353; Huffman GP, 2000, J AIR WASTE MANAGE, V50, P1106, DOI 10.1080/10473289.2000.10464157; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inoue K, 2006, ARCH TOXICOL, V80, P275, DOI 10.1007/s00204-005-0040-6; Kim JY, 2004, ENVIRON HEALTH PERSP, V112, P666, DOI 10.1289/ehp.6827; Klein-Patel ME, 2006, TOXICOL SCI, V92, P115, DOI 10.1093/toxsci/kfj214; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Longphre M, 2000, TOXICOL APPL PHARM, V162, P86, DOI 10.1006/taap.1999.8838; Nikula KJ, 2000, INHAL TOXICOL, V12, P123, DOI 10.1080/089583700750019549; NIOSH, 1994, PUBL NIOSH, P1; Pereira CEL, 2007, BRAZ J MED BIOL RES, V40, P1353, DOI 10.1590/S0100-879X2006005000164; Prahalad AK, 2001, CHEM RES TOXICOL, V14, P879, DOI 10.1021/tx010022e; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Rhoden CR, 2004, TOXICOL SCI, V79, P296, DOI 10.1093/toxsci/kfh122; Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Stringer B, 1998, J TOXICOL ENV HEAL A, V55, P31; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Uysal N, 2003, CURR OPIN PULM MED, V9, P144, DOI 10.1097/00063198-200303000-00009; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Woo CH, 2000, BIOCHEM J, V348, P525, DOI 10.1042/0264-6021:3480525; Zhang Z, 2001, ARCH BIOCHEM BIOPHYS, V392, P311, DOI 10.1006/abbi.2001.2464	40	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99287	10.1371/journal.pone.0099287	http://dx.doi.org/10.1371/journal.pone.0099287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901993	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400117
J	Chen, ST; Siddarth, P; Ercoli, LM; Merrill, DA; Torres-Gil, F; Small, GW				Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Torres-Gil, Fernando; Small, Gary W.			Modifiable Risk Factors for Alzheimer Disease and Subjective Memory Impairment across Age Groups	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BODY-MASS INDEX; OLDER-ADULTS; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; LATE-LIFE; DEPRESSIVE SYMPTOMS; DEVELOPING DEMENTIA; CONTROLLED TRIAL; SELF-APPRAISAL	Introduction: Previous research has identified modifiable risk factors for Alzheimer's disease (AD) in older adults. Research is limited on the potential link between these risk factors and subjective memory impairment (SMI), which may precede AD and other dementias. Examination of these potential relationships may help identify those at risk for AD at a stage when interventions may delay or prevent further memory problems. The objective of this study was to determine whether risk factors for AD are associated with SMI among different age groups. Method: Trained interviewers conducted daily telephone surveys (Gallup-Healthways) of a representative community sample of 18,614 U.S. respondents, including 4,425 younger (age 18 to 39 years), 6,365 middle-aged (40 to 59 years), and 7,824 older (60 to 99 years) adults. The surveyors collected data on demographics, lifestyles, and medical information. Less education, smoking, hypertension, diabetes, less exercise, obesity and depression, and interactions among them, were examined for associations with SMI. Weighted logistic regressions and chi-square tests were used to calculate odds ratios and confidence intervals for SMI with each risk factor and pairwise interactions across age groups. Results: Depression, less education, less exercise, and hypertension were significantly associated with SMI in all three age groups. Several interactions between risk factors were significant in younger and middle-aged adults and influenced their associations with SMI. Frequency of SMI increased with age and number of risk factors. Odds of having SMI increased significantly with just having one risk factor. Conclusions: These results indicate that modifiable risk factors for AD are also associated with SMI, suggesting that these relationships occur in a broad range of ages and may be targeted to mitigate further memory problems. Whether modifying these risk factors reduces SMI and the eventual incidence of AD and other dementias later in life remains to be determined.	[Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Chen, Stephen T.; Siddarth, Prabha; Ercoli, Linda M.; Merrill, David A.; Small, Gary W.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Ercoli, Linda M.; Small, Gary W.] Univ Calif Los Angeles, UCLA Longev Ctr Aging, Los Angeles, CA USA; [Torres-Gil, Fernando] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Torres-Gil, Fernando] Univ Calif Los Angeles, Dept Publ Policy, UCLA Sch Publ Affairs, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Small, GW (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	gsmall@ucla.edu		Merrill, David/0000-0003-2181-3839	Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Semel Institute; Parlow-Solomon Professorship on Aging	Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Semel Institute; Parlow-Solomon Professorship on Aging	Supported by the Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; the Parlow-Solomon Professorship on Aging; and the Semel Institute. No company provided support of any kind for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2002, ADDICTION, V97, P15, DOI 10.1046/j.1360-0443.2002.00016.x; Angevaren M, 2008, COCHRANE DATABASE SY; [Anonymous], ALZHEIMERS DEMENT, V8, P131; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Areosa S. A., 2002, COCHRANE DB SYST REV, V1, DOI [10.1002/ 14651858. CD003804, DOI 10.1002/14651858.CD003804, 10.1002/14651858.CD003804]; Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Balash Y, 2013, ACTA NEUROL SCAND, V127, P344, DOI 10.1111/ane.12038; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; Blazer DG, 1997, J AGING HEALTH, V9, P171, DOI 10.1177/089826439700900202; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Minett TSC, 2008, INT J GERIATR PSYCH, V23, P49, DOI 10.1002/gps.1836; Cohen AK, 2013, SOC SCI MED, V78, P34, DOI 10.1016/j.socscimed.2012.11.025; CUTLER SJ, 1988, J GERONTOL, V43, pS82, DOI 10.1093/geronj/43.3.S82; Dahl AK, 2008, J AM GERIATR SOC, V56, P2261, DOI 10.1111/j.1532-5415.2008.01958.x; Daviglus ML, 2010, NIH CONSENS STATE SC, V27, P1, DOI DOI 10.7326/0003-4819-153-3-201008030-00260; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Dik MG, 2001, NEUROLOGY, V57, P2217, DOI 10.1212/WNL.57.12.2217; DYER AR, 1976, CIRCULATION, V54, P987, DOI 10.1161/01.CIR.54.6.987; Ercoli L, 2006, ARCH GEN PSYCHIAT, V63, P442, DOI 10.1001/archpsyc.63.4.442; Gino S, 2010, GERONTOLOGY, V56, P272, DOI 10.1159/000240048; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Jessen F, 2013, ALZHEIMERS DEMENT; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Jorm AF, 1997, PSYCHOL MED, V27, P91, DOI 10.1017/S0033291796003923; Kessing LV, 2012, CURR OPIN PSYCHIATR, V25, P457, DOI 10.1097/YCO.0b013e328356c368; Kessing LV, 2011, INT CLIN PSYCHOPHARM, V26, P316, DOI 10.1097/YIC.0b013e32834ace0f; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Leroux C, 2014, CAN J DIABETES, V38, P62, DOI 10.1016/j.jcjd.2013.08.268; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; McGuinness B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub3; Merrill DA, 2012, INT PSYCHOGERIATR, V24, P1076, DOI 10.1017/S1041610212000051; Miller KJ, 2012, AM J GERIAT PSYCHIAT, V20, P514, DOI 10.1097/JGP.0b013e318227f821; Minett TSC, 2005, AM J GERIAT PSYCHIAT, V13, P665, DOI 10.1176/appi.ajgp.13.8.665; Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290; Panza F, 2010, AM J GERIAT PSYCHIAT, V18, P98, DOI 10.1097/JGP.0b013e3181b0fa13; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Ponds RWHM, 1997, INT J AGING HUM DEV, V45, P207, DOI 10.2190/MVQ1-WB58-875H-Y4X0; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007; Schneider Lon S, 2013, Continuum (Minneap Minn), V19, P339, DOI 10.1212/01.CON.0000429180.60095.d0; Schofield PW, 1997, ARCH NEUROL-CHICAGO, V54, P756, DOI 10.1001/archneur.1997.00550180064014; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Shah K, 2009, AM J GERIATR PHARMAC, V7, P250, DOI 10.1016/j.amjopharm.2009.11.001; Small GW, 2013, INT PSYCHOGERIATR, V25, P981, DOI 10.1017/S1041610213000082; Small GW, 1999, AM J PSYCHIAT, V156, P1035; Small GW, 2001, INT J GERIATR PSYCH, V16, P1071, DOI 10.1002/gps.481; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Troyer AK, 2002, J GERONTOL B-PSYCHOL, V57, pP19, DOI 10.1093/geronb/57.1.P19; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	62	42	49	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98630	10.1371/journal.pone.0098630	http://dx.doi.org/10.1371/journal.pone.0098630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24896243	Green Published, gold			2022-12-25	WOS:000338430700057
J	Giguere, T; Adkar-Purushothama, CR; Perreault, JP				Giguere, Tamara; Adkar-Purushothama, Charith Raj; Perreault, Jean-Pierre			Comprehensive Secondary Structure Elucidation of Four Genera of the Family Pospiviroidae	PLOS ONE			English	Article							CADANG-CADANG DISEASE; COLEUS-BLUMEI; STRUCTURE PREDICTION; NUCLEOTIDE-SEQUENCE; VIROIDS; INFORMATION; SOFTWARE; HOMOLOGY; ACCURATE; TOMATO	Viroids are small, circular, single stranded RNA molecules that infect plants. Since they are non-coding, their structures play a critical role in their life cycles. To date, little effort has been spend on elucidating viroid structures in solution due to both the experimental difficulties and the time-consuming nature of the methodologies implicated. Recently, the technique of high-throughput selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) was adapted for the probing of the members of family Avsunviroidae, all of whom replicate in the chloroplast and demonstrate ribozyme activity. In the present work, twelve viroid species belonging to four different genera of the family Pospiviroidae, whose members are characterized by the presence of a central conserved region (CCR) and who replicate in nucleus of the host, were probed. Given that the structures of five distinct viroid species from the family Pospiviroidae have been previously reported, an overview of the different structural characteristics for all genera and the beginning of a manual classification of the different viroids based on their structural features are presented here.	[Giguere, Tamara; Adkar-Purushothama, Charith Raj; Perreault, Jean-Pierre] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ J1K 2R1, Canada.	jean-pierre.perreault@usherbrooke.ca	Adkar-Purushothama, Charith Raj/AAR-2159-2020	Adkar-Purushothama, Charith Raj/0000-0001-8868-6008	Natural Sciences and Engineering Research Council of Canada (NSERC) [155219-12]; Universite de Sherbrooke; Centre medicale de l'Universite de Sherbrooke	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite de Sherbrooke; Centre medicale de l'Universite de Sherbrooke	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC, grant number 155219-12) to JPP. The RNA group is supported by grants from the Universite de Sherbrooke. JPP holds the Research Chair of Universite de Sherbrooke in RNA Structure and Genomics and is a member of the Centre de Recherche Clinique Etienne-Lebel. TG has a scholarship from the Centre medicale de l'Universite de Sherbrooke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussiere F, 1996, NUCLEIC ACIDS RES, V24, P1793, DOI 10.1093/nar/24.10.1793; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Desvignes JC, 1999, PLANT DIS, V83, P768, DOI 10.1094/PDIS.1999.83.8.768; Diener TO, 2003, NAT REV MICROBIOL, V1, P75, DOI 10.1038/nrmicro736; Ding BA, 2010, WIRES RNA, V1, P362, DOI 10.1002/wrna.22; Dube A, 2011, MOL PLANT PATHOL, V12, P688, DOI 10.1111/J.1364-3703.2010.00703.X; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Gast FU, 1996, J MOL BIOL, V262, P652, DOI 10.1006/jmbi.1996.0543; Giguere T, 2014, MOL PLANT PATHOL, V15, P767, DOI 10.1111/mpp.12130; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; HAMMOND R, 1989, NUCLEIC ACIDS RES, V17, P10083, DOI 10.1093/nar/17.23.10083; HANOLD D, 1991, PLANT DIS, V75, P330, DOI 10.1094/PD-75-0330; HASELOFF J, 1981, NUCLEIC ACIDS RES, V9, P2741, DOI 10.1093/nar/9.12.2741; HASELOFF J, 1982, NATURE, V299, P316, DOI 10.1038/299316a0; HASHIMOTO J, 1987, NUCLEIC ACIDS RES, V15, P7045, DOI 10.1093/nar/15.17.7045; HERNANDEZ C, 1992, J GEN VIROL, V73, P2503, DOI 10.1099/0022-1317-73-10-2503; Hou WY, 2009, ARCH VIROL, V154, P993, DOI 10.1007/s00705-009-0388-7; Hou WY, 2009, ARCH VIROL, V154, P315, DOI 10.1007/s00705-008-0276-6; Ito T, 2001, ARCH VIROL, V146, P975, DOI 10.1007/s007050170129; Jiang DM, 2014, VIRUS RES, V180, P97, DOI 10.1016/j.virusres.2013.11.014; Jiang DM, 2011, J VIROL METHODS, V174, P123, DOI 10.1016/j.jviromet.2011.03.018; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; KEESE P, 1988, VIROLOGY, V162, P508, DOI 10.1016/0042-6822(88)90497-7; KIEFER MC, 1983, P NATL ACAD SCI-BIOL, V80, P6234, DOI 10.1073/pnas.80.20.6234; Leonard CW, 2013, BIOCHEMISTRY-US, V52, P588, DOI 10.1021/bi300755u; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Singh RP, 1999, J GEN VIROL, V80, P2823, DOI 10.1099/0022-1317-80-11-2823; SPIEKER RL, 1990, NUCLEIC ACIDS RES, V18, P3998, DOI 10.1093/nar/18.13.3998; Spieker RL, 1996, J GEN VIROL, V77, P2839, DOI 10.1099/0022-1317-77-11-2839; Tsushima T, 2011, J GEN PLANT PATHOL, V77, P253, DOI 10.1007/s10327-011-0316-z; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Verhoeven JTJ, 2010, PLANT DIS, V94, P920, DOI 10.1094/PDIS-94-7-0920C; Verhoeven JTJ, 2004, EUR J PLANT PATHOL, V110, P823, DOI 10.1007/s10658-004-2493-5; Xu WX, 2012, MOL PLANT PATHOL, V13, P666, DOI 10.1111/j.1364-3703.2011.00776.x	36	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98655	10.1371/journal.pone.0098655	http://dx.doi.org/10.1371/journal.pone.0098655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897295	gold, Green Published			2022-12-25	WOS:000338430700061
J	Slavik, O; Horky, P; Zavorka, L				Slavik, Ondrej; Horky, Pavel; Zavorka, Libor			Energy Costs of Catfish Space Use as Determined by Biotelemetry	PLOS ONE			English	Article							HOME-RANGE; EUROPEAN CATFISH; SILURUS-GLANIS; CORE AREAS; DENSITY; SIZE; ENERGETICS; RADIOTELEMETRY; MOVEMENTS; PATTERNS	Animals use dispersed resources within their home range (HR) during regular day-to-day activities. The high-quality area intensively used by an individual, where critical resources are concentrated, has been designated as the core area (CA). This study aimed to describe how animals utilize energy in the HR and CA assuming that changes would occur according to the size of the used areas. We observed energetic costs of space use in the largest European freshwater predator catfish, Silurus glanis, using physiological sensors. Catfish consumed significantly more energy within the CA compared to the rest of the HR area. In addition, energetic costs of space use within a large area were lower. These results generally indicate that utilization of larger areas is related to less demanding activities, such as patrolling and searching for new resources and mates. In contrast, fish occurrence in small areas appears to be related to energetically demanding use of spatially limited resources.	[Slavik, Ondrej; Horky, Pavel; Zavorka, Libor] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Zavorka, Libor] Univ Gothenburg, Dept Zool, Gothenburg, Sweden	Czech University of Life Sciences Prague; University of Gothenburg	Slavik, O (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic.	oslavik@af.czu.cz	Slavík, Ondrej/A-4732-2013; Horký, Pavel/A-3857-2013; Slavík, Ondřej/P-4253-2019	Horký, Pavel/0000-0002-1738-7753; Slavík, Ondřej/0000-0003-3443-4125	Czech Science Foundation [13-05872S]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was supported by the Czech Science Foundation (no. 13-05872S), www.gacr.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2012, J ZOOL, V287, P250, DOI 10.1111/j.1469-7998.2012.00911.x; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; BRADBURY C, 1995, CAN J ZOOL, V73, P1268, DOI 10.1139/z95-151; Buskirk S, 2004, SCIENCE, V306, P238, DOI 10.1126/science.1104480; Carfagno GLF, 2008, J ANIM ECOL, V77, P416, DOI 10.1111/j.1365-2656.2008.01342.x; Carol J, 2007, ECOL FRESHW FISH, V16, P450, DOI 10.1111/j.1600-0633.2007.00225.x; Chilton EW, 1997, T AM FISH SOC, V126, P467, DOI 10.1577/1548-8659(1997)126<0467:DAMBOR>2.3.CO;2; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2004, FISH FISH, V5, P21, DOI 10.1111/j.1467-2960.2004.00136.x; Cooke SJ, 2002, CAN J ZOOL, V80, P756, DOI 10.1139/Z02-048; Cooke SJ, 2000, AQUAC RES, V31, P495, DOI 10.1046/j.1365-2109.2000.00470.x; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; HARESTAD AS, 1979, ECOLOGY, V60, P389, DOI 10.2307/1937667; Hawkins LA, 2005, FUNCT ECOL, V19, P794, DOI 10.1111/j.1365-2435.2005.01039.x; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kaseloo PA, 1996, J FISH BIOL, V48, P664, DOI 10.1111/j.1095-8649.1996.tb01462.x; KAUFMANN JOHN H., 1962, UNIV CALIF PUBL ZOOL, V60, P95; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Kelt DA, 1999, ECOLOGY, V80, P337; Krause J, 2002, LIVING GROUPS; Mace G.M., 1983, P32; Marable MK, 2012, BEHAV PROCESS, V91, P119, DOI 10.1016/j.beproc.2012.06.006; Plowman BW, 2006, AM MIDL NAT, V156, P386, DOI 10.1674/0003-0031(2006)156[386:ADOBLR]2.0.CO;2; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; SEAMAN DE, 1990, INT C BEAR, V8, P243; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Slavik O, 2007, J FISH BIOL, V71, P101, DOI 10.1111/j.1095-8649.2007.01471.x; Slavik O, 2012, J FISH BIOL, V81, P2223, DOI 10.1111/j.1095-8649.2012.03436.x; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Slavik O, 2009, ECOL FRESHW FISH, V18, P501, DOI 10.1111/j.1600-0633.2009.00370.x; Stone PA, 2002, J HERPETOL, V36, P427, DOI 10.1670/0022-1511(2002)036[0427:ELHRTR]2.0.CO;2; SWIHART RK, 1985, ECOLOGY, V66, P1176, DOI 10.2307/1939170; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thompson ME, 2007, ANIM BEHAV, V73, P501, DOI 10.1016/j.anbehav.2006.09.007; Vander Wal E, 2012, ECOL MODEL, V224, P48, DOI 10.1016/j.ecolmodel.2011.10.006; White G.C., 1990, ANAL WILDLIFE RADIO; [No title captured]; [No title captured]; [No title captured]; [No title captured]	50	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98997	10.1371/journal.pone.0098997	http://dx.doi.org/10.1371/journal.pone.0098997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896256	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700106
J	Tual-Chalot, S; Mahmoud, M; Allinson, KR; Redgrave, RE; Zhai, ZH; Oh, SP; Fruttiger, M; Arthur, HM				Tual-Chalot, Simon; Mahmoud, Marwa; Allinson, Kathleen R.; Redgrave, Rachael E.; Zhai, Zhenhua; Oh, S. Paul; Fruttiger, Marcus; Arthur, Helen M.			Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; RECEPTOR-LIKE KINASE-1; CELL PROLIFERATION; VESSEL MATURATION; ALK1; BMP9; NOTCH; ANGIOGENESIS; PROTEIN; GENE	Rare inherited cardiovascular diseases are frequently caused by mutations in genes that are essential for the formation and/ or function of the cardiovasculature. Hereditary Haemorrhagic Telangiectasia is a familial disease of this type. The majority of patients carry mutations in either Endoglin (ENG) or ACVRL1 (also known as ALK1) genes, and the disease is characterized by arteriovenous malformations and persistent haemorrhage. ENG and ACVRL1 encode receptors for the TGF beta superfamily of ligands, that are essential for angiogenesis in early development but their roles are not fully understood. Our goal was to examine the role of Acvrl1 in vascular endothelial cells during vascular development and to determine whether loss of endothelial Acvrl1 leads to arteriovenous malformations. Acvrl1 was depleted in endothelial cells either in early postnatal life or in adult mice. Using the neonatal retinal plexus to examine angiogenesis, we observed that loss of endothelial Acvrl1 led to venous enlargement, vascular hyperbranching and arteriovenous malformations. These phenotypes were associated with loss of arterial Jag1 expression, decreased pSmad1/5/8 activity and increased endothelial cell proliferation. We found that Endoglin was markedly down-regulated in Acvrl1-depleted ECs showing endoglin expression to be downstream of Acvrl1 signalling in vivo. Endothelial-specific depletion of Acvrl1 in pups also led to pulmonary haemorrhage, but in adult mice resulted in caecal haemorrhage and fatal anaemia. We conclude that during development, endothelial Acvrl1 plays an essential role to regulate endothelial cell proliferation and arterial identity during angiogenesis, whilst in adult life endothelial Acvrl1 is required to maintain vascular integrity.	[Tual-Chalot, Simon; Mahmoud, Marwa; Allinson, Kathleen R.; Redgrave, Rachael E.; Zhai, Zhenhua; Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oh, S. Paul] Univ Florida, Dept Physiol, Gainesville, FL USA; [Fruttiger, Marcus] Inst Opthalmol, UCL, London, England	Newcastle University - UK; State University System of Florida; University of Florida; University of London; University College London	Arthur, HM (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	helen.arthur@ncl.ac.uk	Zhai, Zhen/GYA-1598-2022; Arthur, Helen/C-7808-2009	Arthur, Helen/0000-0001-6522-1363; Tual-Chalot, Simon/0000-0002-9307-7175; Mahmoud, Marwa/0000-0003-4382-1725; Fruttiger, Marcus/0000-0002-6962-5485	Wellcome Trust; British Heart Foundation; National Institutes of Health [HL64024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064024] Funding Source: NIH RePORTER; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	This study was supported by funding from the Wellcome Trust, the British Heart Foundation and National Institutes of Health grant HL64024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2000, HUM MOL GENET, V9, P1227, DOI 10.1093/hmg/9.8.1227; Allinson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039336; Alt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029948; Bautch VL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006452; BRANT AM, 1989, AM J OPHTHALMOL, V107, P642, DOI 10.1016/0002-9394(89)90261-4; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen WQ, 2014, STROKE, V45, P900, DOI 10.1161/STROKEAHA.113.003655; Chen WQ, 2013, ARTERIOSCL THROM VAS, V33, P305, DOI 10.1161/ATVBAHA.112.300485; Corti P, 2011, DEVELOPMENT, V138, P1573, DOI 10.1242/dev.060467; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gonzalez-Nunez M, 2013, BBA-MOL BASIS DIS, V1832, P1492, DOI 10.1016/j.bbadis.2013.05.016; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krebs LT, 2010, GENESIS, V48, P146, DOI 10.1002/dvg.20599; Krueger J, 2011, DEVELOPMENT, V138, P2111, DOI 10.1242/dev.063933; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lebrin F, 2010, NAT MED, V16, P420, DOI 10.1038/nm.2131; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Mahmoud M, 2009, LAB INVEST, V89, P15, DOI 10.1038/labinvest.2008.112; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald J, 2005, HAEMATOLOGICA, V90, P728; Morikawa M, 2011, NUCLEIC ACIDS RES, V39, P8712, DOI 10.1093/nar/gkr572; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Murphy PA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002670; Niessen K, 2010, BLOOD, V115, P1654, DOI 10.1182/blood-2009-07-235655; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Park SO, 2009, J CLIN INVEST, V119, P3487, DOI 10.1172/JCI39482; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Roman BL, 2002, DEVELOPMENT, V129, P3009; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Siddiki H, 2008, RADIOGRAPHICS, V28, P171, DOI 10.1148/rg.281075037; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; VASE I, 1979, ACTA OPHTHALMOL, V57, P1084; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Young K, 2012, BLOOD, V120, P4263, DOI 10.1182/blood-2012-07-440784	54	76	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98646	10.1371/journal.pone.0098646	http://dx.doi.org/10.1371/journal.pone.0098646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896812	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700059
J	Pugh, TJ; Yu, W; Yang, J; Field, AL; Ambrogio, L; Carter, SL; Cibulskis, K; Giannikopoulos, P; Kiezun, A; Kim, J; McKenna, A; Nickerson, E; Getz, G; Hoffher, S; Messinger, YH; Dehner, LP; Roberts, CWM; Rodriguez-Galindo, C; Williams, GM; Rossi, CT; Meyerson, M; Hill, DA				Pugh, T. J.; Yu, W.; Yang, J.; Field, A. L.; Ambrogio, L.; Carter, S. L.; Cibulskis, K.; Giannikopoulos, P.; Kiezun, A.; Kim, J.; McKenna, A.; Nickerson, E.; Getz, G.; Hoffher, S.; Messinger, Y. H.; Dehner, L. P.; Roberts, C. W. M.; Rodriguez-Galindo, C.; Williams, G. M.; Rossi, C. T.; Meyerson, M.; Hill, D. A.			Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences	ONCOGENE			English	Article							COPY-NUMBER ALTERATION; EMBRYONAL RHABDOMYOSARCOMA; MUTATIONS; CANCER; TUMORS	Pleuropulmonary blastoma is a rare childhood malignancy of lung mesenchymal cells that can remain dormant as epithelial cysts or progress to high-grade sarcoma. Predisposing germline loss-of-function DICER1 variants have been described. We sought to uncover additional contributors through whole exome sequencing of 15 tumor/normal pairs, followed by targeted resequencing, miRNA analysis and immunohistochemical analysis of additional tumors. In addition to frequent biallelic loss of TP53 and mutations of NRAS or BRAF in some cases, each case had compound disruption of DICER1: a germline (12 cases) or somatic (3 cases) loss-of-function variant plus a somatic missense mutation in the RNase IIIb domain. 5p-Derived microRNA (miRNA) transcripts retained abnormal precursor miRNA loop sequences normally removed by DICER1. This work both defines a genetic interaction landscape with DICER1 mutation and provides evidence for alteration in miRNA transcripts as a consequence of DICER1 disruption in cancer.	[Pugh, T. J.; Ambrogio, L.; Carter, S. L.; Cibulskis, K.; Giannikopoulos, P.; Kiezun, A.; Kim, J.; McKenna, A.; Nickerson, E.; Getz, G.; Meyerson, M.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Pugh, T. J.; Roberts, C. W. M.; Rodriguez-Galindo, C.; Meyerson, M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Pugh, T. J.; Roberts, C. W. M.; Rodriguez-Galindo, C.; Meyerson, M.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Yu, W.; Yang, J.; Field, A. L.; Hoffher, S.; Rossi, C. T.; Hill, D. A.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA; [Yu, W.; Yang, J.; Field, A. L.; Hoffher, S.; Hill, D. A.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Yu, W.; Yang, J.; Field, A. L.; Hoffher, S.; Hill, D. A.] Childrens Natl Med Ctr, Dept Pathol, Washington, DC 20010 USA; [Messinger, Y. H.; Williams, G. M.] Childrens Hosp, Minneapolis, MN USA; [Messinger, Y. H.; Williams, G. M.] Clin Minnesota, Minneapolis, MN USA; [Dehner, L. P.] Washington Univ, Med Ctr, Dept Pathol & Immunol, St Louis, MO USA; [Roberts, C. W. M.; Rodriguez-Galindo, C.] Boston Childrens Hosp, Boston, MA USA; [Roberts, C. W. M.; Rodriguez-Galindo, C.] Dana Farber Childrens Canc Ctr, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; George Washington University; Children's National Health System; Children's National Health System; Children's Hospitals & Clinics of Minnesota; Washington University (WUSTL); Harvard University; Boston Children's Hospital	Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 450 Brookline Ave,Mailstop Dana 1540, Boston, MA 02215 USA.	matthew_meyerson@dfci.harvard.edu; dashill@childrensnational.org	Rodriguez-Galindo, Carlos/N-8071-2018; Cibulskis, Kristian/AAC-7380-2019; Pugh, Trevor/Y-2535-2019; Roberts, Charles/N-2541-2018	Pugh, Trevor/0000-0002-8073-5888; Roberts, Charles/0000-0003-1135-1896; Meyerson, Matthew/0000-0002-9133-8108; Cibulskis, Kristian/0000-0003-1343-1582; Kiezun, Adam/0000-0002-6634-1073	Carlos Slim Health Institute in Mexico; Canadian Institutes of Health Research Fellowship; National Cancer Institute [R01CA143167]; National Heart, Lung and Blood Institute [R01HL109265, R01HL111190]; NATIONAL CANCER INSTITUTE [R01CA143167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111190, R01HL109265] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Sequence data used for this analysis are available from dbGaP under accession phs000543. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. We would like to acknowledge the technical expertise and data generation efforts of The Broad Institute Genomics Platform and Cancer Genome Analysis group. TJP was supported by a Canadian Institutes of Health Research Fellowship. DAH is supported by National Cancer Institute (R01CA143167), and National Heart, Lung and Blood Institute (R01HL109265 and R01HL111190). We thank the members of the Ogawa Laboratory for shared insights during reporting of genomic findings of PPB.<SUP>34</SUP>	Anglesio MS, 2013, J PATHOL, V229, P400, DOI 10.1002/path.4135; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Dehner LP, 2012, MODERN PATHOL, V25, P602, DOI 10.1038/modpathol.2011.185; Doros L, 2012, PEDIATR BLOOD CANCER, V59, P558, DOI 10.1002/pbc.24020; Doros LA, 2014, MODERN PATHOL, V27, P1267, DOI 10.1038/modpathol.2013.242; Eisenhardt AE, 2011, INT J CANCER, V129, P2297, DOI 10.1002/ijc.25893; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foulkes WD, 2011, HUM MUTAT, V32, P1381, DOI 10.1002/humu.21600; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Frio TR, 2011, JAMA-J AM MED ASSOC, V305, P68, DOI 10.1001/jama.2010.1910; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gurtan AM, 2012, RNA, V18, P1116, DOI 10.1261/rna.032680.112; Heravi-Moussavi A, 2012, NEW ENGL J MED, V366, P234, DOI 10.1056/NEJMoa1102903; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hill DA, 2008, AM J SURG PATHOL, V32, P282, DOI 10.1097/PAS.0b013e3181484165; Hou P, 2007, CELL CYCLE, V6, P377, DOI 10.4161/cc.6.3.3818; Lawrence MS, 2013, NATURE; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schultz KAP, 2011, GYNECOL ONCOL, V122, P246, DOI 10.1016/j.ygyno.2011.03.024; Seki M, 2014, CANCER RES, V74, P2742, DOI 10.1158/0008-5472.CAN-13-2470; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002	34	92	93	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 6	2014	33	45					5295	5302		10.1038/onc.2014.150	http://dx.doi.org/10.1038/onc.2014.150			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MD	24909177	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000345120400007
J	Isaji, T; Im, S; Gu, W; Wang, YQ; Hang, QL; Lu, JS; Fukuda, T; Hashii, N; Takakura, D; Kawasaki, N; Miyoshi, H; Gu, JG				Isaji, Tomoya; Im, Sanghun; Gu, Wei; Wang, Yuqin; Hang, Qinglei; Lu, Jishun; Fukuda, Tomohiko; Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana; Miyoshi, Hiroyuki; Gu, Jianguo			An Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; BETA-PROPELLER DOMAIN; HUMAN COLON-CANCER; I-LIKE DOMAIN; INCREASED EXPRESSION; SAMBUCUS-NIGRA; BREAST-CANCER; GLYCOSYLATION; SIALYLTRANSFERASE; BINDING	Recently, the Golgi phosphoprotein 3 (GOLPH3) and its yeast homolog Vps74p have been characterized as essential for the Golgi localization of glycosyltransferase in yeast. GOLPH3 has been identified as a new oncogene that is commonly amplified in human cancers to modulate mammalian target of rapamycin signaling. However, the molecular mechanisms of the carcinogenic signaling pathway remain largely unclear. To investigate whether the expression of GOLPH3 was involved in the glycosylation processes in mammalian cells, and whether it affected cell behavior, we performed a loss-of-function study. Cell migration was suppressed in GOLPH3 knockdown (KD) cells, and the suppression was restored by a re-introduction of the GOLPH3 gene. HPLC and LC/MS analysis showed that the sialylation of N-glycans was specifically decreased in KD cells. The specific interaction between sialyltransferases and GOLPH3 was important for the sialylation. Furthermore, overexpression of alpha 2,6-sialyltransferase-I rescued cell migration and cellular signaling, both of which were blocked in GOLPH3 knockdown cells. These results are the first direct demonstration of the role of GOLPH3 in N-glycosylation to regulate cell biological functions.	[Isaji, Tomoya; Im, Sanghun; Gu, Wei; Wang, Yuqin; Hang, Qinglei; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Hashii, Noritaka; Takakura, Daisuke; Kawasaki, Nana] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1580098, Japan; [Miyoshi, Hiroyuki] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan	Tohoku Medical & Pharmaceutical University; National Institute of Health Sciences - Japan; RIKEN	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Hang, Qinglei/GOP-0218-2022; Isaji, Tomoya/ABC-9285-2021; Miyoshi, Hiroyuki/G-9808-2013; Gu, Jianguo/ABC-9257-2020	Hang, Qinglei/0000-0003-0419-6621; 	Japan Society for the Promotion of Science [21370059, 24570169, 23651196]; Scientific Research on Innovative Areas [23110002]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research [24570169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 21370059 (to J. G.) and 24570169 (to T. I.), Challenging Exploratory Research 23651196 (to J. G.) from the Japan Society for the Promotion of Science, Grants from the Scientific Research on Innovative Areas 23110002 (to J. G.), the Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and The Mizutani Foundation for Glycoscience.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Asada M, 1997, CANCER RES, V57, P1073; Chen CL, 2002, EUR J GYNAECOL ONCOL, V23, P514; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chiricolo M, 2006, GLYCOBIOLOGY, V16, P146, DOI 10.1093/glycob/cwj045; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2000, INT J CANCER, V88, P58, DOI 10.1002/1097-0215(20001001)88:1<58::AID-IJC9>3.0.CO;2-Q; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; DWIVEDI C, 1988, CANCER DETECT PREV, V11, P191; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kawasaki N, 2009, BIOL PHARM BULL, V32, P796, DOI 10.1248/bpb.32.796; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; LEMARER N, 1992, GLYCOBIOLOGY, V2, P49, DOI 10.1093/glycob/2.1.49; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Nakagawa H, 1996, EUR J BIOCHEM, V237, P76, DOI 10.1111/j.1432-1033.1996.0076n.x; Pan D, 2010, BIOPHYS J, V99, P208, DOI 10.1016/j.bpj.2010.03.063; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Recchi MA, 1998, GLYCOCONJUGATE J, V15, P19, DOI 10.1023/A:1006983214918; SATA T, 1991, AM J PATHOL, V139, P1435; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Tu LN, 2012, TRAFFIC, V13, P1496, DOI 10.1111/j.1600-0854.2012.01403.x; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wang Peng-Hui, 2007, J Chin Med Assoc, V70, P152; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Xu QS, 2012, J BIOL CHEM, V287, P16563, DOI 10.1074/jbc.M111.262154; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9	54	61	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20694	20705		10.1074/jbc.M113.542688	http://dx.doi.org/10.1074/jbc.M113.542688			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24895123	hybrid, Green Published			2022-12-25	WOS:000339396600027
J	Wu, KY; Ren, RT; Su, WT; Wen, B; Zhang, YY; Yi, F; Qiao, XH; Yuan, TT; Wang, JH; Liu, LM; Belmonte, JCI; Liu, GH; Chen, C				Wu, Kaiyuan; Ren, Ruotong; Su, Wenting; Wen, Bo; Zhang, Yuying; Yi, Fei; Qiao, Xinhua; Yuan, Tingting; Wang, Jinhui; Liu, Limin; Belmonte, Juan Carlos Izpisua; Liu, Guang-Hui; Chen, Chang			A Novel Suppressive Effect of Alcohol Dehydrogenase 5 in Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; CLASS-III; CELLS; NITROSYLATION; EXPRESSION; ADH; NITROSOTHIOLS; NEUROGENESIS; ROLES; BRAIN	Alcohol dehydrogenase 5 (ADH5) is a conserved enzyme for alcohol and aldehyde metabolism in mammals. Despite dynamic expression throughout neurogenesis, its role in neuronal development remains unknown. Here we present the first evidence that ADH5 is a negative regulator of neuronal differentiation. Gene expression analyses identify a constant reduction of ADH5 levels throughout neuronal development. Overexpression of ADH5 reduces both development and adult neuronal differentiation of mouse neurons. This effect depends on the catalytic activity of ADH5 and involves ADH5-mediated denitrosation of histone deacetylase 2 (HDAC2). Our results indicate that ADH5 counteracts neuronal differentiation of human neural stem cells and that this effect can be reversed by pharmacological inhibition of ADH5. Based on these observations, we propose that ADH5 is a novel suppressor of neuronal differentiation and maturation. Inhibition of ADH5 may improve adult neurogenesis in a physiological or pathological setting.	[Wu, Kaiyuan; Ren, Ruotong; Su, Wenting; Wen, Bo; Zhang, Yuying; Qiao, Xinhua; Yuan, Tingting; Wang, Jinhui; Liu, Guang-Hui; Chen, Chang] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Yi, Fei; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liu, Limin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Liu, Guang-Hui; Chen, Chang] Beijing Inst Brain Disorders, Beijing 100069, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Salk Institute; University of California System; University of California San Francisco	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu; ghliu@ibp.ac.cn; changchen@moon.ibp.ac.cn	wu, kaiyuan/AAD-6635-2020; Ren, Ruotong/AAF-4046-2020	wu, kaiyuan/0000-0001-7395-4524; chen, chang/0000-0003-1008-1062	National Basic Research Program of China (973 Program) [2012CB911000, 2011CB503900, 2011CB910900, 2014CB964600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020312]; National Natural Sciences Foundation of China [31225012, 31030023, 81271266, 31222039, 81330008, 81300677, 31201111]; Beijing Natural Science Foundation [7141005]; Thousand Young Talents program of China; National Laboratory of Biomacromolecules [2013kf05, 2013kf1, 2014kf02]; State Key Laboratory of Drug Research [SIMM1302KF-17]; G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Thousand Young Talents program of China(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; State Key Laboratory of Drug Research; G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust	This work was supported by the National Basic Research Program of China (973 Program: Grants 2012CB911000, 2011CB503900, 2011CB910900, and 2014CB964600), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant XDA01020312), the National Natural Sciences Foundation of China (Grants 31225012, 31030023, 81271266, 31222039, 81330008, 81300677, and 31201111), the Beijing Natural Science Foundation (Grant 7141005), the Thousand Young Talents program of China, National Laboratory of Biomacromolecules (Grants 2013kf05, 2013kf1, and 2014kf02), and the State Key Laboratory of Drug Research (Grant SIMM1302KF-17).; Supported by the G. Harold and Leila Y. Mathers Charitable Foundation and The Leona M. and Harry B. Helmsley Charitable Trust. To whom correspondence may be addressed: Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., La Jolla, CA 92037. E-mail: belmonte@salk.edu.	Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; BEISSWENGER TB, 1985, P NATL ACAD SCI USA, V82, P8369, DOI 10.1073/pnas.82.24.8369; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; ENGELAND K, 1993, P NATL ACAD SCI USA, V90, P2491, DOI 10.1073/pnas.90.6.2491; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; He J, 2007, J NEUROCHEM, V102, P1863, DOI 10.1111/j.1471-4159.2007.04651.x; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Huang B, 2010, FREE RADICAL BIO MED, V49, P447, DOI 10.1016/j.freeradbiomed.2010.05.001; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Kawabe H, 2011, NAT REV NEUROSCI, V12, P251, DOI 10.1038/nrn3009; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Nott A, 2013, P NATL ACAD SCI USA, V110, P3113, DOI 10.1073/pnas.1218126110; Parsch J, 2000, GENETICS, V156, P219; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Sarthy V, 2007, NEUROSCIENCE, V144, P1087, DOI 10.1016/j.neuroscience.2006.09.061; SHOLL DA, 1953, J ANAT, V87, P387; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Westerlund M, 2005, CELL TISSUE RES, V322, P227, DOI 10.1007/s00441-005-0038-7; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yang ZY, 2010, J IMMUNOL, V185, P6664, DOI 10.4049/jimmunol.1000080	30	16	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20193	20199		10.1074/jbc.C114.561860	http://dx.doi.org/10.1074/jbc.C114.561860			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895131	hybrid, Green Published			2022-12-25	WOS:000339395200032
J	Awan, TH; Chauhan, BS; Cruz, PCS				Awan, Tahir Hussain; Chauhan, Bhagirath Singh; Cruz, Pompe C. Sta.			Physiological and Morphological Responses of Ischaemum rugosum Salisb. (Wrinkled Grass) to Different Nitrogen Rates and Rice Seeding Rates	PLOS ONE			English	Article							GROWTH; FERTILIZATION; COMPETITION; MANAGEMENT; LIGHT; RATIO	Ischaemum rugosum is a competitive weed in direct-seeded rice systems. Developing integrated weed management strategies that promote the suppression of weeds by crop density, cultivar selection, and nutrition requires better understanding of the extent to which rice interferes with the growth of this weed and how it responds to resource limitation due to rice interference. The growth of I. rugosum was studied when grown with four rice seeding rates (0, 50, and 100 kg ha(-1)) and four nitrogen (N) rates (0, 50, 100, and 150 kg ha(-1)). Compared to the weed plants grown alone, weed tiller number was reduced by 63-80%, leaf number by 68-77%, leaf area by 69-77%, leaf biomass by 72-84%, and inflorescence biomass by 81-93% at the rice seeding rates of-5-100 kg ha(-1). All these parameters increased with increasing rates of N from 0 to 150 kg ha(-1). At weed maturity, I. rugosum plants were 100% taller than rice at 0 kg N ha(-1), whereas, with added N, the weeds were only 50% taller than rice. Weed biomass increased by 82-160%, whereas rice biomass increased by 92-229%, with the application of 50-150 kg N ha(-1). Added N favored rice biomass production more than it did the weed. Rice interference reduced the height and biomass of I. rugosum, but did not suppress its growth completely. I. rugosum showed the ability to reduce the effects of rice interference by increasing leaf area, leaf weight ratio, and specific leaf area, and by decreasing the root-shoot weight ratio in comparison to the weed plants grown alone. The results suggest that rice crop interference alone may reduce I. rugosum growth but may not provide complete control of this weed. The need for integrated weed management practices to effectively control this weed species is highlighted.	[Awan, Tahir Hussain; Chauhan, Bhagirath Singh] Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines; [Cruz, Pompe C. Sta.] Univ Philippines, Coll Agr, Crop Sci Cluster, Dept Agron, Los Banos, Philippines	CGIAR; International Rice Research Institute (IRRI); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Awan, TH (corresponding author), Int Rice Res Inst, Weed Sci Crop & Environm Sci Div, Los Banos, Philippines.	t.awan@irri.org	Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668				AMPONGNYARKO K, 1993, WEED RES, V33, P269, DOI 10.1111/j.1365-3180.1993.tb01941.x; Andersson TN, 1999, WEED SCI, V47, P47, DOI 10.1017/S0043174500090640; Baki Haji Bakar, 2003, Weed Biology and Management, V3, P8, DOI 10.1046/j.1445-6664.2003.00075.x; Blackshaw RE, 2003, WEED SCI, V51, P532, DOI 10.1614/0043-1745(2003)051[0532:DROWST]2.0.CO;2; Bonifas KD, 2005, WEED SCI, V53, P670, DOI 10.1614/WS-05-002R.1; Buhler DD, 2000, WEED SCI, V48, P274, DOI 10.1614/0043-1745(2000)048[0274:TAPCTA]2.0.CO;2; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Chauhan BS, 2012, ADV AGRON, V117, P315, DOI 10.1016/B978-0-12-394278-4.00007-6; Chauhan BS, 2012, WEED TECHNOL, V26, P1, DOI 10.1614/WT-D-11-00105.1; Chauhan BS, 2013, CROP PROT, V54, P142, DOI 10.1016/j.cropro.2013.08.005; Evans SP, 2003, WEED SCI, V51, P408, DOI 10.1614/0043-1745(2003)051[0408:NAITCP]2.0.CO;2; Gibson KD, 2004, WEED SCI, V52, P271, DOI 10.1614/WS-03-103R; Gibson KD, 2001, WEED RES, V41, P59, DOI 10.1046/j.1365-3180.2001.00223.x; Holm L. G., 1977, WORLDS WORST WEEDS D; Itoh K., 1991, LIFE CYCLES RICE FIE, P55; Jornsgard B, 1996, WEED RES, V36, P461, DOI 10.1111/j.1365-3180.1996.tb01675.x; Knops JMH, 2000, AM MIDL NAT, V144, P265, DOI 10.1674/0003-0031(2000)144[0265:SLAAAN]2.0.CO;2; Liebman M., 1990, Sustainable agriculture in temperate zones., P111; Lubigan RT, 1989, INT RICE RES NEWSL, V14, P49; Mahajan G, 2013, FIELD CROP RES, V144, P89, DOI 10.1016/j.fcr.2013.01.008; Marenco Ricardo A., 1998, Revista Brasileira de Fisiologia Vegetal, V10, P107; Mishra J. S., 2001, Indian Journal of Plant Physiology, V6, P386; Phuong LT, 2005, J AGRON CROP SCI, V191, P185, DOI 10.1111/j.1439-037X.2005.00151.x; Ponce RG, 1998, WEED RES, V38, P453, DOI 10.1046/j.1365-3180.1998.00116.x; Reynolds HL, 1996, PLANT SOIL, V185, P75, DOI 10.1007/BF02257566; Shafagh-Kolvanagh J, 2008, J FOOD AGRIC ENVIRON, V6, P368; TERASHIMA I, 1988, PLANT CELL PHYSIOL, V29, P143; Valverde BE, 2007, WEED TECHNOL, V21, P310, DOI 10.1614/WT-06-097.1; Vourlitis GL, 2013, WEED SCI, V61, P117, DOI 10.1614/WS-D-11-00220.1; Zhao D., 2006, THESIS WAGENINGEN U	30	20	21	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98255	10.1371/journal.pone.0098255	http://dx.doi.org/10.1371/journal.pone.0098255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910995	Green Published, gold, Green Submitted			2022-12-25	WOS:000337165600130
J	Bocksteins, E; Mayeur, E; Van Tilborg, A; Regnier, G; Timmermans, JP; Snyders, DJ				Bocksteins, Elke; Mayeur, Evy; Van Tilborg, Abbi; Regnier, Glenn; Timmermans, Jean-Pierre; Snyders, Dirk J.			The Subfamily-Specific Interaction between Kv2.1 and Kv6.4 Subunits Is Determined by Interactions between the N- and C-termini	PLOS ONE			English	Article							CHANNEL ALPHA-SUBUNITS; POTASSIUM CHANNEL; TETRAMERIZATION DOMAIN; CRYSTAL-STRUCTURE; T1 DOMAIN; ACTIVATION	The ``silent'' voltage-gated potassium (KvS) channel subunit Kv6.4 does not form electrically functional homotetramers at the plasma membrane but assembles with Kv2.1 subunits, generating functional Kv2.1/Kv6.4 heterotetramers. The N-terminal T1 domain determines the subfamily-specific assembly of Kv1-4 subunits by preventing interactions between subunits that belong to different subfamilies. For Kv6.4, yeast-two-hybrid experiments showed an interaction of the Kv6.4 N-terminus with the Kv2.1 N-terminus, but unexpectedly also with the Kv3.1 N-terminus. We confirmed this interaction by Fluorescence Resonance Energy Transfer (FRET) and co-immunoprecipitation (co-IP) using N-terminal Kv3.1 and Kv6.4 fragments. However, full-length Kv3.1 and Kv6.4 subunits do not form heterotetramers at the plasma membrane. Therefore, additional interactions between the Kv6.4 and Kv2.1 subunits should be important in the Kv2.1/Kv6.4 subfamily-specificity. Using FRET and co-IP approaches with N-and C-terminal fragments we observed that the Kv6.4 C-terminus physically interacts with the Kv2.1 N-terminus but not with the Kv3.1 N-terminus. The N-terminal amino acid sequence CDD which is conserved between Kv2 and KvS subunits appeared to be a key determinant since charge reversals with arginine substitutions abolished the interaction between the N-terminus of Kv2.1 and the C-terminus of both Kv2.1 and Kv6.4. In addition, the Kv6.4(CKv3.1) chimera in which the C-terminus of Kv6.4 was replaced by the corresponding domain of Kv3.1, disrupted the assembly with Kv2.1. These results indicate that the subfamily-specific Kv2.1/Kv6.4 heterotetramerization is determined by interactions between Kv2.1 and Kv6.4 that involve both the N-and C-termini in which the conserved N-terminal CDD sequence plays a key role.	[Bocksteins, Elke; Mayeur, Evy; Van Tilborg, Abbi; Regnier, Glenn; Snyders, Dirk J.] Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2020 Antwerp, Belgium; [Timmermans, Jean-Pierre] Univ Antwerp, Dept Vet Sci, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Snyders, DJ (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2020 Antwerp, Belgium.	dirk.snyders@uantwerpen.be	Snyders, Dirk/A-2713-2013	Snyders, Dirk/0000-0001-7142-6672; Timmermans, Jean-Pierre/0000-0003-2506-6252	Research Foundation - Flanders (FWO); FWO [G.0449.11N]	Research Foundation - Flanders (FWO)(FWO); FWO(FWO)	This work was supported by a postdoctoral fellowship of the Research Foundation - Flanders (FWO) to EB and the FWO research grant G.0449.11N to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley GN, 1999, BBA-BIOMEMBRANES, V1418, P176, DOI 10.1016/S0005-2736(99)00021-8; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Stocker M, 1999, J NEUROCHEM, V72, P1725, DOI 10.1046/j.1471-4159.1999.721725.x; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	31	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98960	10.1371/journal.pone.0098960	http://dx.doi.org/10.1371/journal.pone.0098960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901643	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400079
J	Borisow, N; Paul, F; Ohlraun, S; Pach, D; Fischer, F; Dorr, J				Borisow, Nadja; Paul, Friedemann; Ohlraun, Stephanie; Pach, Daniel; Fischer, Felix; Doerr, Jan			Pregnancy in Multiple Sclerosis: A Questionnaire Study	PLOS ONE			English	Article							DISEASE-MODIFYING DRUGS; SEXUAL DYSFUNCTION; WOMEN; OUTCOMES; DELIVERY; EXPOSURE; CORTICOSTEROIDS; EPIDEMIOLOGY; METAANALYSIS; ISSUES	Background: Multiple sclerosis (MS) preferentially affects females at childbearing age. For this reason patients and treating physicians were frequently confronted with questions concerning family planning, pregnancy and birth. Objective: The aim of this study was to evaluate the expertise about pregnancy related topics in multiple sclerosis of neurologists in private practice. Methods: We developed a survey with 16 multiple choice questions about pregnancy related topics and sent it to neurologists in private practice in Berlin, Germany. Results: 56 completed questionnaires were sent back. 54% of all questions were answered correctly, 21% of the questions were answered with ``I don't know''. Correct answers were more often given by physicians who treat more than 400 MS patients per year (p = 0.001). Further positive associations were found for assumed relevance of the topic (p = 0.002) and the degree of counseling (p<0.001). Conclusion: To provide a comprehensive counseling, MS patients with desire for children should be counseled by physicians with a lot of experience in MS treatment.	[Borisow, Nadja; Paul, Friedemann; Ohlraun, Stephanie; Doerr, Jan] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Borisow, Nadja; Paul, Friedemann; Doerr, Jan] Charite, Dept Neurol, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Pach, Daniel; Fischer, Felix] Charite, Inst Social Med Epidemiol & Hlth Econ Charite, D-13353 Berlin, Germany; [Fischer, Felix] Charite, Clin Internal Med, Dept Psychosomat Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Borisow, N (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	nadja.borisow@charite.de	Paul, Friedemann/ABF-9415-2020; fischer, felix/AAW-6634-2021	fischer, felix/0000-0002-9693-6676; paul, friedemann/0000-0002-6378-0070; Pach, Daniel/0000-0002-2459-6596	Deutsche Forschungsgemeinschaft [DFG Exc. 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by Deutsche Forschungsgemeinschaft (DFG Exc. 257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amato MP, 2010, NEUROLOGY, V75, P1794, DOI 10.1212/WNL.0b013e3181fd62bb; Borisow N, 2012, EPMA J, V3, DOI 10.1186/1878-5085-3-9; Calabro RS, 2014, INT J NEUROSCI, V124, P547, DOI 10.3109/00207454.2013.865183; Celik DB, 2013, J NEUROL SCI, V324, P17, DOI 10.1016/j.jns.2012.08.019; Charles JA, 2013, NEUROLOGY, V80, P1068, DOI 10.1212/01.wnl.0000428359.07207.f6; Chen YH, 2009, MULT SCLER J, V15, P606, DOI 10.1177/1352458508101937; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Coyle PK, 2004, MULT SCLER J, V10, P582, DOI 10.1191/1352458504ms1083oa; Dahl J, 2005, NEUROLOGY, V65, P1961, DOI 10.1212/01.wnl.0000188898.02018.95; Dung Aldrin Anthony Dung, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2013-201273; Ferrero S, 2004, EUR J OBSTET GYN R B, V115, P3, DOI 10.1016/j.ejogrb.2003.10.020; Finkelsztejn A, 2011, BJOG-INT J OBSTET GY, V118, P790, DOI 10.1111/j.1471-0528.2011.02931.x; Gur C, 2004, REPROD TOXICOL, V18, P93, DOI 10.1016/j.reprotox.2003.10.007; Hellwig K, 2011, MULT SCLER J, V17, P958, DOI 10.1177/1352458511401944; Hellwig K, 2011, J NEUROL, V258, P502, DOI 10.1007/s00415-010-5758-2; Hellwig K, 2009, ARCH NEUROL-CHICAGO, V66, P1580, DOI 10.1001/archneurol.2009.281; Hoevenaren IA, 2011, ACTA NEUROL SCAND, V123, P430, DOI 10.1111/j.1600-0404.2010.01426.x; Hovland E J, 1980, J Dent Educ, V44, P270; Jalkanen A, 2010, MULT SCLER J, V16, P950, DOI 10.1177/1352458510372629; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kotzamani D, 2012, NEUROLOGY, V78, P1728, DOI 10.1212/WNL.0b013e31825830a9; Koutsouraki E, 2010, INT REV PSYCHIATR, V22, P2, DOI 10.3109/09540261003589216; Lu E, 2012, NEUROLOGY, V79, P1130, DOI 10.1212/WNL.0b013e3182698c64; McFarlane E, 2007, EVAL HEALTH PROF, V30, P170, DOI 10.1177/0163278707300632; Mueller BA, 2002, AM J OBSTET GYNECOL, V186, P446, DOI 10.1067/mob.2002.120502; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Portaccio E, 2011, NEUROLOGY, V77, P145, DOI 10.1212/WNL.0b013e318224afc9; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Sandberg-Wollheim M, 2011, MULT SCLER J, V17, P423, DOI 10.1177/1352458510394610; SCHAPIRA K, 1966, BRAIN, V89, P419, DOI 10.1093/brain/89.3.419; Trojano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048078; van der Kop ML, 2011, ANN NEUROL, V70, P41, DOI 10.1002/ana.22483; Weber-Schoendorfer C, 2009, MULT SCLER J, V15, P1037, DOI 10.1177/1352458509106543; Zorzon M, 1999, MULT SCLER J, V5, P418, DOI 10.1191/135245899678846456	35	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99106	10.1371/journal.pone.0099106	http://dx.doi.org/10.1371/journal.pone.0099106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901447	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000336841400099
J	Dorneles, EMS; Santana, JA; Ribeiro, D; Dorella, FA; Guimaraes, AS; Moawad, MS; Selim, SA; Garaldi, ALM; Miyoshi, A; Ribeiro, M'RG; Gouveia, AMG; Azevedo, V; Heinemann, MB; Lage, AP				Dorneles, Elaine M. S.; Santana, Jordana A.; Ribeiro, Dayana; Dorella, Fernanda Alves; Guimaraes, Alessandro S.; Moawad, Mohamed S.; Selim, Salah A.; Garaldi, Ana Luiza M.; Miyoshi, Anderson; Ribeiro, Marcio G.; Gouveia, Aurora M. G.; Azevedo, Vasco; Heinemann, Marcos B.; Lage, Andrey P.			Evaluation of ERIC-PCR as Genotyping Method for Corynebacterium pseudotuberculosis Isolates	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CASEOUS-LYMPHADENITIS; MOLECULAR CHARACTERIZATION; NECROTIZING LYMPHADENITIS; TYPING SYSTEMS; SHEEP; INFECTION; PREVALENCE; SAMPLES; CATTLE	The aim of this study was to evaluate the Enterobacterial Repetitive Intergenic Consensus (ERIC-PCR) as a tool for molecular typing of C. pseudotuberculosis isolates from eight different hosts in twelve countries. Ninety-nine C. pseudotuberculosis field strains, one type strain (ATCC 19410(T)) and one vaccine strain (1002) were fingerprinted using the ERIC-1R and ERIC-2 primers, and the ERIC-1R+ERIC-2 primer pair. Twenty-nine different genotypes were generated by ERIC 1-PCR, 28 by ERIC 2-PCR and 35 by ERIC 1+2-PCR. The discriminatory index calculated for ERIC 1, ERIC 2, and ERIC 1+2-PCR was 0.89, 0.86, and 0.92, respectively. Epidemiological concordance was established for all ERIC-PCR assays. ERIC 1+2-PCR was defined as the best method based on suitability of the amplification patterns and discriminatory index. Minimal spanning tree for ERIC 1+2-PCR revealed three major clonal complexes and clustering around nitrate-positive (biovar Equi) and nitrate-negative (biovar Ovis) strains. Therefore, ERIC 1+2-PCR proved to be the best technique evaluated in this study for genotyping C. pseudotuberculosis strains, due to its usefulness for molecular epidemiology investigations.	[Dorneles, Elaine M. S.; Santana, Jordana A.; Gouveia, Aurora M. G.; Heinemann, Marcos B.; Lage, Andrey P.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil; [Ribeiro, Dayana; Dorella, Fernanda Alves; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Guimaraes, Alessandro S.] Empresa Brasileira Pesquisa Agr, Embrapa Gado Leite, Juiz De Fora, Brazil; [Guimaraes, Alessandro S.] Univ Fed Lavras, Dept Vet Med, Lavras, MG, Brazil; [Moawad, Mohamed S.; Selim, Salah A.] Cairo Univ, Dept Toxicol & Forens Med, Cairo, Egypt; [Garaldi, Ana Luiza M.] Univ Estado Rio de Janeiro, Ctr Biomed, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil; [Ribeiro, Marcio G.] Univ Estadual Paulista, Dept Higiene Vet & Saude Publ, Fac Med Vet & Zootecnia, Botucatu, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Lavras; Egyptian Knowledge Bank (EKB); Cairo University; Universidade do Estado do Rio de Janeiro; Universidade Estadual Paulista	Lage, AP (corresponding author), Univ Fed Minas Gerais, Dept Med Vet Prevent, Escola Vet, Belo Horizonte, MG, Brazil.	alage@vet.ufmg.br	Santana, Jordana Almeida/AAV-3972-2020; Azevedo, Vasco A.C/F-4315-2011; Dorneles, Elaine/V-2816-2019; Heinemann, Marcos Bryan/AAI-9390-2020; Dorneles, Elaine/J-1115-2016; Azevedo, Vasco/B-1556-2019; Heinemann, Marcos B/G-2780-2015; Guimaraes, Alessandro/H-3454-2013; Garcia Ribeiro, Márcio/GLV-6457-2022	Santana, Jordana Almeida/0000-0002-0577-887X; Azevedo, Vasco A.C/0000-0002-4775-2280; Dorneles, Elaine/0000-0002-2753-1296; Heinemann, Marcos Bryan/0000-0001-6444-9788; Azevedo, Vasco/0000-0002-4775-2280; Heinemann, Marcos B/0000-0001-6444-9788; Garcia Ribeiro, Márcio/0000-0003-2682-9389	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig; Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - Fapemig and Fundacao de Estudo e Pesquisa em Medicina Veterinaria e Zootecnia - FEP-MVZ. E. M. S. Dorneles, V. Azevedo, A. P. Lage and M. B. Heinemann had fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu SRD, 2008, PESQUI VET BRASIL, V28, P481, DOI 10.1590/S0100-736X2008001000007; Bregenzer Thomas, 1997, Clin Microbiol Infect, V3, P696, DOI 10.1111/j.1469-0691.1997.tb00482.x; Cerdeira LT, 2011, J BACTERIOL, V193, P7025, DOI 10.1128/JB.06293-11; Cerdeira LT, 2011, J BACTERIOL, V193, P6420, DOI 10.1128/JB.06044-11; Connor KM, 2007, VET RES, V38, P613, DOI 10.1051/vetres:2007013; Costa LRR, 1998, VET MICROBIOL, V62, P135, DOI 10.1016/S0378-1135(98)00202-8; Dorneles EMS, 2012, GENET MOL RES, V11, P2051, DOI 10.4238/2012.August.6.9; Estevao Belchior S, 2006, REV VET ARG, V224, P258; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Foley JE, 2004, AM J VET RES, V65, P1734, DOI 10.2460/ajvr.2004.65.1734; Foxman Betsy, 2005, Epidemiol Perspect Innov, V2, P10, DOI 10.1186/1742-5573-2-10; Guimaraes AS, 2009, SMALL RUMINANT RES, V87, P86, DOI 10.1016/j.smallrumres.2009.09.027; Guimaraes AD, 2011, IIOAB J, V2, P33; Guimaraes AS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-68; Guimares AD, 2011, VET MICROBIOL, V153, P299, DOI 10.1016/j.vetmic.2011.06.002; Hassan SS, 2012, J BACTERIOL, V194, P5718, DOI 10.1128/JB.01373-12; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Instituto Brasileiro de Geografia e Estatistica, 2008, DIR PESQ COORD AGR P; Join-Lambert OF, 2006, PEDIATR INFECT DIS J, V25, P848, DOI 10.1097/01.inf.0000234071.93044.77; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Lopes T, 2012, J BACTERIOL, V194, P3567, DOI 10.1128/JB.00461-12; Matthias Gamer, 2012, **DATA OBJECT**; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Paton MW, 2003, AUST VET J, V81, P91, DOI 10.1111/j.1751-0813.2003.tb11443.x; Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185; Pratt SM, 2005, JAVMA-J AM VET MED A, V227, P441, DOI 10.2460/javma.2005.227.441; Ruiz JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018551; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Selim SA, 2001, J VET MED B, V48, P241, DOI 10.1046/j.1439-0450.2001.00451.x; Seyffert N, 2010, RES VET SCI, V88, P50, DOI 10.1016/j.rvsc.2009.07.002; SHPIGEL NY, 1993, VET REC, V133, P89, DOI 10.1136/vr.133.4.89; Siegel, 1975, ESTATISTICA NAOPARAM; Silva A, 2012, J BACTERIOL, V194, P6663, DOI 10.1128/JB.01782-12; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; SONGER JG, 1988, AM J VET RES, V49, P223; Struelens M, 2002, CURR OPIN INFECT DIS, V15, P383, DOI 10.1097/00001432-200208000-00005; Struelens MJ, 1998, MEM I OSWALDO CRUZ, V93, P581, DOI 10.1590/S0074-02761998000500004; Sutherland SS, 1996, VET MICROBIOL, V49, P1, DOI 10.1016/0378-1135(95)00146-8; SUTHERLAND SS, 1993, AUST VET J, V70, P454, DOI 10.1111/j.1751-0813.1993.tb00851.x; Tejedor-Junco MT, 2008, TROP ANIM HEALTH PRO, V40, P165, DOI 10.1007/s11250-007-9077-2; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yeruham I, 1997, VET REC, V140, P423, DOI 10.1136/vr.140.16.423; Yeruham I, 1996, VET QUART, V18, P87, DOI 10.1080/01652176.1996.9694623	45	23	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98758	10.1371/journal.pone.0098758	http://dx.doi.org/10.1371/journal.pone.0098758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901343	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400049
J	Mizushima, R; Kim, JY; Suetake, I; Tanaka, H; Takai, T; Kamiya, N; Takano, Y; Mishima, Y; Tajima, S; Goto, Y; Fukui, K; Lee, YH				Mizushima, Ryota; Kim, Ju Yaen; Suetake, Isao; Tanaka, Hiroaki; Takai, Tomoyo; Kamiya, Narutoshi; Takano, Yu; Mishima, Yuichi; Tajima, Shoji; Goto, Yuji; Fukui, Kenji; Lee, Young-Ho			NMR Characterization of the Interaction of the Endonuclease Domain of MutL with Divalent Metal Ions and ATP	PLOS ONE			English	Article							C-TERMINAL DOMAIN; DNA MISMATCH REPAIR; BINDING; PROTEIN; SITES; ALPHA; MODEL; HYDROLYSIS; REVEALS	MutL is a multi-domain protein comprising an N-terminal ATPase domain (NTD) and C-terminal dimerization domain (CTD), connected with flexible linker regions, that plays a key role in DNA mismatch repair. To expand understanding of the regulation mechanism underlying MutL endonuclease activity, our NMR-based study investigated interactions between the CTD of MutL, derived from the hyperthermophilic bacterium Aquifex aeolicus (aqMutL-CTD), and putative binding molecules. Chemical shift perturbation analysis with the model structure of aqMutL-CTD and circular dichroism results revealed that tight Zn2+ binding increased thermal stability without changing secondary structures to function at high temperatures. Peak intensity analysis exploiting the paramagnetic relaxation enhancement effect indicated the binding site for Mn2+, which shared binding sites for Zn2+. The coexistence of these two metal ions appears to be important for the function of MutL. Chemical shift perturbation analysis revealed a novel ATP binding site in aqMutL-CTD. A docking simulation incorporating the chemical shift perturbation data provided a putative scheme for the intermolecular interactions between aqMutL-CTD and ATP. We proposed a simple and understandable mechanical model for the regulation of MutL endonuclease activity in MMR based on the relative concentrations of ATP and CTD through ATP binding-regulated interdomain interactions between CTD and NTD.	[Mizushima, Ryota; Kim, Ju Yaen; Suetake, Isao; Tanaka, Hiroaki; Takai, Tomoyo; Kamiya, Narutoshi; Takano, Yu; Mishima, Yuichi; Tajima, Shoji; Goto, Yuji; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Fukui, Kenji] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo, Japan	Osaka University; RIKEN	Lee, YH (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	mr0505@protein.osaka-u.ac.jp	Takano, Yu/H-1785-2014; Mizushima, Ryota/AAL-2503-2020; Kamiya, Narutoshi/C-4548-2016; Suetake, Isao/D-4326-2009; Suetake, Isao/G-3144-2013	Takano, Yu/0000-0002-4165-8672; Mizushima, Ryota/0000-0001-6375-9944; Kamiya, Narutoshi/0000-0002-0527-6968; Suetake, Isao/0000-0002-1246-8474; Fukui, Kenji/0000-0003-2463-7578	Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25440070, 25870407] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dudev M, 2006, J PHYS CHEM B, V110, P1889, DOI 10.1021/jp054975n; Dudev T, 2003, CHEM REV, V103, P773, DOI 10.1021/cr020467n; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukunishi Y, 2005, J MOL GRAPH MODEL, V24, P34, DOI 10.1016/j.jmgm.2005.04.004; Fukushima K, 2011, J DRUG TARGET, V19, P212, DOI [10.3109/1061186X.2010.492521, 10.4061/2010/260512]; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Iino H, 2011, BIOSCIENCE REP, V31, P309, DOI 10.1042/BSR20100116; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Namadurai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013726; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Ryde U, 1999, BIOPHYS J, V77, P2777, DOI 10.1016/S0006-3495(99)77110-9; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Shekhtman A, 2011, PROTEIN NMR TECHNIQU; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Vega-Rocha S, 2007, J MOL BIOL, V367, P473, DOI 10.1016/j.jmb.2007.01.002; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yamamoto T, 2011, J BIOL CHEM, V286, P42337, DOI 10.1074/jbc.M111.277335	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98554	10.1371/journal.pone.0098554	http://dx.doi.org/10.1371/journal.pone.0098554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901533	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400037
J	Xing, H; Wang, DY; Han, FL; Sullivan, C; Ma, QY; He, YM; Hone, DWE; Yan, RH; Du, FM; Xu, X				Xing, Hai; Wang, Deyou; Han, Fenglu; Sullivan, Corwin; Ma, Qingyu; He, Yiming; Hone, David W. E.; Yan, Ronghao; Du, Fuming; Xu, Xing			A New Basal Hadrosauroid Dinosaur (Dinosauria: Ornithopoda) with Transitional Features from the Late Cretaceous of Henan Province, China	PLOS ONE			English	Article							CRANIAL ANATOMY; GANSU PROVINCE; ORNITHISCHIA; BIOGEOGRAPHY; PHYLOGENY; AGE	Background: Southwestern Henan Province in central China contains many down-faulted basins, including the Xixia Basin where the Upper Cretaceous continental sediments are well exposed. The Majiacun Formation is a major dinosaur-bearing stratigraphic unit that occurs in this basin. Methodology/Principal Findings: A new basal hadrosauroid dinosaur, Zhanghenglong yangchengensis gen. et sp. nov., is named based on newly collected specimens from the middle Santonian Majiacun Formation of Zhoujiagou Village, Xixia Basin. Two transitional features between basal hadrosauroids and hadrosaurids are attached to the diagnosis of the new taxon, namely five maxillary foramina consisting of four small scattered ones anteroposteriorly arranged in a row and a large one adjacent to the articular facet for the jugal, and dentary tooth crowns bearing both median and distally offset primary ridges. Zhanghenglong also displays a unique combination of plesiomorphic and derived features of hadrosauroids, and is clearly morphologically transitional between basal hadrosauroids and hadrosaurids. Furthermore, some measurement attributes in osteology are applied to the quantitative analysis of Zhanghenglong. For these attributes, the partition of the dataset on most hadrosauroid species resulting from model-based cluster analysis almost matches taxonomic separation between basal hadrosauroids and hadrosaurids. Data of Zhanghenglong on selected measurement attributes straddle the two combinations of intervals of partitioned datasets respectively related to basal hadrosauroids and hadrosaurids. This condition is similar to mosaic evolution of morphological characters present in the specimens of the taxon. The phylogenetic analysis of Hadrosauroidea recovers a clade composed of Zhanghenglong, Nanyangosaurus, and Hadrosauridae with an unresolved polytomy. Conclusions/Significance: Zhanghenglong is probably a relatively derived non-hadrosaurid hadrosauroid, based on the inferences made from the morphological comparisons, quantitative evaluation of measurements, and cladistic analysis. In combination with information on the stratigraphy, phylogeny and biogeography, the material of Zhanghenglong provides direct evidence for the hypothesis that hadrosaurids might have originated in Asia.	[Xing, Hai] China Univ Geosci, Coll Earth Sci & Resources, Beijing, Peoples R China; [Xing, Hai; Han, Fenglu; Sullivan, Corwin; He, Yiming; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Xing, Hai] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; [Wang, Deyou] Henan Acad Land & Resources Sci, Zhengzhou, Henan, Peoples R China; [Han, Fenglu; He, Yiming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ma, Qingyu] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Yan, Ronghao; Du, Fuming] Xixia Museum Dinosaur Fossil Eggs China, Xixia, Henan, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bristol; University of London; Queen Mary University London	Xing, H (corresponding author), China Univ Geosci, Coll Earth Sci & Resources, Beijing, Peoples R China.	xinghaiivpp@gmail.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41120124002, 41172037]; Graduate School of China University of Geosciences at Beijing [201225-B3001120058]; China Scholarship Council [20133009-201306400032]; Department of Land and Resources of Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate School of China University of Geosciences at Beijing; China Scholarship Council(China Scholarship Council); Department of Land and Resources of Henan Province	This work was funded by grants from the National Natural Science Foundation of China (41120124002 and 41172037), the Graduate School of China University of Geosciences at Beijing (201225-B3001120058), the China Scholarship Council (20133009-201306400032), and the Department of Land and Resources of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov A., 2012, Journal of Stratigraphy, V36, P462; Averianov A. O., 2012, Trudy Zoologicheskogo Instituta, V316, P139; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Bolotsky YL, 2004, J VERTEBR PALEONTOL, V24, P351, DOI 10.1671/1110; BRETTSURMAN MK, 1979, NATURE, V277, P560, DOI 10.1038/277560a0; Cope E.D., 1869, T AM PHIL SOC, V14, P1; CURRIE PJ, 1991, CAN J EARTH SCI, V28, P102, DOI 10.1139/e91-009; Cuthbertson RS, 2010, ZOOL J LINN SOC-LOND, V159, P373, DOI 10.1111/j.1096-3642.2009.00612.x; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Fraley C., 2006, 504 U WASH DEP STAT, P1; Fraley C, 1998, 329 U WASH DEP STAT, P1; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Gilmore CW, 1933, B AM MUS NAT HIST, V67, P23; Godefroit P, 2004, ACTA PALAEONTOL POL, V49, P585; Godefroit Pascal, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P3; Godefroit P, 2008, ACTA PALAEONTOL POL, V53, P47, DOI 10.4202/app.2008.0103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Horner John R., 1994, P312; Horner JR, 1992, MUSEUM ROCKIES OCCAS, V2, P1; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P283; Langston WJ., 1960, FTELDIANA GEOL MEM, V3, P319; Lauters P, 2008, PALAIOS, V23, P153, DOI 10.2110/palo.2006.p06-031r; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MARYANSKA T, 1984, Palaeontologia Polonica, P119; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045712; Mo JY, 2007, ACTA GEOL SIN-ENGL, V81, P550; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Prieto-Marquez A, 2006, ACTA PALAEONTOL POL, V51, P77; Prieto-Marquez A., 2010, ZOOLOGICAL J LINNEAN, V159, P135; Prieto-Marquez A, 2011, ZOOTAXA, P61; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Riabinin AN, 1939, T TSENTRALNOGO NAUCH, V118, P3; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Rozhdestvensky AK, 1968, UPPER PALEOZOIC MESO, P97; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Tang F, 2001, CRETACEOUS RES, V22, P115, DOI 10.1006/cres.2000.0242; Taquet R, 1976, CHAPITRE, P57; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Wang D.Y., 2008, DINOSAUR EGGS SKELET, P1; Wang Deyou, 2013, Dizhi Xuebao, V87, P1049; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Wing Scott L., 1992, P327; Xi W-X, 1997, LITHOSTRATIGRAPHY HE, P1; Xing H., 2012, P 13 ANN M CHIN SOC, P1; Xing Hai, 2012, Vertebrata Palasiatica, V50, P160; Xu X, 2010, ZOOTAXA, P1; Xu Xing, 2000, Vertebrata Palasiatica, V38, P176; You HL, 2009, CAN J EARTH SCI, V46, P949, DOI 10.1139/E09-067; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148; YOUNG CC, 1958, PALAEONTOLOGIA SIN C, V16, P53	72	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98821	10.1371/journal.pone.0098821	http://dx.doi.org/10.1371/journal.pone.0098821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901454	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400057
J	Yu, C; Zhang, YG; Yao, SH; Wei, YQ				Yu, Chuan; Zhang, Yaguang; Yao, Shaohua; Wei, Yuquan			A PCR Based Protocol for Detecting Indel Mutations Induced by TALENs and CRISPR/Cas9 in Zebrafish	PLOS ONE			English	Article							TARGETED MUTAGENESIS; HUMAN-CELLS; GENOME; RECOMBINATION; NUCLEASE; GENE	Genome editing techniques such as the zinc-finger nucleases (ZFNs), transcription activator-like effecter nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system Cas9 can induce efficient DNA double strand breaks (DSBs) at the target genomic sequence and result in indel mutations by the error-prone non-homologous end joining (NHEJ) DNA repair system. Several methods including sequence specific endonuclease assay, T7E1 assay and high resolution melting curve assay (HRM) etc have been developed to detect the efficiency of the induced mutations. However, these assays have some limitations in that they either require specific sequences in the target sites or are unable to generate sequencing-ready mutant DNA fragments or unable to distinguish induced mutations from natural nucleotide polymorphism. Here, we developed a simple PCR-based protocol for detecting indel mutations induced by TALEN and Cas9 in zebrafish. We designed 2 pairs of primers for each target locus, with one putative amplicon extending beyond the putative indel site and the other overlapping it. With these primers, we performed a qPCR assay to efficiently detect the frequencies of newly induced mutations, which was accompanied with a T-vector-based colony analysis to generate single-copy mutant fragment clones for subsequent DNA sequencing. Thus, our work has provided a very simple, efficient and fast assay for detecting induced mutations, which we anticipate will be widely used in the area of genome editing.	[Yao, Shaohua] West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; West China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China; Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Yao, SH (corresponding author), West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China.	Shaohuayao@scu.edu.cn	Zhang, Yaguang/GZM-9859-2022; Yu, Chuan/AAC-1440-2019	Zhang, Yaguang/0000-0002-9216-1834; Yao, Shaohua/0000-0002-0191-4889	National Natural Science Foundation of China [81372143, 31000646]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 81372143 and No. 31000646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Haber JE, 2000, CURR OPIN CELL BIOL, V12, P286, DOI 10.1016/S0955-0674(00)00090-9; Hisano Y, 2013, BIOL OPEN, V2, P363, DOI 10.1242/bio.20133871; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Liu X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3565; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xing LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043968; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	23	58	63	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98282	10.1371/journal.pone.0098282	http://dx.doi.org/10.1371/journal.pone.0098282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901507	Green Submitted, gold, Green Published			2022-12-25	WOS:000336841400023
J	Kang, ZH; Wang, CY; Zhang, WL; Zhang, JT; Yuan, CH; Zhao, PW; Lin, YY; Hong, S; Li, CY; Wang, L				Kang, Zhen-Hua; Wang, Chun-Yan; Zhang, Wen-Liang; Zhang, Jian-Tao; Yuan, Chun-Hua; Zhao, Ping-Wei; Lin, Yu-Yang; Hong, Sen; Li, Chen-Yao; Wang, Lei			Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; EXPRESSION; ACTIVATION; INHIBITORS	Gastric cancer (GC) is one of the leading causes of cancer death in the world. The role of histone deacetylase 4 (HDAC4) in specific cell and tissue types has been identified. However, its biological roles in the development of gastric cancer remain largely unexplored. Quantitative real time PCR (qRT-PCR) and western blot were used to analyze the expression of HDAC4 in the clinical samples. siRNA and overexpression of HDAC4 and siRNA p21 were used to study functional effects in a proliferation, a colony formation, a adenosine 5'-triphosphate (ATP) assay and reactive oxygen species(ROS) generation, cell cycle, cell apoptosis rates, and autophagy assays. HDAC4 was up-regulated in gastric cancer tissues and several gastric cancer cell lines. The proliferation, colony formation ability and ATP level were enhanced in HDAC4 overexpression SGC-7901 cells, but inhibited in HDAC4 knockdown SGC-7901 cells. HDAC4 knockdown led to G0/G1 phase cell arrest and caused apoptosis and ROS increase. Moreover, HDAC4 was found to inhibit p21 expression in gastric cancer SGC-7901 cells. p21 knockdown dramatically attenuated cell proliferation inhibition, cell cycle arrest, cell apoptosis promotion and autophagy up-regulation in HDAC4-siRNA SGC-7901 cells. We demonstrated that HDAC4 promotes gastric cancer cell progression mediated through the repression of p21. Our results provide an experimental basis for understanding the pro-tumor mechanism of HDAC4 as treatment for gastric cancer.	[Kang, Zhen-Hua; Zhang, Wen-Liang; Zhang, Jian-Tao; Yuan, Chun-Hua; Zhao, Ping-Wei; Lin, Yu-Yang; Hong, Sen; Li, Chen-Yao; Wang, Lei] Jilin Univ, Hosp 1, Dept Colorectal & Anus Surg, Changchun 130023, Peoples R China; [Wang, Chun-Yan] Tumor Res Inst JiLin Prov, Changchun, Peoples R China	Jilin University	Wang, L (corresponding author), Jilin Univ, Hosp 1, Dept Colorectal & Anus Surg, Changchun 130023, Peoples R China.	kzh5566@163.com			Health Department of JiLin Province [2012z119]	Health Department of JiLin Province	This work was supported by a grant from the Health Department of JiLin Province (No. 2012z119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aoyagi Keishiro, 2003, Kurume Medical Journal, V50, P1; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Khan HA, 2003, J BIOSCIENCES, V28, P379, DOI 10.1007/BF02705114; Kim JS, 2001, BIOCHEM BIOPH RES CO, V281, P866, DOI 10.1006/bbrc.2001.4434; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Luo DH, 2014, ONCOL LETT, V7, P471, DOI 10.3892/ol.2013.1751; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Mutze K, 2010, ANN SURG ONCOL, V17, P3336, DOI 10.1245/s10434-010-1182-1; Ogawa M, 2001, INT J MOL MED, V7, P479; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Qu WL, 2013, INT J BIOL SCI, V9, P766, DOI 10.7150/ijbs.5711; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Shabason JE, 2010, ONCOLOGY-NY, V24, P180; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45	23	61	64	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98894	10.1371/journal.pone.0098894	http://dx.doi.org/10.1371/journal.pone.0098894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896240	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700092
J	Mooij, SH; Boot, HJ; Speksnijder, AGCL; Meijer, CJLM; King, AJ; Verhagen, DWM; de Vries, HJC; Quint, WGV; Molijn, A; de Koning, MNC; van der Sande, MAB; van der Loeff, MFS				Mooij, Sofie H.; Boot, Hein J.; Speksnijder, Arjen G. C. L.; Meijer, Chris J. L. M.; King, Audrey J.; Verhagen, Dominique W. M.; de Vries, Henry J. C.; Quint, Wim G. V.; Molijn, Anco; de Koning, Maurits N. C.; van der Sande, Marianne A. B.; van der Loeff, Maarten F. Schim			Six-Month Incidence and Persistence of Oral HPV Infection in HIV-Negative and HIV-Infected Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NECK-CANCER; NATURAL-HISTORY; GAMMAPAPILLOMAVIRUS GENERA; UNITED-STATES; RISK-FACTORS; YOUNG MEN; HEAD; PREVALENCE; METAANALYSIS	Objectives: Our aim was to assess incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men (MSM). Methods: MSM aged >= 18 years were included in Amsterdam (the Netherlands) in 2010-2011, and followed up 6 months later. Participants completed risk factor questionnaires. HPV DNA was analyzed in oral-rinse and gargle specimens using the SPF10-PCR DEIA/LiPA(25) system (version 1). A subset of oral samples was subjected to SPF10 sequencing to identify additional HPV types. Multivariable logistic regression analyses using generalized estimating equations (GEE) were performed to assess determinants for oral high-risk HPV incidence and persistence. Results: 689/795 participant MSM provided both baseline and 6-month data. Baseline prevalence of high-risk HPV was 9.4% in HIV-negative and 23.9% in HIV-infected MSM (P<0.001). 56/689 MSM acquired >= 1 high-risk HPV infection (6-month incidence 8.1%; 95%CI 6.2-10.4%); incidence was 4.1% in HIV-negative and 14.1% in HIV-infected MSM (P<0.001). HIV infection and recent use of cannabis were both independently associated with high-risk HPV incidence. Persistent high-risk HPV was observed in 48/130 (36.9%) infections. Conclusion: Incidence of oral high-risk HPV infection in MSM is substantial, and is associated with HIV infection. Over a third of HPV infections persisted over a 6-month period.	[Mooij, Sofie H.; Speksnijder, Arjen G. C. L.; de Vries, Henry J. C.; van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Boot, Hein J.; King, Audrey J.; de Vries, Henry J. C.; van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Meijer, Chris J. L. M.] Vrije Univ Amsterdam, Univ Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Verhagen, Dominique W. M.] Jan van Goyen Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Mooij, Sofie H.; van der Loeff, Maarten F. Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [Quint, Wim G. V.; Molijn, Anco; de Koning, Maurits N. C.] DDL Diagnost Lab, Rijswijk, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Public Health Service Amsterdam; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; DDL Diagnostic Laboratory; Utrecht University; Utrecht University Medical Center	Mooij, SH (corresponding author), Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands.	somooij@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017; de Vries, Henry/K-5963-2012	Speksnijder, Arjen/0000-0002-1966-7265; de Vries, Henry/0000-0001-9784-547X; van der Sande, Marianne AB/0000-0002-4778-6739	Aids Fonds [2009029]; Public Health Service of Amsterdam; RIVM; Sanofi Pasteur MSD; Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); Netherlands National Institute for Public Health and the Environment	Aids Fonds; Public Health Service of Amsterdam; RIVM; Sanofi Pasteur MSD; Stichting Pathologie Onderzoek en Ontwikkeling (SPOO); Netherlands National Institute for Public Health and the Environment	This work was supported by Aids Fonds [grant number 2009029], and additional funding from the Public Health Service of Amsterdam and RIVM. Laboratory analysis of the 6-month oral samples was funded by Sanofi Pasteur MSD through an unrestricted grant. SPF10 sequencing of oral samples was funded by Stichting Pathologie Onderzoek en Ontwikkeling (SPOO). The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Netherlands National Institute for Public Health and the Environment. DDL Diagnostic Laboratory provided support in the form of salaries for authors W. Quint, A. Molijn, and M. de Koning, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Fakhry C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011918; Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-15; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Goon PKC, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-36; Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Isayeva T, 2012, HEAD NECK PATHOL, V6, pS104, DOI 10.1007/s12105-012-0368-1; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuhs KAL, 2013, J INFECT DIS, V208, P1643, DOI 10.1093/infdis/jit369; Louvanto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053413; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Munday JS, 2007, VET DERMATOL, V18, P241, DOI 10.1111/j.1365-3164.2007.00600.x; Pickard RKL, 2012, SEX TRANSM DIS, V39, P559, DOI 10.1097/OLQ.0b013e31824f1c65; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Said AK, 2013, J ORAL PATHOL MED, V42, P435, DOI 10.1111/jop.12009; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Steinau M, 2012, J ORAL PATHOL MED, V41, P288, DOI 10.1111/j.1600-0714.2011.01093.x; Veldhuijzen NJ, 2010, LANCET INFECT DIS, V10, P862, DOI 10.1016/S1473-3099(10)70190-0; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	38	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98955	10.1371/journal.pone.0098955	http://dx.doi.org/10.1371/journal.pone.0098955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896848	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700101
J	Raj, A; Pandya, S; Shen, XB; LoCastro, E; Nguyen, TD; Gauthier, SA				Raj, Ashish; Pandya, Sneha; Shen, Xiaobo; LoCastro, Eve; Nguyen, Thanh D.; Gauthier, Susan A.			Multi-Compartment T2 Relaxometry Using a Spatially Constrained Multi-Gaussian Model	PLOS ONE			English	Article							MYELIN WATER QUANTIFICATION; NMR RELAXATION DATA; HUMAN BRAIN; T-2 RELAXATION; WHITE-MATTER; MAGNETIZATION-TRANSFER; REGULARIZATION; SCLEROSIS; TISSUE; IRON	The brain's myelin content can be mapped by T2-relaxometry, which resolves multiple differentially relaxing T2 pools from multi-echo MRI. Unfortunately, the conventional fitting procedure is a hard and numerically ill-posed problem. Consequently, the T2 distributions and myelin maps become very sensitive to noise and are frequently difficult to interpret diagnostically. Although regularization can improve stability, it is generally not adequate, particularly at relatively low signal to noise ratio (SNR) of around 100-200. The purpose of this study was to obtain a fitting algorithm which is able to overcome these difficulties and generate usable myelin maps from noisy acquisitions in a realistic scan time. To this end, we restrict the T2 distribution to only 3 distinct resolvable tissue compartments, modeled as Gaussians: myelin water, intra/extra-cellular water and a slow relaxing cerebrospinal fluid compartment. We also impose spatial smoothness expectation that volume fractions and T2 relaxation times of tissue compartments change smoothly within coherent brain regions. The method greatly improves robustness to noise, reduces spatial variations, improves definition of white matter fibers, and enhances detection of demyelinating lesions. Due to efficient design, the additional spatial aspect does not cause an increase in processing time. The proposed method was applied to fast spiral acquisitions on which conventional fitting gives uninterpretable results. While these fast acquisitions suffer from noise and inhomogeneity artifacts, our preliminary results indicate the potential of spatially constrained 3-pool T2 relaxometry.	[Raj, Ashish; Pandya, Sneha; Shen, Xiaobo; LoCastro, Eve; Nguyen, Thanh D.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA; [Gauthier, Susan A.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA	Cornell University; Cornell University	Raj, A (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA.	asr2004@med.cornell.edu	Pandya, Sneha/AAA-6879-2020; Gauthier, susan/AAW-7082-2021	Pandya, Sneha/0000-0002-3284-2603; LoCastro, Eve/0000-0003-3975-8153	National MS Society [0711009544]; NIH [5P41RR02953, 1R01NS075425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075425] Funding Source: NIH RePORTER	National MS Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National MS Society grant #0711009544 partially supported AR, TN and SG. AR was additionally supported by NIH grants 5P41RR02953 and 1R01NS075425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews T, 2005, MAGN RESON MED, V54, P449, DOI 10.1002/mrm.20599; BERTERO M, 1982, P ROY SOC LOND A MAT, V383, P15, DOI 10.1098/rspa.1982.0117; Bjarnason TA, 2010, MAGN RESON MED, V63, P212, DOI 10.1002/mrm.22173; CHENG KH, 1994, MAGN RESON IMAGING, V12, P1099, DOI 10.1016/0730-725X(94)91242-O; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Does MD, 1996, MAGNET RESON MED, V35, P207, DOI 10.1002/mrm.1910350212; Du YP, 2007, MAGN RESON MED, V58, P865, DOI 10.1002/mrm.21409; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; Graham SJ, 1996, MAGNET RESON MED, V35, P370, DOI 10.1002/mrm.1910350315; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hwang D, 2009, J MAGN RESON IMAGING, V30, P203, DOI 10.1002/jmri.21783; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; Jones CK, 2003, MAGNET RESON MED, V50, P206, DOI 10.1002/mrm.10492; Kolind SH, 2011, MAGN RESON MED, V65, P551, DOI 10.1002/mrm.22634; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Kumar D, 2012, MAGN RESON MED, V68, P1536, DOI 10.1002/mrm.24170; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Levesque IR, 2010, MAGN RESON MED, V63, P633, DOI 10.1002/mrm.22244; Li X, 2011, IEEE T IMAGE PROCESS, V20, P971, DOI 10.1109/TIP.2010.2081681; LoCastro E, 2013, P INT SOC MAG RESON, V21, P3620; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Meyers SM, 2009, MAGN RESON IMAGING, V27, P1096, DOI 10.1016/j.mri.2009.02.001; Morassi A, 2008, CISM COURSES LECT, P137; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Nguyen TD, 2012, MAGN RESON MED, V67, P614, DOI 10.1002/mrm.24128; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Olafsson V, 2006, I S BIOMED IMAGING, P5; ORDIDGE RJ, 1994, MAGNET RESON MED, V32, P335, DOI 10.1002/mrm.1910320309; Pell GS, 2006, J MAGN RESON IMAGING, V23, P248, DOI 10.1002/jmri.20490; Raj A, 2007, MAGN RESON MED, V57, P8, DOI 10.1002/mrm.21012; Raj A, 2011, NEUROIMAGE, V54, P396, DOI 10.1016/j.neuroimage.2010.07.040; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tychonoff A. N., 1977, SOLUTION ILL POSED P; Vavasour IM, 2009, J NEUROL SCI, V276, P49, DOI 10.1016/j.jns.2008.08.022; WHITTALL KP, 1991, J MAGN RESON, V95, P221, DOI 10.1016/0022-2364(91)90213-D; WHITTALL KP, 1989, J MAGN RESON, V84, P134, DOI 10.1016/0022-2364(89)90011-5; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wood SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P180, DOI 10.1016/j.pscychresns.2009.12.003; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Ziliani F, 2001, REAL-TIME IMAGING, V7, P389, DOI 10.1006/rtim.2000.0208	48	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98391	10.1371/journal.pone.0098391	http://dx.doi.org/10.1371/journal.pone.0098391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896833	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700039
J	Schittko, C; Hawa, M; Wurst, S				Schittko, Conrad; Hawa, Mahmoud; Wurst, Susanne			Using a Multi-Trait Approach to Manipulate Plant Functional Diversity in a Biodiversity-Ecosystem Function Experiment	PLOS ONE			English	Article							SPECIES RICHNESS; PRODUCTIVITY; INVASION; COMPLEMENTARITY; COMMUNITIES; RESISTANCE; REGRESSION; SELECTION; IDENTITY; ECOLOGY	A frequent pattern emerging from biodiversity-ecosystem function studies is that functional group richness enhances ecosystem functions such as primary productivity. However, the manipulation of functional group richness goes along with major disadvantages like the transformation of functional trait data into categories or the exclusion of functional differences between organisms in the same group. In a mesocosm study we manipulated plant functional diversity based on the multi-trait Functional Diversity (FD)-approach of Petchey and Gaston by using database data of seven functional traits and information on the origin of the species in terms of being native or exotic. Along a gradient ranging from low to high FD we planted 40 randomly selected eight-species mixtures under controlled conditions. We found a significant positive linear correlation of FD with aboveground productivity and a negative correlation with invasibility of the plant communities. Based on community-weighted mean calculations for each functional trait, we figured out that the traits N-fixation and species origin, i.e. being native or exotic, played the most important role for community productivity. Our results suggest that the identification of the impact of functional trait diversity and the relative contributions of relevant traits is essential for a mechanistic understanding of the role of biodiversity for ecosystem functions such as aboveground biomass production and resistance against invasion.	[Schittko, Conrad; Hawa, Mahmoud; Wurst, Susanne] Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany	Free University of Berlin	Schittko, C (corresponding author), Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany.	conrad.schittko@fu-berlin.de		Schittko, Conrad/0000-0002-2200-8762	Freie Universitat Berlin	Freie Universitat Berlin	Funded by Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULRAHMAN AA, 1989, J CHEM ECOL, V15, P2289, DOI 10.1007/BF01012082; Byun C, 2013, J ECOL, V101, P128, DOI 10.1111/1365-2745.12016; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Celesti-Grapow L, 2006, DIVERS DISTRIB, V12, P490, DOI 10.1111/j.1366-9516.2006.00282.x; Crawley M. J., 2009, R BOOK; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Elton C., 1958; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Flombaum P, 2014, OECOLOGIA, V174, P559, DOI 10.1007/s00442-013-2775-8; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Kieschnick R, 2003, STAT MODEL, V3, P193, DOI 10.1191/1471082X03st053oa; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; Kowarik I., 2003, BIOLOGISCHE INVASION; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2008, FUNCT ECOL, V22, P134, DOI 10.1111/j.1365-2435.2007.01339.x; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; MORGAN SP, 1988, J MARRIAGE FAM, V50, P929, DOI 10.2307/352104; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pokorny ML, 2005, RESTOR ECOL, V13, P448, DOI 10.1111/j.1526-100X.2005.00056.x; Prasse R, 2001, LISTE WILDWACHSENDEN; Prieur-Richard AH, 2002, OIKOS, V99, P338, DOI 10.1034/j.1600-0706.2002.990215.x; R Core Team, 2021, R LANG ENV STAT COMP; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHROEDER F-G, 1969, Vegetatio, V16, P225; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Spaekova I, 2001, ECOL LETT, V4, P585, DOI 10.1046/j.1461-0248.2001.00277.x; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Zao LH, 2001, APPL ENVIRON MICROB, V67, P2129, DOI 10.1128/AEM.67.5.2129-2135.2001	50	14	15	7	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99065	10.1371/journal.pone.0099065	http://dx.doi.org/10.1371/journal.pone.0099065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897501	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700111
J	van Riet-Nales, DA; Romkens, EGAW; Saint-Raymond, A; Kozarewicz, P; Schobben, AFAM; Egberts, TCG; Rademaker, CMA				van Riet-Nales, Diana A.; Romkens, Erwin G. A. W.; Saint-Raymond, Agnes; Kozarewicz, Piotr; Schobben, Alfred F. A. M.; Egberts, Toine C. G.; Rademaker, Carin M. A.			Oral Medicines for Children in the European Paediatric Investigation Plans	PLOS ONE			English	Article							MINI-TABLETS; FORMULATIONS; ACCEPTANCE; INFANTS	Introduction: Pharmaceutical industry is no longer allowed to develop new medicines for use in adults only, as the 2007 Paediatric Regulation requires children to be considered also. The plans for such paediatric development called Paediatric Investigation Plans (PIPs) are subject to agreement by the European Medicines Agency (EMA) and its Paediatric Committee (PDCO). The aim of this study was to evaluate the key characteristics of oral paediatric medicines in the PIPs and the changes implemented as a result of the EMA/PDCO review. Methods: All PIPs agreed by 31 December 2011 were identified through a proprietary EMA-database. PIPs were included if they contained an agreed proposal to develop an oral medicine for children 0 to 11 years. Information on the therapeutic area (EMA classification system); target age range (as defined by industry) and pharmaceutical characteristics (active substance, dosage form(s) as listed in the PIP, strength of each dosage form, excipients in each strength of each dosage form) was extracted from the EMA website or the EMA/PDCO assessment reports. Results: A hundred and fifty PIPs were included corresponding to 16 therapeutic areas and 220 oral dosage forms in 431 strengths/compositions. Eighty-two PIPs (37%) included tablets, 44 (20%) liquids and 35 (16%) dosage forms with a specific composition/strength that were stored as a solid but swallowed as a liquid e. g. dispersible tablets. The EMA/PDCO review resulted in an increase of 13 (207 to 220) oral paediatric dosage forms and 44 (387 to 431) dosage forms with a specific composition/strength. For many PIPs, the target age range was widened and the excipient composition and usability aspects modified. Conclusion: The EMA/PDCO review realized an increase in the number of requirements for the development of oral dosage forms and a larger increase in the number of dosage forms with a specific composition/strength, both targeting younger children. Changes to their pharmaceutical design were less profound.	[van Riet-Nales, Diana A.; Schobben, Alfred F. A. M.] Med Evaluat Board Netherlands MEB, Dept Chem Pharmaceut Assessment, Utrecht, Netherlands; [van Riet-Nales, Diana A.; Romkens, Erwin G. A. W.; Schobben, Alfred F. A. M.; Egberts, Toine C. G.] Univ Utrecht, Fac Sci, UIPS, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Saint-Raymond, Agnes] European Med Agcy, Human Med Special Areas, London, England; [Kozarewicz, Piotr] European Med Agcy, Qual Med, London, England; [Egberts, Toine C. G.; Rademaker, Carin M. A.] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	van Riet-Nales, DA (corresponding author), Med Evaluat Board Netherlands MEB, Dept Chem Pharmaceut Assessment, Utrecht, Netherlands.	da.v.riet@cbg-meb.nl	Egberts, Toine/A-6625-2012; Egberts, Toine/K-4579-2019	Egberts, Toine/0000-0003-1758-7779; Egberts, Toine/0000-0003-1758-7779	Medicines Evaluation Board in the Netherlands (MEB); National Institute for Public Health and the Environment (RIVM)	Medicines Evaluation Board in the Netherlands (MEB); National Institute for Public Health and the Environment (RIVM)	This study was supported by a grant from the Medicines Evaluation Board in the Netherlands (MEB) and the National Institute for Public Health and the Environment (RIVM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2010, ARCH DIS CHILD, V95, P1054, DOI 10.1136/adc.2010.190330; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.660; Breitkreutz J, 2008, CLIN THER, V30, P2146, DOI 10.1016/j.clinthera.2008.11.016; European Medicines Agency Committee for Medicinal Products for Human use, 2011, GUID PHARM IN PRESS; European Medicines Agency Committee for Medicinal Products for Human Use, 2013, GUID PHARM DEV MED P; Fabiano V, 2011, PHARMACOL RES, V63, P362, DOI 10.1016/j.phrs.2011.01.006; Fowles JR, 2013, CRIT REV TOXICOL, V43, P363, DOI 10.3109/10408444.2013.792328; Klingmann V, 2013, J PEDIATR-US, V163, P1728, DOI 10.1016/j.jpeds.2013.07.014; McCann D, 2007, LANCET, V370, P1542; Mentzer D, 2014, INT J PHARMACEUT, V469, P240, DOI 10.1016/j.ijpharm.2014.03.019; Michele TM, 2002, J ASTHMA, V39, P391, DOI 10.1081/JAS-120004032; Ruiz BQ, 2014, EXPERT REV CLIN PHAR, V7, P25, DOI 10.1586/17512433.2014.857600; Saint Raymond Agnes, 2005, Paediatr Respir Rev, V6, P45; Sam T, 2012, INT J PHARMACEUT, V435, P115, DOI 10.1016/j.ijpharm.2012.05.024; Spomer N, 2012, ARCH DIS CHILD, V97, P283, DOI 10.1136/archdischild-2011-300958; Sundh UB, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3155; Thomson SA, 2009, PEDIATRICS, V123, pE235, DOI 10.1542/peds.2008-2059; van Riet-Nales DA, 2014, INT J PHARMACEUT, V466, P44, DOI 10.1016/j.ijpharm.2014.02.031; van Riet-Nales DA, 2013, ARCH DIS CHILD, V98, P725, DOI 10.1136/archdischild-2012-303303; van Riet-Nales DA, 2012, INT J PHARMACEUT, V435, P132, DOI 10.1016/j.ijpharm.2012.05.053; van Riet-Nales DA, 2011, BRIT J CLIN PHARMACO, V72, P465, DOI 10.1111/j.1365-2125.2011.03982.x; Van Vooren L, 2002, J PHARM PHARM SCI, V5, P190; Walsh J, 2011, INT J PHARMACEUT, V415, P221, DOI 10.1016/j.ijpharm.2011.05.048	23	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98348	10.1371/journal.pone.0098348	http://dx.doi.org/10.1371/journal.pone.0098348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897509	Green Published, gold			2022-12-25	WOS:000338430700035
J	Teramoto, T; Boonyasuppayakorn, S; Handley, M; Choi, KH; Padmanabhan, R				Teramoto, Tadahisa; Boonyasuppayakorn, Siwaporn; Handley, Misty; Choi, Kyung H.; Padmanabhan, Radhakrishnan			Substitution of NS5 N-terminal Domain of Dengue Virus Type 2 RNA with Type 4 Domain Caused Impaired Replication and Emergence of Adaptive Mutants with Enhanced Fitness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO SYNTHESIS; IN-VITRO; VIRAL-RNA; POLYMERASE; HELICASE; REGION; IDENTIFICATION; NUCLEOTIDE; ELEMENTS; VACCINE	Flavivirus NS3 and NS5 are required in viral replication and 5'-capping. NS3 has NS2B-dependent protease, RNA helicase, and 5'-RNA triphosphatase activities. NS5 has 5'-RNA methyltransferase (MT)/guanylyltransferase (GT) activities within the N-terminal 270 amino acids and the RNA-dependent RNA polymerase (POL) activity within amino acids 271-900. A chimeric NS5 containing the D4MT/D4GT and the D2POL domains in the context of wild-type (WT) D2 RNA was constructed. RNAs synthesized in vitro were transfected into baby hamster kidney cells. The viral replication was analyzed by an indirect immunofluorescence assay to monitor NS1 expression and by quantitative real-time PCR. WT D2 RNA-transfected cells were NS1- positive by day 5, whereas the chimeric RNA-transfected cells became NS1-positive similar to 30 days post-transfection in three independent experiments. Sequence analysis covering the entire genome revealed the appearance of a single K74I mutation within the D4MT domain similar to 16 days post-transfection in two experiments. In the third, D290N mutation in the conserved NS3 Walker B motif appeared >= 16 days post-transfection. A time course study of serial passages revealed that the 30-day supernatant had gradually evolved to gain replication fitness. Trans-complementation by co-expression of WT D2 NS5 accelerated viral replication of chimeric RNA without changing the K74I mutation. However, the MT and POL activities of NS5 WT D2 and the chimeric NS5 proteins with or without the K74I mutation are similar. Taken together, our results suggest that evolution of the functional interactions involving the chimeric NS5 protein encoded by the viral genome species is essential for gain of viral replication fitness.	[Teramoto, Tadahisa; Boonyasuppayakorn, Siwaporn; Handley, Misty; Padmanabhan, Radhakrishnan] Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Georgetown University; University of Texas System; University of Texas Medical Branch Galveston	Padmanabhan, R (corresponding author), Georgetown Univ, Sch Med, Dept Microbiol & Immunol, Washington, DC 20057 USA.	rp55@georgetown.edu	Boonyasuppayakorn, Siwaporn/AIF-3692-2022		National Institutes of Health [R01 AI087856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI087856 (to K. H. C and R. P).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Arroyo J, 2001, TRENDS MOL MED, V7, P350, DOI 10.1016/S1471-4914(01)02048-2; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082; Boonyasuppayakorn S, 2014, METHODS MOL BIOL, V1138, P361, DOI 10.1007/978-1-4939-0348-1_22; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kapoor M., 1995, THESIS U KANSAS MED; Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997; Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu Lihui, 2010, Front Biol (Beijing), V5, P286; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P1882, DOI 10.1001/jama.2013.4903; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Padmanabhan R, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P13; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Spencer F., 1993, Methods (Orlando), V5, P161, DOI 10.1006/meth.1993.1021; Takahashi H, 2012, ANTIVIR RES, V96, P305, DOI 10.1016/j.antiviral.2012.09.023; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Teramoto T, 2008, RNA, V14, P2645, DOI 10.1261/rna.1051208; Vasudevan SG, 2001, FARMACO, V56, P33, DOI 10.1016/S0014-827X(01)01014-X; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	55	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22385	22400		10.1074/jbc.M114.584466	http://dx.doi.org/10.1074/jbc.M114.584466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24904061	Green Published, hybrid			2022-12-25	WOS:000340593500049
J	Lorenzen, N; Nielsen, SB; Yoshimura, Y; Vad, BS; Andersen, CB; Betzer, C; Kaspersen, JD; Christiansen, G; Pedersen, JS; Jensen, PH; Mulder, FAA; Otzen, DE				Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Betzer, Cristine; Kaspersen, Jorn D.; Christiansen, Gunna; Pedersen, Jan S.; Jensen, Poul Henning; Mulder, Frans A. A.; Otzen, Daniel E.			How Epigallocatechin Gallate Can Inhibit alpha-Synuclein Oligomer Toxicity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; FIBRIL FORMATION; AMYLOID FIBRILS; ELEVATED LEVELS; BILAYER CHARGE; DOPAMINE; FIBRILLIZATION; DEMENTIA; DEPENDS; EVENTS	Oligomeric species of various proteins are linked to the pathogenesis of different neurodegenerative disorders. Consequently, there is intense focus on the discovery of novel inhibitors, e. g. small molecules and antibodies, to inhibit the formation and block the toxicity of oligomers. In Parkinson disease, the protein alpha-synuclein (alpha SN) forms cytotoxic oligomers. The flavonoid epigallocatechin gallate (EGCG) has previously been shown to redirect the aggregation of alpha SN monomers and remodel alpha SN amyloid fibrils into disordered oligomers. Here, we dissect EGCG's mechanism of action. EGCG inhibits the ability of preformed oligomers to permeabilize vesicles and induce cytotoxicity in a rat brain cell line. However, EGCG does not affect oligomer size distribution or secondary structure. Rather, EGCG immobilizes the C-terminal region and moderately reduces the degree of binding of oligomers to membranes. We interpret our data to mean that the oligomer acts by destabilizing the membrane rather than by direct pore formation. This suggests that reduction (but not complete abolition) of the membrane affinity of the oligomer is sufficient to prevent cytotoxicity.	[Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Kaspersen, Jorn D.; Pedersen, Jan S.; Mulder, Frans A. A.; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Lorenzen, Nikolai; Nielsen, Soren B.; Yoshimura, Yuichi; Vad, Brian S.; Andersen, Camilla Bertel; Mulder, Frans A. A.; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct, DK-8000 Aarhus C, Denmark; [Yoshimura, Yuichi; Kaspersen, Jorn D.; Pedersen, Jan S.; Mulder, Frans A. A.] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Betzer, Cristine; Jensen, Poul Henning] Aarhus Univ, Dept Biomed Med Biochem, DK-8000 Aarhus C, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Immunol, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.	dao@inano.au.dk	Kaspersen, Jørn Døvling/O-6317-2015; Nielsen, Søren B/D-5936-2011; Yoshimura, Yuichi/G-8924-2019; Pedersen, Jan Skov/A-8346-2008; Andersen, Camilla Bertel/AAN-8607-2020; Mulder, Frans AA/C-7158-2017	Yoshimura, Yuichi/0000-0002-9905-453X; Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Camilla Bertel/0000-0003-1298-0598; Mulder, Frans AA/0000-0001-9427-8406; Jensen, Poul Henning/0000-0002-4439-9020; Betzer, Cristine/0000-0001-5429-3548; Christiansen, Gunna/0000-0003-0540-1367; Otzen, Daniel/0000-0002-2918-8989	Michael J. Fox Foundation; Danish Council for Independent Research/Natural Sciences; Lundbeckfonden; EMBO Long Term Fellowship [ALTF 687-2013]; Danish Research Foundation (inSPIN); Novo Nordisk Fonden [NNF13OC0006627] Funding Source: researchfish	Michael J. Fox Foundation; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeckfonden(Lundbeckfonden); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Danish Research Foundation (inSPIN); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by the Michael J. Fox Foundation. Present address: Dept. of Protein Biophysics and Formulation, Novo Nordisk A/S, 2760 Malov, Denmark.; Supported by the Danish Council for Independent Research/Natural Sciences. Present address: Arla Foods Ingredients Group P/S, Sonderupvej 26, DK-6920 Videbaek, Denmark.; Supported by Lundbeckfonden.; Supported by an EMBO Long Term Fellowship ALTF 687-2013.; Supported by the Danish Research Foundation (inSPIN).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; Chandrashekaran IR, 2010, BIOCHEMISTRY-US, V49, P5899, DOI 10.1021/bi902197x; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DEBYE P, 1947, J PHYS COLLOID CHEM, V51, P18, DOI 10.1021/j150451a002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Goddard TD, 2008, SPARKY VERSION 3; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Meng XY, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/650794; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; Pedersen JS, 1996, MACROMOLECULES, V29, P1363, DOI 10.1021/ma9512115; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Roberts BE, 2009, NAT CHEM BIOL, V5, P936, DOI 10.1038/nchembio.246; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; van Rooijen BD, 2008, FEBS LETT, V582, P3788, DOI 10.1016/j.febslet.2008.10.009; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	50	130	132	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2014	289	31					21299	21310		10.1074/jbc.M114.554667	http://dx.doi.org/10.1074/jbc.M114.554667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4LC	24907278	Green Published, hybrid			2022-12-25	WOS:000340558300011
J	Selwa, E; Davi, M; Chenal, A; Sotomayor-Perez, AC; Ladant, D; Malliavin, TE				Selwa, Edithe; Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel; Malliavin, Therese E.			Allosteric Activation of Bordetella pertussis Adenylyl Cyclase by Calmodulin MOLECULAR DYNAMICS AND MUTAGENESIS STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHANGES; CATALYTIC DOMAIN; TOXIN; CALCIUM; PROTEIN; BINDING; PATHWAYS; STABILIZATION; EQUILIBRIUM; MACROPHAGES	Adenylyl cyclase (AC) toxin is an essential toxin that allows Bordetella pertussis to invade eukaryotic cells, where it is activated after binding to calmodulin (CaM). Based on the crystal structure of the AC catalytic domain in complex with the C-terminal half of CaM (C-CaM), our previous molecular dynamics simulations (Selwa, E., Laine, E., and Malliavin, T. (2012) Differential role of calmodulin and calcium ions in the stabilization of the catalytic domain of adenyl cyclase CyaA from Bordetella pertussis. Proteins 80, 1028-040) suggested that three residues (i.e. Arg(338), Asn(347), and Asp(360)) might be important for stabilizing the AC/CaM interaction. These residues belong to a loop-helix-loop motif at the C-terminal end of AC, which is located at the interface between CaM and the AC catalytic loop. In the present study, we conducted the in silico and in vitro characterization of three AC variants, where one (Asn(347); ACm1A), two (Arg(338) and Asp(360); ACm2A), or three residues (Arg(338), Asn(347), and Asp(360); ACm3A) were substituted with Ala. Biochemical studies showed that the affinities of ACm1A and ACm2A for CaM were not affected significantly, whereas that of ACm3A was reduced dramatically. To understand the effects of these modifications, molecular dynamics simulations were performed based on the modified proteins. The molecular dynamics trajectories recorded for the ACm3A center dot C-CaM complex showed that the calcium-binding loops of C-CaM exhibited large fluctuations, which could be related to the weakened interaction between ACm3A and its activator. Overall, our results suggest that the loop-helix-loop motif at the C-terminal end of AC is crucial during CaM binding for stabilizing the AC catalytic loop in an active configuration.	[Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel; Malliavin, Therese E.] Inst Pasteur, F-75015 Paris, France; [Malliavin, Therese E.] CNRS, UMR 3528, Unite Bioinformat Struct, F-75015 Paris, France; [Davi, Marilyne; Chenal, Alexandre; Sotomayor-Perez, Ana-Cristina; Ladant, Daniel] CNRS, UMR 3528, Unite Biochim Interact Macromol, F-75015 Paris, France; [Selwa, Edithe] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Ladant, D (corresponding author), CNRS, UMR 3528, Unite Biochim Interact Macromol, Rue Dr Roux, F-75015 Paris, France.	daniel.ladant@pasteur.fr; therese.malliavin@pasteur.fr	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X; Malliavin, Therese/0000-0002-3276-3366	Institut Pasteur [PTR 374]; CNRS [UMR 3528]; MENRT	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MENRT	This work was supported by the Institut Pasteur and CNRS (UMR 3528, Biologie Structurale et Agents Infectieux).; Supported by an allocation doctorale from MENRT, which was distributed by Universite Pierre et Marie Curie (Paris VI).; Supported by Institut Pasteur Grant PTR 374.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; Cilia E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002794; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dubay KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002168; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Hamacher K, 2006, PLOS COMPUT BIOL, V2, P80, DOI 10.1371/journal.pcbi.0020010; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Laine E, 2009, BIOPHYS J, V96, P1249, DOI 10.1016/j.bpj.2008.10.055; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Nussinov R, 2013, STRUCTURE, V21, P1509, DOI 10.1016/j.str.2013.06.002; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; Seifert R, 2012, TRENDS MICROBIOL, V20, P343, DOI 10.1016/j.tim.2012.04.002; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Selwa E, 2012, PROTEINS, V80, P1028, DOI 10.1002/prot.24005; Shen YQ, 2002, EMBO J, V21, P6721, DOI 10.1093/emboj/cdf681; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Weinkam P, 2013, J MOL BIOL, V425, P647, DOI 10.1016/j.jmb.2012.11.041; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang Y, 2008, FEBS LETT, V582, P1355, DOI 10.1016/j.febslet.2008.03.010	50	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21131	21141		10.1074/jbc.M113.530410	http://dx.doi.org/10.1074/jbc.M113.530410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907274	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000339396600063
J	Vindstad, OPL; Schultze, S; Jepsen, JU; Biuw, M; Kapari, L; Sverdrup-Thygeson, A; Ims, RA				Vindstad, Ole Petter Laksforsmo; Schultze, Sabrina; Jepsen, Jane Uhd; Biuw, Martin; Kapari, Lauri; Sverdrup-Thygeson, Anne; Ims, Rolf Anker			Numerical Responses of Saproxylic Beetles to Rapid Increases in Dead Wood Availability following Geometrid Moth Outbreaks in Sub-Arctic Mountain Birch Forest	PLOS ONE			English	Article							BOREAL FORESTS; NATIONAL-PARK; CONSERVATION; COLEOPTERA; SPRUCE; RETENTION; DYNAMICS; LEPIDOPTERA; RESOURCES; DIVERSITY	Saproxylic insects play an important part in decomposing dead wood in healthy forest ecosystems, but little is known about their role in the aftermath of large-scale forest mortality caused by pest insect outbreaks. We used window traps to study short-term changes in the abundance and community structure of saproxylic beetles following extensive mortality of mountain birch in sub-arctic northern Norway caused by an outbreak of geometrid moths. Three to five years after the outbreak, the proportion of obligate saproxylic individuals in the beetle community was roughly 10% higher in forest damaged by the outbreak than in undamaged forest. This was mainly due to two early-successional saproxylic beetle species. Facultative saproxylic beetles showed no consistent differences between damaged and undamaged forest. These findings would suggest a weak numerical response of the saproxylic beetle community to the dead wood left by the outbreak. We suggest that species-specific preferences for certain wood decay stages may limit the number of saproxylic species that respond numerically to an outbreak at a particular time, and that increases in responding species may be constrained by limitations to the amount of dead wood that can be exploited within a given timeframe (i.e. satiation effects). Low diversity of beetle species or slow development of larvae in our cold sub-arctic study region may also limit numerical responses. Our study suggests that saproxylic beetles, owing to weak numerical responses, may so far have played a minor role in decomposing the vast quantities of dead wood left by the moth outbreak.	[Vindstad, Ole Petter Laksforsmo; Kapari, Lauri; Ims, Rolf Anker] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Schultze, Sabrina] Univ Luneburg, Dept Ecol, D-21335 Luneburg, Germany; [Jepsen, Jane Uhd; Biuw, Martin] Norwegian Inst Nat Res, Fram Ctr, Tromso, Norway; [Sverdrup-Thygeson, Anne] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway	UiT The Arctic University of Tromso; Leuphana University Luneburg; Norwegian Institute Nature Research; Norwegian University of Life Sciences	Vindstad, OPL (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	ole.p.vindstad@uit.no	Vindstad, Ole Petter laksforsmo/P-5821-2019; Sverdrup-Thygeson, Anne/I-2902-2017; Sverdrup-Thygeson, Anne/AAW-7779-2021; Biuw, Martin/AAF-9895-2021	Vindstad, Ole Petter laksforsmo/0000-0003-2483-2568; Sverdrup-Thygeson, Anne/0000-0002-3122-2250; Biuw, Martin/0000-0001-8051-3399; Jepsen, Jane Uhd/0000-0003-1517-1569	University of Tromso; research council of Norway; Norwegian Institute of Nature Research; Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) - Norden Top-Level Initiative "Effect studies and adaptation to climate change''	University of Tromso; research council of Norway(Research Council of Norway); Norwegian Institute of Nature Research; Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) - Norden Top-Level Initiative "Effect studies and adaptation to climate change''	This study was funded by the University of Tromso and the research council of Norway, with additional support from the Norwegian Institute of Nature Research and the Nordic Centre of Excellence - How to preserve the tundra under a warming climate (NCoE-Tundra) funded by the Norden Top-Level Initiative "Effect studies and adaptation to climate change''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa P., 2012, INSECT OUTBREAKS REV; Bell JL, 1997, AM MIDL NAT, V137, P239, DOI 10.2307/2426843; Bergman KO, 2012, FOREST ECOL MANAG, V265, P133, DOI 10.1016/j.foreco.2011.10.030; Bohme J, 2005, KAFAR MITTELEUROPAS; Bouget C, 2004, BIOL CONSERV, V118, P281, DOI 10.1016/j.biocon.2003.09.009; Boulanger Y, 2007, ENVIRON ENTOMOL, V36, P128, DOI 10.1603/0046-225X-36.1.128; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Buckland P.I., 2006, IGBP PAGES WORLD DAT; Bylund Helena, 1999, Ecological Bulletins, V47, P54; Dahlberg A, 2004, VEDLEVANDE ARTERS KR; Drever MC, 2009, ECOLOGY, V90, P1095, DOI 10.1890/08-0575.1; Ehnstr?m B, 2002, INSEKTSGNAG BARK; Eschtruth AK, 2006, CAN J FOREST RES, V36, P1435, DOI 10.1139/X06-050; Eveleigh ES, 2007, P NATL ACAD SCI USA, V104, P16976, DOI 10.1073/pnas.0704301104; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Greenacre M., 2010, BIPLOTS PRACTICE; Grimbacher PS, 2009, OECOLOGIA, V161, P591, DOI 10.1007/s00442-009-1399-5; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Hammond HEJ, 2004, CAN J FOREST RES, V34, P1, DOI 10.1139/X03-192; Haney JC, 1999, FOREST ECOL MANAG, V120, P203, DOI 10.1016/S0378-1127(98)00545-3; Hogstad O, 2005, IBIS, V147, P77, DOI [10.1111/j.1474-919X.2004.00338.x, 10.1111/j.1474-919x.2004.00338]; Hyvurinen, 2006, THESIS U JOENSUU, V2006, P1; Jepsen JU, 2013, ECOSYSTEMS, V16, P561, DOI 10.1007/s10021-012-9629-9; Jepsen JU, 2009, P ROY SOC B-BIOL SCI, V276, P4119, DOI 10.1098/rspb.2009.1148; Jogeir N., 2012, BIODIVERSITY DEAD WO; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Kaila L, 1997, BIODIVERS CONSERV, V6, P1, DOI 10.1023/A:1018399401248; Kalas J. A., 2010, NORWEGIAN RED LIST S; Karlsen S, 2013, OECOLOGIA, P1; Kaukonen M, 2013, ECOLOGY, V94, P267, DOI 10.1890/12-0917.1; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lehnert LW, 2013, J NAT CONSERV, V21, P97, DOI 10.1016/j.jnc.2012.11.003; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lindhe A, 2005, BIODIVERS CONSERV, V14, P3033, DOI 10.1007/s10531-004-0314-y; Makinen H, 2006, ECOL APPL, V16, P1865, DOI 10.1890/1051-0761(2006)016[1865:PTDOSP]2.0.CO;2; Marcello GJ, 2008, J ANIM ECOL, V77, P41, DOI 10.1111/j.1365-2656.2007.01310.x; Martikainen P, 2004, BIOL CONSERV, V120, P171, DOI 10.1016/j.biocon.2004.02.009; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; Menke N, 2006, UNTERSUCHUNGEN STRUK; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2010, BIOL CONSERV, V143, P2559, DOI 10.1016/j.biocon.2010.06.024; Muller MM, 2002, FOREST ECOL MANAG, V166, P165, DOI 10.1016/S0378-1127(01)00671-5; MUONA J, 1994, ANN ZOOL FENN, V31, P109; Price P.W., 2011, INSECT ECOLOGY BEHAV; Reeve JD, 1997, OECOLOGIA, V112, P48, DOI 10.1007/s004420050282; Ruohomaki K, 2000, POPUL ECOL, V42, P211, DOI 10.1007/PL00012000; Saint-Germain M, 2004, ENVIRON ENTOMOL, V33, P1703, DOI 10.1603/0046-225X-33.6.1703; Schowalter T. D., 1992, TROPICAL ECOSYSTEMS, P373; Speight M.C., 1989, SAPROXYLIC INVERTEBR; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; Sverdrup-Thygeson A, 2014, BIODIVERS CONSERV, V23, P513, DOI 10.1007/s10531-014-0628-3; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Tenow O., 1972, Zoologiska Bidr Upps, V2, P1; Ulyshen MD, 2013, INSECT CONSERV DIVER, V6, P393, DOI 10.1111/j.1752-4598.2012.00220.x; Ulyshen MD, 2013, METHODS ECOL EVOL, V4, P345, DOI 10.1111/2041-210x.12012; Vandegrift KJ, 2009, J ANIM ECOL, V78, P202, DOI 10.1111/j.1365-2656.2008.01456.x; Wermelinger Beat, 2002, Forest Snow and Landscape Research, V77, P133; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2012, ECOLOGICAL CONSEQUEN, P197; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; ZHONG H, 1989, CAN J FOREST RES, V19, P943, DOI 10.1139/x89-145	66	9	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99624	10.1371/journal.pone.0099624	http://dx.doi.org/10.1371/journal.pone.0099624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911056	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000337165600111
J	He, DM; Ruan, HH				He, Dongmei; Ruan, Honghua			Long Term Effect of Land Reclamation from Lake on Chemical Composition of Soil Organic Matter and Its Mineralization	PLOS ONE			English	Article							COMMON ARABLE TOPSOILS; CARBON MINERALIZATION; HUMIC SUBSTANCES; SPECTROSCOPIC CHARACTERIZATION; MICROBIAL BIOMASS; FOREST FLOOR; FULVIC-ACIDS; DYNAMICS; LABILE; TEMPERATURE	Since the late 1950s, land reclamation from lakes has been a common human disturbance to ecosystems in China. It has greatly diminished the lake area, and altered natural ecological succession. However, little is known about its impact on the carbon (C) cycle. We conducted an experiment to examine the variations of chemical properties of dissolved organic matter (DOM) and C mineralization under four land uses, i.e. coniferous forest (CF), evergreen broadleaf forest (EBF), bamboo forest (BF) and cropland (CL) in a reclaimed land area from Taihu Lake. Soils and lake sediments (LS) were incubated for 360 days in the laboratory and the CO2 evolution from each soil during the incubation was fit to a double exponential model. The DOM was analyzed at the beginning and end of the incubation using UV and fluorescence spectroscopy to understand the relationships between DOM chemistry and C mineralization. The C mineralization in our study was influenced by the land use with different vegetation and management. The greatest cumulative CO2-C emission was observed in BF soil at 0-10 cm depth. The active C pool in EBF at 10-25 cm had longer (62 days) mean residence time (MRT). LS showed the highest cumulative CO2-C and shortest MRT comparing with the terrestrial soils. The carbohydrates in DOM were positively correlated with CO2-C evolution and negatively correlated to phenols in the forest soils. Cropland was consistently an outlier in relationships between DOM chemistry and CO2-evolution, highlighting the unique effects that this land use on soil C cycling, which may be attributed the tillage practices. Our results suggest that C mineralization is closely related to the chemical composition of DOM and sensitive to its variation. Conversion of an aquatic ecosystem into a terrestrial ecosystem may alter the chemical structure of DOM, and then influences soil C mineralization.	[Ruan, Honghua] Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; Nanjing Forestry Univ, Key Lab Forestry & Ecol Engn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Ruan, HH (corresponding author), Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	hhruan@njfu.edu.cn			MOST of China (973 Program) [2012CB416904]; National Science Foundation of China [31170417]; PAPD; Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University	MOST of China (973 Program); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); PAPD; Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University	This study was supported by the MOST of China (973 Program No. 2012CB416904), the National Science Foundation of China (No. 31170417) and partially supported by PAPD and Collaborative Innovation plan of Jiangsu higher education, Doctorate Fellowship Foundation of Nanjing Forestry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi J, 2007, CHEMOSPHERE, V69, P1040, DOI 10.1016/j.chemosphere.2007.04.036; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Boddy E, 2007, SOIL BIOL BIOCHEM, V39, P827, DOI 10.1016/j.soilbio.2006.09.030; Bu XL, 2011, EUR J SOIL BIOL, V47, P102, DOI 10.1016/j.ejsobi.2010.11.009; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Caravaca F, 2002, SOIL TILL RES, V68, P23, DOI 10.1016/S0167-1987(02)00080-6; Chantigny M.H., 2007, SOIL SAMPLING METHOD, P617; Chantigny MH, 2003, GEODERMA, V113, P357, DOI 10.1016/S0016-7061(02)00370-1; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; Chen J, 2002, CHEMOSPHERE, V48, P59, DOI 10.1016/S0045-6535(02)00041-3; Cookson WR, 2008, SOIL BIOL BIOCHEM, V40, P763, DOI 10.1016/j.soilbio.2007.10.011; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Corvasce M, 2006, CHEMOSPHERE, V62, P1583, DOI 10.1016/j.chemosphere.2005.07.065; Don A, 2005, SOIL BIOL BIOCHEM, V37, P2171, DOI 10.1016/j.soilbio.2005.03.019; Embacher A, 2007, GEODERMA, V139, P11, DOI 10.1016/j.geoderma.2006.12.002; Embacher A, 2008, GEODERMA, V148, P63, DOI 10.1016/j.geoderma.2008.09.006; EWALD M, 1988, GEODERMA, V43, P11, DOI 10.1016/0016-7061(88)90051-1; Faikd HA, 2000, THESIS ZHEJIANG U CH; Fuentes M, 2006, ORG GEOCHEM, V37, P1949, DOI 10.1016/j.orggeochem.2006.07.024; Ge Q., 2000, ACTA GEOGRAPHICA SIN, V55, P698; Glatzel S, 2003, GEODERMA, V113, P397, DOI 10.1016/S0016-7061(02)00372-5; Nguyen HVM, 2011, CHEMOSPHERE, V85, P782, DOI 10.1016/j.chemosphere.2011.06.068; Hansson K, 2010, SOIL BIOL BIOCHEM, V42, P178, DOI 10.1016/j.soilbio.2009.10.013; Hur J, 2011, CHEMOSPHERE, V85, P1360, DOI 10.1016/j.chemosphere.2011.08.001; Hur J, 2009, CHEMOSPHERE, V75, P483, DOI 10.1016/j.chemosphere.2008.12.056; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Juarez S, 2011, GEODERMA, V167-68, P247, DOI 10.1016/j.geoderma.2011.09.007; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, SOIL BIOL BIOCHEM, V35, P1129, DOI 10.1016/S0038-0717(03)00165-2; Kalbitz K, 1999, BIOGEOCHEMISTRY, V47, P219, DOI 10.1007/BF00994924; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kalbitz K, 2001, J PLANT NUTR SOIL SC, V164, P259, DOI 10.1002/1522-2624(200106)164:3<259::AID-JPLN259>3.0.CO;2-T; Kalbitz K, 2007, BIOGEOCHEMISTRY, V86, P301, DOI 10.1007/s10533-007-9161-8; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Khomutova TE, 2000, PLANT SOIL, V219, P13, DOI 10.1023/A:1004793515494; Kiikkila O, 2006, SOIL BIOL BIOCHEM, V38, P737, DOI 10.1016/j.soilbio.2005.06.024; Kowalczuk P, 2009, MAR CHEM, V113, P182, DOI 10.1016/j.marchem.2009.01.015; Lal R, 2002, ENVIRON POLLUT, V116, P353, DOI 10.1016/S0269-7491(01)00211-1; Leinweber P, 2008, SOIL BIOL BIOCHEM, V40, P1496, DOI 10.1016/j.soilbio.2008.01.003; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Majcher EH, 2000, SOIL SCI SOC AM J, V64, P157, DOI 10.2136/sssaj2000.641157x; Marinari S, 2010, SOIL TILL RES, V106, P211, DOI 10.1016/j.still.2009.12.010; Marschner B, 2003, GEODERMA, V113, P211, DOI 10.1016/S0016-7061(02)00362-2; Marschner B, 2002, SOIL BIOL BIOCHEM, V34, P459, DOI 10.1016/S0038-0717(01)00203-6; Martin D, 2010, AGR ECOSYST ENVIRON, V138, P64, DOI 10.1016/j.agee.2010.04.001; Matilainen A, 2011, CHEMOSPHERE, V83, P1431, DOI 10.1016/j.chemosphere.2011.01.018; Mora JL, 2007, SCI TOTAL ENVIRON, V378, P143, DOI 10.1016/j.scitotenv.2007.01.040; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Rey A, 2006, GLOBAL CHANGE BIOL, V12, P1894, DOI 10.1111/j.1365-2486.2006.01230.x; Rodriguez AR, 2004, GEODERMA, V121, P205, DOI 10.1016/j.geoderma.2003.11.009; Rovira P, 2007, SOIL BIOL BIOCHEM, V39, P202, DOI 10.1016/j.soilbio.2006.07.021; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Simonsson M, 2005, GEODERMA, V124, P157, DOI 10.1016/j.geoderma.2004.04.010; Sondergaard M, 2007, J APPL ECOL, V44, P1089, DOI 10.1111/j.1365-2664.2007.01426.x; Teixeira Mariana Carolina, 2011, Acta Limnol. Bras., V23, P333; Tian L, 2010, APPL SOIL ECOL, V46, P426, DOI 10.1016/j.apsoil.2010.09.007; Tobiasova E, 2011, SOIL TILL RES, V114, P183, DOI 10.1016/j.still.2011.05.003; Traversa A, 2008, FOREST ECOL MANAG, V256, P2018, DOI 10.1016/j.foreco.2008.07.038; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang LY, 2009, J ENVIRON SCI, V21, P581, DOI 10.1016/S1001-0742(08)62311-6; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; Wang Y, 2010, SOIL SCI, V175, P624, DOI 10.1097/SS.0b013e3181fe2ee4; Wieder WR, 2008, BIOGEOCHEMISTRY, V88, P127, DOI 10.1007/s10533-008-9200-0; Yang Li-xia, 2006, Journal of Forestry Research (Harbin), V17, P39, DOI 10.1007/s11676-006-0009-1; Yin HB, 2008, PEDOSPHERE, V18, P564, DOI 10.1016/S1002-0160(08)60050-8; You BS, 2007, J ENVIRON SCI, V19, P1055, DOI 10.1016/S1001-0742(07)60172-7; Zhang LY, 2005, MODERN FOOD SCI TECH, V22, P247; Zhao MX, 2008, EUR J SOIL BIOL, V44, P158, DOI 10.1016/j.ejsobi.2007.09.007; Zhou Y, 2009, THESIS NANJING FORES; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0; Zsolnay A, 2003, GEODERMA, V113, P187, DOI 10.1016/S0016-7061(02)00361-0	71	6	11	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99251	10.1371/journal.pone.0099251	http://dx.doi.org/10.1371/journal.pone.0099251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905998	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000114
J	Jiang, L; Xiao, X; Ren, J; Tang, YY; Weng, HQ; Yang, Q; Wu, MJ; Tang, W				Jiang, Li; Xiao, Xiao; Ren, Jin; Tang, YongYong; Weng, HongQing; Yang, Qi; Wu, MingJun; Tang, Wei			Proteomic Analysis of Bladder Cancer Indicates Prx-I as a Key Molecule in BI-TK/GCV Treatment System	PLOS ONE			English	Article							PEROXIREDOXIN-I; GENE-THERAPY; SELECTIVE LOCALIZATION; HYDROGEN-PEROXIDE; SULFINIC ACID; RAT MODEL; EXPRESSION; APOPTOSIS; CELLS; OVEREXPRESSION	In order to understand the molecular mechanisms of Bifidobacterium infantis thymidine kinase/nucleoside analogue ganciclovir (BI-TK/GCV) treatment system which was proven to exhibit sustainable anti-tumor growth activity and induce apoptosis in bladder cancer, a proteomic approach of isobaric tags for relative and absolute quantification (iTRAQ), followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used. 192 down-regulated and 210 up-regulated proteins were identified after treatment with BI-TK/GCV system in Sprague-Dawley (SD) rats. Western blot analysis and immunohistochemistry analysis confirmed that Peroxiredoxin-I (Prx-I) was significantly down-regulated in bladder cancer after treatment. Prx-I silencing by transfection of Prx-I shRNA significantly suppressed growth, promoted apoptosis and regulated the cell cycle in T24 cells and reduced the phospho-NF-kappa B p50 and p65 protein expression which revealed the links between Prx-I and NF-kappa B pathway implied by Ingenuity pathway analysis (IPA). These findings yield new insights into the therapy of bladder cancer, revealing Prx-I as a new therapeutic target and indicating BI-TK/GCV system as a prospective therapy by down-regulation of Prx-I through NF-kappa B signaling pathway.	[Jiang, Li; Xiao, Xiao; Ren, Jin; Tang, YongYong; Weng, HongQing; Yang, Qi; Tang, Wei] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Wu, MingJun] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Tang, W (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China.	tangwei2060@163.com			Natural Scientific Foundation of China [81072087/H1619]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the research grant from the Natural Scientific Foundation of China (No. 81072087/H1619). The URL for National Natural Science Foundation of China: http://www.nsfc.gov.cn/publish/portal0/default.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACS, 2014, CANC FACTS FIG 2014; Aguilar-Melero P, 2013, J PROTEOMICS, V79, P161, DOI 10.1016/j.jprot.2012.12.005; Chae HZ, 2012, ANTIOXID REDOX SIGN, V16, P506, DOI 10.1089/ars.2011.4260; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Du ZX, 2010, ENDOCR-RELAT CANCER, V17, P553, DOI 10.1677/ERC-09-0269; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Gao MC, 2011, ACTA PHARMACOL SIN, V32, P528, DOI 10.1038/aps.2010.235; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim HJ, 2003, CELL BIOL TOXICOL, V19, P285, DOI 10.1023/B:CBTO.0000004952.07979.3d; KIMURA NT, 1980, CANCER RES, V40, P2061; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Knoops Bernard, 2007, V44, P27; Lehtonen ST, 2004, INT J CANCER, V111, P514, DOI 10.1002/ijc.20294; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Noh DY, 2001, ANTICANCER RES, V21, P2085; Pasin Erik, 2008, Rev Urol, V10, P31; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Quan CY, 2006, J UROLOGY, V175, P1512, DOI 10.1016/S0022-5347(05)00659-2; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Tang W, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-155; Wang XM, 2010, MOL BIOL CELL, V21, P2987, DOI 10.1091/mbc.E10-02-0160; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yanagawa T, 2005, INT J ORAL MAX SURG, V34, P915, DOI 10.1016/j.ijom.2005.04.015; Yanagawa T, 1999, CANCER LETT, V145, P127, DOI 10.1016/S0304-3835(99)00243-8; Yazawa K, 2000, CANCER GENE THER, V7, P269, DOI 10.1038/sj.cgt.7700122; Yin X, 2013, CANCER GENE THER, V20, P77, DOI 10.1038/cgt.2012.86; Zhang B, 2009, CANCER LETT, V286, P154, DOI 10.1016/j.canlet.2009.04.043	39	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98764	10.1371/journal.pone.0098764	http://dx.doi.org/10.1371/journal.pone.0098764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24904997	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000061
J	Jin, CJ; Yu, SH; Wang, XM; Woo, SJ; Park, HJ; Lee, HC; Choi, SH; Kim, KM; Kim, JH; Park, KS; Jang, HC; Lim, S				Jin, Cheng Ji; Yu, Sung Hoon; Wang, Xiao-Mei; Woo, Se Joon; Park, Hyo Jin; Lee, Hyun Chul; Choi, Sung Hee; Kim, Kyoung Min; Kim, Jung Hee; Park, Kyong Soo; Jang, Hak Chul; Lim, Soo			The Effect of Lithospermic Acid, an Antioxidant, on Development of Diabetic Retinopathy in Spontaneously Obese Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; TOKUSHIMA FATTY RATS; OXIDATIVE STRESS; VASCULAR LEAKAGE; DOWN-REGULATION; MACULAR EDEMA; VEGF; COMPLICATIONS; FIBRONECTIN	Background: Lithospermic acid B (LAB), an active component isolated from Salvia miltiorrhiza radix, has been reported to have antioxidant effects. We examined the effects of LAB on the prevention of diabetic retinopathy in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an animal model of type 2 diabetes. Methods and Findings: LAB (10 or 20 mg/kg) or normal saline were given orally once daily to 24-week-old male OLETF rats for 52 weeks. At the end of treatment, fundoscopic findings, vascular endothelial growth factor (VEGF) expression in the eyeball, VEGF levels in the ocular fluid, and any structural abnormalities in the retina were assessed. Glucose metabolism, serum levels of high-sensitivity C-reactive protein (hsCRP), monocyte chemotactic protein-1 (MCP1), and tumor necrosis factor-alpha (TNF alpha) and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels were also measured. Treatment with LAB prevented vascular leakage and basement membrane thickening in retinal capillaries in a dose-dependent manner. Insulin resistance and glucose intolerance were significantly improved by LAB treatment. The levels of serum hsCRP, MCP1, TNF alpha, and urinary 8-OHdG were lower in the LAB-treated OLETF rats than in the controls. Conclusions: Treatment with LAB had a preventive effect on the development of diabetic retinopathy in this animal model, probably because of its antioxidative effects and anti-inflammatory effects.	[Jin, Cheng Ji; Yu, Sung Hoon; Choi, Sung Hee; Kim, Kyoung Min; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea; [Jin, Cheng Ji; Yu, Sung Hoon; Woo, Se Joon; Park, Hyo Jin; Choi, Sung Hee; Kim, Kyoung Min; Jang, Hak Chul; Lim, Soo] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea; [Woo, Se Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Songnam, South Korea; [Park, Hyo Jin] Seoul Natl Univ, Coll Med, Dept Pathol, Songnam, South Korea; [Jin, Cheng Ji; Wang, Xiao-Mei] Dalian Univ, ZhongShan Hosp, Dept Endocrinol, Dalian 116012, Peoples R China; [Yu, Sung Hoon] Hallym Univ, Hangang Sacred Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Hyun Chul] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jung Hee; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dalian University; Hallym University; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Lim, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea.	limsoo@snu.ac.kr	Lim, Soo/AAU-8107-2020; Park, Kyong Soo/C-2265-2008	Lim, Soo/0000-0002-4137-1671; Park, Kyong Soo/0000-0003-3597-342X; CHOI, SUNG HEE/0000-0003-0740-8116; Park, Hyo Jin/0000-0002-2198-5211; Kim, Kyoung Min/0000-0001-8150-0266	Korean Diabetes Association	Korean Diabetes Association	This work was supported by the Korean Diabetes Association (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bandello F, 2013, ACTA DIABETOL, V50, P1, DOI 10.1007/s00592-012-0449-3; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; CLARK CM, 1995, NEW ENGL J MED, V332, P1210, DOI 10.1056/NEJM199505043321807; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Dong QY, 2008, EUR J OPHTHALMOL, V18, P94, DOI 10.1177/112067210801800116; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; Hur KY, 2008, EUR J PHARMACOL, V586, P226, DOI 10.1016/j.ejphar.2008.02.072; Hur KY, 2010, ATHEROSCLEROSIS, V211, P69, DOI 10.1016/j.atherosclerosis.2010.01.035; Imesch PD, 1997, RETINA-J RET VIT DIS, V17, P321, DOI 10.1097/00006982-199707000-00008; ISHIBASHI T, 1993, BRIT J OPHTHALMOL, V77, P574, DOI 10.1136/bjo.77.9.574; Jung KI, 2013, J PHARMACOL EXP THER, V345, P457, DOI 10.1124/jpet.113.203067; Jung M, 2002, CHEM PHARM BULL, V50, P1135, DOI 10.1248/cpb.50.1135; Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001; KAMATA K, 1994, GEN PHARMACOL, V25, P69, DOI 10.1016/0306-3623(94)90011-6; Kim YH, 2008, DIABETES, V57, P2181, DOI 10.2337/db07-1431; KLEIN R, 1989, DIABETES METAB REV, V5, P559, DOI 10.1002/dmr.5610050703; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Lee GT, 2003, J AM SOC NEPHROL, V14, P709, DOI 10.1097/01.ASN.0000051660.82593.19; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Limb GA, 2001, INVEST OPHTH VIS SCI, V42, P1586; Lu Y, 2014, INT J OPHTHALMOL-CHI, V7, P1, DOI 10.3980/j.issn.2222-3959.2014.01.01; Lu ZY, 2003, JPN J OPHTHALMOL, V47, P28, DOI 10.1016/S0021-5155(02)00631-7; Makino N, 2005, J DIABETES COMPLICAT, V19, P347, DOI 10.1016/j.jdiacomp.2005.04.002; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitamura Y, 2001, OPHTHALMOLOGICA, V215, P415, DOI 10.1159/000050900; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Nebbioso M, 2012, DIABETES TECHNOL THE, V14, P257, DOI 10.1089/dia.2011.0172; Park KS, 2001, DIABETES, V50, P2837, DOI 10.2337/diabetes.50.12.2837; Pescosolido N, 2008, DRUGS R&D, V9, P15, DOI 10.2165/0126839-200809001-00003; Porta M, 2011, DIABETES OBES METAB, V13, P784, DOI 10.1111/j.1463-1326.2011.01415.x; Praidou A, 2010, CURR DIABETES REV, V6, P304, DOI 10.2174/157339910793360815; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Roy S, 2003, DIABETES, V52, P1229, DOI 10.2337/diabetes.52.5.1229; Roy S, 2010, CURR EYE RES, V35, P1045, DOI 10.3109/02713683.2010.514659; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soung DY, 2003, J PHARM PHARMACOL, V55, P1427, DOI 10.1211/0022357021891; Svoboda P, 2008, ANAL BIOCHEM, V383, P236, DOI 10.1016/j.ab.2008.09.014; Tanaka Y, 1997, LANCET, V349, P1520, DOI 10.1016/S0140-6736(05)62099-5; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; Waisbourd M, 2011, ACTA OPHTHALMOL, V89, P203, DOI 10.1111/j.1755-3768.2010.02010.x; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wong TY, 2012, AM J OPHTHALMOL, V154, P6, DOI 10.1016/j.ajo.2012.03.013; Woo SJ, 2011, INVEST OPHTH VIS SCI, V52, P7697, DOI 10.1167/iovs.11-7784; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Wu YX, 2012, INVEST OPHTH VIS SCI, V53, P8405, DOI 10.1167/iovs.12-10553; Xu X, 2004, CURR EYE RES, V28, P251, DOI 10.1076/ceyr.28.4.251.27834; Yang JH, 2013, INVEST OPHTH VIS SCI, V54, P3844, DOI 10.1167/iovs.12-11309	56	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98232	10.1371/journal.pone.0098232	http://dx.doi.org/10.1371/journal.pone.0098232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905410	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000021
J	Maheswaran, D; Zeng, YY; Chan-Yeung, M; Scott, J; Osornio-Vargas, A; Becker, AB; Kozyrskyj, AL				Maheswaran, Dharini; Zeng, Yiye; Chan-Yeung, Moira; Scott, James; Osornio-Vargas, Alvaro; Becker, Allan B.; Kozyrskyj, Anita L.			Exposure to Beta-(1,3)-D-Glucan in House Dust at Age 7-10 Is Associated with Airway Hyperresponsiveness and Atopic Asthma by Age 11-14	PLOS ONE			English	Article							BETA-GLUCANS; BRONCHIAL HYPERRESPONSIVENESS; RESPIRATORY HEALTH; FLOW VARIABILITY; MOISTURE DAMAGE; MOLD COMPONENTS; INNATE IMMUNITY; HOME DAMPNESS; CHILDREN; ENDOTOXIN	Background: Mould exposure has been linked to childhood asthma and bronchial hyper-responsiveness. Few studies have assessed beta-(1,3)-d-glucan (beta-glucan), a significant fungal cell wall constituent, in relation to asthma in adolescence. Objective: To determine whether house dust-derived beta-glucan exposure at age 7-10 is associated with the development and persistence of atopic and non-atopic asthma, and bronchial hyper-responsiveness (BHR) by age 11-14. Methods: Dust samples were collected from the 1995 Study of Asthma, Genes, and Environment (SAGE) birth cohort. This cohort was derived from Manitoba provincial healthcare administrative records of children high and low risk for asthma. Samples were collected from the homes of 422 children at age 7-10 and analyzed using beta-glucan and endotoxin-specific Limulus Amoebocyte Lysate assays. Asthma, atopy, and BHR status of each child were also assessed at ages 7-10 and 11-14. Results: At age 7-10, beta-glucan dust levels in the home were associated with persistent atopic asthma at age 11-14 (OR 1.79 for each unit increase in levels, 95% CI 1.14-2.81), independent of endotoxin exposure, and Alternaria or Cladosporium sensitization. The likelihood of BHR almost doubled with unit increases in dust beta-glucan in asthmatic children. In children without asthma, exposure to high beta-glucan levels at age 7-10 also elevated risk for BHR in adolescence (OR 1.74, 95% CI 1.05-2.89). New-onset atopic asthma was twice more likely following high beta-glucan exposure in children without asthma but the association did not reach statistical significance. No associations were evident with concurrent asthma phenotype at age 7-10 or non-atopic asthma at age 11-14. Conclusion: These findings implicate home beta-glucan exposure at school-age as a risk factor for persistent atopic asthma and new-onset BHR. The higher prevalence of BHR in urban adolescents may be propagated by this home exposure.	[Maheswaran, Dharini] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Zeng, Yiye; Osornio-Vargas, Alvaro; Kozyrskyj, Anita L.] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [Chan-Yeung, Moira] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Scott, James] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Becker, Allan B.] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Kozyrskyj, Anita L.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	Monash University; University of Alberta; University of British Columbia; University of Toronto; University of Manitoba; University of Alberta	Kozyrskyj, AL (corresponding author), Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada.	kozyrsky@ualberta.ca	Scott, James A/A-8598-2011; Scott, James A/AAN-4011-2021; Osornio Vargas, Alvaro Roman/B-4645-2010	Scott, James A/0000-0002-5073-0832; Scott, James A/0000-0002-5073-0832; Osornio Vargas, Alvaro Roman/0000-0001-8287-7102	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The funding for this project was provided by the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, SCI TOTAL ENVIRON, V408, P5489, DOI 10.1016/j.scitotenv.2010.07.087; Akramiene D, 2007, MEDICINA-LITHUANIA, V43, P597, DOI 10.3390/medicina43080076; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Behbod B, 2013, ALLERGY, V68, P1410, DOI 10.1111/all.12254; Bendelac A, 1997, CURR OPIN IMMUNOL, V9, P1, DOI 10.1016/S0952-7915(97)80151-3; Bundy KW, 2009, ANN ALLERG ASTHMA IM, V103, P26, DOI 10.1016/S1081-1206(10)60139-1; CDC (Centre for Disease Control and Prevention), 2013, FASTSTATS ASTHM; Chan-Yeung M, 2010, ALLERGY, V65, P1404, DOI 10.1111/j.1398-9995.2010.02399.x; Cherid H, 2011, J OCCUP ENVIRON HYG, V8, P540, DOI 10.1080/15459624.2011.601994; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Collins RA, 2011, J ALLERGY CLIN IMMUN, V128, P301, DOI 10.1016/j.jaci.2011.03.016; Dales RE, 1997, INT J EPIDEMIOL, V26, P120, DOI 10.1093/ije/26.1.120; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Foto M, 2004, ANAL BIOANAL CHEM, V379, P156, DOI 10.1007/s00216-004-2583-4; Fraser Institute, 2012, CAN ENV IND AIR QUAL; Garner Rochelle, 2008, Health Rep, V19, P45; Gehring U, 2001, ENVIRON HEALTH PERSP, V109, P139, DOI 10.2307/3434766; Giovannangelo MECA, 2007, ENVIRON INT, V33, P9, DOI 10.1016/j.envint.2006.06.018; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Han YY, 2009, PEDIAT ALLERG IMM-UK, V20, P748, DOI 10.1111/j.1399-3038.2009.00871.x; Haverinen-Shaughnessy U, 2005, INDOOR BUILT ENVIRON, V14, P133, DOI 10.1177/1420326X05051260; Hedman L, 2011, THORAX, V66, P20, DOI 10.1136/thx.2010.143800; Heinrich J, 2003, J EXPO ANAL ENV EPID, V13, P152, DOI 10.1038/sj.jea.7500267; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Iossifova Y, 2008, INDOOR AIR, V18, P225, DOI 10.1111/j.1600-0668.2008.00526.x; Iossifova YY, 2007, ALLERGY, V62, P504, DOI 10.1111/j.1398-9995.2007.01340.x; Jogi R, 2004, INT J TUBERC LUNG D, V8, P1180; Kilpelainen M, 2001, THORAX, V56, P462, DOI 10.1136/thorax.56.6.462; Kim BS, 2010, PEDIATR PULM, V45, P1220, DOI 10.1002/ppul.21312; Kozyrskyj AL, 2009, ALLERGY, V64, P1185, DOI 10.1111/j.1398-9995.2009.02033.x; Krieger M, 1997, CURR OPIN LIPIDOL, V8, P275, DOI 10.1097/00041433-199710000-00006; Kuczmarski R J, 2000, Adv Data, P1; Lawson JA, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-56; Ly NP, 2008, CHEST, V133, P107, DOI 10.1378/chest.07-2130; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Masoli M, 2004, GLOBAL BURDEN ASTHMA, P1; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Mendy A, 2011, J ASTHMA, V48, P685, DOI 10.3109/02770903.2011.594140; Miller JD, 2007, J AIR WASTE MANAGE, V57, P297, DOI 10.1080/10473289.2007.10465337; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Muller A, 1996, J IMMUNOL, V156, P3418; Nathan AT, 2009, J ALLERGY CLIN IMMUN, V123, P612, DOI 10.1016/j.jaci.2008.12.006; Noal RB, 2011, OBES REV, V12, P93, DOI 10.1111/j.1467-789X.2010.00741.x; Novak M, 2008, J IMMUNOTOXICOL, V5, P47, DOI 10.1080/15476910802019045; Papadopoulos NG, 2008, PEDIAT ALLERG IMM-UK, V19, P51, DOI 10.1111/j.1399-3038.2008.00767.x; Pekkanen J, 2007, EUR RESPIR J, V29, P509, DOI 10.1183/09031936.00040806; Reponen T, 2010, SCI TOTAL ENVIRON, V408, P5565, DOI 10.1016/j.scitotenv.2010.07.090; Rylander R, 1997, ARCH ENVIRON HEALTH, V52, P281, DOI 10.1080/00039899709602199; Rylander R, 1998, AM J RESP CRIT CARE, V158, P1685, DOI 10.1164/ajrccm.158.5.9712139; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Sarinho E, 2009, ALLERGOL IMMUNOPATH, V37, P188, DOI 10.1016/j.aller.2009.02.005; Sjostrand M, 1997, INFLAMM RES, V46, P93, DOI 10.1007/s000110050108; Soltanian S, 2009, CRIT REV MICROBIOL, V35, P109, DOI 10.1080/10408410902753746; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; Statistics Canada, 2012, TABL 105 0501 ASTHM; Stopinsek S, 2011, INT IMMUNOPHARMACOL, V11, P939, DOI 10.1016/j.intimp.2011.02.006; ten Have WHO, 2007, CLIN EXP ALLERGY, V37, P1827, DOI 10.1111/j.1365-2222.2007.02841.x; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Tischer C, 2011, EUR RESPIR J, V37, P1050, DOI 10.1183/09031936.00091210; World Health Organization, 2011, ASTHM FACT SHEET; Wu FF, 2012, ANN AGR ENV MED, V17, P327; Yiin LM, 2008, J OCCUP ENVIRON HYG, V5, P94, DOI 10.1080/15459620701805169	65	27	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98878	10.1371/journal.pone.0098878	http://dx.doi.org/10.1371/journal.pone.0098878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905346	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000075
J	Nelson, JA; Bugbee, B				Nelson, Jacob A.; Bugbee, Bruce			Economic Analysis of Greenhouse Lighting: Light Emitting Diodes vs. High Intensity Discharge Fixtures	PLOS ONE			English	Article							FAR-RED LIGHT; BLUE-LIGHT; LETTUCE GROWTH; PLANTS; PHOTOSYNTHESIS; SUPPLEMENTATION; PRODUCTIVITY; RADIATION; SPECTRUM	Lighting technologies for plant growth are improving rapidly, providing numerous options for supplemental lighting in greenhouses. Here we report the photosynthetic (400-700 nm) photon efficiency and photon distribution pattern of two double-ended HPS fixtures, five mogul-base HPS fixtures, ten LED fixtures, three ceramic metal halide fixtures, and two fluorescent fixtures. The two most efficient LED and the two most efficient double-ended HPS fixtures had nearly identical efficiencies at 1.66 to 1.70 micromoles per joule. These four fixtures represent a dramatic improvement over the 1.02 micromoles per joule efficiency of the mogul-base HPS fixtures that are in common use. The best ceramic metal halide and fluorescent fixtures had efficiencies of 1.46 and 0.95 micromoles per joule, respectively. We also calculated the initial capital cost of fixtures per photon delivered and determined that LED fixtures cost five to ten times more than HPS fixtures. The five-year electric plus fixture cost per mole of photons is thus 2.3 times higher for LED fixtures, due to high capital costs. Compared to electric costs, our analysis indicates that the long-term maintenance costs are small for both technologies. If widely spaced benches are a necessary part of a production system, the unique ability of LED fixtures to efficiently focus photons on specific areas can be used to improve the photon capture by plant canopies. Our analysis demonstrates, however, that the cost per photon delivered is higher in these systems, regardless of fixture category. The lowest lighting system costs are realized when an efficient fixture is coupled with effective canopy photon capture.	[Nelson, Jacob A.; Bugbee, Bruce] Utah State Univ, Crop Physiol Lab, Dept Plant Soils & Climate, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Bugbee, B (corresponding author), Utah State Univ, Crop Physiol Lab, Dept Plant Soils & Climate, Logan, UT 84322 USA.	bruce.bugbee@usu.edu		Nelson, Jacob/0000-0002-4663-2420				Blonquist M, 2013, ANAL SPECTRAL COSINE; Both AJ, 2000, ACTA HORT ISHS, P183; Bourget CM, 2008, HORTSCIENCE, V43, P1944, DOI 10.21273/HORTSCI.43.7.1944; Ciolkosz DE, 2001, APPL ENG AGRIC, V17, P875; Cope KR, 2014, PHOTOCHEM PHOTOBIOL, V90, P574, DOI 10.1111/php.12233; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Craig DS, 2013, J AM SOC HORTIC SCI, V138, P167, DOI 10.21273/JASHS.138.3.167; Dougher TAO, 2004, J AM SOC HORTIC SCI, V129, P467, DOI 10.21273/JASHS.129.4.0467; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; Ferentinos KP, 2005, ENG APPL ARTIF INTEL, V18, P473, DOI 10.1016/j.engappai.2004.11.005; Frantz JM, 2000, J AM SOC HORTIC SCI, V125, P694, DOI 10.21273/JASHS.125.6.694; Gomez C, 2013, HORTTECHNOLOGY, V23, P93, DOI 10.21273/HORTTECH.23.1.93; IESNA Testing Procedures Committee, 2008, IES APPR METH EL PHO; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Massa GD, 2008, HORTSCIENCE, V43, P1951, DOI 10.21273/HORTSCI.43.7.1951; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; MORROW RC, 1988, PLANT PHYSIOL, V88, P1110, DOI 10.1104/pp.88.4.1110; Morrow RC, 2008, HORTSCIENCE, V43, P1947, DOI 10.21273/HORTSCI.43.7.1947; Nelson J. A., 2013, SPECTRAL CHARACTERIS; Yang ZC, 2012, SCI HORTIC-AMSTERDAM, V136, P81, DOI 10.1016/j.scienta.2011.12.023; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380	23	169	174	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99010	10.1371/journal.pone.0099010	http://dx.doi.org/10.1371/journal.pone.0099010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905835	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000091
J	Bolla, JR; Su, CC; Do, SV; Radhakrishnan, A; Kumar, N; Long, F; Chou, TH; Delmar, JA; Lei, HT; Rajashankar, KR; Shafer, WM; Yu, EW				Bolla, Jani Reddy; Su, Chih-Chia; Do, Sylvia V.; Radhakrishnan, Abhijith; Kumar, Nitin; Long, Feng; Chou, Tsung-Han; Delmar, Jared A.; Lei, Hsiang-Ting; Rajashankar, Kanagalaghatta R.; Shafer, William M.; Yu, Edward W.			Crystal Structure of the Neisseria gonorrhoeae MtrD Inner Membrane Multidrug Efflux Pump	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; TRANSPORTER ACRB; FUSION PROTEIN; BINDING POCKET; SYSTEM; RESISTANCE; MECHANISM; SOFTWARE; CHANNEL	Neisseria gonorrhoeae is an obligate human pathogen and the causative agent of the sexually-transmitted disease gonorrhea. The control of this disease has been compromised by the increasing proportion of infections due to antibiotic-resistant strains, which are growing at an alarming rate. The MtrCDE tripartite multidrug efflux pump, belonging to the hydrophobic and amphiphilic efflux resistance-nodulation-cell division (HAE-RND) family, spans both the inner and outer membranes of N. gonorrhoeae and confers resistance to a variety of antibiotics and toxic compounds. We here report the crystal structure of the inner membrane MtrD multidrug efflux pump, which reveals a novel structural feature that is not found in other RND efflux pumps.	[Bolla, Jani Reddy; Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Su, Chih-Chia; Long, Feng; Chou, Tsung-Han; Delmar, Jared A.; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA USA; [Do, Sylvia V.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA USA; [Rajashankar, Kanagalaghatta R.] NE CAT, Argonne, IL USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL USA; [Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] VA Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Bolla, Jani Reddy/AAT-1370-2020; Long, Feng/F-5475-2011; Radhakrishnan, Abhijith/V-6182-2019; , Nitin/J-8078-2019	Bolla, Jani Reddy/0000-0003-4346-182X; Long, Feng/0000-0001-6313-8558; Radhakrishnan, Abhijith/0000-0001-8107-3487; 	National Institutes of Health [R37AI021150, R01GM086431]; Medical Research Service of the Department of Veterans Affairs; National Institutes of General Medical Sciences [GM103403]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM086431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37AI021150 (W. M. S.) and R01GM086431 (E.W.Y.) and a Veterans Affairs Merit Award (W. M. S.) from the Medical Research Service of the Department of Veterans Affairs. The Northeastern Collaborative Access Team beamlines of the Advanced Photon Source is supported by the National Institutes of General Medical Sciences under an award GM103403. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Hagman KE, 1997, MICROBIOL-SGM, V143, P2117, DOI 10.1099/00221287-143-7-2117; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Janganan TK, 2013, MOL MICROBIOL, V88, P590, DOI 10.1111/mmi.12211; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; Lei HT, 2014, J MOL BIOL, V426, P403, DOI 10.1016/j.jmb.2013.09.042; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2013, NATURE, V500, P102, DOI 10.1038/nature12300; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Su CC, 2012, J MOL BIOL, V422, P429, DOI 10.1016/j.jmb.2012.05.038; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tapsall John, 2006, Expert Rev Anti Infect Ther, V4, P619, DOI 10.1586/14787210.4.4.619; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x	38	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97903	10.1371/journal.pone.0097903	http://dx.doi.org/10.1371/journal.pone.0097903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901477	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400015
J	O'Hara, B; de la Rosa, DA; Rajendran, VM				O'Hara, Bryan; de la Rosa, Diego Alvarez; Rajendran, Vazhaikkurichi M.			Multiple Mineralocorticoid Response Elements Localized in Different Introns Regulate Intermediate Conductance K+ (Kcnn4) Channel Expression in the Rat Distal Colon	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; GLUCOCORTICOID-RECEPTOR; CHIP-SEQ; DNA; ALDOSTERONE; SPECIFICITY; SECRETION; TRANSPORT; SEQUENCE; GENE	An elevated plasma aldosterone and an increased expression of the intermediate conductance K+ (IK/Kcnn4) channels are linked in colon. This observation suggests that the expression of Kcnn4 gene is controlled through the action of aldosterone on its cognate receptor (i.e., mineralocorticoid receptor; MR). In order to establish this, we performed chromatin immunoprecipitation (ChIP) assay to identify the MR response elements (MREs) in a region that spanned 20 kb upstream and 10 kb downstream of the presumed transcription start site (TSS) using chromatin from the colonic epithelial cells of normal and aldosterone-treated rats. MREs were immunoprecipitated in an approximately 5 kb region that spanned the first and second introns in the aldosterone rats. These regions were individually cloned in luciferase-expression vector lacking enhancer activity. These clones were tested for enhancer activity in vitro by transfecting in HEK293T and CaCo2 cells with MR and aldosterone treatment. At least four regions were found to be responsive to the MR and aldosterone. Two regions were identified to contain MREs using bioinformatics tools. These clones lost their enhancer activity after mutation of the presumptive MREs, and thus, established the functionality of the MREs. The third and fourth clones did not contain any bioinformatically obvious MREs. Further, they lost their activity upon additional sub-cloning, which suggest cooperativity between the regions that were separated upon sub-cloning. These results demonstrate the presence of intronic MREs in Kcnn4 and suggest a highly cooperative interaction between multiple intronic response elements.	[O'Hara, Bryan; Rajendran, Vazhaikkurichi M.] W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA; [de la Rosa, Diego Alvarez] Univ La Laguna, Dept Physiol, Tenerife, Spain	West Virginia University; Universidad de la Laguna	Rajendran, VM (corresponding author), W Virginia Univ, Dept Biochem, Sch Med, Morgantown, WV 26506 USA.	vrajendran@hsc.wvu.edu	Alvarez de la Rosa, Diego/H-8500-2015	Alvarez de la Rosa, Diego/0000-0002-4324-2793	National Institute of Diabetes and Digestive and Kidney Diseases [DK-018777]; Spanish Ministry of Science and Innovation [BFU2010-16265]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018777] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-018777. BFU2010-16265 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves C, 2012, ELECTROPHORESIS; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Binder HJ, 1999, SEMIN NEPHROL, V19, P405; Bujalska O, 1997, STEROIDS, V62, P77, DOI 10.1016/S0039-128X(96)00163-8; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Datson NA, 2011, ENDOCRINOLOGY, V152, P3749, DOI 10.1210/en.2011-0287; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; Fuller PJ, 2012, J ENDOCRINOL, V213, P15, DOI 10.1530/JOE-11-0372; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Joiner WJ, 2003, AM J PHYSIOL-GASTR L, V285, pG185, DOI 10.1152/ajpgi.00337.2002; Kato S, 2011, TRENDS BIOCHEM SCI, V36, P272, DOI 10.1016/j.tibs.2011.01.001; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; MARTIN RS, 1983, KIDNEY INT, V24, P386, DOI 10.1038/ki.1983.171; Martinerie L, 2013, BIOCHIMIE, V95, P148, DOI 10.1016/j.biochi.2012.09.030; McFarlan SC, 1997, MOL CELL ENDOCRINOL, V129, P219, DOI 10.1016/S0303-7207(97)00069-5; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Musch MW, 2008, AM J PHYSIOL-GASTR L, V295, pG909, DOI 10.1152/ajpgi.90312.2008; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Rabinowitz L, 1996, KIDNEY INT, V49, P1738, DOI 10.1038/ki.1996.258; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; Sandle GI, 2010, QJM-INT J MED, V103, P85, DOI 10.1093/qjmed/hcp159; SANDLE GI, 1987, GASTROENTEROLOGY, V93, P188, DOI 10.1016/0016-5085(87)90333-7; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stepanova M, 2006, COMPUT BIOL CHEM, V30, P339, DOI 10.1016/j.compbiolchem.2006.07.002; TURNAMIAN SG, 1989, J CLIN INVEST, V84, P1924, DOI 10.1172/JCI114380; Tyulmenkov VV, 2001, MOL CELL ENDOCRINOL, V182, P109, DOI 10.1016/S0303-7207(01)00508-1; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98695	10.1371/journal.pone.0098695	http://dx.doi.org/10.1371/journal.pone.0098695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901797	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400046
J	Pillai, AG; Henckens, MJAG; Fernandez, G; Joels, M				Pillai, Anup G.; Henckens, Marloes J. A. G.; Fernandez, Guillen; Joels, Marian			Delayed Effects of Corticosterone on Slow After-Hyperpolarization Potentials in Mouse Hippocampal versus Prefrontal Cortical Pyramidal Neurons	PLOS ONE			English	Article							SPIKE-FREQUENCY ADAPTATION; CALCIUM CURRENT AMPLITUDE; LONG-TERM POTENTIATION; GLUCOCORTICOID-RECEPTOR; ACUTE STRESS; BASOLATERAL AMYGDALA; DENDRITIC MORPHOLOGY; DNA-BINDING; CORTEX; AFTERHYPERPOLARIZATION	The rodent stress hormone corticosterone changes neuronal activity in a slow and persistent manner through transcriptional regulation. In the rat dorsal hippocampus, corticosterone enhances the amplitude of calcium-dependent potassium currents that cause a lingering slow after-hyperpolarization (sAHP) at the end of depolarizing events. In this study we compared the putative region-dependency of the delayed effects of corticosterone (approximately 5 hrs after treatment) on sAHP as well as other active and passive properties of layer 2/3 pyramidal neurons from three prefrontal areas, i.e. the lateral orbitofrontal, prelimbic and infralimbic cortex, with the hippocampus of adult mice. In agreement with previous studies, corticosterone increased sAHP amplitude in the dorsal hippocampus with depolarizing steps of increasing amplitude. However, in the lateral orbitofrontal, prelimbic and infralimbic cortices we did not observe any modifications of sAHP amplitude after corticosterone treatment. Properties of single action potentials or % ratio of the last spike interval with respect to the first spike interval, an indicator of accommodation in an action potential train, were not significantly affected by corticosterone in all brain regions examined. Lastly, corticosterone treatment did not induce any lasting changes in passive membrane properties of hippocampal or cortical neurons. Overall, the data indicate that corticosterone slowly and very persistently increases the sAHP amplitude in hippocampal pyramidal neurons, while this is not the case in the cortical regions examined. This implies that changes in excitability across brain regions reached by corticosterone may vary over a prolonged period of time after stress.	[Pillai, Anup G.; Henckens, Marloes J. A. G.; Joels, Marian] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Henckens, Marloes J. A. G.; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dep Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen	Pillai, AG (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	a.g.pillai@umcutrecht.nl	Joëls, Marian/P-6415-2016; Henckens, Marloes J.A.G./J-7132-2015; Fernandez, Guillen/B-3771-2009	Henckens, Marloes J.A.G./0000-0002-2375-1611; Fernandez, Guillen/0000-0002-5522-0604; Pillai, Anup/0000-0001-9788-1286; Joels, Marian/0000-0002-4826-6209	Max Planck Society; Netherlands Organization for Scientific Research (NWO) [021.002.053]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AGP wishes to thank the Max Planck Society for the post-doctoral research fellowship. MH was paid by a grant (021.002.053) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; Badanich KA, 2013, NEUROPSYCHOPHARMACOL, V38, P1176, DOI 10.1038/npp.2013.12; Barzi F, 2004, AM J EPIDEMIOL, V160, P34, DOI 10.1093/aje/kwh175; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Blackwell M, 2012, MULTIPLE OVERIMPUTAT; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Czeh B, 2008, BEHAV BRAIN RES, V190, P1, DOI 10.1016/j.bbr.2008.02.031; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dorey R, 2012, NEUROPSYCHOPHARMACOL, V37, P2870, DOI 10.1038/npp.2012.170; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Faber ESL, 2005, EUR J NEUROSCI, V22, P1627, DOI 10.1111/j.1460-9568.2005.04357.x; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Gerlach AC, 2004, PFLUG ARCH EUR J PHY, V448, P187, DOI 10.1007/s00424-003-1237-2; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; HALBERG F, 1959, AM J PHYSIOL, V197, P1083, DOI 10.1152/ajplegacy.1959.197.5.1083; Hawley DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053126; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Jacobsen KR, 2012, GEN COMP ENDOCR, V179, P406, DOI 10.1016/j.ygcen.2012.09.012; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; Joels M, 2003, EUR J NEUROSCI, V18, P1315, DOI 10.1046/j.1460-9568.2003.02845.x; Joels M, 2012, PHARMACOL REV, V64, P901, DOI 10.1124/pr.112.005892; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; JONES RSG, 1988, BRAIN RES, V462, P367, DOI 10.1016/0006-8993(88)90567-7; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Khawaja FA, 2007, HIPPOCAMPUS, V17, P1143, DOI 10.1002/hipo.20365; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Koot S, 2013, NEUROPHARMACOLOGY, V70, P306, DOI 10.1016/j.neuropharm.2013.02.008; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Ksiazek A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00185; LANCASTER B, 1991, J NEUROSCI, V11, P23; Lancaster B, 2000, J PHYSIOL-LONDON, V522, P231, DOI 10.1111/j.1469-7793.2000.t01-1-00231.x; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Liebmann L, 2008, J NEUROPHYSIOL, V99, P958, DOI 10.1152/jn.01137.2007; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Liu WH, 2010, J BIOL CHEM, V285, P6101, DOI 10.1074/jbc.M109.050229; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Maggio N, 2009, J NEUROSCI, V29, P2857, DOI 10.1523/JNEUROSCI.4399-08.2009; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 1997, ANN NY ACAD SCI, V821, P271, DOI 10.1111/j.1749-6632.1997.tb48286.x; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; Nieuwenhuis R., 2012, INFLUENCE ME TOOLS D; Perez-Cruz C, 2009, BEHAV BRAIN RES, V205, P406, DOI 10.1016/j.bbr.2009.07.021; Pettorossi VE, 2011, NEUROSCIENCE, V187, P1, DOI 10.1016/j.neuroscience.2011.04.040; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rubin DB, 2004, MULTIPLE IMPUTATION; Sah R, 2005, NEUROSCIENCE, V133, P281, DOI 10.1016/j.neuroscience.2005.01.066; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Thomas EA, 2003, NEUROSCIENCE, V120, P333, DOI 10.1016/S0306-4522(03)00039-3; van Gemert NG, 2009, ENDOCRINOLOGY, V150, P4615, DOI 10.1210/en.2009-0525; Velumian AA, 1999, J PHYSIOL-LONDON, V517, P201, DOI 10.1111/j.1469-7793.1999.0201z.x; Vyas A, 2002, J NEUROSCI, V22, P6810; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; Wilber AA, 2011, NEUROSCIENCE, V174, P115, DOI 10.1016/j.neuroscience.2010.10.070; Winter B., 2013, LINEAR MODELS LINEAR; WOMBLE MD, 1993, BRAIN RES, V621, P87, DOI 10.1016/0006-8993(93)90301-3; Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50; Zardooz H, 2010, PHYSIOL RES, V59, P973, DOI 10.33549/physiolres.931896; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	88	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99208	10.1371/journal.pone.0099208	http://dx.doi.org/10.1371/journal.pone.0099208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901987	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400110
J	Troyer, EM; Devitt, SEC; Sunquist, ME; Goswami, VR; Oli, MK				Troyer, Elizabeth M.; Devitt, Susan E. Cameron; Sunquist, Melvin E.; Goswami, Varun R.; Oli, Madan K.			Survival, Recruitment, and Population Growth Rate of an Important Mesopredator: The Northern Raccoon	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; LIFE-HISTORY; PROCYON-LOTOR; BAYLISASCARIS-PROCYONIS; RECAPTURE; PATTERNS; ILLINOIS; ISLANDS; ECOLOGY; TRENDS	Populations of mesopredators (mid-sized mammalian carnivores) are expanding in size and range amid declining apex predator populations and ever-growing human presence, leading to significant ecological impacts. Despite their obvious importance, population dynamics have scarcely been studied for most mesopredator species. Information on basic population parameters and processes under a range of conditions is necessary for managing these species. Here we investigate survival, recruitment, and population growth rate of a widely distributed and abundant mesopredator, the northern raccoon (Procyon lotor), using Pradel's temporal symmetry models and >6 years of monthly capture-mark-recapture data collected in a protected area. Monthly apparent survival probability was higher for females (0.949, 95% CI = 0.936-0.960) than for males (0.908, 95% CI = 0.893-0.920), while monthly recruitment rate was higher for males (0.091, 95% CI = 0.078-0.106) than for females (0.054, 95% CI = 0.042-0.067). Finally, monthly realized population growth rate was 1.000 (95% CI = 0.996-1.004), indicating that our study population has reached a stable equilibrium in this relatively undisturbed habitat. There was little evidence for substantial temporal variation in population growth rate or its components. Our study is one of the first to quantify survival, recruitment, and realized population growth rate of raccoons using long-term data and rigorous statistical models.	[Troyer, Elizabeth M.; Goswami, Varun R.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA; [Troyer, Elizabeth M.; Devitt, Susan E. Cameron; Sunquist, Melvin E.; Goswami, Varun R.; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Troyer, EM (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.	e.m.troyer@ufl.edu	Goswami, Varun R/AAE-8780-2019	Goswami, Varun R/0000-0003-2575-7301	Ordway-Swisher Biological Station; School of Natural Resources and Environment; Department of Wildlife Ecology and Conservation, University of Florida	Ordway-Swisher Biological Station; School of Natural Resources and Environment; Department of Wildlife Ecology and Conservation, University of Florida(University of Florida)	This study was supported by the Ordway-Swisher Biological Station, the School of Natural Resources and Environment, and the Department of Wildlife Ecology and Conservation, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIEV FF, 1966, J WILDLIFE MANAGE, V30, P497, DOI 10.2307/3798740; Asano M, 2003, J VET MED SCI, V65, P369, DOI 10.1292/jvms.65.369; Atwood TC, 2009, J WILDLIFE MANAGE, V73, P647, DOI 10.2193/2008-215; Beasley JC, 2012, J WILDLIFE MANAGE, V76, P1290, DOI 10.1002/jwmg.379; Beasley JC, 2011, LANDSCAPE ECOL, V26, P937, DOI 10.1007/s10980-011-9619-x; Beltran-Beck B, 2012, EUR J WILDLIFE RES, V58, P5, DOI 10.1007/s10344-011-0600-4; Bernstein L, 2008, CLIMATE CHANGE 2007; BIGLER W J, 1981, Florida Scientist, V44, P151; Brashares Justin S., 2010, P221; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Chamberlain MJ, 1999, J WILDLIFE MANAGE, V63, P880, DOI 10.2307/3802801; CLARK WR, 1989, J WILDLIFE MANAGE, V53, P982, DOI 10.2307/3809599; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Eagan TS, 2011, CAN J ZOOL, V89, P724, DOI 10.1139/Z11-045; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fordham DA, 2012, AUSTRAL ECOL, V37, P945, DOI 10.1111/j.1442-9993.2011.02354.x; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; FRITZELL EK, 1985, J WILDLIFE MANAGE, V49, P901, DOI 10.2307/3801366; Galiano D, 2013, MAMMALIA, V77, P173, DOI 10.1515/mammalia-2011-0128; Garmestani AS, 2005, SOUTHEAST NAT, V4, P469, DOI 10.1656/1528-7092(2005)004[0469:RRRSTN]2.0.CO;2; Gehrt SD, 1999, J WILDLIFE MANAGE, V63, P889, DOI 10.2307/3802802; Gehrt SD, 2002, WILDLIFE SOC B, V30, P457; Hartman LH, 1999, BIOL CONSERV, V88, P1, DOI 10.1016/S0006-3207(98)00094-9; HASBROUCK JJ, 1992, J WILDLIFE MANAGE, V56, P693, DOI 10.2307/3809462; Hernandez SM, 2013, PARASITOL RES, V112, P693, DOI 10.1007/s00436-012-3186-1; Hines JE, 2002, J APPL STAT, V29, P573, DOI 10.1080/02664760120108872; Kamler JF, 2004, AM MIDL NAT, V151, P27, DOI 10.1674/0003-0031(2004)151[0027:SACMAF]2.0.CO;2; Laake J., 2010, PROGRAM MARK GENTLE; Lotze J.-H., 1979, Mammalian Species, P1, DOI 10.2307/3503959; MCLEAN RG, 1971, J INFECT DIS, V123, P680, DOI 10.1093/infdis/123.6.680; Nixon Charles M., 2009, Transactions of the Illinois State Academy of Science, V102, P117; Oli MK, 2005, AM NAT, V166, P124, DOI 10.1086/430332; Oli MK, 2004, BASIC APPL ECOL, V5, P449, DOI 10.1016/j.baae.2004.06.002; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Page LK, 1998, AM MIDL NAT, V140, P180, DOI 10.1674/0003-0031(1998)140[0180:RLSAIP]2.0.CO;2; PAYNE N F, 1986, Transactions of the Wisconsin Academy of Sciences Arts and Letters, V74, P75; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; RITKE ME, 1990, AM MIDL NAT, V123, P390, DOI 10.2307/2426567; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Schmidt KA, 2003, CONSERV BIOL, V17, P1141, DOI 10.1046/j.1523-1739.2003.02316.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sunquist Melvin E., 1993, Bulletin of the Florida Museum of Natural History Biological Sciences, V36, P109; Timm SF, 2009, J WILDLIFE DIS, V45, P333, DOI 10.7589/0090-3558-45.2.333; Troyer EM, 2014, J MAMMAL, V95, P421, DOI 10.1644/13-MAMM-A-164.1; Urbanek Rachael E., 2009, Transactions of the Illinois State Academy of Science, V102, P217; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Winchester C, 2009, J WILDLIFE MANAGE, V73, P374, DOI 10.2193/2008-154; Zeveloff S. I., 2002, RACCOONS NATURAL HIS	55	6	6	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98535	10.1371/journal.pone.0098535	http://dx.doi.org/10.1371/journal.pone.0098535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901349	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400035
J	Zhong, S; Navaratnam, D; Santos-Sacchi, J				Zhong, Sheng; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph			A Genetically-Encoded YFP Sensor with Enhanced Chloride Sensitivity, Photostability and Reduced pH Interference Demonstrates Augmented Transmembrane Chloride Movement by Gerbil Prestin (SLC26a5)	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; OUTER HAIR CELL; STATE PROTON-TRANSFER; MOTOR PROTEIN; ENVIRONMENTAL SENSITIVITY; CRYSTAL-STRUCTURE; ANION TRANSPORT; VARIANT; INDICATORS; MECHANISM	Background: Chloride is the major anion in cells, with many diseases arising from disordered Cl- regulation. For the non-invasive investigation of Cl- flux, YFP-H148Q and its derivatives chameleon and Cl-Sensor previously were introduced as genetically encoded chloride indicators. Neither the Cl- sensitivity nor the pH-susceptibility of these modifications to YFP is optimal for precise measurements of Cl- under physiological conditions. Furthermore, the relatively poor photostability of YFP derivatives hinders their application for dynamic and quantitative Cl- measurements. Dynamic and accurate measurement of physiological concentrations of chloride would significantly affect our ability to study effects of chloride on cellular events. Methodology/Principal Findings: In this study, we developed a series of YFP derivatives to remove pH interference, increase photostability and enhance chloride sensitivity. The final product, EYFP-F46L/Q69K/H148Q/I152L/V163S/S175G/ S205V/A206K (monomeric Cl-YFP), has a chloride K-d of 14 mM and pK(a) of 5.9. The bleach time constant of 175 seconds is over 15-fold greater than wild-type EYFP. We have used the sensor fused to the transmembrane protein prestin (gerbil prestin, SLC26a5), and shown for the first time physiological (mM) chloride flux in HEK cells expressing this protein. This modified fluorescent protein will facilitate investigations of dynamics of chloride ions and their mediation of cell function. Conclusions: Modifications to YFP (EYFP-F46L/Q69K/H148Q/I152L/V163S/S175G/S205V/A206K (monomeric Cl-YFP) results in a photostable fluorescent protein that allows measurement of physiological changes in chloride concentration while remaining minimally affected by changes in pH.	[Zhong, Sheng; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA.	joseph.santos-sacchi@yale.edu		Zhong, Sheng/0000-0002-1620-2059	National Institutes of Health National Institute on Deafness and Other Communication Disorders [DC 000273]	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by National Institutes of Health National Institute on Deafness and Other Communication Disorders grants DC 000273 (to J.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Battistutta R, 2000, PROTEINS, V41, P429, DOI 10.1002/1097-0134(20001201)41:4<429::AID-PROT10>3.0.CO;2-D; Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; Bell AF, 2003, J AM CHEM SOC, V125, P6919, DOI 10.1021/ja034588w; Cianchetta S, 2010, TOXICOL APPL PHARM, V243, P372, DOI 10.1016/j.taap.2009.12.004; Erez Y, 2011, J PHYS CHEM B, V115, P11776, DOI 10.1021/jp2052689; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lau L., 2011, P SOC PHOTO-OPT INST, P7910; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Little RC, 2006, SAS MIXED MODELS; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Markova O, 2008, J NEUROSCI METH, V170, P67, DOI 10.1016/j.jneumeth.2007.12.016; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Mistrik P, 2012, J PHYSIOL-LONDON, V590, P5597, DOI 10.1113/jphysiol.2012.241448; Morimoto YV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019598; Murek M, 2010, EXP PHYSIOL, V95, P471, DOI 10.1113/expphysiol.2009.049445; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Perron A, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.005.2009; Planells-Cases R, 2009, BBA-MOL BASIS DIS, V1792, P173, DOI 10.1016/j.bbadis.2009.02.002; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rhoden KJ, 2008, ANAL BIOCHEM, V373, P239, DOI 10.1016/j.ab.2007.10.020; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; Schanzler M, 2012, J PHYSIOL-LONDON, V590, P259, DOI 10.1113/jphysiol.2011.209577; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shu X, 2007, PROTEIN SCI, V16, P2703, DOI 10.1110/ps.073112007; Siegel M. S., 2010, COLD SPRING HARB PRO, V2010; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sullivan LM, 2008, CIRCULATION, V117, P1238, DOI 10.1161/CIRCULATIONAHA.107.654350; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Thor JJ, 2002, NAT STRUCT BIOL, V9, P37, DOI 10.1038/nsb739; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	47	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99095	10.1371/journal.pone.0099095	http://dx.doi.org/10.1371/journal.pone.0099095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901231	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400097
J	Bharaswadkar, S; Kanchar, A; Thakur, N; Shah, S; Patnaik, B; Click, ES; Kumar, AMV; Dewan, PK				Bharaswadkar, Sandeep; Kanchar, Avinash; Thakur, Narendra; Shah, Shubhangi; Patnaik, Brinda; Click, Eleanor S.; Kumar, Ajay M. V.; Dewan, Puneet Kumar			Tuberculosis Management Practices of Private Practitioners in Pune Municipal Corporation, India	PLOS ONE			English	Article							DELHI	Background: Private Practitioners (PP) are the primary source of health care for patients in India. Limited representative information is available on TB management practices of Indian PP or on the efficacy of India's Revised National Tuberculosis Control Programme (RNTCP) to improve the quality of TB management through training of PP. Methods: We conducted a cross-sectional survey of a systematic random sample of PP in one urban area in Western India (Pune, Maharashtra). We presented sample clinical vignettes and determined the proportions of PPs who reported practices consistent with International Standards of TB Care (ISTC). We examined the association between RNTCP training and adherence to ISTC by calculating odds ratios and 95% confidence intervals. Results: Of 3,391 PP practicing allopathic medicine, 249 were interviewed. Of these, 55% had been exposed to RNTCP. For new pulmonary TB patients, 63% (158/249) of provider responses were consistent with ISTC diagnostic practices, and 34% (84/249) of responses were consistent with ISTC treatment practices. However, 48% (120/249) PP also reported use of serological tests for TB diagnosis. In the new TB case vignette, 38% (94/249) PP reported use of at least one second line anti-TB drug in the treatment regimen. RNTCP training was not associated with diagnostic or treatment practices. Conclusion: In Pune, India, despite a decade of training activities by the RNTCP, high proportions of providers resorted to TB serology for diagnosis and second-line anti-TB drug use in new TB patients. Efforts to achieve universal access to quality TB management must account for the low quality of care by PP and the lack of demonstrated effect of current training efforts.	[Bharaswadkar, Sandeep; Kanchar, Avinash; Dewan, Puneet Kumar] Off World Hlth Org WHO Representat India, New Delhi, India; [Thakur, Narendra; Shah, Shubhangi] Pune Municipal Corp, Directorate Hlth Serv, Pune, Maharashtra, India; [Patnaik, Brinda] MIMER Med Coll, Dept Community Med, Pune, Maharashtra, India; [Click, Eleanor S.] Ctr Dis Control & Prevent CDC, Div TB Eliminat, Atlanta, GA USA; [Kumar, Ajay M. V.] Int Union TB & Lung Dis, Reg Off Southeast, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA	Bharaswadkar, S (corresponding author), Off World Hlth Org WHO Representat India, New Delhi, India.	bharaswadkars@rntcp.org	Thakur, N S/ABF-4119-2021	Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	UNION-WHO-CTD-NTI Operational research Project	UNION-WHO-CTD-NTI Operational research Project	This operational research was funded under UNION-WHO-CTD-NTI Operational research Project 2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare, 2012, GUID PROGR MAN DRUG; Centre for health research and development, 2003, HLTH ADM, VXV, P61; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Datta Kisalay, 2010, Indian J Tuberc, V57, P199; Government of India, 2006, NATL FAM HLTH SURV I; Government of India Central TB Division, 2008, REV SCH NONG ORG PRI; Greaves F, 2007, INT J TUBERC LUNG D, V11, P110; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; Srinath S, 2011, PLOS ONE, V6; Tuberculosis coalition for technical assistance, 2009, INT STAND TB CAR; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; UPLEKAR M, 1996, TUBERCULOSIS PATIENT; Uplekar MW, 1996, INDIAN J TUBERC, V43, P19	15	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97993	10.1371/journal.pone.0097993	http://dx.doi.org/10.1371/journal.pone.0097993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897374	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700020
J	Kumar, R; Jain, S; Kumari, B; Kumar, M				Kumar, Ravindra; Jain, Sohni; Kumari, Bandana; Kumar, Manish			Protein Sub-Nuclear Localization Prediction Using SVM and Pfam Domain Information	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; AMINO-ACID-COMPOSITION; SUBCELLULAR-LOCALIZATION; STRUCTURAL CLASS; WEB-SERVER; SUBNUCLEAR LOCALIZATION; BINDING SITES; CLASSIFICATION; LOCATION; IDENTIFICATION	The nucleus is the largest and the highly organized organelle of eukaryotic cells. Within nucleus exist a number of pseudo-compartments, which are not separated by any membrane, yet each of them contains only a specific set of proteins. Understanding protein sub-nuclear localization can hence be an important step towards understanding biological functions of the nucleus. Here we have described a method, SubNucPred developed by us for predicting the sub-nuclear localization of proteins. This method predicts protein localization for 10 different sub-nuclear locations sequentially by combining presence or absence of unique Pfam domain and amino acid composition based SVM model. The prediction accuracy during leave-one-out cross-validation for centromeric proteins was 85.05%, for chromosomal proteins 76.85%, for nuclear speckle proteins 81.27%, for nucleolar proteins 81.79%, for nuclear envelope proteins 79.37%, for nuclear matrix proteins 77.78%, for nucleoplasm proteins 76.98%, for nuclear pore complex proteins 88.89%, for PML body proteins 75.40% and for telomeric proteins it was 83.33%. Comparison with other reported methods showed that SubNucPred performs better than existing methods. A web-server for predicting protein sub-nuclear localization named SubNucPred has been established at http://14.139.227.92/mkumar/subnucpred/. Standalone version of SubNucPred can also be downloaded from the webserver.	[Kumar, Ravindra; Jain, Sohni; Kumari, Bandana; Kumar, Manish] Univ Delhi, Dept Biophys, South Campus, New Delhi, India	University of Delhi	Kumar, M (corresponding author), Univ Delhi, Dept Biophys, South Campus, New Delhi, India.	manish@south.du.ac.in	Kumar, Manish/AGP-1250-2022; Kumar, Ravindra/F-2211-2017	Kumar, Manish/0000-0002-7936-9892; Kumar, Ravindra/0000-0002-0121-8402	Science and Engineering Research Board [SR/FT/LS-84/2010]; University Grant Commission; M. Phil and Non-Net PhD Scholarships of Delhi University; Science and Engineering Research Board [SR/FT/LS-84/2010]; University Grant Commission; M. Phil and Non-Net PhD Scholarships of Delhi University	Science and Engineering Research Board; University Grant Commission(University Grants Commission, India); M. Phil and Non-Net PhD Scholarships of Delhi University; Science and Engineering Research Board; University Grant Commission(University Grants Commission, India); M. Phil and Non-Net PhD Scholarships of Delhi University	This work was supported by Science and Engineering Research Board [grant number SR/FT/LS-84/2010]. Ravindra Kumar is supported as SRF by University Grant Commission (http://www. ugc. ac. in) scholarship [20-12/2009(ii) EU-IV]. Sohni Jain and Bandana Kumari were supported by M. Phil and Non-Net PhD Scholarships of Delhi University respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belkacem R, 2012, TRENDS BIOTECHNOL, V30, P466, DOI 10.1016/j.tibtech.2012.05.006; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW383, DOI 10.1093/nar/gkh416; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Chen C, 2006, ANAL BIOCHEM, V357, P116, DOI 10.1016/j.ab.2006.07.022; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feng PM, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/530696; Fletez-Brant C, 2013, NUCLEIC ACIDS RES, V41, pW544, DOI 10.1093/nar/gkt519; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Gao Y, 2005, AMINO ACIDS, V28, P373, DOI 10.1007/s00726-005-0206-9; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gronemeyer T, 2013, FEBS LETT, V587, P328, DOI 10.1016/j.febslet.2012.12.025; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Han GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057225; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang WL, 2007, BIOSYSTEMS, V90, P573, DOI 10.1016/j.biosystems.2007.01.001; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Johnson Tanya L, 2013, Methods Mol Biol, V966, P157, DOI 10.1007/978-1-62703-245-2_10; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-22; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Li FM, 2008, AMINO ACIDS, V34, P119, DOI 10.1007/s00726-007-0545-9; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Li T, 2013, BIOINFORMATICS, V29, P678, DOI 10.1093/bioinformatics/btt029; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S12; Marsh KL, 1998, HUM MOL GENET, V7, P1795, DOI 10.1093/hmg/7.11.1795; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Mundra P, 2007, PATTERN RECOGN, V28, P6; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Naveed M, 2012, AMINO ACIDS, V42, P1809, DOI 10.1007/s00726-011-0902-6; O'Fallon BD, 2013, BIOINFORMATICS, V29, P1361, DOI 10.1093/bioinformatics/btt172; Ramana J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-445; Shen HB, 2005, BIOCHEM BIOPH RES CO, V337, P752, DOI 10.1016/j.bbrc.2005.09.117; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tang SN, 2013, NUCLEIC ACIDS RES, V41, pW441, DOI 10.1093/nar/gkt428; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Verma R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S9; Wan SB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-290; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Watanabe S, 2012, JOVE-J VIS EXP, DOI 10.3791/3995; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xie H., 2013, P IEEE INT C SIGN PR, P1, DOI DOI 10.1109/ICNP.2013.6733632; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yabuki Y, 2005, NUCLEIC ACIDS RES, V33, pW148, DOI 10.1093/nar/gki495; Yabuki Y, 2009, OPEN STRUCT BIOL J, V3, P149; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	61	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98345	10.1371/journal.pone.0098345	http://dx.doi.org/10.1371/journal.pone.0098345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897370	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700034
J	Liang, HB; Chen, JD; Xie, JX; Sun, L; Ji, FX; He, SY; Zheng, Y; Liang, CM; Zhang, GH; Su, S; Li, SJ				Liang, Huanbin; Chen, Jidang; Xie, Jiexiong; Sun, Long; Ji, Fangxiao; He, Shuyi; Zheng, Yun; Liang, Chumin; Zhang, Guihong; Su, Shuo; Li, Shoujun			Hepatitis E Virus Serosurvey among Pet Dogs and Cats in Several Developed Cities in China	PLOS ONE			English	Article							SPORADIC ACUTE; WILD RATS; INFECTION; SEROPREVALENCE; JAPAN; TRANSMISSION; PREVALENCE; ANTIBODIES; ANIMALS; DISEASE	Infection by Hepatitis E virus (HEV), as a zoonotic disease virus, is well studied in pigs in China, but few studies in pets have been performed. This study was designed to characterize the prevalence of HEV infection among pet dogs and cats in major metropolitan areas of China. We conducted a seroepidemiological survey from 2012 to 2013 in 5 developed cities, Beijing, Shanghai, Canton, Shenzhen and Macao, by enzyme-linked immunosorbent assay (ELISA). The overall HEV seroprevalence in 658 dog and 191 cat serum samples was 21.12% and 6.28%, respectively. The analysis in dogs suggested that there were significant differences among cities, and the positive rate of HEV-specific antibody in all cities ranged from 6.06% (Shenzhen) to 29.34% (Beijing). Older pet cats have a high risk (OR, 10.25) for HEV seropositivity, but no strong relationship was observed between different genders and age groups. Additionally, it was revealed that stray dogs, omnivorous pet dogs and pet cats who share food, such as kitchen residue, with the general population would have a higher risk for HEV seropositivity. The odds ratios for these groups are 2.40, 2.83 and 5.39, respectively, compared with pet dogs and cats fed on commercial food. In this study, we first report that HEV is prevalent in pet dogs and cats in several large cities in China. Swill and kitchen residue may be a potential risk for HEV transmission from human to pets. As the sample size was relatively small in this study and may not be fully representative of China, further investigation is required to confirm the conclusions.	[Liang, Huanbin; Chen, Jidang; Xie, Jiexiong; Sun, Long; Ji, Fangxiao; He, Shuyi; Zheng, Yun; Liang, Chumin; Zhang, Guihong; Su, Shuo; Li, Shoujun] South China Agr Univ, MOA Key Lab Anim Vaccine Dev, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, MOA Key Lab Anim Vaccine Dev, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn	Xie, Jiexiong/I-5454-2019; CHEN, JIDANG/AAF-7628-2020; Chen, Jidang/L-1247-2019	Xie, Jiexiong/0000-0002-3374-6605; CHEN, JIDANG/0000-0002-5719-0429; 	Industry technology system of modern agriculture construction fund [CARS-36]; Ph.D. Programs Foundation of Ministry of Education of China [20104404110009, 20114404120010]	Industry technology system of modern agriculture construction fund; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Industry technology system of modern agriculture construction fund (No. CARS-36) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20104404110009 and No. 20114404120010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANKALLE VA, 1994, P NATL ACAD SCI USA, V91, P3428, DOI 10.1073/pnas.91.8.3428; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Chiu DMY, 2013, J MED VIROL, V85, P459, DOI 10.1002/jmv.23429; Dong C, 2012, HEPAT MON, V12, P386, DOI 10.5812/hepatmon.6194; Goens S. Denise, 2004, Animal Health Research Reviews, V5, P145, DOI 10.1079/AHR200495; Hirano M, 2003, HEPATOL RES, V27, P1, DOI 10.1016/S1386-6346(03)00192-X; Hu WP, 2008, CLIN VACCINE IMMUNOL, V15, P1151, DOI 10.1128/CVI.00186-07; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kuno A, 2003, HEPATOL RES, V26, P237, DOI 10.1016/S1386-6346(03)00197-9; Lee JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067180; Li TC, 2005, EMERG INFECT DIS, V11, P1958, DOI 10.3201/eid1112.051041; Li W, 2013, VET MICROBIOL, V165, P275, DOI 10.1016/j.vetmic.2013.03.017; Liu JF, 2009, SCAND J INFECT DIS, V41, P291, DOI 10.1080/00365540902767031; Mochizuki M, 2006, VET REC, V159, P853; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rutjes SA, 2010, J VIROL METHODS, V168, P197, DOI 10.1016/j.jviromet.2010.05.014; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Shukla P, 2007, J VIRAL HEPATITIS, V14, P310, DOI 10.1111/j.1365-2893.2006.00815.x; Song YJ, 2010, J MED VIROL, V82, P583, DOI 10.1002/jmv.21730; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; Usui R, 2004, INFECTION, V32, P57, DOI 10.1007/s15010-004-3078-0; Vitral CL, 2005, MEM I OSWALDO CRUZ, V100, P117, DOI 10.1590/S0074-02762005000200003; Xiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033480; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Zhang JZ, 2001, J MED VIROL, V64, P125, DOI 10.1002/jmv.1027; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x	29	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98068	10.1371/journal.pone.0098068	http://dx.doi.org/10.1371/journal.pone.0098068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896257	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700023
J	OlaOlorun, FM; Hindin, MJ				OlaOlorun, Funmilola M.; Hindin, Michelle J.			Having a Say Matters: Influence of Decision-Making Power on Contraceptive Use among Nigerian Women Ages 35-49 Years	PLOS ONE			English	Article							AUTONOMY; EMPOWERMENT; BEHAVIOR; YORUBA; INDIA	Background: Research suggests that women of reproductive age who are involved in household decision-making are more likely than those who are not involved to be able to control their fertility. Little is known, however, about this relationship among women at the upper end of the reproductive spectrum. The aim of this study was to determine the association between household decision-making power and modern contraceptive use among Nigerian women ages 35-49 years. Methods: A descriptive, cross-sectional study involving a secondary analysis of data from the Nigerian 2008 Demographic and Health Survey was conducted among women ages 35-49 years who were considered to be in need of contraception. The outcome was modern contraceptive use while the main independent variable was a woman's household decision-making power score, constructed using principal component analysis. Multivariate logistic regression was performed to determine whether the women's household decision-making power score, categorized into tertiles, was independently associated with modern contraceptive use. Data were weighted and adjusted for the complex survey design. Results: Prevalence of modern contraceptive use among Nigerian women deemed to be in need of contraception in this study was 18.7%. Multivariate logistic regression showed that women's decision-making power remained statistically significantly associated with modern contraceptive use, even after adjusting for age, education, religion, polygyny, parity, wealth and domicile. Women who were in the highest decision-making power tertile had more than one and a half times the odds of using modern contraception compared with women in the lowest tertile [Adjusted Odds Ratio = 1.70; 95% Confidence Interval = 1.31-2.21, p<0.001]. Significance: Older Nigerian women who are involved in making household decisions are also able to make decisions related to their fertility. Programs in Nigeria focused on increasing modern contraceptive use should include strategies to increase women's status through encouraging more visible involvement in decision-making across different spheres of their lives.	[OlaOlorun, Funmilola M.] Univ Ibadan, Dept Prevent Med & Primary Care, Coll Med, Ibadan, Nigeria; [Hindin, Michelle J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	University of Ibadan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	OlaOlorun, FM (corresponding author), Univ Ibadan, Dept Prevent Med & Primary Care, Coll Med, Ibadan, Nigeria.	fmolaolorun@gmail.com	OlaOlorun, Funmilola/ABN-6506-2022	OlaOlorun, Funmilola/0000-0001-5544-2875; Hindin, Michelle/0000-0001-9941-7639				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; [Anonymous], 2002, WORLD BANK WORKSH PO; [Anonymous], 2011, WORLD POP PROSP 2010; Barak B., 1981, COGNITIVE AGE NONCHR; Beasley A, 2010, SEMIN REPROD MED, V28, P147, DOI 10.1055/s-0030-1248140; Clark-Kazak CR, 2009, J DEV STUD, V45, P1307, DOI 10.1080/00220380902862952; Dimka Ritgak A, 2013, Afr J Reprod Health, V17, P102; Do M, 2012, INT PERSPECT SEX R H, V38, P23, DOI 10.1363/3802312; Federal Ministry of Women Affairs & Social Development, 2006, NIG NAT GEND POL; Feyisetan BJ, 2000, POPUL RES POLICY REV, V19, P29, DOI 10.1023/A:1006388011947; GAGE AJ, 1995, STUD FAMILY PLANN, V26, P264, DOI 10.2307/2138012; Hindin MJ, 2000, SOC SCI MED, V51, P1517, DOI 10.1016/S0277-9536(00)00051-4; Hogan DP, 1999, STUD FAMILY PLANN, V30, P302, DOI 10.1111/j.1728-4465.1999.t01-2-.x; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jarrett M E, 1990, Nurse Pract, V15, P34; Jejeebhoy SJ, 2002, STUD FAMILY PLANN, V33, P299, DOI 10.1111/j.1728-4465.2002.00299.x; Jejeebhoy SJ, 2001, POPUL DEV REV, V27, P687, DOI 10.1111/j.1728-4457.2001.00687.x; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Koster W, 2010, SOC SCI MED, V71, P1788, DOI 10.1016/j.socscimed.2010.06.033; Lawrence PG, 2003, EVOLUTION HOUSEHOLD; Musalia JM, 2005, SEX ROLES, V53, P835, DOI 10.1007/s11199-005-8296-0; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; ODDENS BJ, 1994, CONTRACEPTION, V49, P73, DOI 10.1016/0010-7824(94)90110-4; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sherman CA, 2005, J SOC ISSUES, V61, P139, DOI 10.1111/j.0022-4537.2005.00398.x; Stephenson R, 2008, HEALTH PLACE, V14, P841, DOI 10.1016/j.healthplace.2008.01.005; Woldemicael G, 2009, J BIOSOC SCI, V41, P161, DOI 10.1017/S0021932008003040	28	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98702	10.1371/journal.pone.0098702	http://dx.doi.org/10.1371/journal.pone.0098702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897300	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700068
J	Pruvost, O; Magne, M; Boyer, K; Leduc, A; Tourterel, C; Drevet, C; Ravigne, V; Gagnevin, L; Guerin, F; Chiroleu, F; Koebnik, R; Verdier, V; Verniere, C				Pruvost, Olivier; Magne, Maxime; Boyer, Karine; Leduc, Alice; Tourterel, Christophe; Drevet, Christine; Ravigne, Virginie; Gagnevin, Lionel; Guerin, Fabien; Chiroleu, Frederic; Koebnik, Ralf; Verdier, Valerie; Verniere, Christian			A MLVA Genotyping Scheme for Global Surveillance of the Citrus Pathogen Xanthomonas citri pv. citri Suggests a Worldwide Geographical Expansion of a Single Genetic Lineage	PLOS ONE			English	Article							VARIABLE-NUMBER; 1ST REPORT; RALSTONIA-SOLANACEARUM; BACTERIAL WILT; TYPING SYSTEMS; CANKER; REPEATS; STRAINS; IDENTIFICATION; 1ST-REPORT	MultiLocus Variable number of tandem repeat Analysis (MLVA) has been extensively used to examine epidemiological and evolutionary issues on monomorphic human pathogenic bacteria, but not on bacterial plant pathogens of agricultural importance albeit such tools would improve our understanding of their epidemiology, as well as of the history of epidemics on a global scale. Xanthomonas citri pv. citri is a quarantine organism in several countries and a major threat for the citrus industry worldwide. We screened the genomes of Xanthomonas citri pv. citri strain IAPAR 306 and of phylogenetically related xanthomonads for tandem repeats. From these in silico data, an optimized MLVA scheme was developed to assess the global diversity of this monomorphic bacterium. Thirty-one minisatellite loci (MLVA-31) were selected to assess the genetic structure of 129 strains representative of the worldwide pathological and genetic diversity of X. citri pv. citri. Based on Discriminant Analysis of Principal Components (DAPC), four pathotype-specific clusters were defined. DAPC cluster 1 comprised strains that were implicated in the major geographical expansion of X. citri pv. citri during the 20th century. A subset of 12 loci (MLVA-12) resolved 89% of the total diversity and matched the genetic structure revealed by MLVA-31. MLVA-12 is proposed for routine epidemiological identification of X. citri pv. citri, whereas MLVA-31 is proposed for phylogenetic and population genetics studies. MLVA-31 represents an opportunity for international X. citri pv. citri genotyping and data sharing. The MLVA-31 data generated in this study was deposited in the Xanthomonas citri genotyping database (http://www.biopred.net/MLVA/).	[Pruvost, Olivier; Magne, Maxime; Boyer, Karine; Leduc, Alice; Gagnevin, Lionel; Chiroleu, Frederic; Verniere, Christian] CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France; [Tourterel, Christophe; Koebnik, Ralf; Verdier, Valerie] IRD CIRAD UM2, UMR Resistance Plantes Bioagresseurs RPB, Inst Rech Dev, Montpellier, France; [Tourterel, Christophe; Drevet, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Tourterel, Christophe; Drevet, Christine] CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Ravigne, Virginie] CIRAD, UMR Biol & Genet Interact Plante Paras BGPI, Montpellier, France; [Guerin, Fabien] Univ Reunion, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France	CIRAD; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CIRAD; University of La Reunion	Pruvost, O (corresponding author), CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, St Pierre, Reunion, France.	olivier.pruvost@cirad.fr	VerniÃre, Christian/AAX-6165-2021; Ravigné, Virginie/AAC-5427-2020; RAVIGNE, Virginie/B-5876-2011; Koebnik, Ralf/J-5627-2014; Verdier, Valerie/K-1004-2016; Gagnevin, Lionel/C-3397-2014	Ravigné, Virginie/0000-0002-4252-2574; RAVIGNE, Virginie/0000-0002-4252-2574; Koebnik, Ralf/0000-0002-4419-0542; Verdier, Valerie/0000-0001-5425-9454; Gagnevin, Lionel/0000-0002-2943-0827; Verniere, Christian/0000-0002-2312-2073; CHIROLEU, Frederic/0000-0002-4874-5357; Pruvost, Olivier/0000-0002-3175-9795	European Union (ERDF); Conseil Regional de La Reunion; French Agence Nationale de la Recherche [ANR-2010-BLAN-1723]; French Direction Generale de l'Armement [2010 34 006, 2011 60 080]; CIRAD	European Union (ERDF)(European Commission); Conseil Regional de La Reunion; French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Direction Generale de l'Armement(French National Research Agency (ANR)); CIRAD	We thank C. Boyer, P. Grygiel, J. Hoareau, C. Juhasz, I.Robene and A.Dereeper for their contributions.The European Union (ERDF; http://europa.eu/legislation_summaries/agriculture/general_framework/g24234_en.htm), Conseil Regional de La Reunion (http://www.regionreunion.com/fr/spip/), the French Agence Nationale de la Recherche (ANR-2010-BLAN-1723; http://www.agence-nationale-recherche.fr/suivi-bilan/recherches-exploratoires-et-emergentes/blancgeneralite-et-contacts/blanc-presentation-synthetique-du-projet/?tx_lwmsuivibilan_pi2% 5BCODE%5D=ANR-10-BLAN-1723), the French Direction Generale de l'Armement (contract no 2010 34 006; http://www.defense.gouv.fr/dga), and CIRAD (http://www.cirad.fr) provided financial support. AL acknowledges support from the French Direction Generale de l'Armement (contract no 2011 60 080) and CIRAD.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Balestra GM, 2008, PLANT DIS, V92, P981, DOI 10.1094/PDIS-92-6-0981C; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BROADBENT P, 1995, AUSTRALAS PLANT PATH, V24, P90, DOI 10.1071/APP9950090; Buhlmann A, 2014, ENVIRON MICROBIOL, V16, P2112, DOI 10.1111/1462-2920.12289; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; CIVEROLO E L, 1984, Journal of the Rio Grande Valley Horticultural Society, V37, P127; Croucher NJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0202; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Della Coletta H, 2001, APPL ENVIRON MICROB, V67, P4091, DOI 10.1128/AEM.67.9.4091-4095.2001; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Derso E, 2009, PLANT DIS, V93, P203, DOI 10.1094/PDIS-93-2-0203B; Doidge EM, 1929, UNION S AFRICA DEP A, V51, P1; DYE DW, 1969, NEW ZEAL J AGR, V118, P20; Escalon A, 2013, MOL PLANT PATHOL, V14, P483, DOI 10.1111/mpp.12019; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Gironde S, 2012, APPL ENVIRON MICROB, V78, P3266, DOI 10.1128/AEM.06655-11; Gough C. L., 1988, Molecular Plant-Microbe Interactions, V1, P275, DOI 10.1094/MPMI-1-275; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Hasse CH, 1915, J AGRIC RES, V4, P97; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Juhasz CC, 2013, PLANT DIS, V97, P1653, DOI 10.1094/PDIS-06-13-0600-PDN; Kado CI., 2010, PLANT BACTERIOLOGY; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Leduc A, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0217; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li WB, 2007, P NATL ACAD SCI USA, V104, P18427, DOI 10.1073/pnas.0705590104; Li XJ, 2013, DIAGN MICR INFEC DIS, V75, P203, DOI 10.1016/j.diagmicrobio.2012.11.007; Macdonald TE, 2011, APPL ENVIRON MICROB, V77, P8625, DOI 10.1128/AEM.05155-11; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; N'Guessan CA, 2013, J MICROBIOL METH, V92, P366, DOI 10.1016/j.mimet.2013.01.012; Ngoc LBT, 2007, PLANT DIS, V91, P771, DOI 10.1094/PDIS-91-6-0771A; Ngoc LBT, 2009, MOL ECOL RESOUR, V9, P125, DOI 10.1111/j.1755-0998.2008.02242.x; Ngoc LBT, 2010, INT J SYST EVOL MICR, V60, P515, DOI 10.1099/ijs.0.009514-0; Ngoc LBT, 2009, APPL ENVIRON MICROB, V75, P1173, DOI 10.1128/AEM.02245-08; Ollitrault P, 2012, HANDB PLANT BREED, V8, P623, DOI 10.1007/978-1-4419-0763-9_16; Parkinson N, 2013, APPL ENVIRON MICROB, V79, P6016, DOI 10.1128/AEM.01219-13; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Pourcel C, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P179; Rossetti V., 1977, CITRUS CANKER LATIN, P918; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Schubert TS, 2001, PLANT DIS, V85, P340, DOI 10.1094/PDIS.2001.85.4.340; Skaria M., 2012, SUBTROP PLANT SCI, V64, P29; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Struelens MJ, 1998, MEM I OSWALDO CRUZ, V93, P581, DOI 10.1590/S0074-02761998000500004; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Traore YN, 2008, PLANT DIS, V92, P977, DOI 10.1094/PDIS-92-6-0977B; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Verniere C, 1998, EUR J PLANT PATHOL, V104, P477, DOI 10.1023/A:1008676508688; Verniere C, 2014, ENVIRON MICROBIOL, V16, P2226, DOI 10.1111/1462-2920.12369; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Young JM, 2008, PHYTOPATHOLOGY, V98, P1060, DOI 10.1094/PHYTO-98-10-1060; Zaluga J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-126; Zhao S, 2012, PHYTOPATHOLOGY, V102, P948, DOI 10.1094/PHYTO-04-12-0078-R	71	48	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98129	10.1371/journal.pone.0098129	http://dx.doi.org/10.1371/journal.pone.0098129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897119	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700026
J	Zumbrennen-Bullough, KB; Becker, L; Garrett, L; Holter, SM; Calzada-Wack, J; Mossbrugger, I; Quintanilla-Fend, L; Racz, I; Rathkolb, B; Klopstock, T; Wurst, W; Zimmer, A; Wolf, E; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Romney, SJ; Leibold, EA				Zumbrennen-Bullough, Kimberly B.; Becker, Lore; Garrett, Lillian; Hoelter, Sabine M.; Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia; Racz, Ildiko; Rathkolb, Birgit; Klopstock, Thomas; Wurst, Wolfgang; Zimmer, Andreas; Wolf, Eckhard; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Romney, Steven J.; Leibold, Elizabeth A.			Abnormal Brain Iron Metabolism in Irp2 Deficient Mice Is Associated with Mild Neurological and Behavioral Impairments	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; REGULATORY PROTEIN-2; NEURODEGENERATIVE DISEASE; TARGETED DELETION; MESSENGER-RNAS; KNOCKOUT MICE; HOMEOSTASIS; MOUSE; GENE; TRANSFERRIN	Iron Regulatory Protein 2 (Irp2, Ireb2) is a central regulator of cellular iron homeostasis in vertebrates. Two global knockout mouse models have been generated to explore the role of Irp2 in regulating iron metabolism. While both mouse models show that loss of Irp2 results in microcytic anemia and altered body iron distribution, discrepant results have drawn into question the role of Irp2 in regulating brain iron metabolism. One model shows that aged Irp2 deficient mice develop adult-onset progressive neurodegeneration that is associated with axonal degeneration and loss of Purkinje cells in the central nervous system. These mice show iron deposition in white matter tracts and oligodendrocyte soma throughout the brain. A contrasting model of global Irp2 deficiency shows no overt or pathological signs of neurodegeneration or brain iron accumulation, and display only mild motor coordination and balance deficits when challenged by specific tests. Explanations for conflicting findings in the severity of the clinical phenotype, brain iron accumulation and neuronal degeneration remain unclear. Here, we describe an additional mouse model of global Irp2 deficiency. Our aged Irp2(-/-) mice show marked iron deposition in white matter and in oligodendrocytes while iron content is significantly reduced in neurons. Ferritin and transferrin receptor 1 (TfR1, Tfrc), expression are increased and decreased, respectively, in the brain from Irp2(-/-) mice. These mice show impairments in locomotion, exploration, motor coordination/balance and nociception when assessed by neurological and behavioral tests, but lack overt signs of neurodegenerative disease. Ultrastructural studies of specific brain regions show no evidence of neurodegeneration. Our data suggest that Irp2 deficiency dysregulates brain iron metabolism causing cellular dysfunction that ultimately leads to mild neurological, behavioral and nociceptive impairments.	[Zumbrennen-Bullough, Kimberly B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Program Membrane Biol,Ctr Syst Biol, Program Anemia Signaling Res,Div Nephrol, Boston, MA USA; [Becker, Lore; Garrett, Lillian; Hoelter, Sabine M.; Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia; Racz, Ildiko; Rathkolb, Birgit; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Garrett, Lillian; Hoelter, Sabine M.; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Calzada-Wack, Julia; Mossbrugger, Ilona; Quintanilla-Fend, Leticia] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Life & Brain Ctr, Bonn, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Klopstock, Thomas] Klinikum Ludwig Maximilians Univ, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Genet, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen, Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] Munich Cluster Syst Neurol, Munich, Germany; [Romney, Steven J.; Leibold, Elizabeth A.] Univ Utah, Dept Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bonn; University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Dept Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA.	betty.leibold@genetics.utah.edu	Becker, Lore/AAJ-1203-2020; Becker, Lore/E-3717-2010; Zimmer, Andreas/B-8357-2009; Gailus-Durner, Valerie/M-7337-2014; Racz, I./C-3074-2009; de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014; Hölter, Sabine M./N-5868-2014	Becker, Lore/0000-0002-6890-4984; Racz, I./0000-0002-1549-3616; de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Hölter, Sabine M./0000-0003-4878-5241; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305; Garrett, Lillian/0000-0003-4880-7076; Wolf, Eckhard/0000-0002-0430-9510	NIH [R01GM45201, T32DK007115]; German Federal Ministry of Education and Research [01KX1012]; German Center for Vertigo and Balance Disorders [01EO 0901]; Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease'; DFG [WU 164/5-1]; Seventh Framework Programme of the European Commission (FP7) [HEALTH-F2-2011];  [277984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease'; DFG(German Research Foundation (DFG)); Seventh Framework Programme of the European Commission (FP7); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grant R01GM45201 to EAL and the NIH Hematology training grant T32DK007115 to KZB. German Mouse Clinic researchers (SMH, WW, BR, EW, LG, LB, IM, JCW, LQF, IR and AZ) were supported by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012); the German Center for Vertigo and Balance Disorders (grant 01EO 0901); by the Helmholtz Alliance HelMA-Helmholtz Alliance for Mental Health in an Ageing Society, through the Initiative and Network Fund of the Helmholtz Association; by the Helmholtz Portfolio Theme 'Metabolic Dysfunction and disease', by the DFG grant 'DJ-1 Linked Neurodegeneration Pathways in New Mouse Models of Parkinson's Disease'(WU 164/5-1). TK was supported by the Seventh Framework Programme of the European Commission (FP7/2007-2013, HEALTH-F2-2011), grant agreement no. 277984 to TIRCON (Treat Iron-Related Childhood-Onset Neurodegeneration). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Burn John, 2006, Semin Pediatr Neurol, V13, P176; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Dickinson TK, 1998, BRAIN RES, V801, P171, DOI 10.1016/S0006-8993(98)00575-7; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Fretham SJB, 2012, HIPPOCAMPUS, V22, P1691, DOI 10.1002/hipo.22004; Galy B, 2005, GENESIS, V43, P181, DOI 10.1002/gene.20169; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2006, NAT GENET, V38, P967, DOI 10.1038/ng0906-967; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Grabill C, 2003, BRAIN RES, V971, P95, DOI 10.1016/S0006-8993(03)02366-7; GUO B, 1994, J BIOL CHEM, V269, P24252; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Kallnik M, 2007, MAMM GENOME, V18, P173, DOI 10.1007/s00335-007-9002-z; Kono S, 2006, BIOL RES, V39, P15, DOI 10.4067/S0716-97602006000100003; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Leitner DF, 2012, BBA-GEN SUBJECTS, V1820, P393, DOI 10.1016/j.bbagen.2011.10.016; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Ohl F, 2001, BEHAV RES METH INS C, V33, P392, DOI 10.3758/BF03195393; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Rouault TA, 2013, NAT REV NEUROSCI; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sanchez M, 2011, BLOOD, V118, pE168, DOI 10.1182/blood-2011-04-343541; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Watase K, 2003, NAT REV GENET, V4, P296, DOI 10.1038/nrg1045; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Youdim MBH, 2008, NEUROTOX RES, V14, P45, DOI 10.1007/BF03033574; YU Y, 1992, J BIOL CHEM, V267, P19005	48	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98072	10.1371/journal.pone.0098072	http://dx.doi.org/10.1371/journal.pone.0098072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896637	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700024
J	Buono, L; Lopez-Villavicencio, M; Shykoff, JA; Snirc, A; Giraud, T				Buono, Lorenza; Lopez-Villavicencio, Manuela; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana			Influence of Multiple Infection and Relatedness on Virulence: Disease Dynamics in an Experimental Plant Population and Its Castrating Parasite	PLOS ONE			English	Article							FUNGUS MICROBOTRYUM-VIOLACEUM; POLYMORPHIC MICROSATELLITE LOCI; WITHIN-HOST COMPETITION; ANTHER-SMUT DISEASE; USTILAGO-VIOLACEA; SPORE PRODUCTION; LIFE-HISTORY; SILENE-ALBA; EVOLUTION; REPRODUCTION	The level of parasite virulence, i.e., the decrease in host's fitness due to a pathogen, is expected to depend on several parameters, such as the type of the disease (e.g., castrating or host-killing) and the prevalence of multiple infections. Although these parameters have been extensively studied theoretically, few empirical data are available to validate theoretical predictions. Using the anther smut castrating disease on Silene latifolia caused by Microbotryum lychnidis-dioicae, we studied the dynamics of multiple infections and of different components of virulence (host death, non-recovery and percentage of castrated stems) during the entire lifespan of the host in an experimental population. We monitored the number of fungal genotypes within plants and their relatedness across five years, using microsatellite markers, as well as the rates of recovery and host death in the population. The mean relatedness among genotypes within plants remained at a high level throughout the entire host lifespan despite the dynamics of the disease, with recurrent new infections. Recovery was lower for plants with multiple infections compared to plants infected by a single genotype. As expected for castrating parasites, M. lychnidis-dioicae did not increase host mortality. Mortality varied across years but was generally lower for plants that had been diseased the preceding year. This is one of the few studies to have empirically verified theoretical expectations for castrating parasites, and to show particularly i) that castrated hosts live longer, suggesting that parasites can redirect resources normally used in reproduction to increase host lifespan, lengthening their transmission phase, and ii) that multiple infections increase virulence, here in terms of non-recovery and host castration.	[Buono, Lorenza; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana] Univ Paris 11, Orsay, France; [Buono, Lorenza; Shykoff, Jacqui A.; Snirc, Alodie; Giraud, Tatiana] CNRS, F-91405 Orsay, France; [Lopez-Villavicencio, Manuela] Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Giraud, T (corresponding author), Univ Paris 11, Orsay, France.	tatiana.giraud@u-psud.fr		Giraud, Tatiana/0000-0002-2685-6478	 [ANR-13-BSV7-0008]		ANR-13-BSV7-0008 (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HM, 1995, J ECOL, V83, P783, DOI 10.2307/2261415; ALEXANDER HM, 1988, J ECOL, V76, P91, DOI 10.2307/2260456; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Antonovics J, 2005, NEW PHYTOL, V165, P71, DOI 10.1111/j.1469-8137.2004.01215.x; Bashey F, 2012, J EVOLUTION BIOL, V25, P431, DOI 10.1111/j.1420-9101.2011.02441.x; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; Best A, 2010, EVOLUTION, V64, P348, DOI 10.1111/j.1558-5646.2009.00819.x; Biere A, 1996, OECOLOGIA, V107, P307, DOI 10.1007/BF00328447; Bonds MH, 2006, AM NAT, V168, P281, DOI 10.1086/506922; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Bucheli E, 1998, MOL ECOL, V7, P665; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Burns CE, 2005, ECOLOGY, V86, P753, DOI 10.1890/03-0735; Cafuir L, 2007, INT J PLANT SCI, V168, P415, DOI 10.1086/511754; Chung E, 2012, ECOL EVOL, V2, P2304, DOI 10.1002/ece3.346; Dawkins R., 1999, THE EXTENDED PHENOTY; DAY AW, 1980, BOT GAZ, V141, P313, DOI 10.1086/337162; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; Delmotte F, 1999, HEREDITY, V82, P300, DOI 10.1038/sj.hdy.6884850; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Ebert D, 1997, P ROY SOC B-BIOL SCI, V264, P985, DOI 10.1098/rspb.1997.0136; Edwards DP, 2008, BEHAV ECOL SOCIOBIOL, V63, P95, DOI 10.1007/s00265-008-0639-8; Flor HH, 1942, PHYTOPATHOLOGY, V32, P653; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Giraud T, 2008, MOL ECOL RESOUR, V8, P387, DOI 10.1111/j.1471-8286.2007.01967.x; Giraud T, 2004, HEREDITY, V93, P559, DOI 10.1038/sj.hdy.6800554; Giraud T, 2002, MOL ECOL NOTES, V2, P142, DOI 10.1046/j.1471-8286.2002.00172.x; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Gold Alexander, 2009, BMC Ecology, V9, P11, DOI 10.1186/1472-6785-9-11; Hechinger RF, 2008, P ROY SOC B-BIOL SCI, V275, P2707, DOI 10.1098/rspb.2008.0875; Hechinger RF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-136; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Kaltz O, 1999, EVOLUTION, V53, P395, DOI [10.1111/j.1558-5646.1999.tb03775.x, 10.2307/2640776]; Kaltz O, 2002, J EVOLUTION BIOL, V15, P850, DOI 10.1046/j.1420-9101.2002.00433.x; Keeney DB, 2007, MOL ECOL, V16, P431, DOI 10.1111/j.1365-294X.2006.03143.x; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; KURIS AM, 1994, ANNU REV ECOL SYST, V25, P189, DOI 10.1146/annurev.es.25.110194.001201; Lafferty KD, 2009, TRENDS PARASITOL, V25, P564, DOI 10.1016/j.pt.2009.09.003; Lefevre T, 2008, TRENDS PARASITOL, V24, P435, DOI 10.1016/j.pt.2008.06.006; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Mageroy JH, 2011, PARASITOLOGY, V138, P1910, DOI 10.1017/S0031182011001302; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Morris WF, 1998, AM J BOT, V85, P784, DOI 10.2307/2446413; Neuhaus P, 2001, CAN J ZOOL, V79, P465, DOI 10.1139/cjz-79-3-465; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Obreski S, 2005, SCIENCE, V188, P1314; Ojosnegros S, 2010, P NATL ACAD SCI USA, V107, P2108, DOI 10.1073/pnas.0909787107; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Schafer AM, 2010, BOTANY, V88, P875, DOI 10.1139/B10-061; Shykoff JA, 1998, INT J PLANT SCI, V159, P236, DOI 10.1086/297544; Thomas A, 2003, INT J PLANT SCI, V164, P641, DOI 10.1086/375374; Thomas F, 2000, J EVOLUTION BIOL, V13, P409, DOI 10.1046/j.1420-9101.2000.00190.x; THRALL PH, 1994, J ECOL, V82, P549, DOI 10.2307/2261263; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	65	12	13	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98526	10.1371/journal.pone.0098526	http://dx.doi.org/10.1371/journal.pone.0098526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892951	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400062
J	Liu, Y; Liu, YY; Sun, C; Gan, L; Zhang, LW; Mao, AH; Du, YT; Zhou, R; Zhang, H				Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Du, Yuting; Zhou, Rong; Zhang, Hong			Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MALIGNANT GLIOMA; GENE; ANGIOGENESIS; RADIOTHERAPY; EXPRESSION; SURVIVAL; INVASION; BIOLOGY; FAK	This study evaluated the effects of carbon ion and X-ray radiation and the tumor microenvironment on the migration of glioma and endothelial cells, a key process in tumorigenesis and angiogenesis during cancer progression. C6 glioma and human microvascular endothelial cells were treated with conditioned medium from cultures of glioma cells irradiated at a range of doses and the migration of both cell types, tube formation by endothelial cells, as well as the expression and secretion of migration-related proteins were evaluated. Exposure to X-ray radiation-conditioned medium induced dose-dependent increases in cell migration and tube formation, which were accompanied by an upregulation of vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-2 and -9 expression. However, glioma cells treated with conditioned medium of cells irradiated at a carbon ion dose of 4.0 Gy showed a marked decrease in migratory potential and VEGF secretion relative to non-irradiated cells. The application of recombinant VEGF165 stimulated migration in glioma and endothelial cells, which was associated with increased FAK phosphorylation at Tyr861, suggesting that the suppression of cell migration by carbon ion radiation could be via VEGF-activated FAK signaling. Taken together, these findings indicate that carbon ion may be superior to X-ray radiation for inhibiting tumorigenesis and angiogenesis through modulation of VEGF level in the glioma microenvironment.	[Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Radiat Med, Lanzhou, Peoples R China; [Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Liu, Yang; Liu, Yuanyuan; Sun, Chao; Gan, Lu; Zhang, Luwei; Mao, Aihong; Zhou, Rong; Zhang, Hong] Key Lab Heavy Ion Radiat Med Gansu Prov, Lanzhou, Peoples R China; [Mao, Aihong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Du, Yuting] Lanzhou Univ, Hosp Stomatol, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Lanzhou University	Zhang, H (corresponding author), Chinese Acad Sci, Inst Modern Phys, Dept Radiat Med, Lanzhou, Peoples R China.	zhangh@impcas.ac.cn			National Basic Research Program of China [2010CB834202]; National Natural Science Foundation of China [11205214, 11305224]; Scientific Technology Research Projects of Gansu Province [0702NKDA045, 0806RJYA020]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Research Projects of Gansu Province	This work was supported by grants from the National Basic Research Program of China (2010CB834202), The National Natural Science Foundation of China (11205214 and 11305224), the Scientific Technology Research Projects of Gansu Province (0702NKDA045, 0806RJYA020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Chu SH, 2007, SURG NEUROL, V68, P610, DOI [10.1016/j.sumeu.2006.12.050, 10.1016/j.surneu.2006.12.050]; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Desai S, 2013, CYTOKINE, V61, P54, DOI 10.1016/j.cyto.2012.08.022; Durante M, 2000, INT J RADIAT ONCOL, V47, P793, DOI 10.1016/S0360-3016(00)00455-7; Gorski DH, 1999, CANCER RES, V59, P3374; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Jensen AD, 2011, BRIT J RADIOL, V84, pS35, DOI 10.1259/bjr/71511359; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; Kargiotis O, 2010, J NEURO-ONCOL, V100, P323, DOI 10.1007/s11060-010-0199-4; Kil WJ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-25; Kim SY, 2013, BIOCHEM BIOPH RES CO, V433, P260, DOI 10.1016/j.bbrc.2013.02.093; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Liu Y, 2012, J PINEAL RES, V52, P47, DOI 10.1111/j.1600-079X.2011.00917.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Marie M, 2012, INT J RADIAT BIOL, V88, P688, DOI 10.3109/09553002.2012.706358; Nakagawa Y, 2012, BIOCHEM BIOPH RES CO, V423, P654, DOI 10.1016/j.bbrc.2012.06.004; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Parthymou A, 2004, INT J CANCER, V110, P807, DOI 10.1002/ijc.20188; Ruegg C, 2011, B CANCER, V98, pE47, DOI 10.1684/bdc.2011.1372; Sieg DJ, 1999, J CELL SCI, V112, P2677; Takahashi Y, 2003, CANCER RES, V63, P4253; Wild-Bode C, 2001, CANCER RES, V61, P2744; Yoshimura M, 2013, BIOMED RES IN PRESS; Zhang H, 2012, BRIT J DERMATOL, V166, P1100, DOI 10.1111/j.1365-2133.2011.10764.x	32	8	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98448	10.1371/journal.pone.0098448	http://dx.doi.org/10.1371/journal.pone.0098448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893038	gold, Green Submitted, Green Published			2022-12-25	WOS:000336911400052
J	Tegtmeyer, N; Lind, J; Schmid, B; Backert, S				Tegtmeyer, Nicole; Lind, Judith; Schmid, Benedikt; Backert, Steffen			Helicobacter pylori CagL Y58/E59 Mutation Turns-Off Type IV Secretion-Dependent Delivery of CagA into Host Cells	PLOS ONE			English	Editorial Material							PATHOGENICITY ISLAND; ADHESION; PROTEIN; PHOSPHORYLATION; EXPRESSION; INDUCTION; SYSTEM; GENES	The type IV secretion system (T4SS) is a major virulence determinant of the gastric pathogen Helicobacter pylori. The CagL protein is a specialized adhesin of the corresponding T4SS pilus, which establishes initial contact with the integrin beta 1 receptor on host target cells. Recent studies proposed that Y58 and E59 amino acid polymorphisms in CagL increase the virulence of H. pylori strains by enhanced translocation and phosphorylation of the CagA effector protein. These polymorphisms were therefore correlated with an increased risk of gastric cancer development. Here we show that the Y58/E59 motif, which is located in a loop connecting two a-helices, and corresponding polymorphisms could influence the function of CagL. However, expression of isogenic CagL Y58/E59 variants in H. pylori strain 26695 significantly blocked the translocation and phosphorylation of CagA as compared to complemented wild-type CagL. These results suggest that the function of the T4SS for delivery of CagA is turned-off by the Y58/E59 mutation in CagL. This activity appears to be similar to the one recently described for another T4SS pilus protein, CagY, which is also sufficient to cause gain or loss of T4SS function. These data support the hypothesis that certain mutations in CagL or recombination events in CagY may serve as a sort of molecular switch or perhaps rheostat in the T4SS, which could alter the function of the pilus and "tunes" injection of CagA and host pro-inflammatory responses, respectively.	[Tegtmeyer, Nicole; Lind, Judith; Backert, Steffen] Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany; [Schmid, Benedikt] Univ Erlangen Nurnberg, Dept Biol, Div Biotech, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Backert, S (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany.	Steffen.Backert@fau.de						Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; Barrozo RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003189; Bijlsma JJE, 1999, INFECT IMMUN, V67, P2433, DOI 10.1128/IAI.67.5.2433-2440.1999; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Conradi J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00070; Conradi J, 2012, AMINO ACIDS, V43, P219, DOI 10.1007/s00726-011-1066-0; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Hirsch C, 2012, J GASTROENTEROL, V47, P936, DOI 10.1007/s00535-012-0618-8; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Pachathundikandi SK, 2013, GUT MICROBES, V4, P454, DOI 10.4161/gmic.27001; Patel SR, 2013, CELL MICROBIOL, V15, P2080, DOI 10.1111/cmi.12174; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072735; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753	26	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97782	10.1371/journal.pone.0097782	http://dx.doi.org/10.1371/journal.pone.0097782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893039	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400022
J	Kuo, CY; Li, X; Kong, XQ; Luo, C; Chang, CC; Chung, YY; Shih, HM; Li, KK; Ann, DK				Kuo, Ching-Ying; Li, Xu; Kong, Xiang-Qian; Luo, Cheng; Chang, Che-Chang; Chung, Yiyin; Shih, Hsiu-Ming; Li, Keqin Kathy; Ann, David K.			An Arginine-rich Motif of Ring Finger Protein 4 (RNF4) Oversees the Recruitment and Degradation of the Phosphorylated and SUMOylated Kruppel-associated Box Domain-associated Protein 1 (KAP1)/TRIM28 Protein during Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN E3 LIGASE; DNA-DAMAGE; POSTTRANSLATIONAL MODIFICATIONS; FAMILY PROTEINS; SUMO; PML; REPAIR; KAP1; IDENTIFICATION; REPLICATION	Kruppel-associated box domain-associated protein 1 (KAP1) is a universal transcriptional corepressor that undergoes multiple posttranslational modifications (PTMs), including SUMOylation and Ser-824 phosphorylation. However, the functional interplay of KAP1 PTMs in regulating KAP1 turnover during DNA damage response remains unclear. To decipher the role and cross-talk of multiple KAP1 PTMs, we show here that DNA double strand break-induced KAP1 Ser-824 phosphorylation promoted the recruitment of small ubiquitin-like modifier (SUMO)-targeted ubiquitin E3 ligase, ring finger protein 4 (RNF4), and subsequent RNF4-mediated, SUMO-dependent degradation. Besides the SUMO interacting motif (SIM), a previously unrecognized, but evolutionarily conserved, arginine-rich motif (ARM) in RNF4 acts as a novel recognition motif for selective target recruitment. Results from combined mutagenesis and computational modeling studies suggest that RNF4 utilizes concerted bimodular recognition, namely SIM for Lys-676 SUMOylation and ARM for Ser(P)-824 of simultaneously phosphorylated and SUMOylated KAP1 (Ser(P)-824-SUMO-KAP1). Furthermore, we proved that arginines 73 and 74 within the ARM of RNF4 are required for efficient recruitment to KAP1 or accelerated degradation of promyelocytic leukemia protein (PML) under stress. In parallel, results of bimolecular fluorescence complementation assays validated the role of the ARM in recognizing Ser(P)-824 in living cells. Taken together, we establish that the ARM is required for RNF4 to efficiently target Ser(P)-824-SUMO-KAP1, conferring ubiquitin Lys-48-mediated proteasomal degradation in the context of double strand breaks. The conservation of such a motif may possibly explain the requirement for timely substrate selectivity determination among a myriad of SUMOylated proteins under stress conditions. Thus, the ARM dynamically regulates the SIM-dependent recruitment of targets to RNF4, which could be critical to dynamically fine-tune the abundance of Ser(P)-824-SUMO-KAP1 and, potentially, other SUMOylated proteins during DNA damage response.	[Kuo, Ching-Ying; Li, Xu; Chung, Yiyin; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Kuo, Ching-Ying; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Kong, Xiang-Qian; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Chang, Che-Chang; Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Li, Keqin Kathy] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, Shanghai 200025, Peoples R China	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Academia Sinica - Taiwan; Chinese Academy of Sciences; Shanghai Jiao Tong University	Li, KK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Rui Jin Hosp, 197 Ruijin 2 Rd, Shanghai 200025, Peoples R China.	kli@epigenetic.us; dann@coh.org	Shih, Hsiu-Ming/S-7023-2018; Kong, Xiangqian/J-4500-2017	Kong, Xiangqian/0000-0002-9596-7825; KUO, CHING-YING/0000-0003-1555-3057	National Institute of Health [R01DE10742, R01DE14183]; National Science Council [99-2321-B-001-010, 98-2321-B-001-012]; National 973 Program [2011CB510102]; National Natural Science Foundation [81270622]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); National 973 Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institute of Health Grants R01DE10742 and R01DE14183 (to D. K. A.). This work was also supported by National Science Council Grants 99-2321-B-001-010 and 98-2321-B-001-012 (to H. M. S.), by National 973 Program Grant 2011CB510102 (to K. K. L.), and by National Natural Science Foundation Grant 81270622 (to K. K. L.).	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bologna Serena, 2013, Frontiers in Genetics, V4, P106, DOI 10.3389/fgene.2013.00106; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Garvin A. J., 2013, EMBO REP, DOI [10.1038/ncb1446, DOI 10.1038/NCB1446]; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Izumiya Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003506; Keusekotten K, 2014, BIOCHEM J, V457, P207, DOI 10.1042/BJ20130753; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li X, 2007, J BIOL CHEM, V282, P36177, DOI 10.1074/jbc.M706912200; Li X, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000781; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Liu JP, 2012, CELL CYCLE, V11, P2643, DOI 10.4161/cc.20957; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nguyen HV, 2006, AM J PATHOL, V168, P1452, DOI 10.2353/ajpath.2006.050782; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Sun H., 2007, EMBO J, V26, P4053; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Yang YC, 2013, J BIOL CHEM, V288, P12866, DOI 10.1074/jbc.M112.413393; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	58	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20757	20772		10.1074/jbc.M114.555672	http://dx.doi.org/10.1074/jbc.M114.555672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24907272	Green Published, hybrid			2022-12-25	WOS:000339396600032
J	Subramanian, H; Gupta, K; Parameswaran, N; Ali, H				Subramanian, Hariharan; Gupta, Kshitij; Parameswaran, Narayanan; Ali, Hydar			Regulation of Fc epsilon RI Signaling in Mast Cells by G Protein-coupled Receptor Kinase 2 and Its RH Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE PRODUCTION; HOMOLOGY DOMAIN; IN-VIVO; PHOSPHORYLATION; GRK2; SYK; DESENSITIZATION; ACTIVATION; INTERNALIZATION; DEGRANULATION	Agonist-induced phosphorylation of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) promotes their desensitization and internalization. Here, we sought to determine the role of GRK2 on Fc epsilon RI signaling and mediator release in mast cells. The strategies utilized included lentiviral shRNA-mediated GRK2 knockdown, GRK2 gene deletion (GRK2(flox/flox)/cre recombinase) and overexpression of GRK2 and its regulator of G protein signaling homology (RH) domain (GRK2-RH). We found that silencing GRK2 expression caused similar to 50% decrease in antigen-induced Ca2+ mobilization and degranulation but resulted in ablation of cytokine (IL-6 and IL-13) generation. The effect of GRK2 on cytokine generation does not require its catalytic activity but is mediated via the phosphorylation of p38 and Akt. Overexpression of GRK2 or its RH domain (GRK2-RH) enhanced antigen-induced mast cell degranulation and cytokine generation without affecting the expression levels of any of the Fc epsilon RI subunits (alpha, beta, and gamma). GRK2 or GRK2-RH had no effect on antigen-induced phosphorylation of Fc epsilon RI gamma or Src but enhanced tyrosine phosphorylation of Syk. These data demonstrate that GRK2 modulates Fc epsilon RI signaling in mast cells via at least two mechanisms. One involves GRK2-RH and modulates tyrosine phosphorylation of Syk, and the other is mediated via the phosphorylation of p38 and Akt.	[Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Parameswaran, Narayanan] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	University of Pennsylvania; Michigan State University	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, 240 South 40th St, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022; Parameswaran, Narayanan/V-1969-2019	Parameswaran, Narayanan/0000-0002-8894-5564	National Institutes of Health [HL085774, AI094896]; American Heart Association [12POST9260009];  [K99-HL121073]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121073, R01HL085774, R01HL095637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094896, R21AI099404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085774 and AI094896 (to H. A.). It was also supported by K99-HL121073 and an American Heart Association Grant 12POST9260009 (to H. S.).	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Andrade MV, 2011, EUR J IMMUNOL, V41, P760, DOI 10.1002/eji.201040718; Cannavo A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00264; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; DeFord-Watts LM, 2007, J BIOL CHEM, V282, P16126, DOI 10.1074/jbc.M609418200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; Gupta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046369; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kamal FA, 2011, J MOL CELL CARDIOL, V51, P462, DOI 10.1016/j.yjmcc.2011.01.006; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Pao C. S., 2002, SCI STKE, V2002, ppe42; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Penela P, 2010, BRIT J PHARMACOL, V160, P821, DOI 10.1111/j.1476-5381.2010.00727.x; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rockman HA, 1996, J CLIN INVEST, V97, P1618, DOI 10.1172/JCI118587; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Sanderson MP, 2010, CELL IMMUNOL, V262, P28, DOI 10.1016/j.cellimm.2009.12.004; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Subramanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051355; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Wong BR, 2004, EXPERT OPIN INV DRUG, V13, P743, DOI 10.1517/13543784.13.7.743	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20917	20927		10.1074/jbc.M113.523969	http://dx.doi.org/10.1074/jbc.M113.523969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904059	hybrid, Green Published			2022-12-25	WOS:000339396600045
J	Hong, J; Kim, BW; Choo, HJ; Park, JJ; Yi, JS; Yu, DM; Lee, H; Yoon, GS; Lee, JS; Ko, YG				Hong, Jin; Kim, Bong-Woo; Choo, Hyo-Jung; Park, Jung-Jin; Yi, Jae-Sung; Yu, Dong-Min; Lee, Hyun; Yoon, Gye-Soon; Lee, Jae-Seon; Ko, Young-Gyu			Mitochondrial Complex I Deficiency Enhances Skeletal Myogenesis but Impairs Insulin Signaling through SIRT1 Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; AUTOREGULATORY LOOP; ACTIVATING SIRT1; MUSCLE; DYSFUNCTION; PGC-1-ALPHA; DIFFERENTIATION; MUTATIONS; DELETION; PROTECTS	To address whether mitochondrial biogenesis is essential for skeletal myogenesis, C2C12 myogenesis was investigated after knockdown of NADH dehydrogenase (ubiquintone) flavoprotein 1 (NDUFV1), which is an oxidative phosphorylation complex I subunit that is the first subunit to accept electrons from NADH. The NDUFVI knockdown enhanced C2C12 myogenesis by decreasing the NAD(+)/NADH ratio and subsequently inactivating SIRT1 and SIRT1 activators (pyruvate, SRT1720, and resveratrol) abolished the NDUFV1 knockdown-induced myogenesis enhancement. However, the insulin-elicited activation of insulin receptor beta (IR beta) and insulin receptor substrate-1 (IRS-1) was reduced with elevated levels of protein-tyrosine phosphatase 1B after NDUFV1 knockdown in C2C12 myotubes. The NDUFV1 knockdown-induced blockage of insulin signaling was released by protein-tyrosine phosphatase 1B knockdown in C2C12 myotubes, and we found that NDUFV1 or SIRT1 knockdown did not affect mitochondria biogenesis during C2C12 myogenesis. Based on these data, we can conclude that complex I dysfunction-induced SIRT1 inactivation leads to myogenesis enhancement but blocks insulin signaling without affecting mitochondria biogenesis.	[Hong, Jin; Choo, Hyo-Jung; Park, Jung-Jin; Yi, Jae-Sung; Yu, Dong-Min; Lee, Hyun; Ko, Young-Gyu] Korea Univ, Div Life Sci, Seoul 136701, South Korea; [Kim, Bong-Woo] Seowon Univ, Dept Cosmet Sci & Technol, Cheongju, Cheongju 361742, South Korea; [Yoon, Gye-Soon] Ajou Univ, Dept Biochem & Mol Biol, Suwon 443721, South Korea; [Lee, Jae-Seon] Inha Univ, Dept Biomed Sci, Coll Med, Inchon 400712, South Korea	Korea University; Seowon University; Ajou University; Inha University	Ko, YG (corresponding author), Korea Univ, Div Life Sci, 145 Anam Ro, Seoul 136701, South Korea.	ygko@korea.ac.kr		Choo, Hyojung/0000-0002-6280-0332	Korea Research Foundation [2011-0017562, C00286]; Korea University Research Fund	Korea Research Foundation(National Research Foundation of Korea); Korea University Research Fund	This work was supported by Korea Research Foundation Grants 2011-0017562 and C00286 (to Y.-G. K.) and by the Korea University Research Fund.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Choo HJ, 2008, EXP MOL MED, V40, P220, DOI 10.3858/emm.2008.40.2.220; Del Prete A, 2008, FREE RADICAL BIO MED, V44, P1443, DOI 10.1016/j.freeradbiomed.2007.12.037; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jafri MS, 2001, ANNU REV BIOMED ENG, V3, P57, DOI 10.1146/annurev.bioeng.3.1.57; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Jung SY, 2010, BIOCHEM BIOPH RES CO, V396, P238, DOI 10.1016/j.bbrc.2010.04.072; Kim BW, 2010, PROTEOMICS, V10, P2498, DOI 10.1002/pmic.200900826; Kim BW, 2004, EXP MOL MED, V36, P476, DOI 10.1038/emm.2004.60; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Krag TO, 2013, MITOCHONDRION, V13, P63, DOI 10.1016/j.mito.2013.01.009; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee CS, 2010, CELL DEATH DIFFER, V17, P1254, DOI 10.1038/cdd.2010.1; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pawlikowska P, 2006, CELL PROLIFERAT, V39, P127, DOI 10.1111/j.1365-2184.2006.00376.x; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wagatsuma A, 2013, THESCIENTIFICWORLDJO, V2013, DOI DOI 10.1155/2013/593267; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zeviani M, 1998, MEDICINE, V77, P59, DOI 10.1097/00005792-199801000-00006; Zhang XT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3703	57	19	20	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20012	20025		10.1074/jbc.M114.560078	http://dx.doi.org/10.1074/jbc.M114.560078			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895128	Green Published, hybrid			2022-12-25	WOS:000339395200017
J	Micale, G; Pulvirenti, A; Giugno, R; Ferro, A				Micale, Giovanni; Pulvirenti, Alfredo; Giugno, Rosalba; Ferro, Alfredo			GASOLINE: a Greedy And Stochastic algorithm for Optimal Local multiple alignment of Interaction NEtworks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; CONSERVED PATHWAYS; DATABASE; YEAST; TOOL	The analysis of structure and dynamics of biological networks plays a central role in understanding the intrinsic complexity of biological systems. Biological networks have been considered a suitable formalism to extend evolutionary and comparative biology. In this paper we present GASOLINE, an algorithm for multiple local network alignment based on statistical iterative sampling in connection to a greedy strategy. GASOLINE overcomes the limits of current approaches by producing biologically significant alignments within a feasible running time, even for very large input instances. The method has been extensively tested on a database of real and synthetic biological networks. A comprehensive comparison with state-of-the art algorithms clearly shows that GASOLINE yields the best results in terms of both reliability of alignments and running time on real biological networks and results comparable in terms of quality of alignments on synthetic networks. GASOLINE has been developed in Java, and is available, along with all the computed alignments, at the following URL: http://ferrolab.dmi.unict.it/gasoline/gasoline.html.	[Micale, Giovanni] Univ Pisa, Dept Comp Sci, Pisa, Italy; [Pulvirenti, Alfredo; Giugno, Rosalba; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy	University of Pisa; University of Catania	Giugno, R (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	apulvirenti@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Micale, Giovanni/AAT-2092-2021	Pulvirenti, Alfredo/0000-0002-9764-0295; Micale, Giovanni/0000-0002-4953-026X; Giugno, Rosalba/0000-0001-9843-7638	Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR); Linea di intervento [CUP G23F11000840004]	Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR); Linea di intervento	This work has been partially founded by Programma Operativo Fondo Europeo per lo Sviluppo Regionale (PO-FESR) 2007-2013), Linea di intervento 4.1.1.2. Grant number: CUP G23F11000840004. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banks E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r138; Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60; Bonnici V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S13; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Dost B, 2007, LECT NOTES COMPUT SC, V4453, P1; Ferro A, 2007, BIOINFORMATICS, V23, P910, DOI 10.1093/bioinformatics/btm032; Flannick J, 2006, GENOME RES, V16, P1169, DOI 10.1101/gr.5235706; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Giugno R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076911; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Jiawei H., 2001, DATA MINING CONCEPTS, P5; Kalaev M, 2009, J COMPUT BIOL, V16, P989, DOI 10.1089/cmb.2009.0136; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Osman A, 2004, METH MOL B, V270, P403; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Sahraeian SME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067995; Sahraeian SME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041474; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	36	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98750	10.1371/journal.pone.0098750	http://dx.doi.org/10.1371/journal.pone.0098750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911103	gold, Green Submitted, Green Published			2022-12-25	WOS:000337165600011
J	Hackradt, CW; Garcia-Charton, JA; Harmelin-Vivien, M; Perez-Ruzafa, A; Le Direach, L; Bayle-Sempere, J; Charbonnel, E; Ody, D; Renones, O; Sanchez-Jerez, P; Valle, C				Werner Hackradt, Carlos; Antonio Garcia-Charton, Jose; Harmelin-Vivien, Mireille; Perez-Ruzafa, Angel; Le Direach, Laurence; Bayle-Sempere, Just; Charbonnel, Eric; Ody, Denis; Renones, Olga; Sanchez-Jerez, Pablo; Valle, Carlos			Response of Rocky Reef Top Predators (Serranidae: Epinephelinae) in and Around Marine Protected Areas in the Western Mediterranean Sea	PLOS ONE			English	Article							HABITAT STRUCTURE; MARGINATUS LOWE; DUSKY GROUPERS; FISH ASSEMBLAGE; RESERVES; SPILLOVER; FISHERIES; BIOMASS; SIZE; DEGRADATION	Groupers species are extremely vulnerable to overfishing and many species are threatened worldwide. In recent decades, Mediterranean groupers experienced dramatic population declines. Marine protected areas (MPAs) can protect populations inside their boundaries and provide individuals to adjacent fishing areas through the process of spillover and larval export. This study aims to evaluate the effectiveness of six marine reserves in the Western Mediterranean Sea to protect the populations of three species of grouper, Epinephelus marginatus, Epinephelus costae and Mycteroperca rubra, and to understand in which circumstances MPAs are able to export biomass to neighbouring areas. All the studied MPAs, except one where no grouper was observed, were able to maintain high abundance, biomass and mean weight of groupers. Size classes were more evenly distributed inside than outside MPAs. In two reserves, biomass gradients could be detected through the boundaries of the reserve as an indication of spillover. In some cases, habitat structure appeared to exert a great influence on grouper abundance, biomass and mean individual weight, influencing the gradient shape. Because groupers are generally sedentary animals with a small home range, we suggest that biomass gradients could only occur where groupers attain sufficient abundance inside MPA limits, indicating a strongly density-dependent process.	[Werner Hackradt, Carlos; Antonio Garcia-Charton, Jose; Perez-Ruzafa, Angel] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Harmelin-Vivien, Mireille] Univ Sud Toulon Var, Aix Marseille Univ, CNRS INSU IRD, Inst Mediterraneen Oceanol MIO, Marseille, France; [Le Direach, Laurence] Inst Mediterraneen Oceanol MIO, GIS Posidonie, Marseille, France; [Bayle-Sempere, Just; Sanchez-Jerez, Pablo; Valle, Carlos] Univ Alicante, Dept Ciencias Mar & Biol Aplicada, E-03080 Alicante, Spain; [Charbonnel, Eric] Parc Marin Cote Bleue, Carry Le Rouet, France; [Ody, Denis] WWF France, Marseille, France; [Renones, Olga] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma De Mallorca, Spain	University of Murcia; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universitat d'Alacant; World Wildlife Fund; Spanish Institute of Oceanography	Hackradt, CW (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	hackradtcw@gmail.com	Pérez-Ruzafa, Angel/A-3406-2009; Bayle-Sempere, Just Tomàs/J-1574-2012; Hackradt, Carlos Werner/B-2037-2013; Sanchez-Jerez, Pablo/L-4750-2014; García-Charton, José Antonio/E-2793-2010; Pérez, Carlos Valle/H-8426-2015	Pérez-Ruzafa, Angel/0000-0003-4769-8912; Bayle-Sempere, Just Tomàs/0000-0001-6841-1824; Hackradt, Carlos Werner/0000-0002-8326-6503; Sanchez-Jerez, Pablo/0000-0003-4047-238X; García-Charton, José Antonio/0000-0002-5973-9913; Pérez, Carlos Valle/0000-0001-7270-5841; Renones, Olga/0000-0003-2217-5576	EC Project BIOMEX [QLRT-2001-0891]; National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil [Proc: 200630/2008-3]; Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain)	EC Project BIOMEX; National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil; Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain)	This work was developed in the framework of the EC Project BIOMEX (QLRT-2001-0891). The authors express thanks to the National Council for Technology and Science Development (CNPq-MCT, Brazil, for Brazilian acronym) from the Ministry of Science of Brazil for giving personal financial support to CWH (Proc: 200630/2008-3), and to the Fundacion BBVA (Foundation of Bilbao-Viscaya Bank, Spain) for additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], MODERN APPL STAT S; Bodilis P, 2003, J FISH BIOL, V62, P242, DOI 10.1046/j.1095-8649.2003.00028.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Chiappone M, 2000, MAR ECOL PROG SER, V198, P261, DOI 10.3354/meps198261; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coll J, 2004, FISH RES, V70, P97, DOI 10.1016/j.fishres.2004.05.004; Crec'hriou R, 2010, FISH OCEANOGR, V19, P135, DOI 10.1111/j.1365-2419.2010.00533.x; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Felix-Hackradt FC, 2014, J SEA RES, V88, P67, DOI 10.1016/j.seares.2013.12.018; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Goni R, 2008, MAR ECOL PROG SER, V366, P159, DOI 10.3354/meps07532; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Harmelin JG, 1995, MAR ECOL-P S Z N I, V16, P233, DOI 10.1111/j.1439-0485.1995.tb00408.x; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; La Mesa G, 2002, MAR BIOL, V140, P175, DOI 10.1007/s002270100682; Lembo G, 2002, HYDROBIOLOGIA, V483, P249, DOI 10.1023/A:1021360419150; Lenfant P, 2003, CYBIUM, V27, P27; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCullagh P, 1989, GEN LINEAR MODELS; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pastor J, 2009, CR BIOL, V332, P732, DOI 10.1016/j.crvi.2009.03.010; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Amargos FP, 2010, ENVIRON BIOL FISH, V87, P363, DOI 10.1007/s10641-010-9612-2; Planes S, 2000, ENVIRON CONSERV, V27, P126, DOI 10.1017/S0376892900000175; Renones Olga, 2002, Marine Life, V9, P45; Renones O, 2010, SCI MAR, V74, P523, DOI 10.3989/scimar.2010.74n3523; ROWLEY RJ, 1994, AQUAT CONSERV, V4, P233, DOI 10.1002/aqc.3270040305; Russ GR, 2010, OECOLOGIA, V163, P1103, DOI 10.1007/s00442-010-1692-3; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Unsworth RKF, 2007, MAR BIOL, V152, P243, DOI 10.1007/s00227-007-0675-3; Hackradt CW, 2011, MAR ENVIRON RES, V72, P235, DOI 10.1016/j.marenvres.2011.09.006; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zabala M, 1997, SCI MAR, V61, P65	60	46	47	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98206	10.1371/journal.pone.0098206	http://dx.doi.org/10.1371/journal.pone.0098206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905331	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000020
J	Liu, C; Han, Y; Chen, X; Zhang, W				Liu, Cheng; Han, Yue; Chen, Xi; Zhang, Wei			Structure-Function Relationship of SW-AT-1, a Serpin-Type Protease Inhibitor in Silkworm	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; CHROMATIN-STRUCTURE; BOMBYX-MORI; PROTEINS; COMPLEX	Although SW-AT-1, a serpin-type trypsin inhibitor from silkworm (Bombyx mori), was identified in previous study, its structure-function relationship has not been studied. In this study, SW-AT-1 was cloned from the body wall of silkworm and expressed in E. coli. rSW-AT-1 inhibited both trypsin and chymotrypsin in a concentration-dependent manner. The association rate constant for rSW-AT-1 and trypsin is 1.31610(-5) M-1 s(-1), for rSW-AT-1 and chymotrpsin is 2.85610(-6) M-1 s(-1). Circular dichroism (CD) assay showed 33% alpha-helices, 16% beta-sheets, 17% turns, and 31% random coils in the secondary structure of the protein. Enzymatic and CD analysis indicated that rSW-AT-1 was stable at wide pH range between 4-10, and exhibited the highest activity at weakly acidic or alkaline condition. The predicted three-dimensional structure of SW-AT-1 by PyMOL (v1.4) revealed a deductive reactive centre loop (RCL) near the C-terminus, which was extended from the body of the molecule. In addition to trypsin cleavage site in RCL, matrix-assisted laser desorption ionization time of flight mass spectrometry indicated that the chymotrypsin cleavage site of SW-AT-1 was between F336 and T337 in RCL. Directed mutagenesis indicated that both the N- and C-terminal sides of RCL have effects on the activity, and G327 and E329 played an important role in the proper folding of RCL. The physiological role of SW-AT-1 in the defense responses of silkworm were also discussed.	[Liu, Cheng; Han, Yue; Chen, Xi; Zhang, Wei] Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, W (corresponding author), Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	wzhang@njau.edu.cn			National Natural Science Foundation of China [31171326]; Jiangsu Sci-Tech Support Project-Agriculture, Jiangsu, China [BE2013428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Sci-Tech Support Project-Agriculture, Jiangsu, China	This work was partially supported by the National Natural Science Foundation of China (31171326), and Jiangsu Sci-Tech Support Project-Agriculture (BE2013428), Jiangsu, China. The funders had no role in study design, data collection and analysis, decision to publish, or prepareation of the manuscript.	ASHIDA M, 1994, INSECT BIOCHEM MOLEC, V24, P1037, DOI 10.1016/0965-1748(94)90141-4; ATKINSON AH, 1993, PLANT CELL, V5, P203, DOI 10.1105/tpc.5.2.203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT J, 1976, BIOCHEMISTRY-US, V15, P3418, DOI 10.1021/bi00661a004; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Clemente A, 2011, CURR PROTEIN PEPT SC, V12, P358, DOI 10.2174/138920311796391133; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dunstone MA, 2000, PROTEIN SCI, V9, P417; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grigoryev SA, 1998, J BIOL CHEM, V273, P3082, DOI 10.1074/jbc.273.5.3082; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; KANOST MR, 1990, INSECT BIOCHEM, V20, P141, DOI 10.1016/0020-1790(90)90006-G; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Liu HF, 2011, MOL BIOL REP, V38, P2793, DOI 10.1007/s11033-010-0424-4; NARUMI H, 1993, EUR J BIOCHEM, V214, P181, DOI 10.1111/j.1432-1033.1993.tb17911.x; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Pak SC, 2004, J BIOL CHEM, V279, P15448, DOI 10.1074/jbc.M400261200; Patston PA, 1996, FEBS LETT, V383, P87, DOI 10.1016/0014-5793(96)00231-1; PLUNKETT G, 1982, ARCH BIOCHEM BIOPHYS, V213, P463, DOI 10.1016/0003-9861(82)90572-0; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; Ricagno S, 2009, J MOL BIOL, V388, P109, DOI 10.1016/j.jmb.2009.02.056; SASAKI T, 1987, J BIOCHEM-TOKYO, V102, P433, DOI 10.1093/oxfordjournals.jbchem.a122071; SASAKI T, 1985, BIOCHEM BIOPH RES CO, V132, P320, DOI 10.1016/0006-291X(85)91025-3; Shirai K, 2000, INSECT BIOCHEM MOLEC, V30, P363, DOI 10.1016/S0965-1748(00)00003-5; Steinert S, 2011, IMMUNOL REV, V240, P129, DOI 10.1111/j.1600-065X.2010.00985.x; TAKAGI H, 1990, J BIOCHEM, V108, P372, DOI 10.1093/oxfordjournals.jbchem.a123208; Takuji S, 1991, EUR J BIOCHEM, V202, P255; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Zhou Y, 2013, GENOMICS, V101, P256, DOI 10.1016/j.ygeno.2013.02.004; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	41	3	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99013	10.1371/journal.pone.0099013	http://dx.doi.org/10.1371/journal.pone.0099013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901510	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400086
J	Kleppa, E; Ramsuran, V; Zulu, S; Karlsen, GH; Bere, A; Passmore, JAS; Ndhlovu, P; Lillebo, K; Holmen, SD; Onsrud, M; Gundersen, SG; Taylor, M; Kjetland, EF; Ndung'u, T				Kleppa, Elisabeth; Ramsuran, Veron; Zulu, Siphosenkosi; Karlsen, Gunn Hege; Bere, Alfred; Passmore, Jo-Ann S.; Ndhlovu, Patricia; Lillebo, Kristine; Holmen, Sigve D.; Onsrud, Mathias; Gundersen, Svein Gunnar; Taylor, Myra; Kjetland, Eyrun F.; Ndung'u, Thumbi			Effect of Female Genital Schistosomiasis and Anti-Schistosomal Treatment on Monocytes, CD4(+) T-Cells and CCR5 Expression in the Female Genital Tract	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 CORECEPTOR EXPRESSION; RURAL ZIMBABWEAN WOMEN; TARGET-CELLS; UROGENITAL SCHISTOSOMIASIS; HAEMATOBIUM INFECTION; IMMUNE ACTIVATION; MANSONI INFECTION; PERIPHERAL-BLOOD; CERVICAL TISSUE	Background: Schistosoma haematobium is a waterborne parasite that may cause female genital schistosomiasis (FGS), characterized by genital mucosal lesions. There is clinical and epidemiological evidence for a relationship between FGS and HIV. We investigated the impact of FGS on HIV target cell density and expression of the HIV co-receptor CCR5 in blood and cervical cytobrush samples. Furthermore we evaluated the effect of anti-schistosomal treatment on these cell populations. Design: The study followed a case-control design with post treatment follow-up, nested in an on-going field study on FGS. Methods: Blood and cervical cytobrush samples were collected from FGS negative and positive women for flow cytometry analyses. Urine samples were investigated for schistosome ova by microscopy and polymerase chain reaction (PCR). Results: FGS was associated with a higher frequency of CD14(+) cells (monocytes) in blood (11.5% in FGS+ vs. 2.2% in FGS-, p = 0.042). Frequencies of CD4(+) cells expressing CCR5 were higher in blood samples from FGS+ than from FGS-women (4.7% vs. 1.5%, p = 0.018). The CD14(+) cell population decreased significantly in both compartments after anti-schistosomal treatment (p = 0.043). Although the frequency of CD4+ cells did not change after treatment, frequencies of CCR5 expression by CD4+ cells decreased significantly in both compartments (from 3.4% to 0.5% in blood, p = 0.036; and from 42.4% to 5.6% in genital samples, p = 0.025). Conclusions: The results support the hypothesis that FGS may increase the risk of HIV acquisition, not only through damage of the mucosal epithelial barrier, but also by affecting HIV target cell populations, and that anti-schistosomal treatment can modify this.	[Kleppa, Elisabeth; Lillebo, Kristine; Holmen, Sigve D.; Kjetland, Eyrun F.] Oslo Univ Hosp OUH, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway; [Kleppa, Elisabeth; Lillebo, Kristine; Holmen, Sigve D.] Univ Oslo, Fac Med, Oslo, Norway; [Ramsuran, Veron; Ndung'u, Thumbi] Univ KwaZulu Natal UKZN, HIV Pathogenesis Programme, Nelson R Mandela Sch Med, Durban, South Africa; [Zulu, Siphosenkosi; Taylor, Myra; Kjetland, Eyrun F.] UKZN, Sch Publ Hlth Med, Nelson R Mandela Sch Med, Durban, South Africa; [Karlsen, Gunn Hege] Aarhus Univ, Aarhus, Denmark; [Bere, Alfred] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Passmore, Jo-Ann S.] Univ Cape Town, Div Med Virol, IDM, ZA-7925 Cape Town, South Africa; [Ndhlovu, Patricia] Univ London Imperial Coll Sci Technol & Med, London, England; [Onsrud, Mathias] OUH, Dept Gynaecol, Oslo, Norway; [Gundersen, Svein Gunnar] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Gundersen, Svein Gunnar] Univ Agder, Ctr Dev Studies, Kristiansand, Norway	University of Oslo; University of Kwazulu Natal; University of Kwazulu Natal; Aarhus University; Emory University; University of Cape Town; Imperial College London; University of Agder	Kleppa, E (corresponding author), Oslo Univ Hosp OUH, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway.	elisabeth.kleppa@medisin.uio.no		Holmen, Sigve/0000-0001-9698-6625; Kjetland, Eyrun Floerecke/0000-0002-5552-1095; Ndung'u, Thumbi/0000-0003-2962-3992; Ramsuran, Veron/0000-0003-1590-9893; Taylor, Myra/0000-0003-3087-2240	South-Eastern Norway Regional Health Authority; Norwegian Research Council	South-Eastern Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was funded by the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/omoss/english/Sider/page.aspx) and the Norwegian Research Council (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron L, 2011, EUR J IMMUNOL, V41, P2509, DOI 10.1002/eji.201141869; Bentwich Z, 2000, AIDS, V14, P2071, DOI 10.1097/00002030-200009290-00002; Bere A, 2013, IMMUNOLOGY, V139, P342, DOI 10.1111/imm.12084; Bere A, 2010, J IMMUNOL METHODS, V354, P68, DOI 10.1016/j.jim.2010.02.002; Bigley V, 2010, BLOOD, V116, P2859, DOI 10.1182/blood-2010-05-285676; Bol SM, 2011, FUTURE VIROL, V6, P187, DOI 10.2217/FVL.10.93; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Department of Health: South Africa, 2008, STAND TREATM GUID ES; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Gopinath R, 2000, J INFECT DIS, V182, P1804, DOI 10.1086/317623; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hegertun IEA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002104; HellingGiese G, 1996, ACTA TROP, V62, P257, DOI 10.1016/S0001-706X(96)00027-7; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Horsnell WGC, 2010, IMMUNOBIOLOGY, V215, P704, DOI 10.1016/j.imbio.2010.05.011; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Jourdan PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001170; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kaul R, 2011, AM J REPROD IMMUNOL, V65, P317, DOI 10.1111/j.1600-0897.2010.00962.x; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Kjetland EF, 2006, T ROY SOC TROP MED H, V100, P740, DOI 10.1016/j.trstmh.2005.09.010; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396; McClure CP, 2013, HIV MED, V14, P108, DOI 10.1111/hiv.12002; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Morgas D. E. T., 2010, Southern African Journal of Epidemiology & Infection, V25, P30; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Passmore JAS, 2006, IMMUNOLOGY, V119, P507, DOI 10.1111/j.1365-2567.2006.02465.x; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Picton ACP, 2012, IMMUNOLOGY, V136, P397, DOI 10.1111/j.1365-2567.2012.03592.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Prakash M, 2003, AM J OBSTET GYNECOL, V188, P376, DOI 10.1067/mob.2003.16; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Secor WE, 2003, INFECT IMMUN, V71, P6668, DOI 10.1128/IAI.71.11.6668-6671.2003; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; Sheffield JS, 2007, J INFECT DIS, V196, P1509, DOI 10.1086/522518; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Siddappa NB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001270; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; The Joint United Nations Programme on HIV and AIDS, 2010, UNAIDS REP GLOB AIDS	55	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98593	10.1371/journal.pone.0098593	http://dx.doi.org/10.1371/journal.pone.0098593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896815	Green Published, Green Accepted, gold			2022-12-25	WOS:000338430700052
J	Smirnova, L; Block, K; Sittka, A; Oelgeschlager, M; Seiler, AEM; Luch, A				Smirnova, Lena; Block, Katharina; Sittka, Alexandra; Oelgeschlaeger, Michael; Seiler, Andrea E. M.; Luch, Andreas			MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS; NEURAL DIFFERENTIATION; EPIGENETIC REGULATION; RESPONSE EVALUATION; MIRNA EXPRESSION; GENE-EXPRESSION; MOOD STABILIZER	Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regulation of neural development and ESC differentiation and specification. Thus, neural differentiation of mESCs in vitro allows investigating the role of miRNAs in chemical-mediated developmental toxicity. We analyzed changes in miRNome and transcriptome during neural differentiation of mESCs exposed to the developmental neurotoxicant sodium valproate (VPA). A total of 110 miRNAs and 377 mRNAs were identified differently expressed in neurally differentiating mESCs upon VPA treatment. Based on miRNA profiling we observed that VPA shifts the lineage specification from neural to myogenic differentiation (upregulation of muscleabundant miRNAs, mir-206, mir-133a and mir-10a, and downregulation of neural-specific mir-124a, mir-128 and mir-137). These findings were confirmed on the mRNA level and via immunochemistry. Particularly, the expression of myogenic regulatory factors (MRFs) as well as muscle-specific genes (Actc1, calponin, myosin light chain, asporin, decorin) were found elevated, while genes involved in neurogenesis (e.g. Otx1, 2, and Zic3, 4, 5) were repressed. These results were specific for valproate treatment and_based on the following two observations_most likely due to the inhibition of histone deacetylase (HDAC) activity: (i) we did not observe any induction of muscle-specific miRNAs in neurally differentiating mESCs exposed to the unrelated developmental neurotoxicant sodium arsenite; and (ii) the expression of muscle-abundant mir-206 and mir-10a was similarly increased in cells exposed to the structurally different HDAC inhibitor trichostatin A (TSA). Based on our results we conclude that miRNA expression profiling is a suitable molecular endpoint for developmental neurotoxicity. The observed lineage shift into myogenesis, where miRNAs may play an important role, could be one of the developmental neurotoxic mechanisms of VPA.	[Smirnova, Lena; Block, Katharina; Sittka, Alexandra; Oelgeschlaeger, Michael; Seiler, Andrea E. M.; Luch, Andreas] BfR Fed Inst Risk Assessment, Berlin, Germany	Federal Institute for Risk Assessment	Smirnova, L (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Alternat Anim Testing CAAT, Baltimore, MD 21218 USA.	lsmirov@jhsph.edu		Block, Katharina/0000-0002-2752-5232	German Federal Institute for Risk Assessment (BfR), SFP [1322-458]	German Federal Institute for Risk Assessment (BfR), SFP	This study was financially supported by intramural funding of the German Federal Institute for Risk Assessment (BfR), SFP grant # 1322-458. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Ambros V, 2000, CURR OPIN GENET DEV, V10, P428, DOI 10.1016/S0959-437X(00)00108-8; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Andersen HR, 2000, TOXICOLOGY, V144, P121, DOI 10.1016/S0300-483X(99)00198-5; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Balmer N. V., 2014, BASIC CLIN PHARM TOX, DOI 10.1111/bcpt.12203; Balmer NV, 2012, HUM MOL GENET, V21, P4104, DOI 10.1093/hmg/dds239; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Bowden CL, 2009, BIPOLAR DISORD, V11, P20, DOI 10.1111/j.1399-5618.2009.00708.x; Boyes WK, 1997, FUND APPL TOXICOL, V40, P175, DOI 10.1006/faat.1997.2388; BOYLE CA, 1994, PEDIATRICS, V93, P399; Briner W, 2000, NEUROTOXICOL TERATOL, V22, P761, DOI 10.1016/S0892-0362(00)00086-6; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Buschmann Jochen, 2013, Methods Mol Biol, V947, P37, DOI 10.1007/978-1-62703-131-8_4; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Feng Y, 2011, CELL BIOCHEM FUNCT, V29, P378, DOI 10.1002/cbf.1760; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Grandjean P, 2007, EPIDEMIOLOGY, V18, P25, DOI 10.1097/01.ede.0000249533.77900.74; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grinberg I, 2005, ZIC GENE FAMILY DEV; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hagiwara H, 2011, BIOCHEM BIOPH RES CO, V414, P826, DOI 10.1016/j.bbrc.2011.10.036; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Jergil M, 2011, TOXICOL SCI, V121, P328, DOI 10.1093/toxsci/kfr070; Jergil M, 2009, TOXICOL SCI, V108, P132, DOI 10.1093/toxsci/kfp002; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kaur P, 2012, J TOXICOLOGY, V2012, P1, DOI [10.2353/ajpath.2010.091202, DOI 10.2353/AJPATH.2010.091202]; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Krug AK, 2013, ARCH TOXICOL, V87, P123, DOI 10.1007/s00204-012-0967-3; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V304, P27, DOI 10.1001/jama.2010.860; Kultima K, 2004, ENVIRON HEALTH PERSP, V112, P1225, DOI 10.1289/txg.7034; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landrigan PJ, 2010, CURR OPIN PEDIATR, V22, P219, DOI 10.1097/MOP.0b013e328336eb9a; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lein P, 2005, ENVIRON TOXICOL PHAR, V19, P735, DOI 10.1016/j.etap.2004.12.035; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu J, 2010, J BIOL CHEM, V285, P26599, DOI 10.1074/jbc.M110.115824; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Pallocca G, 2013, CELL BIOL TOXICOL, V29, P239, DOI 10.1007/s10565-013-9250-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; REDLINE RW, 1992, LAB INVEST, V66, P659; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Sagiv SK, 2010, AM J EPIDEMIOL, V171, P593, DOI 10.1093/aje/kwp427; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Smirnova Lena, 2012, Exp Suppl, V101, P499, DOI 10.1007/978-3-7643-8340-4_18; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Theunissen PT, 2012, TOXICOL SCI, V125, P430, DOI 10.1093/toxsci/kfr293; Theunissen PT, 2011, TOXICOL SCI, V122, P437, DOI 10.1093/toxsci/kfr134; Visan A, 2012, NEUROTOXICOLOGY, V33, P1135, DOI 10.1016/j.neuro.2012.06.006; Waldmann T, 2014, CHEM RES TOXICOL, V27, P408, DOI 10.1021/tx400402j; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu XD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-244; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	94	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98892	10.1371/journal.pone.0098892	http://dx.doi.org/10.1371/journal.pone.0098892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896083	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700091
J	Xiang, Y; Liu, W; Chen, Y; Zhang, CT; Su, WH; Zhang, Y; Sun, JX; Gao, F; Jiang, CL				Xiang, Yue; Liu, Wei; Chen, Yue; Zhang, Chuntao; Su, Weiheng; Zhang, Yan; Sun, Jiaxi; Gao, Feng; Jiang, Chunlai			The Variable Loop 3 in the Envelope Glycoprotein Is Critical for the Atypical Coreceptor Usage of an HIV-1 Strain	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; V3 LOOP; TYPE-1; CCR5; RECEPTORS; INFECTION; ENTRY; TROPISM; CLONING; 7-TRANSMEMBRANE	The majority of HIV-1 strains enter CD4(+) T cells using the CCR5 and/or CXCR4 co-receptor. However, we recently identified a transmitted/founder (T/F) virus (ZP6248) that efficiently used an alternative coreceptor GPR15, rather than commonly used CXCR4 and CCR5, to establish clinical infection. To understand which regions in the env gene were critical for the atypical coreceptor usage, we generated a set of V3 mutants and determined their infectivity in GHOST cells that expressed different coreceptors. When the variable loop 3 (V3) in YU2 was replaced with the ZP6248 V3 (YU2.6248V3), the chimera YU2.6248V3 infected GPR15(+) cells but not CCR5(+) cells. To determine which amino acids in V3 was responsible for this phenotype change, each of the eight amino acids that differed from the subtype B consensus V3 was substituted with alanine. The G306A and S322A mutations significantly reduced the replication capacity of YU2.6248V3 in GPR15(+) cells, while all other alanine substitutions at positions 307, 314, 315, 316, 317 and 318 completely abrogated the infectivity of YU2.6248V3 in GPR15(+) cells. The E314A mutation, as the E314G mutation reported before, also rendered the YU2.6248V3 infectious in CCR5(+) cells, while none of other alanine mutants could infect CCR5+ cells. These results demonstrated that amino acids in ZP6248 V3 might form a unique conformation that was critical for the interaction with GPR15 while the amino acids at position 314 in the V3 crown of ZP6248 played a key role in interaction with both CCR5 and GPR15. The unique phenotypes of ZP6248 can serve as a model to understand how HIV-1 explores the diverse coreceptor reservoir through novel genetic variants to establish clinical infection.	[Xiang, Yue; Liu, Wei; Su, Weiheng; Zhang, Yan; Sun, Jiaxi; Gao, Feng; Jiang, Chunlai] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Chen, Yue; Gao, Feng] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Zhang, Chuntao] Natl Inst Food & Drug Control, Div Vitro Diagnost 2, Beijing, Peoples R China	Jilin University; Duke University; National Institute of Food & Drug Control - China	Gao, F (corresponding author), Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China.	fgao@duke.edu; jiangcl@jlu.edu.cn			National Science and Technology Major Project [2012ZX10001009]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21-AI016443]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106443] Funding Source: NIH RePORTER	National Science and Technology Major Project; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Science and Technology Major Project (2012ZX10001009) and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (R21-AI016443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Beer BE, 2001, J VIROL, V75, P12014, DOI 10.1128/JVI.75.24.12014-12027.2001; Begaud E, 2003, AIDS RES HUM RETROV, V19, P551, DOI 10.1089/088922203322230914; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; BOYD MT, 1993, J VIROL, V67, P3649, DOI 10.1128/JVI.67.6.3649-3652.1993; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Chen ZW, 1998, J EXP MED, V188, P2057, DOI 10.1084/jem.188.11.2057; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Edinger AL, 1999, VIROLOGY, V260, P211, DOI 10.1006/viro.1999.9819; Edinger AL, 1998, VIROLOGY, V249, P367, DOI 10.1006/viro.1998.9306; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Pohlmann S, 1999, J GEN VIROL, V80, P1241, DOI 10.1099/0022-1317-80-5-1241; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; Simmons G, 1998, J VIROL, V72, P8453, DOI 10.1128/JVI.72.10.8453-8457.1998; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang YJ, 1998, J VIROL, V72, P9337, DOI 10.1128/JVI.72.11.9337-9344.1998; Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98058	10.1371/journal.pone.0098058	http://dx.doi.org/10.1371/journal.pone.0098058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897520	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700021
J	Tian, JG; Li, X; Si, M; Liu, T; Li, JM				Tian, Jiguang; Li, Xin; Si, Meng; Liu, Ting; Li, Jianmin			CD271(+) Osteosarcoma Cells Display Stem-Like Properties	PLOS ONE			English	Article							MURAMYL TRIPEPTIDE; BONE-MARROW; CANCER; IDENTIFICATION; PLURIPOTENCY; POPULATIONS; CISPLATIN; LEUKEMIA; SARCOMA; TUMORS	Cancer stem cell (CSC) theory has been proposed and verified in many cancers. The existence of osteosarcoma CSCs has been confirmed for many years and multiple surface markers have been employed to identify them. In this study, we identified CD271(+) subpopulation of osteosarcoma displaying stem-like properties. CD271, known as the neural crest nerve growth factor receptor, is the marker of bone marrow mesenchymal stem cells (MSCs) and human melanoma-initiating cells. We discovered that CD271 was expressed differentially in diverse types of human osteosarcoma and stabilized cell lines. CD271(+) osteosarcoma cells displayed most of the properties of CSC, such as self-renewal, differentiation, drug resistance and tumorigenicity in vivo. Nanog, Oct3/4, STAT3, DNA-PKcs, Bcl-2 and ABCG2 were more expressed in CD271(+) cells compared with CD271(-) cells. Our study supported the osteosarcoma CSC hypothesis and, to a certain extent, revealed one of the possible mechanisms involved in maintaining CSCs properties.	[Tian, Jiguang; Li, Xin; Si, Meng; Li, Jianmin] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China; [Liu, Ting] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University	Li, JM (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China.	gkljmin@outlook.com			National Natural Science Foundation of China [81172551]; Shandong Technological Development Project [ZR2011HM037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project	This study was supported by a National Natural Science Foundation of China (81172551), and a Shandong Technological Development Project (ZR2011HM037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clarke MF, 2005, BIOL BLOOD MARROW TR, V11, P14, DOI 10.1016/j.bbmt.2004.11.011; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; La Porta Caterina Am, 2012, World J Stem Cells, V4, P17, DOI 10.4252/wjsc.v4.i3.17; Lieber MR, 2010, NAT STRUCT MOL BIOL, V17, P393, DOI 10.1038/nsmb0410-393; MANOHARAN A, 1979, BRIT J HAEMATOL, V43, P185, DOI 10.1111/j.1365-2141.1979.tb03740.x; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Meyers PA, 2009, EXPERT REV ANTICANC, V9, P1035, DOI [10.1586/era.09.69, 10.1586/ERA.09.69]; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Rasini V, 2013, CYTOTHERAPY, V15, P292, DOI 10.1016/j.jcyt.2012.11.009; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Wang BX, 2013, J INTERF CYTOK RES, V33, P181, DOI 10.1089/jir.2012.0154; Wu PK, 2009, JPN J CLIN ONCOL, V39, P514, DOI 10.1093/jjco/hyp057	30	43	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98549	10.1371/journal.pone.0098549	http://dx.doi.org/10.1371/journal.pone.0098549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893164	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400064
J	Yang, F; Ji, QQ; Ruan, LL; Ye, Q; Wang, ED				Yang, Fang; Ji, Quan-Quan; Ruan, Liang-Liang; Ye, Qing; Wang, En-Duo			The mRNA of Human Cytoplasmic Arginyl-tRNA Synthetase Recruits Prokaryotic Ribosomes Independently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER RNA; TRANSLATION INITIATION; SECONDARY STRUCTURE; 2 FORMS; REINITIATION; SEQUENCE; EUKARYOTES; COMPLEX; DOMAIN; SHINE	There are two isoforms of cytoplasmic arginyl-tRNA synthetase (hcArgRS) in human cells. The long form is a component of the multiple aminoacyl-tRNA synthetase complex, and the other is an N-terminal truncated form (Delta NhcArgRS), free in the cytoplasm. It has been shown that the two forms of ArgRS arise from alternative translational initiation in a single mRNA. The short form is produced from the initiation at a downstream, in-frame AUG start codon. Interestingly, our data suggest that the alternative translational initiation of hcArgRS mRNA also takes place in Escherichia coli transformants. When the gene encoding full-length hcArgRS was overexpressed in E. coli, two forms of hcArgRS were observed. The N-terminal sequencing experiment identified that the short form was identical to the Delta NhcArgRS in human cytoplasm. By constructing a bicistronic system, our data support that the mRNA encoding the N-terminal extension of hcArgRS has the capacity of independently recruiting E. coli ribosomes. Furthermore, two critical elements for recruiting prokaryotic ribosomes were identified, the "AGGA" core of the Shine-Dalgarno sequence and the "A-rich" sequence located just proximal to the alternative in-frame initiation site. Although the mechanisms of prokaryotic and eukaryotic translational initiation are distinct, they share some common features. The ability of the hcArgRS mRNA to recruit the prokaryotic ribosome may provide clues for shedding light on the mechanism of alternative translational initiation of hcArgRS mRNA in eukaryotic cells.	[Yang, Fang; Ji, Quan-Quan; Ruan, Liang-Liang; Ye, Qing; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Ctr RNA Res,State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn			Natural Science Foundation of China [31100552, 31130064]; Natural Key Basic Research Foundation of China [2012CB911001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Key Basic Research Foundation of China	This work was supported by Natural Science Foundation of China Grants 31100552 and 31130064 and by Natural Key Basic Research Foundation of China Grant 2012CB911001.	DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Dresios J, 2006, NAT STRUCT MOL BIOL, V13, P30, DOI 10.1038/nsmb1031; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GIRJES AA, 1995, GENE, V164, P347, DOI 10.1016/0378-1119(95)00502-W; GOLD L, 1981, ANNU REV MICROBIOL, V35, P365, DOI 10.1146/annurev.mi.35.100181.002053; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Lazard M, 2000, J MOL BIOL, V302, P991, DOI 10.1006/jmbi.2000.4102; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Luttermann C, 2009, GENE DEV, V23, P331, DOI 10.1101/gad.507609; MATTESON RJ, 1991, NUCLEIC ACIDS RES, V19, P3499, DOI 10.1093/nar/19.13.3499; Meng Z, 2010, J CELL BIOCHEM, V110, P531, DOI 10.1002/jcb.22569; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; SCHEPER GC, 1994, FEBS LETT, V352, P271, DOI 10.1016/0014-5793(94)00975-9; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SPANJAARD RA, 1989, NUCLEIC ACIDS RES, V17, P5501, DOI 10.1093/nar/17.14.5501; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; Xia XH, 2011, GENETICS, V189, P469, DOI 10.1534/genetics.111.132068; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	26	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20953	20959		10.1074/jbc.M114.562454	http://dx.doi.org/10.1074/jbc.M114.562454			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24898251	hybrid, Green Published			2022-12-25	WOS:000339396600048
J	Mulukutla, BC; Yongky, A; Daoutidis, P; Hu, WS				Mulukutla, Bhanu Chandra; Yongky, Andrew; Daoutidis, Prodromos; Hu, Wei-Shou			Bistability in Glycolysis Pathway as a Physiological Switch in Energy Metabolism	PLOS ONE			English	Article							PYRUVATE-KINASE; CANCER-CELLS; TUMOR-GROWTH; FRUCTOSE 2,6-BISPHOSPHATE; SKELETAL-MUSCLE; STEM-CELLS; RAT; PHOSPHOFRUCTOKINASE; INHIBITION; EXPRESSION	The flux of glycolysis is tightly controlled by feed-back and feed-forward allosteric regulations to maintain the body's glucose homeostasis and to respond to cell's growth and energetic needs. Using a mathematical model based on reported mechanisms for the allosteric regulations of the enzymes, we demonstrate that glycolysis exhibits multiple steady state behavior segregating glucose metabolism into high flux and low flux states. Two regulatory loops centering on phosphofructokinase and on pyruvate kinase each gives rise to the bistable behavior, and together impose more complex flux control. Steady state multiplicity endows glycolysis with a robust switch to transit between the two flux states. Under physiological glucose concentrations the glycolysis flux does not move between the states easily without an external stimulus such as hormonal, signaling or oncogenic cues. Distinct combination of isozymes in glycolysis gives different cell types the versatility in their response to different biosynthetic and energetic needs. Insights from the switch behavior of glycolysis may reveal new means of metabolic intervention in the treatment of cancer and other metabolic disorders through suppression of glycolysis.	[Mulukutla, Bhanu Chandra; Yongky, Andrew; Daoutidis, Prodromos; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hu, WS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@cems.umn.edu						ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BOSCA L, 1982, BIOCHEM BIOPH RES CO, V106, P486, DOI 10.1016/0006-291X(82)91136-6; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chesney J, 2006, CURR OPIN CLIN NUTR, V9, P535, DOI 10.1097/01.mco.0000241661.15514.fb; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Desai S, 2013, ONCOTARGET; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gui DY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; KITAJIMA S, 1984, J BIOL CHEM, V259, P6896; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KRETSCHMER M, 1984, BIOCHEM BIOPH RES CO, V124, P793, DOI 10.1016/0006-291X(84)91027-1; KRETSCHMER M, 1985, BIOCHEM BIOPH RES CO, V131, P899, DOI 10.1016/0006-291X(85)91324-5; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; KURATA N, 1972, BIOCHEM BIOPH RES CO, V48, P473, DOI 10.1016/0006-291X(72)90371-3; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manes NP, 2005, ARCH BIOCHEM BIOPHYS, V438, P125, DOI 10.1016/j.abb.2005.04.011; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Moreno-Sanchez R, 2012, J CELL BIOCHEM, V113, P1692, DOI 10.1002/jcb.24039; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Park Y, 2010, J BIOTECHNOL, V150, P131, DOI 10.1016/j.jbiotec.2010.08.001; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; Schutt A., 2013, CANC METABOLISM, V1, P10; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tominaga N, 1997, ARCH BIOCHEM BIOPHYS, V347, P275, DOI 10.1006/abbi.1997.0346; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu CD, 2006, ADV ENZYME REGUL, V46, P72, DOI 10.1016/j.advenzreg.2006.01.010; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; YANEY GC, 1995, DIABETES, V44, P1285, DOI 10.2337/diabetes.44.11.1285; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	61	39	40	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98756	10.1371/journal.pone.0098756	http://dx.doi.org/10.1371/journal.pone.0098756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911170	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600012
J	Pinz, S; Unser, S; Rascle, A				Pinz, Sophia; Unser, Samy; Rascle, Anne			The Natural Chemopreventive Agent Sulforaphane Inhibits STAT5 Activity	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; TYROSINE KINASE INHIBITOR; PROSTATE-CANCER CELLS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; JAK/STAT PATHWAY; TRANSACTIVATION DOMAIN; JAK-STAT5 PATHWAY; LEUKEMIA-CELLS	Signal transducer and activator of transcription STAT5 is an essential mediator of cytokine, growth factor and hormone signaling. While its activity is tightly regulated in normal cells, its constitutive activation directly contributes to oncogenesis and is associated to a number of hematological and solid tumor cancers. We previously showed that deacetylase inhibitors can inhibit STAT5 transcriptional activity. We now investigated whether the dietary chemopreventive agent sulforaphane, known for its activity as deacetylase inhibitor, might also inhibit STAT5 activity and thus could act as a chemopreventive agent in STAT5-associated cancers. We describe here sulforaphane (SFN) as a novel STAT5 inhibitor. We showed that SFN, like the deacetylase inhibitor trichostatin A (TSA), can inhibit expression of STAT5 target genes in the B cell line Ba/F3, as well as in its transformed counterpart Ba/F3-1* 6 and in the human leukemic cell line K562 both of which express a constitutively active form of STAT5. Similarly to TSA, SFN does not alter STAT5 initial activation by phosphorylation or binding to the promoter of specific target genes, in favor of a downstream transcriptional inhibitory effect. Chromatin immunoprecipitation assays revealed that, in contrast to TSA however, SFN only partially impaired the recruitment of RNA polymerase II at STAT5 target genes and did not alter histone H3 and H4 acetylation, suggesting an inhibitory mechanism distinct from that of TSA. Altogether, our data revealed that the natural compound sulforaphane can inhibit STAT5 downstream activity, and as such represents an attractive cancer chemoprotective agent targeting the STAT5 signaling pathway.	[Pinz, Sophia; Unser, Samy; Rascle, Anne] Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany	University of Regensburg	Rascle, A (corresponding author), Univ Regensburg, Inst Immunol, Signaling Res Grp Stat5, D-93053 Regensburg, Germany.	anne.rascle@klinik.uni-regensburg.de	Rascle, Anne/AAC-1904-2019	Rascle, Anne/0000-0001-7464-8545; /0000-0001-8613-0655	Deutsche Forschungsgemeinschaft [RA 2010/2-1]; Deutsche Krebshilfe [109750]; institutional research funds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); institutional research funds	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. RA 2010/2-1 to AR), the Deutsche Krebshilfe (Grant No. 109750 to AR) and institutional research funds (Foerderlinie C to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Al-Shami A, 1999, J BIOL CHEM, V274, P5333, DOI 10.1074/jbc.274.9.5333; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Butturini E, 2013, FREE RADIC BIOL MED; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; de Groot RP, 1999, BLOOD, V94, P1108, DOI 10.1182/blood.V94.3.1108.415k07_1108_1112; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P775, DOI 10.1093/nar/19.4.775; Frazier-Jessen MR, 2002, FEBS LETT, V513, P203, DOI 10.1016/S0014-5793(02)02295-0; Fuda NJ, 2013, EMBO J, V32, P1796, DOI 10.1038/emboj.2013.138; Fujihara M, 1998, J IMMUNOL, V161, P3659; Go VLW, 2004, J NUTR, V134, p3513S, DOI 10.1093/jn/134.12.3513S; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hanan EJ, 2012, J MED CHEM, V55, P10090, DOI 10.1021/jm3012239; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Jeong WS, 2004, PHARM RES-DORDR, V21, P649, DOI 10.1023/B:PHAM.0000022412.69380.d7; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Keum YS, 2011, ANN NY ACAD SCI, V1229, P184, DOI 10.1111/j.1749-6632.2011.06092.x; Kim BH, 2013, BIOCHEM PHARMACOL, V86, P950, DOI 10.1016/j.bcp.2013.08.009; KITABAYASHI I, 1993, J BIOL CHEM, V268, P14482; Kong ANT, 2001, MUTAT RES-FUND MOL M, V480, P231, DOI 10.1016/S0027-5107(01)00182-8; Kosan Christian, 2013, JAKSTAT, V2, pe26102, DOI 10.4161/jkst.26102; Kraus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037207; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Litterst CM, 2003, J BIOL CHEM, V278, P45340, DOI 10.1074/jbc.M303644200; Liu CB, 1999, J BIOL CHEM, V274, P6342, DOI 10.1074/jbc.274.10.6342; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Muller J, 2008, ANAL BIOCHEM, V375, P249, DOI 10.1016/j.ab.2008.01.017; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nelson Erik A, 2012, Genes Cancer, V3, P503, DOI 10.1177/1947601912466555; Nelson EA, 2011, ONCOTARGET, V2, P518; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PHINNEY DG, 1994, ONCOGENE, V9, P2353; Pinz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090275; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Rascle A, 2003, NUCLEIC ACIDS RES, V31, P6882, DOI 10.1093/nar/gkg907; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Rascle A, 2009, EXP CELL RES, V315, P76, DOI 10.1016/j.yexcr.2008.10.012; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V309, P709, DOI 10.1016/j.bbrc.2003.08.055; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; U.S. National Institutes of Health. ClinicalTrials.gov, SEARCH SULF; Ullrich A, 2004, ANN ONCOL, V15, P249, DOI 10.1093/annonc/mdh935; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Ward AC, 2000, BLOOD, V95, P19; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Weber A, 2013, PHARMACEUTICALS, V6, P960, DOI 10.3390/ph6080960; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; World Health Organization, 2012, CANC FACT SHEET; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yang J, 2010, MOL CANCER THER, V9, P3386, DOI 10.1158/1535-7163.MCT-10-0416; Yoshimura A, 1996, EMBO J, V15, P1055, DOI 10.1002/j.1460-2075.1996.tb00443.x; Youn HS, 2010, J IMMUNOL, V184, P411, DOI 10.4049/jimmunol.0803988; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	99	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99391	10.1371/journal.pone.0099391	http://dx.doi.org/10.1371/journal.pone.0099391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910998	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600079
J	Lee, GQ; Dong, W; Mo, T; Knapp, DJHF; Brumme, CJ; Woods, CK; Kanters, S; Yip, B; Harrigan, PR				Lee, Guinevere Q.; Dong, Winnie; Mo, Theresa; Knapp, David J. H. F.; Brumme, Chanson J.; Woods, Conan K.; Kanters, Steve; Yip, Benita; Harrigan, P. Richard			Limited Evolution of Inferred HIV-1 Tropism while Viremia Is Undetectable during Standard HAART Therapy	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE PATIENTS; VIRUS TYPE-1 TROPISM; CORECEPTOR USAGE; TREATED PATIENTS; PROVIRAL DNA; VIRAL LOAD; INFECTED PATIENTS; MERIT TRIAL; MARAVIROC	Background: HIV patients on suppressive antiretroviral therapy have undetectable viremia making it impossible to screen plasma HIV tropism if regimen change is required during suppression. We investigated the prevalence and predictors of tropism switch from CCR5-using ("R5'') to non-CCR5-using ("non-R5'') before and after viral suppression in the initially therapy-naive HOMER cohort from British Columbia, Canada. Methods: We compared pre-therapy and post-suppression viral genotypic tropism in patients who initiated on PI/NNRTI-based antiretroviral regimens between 1996-1999 (n=462). Virologic suppression was defined as having two consecutive viral loads of,500 copies/mL, which was the sensitivity limit of most viral load assays at the time. Viral tropism was inferred by V3-loop-population-sequencing and geno2pheno([coreceptor]) with cutoff at 5.75% false positive rate (FPR). Results: When virologic suppression was defined as two-consecutive viral loads <500 copies/mL, 34 (9%) of the 397 patients with pre-therapy R5-virus switched to non-R5 at viral load rebound after a median of 19 months (IQR 8-41 months) of undetectable viremia. Duration of viral load suppression was not a predictor of switch, but lower CD4 count during suppression (median 400 versus 250 cells/mL) and an increased prevalence of pre-therapy non-R5 HIV by "deep'' sequencing (median 0.2% versus 3.2%) were independently associated with switch (p=0.03 and p<0.0001, respectively). Conclusion: R5-to-non-R5 tropism switches in plasma virus after undetectable viremia were relatively rare events especially among patients with higher CD4 counts during virologic suppression. Our study supports the use of pre-suppression tropism results if maraviroc is being considered during virologic suppression in this subgroup of patients.	[Lee, Guinevere Q.; Dong, Winnie; Mo, Theresa; Knapp, David J. H. F.; Brumme, Chanson J.; Woods, Conan K.; Kanters, Steve; Yip, Benita; Harrigan, P. Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lee, Guinevere Q.; Knapp, David J. H. F.; Brumme, Chanson J.; Harrigan, P. Richard] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia	Harrigan, PR (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Lee, Guinevere Q./D-4436-2017	Lee, Guinevere Q./0000-0002-9412-886X; Brumme, Chanson/0000-0003-2722-5288; Knapp, David JHF/0000-0002-2161-9959	ViiV Healthcare; Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR); CIHR/GSK Research Chair in Clinical Virology	ViiV Healthcare; Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR/GSK Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR))	This study was supported by ViiV Healthcare. CJB is supported by a Vanier Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). PRH is supported by CIHR/GSK Research Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asboe D, 2012, HIV MED, V13, P1, DOI 10.1111/j.1468-1293.2011.00971.x; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; Baroncelli S, 2012, J ANTIMICROB CHEMOTH, V67, P1479, DOI 10.1093/jac/dks055; Bello G, 2007, AIDS RES HUM RETROV, V23, P1242, DOI 10.1089/aid.2007.0074; Bonjoch A, 2013, J ANTIMICROB CHEMOTH, V68, P1382, DOI 10.1093/jac/dks539; Briz V, 2008, J ANTIMICROB CHEMOTH, V61, P405, DOI 10.1093/jac/dkm469; Brumme CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043882; Brumme ZL, 2005, J INFECT DIS, V192, P466, DOI 10.1086/431519; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Clinicaltrials.gov, 2014, MAR SWITCH COLL STUD; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Delaugerre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036673; Delobel P, 2005, JAIDS-J ACQ IMM DEF, V38, P382, DOI 10.1097/01.qai.0000152835.17747.47; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUID US ANT AG HIV I, P5; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Durand CM, 2010, AIDS, V24, P2405, DOI 10.1097/QAD.0b013e32833d8a38; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Harrigan P.R., 2013, CLIN INFECT DIS; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Knapp DJHF, 2013, J CLIN MICROBIOL, V51, P444, DOI 10.1128/JCM.00739-12; Knapp DJHF, 2012, CLIN INFECT DIS, V54, P1652, DOI 10.1093/cid/cis253; Lee GQ, 2012, HOT TOP HIV OTHER RE, P7, DOI [10.4147/HTHR-120307, DOI 10.4147/HTHR-120307]; McGovern RA, 2009, 12 EUR AIDS C COL GE; McGovern RA, 2012, JAIDS-J ACQ IMM DEF, V61, P279, DOI 10.1097/QAI.0b013e31826249cf; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Mens H, 2010, J VIROL, V84, P12971, DOI 10.1128/JVI.00387-10; Monogram Biosciences Inc, 2014, TROF DNA COR TROP AS; Paar C, 2011, J CLIN MICROBIOL, V49, P2697, DOI 10.1128/JCM.00336-11; Parisi SG, 2011, J CLIN MICROBIOL, V49, P1441, DOI 10.1128/JCM.02564-10; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Reeves JD, 2009, J VIRAL ENTRY, V3, P94; Saracino A, 2007, VIRUS RES, V130, P34, DOI 10.1016/j.virusres.2007.05.011; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1493, DOI 10.1093/jac/dkq156; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Sing T, 2007, ANTIVIR THER, V12, P1097; Skrabal K, 2003, AIDS, V17, P809, DOI 10.1097/00002030-200304110-00005; Soriano V, 2009, AIDS, V23, P2377, DOI 10.1097/QAD.0b013e328332d32d; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Soulie C, 2011, AIDS, V25, P537, DOI 10.1097/QAD.0b013e32834345d3; Soulie C, 2010, J ANTIMICROB CHEMOTH, V65, P749, DOI 10.1093/jac/dkq029; Strizki JM, 2010, ANTIVIR THER, V15, pA18; Swenson LC, 2009, 12 EUR AIDS C COL GE, V80; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Toma J, 2010, 17 C RETR OPP INF CR; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Verhofstede C, 2011, HIV MED, V12, P544, DOI 10.1111/j.1468-1293.2011.00922.x; Vitiello P, 2012, INTERVIROLOGY, V55, P172, DOI 10.1159/000332023; Wasmuth JC, 2012, EXPERT OPIN DRUG SAF, V11, P161, DOI 10.1517/14740338.2012.640670; Waters L, 2009, 16 C RETR OPP INF CR, p439a; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99000	10.1371/journal.pone.0099000	http://dx.doi.org/10.1371/journal.pone.0099000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905411	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000087
J	Tan, XY; Yang, WL; Guo, J; Zhang, Y; Wu, CW; Sapkota, R; Kushwaha, SP; Gong, SG; Sun, XG; Liu, JM				Tan, Xiaoyue; Yang, Wenlan; Guo, Jian; Zhang, Yan; Wu, Changwei; Sapkota, Rikesh; Kushwaha, Shailendra Prasad; Gong, Sugang; Sun, Xingguo; Liu, Jinming			Usefulness of Decrease in Oxygen Uptake Efficiency to Identify Gas Exchange Abnormality in Patients with Idiopathic Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIORESPIRATORY FUNCTIONAL RESERVE; TIDAL CARBON-DIOXIDE; VENTILATORY EFFICIENCY; PROGNOSTIC VALUE; EXERCISE; CAPACITY; SLOPE; THRESHOLD; PLATEAU	Background: Decline in oxygen uptake efficiency (OUE), especially during exercise, is found in patients with chronic heart failure. In this study we aimed to test the validity and usefulness of OUE in evaluating gas exchange abnormality of patients with idiopathic pulmonary arterial hypertension (IPAH). Methods: We retrospectively investigated the cardiopulmonary exercise test (CPET) with gas exchange measurements in 32 patients with confirmed IPAH. All patients also had resting hemodynamic measurements and pulmonary function test (PFT). Sixteen healthy subjects, matched by age, sex, and body size were used as controls, also had CPET and PFT measurements. Results: In IPAH patients, the magnitude of absolute and percentage of predicted (%pred) oxygen uptake efficiency slope (OUES) and oxygen uptake efficiency plateau (OUEP), as well as several other CPET parameters, were strikingly worse than healthy subjects (P<0.0001). Pattern of changes in OUE in patients is similar to that in controls, In IPAH patients, OUE values at rest, warming up, anaerobic threshold and peak exercise were all significantly lower than in normal (P<0.0001). OUEP%pred, better than OUES%pred, correlated significantly with New York Heart Association (NYHA) functional Class (r = -0.724, P<0.005), Total Pulmonary Vascular Resistance (TPVR) (r = -0.694, P<0.005), diffusing capacity for carbon monoxide (DLCO) (r = 0.577, P<0.05), and the lowest ventilation versus CO2 output ratio during exercise (Lowest(V) over dotE/(V) over dotCO(2)) (r = -0.902, P<0.0001). In addition, the coefficient of variation (COV) of OUEP was lower (20.9%) markedly than OUES (34.3%) (P<0.0001). Conclusions: In patients with IPAH, OUES and OUEP are both significantly lower than the healthy subjects. OUEP is a better physiological parameter than OUES in evaluating the gas exchange abnormality of patients with IPAH.	[Tan, Xiaoyue; Yang, Wenlan; Guo, Jian; Zhang, Yan; Wu, Changwei; Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Dept Pulm Funct Test, Shanghai 200092, Peoples R China; [Zhang, Yan] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Zhejiang Prov Hosp Tradit Chinese Med, Div Resp, Hangzhou, Zhejiang, Peoples R China; [Sapkota, Rikesh; Kushwaha, Shailendra Prasad; Gong, Sugang; Liu, Jinming] Tongji Univ, Shanghai Pulm Hosp, Dept Pulm Circulat, Shanghai 200092, Peoples R China; [Sun, Xingguo] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Heart Lung Funct Testing Ctr,Fuwai Hosp, Beijing 100730, Peoples R China; [Sun, Xingguo] Peking Union Med Coll, Beijing 100021, Peoples R China	Tongji University; Zhejiang Chinese Medical University; Tongji University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Sun, XG (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Heart Lung Funct Testing Ctr,Fuwai Hosp, Beijing 100730, Peoples R China.	xgsun@labiomed.org; jinmingliu2013@163.com			Chinese Academy of Medical Sciences [2012-YJR02]; National Center for Cardiovascular Diseases; Chinese Medicine Association [08020420120]; science and technology commission of shanghai municipality [11411951302, 114119a3000]	Chinese Academy of Medical Sciences; National Center for Cardiovascular Diseases; Chinese Medicine Association; science and technology commission of shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This retrospective CPET data reanalysis is partially supported by Chinese Academy of Medical Sciences (No. 2012-YJR02), Key Project Starting Grant from National Center for Cardiovascular Diseases. CPET data collected at Shanghai Pulmonary Hospital were partially supported from Chinese Medicine Association (No. 08020420120) and science and technology commission of shanghai municipality (NO. 11411951302 and 114119a3000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena R, 2008, AM HEART J, V156, P982, DOI 10.1016/j.ahj.2008.06.024; Arena R, 2008, HEART FAIL REV, V13, P245, DOI 10.1007/s10741-007-9067-5; Arena R, 2007, INT J CARDIOL, V117, P103, DOI 10.1016/j.ijcard.2006.04.058; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Baba R, 1999, EUR J APPL PHYSIOL O, V80, P397, DOI 10.1007/s004210050610; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Davies LC, 2006, EUR HEART J, V27, P684, DOI 10.1093/eurheartj/ehi672; Guazzi M, 2005, J AM COLL CARDIOL, V46, P1883, DOI 10.1016/j.jacc.2005.07.051; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Itoh H, 1990, CIRCULATION, V81, pII31; Mortara A, 1997, CIRCULATION, V96, P3450; Mu K, 1990, SUMMARY CHINESE PULM, V2, P83; Oudiz RJ, 2007, EUR J HEART FAIL, V9, P917, DOI 10.1016/j.ejheart.2007.06.013; Oudiz RJ, 2010, AM J CARDIOL, V105, P1186, DOI 10.1016/j.amjcard.2009.12.024; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Reindl I, 1998, AM HEART J, V136, P778, DOI 10.1016/S0002-8703(98)70121-8; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; SHIMIZU M, 1991, AM HEART J, V122, P509, DOI 10.1016/0002-8703(91)91009-C; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Sun X., 2012, ABST APPL ANAL, V2012, P1, DOI DOI 10.1371/J0URNAL.PGEN.1002674; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Sun XG, 2002, CIRCULATION, V105, P54, DOI 10.1161/hc0102.101509; Sun XG, 2013, MED PHILOS, V4, P22; Sun XG, 2012, CHEST, V141, P1284, DOI 10.1378/chest.11-1270; Sun XG, 2012, EUR J APPL PHYSIOL, V112, P919, DOI 10.1007/s00421-011-2030-0; Ting H, 2001, CHEST, V119, P824, DOI 10.1378/chest.119.3.824; Van Laethem C, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.032; Wasserman K, 2011, PRINCIPLES EXERCISE, P568; Yasunobu Y, 2005, CHEST, V127, P1637, DOI 10.1378/chest.127.5.1637; 孙兴国, 2013, [中国循环杂志, Chinese Circulation Journal], V28, P88	35	16	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98889	10.1371/journal.pone.0098889	http://dx.doi.org/10.1371/journal.pone.0098889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905576	gold, Green Submitted, Green Published			2022-12-25	WOS:000341869000077
J	Corson, TW; Samuels, BC; Wenzel, AA; Geary, AJ; Riley, AA; McCarthy, BP; Hanenberg, H; Bailey, BJ; Rogers, PI; Pollok, KE; Rajashekhar, G; Territo, PR				Corson, Timothy W.; Samuels, Brian C.; Wenzel, Andrea A.; Geary, Anna J.; Riley, Amanda A.; McCarthy, Brian P.; Hanenberg, Helmut; Bailey, Barbara J.; Rogers, Pamela I.; Pollok, Karen E.; Rajashekhar, Gangaraju; Territo, Paul R.			Multimodality Imaging Methods for Assessing Retinoblastoma Orthotopic Xenograft Growth and Development	PLOS ONE			English	Article							FIREFLY LUCIFERASE; MOUSE MODEL; PRECLINICAL MODELS; INTRACELLULAR PH; GENE-EXPRESSION; REPORTER GENE; QUANTUM YIELD; GENOMIC GAIN; CELL-LINE; IN-VITRO	Genomic studies of the pediatric ocular tumor retinoblastoma are paving the way for development of targeted therapies. Robust model systems such as orthotopic xenografts are necessary for testing such therapeutics. One system involves bioluminescence imaging of luciferase-expressing human retinoblastoma cells injected into the vitreous of newborn rat eyes. Although used for several drug studies, the spatial and temporal development of tumors in this model has not been documented. Here, we present a new model to allow analysis of average luciferin flux ((F) over bar) through the tumor, a more biologically relevant parameter than peak bioluminescence as traditionally measured. Moreover, we monitored the spatial development of xenografts in the living eye. We engineered Y79 retinoblastoma cells to express a lentivirally-delivered enhanced green fluorescent protein-luciferase fusion protein. In intravitreal xenografts, we assayed bioluminescence and computed (F) over bar, as well as documented tumor growth by intraocular optical coherence tomography (OCT), brightfield, and fluorescence imaging. In vivo bioluminescence, ex vivo tumor size, and ex vivo fluorescent signal were all highly correlated in orthotopic xenografts. By OCT, xenografts were dense and highly vascularized, with well-defined edges. Small tumors preferentially sat atop the optic nerve head; this morphology was confirmed on histological examination. In vivo, F in xenografts showed a plateau effect as tumors became bounded by the dimensions of the eye. The combination of (F) over bar modeling and in vivo intraocular imaging allows both quantitative and high-resolution, non-invasive spatial analysis of this retinoblastoma model. This technique will be applied to other cell lines and experimental therapeutic trials in the future.	[Corson, Timothy W.; Samuels, Brian C.; Wenzel, Andrea A.; Geary, Anna J.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA; [Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Corson, Timothy W.; Pollok, Karen E.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Corson, Timothy W.; Hanenberg, Helmut; Pollok, Karen E.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Samuels, Brian C.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Samuels, Brian C.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Geary, Anna J.] Eastern Univ, St Davids, PA USA; [Riley, Amanda A.; McCarthy, Brian P.; Territo, Paul R.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Hanenberg, Helmut; Bailey, Barbara J.; Pollok, Karen E.] Indiana Univ Hlth, Riley Hosp Children, Sect Pediat Hematol Oncol, Herman B Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN USA; [Rogers, Pamela I.; Rajashekhar, Gangaraju] Indiana Univ Sch Med, Indiana Ctr Vasc Biol & Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington	Corson, TW (corresponding author), Indiana Univ Sch Med, Dept Ophthalmol, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA.	tcorson@iupui.edu	Gangaraju, Rajashekhar/I-7852-2019; Corson, Timothy W./B-6851-2009	Gangaraju, Rajashekhar/0000-0002-6664-8286; Corson, Timothy W./0000-0002-1402-7875; Samuels, Brian/0000-0003-3860-6879	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TR000006, TR000163]; Alcon Research Institute Young Investigator Award;  [R01 CA138798]; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA138798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; Alcon Research Institute Young Investigator Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Indiana Clinical and Translational Sciences Institute funded, in part by the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (TR000006 and TR000163; TWC, BCS and GR), by R01 CA138798 (BJB and KEP) and by an Alcon Research Institute Young Investigator Award (TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Benavente CA, 2013, ONCOTARGET, V4, P844, DOI 10.18632/oncotarget.1051; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; DELUCA M, 1984, BIOCHEM BIOPH RES CO, V123, P764, DOI 10.1016/0006-291X(84)90295-X; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Fraga H, 2006, CHEMBIOCHEM, V7, P929, DOI 10.1002/cbic.200500443; GALLIE BL, 1977, INVEST OPHTH VIS SCI, V16, P256; Hirokawa K, 2002, BBA-PROTEIN STRUCT M, V1597, P271, DOI 10.1016/S0167-4838(02)00302-3; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Inoue Y, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/471408; Ji XD, 2009, INVEST OPHTH VIS SCI, V50, P5544, DOI 10.1167/iovs.08-3258; Ji XD, 2009, EXP EYE RES, V89, P193, DOI 10.1016/j.exer.2009.03.007; Jo DH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-71; Kulkarni AD, 2009, BRIT J OPHTHALMOL, V93, P1105, DOI 10.1136/bjo.2008.152843; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lembert N, 1996, BIOCHEM J, V317, P273, DOI 10.1042/bj3170273; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Li JH, 1997, RADIOTHER ONCOL, V42, P69, DOI 10.1016/S0167-8140(96)01868-3; Marchong MN, 2004, MOL CANCER RES, V2, P495; MASSOF RW, 1972, VISION RES, V12, P793, DOI 10.1016/0042-6989(72)90005-3; MCELROY WD, 1969, PHOTOCHEM PHOTOBIOL, V10, P153, DOI 10.1111/j.1751-1097.1969.tb05676.x; Mohr PJ, 2012, CODATA RECOMMENDED V; Moriyama EH, 2008, PHOTOCH PHOTOBIO SCI, V7, P675, DOI 10.1039/b719231b; Nassr M, 2010, INVEST OPHTH VIS SCI, V51, P3813, DOI 10.1167/iovs.09-5042; Nemeth KM, 2011, CANCER-AM CANCER SOC, V117, P421, DOI 10.1002/cncr.25574; Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263; Pacal M, 2006, CURR MOL MED, V6, P759; Paroo Z, 2004, MOL IMAGING, V3, P117, DOI 10.1162/1535350041464865; PLANT PJ, 1968, BIOCHEM BIOPH RES CO, V31, P98, DOI 10.1016/0006-291X(68)90036-3; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Ruggeri M, 2008, J INNOV OPT HEAL SCI, V1, P17, DOI 10.1142/S1793545808000066; Ruggeri M, 2009, OPT EXPRESS, V17, P4074, DOI 10.1364/OE.17.004074; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; SELIGER HH, 1960, ARCH BIOCHEM BIOPHYS, V88, P136, DOI 10.1016/0003-9861(60)90208-3; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Shih CS, 2009, NEUROMOL MED, V11, P43, DOI 10.1007/s12017-009-8059-0; Sin CF, 2001, PROCEEDINGS OF 2001 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P283, DOI 10.1109/ISIMP.2001.925389; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Urbanchek MG, 2001, J GERONTOL A-BIOL, V56, pB191, DOI 10.1093/gerona/56.5.B191; Vooijs M, 2002, CANCER RES, V62, P1862; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; Xin GH, 2012, INT J OPHTHALMOL-CHI, V5, P440, DOI 10.3980/j.issn.2222-3959.2012.04.07; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	53	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99036	10.1371/journal.pone.0099036	http://dx.doi.org/10.1371/journal.pone.0099036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901248	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400090
J	Jung, KS; Kim, BK; Kim, SU; Chon, YE; Cheon, KH; Kim, SB; Lee, SH; Ahn, SS; Park, JY; Kim, DY; Ahn, SH; Park, YN; Han, KH				Jung, Kyu Sik; Kim, Beom Kyung; Kim, Seung Up; Chon, Young Eun; Cheon, Kyung Hyun; Kim, Sung Bae; Lee, Sang Hoon; Ahn, Sung Soo; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Park, Young Nyun; Han, Kwang-Hyub			Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; STIFFNESS; DIAGNOSIS; FIBROSIS; METAANALYSIS; VALIDATION; BIOPSY	Background & Aims: Controlled attenuation parameter (CAP) can measure hepatic steatosis. However, factors affecting its accuracy have not been described yet. This study investigated predictors of discordance between liver biopsy (LB) and CAP. Methods: A total of 161 consecutive patients with chronic liver disease who underwent LB and CAP were enrolled prospectively. Histological steatosis was graded as S0 (<5%), S1 (5-33%), S2 (34-66%), and S3 (>66% of hepatocytes). Cutoff CAP values were calculated from our cohort (250, 301, and 325 dB/m for >= S1, >= S2, and S3). Discordance was defined as a discrepancy of at least two steatosis stages between LB and CAP. Results: The median age (102 males and 59 females) was 49 years. Repartition of histological steatosis was as follows; S0 26.1% (n = 42), S1 49.7% (n = 80), S2 20.5% (n = 33), and S3 3.7% (n = 6). In multivariate linear regression analysis, CAP value was independently associated with steatosis grade along with body mass index (BMI) and interquartile range/median of CAP value (IQR/MCAP) (all P<0.05). Discordance was identified in 13 (8.1%) patients. In multivariate analysis, histological S3 (odd ratio [OR], 9.573; 95% confidence interval [CI], 1.207-75.931; P = 0.033) and CAP value (OR, 1.020; 95% CI, 1.006-1.034; P = 0.006) were significantly associated with discordance, when adjusting for BMI, IQR/MCAP, and necroinflammation, reflected by histological activity or ALT level. Conclusions: Patients with high grade steatosis or high CAP values have a higher risk of discordance between LB and CAP. Further studies are needed to improve the accuracy of CAP interpretation, especially in patients with higher CAP values.	[Jung, Kyu Sik; Kim, Beom Kyung; Kim, Seung Up; Chon, Young Eun; Cheon, Kyung Hyun; Kim, Sung Bae; Lee, Sang Hoon; Ahn, Sung Soo; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Beom Kyung; Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	beomkkim@yuhs.ac; ksukorea@yuhs.ac	Ahn, Sung Soo/AAB-4945-2021; Park, Jun Yong/H-7127-2019	Ahn, Sung Soo/0000-0002-9002-9880; Park, Young Nyun/0000-0003-0357-7967; CHUN, KYEONG-HYEON/0000-0002-7798-658X; Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224; Kim, Beom Kyung/0000-0002-5363-2496; Lee, Sang Hoon/0000-0002-3619-4340; Kim, Seung Up/0000-0002-9658-8050	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]; Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea	Liver Cirrhosis Clinical Research Center; Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea; Yonsei Liver Blood Bank (YLBB); sanofi-aventis Korea(Sanofi-Aventis)	This study was supported by the Liver Cirrhosis Clinical Research Center, in part by a grant from the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (no. A102065), and by the Yonsei Liver Blood Bank (YLBB), in part by a grant from sanofi-aventis Korea. BioPredictive kindly provided the complimentary service for calculation of FT score. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Boursier J, 2012, LIVER INT, V32, P875, DOI 10.1111/j.1478-3231.2012.02824.x; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chon YE, 2014, LIVER INT, V34, P102, DOI 10.1111/liv.12282; Chon YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044930; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; de Meijer VE, 2010, BRIT J SURG, V97, P1331, DOI 10.1002/bjs.7194; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, LIVER INT, V29, P810, DOI 10.1111/j.1478-3231.2008.01894.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumar M, 2013, J GASTROEN HEPATOL, V21, P12134; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Mederacke I, 2009, LIVER INT, V29, P1500, DOI 10.1111/j.1478-3231.2009.02100.x; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Myers RP, 2010, LIVER INT, V30, P1471, DOI 10.1111/j.1478-3231.2010.02331.x; Oh MK, 2008, ALIMENT PHARM THER, V28, P503, DOI 10.1111/j.1365-2036.2008.03752.x; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046	34	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98689	10.1371/journal.pone.0098689	http://dx.doi.org/10.1371/journal.pone.0098689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901649	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400045
J	Kim, SH; Oh, SJ				Kim, Sung Han; Oh, Seung-June			Nonspecific Genitourinary Pain Improves after Prostatectomy Using Holmium Laser Enucleation of Prostate in Patients with Benign Prostatic Hyperplasia: A Prospective Study	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; BLADDER OUTLET OBSTRUCTION; TRANSURETHRAL RESECTION; DETRUSOR OVERACTIVITY; MEN; NOCTURIA; BPH; ASSOCIATION; INDEX; SCORE	Objective: To investigate changes in nonspecific genitourinary discomfort or pain (GUDP) before and after holmium laser enucleation of prostate (HoLEP). GUDP associated with lower urinary tract symptoms (LUTS) is a common complaint among benign prostatic hyperplasia (BPH) patients, but very little is known about this clinical entity. Methods: From February 2010 to August 2011, 100 HoLEP patients with complete clinical data at a single institution were enrolled in the study to analyze the degree of GUDP with a visual analog scale (VAS) from 0 to 10 points at baseline and at 3 and 6 months postoperatively, and to investigate any relationships between GUDP and urodynamics, uroflowmetry, and scores from the International Prostate Symptom Score (IPSS) questionnaire. Results: Fifty-six patients had LUTS only, while the remaining 44 had both LUTS and GUDP. Pain was located in the suprapubic (42.0%), perineal/penile (33.0%), back (17.0%), and perianal (8.0%) regions. During the post-operative period, at six months, the VAS, IPSS, peak flow rate and post-void residual volume had improved significantly in 44 GUDP patients (p, 0.010). GUDP had completely resolved in 40 (90.9%) patients and had decreased in four (9.1%) patients, while seven (12.5%) patients developed GUDP with voiding in the urethral and perineal areas by the third month postoperatively. When compared to patients with complete resolution, those with persistent GUDP were found to have a significantly higher preoperative presence of bladder outlet obstruction (BOO) as an independent risk factor (OR 6.173, 95% CI 1.132-1.323). Conclusion: Both GUDP and LUTS improved significantly after HoLEP. Patients with significant preoperative BOO tended to have persistent GUDP after surgery.	[Kim, Sung Han] Natl Canc Ctr, Prostate Canc Ctr, Dept Urol, Goyang, South Korea; [Oh, Seung-June] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Oh, SJ (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	sjo@snu.ac.kr	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539; KIM, Sung Han/0000-0002-1689-5203				Badia X, 2001, UROLOGY, V57, P71, DOI 10.1016/S0090-4295(00)00894-3; Cho MC, 2011, NEUROUROL URODYNAM, V30, P1343, DOI 10.1002/nau.21050; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Fujimura T, 2012, BJU INT, V109, P1512, DOI 10.1111/j.1464-410X.2011.10445.x; Gourova LW, 2006, BJU INT, V97, P528, DOI 10.1111/j.1464-410X.2006.06029.x; Hanno P, 2012, NEUROUROL URODYNAM, V31, P375, DOI 10.1002/nau.22202; Jeong HJ, 2012, INT NEUROUROL J, V16, P175, DOI 10.5213/inj.2012.16.4.175; KAPLAN SA, 1994, J UROLOGY, V152, P2063, DOI 10.1016/S0022-5347(17)32309-1; Kim DS, 2013, ARCH PHYS MED REHAB, V94, P930, DOI 10.1016/j.apmr.2012.12.011; Kingery L, 2012, INT J CLIN PRACT, V66, P883, DOI 10.1111/j.1742-1241.2012.02960.x; Matthiesen TB, 2003, APMIS, V111, P59; Metcalfe Charles, 2011, Curr Urol Rep, V12, P265, DOI 10.1007/s11934-011-0193-1; Nakamura M, 2012, AGING MALE, V15, P111, DOI 10.3109/13685538.2011.646342; Oh MM, 2011, UROLOGY, V77, P167, DOI 10.1016/j.urology.2010.05.034; Peters KM, 2008, UROLOGY, V71, P634, DOI 10.1016/j.urology.2007.11.013; Pinto R, 2013, J UROLOGY, V189, P548, DOI 10.1016/j.juro.2012.09.027; Porru D, 2002, EUR UROL, V41, P246, DOI 10.1016/S0302-2838(02)00021-0; Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013; Shin JH, 2011, CURR PAIN HEADACHE R, V15, P377, DOI 10.1007/s11916-011-0204-4; Tanaka Y, 2006, INT J UROL, V13, P1398, DOI 10.1111/j.1442-2042.2006.01589.x; van Doorn B, 2012, MATURITAS, V71, P8, DOI 10.1016/j.maturitas.2011.10.007; van Melick HHE, 2003, J UROLOGY, V169, P1411, DOI 10.1097/01.ju.0000054657.59200.97; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98979	10.1371/journal.pone.0098979	http://dx.doi.org/10.1371/journal.pone.0098979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901224	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400083
J	Merino, AM; Dugast, AS; Wilson, CM; Goepfert, PA; Alter, G; Kaslow, RA; Tang, JM				Merino, Aimee M.; Dugast, Anne-Sophie; Wilson, Craig M.; Goepfert, Paul A.; Alter, Galit; Kaslow, Richard A.; Tang, Jianming			KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; KIR3DL1(+) NK CELLS; DISEASE PROGRESSION; RECEPTOR; ACTIVATION; INNATE; REPLICATION; RECOGNITION; INHIBITION; IMMUNITY	Background: KIR2DS4 gene variants encode full-length and truncated protein products, with only the former serving as membrane-bound receptors to activate natural killer (NK) cells. We have previously shown that full-length KIR2DS4 was associated with relatively high viral load and accelerated heterosexual HIV-1 transmission. Our objective here was to provide confirmatory data and to offer new insights about the potential mechanisms. Methodology/Principal Findings: Mixed models for repeated (longitudinal) outcome measurements on 207 HIV-1 seropositive American youth revealed an association of full-length KIR2DS4 with relatively high viral load and low CD4(+) T-cell count (p < 0.01 for both). Depending on KIR2DS4 expression (presence or absence) on cell surface, NK cells from 43 individuals with untreated, chronic HIV-1 infection often differed in functional properties, including degranulation and secretion of IFN-gamma and MIP-1 beta. In particular, polyfunctional NK cells were enriched in the KIR2DS4-positive subset. Conclusions/Significance: Full-length KIR2DS4 promotes HIV-1 pathogenesis during chronic infection, probably through the maintenance of an excessively pro-inflammatory state.	[Merino, Aimee M.; Goepfert, Paul A.; Kaslow, Richard A.; Tang, Jianming] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Merino, Aimee M.; Goepfert, Paul A.; Tang, Jianming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Dugast, Anne-Sophie; Alter, Galit] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Wilson, Craig M.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Alabama System; University of Alabama Birmingham	Tang, JM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jtang@uab.edu	Tang, Jianming "James"/O-4980-2019; Dugast, AnneSophie/L-9541-2015; Merino, Aimee/GSD-7651-2022	Tang, Jianming "James"/0000-0003-0137-7486; Merino, Aimee/0000-0003-4433-0127; Wilson, Craig/0000-0001-6869-1053	National Institute of Allergy and Infectious Diseases (NIAID) [AI071906]; National Institute of Child Health and Human Development [U01-HD32830]; NIAID; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071906, R01AI064060] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research summarized in this paper was funded by an R01 grant (AI071906) from the National Institute of Allergy and Infectious Diseases (NIAID) to RAK and JT. The Reaching for Excellence in Adolescent Care and Health (REACH) cohort was supported primarily by the National Institute of Child Health and Human Development (U01-HD32830), with supplemental funding from the NIAID, the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). The funders have no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Biassoni R, 1996, J EXP MED, V183, P645, DOI 10.1084/jem.183.2.645; Christensen MD, 2000, SCAND J IMMUNOL, V51, P557; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Eller MA, 2011, J VIROL, V85, P4802, DOI 10.1128/JVI.00111-11; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Holland CA, 2000, AIDS RES HUM RETROV, V16, P959, DOI 10.1089/08892220050058371; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Jiang YJ, 2013, J CLIN IMMUNOL, V33, P1376, DOI 10.1007/s10875-013-9930-1; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Katz G, 2004, J IMMUNOL, V173, P1819, DOI 10.4049/jimmunol.173.3.1819; Katz G, 2001, J IMMUNOL, V166, P7260, DOI 10.4049/jimmunol.166.12.7260; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu Hong, 2004, In Silico Biology, V4, P489; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; McErlean C, 2010, IMMUNOGENETICS, V62, P431, DOI 10.1007/s00251-010-0449-9; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; Merino A, 2011, J INFECT DIS, V203, P487, DOI 10.1093/infdis/jiq075; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Schellekens J, 2008, MOL IMMUNOL, V45, P981, DOI 10.1016/j.molimm.2007.07.040; Shao WS, 2006, AIDS, V20, P1583, DOI 10.1097/01.aids.0000238403.08497.3f; Wilson CM, 2001, J ADOLESCENT HEALTH, V29, P8, DOI 10.1016/S1054-139X(01)00291-9; Yao HH, 2010, J NEUROIMMUNE PHARM, V5, P489, DOI 10.1007/s11481-010-9211-1	32	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99353	10.1371/journal.pone.0099353	http://dx.doi.org/10.1371/journal.pone.0099353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901871	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400123
J	Zhao, XY; Yang, S; Chen, YR; Li, PC; Dou, MM; Zhang, J				Zhao, Xiao-Yan; Yang, Shen; Chen, You-Ran; Li, Pei-Chun; Dou, Meng-Meng; Zhang, Jie			Resveratrol and Arsenic Trioxide Act Synergistically to Kill Tumor Cells In Vitro and In Vivo	PLOS ONE			English	Article							CANCER-CELLS; APOPTOSIS; VEGF; CHEMOPREVENTION; TRANSCRIPTION; MECHANISMS; PREVENTION; EFFICACY; AS2O3; MODEL	Background and Aims: Arsenic trioxide (As2O3), which used as an effective agent in the treatment of leukaemia and other solid tumors, is largely limited by its toxicity. QT prolongation, torsades de pointes and sudden heart death have been implicated in the cardiotoxicity of As2O3. The present study was designed to explore whether the combination of As2O3 and resveratrol could generate a more powerful anti-cancer effect both in vitro and in vivo. Materials and Methods: MTT assay was performed to assess the proliferation of Hela, MCF-7 and NB4 cells. Isobolographic analysis was used to evaluate combination index values from cell viability data. The apoptosis and the cellular reactive oxygen species (ROS) level were assessed by fluorescent microscopy and flow cytometry separately in vitro. The effect of As2O3, alone and in combination with resveratrol on Hela tumor growth in an orthotopic nude mouse model was also investigated. The tumor volume and the immunohistochemical analysis of CD31, CD34 and VEGF were determined. Results: Resveratrol dramatically enhanced the anti-cancer effect induced by As2O3 in vitro. In addition, isobolographic analysis further demonstrated that As2O3 and resveratrol generated a synergistic action. More apoptosis and ROS generation were observed in the combination treatment group. Similar synergistic effects were found in nude mice in vivo. The combination of As2O3 and resveratrol dramatically suppressed both tumor growth and angiogenesis in nude mice. Conclusions: Combining As2O3 with resveratrol would be a novel strategy to treat cancer in clinical practice.	[Zhao, Xiao-Yan; Yang, Shen; Chen, You-Ran; Li, Pei-Chun; Dou, Meng-Meng] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Zhang, Jie] Ninth Peoples Hosp Chongqing, Dept Neurol, Chongqing, Peoples R China	Southwest University - China	Zhao, XY (corresponding author), Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China.	Zhaoxiaoyan67@163.com; Zhjzhj121@163.com		Yang, Sen/0000-0001-5902-7177	National Natural Science Foundation of China [81001454]; fundamental Research Funds for the Central Universities [XDJK2014B024]; Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC) [2009CB1010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC)	This study was supported by the National Natural Science Foundation of China (81001454), the fundamental Research Funds for the Central Universities (XDJK2014B024), and the Fund for Construction of Scientific and Technical Innovation of Chongqing (CSTC, 2009CB1010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Aziz MH, 2003, INT J ONCOL, V23, P17; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bianchini F, 2003, EUR J CANCER PREV, V12, P417, DOI 10.1097/00008469-200310000-00011; Borriello A, 2014, CANCER TREAT RES, V159, P167, DOI 10.1007/978-3-642-38007-5_10; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Cyranoski D, 2007, NAT MED, V13, P1005, DOI 10.1038/nm0907-1005; Ding WQ, 2006, MOL CANCER THER, V5, P1864, DOI 10.1158/1535-7163.MCT-06-0067; Dobrydneva Y, 1999, BRIT J PHARMACOL, V128, P149, DOI 10.1038/sj.bjp.0702749; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Fukui M, 2010, EUR J CANCER, V46, P1882, DOI 10.1016/j.ejca.2010.02.004; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kamiya H, 2012, CELL PHYSIOL BIOCHEM, V29, P687, DOI 10.1159/000312589; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Leite M, 1999, ANAL CELL PATHOL, V19, P139, DOI 10.1155/1999/176515; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Pettersson HM, 2009, MOL CANCER THER, V8, P160, DOI 10.1158/1535-7163.MCT-08-0595; Piao FY, 2005, J OCCUP HEALTH, V47, P445, DOI 10.1539/joh.47.445; Rezk Youssef A, 2006, Am J Obstet Gynecol, V194, pe23, DOI 10.1016/j.ajog.2005.11.030; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Tong NN, 2012, ONCOL LETT, V3, P1263, DOI 10.3892/ol.2012.644; Wang G, 2004, TRENDS PHARMACOL SCI, V25, P120, DOI 10.1016/j.tips.2004.01.009; Wu EJ, 2014, CANCER BIOL THER, V15, P473, DOI 10.4161/cbt.27824; Xin P, 2010, EUR J PHARMACOL, V649, P293, DOI 10.1016/j.ejphar.2010.09.036; Yang J, 2004, FREE RADICAL BIO MED, V37, P2027, DOI 10.1016/j.freeradbiomed.2004.09.016; Yu J, 2007, GYNECOL ONCOL, V106, P400, DOI 10.1016/j.ygyno.2007.04.016; Zhang WQ, 2013, FOOD CHEM TOXICOL, V51, P87, DOI 10.1016/j.fct.2012.09.023; Zhang Y, 2013, BIOCHEM PHARMACOL, V85, P59, DOI 10.1016/j.bcp.2012.09.002; Zhao XY, 2008, BRIT J PHARMACOL, V154, P105, DOI 10.1038/bjp.2008.81; Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x	34	23	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98925	10.1371/journal.pone.0098925	http://dx.doi.org/10.1371/journal.pone.0098925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901647	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400073
J	Arora, R; Yates, C; Gary, BD; McClellan, S; Tan, M; Xi, YG; Reed, E; Piazza, GA; Owen, LB; Dean-Colomb, W				Arora, Ritu; Yates, Clayton; Gary, Bernard D.; McClellan, Steven; Tan, Ming; Xi, Yaguang; Reed, Eddie; Piazza, Gary A.; Owen, Laurie B.; Dean-Colomb, Windy			Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer	PLOS ONE			English	Article							FACTOR-KAPPA-B; PATHOLOGICAL COMPLETE RESPONSE; TRANSCRIPTION FACTOR; TUMOR-CELLS; GENE-EXPRESSION; CYCLE ARREST; SURVIVIN; ACTIVATION; ANTITUMOR; PROGRESSION	Background: Triple-negative breast cancer (TNBC) is a highly diverse group that is associated with an aggressive phenotype. Its treatment has been challenging due to its heterogeneity and absence of well-defined molecular targets. Thus, there is an urgent need to identify novel agents with therapeutic application. NF-kappa B is over-expressed in many breast cancers; thus, inactivation of the NF-kappa B pathway could serve as a therapeutic target. Here we report for the first time the anti-tumor activity of panepoxydone (PP), a NF-kappa B inhibitor isolated from an edible mushroom, in several breast cancer cell lines. Methods: We investigated the effects of PP on cell growth, migration-invasion, apoptosis and EMT-related proteins expression in MCF-7 and TNBC cell lines MDA-MB-231, MDA-MB-468 and MDA-MB-453. Results: Significant antitumor activity was seen in all cell lines, with differential responses noted in cell-line specific manner. Treatment with PP resulted in significant cytotoxicity, decreased invasion, migration and increased apoptosis in all cell lines tested. Up-regulation of Bax and cleaved PARP and down-regulation of Bcl-2, survivin, cyclin D1 and caspase 3 were noted in PP-treated breast cancer cells. The antitumor effect of PP appeared related to its ability to inhibit the phosphorylation of inhibitor of NF-kappa B (I kappa B alpha) with cytoplasmic accumulation. PP treatment also down-regulated FOXM1 which resulted in a reversal of EMT. Similar results were obtained after silencing of NF-kB and FOXM1. Conclusion: Altogether, these studies show, for the first time the antitumor activity of PP against breast cancer cells, in particular TNBC cells. Furthermore, it highlights the concept that optimal treatment of TNBC warrants attention to the differential sensitivity of various TNBC subtypes to therapeutic agents. These results suggest that the PP may be a potentially effective chemopreventive or therapeutic agent against breast cancer. However, additional studies are required to more fully elucidate the mechanism of antitumor effect of PP.	[Arora, Ritu; Gary, Bernard D.; McClellan, Steven; Tan, Ming; Xi, Yaguang; Reed, Eddie; Piazza, Gary A.; Owen, Laurie B.; Dean-Colomb, Windy] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA; [Yates, Clayton] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Yates, Clayton] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA	University of South Alabama; Tuskegee University; Tuskegee University	Dean-Colomb, W (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA.	windydean@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Xi, Yaguang/0000-0003-3681-9352; Piazza, Gary/0000-0003-4418-887X	University of South Alabama Mitchell Cancer Institute Research Award;  [U54706CA118948]; NATIONAL CANCER INSTITUTE [U54CA118623, U54CA118948, R01CA149646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003059] Funding Source: NIH RePORTER	University of South Alabama Mitchell Cancer Institute Research Award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the University of South Alabama Mitchell Cancer Institute Research Award to Dr. Windy Dean-Colomb and U54706CA118948 (NIH/NCI) [CY]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Agrawal G, 2007, J CLIN ONCOL, V25, P2618, DOI 10.1200/JCO.2007.11.3084; Ahmad A, 2008, BREAST CANC RES TREA, V122, P337; Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Altieri D, 2001, CELL DEATH DIFFER, V8, P4, DOI 10.1038/sj.cdd.4400795; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; de la Mare JA, 2012, INVEST NEW DRUG, V30, P2187, DOI 10.1007/s10637-011-9788-0; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Duangmano S, 2012, J ONCOL, V2012, DOI 10.1155/2012/601682; Erkel G, 2007, INT IMMUNOPHARMACOL, V7, P612, DOI 10.1016/j.intimp.2007.01.001; Erkel G, 1996, BIOCHEM BIOPH RES CO, V226, P214, DOI 10.1006/bbrc.1996.1335; GILLETT C, 1994, CANCER RES, V54, P1812; Gong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033656; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jeong H, 2012, HISTOPATHOLOGY, V60, pE87, DOI 10.1111/j.1365-2559.2012.04195.x; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kostanova-Poliakova D, 2005, NEOPLASMA, V52, P441; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li X, 2012, ONCOGENE, V31, P4979, DOI 10.1038/onc.2011.655; Liu H, 2008, EUR J PHARMACOL, V591, P43, DOI 10.1016/j.ejphar.2008.06.026; Mehta PP, 2011, CLIN CANCER RES, V17, P5432, DOI 10.1158/1078-0432.CCR-11-0592; MIZUNO T, 1995, FOOD REV INT, V11, P23, DOI 10.1080/87559129509541018; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Ramachandran PV, 2009, FUTURE MED CHEM, V1, P179, DOI 10.4155/FMC.09.15; Ramasamy S, 2013, EXP TOXICOL PATHOL, V65, P341, DOI 10.1016/j.etp.2011.11.005; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307; Romieu-Mourez R, 2001, CANCER RES, V61, P3810; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Sun SH, 2012, EUR J PHARMACOL, V690, P22, DOI 10.1016/j.ejphar.2012.05.036; Tanaka K, 2000, CLIN CANCER RES, V6, P127; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Wang Yifan, 2011, Chin J Cancer, V30, P603, DOI 10.5732/cjc.011.10226; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yang C, 2013, CANCER GENE THER, V20, P117, DOI 10.1038/cgt.2012.94; Yang C, 2013, CANCER LETT, V340, P104, DOI 10.1016/j.canlet.2013.07.004; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zhen C, 2013, ONCOGENE, V32, P3452, DOI 10.1038/onc.2012.356	65	44	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98370	10.1371/journal.pone.0098370	http://dx.doi.org/10.1371/journal.pone.0098370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896091	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700036
J	Loras, H; Sigmundsson, H; Stensdotter, AK; Talcott, JB				Loras, Havard; Sigmundsson, Hermundur; Stensdotter, Ann-Katrin; Talcott, Joel B.			Postural Control Is Not Systematically Related to Reading Skills: Implications for the Assessment of Balance as a Risk Factor for Developmental Dyslexia	PLOS ONE			English	Article							DEFICIT HYPOTHESIS; STATIC BALANCE; MOTOR COORDINATION; CHILDREN; DIFFICULTIES; ABNORMALITIES; HYPERACTIVITY; ORGANIZATION; ATTENTION; SAMPLE	Impaired postural control has been associated with poor reading skills, as well as with lower performance on measures of attention and motor control variables that frequently co-occur with reading difficulties. Measures of balance and motor control have been incorporated into several screening batteries for developmental dyslexia, but it is unclear whether the relationship between such skills and reading manifests as a behavioural continuum across the range of abilities or is restricted to groups of individuals with specific disorder phenotypes. Here were obtained measures of postural control alongside measures of reading, attention and general cognitive skills in a large sample of young adults (n = 100). Postural control was assessed using centre of pressure (CoP) measurements, obtained over 5 different task conditions. Our results indicate an absence of strong statistical relationships between balance measures with either reading, cognitive or attention measures across the sample as a whole.	[Loras, Havard; Sigmundsson, Hermundur] Sor Trondelag Univ Coll, Trondheim, Norway; [Sigmundsson, Hermundur; Stensdotter, Ann-Katrin] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Talcott, Joel B.] Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Aston University	Talcott, JB (corresponding author), Aston Univ, Sch Life & Hlth Sci, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England.	j.b.talcott@aston.ac.uk	Sigmundsson, Hermundur/R-7796-2019		Faculty of Health Education and Social Work at Sor-Trondelag University College	Faculty of Health Education and Social Work at Sor-Trondelag University College	Ths study was supported by a studentship grant from the Faculty of Health Education and Social Work at Sor-Trondelag University College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barela JA, 2011, RES DEV DISABIL, V32, P1814, DOI 10.1016/j.ridd.2011.03.011; Bishop DVM, 2002, CORTEX, V38, P491, DOI 10.1016/S0010-9452(08)70018-2; BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Brookes RL, 2005, DYSLEXIA, V11, P174, DOI 10.1002/dys.293; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Fawcett A., 1998, DYSLEXIA ADULT SCREE; Fawcett & Nicolson, 2004, DYSL SCREEN TEST JUN; Forseth AK, 2003, CHILD CARE HLTH DEV, V29, P569, DOI 10.1046/j.1365-2214.2003.00378.x; Geuze RH, 2003, HUM MOVEMENT SCI, V22, P527, DOI 10.1016/j.humov.2003.09.008; Guron LM, 2004, DYSLEXIA, V10, P44, DOI 10.1002/dys.260; Haslum MN, 2007, DYSLEXIA, V13, P257, DOI 10.1002/dys.350; Hoien T., 1997, ORDKJEDETESTEN; Iversen S, 2005, DYSLEXIA, V11, P217, DOI 10.1002/dys.297; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Lonnemann J, 2011, J NEUROLINGUIST, V24, P592, DOI 10.1016/j.jneuroling.2011.02.005; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53, DOI 10.1016/0957-4271(95)00014-3; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Miller-Guron L., 1999, WORDCHAINS WORD READ; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1995, DYSLEXIA, V1, P37; NICOLSON RI, 1997, J RES READ, V20, P77, DOI DOI 10.1111/1467-9817.00022; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Patel M, 2010, DYSLEXIA, V16, P162, DOI 10.1002/dys.398; PENNINGTON BF, 1990, CHILD DEV, V61, P1753, DOI 10.1111/j.1467-8624.1990.tb03564.x; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Piek JP, 1999, DEV MED CHILD NEUROL, V41, P159, DOI 10.1017/S0012162299000341; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Rae C, 1998, LANCET, V351, P1849, DOI 10.1016/S0140-6736(97)99001-2; Rae C, 2002, NEUROPSYCHOLOGIA, V40, P1285, DOI 10.1016/S0028-3932(01)00216-0; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Raven J., 2000, MANUAL RAVENS STANDA; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Rochelle KSH, 2009, EXP BRAIN RES, V192, P627, DOI 10.1007/s00221-008-1568-5; Snowling MJ, 2008, Q J EXP PSYCHOL, V61, P142, DOI 10.1080/17470210701508830; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; Sugden D, 2008, INT J DISABIL DEV ED, V55, P93, DOI 10.1080/10349120802033360; Talcott JB, 2013, NEUROPSYCHOLOGIA, V51, P472, DOI 10.1016/j.neuropsychologia.2012.11.016; Tsai CL, 2008, HUM MOVEMENT SCI, V27, P142, DOI 10.1016/j.humov.2007.08.002; VAN IJZENDOORN MH, 1994, READ RES QUART, V29, P267; Vieira S, 2009, NEUROSCI LETT, V462, P125, DOI 10.1016/j.neulet.2009.06.093; Viholainen H, 2011, DEV MED CHILD NEUROL, V53, P350, DOI 10.1111/j.1469-8749.2010.03856.x; Wechsler D, 1999, MANUAL WECHSLER ADUL; Williams J, 2006, EUR J HUM GENET, V14, P681, DOI 10.1038/sj.ejhg.5201575; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; YAP RL, 1994, J LEARN DISABIL, V27, P660, DOI 10.1177/002221949402701006	54	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98224	10.1371/journal.pone.0098224	http://dx.doi.org/10.1371/journal.pone.0098224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892925	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336911400041
J	Chen, X; Paranjape, T; Stahlhut, C; McVeigh, T; Keane, F; Nallur, S; Miller, N; Kerin, M; Deng, Y; Yao, X; Zhao, H; Weidhaas, JB; Slack, FJ				Chen, X.; Paranjape, T.; Stahlhut, C.; McVeigh, T.; Keane, F.; Nallur, S.; Miller, N.; Kerin, M.; Deng, Y.; Yao, X.; Zhao, H.; Weidhaas, J. B.; Slack, F. J.			Targeted resequencing of the microRNAome and 3 ' UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer	ONCOGENE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ACUTE MYELOID-LEUKEMIA; LARGE GENE LISTS; SOMATIC MUTATIONS; PCM1-JAK2 FUSION; BINDING-SITES; BREAST-CANCER; KRAS-VARIANT; RISK; GENOME	Ovarian cancer is a major cause of cancer deaths, yet there have been few known genetic risk factors identified, the best known of which are disruptions in protein coding sequences (BRCA1 and 2). Recent findings indicate that there are powerful genetic markers of cancer risk outside of these regions, in the noncoding mRNA control regions. To identify additional cancer-associated, functional non-protein-coding sequence germline variants associated with ovarian cancer risk, we captured DNA regions corresponding to all validated human microRNAs and the 3' untranslated regions (UTRs) of similar to 6000 cancer-associated genes from 31 ovarian cancer patients. Multiple single-nucleotide polymorphisms in the 3'UTR of the vascular endothelial growth factor receptor/FLT1, E2F2 and PCM1 oncogenes were highly enriched in ovarian cancer patients compared with the 1000 Genome Project. Sequenom validation in a case-control study (267 cases and 89 controls) confirmed a novel variant in the PCM1 3'UTR is significantly associated with ovarian cancer (P = 0.0086). This work identifies a potential new ovarian cancer locus and further confirms that cancer resequencing efforts should not ignore the study of noncoding regions of cancer patients.	[Chen, X.; Stahlhut, C.; Slack, F. J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Chen, X.; Zhao, H.] Yale Univ, Sch Med, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Paranjape, T.; Nallur, S.; Weidhaas, J. B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [McVeigh, T.; Miller, N.; Kerin, M.] Natl Univ Ireland Galway, Discipline Surg, Galway, Ireland; [McVeigh, T.; Miller, N.; Kerin, M.] Galway Univ, Hosp, Galway, Ireland; [Keane, F.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Deng, Y.; Yao, X.] Yale Univ, Sch Med, Yale Ctr Analyt Sci, New Haven, CT 06520 USA; [Zhao, H.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Zhao, H.] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Yale University; Yale University; Yale University; Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 266 Whitney Ave,POB 208103, New Haven, CT 06520 USA.	joanne.weidhaas@yale.edu; frank.slack@yale.edu	Miller, Nicola/F-4009-2018; McVeigh, Terri/AAX-8075-2021	Miller, Nicola/0000-0002-5416-7047; McVeigh, Terri/0000-0001-9201-9216; Stahlhut, Carlos/0000-0002-8472-7156; Slack, Frank/0000-0001-8263-0409; Weidhaas, Joanne/0000-0002-5096-3281; Kerin, Michael/0000-0003-4164-5561	Lo Graduate Fellowship for Excellence in Stem Cell Research; China Scholars Council; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA157749] Funding Source: NIH RePORTER	Lo Graduate Fellowship for Excellence in Stem Cell Research; China Scholars Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	XC was supported by Lo Graduate Fellowship for Excellence in Stem Cell Research and a fellowship from the China Scholars Council. TP was supported by a donation from William Hyman, Yale College Class of 1980, in memory of Barbara Skydel. We thank I Tikhonova, M Mahajan and S Mane at the YCGA for performing the Nimblegen enrichment and Sequenom arrays. We thank M State for critical reading of this manuscript. This work was supported by a grant from an anonymous foundation.	Adelaide J, 2006, LEUKEMIA, V20, P536, DOI 10.1038/sj.leu.2404104; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Batra J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-119; Blitzblau RC, 2010, MOL DIAGN THER, V14, P335, DOI 10.2165/11587600-000000000-00000; Bousquet M, 2005, ONCOGENE, V24, P7248, DOI 10.1038/sj.onc.1208850; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Corvi R, 2000, ONCOGENE, V19, P4236, DOI 10.1038/sj.onc.1203772; Cromer MK, 2012, J CLIN ENDOCR METAB, V97, pE1774, DOI 10.1210/jc.2012-1743; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Doherty JA, 2010, CANCER EPIDEM BIOMAR, V19, P245, DOI 10.1158/1055-9965.EPI-09-0729; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Kumaran GC, 2009, BRIT J CANCER, V100, P1, DOI 10.1038/sj.bjc.6604767; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2008, GYNECOL ONCOL, V108, P409, DOI 10.1016/j.ygyno.2007.10.024; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020703; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Markman M, 2009, EXPERT OPIN PHARMACO, V10, P2269, DOI 10.1517/14656560903120907; Masciullo V, 2003, CARCINOGENESIS, V24, P1191, DOI 10.1093/carcin/bgg075; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Paranjape T, 2011, LANCET ONCOL, V12, P377, DOI 10.1016/S1470-2045(11)70044-4; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Pearce CL, 2011, HUM MOL GENET, V20, P2263, DOI 10.1093/hmg/ddr087; Peethambaram P, 2011, INT J MOL EPIDEMIOL, V2, P185; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pongsavee M, 2009, GENET TEST MOL BIOMA, V13, P307, DOI 10.1089/gtmb.2008.0127; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Ratner ES, 2012, ONCOGENE, V31, P4559, DOI 10.1038/onc.2011.539; Ratner E, 2010, CANCER RES, V70, P6509, DOI 10.1158/0008-5472.CAN-10-0689; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shen J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-47; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Terry KL, 2010, INT J MOL EPIDEMIOL, V1, P272; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	67	17	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2125	2137		10.1038/onc.2014.117	http://dx.doi.org/10.1038/onc.2014.117			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909162	Green Accepted, Green Published			2022-12-25	WOS:000353173400012
J	Alhilali, LM; Reynolds, AR; Fakhran, S				Alhilali, Lea M.; Reynolds, Arich R.; Fakhran, Saeed			Value of Prominent Flow Voids without Cord Edema in the Detection of Spinal Arteriovenous Fistulae	PLOS ONE			English	Article							ENHANCED MR-ANGIOGRAPHY; VASCULAR MALFORMATIONS; MYELOPATHY	Purpose: To determine the prevalence of spinal dural arteriovenous fistulae (SDAVF) in patients presenting with prominent vascular flow voids on imaging without other imaging findings suggestive of SDAVF. Methods: We retrospectively identified patients from January 1, 2005 to March 1, 2012 who underwent spinal angiography for suspected SDAVF with prominent vascular flow voids on prior imaging. We excluded patients with other major spinal pathology or other imaging findings of SDAVF including cord hyperintensity, enhancement, or expansion. We calculated the proportion of patients with positive findings for SDAVF on angiography and evaluated the prevalence of SDAVF for this finding alone and in correlation with clinical findings. Results: 18 patients underwent spinal angiography for prominent flow voids on imaging without other spinal pathology or imaging findings of SDAVF. Three had a SDAVF detected on angiography. The prevalence of SDAVF in this population was low, only 17% (95% CI 6-39%). All of the patients with positive angiography findings had myelopathy, increasing the prevalence to 100% if the additional clinical finding of myelopathy was present. Conclusions: Prominent flow voids without other imaging findings suggestive of SDAVF is poorly predictive of the presence of a SDAVF, unless myelopathy is present clinically.	[Alhilali, Lea M.; Reynolds, Arich R.; Fakhran, Saeed] Univ Pittsburgh Med Ctr, Dept Radiol, Pittsburgh, PA 15221 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alhilali, LM (corresponding author), Univ Pittsburgh Med Ctr, Dept Radiol, Pittsburgh, PA 15221 USA.	alhilalilm@upmc.edu						Aghakhani N, 2008, STROKE, V39, P2756, DOI 10.1161/STROKEAHA.108.517037; Anson J A, 1992, Clin Neurosurg, V39, P388; Bowen B C, 2000, Magn Reson Imaging Clin N Am, V8, P597; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Donghai W, 2013, SPINE PHILA PA 1976; GULLIVER D, 1988, Australasian Radiology, V32, P57, DOI 10.1111/j.1440-1673.1988.tb02692.x; Hacein-Bey L, 2014, CLIN NEUROL NEUROSUR; Hall C, 1991, PRACTICAL STAT MED R, P404; Hartman J, 2012, NEUROLOGY, V79, P15, DOI 10.1212/WNL.0b013e3182582f1f; Hetts SW, 2012, J NEUROSURG-SPINE, V16, P433, DOI 10.3171/2012.1.SPINE11643; Hurst RW, 2000, AM J NEURORADIOL, V21, P781; Jellema K, 2006, BRAIN, V129, P3150, DOI 10.1093/brain/awl220; Jellema K, 2006, J NEUROL, V253, P159, DOI 10.1007/s00415-005-0936-3; Krings T, 2009, AM J NEURORADIOL, V30, P639, DOI 10.3174/ajnr.A1485; Marcus J, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0335-7; MASARYK TJ, 1987, RADIOLOGY, V164, P845, DOI 10.1148/radiology.164.3.3615886; Mascalchi M, 2001, RADIOLOGY, V219, P346, DOI 10.1148/radiology.219.2.r01ap26346; Mull M, 2007, AM J NEURORADIOL, V28, P1249, DOI 10.3174/ajnr.A0612; Muralidharan R, 2013, SPINE, V38, P1188, DOI 10.1097/BRS.0b013e31828b2e10; Muralidharan R, 2011, SPINE, V36, pE1641, DOI 10.1097/BRS.0b013e31821352dd; ROSENBLUM DS, 1991, ARCH PHYS MED REHAB, V72, P233; Saraf-Lavi E, 2002, AM J NEURORADIOL, V23, P858; Sato K, 2012, J NEUROSURG-SPINE, V16, P441, DOI 10.3171/2012.2.SPINE11500; SYMON L, 1984, J NEUROSURG, V60, P238, DOI 10.3171/jns.1984.60.2.0238; Toossi S, 2012, NEUROLOGY, V79, P25, DOI 10.1212/WNL.0b013e3182582f07; van Rooij WJ, 2012, AM J NEURORADIOL, V33, P1888, DOI 10.3174/ajnr.A3082	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99004	10.1371/journal.pone.0099004	http://dx.doi.org/10.1371/journal.pone.0099004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905497	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000341869000088
J	Chevret, P; Robinson, TJ; Perez, J; Veyrunes, F; Britton-Davidian, J				Chevret, Pascale; Robinson, Terence J.; Perez, Julie; Veyrunes, Frederic; Britton-Davidian, Janice			A Phylogeographic Survey of the Pygmy Mouse Mus minutoides in South Africa: Taxonomic and Karyotypic Inference from Cytochrome b Sequences of Museum Specimens	PLOS ONE			English	Article							SUBGENUS NANNOMYS RODENTIA; MOLECULAR PHYLOGENY; GENUS MUS; MITOCHONDRIAL; MICE; MURINAE; SYSTEMATICS; DIVERSITY; GENES	The African pygmy mice (Mus, subgenus Nannomys) are a group of small-sized rodents that occur widely throughout sub-Saharan Africa. Chromosomal diversity within this group is extensive and numerous studies have shown the karyotype to be a useful taxonomic marker. This is pertinent to Mus minutoides populations in South Africa where two different cytotypes (2n = 34, 2n = 18) and a modification of the sex determination system (due to the presence of a Y chromosome in some females) have been recorded. This chromosomal diversity is mirrored by mitochondrial DNA sequences that unambiguously discriminate among the various pygmy mouse species and, importantly, the different M. minutoides cytotypes. However, the geographic delimitation and taxonomy of pygmy mice populations in South Africa is poorly understood. To address this, tissue samples of M. minutoides were taken and analysed from specimens housed in six South African museum collections. Partial cytochrome b sequences (400 pb) were successfully amplified from 44% of the 154 samples processed. Two species were identified: M. indutus and M. minutoides. The sequences of the M. indutus samples provided two unexpected features: i) nuclear copies of the cytochrome b gene were detected in many specimens, and ii) the range of this species was found to extend considerably further south than is presently understood. The phylogenetic analysis of the M. minutoides samples revealed two well-supported clades: a Southern clade which included the two chromosomal groups previously identified in South Africa, and an Eastern clade that extended from Eastern Africa into South Africa. Congruent molecular phylogenetic and chromosomal datasets permitted the tentative chromosomal assignments of museum specimens within the different clades as well as the correction of misidentified museum specimens.	[Chevret, Pascale] Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Perez, Julie; Veyrunes, Frederic; Britton-Davidian, Janice] Univ Montpellier 2, UMR CNRS 5554, Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Chevret, P (corresponding author), Univ Lyon 1, UMR CNRS 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.	pascale.chevret@univ-lyon1.fr	Chevret, Pascale/B-7299-2009; Robinson, Terence J./K-7342-2017	Veyrunes, Frederic/0000-0002-1706-9915; Robinson, Terence J./0000-0002-4298-4891	University of Stellenbosch; ANR [10-JCJC-1605]	University of Stellenbosch; ANR(French National Research Agency (ANR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders: Ellerman Fellowship from the University of Stellenbosch (http:/www.sun.ac.za) to JBD and TJR; and ANR (http:/www.agence-nationale-recherche.fr/) grant "SEXYMUS" (No 10-JCJC-1605) to FV.	Britton-Davidian J, 2012, ACTA OECOL, V42, P41, DOI 10.1016/j.actao.2012.01.001; Castiglia R, 2002, CHROMOSOME RES, V10, P399, DOI 10.1023/A:1016853719616; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Happold DCD, 2013, MAMMALS AFRICA, V3, P473; Kouassi SK, 2008, MAMMALIA, V72, P237, DOI 10.1515/MAMM.2008.035; Lamb J, 2014, MAMM BIOL, V79, P24, DOI 10.1016/j.mambio.2013.08.010; Macholan M, 2001, ZOOL ANZ, V240, P7, DOI 10.1078/0044-5231-00002; Martinkova N, 2006, MOL ECOL NOTES, V6, P1014, DOI 10.1111/j.1471-8286.2006.01482.x; Mboumba JF, 2011, J ZOOL SYST EVOL RES, V49, P77, DOI 10.1111/j.1439-0469.2010.00579.x; McDonough MM, 2013, ZOOKEYS, P35, DOI 10.3897/zookeys.359.6247; Meester JAJ, 1986, TRANSVAAL MUSEUM MON, V5; Monadjem A, 2008, IUCN 2013 IUCN RED L; Montgelard C, 2002, MOL PHYLOGENET EVOL, V22, P220, DOI 10.1006/mpev.2001.1056; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Pages M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031123; Qu HY, 2008, J GENET GENOMICS, V35, P485, DOI 10.1016/S1673-8527(08)60066-1; Rambaut A, 2009, TRACER; ROBERTS AUSTIN, 1926, ANN TRANSVAAL MUS, V11, P245; Rodriguez F, 2007, J HERED, V98, P243, DOI 10.1093/jhered/esm013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Skinner J. D., 1990, MAMMALS SO AFRICAN S; Smit HA, 2008, J MAMMAL, V89, P1257, DOI 10.1644/07-MAMM-A-254.1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas O, 1910, ANN MAG NAT HIST, V8, P83; Vermeiren L, 1983, ANN MUSEE R AFRIQUE, V237, P137; Veyrunes F, 2005, MOL PHYLOGENET EVOL, V36, P358, DOI 10.1016/j.ympev.2005.02.011; Veyrunes F, 2004, CHROMOSOME RES, V12, P369, DOI 10.1023/B:CHRO.0000034098.09885.e6; Veyrunes F, 2013, SEX DEV, V7, P244, DOI 10.1159/000351223; Veyrunes F, 2009, CHROMOSOME RES UNPUB; Veyrunes F, 2010, CHROMOSOME RES, V18, P563, DOI 10.1007/s10577-010-9144-9; Veyrunes F, 2010, P ROY SOC B-BIOL SCI, V277, P1049, DOI 10.1098/rspb.2009.1925	35	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98499	10.1371/journal.pone.0098499	http://dx.doi.org/10.1371/journal.pone.0098499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905736	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000034
J	Hudson, CM; Bent, ZW; Meagher, RJ; Williams, KP				Hudson, Corey M.; Bent, Zachary W.; Meagher, Robert J.; Williams, Kelly P.			Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae Strain	PLOS ONE			English	Article							QUINOLONE RESISTANCE; ESCHERICHIA-COLI; ENTEROBACTER-AEROGENES; BETA-LACTAMASE; EVOLUTION; PLASMIDS; IDENTIFICATION; DISSEMINATION; ORGANIZATION; ACQUISITION	Multidrug-resistant Enterobacteriaceae are emerging as a serious infectious disease challenge. These strains can accumulate many antibiotic resistance genes though horizontal transfer of genetic elements, those for beta-lactamases being of particular concern. Some beta-lactamases are active on a broad spectrum of beta-lactams including the last-resort carbapenems. The gene for the broad-spectrum and carbapenem-active metallo-beta-lactamase NDM-1 is rapidly spreading. We present the complete genome of Klebsiella pneumoniae ATCC BAA-2146, the first U.S. isolate found to encode NDM-1, and describe its repertoire of antibiotic-resistance genes and mutations, including genes for eight beta-lactamases and 15 additional antibiotic-resistance enzymes. To elucidate the evolution of this rich repertoire, the mobile elements of the genome were characterized, including four plasmids with varying degrees of conservation and mosaicism and eleven chromosomal genomic islands. One island was identified by a novel phylogenomic approach, that further indicated the cps-lps polysaccharide synthesis locus, where operon translocation and fusion was noted. Unique plasmid segments and mosaic junctions were identified. Plasmid-borne bla(CTX-M-15) was transposed recently to the chromosome by ISEcp1. None of the eleven full copies of IS26, the most frequent IS element in the genome, had the expected 8-bp direct repeat of the integration target sequence, suggesting that each copy underwent homologous recombination subsequent to its last transposition event. Comparative analysis likewise indicates IS26 as a frequent recombinational junction between plasmid ancestors, and also indicates a resolvase site. In one novel use of high-throughput sequencing, homologously recombinant subpopulations of the bacterial culture were detected. In a second novel use, circular transposition intermediates were detected for the novel insertion sequence ISKpn21 of the ISNCY family, suggesting that it uses the two-step transposition mechanism of IS3. Robust genome-based phylogeny showed that a unified Klebsiella cluster contains Enterobacter aerogenes and Raoultella, suggesting the latter genus should be abandoned.	[Hudson, Corey M.; Bent, Zachary W.; Williams, Kelly P.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94550 USA; [Meagher, Robert J.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Williams, KP (corresponding author), Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94550 USA.	kpwilli@sandia.gov	Hudson, Corey M./I-1283-2019	Hudson, Corey M./0000-0003-4796-538X; Meagher, Robert/0000-0002-6262-2126	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development) program [165683]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development) program; U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by Sandia National Laboratories' Grand Challenge LDRD (Laboratory-Directed Research and Development, grant number 165683) program. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin company, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1995, INFECT IMMUN, V63, P903; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; ARAKAWA Y, 1995, J BACTERIOL, V177, P1788, DOI 10.1128/jb.177.7.1788-1796.1995; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Brisse S, 1999, ANTIMICROB AGENTS CH, V43, P2051, DOI 10.1128/AAC.43.8.2051; Broberg CA, 2013, GENOME ANNOUNC, V1; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chen ZL, 2011, CLIN INFECT DIS, V52, P692, DOI 10.1093/cid/ciq231; CLEARY JM, 1982, J BACTERIOL, V150, P1467, DOI 10.1128/JB.150.3.1467-1471.1982; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Doyon JP, 2010, LECT N BIOINFORMAT, V6398, P93, DOI 10.1007/978-3-642-16181-0_9; Duvernay C, 2011, MICROBIOL-SGM, V157, P496, DOI 10.1099/mic.0.043885-0; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hentschke M, 2010, ANTIMICROB AGENTS CH, V54, P2720, DOI 10.1128/AAC.00085-10; Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jensen SO, 2004, CAN J MICROBIOL, V50, P299, DOI 10.1139/W04-010; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068988; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P639, DOI 10.1128/AAC.01051-08; Leski T, 2012, INT J ANTIMICROB AG, V40, P282, DOI 10.1016/j.ijantimicag.2012.05.019; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mantri Y, 2004, NUCLEIC ACIDS RES, V32, pD55, DOI 10.1093/nar/gkh059; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; Osborn AM, 1997, FEMS MICROBIOL REV, V19, P239, DOI 10.1111/j.1574-6976.1997.tb00300.x; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Partridge SR, 2002, ANTIMICROB AGENTS CH, V46, P1288, DOI 10.1128/AAC.46.5.1288-1294.2002; Pasquali F, 2005, J ANTIMICROB CHEMOTH, V55, P562, DOI 10.1093/jac/dkh553; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Ramirez MS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00121; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Sabate M, 2002, ANTIMICROB AGENTS CH, V46, P2656, DOI 10.1128/AAC.46.8.2656-2661.2002; Sampei G, 2010, PLASMID, V64, P92, DOI 10.1016/j.plasmid.2010.05.005; Seo JH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-679; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian SF, 2011, ENFERM INFEC MICR CL, V29, P731, DOI 10.1016/j.eimc.2011.07.011; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; TOLMASKY ME, 1993, PLASMID, V29, P31, DOI 10.1006/plas.1993.1004; Ton-Hoang B, 1999, MOL MICROBIOL, V32, P617, DOI 10.1046/j.1365-2958.1999.01379.x; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Warner DM, 2013, ANTIMICROB AGENTS CH, V57, P1935, DOI 10.1128/AAC.02445-12; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Yang HY, 2013, INT J ANTIMICROB AG, V42, P173, DOI 10.1016/j.ijantimicag.2013.04.026; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	70	90	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99209	10.1371/journal.pone.0099209	http://dx.doi.org/10.1371/journal.pone.0099209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905728	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000111
J	Pelletier, A; Delanaud, S; de Seze, R; Bach, V; Libert, JP; Loos, N				Pelletier, Amandine; Delanaud, Stephane; de Seze, Rene; Bach, Veronique; Libert, Jean-Pierre; Loos, Nathalie			Does Exposure to a Radiofrequency Electromagnetic Field Modify Thermal Preference in Juvenile Rats?	PLOS ONE			English	Article							PHONE BASE STATIONS; BEHAVIORAL THERMOREGULATION; HYPOTHALAMIC TEMPERATURE; AMBIENT-TEMPERATURE; BODY-TEMPERATURE; SLEEP; MECHANISMS; ANTENNAS; TAIL	Some studies have shown that people living near a mobile phone base station may report sleep disturbances and discomfort. Using a rat model, we have previously shown that chronic exposure to a low-intensity radiofrequency electromagnetic field (RF-EMF) was associated with paradoxical sleep (PS) fragmentation and greater vasomotor tone in the tail. Here, we sought to establish whether sleep disturbances might result from the disturbance of thermoregulatory processes by a RF-EMF. We recorded thermal preference and sleep stage distribution in 18 young male Wistar rats. Nine animals were exposed to a low-intensity RF-EMF (900 MHz, 1 V.m(-1)) for five weeks and nine served as non-exposed controls. Thermal preference was assessed in an experimental chamber comprising three interconnected compartments, in which the air temperatures (T-a) were set to 24 degrees C, 28 degrees C and 31 degrees C. Sleep and tail skin temperature were also recorded. Our results indicated that relative to control group, exposure to RF-EMF at 31 degrees C was associated with a significantly lower tail skin temperature (-1.6 degrees C) which confirmed previous data. During the light period, the exposed group preferred to sleep at T-a=31 degrees C and the controls preferred T-a=28 degrees C. The mean sleep duration in exposed group was significantly greater (by 15.5%) than in control group (due in turn to a significantly greater amount of slow wave sleep (SWS, +14.6%). Similarly, frequency of SWS was greater in exposed group (by 4.9 episodes.h(-1)). The PS did not differ significantly between the two groups. During the dark period, there were no significant intergroup differences. We conclude that RF-EMF exposure induced a shift in thermal preference towards higher temperatures. The shift in preferred temperature might result from a cold thermal sensation. The change in sleep stage distribution may involve signals from thermoreceptors in the skin. Modulation of SWS may be a protective adaptation in response to RF-EMF exposure.	[Pelletier, Amandine; Delanaud, Stephane; Bach, Veronique; Libert, Jean-Pierre; Loos, Nathalie] Jules Verne Univ Picardy, Fac Med, PeriTox Lab, UMR I INERIS 01, Amiens, France; [de Seze, Rene] Natl Inst Ind Environm & Risks INERIS, Expt Toxicol Unit, PeriTox Lab, UMR I INERIS 01, Verneuil En Halatte, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de l'Environnement Industriel et des Risques (INERIS)	Pelletier, A (corresponding author), Jules Verne Univ Picardy, Fac Med, PeriTox Lab, UMR I INERIS 01, Amiens, France.	amandine.pelletier@u-picardie.fr	de Seze, Rene/R-1894-2018; stepahne, delanaud/AAD-2762-2022; Pelletier, Amandine/AAE-7724-2022; Bach, Veronique/AAD-5958-2022; Libert, Jean-Pierre/AAD-5970-2022	de Seze, Rene/0000-0002-7978-798X; Bach, Veronique/0000-0002-0684-0305	French Ministry of Ecology as part of the Pole applicatif en Toxicologie et Ecotoxicologie program	French Ministry of Ecology as part of the Pole applicatif en Toxicologie et Ecotoxicologie program	This study was funded by a Post-Grenelle grant from the French Ministry of Ecology, as part of the Pole applicatif en Toxicologie et Ecotoxicologie program coordinated by the French National Institute of Environment and Industrial Risks (INERIS) (www.developpement-durable.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rassoul G, 2007, NEUROTOXICOLOGY, V28, P434, DOI 10.1016/j.neuro.2006.07.012; ADAIR E R, 1980, Bioelectromagnetics, V1, P1, DOI 10.1002/bem.2250010102; ADAIR ER, 1984, BIOELECTROMAGNETICS, V5, P13, DOI 10.1002/bem.2250050103; ADAIR ER, 1983, BEHAV NEUROSCI, V97, P49; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Bohr H, 2000, PHYS REV E, V61, P4310, DOI 10.1103/PhysRevE.61.4310; Bohr H, 2000, BIOELECTROMAGNETICS, V21, P68, DOI 10.1002/(SICI)1521-186X(200001)21:1<68::AID-BEM10>3.0.CO;2-9; Bolomey JC, 2004, IEEE T ANTENN PROPAG, V52, P593, DOI 10.1109/TAP.2004.823999; CARLISLE HJ, 1966, J COMP PHYSIOL PSYCH, V61, P388, DOI 10.1037/h0023260; CORBIT JD, 1969, SCIENCE, V166, P256, DOI 10.1126/science.166.3902.256; Durney CH, 1986, USAFSAMTR8573 BROOKS; HELLSTROM B, 1975, CAN J PHYSIOL PHARM, V53, P207, DOI 10.1139/y75-030; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Kumar D, 2009, PHYSIOL BEHAV, V98, P186, DOI 10.1016/j.physbeh.2009.05.008; McGinty D, 2001, ARCH ITAL BIOL, V139, P63; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Opp MR, 1997, PHYSIOL BEHAV, V63, P67, DOI 10.1016/S0031-9384(97)00390-9; Parmeggiani P., 1980, PHYSL SLEEP, P97; PARMEGGIANI PL, 1980, EXPERIENTIA, V36, P6, DOI 10.1007/BF02003941; PARMEGGIANI PL, 1977, ELECTROEN CLIN NEURO, V42, P372, DOI 10.1016/0013-4694(77)90173-0; PARMEGGIANI PL, 1970, ARCH ITAL BIOL, V108, P369; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pelletier A, 2013, ENVIRON SCI POLLUT R, V20, P2735, DOI 10.1007/s11356-012-1266-5; RAND RP, 1965, CAN J PHYSIOL PHARM, V43, P257, DOI 10.1139/y65-025; Ray B, 2004, BEHAV BRAIN RES, V154, P519, DOI 10.1016/j.bbr.2004.03.021; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; SAKAGUCHI S, 1979, AM J PHYSIOL, V237, pR80, DOI 10.1152/ajpregu.1979.237.1.R80; Santini R, 2003, PATHOL BIOL, V51, P412, DOI 10.1016/S0369-8114(03)00020-8; SATINOFF E, 1964, AM J PHYSIOL, V206, P1389, DOI 10.1152/ajplegacy.1964.206.6.1389; STERN S, 1979, SCIENCE, V206, P1198, DOI 10.1126/science.505008; Szymusiak R, 2001, ARCH ITAL BIOL, V139, P77; Vyazovskiy V, 2007, BRAIN RES BULL, V74, P37, DOI 10.1016/j.brainresbull.2007.05.001; WEISS B, 1961, SCIENCE, V133, P1338, DOI 10.1126/science.133.3461.1338	33	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99007	10.1371/journal.pone.0099007	http://dx.doi.org/10.1371/journal.pone.0099007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905635	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000089
J	Yashima, K; Sasaki, A				Yashima, Kenta; Sasaki, Akira			Epidemic Process over the Commute Network in a Metropolitan Area	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE; STRATEGIES; SPREAD; MODEL	An understanding of epidemiological dynamics is important for prevention and control of epidemic outbreaks. However, previous studies tend to focus only on specific areas, indicating that application to another area or intervention strategy requires a similar time-consuming simulation. Here, we study the epidemic dynamics of the disease-spread over a commute network, using the Tokyo metropolitan area as an example, in an attempt to elucidate the general properties of epidemic spread over a commute network that could be used for a prediction in any metropolitan area. The model is formulated on the basis of a metapopulation network in which local populations are interconnected by actual commuter flows in the Tokyo metropolitan area and the spread of infection is simulated by an individual-based model. We find that the probability of a global epidemic as well as the final epidemic sizes in both global and local populations, the timing of the epidemic peak, and the time at which the epidemic reaches a local population are mainly determined by the joint distribution of the local population sizes connected by the commuter flows, but are insensitive to geographical or topological structure of the network. Moreover, there is a strong relation between the population size and the time that the epidemic reaches this local population and we are able to determine the reason for this relation as well as its dependence on the commute network structure and epidemic parameters. This study shows that the model based on the connection between the population size classes is sufficient to predict both global and local epidemic dynamics in metropolitan area. Moreover, the clear relation of the time taken by the epidemic to reach each local population can be used as a novel measure for intervention; this enables efficient intervention strategies in each local population prior to the actual arrival.	[Yashima, Kenta; Sasaki, Akira] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst Sokendai Hayama, Hayama, Kanagawa, Japan; [Sasaki, Akira] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Sasaki, Akira] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan; [Yashima, Kenta] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo 101, Japan	Graduate University for Advanced Studies - Japan; International Institute for Applied Systems Analysis (IIASA); Japan Science & Technology Agency (JST); Meiji University	Yashima, K (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst Sokendai Hayama, Hayama, Kanagawa, Japan.	yashima_kenta@soken.ac.jp			MEXT [21370009]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by MEXT Grant-in-Aid for Scientific Research (B) 21370009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 2007, TECHNICAL REPORT; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; ELLNER S. P., 2011, DYNAMIC MODELS BIOL; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray J.D., 2002, MATH BIOL; Ohkusa Yasushi, 2007, Journal of Infection and Chemotherapy, V13, P380, DOI 10.1007/s10156-007-0556-1; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0	25	13	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98518	10.1371/journal.pone.0098518	http://dx.doi.org/10.1371/journal.pone.0098518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905831	Green Accepted, Green Published, gold			2022-12-25	WOS:000341869000035
J	Zhou, YJ; Zhang, Y; Guo, Y; Zhang, YY; Xu, M; He, B				Zhou, Yujiao; Zhang, Yuan; Guo, Yang; Zhang, Youyi; Xu, Ming; He, Bei			beta 2-Adrenoceptor Involved in Smoking-Induced Airway Mucus Hypersecretion through beta-Arrestin-Dependent Signaling	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; EPITHELIAL-CELLS; GENE-EXPRESSION; ACTIVATION; BLOCKERS; EXACERBATIONS; INFLAMMATION; INHIBITION; RECEPTORS	Progression of chronic obstructive pulmonary disease is associated with small airway obstruction by accumulation of inflammatory mucous exudates. However, the mechanism of mucin hypersecretion after exposure to cigarette smoke (CS) is still not clear. In this study, we explored the contribution of beta(2)-adrenoceptor (beta(2)-AR) signaling to CS extract (CSE)-induced mucus hypersecretion in vitro and examined the effect of a beta-blocker on airway mucin hypersecretion in vivo. NCI-H292 epithelial cell line was used to determine the contribution of beta(2)-AR signaling to CSE-induced MUC5AC production by treatment with beta(2)-AR antagonists propranolol and ICI118551 and beta(2)-AR-targeted small interfering RNA. The effect of propranolol on airway mucus hypersecretion was examined in a rat model exposed to CS. MUC5AC expression was assayed by real-time PCR, immunohistochemistry and ELISA. beta(2)-AR and its downstream signaling were detected by western blot analysis. We found that pretreating NCI-H292 cells with propranolol, ICI118551 for 30 min or beta(2)AR-targeted siRNA for 48 h reduced MUC5AC mRNA and protein levels stimulated by CSE. However, inhibiting the classical beta(2)AR-cAMP-PKA pathway didn't attenuate CSE-induced MUC5AC production, while silencing beta-arretin2 expression significantly decreased ERK and p38MAPK phosphorylation, thus reduced the CSE-stimulated MUC5AC production. In vivo, we found that administration of propranolol (25 mg kg(-1) d(-1)) for 28 days significantly attenuated the airway goblet cell metaplasia, mucus hypersecretion and MUC5AC expression of rats exposed to CS. From the study, beta(2)-AR-beta-arrestin2-ERK1/2 signaling was required for CS-induced airway MUC5AC expression. Chronic propranolol administration ameliorated airway mucus hypersecretion and MUC5AC expression in smoking rats. The exploration of these mechanisms may contribute to the optimization of beta(2)-AR target therapy in chronic obstructive pulmonary disease.	[Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China; [Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Zhou, Yujiao; Zhang, Yuan; Zhang, Youyi; Xu, Ming; He, Bei] Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China; [Guo, Yang] Changji Renmin Hosp, Dept Resp Med, Changji, Xinjiang, Peoples R China	Peking University; Peking University	He, B (corresponding author), Peking Univ, Hosp 3, Dept Resp Med, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; puh3_hb@bjmu.edu.cn			National Natural Science Foundation of China [81270097, 30910103902, 81121061]; Beijing Natural Science Foundation [7112745]; Ph.D. Programs Foundation of Ministry of Education of China [20090001110093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 81270097; 30910103902; 81121061), the Beijing Natural Science Foundation (No. 7112745) and Ph.D. Programs Foundation of Ministry of Education of China (No. 20090001110093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Chakravorty I, 2011, INT J CHRONIC OBSTR, V6, P693, DOI 10.2147/COPD.S22896; Chen YH, 2009, CYTOKINE, V45, P117, DOI 10.1016/j.cyto.2008.11.009; Choi WI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-172; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Deshmukh HS, 2008, AM J RESP CELL MOL, V38, P446, DOI 10.1165/rcmb.2006-0339OC; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; Dicpinigaitis PV, 2003, CHEST, V123, P685, DOI 10.1378/chest.123.3.685; Foresi A, 2010, RESPIRATION, V80, P177, DOI 10.1159/000318583; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Guo Y, 2014, IHALATION T IN PRESS; Guo Y, 2014, INHAL TOXICOL, V26, P271, DOI 10.3109/08958378.2014.885098; Hellermann GR, 2002, RESP RES, V3, DOI 10.1186/rr172; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ikeda T, 2012, BRIT J PHARMACOL, V166, P1804, DOI 10.1111/j.1476-5381.2012.01881.x; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136; Kargin F, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-8; Kim ST, 2011, AM J RHINOL ALLERGY, V25, P303, DOI 10.2500/ajra.2011.25.3627; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGraw DW, 2000, AM J PHYSIOL-LUNG C, V279, pL379, DOI 10.1152/ajplung.2000.279.2.L379; Mebratu YA, 2011, AM J RESP CRIT CARE, V183, P1531, DOI 10.1164/rccm.201011-1930OC; Minor DS, 2013, J CLIN HYPERTENS, V15, P925, DOI 10.1111/jch.12204; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nguyen LP, 2008, AM J RESP CELL MOL, V38, P256, DOI 10.1165/rcmb.2007-0279RC; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nyunoya T, 2013, AM J RESP CELL MOL B; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Por ED, 2012, J BIOL CHEM, V287, P37552, DOI 10.1074/jbc.M112.391847; Qian L, 2009, GLIA, V57, P1600, DOI 10.1002/glia.20873; Quint JK, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6650; Rogers DF, 2001, RESP PHYSIOL, V125, P129, DOI 10.1016/S0034-5687(00)00209-7; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Sarir H, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-12; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Song Jeong-Sup, 2005, Korean Journal of Internal Medicine, V20, P275; Song KS, 2013, ACTA PHYSIOL, V208, P245, DOI 10.1111/apha.12104; Stefan MS, 2012, THORAX, V67, P977, DOI 10.1136/thoraxjnl-2012-201945; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	50	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97788	10.1371/journal.pone.0097788	http://dx.doi.org/10.1371/journal.pone.0097788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905583	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000011
J	Jamsheer, KM; Laxmi, A				Jamsheer, Muhammed K.; Laxmi, Ashverya			DUF581 Is Plant Specific FCS-Like Zinc Finger Involved in Protein-Protein Interaction	PLOS ONE			English	Article							DUF283 DOMAIN; ARABIDOPSIS; GENE; SEQUENCE; RECOGNITION; EVOLUTION; METHYLATION; FAMILY; FOLD; LOCALIZATION	Zinc fingers are a ubiquitous class of protein domain with considerable variation in structure and function. Zf-FCS is a highly diverged group of C-2-C-2 zinc finger which is present in animals, prokaryotes and viruses, but not in plants. In this study we identified that a plant specific domain of unknown function, DUF581 is a zf-FCS type zinc finger. Based on HMM-HMM comparison and signature motif similarity we named this domain as (F) under bar CS-(L) under bar ike (Z) under bar inc finger (FLZ) domain. A genome wide survey identified that FLZ domain containing genes are bryophytic in origin and this gene family is expanded in spermatophytes. Expression analysis of selected FLZ gene family members of A. thaliana identified an overlapping expression pattern suggesting a possible redundancy in their function. Unlike the zf-FCS domain, the FLZ domain found to be highly conserved in sequence and structure. Using a combination of bioinformatic and protein-protein interaction tools, we identified that FLZ domain is involved in protein-protein interaction.	[Jamsheer, Muhammed K.; Laxmi, Ashverya] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Laxmi, A (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	ashverya_laxmi@nipgr.ac.in		Jamsheer K, Muhammed/0000-0002-2135-8760	National Institute of Plant Genome Research (NIPGR); University Grants Commission, Government of India	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); University Grants Commission, Government of India(University Grants Commission, India)	This work was financially supported by the National Institute of Plant Genome Research (NIPGR) core grant and University Grants Commission, Government of India (research fellowship to MJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beuchle D, 2001, DEVELOPMENT, V128, P993; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Coggill P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-265; Crocco CD, 2010, PLANT J, V64, P551, DOI 10.1111/j.1365-313X.2010.04360.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; FarzadFard F, 2008, J STRUCT BIOL, V161, P101, DOI 10.1016/j.jsb.2007.09.024; Goldstein RA, 2008, CURR OPIN STRUC BIOL, V18, P170, DOI 10.1016/j.sbi.2008.01.006; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; He YH, 2001, PLANT PHYSIOL, V126, P707, DOI 10.1104/pp.126.2.707; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohler C, 2008, TRENDS CELL BIOL, V18, P236, DOI 10.1016/j.tcb.2008.02.005; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lechtenberg BC, 2009, PROTEIN SCI, V18, P657, DOI 10.1002/pro.51; Perez-Perez JM, 2013, PLANT PHYSIOL, V162, P589, DOI 10.1104/pp.113.217323; Miller RT, 1996, FASEB J, V10, P171, DOI 10.1096/fasebj.10.1.8566539; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Prakash A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025570; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Qin HN, 2010, RNA, V16, P474, DOI 10.1261/rna.1965310; Reiter A, 1998, BLOOD, V92, P1735, DOI 10.1182/blood.V92.5.1735.417k11_1735_1742; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schuster-Bockler B, 2005, BIOINFORMATICS, V21, P2912, DOI 10.1093/bioinformatics/bti434; Sigrist CJA, 2009, NUCLEIC ACIDS RES, V41, pD344; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; Wang RJ, 2011, BIOCHEMISTRY-US, V50, P4998, DOI 10.1021/bi101487s; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	57	21	39	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99074	10.1371/journal.pone.0099074	http://dx.doi.org/10.1371/journal.pone.0099074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901469	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400092
J	Jurado-Tarifa, E; Napp, S; Gomez-Pacheco, JM; Fernandez-Morente, M; Jaen-Tellez, JA; Arenas, A; Garcia-Bocanegra, I				Jurado-Tarifa, Estefania; Napp, Sebastian; Manuel Gomez-Pacheco, Juan; Fernandez-Morente, Manuel; Antonio Jaen-Tellez, Juan; Arenas, Antonio; Garcia-Bocanegra, Ignacio			Surveillance of Influenza Viruses in Waterfowl Used As Decoys in Andalusia, Spain	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; WILD BIRDS; A-VIRUS; EXPERIMENTAL-INFECTION; ACTIVE SURVEILLANCE; SEROLOGICAL SURVEY; DUCKS; H5N1; CIRCULATION; SUBTYPES	A longitudinal study was carried out to determine the seroprevalence of avian influenza viruses (AIVs) in waterfowl used as decoys in Andalusia, southern Spain. A total of 2319 aquatic birds from 193 flocks were analyzed before and after the hunting season 2011-2012. In the first sampling, 403 out of 2319 (18.0%, CI95%: 15.8-19.0) decoys showed antibodies against AIVs by ELISA. The AI seroprevalence was significantly higher in geese (21.0%) than in ducks (11.7%) (P<0.001). Besides, the spatial distribution of AIVs was not homogeneous as significant differences among regions were observed. The prevalence of antibodies against AIVs subtypes H5 and H7 were 1.1% and 0.3%, respectively, using hemagglutination inhibition test (HI). The overall and H5 seroprevalences slightly increased after the hunting period (to 19.2% and 1.4%, respectively), while the H7 seroprevalence remained at the same level (0.3%). The proportion of flocks infected by AIVs was 65.3%, while 11.2% and 4.9% of flocks were positive for H5 and H7, respectively. Viral shedding was not detected in any of the 47 samples positive by both ELISA and HI, tested by RRT-PCR. The individual incidence after the hunting season was 3.4%. The fact that 57 animals seroconverted, 15 of which were confirmed by HI (12 H5 and 3 H7), was indication of contact with AIVs during the hunting period. The results indicate that waterfowl used as decoys are frequently exposed to AIVs and may be potentially useful as sentinels for AIVs monitoring. The seroprevalence detected and the seropositivity against AIVs H5 and H7, suggest that decoys can act as reservoirs of AIVs, which may be of animal and public health concern.	[Jurado-Tarifa, Estefania; Arenas, Antonio; Garcia-Bocanegra, Ignacio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Napp, Sebastian] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Manuel Gomez-Pacheco, Juan] Consejeria Agr Pesca & Desarrollo Rural Junta And, Lab Sanidad & Prod Anim, Cordoba, Spain; [Fernandez-Morente, Manuel] Consejeria Agr Pesca & Desarrollo Rural Junta And, Serv Sanidad Anim, Seville, Spain; [Antonio Jaen-Tellez, Juan] Consejeria Agr Pesca & Desarrollo Rural Junta And, Agencia Gest Agr & Pesquera Andalucia, Seville, Spain	Universidad de Cordoba; Autonomous University of Barcelona; IRTA	Garcia-Bocanegra, I (corresponding author), Univ Cordoba, Fac Vet, Dept Sanidad Anim, Agrifood Excellence Int Campus, Cordoba, Spain.	nacho.garcia@uco.es	Bocanegra, Ignacio Garcia/G-1443-2016; ARENAS, Antonio J/I-3997-2017; Napp, Sebastian/F-3331-2016	Bocanegra, Ignacio Garcia/0000-0003-3388-2604; ARENAS, Antonio J/0000-0001-5334-2440; Napp, Sebastian/0000-0001-5813-7286; Jaen Tellez, Juan Antonio/0000-0002-7570-6687	Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain	Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by Regional Ministry of Agriculture and Fisheries of the Government of Andalusia, Spain. No additional external funding received for this study.	Alba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044354; Albayrak H, 2010, ZOONOSES PUBLIC HLTH, V57, pE71, DOI 10.1111/j.1863-2378.2010.01327.x; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ARENAS A, 1990, AVIAN PATHOL, V19, P539, DOI 10.1080/03079459008418706; ASTORGA RJ, 1994, AVIAN PATHOL, V23, P339, DOI 10.1080/03079459408419001; Barral M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-50; Baumer A, 2010, AVIAN DIS, V54, P875, DOI 10.1637/9119-110209-Reg.1; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Busquets N, 2010, VIRUS RES, V149, P10, DOI 10.1016/j.virusres.2009.12.005; Cattoli G, 2007, AVIAN DIS, V51, P414, DOI 10.1637/7562-033106R.1; De Marco MA, 2005, AVIAN PATHOL, V34, P480, DOI 10.1080/03079450500368185; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; Delogu M, 2012, AVIAN DIS, V56, P1034, DOI 10.1637/10174-041012-ResNote.1; Fereidouni SR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-43; Fink M, 2010, J VIROL, V84, P5815, DOI 10.1128/JVI.01642-09; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Germundsson A, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-28; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Henriques AM, 2011, AVIAN PATHOL, V40, P597, DOI 10.1080/03079457.2011.618943; Iglesias I, 2010, TRANSBOUND EMERG DIS, V57, P282, DOI 10.1111/j.1865-1682.2010.01145.x; Iqbal M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-100; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kelvin AA, 2012, J INFECT DEV COUNTR, V6, P786, DOI 10.3855/jidc.2793; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Lang V, 2010, ZOONOSES PUBLIC HLTH, V57, pE184, DOI 10.1111/j.1863-2378.2010.01326.x; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Lebarbenchon C, 2010, AVIAN DIS, V54, P446, DOI 10.1637/8665-022509-ResNote.1; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Lindh E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-35; Marche S, 2014, TRANSBOUND EMERG DIS, V61, P526, DOI 10.1111/tbed.12056; Martinez M, 2009, TRANSBOUND EMERG DIS, V56, P86, DOI 10.1111/j.1865-1682.2008.01062.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nicoll A, 2013, EUROSURVEILLANCE, V18, P2; Nielsen AA, 2013, VET MICROBIOL, V166, P419, DOI 10.1016/j.vetmic.2013.06.024; OIE website, 2008, MAN DIAGN TESTS VACC, V1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pannwitz G, 2009, J WILDLIFE DIS, V45, P512, DOI 10.7589/0090-3558-45.2.512; Perez-Ramirez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046418; Perez-Ramirez E, 2010, VET MICROBIOL, V146, P200, DOI 10.1016/j.vetmic.2010.05.008; Rabl S, 2009, BERL MUNCH TIERARZTL, V122, P486, DOI 10.2376/0005-9366-122-486; Schenk C, 2013, EURO SURVEILL, V18; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Slavec B, 2012, AVIAN DIS, V56, P999, DOI 10.1637/10175-041012-ResNote.1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2009, POULTRY SCI, V88, P847, DOI 10.3382/ps.2008-00336; Spackman E, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-331; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tolf C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049002; Tonnessen R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-112; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; Vergara-Alert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058692; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Vittecoq M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043974; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster RG, 2004, REV SCI TECH OIE, V23, P453, DOI 10.20506/rst.23.2.1493; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Wunderwald C, 2002, AVIAN PATHOL, V31, P157, DOI 10.1080/03079450120118649; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050770	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98890	10.1371/journal.pone.0098890	http://dx.doi.org/10.1371/journal.pone.0098890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901946	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400067
J	Sequeira, IR; Lentle, RG; Kruger, MC; Hurst, RD				Sequeira, Ivana R.; Lentle, Roger G.; Kruger, Marlena C.; Hurst, Roger D.			Standardising the Lactulose Mannitol Test of Gut Permeability to Minimise Error and Promote Comparability	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; CROHNS-DISEASE; CELIAC-DISEASE; GASTROINTESTINAL TRANSIT; GLUCOSE-TOLERANCE; INSULIN-SECRETION; SUGAR ABSORPTION; DEGREE RELATIVES; CAPSULE; LENGTH	Background: Lactulose mannitol ratio tests are clinically useful for assessing disorders characterised by changes in gut permeability and for assessing mixing in the intestinal lumen. Variations between currently used test protocols preclude meaningful comparisons between studies. We determined the optimal sampling period and related this to intestinal residence. Methods: Half-hourly lactulose and mannitol urinary excretions were determined over 6 hours in 40 healthy female volunteers after administration of either 600 mg aspirin or placebo, in randomised order at weekly intervals. Gastric and small intestinal transit times were assessed by the SmartPill in 6 subjects from the same population. Half-hourly percentage recoveries of lactulose and mannitol were grouped on a basis of compartment transit time. The rate of increase or decrease of each sugar within each group was explored by simple linear regression to assess the optimal period of sampling. Key Results: The between subject standard errors for each half-hourly lactulose and mannitol excretion were lowest, the correlation of the quantity of each sugar excreted with time was optimal and the difference between the two sugars in this temporal relationship maximal during the period from 2K-4 h after ingestion. Half-hourly lactulose excretions were generally increased after dosage with aspirin whilst those of mannitol were unchanged as was the temporal pattern and period of lowest between subject standard error for both sugars. Conclusion: The results indicate that between subject variation in the percentage excretion of the two sugars would be minimised and the differences in the temporal patterns of excretion would be maximised if the period of collection of urine used in clinical tests of small intestinal permeability were restricted to 2K-4 h post dosage. This period corresponds to a period when the column of digesta column containing the probes is passing from the small to the large intestine.	[Sequeira, Ivana R.; Lentle, Roger G.; Kruger, Marlena C.] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Hurst, Roger D.] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand	Massey University; New Zealand Institute for Plant & Food Research Ltd	Lentle, RG (corresponding author), Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	R.G.Lentle@massey.ac.nz	Sequeira, Ivana/AAG-3501-2020; Hurst, Roger D/B-9460-2014	Sequeira, Ivana/0000-0001-5414-9925; Hurst, Roger D/0000-0002-4097-1368	Ministry of Business Innovation and Employment, New Zealand [C06X0807]	Ministry of Business Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This work was funded by the Ministry of Business Innovation and Employment (formerly Science and Innovation), New Zealand, contract number C06X0807, awarded to The New Zealand Institute for Plant and Food Research Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE F, 1988, GUT, V29, P511, DOI 10.1136/gut.29.4.511; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; BRADEN B, 1995, GASTROENTEROLOGY, V108, P1048, DOI 10.1016/0016-5085(95)90202-3; Cassilly D, 2008, NEUROGASTROENT MOTIL, V20, P311, DOI 10.1111/j.1365-2982.2007.01061.x; Dastych M, 2008, DIGEST DIS SCI, V53, P2789, DOI 10.1007/s10620-007-0184-8; DATZ FL, 1987, J NUCL MED, V28, P1204; DeMeo MT, 2002, J CLIN GASTROENTEROL, V34, P385, DOI 10.1097/00004836-200204000-00003; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Farhadi A, 2010, ALCOHOL, V44, P447, DOI 10.1016/j.alcohol.2010.05.004; FINK AS, 1983, AM J PHYSIOL, V245, pG85, DOI 10.1152/ajpgi.1983.245.1.G85; Fleming SC, 1996, CLIN CHEM, V42, P445; Halme L, 2000, SCAND J CLIN LAB INV, V60, P695, DOI 10.1080/00365510050216420; Hilsden RJ, 1996, GASTROENTEROLOGY, V110, P1395, DOI 10.1053/gast.1996.v110.pm8613043; HOLLANDER D, 1992, SCAND J GASTROENTERO, V27, P721, DOI 10.3109/00365529209011172; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; HOROWITZ M, 1985, BRIT J OBSTET GYNAEC, V92, P743, DOI 10.1111/j.1471-0528.1985.tb01458.x; HUNT JN, 1954, J PHYSIOL-LONDON, V126, P459, DOI 10.1113/jphysiol.1954.sp005222; Kloetzer L, 2010, NEUROGASTROENT MOTIL, V22, P527, DOI 10.1111/j.1365-2982.2010.01468.x; KRUGLIAK P, 1994, DIGEST DIS SCI, V39, P796, DOI 10.1007/BF02087426; Kwiatek MA, 2009, AM J PHYSIOL-GASTR L, V297, pG894, DOI 10.1152/ajpgi.00117.2009; Lambert GP, 2007, INT J SPORTS MED, V28, P722, DOI 10.1055/s-2007-964891; Lambert GP, 2012, INT J SPORTS MED, V33, P421, DOI 10.1055/s-0032-1301892; Lentle RG, 2010, CRIT REV FOOD SCI, V50, P130, DOI 10.1080/10408390802248726; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; LIN HC, 1989, AM J PHYSIOL, V256, pG404, DOI 10.1152/ajpgi.1989.256.2.G404; LIN HC, 1990, AM J PHYSIOL, V259, pG1025, DOI 10.1152/ajpgi.1990.259.6.G1025; LIN HC, 1990, AM J PHYSIOL, V259, pG1031, DOI 10.1152/ajpgi.1990.259.6.G1031; Ma TY, 1997, P SOC EXP BIOL MED, V214, P318; Mahmud T, 1996, ANN RHEUM DIS, V55, P211, DOI 10.1136/ard.55.4.211; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; MENZIES IS, 1979, LANCET, V2, P1107; Meyer JH, 1998, AM J PHYSIOL-REG I, V275, pR1308, DOI 10.1152/ajpregu.1998.275.4.R1308; MOJAVERIAN P, 1991, PHARM RES-DORDR, V8, P97, DOI 10.1023/A:1015894626403; MOJAVERIAN P, 1989, PHARMACEUT RES, V6, P719, DOI 10.1023/A:1015998708560; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; Parkman Henry P, 2009, Gastrointest Endosc Clin N Am, V19, P49, DOI 10.1016/j.giec.2008.12.003; PRYTZ H, 1989, SCAND J GASTROENTERO, V24, P1084, DOI 10.3109/00365528909089259; Rao AS, 2011, AM J PHYSIOL-GASTR L, V301, pG919, DOI 10.1152/ajpgi.00168.2011; Rao SSC, 2011, NEUROGASTROENT MOTIL, V23, P8, DOI 10.1111/j.1365-2982.2010.01612.x; Sequeira IR, 2012, NEUROGASTROENT MOTIL, V24, pe401, DOI 10.1111/j.1365-2982.2012.01969.x; Sequeira IR, 2013, CLIN EXPT PHARM PHYS; Smecuol E, 2009, CLIN GASTROENTEROL H, V7, P524, DOI 10.1016/j.cgh.2008.12.019; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; Timm D, 2011, BRIT J NUTR, V105, P1337, DOI 10.1017/S0007114510004988; Uil JJ, 2000, DIGEST LIVER DIS, V32, P195, DOI 10.1016/S1590-8658(00)80820-8; van Nieuwenhoven MA, 1999, EUR J CLIN INVEST, V29, P160, DOI 10.1046/j.1365-2362.1999.00421.x; van Wijck K, 2012, CLIN NUTR; VANELBURG RM, 1995, J PEDIATR GASTR NUTR, V20, P184, DOI 10.1097/00005176-199502000-00008; VANELBURG RM, 1993, GUT, V34, P354, DOI 10.1136/gut.34.3.354; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; VOGELSANG H, 1995, AM J GASTROENTEROL, V90, P1838; Wilkinson L, 2010, WIRES COMPUT STAT, V2, P256, DOI 10.1002/wics.66	56	63	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99256	10.1371/journal.pone.0099256	http://dx.doi.org/10.1371/journal.pone.0099256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901524	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400114
J	Yang, TT; Goodkin, NF				Yang, Teng Teng; Goodkin, Nathalie Fairbank			Wet Season Upwelling and Dry Season Chlorophyll-a Describe Interannual Growth Rates of Porites in Southern China	PLOS ONE			English	Article							DENSITY BAND FORMATION; SKELETAL GROWTH; CORAL SKELETONS; REEF; COASTAL; PHOTOSYNTHESIS; COMMUNITIES; RESILIENCE; SALINITY; PATTERNS	Southern China hosts coral communities in marginal environments that are characterized by low linear extension rates, low coral cover and/or no reef formation, thus providing natural laboratories to study coral communities with below average growth rates. Here we compare the annual linear extension rates over 10 years (range 1.2 to 11.4 mm yr(-1)) of six Porites sp. coral cores collected from Hong Kong with monthly hydrographic data from the Hong Kong Environmental Protection Department. At all sites, low-density, dry season extension were more variable than high-density, wet season extension and on average, was lower at two of the three sites. We applied multi-variate linear regressions that revealed high-density, wet season band extension to inversely correlate most significantly to temperature (r = -0.39, p<0.01). In contrast, low-density, dry season band extension was more variable and correlated most significantly with dry season chlorophyll-a (Chl-a) (r = 0.64, p<0.001). Additionally, we find that corals at the site with highest dry season Chl-a have the highest dry season extension lengths. Our findings indicate that relative mixing of fresh and salt water in the wet season and primary productivity in the dry season, and their influences on aragonite saturation, are likely to impact interannual coral extension variability in marginal environments.	[Yang, Teng Teng] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Goodkin, Nathalie Fairbank] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Goodkin, NF (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China.	nathalie@ntu.edu.sg		Goodkin, Nathalie/0000-0001-9697-5520	General Research Fund of HK [GRF-HKU702509P]; Ocean Park Conservation Foundation; National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award) [NRFF-2012-03]; National Research Foundation Singapore; Singapore Ministry of Education under the Research Centres of Excellence initiative	General Research Fund of HK; Ocean Park Conservation Foundation; National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award)(National Research Foundation, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under the Research Centres of Excellence initiative(Ministry of Education, Singapore)	The General Research Fund of HK (GRF-HKU702509P) and Ocean Park Conservation Foundation provided funding. This research is also supported by the National Research Foundation Singapore under its Singapore NRF Fellowship scheme (National Research Fellow Award No. NRFF-2012-03) and administered by Earth Observatory of Singapore, the National Research Foundation Singapore and the Singapore Ministry of Education under the Research Centres of Excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.ugc.edu.hk/eng/rgc/grf/grf.htm; http://www.opcf.org.hk/en/; http://www.nrf.gov.sg; http://www.moe.gov.sg).	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; Ang P, 2010, STATUS CORAL REEFS E, P65; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; BARNES DJ, 1993, J EXP MAR BIOL ECOL, V167, P91, DOI 10.1016/0022-0981(93)90186-R; Buddemeier RW, 1999, AM ZOOL, V39, P1; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; Dai MH, 2008, CONT SHELF RES, V28, P1416, DOI 10.1016/j.csr.2007.04.018; DeLong KL, 2013, PALAEOGEOGR PALAEOCL, V373, P6, DOI 10.1016/j.palaeo.2012.08.019; DEVANTIER L, 2003, CORALS CORAL COMMUNI; DODGE RE, 1974, EARTH PLANET SC LETT, V23, P313, DOI 10.1016/0012-821X(74)90121-6; Doney S C, 2013, INT GEOPHYS SERIES, P817, DOI [10.1016/B978-0-12-391851-2.00031-3, DOI 10.1016/B978-0-12-391851-2.00031-3]; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Emerson S, 2008, CHEMICAL OCEANOGRAPHY AND THE MARINE CARBON CYCLE, P1, DOI 10.1017/CBO9780511793202; EPD, 2010, MAR WAT QUAL HONG KO; Fabricius KE, 2006, MAR POLLUT BULL, V52, P22, DOI 10.1016/j.marpolbul.2005.08.004; Glover D. M., 2011, MODELING METHODS MAR; Goodkin NF, 2011, MAR ECOL PROG SER, V426, P185, DOI 10.3354/meps09019; Goodkin NF, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001140; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Helmle KP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1222; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Inoue M, 2006, ENVIRON POLLUT, V144, P1045, DOI 10.1016/j.envpol.2005.11.048; KLEIN R, 1991, MAR ECOL PROG SER, V77, P253, DOI 10.3354/meps077253; Lam K, 2007, MARINE POLLUTION B, V54, P97; LAPOINTE BE, 1992, ESTUARIES, V15, P465, DOI 10.2307/1352391; Lee JHW, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P187, DOI 10.1007/1-4020-3655-8_13; Libes S.M., 1992, INTRO MARINE BIOGEOC; Lirman D, 2009, J EXP MAR BIOL ECOL, V369, P72, DOI 10.1016/j.jembe.2008.10.024; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; LOUGH JM, 1990, J EXP MAR BIOL ECOL, V135, P35, DOI 10.1016/0022-0981(90)90197-K; Manzello D, 2003, CORAL REEFS, V22, P537, DOI 10.1007/s00338-003-0327-0; McCorry D, 1999, CORAL REEFS, V18, P408, DOI 10.1007/s003380050219; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Perry CT, 2003, CORAL REEFS, V22, P485, DOI 10.1007/s00338-003-0339-9; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Porter JW, 1999, LIMNOL OCEANOGR, V44, P941, DOI 10.4319/lo.1999.44.3_part_2.0941; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riegl B, 1999, CORAL REEFS, V18, P63, DOI 10.1007/s003380050156; Roberts LG, 2003, CORAL REEFS, V22, P517, DOI 10.1007/s00338-003-0337-y; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; SCOTT PJB, 1990, J EXP MAR BIOL ECOL, V139, P51, DOI 10.1016/0022-0981(90)90038-E; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; TAYLOR RB, 1993, J EXP MAR BIOL ECOL, V167, P109, DOI 10.1016/0022-0981(93)90187-S; Wicks LC, 2010, MAR ECOL PROG SER, V400, P101, DOI 10.3354/meps08398; Yuan XC, 2011, BIOGEOSCIENCES, V8, P289, DOI 10.5194/bg-8-289-2011; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	56	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99088	10.1371/journal.pone.0099088	http://dx.doi.org/10.1371/journal.pone.0099088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901939	Green Published, gold			2022-12-25	WOS:000336841400095
J	Zhao, L; Li, Y				Zhao, Lei; Li, Yan			The C-TERMINUS of AtGRIP Is Crucial for Its Self-Association and for Targeting to Golgi Stacks in Arabidopsis	PLOS ONE			English	Article							GRIP-DOMAIN PROTEINS; TRANS-GOLGI; STRUCTURAL BASIS; NETWORK; LOCALIZATION; GTPASE; RECRUITMENT; TRAFFICKING; DYNAMICS; SYSTEM	Background: In animals and fungi, dimerization is crucial for targeting GRIP domain proteins to one gene in the Arabidopsis genome, AtGRIP, codes for a GRIP domain protein. It remains unclear properties similar to those of GRIP domain proteins the Golgi apparatus Only ar whether AtGRIP has Results: In this study, western blot and yea two-hybrid analyses indicated that AtGRIPs could form a parallel homodlmer In addition, yeas h two-hybrid analysis indicated a AtGRIR(aa71-75), AtGRIP(aa711-766) and AtGRIP(aa711-776) did no interact with themselves, but h intact GRIP domain with he AtGRIP C-terminus did. Confocal microscopy that only an intact GRIP domain with the AtGRIP C-terminus could localize to the Golgi a P in Arabidopsis leaf protoplasts. A BLAST analysis showed that C-terminus of GRIP proteins was conserved in the plant kingdom. Mutagenesis and yeast two hybrid analyses showed that the L742 of AtGRIP contributed to dimerization and was crucial for Golgi localization. Conclusions:These results indicate that h C-terminus Go in plan cell suggest that several of GRIP proteins is e self-association and or targeting properties of GRIP proteins differ between plant and animal cells.	[Zhao, Lei; Li, Yan] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Li, Y (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	liyan@cau.edu.cn			National Natural Science Foundation of China [30971435, 31270230]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant nos. 30971435 and 31270230 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 2002, CURR BIOL, V9, P381; Chen Y, 2008, CHINESE SCI BULL, V53, P3191, DOI 10.1007/s11434-008-0420-4; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilson PR, 2004, PLANTA, V219, P1050, DOI 10.1007/s00425-004-1311-9; Hawes C, 2005, NEW PHYTOL, V165, P29, DOI 10.1111/j.1469-8137.2004.01218.x; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latijnhouwers M, 2005, PLANT J, V44, P459, DOI 10.1111/j.1365-313X.2005.02542.x; Latijnhouwers M, 2007, J EXP BOT, V58, P4373, DOI 10.1093/jxb/erm304; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2006, TRAFFIC, V7, P1399, DOI 10.1111/j.1600-0854.2006.00473.x; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; McConville MJ, 2002, EUR J CELL BIOL, V81, P485, DOI 10.1078/0171-9335-00268; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Stefano G, 2006, PLANT MOL BIOL, V61, P431, DOI 10.1007/s11103-006-0022-y; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Worden N, 2012, J INTEGR PLANT BIOL, V54, P875, DOI 10.1111/j.1744-7909.2012.01179.x; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Wylie FG, 2003, TRAFFIC, V4, P175, DOI 10.1034/j.1600-0854.2003.00106.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshino A, 2003, J CELL SCI, V116, P4441, DOI 10.1242/jcs.00746	30	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98963	10.1371/journal.pone.0098963	http://dx.doi.org/10.1371/journal.pone.0098963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901770	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400080
J	Cleasby, A; Yon, J; Day, PJ; Richardson, C; Tickle, IJ; Williams, PA; Callahan, JF; Carr, R; Concha, N; Kerns, JK; Qi, HW; Sweitzer, T; Ward, P; Davies, TG				Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Callahan, James F.; Carr, Robin; Concha, Nestor; Kerns, Jeffrey K.; Qi, Hongwei; Sweitzer, Thomas; Ward, Paris; Davies, Thomas G.			Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; NRF2 ENHANCES SUSCEPTIBILITY; NITRIC-OXIDE PRODUCTION; OXIDATIVE STRESS; UBIQUITIN LIGASE; KEAP1-NRF2-ARE PATHWAY; CYSTEINE RESIDUES; RECOGNITION MODEL; MOUSE MACROPHAGES; PHASE-2 RESPONSE	The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation. The BTB domain of Keap1 plays key roles in sensing environmental electrophiles and in mediating interactions with the Cul3/Rbx1 E3 ubiquitin ligase system, and is believed to be the target for several small molecule covalent activators of the Nrf2 pathway. However, despite structural information being available for several BTB domains from related proteins, there have been no reported crystal structures of Keap1 BTB, and this has precluded a detailed understanding of its mechanism of action and interaction with antagonists. We report here the first structure of the BTB domain of Keap1, which is thought to contain the key cysteine residue responsible for interaction with electrophiles, as well as structures of the covalent complex with the antagonist CDDO/bardoxolone, and of the constitutively inactive C151W BTB mutant. In addition to providing the first structural confirmation of antagonist binding to Keap1 BTB, we also present biochemical evidence that adduction of Cys 151 by CDDO is capable of inhibiting the binding of Cul3 to Keap1, and discuss how this class of compound might exert Nrf2 activation through disruption of the BTB-Cul3 interface.	[Cleasby, Anne; Yon, Jeff; Day, Philip J.; Richardson, Caroline; Tickle, Ian J.; Williams, Pamela A.; Davies, Thomas G.] Astex Pharmaceut, Cambridge, England; [Callahan, James F.; Sweitzer, Thomas] GlaxoSmithKline, King Of Prussia, PA USA; [Carr, Robin] GlaxoSmithKline, Stevenage, Herts, England; [Concha, Nestor; Qi, Hongwei; Ward, Paris] GlaxoSmithKline, Collegeville, PA USA	Astex Pharmaceuticals; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Davies, TG (corresponding author), Astex Pharmaceut, Cambridge, England.	tom.davies@astx.com		Tickle, Ian/0000-0003-2977-0650; Williams, Pamela/0000-0002-1257-2351	GlaxoSmithKline; Astex Pharmaceuticals	GlaxoSmithKline(GlaxoSmithKline); Astex Pharmaceuticals	The research described in this article was funded by GlaxoSmithKline and Astex Pharmaceuticals. The funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bricogne G., 2011, BUSTER; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Luo Y, 2007, J AM SOC MASS SPECTR, V18, P2226, DOI 10.1016/j.jasms.2007.09.015; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Mooij WTM, 2006, CHEMMEDCHEM, V1, P827, DOI 10.1002/cmdc.200600074; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wilson AJ, 2013, J MED CHEM, V56, P7463, DOI 10.1021/jm400224q; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yang HJ, 2006, J NAT PROD, V69, P1531, DOI 10.1021/np060159a; Yates MS, 2007, DRUG NEWS PERSPECT, V20, P109, DOI 10.1358/dnp.2007.20.2.1083437; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	71	151	157	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98896	10.1371/journal.pone.0098896	http://dx.doi.org/10.1371/journal.pone.0098896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896564	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700093
J	Maghuly, F; Ramkat, RC; Laimer, M				Maghuly, Fatemeh; Ramkat, Rose C.; Laimer, Margit			Virus versus Host Plant MicroRNAs: Who Determines the Outcome of the Interaction?	PLOS ONE			English	Article							RNA-SILENCING SUPPRESSORS; TIME QUANTITATIVE PCR; CASSAVA MOSAIC-VIRUS; JATROPHA-CURCAS; COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; RT-PCR; PROTEIN; REAL; DNA	Considering the importance of microRNAs (miRNAs) in the regulation of essential processes in plant pathogen interactions, it is not surprising that, while plant miRNA sequences counteract viral attack via antiviral RNA silencing, viruses in turn have developed antihost defense mechanisms blocking these RNA silencing pathways and establish a counter-defense. In the current study, computational and stem-loop Reverse Transcription - Polymerase Chain Reaction (RT-PCR) approaches were employed to a) predict and validate virus encoded mature miRNAs (miRs) in 39 DNA-A sequences of the bipartite genomes of African cassava mosaic virus (ACMV) and East African cassava mosaic virus-Uganda (EACMV-UG) isolates, b) determine whether virus encoded miRs/miRs* generated from the 5'/3' harpin arms have the capacity to bind to genomic sequences of the host plants Jatropha or cassava and c) investigate whether plant encoded miR/miR* sequences have the potential to bind to the viral genomes. Different viral pre-miRNA hairpin sequences and viral miR/miR* length variants occurring as isomiRs were predicted in both viruses. These miRNAs were located in three Open Reading Frames (ORFs) and in the Intergenic Region (IR). Moreover, various target genes for miRNAs from both viruses were predicted and annotated in the host plant genomes indicating that they are involved in biotic response, metabolic pathways and transcription factors. Plant miRs/miRs* from conserved and highly expressed families were identified, which were shown to have potential targets in the genome of both begomoviruses, representing potential plant miRNAs mediating antiviral defense. This is the first assessment of predicted viral miRs/miRs* of ACMV and EACMV-UG and host plant miRNAs, providing a reference point for miRNA identification in pathogens and their hosts. These findings will improve the understanding of host-pathogen interaction pathways and the function of viral miRNAs in Euphorbiaceous crop plants.	[Maghuly, Fatemeh; Ramkat, Rose C.; Laimer, Margit] Univ Nat Resources & Life Sci, BOKU VIBT, Dept Biotechnol, PBU, Vienna, Austria; [Ramkat, Rose C.] Egerton Univ, Dept Biol Sci, Nakuru, Kenya	University of Natural Resources & Life Sciences, Vienna; Egerton University	Laimer, M (corresponding author), Univ Nat Resources & Life Sci, BOKU VIBT, Dept Biotechnol, PBU, Vienna, Austria.	margit.laimer@boku.ac.at	Maghuly, Fatemeh/D-2640-2014; Laimer, Margit/C-3524-2019; Margit, Laimer/P-7096-2019	Margit, Laimer/0000-0002-6796-8126; Maghuly, Fatemeh/0000-0001-5433-0070	Austrian Science Fund (FWF) [P23836-B16]; Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship; Austrian Research Promotion Agency (FFG); Bioplant RD; Austrian Science Fund (FWF) [P 23836] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship; Austrian Research Promotion Agency (FFG); Bioplant RD; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The Austrian Science Fund (FWF) -P23836-B16, The Austrian Partnership Program in Higher Education & Research for Development (APPEAR) scholarship for RCR, Austrian Research Promotion Agency (FFG), and Bioplant R&D provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Amin I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-143; Amiteye S, 2011, AFR J BIOTECHNOL, V10, P2562; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Colaiacovo M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00165; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; de Sant'Anna Q, 2013, GENETIC IMPROVEMENT; Dijkstra JR, 2012, J CELL MOL MED, V16, P683, DOI 10.1111/j.1582-4934.2011.01467.x; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; ETESSAMI P, 1991, J GEN VIROL, V72, P1005, DOI 10.1099/0022-1317-72-5-1005; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Gao RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048736; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2011, METHODS MOL BIOL, V721, P143, DOI 10.1007/978-1-61779-037-9_8; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gubitz GM, 1999, BIORESOURCE TECHNOL, V67, P73, DOI 10.1016/S0960-8524(99)00069-3; Guo L, 2014, GENE, V533, P149, DOI 10.1016/j.gene.2013.09.102; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Haas W, 2000, IND CROP PROD, V12, P111, DOI 10.1016/S0926-6690(00)00043-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hofer P, 1997, VIROLOGY, V236, P288, DOI 10.1006/viro.1997.8751; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kozlowska E, 2013, INT J MOL SCI, V14, P16999, DOI 10.3390/ijms140816999; Kumar A, 2008, IND CROP PROD, V28, P1, DOI 10.1016/j.indcrop.2008.01.001; Lekprasert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020622; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Maghuly F, 2013, GENETIC IMPROVEMENT; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Naqvi AR, 2011, PLANT PHYSIOL BIOCH, V49, P13, DOI 10.1016/j.plaphy.2010.09.013; Narayana D. S. A., 2007, International Journal of Virology, V3, P1; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; PASZKOWSKI U, 1993, J GEN VIROL, V74, P2725, DOI 10.1099/0022-1317-74-12-2725; Patanun O, 2013, MOL BIOTECHNOL, V53, P257, DOI 10.1007/s12033-012-9521-z; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/J.1364-3703.2009.00559.X, 10.1111/j.1364-3703.2009.00559.x]; Perez-Quintero AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-29; Perez-Quintero AL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-138; Ramkat RC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-386; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Sabandar CW, 2013, PHYTOCHEMISTRY, V85, P7, DOI 10.1016/j.phytochem.2012.10.009; Sablok G, 2013, FEBS LETT, V587, P2629, DOI 10.1016/j.febslet.2013.06.047; Sanan-Mishra N, 2009, MOL GENET GENOMICS, V282, P463, DOI 10.1007/s00438-009-0478-y; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Sharma P, 2008, J GEN PLANT PATHOL, V74, P189, DOI 10.1007/s10327-008-0085-5; Shen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048236; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; van Wezel R, 2003, J VIROL, V77, P696, DOI 10.1128/JVI.77.1.696-700.2003; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Vishwakarma NP, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23152; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Vollmann J, 2013, BIOPROCESSING TECHNOLOGIES IN BIOREFINERY FOR SUSTAINABLE PRODUCTION OF FUELS, CHEMICALS, AND POLYMERS, P47; Wang CM, 2012, INT J BIOL SCI, V8, P418, DOI 10.7150/ijbs.3676; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033696; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wang YQ, 2011, GENOMICS, V98, P73, DOI 10.1016/j.ygeno.2011.04.011; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Xu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069995; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yu Guangchuang, 2011, J Clin Bioinforma, V1, P15, DOI 10.1186/2043-9113-1-15; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	100	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98263	10.1371/journal.pone.0098263	http://dx.doi.org/10.1371/journal.pone.0098263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896088	Green Published, gold			2022-12-25	WOS:000338430700029
J	Dolev, Y; Nelson, XJ				Dolev, Yinnon; Nelson, Ximena J.			Innate Pattern Recognition and Categorization in a Jumping Spider	PLOS ONE			English	Article							ANTERIOR-LATERAL EYES; PRINCIPAL EYES; PHIDIPPUS-AUDAX; VISUAL-STIMULI; PERCEPTION; ORIENTATION; BEHAVIOR; VISION; DENDRYPHANTINAE; DISCRIMINATION	The East African jumping spider Evarcha culicivora feeds indirectly on vertebrate blood by preferentially preying upon blood-fed Anopheles mosquitoes, the vectors of human malaria 1, using the distinct resting posture and engorged abdomen characteristic of these specific prey as key elements for their recognition. To understand perceptual categorization of objects by these spiders, we investigated their predatory behavior toward different digital stimuli - abstract 'stick figure' representations of Anopheles constructed solely by known key identification elements, disarranged versions of these, as well as non-prey items and detailed images of alternative prey. We hypothesized that the abstract images representing Anopheles would be perceived as potential prey, and would be preferred to those of non-preferred prey. Spiders perceived the abstract stick figures of Anopheles specifically as their preferred prey, attacking them significantly more often than non-preferred prey, even when the comprising elements of the Anopheles stick figures were disarranged and disconnected from each other. However, if the relative angles between the elements of the disconnected stick figures of Anopheles were altered, the otherwise identical set of elements was no longer perceived as prey. These data show that E. culicivora is capable of making discriminations based on abstract concepts, such as the hypothetical angle formed by discontinuous elements. It is this inter-element angle rather than resting posture that is important for correct identification of Anopheles. Our results provide a glimpse of the underlying processes of object recognition in animals with minute brains, and suggest that these spiders use a local processing approach for object recognition, rather than a holistic or global approach. This study provides an excellent basis for a comparative analysis on feature extraction and detection by animals as diverse as bees and mammals.	[Dolev, Yinnon; Nelson, Ximena J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Dolev, Y (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	yinnond@gmail.com			Royal Society of New Zealand Marsden Fund [M1149]; University of Canterbury	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Canterbury	This research was supported by the Royal Society of New Zealand Marsden Fund to XJN (M1149). YD was supported by an International Doctoral Scholarship from the University of Canterbury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Avargues-Weber A, 2012, P NATL ACAD SCI USA, V109, P7481, DOI 10.1073/pnas.1202576109; Avargues-Weber A, 2011, P ROY SOC B-BIOL SCI, V278, P898, DOI 10.1098/rspb.2010.1891; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P58, DOI 10.1113/jphysiol.1953.sp004828; Bednarski JV, 2012, ANIM BEHAV, V84, P1221, DOI 10.1016/j.anbehav.2012.08.032; BLEST AD, 1990, CELL TISSUE RES, V262, P445, DOI 10.1007/BF00305241; Chen S, 1996, VISION RES, V36, P1721, DOI 10.1016/0042-6989(95)00245-6; Douglas R.H., 1990, P373; DREES OSKAR, 1952, ZEITSCHR TIERPSYCHOL, V9, P169; Edward Bradford Titchener, 1909, LECT EXPT PSYCHOL TH; Enns JT., 2004, THINKING EYE SEEING; Ewert Joerg-Peter, 2004, P117; Ewert JP, 1997, TRENDS NEUROSCI, V20, P332; Forster J, 2005, PSYCHOL SCI, V16, P631, DOI 10.1111/j.1467-9280.2005.01586.x; Forster L., 1985, P249; Harel A, 2011, J VISION, V11, DOI 10.1167/11.8.18; Heinze HJ, 1998, J COGNITIVE NEUROSCI, V10, P485, DOI 10.1162/089892998562898; Horridge A, 2000, J COMP PHYSIOL A, V186, P521, DOI 10.1007/s003590000103; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Ingle DJ., 1983, ADV VERTEBRATE NEURO, P177; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Jackson RR, 2012, ANIM COGN, V15, P461, DOI 10.1007/s10071-012-0469-y; Jackson RR, 2005, P NATL ACAD SCI USA, V102, P15155, DOI 10.1073/pnas.0507398102; Jackson RR, 1996, ANNU REV ENTOMOL, V41, P287, DOI 10.1146/annurev.en.41.010196.001443; Kennedy GJ, 2006, VISION RES, V46, P1530, DOI 10.1016/j.visres.2005.06.003; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; King WV, 1943, J ECON ENTOMOL, V36, P573, DOI 10.1093/jee/36.4.573; Land M.F., 1985, P53; LAND MF, 1969, J EXP BIOL, V51, P443; LAND MF, 1969, J EXP BIOL, V51, P471; LAND MF, 1971, J EXP BIOL, V54, P119; Land MF., 1972, INFORM PROCESSING VI, P231, DOI [10.1007/978-3-642-65477-0%5F34, DOI 10.1007/978-3-642-65477-0%5F34]; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lillywhite K, 2013, PATTERN RECOGN, V46, P3300, DOI 10.1016/j.patcog.2013.06.002; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; MASKE R, 1986, PROC R SOC SER B-BIO, V229, P257, DOI 10.1098/rspb.1986.0085; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; Nelson XJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000132; Nelson XJ, 2012, J EXP BIOL, V215, P2255, DOI 10.1242/jeb.069609; Nelson XJ, 2005, J ARACHNOL, V33, P541, DOI 10.1636/05-3.1; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Prete FR, 2002, ANIM BEHAV, V63, P503, DOI 10.1006/anbe.2001.1955; Prete FR, 2011, J COMP PHYSIOL A, V197, P877, DOI 10.1007/s00359-011-0649-2; Regan D, 1996, VISION RES, V36, P323, DOI 10.1016/0042-6989(95)00113-E; Richler JJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00553; ROCK I, 1990, SCI AM, V263, P84, DOI 10.1038/scientificamerican1290-84; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Shashar N, 1996, J EXP BIOL, V199, P999; Shevelev IA, 1998, BIOSYSTEMS, V48, P195, DOI 10.1016/S0303-2647(98)00066-5; Spano L, 2012, BIOL LETTERS, V8, P949, DOI 10.1098/rsbl.2012.0716; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; VANHATEREN JH, 1990, VISION RES, V30, P603, DOI 10.1016/0042-6989(90)90071-R; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; WILLIAMS DS, 1980, NATURE, V288, P578, DOI 10.1038/288578a0; Won YG, 2000, LECT NOTES COMPUT SC, V1876, P806; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zurek DB, 2012, J COMP PHYSIOL A, V198, P411, DOI 10.1007/s00359-012-0719-0; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	60	26	26	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97819	10.1371/journal.pone.0097819	http://dx.doi.org/10.1371/journal.pone.0097819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893306	gold, Green Published			2022-12-25	WOS:000336911400024
J	Yu, LJ; Zhou, LL; Tan, L; Jiang, HB; Wang, Y; Wei, S; Nie, SF				Yu, Lijing; Zhou, Lingling; Tan, Li; Jiang, Hongbo; Wang, Ying; Wei, Sheng; Nie, Shaofa			Application of a New Hybrid Model with Seasonal Auto-Regressive Integrated Moving Average (ARIMA) and Nonlinear Auto-Regressive Neural Network (NARNN) in Forecasting Incidence Cases of HFMD in Shenzhen, China	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HUMAN ENTEROVIRUS 71; FOOT-MOUTH DISEASE; DENGUE INFECTION; HAND; OUTBREAK; HERPANGINA; PREDICTION; EPIDEMIC; CHILDREN	Background: Outbreaks of hand-foot-mouth disease (HFMD) have been reported for many times in Asia during the last decades. This emerging disease has drawn worldwide attention and vigilance. Nowadays, the prevention and control of HFMD has become an imperative issue in China. Early detection and response will be helpful before it happening, using modern information technology during the epidemic. Method: In this paper, a hybrid model combining seasonal auto-regressive integrated moving average (ARIMA) model and nonlinear auto-regressive neural network (NARNN) is proposed to predict the expected incidence cases from December 2012 to May 2013, using the retrospective observations obtained from China Information System for Disease Control and Prevention from January 2008 to November 2012. Results: The best-fitted hybrid model was combined with seasonal ARIMA ((2,3)1,0)(12) and NARNN with 15 hidden units and 5 delays. The hybrid model makes the good forecasting performance and estimates the expected incidence cases from December 2012 to May 2013, which are respectively -965.03, -1879.58, 4138.26, 1858.17, 4061.86 and 6163.16 with an obviously increasing trend. Conclusion: The model proposed in this paper can predict the incidence trend of HFMD effectively, which could be helpful to policy makers. The usefulness of expected cases of HFMD perform not only in detecting outbreaks or providing probability statements, but also in providing decision makers with a probable trend of the variability of future observations that contains both historical and recent information.	[Yu, Lijing; Zhou, Lingling; Tan, Li; Jiang, Hongbo; Wang, Ying; Wei, Sheng; Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn		Jiang, Hongbo/0000-0002-0631-4460	Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: Medline; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Aladag CH, 2009, APPL MATH LETT, V22, P1467, DOI 10.1016/j.aml.2009.02.006; Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Benschop J, 2008, EPIDEMIOL INFECT, V136, P1511, DOI 10.1017/S0950268807000234; Box G.E., 2013, TIME SERIES ANAL FOR; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen KY, 2007, EXPERT SYST APPL, V32, P254, DOI 10.1016/j.eswa.2005.11.027; CLARKE SKR, 1964, BRIT MED J, V1, P58, DOI 10.1136/bmj.1.5374.58-a; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Frydenberg Alexis, 2003, Aust Fam Physician, V32, P594; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; HAYWARD JC, 1989, PEDIATR INFECT DIS J, V8, P611, DOI 10.1097/00006454-198909000-00009; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hongyuan Z, 1985, J JILIN U MED EDITIO, V5; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Huibin L, 1986, BEIJING MED J, V4; Jianchi S, 1986, BEIJING MED J, V4; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Liehua CXD, 1990, J JINAN U, V4; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Martinez EZ, 2011, CAD SAUDE PUBLICA, V27, P1809, DOI 10.1590/S0102-311X2011000900014; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Roman J., 1996, Proceedings of the Twenty-Ninth Hawaii International Conference on System Sciences, P454, DOI 10.1109/HICSS.1996.495431; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Teheng L, 1983, TIANJIN MED J, V12; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LP, 2007, DIS SURVEILLANCE, V22, P412; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Xu W, 2011, ASIA-PAC J PUBLIC HE, P1; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; ZHENG ZM, 1995, J MED VIROL, V47, P161, DOI 10.1002/jmv.1890470209; Zhilun Z, 1987, TIANJIN MED J, V11; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	46	50	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98241	10.1371/journal.pone.0098241	http://dx.doi.org/10.1371/journal.pone.0098241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893000	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400042
J	Rogerson, FM; Yao, YZ; Young, MJ; Fuller, PJ				Rogerson, Fraser M.; Yao, Yi-Zhou; Young, Morag J.; Fuller, Peter J.			Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator	FASEB JOURNAL			English	Article						aldosterone; cortisol; nuclear receptors	MAMMARY-GLAND DEVELOPMENT; NUCLEAR RECEPTORS; CELL DIFFERENTIATION; ALDOSTERONE BINDING; IN-VITRO; ACTIVATION; PROTEIN; SPECIFICITY; MECHANISMS; TESMIN	The mineralocorticoid receptor (MR) is unique in responding to 2 physiological ligands: aldosterone and cortisol. In epithelial tissues, aldosterone selectivity is determined by the activity of 11 beta-hydroxysteroid dehydrogenase type 2. In other tissues, cortisol is the primary ligand. To understand the structural determinants of ligand-specific MR activation, we sought to identify coregulatory molecules that interact with the ligand-binding domain (LBD) of the MR. A yeast-2-hybrid (Y2H) kidney cDNA library was screened with the human MR-LBD in the presence of aldosterone and cortisol. One clone, identified as aldosterone-specific in the Y2H assay, exhibited a 7-fold greater response, aldosterone vs. cortisol, in a mammalian-2hybrid (M2H) assay. This clone encodes the region of the tesmin gene that has 2 leucine-x-x-leucine-leucine (LxxLL) motifs. Full-length tesmin coactivates (>2-fold) MR-mediated transactivation in the presence of aldosterone, but not of cortisol; this specificity is observed with a range of promoters. GST pulldown and coimmunoprecipitation of the MR by tesmin supports a direct interaction, mediated by the 2 LxxLL motifs. Tesmin thus represents a novel MR coregulator that exhibits a differential interaction, providing further evidence of the adoption of ligand-dependent conformations by the MR-LBD.	[Rogerson, Fraser M.; Yao, Yi-Zhou; Young, Morag J.; Fuller, Peter J.] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research	Fuller, PJ (corresponding author), Prince Henrys Inst Med Res, POB 5152, Clayton, Vic 3168, Australia.	peter.fuller@princehenrys.org		Fuller, Peter/0000-0002-0948-2072; Young, Morag/0000-0003-0450-5375	Australia National Health and Medical Research Council [1002559, 1002575]; Endocrine Society through a bridge grant; National Heart Foundation of Australia through a project grant; Victorian Government's Operational Infrastructure Support Program	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society through a bridge grant; National Heart Foundation of Australia through a project grant(National Heart Foundation of Australia); Victorian Government's Operational Infrastructure Support Program	The authors thank the following individuals for the generous gifts of research materials: Prof. R. M. Evans (Salk Institute, La Jolla, CA, USA) for the pRShGR and pRShMR plasmids; Prof. S. Nordeen (University of Denver, Denver, CO, USA) for the PGC-1 alpha expression plasmid; Prof. G. Ooi (Prince Henry's Institute, Melbourne, VIC, Australia) for the pRen-LUC plasmid; Prof. D. Pearce (University of California, San Francisco, CA, USA) for the pTAT1-LUC and pTAT3-LUC plasmids; Prof. C. Thomas (University of Iowa, Iowa City, IA, USA) for the alpha ENaC-LUC plasmid; Prof. C. Clarke (University of Sydney, Westmead, NSW, Australia) for the pRen-LUC plasmid and the PR expression plasmid; Prof. B. Katzenellenbogen (University of Illinois at Urbana-Champaign, Urbana, IL, USA) for the ERE-LUC plasmid and the ER alpha expression plasmid; Prof. S. Lim-Tio (Westmead Hospital, Westmead, NSW, Australia) for the SRC-1e expression plasmid; Prof. T. Ziera (University of California, San Francisco, CA, USA) for the pGILZ-LUC and pCNKsRE-LUC plasmids; Prof. W. Tilley (University of Adelaide, Adelaide, SA, Australia) for the MMTV-LUC and pAAR3-tk-LUC plasmids and the AR expression plasmid; and Prof. C. Gomez-Sanchez (University of Mississippi Medical Center, Jackson, MS, USA) for the MR antisera. The authors also thank C. Thiedeman and S. Panckridge for help in preparation of the manuscript. This work was supported by the Australia National Health and Medical Research Council through a Career Fellowship (1002559 to P.J.F.) and a project grant (1002575); by the Endocrine Society through a bridge grant; and by the National Heart Foundation of Australia through a project grant. Prince Henry's Institute is supported by the Victorian Government's Operational Infrastructure Support Program.	Andersen SU, 2007, J EXP BOT, V58, P3657, DOI 10.1093/jxb/erm215; Armstrong P. W., 2004, NEW ENGL J MED, V364, P79; BEATO M, 1991, FASEB J, V5, P2044, DOI 10.1096/fasebj.5.7.2010057; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Cachofeiro V, 2008, J STEROID BIOCHEM, V109, P331, DOI 10.1016/j.jsbmb.2008.03.005; Chang CY, 2005, MOL ENDOCRINOL, V19, P2478, DOI 10.1210/me.2005-0072; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fuller PJ, 2005, HYPERTENSION, V46, P1227, DOI 10.1161/01.HYP.0000193502.77417.17; Fuse H, 2000, MOL ENDOCRINOL, V14, P889, DOI 10.1210/me.14.6.889; Glass CK, 2000, GENE DEV, V14, P121; GOMEZSANCHEZ EP, 1990, AM J PHYSIOL, V258, pE649, DOI 10.1152/ajpendo.1990.258.4.E649; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Khanna S, 2011, TOXICOLOGY, V287, P46, DOI 10.1016/j.tox.2011.05.013; Kitagawa H, 2002, MOL CELL BIOL, V22, P3698, DOI 10.1128/MCB.22.11.3698-3706.2002; Kitagawa H, 2014, MOL CELL BIOL, V34, P916, DOI 10.1128/MCB.00018-14; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kralli A, 1996, J BIOL CHEM, V271, P17152, DOI 10.1074/jbc.271.29.17152; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Lopez FJ, 2008, ENDOCRINOLOGY, V149, P2080, DOI 10.1210/en.2007-1353; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Massaad C, 1997, MOL PHARMACOL, V51, P285, DOI 10.1124/mol.51.2.285; Matsuura T, 2002, J INORG BIOCHEM, V88, P183, DOI 10.1016/S0162-0134(01)00377-4; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1438, DOI 10.1210/en.2004-0411; Mihailidou AS, 2006, STEROIDS, V71, P277, DOI 10.1016/j.steroids.2005.09.017; Miner JN, 2007, ENDOCRINOLOGY, V148, P363, DOI 10.1210/en.2006-0793; Murai-Takeda A, 2010, J BIOL CHEM, V285, P8084, DOI 10.1074/jbc.M109.053371; NORDEEN SK, 1995, STEROIDS, V60, P97, DOI 10.1016/0039-128X(94)00001-S; O'Malley BW, 2008, MOL ENDOCRINOL, V22, P2213, DOI 10.1210/me.2008-0201; Obradovic D, 2004, MOL PHARMACOL, V65, P761, DOI 10.1124/mol.65.3.761; Oh JH, 2005, MAMM GENOME, V16, P942, DOI 10.1007/s00335-005-0075-2; Olesen C, 2004, MOL REPROD DEV, V67, P116, DOI 10.1002/mrd.20007; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Pitt B, 2003, CIRCULATION, V108, P1831, DOI 10.1161/01.CIR.0000091405.00772.6E; Portilla D, 2002, KIDNEY INT, V62, P1208, DOI 10.1046/j.1523-1755.2002.00553.x; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Rogerson FM, 2007, MOL ENDOCRINOL, V21, P817, DOI 10.1210/me.2006-0246; Sasaki H, 2007, J CLIN ENDOCR METAB, V92, P616, DOI 10.1210/jc.2006-0898; Sato A, 1996, ENDOCRINOLOGY, V137, P4145, DOI 10.1210/en.137.10.4145; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Sugihara T, 1999, GENOMICS, V57, P130, DOI 10.1006/geno.1999.5756; Sutou S, 2003, BIOL REPROD, V68, P1861, DOI 10.1095/biolreprod.102.005603; Thomas M, 2007, AM J PHYSIOL-HEART C, V293, pH2361, DOI 10.1152/ajpheart.00200.2007; Viengchareun S., 2007, NUCL RECEPT SIGNAL, V5, P1; Weiss RE, 2002, ENDOCRINOLOGY, V143, P1554, DOI 10.1210/en.143.4.1554; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; WRIGHT APH, 1992, J BIOL CHEM, V267, P11191; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yang J, 2011, MOL ENDOCRINOL, V25, P32, DOI 10.1210/me.2010-0193; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; Young MJ, 2008, CURR OPIN NEPHROL HY, V17, P174, DOI 10.1097/MNH.0b013e3282f56854; Zennaro MC, 2001, MOL ENDOCRINOL, V15, P1586, DOI 10.1210/me.15.9.1586; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	62	24	25	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2014	28	10					4200	4210		10.1096/fj.13-242479	http://dx.doi.org/10.1096/fj.13-242479			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AP6XU	24907116				2022-12-25	WOS:000342222700002
J	Musiani, D; Konda, JD; Pavan, S; Torchiaro, E; Sassi, F; Noghero, A; Erriquez, J; Perera, T; Olivero, M; Di Renzo, MF				Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Sassi, Francesco; Noghero, Alessio; Erriquez, Jessica; Perera, Timothy; Olivero, Martina; Di Renzo, Maria Flavia			Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy	FASEB JOURNAL			English	Article						hepatocyte growth factor receptor; EGFR	FUMARASE TUMOR-SUPPRESSOR; CANCER-CELLS; PROSTATE-CANCER; GASTRIC-CANCER; SOMATIC MUTATIONS; MAMMALIAN HSP27; BREAST-CANCER; GROWTH-FACTOR; IN-VITRO; CHEMOTHERAPY	The tyrosine kinase encoded by the MET oncogene is activated by gene mutation or amplification in tumors, which in most instances maintain addiction, i.e., dependency, to MET activation. This makes MET an attractive candidate for targeted therapies. Here we show that, in 3/3 MET-addicted human gastric cancer cell lines, MET kinase inhibition resulted in a 3- to 4-fold increased expression of the antiapoptotic small heat-shock protein of 27 kDa (HSP27, HSPB1). HSP27 increase depended on the inhibition of the MEK/ERK pathway and on heat-shock factor 1 (HSF1) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) regulation. Importantly, HSP27-silenced MET-addicted cells underwent 2- and 3-fold more apoptosis following MET inhibition in vitro and in vivo, respectively. Likewise, in human cancer cells susceptible to epidermal growth factor receptor (EGFR) inhibition, EGFR inhibitors induced HSP27 expression and were strengthened by HSP27 suppression. In control cell lines that were not affected by drugs targeting MET or EGFR, these drugs did not induce HSP27 increase. Therefore, in cancer therapies targeting the MET pathway, the induction of HSP27 might limit the efficacy of anti-MET agents. As HSP27 increase also impairs the effectiveness of EGFR inhibitors and is known to protect cells from chemotherapeutics, the induction of HSP27 by targeted agents might strongly affect the success of combination treatments.	[Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Noghero, Alessio; Olivero, Martina; Di Renzo, Maria Flavia] Univ Turin, Sch Med, Dept Oncol, I-10060 Turin, Italy; [Musiani, Daniele; Konda, John David; Pavan, Simona; Torchiaro, Erica; Erriquez, Jessica; Olivero, Martina; Di Renzo, Maria Flavia] Candiolo Canc Inst, FPO, IRCCS, Canc Genet Lab, Candiolo, Italy; [Sassi, Francesco] Candiolo Canc Inst, FPO, IRCCS, Mol Pharmacol Lab, Candiolo, Italy; [Noghero, Alessio] Candiolo Canc Inst, FPO, IRCCS, Lab Vasc Oncol, Candiolo, Italy; [Perera, Timothy] Janssen Res & Dev, Beerse, Belgium	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; Johnson & Johnson; Janssen Pharmaceuticals	Di Renzo, MF (corresponding author), Univ Turin, Sch Med, Candiolo Canc Inst, Dept Oncol,Lab Canc Genet,FPO IRCCS, SP 142,Km 3 95, I-10060 Turin, Italy.		Torchiaro, Erica/AAW-3628-2020; sassi, francesco/AAB-6844-2020; Musiani, Daniele/N-8121-2017; olivero, martina/J-4811-2018; DI RENZO, Maria Flavia/B-6091-2012; NOGHERO, Alessio/AAL-1573-2020	Torchiaro, Erica/0000-0002-8984-882X; sassi, francesco/0000-0002-4741-0408; olivero, martina/0000-0002-6815-3498; DI RENZO, Maria Flavia/0000-0002-5093-3373; NOGHERO, Alessio/0000-0002-8266-9247; Musiani, Daniele/0000-0001-6851-2633; erriquez, jessica/0000-0002-7152-0930	IG grant [13050]; Special Program Molecular Clinical Oncology 5xMille of the Italian Association of Cancer Research (AIRC) Project [9970]; Cariplo Foundation grant; Progetto di Ateneo-Compagnia di San Paolo grant [ORTO11RKTW]	IG grant; Special Program Molecular Clinical Oncology 5xMille of the Italian Association of Cancer Research (AIRC) Project(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation grant; Progetto di Ateneo-Compagnia di San Paolo grant	The authors thank Livio Trusolino for the helpful discussion and critical reading of the manuscript, Dr. Luca Cirillo for enthusiastic help in performing experiments, Dr. Davide Zecchin [Laboratory of Molecular Genetics, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO)-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Candiolo, Italy] for providing p53 shRNA, and Silvia Giordano (Department of Oncology, University of Torino School of Medicine, Turin, Italy) for providing K-Ras G12V. This work has been supported by the following grants to M. F. D.: 2012 IG grant 13050 and 2010 Special Program Molecular Clinical Oncology 5xMille of the Italian Association of Cancer Research (AIRC) Project 9970, a Cariplo Foundation grant, and Progetto di Ateneo-Compagnia di San Paolo grant ORTO11RKTW. Conflicts of interest: T. P. is a full-time employee and shareholder of Janssen Research and Development (Beerse, Belgium). The other authors declare no conflicts of interest.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; Arrigo AP, 2012, CURR MOL MED, V12, P1151, DOI 10.2174/156652412803306693; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Arts HJG, 1999, INT J CANCER, V84, P234, DOI 10.1002/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; Bardella C, 2012, MOL CELL BIOL, V32, P3081, DOI 10.1128/MCB.06160-11; Baylot V, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.104; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2102er11; Bhargavan B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.57; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Coltella N, 2006, INT J CANCER, V118, P2981, DOI 10.1002/ijc.21766; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Conroy SE, 1998, BRIT J CANCER, V77, P1875, DOI 10.1038/bjc.1998.312; Cornford PA, 2000, CANCER RES, V60, P7099; Costa B, 2010, FASEB J, V24, P2680, DOI 10.1096/fj.09-146928; Di Renzo MF, 2000, ONCOGENE, V19, P1547, DOI 10.1038/sj.onc.1203455; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Eguchi R, 2008, PROTEOMICS, V8, P2897, DOI 10.1002/pmic.200800055; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gao CL, 2000, INT J CANCER, V88, P191, DOI 10.1002/1097-0215(20001015)88:2<191::AID-IJC7>3.3.CO;2-1; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Gibert B, 2011, ONCOGENE, V30, P3672, DOI 10.1038/onc.2011.73; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kang SH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-286; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Mehlen P, 1997, J BIOL CHEM, V272, P31657, DOI 10.1074/jbc.272.50.31657; MEHLEN P, 1994, EUR J BIOCHEM, V221, P327, DOI 10.1111/j.1432-1033.1994.tb18744.x; Okamoto W, 2012, MOL CANCER THER, V11, P1557, DOI 10.1158/1535-7163.MCT-11-0934; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Stella GM, 2011, HUM MUTAT, V32, P44, DOI 10.1002/humu.21374; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	45	29	30	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4055	4067		10.1096/fj.13-247924	http://dx.doi.org/10.1096/fj.13-247924			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24903273	Green Published			2022-12-25	WOS:000340845900023
J	Gupta, K; Brady, T; Dyer, BM; Malani, N; Hwang, Y; Male, F; Nolte, RT; Wang, LP; Velthuisen, E; Jeffrey, J; Van Duyne, GD; Bushman, FD				Gupta, Kushol; Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Nolte, Robert T.; Wang, Liping; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.			Allosteric Inhibition of Human Immunodeficiency Virus Integrase LATE BLOCK DURING VIRAL REPLICATION AND ABNORMAL MULTIMERIZATION INVOLVING SPECIFIC PROTEIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; HIV-1 INTEGRASE; DNA INTEGRATION; STRAND TRANSFER; IN-VITRO; SITE PREFERENCES; TYPE-1 INTEGRASE; TERMINAL DOMAINS; BINDING-SITE; HUMAN-CELLS	HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for additional drug classes. Here we report studies of GSK1264, which was identified as a compound that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75. GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallography. Assays of HIV replication in the presence of GSK1264 showed only modest inhibition of the early infection steps and little effect on integration targeting, which is guided by the LEDGF/p75.IN interaction. In contrast, inhibition of late replication steps was more potent. Particle production was normal, but particles showed reduced infectivity. GSK1264 promoted aggregation of IN and preformed LEDGF/p75.IN complexes, suggesting a mechanism of inhibition. LEDGF/p75 was not displaced from IN during aggregation, indicating trapping of LEDGF/p75 in aggregates. Aggregation assays with truncated IN variants revealed that a construct with catalytic and C-terminal domains of IN only formed an open polymer associated with efficient drug-induced aggregation. These data suggest that the allosteric inhibitors of IN are promising antiviral agents and provide new information on their mechanism of action.	[Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Bushman, Frederic D.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Gupta, Kushol; Van Duyne, Gregory D.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Nolte, Robert T.; Wang, Liping] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC 27709 USA; [Velthuisen, Emile; Jeffrey, Jerry] GlaxoSmithKline, Infect Dis Therapy Area Unit, HIV DPU, Res Triangle Pk, NC 27709 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; GlaxoSmithKline; GlaxoSmithKline	Jeffrey, J (corresponding author), GlaxoSmithKline, Infect Dis Therapy Area Unit, HIV DPU, Res Triangle Pk, NC 27709 USA.	jerry.l.jeffrey@gsk.com; vanduyne@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Gupta, Kushol/GOE-5620-2022	Gupta, Kushol/0000-0002-7006-2667	National Institutes of Health [R01 AI 052845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, R01AI052845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI 052845 ( to F. D. B.). GlaxoSmithKline owns the patent on the compound used in this study.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bischerour J, 2003, J VIROL, V77, P135, DOI 10.1128/JVI.77.1.135-141.2003; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2013, VIROLOGY, V435, P102, DOI 10.1016/j.virol.2012.09.033; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Ciuffi A, 2009, METHODS, V47, P261, DOI 10.1016/j.ymeth.2008.10.028; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Demeulemeester J, 2012, J BIOMOL SCREEN, V17, P618, DOI 10.1177/1087057111436343; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fenwick CW, 2011, ANTIVIR THER, V16, pA9; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Gupta K, 2010, J BIOL CHEM, V285, P20303, DOI 10.1074/jbc.M110.114413; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Hou Y, 2008, J BIOMOL SCREEN, V13, P406, DOI 10.1177/1087057108317060; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Peat TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040147; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Silvers RM, 2010, HUM GENE THER, V21, P337, DOI 10.1089/hum.2009.134; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tintori C, 2012, BIOORG MED CHEM LETT, V22, P3109, DOI 10.1016/j.bmcl.2012.03.064; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Urbani A, 2005, ANAL BIOCHEM, V336, P117, DOI 10.1016/j.ab.2004.09.040; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	70	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20477	20488		10.1074/jbc.M114.551119	http://dx.doi.org/10.1074/jbc.M114.551119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904063	Green Published, hybrid			2022-12-25	WOS:000339396600007
J	Meng, KX; Xu, J; Zhang, CW; Zhang, R; Yang, H; Liao, C; Jiao, JD				Meng, Kexin; Xu, Jia; Zhang, Chengwei; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong			Calcium Sensing Receptor Modulates Extracellular Calcium Entry and Proliferation via TRPC3/6 Channels in Cultured Human Mesangial Cells	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; CA2+-SENSING RECEPTOR; EPITHELIAL-CELLS; CONTRIBUTES; EXPRESSION; LOCALIZATION; STIMULATION; PROTEINS	Calcium-sensing receptor (CaSR) has been demonstrated to be present in several tissues and cells unrelated to systemic calcium homeostasis, where it regulates a series of diverse cellular functions. A previous study indicated that CaSR is expressed in mouse glomerular mesangial cells (MCs), and stimulation of CaSR induces cell proliferation. However, the signaling cascades initiated by CaSR activation in MCs are currently unknown. In this study, our data demonstrate that CaSR mRNA and protein are expressed in a human mesangial cell line. Activating CaSR with high extracellular Ca2+ concentration ([Ca2+](o)) or spermine induces a phospholipase C (PLC)-dependent increase in intracellular Ca2+ concentration ([Ca2+](i)). Interestingly, the CaSR activation-induced increase in [Ca2+](i) results not only from intracellular Ca2+ release from internal stores but also from canonical transient receptor potential (TRPC)-dependent Ca2+ influx. This increase in Ca2+ was attenuated by treatment with a nonselective TRPC channel blocker but not by treatment with a voltage-gated calcium blocker or Na+/Ca2+ exchanger inhibitor. Furthermore, stimulation of CaSR by high [Ca2+](o) enhanced the expression of TRPC3 and TRPC6 but not TRPC1 and TRPC4, and siRNA targeting TRPC3 and TRPC6 attenuated the CaSR activation-induced [Ca2+](i) increase. Further experiments indicate that 1-oleoyl-2-acetyl-sn-glycerol (OAG), a known activator of receptor-operated calcium channels, significantly enhances the CaSR activation-induced [Ca2+](i) increase. Moreover, under conditions in which intracellular stores were already depleted with thapsigargin (TG), CaSR agonists also induced an increase in [Ca2+](i), suggesting that calcium influx stimulated by CaSR agonists does not require the release of calcium stores. Finally, our data indicate that pharmacological inhibition and knock down of TRPC3 and TRPC6 attenuates the CaSR activation-induced cell proliferation in human MCs. With these data, we conclude that CaSR activation mediates Ca2+ influx and cell proliferation via TRPC3 and TRPC6 in human MCs.	[Meng, Kexin; Zhang, Chengwei; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Peoples R China; [Xu, Jia] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China.	jiaojundong@163.com			National Nature Science Foundation of China [31071016]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (31071016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Bandyopadhyay BC, 2012, J BIOL CHEM, V287, P30305, DOI 10.1074/jbc.M112.394122; Bennett BD, 2001, ENDOCRINOLOGY, V142, P1968, DOI 10.1210/en.142.5.1968; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Chow JYC, 2011, AM J PHYSIOL-CELL PH, V301, pC461, DOI 10.1152/ajpcell.00389.2010; Diez-Fraile A, 2013, CURR MOL MED, V13, P282, DOI 10.2174/156652413804810763; Eder P, 2008, CHANNELS, V2, P94, DOI 10.4161/chan.2.2.6015; El Hiani Y, 2006, J MEMBRANE BIOL, V211, P127, DOI 10.1007/s00232-006-0017-2; Hiani YEL, 2009, CELL PHYSIOL BIOCHEM, V23, P335, DOI 10.1159/000218179; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lembrechts R, 2013, J CELL SCI, V126, P4490, DOI 10.1242/jcs.131656; Liao C, 2012, BIOCHEM BIOPH RES CO, V421, P750, DOI 10.1016/j.bbrc.2012.04.075; Ma R, 2005, PHYSIOLOGY, V20, P102, DOI 10.1152/physiol.00050.2004; Oh J, 2011, KIDNEY INT, V80, P483, DOI 10.1038/ki.2011.105; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Piecha G, 2008, AM J PHYSIOL-RENAL, V294, pF748, DOI 10.1152/ajprenal.00220.2007; RADTKE HW, 1981, J CLIN INVEST, V67, P1623, DOI 10.1172/JCI110197; Rey O, 2010, J CELL PHYSIOL, V225, P73, DOI 10.1002/jcp.22198; Riccardi D, 1996, AM J PHYSIOL-RENAL, V271, pF951, DOI 10.1152/ajprenal.1996.271.4.F951; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Sours-Brorhers S, 2009, EXP BIOL MED, V234, P673, DOI 10.3181/0809-RM-279; Sraer JD, 1996, KIDNEY INT, V49, P267, DOI 10.1038/ki.1996.38; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Thebault S, 2005, J CELL PHYSIOL, V204, P320, DOI 10.1002/jcp.20301; Torres PAU, 2012, KIDNEY INT, V82, P19, DOI 10.1038/ki.2012.69; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Ye CP, 1996, BIOCHEM BIOPH RES CO, V226, P572, DOI 10.1006/bbrc.1996.1396	31	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98777	10.1371/journal.pone.0098777	http://dx.doi.org/10.1371/journal.pone.0098777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905090	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000062
J	Menichetti, G; Remondini, D; Panzarasa, P; Mondragon, RJ; Bianconi, G				Menichetti, Giulia; Remondini, Daniel; Panzarasa, Pietro; Mondragon, Raul J.; Bianconi, Ginestra			Weighted Multiplex Networks	PLOS ONE			English	Article							COMPLEX; ORGANIZATION; MULTISCALE; FEATURES	One of the most important challenges in network science is to quantify the information encoded in complex network structures. Disentangling randomness from organizational principles is even more demanding when networks have a multiplex nature. Multiplex networks are multilayer systems of N nodes that can be linked in multiple interacting and co-evolving layers. In these networks, relevant information might not be captured if the single layers were analyzed separately. Here we demonstrate that such partial analysis of layers fails to capture significant correlations between weights and topology of complex multiplex networks. To this end, we study two weighted multiplex co-authorship and citation networks involving the authors included in the American Physical Society. We show that in these networks weights are strongly correlated with multiplex structure, and provide empirical evidence in favor of the advantage of studying weighted measures of multiplex networks, such as multistrength and the inverse multiparticipation ratio. Finally, we introduce a theoretical framework based on the entropy of multiplex ensembles to quantify the information stored in multiplex networks that would remain undetected if the single layers were analyzed in isolation.	[Menichetti, Giulia; Remondini, Daniel] Univ Bologna, Dept Phys & Astron, Bologna, Italy; [Menichetti, Giulia; Remondini, Daniel] Univ Bologna, INFN Sez Bologna, Bologna, Italy; [Panzarasa, Pietro] Queen Mary Univ London, Sch Business & Management, London, England; [Mondragon, Raul J.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Bianconi, Ginestra] Queen Mary Univ London, Sch Math Sci, London, England	University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Bianconi, G (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.	ginestra.bianconi@gmail.com	Bianconi, Ginestra/AAE-4114-2020; Bianconi, Ginestra/I-5742-2018; Remondini, Daniel/ABA-9971-2020	Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Menichetti, Giulia/0000-0001-5201-6774; Remondini, Daniel/0000-0003-3185-7456	Italian Ministry of Education and Research through the Flagship InterOmics [PB05]; European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) projects [305280]	Italian Ministry of Education and Research through the Flagship InterOmics; European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) projects	DR and GM acknowledge support by the Italian Ministry of Education and Research through the Flagship (PB05) InterOmics and the European Methods for Integrated analysis of multiple Omics datasets (MIMOmics) (305280) projects. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2003, PHYSICA A, V319, P633, DOI 10.1016/S0378-4371(02)01382-1; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardillo A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01344; Donges JF, 2011, EUR PHYS J B, V84, P635, DOI 10.1140/epjb/e2011-10795-8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Halu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078293; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Karsai M, 2013, ARXIV13035966; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Morris RG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128703; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Radicchi F, 2008, PNAS, V105, P17266; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sagarra O, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062806; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107	34	134	134	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97857	10.1371/journal.pone.0097857	http://dx.doi.org/10.1371/journal.pone.0097857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906003	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000015
J	Woyda-Ploszczyca, AM; Jarmuszkiewicz, W				Woyda-Ploszczyca, Andrzej M.; Jarmuszkiewicz, Wieslawa			Different Effects of Guanine Nucleotides (GDP and GTP) on Protein-Mediated Mitochondrial Proton Leak	PLOS ONE			English	Article							RAT-LIVER MITOCHONDRIA; NUCLEOSIDE-DIPHOSPHATE-KINASE; SKELETAL-MUSCLE MITOCHONDRIA; ISOLATED HEART-MITOCHONDRIA; OXYGEN SPECIES PRODUCTION; BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN; OXIDATIVE-PHOSPHORYLATION; SUBMITOCHONDRIAL PARTICLES; PURINE NUCLEOTIDES	In this study, we compared the influence of GDP and GTP on isolated mitochondria respiring under conditions favoring oxidative phosphorylation (OXPHOS) and under conditions excluding this process, i.e., in the presence of carboxyatractyloside, an adenine nucleotide translocase inhibitor, and/or oligomycin, an FOF1-ATP synthase inhibitor. Using mitochondria isolated from rat kidney and human endothelial cells, we found that the action of GDP and GTP can differ diametrically depending on the conditions. Namely, under conditions favoring OXPHOS, both in the absence and presence of linoleic acid, an activator of uncoupling proteins (UCPs), the addition of 1 mM GDP resulted in the state 4 (non-phosphorylating respiration)-state 3 (phosphorylating respiration) transition, which is characteristic of ADP oxidative phosphorylation. In contrast, the addition of 1 mM GTP resulted in a decrease in the respiratory rate and an increase in the membrane potential, which is characteristic of UCP inhibition. The stimulatory effect of GDP, but not GTP, was also observed in inside-out submitochondrial particles prepared from rat kidney mitochondria. However, the effects of GDP and GTP were more similar in the presence of OXPHOS inhibitors. The importance of these observations in connection with the action of UCPs, adenine nucleotide translocase (or other carboxyatractyloside-sensitive carriers), carboxyatractyloside-and purine nucleotide-insensitive carriers, as well as nucleoside-diphosphate kinase (NDPK) are considered. Because the measurements favoring oxidative phosphorylation better reflect in vivo conditions, our study strongly supports the idea that GDP cannot be considered a significant physiological inhibitor of UCP. Moreover, it appears that, under native conditions, GTP functions as a more efficient UCP inhibitor than GDP and ATP.	[Woyda-Ploszczyca, Andrzej M.; Jarmuszkiewicz, Wieslawa] Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland	Adam Mickiewicz University	Jarmuszkiewicz, W (corresponding author), Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland.	wiesiaj@amu.edu.pl	Woyda-Ploszczyca, Andrzej Marek/D-6195-2019	Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337; Woyda-Ploszczyca, Andrzej Marek/0000-0002-3324-3397	Polish Ministry of Science and Higher Education [NN 301 636440, 2013 2015 IP2012 059172]; European Union; European Regional Development Fund under the Innovative Economy Programme [POIG.01.01.02-00-069/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); European Regional Development Fund under the Innovative Economy Programme	This work was supported by grants of the Polish Ministry of Science and Higher Education (NN 301 636440 and Iuventus Plus program 2013 2015 IP2012 059172) and partially by European Union with resources from the European Regional Development Fund under the Innovative Economy Programme (POIG.01.01.02-00-069/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P1716, DOI 10.1016/j.bbabio.2010.06.009; ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Barile M, 1997, BIOCHEM PHARMACOL, V53, P913, DOI 10.1016/S0006-2952(96)00831-3; Bevilacqua L, 2010, BBA-BIOENERGETICS, V1797, P1389, DOI 10.1016/j.bbabio.2010.02.018; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; BRIERLEY G, 1965, J BIOL CHEM, V240, P4532; Cadenas S, 2000, BIOCHEM J, V348, P209, DOI 10.1042/0264-6021:3480209; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; COLE RJ, 1980, J AGR FOOD CHEM, V28, P1330, DOI 10.1021/jf60232a043; Czarna M, 2005, FEBS LETT, V579, P3136, DOI 10.1016/j.febslet.2005.04.081; Dlaskova A, 2010, BBA-BIOENERGETICS, V1797, P1470, DOI 10.1016/j.bbabio.2010.04.008; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; DUEE ED, 1969, J BIOL CHEM, V244, P3920; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Friederich-Persson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039635; GOFFEAU A, 1967, J BIOL CHEM, V242, P1845; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; GRUBMEYER C, 1979, PLANT PHYSIOL, V64, P757, DOI 10.1104/pp.64.5.757; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; JACOBUS WE, 1977, J BIOL CHEM, V252, P4232; Jarmuszkiewicz W, 2010, BBA-BIOENERGETICS, V1797, P792, DOI 10.1016/j.bbabio.2009.12.005; KAY CJ, 1985, FEBS LETT, V193, P169, DOI 10.1016/0014-5793(85)80144-7; Khailova LS, 2006, BBA-BIOENERGETICS, V1757, P1324, DOI 10.1016/j.bbabio.2006.04.024; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Komelina NP, 2010, ACTA BIOCHIM POL, V57, P413; Kowluru A, 2002, ARCH BIOCHEM BIOPHYS, V398, P160, DOI 10.1006/abbi.2001.2710; Koziel A, 2012, PFLUG ARCH EUR J PHY, V464, P657, DOI 10.1007/s00424-012-1156-1; Lacombe ML, 2009, BIOCHIMIE, V91, P779, DOI 10.1016/j.biochi.2009.02.006; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P20308; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; McKee EE, 1999, BIOCHEM BIOPH RES CO, V257, P466, DOI 10.1006/bbrc.1999.0489; McKee EE, 2000, AM J PHYSIOL-CELL PH, V279, pC1870, DOI 10.1152/ajpcell.2000.279.6.C1870; MOREL F, 1974, FEBS LETT, V39, P133, DOI 10.1016/0014-5793(74)80035-9; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; PEDERSEN PL, 1973, J BIOL CHEM, V248, P3956; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; PFAFF E, 1968, EUR J BIOCHEM, V6, P66, DOI 10.1111/j.1432-1033.1968.tb00420.x; Popov VN, 2002, BBA-BIOENERGETICS, V1553, P232, DOI 10.1016/S0005-2728(01)00244-4; ROTTENBERG H, 1977, BIOCHEMISTRY-US, V16, P3220, DOI 10.1021/bi00633a028; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Simonyan RA, 1998, FEBS LETT, V436, P81, DOI 10.1016/S0014-5793(98)01106-5; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Swida A, 2008, BIOCHEM J, V413, P359, DOI 10.1042/BJ20080333; Swida-Barteczka A, 2009, BIOCHEM J, V424, P297, DOI 10.1042/BJ20091158; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Valenti D, 1999, FEBS LETT, V444, P291, DOI 10.1016/S0014-5793(99)00071-X; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x; WINKLER HH, 1968, J BIOL CHEM, V243, P20; Woriax VL, 1996, BBA-GENE STRUCT EXPR, V1307, P66, DOI 10.1016/0167-4781(95)00240-5; Woyda-Ploszczyca A, 2011, BBA-BIOENERGETICS, V1807, P42, DOI 10.1016/j.bbabio.2010.08.012	60	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98969	10.1371/journal.pone.0098969	http://dx.doi.org/10.1371/journal.pone.0098969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24904988	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000083
J	Bielecki, J; Zaharoff, AK; Leung, NY; Garm, A; Oakley, TH				Bielecki, Jan; Zaharoff, Alexander K.; Leung, Nicole Y.; Garm, Anders; Oakley, Todd H.			Ocular and Extraocular Expression of Opsins in the Rhopalium of Tripedalia cystophora (Cnidaria: Cubozoa)	PLOS ONE			English	Article							BOX JELLYFISH; NERVOUS-SYSTEM; LENS EYES; EVOLUTION; LIGHT; PHOTOTRANSDUCTION; VISION; COLOR	A growing body of work on the neuroethology of cubozoans is based largely on the capabilities of the photoreceptive tissues, and it is important to determine the molecular basis of their light sensitivity. The cubozoans rely on 24 special purpose eyes to extract specific information from a complex visual scene to guide their behavior in the habitat. The lens eyes are the most studied photoreceptive structures, and the phototransduction in the photoreceptor cells is based on light sensitive opsin molecules. Opsins are photosensitive transmembrane proteins associated with photoreceptors in eyes, and the amino acid sequence of the opsins determines the spectral properties of the photoreceptors. Here we show that two distinct opsins (Tripedalia cystophora-lens eye expressed opsin and Tripedalia cystophora-neuropil expressed opsin, or Tc-leo and Tc-neo) are expressed in the Tripedalia cystophora rhopalium. Quantitative PCR determined the level of expression of the two opsins, and we found Tc-leo to have a higher amount of expression than Tc-neo. In situ hybridization located Tc-leo expression in the retinal photoreceptors of the lens eyes where the opsin is involved in image formation. Tc-neo is expressed in a confined part of the neuropil and is probably involved in extraocular light sensation, presumably in relation to diurnal activity.	[Bielecki, Jan; Zaharoff, Alexander K.; Leung, Nicole Y.; Oakley, Todd H.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Garm, Anders] Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark	University of California System; University of California Santa Barbara; University of Copenhagen	Bielecki, J (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	jan@bielecki.dk	Garm, Anders/K-4362-2014	Garm, Anders/0000-0002-2080-735X; Leung, Nicole/0000-0001-8823-1783; Oakley, Todd/0000-0002-4478-915X	Journal of Experimental Biology; Danish Independent Research Council [DFF132500146]; Villum-Kahn Rasmussen grant [VKR022166]; National Science Foundation [ISO-1045257]; Direct For Biological Sciences [1146337] Funding Source: National Science Foundation	Journal of Experimental Biology; Danish Independent Research Council(Det Frie Forskningsrad (DFF)); Villum-Kahn Rasmussen grant; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was funded by a travel grant from Journal of Experimental Biology and Danish Independent Research Council grant DFF132500146 awarded to JB, Villum-Kahn Rasmussen grant VKR022166 to AG and National Science Foundation grant ISO-1045257 to THO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Coates MM, 2006, J EXP BIOL, V209, P3758, DOI 10.1242/jeb.02431; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2007, J COMP PHYSIOL A, V193, P547, DOI 10.1007/s00359-007-0211-4; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gray GC, 2009, BIOL BULL-US, V217, P35, DOI 10.1086/BBLv217n1p35; Grens A, 1995, DEVELOPMENT, V121, P4027; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Nilsson DE, 2013, VISUAL NEUROSCI, V30, P5, DOI 10.1017/S0952523813000035; O'Connor M, 2009, J COMP PHYSIOL A, V195, P557, DOI 10.1007/s00359-009-0431-x; Oakley TH, BMC BIOINFO IN PRESS; Petie R, 2011, J EXP BIOL, V214, P2809, DOI 10.1242/jeb.057190; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Plachetzki DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001054; Plachetzki DC, 2007, INTEGR COMP BIOL, V47, P759, DOI 10.1093/icb/icm050; Plachetzki DC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-17; Plachetzki DC, 2010, P ROY SOC B-BIOL SCI, V277, P1963, DOI 10.1098/rspb.2009.1797; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Ramirez MD, 2011, VISUAL NEUROSCI, V28, P265, DOI 10.1017/S0952523811000150; Rivera AS, 2012, J EXP BIOL, V215, P1278, DOI 10.1242/jeb.067140; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Yatsu Naohide, 1917, Tokyo Journal of the College of Science, V40	41	18	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98870	10.1371/journal.pone.0098870	http://dx.doi.org/10.1371/journal.pone.0098870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901369	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000336841400063
J	Scribbans, TD; Edgett, BA; Vorobej, K; Mitchell, AS; Joanisse, SD; Matusiak, JBL; Parise, G; Quadrilatero, J; Gurd, BJ				Scribbans, Trisha D.; Edgett, Brittany A.; Vorobej, Kira; Mitchell, Andrew S.; Joanisse, Sophie D.; Matusiak, Jennifer B. L.; Parise, Gianni; Quadrilatero, Joe; Gurd, Brendon J.			Fibre-Specific Responses to Endurance and Low Volume High Intensity Interval Training: Striking Similarities in Acute and Chronic Adaptation	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SPRINT-INTERVAL; GLYCOGEN DEPLETION; MITOCHONDRIAL BIOGENESIS; METABOLIC ADAPTATIONS; CONTINUOUS EXERCISE; NUCLEAR ABUNDANCE; AEROBIC FITNESS; AMPK ACTIVATION; MESSENGER-RNA	The current study involved the completion of two distinct experiments. Experiment 1 compared fibre specific and whole muscle responses to acute bouts of either low-volume high-intensity interval training (LV-HIT) or moderate-intensity continuous endurance exercise (END) in a randomized crossover design. Experiment 2 examined the impact of a six-week training intervention (END or LV-HIT; 4 days/week), on whole body and skeletal muscle fibre specific markers of aerobic and anaerobic capacity. Six recreationally active men (Age: 20.7 +/- 3.8 yrs; VO(2)peak: 51.9 +/- 5.1 mL/kg/min) reported to the lab on two separate occasions for experiment 1. Following a muscle biopsy taken in a fasted state, participants completed an acute bout of each exercise protocol (LV-HIT: 8, 20-second intervals at,170% of VO(2)peak separated by 10 seconds of rest; END: 30 minutes at similar to 65% of VO(2)peak), immediately followed by a muscle biopsy. Glycogen content of type I and IIA fibres was significantly (p<0.05) reduced, while p-ACC was significantly increased (p<0.05) following both protocols. Nineteen recreationally active males (n = 16) and females (n = 3) were VO(2)peak-matched and assigned to either the LV-HIT (n = 10; 21 +/- 2 yrs) or END (n = 9; 20.7 +/- 3.8 yrs) group for experiment 2. After 6 weeks, both training protocols induced comparable increases in aerobic capacity (END: Pre: 48.3 +/- 6.0, Mid: 51.8 +/- 6.0, Post: 55.0 +/- 6.3 mL/kg/min LV-HIT: Pre: 47.9 +/- 8.1, Mid: 50.4 +/- 7.4, Post: 54.7 +/- 7.6 mL/kg/min), fibre-type specific oxidative and glycolytic capacity, glycogen and IMTG stores, and whole-muscle capillary density. Interestingly, only LV-HIT induced greater improvements in anaerobic performance and estimated whole-muscle glycolytic capacity. These results suggest that 30 minutes of END exercise at similar to 65% VO(2)peak or 4 minutes of LV-HIT at,170% VO(2)peak induce comparable changes in the intra-myocellular environment (glycogen content and signaling activation); correspondingly, training-induced adaptations resulting for these protocols, and other HIT and END protocols are strikingly similar.	[Scribbans, Trisha D.; Edgett, Brittany A.; Matusiak, Jennifer B. L.; Gurd, Brendon J.] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Vorobej, Kira; Mitchell, Andrew S.; Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Joanisse, Sophie D.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	Queens University - Canada; University of Waterloo; McMaster University	Gurd, BJ (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	gurdb@queensu.ca		Joanisse, Sophie/0000-0001-9983-9401; Edgett, Brittany/0000-0002-8232-0432	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMEIER CA, 1994, J APPL PHYSIOL, V77, P2385, DOI 10.1152/jappl.1994.77.5.2385; [Anonymous], 2013, OPEN J MOL INTEGR PH, V03, P202, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Bishop D, 2008, AM J PHYSIOL-REG I, V295, pR1991, DOI 10.1152/ajpregu.00863.2007; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boyd JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068091; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cebasek V, 2004, EUR J HISTOCHEM, V48, P151; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Creer AR, 2004, INT J SPORTS MED, V25, P92; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Dawson B, 1998, EUR J APPL PHYSIOL O, V78, P163, DOI 10.1007/s004210050402; EDDY DO, 1977, EUR J APPL PHYSIOL O, V37, P83, DOI 10.1007/BF00421694; Edgett BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071623; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; ESBJORNSSON M, 1993, ACTA PHYSIOL SCAND, V149, P245, DOI 10.1111/j.1748-1716.1993.tb09618.x; ESSEN B, 1978, ACTA PHYSIOL SCAND, V103, P446, DOI 10.1111/j.1748-1716.1978.tb06239.x; FOURNIER M, 1982, MED SCI SPORT EXER, V14, P453, DOI 10.1249/00005768-198206000-00008; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GREENHAFF PL, 1994, J PHYSIOL-LONDON, V478, P149, DOI 10.1113/jphysiol.1994.sp020238; HALKJAERKRISTENSEN J, 1979, HISTOCHEM J, V11, P127, DOI 10.1007/BF01002990; Hazell TJ, 2010, EUR J APPL PHYSIOL, V110, P153, DOI 10.1007/s00421-010-1474-y; Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012; JANSSON E, 1990, ACTA PHYSIOL SCAND, V140, P359, DOI 10.1111/j.1748-1716.1990.tb09010.x; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; Macpherson REK, 2011, MED SCI SPORT EXER, V43, P115, DOI 10.1249/MSS.0b013e3181e5eacd; McRae G, 2012, APPL PHYSIOL NUTR ME, V37, P1124, DOI [10.1139/h2012-093, 10.1139/H2012-093]; PETTE D, 1985, MUSCLE NERVE, V8, P676, DOI 10.1002/mus.880080810; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Quadrilatero J, 2010, AM J PHYSIOL-ENDOC M, V298, pE534, DOI 10.1152/ajpendo.00678.2009; Rodas G, 2000, EUR J APPL PHYSIOL, V82, P480, DOI 10.1007/s004210000223; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; SALTIN B, 1976, ACTA PHYSIOL SCAND, V96, P289, DOI 10.1111/j.1748-1716.1976.tb10200.x; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; SIMONEAU JA, 1985, EUR J APPL PHYSIOL O, V54, P250, DOI 10.1007/BF00426141; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Terada S, 2004, JPN J PHYSIOL, V54, P47, DOI 10.2170/jjphysiol.54.47; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Vogiatzis I, 2005, CHEST, V128, P3838, DOI 10.1378/chest.128.6.3838; VOLLESTAD NK, 1984, ACTA PHYSIOL SCAND, V122, P433; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; VOLLESTAD NK, 1992, ACTA PHYSIOL SCAND, V144, P135; Wang L, 2012, ACTA PHYSIOL, V204, P525, DOI 10.1111/j.1748-1716.2011.02354.x; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	60	80	82	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98119	10.1371/journal.pone.0098119	http://dx.doi.org/10.1371/journal.pone.0098119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901767	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000336841400017
J	Bar-Haim, E; Erez, N; Malloy, AMW; Graham, BS; Ruckwardt, TJ				Bar-Haim, Erez; Erez, Noam; Malloy, Allison M. W.; Graham, Barney S.; Ruckwardt, Tracy J.			CD8+TCR Transgenic Strains Expressing Public versus Private TCR Targeting the Respiratory Syncytial Virus K(d)M2(82-90) Epitope Demonstrate Similar Functional Profiles	PLOS ONE			English	Article							REGULATORY T-CELLS; AIRWAY HYPERRESPONSIVENESS; SENSITIZED MICE; MOUSE MODEL; INFECTION; IMMUNOPATHOLOGY; RESPONSES; IMMUNITY; LYMPHOCYTES; ALPHA	Our previous work has characterized the functional and clonotypic features of two respiratory syncytial virus (RSV) epitope-specific T cell responses in mice. Following single-cell sequencing, we selected T cell receptor sequences to represent both a public and a private clone specific for the dominant K(d)M2(82-90) epitope for the generation of T cell receptor transgenic (TCR Tg) mice. We evaluated cells from these TCR Tg strains for three major functions of CD8+ T cells: proliferation, cytokine production and cytolytic activity. In vitro comparisons of the functional characteristics of T cells from the newly-generated mice demonstrated many similarities in their responsiveness to cognate antigen stimulation. Cells from both TRBV13-1 (private) and TRBV13-2 (public) TCR Tg mice had similar affinity, and proliferated similarly in vitro in response to cognate antigen stimulation. When transferred to BALB/c mice, cells from both strains demonstrated extensive proliferation in mediastinal lymph nodes following RSV infection, with TRBV13-2 demonstrating better in vivo proliferation. Both strains similarly expressed cytokines and chemokines following stimulation, and had similar Granzyme B and perforin expression, however cells expressing TRBV13-1 demonstrated better cytolytic activity than TRBV13-2 cells. These new, well-characterized mouse strains provide new opportunities to study molecular mechanisms that control the phenotype and function of CD8+ T cell responses.	[Bar-Haim, Erez; Erez, Noam; Malloy, Allison M. W.; Graham, Barney S.; Ruckwardt, Tracy J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Bar-Haim, Erez] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel; [Erez, Noam] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ruckwardt, TJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	truckwardt@mail.nih.gov	Erez, Noam/AAW-4953-2021; Graham, Barney S./AAC-5898-2019; Bar-Haim, Erez/AAA-6444-2020	Graham, Barney S./0000-0001-8112-0853; Bar-Haim, Erez/0000-0003-3435-8599; Malloy, Allison Marie Wahl/0000-0003-2962-0302; Erez, Noam/0000-0001-5241-8028	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005027] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Billam P, 2011, J BIOL CHEM, V286, P4829, DOI 10.1074/jbc.M110.191437; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Hwang LN, 2006, CANCER RES, V66, P1132, DOI 10.1158/0008-5472.CAN-05-1679; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; KULKARNI AB, 1993, J VIROL, V67, P4086, DOI 10.1128/JVI.67.7.4086-4092.1993; KULKARNI AB, 1993, J VIROL, V67, P1044, DOI 10.1128/JVI.67.2.1044-1049.1993; Lee DCP, 2010, J VIROL, V84, P8790, DOI 10.1128/JVI.00796-10; Newell Evan W, 2012, IMMUNITY, V36, P142; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Ostler T, 2002, EUR J IMMUNOL, V32, P2117, DOI 10.1002/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Peebles RS, 2000, J INFECT DIS, V182, P671; Peebles RS, 1999, J MED VIROL, V57, P186, DOI 10.1002/(SICI)1096-9071(199902)57:2<186::AID-JMV17>3.0.CO;2-Q; Peebles RS, 2001, J INFECT DIS, V184, P1374; Ruckwardt TJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003934; Ruckwardt TJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002377; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Welten SPM, 2013, CURR OPIN VIROL, V3, P475, DOI 10.1016/j.coviro.2013.06.012; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423	34	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99249	10.1371/journal.pone.0099249	http://dx.doi.org/10.1371/journal.pone.0099249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897427	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700125
J	Bolet, A; Delfino, M; Fortuny, J; Almecija, S; Robles, JM; Alba, DM				Bolet, Arnau; Delfino, Massimo; Fortuny, Josep; Almecija, Sergio; Robles, Josep M.; Alba, David M.			An Amphisbaenian Skull from the European Miocene and the Evolution of Mediterranean Worm Lizards	PLOS ONE			English	Article							SQUAMATE REPTILES; MIDDLE MIOCENE; BURROWING REPTILES; CRANIAL ANATOMY; LOWER EOCENE; RESOLUTION; PHYLOGENY; OLIGOCENE; SNAKES; PLEISTOCENE	The evolution of blanid amphisbaenians (Mediterranean worm lizards) is mainly inferred based on molecular studies, despite their fossils are common in Cenozoic European localities. This is because the fossil record exclusively consists in isolated elements of limited taxonomic value. We describe the only known fossil amphisbaenian skull from Europe - attributed to Blanus mendezi sp. nov. (Amphisbaenia, Blanidae) - which represents the most informative fossil blanid material ever described. This specimen, from the Middle Miocene of Abocador de Can Mata (11.6 Ma, MN7+8) in the Valles-Penedes Basin (Catalonia, NE Iberian Peninsula), unambiguously asserts the presence of Blanus in the Miocene of Europe. This reinforces the referral to this genus of the previously-known, much more incomplete and poorly-diagnostic material from other localities of the European Neogene. Our analysis - integrating the available molecular, paleontological and biogeographic data - suggests that the new species postdates the divergence between the two main (Eastern and Western Mediterranean) extant clades of blanids, and probably precedes the split between the Iberian and North-Western African subclades. This supports previous paleobiogeographic scenarios for blanid evolution and provides a significant minimum divergence time for calibrating molecular analyses of blanid phylogeny.	[Bolet, Arnau; Delfino, Massimo; Fortuny, Josep; Almecija, Sergio; Robles, Josep M.; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain; [Delfino, Massimo; Alba, David M.] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Almecija, Sergio] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Robles, Josep M.] FOSSILIA Serv Paleontol & Geol SL, Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University of Turin; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bolet, A (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, E-08193 Barcelona, Spain.	arnau.bolet@icp.cat	Bolet, Arnau/N-1059-2016; Fortuny, Josep/L-2523-2014; Alba, David/G-9716-2015; Almécija, Sergio/ABG-8129-2020	Bolet, Arnau/0000-0003-4416-4560; Fortuny, Josep/0000-0003-4282-1619; Alba, David/0000-0002-8886-5580; Almécija, Sergio/0000-0003-1373-1497; Robles Gimenez, Josep Maria/0000-0002-5410-3529	Spanish Ministerio de Economia y Competitividad [CGL0211-28681, CGL2011-30069-C02-01, CGL2011-27343, RYC-2009-04533, BES-2009-026731]; Generalitat de Catalunya [2009 SGR 754 GRC]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by the Spanish Ministerio de Economia y Competitividad (CGL0211-28681, CGL2011-30069-C02-01, CGL2011-27343, RYC-2009-04533 to DMA, and BES-2009-026731 associated to CGL2008-06533-C03-01/BTE to AB) and the Generalitat de Catalunya (2009 SGR 754 GRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J., 1985, PALEONTOLOGIA EVOLUC, V18, P57, DOI DOI 10.1016/J.GEOBIOS.2003.11.011; Alba D.M., 2006, Estudios Geologicos (Madrid), V62, P295; Alba D.M., 2011, PALEONTOL EVOL MEM E, V6, P95; Alba David M., 2009, Paleolusitana, V1, P59; Albert EM, 2007, MOL ECOL, V16, P1519, DOI 10.1111/j.1365-294X.2007.03248.x; Albert EM, 2009, ZOOTAXA, P56, DOI 10.11646/zootaxa.2234.1.4; ALEXANDER AA, 1966, COPEIA, P205; [Anonymous], 2006, DEEP SCALY PROJECT; Auge M, 2003, GEODIVERSITAS, V25, P539; Auge M, 2000, MEMOIR MUS NATL HIST, V183, P263; AUGE M, 1992, CR ACAD SCI II, V315, P885; Auge M.L., 2005, MEMOIRES MUSEUM NATL, V192, P1; Auge Marc Louis, 2012, Palaeobiodiversity Palaeoenvironments, V92, P425, DOI 10.1007/s12549-012-0104-6; BAILON S., 1991, THESIS; Bailon Salvador, 2000, Geodiversitas, V22, P539; Barbadillo LJ, 1989, TRAB NEOGENO CUATERN, V11, P151; BARTRINA MT, 1992, TECTONOPHYSICS, V203, P219, DOI 10.1016/0040-1951(92)90225-U; BEDRIAGA J. V., 1884, ARCH NATURGESCH, V50, P23; BERMAN DS, 1976, J PALEONTOL, V50, P165; BERMAN DS, 1977, J PALEONTOL, V51, P986; BERMAN DS, 1973, COPEIA, P704; Blain HA, 2007, GEODIVERSITAS, V29, P269; Blain Hugues-Alexandre, 2009, Treballs del Museu de Geologia de Barcelona, V16, P39; Bohme M, 2010, PALAEONTOL Z, V84, P3, DOI 10.1007/s12542-010-0050-4; Bohme Madelaine, 1999, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V39, P85; Bolet A, 2013, LIZARDS AMPHISBAENIA; Bolet A, 2014, ANAT REC, V297, P505, DOI 10.1002/ar.22855; BUSACK SD, 1988, COPEIA, P101; Cabrera L, 1991, LIBRO GUIA EXCURSION, V4, P1; Cabrera L, 2004, GEOLOGIA ESPANA, P569; Casanovas-Vilar I., 2011, PALEONTOL EVOL MEM E, V6, P55; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; Charig A.J., 1990, Bulletin of the British Museum (Natural History) Geology, V46, P19; Colombero S, 2013, GEOBIOS-LYON, V46, P111, DOI 10.1016/j.geobios.2012.10.007; Crusafont Pairo M., 1952, Estudios Geologicos Instituto Lucas Mallada, V8, P213; Delfino M, 2003, AMPHIBIA-REPTILIA, V24, P407, DOI 10.1163/156853803322763873; Delfino M., 2002, THESIS U MODENA REGG; Delfino M, 2004, 5 C SOC HERP IT, P24; Delfino Massimo, 1997, P89; desRochebrune AT, 1884, MEM SOC SCI NAT SAON, V5, P149; Daza JD, 2011, ANAT REC, V294, P1765, DOI 10.1002/ar.21467; Folie A, 2013, GEOL BELG, V16, P227; Gans C., 1967, Bulletin of the American Museum of Natural History, V135, P61; Gans C, 2005, B AM MUS NAT HIST, P7; GANS C, 1978, Transactions of the Zoological Society of London, V34, P347; Gans C., 2008, BIOL REPTILIA MORPHO, P621; GANS CARL, 1957, BREVIORA MUS COMP ZOOL [HARVARD], V70, P1; GANS CARL, 1960, BULL AMER MUS NAT HIST, V119, P129; Garcia-Porta J, 2001, BUTLL SOC CAT HERP, V15, P91; Garcia-Porta Joan, 2002, Revista Espanola de Herpetologia, V16, P19; Gervais P, 1853, ANN SCI NAT, V19-20, P293; Hembree DI, 2006, PALAEOGEOGR PALAEOCL, V235, P340, DOI 10.1016/j.palaeo.2005.11.006; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; Kearney M, 2005, J MORPHOL, V264, P1, DOI 10.1002/jmor.10210; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Lee MSY, 2009, J EVOLUTION BIOL, V22, P1308, DOI 10.1111/j.1420-9101.2009.01751.x; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lopez Martinez N, 1981, TRABAJOS PREHIST, V38, P134; Maisano JA, 2006, J MORPHOL, V267, P70, DOI 10.1002/jmor.10388; Milner A.C., 1982, Tertiary Research, V4, P149; Montero R, 1999, ANN CARNEGIE MUS, V68, P15; Montero R, 1999, J MORPHOL, V239, P1, DOI 10.1002/(SICI)1097-4687(199901)239:1<1::AID-JMOR1>3.0.CO;2-A; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; Muller J, 2011, NATURE, V473, P364, DOI 10.1038/nature09919; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rage J.C., 2003, Universidade Nova de Lisboa Ciencias da Terra, V15, P103; Rage J-C, 1976, GEOL MEDITERR, V3, P47; RAGE JC, 1984, B SOC GEOL FR, V26, P1251; ROCA E, 1992, TECTONOPHYSICS, V203, P203, DOI 10.1016/0040-1951(92)90224-T; Rocek Z., 1984, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V94, P1; Schleich H.H., 1985, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V4, P1; SCHLEICH H H, 1988, Palaeontologische Zeitschrift, V62, P95; Sindaco R, 2008, REPTILES W PALEARCTI, V1; Speybroeck J, 2010, ZOOTAXA, P1; Taylor E. H., 1951, University of Kansas Science Bulletin, V34, P521; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vaconcelos R, 2006, AMPHIBIA-REPTILIA, V27, P339, DOI 10.1163/156853806778190033; Vandelli D., 1797, ACAD REAL SCI LISBOA, V1, P37; VANZOLINI P. E., 1951, HERPETOLOGICA, V7, P113; Venczel Marton, 2006, Hantkeniana, V5, P72; Venczel M, 2008, GEODIVERSITAS, V30, P731; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Wellnhofer P., 1983, HDB PALAOHERPETOLOGI, P1; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; ZANGERL R, 1945, AM MIDL NAT, V33, P764, DOI 10.2307/2421188	87	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98082	10.1371/journal.pone.0098082	http://dx.doi.org/10.1371/journal.pone.0098082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896828	Green Published, gold			2022-12-25	WOS:000338430700025
J	Grebely, J; Lima, VD; Marshall, BDL; Milloy, MJ; DeBeck, K; Montaner, J; Simo, A; Krajden, M; Dore, GJ; Kerr, T; Wood, E				Grebely, Jason; Lima, Viviane Dias; Marshall, Brandon D. L.; Milloy, M-J; DeBeck, Kora; Montaner, Julio; Simo, Annick; Krajden, Mel; Dore, Gregory J.; Kerr, Thomas; Wood, Evan			Declining Incidence of Hepatitis C Virus Infection among People Who Inject Drugs in a Canadian Setting, 1996-2012	PLOS ONE			English	Article							RISK-FACTORS; USERS; HIV; COHORT; SEROCONVERSION; PREVALENCE; HCV; PREVENTION; PROGRAMS; ACCESS	Background: People who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) infection. Trends in HCV incidence and associated risk factors among PWID recruited between 1996 and 2012 in Vancouver, Canada were evaluated. Methods: Data were derived from a long-term cohort of PWID in Vancouver. Trends in HCV incidence were evaluated. Factors associated with time to HCV infection were assessed using Cox proportional hazards regression. Results: Among 2,589, 82% (n = 2,121) were HCV antibody-positive at enrollment. Among 364 HCV antibody-negative participants with recent (last 30 days) injecting at enrollment, 126 HCV seroconversions were observed [Overall HCV incidence density: 8.6 cases/100 person-years (py); 95% confidence interval (95% CI): 7.2, 10.1; HCV incidence density among those with injecting during follow-up: 11.5 cases/100 py; 95% CI 9.7, 13.6]. The overall HCV incidence density declined significantly from 25.0/100 py (95% CI: 20.2, 30.3) in 1996-99, as compared to 6.0/100 py (95% CI: 4.1, 8.5) in 2000-2005, and 3.1/100 py (95% CI: 2.0, 4.8) in 2006-2012. Among those with injecting during follow-up, the overall HCV incidence density declined significantly from 27.9/100 py (95% CI: 22.6, 33.6) in 1996-99, as compared to 7.5/100 py (95% CI: 5.1, 10.6) in 2000-2005, and 4.9/100 py (95% CI: 3.1, 7.4) in 2006-2012. Unstable housing, HIV infection, and injecting of cocaine, heroin and methamphetamine were independently associated with HCV seroconversion. Conclusions: HCV incidence has dramatically declined among PWID in this setting. However, improved public health strategies to prevent and treat HCV are urgently required to reduce HCV-associated morbidity and mortality.	[Grebely, Jason; Dore, Gregory J.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Lima, Viviane Dias; Milloy, M-J; DeBeck, Kora; Montaner, Julio; Simo, Annick; Kerr, Thomas; Wood, Evan] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lima, Viviane Dias; Montaner, Julio; Simo, Annick; Kerr, Thomas; Wood, Evan] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Milloy, M-J] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada; [DeBeck, Kora] Simon Fraser Univ, Sch Publ Policy, Vancouver, BC, Canada; [Krajden, Mel] British Columbia Ctr Dis Control, Vancouver, BC, Canada	University of New South Wales Sydney; Kirby Institute; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Brown University; University of British Columbia; Simon Fraser University	Grebely, J (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	jgrebely@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Marshall, Brandon/B-4895-2010; Milloy, M-J/AAY-3618-2020	Dore, Gregory John/0000-0002-4741-2622; Marshall, Brandon/0000-0002-0134-7052; DeBeck, Kora/0000-0003-2045-1653	National Institutes of Health (NIH) [R01DA011591]; Canadian Institutes of Health (CIHR) [HHP-67262, RAA-79918, HES-115697, MOP-125948]; Australian Government Department of Health and Ageing; National Health andMedical Research Council (NHMRC) Career Development Fellowship; Michael Institute for Health Research; CIHR; Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research; Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH) [1DP1DA026182]; International AIDS Society; United Nations AIDS Program; World Health Organization; National Institutes of Health Research-Office of AIDS Research; National Institute of Allergy & Infectious Diseases; United States President's Emergency Plan for AIDS Relief (PEPfAR); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; NHMRC Practitioner Research Fellowship; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R01DA011591, R03DA033851] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health andMedical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Michael Institute for Health Research; CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research; Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award; British Columbia Ministry of Health; National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH); International AIDS Society; United Nations AIDS Program; World Health Organization(World Health Organization); National Institutes of Health Research-Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy & Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States President's Emergency Plan for AIDS Relief (PEPfAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF; University of British Columbia; Simon Fraser University; Providence Health Care; Vancouver Coastal Health Authority; NHMRC Practitioner Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine(Canada Research Chairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the National Institutes of Health (NIH) (R01DA011591) and the Canadian Institutes of Health (CIHR) (HHP-67262, RAA-79918, HES-115697; MOP-125948). NIH and CIHR had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government. JG is supported by a National Health andMedical Research Council (NHMRC) Career Development Fellowship. VDL is supported by a Scholar Award from the Michael Institute for Health Research and a New Investigator Award from CIHR. M-JM is supported by fellowships from the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research. KD is supported by a Michael Smith Foundation for Health Research/St. Paul's Hospital Foundation Providence Health Care CareerScholar Award. JM is supported by the British Columbia Ministry of Health and through an Avant-Garde Award (No. 1DP1DA026182) from the National Institute of Drug Abuse (NIDA), at the United States National Institutes of Health (NIH). JM has also received financial support from the International AIDS Society, United Nations AIDS Program, World Health Organization, National Institutes of Health Research-Office of AIDS Research, National Institute of Allergy & Infectious Diseases, The United States President's Emergency Plan for AIDS Relief (PEPfAR), UNICEF, the University of British Columbia, Simon Fraser University, Providence Health Care and Vancouver Coastal Health Authority. GD is supported by an NHMRC Practitioner Research Fellowship. This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports EW.	BCCDC, 2010, TRENDS HCV INC BRIT; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Bruneau J, 2012, ADDICTION, V107, P1318, DOI 10.1111/j.1360-0443.2012.03803.x; Bruneau J, 2010, INT J DRUG POLICY, V21, P477, DOI 10.1016/j.drugpo.2010.05.001; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Grebely J, 2014, ANTIVIR RES; Grebely J, 2011, J INFECT DIS, V203, P571, DOI 10.1093/infdis/jiq111; Hadland SE, 2012, AM J ADDICTION, V21, P488, DOI 10.1111/j.1521-0391.2012.00257.x; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Iversen Jenny, 2013, Am J Public Health, V103, P1436, DOI 10.2105/AJPH.2012.301206; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Kim C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-270; Kwon JA, 2009, JAIDS-J ACQ IMM DEF, V51, P462, DOI 10.1097/QAI.0b013e3181a2539a; Li XH, 2003, AM STAT, V57, P193, DOI 10.1198/0003130031883; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lima VD, 2012, AIDS, V26, P1491, DOI 10.1097/QAD.0b013e3283550b68; Lucidarme D, 2004, EPIDEMIOL INFECT, V132, P699, DOI 10.1017/S095026880400247X; Maher L, 2007, AUST NZ J PUBL HEAL, V31, P30, DOI 10.1111/j.1753-6405.2007.00007.x; Maher L, 2006, ADDICTION, V101, P1499, DOI 10.1111/j.1360-0443.2006.01543.x; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Miller CL, 2002, HEPATOLOGY, V36, P737, DOI 10.1053/jhep.2002.35065; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Patrick DM, 2001, CAN MED ASSOC J, V165, P889; Pouget ER, 2012, ADDICTION, V107, P1057, DOI 10.1111/j.1360-0443.2011.03765.x; Roy E, 2007, INT J STD AIDS, V18, P23, DOI 10.1258/095646207779949880; Roy E, 2012, DRUG ALCOHOL DEPEN, V126, P246, DOI 10.1016/j.drugalcdep.2012.05.018; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; Ruan YH, 2013, SEX TRANSM DIS, V40, P323, DOI 10.1097/OLQ.0b013e31827fd4d4; Tyndall MW, 2001, J ACQ IMMUN DEF SYND, V28, P351, DOI 10.1097/00126334-200112010-00008; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; Werb D, 2013, DRUG ALCOHOL DEPEN, V132, P535, DOI 10.1016/j.drugalcdep.2013.03.024; Werb D, 2010, DRUG ALCOHOL REV, V29, P271, DOI 10.1111/j.1465-3362.2009.00145.x	38	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97726	10.1371/journal.pone.0097726	http://dx.doi.org/10.1371/journal.pone.0097726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897109	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700012
J	Jankovics, F; Henn, L; Bujna, A; Vilmos, P; Spirohn, K; Boutros, M; Erdelyi, M				Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Spirohn, Kerstin; Boutros, Michael; Erdelyi, Miklos			Functional Analysis of the Drosophila Embryonic Germ Cell Transcriptome by RNA Interference	PLOS ONE			English	Article							MESSENGER-RNA; STEM-CELLS; TRANSEPITHELIAL MIGRATION; TRANSLATIONAL CONTROL; BRAIN-TUMOR; MELANOGASTER; GENES; NANOS; PEBBLE; GROWTH	In Drosophila melanogaster, primordial germ cells are specified at the posterior pole of the very early embryo. This process is regulated by the posterior localized germ plasm that contains a large number of RNAs of maternal origin. Transcription in the primordial germ cells is actively down-regulated until germ cell fate is established. Bulk expression of the zygotic genes commences concomitantly with the degradation of the maternal transcripts. Thus, during embryogenesis, maternally provided and zygotically transcribed mRNAs determine germ cell development collectively. In an effort to identify novel genes involved in the regulation of germ cell behavior, we carried out a large-scale RNAi screen targeting both maternal and zygotic components of the embryonic germ line transcriptome. We identified 48 genes necessary for distinct stages in germ cell development. We found pebble and fascetto to be essential for germ cell migration and germ cell division, respectively. Our data uncover a previously unanticipated role of mei-P26 in maintenance of embryonic germ cell fate. We also performed systematic co-RNAi experiments, through which we found a low rate of functional redundancy among homologous gene pairs. As our data indicate a high degree of evolutionary conservation in genetic regulation of germ cell development, they are likely to provide valuable insights into the biology of the germ line in general.	[Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Erdelyi, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary; [Spirohn, Kerstin; Boutros, Michael] German Canc Res Ctr, Heidelberg, Germany; [Spirohn, Kerstin; Boutros, Michael] Heidelberg Univ, Div Signaling & Funct Genom, Heidelberg, Germany	Hungarian Academy of Sciences; Hungarian Biological Research Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Jankovics, F (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	jankovics.ferenc@brc.mta.hu; erdelyi.miklos@brc.mta.hu	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Jankovics, Ferenc/0000-0001-9697-4472; Vilmos, Peter/0000-0001-5692-8818; Henn, Laszlo/0000-0002-4071-5719	Howard Hughes Medical Institutes (HHMI) [55005606]; Hungarian National Science Foundation [OTKA-NK84121, OTKA-K108538]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences; European Union; State of Hungary [TAMOP 4.2.4.A/2-11-1-20120001]; German Research Foundation (DFG.)	Howard Hughes Medical Institutes (HHMI)(Howard Hughes Medical Institute); Hungarian National Science Foundation; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; German Research Foundation (DFG.)(German Research Foundation (DFG))	This work was supported by grants from the Howard Hughes Medical Institutes (HHMI, 55005606 to M.E.) and from the Hungarian National Science Foundation (OTKA-NK84121 to M.E. and OTKA-K108538 to P.V.). P.V. and F.J. is supported by the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences, L.H. was supported by the European Union and the State of Hungary (TAMOP 4.2.4.A/2-11-1-20120001). Work in the group of M.B. was supported by the German Research Foundation (DFG.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka M, 2004, DEVELOPMENT, V131, P5079, DOI 10.1242/dev.01391; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Axelsson E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-342; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Chanet S, 2012, NAT CELL BIOL, V14, P467, DOI 10.1038/ncb2481; Coffman CR, 2002, GENETICS, V162, P273; DeGennaro M, 2011, DEV CELL, V20, P233, DOI 10.1016/j.devcel.2010.12.007; Dorfman R, 2001, DEVELOPMENT, V128, P965; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Forbes A, 1998, DEVELOPMENT, V125, P679; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Hanyu-Nakamura K, 2004, DEVELOPMENT, V131, P4545, DOI 10.1242/dev.01321; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Insco ML, 2012, CELL STEM CELL, V11, P689, DOI 10.1016/j.stem.2012.08.012; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jankovics F, 2001, GENETICS, V158, P1177; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jankovics F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022229; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kugler JM, 2013, G3-GENES GENOM GENET, V3, P1573, DOI 10.1534/g3.113.007591; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LEHNER CF, 1992, J CELL SCI, V103, P1021; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058301; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Moore LA, 1998, DEVELOPMENT, V125, P667; Mukai M, 2006, GENE EXPR PATTERNS, V6, P256, DOI 10.1016/j.modgep.2005.08.002; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006; Neumuller RA, 2008, NATURE, V454, P241, DOI 10.1038/nature07014; Niki Y, 2003, P NATL ACAD SCI USA, V100, P14042, DOI 10.1073/pnas.2235591100; Olesnicky EC, 2012, DEV BIOL, V365, P208, DOI 10.1016/j.ydbio.2012.02.028; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Prokopenko SN, 2000, MECH DEVELOP, V90, P269, DOI 10.1016/S0925-4773(99)00233-6; Sano H, 2005, J CELL BIOL, V171, P675, DOI 10.1083/jcb.200506038; Shigenobu S, 2006, P NATL ACAD SCI USA, V103, P13728, DOI 10.1073/pnas.0603767103; Siddiqui NU, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r11; Smallhorn M, 2004, DEVELOPMENT, V131, P2641, DOI 10.1242/dev.01150; Solana J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-2; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Vilmos P, 2007, ACTA BIOL HUNG, V58, P81, DOI 10.1556/ABiol.58.2007.Suppl.7; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; Weyers JJ, 2011, DEV BIOL, V353, P217, DOI 10.1016/j.ydbio.2011.02.023; Yohn CB, 2003, GENETICS, V165, P1889; Yuan HB, 2010, CURR OPIN CELL BIOL, V22, P730, DOI 10.1016/j.ceb.2010.08.013	66	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98579	10.1371/journal.pone.0098579	http://dx.doi.org/10.1371/journal.pone.0098579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896584	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000338430700051
J	Silberman, DM; Ross, K; Sande, PH; Kubota, S; Ramaswamy, S; Apte, RS; Mostoslavsky, R				Silberman, Dafne M.; Ross, Kenneth; Sande, Pablo H.; Kubota, Shunsuke; Ramaswamy, Sridhar; Apte, Rajendra S.; Mostoslavsky, Raul			SIRT6 Is Required for Normal Retinal Function	PLOS ONE			English	Article							ACUTE HYPOGLYCEMIA; HOMEOSTASIS; EXPRESSION; LONGEVITY	The retina is one of the major energy consuming tissues within the body. In this context, synaptic transmission between light-excited rod and cone photoreceptors and downstream ON-bipolar neurons is a highly demanding energy consuming process. Sirtuin 6 (SIRT6), a NAD-dependent deacylase, plays a key role in regulating glucose metabolism. In this study, we demonstrate that SIRT6 is highly expressed in the retina, controlling levels of histone H3K9 and H3K56 acetylation. Notably, despite apparent normal histology, SIRT6 deficiency caused major retinal transmission defects concomitant to changes in expression of glycolytic genes and glutamate receptors, as well as elevated levels of apoptosis in inner retina cells. Our results identify SIRT6 as a critical modulator of retinal function, likely through its effects on chromatin.	[Silberman, Dafne M.; Sande, Pablo H.] CEFyBO CONICET UBA, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina; [Silberman, Dafne M.; Ross, Kenneth; Ramaswamy, Sridhar; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Kubota, Shunsuke; Apte, Rajendra S.] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Kubota, Shunsuke; Apte, Rajendra S.] Washington Univ, St Louis, MO USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Harvard University; Harvard Medical School; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL)	Silberman, DM (corresponding author), CEFyBO CONICET UBA, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina.	dsilberman@fmed.uba.ar			CONICET [PIP 0030]; National Institutes of Health [GM093072-01]; NIH [R01EY019287, P30EY02687]; Carl Marshall and Mildred Almen Reeves Foundation Inc.; Lacy Foundation; Research to Prevent Blindness Inc. Unrestrict University; NATIONAL EYE INSTITUTE [P30EY002687, R01EY019287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl Marshall and Mildred Almen Reeves Foundation Inc.; Lacy Foundation; Research to Prevent Blindness Inc. Unrestrict University(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by PIP 0030 CONICET (D.M.S.), National Institutes of Health grant GM093072-01 (R.M.), NIH grant R01EY019287, NIH Vision Core Grant P30EY02687, the Carl Marshall and Mildred Almen Reeves Foundation Inc. Award, the Lacy Foundation research Award, and a Research to Prevent Blindness Inc. Unrestrict University (R.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2013, EXP GERONTOL, V48, P1212, DOI 10.1016/j.exger.2013.04.010; Barlow RB, 2003, ADV EXP MED BIOL, V533, P259; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dhingra A, 2000, J NEUROSCI, V20, P9053; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Ewing FME, 1998, PHYSIOL BEHAV, V64, P653, DOI 10.1016/S0031-9384(98)00120-6; Fernandez DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051966; Graymore C. N., 1970, BIOCH EYE, P645; Hennig AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069721; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Izumi Y, 2002, GLIA, V39, P58, DOI 10.1002/glia.10082; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; KUMAGAI AK, 1994, INVEST OPHTH VIS SCI, V35, P2887; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; McCrimmon RJ, 1996, BRAIN, V119, P1277, DOI 10.1093/brain/119.4.1277; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pelzel HR, 2012, INVEST OPHTH VIS SCI, V53, P1428, DOI 10.1167/iovs.11-8872; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; SKRANDIES W, 1992, NEUROSCI LETT, V134, P165, DOI 10.1016/0304-3940(92)90507-4; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhong Q, 2011, DIABETES, V60, P1304, DOI 10.2337/db10-0133	32	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98831	10.1371/journal.pone.0098831	http://dx.doi.org/10.1371/journal.pone.0098831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896097	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700084
J	Simon-Szabo, L; Kokas, M; Mandl, J; Keri, G; Csala, M				Simon-Szabo, Laura; Kokas, Marton; Mandl, Jozsef; Keri, Gyoergy; Csala, Miklos			Metformin Attenuates Palmitate-Induced Endoplasmic Reticulum Stress, Serine Phosphorylation of IRS-1 and Apoptosis in Rat Insulinoma Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INDUCED ER STRESS; FREE FATTY-ACIDS; RESISTANCE; LIPOTOXICITY; ACTIVATION; PROTECTION; SECRETION; OBESITY	Lipotoxicity refers to cellular dysfunctions caused by elevated free fatty acid levels playing a central role in the development and progression of obesity related diseases. Saturated fatty acids cause insulin resistance and reduce insulin production in the pancreatic islets, thereby generating a vicious cycle, which potentially culminates in type 2 diabetes. The underlying endoplasmic reticulum (ER) stress response can lead to even beta-cell death (lipoapoptosis). Since improvement of beta-cell viability is a promising anti-diabetic strategy, the protective effect of metformin, a known insulin sensitizer was studied in rat insulinoma cells. Assessment of palmitate-induced lipoapoptosis by fluorescent microscopy and by detection of caspase-3 showed a significant decrease in metformin treated cells. Attenuation of beta-cell lipotoxicity was also revealed by lower induction/activation of various ER stress markers, e.g. phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 alpha), c-Jun N-terminal kinase (JNK), insulin receptor substrate-1 (IRS-1) and induction of CCAAT/enhancer binding protein homologous protein (CHOP). Our results indicate that the beta-cell protective activity of metformin in lipotoxicity can be at least partly attributed to suppression of ER stress.	[Simon-Szabo, Laura; Mandl, Jozsef; Csala, Miklos] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Simon-Szabo, Laura; Kokas, Marton; Keri, Gyoergy] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, MTA SE Pathobiochem Res Grp, H-1085 Budapest, Hungary; [Keri, Gyoergy] Vichem Chem Res Ltd, Budapest, Hungary	Semmelweis University; Semmelweis University; Vichem Chemie Research Ltd.	Keri, G (corresponding author), Vichem Chem Res Ltd, Budapest, Hungary.	keri.gyorgy@med.semmelweis-univ.hu	Csala, Miklos/H-5369-2011	Csala, Miklos/0000-0002-3829-4361	Hungarian Scientific Research Fund [OTKA 104113, 106060]; Hungarian Research and Technological Innovation Fund [KMR_12-1-2012-0074]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technological Innovation Fund	This work was supported by the Hungarian Scientific Research Fund (OTKA 104113 and 106060) and by the Hungarian Research and Technological Innovation Fund (KMR_12-1-2012-0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baldwin AC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1390, DOI 10.1152/ajpendo.00519.2011; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004; Cho H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-9; Cnop M, 2008, BIOCHEM SOC T, V36, P909, DOI 10.1042/BST0360909; Combettes-Souverain M, 1998, DIABETES METAB, V24, P477; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Frohnert BI, 2013, DIABETES; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jung TW, 2012, BIOCHEM BIOPH RES CO, V417, P147, DOI 10.1016/j.bbrc.2011.11.073; Kim DS, 2010, IMMUNOPHARM IMMUNOT, V32, P251, DOI 10.3109/08923970903252220; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lupi R, 2002, DIABETES, V51, pS134, DOI 10.2337/diabetes.51.2007.S134; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; OBRIEN R, 1970, J HISTOCHEM CYTOCHEM, V18, P581, DOI 10.1177/18.8.581; Oh YS, 2013, J ENDOCRINOL, V216, P343, DOI 10.1530/JOE-12-0311; Olsen GS, 2002, AM J PHYSIOL-ENDOC M, V283, pE965, DOI 10.1152/ajpendo.00118.2002; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sommerweiss D, 2013, BIOCHEM BIOPH RES CO, V441, P770, DOI 10.1016/j.bbrc.2013.10.130; Tao JL, 2012, CHINESE MED J-PEKING, V125, P3137, DOI 10.3760/cma.j.issn.0366-6999.2012.17.031; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Welters HJ, 2004, FEBS LETT, V560, P103, DOI 10.1016/S0014-5793(04)00079-1; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6	29	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97868	10.1371/journal.pone.0097868	http://dx.doi.org/10.1371/journal.pone.0097868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896641	Green Published, gold			2022-12-25	WOS:000338430700017
J	Tulloch, O; Theobald, S; Ananworanich, J; Chasombat, S; Kosalaraksa, P; Jirawattanapisal, T; Lakonphon, S; Lumbiganon, P; Taegtmeyer, M				Tulloch, Olivia; Theobald, Sally; Ananworanich, Jintanat; Chasombat, Sanchai; Kosalaraksa, Pope; Jirawattanapisal, Thidaporn; Lakonphon, Sudrak; Lumbiganon, Pagakrong; Taegtmeyer, Miriam			From Transmission to Transition: Lessons Learnt from the Thai Paediatric Antiretroviral Programme	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; QUALITATIVE RESEARCH; NATIONAL PROGRAM; ADULT CARE; OUTCOMES; ADOLESCENTS; MODEL	Background: The Thai HIV programme is a leader in the public health approach to HIV treatment. Starting at transmission of HIV and ending with transition to adult services this paper assesses the paediatric HIV treatment continuum from three perspectives: service-user, provider and policy maker, to understand what works well and why. Methods: A qualitative research design was used to assess and triangulate the stakeholder perspectives. Semi-structured interviews were conducted with ART service-users (n = 35), policy actors (n = 20); telephone interviews with prior caregivers of orphans (n = 10); and three focus group discussions with service-providers (hospital staff and volunteers) from a district, provincial and a university hospital. Findings: Children accessing HIV care were often orphaned, cared for by elderly relatives and experiencing multiple vulnerabilities. Services were divided into three stages, 1. Diagnosis and linkage: Despite strong policies there were supply and demand-side gaps in the prevention of mother-to-child transmission 'cascade' preventing early diagnosis and/or treatment. 2. Maintenance on ART - Children did well on treatment; caregivers took adherence seriously and valued the quality of services. Drug resistance, adherence and psychosocial issues were important concerns from all perspectives. 3. Adolescents and transition: Adolescent service-users faced greater complexity in their physical and emotional lives for which providers lacked skills; transition from the security of paediatric clinic was a daunting prospect. Dedicated healthcare providers felt they struggled to deliver services that met service-users' diverse needs at all stages. Child-and adolescent-specific elements of HIV policy were considered low priority. Conclusions: Using the notion of the continuum of care a number of strengths and weaknesses were identified. Features of paediatric services need to evolve alongside the changing needs of service users. Peer-support volunteers have potential to add continuity and support at all stages. It is critical that adolescents receive targeted support, particularly during transition to adult services.	[Tulloch, Olivia; Theobald, Sally; Taegtmeyer, Miriam] Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England; [Ananworanich, Jintanat; Lakonphon, Sudrak] Thai Red Cross AIDS Res Ctr, SEARCH & HIV NAT, Bangkok, Thailand; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Chasombat, Sanchai; Jirawattanapisal, Thidaporn] Minist Publ Hlth, Dept Dis Control, Bur AIDS TB & Sexually Transmitted Infect, Nonthaburi, Thailand; [Kosalaraksa, Pope; Lumbiganon, Pagakrong] Khon Kaen Univ, Fac Med, Dept Pediat, Khon Kaen, Thailand	Liverpool School of Tropical Medicine; University of Liverpool; Thai Red Cross Society; Chulalongkorn University; Ministry of Public Health - Thailand; Khon Kaen University	Tulloch, O (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool L3 5QA, Merseyside, England.	oht@liv.ac.uk	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Taegtmeyer, Miriam/0000-0002-5377-2536; Theobald, Sally/0000-0002-9053-211X	Global Fund to Fight AIDS TB and Malaria	Global Fund to Fight AIDS TB and Malaria(United States Agency for International Development (USAID))	Data collection was funded by the Global Fund to Fight AIDS TB and Malaria, allocated by the Thai Ministry of Public Health. Ministry of Public Health co-authors were involved in the study design, analysis and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon-Yasidhi V, 2013, AIDS CARE, V25, P756, DOI 10.1080/09540121.2012.749331; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Cervia JS, 2013, AIDS PATIENT CARE ST, V27, P692, DOI 10.1089/apc.2013.0253; Chokephaibulkit K, 2013, PEDIAT INFECT DIS J; Department of Disease Control, COMM BAS PED HIV TRE; Department of Disease Control, 2011, THAIL NAT ANT TREATM; Doherty K, 2013, CURR OPIN HIV AIDS, V8, P457, DOI 10.1097/COH.0b013e328362db0d; Epidemiological Information Section Bureau of Epidemiology Department of Disease Control Thai Ministry of Public Health, 2010, 2545 TOT SENT SURV; Family Health International Bureau of AIDS TB and STIs Department of Disease Control MOPH Thailand, 2008, AS EP MOD AEM PROJ H, P2008; Hansudewechakul R, 2012, JIAS, V15; Hansudewechakul R, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17358; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jongudomkarn Darunee, 2006, Nurs Health Sci, V8, P156, DOI 10.1111/j.1442-2018.2006.00273.x; Kanshana S, 2002, AIDS, V16, P953, DOI 10.1097/00002030-200205030-00001; King E, 2009, INTERVENTIONS IMPROV; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kuntawee C, 2010, SE ASIAN J TROP MED, V41, P1136; Lee SJ, 2013, AIDS CARE, V25, P1536, DOI 10.1080/09540121.2013.793264; Lolekha R, 2010, JT COMM J QUAL PATIE, V36, P541, DOI 10.1016/S1553-7250(10)36082-X; Louthrenoo O, 2013, J INT ASS AIDS CARE; Lumbiganon D, 2009, ASIAN BIOMED, V3, P143; Maturo D, 2011, J PEDIATR HEALTH CAR, V25, P16, DOI 10.1016/j.pedhc.2009.12.005; Mays N, 2000, BRIT MED J, V320, P320, DOI DOI 10.1136/BMJ.320.7226.50.PUBMED:10617534; McConnell MS, 2010, JAIDS-J ACQ IMM DEF, V54, P423, DOI 10.1097/QAI.0b013e3181dc5eb0; National AIDS Prevention and Alleviation Committee UNGASS Country, 2009, NAT AIDS PREV ALL CO; National Statistical Office: Ministry of Information and Communication Technology, 2008, THAIL MULT IND CLUST; Press B, 2009, MIGRANTS HLTH VULNER; Punpanich W, 2011, J PAEDIATR CHILD H, V47, P27, DOI 10.1111/j.1440-1754.2010.01886.x; Puthanakit T, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-20; RITCHIE J, 1996, ANAL QUALITATIVE DAT; Sankar A, 2006, JAIDS-J ACQ IMM DEF, V43, pS54, DOI 10.1097/01.qai.0000248341.28309.79; Sharma N, 2013, J ASS NURSES AIDS CA; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Sirinirund P, 2010, COMPREHENSIVE HIV AI; Torpey K, 2010, BMC HEALTH SERV RES, V10, P1472, DOI [10.1186/1472-6963-10-29, DOI 10.1186/1472-6963-10-29]; Voramongkol N, 2013, SE ASIAN J TROP MED, V44, P997; Weigel R, 2009, BMC PEDIATR, V9; Wolf F, 2010, J MIX METHOD RES, V4, P144, DOI 10.1177/1558689810364987; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization SEARO Ministry of Public Health Thai MOPH-US CDC Collaboration Thai AIDS Society Pediatric Infectious Disease Society, 2007, SCAL ANT TREATM LESS	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99061	10.1371/journal.pone.0099061	http://dx.doi.org/10.1371/journal.pone.0099061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24893160	gold, Green Published, Green Accepted			2022-12-25	WOS:000336911400123
J	Moody, SE; Schinzel, AC; Singh, S; Izzo, F; Strickland, MR; Luo, L; Thomas, SR; Boehm, JS; Kim, SY; Wang, ZC; Hahn, WC				Moody, S. E.; Schinzel, A. C.; Singh, S.; Izzo, F.; Strickland, M. R.; Luo, L.; Thomas, S. R.; Boehm, J. S.; Kim, S. Y.; Wang, Z. C.; Hahn, W. C.			PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling	ONCOGENE			English	Article							DEPENDENT PROTEIN-KINASE; TRASTUZUMAB RESISTANCE; MONOCLONAL-ANTIBODY; SINGLE-AGENT; BETA-CATENIN; PHOSPHORYLATION; LAPATINIB; ACTIVATION; CHEMOTHERAPY; INHIBITION	Targeting HER2 with antibodies or small molecule inhibitors in HER2-positive breast cancer leads to improved survival, but resistance is a common clinical problem. To uncover novel mechanisms of resistance to anti-HER2 therapy in breast cancer, we performed a kinase open reading frame screen to identify genes that rescue HER2-amplified breast cancer cells from HER2 inhibition or suppression. In addition to multiple members of the MAPK (mitogen-activated protein kinase) and PI3K (phosphoinositide 3-kinase) signaling pathways, we discovered that expression of the survival kinases PRKACA and PIM1 rescued cells from anti-HER2 therapy. Furthermore, we observed elevated PRKACA expression in trastuzumab-resistant breast cancer samples, indicating that this pathway is activated in breast cancers that are clinically resistant to trastuzumab-containing therapy. We found that neither PRKACA nor PIM1 restored MAPK or PI3K activation after lapatinib or trastuzumab treatment, but rather inactivated the pro-apoptotic protein BAD, the BCl-2-associated death promoter, thereby permitting survival signaling through BCL-XL. Pharmacological blockade of BCL-XL/BCL-2 partially abrogated the rescue effects conferred by PRKACA and PIM1, and sensitized cells to lapatinib treatment. These observations suggest that combined targeting of HER2 and the BCL-XL/BCL-2 anti-apoptotic pathway may increase responses to anti-HER2 therapy in breast cancer and decrease the emergence of resistant disease.	[Moody, S. E.; Schinzel, A. C.; Singh, S.; Izzo, F.; Strickland, M. R.; Luo, L.; Hahn, W. C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Moody, S. E.; Luo, L.; Hahn, W. C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Moody, S. E.; Luo, L.; Wang, Z. C.; Hahn, W. C.] Harvard Univ, Sch Med, Boston, MA USA; [Thomas, S. R.; Boehm, J. S.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Kim, S. Y.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Wang, Z. C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Wang, Z. C.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Duke University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,Dana 1538, Boston, MA 02115 USA.	William_Hahn@dfci.harvard.edu		Luo, Leo/0000-0002-3061-4287; Boehm, Jesse/0000-0002-6795-6336	Department of Defense [W81XWH-10-1-0575]; Komen Grant [CCR13262292]; Breast Cancer Research Foundation; NIH [R01 CA130988, U01 CA176058, U54 CA112962]; NATIONAL CANCER INSTITUTE [U01CA176058, R01CA130988, U54CA112962] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Komen Grant(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Drs Ines Luis, Nancy Lin and Eric Winer for assistance in obtaining patient tissue samples. This work was supported by the Department of Defense Grant W81XWH-10-1-0575 and the Komen Grant CCR13262292 (to SEM), by the Breast Cancer Research Foundation (to ZCW), and by the NIH grants R01 CA130988, U01 CA176058 and U54 CA112962 (to WCH).	Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Blackwell KL, 2009, ANN ONCOL, V20, P1026, DOI 10.1093/annonc/mdn759; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fleming GF, 2012, BREAST CANCER RES TR, V136, P355, DOI 10.1007/s10549-011-1910-7; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gu L, 2009, CLIN CANCER RES, V15, P7196, DOI 10.1158/1078-0432.CCR-09-0585; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Jegg AM, 2012, BREAST CANCER RES TR, V136, P683, DOI 10.1007/s10549-012-2252-9; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Morrow PK, 2011, J CLIN ONCOL, V29, P3126, DOI 10.1200/JCO.2010.32.2321; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2007, MOL CANCER THER, V6, P667, DOI 10.1158/1535-7163.MCT-06-0423; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; Vegran F, 2009, BRIT J CANCER, V101, P1357, DOI 10.1038/sj.bjc.6605310; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Vogel C, 2001, EUR J CANCER, V37, pS25, DOI 10.1016/S0959-8049(00)00405-6; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	42	56	59	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2015	34	16					2061	2071		10.1038/onc.2014.153	http://dx.doi.org/10.1038/onc.2014.153			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CG3IL	24909179	Green Accepted, Green Submitted			2022-12-25	WOS:000353173400006
J	Weitkamp, JH; Rosen, MJ; Zhao, Z; Koyama, T; Geem, D				Weitkamp, J-H; Rosen, M. J.; Zhao, Z.; Koyama, T.; Geem, D.			Small Intestinal Intraepithelial TCR gamma delta(+) T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis (vol 9, e99042, 2014)	PLOS ONE			English	Correction													Weitkamp, Joern-Hendrik/AAZ-8272-2020; Moore, Daniel J/A-4924-2008; Denning, Patricia W/G-4485-2011; Moore, Daniel/V-6145-2019	Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Denning, Timothy/0000-0002-1072-7444; Rosen, Michael/0000-0002-5149-718X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059122, K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090146, P30DK058404, P30DK020593, R24DK064399, K23DK094832, R21DK102058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NCATS NIH HHS [2 UL1 TR000445-06, UL1 TR000445] Funding Source: Medline; NCRR NIH HHS [UL1 RR024975, UL1 RR024975-01] Funding Source: Medline; NICHD NIH HHS [R01 HD059122, R01HD05922, K08HD061607, K08 HD061607] Funding Source: Medline; NIDDK NIH HHS [P30DK058404, K08 DK090146, 5K08DK090146-03, P30DK20593, R24 DK064399, R21 DK102058, P30 DK058404, K23DK094832, K23 DK094832, DK 063399, P30 DK020593] Funding Source: Medline; NIGMS NIH HHS [T32 GM008169] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Weitkamp JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099042, 10.1371/journal.pone.0105487]	1	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e105487	10.1371/journal.pone.0105487	http://dx.doi.org/10.1371/journal.pone.0105487			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	24905458	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100097
J	Wang, LH; Cao, HL; Liu, LP; Wang, BM; Walker, WA; Acra, SA; Yan, F				Wang, Lihong; Cao, Hailong; Liu, Liping; Wang, Bangmao; Walker, W. Allan; Acra, Sari A.; Yan, Fang			Activation of Epidermal Growth Factor Receptor Mediates Mucin Production Stimulated by p40, a Lactobacillus rhamnosus GG-derived Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; GENE-EXPRESSION; IN-VITRO; DEPENDENT MECHANISM; SOLUBLE-PROTEIN; DRUG-DELIVERY; MOUSE STOMACH; MUCUS LAYERS; SECRETION; COLON	The mucus layer coating the gastrointestinal tract serves as the first line of intestinal defense against infection and injury. Probiotics promote mucin production by goblet cells in the intestine. p40, a Lactobacillus rhamnosus GG-derived soluble protein, has been shown to transactivate the EGF receptor (EGFR) in intestinal epithelial cells, which is required for inhibition of apoptosis and preservation of barrier function in the colon, thereby ameliorating intestinal injury and colitis. Because activation of EGFR has been shown to up-regulate mucin production in goblet cells, the purpose of this study was to investigate the effects and mechanisms of p40 regulation of mucin production. p40 activated EGFR and its downstream target, Akt, in a concentration-dependent manner in LS174T cells. p40 stimulated Muc2 gene expression and mucin production in LS174T cells, which were abolished by inhibition of EGFR kinase activity, down-regulation of EGFR expression by EGFR siRNA transfection, or suppression of Akt activation. Treatment with p40 increased mucin production in the colonic epithelium, thus thickening the mucus layer in the colon of wild type, but not of Egfr(wa5) mice, which have a dominant negative mutation in the EGFR kinase domain. Furthermore, inhibition of mucin-type O-linked glycosylation suppressed the effect of p40 on increasing mucin production and protecting intestinal epithelial cells from TNF-induced apoptosis in colon organ culture. Thus, these results suggest that p40-stimulated activation of EGFR mediates up-regulation of mucin production, which may contribute to the mechanisms by which p40 protects the intestinal epithelium from injury.	[Wang, Lihong; Liu, Liping; Acra, Sari A.; Yan, Fang] Vanderbilt Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Med Ctr, Nashville, TN 37232 USA; [Cao, Hailong; Wang, Bangmao] Tianjin Med Univ, Dept Gastroenterol, Gen Hosp, Tianjin 300052, Peoples R China; [Walker, W. Allan] Harvard Univ, Mucosal Immunol & Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	Vanderbilt University; Tianjin Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yan, F (corresponding author), Vanderbilt Univ, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Med Ctr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01 DK081134, P01 DK033506, R01 HD059126, P30 DK058404]; Research Fund for the Doctoral Program of Higher Education of China [20121202110018]; National Natural Science Foundation of China [81300272]; Tianjin Research Program of Application Foundation and Advanced Technology of China [13JCQNJC10600]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK033506, R01DK081134, P30DK040561, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK081134 (to F. Y.), and P01 DK033506 and R01 HD059126 (to W. A. W.), and P30 DK058404 (to Vanderbilt University Medical Center's Digestive Disease Research Center). This work was also supported by Research Fund for the Doctoral Program of Higher Education of China Grant 20121202110018 (to B. M. W.), and National Natural Science Foundation of China Grant 81300272 (to H. L. C.) and Tianjin Research Program of Application Foundation and Advanced Technology of China Grant 13JCQNJC10600 (to H. L. C.).	Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Dartt DA, 2000, EXP EYE RES, V71, P619, DOI 10.1006/exer.2000.0915; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Garcia MAS, 2009, J CLIN INVEST, V119, P2613, DOI 10.1172/JCI38662; Gorbach SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Hodges RR, 2012, EXP EYE RES, V103, P99, DOI 10.1016/j.exer.2012.08.010; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kim YD, 2002, J KOREAN MED SCI, V17, P765, DOI 10.3346/jkms.2002.17.6.765; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mattar AF, 2002, PEDIATR SURG INT, V18, P586, DOI 10.1007/s00383-002-0855-7; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Okamoto R, 2009, AM J PHYSIOL-GASTR L, V296, pG23, DOI 10.1152/ajpgi.90225.2008; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Perrais M, 2002, J BIOL CHEM, V277, P32258, DOI 10.1074/jbc.M204862200; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Rubin Bruce K, 2002, Respir Care, V47, P761; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Truant S, 2003, INT J CANCER, V104, P683, DOI 10.1002/ijc.11011; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2013, J BIOL CHEM, V288, P30742, DOI 10.1074/jbc.M113.492397; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	51	88	93	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20234	20244		10.1074/jbc.M114.553800	http://dx.doi.org/10.1074/jbc.M114.553800			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895124	Green Published, hybrid			2022-12-25	WOS:000339395200036
J	Du, J; Cui, CH; Park, SC; Kim, JK; Yu, HS; Jin, FX; Sun, CK; Kim, SC; Im, WT				Du, Juan; Cui, Chang-Hao; Park, Sung Chul; Kim, Jin-Kwang; Yu, Hong-Shan; Jin, Feng-Xie; Sun, Changkai; Kim, Sun-Chang; Im, Wan-Taek			Identification and Characterization of a Ginsenoside-Transforming beta-Glucosidase from Pseudonocardia sp Gsoil 1536 and Its Application for Enhanced Production of Minor Ginsenoside Rg(2)(S)	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PANAX-GINSENG; COMPOUND K; ENZYMATIC BIOTRANSFORMATION; SIMULTANEOUS QUANTIFICATION; RARE GINSENOSIDES; PA14 DOMAIN; RED GINSENG; SP NOV.; GLYCOSIDE	The ginsenoside Rg(2)(S), which is one of the pharmaceutical components of ginseng, is known to have neuroprotective, antiinflammation, and anti-diabetic effects. However, the usage of ginsenoside Rg2(S) is restricted owing to the small amounts found in white and red ginseng. To enhance the production of ginsenoside Rg2(S) as a 100 gram unit with high specificity, yield, and purity, an enzymatic bioconversion method was developed to adopt the recombinant glycoside hydrolase (BglPC28), which is a ginsenoside-transforming recombinant beta-glucosidase from Pseudonocardia sp. strain Gsoil 1536. The gene, termed bglPC28, encoding beta-glucosidase (BglPC28) belonging to the glycoside hydrolase family 3 was cloned. bglPC28 consists of 2,232 bp (743 amino acid residues) with a predicted molecular mass of 78,975 Da. This enzyme was overexpressed in Escherichia coli BL21(DE3) using a GST-fused pGEX 4T-1 vector system. The optimum conditions of the recombinant BglPC28 were pH 7.0 and 37 degrees C. BglPC28 can effectively transform the ginsenoside Re to Rg2(S); the Km values of PNPG and Re were 6.36 +/- 1.10 and 1.42 +/- 0.13 mM, respectively, and the V-max values were 40.0 +/- 2.55 and 5.62 +/- 0.21 mmol min(-1) mg(-)1 of protein, respectively. A scaled-up biotransformation reaction was performed in a 10 L jar fermenter at pH 7.0 and 30 degrees C for 12 hours with a concentration of 20 mg/ml of ginsenoside Re from American ginseng roots. Finally, 113 g of Rg2(S) was produced from 150 g of Re with 84.0 +/- 1.1% chromatographic purity. These results suggest that this enzymatic method could be usefully exploited in the preparation of ginsenoside Rg(2)(S) in the cosmetics, functional food, and pharmaceutical industries.	[Du, Juan; Kim, Jin-Kwang; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Taejon 305701, South Korea; [Du, Juan; Yu, Hong-Shan; Jin, Feng-Xie] Dalian Polytech Univ, Coll Biotechnol, Dalian, Peoples R China; [Cui, Chang-Hao; Kim, Sun-Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Sung Chul; Kim, Sun-Chang] Intelligent Synthet Biol Ctr, Taejon, South Korea; [Sun, Changkai] Dalian Med Univ, Inst Brain Disorders, Dalian, Peoples R China; [Im, Wan-Taek] Hankyoung Natl Univ, Dept Biotechnol, Chungang No, Anseong Si, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Dalian Polytechnic University; Korea Advanced Institute of Science & Technology (KAIST); Dalian Medical University	Im, WT (corresponding author), Hankyoung Natl Univ, Dept Biotechnol, Chungang No, Anseong Si, South Korea.	wandra@hknu.ac.kr	Cui, Changhao/ABC-8055-2021; SUN, CHANG/GXM-3680-2022; Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011		Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology of Republic of Korea [2011-0031967]; China Major Projects [2012ZX09503001-003]	Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); China Major Projects	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031967) of Republic of Korea and by the China Major Projects No. 2012ZX09503001-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2012, APPL MICROBIOL BIOT, V94, P673, DOI 10.1007/s00253-011-3614-7; An DS, 2011, INT J SYST EVOL MICR, V61, P2606, DOI 10.1099/ijs.0.028431-0; An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bae EA, 2005, BIOL PHARM BULL, V28, P1903, DOI 10.1248/bpb.28.1903; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Chi H, 2005, BIOTECHNOL LETT, V27, P765, DOI 10.1007/s10529-005-5632-y; Cho IH, 2012, J GINSENG RES, V36, P342, DOI 10.5142/jgr.2012.36.4.342; Cho YS, 2013, KOREAN J PHYSIOL PHA, V17, P133, DOI 10.4196/kjpp.2013.17.2.133; Choi SH, 2011, J GINSENG RES, V35, P191, DOI 10.5142/jgr.2011.35.2.191; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Christensen LP, 2009, ADV FOOD NUTR RES, V55, P1, DOI 10.1016/S1043-4526(08)00401-4; Cleland W W, 1979, Methods Enzymol, V63, P103; Cui CH, 2013, APPL ENVIRON MICROB, V79, P5788, DOI 10.1128/AEM.01150-13; Cui CH, 2013, APPL MICROBIOL BIOT, V97, P649, DOI 10.1007/s00253-012-4324-5; Cui CH, 2011, J MICROBIOL, V49, P393, DOI 10.1007/s12275-011-1176-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ha SE, 2010, N-S ARCH PHARMACOL, V382, P89, DOI 10.1007/s00210-010-0522-9; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Hofseth LJ, 2007, J NUTR, V137, p183S, DOI 10.1093/jn/137.1.183S; Hong H, 2012, J GINSENG RES, V36, P418, DOI 10.5142/jgr.2012.36.4.418; In G, 2012, J GINSENG RES, V36, P205, DOI 10.5142/jgr.2012.36.2.205; Jeong SJ, 2007, INT J TOXICOL, V26, P151, DOI 10.1080/10915810701226370; Jin XF, 2012, J MICROBIOL BIOTECHN, V22, P343, DOI 10.4014/jmb.1107.07066; Kang S, 2012, J GINSENG RES, V36, P354, DOI 10.5142/jgr.2012.36.4.354; Kim JK, 2013, FOOD CHEM, V141, P1369, DOI 10.1016/j.foodchem.2013.04.012; Kim JK, 2012, J BIOTECHNOL, V161, P294, DOI 10.1016/j.jbiotec.2012.06.021; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Kim SN, 2007, J PHARMACEUT BIOMED, V45, P164, DOI 10.1016/j.jpba.2007.05.001; Kim YJ, 2013, J AGR FOOD CHEM, V61, P9185, DOI 10.1021/jf402774d; Kimura MA, 1985, NEUTRAL THEORY MOL E; Ko SR, 2003, PLANTA MED, V69, P285, DOI 10.1055/s-2003-38476; Korea Food & Drug Administration (KFDA), PROD REC HLTH FUNCT; Lee F.C., 1992, FACTS GINSENG ELIXIR; Lee GW, 2012, BIOTECHNOL LETT, V34, P1679, DOI 10.1007/s10529-012-0949-9; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Lee JH, 2011, J GINSENG RES, V35, P375, DOI 10.5142/jgr.2011.35.3.375; Leung K.W., 2010, BIOMED CENTRAL, V5, P20; Li N, 2007, J ETHNOPHARMACOL, V111, P458, DOI 10.1016/j.jep.2006.12.015; Liu QM, 2013, ANTON LEEUW INT J G, V103, P747, DOI 10.1007/s10482-012-9856-2; Lu Jie, 2001, Zhongguo Zhongyao Zazhi, V26, P556; Noh KH, 2009, BIOL PHARM BULL, V32, P1830, DOI 10.1248/bpb.32.1830; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park HJ, 2012, J GINSENG RES, V36, P225, DOI 10.5142/jgr.2012.36.3.225; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Quan LH, 2012, J IND MICROBIOL BIOT, V39, P1557, DOI 10.1007/s10295-012-1158-1; Quan LH, 2012, BIOTECHNOL LETT, V34, P913, DOI 10.1007/s10529-012-0849-z; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Quan LH, 2012, APPL MICROBIOL BIOT, V94, P377, DOI 10.1007/s00253-011-3861-7; Rigden DJ, 2004, TRENDS BIOCHEM SCI, V29, P335, DOI 10.1016/j.tibs.2004.05.002; Ruan CC, 2009, MOLECULES, V14, P2043, DOI 10.3390/molecules14062043; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SUN LQ, 2004, ASIAN J DRUG METABOL, V4, P261; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian JW, 2009, PHYTOTHER RES, V23, P486, DOI 10.1002/ptr.2653; Wang L, 2012, J MICROBIOL BIOTECHN, V22, P311, DOI 10.4014/jmb.1106.06041; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Yuan HD, 2012, CHEM-BIOL INTERACT, V195, P35, DOI 10.1016/j.cbi.2011.10.006; Yuan HD, 2011, METABOLISM, V60, P43, DOI 10.1016/j.metabol.2009.12.024; Zhang GZ, 2008, J ETHNOPHARMACOL, V115, P441, DOI 10.1016/j.jep.2007.10.026; Zmudka MW, 2013, PROTEIN SCI, V22, P883, DOI 10.1002/pro.2204	65	31	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e96914	10.1371/journal.pone.0096914	http://dx.doi.org/10.1371/journal.pone.0096914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911166	Green Submitted, gold, Green Published			2022-12-25	WOS:000337165600123
J	Hellewell, AL; Foresti, O; Gover, N; Porter, MY; Hewitt, EW				Hellewell, Andrew L.; Foresti, Ombretta; Gover, Nicola; Porter, Morwenna Y.; Hewitt, Eric W.			Analysis of Familial Hemophagocytic Lymphohistiocytosis Type 4 (FHL-4) Mutant Proteins Reveals that S-Acylation Is Required for the Function of Syntaxin 11 in Natural Killer Cells	PLOS ONE			English	Article							N-TERMINAL PEPTIDE; MUTATIONS; BINDING; SNARE; PALMITOYLATION; MUNC18-1; SNAP-23; GOLGI; CYTOTOXICITY; DISSECTION	Natural killer (NK) cell secretory lysosome exocytosis and cytotoxicity are impaired in familial hemophagocytic lymphohistiocytosis type 4 (FHL-4), a disorder caused by mutations in the gene encoding the SNARE protein syntaxin 11. We show that syntaxin 11 binds to SNAP23 in NK cells and that this interaction is reduced by FHL-4 truncation and frameshift mutation proteins that delete all or part of the SNARE domain of syntaxin 11. In contrast the FHL-4 mutant proteins bound to the Sec-1/Munc18-like (SM) protein Munc18-2. We demonstrate that the C-terminal cysteine rich region of syntaxin 11, which is deleted in the FHL-4 mutants, is S-acylated. This posttranslational modification is required for the membrane association of syntaxin 11 and for its polarization to the immunological synapse in NK cells conjugated to target cells. Moreover, we show that Munc18-2 is recruited by syntaxin 11 to intracellular membranes in resting NK cells and to the immunological synapse in activated NK cells. This recruitment of Munc18-2 is abolished by deletion of the C-terminal cysteine rich region of syntaxin 11. These results suggest a pivotal role for S-acylation in the function of syntaxin 11 in NK cells.	[Hewitt, Eric W.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Hewitt, EW (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	e.w.hewitt@leeds.ac.uk	Foresti, Ombretta/M-3930-2019; Foresti, Ombretta/J-8165-2015	Foresti, Ombretta/0000-0002-6878-0395; Foresti, Ombretta/0000-0002-6878-0395; Hewitt, Eric/0000-0002-6238-6303	Wellcome Trust [089410/Z/09/Z]; BBSRC [BB/526502/1]	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust (089410/Z/09/Z) and BBSRC (BB/526502/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneson LN, 2007, J IMMUNOL, V179, P3397, DOI 10.4049/jimmunol.179.6.3397; Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Cetica V, 2010, J MED GENET, V47, P595, DOI 10.1136/jmg.2009.075341; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; D'Orlando O, 2013, EUR J IMMUNOL, V43, P194, DOI 10.1002/eji.201142343; Dabrazhynetskaya A, 2012, J CELL MOL MED, V16, P129, DOI 10.1111/j.1582-4934.2011.01280.x; Danielian S, 2010, J CLIN IMMUNOL, V30, P330, DOI 10.1007/s10875-009-9350-4; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Dugan GE, 2008, J VIROL, V82, P3271, DOI 10.1128/JVI.01705-07; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; He YH, 2009, J LIPID RES, V50, P398, DOI 10.1194/jlr.M800360-JLR200; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Macartney CA, 2011, PEDIATR BLOOD CANCER, V56, P654, DOI 10.1002/pbc.22676; Marsh RA, 2010, PEDIATR BLOOD CANCER, V55, P134, DOI 10.1002/pbc.22499; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Meeths M, 2010, BLOOD, V116, P2635, DOI 10.1182/blood-2010-05-282541; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Muller ML, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00515; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; Prekeris R, 2000, EUR J CELL BIOL, V79, P771, DOI 10.1078/0171-9335-00109; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rowe J, 2001, J CELL SCI, V114, P3323; Rowe J, 1999, J CELL SCI, V112, P1865; Sakurai C, 2012, MOL BIOL CELL, V23, P4849, DOI 10.1091/mbc.E12-01-0069; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Topham NJ, 2009, IMMUNOLOGY, V128, P7, DOI 10.1111/j.1365-2567.2009.03123.x; Valdez AC, 1999, J CELL SCI, V112, P845; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Xie LX, 2009, INFLAMM RES, V58, P407, DOI 10.1007/s00011-009-0006-x; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603; Zhang ST, 2008, BRIT J HAEMATOL, V142, P469, DOI 10.1111/j.1365-2141.2008.07191.x; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98900	10.1371/journal.pone.0098900	http://dx.doi.org/10.1371/journal.pone.0098900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24910990	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600019
J	Jin, JO; Zhang, W; Du, JY; Wong, KW; Oda, T; Yu, Q				Jin, Jun-O; Zhang, Wei; Du, Jiang-Yuan; Wong, Ka-Wing; Oda, Tatsuya; Yu, Qing			Fucoidan Can Function as an Adjuvant In Vivo to Enhance Dendritic Cell Maturation and Function and Promote Antigen-Specific T Cell Immune Responses	PLOS ONE			English	Article							A SCAVENGER RECEPTOR; LANGERHANS CELLS; VIRUS-INFECTION; CANCER; CTL; MACROPHAGES; CYTOTOXICITY; STIMULATION; VACCINES	Fucoidan, a sulfated polysaccharide purified from brown algae, has a variety of immune-modulation effects, including promoting antigen uptake and enhancing anti-viral and anti-tumor effects. However, the effect of fucoidan in vivo, especially its adjuvant effect on in vivo anti-tumor immune responses, was not fully investigated. In this study, we investigated the effect of fucoidan on the function of spleen dendritic cells (DCs) and its adjuvant effect in vivo. Systemic administration of fucoidan induced up-regulation of CD40, CD80 and CD86 expression and production of IL-6, IL-12 and TNF-alpha in spleen cDCs. Fucoidan also promoted the generation of IFN-gamma-producing Th1 and Tc1 cells in an IL-12-dependent manner. When used as an adjuvant in vivo with ovalbumin (OVA) antigen, fucoidan promoted OVA-specific antibody production and primed IFN-gamma production in OVA-specific T cells. Moreover, fucoidan enhanced OVA-induced up-regulation of MHC class I and II on spleen cDCs and strongly prompted the proliferation of OVA-specific CD4 and CD8 T cells. Finally, OVA immunization with fucoidan as adjuvant protected mice from the challenge with B16-OVA tumor cells. Taken together, these results suggest that fucoidan can function as an adjuvant to induce Th1 immune response and CTL activation, which may be useful in tumor vaccine development.	[Jin, Jun-O; Zhang, Wei; Du, Jiang-Yuan; Wong, Ka-Wing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Oda, Tatsuya] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 852, Japan; [Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Fudan University; Nagasaki University; Harvard University; Forsyth Institute	Jin, JO (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	Junojin1@gmail.com	yu, qing/HGC-4611-2022; Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	Shanghai Public Health Clinical Center in Fudan University [RCJJP17]; NIH [R01 DE023838]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023838] Funding Source: NIH RePORTER	Shanghai Public Health Clinical Center in Fudan University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the Shanghai Public Health Clinical Center in Fudan University (RCJJP17) and NIH grant R01 DE023838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Cao T, 2007, EUR J IMMUNOL, V37, P2657, DOI 10.1002/eji.200636499; Cerundolo V, 2004, NAT IMMUNOL, V5, P7, DOI 10.1038/ni0104-7; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Dubensky TW, 2010, SEMIN IMMUNOL, V22, P155, DOI 10.1016/j.smim.2010.04.007; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Hu YL, 2010, BIOCHEM BIOPH RES CO, V392, P329, DOI 10.1016/j.bbrc.2010.01.018; Jin JO, 2009, BLOOD, V113, P5839, DOI 10.1182/blood-2008-10-184796; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kawashima T, 2012, INT J MOL MED, V29, P447, DOI 10.3892/ijmm.2011.854; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851; Lasarte JJ, 2007, J IMMUNOL, V178, P748, DOI 10.4049/jimmunol.178.2.748; Miconnet I, 2001, J IMMUNOL, V166, P4612, DOI 10.4049/jimmunol.166.7.4612; Mori N, 2012, WORLD J GASTROENTERO, V18, P2225, DOI 10.3748/wjg.v18.i18.2225; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Perret R, 2013, CANCER RES, V73, P6597, DOI 10.1158/0008-5472.CAN-13-0875; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Takeda K, 2012, INT J ONCOL, V40, P251, DOI 10.3892/ijo.2011.1168; Thelen T, 2010, J IMMUNOL, V185, P4328, DOI 10.4049/jimmunol.1000989; Watts C, 2004, NAT IMMUNOL, V5, P685, DOI 10.1038/ni1088; Yang M, 2008, INT IMMUNOPHARMACOL, V8, P1754, DOI 10.1016/j.intimp.2008.08.007	34	62	66	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99396	10.1371/journal.pone.0099396	http://dx.doi.org/10.1371/journal.pone.0099396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911024	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600080
J	Jing, SL; Zhang, L; Ma, YH; Liu, BF; Zhao, Y; Yu, HJ; Zhou, X; Qin, R; Zhu, LL; He, GC				Jing, Shengli; Zhang, Lei; Ma, Yinhua; Liu, Bingfang; Zhao, Yan; Yu, Hangjin; Zhou, Xi; Qin, Rui; Zhu, Lili; He, Guangcun			Genome-Wide Mapping of Virulence in Brown Planthopper Identifies Loci That Break Down Host Plant Resistance	PLOS ONE			English	Article							NILAPARVATA-LUGENS HOMOPTERA; GENETIC-LINKAGE MAP; RICE; COEVOLUTION; BIOTYPES; DELPHACIDAE; POPULATIONS; MARKERS; POTATO; IRRI	Insects and plants have coexisted for over 350 million years and their interactions have affected ecosystems and agricultural practices worldwide. Variation in herbivorous insects' virulence to circumvent host resistance has been extensively documented. However, despite decades of investigation, the genetic foundations of virulence are currently unknown. The brown planthopper (Nilaparvata lugens) is the most destructive rice (Oryza sativa) pest in the world. The identification of the resistance gene Bph1 and its introduction in commercial rice varieties prompted the emergence of a new virulent brown planthopper biotype that was able to break the resistance conferred by Bph1. In this study, we aimed to construct a high density linkage map for the brown planthopper and identify the loci responsible for its virulence in order to determine their genetic architecture. Based on genotyping data for hundreds of molecular markers in three mapping populations, we constructed the most comprehensive linkage map available for this species, covering 96.6% of its genome. Fifteen chromosomes were anchored with 124 gene-specific markers. Using genome-wide scanning and interval mapping, the Qhp7 locus that governs preference for Bph1 plants was mapped to a 0.1 cM region of chromosome 7. In addition, two major QTLs that govern the rate of insect growth on resistant rice plants were identified on chromosomes 5 (Qgr5) and 14 (Qgr14). This is the first study to successfully locate virulence in the genome of this important agricultural insect by marker-based genetic mapping. Our results show that the virulence which overcomes the resistance conferred by Bph1 is controlled by a few major genes and that the components of virulence originate from independent genetic characters. The isolation of these loci will enable the elucidation of the molecular mechanisms underpinning the rice-brown planthopper interaction and facilitate the development of durable approaches for controlling this most destructive agricultural insect.	[Jing, Shengli; Ma, Yinhua; Liu, Bingfang; Zhao, Yan; Yu, Hangjin; Zhou, Xi; Zhu, Lili; He, Guangcun] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Zhang, Lei; Qin, Rui] South Cent Univ Nationalities, Coll Life Sci, Engn Res Ctr Protect & Utilizat Biol Resources Mi, Wuhan, Peoples R China	Wuhan University; South Central Minzu University	He, GC (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	gche@whu.edu.cn		He, Guangcun/0000-0001-6395-4774	National Natural Science Foundation of China [31230060]; China Postdoctoral Science Foundation [2012M521463]; Science and Technology Project of Zhejiang Province [2012C22041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Project of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31230060), the China Postdoctoral Science Foundation (Grant No. 2012M521463) and the Science and Technology Project of Zhejiang Province (Grant No. 2012C22041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias MC, 2012, MOL ECOL RESOUR, V12, P570, DOI 10.1111/j.1755-0998.2012.03133.x; ATHWAL DS, 1971, CROP SCI, V11, P747, DOI 10.2135/cropsci1971.0011183X001100050043x; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bass C, 2012, INSECT SCI, V19, P1, DOI 10.1111/j.1744-7917.2011.01440.x; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; BUHL A, 2006, SPSS 14 PEARSON STUD; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Cheng XY, 2013, PLANT J, V76, P687, DOI 10.1111/tpj.12328; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHURCHILL GA, 1994, GENETICS, V138, P963; CLARIDGE MF, 1982, ENTOMOL EXP APPL, V32, P213, DOI 10.1111/j.1570-7458.1982.tb03208.x; CLARIDGE MF, 1980, ENTOMOL EXP APPL, V27, P23, DOI 10.1007/BF00377236; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; DENHOLLANDER J, 1981, ENTOMOL EXP APPL, V29, P76, DOI 10.1007/BF00300752; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fishman L, 2001, GENETICS, V159, P1701; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Fujita D., 2009, PLANTHOPPERS NEW THR, P389; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Han YC, 2008, ELECTROPHORESIS, V29, P1355, DOI 10.1002/elps.200700558; HE GC, 2013, GENETICS GENOMICS RI, P177; Jairin J, 2013, DNA RES, V20, P17, DOI 10.1093/dnares/dss030; Jena KK, 2010, RICE, V3, P161, DOI 10.1007/s12284-010-9050-y; Jing S, 2012, B ENTOMOL RES, V102, P113, DOI 10.1017/S0007485311000435; Jing SL, 2012, INT J MOL SCI, V13, P9527, DOI 10.3390/ijms13089527; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katiyar SK, 2000, GENOME, V43, P322, DOI 10.1139/gen-43-2-322; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Knott SA, 1997, THEOR APPL GENET, V94, P810, DOI 10.1007/s001220050482; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; Myint KKM, 2009, APPL ENTOMOL ZOOL, V44, P149, DOI 10.1303/aez.2009.149; Occhipinti A, 2013, J PLANT INTERACT, V8, P188, DOI 10.1080/17429145.2013.816881; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; PATHAK MD, 1969, NATURE, V223, P502, DOI 10.1038/223502a0; Pauquet J, 2004, MAP BASED CLONING VA, P325; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Ratcliffe RH, 2000, J ECON ENTOMOL, V93, P1319, DOI 10.1603/0022-0493-93.4.1319; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Roderick George K., 1994, P551; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; SOGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P193, DOI 10.1303/aez.16.193; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SOGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P129, DOI 10.1303/aez.16.129; Sun JT, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13401; Tanaka K, 1999, ENTOMOL EXP APPL, V90, P279, DOI 10.1023/A:1026456230292; Tang M, 2010, APPL ENVIRON MICROB, V76, P1740, DOI 10.1128/AEM.02240-09; Van Ooijen J.W, 2009, MAPQTL 6 0 SOFTWARE; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	63	21	24	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98911	10.1371/journal.pone.0098911	http://dx.doi.org/10.1371/journal.pone.0098911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911169	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600022
J	Lv, CY; Chen, ML; Xu, M; Xu, GP; Zhang, Y; He, SM; Xue, MJ; Gao, J; Yu, MX; Gao, X; Zhu, TY				Lv, Chaoyang; Chen, Minling; Xu, Ming; Xu, Guiping; Zhang, Yao; He, Shunmei; Xue, Mengjuan; Gao, Jian; Yu, Mingxiang; Gao, Xin; Zhu, Tongyu			Influencing Factors of New-Onset Diabetes after a Renal Transplant and Their Effects on Complications and Survival Rate	PLOS ONE			English	Article							KIDNEY-PANCREAS TRANSPLANTATION; ENERGY PHOSPHATE-METABOLISM; GLUCOSE-METABOLISM; RISK-FACTORS; INSULIN SENSITIVITY; MELLITUS; CYCLOSPORINE; RECIPIENTS; DISEASE; IMPACT	Objective: To discuss the onset of and relevant risk factors for new-onset diabetes after a transplant (NODAT) in patients who survive more than 1 year after undergoing a renal transplant and the influence of these risk factors on complications and long-term survival. Method: A total of 428 patients who underwent a renal transplant between January 1993 and December 2008 and were not diabetic before surgery were studied. The prevalence rate of and relevant risk factors for postoperative NODAT were analyzed on the basis of fasting plasma glucose (FPG) levels, and differences in postoperative complications and survival rates between patients with and without NODAT were compared. Results: The patients in this study were followed up for a mean of 5.65 +/- 3.68 years. In total, 87 patients (20.3%) developed NODAT. Patients who converted from treatment with CSA to FK506 had increased prevalence rates of NODAT (P<0.05). Multi-factor analysis indicated that preoperative FPG level (odds ratio [OR] = 1.48), age (OR = 1.10), body mass index (OR = 1.05), hepatitis C virus infection (OR = 2.72), and cadaveric donor kidney (OR = 1.18) were independent risk factors for NODAT (All P,0.05). Compared with the N-NODAT group, the NODAT group had higher prevalence rates (P< 0.05) of postoperative infection, hypertension, and dyslipidemia; in addition, the survival rate and survival time of the 2 groups did not significantly differ. Conclusion: Among the patients who survived more than 1 year after a renal transplant, the prevalence rate of NODAT was 20.32%. Preoperative FPG level, age, body mass index, hepatitis C virus infection, and cadaveric donor kidney were independent risk factors for NODAT. Patients who converted from treatment with CSA to FK506 after a renal transplant had aggravated impairments in glycometabolism. Patients with NODAT were also more vulnerable to postoperative complications such as infection, hypertension, and hyperlipidemia.	[Lv, Chaoyang; Chen, Minling; Xu, Guiping; Zhang, Yao; He, Shunmei; Xue, Mengjuan; Yu, Mingxiang; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Xu, Ming; Zhu, Tongyu] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai Key Lab Organ Transplantat, Shanghai 200433, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Evidence Base Med Ctr, Shanghai 200433, Peoples R China; [Chen, Minling] Fujian Univ Tradit Chinese Med, Peoples Hosp Fujian Prov, Peoples Hosp, Dept Endocrinol & Metab, Fuzhou, Peoples R China; [Xu, Guiping] Fujian Med Univ, Fujian Prov Hosp, Dept Cadres Ward, Fuzhou, Fujian, Peoples R China	Fudan University; Fudan University; Fudan University; Fujian University of Traditional Chinese Medicine; Fujian Medical University; Fujian Provincial Hospital	Yu, MX (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China.	yu.mingxiang@zs-hospital.sh.cn; gao.xin@zs-hospital.sh.cn		Gao, Xin/0000-0003-1864-7796				Abu Elmagd MM, 2008, EXP CLIN TRANSPLANT, V6, P42; Aktas A, 2014, SEMIN NUCL MED, V44, P129, DOI 10.1053/j.semnuclmed.2013.10.005; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Baid-Agrawal S, 2009, AM J TRANSPLANT, V9, P2777, DOI 10.1111/j.1600-6143.2009.02843.x; Bergrem HA, 2010, NEPHROL DIAL TRANSPL, V25, P985, DOI 10.1093/ndt/gfp566; Borda B, 2012, ACTA PHYSIOL HUNG, V99, P206, DOI 10.1556/APhysiol.99.2012.2.14; Brzezinska B, 2013, ENDOKRYNOL POL, V64, P21; Cighetti G, 2009, FREE RADICAL BIO MED, V47, P307, DOI 10.1016/j.freeradbiomed.2009.05.007; Cotovio P, 2013, TRANSPL P, V45, P1079, DOI 10.1016/j.transproceed.2013.03.009; D'Addio Francesca, 2012, G Ital Nefrol, V29, P44; Davidson J, 2003, TRANSPLANTATION, V75, pSS3, DOI 10.1097/01.TP.0000069952.49242.3E; Davidson JA, 2004, DIABETES CARE, V27, P805, DOI 10.2337/diacare.27.3.805; Del Carro U, 2007, DIABETES CARE, V30, P3063, DOI 10.2337/dc07-0206; Ducloux D, 2005, TRANSPLANTATION, V79, P438, DOI 10.1097/01.TP.0000151799.98612.EB; Fernandez LA, 1999, TRANSPLANTATION, V68, P1532, DOI 10.1097/00007890-199911270-00017; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Fiorina P, 2004, DIABETES, V53, P2291, DOI 10.2337/diabetes.53.9.2291; Fiorina P, 2007, DIABETES CARE, V30, P597, DOI 10.2337/dc06-1324; Fiorina P, 2012, ACTA DIABETOL, V49, pS133, DOI 10.1007/s00592-012-0369-2; Fiorina P, 2012, DIABETES CARE, V35, P367, DOI 10.2337/dc11-1697; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; Hagen M, 2003, NEPHROL DIAL TRANSPL, V18, P2154, DOI 10.1093/ndt/gfg338; Hanto DW, 2008, AM J TRANSPLANT, V8, P1765, DOI 10.1111/j.1600-6143.2008.02348.x; Hecking M, 2013, NEPHROL DIAL TRANSPL, V28, P1; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Huang JF, 2007, LIVER TRANSPLANT, V13, P193, DOI 10.1002/lt.21081; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Hur KY, 2007, DIABETES CARE, V30, P609, DOI 10.2337/dc06-1277; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; Kuo HT, 2010, TRANSPLANTATION, V89, P434, DOI 10.1097/TP.0b013e3181c47a91; Luan FL, 2008, AM J TRANSPLANT, V8, P1871, DOI 10.1111/j.1600-6143.2008.02328.x; Luan FL, 2011, TRANSPLANTATION, V91, P334, DOI 10.1097/TP.0b013e318203c25f; Luan FL, 2010, CLIN TRANSPLANT, V24, P778, DOI 10.1111/j.1399-0012.2009.01194.x; Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794; Maldonado F, 2009, TRANSPL P, V41, P2664, DOI 10.1016/j.transproceed.2009.06.133; Marin M, 2005, TRANSPL P, V37, P1851, DOI 10.1016/j.transproceed.2005.03.140; Mathew JT, 2003, NEPHROL DIAL TRANSPL, V18, P164, DOI 10.1093/ndt/18.1.164; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Neetha S, 2008, J INDIAN SOC PERIODO, V12, P41; Neumayer HH, 1996, NEPHROL DIAL TRANSPL, V11, P165; Orsenigo E, 2005, TRANSPL P, V37, P3570, DOI 10.1016/j.transproceed.2005.09.059; Orsenigo E, 2004, TRANSPL P, V36, P1072, DOI 10.1016/j.transproceed.2004.04.056; Orsenigo E, 2004, TRANSPL P, V36, P568; Ozbay LA, 2011, BRIT J PHARMACOL, V162, P136, DOI 10.1111/j.1476-5381.2010.01018.x; Paroni R, 2005, AMINO ACIDS, V28, P389, DOI 10.1007/s00726-005-0191-z; Perseghin G, 2005, J AM COLL CARDIOL, V46, P1085, DOI 10.1016/j.jacc.2005.05.075; Polastri L, 2002, ACTA DIABETOL, V39, P229, DOI 10.1007/s005920200039; Porrini E, 2006, AM J KIDNEY DIS, V48, P134, DOI 10.1053/j.ajkd.2006.04.078; Salonia A, 2011, TRANSPLANTATION, V92, P802, DOI 10.1097/TP.0b013e31822c6eb8; Sezer S, 2012, TRANSPL P, V44, P2893, DOI 10.1016/j.transproceed.2012.09.111; TAMURA K, 1995, TRANSPLANTATION, V59, P1606, DOI 10.1097/00007890-199506150-00018; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Valderhaug TG, 2011, DIABETOLOGIA, V54, P1341, DOI 10.1007/s00125-011-2105-9; van Duijnhoven EM, 2001, J AM SOC NEPHROL, V12, P583, DOI 10.1681/ASN.V123583; Wiesbauer F, 2010, TRANSPLANTATION, V89, P612, DOI 10.1097/TP.0b013e3181c6ffa4; Wilkinson A, 2005, CLIN TRANSPLANT, V19, P291, DOI 10.1111/j.1399-0012.2005.00359.x; Wyzgal J, 2007, ANN TRANSPL, V12, P26; Xu Y, 2011, DIABETES RES CLIN PR, V92, P11, DOI 10.1016/j.diabres.2010.12.006; Zelle DM, 2010, AM J TRANSPLANT, V10, P106, DOI 10.1111/j.1600-6143.2009.02876.x	60	22	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99406	10.1371/journal.pone.0099406	http://dx.doi.org/10.1371/journal.pone.0099406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911157	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600082
J	Endo, H; Okuyama, H; Ohue, M; Inoue, M				Endo, Hiroko; Okuyama, Hiroaki; Ohue, Masayuki; Inoue, Masahiro			Dormancy of Cancer Cells with Suppression of AKT Activity Contributes to Survival in Chronic Hypoxia	PLOS ONE			English	Article							ACTIVATION; CULTURE; OXYGEN; MECHANISMS; PHYSIOLOGY; MODELS; SYSTEM; KINASE; TARGET; GROWTH	A hypoxic microenvironment in tumors has been recognized as a cause of malignancy or resistance to various cancer therapies. In contrast to recent progress in understanding the acute response of cancer cells to hypoxia, the characteristics of tumor cells in chronic hypoxia remain elusive. We have identified a pancreatic cancer cell line, AsPC-1, that is exceptionally able to survive for weeks under 1% oxygen conditions while most tested cancer cell lines die after only some days under these conditions. In chronic hypoxia, AsPC-1 cells entered a state of dormancy characterized by no proliferation, no death, and metabolic suppression. They reversibly switched to active status after being placed again in optimal culture conditions. ATP turnover, an indicator of energy demand, was markedly decreased and accompanied by reduced AKT phosphorylation. Forced activation of AKT resulted in increased ATP turnover and massive cell death in vitro and a decreased number of dormant cells in vivo. In contrast to most cancer cell lines, primary-cultured colorectal cancer cells easily entered the dormant status with AKT suppression under hypoxia combined with growth factor-depleted conditions. Primary colorectal cancer cells in dormancy were resistant to chemotherapy. Thus, the ability to survive in a deteriorated microenvironment by entering into dormancy under chronic hypoxia might be a common property among cancer cells. Targeting the regulatory mechanism inducing this dormant status could provide a new strategy for treating cancer.	[Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan; [Okuyama, Hiroaki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Ohue, Masayuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases	Inoue, M (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan.	inoue-ma2@mc.pref.osaka.jp			KAKENHI [25461937]; Charitable Trust Osaka Cancer Researcher-Found; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [25461937] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Charitable Trust Osaka Cancer Researcher-Found; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (25461937) (www.jsps.go.jp/j-grantsinaid/, H.E., M.I.), the Charitable Trust Osaka Cancer Researcher-Found (H.E.), Japan Foundation for Applied Enzymology (www.mt-pharma.co.jp/jfae/, H.E., H.O., M.I.), Takeda Science Foundation (www.takeda-sci.or.jp/, M.I.), and The Naito Foundation (www.naito-f.or.jp/, M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Berg S, 2003, CRIT CARE MED, V31, P1203, DOI 10.1097/01.CCM.0000059647.92390.92; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dekervel J, 2014, CLIN CANCER RES, V20, P2159, DOI 10.1158/1078-0432.CCR-13-2958; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; El Touny LH, 2014, J CLIN INVEST, V124, P156, DOI 10.1172/JCI70259; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Guppy M, 1997, J CELL PHYSIOL, V170, P1, DOI 10.1002/(SICI)1097-4652(199701)170:1<1::AID-JCP1>3.0.CO;2-S; Harada H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1786; Hochachka P. W., 2002, BIOCH ADAPTATION; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiao M, 2012, INT J ONCOL, V40, P461, DOI 10.3892/ijo.2011.1197; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kyle AH, 2012, CANCER RES, V72, P801, DOI 10.1158/0008-5472.CAN-11-3059; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Mardilovich K, 2009, CANCER RES, V69, P8894, DOI 10.1158/0008-5472.CAN-09-1152; Masuyama N, 2001, J BIOL CHEM, V276, P32799, DOI 10.1074/jbc.M105431200; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Okuyama H, 2010, CANCER RES, V70, P10213, DOI 10.1158/0008-5472.CAN-10-2720; Polytarchou C, 2011, CANCER RES, V71, P4720, DOI 10.1158/0008-5472.CAN-11-0365; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Saggar JK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00154; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Stegeman H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-463; Storey KB, 2001, MOL MECH METABOLIC; Tannock IF, 2001, CANCER METAST REV, V20, P123, DOI 10.1023/A:1013125027697; TANNOCK IF, 1968, BRIT J CANCER, V22, P258, DOI 10.1038/bjc.1968.34; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoshimura M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685308	41	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98858	10.1371/journal.pone.0098858	http://dx.doi.org/10.1371/journal.pone.0098858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905002	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000072
J	Nagar, H; Jung, SB; Kwon, SK; Park, JB; Shong, M; Song, HJ; Jeon, BH; Irani, K; Kim, CS				Nagar, Harsha; Jung, Saet-byel; Kwon, Sun Kwan; Park, Jung-Bum; Shong, Minho; Song, Hee-Jung; Jeon, Byeong Hwa; Irani, Kaikobad; Kim, Cuk-Seong			CRIF1 Deficiency Induces p66shc-Mediated Oxidative Stress and Endothelial Activation	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL DYSFUNCTION; LIFE-SPAN; PHOSPHORYLATION; P66(SHC); PROTEIN; P66SHC; SHC; DELETION; ASSOCIATION	Mitochondrial dysfunction has been implicated in the pathophysiology of various cardiovascular diseases. CRIF1 is a protein present in the mitochondria associated with large mitoribosomal subunits, and CRIF1 knockdown induces mitochondrial dysfunction and promotes ROS production. p66shc is a redox enzyme implicated in mitochondrial ROS generation and translation of oxidative signals and, therefore, is a key factor for oxidative stress in endothelial cells. In this study, we investigated whether mitochondrial dysfunction induced by CRIF1 knockdown induces p66shc stimulation and plays any role in mitochondrial dysfunction-induced endothelial activation. Knockdown of CRIF1 decreased the expression of mitochondrial oxidative phosphorylation (OXPHOS) complexes I, III and IV, leading to increased mitochondrial ROS (mtROS) and hyperpolarization of the mitochondrial membrane potential. Knockdown of CRIF1 also stimulated phosphorylation of p66shc and increased cytosolic ROS in endothelial cells. Furthermore, the expression of vascular cell adhesion molecule-1 and endoplasmic reticulum stress proteins were increased upon CRIF1 knockdown in endothelial cells. However, p66shc knockdown blunted the alteration in mitochondrial dynamics and ROS production in CRIF1 knockdown endothelial cells. In addition, p66shc knockdown reduced the CRIF1 knockdown-induced increases in adhesion between monocytes and endothelial cells. Taken together, these results suggest that CRIF1 knockdown partially induces endothelial activation via increased ROS production and phosphorylation of p66shc.	[Nagar, Harsha; Kwon, Sun Kwan; Park, Jung-Bum; Jeon, Byeong Hwa; Kim, Cuk-Seong] Chungnam Natl Univ, Sch Med, Dept Physiol, Taejon, South Korea; [Jung, Saet-byel; Shong, Minho] Chungnam Natl Univ Hosp, Dept Endocrinol, Taejon, South Korea; [Song, Hee-Jung] Chungnam Natl Univ Hosp, Dept Neurol, Taejon, South Korea; [Irani, Kaikobad] Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA	Chungnam National University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Chungnam National University Hospital; University of Iowa	Kim, CS (corresponding author), Chungnam Natl Univ, Sch Med, Dept Physiol, Taejon, South Korea.	cskim@cnu.ac.kr	Jeon, Byeong Hwa/D-4160-2012; /H-7803-2012	Jeon, Byeong Hwa/0000-0002-3347-2739; Song, Hee-Jung/0000-0001-9572-4105; Kim, Cuk-Seong/0000-0001-7647-6089; Irani, Kaikobad/0000-0001-9194-7387; shong, minho/0000-0002-0247-7115; Nagar, Harsha/0000-0002-2879-0118	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0023858]; Chungnam National University; Chungnam National University Hospital	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Chungnam National University; Chungnam National University Hospital	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0023858), Chungnam National University and Chungnam National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Camici GG, 2008, J APPL PHYSIOL, V105, P1628, DOI 10.1152/japplphysiol.90579.2008; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; De Marchi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/564961; Fink BD, 2005, AM J PHYSIOL-ENDOC M, V288, pE71, DOI 10.1152/ajpendo.00332.2004; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kao AW, 1997, ENDOCRINOLOGY, V138, P2474, DOI 10.1210/en.138.6.2474; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Martin-Padura I, 2008, ENDOTHELIUM-J ENDOTH, V15, P276, DOI 10.1080/10623320802487791; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pinton P, 2008, CELL CYCLE, V7, P304, DOI 10.4161/cc.7.3.5360; Rimessi A, 2007, CELL STRESS CHAPERON, V12, P291, DOI 10.1379/CSC-211.1; Robinson BH, 1998, J INHERIT METAB DIS, V21, P598, DOI 10.1023/A:1005427323835; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Ryu MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003356; Ryu MJ, 2013, MOL CELLS, V35, P134, DOI 10.1007/s10059-012-2257-1; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Skulachev VP, 2000, IUBMB LIFE, V49, P177; Thorburn DR, 2004, NAT GENET, V36, P13, DOI 10.1038/ng0104-13; Trinei M, 2009, AGING-US, V1, P503, DOI 10.18632/aging.100057; Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182; Yang CPH, 2000, CANCER RES, V60, P5171; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98670	10.1371/journal.pone.0098670	http://dx.doi.org/10.1371/journal.pone.0098670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906005	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000048
J	Gu, YH; Tao, X; Lai, XJ; Wang, HY; Zhang, YZ				Gu, Ying-Hong; Tao, Xiang; Lai, Xian-Jun; Wang, Hai-Yan; Zhang, Yi-Zheng			Exploring the Polyadenylated RNA Virome of Sweet Potato through High-Throughput Sequencing	PLOS ONE			English	Article							FEATHERY-MOTTLE-VIRUS; GENOME SEQUENCE; COAT PROTEIN; IDENTIFICATION; DISEASE; GENUS; SWEET-POTATO-VIRUS-2; DIFFERENTIATION; POTYVIRUSES; SYMPTOMS	Background: Viral diseases are the second most significant biotic stress for sweet potato, with yield losses reaching 20% to 40%. Over 30 viruses have been reported to infect sweet potato around the world, and 11 of these have been detected in China. Most of these viruses were detected by traditional detection approaches that show disadvantages in detection throughput. Next-generation sequencing technology provides a novel, high sensitive method for virus detection and diagnosis. Methodology/Principal Findings: We report the polyadenylated RNA virome of three sweet potato cultivars using a high throughput RNA sequencing approach. Transcripts of 15 different viruses were detected, 11 of which were detected in cultivar Xushu18, whilst 11 and 4 viruses were detected in Guangshu 87 and Jingshu 6, respectively. Four were detected in sweet potato for the first time, and 4 were found for the first time in China. The most prevalent virus was SPFMV, which constituted 88% of the total viral sequence reads. Virus transcripts with extremely low expression levels were also detected, such as transcripts of SPLCV, CMV and CymMV. Digital gene expression (DGE) and reverse transcription polymerase chain reaction (RT-PCR) analyses showed that the highest viral transcript expression levels were found in fibrous and tuberous roots, which suggest that these tissues should be optimum samples for virus detection. Conclusions/Significance: A total of 15 viruses were presumed to present in three sweet potato cultivars growing in China. This is the first insight into the sweet potato polyadenylated RNA virome. These results can serve as a basis for further work to investigate whether some of the 'new' viruses infecting sweet potato are pathogenic.	[Gu, Ying-Hong; Lai, Xian-Jun; Wang, Hai-Yan; Zhang, Yi-Zheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China; [Tao, Xiang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Zhang, YZ (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Sichuan Key Lab Mol Biol & Biotechnol, Coll Life Sci,Minist Educ,Ctr Funct Genom & Bioin, Chengdu 610064, Sichuan, Peoples R China.	yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleven-Five" Key Project of Sichuan Province [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleven-Five" Key Project of Sichuan Province	This work was financially supported by the National Science & Technology Pillar Program of China (No. 2007BAD78B03) and the "Eleven-Five" Key Project of Sichuan Province (No. 07SG111-003-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Aritua V, 1998, ANN APPL BIOL, V132, P387, DOI 10.1111/j.1744-7348.1998.tb05216.x; Ateka EM, 2007, ARCH VIROL, V152, P479, DOI 10.1007/s00705-006-0879-8; Ateka EM, 2004, ANN APPL BIOL, V144, P371, DOI 10.1111/j.1744-7348.2004.tb00353.x; Ateka EM, 2004, ARCH VIROL, V149, P225, DOI 10.1007/s00705-003-0233-3; Chen XuanYang, 2001, Journal of Fujian Agricultural University, V30, P449; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Clark CA, 2012, PLANT DIS, V96, P168, DOI 10.1094/PDIS-07-11-0550; Clark CA, 2010, HORTTECHNOLOGY, V20, P977, DOI 10.21273/HORTSCI.20.6.977; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; COLINET D, 1993, J VIROL METHODS, V45, P149, DOI 10.1016/0166-0934(93)90099-D; Colinet D, 1996, AGRO FOOD IND HI TEC, V7, P33; Colinet D, 1997, VIRUS RES, V49, P91, DOI 10.1016/S0168-1702(97)01456-1; Colinet D, 1998, PLANT DIS, V82, P223, DOI 10.1094/PDIS.1998.82.2.223; de VRIES C. A., 1967, NETH J AGR SCI, V15, P241; Du XiHua, 1999, Plant Physiology Communications, V35, P185; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gao F, 2000, CROP PROT, V19, P105, DOI 10.1016/S0261-2194(99)00085-X; GEDDES AMW, 1990, RELATIVE IMPORTANCE; Gibbs A, 1997, J VIROL METHODS, V63, P9, DOI 10.1016/S0166-0934(96)02103-9; Gibson RW, 1998, PLANT PATHOL, V47, P95, DOI 10.1046/j.1365-3059.1998.00196.x; Karyeija RF, 1998, PLANT DIS, V82, P4, DOI 10.1094/PDIS.1998.82.1.4; Khan MB, 2012, J ANIM PLANT SCI, V22, P309; Kokkinos CD, 2006, PLANT DIS, V90, P783, DOI 10.1094/PD-90-0783; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kreuze JF, 2000, ARCH VIROL, V145, P567, DOI 10.1007/s007050050047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2012, J VIROL METHODS, V186, P161, DOI 10.1016/j.jviromet.2012.07.021; Li F, 2012, VIRUS GENES, V45, P118, DOI 10.1007/s11262-012-0749-2; Loebenstein G., 2009, P105, DOI 10.1007/978-1-4020-9475-0_8; Luan YS, 2006, PLANT DIS, V90, P1111, DOI 10.1094/PD-90-1111C; Ma CJ, 2012, BIODEGRADATION, V23, P907, DOI 10.1007/s10532-012-9583-4; Mbanzibwa DR, 2012, PLANT DIS, V96, P1430; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIE F, 2000, CHINESE AGR SCI B, V16, P13; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Perez-Egusquiza Z, 2009, PLANT DIS, V93, P427, DOI 10.1094/PDIS-93-4-0427B; Qiao Q, 2011, PLANT DIS, V95, P356, DOI 10.1094/PDIS-09-10-0675; SCHAEFERS GA, 1976, PHYTOPATHOLOGY, V66, P642, DOI 10.1094/Phyto-66-642; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Stathers T., 2005, MANUAL SWEETPOTATO I, P168; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tao X, 2013, BIOSCI BIOTECH BIOCH, V77, P2169, DOI 10.1271/bbb.130218; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Trenado HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027329; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; Wang QM, 2010, CROP PROT, V29, P110, DOI 10.1016/j.cropro.2009.11.002; Wang RL, 2008, ARCH VIROL, V153, P1765, DOI 10.1007/s00705-008-0180-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang ChongLiang, 1998, Acta Phytophylacica Sinica, V25, P51; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15; Zhang LM, 2006, ACTA HORTIC, P71; Zhang LiMing, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P316; Zhang Yu-qi, 2005, Chinese Journal of Medical Imaging Technology, V21, P74	57	19	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98884	10.1371/journal.pone.0098884	http://dx.doi.org/10.1371/journal.pone.0098884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901789	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400066
J	Olivares, MJ; Gonzalez-Jamett, AM; Guerra, MJ; Baez-Matus, X; Haro-Acuna, V; Martinez-Quiles, N; Cardenas, AM				Jose Olivares, Maria; Gonzalez-Jamett, Arlek M.; Jose Guerra, Maria; Baez-Matus, Ximena; Haro-Acuna, Valentina; Martinez-Quiles, Narcisa; Cardenas, Ana M.			Src Kinases Regulate De Novo Actin Polymerization during Exocytosis in Neuroendocrine Chromaffin Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASE; FUSION PORE EXPANSION; N-WASP; FAMILY KINASES; CORTICAL ACTIN; F-ACTIN; C-SRC; CORTACTIN; PHOSPHORYLATION; DYNAMICS	The cortical actin network is dynamically rearranged during secretory processes. Nevertheless, it is unclear how de novo actin polymerization and the disruption of the preexisting actin network control transmitter release. Here we show that in bovine adrenal chromaffin cells, both formation of new actin filaments and disruption of the preexisting cortical actin network are induced by Ca2+ concentrations that trigger exocytosis. These two processes appear to regulate different stages of exocytosis; whereas the inhibition of actin polymerization with the N-WASP inhibitor wiskostatin restricts fusion pore expansion, thus limiting the release of transmitters, the disruption of the cortical actin network with cytochalasin D increases the amount of transmitter released per event. Further, the Src kinase inhibitor PP2, and cSrc SH2 and SH3 domains also suppress Ca2+-dependent actin polymerization, and slow down fusion pore expansion without disturbing the cortical Factin organization. Finally, the isolated SH3 domain of c-Src prevents both the disruption of the actin network and the increase in the quantal release induced by cytochalasin D. These findings support a model where a rise in the cytosolic Ca2+ triggers actin polymerization through a mechanism that involves Src kinases. The newly formed actin filaments would speed up the expansion of the initial fusion pore, whereas the preexisting actin network might control a different step of the exocytosis process.	[Jose Olivares, Maria; Gonzalez-Jamett, Arlek M.; Jose Guerra, Maria; Baez-Matus, Ximena; Haro-Acuna, Valentina; Cardenas, Ana M.] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Martinez-Quiles, Narcisa] Univ Complutense Madrid, Fac Med, Dept Microbiol Inmunol, Madrid, Spain	Universidad de Valparaiso; Complutense University of Madrid	Cardenas, AM (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	ana.cardenas@uv.cl	Martinez-Quiles, Narcisa/G-8514-2013	Martinez Quiles, Narcisa/0000-0002-0366-6591; Baez-Matus, Ximena/0000-0002-4176-0239	ICM-ECONOMIA, Chile [FONDECYT 1110552, P09-022-F]	ICM-ECONOMIA, Chile	This work has been supported by grants FONDECYT 1110552 and P09-022-F from ICM-ECONOMIA, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Allen CM, 1996, J NEUROSCI RES, V44, P421, DOI 10.1002/(SICI)1097-4547(19960601)44:5<421::AID-JNR2>3.0.CO;2-H; Ardiles AO, 2007, J NEUROCHEM, V103, P1574, DOI 10.1111/j.1471-4159.2007.04871.x; Ardiles AO, 2006, J NEUROCHEM, V99, P29, DOI 10.1111/j.1471-4159.2006.04080.x; Berberian K, 2009, J NEUROSCI, V29, P863, DOI 10.1523/JNEUROSCI.2818-08.2009; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; De Corte V, 1999, PROTEIN SCI, V8, P234; Doreian BW, 2008, J NEUROSCI, V28, P4470, DOI 10.1523/JNEUROSCI.0008-08.2008; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Finkelstein M, 2010, J BIOL CHEM, V285, P39702, DOI 10.1074/jbc.M110.170951; Garcia-Palomero E, 2000, J NEUROCHEM, V74, P1049, DOI 10.1046/j.1471-4159.2000.0741049.x; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Giner D, 2005, J CELL SCI, V118, P2871, DOI 10.1242/jcs.02419; Gonzalez-Jamett Arlek M, 2013, Front Endocrinol (Lausanne), V4, P126, DOI 10.3389/fendo.2013.00126; Gonzalez-Jamett AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070638; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Monteiro ANA, 2006, BIOCHIMIE, V88, P905, DOI 10.1016/j.biochi.2006.01.013; Neco P, 2008, J BIOL CHEM, V283, P10949, DOI 10.1074/jbc.M709058200; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PARSONS SJ, 1986, BIOCHEM BIOPH RES CO, V134, P736, DOI 10.1016/S0006-291X(86)80482-X; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Samasilp P, 2012, J NEUROSCI, V32, P10438, DOI 10.1523/JNEUROSCI.1299-12.2012; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Trifaro JM, 2000, NEUROCHEM RES, V25, P133, DOI 10.1023/A:1007503919265; VITALE N, 1993, J BIOL CHEM, V268, P14715; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Wang SJ, 2003, NEUROREPORT, V14, P1519, DOI 10.1097/00001756-200308060-00024; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Wijetunge S, 2000, BRIT J PHARMACOL, V129, P1347, DOI 10.1038/sj.bjp.0703186; Wollman R, 2012, NAT CELL BIOL, V14, P1261, DOI 10.1038/ncb2614; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zhang ZT, 2013, J CELL BIOCHEM, V114, P144, DOI 10.1002/jcb.24311; ZHAO YH, 1992, P NATL ACAD SCI USA, V89, P8298, DOI 10.1073/pnas.89.17.8298; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7	53	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99001	10.1371/journal.pone.0099001	http://dx.doi.org/10.1371/journal.pone.0099001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901433	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400085
J	Marshall, SM; Gromovsky, AD; Kelley, KL; Davis, MA; Wilson, MD; Lee, RG; Crooke, RM; Graham, MJ; Rudel, LL; Brown, JM; Temel, RE				Marshall, Stephanie M.; Gromovsky, Anthony D.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.			Acute Sterol O-Acyltransferase 2 (SOAT2) Knockdown Rapidly Mobilizes Hepatic Cholesterol for Fecal Excretion	PLOS ONE			English	Article							APOLIPOPROTEIN-E; ACYL-COENZYME; DENSITY-LIPOPROTEIN; HEART-DISEASE; ACAT2; BILIARY; ESTER; LIVER; LDL; ATHEROSCLEROSIS	The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux (TICE). We previously showed that chronic knockdown of the hepatic cholesterol esterifying enzyme sterol O-acyltransferase 2 (SOAT2) increased fecal cholesterol loss via TICE. To elucidate the initial events that stimulate TICE, C57Bl/6 mice were fed a high cholesterol diet to induce hepatic cholesterol accumulation and were then treated for 1 or 2 weeks with an antisense oligonucleotide targeting SOAT2. Within 2 weeks of hepatic SOAT2 knockdown (SOAT2(HKD)), the concentration of cholesteryl ester in the liver was reduced by 70% without a reciprocal increase in hepatic free cholesterol. The rapid mobilization of hepatic cholesterol stores resulted in a similar to 2-fold increase in fecal neutral sterol loss but no change in biliary cholesterol concentration. Acute SOAT2(HKD) increased plasma cholesterol carried primarily in lipoproteins enriched in apoB and apoE. Collectively, our data suggest that acutely reducing SOAT2 causes hepatic cholesterol to be swiftly mobilized and packaged onto nascent lipoproteins that feed cholesterol into the TICE pathway for fecal excretion.	[Marshall, Stephanie M.; Kelley, Kathryn L.; Davis, Matthew A.; Wilson, Martha D.; Rudel, Lawrence L.; Brown, J. Mark; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA; [Lee, Richard G.; Crooke, Rosanne M.; Graham, Mark J.] ISIS Pharmaceut, Cardiovasc Grp, Antisense Drug Discovery, Carlsbad, CA 92008 USA; [Gromovsky, Anthony D.; Brown, J. Mark] Cleveland Clin Fdn, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Temel, Ryan E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	Wake Forest University; Wake Forest Baptist Medical Center; Isis Pharmaceuticals Inc; Cleveland Clinic Foundation; University of Kentucky	Brown, JM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27103 USA.	brownm5@ccf.org; ryan.temel@uky.edu			National Heart, Lung, and Blood Institute of the National Institutes of Health [P01-HL049373, K99/R00-HL096166, K99/R00-HL088528]; Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096166, P01HL049373, K99HL088528] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute of the National Institutes of Health (http://www.nhlbi.nih.gov/) funded this work through the following awards: P01-HL049373 to LLR, K99/R00-HL096166 to JMB, and K99/R00-HL088528 to RET. Co authors RMC, RGL, and MJG are employees of and have ownership interest in Isis Pharmaceuticals. Isis Pharmaceuticals provided support in the form of salaries for authors RMC, RGL, and MJG, but did not have any additional role in the study design, data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Besseling J, 2013, DRUGS, V73, P293, DOI 10.1007/s40265-013-0028-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brufau G, 2011, ARTERIOSCL THROM VAS, V31, P1726, DOI 10.1161/ATVBAHA.108.181206; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Furbee JW, 2002, J LIPID RES, V43, P428; Gilham D, 2004, REV ENDOCR METAB DIS, V5, P303, DOI 10.1023/B:REMD.0000045101.42431.c7; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOODMAN DS, 1965, PHYSIOL REV, V45, P747, DOI 10.1152/physrev.1965.45.4.747; Jiang XC, 2003, J BIOL CHEM, V278, P49072, DOI 10.1074/jbc.M304274200; Le May Cedric, 2013, Arterioscler Thromb Vasc Biol, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Melchior JT, 2013, J LIPID RES, V54, P2495, DOI 10.1194/jlr.M039644; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Robinet P, 2013, ARTERIOSCL THROM VAS, V33, P903, DOI 10.1161/ATVBAHA.112.301041; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200; Temel RE, 2012, CURR OPIN LIPIDOL, V23, P85, DOI 10.1097/MOL.0b013e3283508c21; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; Vrins CLJ, 2012, J LIPID RES, V53, P2017, DOI 10.1194/jlr.M022194; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356	39	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98953	10.1371/journal.pone.0098953	http://dx.doi.org/10.1371/journal.pone.0098953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901470	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400078
J	Park, SK; Tao, YB; Meeker, JD; Harlow, SD; Mukherjee, B				Park, Sung Kyun; Tao, Yebin; Meeker, John D.; Harlow, Sioban D.; Mukherjee, Bhramar			Environmental Risk Score as a New Tool to Examine Multi-Pollutants in Epidemiologic Research: An Example from the NHANES Study Using Serum Lipid Levels	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; PARTICULATE AIR-POLLUTION; DAILY MORTALITY; BLOOD-PRESSURE; SYSTEMATIC EVALUATION; ATHEROSCLEROSIS RISK; EXPOSURE MEASUREMENT; WIDE ASSOCIATION; ODDS RATIO; PREDICTION	Objective: A growing body of evidence suggests that environmental pollutants, such as heavy metals, persistent organic pollutants and plasticizers play an important role in the development of chronic diseases. Most epidemiologic studies have examined environmental pollutants individually, but in real life, we are exposed to multi-pollutants and pollution mixtures, not single pollutants. Although multi-pollutant approaches have been recognized recently, challenges exist such as how to estimate the risk of adverse health responses from multi-pollutants. We propose an "Environmental Risk Score (ERS)" as a new simple tool to examine the risk of exposure to multi-pollutants in epidemiologic research. Methods and Results: We examined 134 environmental pollutants in relation to serum lipids (total cholesterol, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL) and triglycerides) using data from the National Health and Nutrition Examination Survey between 1999 and 2006. Using a two-stage approach, stage-1 for discovery (n = 10818) and stage-2 for validation (n = 4615), we identified 13 associated pollutants for total cholesterol, 9 for HDL, 5 for LDL and 27 for triglycerides with adjustment for sociodemographic factors, body mass index and serum nutrient levels. Using the regression coefficients (weights) from joint analyses of the combined data and exposure concentrations, ERS were computed as a weighted sum of the pollutant levels. We computed ERS for multiple lipid outcomes examined individually (single-phenotype approach) or together (multi-phenotype approach). Although the contributions of ERS to overall risk predictions for lipid outcomes were modest, we found relatively stronger associations between ERS and lipid outcomes than with individual pollutants. The magnitudes of the observed associations for ERS were comparable to or stronger than those for socio-demographic factors or BMI. Conclusions: This study suggests ERS is a promising tool for characterizing disease risk from multi-pollutant exposures. This new approach supports the need for moving from a single-pollutant to a multi-pollutant framework.	[Park, Sung Kyun; Harlow, Sioban D.] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Park, Sung Kyun; Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Tao, Yebin; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Park, SK (corresponding author), Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA.	sungkyun@umich.edu		Park, Sung Kyun/0000-0001-9981-6250; Meeker, John/0000-0001-8357-5085	NIEHS (National Institute of Environmental Health Sciences) [ES20811, K01-ES016587, R01-ES021465, P01-ES022844]; NIEHS [P30-ES017885, P42-ES017198]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020811, P01ES022844, P42ES017198, R01ES021465, P30ES017885, K01ES016587] Funding Source: NIH RePORTER	NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by NIEHS (National Institute of Environmental Health Sciences) grant ES20811 (BM), and K01-ES016587 (SKP), and R01-ES021465 and P01-ES022844 (JDM). Additional support was provided by NIEHS Grant P30-ES017885 entitled "Lifestage Exposure and Adult Disease'' and NIEHS Grant P42-ES017198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Billionnet C, 2011, ENVIRON RES, V111, P425, DOI 10.1016/j.envres.2011.02.008; Bobb JF, 2013, APPL STAT, V62; Boonstra PS, 2013, BIOSTATISTICS, V14, P259, DOI 10.1093/biostatistics/kxs036; Brautbar A, 2012, ATHEROSCLEROSIS, V223, P421, DOI 10.1016/j.atherosclerosis.2012.05.035; Brunekreef B, 2013, ENVIRON MOL MUTAGEN, V54, P596, DOI 10.1002/em.21767; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Cole SR, 2009, INT J EPIDEMIOL, V38, P1674, DOI 10.1093/ije/dyp269; Derks EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037852; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Garcia-Closas M, 2013, CANCER RES, V73, P2211, DOI 10.1158/0008-5472.CAN-12-2388; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hammond E C, 1979, Ann N Y Acad Sci, V330, P473, DOI 10.1111/j.1749-6632.1979.tb18749.x; Hicken MT, 2013, ENVIRON HEALTH PERSP, V121, P205, DOI 10.1289/ehp.1104517; Hong YC, 1999, ENVIRON HEALTH PERSP, V107, P873, DOI 10.2307/3454474; Janssens ACJW, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2011.27; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Johns DO, 2012, ENVIRON HEALTH PERSP, V120, P1238, DOI 10.1289/ehp.1204939; Kim S, 2009, BIOINFORMATICS, V25, pI204, DOI 10.1093/bioinformatics/btp218; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lind PM, 2013, ENVIRON INT, V55, P1, DOI 10.1016/j.envint.2013.01.017; Louis GMB, 2012, STAT MED, V31, P2569, DOI 10.1002/sim.5496; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Mauderly JL, 2009, ENVIRON HEALTH PERSP, V117, P1, DOI 10.1289/ehp.11654; Mondul AM, 2013, CANCER EPIDEM BIOMAR, V22, P688, DOI 10.1158/1055-9965.EPI-13-0007-T; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; National Institutes of Health National Heart Lung and Blood Institute, 2001, 3 NCEP NIH US DEP HL; Nie L, 2010, EPIDEMIOLOGY, V21, pS17, DOI 10.1097/EDE.0b013e3181ce97d8; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; Ostro B, 2011, ENVIRON HEALTH PERSP, V119, P1781, DOI 10.1289/ehp.1103618; Park SK, 2008, AM J RESP CRIT CARE, V178, P283, DOI 10.1164/rccm.200708-1286OC; Park SK, 2007, J EXPO SCI ENV EPID, V17, P488, DOI 10.1038/sj.jes.7500552; Patel CJ, 2013, INT J EPIDEMIOL, V42, P1795, DOI 10.1093/ije/dyt208; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Porta M, 2012, ENVIRON INT, V44, P106, DOI 10.1016/j.envint.2012.02.005; Qian ZM, 2004, INT J EPIDEMIOL, V33, P582, DOI 10.1093/ije/dyg278; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015; Roberts S, 2005, ATMOS ENVIRON, V39, P6223, DOI 10.1016/j.atmosenv.2005.07.004; Roberts S, 2006, ENVIRON HEALTH PERSP, V114, P1877, DOI 10.1289/ehp.9226; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Samet JM, 2001, AM J RESP CRIT CARE, V164, P819, DOI 10.1164/ajrccm.164.5.2008003; SARACCI R, 1977, INT J CANCER, V20, P323, DOI 10.1002/ijc.2910200302; Sarnat SE, 2006, OCCUP ENVIRON MED, V63, P700, DOI 10.1136/oem.2006.027292; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Scinicariello F, 2011, ENVIRON RES, V111, P1249, DOI 10.1016/j.envres.2011.08.011; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stern AH, 2011, ENVIRON HEALTH PERSP, V119, P1043, DOI 10.1289/ehp.1002824; Sun ZC, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-85; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong HY, 2012, ENVIRON HEALTH PERSP, V120, P952, DOI 10.1289/ehp.1104472; Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vupputuri S, 2003, HYPERTENSION, V41, P463, DOI 10.1161/01.HYP.0000055015.39788.29; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willems SM, 2011, CURR DIABETES REP, V11, P511, DOI 10.1007/s11892-011-0235-6; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zou H, 2009, ANN STAT, V37, P1733, DOI 10.1214/08-AOS625	77	38	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98632	10.1371/journal.pone.0098632	http://dx.doi.org/10.1371/journal.pone.0098632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901996	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400040
J	Coeur d'acier, A; Cruaud, A; Artige, E; Genson, G; Clamens, AL; Pierre, E; Hudaverdian, S; Simon, JC; Jousselin, E; Rasplus, JY				Coeur d'acier, Armelle; Cruaud, Astrid; Artige, Emmanuelle; Genson, Gwenaelle; Clamens, Anne-Laure; Pierre, Eric; Hudaverdian, Sylvie; Simon, Jean-Christophe; Jousselin, Emmanuelle; Rasplus, Jean-Yves			DNA Barcoding and the Associated PhylAphidB@se Website for the Identification of European Aphids (Insecta: Hemiptera: Aphididae)	PLOS ONE			English	Article							SYMPATRIC HOST RACES; REPRODUCTIVE ISOLATION; PEA APHIDS; COMPLEX; BRACHYCAUDUS; HOMOPTERA; BUCHNERA; DIFFERENTIATION; PHYLOGENETICS; AMPLIFICATION	Aphids constitute a diverse group of plant-feeding insects and are among the most important crop pests in temperate regions. Their morphological identification is time-consuming and requires specific knowledge, training and skills that may take years to acquire. We assessed the advantages and limits of DNA barcoding with the standard COI barcode fragment for the identification of European aphids. We constructed a large reference dataset of barcodes from 1020 specimens belonging to 274 species and 87 genera sampled throughout Europe and set up a database-driven website allowing species identification from query sequences. Results: In this unbiased sampling of the taxonomic diversity of European aphids, intraspecific divergence ranged from 0.0% to 3.9%, with a mean value of 0.29%, whereas mean congeneric divergence was 6.4%, ranging from 0.0% to 15%. Neighbor-joining analysis generated a tree in which most species clustered in distinct genetic units. Most of the species with undifferentiated or overlapping barcodes belonged to the genus Aphis or, to a lesser extent, the genera Brachycaudus, Dysaphis and Macrosiphum. The taxa involved were always morphologically similar or closely related and belonged to species groups known to present taxonomic difficulties. Conclusions: These data confirm that COI barcoding is a useful identification tool for aphids. Barcode identification is straightforward and reliable for 80% of species, including some difficult to distinguish on the basis of morphological characters alone. Unsurprisingly, barcodes often failed to distinguish between species from groups for which classical taxonomy has also reached its limits, leading to endless revisions and discussions about species and subspecies definitions. In such cases, the development of an effective procedure for the accurate identification of aphid specimens continues to pose a difficult challenge.	[Coeur d'acier, Armelle; Cruaud, Astrid; Artige, Emmanuelle; Genson, Gwenaelle; Clamens, Anne-Laure; Pierre, Eric; Jousselin, Emmanuelle; Rasplus, Jean-Yves] INRA, CBGP, UMR 1062, Montferrier Sur Lez, France; [Hudaverdian, Sylvie; Simon, Jean-Christophe] INRA, UMR, IGEPP, Le Rheu, France	INRAE; Institut de Recherche pour le Developpement (IRD); INRAE	Coeur d'acier, A (corresponding author), INRA, CBGP, UMR 1062, Montferrier Sur Lez, France.	coeur@supagro.inra.fr	Simon, Jean-Christophe/I-2700-2014; Rasplus, Jean-Yves/O-2873-2017; Coeur d'acier, Armelle/N-6916-2014	Rasplus, Jean-Yves/0000-0001-8614-6665; Coeur d'acier, Armelle/0000-0002-8915-1395	BIOFIS project [1001-001]; project @-Speed-ID included in the network "Bibliotheque du Vivant'' - CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope); SDIPS project; ANR JCJC-05 (Brachycaudus) grant	BIOFIS project; project @-Speed-ID included in the network "Bibliotheque du Vivant'' - CNRS; Museum National d'Histoire Naturelle; INRA; CEA (Genoscope); SDIPS project; ANR JCJC-05 (Brachycaudus) grant(French National Research Agency (ANR))	This work was based on financial supports received from the BIOFIS project (number 1001-001) allocated by the French Agropolis Fondation (RTRA - Montpellier) to JYR, the project @-Speed-ID included in the network "Bibliotheque du Vivant'' funded by the CNRS, the Museum National d'Histoire Naturelle, the INRA and the CEA (Genoscope), the SDIPS project allocated by INRA to EJ and the ANR JCJC-05 (Brachycaudus) grant awarded to EJ and ACDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBAGALLO S, 1995, HOMOPTERA STERNORRHY; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blackman R.L., 1994, APHIDS WORLDS TREES; Blackman R. L., 2000, APHIDS WORLDS CROPS; BLACKMAN RL, 2013, APHIDS WORLDS PLANTS; Blackman RL, 2006, APHIDS WORLDS HERBAC; BORNER C., 1949, NACHRICHTENBL DEUTSCH PFLANZENSCHUTZDIENST, V3, P121; Borner C., 1950, NEUE EUROPAISCHE BLA; BORNER C, 1952, MITTEILUNGEN THURING, V3, P1; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Carletto J, 2009, SYST ENTOMOL, V34, P307, DOI 10.1111/j.1365-3113.2008.00458.x; CHAN CK, 1991, AGR CANADA TECHNIC B; Chen R, 2013, SYST ENTOMOL, V38, P615, DOI 10.1111/syen.12018; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046190; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cocuzza Giuseppe, 2007, Redia, V90, P33; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Coeur d'Acier A, 2008, ZOOL SCR, V37, P175, DOI 10.1111/j.1463-6409.2007.00317.x; Cruaud A, 2010, CLADISTICS, V26, P359, DOI 10.1111/j.1096-0031.2009.00291.x; DACIER AC, 2010, ALIEN TERRESTRIAL AR, P435; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dixon AF G, 1998, APHID ECOLOGY; DRUMMOND AJ, 2010, GENEIOUS V5 5; Eastop VF, 2005, ZOOTAXA, P1; EASTOP VF, 1973, APHIDS VIRUS VECTORS, P4; Favret C., 2013, APHID SPECIES FILE V; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Foottit RG, 2009, CAN ENTOMOL, V141, P478, DOI 10.4039/n09-037; Foottit RG, 2006, P ENTOMOL SOC WASH, V108, P583; Foottit Robert G., 2009, Redia, V92, P87; Gauffre B, 2006, MOL ECOL NOTES, V6, P440, DOI 10.1111/j.1471-8286.2006.01264.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heie O. E., 1967, Spolia Zoologica Musei Hauniensis, V26, P1; Heie O. E., 1986, APHIDOIDEA HEMIPTERA; Huang XL, 2013, NATURE, V497, P40, DOI 10.1038/497040b; IGLISCH I, 1968, MITTEILUNGEN BIOLOGI, V131, P5; Janisch R., 1926, Arb biol Reichsanst Berlin, V14, P291; Jorg E., 1995, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V68, P387; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Jousselin E, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-295; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim H, 2010, ANN ENTOMOL SOC AM, V103, P532, DOI 10.1603/AN09166; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAMBERS DHR, 1947, ZOOLOGISCHE MEDEDEEL, V28, P291; LAMBERS DHR, 1956, Z ANGEW ENTOMOL, V39, P467; Lee W, 2011, MOL ECOL RESOUR, V11, P32, DOI 10.1111/j.1755-0998.2010.02877.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller Gary L., 2009, P463, DOI 10.1002/9781444308211.ch20; MINKS AK, 1987, APHIDS THEIR BIOL NA; Moller F.W., 1972, Archiv Pflanzenschutz, V8, P305; Moller F. W., 1970, Zool. Anz., V184, P107; Moller F. W., 1971, Dt ent Z, V18, P207; MORDWILKO AK, 1907, BIOL ZBL, V27, P769; Muller F. P., 1968, Faun Abh St Mus Tierk Dresden, V2, P101; MULLER FP, 1982, Z ANGEW ENTOMOL, V94, P432; MULLER FP, 1985, ENTOMOL GEN, V10, P161; Naaum AM, 2012, J APPL ENTOMOL, V136, P704, DOI 10.1111/j.1439-0418.2012.01706.x; NAFRIA JMN, 1998, REV FRANCAISE ENTOMO, V19, P77; NAFRIA JMN, 2013, FAUNA EUROPAEA APHID; Nieto Nafria JM, 2005, HEMIPTERA APHIDIDAE; Novakova E, 2013, MOL PHYLOGENET EVOL, V68, P42, DOI 10.1016/j.ympev.2013.03.016; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Peccoud J, 2010, CR BIOL, V333, P474, DOI 10.1016/j.crvi.2010.03.004; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Piffaretti J, 2013, APPL ENTOMOL ZOOL, V48, P155, DOI 10.1007/s13355-013-0165-7; Piffaretti J, 2012, ZOOL SCR, V41, P266, DOI 10.1111/j.1463-6409.2012.00531.x; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Prieto F. Garcia, 2004, Graellsia, V60, P197; Rakauskas R., 1998, P451; Raymond B, 2001, BIOL J LINN SOC, V74, P205, DOI 10.1111/j.1095-8312.2001.tb01387.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Robert V, 2011, OPEN APPL INFORM J, V5, P87, DOI DOI 10.2174/1874136301005010087; Roques Alain, 2010, BioRisk, V4, P11; Shaposhnikov G.C., 1985, P19; Shaposhnikov G.Kh., 1986, Entomologicheskoe Obozrenie, V65, P535; SHAPOSHNIKOV G. Kh, 1965, ENTOMOL OBOZRENIE, V44, P3; Shaposhnikov G. Kh., 1961, Entomologicheskoe Obozrenie, V40, P739; SHAPOSHNIKOV GC, 1981, POPULATIONS SPECIES; Shaposhnikov GC., 1987, APHIDS THEIR BIOL NA, V2A, P415; SHAPOSHNIKOV GC, 1985, DEFINING NOTION SPEC, P167; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Shufran KA, 2011, ANN ENTOMOL SOC AM, V104, P39, DOI 10.1603/AN10129; Stekolshchikov AV, 2004, SCI UPDATE, P183; STROYAN HLG, 1963, REVISION BRIT SPEC 2; STROYAN HLG, 1984, APHIDS PTEROCOMMATIN; STROYAN HLG, 1958, J LINN SOC LOND, V43, P643; STROYAN HLG, 1985, RECENT DEV TAXONOMIC, P347; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thieme T., 1987, P314; THOMAS K. H., 1962, Wissenschaftliche Zeitschrift der Universitat Rostock, V11, P325; Thomas K. H., 1968, Ent. Abh. Mus. Tierk. Dresden, V35, P337; Tosh CR, 2004, ENVIRON ENTOMOL, V33, P1081, DOI 10.1603/0046-225X-33.4.1081; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Jian-Feng, 2011, ZooKeys, V122, P1; Wang JF, 2009, INSECT SCI, V16, P475, DOI 10.1111/j.1744-7917.2009.01270.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014	105	38	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97620	10.1371/journal.pone.0097620	http://dx.doi.org/10.1371/journal.pone.0097620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896814	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700011
J	Roggia, MF; Imai, H; Shiraya, T; Noda, Y; Ueta, T				Roggia, Murilo Felix; Imai, Hirotaka; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi			Protective Role of Glutathione Peroxidase 4 in Laser-Induced Choroidal Neovascularization in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INCREASED EXPRESSION; MODEL; SUPPRESSION; PREVALENCE; CELLS	Purpose: To evaluate the influence of glutathione peroxidase 4 (GPx4) expression in retinal pigment epithelium (RPE)/choroid tissue using a mouse model of laser-induced choroidal neovascularization (CNV). Methods: In this study, GPx4(+/-), GPx4(+/+), and GPx4-overexpressing transgenic mice were created for comparison. The mRNA and protein expression of vascular endothelial growth factor (VEGF)-A in RPE/choroid tissue were evaluated before and after CNV induction by laser. Moreover, we investigated the changes in the VEGF-A mRNA level in RPE/choroid tissue in the CNV model that have not been clearly shown previously. Lipid peroxidation in RPE/choroid tissue was evaluated by immunohistochemistry using antibody against 4-hydroxy-2-nonenal. To investigate the protective role of GPx4, the size of laser-induced CNV was compared on day 7 among the mice expressing different levels of GPx4. Results: In the laser-induced CNV mouse model, laser treatment reduced the VEGF-A mRNA level in RPE/choroid tissue, while it increased the VEGF-A protein level. Evaluation of VEGF-A expression in RPE/choroid tissue of the GPx4(+/-), GPx4(+/+), and GPx4 transgenic mice revealed that GPx4 increased the VEGF-A protein level under physiological conditions (i.e., without laser treatment), while GPx4 suppressed the increase in the VEGF-A protein level under pathological conditions (i.e., after CNV induction by laser). In addition, GPx4 reduced the CNV size in a dose-dependent manner in vivo. Conclusions: GPx4 suppresses the increase in the VEGF-A protein level, which occurs during the development of pathological CNV, thus partly explaining the protective effect of GPx4 against CNV.	[Roggia, Murilo Felix; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Roggia, Murilo Felix; Shiraya, Tomoyasu; Noda, Yasuo; Ueta, Takashi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Imai, Hirotaka] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 108, Japan	University of Tokyo; University of Tokyo; Kitasato University	Ueta, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	ueta-tky@umin.ac.jp			 [40323547]		Funding provided by Grants-in-Aid for Scientific Research (40323547). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; Hu WZ, 2009, EXP EYE RES, V88, P79, DOI 10.1016/j.exer.2008.10.014; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2001, BIOL REPROD, V64, P674, DOI 10.1095/biolreprod64.2.674; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Liu J, 2011, J BIOL CHEM, V286, P20991, DOI 10.1074/jbc.M111.226266; Lu LL, 2009, ANTIOXID REDOX SIGN, V11, P715, DOI [10.1089/ars.2008.2171, 10.1089/ARS.2008.2171]; Mizutani T, 2009, INVEST OPHTH VIS SCI, V54, P1564; Oshima Y, 2004, J CELL PHYSIOL, V201, P393, DOI 10.1002/jcp.20110; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; Ueta T, 2012, ARTERIOSCL THROM VAS, V32, P1366, DOI 10.1161/ATVBAHA.112.248021; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Wortmann M, 2013, CIRC RES, V113, P408, DOI 10.1161/CIRCRESAHA.113.279984; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933	27	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98864	10.1371/journal.pone.0098864	http://dx.doi.org/10.1371/journal.pone.0098864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897344	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700089
J	Schunder, E; Gillmaier, N; Kutzner, E; Herrmann, V; Lautner, M; Heuner, K; Eisenreich, W				Schunder, Eva; Gillmaier, Nadine; Kutzner, Erika; Herrmann, Vroni; Lautner, Monika; Heuner, Klaus; Eisenreich, Wolfgang			Amino Acid Uptake and Metabolism of Legionella pneumophila Hosted by Acanthamoeba castellanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR MULTIPLICATION; MOLECULAR ECOLOGY; SHIKIMATE PATHWAY; LIQUID-MEDIUM; EXPRESSION; VIRULENCE; GROWTH; MACROPHAGES; ADAPTATION; INFECTION	Legionella pneumophila survives and replicates within a Legionella-containing vacuole (LCV) of amoebae and macrophages. Less is known about the carbon metabolism of the bacteria within the LCV. We have now analyzed the transfer and usage of amino acids from the natural host organism Acanthamoeba castellanii to Legionella pneumophila under in vivo (LCV) conditions. For this purpose, A. castellanii was C-13-labeled by incubation in buffer containing [U-C-13(6)] glucose. Subsequently, these C-13-prelabeled amoebae were infected with L. pneumophila wild type or some mutants defective in putative key enzymes or regulators of carbon metabolism. C-13-Isotopologue compositions of amino acids from bacterial and amoebal proteins were then determined by mass spectrometry. In a comparative approach, the profiles documented the efficient uptake of Acanthamoeba amino acids into the LCV and further into L. pneumophila where they served as precursors for bacterial protein biosynthesis. More specifically, A. castellanii synthesized from exogenous [U-C-13(6)] glucose unique isotopologue mixtures of several amino acids including Phe and Tyr, which were also observed in the same amino acids from LCV-grown L. pneumophila. Minor but significant differences were only detected in the isotopologue profiles of Ala, Asp, and Glu from the amoebal or bacterial protein fractions, respectively, indicating partial de novo synthesis of these amino acids by L. pneumophila. The similar isotopologue patterns in amino acids from L. pneumophila wild type and the mutants under study reflected the robustness of amino acid usage in the LCV of A. castellannii.	[Schunder, Eva; Herrmann, Vroni; Lautner, Monika; Heuner, Klaus] Robert Koch Inst, D-13353 Berlin, Germany; [Gillmaier, Nadine; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	Robert Koch Institute; Technical University of Munich	Heuner, K (corresponding author), Robert Koch Inst, Working Grp Cellular Interact Bacterial Pathogens, ZBS 2, Nordufer 20, D-13353 Berlin, Germany.	heunerk@rki.de; wolfgang.eisenreich@ch.tum.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	Deutsche Forschungsgemeinschaft [EI 384/4-1]; Robert Koch Institute [HE 2845/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Koch Institute	This work was supported by Deutsche Forschungsgemeinschaft Grant EI 384/4-1 (to W. E.) and Robert Koch Institute Grant HE 2845/6-1 (to K. H.).	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Albert-Weissenberger C, 2008, THESIS U WURZBURG WU; Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Berg J.M., 2002, BIOCHEMISTRY-US, P433; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Brown MJ, 2014, MICROBES INFECT, V16, P300, DOI 10.1016/j.micinf.2013.12.003; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; CATRENICH CE, 1989, INFECT IMMUN, V57, P1862, DOI 10.1128/IAI.57.6.1862-1864.1989; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; DOLPHIN WD, 1976, J PROTOZOOL, V23, P445; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Elandalloussi LM, 2005, MOL BIOCHEM PARASIT, V142, P106, DOI 10.1016/j.molbiopara.2005.03.014; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Faucher SP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00060; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Fonseca MV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00012; Fonseca Maris V., 2008, P213; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; Garduno RA, 2002, INFECT IMMUN, V70, P6273, DOI 10.1128/IAI.70.11.6273-6283.2002; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Gesbert G, 2014, CELL MICROBIOL, V16, P434, DOI 10.1111/cmi.12227; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Herrmann V, 2011, INT J MED MICROBIOL, V301, P133, DOI 10.1016/j.ijmm.2010.08.016; Heuner K, 1999, FEMS MICROBIOL LETT, V175, P69, DOI 10.1016/S0378-1097(99)00160-3; Heuner K, 2002, INFECT IMMUN, V70, P1604, DOI 10.1128/IAI.70.3.1604-1608.2002; Heuner Klaus, 2013, Methods Mol Biol, V954, P163, DOI 10.1007/978-1-62703-161-5_8; Hoffman PS, 2008, INFEC AGENT, P113; Jacobi S, 2004, J BACTERIOL, V186, P2540, DOI 10.1128/JB.186.9.2540-2547.2004; James BW, 1999, APPL ENVIRON MICROB, V65, P822; KEEN MG, 1984, CURR MICROBIOL, V11, P81, DOI 10.1007/BF01567708; KHAN NA, 2009, AC BIOL PATH, P1; Kiderlen AF, 2009, PARASITOL RES, V104, P663, DOI 10.1007/s00436-008-1243-6; KORZEKWA K, 1990, BIOMED ENVIRON MASS, V19, P211, DOI 10.1002/bms.1200190402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; Molmeret M, 2010, ENVIRON MICROBIOL, V12, P704, DOI 10.1111/j.1462-2920.2009.02114.x; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; O'Shaughnessy JB, 2003, BIOTECHNIQUES, V35, P112; PINE L, 1979, J CLIN MICROBIOL, V9, P615; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2014, ENVIRON MICROBIOL, V16, P350, DOI 10.1111/1462-2920.12290; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; REEVES MW, 1981, J CLIN MICROBIOL, V13, P688, DOI 10.1128/JCM.13.4.688-695.1981; Richards AM, 2013, VIRULENCE, V4, P307, DOI 10.4161/viru.24290; RISTROPH JD, 1981, J CLIN MICROBIOL, V13, P115, DOI 10.1128/JCM.13.1.115-119.1981; RISTROPH JD, 1980, J CLIN MICROBIOL, V11, P19, DOI 10.1128/JCM.11.1.19-21.1980; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; Sambrook J., 1989, MOL CLONING LABORATO, P31; Sauer JD, 2005, P NATL ACAD SCI USA, V102, P9924, DOI 10.1073/pnas.0502767102; Schulz T, 2012, ARCH MICROBIOL, V194, P977, DOI 10.1007/s00203-012-0833-y; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; TESH MJ, 1983, J BACTERIOL, V154, P1104, DOI 10.1128/JB.154.3.1104-1109.1983; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISS E, 1984, APPL ENVIRON MICROB, V48, P380, DOI 10.1128/AEM.48.2.380-385.1984; WEISS E, 1980, CURR MICROBIOL, V4, P1, DOI 10.1007/BF02602882; Wieland H, 2005, MOL MICROBIOL, V55, P1528, DOI 10.1111/j.1365-2958.2005.04490.x	80	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21040	21054		10.1074/jbc.M114.570085	http://dx.doi.org/10.1074/jbc.M114.570085			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24904060	Green Published, hybrid			2022-12-25	WOS:000339396600056
J	Kaur, H; Singh, S; Rathore, YS; Sharma, A; Furukawa, K; Hohmann, S; Ashish; Mondal, AK				Kaur, Harsimran; Singh, Shikha; Rathore, Yogendra S.; Sharma, Anupam; Furukawa, Kentaro; Hohmann, Stefan; Ashish; Mondal, Alok K.			Differential Role of HAMP-like Linkers in Regulating the Functionality of the Group III Histidine Kinase DhNik1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SYSTEM; SIGNAL-TRANSDUCTION; NITRATE SENSOR; DOMAIN; FLUDIOXONIL; SENSITIVITY; RESISTANCE; MECHANISM; YEAST; GENE	Nik1 orthologs are sensor kinases that function upstream of the high osmolarity glycerol/p38 MAPK pathway in fungi. They contain a poly-HAMP module at their N terminus, which plays a pivotal role in osmosensing as well as fungal death upon exposure to fludioxonil. DhNik1p is a typical member of this class that contains five HAMP domains and four HAMP-like linkers. We investigated the contribution of each of the HAMP-like linker regions to the functionality of DhNik1p and found that the HAMP4b linker was essential as its deletion resulted in the complete loss of activity. Replacement of this linker with flexible peptide sequences did not restore DhNik1p activity. Thus, the HAMP-like sequence and possibly structural features of this linker region are indispensable for the kinase activity of DhNik1p. To gain insight into the global shape of the poly-HAMP module in DhNik1p (HAMP1-5), multi-angle laser light and small angle x-ray scattering studies were carried out. Those data demonstrate that the maltose-binding protein-tagged HAMP1-5 protein exist as a dimer in solution with an elongated shape of maximum linear dimension similar to 365 angstrom. Placement of a sequence similarity based model of the HAMP1-5 protein inside experimental data-based models showed how two chains of HAMP1-5 are entwined on each other and the overall structure retained a periodicity. Normal mode analysis of the structural model is consistent with the H4b linker being a key to native-like collective motion in the protein. Overall, our shape-function studies reveal how different elements in the HAMP1-5 structure mediate its function.	[Kaur, Harsimran; Singh, Shikha; Rathore, Yogendra S.; Sharma, Anupam; Ashish; Mondal, Alok K.] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Furukawa, Kentaro; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Gothenburg	Ashish (corresponding author), CSIR Inst Microbial Technol, Sec 39-A, Chandigarh 160036, India.	ashgang@imtech.res.in; alok@imtech.res.in	Hohmann, Stefan/K-9895-2013; MAHTO, ANUPAM SHARMA/CAG-1514-2022	Hohmann, Stefan/0000-0002-0809-1985; MAHTO, ANUPAM SHARMA/0000-0002-9974-3001; Furukawa, Kentaro/0000-0002-1551-1538; Singh, Shikha/0000-0003-0266-4241	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DEAC02-98CH10886]	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We acknowledge the use of National Synchrotron Light Source, Brookhaven National Laboratory, which was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract number DEAC02-98CH10886. We acknowledge the technical help provided by R. Sharma and D. Bhatt.	Airola MV, 2013, J MOL BIOL, V425, P886, DOI 10.1016/j.jmb.2012.12.011; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Cui W, 2002, FUNGAL GENET BIOL, V36, P187, DOI 10.1016/S1087-1845(02)00009-9; Dunin-Horkawicz S, 2010, J MOL BIOL, V397, P1156, DOI 10.1016/j.jmb.2010.02.031; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Furukawa K, 2012, FEBS LETT, V586, P2417, DOI 10.1016/j.febslet.2012.05.057; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P844, DOI 10.1271/bbb.70051; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Miller TK, 2002, FUNGAL GENET BIOL, V35, P147, DOI 10.1006/fgbi.2001.1306; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Ochiai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2209, DOI 10.1271/bbb.66.2209; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Randhawa A, 2013, BIOCHEM BIOPH RES CO, V438, P140, DOI 10.1016/j.bbrc.2013.07.041; Sanchez R, 2000, METH MOL B, V143, P97; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x	41	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20245	20258		10.1074/jbc.M114.554303	http://dx.doi.org/10.1074/jbc.M114.554303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24895133	hybrid, Green Published			2022-12-25	WOS:000339395200037
J	Ruther, NN; Tettamanti, M; Cappa, SF; Bellebaum, C				Ruether, Norma Naima; Tettamanti, Marco; Cappa, Stefano F.; Bellebaum, Christian			Observed Manipulation Enhances Left Fronto-Parietal Activations in the Processing of Unfamiliar Tools	PLOS ONE			English	Article							PREMOTOR CORTEX; NEURAL REPRESENTATIONS; GRASPABLE OBJECTS; ACTION KNOWLEDGE; RECOGNITION; PERCEPTION; EXPERIENCE; MEMORY; BRAIN	Tools represent a special class of objects, as functional details of tools can afford certain actions. In addition, information gained via prior experience with tools can be accessed on a semantic level, providing a basis for meaningful object interactions. Conceptual representations of tools also encompass knowledge about tool manipulation which can be acquired via direct (active manipulation) or indirect (observation of others manipulating objects) motor experience. The present study aimed to explore the impact of observation of manipulation on the neural processing of previously unfamiliar, manipulable objects. Brain activity was assessed by means of functional magnetic resonance imaging while participants accomplished a visual matching task involving pictures of the novel objects before and after they received object-related training. Three training session in which subjects observed an experimenter manipulating one set of objects and visually explored another set of objects were used to make subjects familiar with the tools and to allow the formation of new tool representations. A control object set was not part of the training. Training-related brain activation increases were found for observed manipulation objects compared to not trained objects in a left-hemispheric network consisting of inferior frontal gyrus (iFG) pars opercularis and triangularis and supramarginal/angular gyrus. This illustrates that direct manipulation experience is not required to elicit tool-associated activation changes in the action system. While the iFG activation might indicate a close relationship between the areas involved in tool representation and those involved in observational knowledge acquisition, the parietal activation is discussed in terms of non-semantic effects of object affordances and handtool spatial relationships.	[Ruether, Norma Naima] Ruhr Univ Bochum, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany; [Ruether, Norma Naima] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Tettamanti, Marco] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Tettamanti, Marco; Cappa, Stefano F.] Ist Sci San Raffaele, Dept Nucl Med, I-20132 Milan, Italy; [Cappa, Stefano F.] Univ Vita Salute San Raffaele, Fac Psychol, Milan, Italy; [Bellebaum, Christian] Univ Dusseldorf, Inst Expt Psychol, Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Heinrich Heine University Dusseldorf	Ruther, NN (corresponding author), Ruhr Univ Bochum, Dept Neuropsychol, Inst Cognit Neurosci, Univ Str 150, Bochum, Germany.	naima.ruether@rub.de	Tettamanti, Marco/K-1510-2016; Cappa, Stefano/B-1874-2014	Tettamanti, Marco/0000-0003-3039-1500; Cappa, Stefano/0000-0003-1003-3925	German Research Foundation(Deutsche Forschungsgemeinschaft, DFG) [SFB 874/TP B6]	German Research Foundation(Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The authors thank the German Research Foundation for supporting this work (Deutsche Forschungsgemeinschaft, DFG; SFB 874/TP B6 to C. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Bellebaum C, 2013, CORTEX, V49, P1110, DOI 10.1016/j.cortex.2012.03.023; Buxbaum LJ, 2010, ANN NY ACAD SCI, V1191, P201, DOI 10.1111/j.1749-6632.2010.05447.x; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Creem-Regehr SH, 2007, J INT NEUROPSYCH SOC, V13, P1009, DOI 10.1017/S1355617707071093; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Cross ES, 2012, NEUROPSYCHOLOGIA, V50, P3207, DOI 10.1016/j.neuropsychologia.2012.09.028; DERENZI E, 1988, BRAIN, V111, P1173, DOI 10.1093/brain/111.5.1173; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibson J.J., 1977, PERCEIVING ACTING KN, P67, DOI DOI 10.2307/1421838; Goldenberg G, 1998, NEUROPSYCHOLOGIA, V36, P581, DOI 10.1016/S0028-3932(97)00165-6; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Goldenberg G, 2013, WIRES COGN SCI, V4, P453, DOI 10.1002/wcs.1241; Goldenberg G, 2009, NEUROPSYCHOLOGIA, V47, P1449, DOI 10.1016/j.neuropsychologia.2008.07.014; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Hodges JR, 1999, P NATL ACAD SCI USA, V96, P9444, DOI 10.1073/pnas.96.16.9444; Jacquet PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039629; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Kiefer M, 2007, J COGNITIVE NEUROSCI, V19, P525, DOI 10.1162/jocn.2007.19.3.525; LEHMKUHL G, 1981, CORTEX, V17, P153, DOI 10.1016/S0010-9452(81)80017-2; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Martin A, 1998, MEM CALIF ACAD SCI, P69; Martin A, 2001, HDB FUNCTIONAL NEURO, P153; Martin A. C, 2000, NEW COGNITIVE NEUROS, P1023; Molnar-Szakacs I, 2005, CEREB CORTEX, V15, P986, DOI 10.1093/cercor/bhh199; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; Proverbio AM, 2012, BIOL PSYCHOL, V91, P1, DOI 10.1016/j.biopsycho.2012.04.003; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; Rothi LJG, 1997, BRAIN DAM B, P29; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SIRIGU A, 1991, BRAIN, V114, P2555, DOI 10.1093/brain/114.6.2555; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Symes E, 2007, ACTA PSYCHOL, V124, P238, DOI 10.1016/j.actpsy.2006.03.005; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tucker M, 2001, VIS COGN, V8, P769, DOI 10.1080/13506280042000144; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Valenstein E., 2003, CLIN NEUROPSYCHOLOGY, P215; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	56	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99401	10.1371/journal.pone.0099401	http://dx.doi.org/10.1371/journal.pone.0099401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911053	Green Published, Green Submitted, gold			2022-12-25	WOS:000337165600081
J	Kosiorek, M; Podszywalow-Bartnicka, P; Zylinska, L; Pikula, S				Kosiorek, Michalina; Podszywalow-Bartnicka, Paulina; Zylinska, Ludmila; Pikula, Slawomir			NFAT1 and NFAT3 Cooperate with HDAC4 during Regulation of Alternative Splicing of PMCA Isoforms in PC12 Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; ACTIVATED T-CELLS; GATED CALCIUM-CHANNELS; NONCODING RNAS; FUNCTIONAL DIVERSITY; NERVOUS-SYSTEM; TRANSCRIPTION; EXPRESSION; GENE; MECHANISMS	Background: The bulk of human genes undergo alternative splicing (AS) upon response to physiological stimuli. AS is a great source of protein diversity and biological processes and is associated with the development of many diseases. Pheochromocytoma is a neuroendocrine tumor, characterized by an excessive Ca2+-dependent secretion of catecholamines. This underlines the importance of balanced control of calcium transport via regulation of gene expression pattern, including different calcium transport systems, such as plasma membrane Ca2+-ATPases (PMCAs), abundantly expressed in pheochromocytoma chromaffin cells (PC12 cells). PMCAs are encoded by four genes (Atp2b1, Atp2b2, Atp2b3, Atp2b4), whose transcript products undergo alternative splicing giving almost 30 variants. Results: In this scientific report, we propose a novel mechanism of regulation of PMCA alternative splicing in PC12 cells through cooperation of the nuclear factor of activated T-cells (NFAT) and histone deacetylases (HDACs). Luciferase assays showed increased activity of NFAT in PC12 cells, which was associated with altered expression of PMCA. RT-PCR experiments suggested that inhibition of the transcriptional activity of NFAT might result in the rearrangement of PMCA splicing variants in PC12 cells. NFAT inhibition led to dominant expression of 2x/c, 3x/a and 4x/a PMCA variants, while in untreated cells the 2w, z/b, 3z, x/b, c, e, f, and 4x/b variants were found as well. Furthermore, chromatin immunoprecipitation experiments showed that NFAT1-HDAC4 or NFAT3-HDAC4 complexes might be involved in regulation of PMCA2x splicing variant generation. Conclusions: We suggest that the influence of NFAT/HDAC on PMCA isoform composition might be important for altered dopamine secretion by PC12 cells.	[Kosiorek, Michalina; Pikula, Slawomir] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Kosiorek, Michalina] Mossakowski Med Res Ctr PAS, Dept Neurodegenerat Disorders, Neurogenet Lab, Warsaw, Poland; [Podszywalow-Bartnicka, Paulina] M Nencki Inst Expt Biol, Lab Cytometry, PL-02093 Warsaw, Poland; [Zylinska, Ludmila] Med Univ Lodz, Dept Mol Neurochem, Lodz, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Medical University Lodz	Pikula, S (corresponding author), M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland.	s.pikula@nencki.gov.pl	Wężyk, Michalina Maria/R-2208-2018; Zylinska, Ludmila/ABE-9113-2020	Wężyk, Michalina Maria/0000-0001-7498-4610; Zylinska, Ludmila/0000-0002-3876-8942; Podszywalow-Bartnicka, Paulina/0000-0002-4965-828X; Pikula, Slawomir/0000-0003-4640-3094				Abraham F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037750; Abramowitz J, 2000, J MOL CELL CARDIOL, V32, P777, DOI 10.1006/jmcc.2000.1120; Allen SE, 2010, CHANNELS, V4, P483, DOI 10.4161/chan.4.6.12868; Asadi S, 2009, J MOL NEUROSCI, V39, P40, DOI 10.1007/s12031-008-9159-2; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Badran BM, 2002, J BIOL CHEM, V277, P47136, DOI 10.1074/jbc.M206330200; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; Berglund L, 1996, BIOCHEM BIOPH RES CO, V264, P777; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chen Lu, 2012, Int J Evol Biol, V2012, P596274, DOI 10.1155/2012/596274; Chiang CS, 2009, CIRC RES, V104, P522, DOI 10.1161/CIRCRESAHA.108.184051; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Desai-Shah M, 2009, SYNAPSE, V63, P1100, DOI 10.1002/syn.20695; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Domi T, 2007, ANN NY ACAD SCI, V1099, P237, DOI 10.1196/annals.1387.043; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Enyedi Agnes, 2011, Commun Integr Biol, V4, P340, DOI 10.4161/cib.4.3.15040; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Grabowski P, 2011, CURR OPIN GENET DEV, V21, P388, DOI 10.1016/j.gde.2011.03.005; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Kamagate A, 2000, CELL CALCIUM, V27, P231, DOI 10.1054/ceca.2000.0116; Kee HJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/928326; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kosiorek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092176; Kosiorek M, 2011, BIOCHEM BIOPH RES CO, V411, P235, DOI 10.1016/j.bbrc.2011.06.098; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee CJ, 2003, BIOL PSYCHIAT, V54, P771, DOI 10.1016/S0006-3223(03)00375-5; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liao P, 2009, PFLUG ARCH EUR J PHY, V458, P481, DOI 10.1007/s00424-009-0635-5; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; Lipscombe D, 2013, BBA-BIOMEMBRANES, V1828, P1522, DOI 10.1016/j.bbamem.2012.09.018; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mascarell L, 2006, MOL IMMUNOL, V43, P1846, DOI 10.1016/j.molimm.2005.10.019; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Nagy G, 2005, MOL BIOL CELL, V16, P5675, DOI 10.1091/mbc.E05-07-0595; Nakayama T, 2012, J CELL SCI, V125, P817, DOI 10.1242/jcs.081943; Nilsson LM, 2008, FASEB J S, V22, P49; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Santoro M, 2013, NEUROPATHOL APPL NEU, V29, DOI [10.1111/nap.12076, DOI 10.1111/NAP.12076]; Santoro M, 2013, MOL CELL BIOCHEM, V380, P259, DOI 10.1007/s11010-013-1681-z; Shen TS, 2006, J MUSCLE RES CELL M, V27, P405, DOI 10.1007/s10974-006-9080-7; Shubair M, 2012, MOL CELL BIOCHEM, V370, P15, DOI 10.1007/s11010-012-1393-9; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Talarico EF, 2007, EXP EYE RES, V85, P869, DOI 10.1016/j.exer.2007.08.023; UNSICKER K, 1993, J ANAT, V183, P207; Van Eylen F, 2001, CELL CALCIUM, V30, P191, DOI 10.1054/ceca.2001.0223; Venables JP, 2012, NUCLEIC ACIDS RES, V40, P1, DOI 10.1093/nar/gkr648; Waguespack SG, 2010, J CLIN ENDOCR METAB, V95, P2023, DOI 10.1210/jc.2009-2830; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Walters RD, 2013, MOL IMMUNOL, V56, P48, DOI 10.1016/j.molimm.2013.03.022; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Ximenes HM, 2003, J BIOL CHEM, V278, P22956, DOI 10.1074/jbc.M212339200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zaidi A, 2010, WORLD J BIOL CHEM, V1, P271, DOI DOI 10.4331/WJBC.V1.I9.271; Zylinska L, 2007, ANN NY ACAD SCI, V1099, P254, DOI 10.1196/annals.1387.008	91	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99118	10.1371/journal.pone.0099118	http://dx.doi.org/10.1371/journal.pone.0099118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905014	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000105
J	Liberio, MD; Bastos, IMD; Pires, OR; Fontes, W; Santana, JM; Castro, MS				Liberio, Michelle da Silva; Bastos, Izabela M. D.; Pires Junior, Osmindo R.; Fontes, Wagner; Santana, Jaime M.; Castro, Mariana S.			The Crude Skin Secretion of the Pepper Frog Leptodactylus labyrinthicus Is Rich in Metallo and Serine Peptidases	PLOS ONE			English	Article							BOTHROPS PROTEASE-A; ANTIMICROBIAL PEPTIDES; MOLECULAR-CLONING; AMPHIBIAN SKIN; TRYPSIN-INHIBITOR; IV; PURIFICATION; ENZYMES; XENOPUS; AMINOPEPTIDASE	Peptidases are ubiquitous enzymes involved in diverse biological processes. Fragments from bioactive peptides have been found in skin secretions from frogs, and their presence suggests processing by peptidases. Thus, the aim of this work was to characterize the peptidase activity present in the skin secretion of Leptodactylus labyrinthicus. Zymography revealed the presence of three bands of gelatinase activity of approximately 60 kDa, 66 kDa, and 80 kDa, which the first two were calcium-dependent. These three bands were inhibited either by ethylenediaminetetraacetic acid (EDTA) and phenathroline; thus, they were characterized as metallopeptidases. Furthermore, the proteolytic enzymes identified were active only at pH 6.0-10.0, and their activity increased in the presence of CHAPS or NaCl. Experiments with fluorogenic substrates incubated with skin secretions identified aminopeptidase activity, with cleavage after leucine, proline, and alanine residues. This activity was directly proportional to the protein concentration, and it was inhibited in the presence of metallo and serine peptidase inhibitors. Besides, the optimal pH for substrate cleavage was determined to be 7.0-8.0. The results of the in gel activity assay showed that all substrates were hydrolyzed by a 45 kDa peptidase. Gly-Pro-AMC was also cleaved by a peptidase greater than 97 kDa. The data suggest the presence of dipeptidyl peptidases (DPPs) and metallopeptidases; however, further research is necessary. In conclusion, our work will help to elucidate the implication of these enzymatic activities in the processing of the bioactive peptides present in frog venom, expanding the knowledge of amphibian biology.	[Liberio, Michelle da Silva; Pires Junior, Osmindo R.; Castro, Mariana S.] Univ Brasilia, Toxinol Lab, Dept Physiol Sci, Inst Biol, Brasilia, DF, Brazil; [Liberio, Michelle da Silva; Fontes, Wagner; Castro, Mariana S.] Univ Brasilia, Dept Cell Biol, Inst Biol, Brazilian Ctr Prot Res, Brasilia, DF, Brazil; [Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Inst Biol, Lab Host Pathogen Interact, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Castro, MS (corresponding author), Univ Brasilia, Toxinol Lab, Dept Physiol Sci, Inst Biol, Brasilia, DF, Brazil.	mscastro@unb.br	Santana, Jaime/H-5319-2013; Fontes, Wagner/A-1771-2008; Pires, O.r./ABC-8410-2020; Rodrigues Pires Junior, Osmindo/Q-8384-2016	Fontes, Wagner/0000-0001-5140-8573; S. Castro, Mariana/0000-0001-5143-152X; Bastos, Izabela/0000-0002-2785-4255; Rodrigues Pires Junior, Osmindo/0000-0002-9875-9407	Brazilian National Council for Scientific and Technological Development (CNPq) [563972/2010-6, 302925/2012-0]; Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES); Funding Authority for Studies and Projects (FINEP); Foundation for Research Support of the Federal District (FAPDF) [193.000.414/2008, 193.000.461/2011]; University of Brasilia Foundation (FUB/UnB)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Funding Authority for Studies and Projects (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Foundation for Research Support of the Federal District (FAPDF)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); University of Brasilia Foundation (FUB/UnB)	This study was supported by the Brazilian National Council for Scientific and Technological Development (CNPq, grant numbers 563972/2010-6 and 302925/2012-0), the Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES), the Funding Authority for Studies and Projects (FINEP), the Foundation for Research Support of the Federal District (FAPDF, grant numbers 193.000.414/2008 and 193.000.461/2011) and the University of Brasilia Foundation (FUB/UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2002, BBA-PROTEINS PROTEOM, V1601, P55, DOI 10.1016/S1570-9639(02)00432-6; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Leite JMA, 2010, J EXP ZOOL PART A, V313A, P1, DOI 10.1002/jez.551; BARRA D, 1995, TRENDS BIOTECHNOL, V13, P205, DOI 10.1016/S0167-7799(00)88947-7; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; Bastos IMD, 2010, MICROBES INFECT, V12, P457, DOI 10.1016/j.micinf.2010.02.007; Berthonneau J, 2000, EXP PARASITOL, V95, P158, DOI 10.1006/expr.2000.4524; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Buckley SJ, 2004, INT J BIOCHEM CELL B, V36, P1281, DOI 10.1016/j.biocel.2003.02.001; Cadavid-Restrepo G, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-46; Calderon LD, 2011, AMINO ACIDS, V40, P29, DOI 10.1007/s00726-010-0622-3; Charpentier S, 1998, J BIOL CHEM, V273, P14690, DOI 10.1074/jbc.273.24.14690; Chen TB, 2003, PEPTIDES, V24, P873, DOI 10.1016/S0196-9781(03)00165-7; Clamagirand C, 2002, COMP BIOCHEM PHYS B, V132, P751, DOI 10.1016/S1096-4959(02)00093-3; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2006, PROTEIN PEPTIDE LETT, V13, P411, DOI 10.2174/092986606775974410; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Daly JW, 2004, TOXICON, V44, P805, DOI 10.1016/j.toxicon.2004.08.016; DARBY NJ, 1988, BIOCHEM BIOPH RES CO, V153, P1193, DOI 10.1016/S0006-291X(88)81354-8; Dionisio G, 2001, PROTEOLYTIC ENZYMES, P77; Dourado FS, 2007, TOXICON, V50, P572, DOI 10.1016/j.toxicon.2007.04.027; Doyle J, 2003, EUR J BIOCHEM, V270, P1141, DOI 10.1046/j.1432-1033.2003.03462.x; Erspamer Vittorio, 1994, P178; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; GIOVANNINI MG, 1987, BIOCHEM J, V243, P113, DOI 10.1042/bj2430113; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P6; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; KELLEHER PJ, 1984, ANAL BIOCHEM, V136, P470, DOI 10.1016/0003-2697(84)90246-X; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; King JD, 2005, COMP BIOCHEM PHYS C, V141, P393, DOI 10.1016/j.cbpc.2005.09.002; Kruger NJ, 2002, PROTEIN PROTOCOLS HD, P747; Leme AFP, 2008, J THROMB HAEMOST, V6, P1363, DOI 10.1111/j.1538-7836.2008.02995.x; Liberio MS, 2011, AMINO ACIDS, V40, P51, DOI 10.1007/s00726-009-0384-y; Maes MB, 2007, CLIN CHIM ACTA, V380, P31, DOI 10.1016/j.cca.2007.01.024; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Menezes MC, 2006, TOXICON, V47, P304, DOI 10.1016/j.toxicon.2005.11.007; Merchant M, 2010, VET IMMUNOL IMMUNOP, V136, P28, DOI 10.1016/j.vetimm.2010.01.005; Motta FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030431; Murayama N, 2003, BBA-PROTEINS PROTEOM, V1652, P1, DOI 10.1016/j.bbapap.2003.08.001; Nascimento ACC, 2004, PROTEIN J, V23, P501, DOI 10.1007/s10930-004-7877-z; Nascimento A, 2007, TOXICON, V50, P1095, DOI 10.1016/j.toxicon.2007.07.014; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; RESNICK NM, 1991, CELL, V66, P541, DOI 10.1016/0092-8674(81)90017-9; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rollins-Smith LA, 2005, REGUL PEPTIDES, V124, P173, DOI 10.1016/j.regpep.2004.07.013; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Sah H, 2006, BIOTECHNOL LETT, V28, P567, DOI 10.1007/s10529-006-0016-5; Schroder JM, 1999, BIOCHEM PHARMACOL, V57, P121, DOI 10.1016/S0006-2952(98)00226-3; Sentandreu MA, 2001, MEAT SCI, V57, P93, DOI 10.1016/S0309-1740(00)00082-6; Shinnar AE, 2003, BIOORG CHEM, V31, P425, DOI 10.1016/S0045-2068(03)00080-4; Sitaram N, 1999, BBA-BIOMEMBRANES, V1462, P29, DOI 10.1016/S0005-2736(99)00199-6; Souza AP, 2001, BIOMATERIALS, V22, P2025, DOI 10.1016/S0142-9612(00)00388-4; STLEGER RJ, 1993, J GEN MICROBIOL, V139, P237, DOI 10.1099/00221287-139-2-237; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Wang M, 2012, PEPTIDES, V33, P245, DOI 10.1016/j.peptides.2012.01.003; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x	65	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96893	10.1371/journal.pone.0096893	http://dx.doi.org/10.1371/journal.pone.0096893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906116	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000004
J	Meshcheryakova, A; Tamandl, D; Bajna, E; Stift, J; Mittlboeck, M; Svoboda, M; Heiden, D; Stremitzer, S; Jensen-Jarolim, E; Grunberger, T; Bergmann, M; Mechtcheriakova, D				Meshcheryakova, Anastasia; Tamandl, Dietmar; Bajna, Erika; Stift, Judith; Mittlboeck, Martina; Svoboda, Martin; Heiden, Denise; Stremitzer, Stefan; Jensen-Jarolim, Erika; Gruenberger, Thomas; Bergmann, Michael; Mechtcheriakova, Diana			B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							IMMUNE CELLS; DENDRITIC CELLS; LIVER METASTASES; T-CELLS; RITUXIMAB; CD20; CHEMOTHERAPY; CARCINOMA; SURVIVAL; DRIVEN	Remarkably limited information is available about biological mechanisms that determine the disease entity of metastatic colorectal cancer in the liver (CRCLM) with no good clinical parameters to estimate prognosis. For the last few years, understanding the relationship between tumor characteristics and local immune response has gained increasing attention. Given the multifaceted roles of B-cell-driven responses, we aimed to elucidate the immunological imprint of B lymphocytes at the metastatic site, the interrelation with macrophages, and their prognostic relevance. Here we present novel algorithm allowing to assess a link between the local patient-specific immunological capacity and clinical outcome. The microscopy-based imaging platform was used for automated scanning of large-scale tissue sections and subsequent qualitative and quantitative analyses of immune cell subtypes using lineage markers and single-cell recognition strategy. Results indicate massive infiltration of CD45-positive leukocytes confined to the metastatic border. We report for the first time the accumulation of CD20-positive B lymphocytes at the tumor - liver interface comprising the major population within the large CD45-positive aggregates. Strikingly, functionally active, activation-induced cytidine deaminase (AID)-positive ectopic lymphoid structures were found to be assembled within the metastatic margin. Furthermore, the CD20-based data set revealed a strong prognostic power: patients with high CD20 content and/or ectopic follicles had significantly lower risk for disease recurrence as revealed by univariate analysis (p<0.001 for both) and in models adjusted for clinicopathological variables (p<0.001 and p = 0.01, respectively), and showed prolonged overall survival. In contrast, CD68 staining-derived data set did not show an association with clinical outcome. Taken together, we nominate the magnitude of B lymphocytes, including those organized in ectopic follicles, as novel prognostic marker which is superior to clinicopathological parameters. Findings emphasize anti-tumoral role of B cell-driven mechanism(s) and thus indicate a new way of thinking about potential treatment strategies for CRCLM patients.	[Meshcheryakova, Anastasia; Bajna, Erika; Svoboda, Martin; Heiden, Denise; Jensen-Jarolim, Erika; Mechtcheriakova, Diana] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Tamandl, Dietmar; Stremitzer, Stefan; Gruenberger, Thomas; Bergmann, Michael] Med Univ Vienna, Dept Surg, Vienna, Austria; [Stift, Judith] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Mittlboeck, Martina] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Jensen-Jarolim, Erika] Vet Univ Vienna, Med Univ Vienna, Messerli Res Inst, A-1030 Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Tamandl, D (corresponding author), Med Univ Vienna, Dept Surg, Vienna, Austria.	dietmar.tamandl@meduniwien.ac.at; diana.mechtcheriakova@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022; Gruenberger, Thomas/ABA-1661-2020; Jensen-Jarolim, Erika/C-5120-2018	Gruenberger, Thomas/0000-0002-2671-0540; Jensen-Jarolim, Erika/0000-0003-4019-5765; Bergmann, Michael/0000-0001-8529-1166; Mittlboeck, Martina/0000-0003-1097-4047; Meshcheryakova, Anastasia/0000-0003-4359-9546; Stift, Judith/0000-0001-5334-9343; Mechtcheriakova, Diana/0000-0002-8737-3592	Austrian Science Fund (FWF) [P 23228, P 22441] Funding Source: researchfish; Austrian Science Fund FWF [P 23228, P 22441] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Aguilar LK, 2011, J CELL BIOCHEM, V112, P1969, DOI 10.1002/jcb.23126; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bogusz AM, 2012, CLIN CANCER RES, V18, P6122, DOI 10.1158/1078-0432.CCR-12-0397; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Coronella JA, 2002, J IMMUNOL, V169, P1829, DOI 10.4049/jimmunol.169.4.1829; Czuczman MS, 2008, CLIN CANCER RES, V14, P1561, DOI 10.1158/1078-0432.CCR-07-1254; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2012, MOL ONCOL, V6, P242, DOI 10.1016/j.molonc.2012.01.002; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Goc J, 2014, CANCER RES, V74, P705, DOI 10.1158/0008-5472.CAN-13-1342; Halama N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24116; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Halama N, 2010, ANAL QUANT CYTOL, V32, P333; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Keim S, 2012, ONCOIMMUNOLOGY, V1, P593, DOI 10.4161/onci.20179; Lahrmann B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028048; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Leandro MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3908; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Maletzki C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032639; Mankai A, 2008, CANCER RES, V68, P7512, DOI 10.1158/0008-5472.CAN-07-6446; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; Mechtcheriakova D, 2012, CANCER IMMUNOL IMMUN, V61, P1591, DOI 10.1007/s00262-012-1255-z; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Morita S, 2011, CARCINOGENESIS, V32, P1706, DOI 10.1093/carcin/bgr194; Naito Y, 1998, CANCER RES, V58, P3491; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sasaki M, 2014, J CLIN PATHOL, V67, P470, DOI 10.1136/jclinpath-2013-201917; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; Stremitzer S, 2012, BRIT J SURG, V99, P1575, DOI 10.1002/bjs.8909; Takhar P, 2007, J ALLERGY CLIN IMMUN, V119, P213, DOI 10.1016/j.jaci.2006.09.045; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Winiarska M, 2012, J BIOL CHEM, V287, P31983, DOI 10.1074/jbc.M112.374751; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312	62	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99008	10.1371/journal.pone.0099008	http://dx.doi.org/10.1371/journal.pone.0099008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905750	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000090
J	Midorikawa, K; Kuroda, M; Terauchi, K; Hoshi, M; Ikenaga, S; Ishimaru, Y; Abe, K; Asakura, T				Midorikawa, Keiko; Kuroda, Masaharu; Terauchi, Kaede; Hoshi, Masako; Ikenaga, Sachiko; Ishimaru, Yoshiro; Abe, Keiko; Asakura, Tomiko			Additional Nitrogen Fertilization at Heading Time of Rice Down-Regulates Cellulose Synthesis in Seed Endosperm	PLOS ONE			English	Article							SUCROSE SYNTHASE; ALPHA-AMYLASE; GENE-EXPRESSION; PROTEIN BODIES; CULTURED-CELLS; ARABIDOPSIS; METABOLISM; PLANTS; WALL; MICROARRAY	The balance between carbon and nitrogen is a key determinant of seed storage components, and thus, is of great importance to rice and other seed-based food crops. To clarify the influence of the rhizosphere carbon/nitrogen balance during the maturation stage of several seed components, transcriptome analysis was performed on the seeds from rice plants that were provided additional nitrogen fertilization at heading time. As a result, it was assessed that genes associated with molecular processes such as photosynthesis, trehalose metabolism, carbon fixation, amino acid metabolism, and cell wall metabolism were differentially expressed. Moreover, cellulose and sucrose synthases, which are involved in cellulose synthesis, were down-regulated. Therefore, we compared cellulose content of mature seeds that were treated with additional nitrogen fertilization with those from control plants using calcofluor staining. In these experiments, cellulose content in endosperm from plants receiving additional nitrogen fertilization was less than that in control endosperm. Other starch synthesis-related genes such as starch synthase 1, starch phosphorylase 2, and branching enzyme 3 were also down-regulated, whereas some alpha-amylase and beta-amylase genes were up-regulated. On the other hand, mRNA expression of amino acid biosynthesis-related molecules was up-regulated. Moreover, additional nitrogen fertilization caused accumulation of storage proteins and up-regulated Cys-poor prolamin mRNA expression. These data suggest that additional nitrogen fertilization at heading time changes the expression of some storage substance-related genes and reduces cellulose levels in endosperm.	[Midorikawa, Keiko; Terauchi, Kaede; Hoshi, Masako; Ishimaru, Yoshiro; Abe, Keiko; Asakura, Tomiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Kuroda, Masaharu] NARO Agr Res Ctr, Crop Dev Div, Niigata, Japan; [Ikenaga, Sachiko] NARO Tohoku Agr Res Ctr, Field Crop & Hort Res Div, Morioka, Iwate, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Food Safety & Reliabil Project, Takatsu Ku, Kawasaki, Kanagawa, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Kanagawa Academy Science & Technology	Kuroda, M (corresponding author), NARO Agr Res Ctr, Crop Dev Div, Niigata, Japan.	kurodama@affrc.go.jp; asakura@mail.ecc.u-tokyo.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020	Midorikawa, Keiko/0000-0003-2297-1564	Nissin Food Holdings Co., LTD; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Nissin Food Holdings Co., LTD; Tojuro Iijima Foundation for Food Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Nissin Food Holdings Co., LTD (http://www.nissinfoods-holdings.co.jp/). It was supported by grant in aid for food science research to T. A. and M. K. from the Tojuro Iijima Foundation for Food Science and Technology (http://www.iijima-kinenzaidan.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Atanassov II, 2009, J BIOL CHEM, V284, P3833, DOI 10.1074/jbc.M807456200; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Burton RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00130; Chen ZX, 2007, BIOINFORMATICS, V23, P321, DOI 10.1093/bioinformatics/btl609; Fabian C, 2011, CRIT REV FOOD SCI, V51, P816, DOI 10.1080/10408398.2010.482678; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Hirose T, 2008, PLANT SCI, V174, P534, DOI 10.1016/j.plantsci.2008.02.009; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JW, 1996, BIOSCI BIOTECH BIOCH, V60, P233, DOI 10.1271/bbb.60.233; KARRER EE, 1992, PLANT J, V2, P517; Ken'ichi O, 1993, JAPAN AGR RES Q, P95; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; Kuroda M, 2010, BIOSCI BIOTECH BIOCH, V74, P2348, DOI 10.1271/bbb.100465; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Matsushima S, 1995, SCI RICE PLANT, P753; OGAWA M, 1987, PLANT CELL PHYSIOL, V28, P1517; Okadome H, 2005, JARQ-JPN AGR RES Q, V39, P261, DOI 10.6090/jarq.39.261; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Saito Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2779, DOI 10.1271/bbb.80337; Saito Y, 2012, PLANT J, V70, P1043, DOI 10.1111/j.1365-313X.2012.04947.x; Scheible WR, 1997, PLANT CELL, V9, P783, DOI 10.1105/tpc.9.5.783; SHIBUYA N, 1985, CEREAL CHEM, V62, P252; Shigemitsu T, 2012, BIOSCI BIOTECH BIOCH, V76, P594, DOI 10.1271/bbb.110791; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Suzuki Kiyoshi, 2005, Functional & Integrative Genomics, V5, P117, DOI 10.1007/s10142-004-0125-y; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taira H, 1995, SCI RICE PLANT, P1064; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; TANAKA Y, 1975, AGR BIOL CHEM TOKYO, V39, P515, DOI 10.1080/00021369.1975.10861629; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Thum KE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r10; Umemura T, 1998, PLANTA, V204, P420, DOI 10.1007/s004250050275; Usuda H, 1999, PLANT CELL PHYSIOL, V40, P369, DOI 10.1093/oxfordjournals.pcp.a029552; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; YU SM, 1991, J BIOL CHEM, V266, P21131; Zhou ZK, 2002, INT J FOOD SCI TECH, V37, P849, DOI 10.1046/j.1365-2621.2002.00625.x	45	18	18	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98738	10.1371/journal.pone.0098738	http://dx.doi.org/10.1371/journal.pone.0098738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905454	gold, Green Published, Green Submitted			2022-12-25	WOS:000341869000054
J	Orlandi, JG; Stetter, O; Soriano, J; Geisel, T; Battaglia, D				Orlandi, Javier G.; Stetter, Olav; Soriano, Jordi; Geisel, Theo; Battaglia, Demian			Transfer Entropy Reconstruction and Labeling of Neuronal Connections from Simulated Calcium Imaging	PLOS ONE			English	Article							IN-VIVO; FUNCTIONAL CONNECTIVITY; INFORMATION-TRANSFER; CORTICAL CULTURES; NETWORK ACTIVITY; BRAIN NETWORKS; DYNAMICS; ORGANIZATION; EXCITATION/INHIBITION; SYNCHRONIZATION	Neuronal dynamics are fundamentally constrained by the underlying structural network architecture, yet much of the details of this synaptic connectivity are still unknown even in neuronal cultures in vitro. Here we extend a previous approach based on information theory, the Generalized Transfer Entropy, to the reconstruction of connectivity of simulated neuronal networks of both excitatory and inhibitory neurons. We show that, due to the model-free nature of the developed measure, both kinds of connections can be reliably inferred if the average firing rate between synchronous burst events exceeds a small minimum frequency. Furthermore, we suggest, based on systematic simulations, that even lower spontaneous inter-burst rates could be raised to meet the requirements of our reconstruction algorithm by applying a weak spatially homogeneous stimulation to the entire network. By combining multiple recordings of the same in silico network before and after pharmacologically blocking inhibitory synaptic transmission, we show then how it becomes possible to infer with high confidence the excitatory or inhibitory nature of each individual neuron.	[Orlandi, Javier G.; Soriano, Jordi] Univ Barcelona, Dept Estruct & Consituents Mat, Barcelona, Spain; [Stetter, Olav; Geisel, Theo; Battaglia, Demian] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Stetter, Olav; Geisel, Theo] Univ Gottingen, Dept Phys, D-37073 Gottingen, Germany; [Stetter, Olav; Geisel, Theo; Battaglia, Demian] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Battaglia, Demian] Aix Marseille Univ, Inserm UMR1106, Inst Neurosci Syst, Marseille, France	University of Barcelona; Max Planck Society; University of Gottingen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Battaglia, D (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	demian.battaglia@univ-amu.fr	Orlandi, Javier/AFD-9072-2022; Battaglia, Demian/C-1281-2017; Soriano, Jordi/B-4756-2016; Orlandi, Javier G./B-1314-2009	Battaglia, Demian/0000-0003-2021-7920; Soriano, Jordi/0000-0003-2676-815X; Orlandi, Javier G./0000-0001-5683-1717	Ministerio de Ciencia e Innovacion (Spain) [FIS2009-07523, FIS2010-21924-C02-02, FIS2011-28820-C02-01]; Generalitat de Catalunya [2009-SGR-00014]; German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen [01GQ0430]; FP7 Marie Curie career development fellowship [IEF 330792]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen(Federal Ministry of Education & Research (BMBF)); FP7 Marie Curie career development fellowship	JO and JS received financial support from Ministerio de Ciencia e Innovacion (Spain) under projects FIS2009-07523, and FIS2010-21924-C02-02, FIS2011-28820-C02-01 and from the Generalitat de Catalunya under project 2009-SGR-00014. OS, TG and DB were supported by the German Ministry for Education and Science (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Goettingen (Grant No. 01GQ0430). OS and DB acknowledge in addition, respectively, the Minerva Foundation (Muenchen, Germany) and funding from the FP7 Marie Curie career development fellowship IEF 330792 (DynViB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2013, NATURE, V499, P272, DOI 10.1038/499272a; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Bansal S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-405; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chicurel M, 2000, NATURE, V406, P822, DOI 10.1038/35022659; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cohen O, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18008; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Durand DM, 2001, P IEEE, V89, P1065, DOI 10.1109/5.939821; Eckmann JP, 2007, PHYS REP, V449, P54, DOI 10.1016/j.physrep.2007.02.014; Eckmann JP, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00132; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Jacobi S, 2009, EUR J NEUROSCI, V30, P998, DOI 10.1111/j.1460-9568.2009.06891.x; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kandel E, 1967, ELECTROPHYSIOLOGICAL, P385; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kobayashi R, 2013, J COMPUT NEUROSCI, V35, P109, DOI 10.1007/s10827-013-0443-y; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Linaro D, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00043; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Madhavan Radhika, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1593; MAEDA E, 1995, J NEUROSCI, V15, P6834; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marconi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034648; Marissal T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2318; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Nicoll RA, 1998, SCIENCE, V281, P360, DOI 10.1126/science.281.5375.360; Orlandi JG, 2013, NAT PHYS, V9, P582, DOI [10.1038/NPHYS2686, 10.1038/nphys2686]; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; Schmeltzer C, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012116; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; SEGAL M, 1992, J PHYSIOL-LONDON, V448, P655, DOI 10.1113/jphysiol.1992.sp019063; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Tibau E, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00199; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	88	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98842	10.1371/journal.pone.0098842	http://dx.doi.org/10.1371/journal.pone.0098842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905689	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000067
J	Wang, YD; Wu, H; Wu, XL; Bian, ZQ; Gao, Q				Wang, Yidong; Wu, Hong; Wu, Xiaoling; Bian, Zhuoqiong; Gao, Qing			Interleukin 17A Promotes Gastric Cancer Invasiveness via NF-kappa B Mediated Matrix Metalloproteinases 2 and 9 Expression	PLOS ONE			English	Article							CUTTING EDGE; IL-17; CELL; ANGIOGENESIS; RECRUITMENT; INHIBITION; RECEPTOR	Interleukin 17A (IL-17A), as a pro-inflammatory cytokine, is involved in pathology of inflammatory diseases and tumor microenvironment. The aim of this study is to investigate the effect of IL-17A on the invasiveness of gastric cancer (GC). In the study, we found that IL-17A could promote the migration and invasion of GC cells. Furthermore, after treated with IL-17A, the expressions and activities of matrix metalloproteinase 2 (MMP-2) and MMP-9 were upregulated, while the expressions of TIMP-1 and TIMP-2 were downregulated. Moreover, the nuclear/overall fractions of p65 and p50 were dramatically elevated by IL-17A. Pretreatment with helenalin, a nuclear factor-kappa B (NF-kappa B) inhibitor, was proved to abolish the promoting effect of IL-17A on the invasion ability of GC cells and upregulation of MMP-2 and MMP-9. In conclusion, our findings illustrated that IL-17A could promote the invasion of GC cells by activating NF-kappa B pathway, and subsequently upregulating the expression of MMP-2 and MMP-9. These results may lead to the identification of new diagnostic markers and therapeutic targets of GC.	[Wang, Yidong; Wu, Xiaoling; Gao, Qing] Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Wu, Hong] XIAN XD GRP Hosp, Dept Gen Surg, Xian, Shaanxi, Peoples R China; [Bian, Zhuoqiong] Fifth Hosp Xian City, Dept Rheumatol 5, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; China XD Group	Gao, Q (corresponding author), Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Sch Med, Xian 710049, Shaanxi, Peoples R China.	dqinggao@163.com			National Natural Science Foundation of China [81070536]; Youth Scientific Funds of The Central Hospital of Taian [2011ZRQNO35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Scientific Funds of The Central Hospital of Taian	The project was supported by National Natural Science Foundation of China (No. 81070536) and Youth Scientific Funds of The Central Hospital of Taian (2011ZRQNO35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Chen JG, 2011, INT J BIOL SCI, V7, P53, DOI 10.7150/ijbs.7.53; Chen KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072927; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Gao C, 2009, CELL MOL NEUROBIOL, V29, P1161, DOI 10.1007/s10571-009-9409-z; Holck S, 2003, FEMS IMMUNOL MED MIC, V36, P175, DOI 10.1016/S0928-8244(03)00028-2; Hus I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078091; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lavu H, 2013, J SURG RES, V185, P516, DOI 10.1016/j.jss.2012.09.034; Lee J, 2001, J BIOL CHEM, V276, P1660, DOI 10.1074/jbc.M008289200; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Lu L, 2013, J IMMUNOTHER, V36, P451, DOI 10.1097/CJI.0b013e3182a802cf; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Shalom-Barak T, 1998, J BIOL CHEM, V273, P27467, DOI 10.1074/jbc.273.42.27467; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tan B, 2013, TUMOUR BIOL; Zambon CF, 2002, CYTOKINE, V18, P242, DOI 10.1006/cyto.2002.0891; Zhao L, 2010, CANCER BIOL THER, V9, P42, DOI 10.4161/cbt.9.1.10282; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	29	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e96678	10.1371/journal.pone.0096678	http://dx.doi.org/10.1371/journal.pone.0096678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905806	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000001
J	Cuadra, VMB; Gonzalez-Huerta, NC; Romero-Cordoba, S; Hidalgo-Miranda, A; Miranda-Duarte, A				Borgonio Cuadra, Veronica M.; Celia Gonzalez-Huerta, Norma; Romero-Cordoba, Sandra; Hidalgo-Miranda, Alfredo; Miranda-Duarte, Antonio			Altered Expression of Circulating MicroRNA in Plasma of Patients with Primary Osteoarthritis and In Silico Analysis of Their Pathways	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHONDROCYTE APOPTOSIS; RHEUMATOID-ARTHRITIS; INHIBITION; BIOMARKERS; MECHANISM; MIRNA; PCR; DIAGNOSIS; CARTILAGE	Objective: To analyze a set of circulating microRNA (miRNA) in plasma from patients with primary Osteoarthritis (OA) and describe the biological significance of altered miRNA in OA based on an in silico analysis of their target genes. Methods: miRNA expression was analyzed using TaqMan Low Density Arrays and independent assays. The search for potential messenger RNA (mRNA) targets of the differentially expressed miRNA was performed by means of the miRWalk and miRecords database; we conducted the biological relevance of the predicted miRNA targets by pathway analysis with the Reactome and DAVID databases. Results: We measured the expression of 380 miRNA in OA; 12 miRNA were overexpressed under the OA condition (p value, <= 0.05; fold change, >2). These results were validated by the detection of some selected miRNA by quantitative PCR (qPCR). In silico analysis showed that target messenger RNA (mRNA) were potentially regulated by these miRNA, including genes such as SMAD1, IL-1B, COL3A, VEGFA, and FGFR1, important in chondrocyte maintenance and differentiation. Some metabolic pathways affected by the miRNA: mRNA ratio are signaling Bone morphogenetic proteins (BMP), Platelet-derived growth factor (PDGF), and Nerve growth factor (NGF), these latter two involved in the process of pain. Conclusions: We identified 12 miRNA in the plasma of patients with primary OA. Specific miRNA that are altered in the disease could be released into plasma, either due to cartilage damage or to an inherent cellular mechanism. Several miRNA could regulate genes and pathways related with development of the disease; eight of these circulating miRNA are described, to our knowledge, for first time in OA.	[Borgonio Cuadra, Veronica M.; Celia Gonzalez-Huerta, Norma; Miranda-Duarte, Antonio] INR, Dept Genet, Mexico City, DF, Mexico; [Romero-Cordoba, Sandra; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom INMEGEN, Lab Genom Canc, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica	Cuadra, VMB (corresponding author), INR, Dept Genet, Mexico City, DF, Mexico.	vborgoni@yahoo.com.mx	Romero, Sandra/A-2246-2014; Hidalgo-Miranda, Alfredo/B-2123-2010; Romero-Cordoba, Sandra/AAY-2625-2020	Romero, Sandra/0000-0002-5591-696X; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Miranda-Duarte, Antonio/0000-0001-6530-4636	National Council for Science and Technology (CONACyT-Mexico) [114945]	National Council for Science and Technology (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was financially supported by grant No. 114945 of the National Council for Science and Technology (CONACyT-Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caporali A, 2011, TRENDS CARDIOVAS MED, V21, P162, DOI 10.1016/j.tcm.2012.05.003; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chapman K, 2012, BONE, V51, P258, DOI 10.1016/j.bone.2011.11.026; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Diaz-Prado S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-144; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Gilbert AM, 2008, BIOORG MED CHEM LETT, V18, P6454, DOI 10.1016/j.bmcl.2008.10.065; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Iuliano R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/591931; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3798; Li X, 2010, RECENT PAT ANTI-CANC, V5, P109, DOI 10.2174/157489210790936234; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael JWP, 2010, DTSCH ARZTEBL INT, V107, P152, DOI 10.3238/arztebl.2010.0152; Miyaki S, 2012, NAT REV RHEUMATOL, V8, P543, DOI 10.1038/nrrheum.2012.128; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Sapre N, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/539680; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tang D, 2013, EUR J CANC PREV; Tomaselli S, 2012, BIOMARK MED, V6, P729, DOI [10.2217/bmm.12.91, 10.2217/BMM.12.91]; Tortorella MD, 2009, J BIOL CHEM, V284, P24185, DOI 10.1074/jbc.M109.029116; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Yamasaki K, 2009, ARTHRITIS RHEUM-US, V60, P1035, DOI 10.1002/art.24404; Yang N, 2008, INT J CANCER, V122, P963, DOI 10.1002/ijc.23325; Zamli Z, 2011, INT J RHEUM DIS, V14, P159, DOI 10.1111/j.1756-185X.2011.01618.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	45	72	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e97690	10.1371/journal.pone.0097690	http://dx.doi.org/10.1371/journal.pone.0097690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901787	Green Published, Green Submitted, gold			2022-12-25	WOS:000336841400010
J	Raz, O; Lev, DL; Battler, A; Lev, EI				Raz, Oshrat; Lev, Dorit L.; Battler, Alexander; Lev, Eli I.			Pathways Mediating the Interaction between Endothelial Progenitor Cells (EPCs) and Platelets	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCE DIFFERENTIATION; ACTIVATED PLATELETS; CARDIOVASCULAR RISK; VASCULAR INJURY; ANGIOGENESIS; NEOVASCULARIZATION; MICROPARTICLES; MOBILIZATION; VEGF	Introduction: Endothelial progenitor cells (EPCs) have an important role in the process of vascular injury repair. Platelets have been shown to mediate EPC recruitment, maturation and differentiation. Yet, the mechanism underlying this interaction is unclear. We, therefore, aimed to examine whether direct contact between platelets and EPCs is essential for the positive platelets-EPC effect, and to investigate the main mediators responsible for the improvement in EPCs function. Methods: Human EPCs were isolated from donated buffy coats and cultured in either: 1. EPCs co-incubated with platelets placed in a 1 mu m-Boyden chamber. 2. EPCs incubated with or without platelets in the presence or absence of bFGF/PDGF Receptor inhibitor (PDGFRI). After 7 days culture, EPCs ability to form colonies, proliferate and differentiate was examined. Culture supernatants were collected and growth factors levels were evaluated using ELISA. Growth factors mRNA levels in EPCs were evaluated using RT-PCR. Results and Conclusions: After 7 days culture, EPCs functional properties were higher following co-incubation with platelets (directly or indirectly), implying that direct contact is not essential for the platelet's positive effect on EPCs. This effect was reduced by PDGFRI inhibition. Additionally, higher levels of PDGFB in EPCs-platelets supernatant and higher levels of PDGFC mRNA in EPCs co-incubated with platelets were found. In contrast, FGF and other potential mediators that were examined and inhibited did not significantly affect the interaction between platelets and EPCs. Thus, we conclude that PDGF has a central role in the interaction between platelets and EPCs. Further study is required to examine additional aspects of EPC-platelets interaction.	[Lev, Dorit L.; Lev, Eli I.] Felsenstein Med Res Inst, Petah Tiqwa, Israel; [Raz, Oshrat; Lev, Dorit L.; Lev, Eli I.] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Raz, Oshrat; Battler, Alexander; Lev, Eli I.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Raz, O (corresponding author), Rabin Med Ctr, Dept Cardiol, Jabotinsky St, Petah Tiqwa, Israel.	oshratra@clalit.org.il			Leo Mintz Foundation; David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University	Leo Mintz Foundation; David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University	This work was supported by the Leo Mintz Foundation and the David Halperne Chair in Cellular and Molecular Cardiology, Sackler Faculty of Medicine, Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Banerjee S, 2006, ATHEROSCLEROSIS, V189, P70, DOI 10.1016/j.atherosclerosis.2006.04.026; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Dimmeler S, 2005, NEW ENGL J MED, V352, P1815, DOI 10.1056/NEJMcibr050670; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Garg R, 2008, CATHETER CARDIO INTE, V72, P205, DOI 10.1002/ccd.21611; Gill M, 2001, CIRC RES, V88, P167; Guo SF, 2012, CELL BIOL INT, V36, P945, DOI 10.1042/CBI20110657; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Leshem-Lev D, 2010, J THROMB THROMBOLYS, V30, P398, DOI 10.1007/s11239-010-0514-0; Lev EI, 2013, EUR J PREV CARDIOL; Lev EI, 2006, THROMB HAEMOSTASIS, V96, P498, DOI 10.1160/TH06-05-0250; Lev EI, 2010, EUR HEART J, V31, P2625, DOI 10.1093/eurheartj/ehq184; Li XR, 2005, J CLIN INVEST, V115, P118, DOI 10.1172/JCI200519189; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Solomon A, 2012, AM J MED, V125, P604, DOI 10.1016/j.amjmed.2011.10.025; Sufen G, 2010, CELL BIOL INT, V35, P545; Vaturi M, 2011, AM J CARDIOL, V108, P272, DOI 10.1016/j.amjcard.2011.03.039; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e95156	10.1371/journal.pone.0095156	http://dx.doi.org/10.1371/journal.pone.0095156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901498	gold, Green Published, Green Submitted			2022-12-25	WOS:000336841400002
J	Bouabid, S; Delaville, C; De Deurwaerdere, P; Lakhdar-Ghazal, N; Benazzouz, A				Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Lakhdar-Ghazal, Nouria; Benazzouz, Abdelhamid			Manganese-Induced Atypical Parkinsonism Is Associated with Altered Basal Ganglia Activity and Changes in Tissue Levels of Monoamines in the Rat	PLOS ONE			English	Article							GLOBUS-PALLIDUS NEURONS; SUBTHALAMIC NUCLEUS; NIGROSTRIATAL PATHWAY; FIRING PATTERN; SUBSTANTIA-NIGRA; MOTOR DEFICITS; DOPAMINE; BRAIN; EXPOSURE; NORADRENALINE	Manganese neurotoxicity is associated with motor and cognitive disturbances known as Manganism. However, the mechanisms underlying these deficits remain unknown. Here we investigated the effects of manganese intoxication on motor and non-motor parkinsonian-like deficits such as locomotor activity, motor coordination, anxiety and "depressive-like'' behaviors. Then, we studied the impact of this intoxication on the neuronal activity, the globus pallidus (GP) and subthalamic nucleus (STN). At the end of experiments, post-mortem tissue level of the three monoamines (dopamine, norepinephrine and serotonin) has been determined. The experiments were carried out in adult Sprague-Dawley rats, daily treated with MnCl2 (10 mg/kg/, i.p.) for 5 weeks. We show that manganese progressively reduced locomotor activity as well as motor coordination in parallel with the manifestation of anxiety and "depressive-like'' behaviors. Electrophysiological results show that, while majority of GP and STN neurons discharged regularly in controls, manganese increased the number of GP and STN neurons discharging irregularly and/or with bursts. Biochemical results show that manganese significantly decreased tissue levels of norepinephrine and serotonin with increased metabolism of dopamine in the striatum. Our data provide evidence that manganese intoxication is associated with impaired neurotransmission of monoaminergic systems, which is at the origin of changes in basal ganglia neuronal activity and the manifestation of motor and non-motor deficits similar to those observed in atypical Parkinsonism.	[Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Benazzouz, Abdelhamid] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bouabid, Safa; Delaville, Claire; De Deurwaerdere, Philippe; Benazzouz, Abdelhamid] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bouabid, Safa; Lakhdar-Ghazal, Nouria] Univ Mohamed V Agdal, Fac Sci, Equipe Rythmes Biol Neurosci & Environm, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Mohammed V University in Rabat	Benazzouz, A (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	Abdelhamid.Benazzouz@u-bordeaux.fr	De Deurwaerdère, Philippe/I-5834-2019; Benazzouz, Abdelhamid/E-5050-2016	De Deurwaerdère, Philippe/0000-0002-1226-3516; Bouabid, Safa/0000-0003-4184-3795	Universite Bordeaux Segalen; "Groupement de Recherche International" [GDRI N198]; "Groupement de Recherche International'' (CNRS INSERM France); "Groupement de Recherche International'' (CNRST Morocco); Egide-Volubilis [20565ZM]	Universite Bordeaux Segalen; "Groupement de Recherche International"; "Groupement de Recherche International'' (CNRS INSERM France); "Groupement de Recherche International'' (CNRST Morocco); Egide-Volubilis	This study was supported by the "Universite Bordeaux Segalen'' and exchange grants of the "Groupement de Recherche International'' (GDRI N198, CNRS & INSERM France, and CNRST Morocco), Egide-Volubilis No 20565ZM, CNRS-CNRST Convention Adivmar 22614 and NEUROMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; ASTONJONES G, 1991, J NEUROSCI, V11, P760; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Avila DS, 2010, TOXICOL SCI, V115, P194, DOI 10.1093/toxsci/kfq036; Belujon P, 2007, J NEUROSCI, V27, P9595, DOI 10.1523/JNEUROSCI.2583-07.2007; Betharia S, 2012, NEUROTOXICOLOGY, V33, P1117, DOI 10.1016/j.neuro.2012.06.002; Bouchard M, 2007, NEUROTOXICOLOGY, V28, P290, DOI 10.1016/j.neuro.2006.08.002; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Breit S, 2007, EXP NEUROL, V205, P36, DOI 10.1016/j.expneurol.2006.12.016; Butterworth RF, 2010, NEUROTOX RES, V18, P100, DOI 10.1007/s12640-010-9185-z; Calabresi P, 2001, NEUROBIOL DIS, V8, P419, DOI 10.1006/nbdi.2000.0379; CHANDRA SV, 1981, J NEUROCHEM, V36, P683, DOI 10.1111/j.1471-4159.1981.tb01642.x; Chetrit J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006208; Cordova FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033057; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; DEDEURWAERDERE P, 1995, J NEUROCHEM, V65, P1100; Delaville C, 2012, NEUROSCIENCE, V202, P424, DOI 10.1016/j.neuroscience.2011.11.024; Delaville C, 2012, NEUROBIOL DIS, V45, P763, DOI 10.1016/j.nbd.2011.10.023; Delaville C, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00031; DESOLE MS, 1995, NEUROPHARMACOLOGY, V34, P289, DOI 10.1016/0028-3908(94)00140-N; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Diaz-Veliz G, 2004, PHARMACOL BIOCHEM BE, V77, P245, DOI 10.1016/j.pbb.2003.10.016; Dietz MC, 2001, ENVIRON RES, V85, P37, DOI 10.1006/enrs.2000.4068; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; ERIKSSON H, 1987, ARCH TOXICOL, V59, P426, DOI 10.1007/BF00316209; EXON JH, 1975, B ENVIRON CONTAM TOX, V14, P370, DOI 10.1007/BF01685652; Fitoussi A, 2013, NEUROSCIENCE, V255, P233, DOI 10.1016/j.neuroscience.2013.09.059; Golub MS, 2005, NEUROTOXICOL TERATOL, V27, P615, DOI 10.1016/j.ntt.2005.04.003; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P625, DOI 10.1017/S1461145707008383; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00023; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Gwiazda R, 2007, J TOXICOL ENV HEAL A, V70, P594, DOI 10.1080/10937400600882897; INGERSOLL RT, 1995, FUND APPL TOXICOL, V27, P106, DOI 10.1006/faat.1995.1113; Jackson SJ, 2011, BEHAV BRAIN RES, V216, P293, DOI 10.1016/j.bbr.2010.08.007; Josephs KA, 2005, NEUROLOGY, V64, P2033, DOI 10.1212/01.WNL.0000167411.93483.A1; Kaneoke Y, 1996, J NEUROSCI METH, V68, P211, DOI 10.1016/0165-0270(96)00081-7; Klos KJ, 2006, EUR J NEUROL, V13, P1139, DOI 10.1111/j.1468-1331.2006.01407.x; Labarre D, 2008, INT CONF ACOUST SPEE, P489, DOI 10.1109/ICASSP.2008.4517653; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; dos Santos APM, 2011, BRAIN RES, V1382, P282, DOI 10.1016/j.brainres.2011.01.047; Nam J, 2008, BIOL PHARM BULL, V31, P1894, DOI 10.1248/bpb.31.1894; Ni ZG, 2001, SYNAPSE, V40, P145, DOI 10.1002/syn.1036.abs; Ni ZG, 2000, EUR J NEUROSCI, V12, P4338, DOI 10.1111/j.1460-9568.2000.01346.x; Normandin Louise, 2002, Rev Environ Health, V17, P189; PAN HS, 1988, SYNAPSE, V2, P650, DOI 10.1002/syn.890020612; PAPP M, 1987, BEHAV BRAIN RES, V23, P221, DOI 10.1016/0166-4328(87)90022-2; Paxinos G., 1996, RAT BRAIN STEREOTATI; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Roels H, 1997, ARCH TOXICOL, V71, P223, DOI 10.1007/s002040050380; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Sabbar M, 2012, NEUROSCIENCE, V210, P375, DOI 10.1016/j.neuroscience.2012.02.026; SALLER CF, 1990, J PHARMACOL EXP THER, V253, P1162; Sanchez-Betancourt J, 2012, NEUROTOXICOLOGY, V33, P1346, DOI 10.1016/j.neuro.2012.08.012; Sclafani A, 2003, PHYSIOL BEHAV, V79, P663, DOI 10.1016/S0031-9384(03)00143-4; SETH PK, 1981, TOXICOL LETT, V9, P247, DOI 10.1016/0378-4274(81)90157-0; Sistrunk SC, 2007, ENVIRON TOXICOL PHAR, V23, P286, DOI 10.1016/j.etap.2006.11.004; Struve MF, 2007, AM J IND MED, V50, P772, DOI 10.1002/ajim.20489; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Temel Y, 2005, PROG NEUROBIOL, V76, P393, DOI 10.1016/j.pneurobio.2005.09.005; Temel Y, 2007, P NATL ACAD SCI USA, V104, P17087, DOI 10.1073/pnas.0704144104; Tomas-Camardiel M, 2002, MOL BRAIN RES, V103, P116, DOI 10.1016/S0169-328X(02)00192-4; Tordoff MG, 2003, CHEM SENSES, V28, P315, DOI 10.1093/chemse/28.4.315; Torrente M, 2005, TOXICOLOGY, V211, P59, DOI 10.1016/j.tox.2005.02.010; Uchino A, 2007, NEURORADIOLOGY, V49, P715, DOI 10.1007/s00234-007-0243-z; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Vezer T, 2007, AM J IND MED, V50, P841, DOI 10.1002/ajim.20485; Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5	72	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98952	10.1371/journal.pone.0098952	http://dx.doi.org/10.1371/journal.pone.0098952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896650	gold, Green Submitted, Green Published			2022-12-25	WOS:000338430700100
J	Choi, SL; Lee, SJ; Yeom, SJ; Kim, HJ; Rhee, YH; Jung, HC; Lee, SG				Choi, Su-Lim; Lee, Sang Jun; Yeom, Soo-Jin; Kim, Hyun Ju; Rhee, Young Ha; Jung, Heung-Chae; Lee, Seung-Goo			Controlled Localization of Functionally Active Proteins to Inclusion Bodies Using Leucine Zippers	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RECOMBINANT BACTERIA; CELLULOMONAS-FIMI; ESCHERICHIA-COLI; AGGREGATION; MICROSCOPY; BINDING; FUSION; DOMAIN; CELLS	Inclusion bodies (IBs) are typically non-functional particles of aggregated proteins. However, some proteins in fusion with amyloid-like peptides, viral coat proteins, and cellulose binding domains (CBDs) generate IB particles retaining the original functions in cells. Here, we attempted to generate CBD IBs displaying functional leucine zipper proteins (LZs) as bait for localizing cytosolic proteins in E. coli. When a red fluorescent protein was tested as a target protein, microscopic observations showed that the IBs red-fluoresced strongly. When different LZ pairs with K(D)s of 8-1,000 mu M were tested as the bait and prey, the localization of the red fluorescence appeared to change following the affinities between the LZs, as observed by fluorescence imaging and flow cytometry. This result proposed that LZ-tagged CBD IBs can be applied as an in vivo matrix to entrap cytosolic proteins in E. coli while maintaining their original activities. In addition, easy detection of localization to IBs provides a unique platform for the engineering and analyses of protein-protein interactions in E. coli.	[Choi, Su-Lim; Yeom, Soo-Jin; Jung, Heung-Chae; Lee, Seung-Goo] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea; [Choi, Su-Lim; Rhee, Young Ha] Chungnam Natl Univ, Dept Biosci & Biotechnol, Taejon, South Korea; [Lee, Sang Jun; Kim, Hyun Ju] KRIBB, Infect & Immun Biol Res Ctr, Taejon, South Korea; [Lee, Sang Jun; Kim, Hyun Ju; Lee, Seung-Goo] Korea Univ Sci & Technol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SG (corresponding author), KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea.	sglee@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021; Yeom, Soojin/AAE-3558-2022	Lee, Seung-Goo/0000-0003-4539-9812; Lee, Sang Jun/0000-0002-2803-753X; Yeom, Soo-Jin/0000-0001-7307-237X; JUNG, Heungchae/0000-0003-4226-8235	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944]; Pioneer Research Program for Converging Technology [20110001745]; Bio-industry Technology Development Program [310006-5]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning [20133030000300]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Intelligent Synthetic Biology Center of Global Frontier Project; Pioneer Research Program for Converging Technology; Bio-industry Technology Development Program; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by grants from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031944), the Pioneer Research Program for Converging Technology (20110001745), Bio-industry Technology Development Program (No. 310006-5), the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (20133030000300), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrio MM, 1998, FEMS MICROBIOL LETT, V169, P9, DOI 10.1016/S0378-1097(98)00444-3; Chen AH, 2012, TRENDS CELL BIOL, V22, P662, DOI 10.1016/j.tcb.2012.07.002; Choi SL, 2011, BIOTECHNOL BIOPROC E, V16, P1173, DOI 10.1007/s12257-011-0336-8; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Hanaor D, 2012, J EUR CERAM SOC, V32, P235, DOI 10.1016/j.jeurceramsoc.2011.08.015; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Nahalka J, 2007, BIOTECHNOL BIOENG, V97, P454, DOI 10.1002/bit.21244; Palmer Ira, 2004, Curr Protoc Protein Sci, VChapter 6, DOI [10.1002/0471140864.ps0603s70, 10.1002/0471140864.ps0603s38]; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Steinmann B, 2010, APPL ENVIRON MICROB, V76, P5563, DOI 10.1128/AEM.00612-10; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wu W, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-9; You C, 2013, ACS SYNTH BIOL, V2, P102, DOI 10.1021/sb300068g; Young PA, 2011, J MICROSC-OXFORD, V242, P148, DOI 10.1111/j.1365-2818.2010.03448.x	27	81	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97093	10.1371/journal.pone.0097093	http://dx.doi.org/10.1371/journal.pone.0097093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897378	Green Published, gold, Green Submitted			2022-12-25	WOS:000338430700006
J	Kawakami, Y; Nomura, K; Tanaka, H				Kawakami, Yutaka; Nomura, Kazuharu; Tanaka, Hideki			Growth Promoting Effect of Hyaluronan Synthesis Promoting Substances on Japanese Eel Leptocephali	PLOS ONE			English	Article							HORMONE-RECEPTOR-BETA; MOLECULAR-CLONING; ANGUILLA-JAPONICA; 17,20 BETA-DIHYDROXY-4-PREGNEN-3-ONE; NORTHERN KYUSHU; GLASS-EELS; CONGER EEL; CDNA; IDENTIFICATION; OVULATION	Hyaluronans (HAs) are glycosaminoglycans produced in the bodies of Anguilliform and Elopiform leptocephali, and play a role in metabolic energy. In mammals, HA synthesis-promoting substances (HASPS) up-regulate the expression of HA synthase (HAS) and increase the amount of HA in the body. In this study, Japanese eel leptocephali were fed a HASPS containing diet. We analyzed HAS1s and HAS2 expression, HA content, and their influence on growth. HASPS extracted from Grifola frondosa promoted HAS1s and HAS2 mRNA and HA content. Other than mammals, these results are first reported in vertebrate. Moreover, HASPS extracted from G. frondosa promoted leptocephalus growth. The relationship between growth and HA in the leptocephali is not yet clear. However, based on our results we hypothesize that HA is involved in the storage of energy, which is metabolized to sugars when needed for metabolic energy.	[Kawakami, Yutaka; Nomura, Kazuharu; Tanaka, Hideki] Fisheries Res Agcy, Nansei Stn, Natl Res Inst Aquaculture, Minamiise, Japan	Japan Fisheries Research & Education Agency (FRA)	Kawakami, Y (corresponding author), Fisheries Res Agcy, Nansei Stn, Natl Res Inst Aquaculture, Minamiise, Japan.	yutakakjp@yahoo.co.jp			Ministry of Agriculture Forestry and Fisheries, Government of Japan	Ministry of Agriculture Forestry and Fisheries, Government of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a grant-in-aid for "Development of Sustainable Aquaculture Technology Independent of Wild Fishery Resources'' from the Ministry of Agriculture Forestry and Fisheries, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender DA, 2006, HARPERS ILLUSTRATED, P177; Brecht M, 1986, J IMMUNOL, V148, P3912; CHEN WYJ, 1989, J CELL SCI, V94, P577; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kagawa H, 1997, FISHERIES SCI, V63, P365, DOI 10.2331/fishsci.63.365; Kagawa H, 2005, FISH PHYSIOL BIOCHEM, V31, P193, DOI 10.1007/s10695-006-0024-3; Kawakami Y, 2003, GEN COMP ENDOCR, V132, P321, DOI 10.1016/S0016-6480(03)00087-X; Kawakami Y, 2003, GEN COMP ENDOCR, V131, P232, DOI 10.1016/S0016-6480(02)00638-X; Kawakami Y, 1999, J EXP MAR BIOL ECOL, V238, P1, DOI 10.1016/S0022-0981(98)00166-X; Kawakami Y, 1999, B MAR SCI, V64, P315; Kawakami Y, 2009, RES LETT BIOCH; Kawakami Y, 2006, COMP BIOCHEM PHYS B, V144, P503, DOI 10.1016/j.cbpb.2006.05.003; KOJIMA M, 1991, Journal of the Japan Oil Chemists' Society, V40, P53; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Masuda Yoshitsugu, 2012, Bulletin of Fisheries Research Agency, P111; Miller MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0826; Miyahara Y, 1995, Japan patent Kokai H, Patent No. [7-101871, 7101871]; Ohta H, 1996, AQUACULTURE, V139, P291, DOI 10.1016/0044-8486(95)01167-6; Okamura A, 2009, AQUAC RES, V40, P509, DOI 10.1111/j.1365-2109.2008.02127.x; Pfeiler E, 2002, COMP BIOCHEM PHYS B, V132, P443, DOI 10.1016/S1096-4959(02)00060-X; Pfeiler E, 1996, FISH PHYSIOL BIOCHEM, V15, P359, DOI 10.1007/BF02112363; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiojiri M, 2010, European Patent, Patent No. [2010-09717725.7, 2010097177257]; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Takahashi M, 2009, WO Patent, Patent No. [2,009,063,885, 2009063885]; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2011, NIPPON SUISAN GAKK, V77, P345, DOI 10.2331/suisan.77.345; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945	33	7	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98688	10.1371/journal.pone.0098688	http://dx.doi.org/10.1371/journal.pone.0098688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896609	Green Submitted, Green Published, gold			2022-12-25	WOS:000338430700065
J	Zhu, FH; Wang, WX; Di, ZR; Fan, Y				Zhu, Fenghui; Wang, Wenxu; Di, Zengru; Fan, Ying			Identifying and Characterizing Key Nodes among Communities Based on Electrical-Circuit Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; CENTRALITY	Complex networks with community structures are ubiquitous in the real world. Despite many approaches developed for detecting communities, we continue to lack tools for identifying overlapping and bridging nodes that play crucial roles in the interactions and communications among communities in complex networks. Here we develop an algorithm based on the local flow conservation to effectively and efficiently identify and distinguish the two types of nodes. Our method is applicable in both undirected and directed networks without a priori knowledge of the community structure. Our method bypasses the extremely challenging problem of partitioning communities in the presence of overlapping nodes that may belong to multiple communities. Due to the fact that overlapping and bridging nodes are of paramount importance in maintaining the function of many social and biological networks, our tools open new avenues towards understanding and controlling real complex networks with communities accompanied with the key nodes.	[Zhu, Fenghui; Wang, Wenxu; Di, Zengru; Fan, Ying] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, WX (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	wenxuwang@bnu.edu.cn; yfan@bnu.edu.cn			National Natural Science Foundation of China [61174150, NCET-09-0228]; Ministry of Education [20110003110027]; National Social Science Fund [12ZD217]; MOE (Ministry of Education in China) [11YJC840006]; NSFC [11105011]; CNNSF [61074116]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; National Social Science Fund; MOE (Ministry of Education in China)(Ministry of Education, China); NSFC(National Natural Science Foundation of China (NSFC)); CNNSF(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by the National Natural Science Foundation of China under Grant No. 61174150, NCET-09-0228 and the Doctoral Fund of the Ministry of Education (20110003110027); the major project of National Social Science Fund (12 & ZD217); MOE (Ministry of Education in China) Youth Fund Project of Humanities and Social Sciences (Project No. 11YJC840006) and NSFC under Grant No. 11105011, CNNSF under Grant No. 61074116 and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Almendral JA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016115; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Kaul R, 2009, COMMUN ACM, V52, P132, DOI 10.1145/1536616.1536649; Kim YA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035012; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Li G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.018701; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Newman ME., 2005, SOC NETWORKS, V27, P39, DOI [DOI 10.1016/j.socnet.2004.11.009, 10.1016/j.socnet.2004.11.009, DOI 10.1016/J.SOCNET.2004.11.009]; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027418; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu F, 2004, EUR PHYS J B, V38, P331, DOI 10.1140/epjb/e2004-00125-x; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	24	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e97021	10.1371/journal.pone.0097021	http://dx.doi.org/10.1371/journal.pone.0097021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK4YO	24897125	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700005
J	Arostegui, I; Esteban, C; Garcia-Gutierrez, S; Bare, M; Fernandez-de-Larrea, N; Briones, E; Quintana, JM				Arostegui, Inmaculada; Esteban, Cristobal; Garcia-Gutierrez, Susana; Bare, Marisa; Fernandez-de-Larrea, Nerea; Briones, Eduardo; Quintana, Jose M.		IRYSS-COPD Grp	Subtypes of Patients Experiencing Exacerbations of COPD and Associations with Outcomes	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CLUSTER-ANALYSIS; PHENOTYPES; BIOMARKERS	Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous condition characterized by occasional exacerbations. Identifying clinical subtypes among patients experiencing COPD exacerbations (ECOPD) could help better understand the pathophysiologic mechanisms involved in exacerbations, establish different strategies of treatment, and improve the process of care and patient prognosis. The objective of this study was to identify subtypes of ECOPD patients attending emergency departments using clinical variables and to validate the results using several outcomes. We evaluated data collected as part of the IRYSS-COPD prospective cohort study conducted in 16 hospitals in Spain. Variables collected from ECOPD patients attending one of the emergency departments included arterial blood gases, presence of comorbidities, previous COPD treatment, baseline severity of COPD, and previous hospitalizations for ECOPD. Patient subtypes were identified by combining results from multiple correspondence analysis and cluster analysis. Results were validated using key outcomes of ECOPD evolution. Four ECOPD subtypes were identified based on the severity of the current exacerbation and general health status (largely a function of comorbidities): subtype A (n = 934), neither high comorbidity nor severe exacerbation; subtype B (n = 682), moderate comorbidities; subtype C (n = 562), severe comorbidities related to mortality; and subtype D (n = 309), very severe process of exacerbation, significantly related to mortality and admission to an intensive care unit. Subtype D experienced the highest rate of mortality, admission to an intensive care unit and need for noninvasive mechanical ventilation, followed by subtype C. Subtypes A and B were primarily related to other serious complications. Hospitalization rate was more than 50% for all the subtypes, although significantly higher for subtypes C and D than for subtypes A and B. These results could help identify characteristics to categorize ECOPD patients for more appropriate care, and help test interventions and treatments in subgroups with poor evolution and outcomes.	[Arostegui, Inmaculada] Univ Pais Vasco UPV EHU, Dept Matemat Aplicada & Estadist, Leioa, Bizkaia, Spain; [Arostegui, Inmaculada] Univ Pais Vasco UPV EHU, IO, Leioa, Bizkaia, Spain; [Esteban, Cristobal] Hosp Galdakao Usansolo, Serv Neumol, Galdakao, Bizkaia, Spain; [Garcia-Gutierrez, Susana; Quintana, Jose M.] Hosp Galdakao Usansolo, Serv Epidemiol Clin, Galdakao, Bizkaia, Spain; [Arostegui, Inmaculada; Esteban, Cristobal; Garcia-Gutierrez, Susana; Bare, Marisa; Fernandez-de-Larrea, Nerea; Quintana, Jose M.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Galdakao, Bizkaia, Spain; [Bare, Marisa] Unidad Epidemiol Clin, Barcelona, Spain; [Fernandez-de-Larrea, Nerea] Consejeri Sanidad Comunidad Madrid, Subdirecc Gen Tecnol & Innovac Sanitarias, Madrid, Spain; [Briones, Eduardo] Dist Sanitario Atenc Primaria, Seville, Spain	University of Basque Country; University of Basque Country; Galdakao Hospital; Galdakao Hospital	Arostegui, I (corresponding author), Univ Pais Vasco UPV EHU, Dept Matemat Aplicada & Estadist, Leioa, Bizkaia, Spain.	inmaculada.arostegui@ehu.es	González, Nerea/L-5979-2017; , 0000-0001-8085-2833/ABI-7466-2020; Bare, Marisa/H-4806-2011; Rivas-Ruiz, Francisco/I-2814-2017; AROSTEGUI, INMACULADA/G-5941-2014	González, Nerea/0000-0003-3928-3274; , 0000-0001-8085-2833/0000-0001-8085-2833; Bare, Marisa/0000-0001-8085-2833; ESTEBAN, CRISTOBAL/0000-0001-9878-7806; Rivas-Ruiz, Francisco/0000-0002-8894-0501; Orive Calzada, Miren/0000-0003-1848-6638; Quintana, Jose M./0000-0003-2170-7876; AROSTEGUI, INMACULADA/0000-0002-6848-2240; Aguirre Larracoechea, Urko/0000-0002-8049-3030	Ministerio de Economia y Competitividad del Gobierno Espanol [MTM2010-14913]; Universidad del Pais Vasco UPV/EHU [GIU10/21, UFI11/52]; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco [IT620-13]; Departamento de Sanidad del Gobierno Vasco [2012111008]; Fondo de Investigacion Sanitaria [PI06\1010, PI06\1017, PI06\714, PI06\0326, PI06\00664]	Ministerio de Economia y Competitividad del Gobierno Espanol; Universidad del Pais Vasco UPV/EHU; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco; Departamento de Sanidad del Gobierno Vasco; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This research was supported by Ministerio de Economia y Competitividad del Gobierno Espanol (MTM2010-14913), Universidad del Pais Vasco UPV/EHU (GIU10/21, UFI11/52), Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco (IT620-13), Departamento de Sanidad del Gobierno Vasco (2012111008) and Fondo de Investigacion Sanitaria (PI06\1010, PI06\1017, PI06\714, PI06\0326, PI06\00664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Anzueto A, 2009, Int J Chron Obstruct Pulmon Dis, V4, P245; Arostegui I, 2006, METHOD INFORM MED, V45, P622; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Benzecri J. P., 1969, Proceedings of the international conference on methodologies of pattern recognition, P35; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Burgel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051048; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DORNHORST AC, 1955, LANCET, V1, P1185; Esteban C, 2011, EUR RESPIR J, V38, P1294, DOI 10.1183/09031936.00189010; Esteban C, 2009, RESP MED, V103, P1201, DOI 10.1016/j.rmed.2009.02.002; Gao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057678; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOBAL STRATEGY FOR; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jambu M, 1978, METHODES ET ALGORITM, V1; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Varela MVL, 2013, ARCH BRONCONEUMOL, V49, P468, DOI 10.1016/j.arbres.2013.05.003; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Miravitlles M, 2014, ARCH BRONCONEUMOL, V50, P155, DOI 10.1016/j.arbres.2013.09.001; Perera PN, 2012, COPD, V9, P131, DOI 10.3109/15412555.2011.650239; Pozo-Rodriguez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042156; Quintana JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-322; TEASDALE G, 1974, LANCET, V2, P81; Turino GM, 2008, THORAX, V63, P1032, DOI 10.1136/thx.2008.105957; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	30	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98580	10.1371/journal.pone.0098580	http://dx.doi.org/10.1371/journal.pone.0098580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892936	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400071
J	Kim, HJ; Ryu, J; Woo, HM; Cho, SS; Sung, MK; Kim, SC; Park, MH; Park, T; Koo, SK				Kim, Hyung Jin; Ryu, Jihee; Woo, Hae-Mi; Cho, Samuel Sunghwan; Sung, Min Kyung; Kim, Sang Cheol; Park, Mi-Hyun; Park, Taesung; Koo, Soo Kyung			Patterns of Gene Expression Associated with Pten Deficiency in the Developing Inner Ear	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; TRANSCRIPTION FACTORS; PARKINSONS-DISEASE; TECTORIAL MEMBRANE; DEAFNESS DFNB22; AXON GUIDANCE; CANCER-CELLS; MUTANT MICE; HAIR-CELLS; OSTEOPONTIN	In inner ear development, phosphatase and tensin homolog (PTEN) is necessary for neuronal maintenance, such as neuronal survival and accurate nerve innervations of hair cells. We previously reported that Pten conditional knockout (cKO) mice exhibited disorganized fasciculus with neuronal apoptosis in spiral ganglion neurons (SGNs). To better understand the genes and signaling networks related to auditory neuron maintenance, we compared the profiles of differentially expressed genes (DEGs) using microarray analysis of the inner ear in E14.5 Pten cKO and wild-type mice. We identified 46 statistically significant transcripts using significance analysis of microarrays, with the false-discovery rate set at 0%. Among the DEGs, expression levels of candidate genes and expression domains were validated by quantitative real-time RT-PCR and in situ hybridization, respectively. Ingenuity pathway analysis using DEGs identified significant signaling networks associated with apoptosis, cellular movement, and axon guidance (i.e., secreted phosphoprotein 1 (Spp1)-mediated cellular movement and regulator of G-protein signaling 4 (Rgs4)-mediated axon guidance). This result was consistent with the phenotypic defects of SGNs in Pten cKO mice (e. g., neuronal apoptosis, abnormal migration, and irregular nerve fiber patterns of SGNs). From this study, we suggest two key regulatory signaling networks mediated by Spp1 and Rgs4, which may play potential roles in neuronal differentiation of developing auditory neurons.	[Kim, Hyung Jin; Ryu, Jihee; Woo, Hae-Mi; Park, Mi-Hyun; Koo, Soo Kyung] Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea; [Cho, Samuel Sunghwan; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea; [Sung, Min Kyung; Kim, Sang Cheol] Korea Res Inst Biosci & Biotechnol, Korean BioInformat Ctr KOBIC, Taejon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Koo, SK (corresponding author), Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea.	skkoo@nih.go.kr		Sung, Minkyung/0000-0001-6573-2622	Korea National Institute of Health [4800-4845-302-210 (2012-N61001-00), 4861-307-210-13]	Korea National Institute of Health	This work was supported by Korea National Institute of Health intramural research grant 4800-4845-302-210 (no. 2012-N61001-00) and 4861-307-210-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Aviles EC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00086; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Ben Said M, 2011, EUR J MED GENET, V54, pE535, DOI 10.1016/j.ejmg.2011.06.008; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Cheng YC, 2013, CELL MOL LIFE SCI, V70, P935, DOI 10.1007/s00018-012-1178-z; Coate TM, 2013, SEMIN CELL DEV BIOL, V24, P460, DOI 10.1016/j.semcdb.2013.04.003; Comi C, 2010, J ALZHEIMERS DIS, V19, P1143, DOI 10.3233/JAD-2010-1309; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; DAVIS RL, 1995, ANN NY ACAD SCI, V760, P279, DOI 10.1111/j.1749-6632.1995.tb44638.x; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Dudoit S, 2003, BIOTECHNIQUES, P45; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; Grillet N, 2005, MOL CELL BIOL, V25, P4221, DOI 10.1128/MCB.25.10.4221-4228.2005; Grillet N, 2003, J NEUROSCI, V23, P10613; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hains MD, 2004, METHOD ENZYMOL, V389, P71; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Iczkiewicz J, 2006, BRAIN RES, V1118, P239, DOI 10.1016/j.brainres.2006.08.036; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055609; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; Lee K, 2012, CLIN GENET; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Lukashkin AN, 2012, P NATL ACAD SCI USA, V109, P19351, DOI 10.1073/pnas.1210159109; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Marino S, 2002, DEVELOPMENT, V129, P3513; Mi ZY, 2006, CARCINOGENESIS, V27, P1134, DOI 10.1093/carcin/bgi352; Milo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007144; Morsli H, 1998, J NEUROSCI, V18, P3327; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; Sakagami Masafumi, 2000, Medical Electron Microscopy, V33, P3, DOI 10.1007/s007950000001; Salinas PC, 2012, COLD SPRING HARB PER, V4; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Shah SM, 2009, NEUROSCIENCE, V164, P478, DOI 10.1016/j.neuroscience.2009.08.049; Stuebner S, 2010, DEV DYNAM, V239, P246, DOI 10.1002/dvdy.22127; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Yan YP, 2009, NEUROCHEM INT, V55, P826, DOI 10.1016/j.neuint.2009.08.007; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97544	10.1371/journal.pone.0097544	http://dx.doi.org/10.1371/journal.pone.0097544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893171	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400014
J	Loebel, DAF; Hor, ACC; Bildsoe, HK; Tam, PPL				Loebel, David A. F.; Hor, Angelyn C. C.; Bildsoe, Heidi K.; Tam, Patrick P. L.			Timed Deletion of Twist1 in the Limb Bud Reveals Age-Specific Impacts on Autopod and Zeugopod Patterning	PLOS ONE			English	Article							SAETHRE-CHOTZEN-SYNDROME; DNA-BINDING; HOX GENES; MOUSE; SHH; EXPRESSION; FGF; ABSENCE	Twist1 encodes a transcription factor that plays a vital role in limb development. We have used a tamoxifen-inducible Cre transgene, Ubc-CreERT2, to generate time-specific deletions of Twist1 by inducing Cre activity in mouse embryos at different ages from embryonic (E) day 9.5 onwards. A novel forelimb phenotype of supernumerary pre-axial digits and enlargement or partial duplication of the distal radius was observed when Cre activity was induced at E9.5. Gene expression analysis revealed significant upregulation of Hoxd10, Hoxd11 and Grem1 in the anterior half of the forelimb bud at E11.5. There is also localized upregulation of Ptch1, Hand2 and Hoxd13 at the site of ectopic digit formation, indicating a posterior molecular identity for the supernumerary digits. The specific skeletal phenotypes, which include duplication of digits and distal zeugopods but no overt posteriorization, differ from those of other Twist1 conditional knockout mutants. This outcome may be attributed to the deferment of Twist1 ablation to a later time frame of limb morphogenesis, which leads to the ectopic activation of posterior genes in the anterior tissues after the establishment of anterior-posterior anatomical identities in the forelimb bud.	[Loebel, David A. F.; Hor, Angelyn C. C.; Bildsoe, Heidi K.; Tam, Patrick P. L.] Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia; [Loebel, David A. F.; Bildsoe, Heidi K.; Tam, Patrick P. L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney	Loebel, DAF (corresponding author), Childrens Med Res Inst, Embryol Unit, Westmead, NSW, Australia.	dloebel@cmri.org.au		Bildsoe, Heidi/0000-0003-4504-9476	Australian Research Council [DP1094008]; University of Sydney [2013-00050]	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This research was funded by a Discovery Project Grant from the Australian Research Council (www.arc.gov.au), grant number DP1094008 and a Bridging Grant from The University of Sydney ID 2013-00050. David Loebel was CMRI Kimberly Clark-Research Fellow, Heidi Bildsoe is a postgraduate scholar of the National Health and Medical Reserch Council (www.nhmrc.gov.au), and Patrick Tam is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418; Bildsoe H, 2013, DEV BIOL, V374, P295, DOI 10.1016/j.ydbio.2012.12.004; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Firulli BA, 2007, J BIOL CHEM, V282, P27536, DOI 10.1074/jbc.M702613200; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hogan B, 1994, MANIPULATING MOUSE E; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Krawchuk D, 2010, DEV BIOL, V347, P133, DOI 10.1016/j.ydbio.2010.08.015; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038403; Loebel DAF, 2004, GENE EXPR PATTERNS, V4, P467, DOI 10.1016/j.modgep.2003.12.003; Loebel DAF, 2012, DEV BIOL, V362, P132, DOI 10.1016/j.ydbio.2011.11.020; McFadden DG, 2002, DEVELOPMENT, V129, P3077; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Sheth R, 2013, DEVELOPMENT, V140, P2130, DOI 10.1242/dev.089409; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98945	10.1371/journal.pone.0098945	http://dx.doi.org/10.1371/journal.pone.0098945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893291	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400114
J	Shakoor, S; Kabir, F; Khowaja, AR; Qureshi, SM; Jehan, F; Qamar, F; Whitney, CG; Zaidi, AKM				Shakoor, Sadia; Kabir, Furqan; Khowaja, Asif R.; Qureshi, Shahida M.; Jehan, Fyezah; Qamar, Farah; Whitney, Cynthia G.; Zaidi, Anita K. M.			Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005-2013	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN; SURVEILLANCE; MENINGITIS	While pneumococcal conjugate vaccines have been implemented in most countries worldwide, use in Asia has lagged in part because of a lack of data on the amount of disease that is vaccine preventable in the region. We describe pneumococcal serotypes elicited from 111 episodes of invasive pneumococcal disease (IPD) from 2005 to 2013 among children and adults in Pakistan. Seventy-three percent (n = 81) of 111 IPD episodes were cases of meningitis (n = 76 in children 0-15 years and n = 5 among adults). Serotypes were determined by target amplification of DNA extracted from pneumococcal isolates (n = 52) or CSF specimens (n = 59). Serogroup 18 was the most common serogroup causing meningitis in children <5 years, accounting for 21% of cases (n = 13). The 10-valent pneumococcal conjugate vaccine (PCV 10) or PCV10- related serotypes were found in 61% (n = 47) of childhood (age 0-15 years) meningitis episodes. PCV-13 increased this coverage to 63% (one additional serotype 19A; n = 48). Our data indicate that use of PCVs would prevent a large proportion of serious pneumococcal disease.	[Shakoor, Sadia; Kabir, Furqan; Khowaja, Asif R.; Qureshi, Shahida M.; Jehan, Fyezah; Qamar, Farah; Zaidi, Anita K. M.] Aga Khan Univ Hosp, Dept Pediat & Child Hlth, Karachi, Pakistan; [Shakoor, Sadia] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Whitney, Cynthia G.] CDC, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Aga Khan University; Aga Khan University; Centers for Disease Control & Prevention - USA	Zaidi, AKM (corresponding author), Aga Khan Univ Hosp, Dept Pediat & Child Hlth, Karachi, Pakistan.	anita.zaidi@aku.edu	Furqan Kabir/AAY-7400-2020		Johns Hopkins University [PO2000273560]; National Institute of Health's Fogarty International Center [1 D43 TW007585-01]; FOGARTY INTERNATIONAL CENTER [D43TW007585] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); National Institute of Health's Fogarty International Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Collection of CSF samples used in the study was done through the Johns-Hopkins and GAVI collaboration for the study: Impact of Introduction of HiB Vaccine in selected districts of Pakistan. Grant No. PO2000273560 Johns Hopkins University. Dr. Sadia Shakoor received research training support from the National Institute of Health's Fogarty International Center (1 D43 TW007585-01). The funders of this primary study had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Khowaja AR, 2013, J PEDIATR-US, V163, pS86, DOI 10.1016/j.jpeds.2013.03.035; Khowaja AR, 2013, J PEDIATR-US, V163, pS79, DOI 10.1016/j.jpeds.2013.03.034; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; McIntosh EDG, 2011, EXPERT REV VACCINES, V10, P109, DOI 10.1586/ERV.10.145; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Pneumococcal vaccines WHO position paper, 2012, WKLY EPIDEMIOL REC, V14, P129; Popovic T, 1998, LAB METHODS DIAGNOSI; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; WHO/IVB, 2012, EST HIB PNEUM DEATHS; Zaidi AKM, 2009, CLIN INFECT DIS, V48, pS129, DOI 10.1086/596491	23	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98796	10.1371/journal.pone.0098796	http://dx.doi.org/10.1371/journal.pone.0098796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892937	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400092
J	Ribeiro-Pereira, C; Moraes, JA; Souza, MD; Laurindo, FR; Arruda, MA; Barja-Fidalgo, C				Ribeiro-Pereira, Cristiane; Moraes, Joao Alfredo; Souza, Mariele de Jesus; Laurindo, Francisco R.; Arruda, Maria Augusta; Barja-Fidalgo, Christina			RedoxModulation of FAK Controls Melanoma Survival - Role of NOX4	PLOS ONE			English	Article							FOCAL ADHESION KINASE; OXIDASE REGULATES GROWTH; CELL-CYCLE PROGRESSION; PROSTATE-CANCER CELLS; OXIDATIVE STRESS; ESSENTIAL MEDIATORS; ANOIKIS RESISTANCE; HYDROGEN-PEROXIDE; REDOX REGULATION; FREE-RADICALS	Studies have demonstrated that reactive oxygen species (ROS) generated by NADPH oxidase are essential for melanoma proliferation and survival. However, the mechanisms by which NADPH oxidase regulates these effects are still unclear. In this work, we investigate the role of NADPH oxidase-derived ROS in the signaling events that coordinate melanoma cell survival. Using the highly metastatic human melanoma cell line MV3, we observed that pharmacological NADPH oxidase inhibition reduced melanoma viability and induced dramatic cellular shape changes. These effects were accompanied by actin cytoskeleton rearrangement, diminished FAK(Y397) phosphorylation, and decrease of FAK-actin and FAK-cSrc association, indicating disassembly of focal adhesion processes, a phenomenon that often results in anoikis. Accordingly, NADPH oxidase inhibition also enhanced hypodiploid DNA content, and caspase-3 activation, suggesting activation of the apoptotic machinery. NOX4 is likely to be involved in these effects, since silencing of NOX4 significantly inhibited basal ROS production, reduced FAK(Y397) phosphorylation and decreased tumor cell viability. Altogether, the results suggest that intracellular ROS generated by the NADPH oxidase, most likely NOX4, transmits cell survival signals on melanoma cells through the FAK pathway, maintaining adhesion contacts and cell viability.	[Ribeiro-Pereira, Cristiane; Moraes, Joao Alfredo; Souza, Mariele de Jesus; Arruda, Maria Augusta; Barja-Fidalgo, Christina] Univ Estado Rio de Janeiro, IBRAG, Dept Cell Biol, Lab Cellular & Mol Pharmacol, BR-20550011 Rio De Janeiro, RJ, Brazil; [Laurindo, Francisco R.] Univ Sao Paulo, Inst Coracao, Lab Vasc Biol, Sao Paulo, Brazil; [Arruda, Maria Augusta] Fiocruz MS, Farmanguinhos, BR-21045900 Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Barja-Fidalgo, C (corresponding author), Univ Estado Rio de Janeiro, IBRAG, Dept Cell Biol, Lab Cellular & Mol Pharmacol, BR-20550011 Rio De Janeiro, RJ, Brazil.	barja-fidalgo@uerj.br	Moraes, João Alfredo A/E-3557-2017; Laurindo, Francisco R/J-6575-2015	Moraes, João Alfredo A/0000-0002-8563-6432; Arruda, Maria Augusta/0000-0002-0828-9430	CNPq; CAPES; FAPERJ; Sub-reitoria de Pos-Graduacao e Pesquisa [SR-2/UERJ]; Women In Science National Fellowship	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Sub-reitoria de Pos-Graduacao e Pesquisa; Women In Science National Fellowship	This work was supported by CNPq (www.cnpq.br), CAPES (www.capes.gov.br), FAPERJ (www.faperj.br) and Sub-reitoria de Pos-Graduacao e Pesquisa (SR-2/UERJ-www.sr2.uerj.br). M.A. Arruda is a L'Oreal-UNESCO-ABC For Women In Science National Fellowship - 2008 awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, AGING DIS, V2, P219; Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Beausejour M, 2012, APOPTOSIS, V17, P566, DOI 10.1007/s10495-012-0713-6; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chiarugi P, 2005, FREE RADICAL RES, V39, P353, DOI 10.1080/10715760400027987; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Cooper KL, 2009, FREE RADICAL BIO MED, V47, P381, DOI 10.1016/j.freeradbiomed.2009.04.034; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; de Vries E, 2012, BRIT J DERMATOL, V167, P53, DOI 10.1111/j.1365-2133.2012.11087.x; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; DOOLEY DC, 1982, EXP HEMATOL, V10, P591; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Du J, 2012, MOL CARCINOGENESIS; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hess AR, 2006, CELL CYCLE, V5, P478, DOI 10.4161/cc.5.5.2518; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Klees RF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/87246; Kleniewska P, 2012, ARCH IMMUNOL THER EX, V60, P277, DOI 10.1007/s00005-012-0176-z; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Liu F, 2012, J INVEST DERMATOL, P1; Liu GY, 2008, CELL BIOL INT, V32, P663, DOI 10.1016/j.cellbi.2008.01.292; Luo H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.3; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Poljsak B, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/135206; Qin Y, 2008, CELL BIOL INT, V32, P224, DOI 10.1016/j.cellbi.2007.08.028; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; VANDELOOSDRECHT AA, 1991, J IMMUNOL METHODS, V141, P15, DOI 10.1016/0022-1759(91)90205-T; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; Weaver JR, 2013, MOL CELL ENDOCRINOL, V369, P35, DOI 10.1016/j.mce.2013.01.011; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Woodhead A D, 1999, J Epidemiol, V9, pS102; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Young C, 2009, OCCUP MED-OXFORD, V59, P82, DOI 10.1093/occmed/kqn170; Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352	65	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e99481	10.1371/journal.pone.0099481	http://dx.doi.org/10.1371/journal.pone.0099481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	24911159	gold, Green Published, Green Submitted			2022-12-25	WOS:000337165600092
J	Bhat, S; Boynton, TO; Pham, D; Shimkets, LJ				Bhat, Swapna; Boynton, Tye O.; Pham, Dan; Shimkets, Lawrence J.			Fatty Acids from Membrane Lipids Become Incorporated into Lipid Bodies during Myxococcus xanthus Differentiation	PLOS ONE			English	Article							DEVELOPMENTAL GENE-EXPRESSION; ADVENTUROUS GLIDING MOTILITY; FRUITING BODY DEVELOPMENT; GUANOSINE PENTAPHOSPHATE; COMBINATORIAL REGULATION; CELL-INTERACTIONS; ISOVALERYL-COA; C-FACTOR; PROTEIN; IDENTIFICATION	Myxococcus xanthus responds to amino acid limitation by producing fruiting bodies containing dormant spores. During development, cells produce triacylglycerides in lipid bodies that become consumed during spore maturation. As the cells are starved to induce development, the production of triglycerides represents a counterintuitive metabolic switch. In this paper, lipid bodies were quantified in wild-type strain DK1622 and 33 developmental mutants at the cellular level by measuring the cross sectional area of the cell stained with the lipophilic dye Nile red. We provide five lines of evidence that triacylglycerides are derived from membrane phospholipids as cells shorten in length and then differentiate into myxospores. First, in wild type cells, lipid bodies appear early in development and their size increases concurrent with an 87% decline in membrane surface area. Second, developmental mutants blocked at different stages of shortening and differentiation accumulated lipid bodies proportionate with their cell length with a Pearson's correlation coefficient of 0.76. Third, peripheral rods, developing cells that do not produce lipid bodies, fail to shorten. Fourth, genes for fatty acid synthesis are down-regulated while genes for fatty acid degradation are up regulated. Finally, direct movement of fatty acids from membrane lipids in growing cells to lipid bodies in developing cells was observed by pulse labeling cells with palmitate. Recycling of lipids released by Programmed Cell Death appears not to be necessary for lipid body production as a fadL mutant was defective in fatty acid uptake but proficient in lipid body production. The lipid body regulon involves many developmental genes that are not specifically involved in fatty acid synthesis or degradation. MazF RNA interferase and its target, enhancer-binding protein NIa6, appear to negatively regulate cell shortening and TAG accumulation whereas most cell-cell signals activate these processes.	[Bhat, Swapna; Boynton, Tye O.; Pham, Dan; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Shimkets, LJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [MCB 0742976]; National Institute of General Medical Sciences of the National Institutes of Health [1RO1GM095826]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095826] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in this publication was supported by the National Science Foundation under award number MCB 0742976 and by the National Institute of General Medical Sciences of the National Institutes of Health under award number 1RO1GM095826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HM, 2002, APPL MICROBIOL BIOT, V60, P367, DOI 10.1007/s00253-002-1135-0; Bhat S, 2014, MBIO, V5, DOI 10.1128/mBio.00939-13; Bode HB, 2006, J BACTERIOL, V188, P5632, DOI 10.1128/JB.00438-06; Bode HB, 2009, CHEMBIOCHEM, V10, P128, DOI 10.1002/cbic.200800219; Bonner PJ, 2006, MOL MICROBIOL, V61, P1283, DOI 10.1111/j.1365-2958.2006.05298.x; Bonner PJ, 2006, J BACTERIOL, V188, P4585, DOI 10.1128/JB.00237-06; Boynton TO, 2013, MOL MICROBIOL, V87, P1267, DOI 10.1111/mmi.12165; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Caberoy NB, 2003, J BACTERIOL, V185, P6083, DOI 10.1128/JB.185.20.6083-6094.2003; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; CHENG Y, 1989, J BACTERIOL, V171, P3727, DOI 10.1128/jb.171.7.3727-3731.1989; Dickschat JS, 2005, ORG BIOMOL CHEM, V3, P2824, DOI 10.1039/b504889c; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; Ellehauge E, 1998, MOL MICROBIOL, V30, P807, DOI 10.1046/j.1365-2958.1998.01113.x; Giglio KM, 2011, P NATL ACAD SCI USA, V108, pE431, DOI 10.1073/pnas.1105876108; GILL RE, 1988, J BACTERIOL, V170, P5289, DOI 10.1128/jb.170.11.5289-5297.1988; GILL RE, 1988, J BACTERIOL, V170, P5279, DOI 10.1128/jb.170.11.5279-5288.1988; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gronewold TMA, 2007, J BACTERIOL, V189, P1836, DOI 10.1128/JB.01618-06; Gronewold TMA, 2002, J BACTERIOL, V184, P1172, DOI 10.1128/jb.184.4.1172-1179.2002; Gronewold TMA, 2001, MOL MICROBIOL, V40, P744, DOI 10.1046/j.1365-2958.2001.02428.x; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Harris BZ, 1998, GENE DEV, V12, P1022, DOI 10.1101/gad.12.7.1022; HARTZELL P, 1991, J BACTERIOL, V173, P7615, DOI 10.1128/jb.173.23.7615-7624.1991; Hoiczyk E, 2009, MOL MICROBIOL, V74, P497, DOI 10.1111/j.1365-2958.2009.06879.x; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; KIM SK, 1991, J BACTERIOL, V173, P1722, DOI 10.1128/jb.173.5.1722-1728.1991; KIM SK, 1990, CELL, V61, P19, DOI 10.1016/0092-8674(90)90211-V; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; KUSPA A, 1992, J BACTERIOL, V174, P7360, DOI 10.1128/jb.174.22.7360-7369.1992; KUSPA A, 1989, J BACTERIOL, V171, P2762, DOI 10.1128/jb.171.5.2762-2772.1989; KUSPA A, 1986, DEV BIOL, V117, P267, DOI 10.1016/0012-1606(86)90369-6; Lee B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028968; LI SF, 1992, GENE DEV, V6, P401, DOI 10.1101/gad.6.3.401; LI SF, 1993, J BACTERIOL, V175, P3648, DOI 10.1128/jb.175.11.3648-3652.1993; Li YY, 2013, ANGEW CHEM INT EDIT, V52, P1304, DOI 10.1002/anie.201207984; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; MANOIL C, 1980, J BACTERIOL, V141, P305, DOI 10.1128/JB.141.1.305-315.1980; MANOIL C, 1980, J BACTERIOL, V141, P297, DOI 10.1128/JB.141.1.297-304.1980; Mittal S, 2009, J BACTERIOL, V191, P2753, DOI 10.1128/JB.01818-08; Moraleda-Munoz A, 2007, J BACTERIOL, V189, P3072, DOI 10.1128/JB.01772-06; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; ORNDORFF PE, 1980, J BACTERIOL, V141, P914, DOI 10.1128/JB.141.2.914-927.1980; Ossa F, 2007, J BACTERIOL, V189, P8474, DOI 10.1128/JB.00894-07; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; PLAMANN L, 1994, J BACTERIOL, V176, P2013, DOI 10.1128/jb.176.7.2013-2020.1994; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Shi WY, 2000, FEMS MICROBIOL LETT, V192, P211, DOI 10.1016/S0378-1097(00)00434-1; Shi XQ, 2008, J BACTERIOL, V190, P613, DOI 10.1128/JB.01502-07; SHIMKETS L, 1975, J BACTERIOL, V121, P711, DOI 10.1128/JB.121.2.711-720.1975; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; SINGER M, 1995, GENE DEV, V9, P1633, DOI 10.1101/gad.9.13.1633; SogaardAndersen L, 1996, GENE DEV, V10, P740, DOI 10.1101/gad.10.6.740; Sun H, 2001, J BACTERIOL, V183, P6733, DOI 10.1128/JB.183.23.6733-6739.2001; Sun H, 2001, J BACTERIOL, V183, P4786, DOI 10.1128/JB.183.16.4786-4795.2001; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; THONYMEYER L, 1993, J BACTERIOL, V175, P7450; Tucker AC, 2013, MOL MICROBIOL, V87, P152, DOI 10.1111/mmi.12088; Ueki T, 2003, P NATL ACAD SCI USA, V100, P8782, DOI 10.1073/pnas.1533026100; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Viswanathan P, 2007, P NATL ACAD SCI USA, V104, P7969, DOI 10.1073/pnas.0701569104; Viswanathan P, 2007, J BACTERIOL, V189, P3738, DOI 10.1128/JB.00187-07; VOELZ H, 1962, J BACTERIOL, V84, P943, DOI 10.1128/JB.84.5.943-952.1962; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; White DJ, 2000, MOL MICROBIOL, V36, P662, DOI 10.1046/j.1365-2958.2000.01887.x; WITKIN SS, 1970, J BACTERIOL, V103, P641, DOI 10.1128/JB.103.3.641-649.1970; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	79	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99622	10.1371/journal.pone.0099622	http://dx.doi.org/10.1371/journal.pone.0099622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24906161	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000126
J	Cafazzo, S; Bonanni, R; Valsecchi, P; Natoli, E				Cafazzo, Simona; Bonanni, Roberto; Valsecchi, Paola; Natoli, Eugenia			Social Variables Affecting Mate Preferences, Copulation and Reproductive Outcome in a Pack of Free-Ranging Dogs	PLOS ONE			English	Article							MALE MATING SUCCESS; JAPANESE MACAQUES; DOMINANCE RANK; CANIS-FAMILIARIS; BREEDING SUCCESS; SEXUAL COERCION; FECUND FEMALES; SPOTTED HYENAS; STRAY DOGS; BODY-SIZE	Mating and reproductive outcome is often determined by the simultaneous operation of different mechanisms like intra-sexual competition, mating preferences and sexual coercion. The present study investigated how social variables affected mating outcome in a pack of free-ranging dogs, a species supposed to have lost most features of the social system of wolves during domestication. We found that, although the pack comprised multiple breeding individuals, both male copulation success and female reproductive success were positively influenced by a linear combination of dominance rank, age and leadership. Our results also suggest that mate preferences affect mating outcome by reinforcing the success of most dominant individuals. In particular, during their oestrous period bitches clearly searched for the proximity of high-ranking males who displayed affiliative behaviour towards them, while they were more likely to reject the males who intimidated them. At the same time, male courting effort and male-male competition for receptive females appeared to be stronger in the presence of higher-ranking females, suggesting a male preference for dominant females. To our knowledge, these results provide the first clear evidence of social regulation of reproductive activities in domestic dogs, and suggest that some common organizing mechanisms may contribute to shape the social organization of both dogs and wolves.	[Cafazzo, Simona; Bonanni, Roberto; Valsecchi, Paola] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Cafazzo, Simona] Wolf Sci Ctr, Ernstbrunn, Austria; [Natoli, Eugenia] Azienda USL Roma D, Area Dipartimentale Sanita Pubbl Vet, Rome, Italy	University of Parma	Cafazzo, S (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	simona.cafazzo@inwind.it	Natoli, Eugenia/AAE-2156-2020	, Eugenia/0000-0002-9232-7048; Valsecchi, Paola/0000-0002-0491-9845	Department of Education, University and Research of Italian Government (PRIN); University of Parma; FIL; Austrian Science Fund (FWF) [M 1400-B19]	Department of Education, University and Research of Italian Government (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Parma; FIL; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was partially funded by the Department of Education, University and Research of Italian Government (PRIN 2004), and by University of Parma with FIL 2005 to Paola Valsecchi; it also complies with all laws of the country (Italy) in which it was performed. Manuscript preparation was funded by the Austrian Science Fund (FWF): [M 1400-B19] to Simona Cafazzo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; [Anonymous], ADAPTATION NATURAL S; [Anonymous], 1994, SEXUAL SELECTION; [Anonymous], 2014, THE SOCIAL DOG; BEACH FA, 1967, ANIM BEHAV, V15, P546, DOI 10.1016/0003-3472(67)90057-7; Beck A.M., 1973, ECOLOGY STRAY DOGS S; BERCOVITCH FB, 1995, ANIM BEHAV, V50, P137, DOI 10.1006/anbe.1995.0227; BERENSTAIN L, 1983, INT J PRIMATOL, V4, P201, DOI 10.1007/BF02743758; BERGLUND A, 1993, BEHAV ECOL SOCIOBIOL, V32, P331; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Boitani L, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P147, DOI 10.1079/9781845931872.0147; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Bradshaw JWS, 2009, J VET BEHAV, V4, P135, DOI 10.1016/j.jveb.2008.08.004; BURLEY N, 1979, ANIM BEHAV, V27, P686, DOI 10.1016/0003-3472(79)90005-8; Cafazzo S, 2012, ETHOLOGY, V118, P955, DOI 10.1111/j.1439-0310.2012.02088.x; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Camenzind FJ, 1978, COYOTES BIOL BEHAV M; Cassinello J, 1996, J ZOOL, V239, P141, DOI 10.1111/j.1469-7998.1996.tb05442.x; CHAPAIS B, 1983, BEHAV ECOL SOCIOBIOL, V12, P215, DOI 10.1007/BF00290774; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Coppinger R., 2001, DOGS NEW UNDERSTANDI; CORBETT LK, 1988, ETHOLOGY, V78, P177, DOI 10.1111/j.1439-0310.1988.tb00229.x; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; COX CR, 1977, AM NAT, V111, P317, DOI 10.1086/283163; Cunningham EJA, 1998, ANIM BEHAV, V56, P1311, DOI 10.1006/anbe.1998.0953; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; DANIELS TJ, 1983, APPL ANIM ETHOL, V10, P365, DOI 10.1016/0304-3762(83)90185-2; DANIELS TJ, 1989, ETHOLOGY, V81, P300; Davies N. B., 1992, DUNNOCK BEHAV SOCIAL; DERIX R, 1993, BEHAVIOUR, V127, P141, DOI 10.1163/156853993X00461; DERIX RRWM, 1995, BEHAVIOUR, V132, P127, DOI 10.1163/156853995X00333; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson AF, 1998, PRIMATE SEXUALITY; DUNBAR RIM, 1977, NATURE, V266, P351, DOI 10.1038/266351a0; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; EMLEN ST, 1986, ETHOLOGY, V71, P2; FEDIGAN LM, 1983, YEARB PHYS ANTHROPOL, V26, P91; FESTABIANCHET M, 1988, J MAMMAL, V69, P157, DOI 10.2307/1381764; FONT E, 1987, APPL ANIM BEHAV SCI, V17, P319, DOI 10.1016/0168-1591(87)90155-9; GHOSH B, 1984, APPL ANIM BEHAV SCI, V13, P113, DOI 10.1016/0168-1591(84)90057-1; Gier HT., 1968, KAN STATE COLL AG EX, V939, P1; Gipson PS, 1983, VERTEBRATE PEST CONT, V4, P285; Girman DJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P187, DOI 10.1007/s002650050332; GWYNNE DT, 1981, SCIENCE, V213, P779, DOI 10.1126/science.213.4509.779; HALEY MP, 1994, ANIM BEHAV, V48, P1249, DOI 10.1006/anbe.1994.1361; Harrington F.H., 1982, P81; Hayakawa S, 2007, INT J PRIMATOL, V28, P73, DOI 10.1007/s10764-006-9109-1; Honer OP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1059; Hoffman CL, 2008, BEHAV ECOL SOCIOBIOL, V62, P1711, DOI 10.1007/s00265-008-0599-z; Horne TJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P401, DOI 10.1007/s002650050257; Hrdy SB, 1984, INFANTICIDE COMP EVO; Jenks SM, 2011, BEHAV GENET, V41, P810, DOI 10.1007/s10519-011-9453-6; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Kirk RW, 1977, CURRENT VET THERAPY, VVI; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Klinkova E, 2005, INT J PRIMATOL, V26, P357, DOI 10.1007/s10764-005-2929-6; Kraak SBM, 1998, ANIM BEHAV, V56, P859, DOI 10.1006/anbe.1998.0822; Le Boeuf BJ, 1967, PSYCHON SCI, V7, P313; Longpre KM, 2011, HORM BEHAV, V60, P505, DOI 10.1016/j.yhbeh.2011.07.019; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; MacDonald D. W., 1995, P199; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MCLEOD PJ, 1990, CAN J ZOOL, V68, P402, DOI 10.1139/z90-058; Mech L. David, 2003, P1; MECH LD, 1989, J MAMMAL, V70, P675, DOI 10.2307/1381450; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mech LD, 2000, CAN FIELD NAT, V114, P259; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Medina Martin, 2007, WORLDS SCAVENGERS SA; Moehlman P.D., 1983, AM SOC MAMMAL SPEC P, V7, P423; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nichols HJ, 2010, ANIM BEHAV, V80, P649, DOI 10.1016/j.anbehav.2010.06.025; Nolan PM, 2010, ETHOLOGY, V116, P635, DOI 10.1111/j.1439-0310.2010.01775.x; Ognev SI, 1931, MAMMALS E EUROPE NO; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; Packard J.M., 1980, BIOSOCIAL MECH POPUL, P135; Packard Jane M., 2003, P35; PACKARD JM, 1985, Z TIERPSYCHOL, V68, P24; Packard JM, 1983, REPORT SERIES CANADI, V45, P78; Packard JM, 2011, ENCY BEHAV; Pal S.K., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/314216; Pal SK, 1998, APPL ANIM BEHAV SCI, V61, P123, DOI 10.1016/S0168-1591(98)00185-3; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pal SK, 2003, ACTA THERIOL, V48, P271, DOI 10.1007/BF03194167; Pal SK, 1999, APPL ANIM BEHAV SCI, V62, P267, DOI 10.1016/S0168-1591(98)00220-2; Pal SK, 1998, APPL ANIM BEHAV SCI, V59, P331, DOI 10.1016/S0168-1591(98)00108-7; Parker GA, 1983, MATE CHOICE; PEMBERTON JM, 1992, BEHAV ECOL, V3, P66, DOI 10.1093/beheco/3.1.66; PEREIRA ME, 1991, BEHAV ECOL SOCIOBIOL, V28, P141; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; RASA OAE, 1977, Z TIERPSYCHOL, V43, P337; RAUSCH RA, 1967, AM ZOOL, V7, P253; REITER J, 1981, ANIM BEHAV, V29, P670, DOI 10.1016/S0003-3472(81)80002-4; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; ROBINSON JG, 1982, AM J PRIMATOL, V2, P131; Rubenstein DI, 1986, ECOLOGICAL ASPECTS S, P463; Sand H, 1996, OECOLOGIA, V106, P212, DOI 10.1007/BF00328601; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SARGENT RC, 1986, ANIM BEHAV, V34, P545, DOI 10.1016/S0003-3472(86)80123-3; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Say L, 1999, P ROY SOC B-BIOL SCI, V266, P2071, DOI 10.1098/rspb.1999.0889; Schmidt K, 2008, J ETHOL, V26, P69, DOI 10.1007/s10164-006-0031-y; SMALL MF, 1982, ANIM BEHAV, V30, P626, DOI 10.1016/S0003-3472(82)80076-6; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; Smuts BB, 1983, PRIMATE SOCIAL RELAT; SOLOMON NG, 1993, ANIM BEHAV, V45, P1031, DOI 10.1006/anbe.1993.1122; Soltis J, 2001, ANIM BEHAV, V62, P485, DOI 10.1006/anbe.2001.1774; Soltis J, 1997, ANIM BEHAV, V54, P737, DOI 10.1006/anbe.1997.0568; Spritzer MD, 2006, ETHOLOGY, V112, P1027, DOI 10.1111/j.1439-0310.2006.01260.x; Stumpf RM, 2006, BEHAV ECOL SOCIOBIOL, V60, P749, DOI 10.1007/s00265-006-0219-8; Stumpf RM, 2010, ANIM BEHAV, V79, P333, DOI 10.1016/j.anbehav.2009.11.008; Stumpf RM, 2005, BEHAV ECOL SOCIOBIOL, V57, P511, DOI 10.1007/s00265-004-0868-4; Szykman M, 2001, BEHAV ECOL SOCIOBIOL, V50, P231, DOI 10.1007/s002650100356; Takahata Y, 1999, PRIMATES, V40, P143, DOI 10.1007/BF02557707; THORNHILL R, 1980, ANIM BEHAV, V28, P52, DOI 10.1016/S0003-3472(80)80007-8; Trivers RL, 1972, SELECTION DESCENT MA; VERRELL PA, 1995, ETHOLOGY, V99, P162; VERRELL PA, 1989, ANIM BEHAV, V38, P1086, DOI 10.1016/S0003-3472(89)80150-2; VERRELL PA, 1985, HERPETOLOGICA, V41, P382; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; WOOLPY JH, 1967, AM ZOOL, V7, P305; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Young S. P., 1964, WOLVES N AM; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300; [No title captured]	138	31	31	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98594	10.1371/journal.pone.0098594	http://dx.doi.org/10.1371/journal.pone.0098594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905360	Green Submitted, Green Published, gold			2022-12-25	WOS:000341869000042
J	Chisholm, V; Gonzalez, A; Atkinson, L				Chisholm, Vivienne; Gonzalez, Andrea; Atkinson, Leslie			Interpersonal Engagement Mediates the Relation between Maternal Affect and Externalising Behaviour in Young Children with Type 1 Diabetes	PLOS ONE			English	Article							CROSS-SECTIONAL ANALYSES; MOTHER-CHILD; METABOLIC-CONTROL; GLYCEMIC CONTROL; PSYCHOSOCIAL ADJUSTMENT; MEALTIME INTERACTIONS; DEPRESSIVE SYMPTOMS; ADHERENCE; PREDICTORS; OUTCOMES	Mother-child interactions around a shared activity have been shown to play a key role in the development of young children's capacity to interact cooperatively with others. This evidence is particularly germane to type 1 diabetes (T1D) management in younger children where cooperation with parental treatment efforts is crucial for treatment success and where maternal distress and child behavioural problems are risk factors for treatment management, biomedical and psychological outcomes. In 49 4-to-8 year old children with T1D, we investigated whether the association between maternal affect and child problematic behaviour is mediated by mother-child interactions in the context of a T1D-relevant collaborative problem-solving activity. Mothers completed standardised measures of maternal and child psychological adjustment and interacted with their children in the problem-solving activity, analysed for quality of interpersonal engagement based on evaluations of maternal (sensitivity and cognitive stimulation) and dyadic (joint attention and warmth) behaviours. Mediation analyses confirmed the hypothesis that interpersonal engagement mediates the relation between maternal affective state and child behavioural problems. Specifically, more negative maternal affect is associated with lower levels of interpersonal engagement; these less engaged interactions in turn are associated with more behavioural problems in children. These findings are consistent with research involving typically developing children. The implications of our findings are twofold. First, in the context of psychological adjustment to T1D, maternal affect and mother-child interactions are 2 potential targets for interventions which promote cooperative interactions. Second, understanding and caring for children at biological risk requires attention to developmental psychology theory and method; in particular, research addressing parent-child cooperation carries both conceptual and clinical relevance.	[Chisholm, Vivienne] Queen Margaret Univ, Div Psychol & Sociol, Musselburgh, Scotland; [Gonzalez, Andrea] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Atkinson, Leslie] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Queen Margaret University; McMaster University; Toronto Metropolitan University	Chisholm, V (corresponding author), Queen Margaret Univ, Div Psychol & Sociol, Musselburgh, Scotland.	vchisholm@qmu.ac.uk	González Ríos, Andrea/HGU-7618-2022; Gonzalez, Andrea/HDM-9987-2022; Gonzalez, Andrea/G-4302-2017	Atkinson, Leslie/0000-0003-1265-3298; Gonzalez, Andrea/0000-0003-0087-830X	Chief Scientist Office, NHS, Scotland; Queen Margaret University	Chief Scientist Office, NHS, Scotland; Queen Margaret University	This research was supported by the Chief Scientist Office, NHS, Scotland and Queen Margaret University Research Theme funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allhusen V, 2003, CHILD DEV, V74, P1639; [Anonymous], 1991, MANUAL CHILD BEHAV C; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berg CA, 2011, J PEDIATR PSYCHOL, V36, P329, DOI 10.1093/jpepsy/jsq088; Borge AIH, 2004, EUR J DEV PSYCHOL, V1, P19, DOI 10.1080/17405620344000004; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603; Campbell SB, 2009, J ABNORM PSYCHOL, V118, P479, DOI 10.1037/a0015923; Cardoso C, 2012, EXP CLIN PSYCHOPHARM, V20, P84, DOI 10.1037/a0025763; Chisholm V, 2014, CHILD CARE HLTH DEV, V40, P85, DOI 10.1111/cch.12004; Chisholm V, 2010, CLIN CHILD PSYCHOL P, V16, P443, DOI DOI 10.1177/1359104510373312; Chisholm V, 2007, J ADV NURS, V57, P482, DOI 10.1111/j.1365-2648.2006.04137.x; Cohen DM, 2004, J PEDIATR PSYCHOL, V29, P171, DOI 10.1093/jpepsy/jsh019; Combs-Ronto LA, 2009, J ABNORM CHILD PSYCH, V37, P1151, DOI 10.1007/s10802-009-9332-2; Cummings EM, 2005, J CHILD PSYCHOL PSYC, V46, P479, DOI 10.1111/j.1469-7610.2004.00368.x; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Deater-Deckard K, 2004, J ABNORM CHILD PSYCH, V32, P609, DOI 10.1023/B:JACP.0000047210.81880.14; DENHAM SA, 1991, CHILD DEV, V62, P242, DOI 10.1111/j.1467-8624.1991.tb01528.x; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Duke DC, 2008, J PEDIATR PSYCHOL, V33, P719, DOI 10.1093/jpepsy/jsn012; Fivush R, 2006, CHILD DEV, V77, P1568, DOI 10.1111/j.1467-8624.2006.00960.x; Foster CJE, 2008, J ABNORM CHILD PSYCH, V36, P527, DOI 10.1007/s10802-007-9197-1; Galboda-Liyanage KC, 2003, J CHILD PSYCHOL PSYC, V44, P1037, DOI 10.1111/1469-7610.00188; Gartstein MA, 2003, J APPL DEV PSYCHOL, V24, P143, DOI 10.1016/S0193-3973(03)00043-1; Gauvain M, 2008, CHILD DEV, V79, P761, DOI 10.1111/j.1467-8624.2008.01156.x; Gelman SA, 2011, WIRES COGN SCI, V2, P95, DOI 10.1002/wcs.96; Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832; GOLDSMITH DF, 1995, DEV PSYCHOL, V31, P388, DOI 10.1037/0012-1649.31.3.388; Goldsmith DF, 1997, DEV PSYCHOL, V33, P113; Goodman SH, 2007, ANNU REV CLIN PSYCHO, V3, P107, DOI 10.1146/annurev.clinpsy.3.022806.091401; Harris JA, 2003, PERS INDIV DIFFER, V35, P1903, DOI 10.1016/S0191-8869(03)00039-4; Harvey JN, 2004, DIABETIC MED, V21, P26, DOI 10.1046/j.1464-5491.2003.01062.x; Hayes A.F, 2013, MEDIATION MODERATION; Hayes AF, 2011, SPSS INDIRECT MACROS; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hill-Briggs F, 2001, DIABETES CARE, V24, P959, DOI 10.2337/diacare.24.5.959; Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x; Hirsh-Pasek K, 2006, MERRILL PALMER QUART, V52, P449, DOI 10.1353/mpq.2006.0027; Holmbeck GN, 2008, J PEDIATR PSYCHOL, V33, P958, DOI 10.1093/jpepsy/jsm059; Horton D, 2009, J PEDIATR PSYCHOL, V34, P1008, DOI 10.1093/jpepsy/jsp022; Huebner CE, 2002, PUBLIC HEALTH NURS, V19, P377, DOI 10.1046/j.1525-1446.2002.19507.x; JACOBSON AM, 1990, J PEDIATR PSYCHOL, V15, P511; Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229; KOVACS M, 1995, DIABETIC MED, V12, P142, DOI 10.1111/j.1464-5491.1995.tb00445.x; Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01.chi.0000161645.98022.35; Lorr M., 1988, MANUAL PROFILE MOOD; Lunkenheimer ES, 2011, DEV PSYCHOPATHOL, V23, P577, DOI 10.1017/S095457941100006X; Ma RCW, 2009, NAT REV ENDOCRINOL, V5, P529, DOI 10.1038/nrendo.2009.180; MACCOBY EE, 1992, DEV PSYCHOL, V28, P1006, DOI 10.1037/0012-1649.28.6.1006; Maxwell SE, 2007, PSYCHOL METHODS, V12, P23, DOI 10.1037/1082-989X.12.1.23; Maxwell SE, 2011, MULTIVAR BEHAV RES, V46, P816, DOI 10.1080/00273171.2011.606716; McNair D., 2005, PROFILE MOOD STATES; Miller VA, 2011, J PEDIATR PSYCHOL, V36, P1102, DOI 10.1093/jpepsy/jsr033; Moss E, 2011, DEV PSYCHOPATHOL, V23, P195, DOI 10.1017/S0954579410000738; Naar-King S, 2006, J PEDIATR PSYCHOL, V31, P793, DOI 10.1093/jpepsy/jsj090; Nguyen SP, 2008, INFANT CHILD DEV, V17, P285, DOI 10.1002/icd.553; Nguyen SP, 2012, CHILD DEV, V83, P1748, DOI 10.1111/j.1467-8624.2012.01812.x; Nguyen SP, 2012, INFANT CHILD DEV, V21, DOI 10.1002/icd.745; Nguyen SP, 2003, CHILD DEV, V74, P1783, DOI 10.1046/j.1467-8624.2003.00638.x; Northam EA, 2006, DIABETIC MED, V23, P113, DOI 10.1111/j.1464-5491.2005.01678.x; Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x; Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232; O'Halloran PD, 2004, PSYCHOL REP, V95, P459, DOI 10.2466/pr0.95.2.459-463; Ohr PS, 2010, J FAM PSYCHOL, V24, P625, DOI 10.1037/a0021007; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Patton SR, 2006, DIABETES CARE, V29, P1002, DOI 10.2337/dc05-2354; Patton SR, 2008, J PEDIATR PSYCHOL, V33, P885, DOI 10.1093/jpepsy/jsn026; Poole K, 1999, BREAST, V8, P334, DOI 10.1054/brst.1999.0085; Powers SW, 2002, DIABETES CARE, V25, P313, DOI 10.2337/diacare.25.2.313; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Reising MM, 2013, J CHILD FAM STUD, V22, P335, DOI 10.1007/s10826-012-9582-4; Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4; Weinfield NS, 2002, CHILD DEV, V73, P528, DOI 10.1111/1467-8624.00422; Wilson AC, 2009, J CLIN PSYCHOL MED S, V16, P216, DOI 10.1007/s10880-009-9163-x; Xinshu Z, 2010, J CONSUM RES, V37, P97	76	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e97672	10.1371/journal.pone.0097672	http://dx.doi.org/10.1371/journal.pone.0097672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AP1YS	24905358	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000009
J	Ge, D; Jing, QC; Zhao, WB; Yue, HW; Su, L; Zhang, SL; Zhao, J				Ge, Di; Jing, Qingchuan; Zhao, Wenbo; Yue, Hongwei; Su, Le; Zhang, ShangLi; Zhao, Jing			Finding ATF4/p75NTR/IL-8 Signal Pathway in Endothelial-Mesenchymal Transition by Safrole Oxide	PLOS ONE			English	Article							PRECURSOR CELLS; SMALL-MOLECULE; APOPTOSIS; GROWTH; 1-ETHOXY-3-(3,4-METHYLENEDIOXYPHENYL)-2-PROPANOL; TRANSDIFFERENTIATION; DIFFERENTIATION; ANGIOGENESIS; DEPRIVATION; INDUCTION	Targeting the endothelial-to-mesenchymal transition Endo T) may be a novel therapeutic strategy for cancer and various diseases induced by fibrosis. We aimed to den small chemical molecule as an inducer of EndoMT and find a new signal pathway by using the inducer. Safrole oxide (SFO) 50 mu g/ml, could most effectively induce EndoMT within 12 h. To understand the underlying molecular mechanism, we performed microarray, quantitative real-time PCR and western blot analysis to find key factors involved in SFO-induced EndoMT and demonstrated the involvement of the factors by RNAi. The expression of activating transcription factor 4 (ATF4), p75 neurotrophin receptor (p75NTR), and interleukin 8 (IL-8) was greatly increased in SFO-induced EndoMT. Knockdown of ATF4 inhibited the SFO-induced EndoMT completely, and knockdown of p75NTR or 1L-8 partially inhibited the EnoMT, which suggests that all three factors were involved in the process. Furthermore knockdown of p75NTR inhibited the SFO-increased IL-8 expression and secretion and knockdown of ATF4 inhibited SFO-increased p75NTR level significantly. The ATF4/p75NTR/1L-8 signal pathway may have an important role in EndoMT induced by SFO. Our findings support potential novel targets for the therapeutics of cancer and fibrosis disease.	[Ge, Di; Zhao, Wenbo; Yue, Hongwei; Su, Le; Zhang, ShangLi; Zhao, Jing] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China; [Jing, Qingchuan] Shandong Acad Agr Sci, Inst Poultry Sci, Jinan, Peoples R China	Shandong University; Shandong Academy of Agricultural Sciences	Zhao, J (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Peoples R China.	jingzhao@sdu.edu.cn	zhao, jing/B-3868-2019		National Natural Science Foundation of China [30800398, 81021001]; Science Foundation for the Excellent Youth Scholars of Ministry of Education of China [200804221004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China	This work was supported by National Natural Science Foundation of China (No. 30800398 and 81021001 http://isisn.nsfc.gov.cn/egrantweb/); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China (No. 200804221004 http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/moe_257/index.html) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2002, CRIT REV ORAL BIOL M, V13, P465, DOI 10.1177/154411130201300604; Caporali A, 2008, CIRC RES, V103, pE15, DOI 10.1161/CIRCRESAHA.108.177386; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Choi M, 2013, INT J BIOCHEM CELL B, V45, P560, DOI 10.1016/j.biocel.2012.12.001; Colombo E, 2011, J NEUROPATH EXP NEUR, V70, P133, DOI 10.1097/NEN.0b013e3182084391; Du AY, 2005, BIOORGAN MED CHEM, V13, P4176, DOI 10.1016/j.bmc.2005.04.031; Emmanuel C, 2013, CYTOKINE, V61, P38, DOI 10.1016/j.cyto.2012.09.017; Firestone AJ, 2010, ACS CHEM BIOL, V5, P15, DOI 10.1021/cb900249y; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Ge D, 2012, ACTA PHARMACOL SIN, V33, P57, DOI 10.1038/aps.2011.142; Ge D, 2011, J CELL PHYSIOL, V226, P2827, DOI 10.1002/jcp.22632; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Hashmi AZ, 2007, AM J PHYSIOL-GASTR L, V292, pG395, DOI 10.1152/ajpgi.00208.2006; Hertig A, 2010, J MOL CELL CARDIOL, V48, P497, DOI 10.1016/j.yjmcc.2009.07.022; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Malabanan KP, 2010, J MOL MED, V88, P545, DOI 10.1007/s00109-010-0615-4; Miao JY, 2002, ACTA PHARMACOL SIN, V23, P323; Mitra RS, 1997, LAB INVEST, V76, P99; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; Su L, 2006, BBA-MOL CELL RES, V1763, P247, DOI 10.1016/j.bbamcr.2006.01.002; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Tennakoon AH, 2013, EXP TOXICOL PATHOL; Weiss N, 2010, J NEUROIMMUNOL, V223, P131, DOI 10.1016/j.jneuroim.2010.03.009; Zhang Q, 2009, TOXICOL IN VITRO, V23, P797, DOI 10.1016/j.tiv.2009.04.007; Zhao BX, 2003, VASC PHARMACOL, V40, P183, DOI 10.1016/S1537-1891(03)00050-8; Zhao J, 2006, INT J BIOCHEM CELL B, V38, P1603, DOI 10.1016/j.biocel.2006.03.018	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e99378	10.1371/journal.pone.0099378	http://dx.doi.org/10.1371/journal.pone.0099378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905361	Green Published, Green Submitted, gold			2022-12-25	WOS:000341869000119
J	Rechsteiner, MP; Floros, X; Boehm, BO; Marselli, L; Marchetti, P; Stoffel, M; Moch, H; Spinas, GA				Rechsteiner, Markus P.; Floros, Xenofon; Boehm, Bernhard O.; Marselli, Lorella; Marchetti, Piero; Stoffel, Markus; Moch, Holger; Spinas, Giatgen A.			Automated Assessment of beta-Cell Area and Density per Islet and Patient Using TMEM27 and BACE2 Immunofluorescence Staining in Human Pancreatic beta-Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; MASS; APOPTOSIS	In this study we aimed to establish an unbiased automatic quantification pipeline to assess islet specific features such as beta-cell area and density per islet based on immunofluorescence stainings. To determine these parameters, the in vivo protein expression levels of TMEM27 and BACE2 in pancreatic islets of 32 patients with type 2 diabetes (T2D) and in 28 non-diabetic individuals (ND) were used as input for the automated pipeline. The output of the automated pipeline was first compared to a previously developed manual area scoring system which takes into account the intensity of the staining as well as the percentage of cells which are stained within an islet. The median TMEM27 and BACE2 area scores of all islets investigated per patient correlated significantly with the manual scoring and with the median area score of insulin. Furthermore, the median area scores of TMEM27, BACE2 and insulin calculated from all T2D were significantly lower compared to the one of all ND. TMEM27, BACE2, and insulin area scores correlated as well in each individual tissue specimen. Moreover, islet size determined by costaining of glucagon and either TMEM27 or BACE2 and beta-cell density based either on TMEM27 or BACE2 positive cells correlated significantly. Finally, the TMEM27 area score showed a positive correlation with BMI in ND and an inverse pattern in T2D. In summary, automated quantification outperforms manual scoring by reducing time and individual bias. The simultaneous changes of TMEM27, BACE2, and insulin in the majority of the beta-cells suggest that these proteins reflect the total number of functional insulin producing beta-cells. Additionally, beta-cell subpopulations may be identified which are positive for TMEM27, BACE2 or insulin only. Thus, the cumulative assessment of all three markers may provide further information about the real beta-cell number per islet.	[Rechsteiner, Markus P.; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Floros, Xenofon] ETH, Dept Comp Sci, Zurich, Switzerland; [Boehm, Bernhard O.] Ulm Univ Med Ctr, Div Endocrinol Diabet & Metab, Ulm, Germany; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, Pisa, Italy; [Stoffel, Markus] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Spinas, Giatgen A.] Univ Zurich Hosp, Div Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ulm University; University of Pisa; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital	Rechsteiner, MP (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	markus.rechsteiner@usz.ch	Boehm, Bernhard Otto/F-8750-2015; Marchetti, Piero/J-7439-2013	Marchetti, Piero/0000-0003-4907-0635; Marselli, Lorella/0000-0002-6698-2962; Stoffel, Markus/0000-0003-1304-5817	Hoffmann La Roche Ltd. [34310037]	Hoffmann La Roche Ltd.(Hoffmann-La Roche)	The project was funded by Hoffmann La Roche Ltd. (Project-Nr. 34310037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2012, DIABETOLOGIA, V55, P2316, DOI 10.1007/s00125-012-2609-y; Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Altirriba J, 2010, DIABETOLOGIA, V53, P1406, DOI 10.1007/s00125-010-1728-6; Bonner-Weir S, 2000, J MOL ENDOCRINOL, V24, P297, DOI 10.1677/jme.0.0240297; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Floros X, 2009, LECT NOTES COMPUT SC, V5762, P633, DOI 10.1007/978-3-642-04271-3_77; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Puri S, 2012, CELL, V150, P1103, DOI 10.1016/j.cell.2012.08.021; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vats D, 2012, DIABETOLOGIA, V55, P2407, DOI 10.1007/s00125-012-2605-2	19	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98932	10.1371/journal.pone.0098932	http://dx.doi.org/10.1371/journal.pone.0098932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905913	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000341869000080
J	Zhong, YQW; Shangguan, ZP				Zhong, Yangquanwei; Shangguan, Zhouping			Water Consumption Characteristics and Water Use Efficiency of Winter Wheat under Long-Term Nitrogen Fertilization Regimes in Northwest China	PLOS ONE			English	Article							RAINFALL-USE EFFICIENCY; LOESS PLATEAU; YIELD RELATIONS; SOIL FERTILITY; DRYLAND WHEAT; PEARL-MILLET; GRAIN-YIELD; MANAGEMENT; MAIZE; IRRIGATION	Water shortage and nitrogen (N) deficiency are the key factors limiting agricultural production in arid and semi-arid regions, and increasing agricultural productivity under rain-fed conditions often requires N management strategies. A field experiment on winter wheat (Triticum aestivum L.) was begun in 2004 to investigate effects of long-term N fertilization in the traditional pattern used for wheat in China. Using data collected over three consecutive years, commencing five years after the experiment began, the effects of N fertilization on wheat yield, evapotranspiration (ET) and water use efficiency (WUE, i.e. the ratio of grain yield to total ET in the crop growing season) were examined. In 2010, 2011 and 2012, N increased the yield of wheat cultivar Zhengmai No. 9023 by up to 61.1, 117.9 and 34.7%, respectively, and correspondingly in cultivar Changhan No. 58 by 58.4, 100.8 and 51.7%. N-applied treatments increased water consumption in different layers of 0-200 cm of soil and thus ET was significantly higher in N-applied than in non-N treatments. WUE was in the range of 1.0-2.09 kg/m(3) for 2010, 2011 and 2012. N fertilization significantly increased WUE in 2010 and 2011, but not in 2012. The results indicated the following: (1) in this dryland farming system, increased N fertilization could raise wheat yield, and the drought-tolerant Changhan No. 58 showed a yield advantage in drought environments with high N fertilizer rates; (2) N application affected water consumption in different soil layers, and promoted wheat absorbing deeper soil water and so increased utilization of soil water; and (3) comprehensive consideration of yield and WUE of wheat indicated that the N rate of 270 kg/ha for Changhan No. 58 was better to avoid the risk of reduced production reduction due to lack of precipitation; however, under conditions of better soil moisture, the N rate of 180 kg/ha was more economic.	[Zhong, Yangquanwei; Shangguan, Zhouping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Shangguan, ZP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn	mahsum, masot/ABC-4546-2020		National Natural Science Foundation of China [41390463, 61273329]; CAS [KZCX2-YW-JC408]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	The study was sponsored by the National Natural Science Foundation of China (41390463, 61273329) and the Important Direction Project of Innovation of CAS (KZCX2-YW-JC408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Basso B, 2010, EUR J AGRON, V33, P132, DOI 10.1016/j.eja.2010.04.004; Borlaug N, 2009, FOOD SECUR, V1, P1, DOI 10.1007/s12571-009-0012-4; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Hai L, 2010, SOIL BIOL BIOCHEM, V42, P253, DOI 10.1016/j.soilbio.2009.10.023; Halvorson AD, 2004, AGRON J, V96, P1196, DOI 10.2134/agronj2004.1196; HAMBLIN A, 1987, AUST J AGR RES, V38, P513, DOI 10.1071/AR9870513; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; HOWELL TA, 1995, T ASAE, V38, P745, DOI 10.13031/2013.27888; Huifang H, 2012, MAYDICA, V56; Hunsaker DJ, 2000, AGR FOREST METEOROL, V104, P85, DOI 10.1016/S0168-1923(00)00157-X; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; JOHNSON WENDELL C., 1964, AGRONJ, V56, P29; JUPP AP, 1987, NEW PHYTOL, V105, P393, DOI 10.1111/j.1469-8137.1987.tb00876.x; Kang SZ, 2002, AGR WATER MANAGE, V55, P203, DOI 10.1016/S0378-3774(01)00180-9; Kirda C, 2005, FIELD CROP RES, V93, P132, DOI 10.1016/j.fcr.2004.09.015; Li SX, 2009, ADV AGRON, V102, P223, DOI 10.1016/S0065-2113(09)01007-4; Li Y.S., 1982, J AGRONOMY SHAANXI P, V2, P1; Malhi SS, 2011, NUTR CYCL AGROECOSYS, V90, P227, DOI 10.1007/s10705-011-9424-6; MCINTYRE BD, 1995, FIELD CROP RES, V43, P67, DOI 10.1016/0378-4290(95)00035-O; Morell FJ, 2011, SOIL TILL RES, V117, P76, DOI 10.1016/j.still.2011.09.002; MUSICK JT, 1994, AGRON J, V86, P980, DOI 10.2134/agronj1994.00021962008600060010x; Perry C, 2009, AGR WATER MANAGE, V96, P1517, DOI 10.1016/j.agwat.2009.05.005; PIMENTEL D, 1973, SCIENCE, V182, P443, DOI 10.1126/science.182.4111.443; Qiu GY, 2008, AGR FOREST METEOROL, V148, P1848, DOI 10.1016/j.agrformet.2008.06.010; Rahman MA, 2005, FIELD CROP RES, V91, P71, DOI 10.1016/j.fcr.2004.06.010; Regmi AP, 2002, SOIL SCI SOC AM J, V66, P857, DOI 10.2136/sssaj2002.0857; Rockstrom J, 1997, PLANT SOIL, V195, P311, DOI 10.1023/A:1004233303066; Schindler DW, 2009, SCIENCE, V324, P721, DOI 10.1126/science.324_721b; Schneider AD, 1997, T ASAE, V40, P137, DOI 10.13031/2013.21258; Shan L., 1983, NEWSLETTERS PLANT PH, V5, P7; Shangguan ZP, 2002, INT J SUST DEV WORLD, V9, P341, DOI 10.1080/13504500209470129; Shangguan ZP, 2000, J PLANT PHYSIOL, V156, P46, DOI 10.1016/S0176-1617(00)80271-0; Shen JY, 2012, PLANT SOIL ENVIRON, V58, P161, DOI 10.17221/404/2011-PSE; Sheng HD, 1985, ACTA U AGR BOREALI O, V13, P73; Timsina J, 2001, FIELD CROP RES, V72, P143, DOI 10.1016/S0378-4290(01)00171-X; Turner NC, 2005, AUST J AGR RES, V56, P1123, DOI 10.1071/AR05076; Turner NC, 2004, J EXP BOT, V55, P2413, DOI 10.1093/jxb/erh154; Unger PW, 1972, DRYLAND WINTER WHEAT, P11; Zand-Parsa S, 2006, AGR WATER MANAGE, V81, P227, DOI 10.1016/j.agwat.2005.03.010; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069; Zhang HP, 1999, AGR WATER MANAGE, V38, P195, DOI 10.1016/S0378-3774(98)00069-9; Zhang JH, 1998, FIELD CROP RES, V59, P91, DOI 10.1016/S0378-4290(98)00104-X; Zhang XC, 2007, CHINESE J ECOAGRICUL, V15; Zhou JB, 2011, FIELD CROP RES, V122, P157, DOI 10.1016/j.fcr.2011.03.009; Zhou XB, 2011, PLANT SOIL ENVIRON, V57, P115, DOI 10.17221/130/2010-PSE	50	64	68	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2014	9	6							e98850	10.1371/journal.pone.0098850	http://dx.doi.org/10.1371/journal.pone.0098850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP1YS	24905909	Green Published, gold, Green Submitted			2022-12-25	WOS:000341869000069
J	Banszegi, O; Kosztolanyi, A; Bakonyi, G; Szabo, B; Dombos, M				Banszegi, Oxana; Kosztolanyi, Andras; Bakonyi, Gabor; Szabo, Borbala; Dombos, Miklos			New Method for Automatic Body Length Measurement of the Collembolan, Folsomia candida Willem 1902 (Insecta: Collembola)	PLOS ONE			English	Article							NATURAL SOILS; GROWTH; REPRODUCTION; TOXICITY; CADMIUM; SPRINGTAIL; POPULATION; INDICATORS; ZINC	The collembolan, Folsomia candida, is widely used in soil ecotoxicology. In recent years, growth rate of collembolans has become as frequently used endpoint as reproduction rate in ecotoxicological studies. However, measuring collembolan body sizes to estimate growth rate is a complicated and time-consuming task. Here we present a new image analysis method, which facilitates and accelerates the body length measurement of the collembolan Folsomia candida. The new software package, called CollScope, consists of three elements: 1) an imaging device; 2) photographing software; 3) an ImageJ macro for image processing, measurement and data analysis. We give a complete description of the operation of the software, the image analyzing process and describe its accuracy and reliability. The software with a detailed usage manual is attached as Supplementary Material. We report a case study to demonstrate that the automated measurement of collembolan body sizes is highly correlated with the traditional manual measurements (estimated measuring accuracy 0.05 mm). Furthermore, we performed a dose-response ecotoxicity test using cadmium-sulfate by using CollScope as well as classical methods for size measurement. Size data measured by CollScope or manually did not differ significantly. Furthermore the new software package decreased time consumption of the measurements to 42% when tested on 35 animals. Consequently, methodological investigations performed in this study should be regarded as a recommendation for any other routine dose-response study where body growth is an endpoint.	[Banszegi, Oxana; Dombos, Miklos] Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary; [Kosztolanyi, Andras] Univ Debrecen, Dept Evolutionary Zool & Human Biol, MTA DE Lendulet Behav Ecol Res Grp, H-4012 Debrecen, Hungary; [Bakonyi, Gabor] Szent Istvan Univ, Fac Agr & Environm Sci, Godollo, Hungary; [Szabo, Borbala] Szent Istvan Univ, Fac Vet Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Debrecen; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Dombos, M (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary.	dombos.miklos@gmail.com	Bánszegi, Oxána/ABF-7208-2020; Szabó, Borbála/ABA-2223-2020; Kosztolanyi, Andras/B-8008-2016; Bakonyi, Gabor/AAD-4298-2019	Bánszegi, Oxána/0000-0002-1704-3539; Kosztolanyi, Andras/0000-0002-9109-5871; Szabo, Borbala/0000-0001-7587-1597	MEDAPHON LIFE+ project [LIFE 08ENV/H/000292]	MEDAPHON LIFE+ project	This study was supported financially by MEDAPHON LIFE+ project (LIFE 08ENV/H/000292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON G, 1983, OIKOS, V40, P216, DOI 10.2307/3544585; Bur T, 2012, SCI TOTAL ENVIRON, V414, P187, DOI 10.1016/j.scitotenv.2011.10.029; Bur T, 2010, ECOTOX ENVIRON SAFE, V73, P415, DOI 10.1016/j.ecoenv.2009.10.010; Caridade CMR, 2011, 4 INT C IM SIGN PROC, P1837; Crommentuijn T, 1997, CH ECOTOXIC, V5, P275; CROMMENTUIJN T, 1993, ECOTOX ENVIRON SAFE, V26, P216, DOI 10.1006/eesa.1993.1051; Crouau Y, 2006, ECOTOX ENVIRON SAFE, V64, P115, DOI 10.1016/j.ecoenv.2005.06.002; Filser J, 2013, APPL SOIL ECOL; FolkerHansen P, 1996, ECOTOX ENVIRON SAFE, V33, P207, DOI 10.1006/eesa.1996.0027; Fountain MT, 2001, ECOTOX ENVIRON SAFE, V48, P275, DOI 10.1006/eesa.2000.2007; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; ISO, 2011, 1751222011 ISO; ISO, 2006, 2361122006 ISO; ISO, 1999, 11267 ISO; Krogh PH, 1998, APPL SOIL ECOL, V7, P201, DOI 10.1016/S0929-1393(97)00043-7; Mallard F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064387; Marcal ARS, 2006, LECT NOTES COMPUT SC, V4142, P814; Nursita AI, 2005, ECOTOX ENVIRON SAFE, V60, P306, DOI 10.1016/j.ecoenv.2004.05.001; OECD, 2009, OECD GUID TEST CHEM; Scheu S, 2004, OECOLOGIA, V139, P347, DOI 10.1007/s00442-004-1513-7; Scott-Fordsmand JJ, 1999, ECOTOX ENVIRON SAFE, V43, P57, DOI 10.1006/eesa.1998.1758; Smit CE, 1997, ECOTOX ENVIRON SAFE, V37, P213, DOI 10.1006/eesa.1997.1558; Staempfli C, 2007, ECOTOX ENVIRON SAFE, V68, P263, DOI 10.1016/j.ecoenv.2006.11.007; TRANVIK L, 1993, J APPL ECOL, V30, P43, DOI 10.2307/2404269; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; VANSTRAALEN NM, 1989, ECOTOX ENVIRON SAFE, V17, P190, DOI 10.1016/0147-6513(89)90038-9; Xu J, 2009, INSECT SCI, V16, P57, DOI 10.1111/j.1744-7917.2009.00254.x	27	11	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98230	10.1371/journal.pone.0098230	http://dx.doi.org/10.1371/journal.pone.0098230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901322	Green Submitted, Green Published, gold			2022-12-25	WOS:000336841400021
J	Hernandez-Ruedas, MA; Arroyo-Rodriguez, V; Meave, JA; Martinez-Ramos, M; Ibarra-Manriquez, G; Martinez, E; Jamangape, G; Melo, FPL; Santos, BA				Hernandez-Ruedas, Manuel A.; Arroyo-Rodriguez, Victor; Meave, Jorge A.; Martinez-Ramos, Miguel; Ibarra-Manriquez, Guillermo; Martinez, Esteban; Jamangape, Gilberto; Melo, Felipe P. L.; Santos, Braulio A.			Conserving Tropical Tree Diversity and Forest Structure: The Value of Small Rainforest Patches in Moderately-Managed Landscapes	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ATLANTIC FOREST; CONSERVATION; BIODIVERSITY; ATTRIBUTES; PROSPECTS; MAMMALS; BIRDS	Rainforests are undergoing severe deforestation and fragmentation worldwide. A huge amount of small forest patches are being created, but their value in conserving biodiversity and forest structure is still controversial. Here, we demonstrate that in a species-rich and moderately-managed Mexican tropical landscape small rainforest patches (<100 ha) can be highly valuable for the conservation of tree diversity and forest structure. These patches showed diverse communities of native plants, including endangered species, and a new record for the country. Although the number of logged trees increased in smaller patches, patch size was a poor indicator of basal area, stem density, number of species, genera and families, and community evenness. Cumulative species-area curves indicated that all patches had a similar contribution to the regional species diversity. This idea also was supported by the fact that patches strongly differed in floristic composition (high beta-diversity), independently of patch size. Thus, in agreement with the land-sharing approach, our findings support that small forest patches in moderately-managed landscapes should be included in conservation initiatives to maintain landscape heterogeneity, species diversity, and ecosystem services.	[Hernandez-Ruedas, Manuel A.; Arroyo-Rodriguez, Victor; Martinez-Ramos, Miguel; Ibarra-Manriquez, Guillermo] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Meave, Jorge A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico; [Martinez, Esteban] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; [Jamangape, Gilberto] Ejido Loma Bonita, Ocosingo, Chiapas, Mexico; [Melo, Felipe P. L.] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil; [Santos, Braulio A.] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal de Pernambuco; Universidade Federal da Paraiba	Arroyo-Rodriguez, V (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	victorarroyo_rodriguez@hotmail.com	Martínez-Ramos, Miguel/G-8451-2019; Santos, Bráulio A./M-2582-2013; Melo, Felipe P.L./B-7720-2008; Arroyo-Rodríguez, Víctor/C-9255-2009; Meave, Jorge/B-3673-2008	Martínez-Ramos, Miguel/0000-0002-7785-1917; Santos, Bráulio A./0000-0001-6046-4024; Melo, Felipe P.L./0000-0002-1271-3214; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Meave, Jorge/0000-0002-6241-8803; Hernandez-Ruedas, Manuel A./0000-0003-1471-7603	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM [IA-203111, IB-200812, RR-280812]; CONACyT, Mexico; Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM; Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT; Direct For Biological Sciences [1147429] Funding Source: National Science Foundation	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM; Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), DGAPA-UNAM (Projects IA-203111, IB-200812 and RR-280812). MAHR obtained a scholarship from the CONACyT, Mexico. The Centro de Investigaciones en Ecosistemas (UNAM) provided logical support. H. Ferreira and A. Palencia provided technical support, and A. Navarrete provided the SPOT images. C. Dobler digitized the maps and S. Nicasio-Arzeta elaborated the Figure 1. A. Garmendia, M. San-Jose and M. Sola assisted the field work. MAHR is grateful to M. G. F. Mendes, K. M. Demetrio, U. Gonzalez-Gordillo, and their families for their support. The authors are indebted to the local people of the Marques de Comillas region. Part of this paper was written while MAHR was on a research stay at the Departamento de Botanica, Universidade Federal de Pernambuco, and Departamento de Sistematica e Ecologia, Universidade Federal da Paraiba funded by the Programa de Apoyo a los Estudios de Posgrado (PAEP), UNAM, and the Programa de Becas Mixtas para Becarios CONACyT nacionales, CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar LF, 1992, REV GEOGR, V116, P67; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Arroyo-Rodriguez V, 2012, J ECOL, V100, P702, DOI 10.1111/j.1365-2745.2011.01952.x; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; CONAFOR, 2013, PROGR ESP SELV LAC 2; CONAFOR, 2010, COORD GEN PROD PROD; COOK RR, 1995, OECOLOGIA, V101, P204, DOI 10.1007/BF00317285; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2002, BIOL CONSERV, V106, P129, DOI 10.1016/S0006-3207(01)00241-5; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; Gentry A. H., 1982, FLORA VENEZUELA, V8, P1; Hsieh T. C., 2013, INEXT ONLINE INTERPO; Ibarra-Manriquez G, 2002, PLANT ECOL, V160, P91, DOI 10.1023/A:1015839400578; Ibarra-Manriquez G, 2012, BOT SCI, V90, P389, DOI 10.17129/botsci.472; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Martinez E, 1994, B SOC BOT MEX, V54, P99, DOI DOI 10.17129/BOTSCI.1430; Martinez E, 2003, DEFORESTACION 24 REG, P124; Martinez-Ramos M, 1998, TRENDS PLANT SCI, V3, P400, DOI 10.1016/S1360-1385(98)01313-2; Melo FPL, 2013, TRENDS ECOL EVOL, V28, P462, DOI 10.1016/j.tree.2013.01.001; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Perfecto I., 2009, NATURES MATRIX LINKI; Pinto SRR, 2010, TROP CONSERV SCI, V3, P389, DOI 10.1177/194008291000300404; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2009, REV MEX BIODIVERS, V80, P857; Santos GGA, 2012, BIOTROPICA, V44, P771, DOI 10.1111/j.1744-7429.2012.00882.x; Schutzman B, 1998, NOVON, V8, P441, DOI 10.2307/3391871; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452	46	63	63	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98931	10.1371/journal.pone.0098931	http://dx.doi.org/10.1371/journal.pone.0098931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901954	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400075
J	Kimpler, LA; Glosson, NL; Downs, D; Gonyo, P; May, NA; Hudson, AW				Kimpler, Lisa A.; Glosson, Nicole L.; Downs, Deanna; Gonyo, Patrick; May, Nathan A.; Hudson, Amy W.			Adaptor Protein Complexes AP-1 and AP-3 Are Required by the HHV-7 Immunoevasin U21 for Rerouting of Class I MHC Molecules to the Lysosomal Compartment	PLOS ONE			English	Article							POLARIZED EPITHELIAL-CELLS; MEMBRANE-PROTEINS; ANTIGEN PRESENTATION; DOWN-REGULATION; HEAVY-CHAINS; TRAFFICKING; CLATHRIN; GLYCOPROTEIN; TRANSPORT; DEGRADATION	The human herpesvirus-7 (HHV-7) U21 gene product binds to class I major histocompatibility complex (MHC) molecules and reroutes them to a lysosomal compartment. Trafficking of integral membrane proteins to lysosomes is mediated through cytoplasmic sorting signals that recruit heterotetrameric clathrin adaptor protein (AP) complexes, which in turn mediate protein sorting in post-Golgi vesicular transport. Since U21 can mediate rerouting of class I molecules to lysosomes even when lacking its cytoplasmic tail, we hypothesize the existence of a cellular protein that contains the lysosomal sorting information required to escort class I molecules to the lysosomal compartment. If such a protein exists, we expect that it might recruit clathrin adaptor protein complexes as a means of lysosomal sorting. Here we describe experiments demonstrating that the m adaptins from AP-1 and AP-3 are involved in U21-mediated trafficking of class I molecules to lysosomes. These experiments support the idea that a cellular protein(s) is necessary for U21-mediated lysosomal sorting of class I molecules. We also examine the impact of transient versus chronic knockdown of these adaptor protein complexes, and show that the few remaining m subunits in the cells are eventually able to reroute class I molecules to lysosomes.	[Kimpler, Lisa A.; Glosson, Nicole L.; Downs, Deanna; Gonyo, Patrick; May, Nathan A.; Hudson, Amy W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Hudson, AW (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	ahudson@mcw.edu			National Instititues of Health/National Institute of Allergy and Infectious Disease [1R01AI069099-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069099] Funding Source: NIH RePORTER	National Instititues of Health/National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Instititues of Health/National Institute of Allergy and Infectious Disease Grant # 1R01AI069099-01 to AWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Glosson NL, 2007, VIROLOGY, V365, P125, DOI 10.1016/j.virol.2007.03.048; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hudson AW, 2003, TRAFFIC, V4, P824, DOI 10.1046/j.1398-9219.2003.0137.x; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Reusch U, 2002, TRAFFIC, V3, P752, DOI 10.1034/j.1600-0854.2002.31007.x; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schneider CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002362; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Yang W, 2000, J CELL SCI, V113, P4077	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99139	10.1371/journal.pone.0099139	http://dx.doi.org/10.1371/journal.pone.0099139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901711	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400101
J	Pan, ZH; Ganjawala, TH; Lu, Q; Ivanova, E; Zhang, ZF				Pan, Zhuo-Hua; Ganjawala, Tushar H.; Lu, Qi; Ivanova, Elena; Zhang, Zhifei			ChR2 Mutants at L132 and T159 with Improved Operational Light Sensitivity for Vision Restoration	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; OPTOGENETIC EXCITATION; RETINAL DEGENERATION; CHANNELRHODOPSIN-2; CHANNEL; MICE; STIMULATION; ACTIVATION	The ectopic expression of microbial opsin-based optogenetic sensors, such as channelrhodopsin-2 (ChR2) in surviving inner retinal neurons, is a promising approach to restoring vision after retinal degeneration. However, a major limitation in using native ChR2 as a light sensor for vision restoration is the low light sensitivity of its expressing cells. Recently, two ChR2 mutations, T159C and L132C, were reported to produce higher photocurrents or have ultra light sensitivity. In this study, we created additional ChR2 mutants at these two sites to search for more light responsive ChR2 forms and evaluate their suitability for vision restoration by examining their light responsive properties in HEK cells and mouse retinal ganglion cells. We found additional ChR2 mutants at these two sites that showed a further increase in current amplitude at low light levels in the cells expressing these mutants, or operational light sensitivity. However, the increase in the operational light sensitivity was correlated with a decrease in temporal kinetics. Therefore, there is a trade-off between operational light sensitivity and temporal resolution for these more light responsive ChR2 mutants. Our results showed that for the two most light responsive mutants, L132C/T159C and L132C/T159S, the required light intensities for generating the threshold spiking activity in retinal ganglion cells were 1.5 and nearly 2 log units lower than wild-type ChR2 (wt-ChR2), respectively. Additionally, their ChR2-mediated spiking activities could follow flicker frequencies up to 20 and 10 Hz, respectively, at light intensities up to 1.5 log units above their threshold levels. Thus, the use of these more light responsive ChR2 mutants could make the optogenetic approach to restoring vision more feasible.	[Pan, Zhuo-Hua; Ganjawala, Tushar H.; Lu, Qi; Ivanova, Elena; Zhang, Zhifei] Wayne State Univ, Dept Anat Cell Biol, Sch Med, Detroit, MI 48202 USA; [Pan, Zhuo-Hua] Wayne State Univ Sch Med, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Dept Anat Cell Biol, Sch Med, Detroit, MI 48202 USA.	zhpan@med.wayne.edu	LU, QI/K-5684-2015; Lu, Qi/Y-6568-2019	LU, QI/0000-0002-8353-765X; Lu, Qi/0000-0002-8353-765X; Ganjawala, Tushar/0000-0002-5070-1572	National Institutes of Health (NIH) [EY04068, EY17130]; Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dryer Foundation; Ligon Research Center of Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by National Institutes of Health (NIH) grant EY17130, core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, Dryer Foundation, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hart Jr W M, 1987, ADLERS PHYSL EYE CLI; Ivanova E, 2009, MOL VIS, V15, P1680; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Wang H., J BIOL CHEM, V284, P5685; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066332; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	32	27	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e98924	10.1371/journal.pone.0098924	http://dx.doi.org/10.1371/journal.pone.0098924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901492	gold, Green Submitted, Green Published			2022-12-25	WOS:000336841400072
J	Tichy, H; Kallina, W				Tichy, Harald; Kallina, Wolfgang			Sensitivity of Honeybee Hygroreceptors to Slow Humidity Changes and Temporal Humidity Variation Detected in High Resolution by Mobile Measurements	PLOS ONE			English	Article							STICK INSECT; COCKROACH; ANTENNA; MOIST	The moist cell and the dry cell on the antenna of the male honeybee were exposed to humidities slowly rising and falling at rates between -1.5%/s and + 1.5%/s and at varying amplitudes in the 10 to 90% humidity range. The two cells respond to these slow humidity oscillations with oscillations in impulse frequency which depend not only on instantaneous humidity but also on the rate with which humidity changes. The impulse frequency of each cell was plotted as a function of these two parameters and regression planes were fitted to the data points of single oscillation periods. The regression slopes, which estimate sensitivity, rose with the amplitude of humidity oscillations. During large-amplitude oscillations, moist and dry cell sensitivity for instantaneous humidity and its rate of change was high. During small-amplitude oscillations, their sensitivity for both parameters was low, less exactly reflecting humidity fluctuations. Nothing is known about the spatial and temporal humidity variations a honeybee may encounter when flying through natural environments. Microclimatic parameters (absolute humidity, temperature, wind speed) were measured from an automobile traveling through different landscapes of Lower Austria. Landscape type affected extremes and mean values of humidity. Differences between peaks and troughs of humidity fluctuations were generally smaller in open grassy fields or deciduous forests than in edge habitats or forest openings. Overall, fluctuation amplitudes were small. In this part of the stimulus range, hygroreceptor sensitivity is not optimal for encoding instantaneous humidity and the rate of humidity change. It seems that honeybee's hygroreceptors are specialized for detecting large-amplitude fluctuations that are relevant for a specific behavior, namely, maintaining a sufficiently stable state of water balance. The results suggest that optimal sensitivity of both hygroreceptors is shaped not only by humidity oscillation amplitudes but also according to their impact on behavior.	[Tichy, Harald; Kallina, Wolfgang] Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria	University of Vienna	Tichy, H (corresponding author), Univ Vienna, Fac Life Sci, Dept Neurobiol, Vienna, Austria.	harald.tichy@univie.ac.at		Harald, Tichy/0000-0003-1582-5139	Austrian Science Fund [P20.197-B17]; Austrian Science Fund (FWF) [P 20196] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (Project P20.197-B17)(www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ITOH T, 1984, ZOOL SCI, V1, P533; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Resch R, 1998, APPL PHYS A-MATER, V66, pS607, DOI 10.1007/s003390051209; TICHY H, 1987, J COMP PHYSIOL A, V160, P43, DOI 10.1007/BF00613440; Tichy H, 2003, J COMP PHYSIOL A, V189, P175, DOI 10.1007/s00359-003-0397-z; Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009; TICHY H, 1990, J COMP PHYSIOL A, V166, P507, DOI 10.1007/BF00192021; Tichy H, 1996, NATURWISSENSCHAFTEN, V83, P255; Tichy H., 2001, ECOLOGY SENSING, P271, DOI [10.1007/978-3-662-22644-5_14, DOI 10.1007/978-3-662-22644-5_14]; Tichy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053998; von Frisch K, 1955, NATURWISSENSCHAFTEN, V13, P376; YOKOHARI F, 1976, J COMP PHYSIOL, V106, P137, DOI 10.1007/BF00620495; YOKOHARI F, 1978, J COMP PHYSIOL, V124, P53, DOI 10.1007/BF00656391; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	14	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2014	9	6							e99032	10.1371/journal.pone.0099032	http://dx.doi.org/10.1371/journal.pone.0099032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NF	24901985	Green Published, gold, Green Submitted			2022-12-25	WOS:000336841400089
J	Kawamura, K; Takahashi, T; Kanazawa, M; Igarashi, H; Nakada, T; Nishizawa, M; Shimohata, T				Kawamura, Kunio; Takahashi, Tetsuya; Kanazawa, Masato; Igarashi, Hironaka; Nakada, Tsutomu; Nishizawa, Masatoyo; Shimohata, Takayoshi			Effects of Angiopoietin-1 on Hemorrhagic Transformation and Cerebral Edema after Tissue Plasminogen Activator Treatment for Ischemic Stroke in Rats	PLOS ONE			English	Article							ARTERY OCCLUSION; TIE2 RECEPTOR; EXPRESSION; BRAIN; ANGIOGENESIS; THROMBOLYSIS; LIGAND	An angiogenesis factor, angiopoietin-1 (Ang1), is associated with the blood-brain barrier (BBB) disruption after focal cerebral ischemia. However, whether hemorrhagic transformation and cerebral edema after tissue plasminogen activator (tPA) treatment are related to the decrease in Ang1 expression in the BBB remains unknown. We hypothesized that administering Ang1 might attenuate hemorrhagic transformation and cerebral edema after tPA treatment by stabilizing blood vessels and inhibiting hyperpermeability. Sprague-Dawley rats subjected to thromboembolic focal cerebral ischemia were assigned to a permanent ischemia group (permanent middle cerebral artery occlusion; PMCAO) and groups treated with tPA at 1 h or 4 h after ischemia. Endogenous Ang1 expression was observed in pericytes, astrocytes, and neuronal cells. Western blot analyses revealed that Ang1 expression levels on the ischemic side of the cerebral cortex were decreased in the tPA-1h, tPA-4h, and PMCAO groups as compared to those in the control group (P = 0.014, 0.003, and 0.014, respectively). Ang1-positive vessel densities in the tPA-4h and PMCAO groups were less than that in the control group (p = 0.002 and <0.001, respectively) as well as that in the tPA-1h group (p = 0.047 and 0.005, respectively). These results suggest that Ang1-positive vessel density was maintained when tPA was administered within the therapeutic time window (1 h), while it was decreased when tPA treatment was given after the therapeutic time window (4 h). Administering Ang1 fused with cartilage oligomeric protein (COMP) to supplement this decrease has the potential to suppress hemorrhagic transformation as measured by hemoglobin content in a whole cerebral homogenate (p = 0.007) and cerebral edema due to BBB damage (p = 0.038), as compared to administering COMP protein alone. In conclusion, Ang1 might be a promising target molecule for developing vasoprotective therapies for controlling hemorrhagic transformation and cerebral edema after tPA treatment.	[Kawamura, Kunio; Takahashi, Tetsuya; Kanazawa, Masato; Nishizawa, Masatoyo; Shimohata, Takayoshi] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; [Igarashi, Hironaka; Nakada, Tsutomu] Niigata Univ, Brain Res Inst, Dept Ctr Integrated Human Brain Sci, Niigata, Japan	Niigata University; Niigata University	Shimohata, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan.	t-shimo@bri.niigata-u.ac.jp	Kanazawa, Masato/J-3267-2017; Kanazawa, Masato/AAK-1982-2020	Kanazawa, Masato/0000-0001-6337-8156; 	Yujin Memorial Grant; JSPS KAKENHI [25430063]; Tsubaki Memorial Neuroscience Research Foundation; Grants-in-Aid for Scientific Research [25430063] Funding Source: KAKEN	Yujin Memorial Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tsubaki Memorial Neuroscience Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Yujin Memorial Grant (TS), JSPS KAKENHI Grant Number 25430063 (TT), and the Tsubaki Memorial Neuroscience Research Foundation (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH107, DOI 10.1152/ajpheart.00542.2005; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fuxe J, 2011, AM J PATHOL, V178, P2897, DOI 10.1016/j.ajpath.2011.02.008; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Kanazawa M, 2011, J CEREBR BLOOD F MET, V31, P1461, DOI 10.1038/jcbfm.2011.9; Kanazawa M, 2011, J NEUROCHEM, V116, P957, DOI 10.1111/j.1471-4159.2010.06860.x; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Makinde T, 2008, J CELL MOL MED, V12, P810, DOI 10.1111/j.1582-4934.2008.00254.x; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Okubo S, 2007, BRAIN RES, V1143, P221, DOI 10.1016/j.brainres.2007.01.050; Salmon AHJ, 2009, CARDIOVASC RES, V83, P24, DOI 10.1093/cvr/cvp093; Shimohata T, 2007, J CEREBR BLOOD F MET, V27, P1463, DOI 10.1038/sj.jcbfm.9600450; Shin HY, 2010, J NEUROSCI RES, V88, P1052, DOI 10.1002/jnr.22274; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sundberg C, 2002, LAB INVEST, V82, P387, DOI 10.1038/labinvest.3780433; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	29	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98639	10.1371/journal.pone.0098639	http://dx.doi.org/10.1371/journal.pone.0098639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896569	gold, Green Published, Green Submitted			2022-12-25	WOS:000338430700058
J	Olson, DD; Bissonette, JA; Cramer, PC; Green, AD; Davis, ST; Jackson, PJ; Coster, DC				Olson, Daniel D.; Bissonette, John A.; Cramer, Patricia C.; Green, Ashley D.; Davis, Scott T.; Jackson, Patrick J.; Coster, Daniel C.			Monitoring Wildlife-Vehicle Collisions in the Information Age: How Smartphones Can Improve Data Collection	PLOS ONE			English	Article							NATIONAL-PARK; UNITED-STATES; UNDERPASSES; ROADS; HIGHWAY; IMPACTS	Background: Currently there is a critical need for accurate and standardized wildlife-vehicle collision data, because it is the underpinning of mitigation projects that protect both drivers and wildlife. Gathering data can be challenging because wildlife-vehicle collisions occur over broad areas, during all seasons of the year, and in large numbers. Collecting data of this magnitude requires an efficient data collection system. Presently there is no widely adopted system that is both efficient and accurate. Methodology/Principal Findings: Our objective was to develop and test an integrated smartphone-based system for reporting wildlife-vehicle collision data. The WVC Reporter system we developed consisted of a mobile web application for data collection, a database for centralized storage of data, and a desktop web application for viewing data. The smartphones that we tested for use with the application produced accurate locations (median error = 4.6-5.2 m), and reduced location error 99% versus reporting only the highway/marker. Additionally, mean times for data entry using the mobile web application (22.0-26.5 s) were substantially shorter than using the pen/paper method (52 s). We also found the pen/paper method had a data entry error rate of 10% and those errors were virtually eliminated using the mobile web application. During the first year of use, 6,822 animal carcasses were reported using WVC Reporter. The desktop web application improved access to WVC data and allowed users to easily visualize wildlife-vehicle collision patterns at multiple scales. Conclusions/Significance: The WVC Reporter integrated several modern technologies into a seamless method for collecting, managing, and using WVC data. As a result, the system increased efficiency in reporting, improved accuracy, and enhanced visualization of data. The development costs for the system were minor relative to the potential benefits of having spatially accurate and temporally current wildlife-vehicle collision data.	[Olson, Daniel D.; Bissonette, John A.; Cramer, Patricia C.; Jackson, Patrick J.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Green, Ashley D.] Utah Div Wildlife Resources, Salt Lake City, UT USA; [Davis, Scott T.] Automated Geog Reference Ctr, Salt Lake City, UT USA; [Coster, Daniel C.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Olson, DD (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	dolson22@gmail.com	Bissonette, John A./J-7494-2019		Utah Department of Transportation; Utah Division of Wildlife Resources	Utah Department of Transportation; Utah Division of Wildlife Resources	This project was funded by the Utah Department of Transportation and the Utah Division of Wildlife Resources. The funding agencies provided input on the initial design of the WVC Reporter system and assisted in testing and collecting data. They did not participate in data analysis or the decision to publish the results.	Al-Ghamdi AS, 2004, ACCIDENT ANAL PREV, V36, P749, DOI 10.1016/j.aap.2003.05.006; Ament R, 2007, ROADKILL OBSERVATION; Bernales H. H., 2011, UTAH BIG GAME ANN RE; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Bissonette JA, 2008, 615 NAT RES COUNC NA; Bissonette JA, 2012, WILDLIFE BIOL, V18, P414, DOI 10.2981/11-122; Bissonette John A., 2008, Human-Wildlife Conflicts, V2, P17; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; Cramer P, 2012, UT1207 UT STAT U; Donaldson BM, 2010, TRANSP RES RECORD, P18, DOI 10.3141/2147-03; Economic Research Service, 2013, STAT FACT SHEETS; Ford AT, 2009, J WILDLIFE MANAGE, V73, P1213, DOI 10.2193/2008-387; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Gagnon JW, 2011, J WILDLIFE MANAGE, V75, P1477, DOI 10.1002/jwmg.160; GILLIES R. R., 2009, RANGELAND RESOURCES, P39; GRIFFITH G, 2009, ENCY EARTH; Gunson KE, 2009, ENVIRON MANAGE, V44, P268, DOI 10.1007/s00267-009-9303-y; Gura Trisha, 2013, Nature, V496, P259; Hesse, 2010, WILDLIFE BIOL PRACTI, V6, P1, DOI DOI 10.2461/WBP.2010.6.1; Hubbard MW, 2000, J WILDLIFE MANAGE, V64, P707, DOI 10.2307/3802740; Huijser MP, 2009, ECOL SOC, V14; Huijser MP, 2008, FHWAHRT08034; Langley RL, 2006, WILD ENVIRON MED, V17, P229, DOI 10.1580/06-WEME-OR-001R1.1; Lee T, 2006, ECOL SOC, V11; Lefler N., 2011, BACKGROUND REPORT GU; Leydsman McGinty EI, 2009, RANGELANDS RESOURCES, P153; Leydsman-McGinty E.I., 2009, RANGELAND RESOURCES, P9; Mkande FX, 2011, S AFR J WILDL RES, V41, P68, DOI 10.3957/056.041.0114; Noro M, 2010, ANAL DEER ECOLOGY LA; Pope C, 2012, 2012 UDOT ANN STAT S; Ramp D, 2006, BIOL CONSERV, V129, P348, DOI 10.1016/j.biocon.2005.11.002; Sawyer H, 2012, WILDLIFE SOC B, V36, P492, DOI 10.1002/wsb.166; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Sinha P, 2010, REGULATORY IMPACT AN; Stoner D, 1925, Science, V61, P56, DOI 10.1126/science.61.1568.56; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; U. S. Census Bureau, 2010, RES POP DAI; UDOT, 2010, VEH MIL TRAV; Van Der Grift E, 2006, ENVIRONM POLLUT SER, V10, P205, DOI 10.1007/1-4020-4504-2_10; Wagner M.E., 2007, ANIMAL VEHICLE COLLI; Welsh S.L., 1993, A UTAH FLORA, V2; West P. W., 2008, UDOT WILDLIFE DOMEST	46	36	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98613	10.1371/journal.pone.0098613	http://dx.doi.org/10.1371/journal.pone.0098613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897502	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700055
J	Rivalin, R; Lepinoux-Chambaud, C; Eyer, J; Savagner, F				Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique			The NFL-TBS.40-63 Anti-Glioblastoma Peptide Disrupts Microtubule and Mitochondrial Networks in the T98G Glioma Cell Line	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; DIABETES PREVENTION; RISK; EXERCISE; OBESITY; ADULTS; A1C	Despite aggressive therapies, including combinations of surgery, radiotherapy and chemotherapy, glioblastoma remains a highly aggressive brain cancer with the worst prognosis of any central nervous system disease. We have previously identified a neurofilament-derived cell-penetrating peptide, NFL-TBS.40-63, that specifically enters by endocytosis in glioblastoma cells, where it induces microtubule destruction and inhibits cell proliferation. Here, we explore the impact of NFL-TBS.40-63 peptide on the mitochondrial network and its functions by using global cell respiration, quantitative PCR analysis of the main actors directing mitochondrial biogenesis, western blot analysis of the oxidative phosphorylation (OXPHOS) subunits and confocal microscopy. We show that the internalized peptide disturbs mitochondrial and microtubule networks, interferes with mitochondrial dynamics and induces a rapid depletion of global cell respiration. This effect may be related to reduced expression of the NRF-1 transcription factor and of specific miRNAs, which may impact mitochondrial biogenesis, in regard to default mitochondrial mobility.	[Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique] Univ Angers, Angers, France; [Rivalin, Romain; Lepinoux-Chambaud, Claire; Eyer, Joel; Savagner, Frederique] Univ Angers, UPRES EA 3143, LNBT, Lab Neurobiol & Transgenese, Angers, France; [Savagner, Frederique] CHU Angers, Biochim Lab, Angers, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Savagner, F (corresponding author), Univ Angers, Angers, France.	Frederique.savagner@univ-angers.fr	Eyer, Joel/K-4265-2015; Eyer, Joel/V-8679-2019	Eyer, Joel/0000-0001-6301-7465; Eyer, Joel/0000-0001-6301-7465	CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire; L'INSERM; Ligue Contre le Cancer	CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire(Region Pays de la Loire); L'INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from CIMATH-2 (ciblage moleculaire et applications therapeutiques) Region Pays de la Loire, Ligue Contre le Cancer and L'INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; American College of Sports Medicine, 2010, ACSMS GUID EX TEST P; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Haskell WL, 2000, AM J CLIN NUTR, V72, p541S, DOI 10.1093/ajcn/72.2.541S; Hu G, 2007, APPL PHYSIOL NUTR ME, V32, P583, DOI 10.1139/H07-030; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI 10.1007/s13340-012-0069-8; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Klein S, 2004, DIABETES CARE, V27, P2067, DOI 10.2337/diacare.27.8.2067; Lee DC, 2009, DIABETES CARE, V32, P257, DOI 10.2337/dc08-1377; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Malin SK, 2013, AM J PHYSIOL-ENDOC M, V305, pE1248, DOI 10.1152/ajpendo.00260.2013; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Miyashita M, 1984, JPN J SPORTS SCI, V3, P559; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; PATE RR, 1984, SPORTS MED, V1, P87, DOI 10.2165/00007256-198401020-00001; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Slentz CA, 2009, DIABETES CARE, V32, P1807, DOI 10.2337/dc09-0032; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Williams PT, 2013, ARTERIOSCL THROM VAS, V33, P1085, DOI 10.1161/ATVBAHA.112.300878	31	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98473	10.1371/journal.pone.0098473	http://dx.doi.org/10.1371/journal.pone.0098473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896268	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700044
J	Simmons, GE; Pandey, S; Nedeljkovic-Kurepa, A; Saxena, M; Wang, A; Pruitt, K				Simmons, Glenn E., Jr.; Pandey, Somnath; Nedeljkovic-Kurepa, Ana; Saxena, Madhurima; Wang, Allison; Pruitt, Kevin			Frizzled 7 Expression Is Positively Regulated by SIRT1 and beta-Catenin in Breast Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; POTENTIAL THERAPEUTIC TARGET; WNT SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; COLORECTAL-CANCER; POOR-PROGNOSIS; INHIBITION; PATHWAY; FZD7; GROWTH	The Wnt signaling pathway is often chronically activated in diverse human tumors, and the Frizzled (FZD) family of receptors for Wnt ligands, are central to propagating oncogenic signals in a beta-catenin-dependent and independent manner. SIRT1 is a class III histone deacetylase (HDAC) that deacetylates histone and non-histone proteins to regulate gene transcription and protein function. We previously demonstrated that SIRT1 loss of function led to a significant decrease in the levels of Dishevelled (DvI) proteins. To further explore this connection between the sirtuins and components of the Wnt pathway, we analyzed sirtuin-mediated regulation of FZD proteins. Here we explore the contribution of sirtuin deacetylases in promoting constitutive Wnt pathway activation in breast cancer cells. We demonstrate that the use of small molecule inhibitors of SIRT1 and SIRT2, and siRNA specific to SIRT1, all reduce the levels of FZD7 mRNA. We further demonstrate that pharmacologic inhibition of SIRT1/2 causes a marked reduction in FZD7 protein levels. Additionally, we show that beta-catenin and c-Jun occupy the 7 kb region upstream of the transcription start site of the FZD7 gene, and SIRT1 inhibition leads to a reduction in the occupancy of both b-catenin and c-Jun at points along this region. This work uncovers a new mechanism for the regulation of FZD7 and provides a critical new link between the sirtuins and FZD7, one of the earliest nodal points from which oncogenic Wnt signaling emanates. This study shows that inhibition of specific sirtuins may provide a unique strategy for inhibiting the constitutively active Wnt pathway at the level of the receptor.	[Simmons, Glenn E., Jr.; Pandey, Somnath; Nedeljkovic-Kurepa, Ana; Saxena, Madhurima; Wang, Allison; Pruitt, Kevin] LSU Hlth Sci Ctr Sch Med Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71103 USA; [Pruitt, Kevin] LSU Hlth Sci Ctr Sch Med Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Pruitt, K (corresponding author), LSU Hlth Sci Ctr Sch Med Shreveport, Dept Mol & Cellular Physiol, Shreveport, LA 71103 USA.	kpruit@lsuhsc.edu	Simmons, Glenn/AAT-6135-2020; Pandey, Somnath/GRX-5166-2022; Simmons, Glenn/A-1777-2015	Simmons, Glenn/0000-0003-2081-5672; Simmons, Glenn/0000-0003-2081-5672; Pandey, Somnath/0000-0002-4544-8939	NIH [R01 CA155223]; NATIONAL CANCER INSTITUTE [R01CA155223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by an NIH R01 grant CA155223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Byles V, 2012, ONCOGENE, V31, P4619, DOI 10.1038/onc.2011.612; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen ZL, 2013, CELL SIGNAL, V25, P2693, DOI 10.1016/j.cellsig.2013.08.032; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Kaler P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045462; Katoh M, 2007, INT J MOL MED, V19, P529; King TD, 2012, CELL SIGNAL, V24, P846, DOI 10.1016/j.cellsig.2011.12.009; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Leal LF, 2011, J CLIN ENDOCR METAB, V96, P3106, DOI 10.1210/jc.2011-0363; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Leko V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066283; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Mei H, 2014, STEM CELLS, V32, P938, DOI 10.1002/stem.1582; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Saxena M, 2013, ONCOGENE; Ueno K, 2009, BRIT J CANCER, V101, P1374, DOI 10.1038/sj.bjc.6605307; Ueno K, 2008, NEOPLASIA, V10, P697, DOI 10.1593/neo.08320; Vincan E, 2010, DEV DYNAM, V239, P311, DOI 10.1002/dvdy.22045; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang Q, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.202; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388	38	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98861	10.1371/journal.pone.0098861	http://dx.doi.org/10.1371/journal.pone.0098861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897117	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700088
J	Solis, AD				Solis, Armando D.			Deriving High-Resolution Protein Backbone Structure Propensities from All Crystal Data Using the Information Maximization Device	PLOS ONE			English	Article							STATISTICAL POTENTIALS; VALIDATION	The most informative probability distribution functions (PDFs) describing the Ramachandran phi-psi dihedral angle pair, a fundamental descriptor of backbone conformation of protein molecules, are derived from high-resolution X-ray crystal structures using an information-theoretic approach. The Information Maximization Device (IMD) is established, based on fundamental information-theoretic concepts, and then applied specifically to derive highly resolved phi-psi maps for all 20 single amino acid and all 8000 triplet sequences at an optimal resolution determined by the volume of current data. The paper shows that utilizing the latent information contained in all viable high-resolution crystal structures found in the Protein Data Bank (PDB), totaling more than 77,000 chains, permits the derivation of a large number of optimized sequence-dependent PDFs. This work demonstrates the effectiveness of the IMD and the superiority of the resulting PDFs by extensive fold recognition experiments and rigorous comparisons with previously published triplet PDFs. Because it automatically optimizes PDFs, IMD results in improved performance of knowledge-based potentials, which rely on such PDFs. Furthermore, it provides an easy computational recipe for empirically deriving other kinds of sequence-dependent structural PDFs with greater detail and precision. The high-resolution phi-psi maps derived in this work are available for download.	CUNY, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11210 USA	City University of New York (CUNY) System	Solis, AD (corresponding author), CUNY, Dept Biol Sci, New York City Coll Technol, Brooklyn, NY 11210 USA.	asolis@citytech.cuny.edu	Solis, Armando/AAF-2853-2019		PSC-CUNY Grant Award [60081-4041]	PSC-CUNY Grant Award	PSC-CUNY Grant Award # 60081-4041; https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Beck DAC, 2008, P NATL ACAD SCI USA, V105, P12259, DOI 10.1073/pnas.0706527105; Bertinia I, 2003, J BIOMOL NMR, V26, P355, DOI 10.1023/A:1024092421649; Betancourt MR, 2008, J PHYS CHEM B, V112, P5058, DOI 10.1021/jp076906+; Dahl DB, 2008, J MOL BIOL, V378, P749, DOI 10.1016/j.jmb.2008.02.043; Eyal E, 2005, J MOL BIOL, V351, P431, DOI 10.1016/j.jmb.2005.05.066; Haddadian EJ, 2011, BIOPHYS J, V101, P899, DOI 10.1016/j.bpj.2011.06.063; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hollingsworth Scott A, 2010, Biomol Concepts, V1, P271, DOI 10.1515/BMC.2010.022; Jiang F, 2010, J PHYS CHEM B, V114, P5840, DOI 10.1021/jp909088e; Kleinman CL, 2010, MOL BIOL EVOL, V27, P1546, DOI 10.1093/molbev/msq047; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; Lakshmi B, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P128; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rata IA, 2010, J PHYS CHEM B, V114, P1859, DOI 10.1021/jp909874g; Richardson JS, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P46; Shelar A, 2013, BIOMOLECULAR FORMS AND FUNCTIONS: A CELEBRATION OF 50 YEARS OF THE RAMACHANDRAN MAP, P116; Shortle D, 2002, PROTEIN SCI, V11, P18, DOI 10.1110/ps.ps.31002; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Solis AD, 2006, PROTEINS, V62, P892, DOI 10.1002/prot.20501; Solis AD, 2002, PROTEINS, V48, P463, DOI 10.1002/prot.10126; Solis AD, 2008, PROTEINS, V71, P1071, DOI 10.1002/prot.21733; Thomas MC, 2006, ELEMENTS INFORM THEO; Ting D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000763; Walther D, 1999, ACTA CRYSTALLOGR D, V55, P506, DOI 10.1107/S0907444998013353; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e94334	10.1371/journal.pone.0094334	http://dx.doi.org/10.1371/journal.pone.0094334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896099	gold, Green Published			2022-12-25	WOS:000338430700001
J	Yoneda, S; Loeser, B; Feng, J; Dmytryk, J; Qi, FX; Merritt, J				Yoneda, Saori; Loeser, Brandon; Feng, Joseph; Dmytryk, John; Qi, Fengxia; Merritt, Justin			Ubiquitous Sialometabolism Present among Oral Fusobacteria	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; CAMPYLOBACTER-JEJUNI LIPOOLIGOSACCHARIDES; SIALYLATED NEISSERIA-GONORRHOEAE; OUTER-MEMBRANE PROTEIN; ACID O-ACETYLATION; SIALIC-ACID; SERUM RESISTANCE; MULTISPECIES BIOFILM; ACUTE APPENDICITIS; FACTOR-H	Fusobacterium nucleatum is a ubiquitous member of the human oral flora and is associated with the development of periodontitis and a variety of other types of polymicrobial infections of the mucosa. In the oral cavity, this species is one of the few that is prevalent in both healthy and diseased subgingival plaque. Using microarray analysis, we examined the transcriptional response of F. nucleatum subspecies nucleatum to whole blood in order to identify some of the genetic responses that might occur during the transition from health to disease. From these studies, we identified a sialic acid catabolism operon that was induced by the presence of blood. We subsequently confirmed that this operon was inducible by the presence of synthetic sialic acid, but we found no evidence suggesting sialic acid was used as a major carbon source. However, this organism was found to possess a de novo synthesized surface sialylation ability that is widely conserved among the various F. nucleatum subspecies as well as in F. periodonticum. We provide evidence that fusobacterial sialylation does occur in the oral cavity irrespective of health status. Interestingly, only a minority of fusobacterial cells exhibit surface sialylation within dental plaque, whereas most cells are uniformly sialylated when grown in pure culture. The implications of these results are discussed.	[Yoneda, Saori] Ohu Univ, Dept Oral Med Sci, Fukushima, Japan; [Loeser, Brandon; Feng, Joseph; Dmytryk, John] Univ Oklahoma, Hlth Sci Ctr, Dept Periodontol, Oklahoma City, OK USA; [Qi, Fengxia; Merritt, Justin] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Qi, Fengxia; Merritt, Justin] Univ Oklahoma, Hlth Sci Ctr, Div Oral Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Merritt, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	justin-merritt@ouhsc.edu			National Institute of Dental and Craniofacial Research grant [DE018893]; J. Dean Robertson Society; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018893] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research grant; J. Dean Robertson Society; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a National Institute of Dental and Craniofacial Research grant DE018893 to JM (https://www.nidcr.nih.gov/). BL was supported by funds provided by the J. Dean Robertson Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bolstad AI, 1996, CLIN MICROBIOL REV, V9, P55, DOI 10.1128/CMR.9.1.55; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11; Edwards AM, 2007, ORAL MICROBIOL IMMUN, V22, P217, DOI 10.1111/j.1399-302X.2006.00343.x; Engstler M, 1997, ANAL BIOCHEM, V250, P176, DOI 10.1006/abio.1997.2205; Fujita T, 1999, J CLIN LAB ANAL, V13, P173, DOI 10.1002/(SICI)1098-2825(1999)13:4<173::AID-JCLA6>3.3.CO;2-L; Gmur R, 2004, EUR J ORAL SCI, V112, P33, DOI 10.1111/j.0909-8836.2004.00103.x; Guerry P, 2000, INFECT IMMUN, V68, P6656, DOI 10.1128/IAI.68.12.6656-6662.2000; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Hofbauer J, 1998, UROL RES, V26, P49, DOI 10.1007/s002400050023; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Ikegami A, 2009, INFECT IMMUN, V77, P3075, DOI 10.1128/IAI.00209-09; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kaplan CW, 2005, J DENT RES, V84, P700, DOI 10.1177/154405910508400803; Kim HS, 2010, J CLIN MICROBIOL, V48, P545, DOI 10.1128/JCM.01631-09; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Kinder Haake S, 1997, J PERIODONTOL, V68, P39; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; MANGAN DF, 1989, INFECT IMMUN, V57, P3601, DOI 10.1128/IAI.57.11.3601-3611.1989; MARQUES MB, 1992, INFECT IMMUN, V60, P3986, DOI 10.1128/IAI.60.10.3986-3993.1992; Merritt J, 2009, APPL ENVIRON MICROB, V75, P7725, DOI 10.1128/AEM.00916-09; Nistico Laura, 2009, V493, P191, DOI 10.1007/978-1-59745-523-7_12; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shaughnessy J, 2011, J BIOL CHEM, V286, P22235, DOI 10.1074/jbc.M111.225516; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stafford G, 2012, MOL ORAL MICROBIOL, V27, P11, DOI 10.1111/j.2041-1014.2011.00630.x; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 2012, SAUDI J GASTROENTERO, V18, P55, DOI 10.4103/1319-3767.91734; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]	51	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99263	10.1371/journal.pone.0099263	http://dx.doi.org/10.1371/journal.pone.0099263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24896093	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700126
J	Zinkevich, V; Sapojnikova, N; Mitchell, J; Kartvelishvili, T; Asatiani, N; Alkhalil, S; Bogdarina, I; Al-Humam, AA				Zinkevich, Vitaly; Sapojnikova, Nelly; Mitchell, Julian; Kartvelishvili, Tamar; Asatiani, Nino; Alkhalil, Samia; Bogdarina, Irina; Al-Humam, Abdulmohsen A.			A Novel Cassette Method for Probe Evaluation in the Designed Biochips	PLOS ONE			English	Article							OLIGONUCLEOTIDE; DNA; MICROARRAYS; PLATFORM	A critical step in biochip design is the selection of probes with identical hybridisation characteristics. In this article we describe a novel method for evaluating DNA hybridisation probes, allowing the fine-tuning of biochips, that uses cassettes with multiple probes. Each cassette contains probes in equimolar proportions so that their hybridisation performance can be assessed in a single reaction. The model used to demonstrate this method was a series of probes developed to detect TORCH pathogens. DNA probes were designed for Toxoplasma gondii, Chlamidia trachomatis, Rubella, Cytomegalovirus, and Herpes virus and these were used to construct the DNA cassettes. Five cassettes were constructed to detect TORCH pathogens using a variety of genes coding for membrane proteins, viral matrix protein, an early expressed viral protein, viral DNA polymerase and the repetitive gene B1 of Toxoplasma gondii. All of these probes, except that for the B1 gene, exhibited similar profiles under the same hybridisation conditions. The failure of the B1 gene probe to hybridise was not due to a position effect, and this indicated that the probe was unsuitable for inclusion in the biochip. The redesigned probe for the B1 gene exhibited identical hybridisation properties to the other probes, suitable for inclusion in a biochip.	[Zinkevich, Vitaly; Alkhalil, Samia; Bogdarina, Irina] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England; [Sapojnikova, Nelly; Kartvelishvili, Tamar; Asatiani, Nino] I Javakhishvili Tbilisi State Univ, Andronikashvili Inst Phys, Tbilisi, Georgia; [Mitchell, Julian] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; [Al-Humam, Abdulmohsen A.] Saudi Aramcos Res & Dev Ctr, Dhahran, Saudi Arabia	University of Portsmouth; Ivane Javakhishvili Tbilisi State University; University of Portsmouth	Zinkevich, V (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England.	vitaly.zinkevich@port.ac.uk	Sapojnikova, Nelly/H-4340-2017	Sapojnikova, Nelly/0000-0001-6126-6185	International Science and Technology Center [G-1761p]	International Science and Technology Center	This work was supported by International Science and Technology Center (G-1761p) http://www.istc.ru/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; Arron ST, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/756905; Chandler Darrell P, 2012, Microarrays (Basel), V1, P107, DOI 10.3390/microarrays1030107; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Dugat-Bony E, 2012, ENVIRON MICROBIOL, V14, P356, DOI 10.1111/j.1462-2920.2011.02559.x; Fang XE, 2011, ANAL CHEM, V83, P690, DOI 10.1021/ac102858j; Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209; Hager J, 2006, METHOD ENZYMOL, V410, P135, DOI 10.1016/S0076-6879(06)10007-5; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Kamal SAA, 2013, J BIOL AGR HEALTHCAR, V3, P49; Kim MJ, 2011, BIOCHIP J, V5, P39, DOI 10.1007/s13206-011-5107-2; Kimura Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr041; Livshits MA, 1996, BIOPHYS J, V71, P2795, DOI 10.1016/S0006-3495(96)79473-0; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Safavieh M, 2014, ANALYST, V139, P482, DOI 10.1039/c3an01859h; Timofeev EN, 1996, NUCLEIC ACIDS RES, V24, P3142, DOI 10.1093/nar/24.16.3142; Yoon HK, 2010, BIOCHIP J, V4, P105, DOI 10.1007/s13206-010-4203-z; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08; Zhou WM, 2004, J CLIN MICROBIOL, V42, P5819, DOI 10.1128/JCM.42.12.5819-5824.2004	24	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e98596	10.1371/journal.pone.0098596	http://dx.doi.org/10.1371/journal.pone.0098596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897111	Green Published, Green Submitted, gold			2022-12-25	WOS:000338430700053
J	Genc, Y; Taylor, J; Rongala, J; Oldach, K				Genc, Yusuf; Taylor, Julian; Rongala, Jay; Oldach, Klaus			A Major Locus for Chloride Accumulation on Chromosome 5A in Bread Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; PHYSIOLOGICAL TRAITS; SALINITY TOLERANCE; NA+ TRANSPORT; SPRING WHEAT; BARLEY; GENOTYPES; SODIUM; RICE	Chloride (CL-) is an essential micronutrient for plant growth, but can be toxic at high concentrations resulting in reduced growth and yield. Although saline soils are generally dominated by both sodium (Na+ and Cl- ions, compared to Na+ toxicity very little is known about physiological and genetic control mechanisms of tolerance to Cl- toxicity. In hydroponics and field studies, a bread wheat mapping population was tested to examine the relationships between physiological traits [Na+, potassium (K+) and Cl- ucidate the genetic control mechanism of plantconcentration] involved in salinity tolerance (ST) and seedling growth or grain yield, and to Cl- accumulation differed entirely between hydroponics and field locations and few were detected in two or more environments, demonstrating substantial QTL-by-environment interactions. The presence of several QTL for Cl- concentration indicated that uptake and accumulation was a polygenic trait. A major Cl- concentration QTL (5A; barc56/gwm 7 86) was identified in three field environments, and accounted for 27-32% he total genetic variance. Alignment between the 5A QTL interval and its corresponding physical genome regions in wheat heat and other grasses has enabled the search for candidate genes involved in Cl- transport, which is discussed.	[Genc, Yusuf; Taylor, Julian; Oldach, Klaus] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Genc, Yusuf; Rongala, Jay; Oldach, Klaus] Plant Genom Ctr, South Australian Res & Dev Inst, Glen Osmond, SA, Australia	University of Adelaide; South Australian Research & Development Institute (SARDI)	Oldach, K (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Campus, Glen Osmond, SA, Australia.	klaus.oldach@sa.gov.au	Taylor, Julian/AAO-6302-2020	Taylor, Julian/0000-0002-9145-052X	Molecular Plant Breeding Cooperative Research Centre; South Australian Research and Development Institute; Grains Research and Development Corporation; University of Adelaide, Australia	Molecular Plant Breeding Cooperative Research Centre; South Australian Research and Development Institute; Grains Research and Development Corporation(Grains R&D Corp); University of Adelaide, Australia	This work was supported by the Molecular Plant Breeding Cooperative Research Centre, the South Australian Research and Development Institute, the Grains Research and Development Corporation and the University of Adelaide, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KG, 2001, J PLANT NUTR, V24, P1217, DOI 10.1081/PLN-100106977; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; Ashraf M, 1996, J AGRON CROP SCI, V176, P91, DOI 10.1111/j.1439-037X.1996.tb00451.x; ASHRAF M, 1988, J AGRON CROP SCI, V160, P14, DOI 10.1111/j.1439-037X.1988.tb01160.x; Bagci SA, 2007, TURK J AGRIC FOR, V31, P363; Bergmann W., 1992, NUTR DISORDERS PLANT; Bonneau J, 2013, THEOR APPL GENET, V126, P747, DOI 10.1007/s00122-012-2015-3; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; CHEESEMAN JM, 1982, J MEMBRANE BIOL, V70, P157, DOI 10.1007/BF01870225; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Cramer GR, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P205; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; EHRET DL, 1990, PLANT SOIL, V128, P143, DOI 10.1007/BF00011103; El-Hendawy SE, 2005, AUST J AGR RES, V56, P123, DOI 10.1071/AR04019; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Genc Y, 2010, PLANT SOIL, V327, P331, DOI 10.1007/s11104-009-0057-3; Genc Y, 2007, PLANT CELL ENVIRON, V30, P1486, DOI 10.1111/j.1365-3040.2007.01726.x; Hechenberger M, 1996, J BIOL CHEM, V271, P33632, DOI 10.1074/jbc.271.52.33632; Hollington PA, 2000, P NAT C SAL MAN AGR, P273; Horie T, 2011, PLANT PHYSIOL, V156, P1493, DOI 10.1104/pp.110.168047; Huang YZ, 2006, COMMUN SOIL SCI PLAN, V37, P557, DOI 10.1080/00103620500449419; Isla R, 1997, PLANT SOIL, V197, P105, DOI 10.1023/A:1004240622652; Khan MA, 2009, PAK J BOT, V41, P633; KINGSBURY RW, 1986, PLANT PHYSIOL, V80, P651, DOI 10.1104/pp.80.3.651; Kong XQ, 2011, PLANT MOL BIOL, V75, P567, DOI 10.1007/s11103-011-9744-6; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Lurin C, 1996, PLANT CELL, V8, P701, DOI 10.1105/tpc.8.4.701; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MART PK, 1995, BIOL PLANTARUM, V37, P265, DOI 10.1007/BF02913224; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; Mian A. A., 2011, PLANT STRESS, V5, P64; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; PANDIT A, 2010, MOL GENET GENOMICS, V284, P121, DOI DOI 10.1007/s00438-010-0551-6; Peng S, 2004, PHYSL BIOTECHNOLOGY, P72; Poustini K, 2004, FIELD CROP RES, V85, P125, DOI 10.1016/S0378-4290(03)00157-6; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAWSON HM, 1988, AUST J AGR RES, V39, P759, DOI 10.1071/AR9880759; Royo A, 1999, PLANT SOIL, V209, P9, DOI 10.1023/A:1004549927123; Salam A, 1999, J AGRON CROP SCI, V183, P145, DOI 10.1046/j.1439-037x.1999.00361.x; SCHACHTMAN DP, 1991, CROP SCI, V31, P992, DOI 10.2135/cropsci1991.0011183X003100040030x; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Tavakkoli E, 2010, FUNCT PLANT BIOL, V37, P621, DOI 10.1071/FP09202; Taylor JD, 2013, WGAIM WHOLE GENOME A; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Verbyla AP, 2007, THEOR APPL GENET, V116, P95, DOI 10.1007/s00122-007-0650-x; Verbyla AP, 2012, GENET RES, V94, P291, DOI 10.1017/S0016672312000493; Nguyen VL, 2013, MOL BREEDING, V31, P137, DOI 10.1007/s11032-012-9777-9; Wheal MS, 2011, ANAL METHODS-UK, V3, P2854, DOI 10.1039/c1ay05430a; Wheal MS, 2010, J ANAL ATOM SPECTROM, V25, P1946, DOI 10.1039/c0ja00059k; White PJ, 2001, ANN BOT-LONDON, V88, P967, DOI 10.1006/anbo.2001.1540; Wong TH, 2013, J PLANT PHYSIOL, V170, P101, DOI 10.1016/j.jplph.2012.08.003; Xu G., 2000, ADV AGRON, V68, P96	60	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98845	10.1371/journal.pone.0098845	http://dx.doi.org/10.1371/journal.pone.0098845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893005	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400102
J	Murad, AM; Molinari, HBC; Magalhaes, BS; Franco, AC; Takahashi, FSC; de Oliveira, NG; Franco, OL; Quirino, BF				Murad, Aline Melro; Correa Molinari, Hugo Bruno; Magalhaes, Beatriz Simas; Franco, Augusto Cesar; Caldeira Takahashi, Frederico Scherr; de Oliveira-Junior, Nelson Gomes; Franco, Octavio Luiz; Quirino, Betania Ferraz			Physiological and Proteomic Analyses of Saccharum spp. Grown under Salt Stress	PLOS ONE			English	Article							GERMIN-LIKE PROTEINS; HEAT-SHOCK PROTEINS; CHLOROPHYLL FLUORESCENCE; RESPONSIVE PROTEINS; OSMOTIC ADJUSTMENT; OXALATE OXIDASE; NACL STRESS; PLANT; SUGARCANE; TOLERANCE	Sugarcane (Saccharum spp.) is the world most productive sugar producing crop, making an understanding of its stress physiology key to increasing both sugar and ethanol production. To understand the behavior and salt tolerance mechanisms of sugarcane, two cultivars commonly used in Brazilian agriculture, RB867515 and RB855536, were submitted to salt stress for 48 days. Physiological parameters including net photosynthesis, water potential, dry root and shoot mass and malondialdehyde (MDA) content of leaves were determined. Control plants of the two cultivars showed similar values for most traits apart from higher root dry mass in RB867515. Both cultivars behaved similarly during salt stress, except for MDA levels for which there was a delay in the response for cultivar RB867515. Analysis of leaf macro-and micronutrients concentrations was performed and the concentration of Mn2+ increased on day 48 for both cultivars. In parallel, to observe the effects of salt stress on protein levels in leaves of the RB867515 cultivar, two-dimensional gel electrophoresis followed by MS analysis was performed. Four proteins were differentially expressed between control and salt-treated plants. Fructose 1,6-bisphosphate aldolase was down-regulated, a germin-like protein and glyceraldehyde 3-phosphate dehydrogenase showed increased expression levels under salt stress, and heat-shock protein 70 was expressed only in salt-treated plants. These proteins are involved in energy metabolism and defense-related responses and we suggest that they may be involved in protection mechanisms against salt stress in sugarcane.	[Murad, Aline Melro; Magalhaes, Beatriz Simas; Franco, Octavio Luiz; Quirino, Betania Ferraz] Univ Catolica Brasilia, Genome Sci & Biotechnol Program, Brasilia, DF, Brazil; [Murad, Aline Melro; de Oliveira-Junior, Nelson Gomes; Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil; [Correa Molinari, Hugo Bruno; Quirino, Betania Ferraz] Embrapa Agroenergy, Brasilia, DF, Brazil; [Franco, Augusto Cesar] Univ Brasilia, Dept Bot, Brasilia, DF, Brazil; [Caldeira Takahashi, Frederico Scherr] Univ Brasilia, Dept Ecol, Brasilia, DF, Brazil	Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Genome Sci & Biotechnol Program, Brasilia, DF, Brazil.	ocfranco@gmail.com; betania.quirino@embrapa.br	Quirino, Betania F/H-8835-2013; Franco, Octavio L/T-3020-2017; Franco, Augusto C/B-1615-2008; Oliveira-Júnior, Nelson/M-5794-2014	Franco, Augusto C/0000-0003-0869-5989; Oliveira-Júnior, Nelson/0000-0001-9437-6778; Franco, Octavio/0000-0001-9546-0525; Quirino, Betania/0000-0002-7578-6314	Conselho Nacional de PEsquisa e Desenvolvimento; Fundacao de Amparo a Pesquisa do Distrito Federal	Conselho Nacional de PEsquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Authors are also grateful to Conselho Nacional de PEsquisa e Desenvolvimento and Fundacao de Amparo a Pesquisa do Distrito Federal for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2004, PROTEOMICS, V4, P2072, DOI 10.1002/pmic.200300741; Aghaei K, 2008, J PROTEOME RES, V7, P4858, DOI 10.1021/pr800460y; Amorim JRAd, 2009, SALINIDADE AREAS IRR; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Borba MMZ, 2009, ESTUDO EC CICLO PROD; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheavegatti-Gianotto Adriana, 2011, Trop Plant Biol, V4, P62, DOI 10.1007/s12042-011-9068-3; Chopart J-L, 2009, INT S ROOT RES APPL, P1; Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Du CX, 2010, PHYTOCHEMISTRY, V71, P1450, DOI 10.1016/j.phytochem.2010.05.020; DUMAS B, 1993, CR ACAD SCI III-VIE, V316, P793; Esteves BS, 2008, OECOL BRAS, V4, P662, DOI DOI 10.4257/0EC0.2008.1204.06; EVANS H., 1936, EMPIRE JOUR EXP AGRIC, V4, P208; FAO, 2011, STAT WORLDS LAND WAT; [FAO] Food and Agriculture Organization of the United Nations, 2009, FAOSTAT; Gava GJD, 2011, REV BRAS ENG AGR AMB, V15, P250, DOI 10.1590/S1415-43662011000300005; Ghaffari A, 2014, J PLANT PHYSIOL, V171, P31, DOI 10.1016/j.jplph.2013.07.014; Ghassemi F., 1995, SALINISATION LAND WA; Grimplet J, 2009, PROTEOMICS, V9, P2503, DOI 10.1002/pmic.200800158; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; Hakeem KR, 2012, APPL BIOCHEM BIOTECH, V168, P2309, DOI 10.1007/s12010-012-9939-6; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HOFFMANN H.P., 2008, VARIEDADES RB CANA D; Jangpromma Nisachon, 2010, American Journal of Biochemistry and Biotechnology, V6, P89, DOI 10.3844/ajbbsp.2010.89.102; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kosova K, 2013, INT J MOL SCI, V14, P6757, DOI 10.3390/ijms14046757; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Laclau PB, 2009, FIELD CROP RES, V114, P351, DOI 10.1016/j.fcr.2009.09.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE BG, 1993, J BIOL CHEM, V268, P12239; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv DW, 2014, MOL CELL PROTEOMICS, V13, P632, DOI 10.1074/mcp.M113.030171; Miranda JR, 2008, HIST CANA DE ACUCAR; Molinari HBC, 2004, PLANT SCI, V167, P1375, DOI 10.1016/j.plantsci.2004.07.007; Moons A, 1997, PLANTA, V202, P443, DOI 10.1007/s004250050148; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Morris D. R., 2004, Journal - American Society of Sugar Cane Technologists, V24, P41; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ngamhui NO, 2012, PLANT OMICS, V5, P365; Nogueira ARA., 2005, MANUAL LAB SOLO AGUA; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pacheco CM, 2013, J PROTEOME RES, V12, P5681, DOI 10.1021/pr400654a; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Quirino BF, 2010, PHYTOCHEMISTRY, V71, P351, DOI 10.1016/j.phytochem.2009.11.005; Rodrigues FA, 2009, PLANT SCI, V176, P286, DOI 10.1016/j.plantsci.2008.11.007; Saciloto RFZ, 2003, FISIOLOGIA BIOQUIMIC, P74; Sahi C, 2006, PHYSIOL PLANTARUM, V127, P1, DOI 10.1111/j.1399-3054.2005.00610.x; Sairam RK, 2004, CURR SCI INDIA, V86, P407; Salekdeh GH, 2002, FIELD CROP RES, V76, P199, DOI 10.1016/S0378-4290(02)00040-0; Sarkar D., 2019, NLME LINEAR NONLINEA; SCHOLANDER PF, 1964, P NATL ACAD SCI USA, V52, P119, DOI 10.1073/pnas.52.1.119; Shao HB, 2007, COLLOID SURFACE B, V54, P143, DOI 10.1016/j.colsurfb.2006.09.004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Silva MD, 2008, SCI AGR, V65, P620, DOI 10.1590/S0103-90162008000600008; Smith DM, 2005, FIELD CROP RES, V92, P169, DOI 10.1016/j.fcr.2005.01.017; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Sobhanian H, 2010, J PROTEOME RES, V9, P2882, DOI 10.1021/pr900974k; Solari LI, 2006, TREE PHYSIOL, V26, P1333, DOI 10.1093/treephys/26.10.1333; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song Y, 2011, J PROTEOMICS, V74, P1045, DOI 10.1016/j.jprot.2011.03.009; Stepien P, 2006, BIOL PLANTARUM, V50, P610, DOI 10.1007/s10535-006-0096-z; Tada Y, 2009, PLANT CELL PHYSIOL, V50, P439, DOI 10.1093/pcp/pcp002; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Team RC, 2012, R LANG ENV STAT COMP; Thammasirirak, 2007, KMITL STJ, V7, P44; Thomson EW, 1980, J BIOL CHEM, V255, P5964; Tiroli AO, 2007, INT J BIOCHEM CELL B, V39, P818, DOI 10.1016/j.biocel.2007.01.014; Tiroli-Cepeda AO, 2010, PLANT PHYSIOL BIOCH, V48, P108, DOI 10.1016/j.plaphy.2010.01.001; Tuncturk M, 2008, AFR J BIOTECHNOL, V7, P1650; van den Berg M, 2000, AGR ECOSYST ENVIRON, V81, P43, DOI 10.1016/S0167-8809(00)00167-5; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yang F, 2009, PLANT SCI, V176, P669, DOI 10.1016/j.plantsci.2009.02.008; Zamboni A, 2008, J EXP BOT, V59, P4145, DOI 10.1093/jxb/ern256; Zhou G, 2011, PLANT MOL BIOL REP, DOI [10.1007/s11105-011-0343-0: 1-11, DOI 10.1007/S11105-011-0343-0:1-11]; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	87	29	30	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98463	10.1371/journal.pone.0098463	http://dx.doi.org/10.1371/journal.pone.0098463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24893295	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400054
J	Lee, YH; Su, SB; Huang, CC; Sheu, HM; Tsai, JC; Lin, CH; Wang, YJ; Wang, BJ				Lee, Yu-Hsuan; Su, Shih-Bin; Huang, Chien-Cheng; Sheu, Hamm-Ming; Tsai, Jui-Chen; Lin, Chia-Ho; Wang, Ying-Jan; Wang, Bour-Jr			N-Acetylcysteine Attenuates Hexavalent Chromium-Induced Hypersensitivity through Inhibition of Cell Death, ROS-Related Signaling and Cytokine Expression	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; ARSENIC TRIOXIDE; REDOX REGULATION; SKIN-DISEASE; CANCER-CELLS; FACTOR-ALPHA; TNF-ALPHA	Chromium hypersensitivity (chromium-induced allergic contact dermatitis) is an important issue in occupational skin disease. Hexavalent chromium (Cr(VI)) can activate the Akt, Nuclear factor kappa B (NF-kappa B), and Mitogen-activated protein kinase (MAPK) pathways and induce cell death, via the effects of reactive oxygen species (ROS). Recently, cell death stimuli have been proposed to regulate the release of inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1). However, the exact effects of ROS on the signaling molecules and cytotoxicity involved in Cr(VI)-induced hypersensitivity have not yet been fully demonstrated. N-acetylcysteine (NAC) could increase glutathione levels in the skin and act as an antioxidant. In this study, we investigated the effects of NAC on attenuating the Cr(VI)-triggered ROS signaling in both normal keratinocyte cells (HaCaT cells) and a guinea pig (GP) model. The results showed the induction of apoptosis, autophagy and ROS were observed after different concentrations of Cr(VI) treatment. HaCaT cells pretreated with NAC exhibited a decrease in apoptosis and autophagy, which could affect cell viability. In addition, Cr (VI) activated the Akt, NF-kappa B and MAPK pathways thereby increasing IL-1 alpha and TNF-alpha production. However, all of these stimulation phenomena could be inhibited by NAC in both of in vitro and in vivo studies. These novel findings indicate that NAC may prevent the development of chromium hypersensitivity by inhibiting of ROS-induced cell death and cytokine expression.	[Lee, Yu-Hsuan; Wang, Ying-Jan; Wang, Bour-Jr] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Occupat Med, Tainan, Taiwan; [Su, Shih-Bin] Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management, Tainan, Taiwan; [Su, Shih-Bin] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Chien-Cheng] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Huang, Chien-Cheng] Southern Taiwan Univ Sci & Technol, Dept Child Care & Educ, Tainan, Taiwan; [Sheu, Hamm-Ming] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Tsai, Jui-Chen] Natl Cheng Kung Univ, Inst Clin Pharm, Tainan 70101, Taiwan; [Lin, Chia-Ho] Chi Mei Med Ctr, Dept Surg, Div Urol, Liouying, Taiwan; [Lin, Chia-Ho] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Ying-Jan] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wang, Bour-Jr] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci & Inst Cosmet Sci, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Asia University Taiwan; Chia Nan University of Pharmacy & Science	Wang, YJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	yjwang@mail.ncku.edu.tw; pochih.wang@msa.hinet.net	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573	Chi Mei Medical Center, Tainan, Taiwan [CMNCKU10110]; National Science Council, Taiwan [NSC-102-2314-B006-034]	Chi Mei Medical Center, Tainan, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Chi Mei Medical Center, Tainan, Taiwan (CMNCKU10110) and the National Science Council, Taiwan (NSC-102-2314-B006-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bonnet MC, 2013, EUR J DERMATOL; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cheng Y, 2009, FEBS J, V276, P1291, DOI 10.1111/j.1742-4658.2008.06864.x; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Faurschou A, 2008, EXP DERMATOL, V17, P992, DOI 10.1111/j.1600-0625.2008.00740.x; Freitas M, 2010, J BIOL INORG CHEM, V15, P1275, DOI 10.1007/s00775-010-0685-3; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; Harris J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00083; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Pena-Sanoja MJ, 2013, INVEST CLIN, V54, P325; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kanzawa T, 2003, CANCER RES, V63, P2103; Khan MI, 2012, BIOMATERIALS, V33, P1477, DOI 10.1016/j.biomaterials.2011.10.080; Khatami A, 2013, INT J DERMATOL, V52, P1513, DOI 10.1111/j.1365-4632.2012.05623.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; LOPEZTORRES M, 1994, J INVEST DERMATOL, V102, P476, DOI 10.1111/1523-1747.ep12373032; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Luczak MW, 2013, FREE RADICAL BIO MED, V65, P262, DOI 10.1016/j.freeradbiomed.2013.06.028; Martin BD, 1998, CHEM RES TOXICOL, V11, P1402, DOI 10.1021/tx9801559; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McCall MR, 1999, FREE RADICAL BIO MED, V26, P1034, DOI 10.1016/S0891-5849(98)00302-5; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Paglin S, 2001, CANCER RES, V61, P439; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Polak L, 1983, CHROMIUM METABOLISM; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Robert LR, 2001, FISHERS CONTACT DERM; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shelnutt SR, 2007, CRIT REV TOXICOL, V37, P375, DOI 10.1080/10408440701266582; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; VANHOOGSTRATEN IMW, 1992, INT ARCH ALLERGY IMM, V97, P258, DOI 10.1159/000236131; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wang BJ, 2010, TOXICOL LETT, V198, P216, DOI 10.1016/j.toxlet.2010.06.024; Wang BJ, 2010, EXP DERMATOL, V19, pE191, DOI 10.1111/j.1600-0625.2009.01045.x; Winyard P G, 1997, Adv Pharmacol, V38, P403; Xie Y, 2014, CELL PHYSIOL BIOCHEM, V33, P705, DOI 10.1159/000358646; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	58	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2014	9	9							e108317	10.1371/journal.pone.0108317	http://dx.doi.org/10.1371/journal.pone.0108317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP8TL	25248126	Green Published, Green Submitted, gold			2022-12-25	WOS:000342351800081
J	Lee, YC; Lin, CH; Wu, RM; Lin, JW; Chang, CH; Lai, MS				Lee, Yen-Chieh; Lin, Chin-Hsien; Wu, Ruey-Meei; Lin, Jou-Wei; Chang, Chia-Hsuin; Lai, Mei-Shu			Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME; OXIDATIVE STRESS; BLOOD-PRESSURE; MPTP MODEL; HYPERTENSION; DEGENERATION; ASSOCIATION; INHIBITION; MANAGEMENT	Background and Purpose: Hypertension has been associated with Parkinson's disease (PD), but data on antihypertensive drugs and PD are inconclusive. We aim to evaluate antihypertensive drugs for an association with PD in hypertensive patients. Methods: Hypertensive patients who were free of PD, dementia and stroke were recruited from 2005-2006 using Taiwan National Health Insurance Database. We examined the association between the use of calcium channel blockers (CCBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs) and the incidence of PD using betablockers as the reference. Cox regression model with time-varying medication use was applied. Results: Among 65,001 hypertensive patients with a mean follow-up period of 4.6 years, use of dihydropyridine CCBs, but not non-dihydropyridine CCBs, was associated with a reduced risk of PD (adjusted hazard ratio [aHR] = 0.71; 95% CI, 0.570.90). Additionally, use of central-acting CCBs, rather than peripheral-acting ones, was associated with a decreased risk of PD (aHR =.69 [55-0.87]. Further decreased association was observed for higher cumulative doses of felodipine (aHR = 0.54 [0.36-0.80]) and amlodipine (aHR = 0.60 [0.45-0.79]). There was no association between the use of ACEIs (aHR = 0.80 [0.641.00]) or ARBs (aHR = 0.86 [0.69-1.08]) with PD. A potentially decreased association was only found for higher cumulative use of ACEIs (HR = 0.52 [0.34-0.80]) and ARBs (HR = 0.52 [0.33-0.80]). Conclusions: Our study suggests centrally-acting dihydropyridine CCB use and high cumulative doses of ACEIs and ARBs may associate with a decreased incidence of PD in hypertensive patients. Further long-term follow-up studies are needed to confirm the potential beneficial effects of antihypertensive agents in PD.	[Lee, Yen-Chieh] Cathay Gen Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Chin-Hsien; Wu, Ruey-Meei] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Jou-Wei; Chang, Chia-Hsuin] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin County, Taiwan; [Chang, Chia-Hsuin; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan	Cathay General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, JW (corresponding author), Natl Taiwan Univ, Coll Med, Dept Med, Taipei 10764, Taiwan.	jouweilin@yahoo.com; chiahsuin123@yahoo.com.tw	Lee, Yu-Hsuan/AAT-3856-2021	Lee, Yu-Hsuan/0000-0001-7660-3770; Lai, Mei-shu/0000-0001-6130-3468; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Beveridge, Ross/0000-0001-6489-6676; Wu, Ruey-Meei/0000-0002-4947-5467; Lin, Chin-Hsien/0000-0001-8566-7573				Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Driver JA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d198; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Grammatopoulos TN, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-1; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Louis ED, 2009, NEUROEPIDEMIOLOGY, V33, P286, DOI 10.1159/000235641; Marras C, 2012, ANN NEUROL, V71, P362, DOI 10.1002/ana.22616; Munoz A, 2006, NEUROPHARMACOLOGY, V51, P112, DOI 10.1016/j.neuropharm.2006.03.004; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Pasternak B, 2012, AM J EPIDEMIOL, V175, P627, DOI 10.1093/aje/kwr362; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Reardon KA, 2000, AUST NZ J MED, V30, P48, DOI 10.1111/j.1445-5994.2000.tb01054.x; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Schernhammer E, 2011, DIABETES CARE, V34, P1102, DOI 10.2337/dc10-1333; Simon KC, 2010, MOVEMENT DISORD, V25, P1818, DOI 10.1002/mds.23191; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Ton TGN, 2007, PARKINSONISM RELAT D, V13, P165, DOI 10.1016/j.parkreldis.2006.08.011; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wahner AD, 2008, NEUROLOGY, V70, P1418, DOI 10.1212/01.wnl.0000286942.14552.51; Wright JW, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/860923	29	135	139	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2014	9	6							e98961	10.1371/journal.pone.0098961	http://dx.doi.org/10.1371/journal.pone.0098961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI8LF	25248126	Green Submitted, Green Published, gold			2022-12-25	WOS:000337165600029
J	Luo, Y; He, FL; Hu, L; Hai, L; Huang, MF; Xu, ZP; Zhang, JJ; Zhou, ZG; Liu, F; Dai, YS				Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan			Transcription Factor Ets1 Regulates Expression of Thioredoxin-Interacting Protein and Inhibits Insulin Secretion in Pancreatic beta-Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; OXIDATIVE STRESS; GLUCOSE; INFLAMMASOME; ACTIVATION; KINASE; TXNIP; LINK; PHOSPHORYLATION	Long-term activation of extracellular-regulated kinase (ERK1/2) pathway has been shown to cause glucotoxicity and inhibit insulin gene expression in beta-cells. Transcription factor Ets1 is activated by ERK1/2-mediated phosphorylation at the Thr38 residue. We hypothesize that Ets1 plays an important role in mediating ERK1/2 induced glucotoxicity in beta-cells. We determined the role of Ets1 in Min6 cells and isolated mouse islets using overexpression and siRNA mediated knockdown of Ets1. The results show that Ets1 was localized in insulin-staining positive cells but not in glucagon-staining positive cells. Overexpression of Ets1 reduced glucose-stimulated insulin secretion in primary mouse islets. Overexpression of Ets1 in Min6 beta-cells and mouse islets increased expression of thioredoxin-interacting protein (TXNIP). Conversely, knockdown of Ets1 by siRNA reduced expression of TXNIP in Min6 cells. Ets1 was associated with the txnip promoter in min6 cells and transfection of 293 cells with Ets1 and p300 synergistically increased txnip promoter reporter activity. Moreover, overexpression of Ets1 inhibited Min6 cell proliferation. Our results suggest that Ets1, by promoting TXNIP expression, negatively regulates beta-cell function. Thus, over-activation of Ets1 may contribute to diet-induced beta-cell dysfunction.	[Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan] Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	Central South University; University of Texas System; University of Texas Health San Antonio	Dai, YS (corresponding author), Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China.	ydai88@csu.edu.cn	Hai, Luo/ABE-5483-2020; Dai, Yanshan/B-8577-2009; Chen, Huai/AAI-1024-2020; Chen, Huai/A-7418-2015; Zhang, Yao/P-2009-2015	Chen, Huai/0000-0001-7650-289X; Zhou, Zhiguang/0000-0002-0374-1838; Dai, Yanshan/0000-0001-5048-7417; Yang, Yanzheng/0000-0002-3299-0403; Chen, Huai/0000-0001-6208-1481; Zhang, Yao/0000-0002-7468-2409	Natural Science Foundation of China [81270905, 81130015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China grant no. 81270905 (Y.-S. Dai) and 81130015 (F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2011, HUM MOL GENET, V20, P165, DOI 10.1093/hmg/ddq455; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2014, MOL ENDOCRINOL, V28, P674, DOI 10.1210/me.2014-1041; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Choy WW, 2014, ACTA CRYSTALLOGR F, V70, P44, DOI 10.1107/S2053230X13024795; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fang SH, 2011, MOL CELL BIOCHEM, V347, P175, DOI 10.1007/s11010-010-0626-z; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Hamzaoui H, 2007, MOL CELL ENDOCRINOL, V268, P75, DOI 10.1016/j.mce.2007.01.014; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Hashiguchi K, 2010, BIOCHEM BIOPH RES CO, V391, P621, DOI 10.1016/j.bbrc.2009.11.109; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Jin CC, 2010, IMMUNOL CELL BIOL, V88, P510, DOI 10.1038/icb.2010.56; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kibbe C, 2013, J BIOL CHEM, V288, P23194, DOI 10.1074/jbc.M113.473082; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lombardi A, 2012, DIABETOLOGIA, V55, P141, DOI 10.1007/s00125-011-2315-1; Luo Y, 2013, DIABETES, V62, pA582; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Sarkar A, 2011, FASEB J, V25, P2592, DOI 10.1096/fj.10-173757; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhang XF, 2014, ENDOCRINE, V46, P470, DOI 10.1007/s12020-013-0114-9; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	47	30	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99049	10.1371/journal.pone.0099049	http://dx.doi.org/10.1371/journal.pone.0099049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897113	Green Submitted, gold, Green Published			2022-12-25	WOS:000338430700109
